Citrus Sinensis ID: 035861

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330--
Protein Sequence
MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK
Secondary Structure (PSIPRED)
ccccccccccccHHccccccccccEEEEEEEEcccccEEEEEEEEcccccccccccccccHHHHHHHHHHHHccccccEEEEEEEEcccccEEEEEccHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEccccccccccccccccccccEEEEccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEcccccccccHcccccHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEEHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHcccccccccccccccHHHHcccccHHHHHHHHHHHHHHHHHHccccccccccHHHHcccHHHccccccccccccccccccHHccc
Coil and Loop (DISEMBL)
mnmlqgcrsvfefeklnkisegtyGIVYRARDKKSGEIVALKKVKmnvgrkedcleygfpissLREINIllsfdhpsivnvkevvmddhdSVYMVMEYMEHDLKWLMEsmkqpfstsEVKCLMLQLLEGVKYlhdnwvlhrdlktsnlllnnqgvlkicdfgmsrqygsplkpytsLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELlakkplfsgtteVDQIDKIFKtlgtptetiwpglselpgakanfakqpynllrkrfpaasftgspvlsesGFDLLNRlltydpekritvddalnhywfhevplpkskdfmptfppqharnk
Flexible Loop (DISEMBL)
MNMLQGCRSVFEfeklnkisegtygivyrardkksgeivalkkvkmnvgrkedCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEvplpkskdfmptfppqharnk
Low Complexity Region (SEG)
MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK
Disordered region (IsUnstruct)
*****GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL******************
Disordered Region (DISOPRED)
*******RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD*************
Disordered Region (DISEMBL)
MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPT*********
Disordered Region (DISPRO)
*****GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC*EYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFP*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	332	2.2.26 [Sep-21-2011]
Q7XUF4	710	Cyclin-dependent kinase G	yes	no	0.960	0.449	0.788	1e-155
A2XUW1	710	Cyclin-dependent kinase G	N/A	no	0.960	0.449	0.788	1e-155
Q6K5F8	693	Cyclin-dependent kinase G	no	no	0.981	0.470	0.741	1e-149
A2X6X1	693	Cyclin-dependent kinase G	N/A	no	0.981	0.470	0.741	1e-149
P21127	795	Cyclin-dependent kinase 1	yes	no	0.951	0.397	0.613	1e-117
Q9UQ88	783	Cyclin-dependent kinase 1	yes	no	0.951	0.403	0.610	1e-116
P24788	784	Cyclin-dependent kinase 1	yes	no	0.951	0.403	0.607	1e-116
P46892	436	Cyclin-dependent kinase 1	no	no	0.930	0.708	0.614	1e-113
Q9VPC0	952	Serine/threonine-protein	yes	no	0.930	0.324	0.557	1e-103
Q3UMM4	360	Cyclin-dependent kinase 1	no	no	0.942	0.869	0.564	1e-98

>sp|Q7XUF4|CDKG2_ORYSJ Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. japonica GN=CDKG-2 PE=2 SV=2

 Score =  547 bits (1409), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 257/326 (78%), Positives = 289/326 (88%), Gaps = 7/326 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI+EGTYG+VYRARDKK+GEIVALKKVKM   R+      GFP
Sbjct: 353 INMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFP 406

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK +ME+MKQP+S SEV
Sbjct: 407 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEV 466

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG+SRQYGSPLKPYT LVV
Sbjct: 467 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVV 526

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLG K+YSTA+DMWSVGCIMAELLAK+PLF+G TE +Q+DKIF+TLGTP E
Sbjct: 527 TLWYRAPELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKIFRTLGTPNE 586

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            IWPG ++LPG K NF KQPYN LR +FPAASF+G P+LSE+GFDLLN LLTYDPEKR++
Sbjct: 587 KIWPGYAKLPGVKVNFVKQPYNRLRDKFPAASFSGRPILSEAGFDLLNNLLTYDPEKRLS 646

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFP 325
            D AL H WF EVPLPKSKDFMPTFP
Sbjct: 647 ADAALQHEWFREVPLPKSKDFMPTFP 672

Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|A2XUW1|CDKG2_ORYSI Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. indica GN=CDKG-2 PE=2 SV=1

 Score =  547 bits (1409), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 257/326 (78%), Positives = 289/326 (88%), Gaps = 7/326 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI+EGTYG+VYRARDKK+GEIVALKKVKM   R+      GFP
Sbjct: 353 INMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFP 406

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK +ME+MKQP+S SEV
Sbjct: 407 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEV 466

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG+SRQYGSPLKPYT LVV
Sbjct: 467 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVV 526

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLG K+YSTA+DMWSVGCIMAELLAK+PLF+G TE +Q+DKIF+TLGTP E
Sbjct: 527 TLWYRAPELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKIFRTLGTPNE 586

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            IWPG ++LPG K NF KQPYN LR +FPAASF+G P+LSE+GFDLLN LLTYDPEKR++
Sbjct: 587 KIWPGYAKLPGVKVNFVKQPYNRLRDKFPAASFSGRPILSEAGFDLLNNLLTYDPEKRLS 646

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFP 325
            D AL H WF EVPLPKSKDFMPTFP
Sbjct: 647 ADAALQHEWFREVPLPKSKDFMPTFP 672

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q6K5F8|CDKG1_ORYSJ Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. japonica GN=CDKG-1 PE=2 SV=1

 Score =  527 bits (1358), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 247/333 (74%), Positives = 288/333 (86%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LN I+EGTYG+V+R RDK++GEIVALKKVKM   R+      GFP
Sbjct: 337 INMLQGCRSVDEFERLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKERE------GFP 390

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLRE+NILLSF HPSIV VKEVV+  +D  ++MVMEYMEHDLK +ME+MKQP+S SEV
Sbjct: 391 LTSLREMNILLSFHHPSIVEVKEVVVGSNDRDIFMVMEYMEHDLKGVMETMKQPYSQSEV 450

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG+SRQYGSPLKPYT LVV
Sbjct: 451 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVV 510

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK YSTA+DMWS+GCIM ELL+K PLF+G +E+DQ+DKIF+TLGTP E
Sbjct: 511 TLWYRAPELLLGAKDYSTAIDMWSLGCIMGELLSKGPLFNGKSEIDQLDKIFRTLGTPDE 570

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            IWPG S+LPGA   F KQ +N LR +F A SFTG P+LSE+GFDLLNRLLTYDPEKRI+
Sbjct: 571 NIWPGYSKLPGATVKFGKQTHNRLRDKFRAVSFTGGPMLSEAGFDLLNRLLTYDPEKRIS 630

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            +DALNH WF E+PLP+SKDFMPTFP  + +++
Sbjct: 631 AEDALNHEWFRELPLPRSKDFMPTFPALNEQDR 663

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|A2X6X1|CDKG1_ORYSI Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. indica GN=CDKG-1 PE=2 SV=1

 Score =  527 bits (1357), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 247/333 (74%), Positives = 288/333 (86%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LN I+EGTYG+V+R RDK++GEIVALKKVKM   R+      GFP
Sbjct: 337 INMLQGCRSVDEFERLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKERE------GFP 390

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLRE+NILLSF HPSIV VKEVV+  +D  ++MVMEYMEHDLK +ME+MKQP+S SEV
Sbjct: 391 LTSLREMNILLSFHHPSIVEVKEVVVGSNDRDIFMVMEYMEHDLKGVMETMKQPYSQSEV 450

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG+SRQYGSPLKPYT LVV
Sbjct: 451 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVV 510

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK YSTA+DMWS+GCIM ELL+K PLF+G +E+DQ+DKIF+TLGTP E
Sbjct: 511 TLWYRAPELLLGAKDYSTAIDMWSLGCIMGELLSKGPLFNGKSEIDQLDKIFRTLGTPDE 570

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            IWPG S+LPGA   F KQ +N LR +F A SFTG P+LSE+GFDLLNRLLTYDPEKRI+
Sbjct: 571 NIWPGYSKLPGATVKFGKQTHNRLRDKFRAVSFTGGPMLSEAGFDLLNRLLTYDPEKRIS 630

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            +DALNH WF E+PLP+SKDFMPTFP  + +++
Sbjct: 631 AEDALNHEWFRELPLPRSKDFMPTFPALNEQDR 663

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3

 Score =  423 bits (1087), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 203/331 (61%), Positives = 255/331 (77%), Gaps = 15/331 (4%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM   ++      GFPI+S
Sbjct: 429 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE------GFPITS 482

Query: 64  LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct: 483 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 542

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct: 543 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 602

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct: 603 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 662

Query: 243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct: 663 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 715

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           D L H +F E PLP      PT+P +  + +
Sbjct: 716 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 746

Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q9UQ88|CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4

 Score =  419 bits (1076), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 202/331 (61%), Positives = 254/331 (76%), Gaps = 15/331 (4%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM   ++      GFPI+S
Sbjct: 417 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE------GFPITS 470

Query: 64  LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct: 471 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 530

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVT W
Sbjct: 531 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTQW 590

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct: 591 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGNSEIDQINKVFKELGTPSEKIW 650

Query: 243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct: 651 PGYSELPVVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 703

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           D L H +F E PLP      PT+P +  + +
Sbjct: 704 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 734

Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P24788|CD11B_MOUSE Cyclin-dependent kinase 11B OS=Mus musculus GN=Cdk11b PE=1 SV=2

 Score =  417 bits (1073), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 201/331 (60%), Positives = 254/331 (76%), Gaps = 15/331 (4%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM   ++      GFPI+S
Sbjct: 418 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE------GFPITS 471

Query: 64  LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct: 472 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 531

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct: 532 MIQLLSGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 591

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +++DQI+KIFK LGTP+E IW
Sbjct: 592 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSDIDQINKIFKDLGTPSEKIW 651

Query: 243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           PG ++LP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI  +
Sbjct: 652 PGYNDLPAVKKMTFSEYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYYPGRRINAE 704

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           D L H +F E PLP      PT+P +  + +
Sbjct: 705 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 735

Acts as a negative regulator of the normal cell cycle progression. In vitro, this protein kinase has been shown to phosphorylate a number of substrates, including histone h1, casein, and galactosyltransferase. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P46892|CD11B_RAT Cyclin-dependent kinase 11B OS=Rattus norvegicus GN=Cdk11b PE=2 SV=1

 Score =  410 bits (1053), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 199/324 (61%), Positives = 249/324 (76%), Gaps = 15/324 (4%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM   ++      GFP++S
Sbjct: 70  LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE------GFPLTS 123

Query: 64  LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           +REIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct: 124 IREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 183

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           M+QLL GVK+LHDNW+LHRDLKTSNLLL + G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct: 184 MIQLLSGVKHLHDNWILHRDLKTSNLLLTHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 243

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLGAK+YSTA DMWSVGCI  ELL +KPLF G +++DQI+KIFK +GTP+E IW
Sbjct: 244 YRAPELLLGAKEYSTACDMWSVGCIFGELLTQKPLFPGKSDIDQINKIFKDIGTPSEKIW 303

Query: 243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI  +
Sbjct: 304 PGYSELPAVKKMTFSELPYNNLRKRFGA-------LLSDQGFDLMNKFLTYYPGRRINAE 356

Query: 302 DALNHYWFHEVPLPKSKDFMPTFP 325
           D L H +F E PLP      PT+P
Sbjct: 357 DGLKHEYFRETPLPIDPSMFPTWP 380

Acts as a negative regulator of the normal cell cycle progression. In vitro, this protein kinase has been shown to phosphorylate a number of substrates, including histone h1, casein, and galactosyltransferase. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q9VPC0|KP58_DROME Serine/threonine-protein kinase PITSLRE OS=Drosophila melanogaster GN=Pitslre PE=1 SV=1

 Score =  374 bits (961), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 185/332 (55%), Positives = 240/332 (72%), Gaps = 23/332 (6%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           +QGCRSV EF+ LN+I EGTYG+VYRA+DK++ EIVALK++KM   ++      GFPI+S
Sbjct: 549 VQGCRSVEEFQCLNRIEEGTYGVVYRAKDKRTNEIVALKRLKMEKEKE------GFPITS 602

Query: 64  LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMK---QPFSTSEV 119
           LREIN LL   HP+IV V+E+V+  + D +++VM+Y+EHDLK LME+MK   Q F   EV
Sbjct: 603 LREINTLLKGQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKNRKQSFFPGEV 662

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCL  QLL  V +LHDNW+LHRDLKTSNLLL+++G+LK+ DFG++R+YGSP+K YTSLVV
Sbjct: 663 KCLTQQLLRAVAHLHDNWILHRDLKTSNLLLSHKGILKVGDFGLAREYGSPIKKYTSLVV 722

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLL +  YST +D+WSVGCI AE L   PLF G +E+D++++IFK LGTP E
Sbjct: 723 TLWYRAPELLLCSPVYSTPIDVWSVGCIFAEFLQMLPLFPGKSEIDELNRIFKELGTPNE 782

Query: 240 TIWPGLSELPGAK------ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
            IWPG +ELP  K      + F + P + LRK F   +       SE G  LL  LLTYD
Sbjct: 783 KIWPGYTELPAVKNMLSQNSQFTEYPVSQLRKHFQEKT-------SEMGLSLLQGLLTYD 835

Query: 294 PEKRITVDDALNHYWFHEVPLPKSKDFMPTFP 325
           P++R++ D AL H +F E+PLP      PT+P
Sbjct: 836 PKQRLSADAALKHGFFKELPLPIDPSMFPTWP 867

Acts as a negative regulator of the normal cell cycle progression. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus GN=Cdk10 PE=2 SV=1

 Score =  359 bits (922), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 187/331 (56%), Positives = 240/331 (72%), Gaps = 18/331 (5%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           L  CRSV EFEKLN+I EGTYGIVYRARD ++ EIVALKKV+M+  +++D    G PISS
Sbjct: 30  LGRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMD--KEKD----GIPISS 83

Query: 64  LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           LREI +LL   HP+IV +KEVV+ +H +S+++VM Y E DL  L+E+M  PFS ++VKC+
Sbjct: 84  LREITLLLRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCI 143

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           MLQ+L G++YLH N+++HRDLK SNLL+ ++G +K  DFG++R YG P+KP T  VVTLW
Sbjct: 144 MLQVLRGLQYLHRNFIIHRDLKVSNLLMTDKGCVKTADFGLARAYGVPVKPMTPKVVTLW 203

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLG    +T++DMW+VGCI+AELLA KPL  GT+E+ QID I + LGTP+E IW
Sbjct: 204 YRAPELLLGTTTQTTSIDMWAVGCILAELLAHKPLLPGTSEIHQIDLIVQLLGTPSENIW 263

Query: 243 PGLSELP-GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           PG S+LP   + +  KQPYN L+ +FP         LSE+G  LLN L  YDP+KR T  
Sbjct: 264 PGFSKLPLAGQYSLRKQPYNNLKHKFPW--------LSEAGLRLLNFLFMYDPKKRATSG 315

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           D L   +F E PLP   + MPTFP  H RNK
Sbjct: 316 DCLESSYFKEKPLPCEPELMPTFP--HHRNK 344

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	332
224119614	330	predicted protein [Populus trichocarpa]	0.993	1.0	0.836	1e-165
224133884	330	predicted protein [Populus trichocarpa]	0.993	1.0	0.818	1e-161
359473713	754	PREDICTED: cyclin-dependent kinase G-2-l	0.981	0.432	0.798	1e-159
224110752	746	predicted protein [Populus trichocarpa]	0.981	0.436	0.801	1e-158
449435041	752	PREDICTED: cyclin-dependent kinase G-2-l	0.981	0.433	0.789	1e-158
255547862	754	cdk10/11, putative [Ricinus communis] gi	0.981	0.432	0.792	1e-156
297841455	756	kinase family protein [Arabidopsis lyrat	0.981	0.431	0.783	1e-155
17064846	752	putative protein kinase [Arabidopsis tha	0.981	0.433	0.780	1e-155
15220477	752	protein kinase-like protein [Arabidopsis	0.981	0.433	0.780	1e-155
115459094	710	Os04g0488000 [Oryza sativa Japonica Grou	0.960	0.449	0.788	1e-153

>gi|224119614|ref|XP_002318117.1| predicted protein [Populus trichocarpa] gi|222858790|gb|EEE96337.1| predicted protein [Populus trichocarpa]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 276/330 (83%), Positives = 306/330 (92%)

Query: 3   MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
           ML+GCRSVFE+E+LN+I+EGTYG VY+ARDKK+GE VALKKVKMNVGR +   EYGFP++
Sbjct: 1   MLEGCRSVFEYERLNEINEGTYGKVYKARDKKTGEFVALKKVKMNVGRDKYLEEYGFPLT 60

Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           SLREINIL+SFDHPSIV VKEVVM D DSV+MVMEYMEHDLK LM++MKQPFSTSEVKCL
Sbjct: 61  SLREINILMSFDHPSIVRVKEVVMGDLDSVFMVMEYMEHDLKGLMQAMKQPFSTSEVKCL 120

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           MLQLLEGVKYLHDNWVLHRDLKTSNLL NNQG LK+CDFGMSRQYGSPLKPYTSLVVTLW
Sbjct: 121 MLQLLEGVKYLHDNWVLHRDLKTSNLLFNNQGELKVCDFGMSRQYGSPLKPYTSLVVTLW 180

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLGAKKYSTAVDMWSVGCIMAE+L K+PLF+G  E+DQ+DKIFKTLGTP ETIW
Sbjct: 181 YRAPELLLGAKKYSTAVDMWSVGCIMAEMLTKEPLFTGKGEIDQLDKIFKTLGTPNETIW 240

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           PGLS+LPGAKANF +QPYN LRK+FP   FTGSPVLS+SGFDLLNRLLTYDP+KRIT DD
Sbjct: 241 PGLSKLPGAKANFVQQPYNQLRKKFPFTPFTGSPVLSDSGFDLLNRLLTYDPDKRITADD 300

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           ALNH WF+EVPL KSK+FMPTFPPQ+A+N+
Sbjct: 301 ALNHPWFNEVPLSKSKEFMPTFPPQYAKNR 330

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133884|ref|XP_002321684.1| predicted protein [Populus trichocarpa] gi|222868680|gb|EEF05811.1| predicted protein [Populus trichocarpa]

 Score =  575 bits (1481), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 270/330 (81%), Positives = 302/330 (91%)

Query: 3   MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
           ML+GCRSVF++E+LN+I+EGTYG VY+ARDKK+GE VALKKVKM+VGR     EYGFP++
Sbjct: 1   MLEGCRSVFKYERLNEINEGTYGKVYKARDKKTGEFVALKKVKMDVGRDRYLEEYGFPLT 60

Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
           SLREINIL+SFDHPSIV VKEVVM D DSV+MVMEYMEHDLK + ++MKQPFSTSEVKCL
Sbjct: 61  SLREINILMSFDHPSIVKVKEVVMGDLDSVFMVMEYMEHDLKGVTQAMKQPFSTSEVKCL 120

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           MLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LK+CDFGMSRQY SPLKPYTSLVVTLW
Sbjct: 121 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNKGELKVCDFGMSRQYSSPLKPYTSLVVTLW 180

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPELLLGAK+YSTAVDMWSVGCIMAE+L K+PLF+G  E+DQ+DKIFKTLGTP ET W
Sbjct: 181 YRAPELLLGAKQYSTAVDMWSVGCIMAEMLTKEPLFTGKGEIDQLDKIFKTLGTPNETTW 240

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           PGLS+LPGAKANF KQPYN LRK+FP   FTGSPVLS+SGFDLLN+LLTYDPEKRIT DD
Sbjct: 241 PGLSKLPGAKANFVKQPYNQLRKKFPFTPFTGSPVLSDSGFDLLNKLLTYDPEKRITADD 300

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           ALNH WFHEVPLPKSK+ MPTFPPQ+A+ +
Sbjct: 301 ALNHPWFHEVPLPKSKESMPTFPPQYAKKR 330

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473713|ref|XP_002266306.2| PREDICTED: cyclin-dependent kinase G-2-like [Vitis vinifera]

 Score =  568 bits (1463), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 266/333 (79%), Positives = 301/333 (90%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI EGTYG+VYRA+DKK+GEIVALKKVKM   R+      GFP
Sbjct: 396 VNMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKERE------GFP 449

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+  + DS++MVMEYMEHDLK LME+MKQPFS SEV
Sbjct: 450 LTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEV 509

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEG+KYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct: 510 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 569

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL+K+PLF+G TE+DQIDKIF+TLGTP+E
Sbjct: 570 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLSKEPLFNGKTELDQIDKIFRTLGTPSE 629

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           TIWPG S+LPG K NF K  YNLLRK+FPA SFTGSPVLS+SGFDLLN+LLTYDPEKRIT
Sbjct: 630 TIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRIT 689

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            + ALNH WF EVPLPKSKDFMPTFP QHA+++
Sbjct: 690 AEAALNHDWFREVPLPKSKDFMPTFPAQHAQDR 722

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110752|ref|XP_002315624.1| predicted protein [Populus trichocarpa] gi|222864664|gb|EEF01795.1| predicted protein [Populus trichocarpa]

 Score =  563 bits (1452), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 267/333 (80%), Positives = 298/333 (89%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI EGTYG+VYRARDKK+GEIVALKKVKM   R+      GFP
Sbjct: 388 INMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFP 441

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+  + DS++MVMEYMEHDLK LMESM+QPFS SEV
Sbjct: 442 LTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMESMRQPFSQSEV 501

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEG KYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct: 502 KCLMLQLLEGTKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 561

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL+K PLF+G TEVDQ+DKIF+ LGTP E
Sbjct: 562 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLSKDPLFNGKTEVDQLDKIFRILGTPNE 621

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           TIWPG S+LPG K NF KQ YNLLRK+FPA SFTGSPVLS+SGFDLLN+LLTYDPEKRIT
Sbjct: 622 TIWPGFSKLPGVKVNFVKQQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRIT 681

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            + ALNH WF EVPLPKSKDFMPTFP QHA+++
Sbjct: 682 AEAALNHDWFREVPLPKSKDFMPTFPAQHAQDR 714

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449435041|ref|XP_004135304.1| PREDICTED: cyclin-dependent kinase G-2-like [Cucumis sativus] gi|449494879|ref|XP_004159672.1| PREDICTED: cyclin-dependent kinase G-2-like [Cucumis sativus]

 Score =  562 bits (1448), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 263/333 (78%), Positives = 297/333 (89%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI EGTYG+VYRARDKKSGE+VALKKVKM   R+      GFP
Sbjct: 394 VNMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKSGEVVALKKVKMEKERE------GFP 447

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK LME+MKQPFS SEV
Sbjct: 448 MTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQPFSQSEV 507

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLL+NNQG LKICDFG++RQYGSPLK YT +VV
Sbjct: 508 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLMNNQGELKICDFGLARQYGSPLKTYTHMVV 567

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLG +KYSTA+DMWS+GCIMAELL+K+PLF+G TEVDQ+DKIF+TLGTP E
Sbjct: 568 TLWYRAPELLLGTRKYSTAIDMWSLGCIMAELLSKQPLFNGKTEVDQLDKIFRTLGTPNE 627

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           TIWPG S+LPG + NF K  YNLLRK+FPA SFTGSPVLS+SGFDLLN+LLTYDPEKRIT
Sbjct: 628 TIWPGFSKLPGVRVNFVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRIT 687

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            + ALNH WF EVPLPKSK+FMPTFP QHA+++
Sbjct: 688 AEAALNHEWFSEVPLPKSKEFMPTFPAQHAQDR 720

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255547862|ref|XP_002514988.1| cdk10/11, putative [Ricinus communis] gi|223546039|gb|EEF47542.1| cdk10/11, putative [Ricinus communis]

 Score =  557 bits (1436), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 264/333 (79%), Positives = 297/333 (89%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NML GCRSV EFE+LNKI EGTYG+VYRA+DKK+GEIVALKKVKM   R+      GFP
Sbjct: 396 VNMLLGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKERE------GFP 449

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+  + DS++MVMEYMEHDLK LMESMKQPFS SEV
Sbjct: 450 LTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMESMKQPFSQSEV 509

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct: 510 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 569

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL+K+PLF+G TE DQ+DKIF+ LGTP E
Sbjct: 570 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLSKEPLFNGKTEFDQLDKIFRILGTPNE 629

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           TIWPG S+LPG K NF K  YNLLRK+FPA SFTGSPVLS+SGFDLLN+LLTYDPEKRIT
Sbjct: 630 TIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRIT 689

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            + A+NH WF EVPLPKSKDFMPTFP QHA+++
Sbjct: 690 AEAAINHEWFREVPLPKSKDFMPTFPAQHAQDR 722

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297841455|ref|XP_002888609.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297334450|gb|EFH64868.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 261/333 (78%), Positives = 295/333 (88%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI EGTYG+VYRA+DKK+GEIVALKKVKM   R+      GFP
Sbjct: 398 INMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKERE------GFP 451

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK LME+MKQ FS SEV
Sbjct: 452 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEV 511

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct: 512 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 571

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL K PLF+G TE DQ+DKIF+ LGTP E
Sbjct: 572 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNE 631

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +IWPG S+LPG K NF K  YNLLRK+FPA SFTG+PVLS++GFDLLN+LLTYDPE+RIT
Sbjct: 632 SIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRIT 691

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           VD+AL H WF EVPLPKSKDFMPTFP QHA+++
Sbjct: 692 VDEALKHDWFREVPLPKSKDFMPTFPAQHAQDR 724

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|17064846|gb|AAL32577.1| putative protein kinase [Arabidopsis thaliana]

 Score =  552 bits (1422), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 260/333 (78%), Positives = 295/333 (88%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI EGTYG+VYRA+DKK+GEIVALKKVKM   R+      GFP
Sbjct: 394 INMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKERE------GFP 447

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK LME+MKQ FS SEV
Sbjct: 448 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEV 507

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct: 508 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 567

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL K PLF+G TE DQ+DKIF+ LGTP E
Sbjct: 568 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNE 627

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +IWPG S+LPG K NF K  YNLLRK+FPA SFTG+PVLS++GFDLLN+LLTYDPE+RIT
Sbjct: 628 SIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRIT 687

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           V++AL H WF EVPLPKSKDFMPTFP QHA+++
Sbjct: 688 VNEALKHDWFREVPLPKSKDFMPTFPAQHAQDR 720

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15220477|ref|NP_176925.1| protein kinase-like protein [Arabidopsis thaliana] gi|238478996|ref|NP_001154456.1| protein kinase-like protein [Arabidopsis thaliana] gi|12324671|gb|AAG52294.1|AC011020_1 putative protein kinase [Arabidopsis thaliana] gi|17065202|gb|AAL32755.1| putative protein kinase [Arabidopsis thaliana] gi|332196545|gb|AEE34666.1| protein kinase-like protein [Arabidopsis thaliana] gi|332196546|gb|AEE34667.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  552 bits (1422), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 260/333 (78%), Positives = 295/333 (88%), Gaps = 7/333 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI EGTYG+VYRA+DKK+GEIVALKKVKM   R+      GFP
Sbjct: 394 INMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKERE------GFP 447

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK LME+MKQ FS SEV
Sbjct: 448 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEV 507

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct: 508 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 567

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL K PLF+G TE DQ+DKIF+ LGTP E
Sbjct: 568 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNE 627

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +IWPG S+LPG K NF K  YNLLRK+FPA SFTG+PVLS++GFDLLN+LLTYDPE+RIT
Sbjct: 628 SIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRIT 687

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           V++AL H WF EVPLPKSKDFMPTFP QHA+++
Sbjct: 688 VNEALKHDWFREVPLPKSKDFMPTFPAQHAQDR 720

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115459094|ref|NP_001053147.1| Os04g0488000 [Oryza sativa Japonica Group] gi|75233131|sp|Q7XUF4.2|CDKG2_ORYSJ RecName: Full=Cyclin-dependent kinase G-2; Short=CDKG;2 gi|158512881|sp|A2XUW1.1|CDKG2_ORYSI RecName: Full=Cyclin-dependent kinase G-2; Short=CDKG;2 gi|38344237|emb|CAD41330.2| OJ991113_30.14 [Oryza sativa Japonica Group] gi|113564718|dbj|BAF15061.1| Os04g0488000 [Oryza sativa Japonica Group] gi|125548799|gb|EAY94621.1| hypothetical protein OsI_16398 [Oryza sativa Indica Group] gi|215767108|dbj|BAG99336.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 257/326 (78%), Positives = 289/326 (88%), Gaps = 7/326 (2%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +NMLQGCRSV EFE+LNKI+EGTYG+VYRARDKK+GEIVALKKVKM   R+      GFP
Sbjct: 353 INMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFP 406

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK +ME+MKQP+S SEV
Sbjct: 407 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEV 466

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG+SRQYGSPLKPYT LVV
Sbjct: 467 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVV 526

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           TLWYRAPELLLG K+YSTA+DMWSVGCIMAELLAK+PLF+G TE +Q+DKIF+TLGTP E
Sbjct: 527 TLWYRAPELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKIFRTLGTPNE 586

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            IWPG ++LPG K NF KQPYN LR +FPAASF+G P+LSE+GFDLLN LLTYDPEKR++
Sbjct: 587 KIWPGYAKLPGVKVNFVKQPYNRLRDKFPAASFSGRPILSEAGFDLLNNLLTYDPEKRLS 646

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFP 325
            D AL H WF EVPLPKSKDFMPTFP
Sbjct: 647 ADAALQHEWFREVPLPKSKDFMPTFP 672

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	332
TAIR|locus:2008595	752	AT1G67580 [Arabidopsis thalian	0.981	0.433	0.780	8.9e-141
TAIR|locus:2158554	612	CDKG1 "cyclin-dependent kinase	0.975	0.529	0.724	8.1e-131
UNIPROTKB|J3KTL7	738	CDK11B "Cyclin-dependent kinas	0.951	0.428	0.619	2.7e-107
UNIPROTKB|J3QKR5	783	CDK11B "Cyclin-dependent kinas	0.951	0.403	0.619	2.7e-107
UNIPROTKB|J3QL65	618	CDK11B "Cyclin-dependent kinas	0.951	0.511	0.619	2.7e-107
UNIPROTKB|J3QR29	772	CDK11B "Cyclin-dependent kinas	0.951	0.409	0.619	2.7e-107
UNIPROTKB|J3QR44	785	CDK11B "Cyclin-dependent kinas	0.951	0.402	0.619	2.7e-107
UNIPROTKB|P21127	795	CDK11B "Cyclin-dependent kinas	0.951	0.397	0.619	2.7e-107
UNIPROTKB|E1BWQ7	772	CDC2L1 "Uncharacterized protei	0.951	0.409	0.616	7.2e-107
UNIPROTKB|F1NJL5	772	CDC2L1 "Uncharacterized protei	0.951	0.409	0.616	7.2e-107

TAIR|locus:2008595 AT1G67580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1377 (489.8 bits), Expect = 8.9e-141, P = 8.9e-141
 Identities = 260/333 (78%), Positives = 295/333 (88%)

Query:     1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
             +NMLQGCRSV EFE+LNKI EGTYG+VYRA+DKK+GEIVALKKVKM   R+      GFP
Sbjct:   394 INMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKERE------GFP 447

Query:    61 ISSLREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
             ++SLREINILLSF HPSIV+VKEVV+    DS++MVMEYMEHDLK LME+MKQ FS SEV
Sbjct:   448 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEV 507

Query:   120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
             KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN+G LKICDFG++RQYGSPLKPYT LVV
Sbjct:   508 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 567

Query:   180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
             TLWYRAPELLLGAK+YSTA+DMWS+GCIMAELL K PLF+G TE DQ+DKIF+ LGTP E
Sbjct:   568 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNE 627

Query:   240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
             +IWPG S+LPG K NF K  YNLLRK+FPA SFTG+PVLS++GFDLLN+LLTYDPE+RIT
Sbjct:   628 SIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRIT 687

Query:   300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             V++AL H WF EVPLPKSKDFMPTFP QHA+++
Sbjct:   688 VNEALKHDWFREVPLPKSKDFMPTFPAQHAQDR 720

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0000956 "nuclear-transcribed mRNA catabolic process" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009888 "tissue development" evidence=RCA

GO:0010638 "positive regulation of organelle organization" evidence=RCA

GO:0033044 "regulation of chromosome organization" evidence=RCA

TAIR|locus:2158554 CDKG1 "cyclin-dependent kinase G1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1283 (456.7 bits), Expect = 8.1e-131, P = 8.1e-131
 Identities = 239/330 (72%), Positives = 283/330 (85%)

Query:     1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
             MNM+ G RSV EF+KLNKI+EGTYGIVY+ARD+K+ EIVALKK+KM   R E+  EYGFP
Sbjct:   285 MNMMFGSRSVNEFQKLNKINEGTYGIVYKARDEKTKEIVALKKIKMKEDRFEE--EYGFP 342

Query:    61 ISSLREINILLSFDHPSIVNVKEVVM---DDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
             ++SLREINILLS +HP+IVNVKEVV+   +D+D VYMVME++EHDL+ +M+  K+PFSTS
Sbjct:   343 LTSLREINILLSCNHPAIVNVKEVVVGGKNDND-VYMVMEHLEHDLRGVMDRRKEPFSTS 401

Query:   118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
             EVKCLM+QLL+G+KYLH NW++HRDLK SNLL+NN G LKICDFGM+RQYGSP+KPYT +
Sbjct:   402 EVKCLMMQLLDGLKYLHTNWIIHRDLKPSNLLMNNCGELKICDFGMARQYGSPIKPYTQM 461

Query:   178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
             V+T WYR PELLLGAK+YSTAVDMWSVGCIMAELL++KPLF G +E+DQ+ KIF  LGTP
Sbjct:   462 VITQWYRPPELLLGAKEYSTAVDMWSVGCIMAELLSQKPLFPGKSELDQLQKIFAVLGTP 521

Query:   238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
              E IWPG S  P AKA F  QPYN+LRK+FPA SF G  +LSE GFDLLN LLT DPEKR
Sbjct:   522 NEAIWPGFSSFPNAKAKFPTQPYNMLRKKFPAISFVGGQILSERGFDLLNSLLTLDPEKR 581

Query:   298 ITVDDALNHYWFHEVPLPKSKDFMPTFPPQ 327
             +TV+DALNH WFHEVPLPKSKDFMPT+PP+
Sbjct:   582 LTVEDALNHGWFHEVPLPKSKDFMPTYPPK 611

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0000398 "mRNA splicing, via spliceosome" evidence=IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0032953 "regulation of (1->3)-beta-D-glucan biosynthetic process" evidence=IMP

UNIPROTKB|J3KTL7 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 205/331 (61%), Positives = 256/331 (77%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   372 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 425

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   426 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 485

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct:   486 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 545

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   546 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 605

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct:   606 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 658

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   659 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 689

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|J3QKR5 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 205/331 (61%), Positives = 256/331 (77%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   417 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 470

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   471 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 530

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct:   531 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 590

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   591 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 650

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct:   651 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 703

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   704 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 734

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|J3QL65 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 205/331 (61%), Positives = 256/331 (77%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   252 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 305

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   306 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 365

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct:   366 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 425

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   426 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 485

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct:   486 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 538

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   539 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 569

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|J3QR29 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 205/331 (61%), Positives = 256/331 (77%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   406 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 459

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   460 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 519

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct:   520 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 579

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   580 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 639

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct:   640 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 692

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   693 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 723

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|J3QR44 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 205/331 (61%), Positives = 256/331 (77%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   419 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 472

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   473 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 532

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct:   533 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 592

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   593 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 652

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct:   653 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 705

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   706 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 736

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P21127 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 205/331 (61%), Positives = 256/331 (77%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   429 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 482

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   HP+IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   483 LREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 542

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLK YT +VVTLW
Sbjct:   543 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLW 602

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTAVDMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   603 YRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 662

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG SELP  K   F++ PYN LRKRF A       +LS+ GFDL+N+ LTY P +RI+ +
Sbjct:   663 PGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAE 715

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   716 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 746

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=NAS

GO:0006915 "apoptotic process" evidence=NAS

GO:0005524 "ATP binding" evidence=IDA

GO:0001558 "regulation of cell growth" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0007067 "mitosis" evidence=NAS

GO:0050684 "regulation of mRNA processing" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

UNIPROTKB|E1BWQ7 CDC2L1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
 Identities = 204/331 (61%), Positives = 254/331 (76%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   406 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 459

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   H +IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   460 LREINTILKAQHLNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 519

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLKPYT +VVTLW
Sbjct:   520 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHSGILKVGDFGLAREYGSPLKPYTPVVVTLW 579

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTA+DMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   580 YRAPELLLGAKEYSTAIDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 639

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG +ELP  K   F + PYN LRKRF A       +LS+ GFDL+N  LTY P +RIT +
Sbjct:   640 PGYNELPAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNNFLTYYPARRITAE 692

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   693 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 723

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1NJL5 CDC2L1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
 Identities = 204/331 (61%), Positives = 254/331 (76%)

Query:     4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
             LQGCRSV EF+ LN+I EGTYG+VYRA+DKK+ EIVALK++KM    KE   + GFPI+S
Sbjct:   406 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME---KE---KEGFPITS 459

Query:    64 LREINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL 122
             LREIN +L   H +IV V+E+V+  + D +Y+VM Y+EHDLK LME+MKQPF   EVK L
Sbjct:   460 LREINTILKAQHLNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTL 519

Query:   123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             M+QLL GVK+LHDNW+LHRDLKTSNLLL++ G+LK+ DFG++R+YGSPLKPYT +VVTLW
Sbjct:   520 MIQLLRGVKHLHDNWILHRDLKTSNLLLSHSGILKVGDFGLAREYGSPLKPYTPVVVTLW 579

Query:   183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             YRAPELLLGAK+YSTA+DMWSVGCI  ELL +KPLF G +E+DQI+K+FK LGTP+E IW
Sbjct:   580 YRAPELLLGAKEYSTAIDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIW 639

Query:   243 PGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
             PG +ELP  K   F + PYN LRKRF A       +LS+ GFDL+N  LTY P +RIT +
Sbjct:   640 PGYNELPAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNNFLTYYPARRITAE 692

Query:   302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             D L H +F E PLP      PT+P +  + +
Sbjct:   693 DGLKHEYFRETPLPIDPSMFPTWPAKSEQQR 723

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001824 "blastocyst development" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007088 "regulation of mitosis" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q7XUF4	CDKG2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.7883	0.9608	0.4492	yes	no
O60145	PPK23_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5076	0.9277	0.7738	yes	no
Q54RB2	CDK11_DICDI	2, ., 7, ., 1, 1, ., 2, 2	0.5259	0.9367	0.8687	yes	no
P00546	CDK1_YEAST	2, ., 7, ., 1, 1, ., 2, 2	0.4407	0.8584	0.9563	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	LOW CONFIDENCE prediction!
4th Layer	2.7.11.22	0.946
3rd Layer	2.7.11.23	0.914
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	332
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.0
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-170
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-161
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-144
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-128
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-120
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-119
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-114
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-114
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-107
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-104
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-104
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-103
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-100
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-99
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-99
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-99
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-99
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-97
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-94
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-94
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-94
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-94
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-88
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-82
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-80
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-80
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-76
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-76
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-76
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-76
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-76
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-75
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-75
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-72
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-68
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-67
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-67
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-65
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-64
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-63
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-62
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-61
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-60
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-60
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-56
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-56
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-55
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-55
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-55
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-55
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-54
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-53
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-52
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-49
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-48
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-45
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-44
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-43
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-43
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-42
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-38
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-37
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-35
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-34
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-34
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-33
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-33
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-33
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-31
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-31
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-29
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-29
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-29
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-29
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-28
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-28
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-27
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-27
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-24
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-23
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-23
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-23
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-23
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-23
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-23
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-22
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-22
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-20
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-20
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-20
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-20
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-20
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-20
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-19
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-18
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-17
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-17
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-16
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-16
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-15
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-13
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	3e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	8e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  563 bits (1454), Expect = 0.0
 Identities = 225/305 (73%), Positives = 256/305 (83%), Gaps = 14/305 (4%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           CRSV E+EKLN+I EGTYG+VYRARDKK+GEIVALKK+KM    KE     GFPI+SLRE
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM---EKEK---EGFPITSLRE 54

Query: 67  INILLSFDHPSIVNVKEVVM-DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           INILL   HP+IV VKEVV+  + D +YMVMEY+EHDLK LME+MKQPF  SEVKCLMLQ
Sbjct: 55  INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ 114

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           LL GV +LHDNW+LHRDLKTSNLLLNN+G+LKICDFG++R+YGSPLKPYT LVVTLWYRA
Sbjct: 115 LLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRA 174

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PELLLGAK+YSTA+DMWSVGCI AELL KKPLF G +E+DQ++KIFK LGTPTE IWPG 
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234

Query: 246 SELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           SELPGAK   F K PYN LRK+FPA S      LS++GFDLLNRLLTYDP KRI+ +DAL
Sbjct: 235 SELPGAKKKTFTKYPYNQLRKKFPALS------LSDNGFDLLNRLLTYDPAKRISAEDAL 288

Query: 305 NHYWF 309
            H +F
Sbjct: 289 KHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  475 bits (1224), Expect = e-170
 Identities = 193/321 (60%), Positives = 238/321 (74%), Gaps = 16/321 (4%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           CRSV EFEKLN+I EGTYGIVYRARD  SGEIVALKKV+M+   + D    G PISSLRE
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD--NERD----GIPISSLRE 56

Query: 67  INILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           I +LL+  HP+IV +KEVV+  H DS+++VMEY E DL  L+++M  PFS S+VKCLMLQ
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQ 116

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           LL G++YLH+N+++HRDLK SNLLL ++G LKI DFG++R YG P KP T  VVTLWYRA
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PELLLG   Y+TA+DMW+VGCI+AELLA KPL  G +E++Q+D I + LGTP E+IWPG 
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236

Query: 246 SELPGA-KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           S+LP   K    KQPYN L+ +FP         LSE+G  LLN LL YDP+KR T ++AL
Sbjct: 237 SDLPLVGKFTLPKQPYNNLKHKFPW--------LSEAGLRLLNFLLMYDPKKRATAEEAL 288

Query: 305 NHYWFHEVPLPKSKDFMPTFP 325
              +F E PLP   + MPTFP
Sbjct: 289 ESSYFKEKPLPCEPEMMPTFP 309

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  451 bits (1162), Expect = e-161
 Identities = 149/297 (50%), Positives = 203/297 (68%), Gaps = 15/297 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +EKL K+ EGTYG+VY+ARDKK+GEIVALKK+++      D  E G P ++LREI++L  
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL------DNEEEGIPSTALREISLLKE 54

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV + +V+  +   +Y+V EY + DLK  ++    P S + +K +M QLL G+ Y
Sbjct: 55  LKHPNIVKLLDVIHTE-RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H + +LHRDLK  N+L+N  GVLK+ DFG++R +G PL+ YT  VVTLWYRAPE+LLG+
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           K YSTAVD+WSVGCI AE++  KPLF G +E+DQ+ KIF+ LGTPTE  WPG+++LP  K
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233

Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             F K P   L K  P         L   G DLL+++L Y+P KRI+  +AL H +F
Sbjct: 234 PTFPKFPPKDLEKVLPR--------LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  407 bits (1049), Expect = e-144
 Identities = 152/300 (50%), Positives = 212/300 (70%), Gaps = 16/300 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +EK+ +I EGTYG VY+AR+KK+GE+VALKK++M   ++      GFPI+++REI +L  
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE------GFPITAIREIKLLQK 54

Query: 73  FDHPSIVNVKEVV-MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP+IV +KE+V      S+YMV EYM+HDL  L++S +  F+ S++KC M QLLEG++
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK-PYTSLVVTLWYRAPELLL 190
           YLH N +LHRD+K SN+L+NN GVLK+ DFG++R Y       YT+ V+TLWYR PELLL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           GA +Y   VDMWSVGCI+AEL   KP+F G+TE++Q++KIF+  G+PT+  WPG+S+LP 
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234

Query: 251 AKANFAKQPY-NLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
            +    K+PY   LR+ F         ++  S  DLL++LLT DP+KRI+ D AL H +F
Sbjct: 235 FENLKPKKPYKRRLREFF-------KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  367 bits (944), Expect = e-128
 Identities = 140/310 (45%), Positives = 198/310 (63%), Gaps = 13/310 (4%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +EK  K+ EGTY +VY+ARDK++G IVA+KK+K  +G +++  + G   ++LREI +L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKD-GINFTALREIKLLQE 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+I+ + +V      ++ +V E+ME DL+ +++      + +++K  ML  L G++Y
Sbjct: 59  LKHPNIIGLLDVFGHK-SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH NW+LHRDLK +NLL+ + GVLK+ DFG++R +GSP +  T  VVT WYRAPELL GA
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           + Y   VDMWSVGCI AELL + P   G +++DQ+ KIF+ LGTPTE  WPG++ LP   
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237

Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
             F   P   L++ FPAA        S+   DLL RLLT +P KRIT   AL H +F   
Sbjct: 238 E-FKPFPPTPLKQIFPAA--------SDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Query: 313 PLPKSKDFMP 322
           P P     +P
Sbjct: 289 PAPTPPSQLP 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  348 bits (894), Expect = e-120
 Identities = 146/324 (45%), Positives = 206/324 (63%), Gaps = 33/324 (10%)

Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
            GC  + ++E L K+ EGT+G VY+AR  K+G +VALKK+ M+  +       GFPI++L
Sbjct: 2   YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD------GFPITAL 55

Query: 65  REINILLSFDHPSIVNVKEVVMDDHD-------SVYMVMEYMEHDLKWLMESMKQPFSTS 117
           REI IL    HP++V + ++ ++  D       SVYMV  YM+HDL  L+E+     + S
Sbjct: 56  REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKP--- 173
           ++KC MLQLLEG+ YLH+N +LHRD+K +N+L++NQG+LKI DFG++R Y G P  P   
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 174 -------YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ 226
                  YT+LVVT WYR PELLLG ++Y+TAVD+W +GC+ AE+  ++P+  G +++DQ
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPY-NLLRKRFPAASFTGSPVLSESGFDL 285
           +  IFK  GTPTE  WPG   LPG +   +   Y   L +RF          L   G DL
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK--------LGPEGLDL 287

Query: 286 LNRLLTYDPEKRITVDDALNHYWF 309
           L++LL+ DP KR+T  DAL H +F
Sbjct: 288 LSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  344 bits (885), Expect = e-119
 Identities = 138/298 (46%), Positives = 203/298 (68%), Gaps = 16/298 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++K+ KI EGTYG+VY+ARDK +GEIVALKK+++      +  + G P +++REI++L  
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL------ETEDEGVPSTAIREISLLKE 54

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +VV  ++  +Y+V E+++ DLK  M+S          +K  + QLL+G+ 
Sbjct: 55  LNHPNIVRLLDVVHSEN-KLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H + VLHRDLK  NLL++ +G LK+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 173

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +++YST VD+WS+GCI AE++ ++PLF G +E+DQ+ +IF+TLGTP E +WPG++ LP  
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           K  F K     L K  P         L E G DLL+++L YDP KRI+   AL H +F
Sbjct: 234 KPTFPKWARQDLSKVVPN--------LDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  333 bits (855), Expect = e-114
 Identities = 130/300 (43%), Positives = 181/300 (60%), Gaps = 17/300 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            ++ L +I EG +GIV++A+D+++GE VALKKV   + R E     G P  +LREI  L 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKV--ALRRLEG----GIPNQALREIKALQ 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +V + +V         +VMEYM  DL  ++   ++P   ++VK  M  LL+GV 
Sbjct: 55  ACQHPYVVKLLDVFPHG-SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTSLVVTLWYRAPELLL 190
           Y+H N ++HRDLK +NLL++  GVLKI DFG++R +     + Y+  V T WYRAPELL 
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           GA+KY   VD+W+VGCI AELL   PLF G  +++Q+  +F+TLGTP E  WPGL+ LP 
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233

Query: 251 A-KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             K  F +     L + FP A        S    DLL  LL YDP KR++  +AL H +F
Sbjct: 234 YNKITFPESKPIPLEEIFPDA--------SPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  331 bits (850), Expect = e-114
 Identities = 143/298 (47%), Positives = 200/298 (67%), Gaps = 16/298 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++KL KI EGTYG+VY+ARDK +GEIVA+KK+K     + +    G P ++LREI +L  
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK----LRFE--SEGIPKTALREIKLLKE 54

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+I+ + +V       +Y+V E+M+ DL  L++  ++    S +K  + QLL+G+ +
Sbjct: 55  LNHPNIIKLLDVFRHK-GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H + +LHRDLK  NLL+N +GVLK+ DFG++R +GSP++PYT  VVT WYRAPELLLG 
Sbjct: 114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD 173

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA- 251
           K YST VD+WSVGCI AELL+++PLF G +E+DQ+ KIF+TLGTP   +WP  + L    
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           K +F K+    L K FP A        S    DLL+++L YDP KRIT + AL H +F
Sbjct: 234 KFSFPKKAGMPLPKLFPNA--------SPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  314 bits (806), Expect = e-107
 Identities = 135/298 (45%), Positives = 199/298 (66%), Gaps = 16/298 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 55

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M++          +K  + QLL+G+ 
Sbjct: 56  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ LP  
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           K +F K       K  P         L E G DLL+++L YDP KRI+   AL H +F
Sbjct: 235 KPSFPKWARQDFSKVVPP--------LDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  307 bits (787), Expect = e-104
 Identities = 136/300 (45%), Positives = 200/300 (66%), Gaps = 17/300 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ K+ KI EGTYG+VY+ R+KK+G+IVA+KK+++         E G P +++REI++L 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE------EEGVPSTAIREISLLK 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK--QPFSTSEVKCLMLQLLEG 129
              HP+IV +++V+M +   +Y++ E++  DLK  ++S+   Q      VK  + Q+L+G
Sbjct: 55  ELQHPNIVCLQDVLMQE-SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           + + H   VLHRDLK  NLL++N+GV+K+ DFG++R +G P++ YT  VVTLWYRAPE+L
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           LG+ +YST VD+WS+G I AE+  KKPLF G +E+DQ+ +IF+ LGTPTE +WPG++ LP
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             K  F K     LR             L E G DLL ++L YDP KRI+   ALNH +F
Sbjct: 234 DYKNTFPKWKKGSLRSAVKN--------LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  307 bits (788), Expect = e-104
 Identities = 135/325 (41%), Positives = 190/325 (58%), Gaps = 38/325 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +E    I  GTYG VY+A+ K  K G+  A+KK K +  +       G   S+ REI +L
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-----GISQSACREIALL 56

Query: 71  LSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDL----KWLMESMKQPFSTSEVKCLMLQ 125
               H ++V++ EV ++  D SVY++ +Y EHDL    K+  ++ +     S VK L+ Q
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSL---V 178
           +L GV YLH NWVLHRDLK +N+L+      +GV+KI D G++R + +PLKP   L   V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---------VDQIDK 229
           VT+WYRAPELLLGA+ Y+ A+D+W++GCI AELL  +P+F G             DQ+++
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 230 IFKTLGTPTETIWPGLSELP---GAKANFAKQPY--NLLRKRFPAASFTGSPVLSESGFD 284
           IF+ LGTPTE  WP + ++P       +F  + Y  N L K         S      GFD
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ-----GFD 291

Query: 285 LLNRLLTYDPEKRITVDDALNHYWF 309
           LL +LL YDP KRIT ++AL H +F
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  304 bits (780), Expect = e-103
 Identities = 146/314 (46%), Positives = 201/314 (64%), Gaps = 25/314 (7%)

Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           G R V +F+ + +I EGTYG VY+ARDK +GE+VALKKV+++   KE     GFPI+++R
Sbjct: 2   GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-NEKE-----GFPITAIR 55

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSV---------YMVMEYMEHDLKWLMESMKQPFST 116
           EI IL   +H +IVN+KE+V D  D++         Y+V EYM+HDL  L+ES    FS 
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS-PLKPYT 175
             +K  M QLLEG+ Y H    LHRD+K SN+LLNN+G +K+ DFG++R Y S   +PYT
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + V+TLWYR PELLLG ++Y  A+D+WS GCI+ EL  KKP+F    E+ Q++ I +  G
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235

Query: 236 TPTETIWPGLSELPGAKANFAKQPYNL-LRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           +P   +WP + +LP       K+ Y   LR+ F   SF  +P L     DLL+ +LT DP
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF---SFIPTPAL-----DLLDHMLTLDP 287

Query: 295 EKRITVDDALNHYW 308
            KR T ++ALN  W
Sbjct: 288 SKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  299 bits (767), Expect = e-100
 Identities = 129/330 (39%), Positives = 183/330 (55%), Gaps = 36/330 (10%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E L  I  G YG+V  A DK++G  VA+KK+        D L     I  LREI +L  
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI----SNVFDDLIDAKRI--LREIKLLRH 55

Query: 73  FDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
             H +I+ + +++     +D + VY+V E ME DL  +++S  QP +   ++  + Q+L 
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILR 114

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY---TSLVVTLWYRA 185
           G+KYLH   V+HRDLK SN+L+N+   LKICDFG++R            T  VVT WYRA
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PELLL + +Y+ A+D+WSVGCI AELL +KPLF G   +DQ++ I + LGTP+E     L
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE---DL 231

Query: 246 SELPGAKA-----NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
             +   KA     +  K+P   L K FP A        S    DLL ++L +DP+KRIT 
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGA--------SPEAIDLLEKMLVFDPKKRITA 283

Query: 301 DDALNHYWFHEV------PLPKSKDFMPTF 324
           D+AL H +  ++      P+ K       F
Sbjct: 284 DEALAHPYLAQLHDPEDEPVAKPPFDFDFF 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  294 bits (756), Expect = 1e-99
 Identities = 132/305 (43%), Positives = 187/305 (61%), Gaps = 26/305 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL- 71
           +E+L +I EG YG VY+ARD  +G  VALKKV++ +       E G P+S+LREI +L  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLREIALLKQ 54

Query: 72  --SFDHPSIV---NVKEVVMDDHD-SVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLML 124
             SF+HP+IV   +V      D +  + +V E+++ DL   +    +P      +K LM 
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           QLL GV +LH + ++HRDLK  N+L+ + G +KI DFG++R Y   +   TS+VVTLWYR
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYR 173

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LL +  Y+T VDMWSVGCI AEL  ++PLF GT+E DQ+DKIF  +G P+E  WP 
Sbjct: 174 APEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
              LP  +++F               SF   P + E G DLL ++LT++P KRI+  +AL
Sbjct: 233 NVSLP--RSSFPSYT------PRSFKSFV--PEICEEGLDLLKKMLTFNPHKRISAFEAL 282

Query: 305 NHYWF 309
            H +F
Sbjct: 283 QHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  295 bits (757), Expect = 2e-99
 Identities = 128/315 (40%), Positives = 181/315 (57%), Gaps = 24/315 (7%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C  V ++EKL KI +GT+G V++AR KK+ +IVALKKV M    KE     GFPI++LRE
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME-NEKE-----GFPITALRE 61

Query: 67  INILLSFDHPSIVNVKEVVM-------DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           I IL    H ++VN+ E+             S Y+V E+ EHDL  L+ +    F+ SE+
Sbjct: 62  IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI 121

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP----YT 175
           K +M  LL G+ Y+H N +LHRD+K +N+L+   G+LK+ DFG++R +          YT
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + VVTLWYR PELLLG + Y   +DMW  GCIMAE+  + P+  G TE  Q+  I +  G
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241

Query: 236 TPTETIWPGLSELP-GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           + T  +WPG+ +L    K    +     +++R          V      DL+++LL  DP
Sbjct: 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY------VKDPHALDLIDKLLVLDP 295

Query: 295 EKRITVDDALNHYWF 309
            KRI  D ALNH +F
Sbjct: 296 AKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  293 bits (752), Expect = 4e-99
 Identities = 137/300 (45%), Positives = 192/300 (64%), Gaps = 20/300 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +EKL KI EGTYG V++A+++++ EIVALK+V     R +D  E G P S+LREI +L  
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDE-GVPSSALREICLLKE 55

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IV + +V+  D   + +V EY + DLK   +S         VK  M QLL+G+ +
Sbjct: 56  LKHKNIVRLYDVLHSDK-KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H + VLHRDLK  NLL+N  G LK+ DFG++R +G P++ Y++ VVTLWYR P++L GA
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 174

Query: 193 KKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           K YST++DMWS GCI AEL  A +PLF G    DQ+ +IF+ LGTPTE  WPG+S+LP  
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234

Query: 252 KANFAKQPYNLLRKRFPAASFTGS--PVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           K      PY +    +PA +   +  P L+ +G DLL  LL  +P +RI+ ++AL H +F
Sbjct: 235 K------PYPM----YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  292 bits (750), Expect = 8e-99
 Identities = 133/299 (44%), Positives = 200/299 (66%), Gaps = 18/299 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F++L K+ EGTY  VY+ R++ +GEIVALK++ ++        E G P +++REI+++  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA-------EEGTPSTAIREISLMKE 54

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMES--MKQPFSTSEVKCLMLQLLEGV 130
             H +IV + +V+  + + + +V EYM+ DLK  M++  ++     + VK    QLL+G+
Sbjct: 55  LKHENIVRLHDVIHTE-NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            + H+N VLHRDLK  NLL+N +G LK+ DFG++R +G P+  +++ VVTLWYRAP++LL
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G++ YST++D+WSVGCIMAE++  +PLF GT   DQ+ KIF+ +GTPTE+ WPG+S+LP 
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
            K  F + P   L++ FP A           G DLL+RLL  +PE RI+  DAL H WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPL--------GIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  291 bits (747), Expect = 9e-99
 Identities = 112/298 (37%), Positives = 160/298 (53%), Gaps = 45/298 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E L K+ EG++G VY ARDKK+G++VA+K +K    +K            LREI IL  
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-------DRERILREIKILKK 53

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP+IV + +V  D+ D +Y+VMEY E  DL  L++  +   S  E +  + Q+L  ++
Sbjct: 54  LKHPNIVRLYDVFEDE-DKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALE 111

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   ++HRDLK  N+LL+  G +K+ DFG++RQ     K  T+ V T  Y APE+LLG
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK-LTTFVGTPEYMAPEVLLG 170

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K Y  AVD+WS+G I+ ELL  KP F G    DQ+ ++FK +G P     P        
Sbjct: 171 -KGYGKAVDIWSLGVILYELLTGKPPFPG---DDQLLELFKKIGKPKPPFPP-------- 218

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                                     +S    DL+ +LL  DPEKR+T ++AL H +F
Sbjct: 219 ----------------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  290 bits (743), Expect = 1e-97
 Identities = 136/304 (44%), Positives = 202/304 (66%), Gaps = 19/304 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EK+ KI EGTYG+VY+ARD+ + E +ALKK+++    +ED    G P +++REI++L 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE---QED---EGVPSTAIREISLLK 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
              H +IV +++VV  +   +Y+V EY++ DLK  M+S    F+ +   +K  + Q+L G
Sbjct: 57  EMQHGNIVRLQDVVHSEK-RLYLVFEYLDLDLKKHMDSSPD-FAKNPRLIKTYLYQILRG 114

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + Y H + VLHRDLK  NLL++ +   LK+ DFG++R +G P++ +T  VVTLWYRAPE+
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           LLG++ YST VD+WSVGCI AE++ +KPLF G +E+D++ KIF+ LGTP E  WPG++ L
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           P  K+ F K P        P    T  P L  +G DLL+++L  DP KRIT   AL H +
Sbjct: 235 PDYKSAFPKWP--------PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Query: 309 FHEV 312
           F ++
Sbjct: 287 FKDL 290

Length = 294

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  283 bits (726), Expect = 2e-94
 Identities = 130/324 (40%), Positives = 186/324 (57%), Gaps = 32/324 (9%)

Query: 13  FEKLNK-ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCL------EYGFPISSLR 65
           + +    + EGTYG V +A D  +G+IVA+KKVK+     +           G   ++LR
Sbjct: 10  YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           E+ I+    H +I+ + +V ++  D + +VM+ M  DLK +++  K   + S+VKC++LQ
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEG-DFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQ 127

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL-------------- 171
           +L G+  LH  + +HRDL  +N+ +N++G+ KI DFG++R+YG P               
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
           +  TS VVTLWYRAPELL+GA+KY  AVDMWSVGCI AELL  KPLF G  E+DQ+ +IF
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLT 291
           + LGTP E  WP   +LP          Y     R P    T  P  S+   DLL  LL 
Sbjct: 248 ELLGTPNEDNWPQAKKLP---------LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298

Query: 292 YDPEKRITVDDALNHYWFHEVPLP 315
            +P +RI+  +AL H +F   PLP
Sbjct: 299 LNPLERISAKEALKHEYFKSDPLP 322

Length = 335

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  280 bits (718), Expect = 3e-94
 Identities = 112/298 (37%), Positives = 156/298 (52%), Gaps = 39/298 (13%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E L K+  G++G VY+A+ K +G+IVA+K +K    R E   +     ++ REI IL  
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK---KRSEKSKK---DQTARREIRILRR 54

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP+IV + +   D  D +Y+VMEY E  DL   +     P S  E K + LQ+L G++
Sbjct: 55  LSHPNIVRLIDAFEDK-DHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLE 112

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH N ++HRDLK  N+LL+  GV+KI DFG++++        T+ V T WY APE+LLG
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
              Y   VD+WS+G I+ ELL  KP FSG   +DQ+  I + LG P E   P  S     
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG--- 229

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                                      SE   DL+ + L  DP KR T ++ L H WF
Sbjct: 230 ---------------------------SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  280 bits (719), Expect = 5e-94
 Identities = 140/308 (45%), Positives = 191/308 (62%), Gaps = 25/308 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +EKL KI EGTYG VY+ARDK +G++VALKK ++ +       E G P ++LREI++L 
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD------EEGIPPTALREISLLQ 55

Query: 72  SFDH-PSIVNVKEVVMDDHD----SVYMVMEYMEHDLKWLMESMKQ----PFSTSEVKCL 122
                  IV + +V   +      S+Y+V EY++ DLK  M+S  +    P     +K  
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           M QLL+GV + H + V+HRDLK  NLL++ Q G+LKI D G+ R +  P+K YT  +VTL
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           WYRAPE+LLG+  YST VD+WSVGCI AE+  K+PLF G +E+ Q+  IFK LGTPTE +
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           WPG+S+L         +P +L R      +    P LS  G DLL ++L YDP KRI+  
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSR------AV---PDLSPEGLDLLQKMLRYDPAKRISAK 286

Query: 302 DALNHYWF 309
            AL H +F
Sbjct: 287 AALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  280 bits (718), Expect = 7e-94
 Identities = 123/302 (40%), Positives = 184/302 (60%), Gaps = 24/302 (7%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ + ++ +GT+G VY AR+K++GE+VA+KK+K      E+C+       +LRE+  L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM-------NLREVKSLRK 53

Query: 73  F-DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ-PFSTSEVKCLMLQLLEGV 130
             +HP+IV +KEV  + +D +Y V EYME +L  LM+  K  PFS S ++ ++ Q+L+G+
Sbjct: 54  LNEHPNIVKLKEVFRE-NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            ++H +   HRDLK  NLL++   V+KI DFG++R+  S   PYT  V T WYRAPE+LL
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDYVSTRWYRAPEILL 171

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            +  YS+ VD+W++GCIMAEL   +PLF G++E+DQ+ KI   LGTPT+  WP   +L  
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL-- 229

Query: 251 AKA---NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           A      F +     L +  P A        S    DL+  +L +DP+KR T   AL H 
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNA--------SPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Query: 308 WF 309
           +F
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  265 bits (680), Expect = 4e-88
 Identities = 119/299 (39%), Positives = 181/299 (60%), Gaps = 16/299 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++KL+K+ EG+Y  VY+ R K +G++VALK++++         E G P +++RE ++L  
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH-------EEGAPFTAIREASLLKD 59

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IV + +++     ++ +V EY++ DLK  M+      S   V+  + QLL G+ Y
Sbjct: 60  LKHANIVTLHDIIHTK-KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H   VLHRDLK  NLL++ +G LK+ DFG++R    P K Y++ VVTLWYR P++LLG+
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLSELPGA 251
            +YST++DMW VGCI  E+   +PLF G+T+V DQ+ KIF+ LGTPTE  WPG+S  P  
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 252 KA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           K  +F   P   L    P             G +L  + L Y+P+KRI+  +A+ H +F
Sbjct: 239 KPYSFPFYPPRPLINHAPRLD------RIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  249 bits (639), Expect = 7e-82
 Identities = 115/305 (37%), Positives = 167/305 (54%), Gaps = 27/305 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E L  + EG YG+V + R+K +GEIVA+KK K +   ++         ++LRE+ +L  
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED------VKKTALREVKVLRQ 56

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IVN+KE        +Y+V EY+E  L  L+E+         V+  + QLL+ + Y
Sbjct: 57  LRHENIVNLKEAFRRK-GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSLVVTLWYRAPELLLG 191
            H + ++HRD+K  N+L++  GVLK+CDFG +R     P  P T  V T WYRAPELL+G
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
              Y   VD+W++GCIMAELL  +PLF G +++DQ+  I K LG       P   EL  +
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP----PSHQELFSS 231

Query: 252 KANFA-------KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
              FA        QP +L R R+P         +S    D L   L  DP++R+T D+ L
Sbjct: 232 NPRFAGVAFPEPSQPESLER-RYPGK-------VSSPALDFLKACLRMDPKERLTCDELL 283

Query: 305 NHYWF 309
            H +F
Sbjct: 284 QHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  247 bits (634), Expect = 2e-80
 Identities = 118/308 (38%), Positives = 177/308 (57%), Gaps = 35/308 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E L K+ +G YGIV++A D+++ E+VALKK+        D         + REI  L  
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR------TFREIMFLQE 62

Query: 73  F-DHPSIVNVKEVVMDDHDS-VYMVMEYMEHDL-----KWLMESMKQPFSTSEVKCLMLQ 125
             DHP+IV +  V+  ++D  +Y+V EYME DL       ++E +         + +M Q
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-------HKRYIMYQ 115

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR----QYGSPLKP-YTSLVVT 180
           LL+ +KY+H   V+HRDLK SN+LLN+   +K+ DFG++R       +P  P  T  V T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            WYRAPE+LLG+ +Y+  VDMWSVGCI+ E+L  KPLF GT+ ++Q++KI + +G P+  
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA- 234

Query: 241 IWPGLSELPGAKANFAKQPYNLL--RKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
                 ++   K+ FA    + L  R R P       P  S+   DLL +LL ++P KR+
Sbjct: 235 -----EDIESIKSPFAATMLDSLPSRPRKPLDELL--PKASDDALDLLKKLLVFNPNKRL 287

Query: 299 TVDDALNH 306
           T ++AL H
Sbjct: 288 TAEEALEH 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  247 bits (633), Expect = 2e-80
 Identities = 122/330 (36%), Positives = 178/330 (53%), Gaps = 39/330 (11%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS---SLREIN 68
            ++ +  I  G YG+V  A D +SG+ VA+KK+            +  P     +LRE+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI---------PHAFDVPTLAKRTLRELK 56

Query: 69  ILLSFDHPSIVNVKEVVM---DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           IL  F H +I+ +++++     D   VY+VM+ ME DL  ++ S  QP +   ++  + Q
Sbjct: 57  ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQ 115

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----TSLVVTL 181
           LL G+KY+H   V+HRDLK SNLL+N    L+I DFGM+R   S    +    T  V T 
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           WYRAPELLL   +Y+TA+DMWSVGCI AE+L ++ LF G   V Q+  I   LG+P+E +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235

Query: 242 WPGLSELPGAKA-----NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
              L+ +   +      N  ++      K FP A        S    DLL+++L +DPE+
Sbjct: 236 ---LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA--------SPEALDLLSQMLQFDPEE 284

Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTFPP 326
           RITV+ AL H +  +       D  PT PP
Sbjct: 285 RITVEQALQHPFLAQYH---DPDDEPTCPP 311

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  238 bits (609), Expect = 1e-76
 Identities = 124/341 (36%), Positives = 182/341 (53%), Gaps = 51/341 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            ++ L+ I EG YG+V  A  K +G  VA+KK+              F   +LREI IL 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILR 58

Query: 72  SFDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            F H +I+ + +++     +  + VY+V E ME DL  L+++  Q  S   ++  + Q+L
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQIL 116

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWY 183
            G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WY
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLTEYVATRWY 175

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAPE++L +K Y+ A+D+WSVGCI+AE+L+ +PLF G   + Q++ I   LGTP++    
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE--- 232

Query: 244 GLSELPGAKA--------NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
            L+ +   +A           K P+N L   FP A             DLL+++LT++P 
Sbjct: 233 DLNCIISLRARNYIKSLPFKPKVPWNKL---FPNA--------DPKALDLLDKMLTFNPH 281

Query: 296 KRITVDDALNHYW---FH--------EVPLPKSKDFMPTFP 325
           KRITV++AL H +   +H        E P P   +     P
Sbjct: 282 KRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLP 322

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  238 bits (608), Expect = 1e-76
 Identities = 120/303 (39%), Positives = 166/303 (54%), Gaps = 33/303 (10%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G YGIV  A++ ++ E VA+KK+      + D         +LREI +L   DH ++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKR------TLREIKLLRHLDHENV 66

Query: 79  VNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           + +K+++   H    + VY+V E M+ DL  ++ S  Q  S    +  + QLL G+KY+H
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
              VLHRDLK SNLLLN    LKICDFG++R         T  VVT WYRAPELLL   +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA- 253
           Y+TA+D+WSVGCI AELL +KPLF G   V Q+  I + LG+P+E     L  +   KA 
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE---DLGFIRNEKAR 242

Query: 254 -------NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                     +Q      + FP A+            DLL ++L +DP KRITV++AL H
Sbjct: 243 RYIRSLPYTPRQS---FARLFPHANPL--------AIDLLEKMLVFDPSKRITVEEALAH 291

Query: 307 YWF 309
            + 
Sbjct: 292 PYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  234 bits (599), Expect = 4e-76
 Identities = 114/297 (38%), Positives = 180/297 (60%), Gaps = 15/297 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           + KL+K+ EGTY  V++ R K +  +VALK++++         E G P +++RE+++L +
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLE-------HEEGAPCTAIREVSLLKN 59

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IV + +++  +   + +V EY++ DLK  +++     S   VK  M QLL G+ Y
Sbjct: 60  LKHANIVTLHDIIHTER-CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H   +LHRDLK  NLL+N +G LK+ DFG++R    P K Y++ VVTLWYR P++LLG+
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
            +YST +DMW VGCI+ E+   +P+F G+T  +++  IF+ LGTPTE  WPG++      
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT------ 232

Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           +N   + Y   + R        +P L   G DLL+ LL Y+ + RI+ + AL H +F
Sbjct: 233 SNEEFRSYLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  235 bits (601), Expect = 5e-76
 Identities = 119/295 (40%), Positives = 180/295 (61%), Gaps = 15/295 (5%)

Query: 15  KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           KL K+ EGTY  V++ R K +  +VALK++++         E G P +++RE+++L    
Sbjct: 10  KLEKLGEGTYATVFKGRSKLTENLVALKEIRLE-------HEEGAPCTAIREVSLLKDLK 62

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           H +IV + ++V  D  S+ +V EY++ DLK  M+      S   VK  + Q+L G+ Y H
Sbjct: 63  HANIVTLHDIVHTD-KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
              VLHRDLK  NLL+N +G LK+ DFG++R    P K Y++ VVTLWYR P++LLG+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
           YST +DMW VGCI  E+ + +PLF G+T  D++  IF+ LGTPTE  WPG+S      +N
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS------SN 235

Query: 255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              + YN  + + P      +P L   G +LL + L Y+ +KRI+ ++A+ H +F
Sbjct: 236 DEFKNYNFPKYK-PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  234 bits (598), Expect = 8e-76
 Identities = 125/306 (40%), Positives = 179/306 (58%), Gaps = 26/306 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++E + +I  G YG VY+ARD  SG  VALK V++         E G P+S++RE+ +L 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN------EDGLPLSTVREVALLK 54

Query: 72  ---SFDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLM 123
              +FDHP+IV + +V      D    V +V E+++ DL+  ++ +  P      +K LM
Sbjct: 55  RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLM 114

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            Q L G+ +LH N ++HRDLK  N+L+ + G +K+ DFG++R Y   +   T +VVTLWY
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWY 173

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAPE+LL +  Y+T VDMWSVGCI AE+  +KPLF G +E DQ+ KIF  +G P E  WP
Sbjct: 174 RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
               LP  +  F+       R   P  S    P + ESG  LL  +LT++P KRI+   A
Sbjct: 233 RDVTLP--RGAFSP------RGPRPVQSVV--PEIEESGAQLLLEMLTFNPHKRISAFRA 282

Query: 304 LNHYWF 309
           L H +F
Sbjct: 283 LQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  234 bits (597), Expect = 1e-75
 Identities = 117/298 (39%), Positives = 180/298 (60%), Gaps = 15/298 (5%)

Query: 15  KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           KL+K+ EGTY  VY+ R K +  +VALK++++         E G P +++RE+++L    
Sbjct: 10  KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLE-------HEEGAPCTAIREVSLLKDLK 62

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           H +IV + +++  +  S+ +V EY++ DLK  ++      +   VK  + QLL G+ Y H
Sbjct: 63  HANIVTLHDIIHTEK-SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
              VLHRDLK  NLL+N +G LK+ DFG++R    P K Y++ VVTLWYR P++LLG+  
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
           YST +DMW VGCI  E+   +PLF G+T  +Q+  IF+ LGTPTE  WPG+       +N
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL------SN 235

Query: 255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
              + YN  + R        +P L   G +LL++LL ++  KRI+ ++A+ H +FH +
Sbjct: 236 EEFKSYNYPKYR-ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  233 bits (597), Expect = 5e-75
 Identities = 118/306 (38%), Positives = 179/306 (58%), Gaps = 27/306 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKS--GEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +E + ++ +G YGIV  AR+ ++   E VA+KK+  NV  K+   +      +LRE+ +L
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-NVFSKKILAK-----RALRELKLL 55

Query: 71  LSF-DHPSIVNVKE---VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
             F  H +I  + +   V   + + +Y+  E ME DL  ++ S  QP + +  +  + Q+
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQI 114

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK----PY-TSLVVTL 181
           L G+KY+H   VLHRDLK  NLL+N    LKICDFG++R + S        + T  V T 
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF-SENPGENAGFMTEYVATR 173

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           WYRAPE++L  + Y+ A+D+WSVGCI+AELL +KP+F G   VDQ+++I + LGTP E  
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233

Query: 242 WPGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
              LS +   KA N+ +   N+ +K F     +  P  +    DLL +LL +DP KRI+V
Sbjct: 234 ---LSRIGSPKAQNYIRSLPNIPKKPFE----SIFPNANPLALDLLEKLLAFDPTKRISV 286

Query: 301 DDALNH 306
           ++AL H
Sbjct: 287 EEALEH 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  225 bits (577), Expect = 1e-72
 Identities = 112/301 (37%), Positives = 161/301 (53%), Gaps = 29/301 (9%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-D 74
           L KI EGT+  V +A+ +K+G+  A+K +K +    E        +++LREI  L     
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-------VNNLREIQALRRLSP 56

Query: 75  HPSIVNVKEVVMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           HP+I+ + EV+ D     + +V E M+ +L  L++  K+P     VK  M QLL+ + ++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTLWYRAPELLLGA 192
           H N + HRD+K  N+L+    +LK+ DFG  R  Y  P  PYT  + T WYRAPE LL  
Sbjct: 117 HRNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTD 173

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
             Y   +D+W+VGC+  E+L+  PLF GT E+DQI KI   LGT            P A+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT------------PDAE 221

Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVL----SESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                +    +   FP+   TG   L    S  G DLL +LL YDP++RIT   AL H +
Sbjct: 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Query: 309 F 309
           F
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  214 bits (547), Expect = 3e-68
 Identities = 114/302 (37%), Positives = 167/302 (55%), Gaps = 28/302 (9%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L K+ EG+Y  VY+   + +G++VALK + M         E G P +++RE ++L    H
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKH 62

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
            +IV + +++    +++  V EYM  DL   M           V+  M QLL G+ Y+H 
Sbjct: 63  ANIVLLHDII-HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
             +LHRDLK  NLL++  G LK+ DFG++R    P + Y+S VVTLWYR P++LLGA  Y
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
           S+A+D+W  GCI  E+L  +P F G ++V +Q++KI+  LG PTE  WPG+S+LP  K  
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241

Query: 255 -FAKQPYNLLR------KRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
            F       LR       R P A             DL +++L   P+ RI+  DAL H 
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAE------------DLASQMLMMFPKDRISAQDALLHP 289

Query: 308 WF 309
           +F
Sbjct: 290 YF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  216 bits (551), Expect = 1e-67
 Identities = 115/310 (37%), Positives = 175/310 (56%), Gaps = 27/310 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           + E    I  G +G+V+   D + G+ VALKK+  NV        +   +S     RE+ 
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NV--------FQNLVSCKRVFRELK 51

Query: 69  ILLSFDHPSIVNVKEVVMDDHDS----VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
           +L  F H ++++  +++   H      +Y+V E M+ DL  ++ S  QP S+  VK  + 
Sbjct: 52  MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLY 110

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWY 183
           Q+L G+KYLH   +LHRD+K  NLL+N+  VLKICDFG++R +     K  T  VVT +Y
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAPE+L+G++ Y++AVD+WSVGCI AELL ++ LF   + + Q+D I   LGTP+     
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAAS--FTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
              E  GA+A+  + P      + P+    +T S   +     LL R+L +DP+KRI+  
Sbjct: 231 SACE--GARAHILRGP-----HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA 283

Query: 302 DALNHYWFHE 311
           DAL H +  E
Sbjct: 284 DALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  213 bits (543), Expect = 1e-67
 Identities = 121/307 (39%), Positives = 185/307 (60%), Gaps = 27/307 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           ++E + +I EG YG V++ARD K  G  VALK+V++  G      E G P+S++RE+ +L
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIREVAVL 55

Query: 71  L---SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCL 122
               +F+HP++V + +V      D    + +V E+++ DL   ++ + +P   T  +K +
Sbjct: 56  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 115

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           M QLL G+ +LH + V+HRDLK  N+L+ + G +K+ DFG++R Y S     TS+VVTLW
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLW 174

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPE+LL +  Y+T VD+WSVGCI AE+  +KPLF G+++VDQ+ KI   +G P E  W
Sbjct: 175 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P    LP  +  F  +    + K            + E G DLL + LT++P KRI+   
Sbjct: 234 PRDVALP--RQAFHSKSAQPIEKFVTD--------IDELGKDLLLKCLTFNPAKRISAYS 283

Query: 303 ALNHYWF 309
           AL+H +F
Sbjct: 284 ALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  207 bits (527), Expect = 4e-65
 Identities = 110/303 (36%), Positives = 175/303 (57%), Gaps = 16/303 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +EKL K+ EG+Y  VY+ + K +G++VALK +++         E G P +++RE ++L  
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-------EEGTPFTAIREASLLKG 59

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IV + +++    +++ +V EY+  DL   M+          VK  + QLL G+ Y
Sbjct: 60  LKHANIVLLHDII-HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H  ++LHRDLK  NLL+++ G LK+ DFG++R    P   Y++ VVTLWYR P++LLG+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLSELPGA 251
            +YST +DMW VGCI  E++     F G  ++ DQ+++IF  LGTP E  WPG+  LP  
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238

Query: 252 KAN-FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
           K   F       LR+ +   S+           DL ++LL   P+ R++   AL+H +F 
Sbjct: 239 KPERFTLYSPKNLRQAWNKLSYV------NHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Query: 311 EVP 313
           ++P
Sbjct: 293 DLP 295

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  207 bits (528), Expect = 1e-64
 Identities = 108/316 (34%), Positives = 162/316 (51%), Gaps = 36/316 (11%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL------- 64
            ++ L+ +  G YG V  A D K+G  VA+KK+               P  S        
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-------------PFQSAIHAKRTY 62

Query: 65  REINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           RE+ +L   DH +++ + +V      ++D   VY+V   M  DL  +++   Q  S   +
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHI 120

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           + L+ Q+L G+KY+H   ++HRDLK SN+ +N    LKI DFG++R     +  Y   V 
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---VA 177

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           T WYRAPE++L    Y+  VD+WSVGCIMAELL  K LF G+  +DQ+ +I   +GTP E
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            +   +S    A+      P  + +K F       +P+      DLL ++L  DP+KRIT
Sbjct: 238 ELLQKIS-SESARNYIQSLPQ-MPKKDFKEVFSGANPLA----IDLLEKMLVLDPDKRIT 291

Query: 300 VDDALNHYWFHEVPLP 315
             +AL H +  E   P
Sbjct: 292 AAEALAHPYLAEYHDP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  201 bits (512), Expect = 8e-63
 Identities = 114/311 (36%), Positives = 173/311 (55%), Gaps = 41/311 (13%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS---SLREINI 69
           +EKL+KI EG+YG+V++ R++++G+IVA+KK    V  ++D      P+    +LREI +
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF---VESEDD------PVIKKIALREIRM 53

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLL 127
           L    HP++VN+ EV       +++V EY +H +  L E  K P    E  +K ++ Q L
Sbjct: 54  LKQLKHPNLVNLIEVFRRKR-KLHLVFEYCDHTV--LNELEKNPRGVPEHLIKKIIWQTL 110

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + V + H +  +HRD+K  N+L+  QG +K+CDFG +R    P   YT  V T WYRAPE
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT---------PT 238
           LL+G  +Y   VD+W++GC+ AELL  +PL+ G ++VDQ+  I KTLG           T
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
              + GLS +P        +    L  +FP  S   SP L       L   L  DP +R+
Sbjct: 231 NQFFKGLS-IPEP------ETREPLESKFPNIS---SPAL-----SFLKGCLQMDPTERL 275

Query: 299 TVDDALNHYWF 309
           + ++ L H +F
Sbjct: 276 SCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  200 bits (510), Expect = 2e-62
 Identities = 124/337 (36%), Positives = 186/337 (55%), Gaps = 57/337 (16%)

Query: 10  VFEFEKLNKISEGTYGIVYRAR--DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           +FE+E   K+  GTYG VY+A+  D K  +  ALK+++            G  +S+ REI
Sbjct: 1   LFEYEGC-KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----------GISMSACREI 49

Query: 68  NILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLME------SMKQPFS--TSE 118
            +L    HP+++ +++V +   D  V+++ +Y EHDL  +++      + K+P     S 
Sbjct: 50  ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPY 174
           VK L+ Q+L+G+ YLH NWVLHRDLK +N+L+  +G     +KI D G +R + SPLKP 
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 175 TSL---VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF---------SGTT 222
             L   VVT WYRAPELLLGA+ Y+ A+D+W++GCI AELL  +P+F         S   
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229

Query: 223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLS--- 279
             DQ+D+IF  +G P +  W  + ++P          Y  L+K F   ++  S ++    
Sbjct: 230 HHDQLDRIFSVMGFPADKDWEDIRKMP---------EYPTLQKDFRRTTYANSSLIKYME 280

Query: 280 -------ESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                     F LL +LLT DP KRIT + AL   +F
Sbjct: 281 KHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  198 bits (504), Expect = 2e-61
 Identities = 121/337 (35%), Positives = 185/337 (54%), Gaps = 57/337 (16%)

Query: 10  VFEFEKLNKISEGTYGIVYRAR--DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           +FE+E   K+  GTYG VY+A+  D K     ALK+++            G  +S+ REI
Sbjct: 1   LFEYEGC-KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----------GISMSACREI 49

Query: 68  NILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLME------SMKQPFSTSE-- 118
            +L    HP+++++++V +   D  V+++ +Y EHDL  +++      + K+P       
Sbjct: 50  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPY 174
           VK L+ Q+L+G+ YLH NWVLHRDLK +N+L+  +G     +KI D G +R + SPLKP 
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 175 TSL---VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF---------SGTT 222
             L   VVT WYRAPELLLGA+ Y+ A+D+W++GCI AELL  +P+F         S   
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 229

Query: 223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLS--- 279
             DQ+D+IF  +G P +  W  + ++P          ++ L K F   ++T   ++    
Sbjct: 230 HHDQLDRIFNVMGFPADKDWEDIKKMP---------EHSTLMKDFRRNTYTNCSLIKYME 280

Query: 280 -------ESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                     F LL +LLT DP KRIT + A+   +F
Sbjct: 281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  196 bits (500), Expect = 4e-61
 Identities = 103/300 (34%), Positives = 167/300 (55%), Gaps = 19/300 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E L  + EG+YG+V + + K++G+IVA+KK    +  ++D +       ++REI +L  
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKI---AMREIRMLKQ 56

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H ++VN+ EV       +Y+V E+++H +   +E        S V+  + Q+L G+++
Sbjct: 57  LRHENLVNLIEV-FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H + ++HRD+K  N+L++  GV+K+CDFG +R   +P + YT  V T WYRAPELL+G 
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP--- 249
            KY  AVD+W+VGC++ E+L  +PLF G +++DQ+  I K LG           + P   
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           G +    K+    L KRFP         LS    DL  + L  DP+ R +    L+H +F
Sbjct: 236 GMRLPEVKEIEP-LEKRFPK--------LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  192 bits (490), Expect = 2e-60
 Identities = 80/195 (41%), Positives = 117/195 (60%), Gaps = 10/195 (5%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + EG +G VY ARDKK+G+ VA+K +K                  LREI IL   +HP+I
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           V +  V  D+ + +Y+VMEY E   LK L++  +   S  E+  ++LQ+LEG++YLH N 
Sbjct: 54  VKLYGVFEDE-NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG 112

Query: 138 VLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
           ++HRDLK  N+LL++  G +K+ DFG+S+   S      ++V T  Y APE+LLG   YS
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 197 TAVDMWSVGCIMAEL 211
              D+WS+G I+ EL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  195 bits (498), Expect = 5e-60
 Identities = 111/323 (34%), Positives = 165/323 (51%), Gaps = 42/323 (13%)

Query: 22  GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV 81
           G+ G+V+ A D    + VA+KK+ +   +            +LREI I+   DH +IV V
Sbjct: 16  GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK--------HALREIKIIRRLDHDNIVKV 67

Query: 82  KEVVMDDH-------------DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            EV+                 +SVY+V EYME DL  ++E  + P S    +  M QLL 
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLR 125

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSR----QYGSPLKPYTSL-VVTLW 182
           G+KY+H   VLHRDLK +N+ +N +  VLKI DFG++R     Y    K Y S  +VT W
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH--KGYLSEGLVTKW 183

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG-TPTETI 241
           YR+P LLL    Y+ A+DMW+ GCI AE+L  KPLF+G  E++Q+  I +++     E  
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
              L+ +P    N   +P   LR   P         ++    D L ++LT++P  R+T +
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPG--------VNPEALDFLEQILTFNPMDRLTAE 295

Query: 302 DALNHYWF--HEVPLPKSKDFMP 322
           +AL H +   +  P  +     P
Sbjct: 296 EALMHPYMSCYSCPFDEPVSLHP 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  183 bits (468), Expect = 1e-56
 Identities = 82/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + +I +G++G VY  R K  G++  LK++ ++    E   E      +L E+ IL  
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-NMSEKERED-----ALNEVKILKK 55

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---QPFSTSEVKCLMLQLLE 128
            +HP+I+   E   +    + +VMEY +  DL   ++  K   +PF   ++    +QL  
Sbjct: 56  LNHPNIIKYYESFEEK-GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            +KYLH   +LHRD+K  N+ L + G++K+ DFG+S+   S +    ++V T +Y +PEL
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
               K Y+   D+WS+GC++ EL   K  F G   ++   KI                  
Sbjct: 175 CQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI------------------ 215

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                         L+ ++P      S  L     +L++ LL  DPE+R ++   L 
Sbjct: 216 --------------LKGQYPPIPSQYSSELR----NLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  185 bits (472), Expect = 3e-56
 Identities = 110/301 (36%), Positives = 156/301 (51%), Gaps = 25/301 (8%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I +G+YG+V  A D  +GE VA+KK+        D          LREI +L    HP I
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI------LREIKLLRLLRHPDI 61

Query: 79  VNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           V +K +++     +   +Y+V E ME DL  ++++     +    +  + QLL  +KY+H
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIH 120

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLG 191
              V HRDLK  N+L N    LKICDFG++R           +T  V T WYRAPEL  G
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-G 179

Query: 192 A--KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT-ETIWPGLSEL 248
           +   KY+ A+D+WS+GCI AE+L  KPLF G   V Q+D I   LGTP+ ETI       
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI------- 232

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
              +   A++  + +RK+ P       P        LL RLL +DP+ R T ++AL   +
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 309 F 309
           F
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  182 bits (464), Expect = 4e-55
 Identities = 109/326 (33%), Positives = 164/326 (50%), Gaps = 25/326 (7%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L ++  G YG V  A DK++GE VA+KK+      +       F   + RE+ +L  
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI------FAKRAYRELTLLKH 70

Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V       D+    Y+VM YM+ DL+   + M  P S  +V+ L+ Q+L
Sbjct: 71  MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQML 127

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK  NL +N    LKI DFG++R   + +  Y   VVT WYRAPE
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPE 184

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAE+L  K LF G   +DQ+ +I K  G P       L +
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTG-SPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
              AK+     P      ++P   F+   P  S    DLL ++L  D +KR+T  +AL H
Sbjct: 245 K-AAKSYIKSLP------KYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297

Query: 307 YWFHEVPLPKSKDFMPTFPPQHARNK 332
            +F        +     +       K
Sbjct: 298 PYFDSFRDADEETEQQPYDDSLENEK 323

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  181 bits (462), Expect = 6e-55
 Identities = 107/306 (34%), Positives = 163/306 (53%), Gaps = 29/306 (9%)

Query: 9   SVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS- 63
           +VFE    +  L  +  G +G+V  ARD+ +G+ VA+KK+ M          +  P+ + 
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MK--------PFSTPVLAK 54

Query: 64  --LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
              RE+ +L    H +I+++ ++ +   + +Y V E +  DL  L+ S  +P     ++ 
Sbjct: 55  RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQY 112

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            + Q+L G+KY+H   V+HRDLK SN+L+N    LKICDFG++R     +  Y S   T 
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---TR 169

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +YRAPE++L  +KY   VD+WS GCI AE+L  KPLF G   V+Q   I   LGTP + +
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229

Query: 242 WPGL-SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
              + SE       F +     L KR P            S  DLL ++L +DP+KRI+ 
Sbjct: 230 INTICSE---NTLRFVQS----LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA 282

Query: 301 DDALNH 306
            +AL H
Sbjct: 283 AEALAH 288

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  179 bits (456), Expect = 6e-55
 Identities = 95/299 (31%), Positives = 146/299 (48%), Gaps = 52/299 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            FE L KI +G +G VY+AR K++G+ VA+K +K+    K++ +        + EI IL 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI--------INEIQILK 52

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP+IV      +   D +++VME+     LK L++S  Q  + S++  +  +LL+G+
Sbjct: 53  KCKHPNIVKYYGSYLKK-DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGL 111

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           +YLH N ++HRD+K +N+LL + G +K+ DFG+S Q  S  K   ++V T ++ APE++ 
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ-LSDTKARNTMVGTPYWMAPEVIN 170

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K Y    D+WS+G    EL   KP +                           SELP 
Sbjct: 171 G-KPYDYKADIWSLGITAIELAEGKPPY---------------------------SELPP 202

Query: 251 AKANF---AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
            KA F      P  L      +  F           D L + L  +PEKR T +  L H
Sbjct: 203 MKALFKIATNGPPGLRNPEKWSDEFK----------DFLKKCLQKNPEKRPTAEQLLKH 251

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  182 bits (462), Expect = 7e-55
 Identities = 108/305 (35%), Positives = 166/305 (54%), Gaps = 24/305 (7%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L ++  G YG V  A D+++G  VA+KK+      +       F   + RE+ +L  
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLLKH 70

Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +D     Y+VM +M  DL  LM+  K   S   ++ L+ Q+L
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQML 128

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+KY+H   ++HRDLK  NL +N    LKI DFG++RQ  S +  Y   VVT WYRAPE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY---VVTRWYRAPE 185

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAE+L  KPLF G   +DQ+ +I K  GTP++     + +
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF---VQK 242

Query: 248 LPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
           L    A N+ K+     +K F +     +P+      ++L ++L  D E RIT  +AL H
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPL----AVNVLEKMLVLDAESRITAAEALAH 298

Query: 307 YWFHE 311
            +F E
Sbjct: 299 PYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  179 bits (454), Expect = 3e-54
 Identities = 111/305 (36%), Positives = 160/305 (52%), Gaps = 26/305 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  + EG YG+V + R K++ EIVA+KK K +   +E         ++LRE+ +L 
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE------VKETTLRELKMLR 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +    +IV +KE        +Y+V EY+E ++  L+E M       +V+  + QL++ + 
Sbjct: 56  TLKQENIVELKEA-FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP-YTSLVVTLWYRAPELLL 190
           + H N ++HRD+K  NLL+++  VLK+CDFG +R         YT  V T WYR+PELLL
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           GA  Y  AVDMWSVGCI+ EL   +PLF G +E+DQ+  I K LG            LP 
Sbjct: 175 GA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-----------LPA 222

Query: 251 AKANFAKQPYNLLRKRFPAASFTGS------PVLSESGFDLLNRLLTYDPEKRITVDDAL 304
            +             RFPA +   S       +LS    DL+  LL  +P  R   +  L
Sbjct: 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282

Query: 305 NHYWF 309
           NH  F
Sbjct: 283 NHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  179 bits (456), Expect = 1e-53
 Identities = 112/334 (33%), Positives = 175/334 (52%), Gaps = 46/334 (13%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVK---MNVGRKEDCLEYGFPISSLREINI 69
           ++ L  I  G  GIV  A D  +G+ VA+KK+     NV   +          + RE+ +
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---------RAYRELVL 68

Query: 70  LLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
           +   +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ 
Sbjct: 69  MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMDLDHERMSYLLY 125

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLW 182
           Q+L G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRY 182

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +KI + LGTP++   
Sbjct: 183 YRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF- 240

Query: 243 PGLSELPGAKANFAKQ-------PYNLL--RKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
             +S L     N+ +         +  L     FP  S + + + +    DLL+++L  D
Sbjct: 241 --MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298

Query: 294 PEKRITVDDALNH----YWFH----EVPLPKSKD 319
           PEKRI+VDDAL H     W+     E P P   D
Sbjct: 299 PEKRISVDDALQHPYINVWYDPSEVEAPPPAPYD 332

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  173 bits (440), Expect = 2e-52
 Identities = 86/303 (28%), Positives = 152/303 (50%), Gaps = 48/303 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINIL 70
           E+ +   +  G++G VY A DK +GE++A+K V+++   +E+       + +L REI IL
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-------LEALEREIRIL 53

Query: 71  LSFDHPSIVNVKEV-VMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            S  HP+IV        ++ +++ + +EY+    L  L++          ++    Q+LE
Sbjct: 54  SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILE 112

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY--TSLVVTLWYRAP 186
           G+ YLH N ++HRD+K +N+L+++ GV+K+ DFG +++ G         S+  T ++ AP
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           E++ G ++Y  A D+WS+GC + E+   KP +S     + +  ++K  G+  E   P + 
Sbjct: 173 EVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKI-GSSGEP--PEIP 226

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
           E                              LSE   D L + L  DP+KR T D+ L H
Sbjct: 227 EH-----------------------------LSEEAKDFLRKCLRRDPKKRPTADELLQH 257

Query: 307 YWF 309
            + 
Sbjct: 258 PFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  168 bits (427), Expect = 1e-49
 Identities = 106/316 (33%), Positives = 161/316 (50%), Gaps = 36/316 (11%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL------- 64
            ++ L+ +  G YG V  A D K+G  VA+KK+               P  S+       
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------------PFQSIIHAKRTY 64

Query: 65  REINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           RE+ +L    H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 122

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           + L+ Q+L G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V 
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 179

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           T WYRAPE++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP  
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            +   L ++    A    Q    + K   A  F G+   +    DLL ++L  D +KRIT
Sbjct: 240 EL---LKKISSESARNYIQSLTQMPKMNFANVFIGA---NPLAVDLLEKMLVLDSDKRIT 293

Query: 300 VDDALNHYWFHEVPLP 315
              AL H +F +   P
Sbjct: 294 AAQALAHAYFAQYHDP 309

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  166 bits (421), Expect = 8e-49
 Identities = 106/326 (32%), Positives = 168/326 (51%), Gaps = 39/326 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-------R 65
           ++ L  +  G YG V  A D +  + VA+KK+               P  SL       R
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-------------PFQSLIHARRTYR 63

Query: 66  EINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVK 120
           E+ +L    H +++ + +V      +++ + VY+V   M  DL  +++   Q  S   V+
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQ 121

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
            L+ QLL G+KY+H   ++HRDLK SN+ +N    L+I DFG++RQ    +  Y   V T
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VAT 178

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            WYRAPE++L    Y+  VD+WSVGCIMAELL  K LF G   +DQ+ +I + +GTP+  
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
           +   +S    A+      P+  + ++     F G+  L+    DLL ++L  D +KRI+ 
Sbjct: 239 VLKKISS-EHARKYIQSLPH--MPQQDLKKIFRGANPLA---IDLLEKMLVLDSDKRISA 292

Query: 301 DDALNHYWFHEVPLPKSKDFMPTFPP 326
            +AL H +F +   P+ +   P   P
Sbjct: 293 SEALAHPYFSQYHDPEDE---PEAEP 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  166 bits (421), Expect = 2e-48
 Identities = 96/327 (29%), Positives = 156/327 (47%), Gaps = 46/327 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +  L K+ EG++G VY ARD+K   +VALK +      K+   +       LREI IL 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLA-----KKLESKSKEVERFLREIQILA 52

Query: 72  SFDHPS-IVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQ--PFSTSEVKCLMLQLL 127
           S +HP  IV + +   D+  S+Y+VMEY++   L+ L++ + +  P S SE   ++ Q+L
Sbjct: 53  SLNHPPNIVKLYDFFQDE-GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSP------LKPYTSLVVT 180
             ++YLH   ++HRD+K  N+LL+ +  V+K+ DFG+++    P          ++ V T
Sbjct: 112 SALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 181 LWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
             Y APE+LLG      S++ D+WS+G  + ELL   P F G        +  K      
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK------ 225

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
                             + P   L       S +   ++S++  DLL +LL  DP+ R+
Sbjct: 226 ---------------IILELPTPSLASPL---SPSNPELISKAASDLLKKLLAKDPKNRL 267

Query: 299 TVDDALNHYWFHEVPLPKSKDFMPTFP 325
           +    L+H     + L +S       P
Sbjct: 268 SSSSDLSHDLLAHLKLKESDLSDLLKP 294

Length = 384

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  156 bits (396), Expect = 5e-45
 Identities = 108/335 (32%), Positives = 167/335 (49%), Gaps = 49/335 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +++L  I  G  GIV  A D   G  VA+KK+      +           + RE+ +L  
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR------AYRELVLLKC 76

Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + +        +  L+ Q+L
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQML 133

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R   +   + PY   VVT +YRA
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRYYRA 190

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM EL+    +F GT  +DQ +K+ + LGTP+      L
Sbjct: 191 PEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFT------GSPVLSE-------SGFDLLNRLLTY 292
                       + Y   R ++P  SF         P  SE          DLL+++L  
Sbjct: 250 QP--------TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301

Query: 293 DPEKRITVDDALNHYWFH--------EVPLPKSKD 319
           DP+KRI+VD+AL H +          E P P+  D
Sbjct: 302 DPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYD 336

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 5e-44
 Identities = 82/295 (27%), Positives = 135/295 (45%), Gaps = 49/295 (16%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +G++G V   R K +G++ A+K +K     K+  ++      +L E NIL   +HP I
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK-----KKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           V +        + +Y+V+EY    +L   +    + FS    +    +++  ++YLH   
Sbjct: 56  VKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAAEIVLALEYLHSLG 113

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           +++RDLK  N+LL+  G +K+ DFG++++  S      +   T  Y APE+LLG K Y  
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGK 172

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
           AVD WS+G ++ E+L  KP F      +  +KI K               L         
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-------------DPL--------- 210

Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT---VDDALNHYWF 309
                   RFP         LS    DL++ LL  DP KR+     ++   H +F
Sbjct: 211 --------RFP-------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  149 bits (379), Expect = 3e-43
 Identities = 86/306 (28%), Positives = 149/306 (48%), Gaps = 55/306 (17%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           IS+G YG V+ A+ K +G+I A+K +K     +++ ++       L E +IL     P +
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD-----QVLTERDILSQAQSPYV 55

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           V +         ++Y+VMEY+   DL  L+E++         +  + +++  ++YLH N 
Sbjct: 56  VKLYYSFQGKK-NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNG 113

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQ--------YGSPLKPYTSLVVTLWYRAPELL 189
           ++HRDLK  N+L+++ G LK+ DFG+S+              K    +V T  Y APE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           LG + +S  VD WS+GCI+ E L   P F G T     ++IF+                 
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQ----------------- 211

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNH 306
                      N+L  +     +     +S+   DL+++LL  DPEKR+   ++++  NH
Sbjct: 212 -----------NILNGKIE---WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257

Query: 307 YWFHEV 312
            +F  +
Sbjct: 258 PFFKGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  151 bits (382), Expect = 6e-43
 Identities = 108/329 (32%), Positives = 169/329 (51%), Gaps = 37/329 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 72

Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 129

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 186

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 187 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 246 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VD+AL H     W+     E P P+  D
Sbjct: 304 SVDEALQHPYINVWYDPAEVEAPPPQIYD 332

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  152 bits (385), Expect = 1e-42
 Identities = 102/327 (31%), Positives = 168/327 (51%), Gaps = 47/327 (14%)

Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           N I  G++G+VY A    + E VA+KKV  +            P    RE+ I+ + +H 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------------PQYKNRELLIMKNLNHI 119

Query: 77  SIVNVK-----EVVMDDHDSVYM--VMEYMEHDLKWLMESM---KQPFSTSEVKCLMLQL 126
           +I+ +K     E    +  ++++  VME++   +   M+             VK    QL
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
              + Y+H  ++ HRDLK  NLL++ N   LK+CDFG ++   +  +   S + + +YRA
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-VSYICSRFYRA 238

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PEL+LGA  Y+T +D+WS+GCI+AE++   P+FSG + VDQ+ +I + LGTPTE      
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE------ 292

Query: 246 SELPGAKANFAKQPY-----NLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            +L     N+A   +       L+K FP     G+P   +   + +++ L Y+P KR+  
Sbjct: 293 DQLKEMNPNYADIKFPDVKPKDLKKVFP----KGTP---DDAINFISQFLKYEPLKRLNP 345

Query: 301 DDALNHYWFHE-----VPLPKSKDFMP 322
            +AL   +F +     + LPK  D +P
Sbjct: 346 IEALADPFFDDLRDPCIKLPKYIDKLP 372

Length = 440

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  150 bits (379), Expect = 2e-42
 Identities = 107/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79

Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 136

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252

Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309

Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  145 bits (369), Expect = 5e-42
 Identities = 68/208 (32%), Positives = 122/208 (58%), Gaps = 14/208 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINIL 70
            ++  + I  G +G+VY+  + ++G+ VA+K++ +   ++E        + S+  EI++L
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA-------LKSIMQEIDLL 53

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ--PFSTSEVKCLMLQLLE 128
            +  HP+IV     + +  DS+Y+++EY E+    L + +K+  PF  S V   + Q+L+
Sbjct: 54  KNLKHPNIVKYIGSI-ETSDSLYIILEYAENGS--LRQIIKKFGPFPESLVAVYVYQVLQ 110

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G+ YLH+  V+HRD+K +N+L    GV+K+ DFG++ +     K   S+V T ++ APE+
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKP 216
           +      STA D+WS+GC + ELL   P
Sbjct: 171 IEM-SGASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  142 bits (360), Expect = 3e-40
 Identities = 90/306 (29%), Positives = 144/306 (47%), Gaps = 53/306 (17%)

Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           +G      ++ L KI EG  G VY+A D+ +G+ VA+KK+++    KE           +
Sbjct: 14  EGDPREL-YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE---------LII 63

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
            EI I+    HP+IV+  +  +   D +++VMEYM+   L  ++       +  ++  + 
Sbjct: 64  NEILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            ++L+G++YLH   V+HRD+K+ N+LL+  G +K+ DFG + Q         S+V T ++
Sbjct: 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYW 182

Query: 184 RAPELLLGAKKYSTAVDMWSVG--CI-MAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            APE++   K Y   VD+WS+G  CI MAE                        G P   
Sbjct: 183 MAPEVIKR-KDYGPKVDIWSLGIMCIEMAE------------------------GEP--- 214

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
             P L E P  +A F      L+  +            S    D LN+ L  DPEKR + 
Sbjct: 215 --PYLRE-PPLRALF------LITTKGIPP-LKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264

Query: 301 DDALNH 306
           ++ L H
Sbjct: 265 EELLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  136 bits (344), Expect = 4e-38
 Identities = 81/310 (26%), Positives = 139/310 (44%), Gaps = 66/310 (21%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMN---VGRKEDCLEYGFPISSLREIN 68
           + E++  + +G+ G+VY+ R K +G+I ALKK+ ++     RK+           LRE+ 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ----------LLRELK 51

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLML 124
            L S + P +V        +   + +V+EYM+     DL   +  + +P     +  +  
Sbjct: 52  TLRSCESPYVVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIAR 106

Query: 125 QLLEGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           Q+L+G+ YLH    ++HRD+K SNLL+N++G +KI DFG+S+   + L    + V T+ Y
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY 166

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            +PE + G + YS A D+WS+G  + E                                 
Sbjct: 167 MSPERIQG-ESYSYAADIWSLGLTLLECA------------------------------- 194

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF-----DLLNRLLTYDPEKRI 298
            L + P          + L++    A      P L    F     D ++  L  DP+KR 
Sbjct: 195 -LGKFPFLPPGQPS-FFELMQ----AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248

Query: 299 TVDDALNHYW 308
           +  + L H +
Sbjct: 249 SAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  133 bits (336), Expect = 5e-37
 Identities = 86/302 (28%), Positives = 138/302 (45%), Gaps = 50/302 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE L  I +G +G V   + + + ++ A+K   MN   K+ C+E G   + L E  IL  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKY--MN---KQKCVEKGSVRNVLNERRILQE 56

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            +HP +VN+     D+ + +Y+V++ +   DL++ +      FS  +VK  + +++  ++
Sbjct: 57  LNHPFLVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKV-KFSEEQVKFWICEIVLALE 114

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   ++HRD+K  N+LL+ QG + I DF ++ +  +P    TS   T  Y APE+L  
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEVLC- 172

Query: 192 AKKYSTAVDMWSVGCIMAELL-AKKPL-FSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            + YS AVD WS+G    E L  K+P      T  DQI    +   T             
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPAT----- 224

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDALNHY 307
                                        S    D +N+LL  DP+KR+   + D  NH 
Sbjct: 225 ----------------------------WSTEAIDAINKLLERDPQKRLGDNLKDLKNHP 256

Query: 308 WF 309
           +F
Sbjct: 257 YF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  133 bits (337), Expect = 6e-37
 Identities = 78/328 (23%), Positives = 132/328 (40%), Gaps = 79/328 (24%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREI 67
           F+F K+  I EG++  V  A++K++ +  A+K   K ++   +K              E 
Sbjct: 3   FKFGKI--IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK--------YVKIEK 52

Query: 68  NILLSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            +L   + HP I+ +     D+ +++Y V+EY  + +L   +            +    +
Sbjct: 53  EVLTRLNGHPGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAE 110

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----------- 174
           +L  ++YLH   ++HRDLK  N+LL+    +KI DFG ++       P            
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 175 ---------TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD 225
                     S V T  Y +PELL   K    + D+W++GCI+ ++L  KP F G+ E  
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Query: 226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDL 285
              KI K                           Y+      P A             DL
Sbjct: 230 TFQKILKLE-------------------------YSFPPNFPPDAK------------DL 252

Query: 286 LNRLLTYDPEKRITVDDAL----NHYWF 309
           + +LL  DP+ R+ V++       H +F
Sbjct: 253 IEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  132 bits (334), Expect = 9e-37
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)

Query: 14  EKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
               K+ EG +G VY+ +      K    VA+K +K +   ++           LRE  I
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-------EEFLREARI 54

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
           +   DHP++V +  V  ++ + +Y+VMEYME  DL   +   +   S S++    LQ+  
Sbjct: 55  MRKLDHPNVVKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS-----------PLKPYTSL 177
           G++YL     +HRDL   N L+    V+KI DFG+SR               P++     
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----- 168

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
               W  APE L    K+++  D+WS G ++ E+  L ++P
Sbjct: 169 ----WM-APESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  130 bits (329), Expect = 6e-36
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV---KMNVGRKEDCLEYGFPISSLREIN 68
           ++E L  I +G++G V + R K  G+I+  K++    M    K+  +          E+N
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS---------EVN 51

Query: 69  ILLSFDHPSIVNV--KEVVMDDHDSVYMVMEYMEH-DLKWLME---SMKQPFSTSEVKCL 122
           IL    HP+IV    + +   +  ++Y+VMEY E  DL  L++     ++      +  +
Sbjct: 52  ILRELKHPNIVRYYDRIIDRSNQ-TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110

Query: 123 MLQLLEGVKYLH-----DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
           + QLL  +   H      N VLHRDLK +N+ L+    +K+ DFG+++  G       + 
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
           V T +Y +PE L     Y    D+WS+GC++ EL A  P F+   ++    KI
Sbjct: 171 VGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  129 bits (327), Expect = 1e-35
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 22/215 (10%)

Query: 13  FEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            E   K+ EG +G VY+       + +   VA+K +K     +E           L E +
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-------EEFLEEAS 53

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
           I+    HP+IV +  V     + +Y+V EYM   DL   +    +  +  ++  + LQ+ 
Sbjct: 54  IMKKLSHPNIVRLLGVCTQG-EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIA 112

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WY 183
           +G++YL     +HRDL   N L+    V+KI DFG+SR        Y           W 
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR-DIYEDDYYRKRGGGKLPIKWM 171

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            APE L    K+++  D+WS G ++ E+  L ++P
Sbjct: 172 -APESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  128 bits (324), Expect = 2e-35
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 14  EKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
               K+ EG +G VY+             VA+K +K +   ++   E+      LRE  I
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ-IEEF------LREARI 54

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLL 127
           +   DHP+IV +  V  ++ + + +VMEYM   DL  +L ++  +  S S++    LQ+ 
Sbjct: 55  MRKLDHPNIVKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL------ 181
            G++YL     +HRDL   N L+    V+KI DFG+SR     L       V        
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYYKVKGGKLPIR 169

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           W  APE L    K+++  D+WS G ++ E+ 
Sbjct: 170 WM-APESLK-EGKFTSKSDVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  126 bits (319), Expect = 1e-34
 Identities = 82/310 (26%), Positives = 137/310 (44%), Gaps = 74/310 (23%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVK---MNVGRKEDCLEYGFPISSLREINI 69
           F+ L K+ +G+YG VY+ +     +  ALK+V    M+   +ED         ++ EI I
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED---------AVNEIRI 52

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLM---ESMKQPFSTSEVKCLMLQ 125
           L S +HP+I++ KE  +D  + + +VMEY    DL   +   +  ++     E+  + +Q
Sbjct: 53  LASVNHPNIISYKEAFLDG-NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---------QYGSPLKPYTS 176
           LL G++ LH+  +LHRDLK++N+LL    ++KI D G+S+         Q G+P      
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH----- 166

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
                 Y APE+  G + YS   D+WS+GC++ E+    P F   +              
Sbjct: 167 ------YMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------------- 205

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                   + +L           Y + R ++P      S  L       +  +L   P+ 
Sbjct: 206 --------MQDL----------RYKVQRGKYPPIPPIYSQDLQN----FIRSMLQVKPKL 243

Query: 297 RITVDDALNH 306
           R   D  L  
Sbjct: 244 RPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  126 bits (319), Expect = 2e-34
 Identities = 90/315 (28%), Positives = 142/315 (45%), Gaps = 65/315 (20%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMN--VGRKEDCLEYGFPISSLR-EI 67
           F++ K   I +GTYG VY A +  +GE++A+K+V++   +  + D  +    + +LR EI
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDM-VKALRSEI 59

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-----------SMKQPFST 116
             L   DH +IV             Y+  E  E  L   +E                F  
Sbjct: 60  ETLKDLDHLNIVQ------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE 107

Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ----YGSPLK 172
             V+    Q+LEG+ YLH   +LHRDLK  NLL++  G+ KI DFG+S++    Y +   
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167

Query: 173 PYTSLVVTLWYRAPELL-LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
              S+  ++++ APE++   ++ YS  VD+WS+GC++ E+ A +  +S   + + I  +F
Sbjct: 168 --MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMF 222

Query: 232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLT 291
           K LG                            R   P      S  LS    D LN   T
Sbjct: 223 K-LGN--------------------------KRSAPPIPPDV-SMNLSPVALDFLNACFT 254

Query: 292 YDPEKRITVDDALNH 306
            +P+ R T  + L H
Sbjct: 255 INPDNRPTARELLQH 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (318), Expect = 2e-34
 Identities = 87/311 (27%), Positives = 142/311 (45%), Gaps = 62/311 (19%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +++ NKI  GT+G VY A +  +GE++A+K++++     +   E         E+ +L 
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA------DEMKVLE 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME--------HDLKWLMESMKQPFSTSEVKCLM 123
              HP++V    V +   + VY+ MEY             + L E + + ++        
Sbjct: 55  LLKHPNLVKYYGVEVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT-------- 105

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----TSLVV 179
           LQLLEG+ YLH + ++HRD+K +N+ L++ GV+K+ DFG + +  +          SL  
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 180 TLWYRAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           T  Y APE++ G K   +  A D+WS+GC++ E+   K  +S      QI  +F      
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHV---- 219

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                       GA            +   P      S  LS  G D L+R L  DP+KR
Sbjct: 220 ------------GAGH----------KPPIPD-----SLQLSPEGKDFLDRCLESDPKKR 252

Query: 298 ITVDDALNHYW 308
            T  + L H +
Sbjct: 253 PTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  125 bits (317), Expect = 2e-34
 Identities = 83/302 (27%), Positives = 137/302 (45%), Gaps = 61/302 (20%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           F+ L K+ EG+YG VY+A  K++G++VA+K V +     ED       +  + +EI+IL 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----ED-------LQEIIKEISILK 53

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLMLQLL 127
             D P IV        + D +++VMEY       D+   M+   +  +  E+  ++ Q L
Sbjct: 54  QCDSPYIVKYYGSYFKNTD-LWIVMEYCGAGSVSDI---MKITNKTLTEEEIAAILYQTL 109

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G++YLH N  +HRD+K  N+LLN +G  K+ DFG+S Q    +    +++ T ++ APE
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 188 LLLGAKKYSTAVDMWSVG--CI-MAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           ++     Y+   D+WS+G   I MAE                                P 
Sbjct: 170 VIQE-IGYNNKADIWSLGITAIEMAEGK------------------------------PP 198

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
            S++   +A F            P  + +     S    D + + L  DPE+R +    L
Sbjct: 199 YSDIHPMRAIFMI-------PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251

Query: 305 NH 306
            H
Sbjct: 252 QH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  124 bits (313), Expect = 8e-34
 Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 56/293 (19%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV---KMNVGRKEDCLEYGFPISSLREIN 68
           +FE LNKI +G++G+V++   K    + A+K++   KMN   +E+ +          E  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI---------DEAR 51

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLML 124
           +L   D   I+   E  +D    + +VMEY E    H L  L     +P    +V    +
Sbjct: 52  VLAKLDSSYIIRYYESFLDK-GKLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFI 108

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q+L G+ +LH   +LHRD+K+ NL L+    +KI D G+++          ++V T +Y 
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYL 168

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           +PE L   K Y+   D+W++G ++ E    K  F    +   I KI              
Sbjct: 169 SPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-------------- 213

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                             +R  FP  S   S  L+     L+++ LT D  +R
Sbjct: 214 ------------------IRGVFPPVSQMYSQQLA----QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (312), Expect = 2e-33
 Identities = 73/292 (25%), Positives = 130/292 (44%), Gaps = 48/292 (16%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKM--NVGRKEDCLEYGFPISSL-REINILLSFDH 75
           +  G++G VY   +   G+  A+K+V +  +    ++       +  L +EI +L    H
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEA------VKQLEQEIALLSKLQH 61

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+IV       ++ D++Y+ +E +    L  L++     F    ++    Q+L G++YLH
Sbjct: 62  PNIVQYLGTEREE-DNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH 119

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
           D   +HRD+K +N+L++  GV+K+ DFGM++Q         S   + ++ APE++     
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
           Y  A D+WS+GC + E+   KP +S    V  + KI ++   P          +P     
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------PIPDH--- 226

Query: 255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                                  LS+   D + + L  DP  R T  + L H
Sbjct: 227 -----------------------LSDEAKDFILKCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  123 bits (310), Expect = 3e-33
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 46/296 (15%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  G +G V   + K      ALK VK     K   +E G       E  IL   +HP I
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK-----KRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
           V +     D    +YM+MEY      W +   +  F     +  +  ++   +YLH+  +
Sbjct: 56  VKLYRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI 114

Query: 139 LHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTA 198
           ++RDLK  NLLL++ G +K+ DFG +++  S  K +T    T  Y APE++L  K Y  +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILN-KGYDFS 172

Query: 199 VDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQ 258
           VD WS+G ++ ELL  +P F    E     +I+  +      +                 
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPM--EIYNDILKGNGKL----------------- 213

Query: 259 PYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWF 309
                   FP         + ++  DL+ +LL  +PE+R+      + D   H WF
Sbjct: 214 -------EFP-------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 6e-33
 Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            F  L  I +G++G VY+A DK++ ++VA+K +  ++   ED +E        +EI  L 
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIE-----DIQQEIQFLS 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               P I       +     ++++MEY        L++        + +  ++ ++L G+
Sbjct: 55  QCRSPYITKYYGSFLKGS-KLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGL 111

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           +YLH+   +HRD+K +N+LL+ +G +K+ DFG+S Q  S +    + V T ++ APE++ 
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKP 216
            +  Y    D+WS+G    EL   +P
Sbjct: 172 QS-GYDEKADIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 1e-32
 Identities = 69/214 (32%), Positives = 119/214 (55%), Gaps = 19/214 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINIL 70
           ++E + +I  GTYG VY+ARD  +GE+VA+K +K+  G  +D          ++ EI++L
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DD-------FEIIQQEISML 54

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
               HP+IV      +   D +++VMEY     L+ + +  + P S  ++  +  + L+G
Sbjct: 55  KECRHPNIVAYFGSYLRR-DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKG 113

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           + YLH+   +HRD+K +N+LL   G +K+ DFG+S Q  + +    S + T ++ APE+ 
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 190 LGAKK--YSTAVDMWSVG--CI-MAELLAKKPLF 218
              +K  Y    D+W++G   I +AEL    P+F
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  119 bits (300), Expect = 9e-32
 Identities = 71/251 (28%), Positives = 131/251 (52%), Gaps = 22/251 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKM---NVGRKEDCLEYGFPISSLREIN 68
           E+ K  ++  G +   Y+ARD K+G ++A+K+V         +E+ +E     +  +EI 
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-----ALRKEIR 55

Query: 69  ILLSFDHPSIVN-VKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
           ++   +HP I+  +     D H ++++  E+M       + S    F  + +     QLL
Sbjct: 56  LMARLNHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL 113

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKP----YTSLVVTLW 182
            G+ YLH+N ++HRD+K +NLL+++ G  L+I DFG + +  +           L+ T+ 
Sbjct: 114 RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK---TLGTPT- 238
           + APE+L G ++Y  + D+WSVGC++ E+   KP ++     + +  IFK       P+ 
Sbjct: 174 FMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232

Query: 239 -ETIWPGLSEL 248
            E + PGL ++
Sbjct: 233 PEHLSPGLRDV 243

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 3e-31
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 35/221 (15%)

Query: 17  NKISEGTYGIVYRA--RDKKSGEI-VALKKVK---MNVGRKEDCLEYGFPISSLREINIL 70
            K+ EG +G VY+   + K      VA+K +K       RK+           L+E  ++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD----------FLKEARVM 50

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK--------WLMESMKQPFSTSEVKC 121
               HP++V +  V  ++ + +Y+V+EYME  DL               K   S  ++  
Sbjct: 51  KKLGHPNVVRLLGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
             +Q+ +G++YL     +HRDL   N L+    V+KI DFG+SR        Y       
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGK 168

Query: 182 ----WYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
               W  APE L     +++  D+WS G ++ E+  L   P
Sbjct: 169 LPIRWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  119 bits (299), Expect = 5e-31
 Identities = 96/318 (30%), Positives = 156/318 (49%), Gaps = 43/318 (13%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L ++ +G YG V+ A+ K +GEIVALK++K ++  K + + +      L E +IL 
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-----VLTERDILT 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           +     +V +     DD + +Y+ MEY+   D + L+ +     S    +  M ++ E V
Sbjct: 57  TTKSEWLVKLLYAFQDD-EYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAV 114

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
             LH+   +HRDLK  N L++  G +K+ DFG+S+   +      S+V +  Y APE+L 
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLR 171

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K Y   VD WS+GC++ E L   P FSG+              TP ET          
Sbjct: 172 G-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------------TPNETW--------- 207

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDALNHYWF 309
              N       L R  +    F     LS+  +DL+ +L+  DP +R  +++D  NH +F
Sbjct: 208 --ENLKYWKETLQRPVYDDPRFN----LSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFF 260

Query: 310 HEVPLPKSKDFMPTFPPQ 327
            EV   + ++  P F P+
Sbjct: 261 KEVDWNELRELKPPFVPE 278

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 5e-31
 Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 23/221 (10%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE +  I EGTYG VY+AR KK+G++VA+K + +    +E+  E         E NIL  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---------EYNILRK 58

Query: 73  F-DHPSIVN-----VKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCL 122
           + +HP+I       +K+    + D +++VME        DL   +    +      +  +
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           + + L G+ YLH+N V+HRD+K  N+LL     +K+ DFG+S Q  S L    + + T +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 183 YRAPELLLGAKK----YSTAVDMWSVGCIMAELLAKKPLFS 219
           + APE++   ++    Y    D+WS+G    EL   KP   
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  118 bits (297), Expect = 5e-31
 Identities = 69/210 (32%), Positives = 114/210 (54%), Gaps = 13/210 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK  M+   K+   ++      ++E+  L  
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKK--MSYSGKQSNEKWQ---DIIKEVRFLQQ 71

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  K   + +H + ++VMEY       ++E  K+P    E+  +    L+G+ Y
Sbjct: 72  LRHPNTIEYKGCYLREH-TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH +  +HRD+K  N+LL   G +K+ DFG +    S + P  S V T ++ APE++L  
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSA----SLVSPANSFVGTPYWMAPEVILAM 186

Query: 193 K--KYSTAVDMWSVGCIMAELLAKK-PLFS 219
              +Y   VD+WS+G    EL  +K PLF+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  116 bits (292), Expect = 2e-30
 Identities = 63/218 (28%), Positives = 118/218 (54%), Gaps = 21/218 (9%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVK----MNVGRKEDCLEYGFPISSLRE 66
           F+ EK  KI +G + +VY+A     G +VALKKV+    M+   ++DCL         +E
Sbjct: 4   FKIEK--KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL---------KE 52

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLME---SMKQPFSTSEVKCL 122
           I++L   DHP+++      +++++ + +V+E  +  DL  +++     K+      +   
Sbjct: 53  IDLLKQLDHPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
            +QL   ++++H   ++HRD+K +N+ +   GV+K+ D G+ R + S      SLV T +
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           Y +PE +     Y+   D+WS+GC++ E+ A +  F G
Sbjct: 172 YMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  114 bits (287), Expect = 9e-30
 Identities = 83/306 (27%), Positives = 145/306 (47%), Gaps = 47/306 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
            +   KI EG+ GIV  A DK +G  VA+KK  M++ RK+   E  F      E+ I+  
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKK--MDL-RKQQRRELLF-----NEVVIMRD 72

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           + HP+IV +    +   D +++VME++E   L  ++   +   +  ++  + L +L+ + 
Sbjct: 73  YQHPNIVEMYSSYLVG-DELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALS 129

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   V+HRD+K+ ++LL + G +K+ DFG   Q    +    SLV T ++ APE ++ 
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-VIS 188

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
              Y T VD+WS+G ++ E++  +P +     +  + +I +    P              
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPP-------------- 233

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                K  + +            SP L       L+R+L  DP +R T  + LNH +  +
Sbjct: 234 ---KLKNLHKV------------SPRLRS----FLDRMLVRDPAQRATAAELLNHPFLAK 274

Query: 312 VPLPKS 317
              P S
Sbjct: 275 AGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 1e-29
 Identities = 74/297 (24%), Positives = 139/297 (46%), Gaps = 48/297 (16%)

Query: 21  EGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN 80
           +G +G VY+A+ K++G   A K +++     E+ LE       + EI+IL    HP+IV 
Sbjct: 15  DGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELE-----DFMVEIDILSECKHPNIVG 66

Query: 81  VKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVL 139
           + E    ++  +++++E+ +   L  +M  +++  +  +++ +  Q+LE + +LH + V+
Sbjct: 67  LYEAYFYENK-LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 140 HRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL----GAKKY 195
           HRDLK  N+LL   G +K+ DFG+S +  S L+   + + T ++ APE++         Y
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF 255
               D+WS+G  + EL   +P      E++ +  + K L +                   
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHH---ELNPMRVLLKILKSE------------------ 224

Query: 256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
              P  L +    ++SF           D L   L  DP+ R T  + L H +  + 
Sbjct: 225 ---PPTLDQPSKWSSSFN----------DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 2e-29
 Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 52/303 (17%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L  IS+G +G VY A+ + +G+  A+K +K     K D +      +   E  I++    
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLK-----KSDMIAKNQVTNVKAERAIMMIQGE 55

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
              V          D +Y+VMEY+   D   L++++         K  + +++ GV+ LH
Sbjct: 56  SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH 114

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
              ++HRD+K  NLL++  G LK+ DFG+SR      K     V T  Y APE +LG   
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETILG-VG 169

Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
                D WS+GC++ E L   P F   T     D +F                       
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAET----PDAVFD---------------------- 203

Query: 255 FAKQPYNLLRKR--FPAASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNHYWF 309
                 N+L +R  +P          S    DL+NRLL  DP KR+      +  +H +F
Sbjct: 204 ------NILSRRINWPEEVKEF---CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Query: 310 HEV 312
             +
Sbjct: 255 KSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-29
 Identities = 77/261 (29%), Positives = 136/261 (52%), Gaps = 25/261 (9%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINILLSFDHPS 77
           + +G +G VY   D  +G  +A+K+V  +    E   E    +++L  EI +L +  H  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE----VNALECEIQLLKNLQHER 65

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ--PFSTSEVKCLMLQLLEGVKYLHD 135
           IV     + DD +++ + MEYM      + + +K     + +  +    Q+LEGV+YLH 
Sbjct: 66  IVQYYGCLRDD-ETLSIFMEYMPGGS--VKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ------YGSPLKPYTSLVVTLWYRAPELL 189
           N ++HRD+K +N+L ++ G +K+ DFG S++       G+ +K  T    T ++ +PE++
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG---TPYWMSPEVI 179

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            G + Y    D+WSVGC + E+L +KP ++   E + +  IFK    PT    P  S + 
Sbjct: 180 SG-EGYGRKADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPQLP--SHVS 233

Query: 250 GAKANFAKQPYNLLRKRFPAA 270
               NF ++ +    K+ P+A
Sbjct: 234 PDARNFLRRTFVENAKKRPSA 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  113 bits (286), Expect = 2e-29
 Identities = 97/320 (30%), Positives = 141/320 (44%), Gaps = 80/320 (25%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE +  +  G++G V   R K SG+  ALK +      K   ++       L E  IL 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS-----KAKIVKLKQVEHVLNEKRILQ 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDL-KWLMESMKQP-----FSTSEVKCLML 124
           S  HP +VN+     DD  ++Y+VMEY+   +L   L +S + P     F  ++V  L L
Sbjct: 57  SIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV-VLAL 114

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           +      YLH   +++RDLK  NLLL++ G +KI DFG +++    +K  T +L  T  Y
Sbjct: 115 E------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR----VKGRTYTLCGTPEY 164

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L  K Y  AVD W++G ++ E+LA  P F                         
Sbjct: 165 LAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPF------------------------- 198

Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      F   P  +  K      RFP  SF      S    DL+  LL  D  KR
Sbjct: 199 -----------FDDNPIQIYEKILEGKVRFP--SF-----FSPDAKDLIRNLLQVDLTKR 240

Query: 298 I-----TVDDALNHYWFHEV 312
           +      V+D  NH WF  +
Sbjct: 241 LGNLKNGVNDIKNHPWFAGI 260

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (283), Expect = 2e-29
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 10/227 (4%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  +  + +G +G     R  +   +V  K+V +         E     + L EI IL  
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT-----RLSEKERRDA-LNEIVILSL 55

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             HP+I+      MDD +++ + MEY         ++    Q F    V   + Q++  V
Sbjct: 56  LQHPNIIAYYNHFMDD-NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            Y+H   +LHRD+KT N+ L   G++K+ DFG+S+  GS      ++V T +Y +PEL  
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           G  KY+   D+W++GC++ ELL  K  F  T  ++ + KI +   TP
Sbjct: 175 G-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  113 bits (284), Expect = 3e-29
 Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 12/206 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK+  +  +  +  +       ++E+  L  
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQK 71

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  +   + +H + ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 72  LRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL+  G++K+ DFG +    S + P    V T ++ APE++L  
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANXFVGTPYWMAPEVILAM 186

Query: 193 K--KYSTAVDMWSVGCIMAELLAKKP 216
              +Y   VD+WS+G    EL  +KP
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  112 bits (282), Expect = 7e-29
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 12/206 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK  M+   K+   ++      ++E+  L  
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKK--MSYSGKQSNEKWQ---DIIKEVKFLQR 81

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  K   + +H + ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 82  IKHPNSIEYKGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL   G +K+ DFG +    S   P  S V T ++ APE++L  
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSA----SIASPANSFVGTPYWMAPEVILAM 196

Query: 193 K--KYSTAVDMWSVGCIMAELLAKKP 216
              +Y   VD+WS+G    EL  +KP
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  109 bits (275), Expect = 4e-28
 Identities = 60/202 (29%), Positives = 110/202 (54%), Gaps = 13/202 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + E L ++  G  G+V +   + +G+I+A+K +++ +               LRE++IL 
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-------KQILRELDILH 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             + P IV       ++ D + + MEYM+   L  +++ ++       +  + + +L+G+
Sbjct: 55  KCNSPYIVGFYGAFYNNGD-ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGL 113

Query: 131 KYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            YLH+   ++HRD+K SN+L+N++G +K+CDFG+S Q  + L    + V T  Y APE +
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERI 171

Query: 190 LGAKKYSTAVDMWSVGCIMAEL 211
            G   YS   D+WS+G  + EL
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 5e-28
 Identities = 61/225 (27%), Positives = 114/225 (50%), Gaps = 14/225 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +++L  I  G YG VYR +   +G +VALK +  N+   +D +         RE+ +L  
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKII--NLDTPDDDVS-----DIQREVALLSQ 55

Query: 73  FDHPSIVNVKEV---VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
                  N+ +     +     ++++MEY E   ++ LM++   P +   +  ++ ++L 
Sbjct: 56  LRQSQPPNITKYYGSYLKG-PRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLV 112

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            +KY+H   V+HRD+K +N+L+ N G +K+CDFG++          ++ V T ++ APE+
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT 233
           +   K Y T  D+WS+G  + E+    P +S       +  I K+
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS 217

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  108 bits (272), Expect = 9e-28
 Identities = 71/257 (27%), Positives = 130/257 (50%), Gaps = 24/257 (9%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHPS 77
           I  G++G VY   +  SGE++A+K+V++              + +L REI +L    H +
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 78  IVNVKEVVMD-DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           IV      +D DH ++++  EY+       + +    F  + V+  + Q+L+G+ YLH+ 
Sbjct: 68  IVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQY------GSPLKPYTSLVVTLWYRAPELLL 190
            ++HRD+K +N+L++N+G +KI DFG+S++               SL  ++++ APE ++
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-VV 184

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
               Y+   D+WS+GC++ E+L  K  F    +  Q+  IFK           G +  P 
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI----------GENASPE 231

Query: 251 AKANFAKQPYNLLRKRF 267
             +N + +  + L K F
Sbjct: 232 IPSNISSEAIDFLEKTF 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 9e-28
 Identities = 92/351 (26%), Positives = 145/351 (41%), Gaps = 83/351 (23%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINIL 70
           +FE +  I  G +G V+  RDK +G++ A+K +     RK D ++    I+ +R E +IL
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-----RKSDMIKRNQ-IAHVRAERDIL 55

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLLE 128
              D P IV +      D + +Y+VMEYM   DL   L+   K  F     +  + +L+ 
Sbjct: 56  ADADSPWIVKL-YYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVL 112

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS------------------- 169
            +  +H    +HRD+K  N+L++  G +K+ DFG+ ++                      
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 170 ------PLKPYT----SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS 219
                   K       S V T  Y APE+L G   Y    D WS+G I+ E+L   P F 
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 220 GTTEVDQIDKIF---KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSP 276
             T  +  +KI    ++L                               RFP       P
Sbjct: 232 SDTLQETYNKIINWKESL-------------------------------RFPP-----DP 255

Query: 277 VLSESGFDLLNRLLTYDPEKRIT-VDDALNHYWFHEVPLPKSKDFMPTFPP 326
            +S    DL+ RLL  DPE R+   ++  +H +F  +     ++  P F P
Sbjct: 256 PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVP 305

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  109 bits (274), Expect = 1e-27
 Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 12/206 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L++I  G++G VY A +  + E+VA+KK+  +  +  +  +       ++E+  L  
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-----DIIKEVKFLQQ 77

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  K   + +H + ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 78  LKHPNTIEYKGCYLKEH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 136

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL   G +K+ DFG +    S   P  S V T ++ APE++L  
Sbjct: 137 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFVGTPYWMAPEVILAM 192

Query: 193 K--KYSTAVDMWSVGCIMAELLAKKP 216
              +Y   VD+WS+G    EL  +KP
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  107 bits (269), Expect = 2e-27
 Identities = 74/242 (30%), Positives = 125/242 (51%), Gaps = 24/242 (9%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKV---KMNVGRKEDCLEYGFPISSLREINI 69
           +E + KI EG++G +Y A+ K   E   +K++   KM V  KE         +S +E+ +
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE---------ASKKEVIL 52

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FSTSEVKCLMLQ 125
           L    HP+IV        ++  +++VMEY   D   LM+ + +     FS  ++    +Q
Sbjct: 53  LAKMKHPNIVTFFAS-FQENGRLFIVMEYC--DGGDLMKRINRQRGVLFSEDQILSWFVQ 109

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           +  G+K++HD  +LHRD+K+ N+ L+  G V K+ DFG++RQ    ++   + V T +Y 
Sbjct: 110 ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYL 169

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           +PE+    + Y+   D+WS+GC++ EL   K  F G      + KI +    P   I P 
Sbjct: 170 SPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPN 225

Query: 245 LS 246
            S
Sbjct: 226 FS 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  107 bits (268), Expect = 3e-27
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 24/210 (11%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GTYGIVY ARD  +   +A+K++       E    Y  P+    EI +     H +I
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIP------ERDSRYVQPLH--EEIALHSYLKHRNI 67

Query: 79  VN-VKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSE--VKCLMLQLLEGVK 131
           V  +     +    ++M     E      L  L+ S   P   +E  +     Q+LEG+K
Sbjct: 68  VQYLGSDSENGFFKIFM-----EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 132 YLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYT-SLVVTLWYRAPELL 189
           YLHDN ++HRD+K  N+L+N   GV+KI DFG S++    + P T +   TL Y APE++
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG-INPCTETFTGTLQYMAPEVI 181

Query: 190 -LGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
             G + Y    D+WS+GC + E+   KP F
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  106 bits (267), Expect = 4e-27
 Identities = 58/212 (27%), Positives = 118/212 (55%), Gaps = 16/212 (7%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV---KMNVGRKEDCLEYGFPISSLREIN 68
           ++ K+ KI EG++G     + K+ G+   +K++   KM+   +E+         S +E+ 
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREE---------SRKEVA 51

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ-PFSTSEVKCLMLQL 126
           +L +  HP+IV  +E   +++ ++Y+VM+Y E  DL   + + +   F   ++    +Q+
Sbjct: 52  VLSNMKHPNIVQYQES-FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI 110

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
              +K++HD  +LHRD+K+ N+ L   G +K+ DFG++R   S ++   + + T +Y +P
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
           E+    + Y+   D+W++GC++ E+   K  F
Sbjct: 171 EICEN-RPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  106 bits (267), Expect = 4e-27
 Identities = 64/212 (30%), Positives = 115/212 (54%), Gaps = 12/212 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EK+  +  G +GIV+  R K   ++V +K++ +    K++ L      ++  E  +L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL------AAQNECQVLK 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL--KWLMESMKQPFSTSEVKCLMLQLLEG 129
              HP+I+   E  ++D  ++ +VMEY       +++ +          +    +Q+L  
Sbjct: 55  LLSHPNIIEYYENFLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113

Query: 130 VKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + ++H   +LHRDLKT N+LL+ ++ V+KI DFG+S+   S  K YT +V T  Y +PEL
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPEL 172

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
             G K Y+   D+W++GC++ EL + K  F  
Sbjct: 173 CEG-KPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  106 bits (266), Expect = 7e-27
 Identities = 80/297 (26%), Positives = 136/297 (45%), Gaps = 43/297 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE + +I  GTYG VY+AR+  +GE+ A+K +K+  G     ++        +EI ++ 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--------QEIIMMK 61

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV      +   D +++ ME+        +  +  P S S++  +  + L+G+ 
Sbjct: 62  DCKHSNIVAYFGSYLR-RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL + G +K+ DFG+S Q  + +    S + T ++ APE+   
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 192 AKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            +K  Y+   D+W+VG    EL   +P                    P   + P  +   
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQP--------------------PMFDLHPMRALFL 220

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
             K+NF  QP  L  K   + SF             +   LT +P+KR T +  L H
Sbjct: 221 MTKSNF--QPPKLKDKMKWSNSF----------HHFVKMALTKNPKKRPTAEKLLQH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  106 bits (266), Expect = 1e-26
 Identities = 85/304 (27%), Positives = 135/304 (44%), Gaps = 44/304 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +  +L+++ EG  G V + R K +G I ALK +  +        +    I  LRE+ I  
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-----DLQKQI--LRELEINK 54

Query: 72  SFDHPSIVNVKEVVMDDHDS-VYMVMEYME-HDLKWLMESM-KQPFSTSEVKCLMLQ--L 126
           S   P IV      +D+  S + + MEY E   L  + + + K+     E     +   +
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESV 114

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           L+G+ YLH   ++HRD+K SN+LL  +G +K+CDFG+S +  + L    +   T +Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAP 172

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF--SGTTEVDQIDKIFKTLGTPTETIWPG 244
           E + G K YS   D+WS+G  + E+   +  F   G   +  I+ +   +  P     P 
Sbjct: 173 ERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN----PE 227

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           L + PG    +                       SE   D + + L  DP +R T  D L
Sbjct: 228 LKDEPGNGIKW-----------------------SEEFKDFIKQCLEKDPTRRPTPWDML 264

Query: 305 NHYW 308
            H W
Sbjct: 265 EHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  101 bits (252), Expect = 5e-25
 Identities = 70/208 (33%), Positives = 108/208 (51%), Gaps = 12/208 (5%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVK-MNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           ++ +G++G VY  +DKK+     LK +K + VG     L     + + +E  +L   DHP
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGE----LNPNETVQANQEAQLLSKLDHP 62

Query: 77  SIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQP---FSTSEVKCLMLQLLEGVKY 132
           +IV      ++  D+  ++ EY E  DL   +E +K      S ++V    +QLL GV Y
Sbjct: 63  AIVKFHASFLE-RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H   +LHRDLK  N+ L N  +LKI DFG+SR         T+   T +Y +PE  L  
Sbjct: 122 MHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKH 179

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           + Y +  D+WS+GCI+ E+      F G
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEG 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  102 bits (254), Expect = 5e-25
 Identities = 84/305 (27%), Positives = 143/305 (46%), Gaps = 47/305 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
            E   KI EG+ GIV  AR+K SG  VA   VKM   RK+   E  F      E+ I+  
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVA---VKMMDLRKQQRRELLF-----NEVVIMRD 74

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE-VKCLMLQLLEGVK 131
           + H ++V + +  +   + ++++ME+++     L + + Q     E +  +   +L+ + 
Sbjct: 75  YQHQNVVEMYKSYLVGEE-LWVLMEFLQGGA--LTDIVSQTRLNEEQIATVCESVLQALC 131

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V+HRD+K+ ++LL   G +K+ DFG   Q    +    SLV T ++ APE ++ 
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE-VIS 190

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
              Y T VD+WS+G ++ E++  +P +   + V  + ++                  P  
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------------RDSPPPK 236

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             N  K                 SPVL     D L R+LT +P++R T  + L+H +  +
Sbjct: 237 LKNAHKI----------------SPVLR----DFLERMLTREPQERATAQELLDHPFLLQ 276

Query: 312 VPLPK 316
             LP+
Sbjct: 277 TGLPE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 58/209 (27%), Positives = 120/209 (57%), Gaps = 14/209 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++G + A K +     + E+ LE       + EI+IL S
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT---KSEEELE-----DYMVEIDILAS 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP+IV + +    + +++++++E+     +  +M  +++P +  +++ +  Q LE + 
Sbjct: 59  CDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN 117

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL- 190
           YLH+N ++HRDLK  N+L    G +K+ DFG+S +    ++   S + T ++ APE+++ 
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 191 ---GAKKYSTAVDMWSVGCIMAELLAKKP 216
                + Y    D+WS+G  + E+   +P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  100 bits (251), Expect = 2e-24
 Identities = 83/314 (26%), Positives = 153/314 (48%), Gaps = 50/314 (15%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V  A  K + E  A+K +K +V  ++D +E      ++ E  +L L+++HP 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVE-----CTMVERRVLALAWEHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           + ++        + ++ VMEY+   DL + ++S  + F  +  +    +++ G+++LH  
Sbjct: 58  LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKK 115

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            +++RDLK  N+LL+  G +KI DFGM ++  +     ++   T  Y APE+L G +KY+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYN 174

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
            +VD WS G ++ E+L  +  F G  E    D++F             L++ P       
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDE----DELF----------DSILNDRP------- 213

Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD-DALNHYWFHEVPLP 315
                     FP         +S+   D L++L   DP KR+ VD D   H +F  +   
Sbjct: 214 ---------HFPR-------WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE 257

Query: 316 K--SKDFMPTFPPQ 327
           +   ++  P F P+
Sbjct: 258 RLEKREIPPPFKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 97.8 bits (243), Expect = 1e-23
 Identities = 72/241 (29%), Positives = 127/241 (52%), Gaps = 35/241 (14%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINILLSFDHPS 77
           + +G +G VY   D  +G  +A+K+V+ +    E   E    +++L  EI +L +  H  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE----VNALECEIQLLKNLLHER 65

Query: 78  IVNVKEVVMDDHD-SVYMVMEYM-----EHDLK---WLMESMKQPFSTSEVKCLMLQLLE 128
           IV     + D  + ++ + ME+M     +  LK    L E++ + ++         Q+LE
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR--------QILE 117

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY------GSPLKPYTSLVVTLW 182
           GV YLH N ++HRD+K +N+L ++ G +K+ DFG S++       G+ +K  T    T +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG---TPY 174

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           + +PE++ G + Y    D+WSVGC + E+L +KP ++   E + +  IFK    PT  + 
Sbjct: 175 WMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230

Query: 243 P 243
           P
Sbjct: 231 P 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 81/314 (25%), Positives = 136/314 (43%), Gaps = 68/314 (21%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI---- 67
           + E++  +  GT+G V+  RD+ S    ALK   M +            +  L++     
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKV--MAIPE----------VIRLKQEQHVH 49

Query: 68  ---NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
               +L    HP I+ +      D   +YM+MEY+   +L   + +  + FS S      
Sbjct: 50  NEKRVLKEVSHPFIIRL-FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYA 107

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            +++  ++YLH   +++RDLK  N+LL+ +G +K+ DFG +++     + +T L  T  Y
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWT-LCGTPEY 164

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE ++ +K ++ AVD W++G ++ E+L   P F      D    I+       E I  
Sbjct: 165 LAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFD----DNPFGIY-------EKILA 212

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI----- 298
           G  E P     +AK                          DL+ +LL  D  +R+     
Sbjct: 213 GKLEFPRHLDLYAK--------------------------DLIKKLLVVDRTRRLGNMKN 246

Query: 299 TVDDALNHYWFHEV 312
             DD  NH WF  V
Sbjct: 247 GADDVKNHRWFKSV 260

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 64/312 (20%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    +  G++G V  A+ K +GE  A+K +K     K + L+        +E +IL+
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-----KREILKMKQVQHVAQEKSILM 73

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYM------EHDLKWLMESMKQPFSTSEVKCLMLQ 125
              HP IVN+     D+ + VY ++E++       H    L ++ + P   ++     L 
Sbjct: 74  ELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTH----LRKAGRFPNDVAKFYHAELV 128

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           L    +YLH   +++RDLK  NLLL+N+G +K+ DFG +++   P + +T L  T  Y A
Sbjct: 129 L--AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV--PDRTFT-LCGTPEYLA 183

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE ++ +K +  AVD W++G ++ E +A  P F   T     +KI               
Sbjct: 184 PE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--------------- 227

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TV 300
             L G             R +FP               DL+  LL  D  KR+      V
Sbjct: 228 --LAG-------------RLKFPNW-------FDGRARDLVKGLLQTDHTKRLGTLKGGV 265

Query: 301 DDALNHYWFHEV 312
            D  NH +FH  
Sbjct: 266 ADVKNHPYFHGA 277

Length = 329

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 97.6 bits (243), Expect = 4e-23
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 23/214 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E++N+I  G  G VY+   + +G + ALK +    G  ED +         REI IL 
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVR----RQICREIEILR 127

Query: 72  SFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLE 128
             +HP++V   +  M DH+  + +++E+M+        S++      E  +  +  Q+L 
Sbjct: 128 DVNHPNVVKCHD--MFDHNGEIQVLLEFMDGG------SLEGTHIADEQFLADVARQILS 179

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G+ YLH   ++HRD+K SNLL+N+   +KI DFG+SR     + P  S V T+ Y +PE 
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPER 239

Query: 189 L---LGAKKYS-TAVDMWSVGCIMAEL-LAKKPL 217
           +   L    Y   A D+WS+G  + E  L + P 
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 96.0 bits (239), Expect = 4e-23
 Identities = 68/241 (28%), Positives = 127/241 (52%), Gaps = 13/241 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGE-IVALKKVKM-NVGRKEDCLEYGFPISSL-REIN 68
           E+  L  +  G +G VY+ R K +G+ ++ALK++ + N    +D  E    I  +  E+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 69  ILL-SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMK---QPFSTSEVKCLM 123
           I+     HP+IV   +  +++ D +Y+VM+ +E   L     S+K   Q F+   +  + 
Sbjct: 61  IIKEQLRHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 124 LQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           +Q++  ++YLH +  ++HRDL  +N++L     + I DFG+++Q     K  TS+V T+ 
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTIL 178

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP-TETI 241
           Y  PE++   + Y    D+W+ GCI+ ++   +P F  T  +    KI + +  P  E +
Sbjct: 179 YSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 242 W 242
           +
Sbjct: 238 Y 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 97.2 bits (242), Expect = 5e-23
 Identities = 76/323 (23%), Positives = 134/323 (41%), Gaps = 49/323 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNV-GRKEDCLEYGFPISSLREINIL 70
           +F+  + +  G +G V   R+K +G+I A+K +K +V   +E    +        E +IL
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFE------EERDIL 55

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
              + P I  + +    D D++Y+VMEY    DL  L+   +  F     +  + +L+  
Sbjct: 56  SISNSPWIPQL-QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPEL 188
           +  +H    +HRD+K  N+L++  G +K+ DFG + +  +     + L V T  Y APE+
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 189 LLGAKKYSTAV-----DMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           L               D WS+G I  E++  +  F   T     + I             
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------------ 222

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
                     NF         +RF    F   P +S    DL+  LL    ++R+  +  
Sbjct: 223 ----------NF---------QRF--LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260

Query: 304 LNHYWFHEVPLPKSKDFMPTFPP 326
             H +F ++     ++ +P F P
Sbjct: 261 CCHPFFSKIDWNNIRNSLPPFVP 283

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (241), Expect = 6e-23
 Identities = 68/199 (34%), Positives = 107/199 (53%), Gaps = 15/199 (7%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINIL---LSF 73
           I +GT+G VY+ R K +  I A+K +  K  V +KE     G       E NIL   L  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG-------ERNILVRTLLD 53

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           + P IV +K     D D +Y+V +YM   +L W ++   + FS    K  + +L+  +++
Sbjct: 54  ESPFIVGLKFSFQTDSD-LYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEH 111

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH   +++RDLK  N+LL+  G + +CDFG+S+   +  K   +   T  Y APE+LL  
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 193 KKYSTAVDMWSVGCIMAEL 211
           K Y+  VD WS+G ++ E+
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 7e-23
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 17/202 (8%)

Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V R R K  G+    VA+K +K     K+      F    L E +I+  FDH
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DF----LTEASIMGQFDH 64

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V ++ EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 65  PNIIRLEGVVTK-SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL---VVTLWYRAPELLLG 191
           +   +HRDL   N+L+N+  V K+ DFG+SR+       YT+    +   W  APE  + 
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPE-AIA 181

Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G +M E+++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (236), Expect = 9e-23
 Identities = 81/271 (29%), Positives = 140/271 (51%), Gaps = 40/271 (14%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINILLSFDHPS 77
           +  G +G VY   D  +G  +A+K+V  +     D  E    +++L  EI +L +  H  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFD----PDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 78  IVNVKEVVMD-DHDSVYMVMEYM-----EHDLKW---LMESMKQPFSTSEVKCLMLQLLE 128
           IV     + D +   + + +EYM     +  LK    L E++ + ++         Q+L+
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR--------QILQ 117

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY------GSPLKPYTSLVVTLW 182
           GV YLH N ++HRD+K +N+L ++ G +K+ DFG S++       G+ +K  T    T +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPY 174

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           + +PE++ G + Y    D+WSV C + E+L +KP ++   E + +  IFK    PT+ + 
Sbjct: 175 WMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQPTKPML 230

Query: 243 P-GLSELPGAKANFAKQPYNLLRKRFPAASF 272
           P G+S+   A  +F KQ + +  KR P A F
Sbjct: 231 PDGVSD---ACRDFLKQIF-VEEKRRPTAEF 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 96.2 bits (239), Expect = 9e-23
 Identities = 80/314 (25%), Positives = 151/314 (48%), Gaps = 50/314 (15%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V+ A  K + +  A+K +K +V   +D +E      ++ E  +L L+++HP 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLSLAWEHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           + ++        ++++ VMEY+   DL + ++S  + F          +++ G+++LH  
Sbjct: 58  LTHLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK 115

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            +++RDLK  N+LL+  G +KI DFGM ++         +   T  Y APE+LLG +KY+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYN 174

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
           T+VD WS G ++ E+L  +  F G  E    +++F+++                      
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRMD------------------- 211

Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD-DALNHYWFHEVPLP 315
               N    R+          L+    D+L +L   +PE+R+ V  D   H +F E+   
Sbjct: 212 ----NPCYPRW----------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257

Query: 316 K--SKDFMPTFPPQ 327
               ++  P F P+
Sbjct: 258 ALEEREIEPPFKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.0 bits (236), Expect = 9e-23
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 15/230 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++  L  + EG++G     +   S +  A+K++++                S +E  +L 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-------VEDSRKEAVLLA 53

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FSTSEVKCLMLQLL 127
              HP+IV  KE    D   +Y+VMEY   D   LM+ +K      F    +    +Q+ 
Sbjct: 54  KMKHPNIVAFKESFEAD-GHLYIVMEYC--DGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            GV+++H+  VLHRD+K+ N+ L   G +K+ DFG +R   SP     + V T +Y  PE
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           +      Y+   D+WS+GCI+ EL   K  F   +  + I K+ +    P
Sbjct: 171 IWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 94.8 bits (235), Expect = 1e-22
 Identities = 72/238 (30%), Positives = 124/238 (52%), Gaps = 29/238 (12%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINILLSFDHPS 77
           + +G +G VY   D  +G  +A K+V+ +    E   E    +S+L  EI +L +  H  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE----VSALECEIQLLKNLQHER 65

Query: 78  IVNVKEVVMDDHD-SVYMVMEYM-----EHDLKW---LMESMKQPFSTSEVKCLMLQLLE 128
           IV     + D  + ++ + MEYM     +  LK    L ES+ + ++         Q+LE
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR--------QILE 117

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRA 185
           G+ YLH N ++HRD+K +N+L ++ G +K+ DFG S++  +     T   S+  T ++ +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           PE++ G + Y    D+WS+GC + E+L +KP ++   E + +  IFK    PT    P
Sbjct: 178 PEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 81/290 (27%), Positives = 127/290 (43%), Gaps = 50/290 (17%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL- 71
           F  L  +  G +G V  A  KK+GE+ A+K +K     K D +      S + E  I   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALK-----KGDIIARDEVESLMCEKRIFET 55

Query: 72  --SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
             S  HP +VN+      + D V  VMEY    DL  +M      FS          ++ 
Sbjct: 56  ANSERHPFLVNLFACFQTE-DHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVL 112

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G++YLH+N +++RDLK  NLLL+ +G +KI DFG+ ++        ++   T  + APE+
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L     Y+ AVD W +G ++ E+L  +  F G  E +  D I              +++ 
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--------------VNDE 217

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
                            R+P         LS     ++ RLL  +PE+R+
Sbjct: 218 V----------------RYPR-------FLSREAISIMRRLLRRNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 96.1 bits (239), Expect = 1e-22
 Identities = 81/317 (25%), Positives = 146/317 (46%), Gaps = 46/317 (14%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
             +  +  ++ G+ G V+ A      + V LK     +G+K          ++L E  +L
Sbjct: 66  LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLK-----IGQKG---------TTLIEAMLL 111

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            + +HPS++ +K+ ++    +  MV+ +   DL   +    +P    +   +  Q+LEG+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITC-MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGL 170

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           +YLH   ++HRD+KT N+ +N+   + I D G + Q+      +  L  T+   APE+L 
Sbjct: 171 RYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLGLAGTVETNAPEVLA 229

Query: 191 GAKKYSTAVDMWSVGCIMAELLA-KKPLF----SGTTEV-----DQIDKIFKTLGTPTET 240
              KY++  D+WS G ++ E+LA    +F    S   E        + KI  TL    E 
Sbjct: 230 RD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288

Query: 241 IWPGLSELPGAK--------ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
            +P     PG++        A+  +QPY     R+P         L   G  L++++LT+
Sbjct: 289 -FPR---DPGSRLVRGFIEYASLERQPYT----RYPCFQRVN---LPIDGEFLVHKMLTF 337

Query: 293 DPEKRITVDDALNHYWF 309
           D   R + ++ LN+  F
Sbjct: 338 DAAMRPSAEEILNYPMF 354

Length = 357

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 33/223 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS---SLREINI 69
           +E +  I  G   +VY A    + E VA+K++ +     E C       S     +E+  
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-----EKC-----QTSVDELRKEVQA 52

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFST-----SEVK 120
           +   +HP++V      +   D +++VM Y+      D+      MK  +       + + 
Sbjct: 53  MSQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIA 105

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP----LKPYTS 176
            ++ ++L+G++YLH N  +HRD+K  N+LL   G +KI DFG+S           K   +
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS 219
            V T  + APE++     Y    D+WS G    EL      +S
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 81/317 (25%), Positives = 145/317 (45%), Gaps = 54/317 (17%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V  A  K + E+ A+K +K +V  ++D +E      ++ E  +L L+  HP 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVE-----CTMTEKRVLALAGKHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +  +        D ++ VMEY+   DL + ++   + F     +    +++ G+++LH+ 
Sbjct: 58  LTQL-HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHER 115

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            +++RDLK  N+LL+++G +KI DFGM ++        ++   T  Y APE+L   + Y 
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYG 174

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
            AVD W++G ++ E+LA +  F G  E +    I +                        
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE------------------------ 210

Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-----DDALNHYWFHE 311
            +       R+P         LS+    +L   LT +PEKR+        D   H +F E
Sbjct: 211 DEV------RYPRW-------LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Query: 312 VPLPK--SKDFMPTFPP 326
           +   K   K+  P F P
Sbjct: 258 IDWDKLERKEIKPPFKP 274

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 94.4 bits (234), Expect = 4e-22
 Identities = 77/296 (26%), Positives = 141/296 (47%), Gaps = 47/296 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G V+ A D  +G+ VA+K++ +    K++ +        + EI ++ 
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--------INEILVMK 71

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLLEGV 130
              +P+IVN  +  +   D +++VMEY+      L + + +     +++  +  + L+ +
Sbjct: 72  ELKNPNIVNFLDSFLVG-DELFVVMEYLAGGS--LTDVVTETCMDEAQIAAVCRECLQAL 128

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           ++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE++ 
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         EL  
Sbjct: 189 -RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP---------EL-- 235

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                 + P  L            SP+      D LNR L  D EKR +  + L H
Sbjct: 236 ------QNPEKL------------SPIFR----DFLNRCLEMDVEKRGSAKELLQH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 93.5 bits (232), Expect = 4e-22
 Identities = 65/218 (29%), Positives = 113/218 (51%), Gaps = 21/218 (9%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVK----MNVGRKEDCLEYGFPISSLRE 66
           F  EK  KI  G +  VYRA     G  VALKKV+    M+   + DC+         +E
Sbjct: 4   FRIEK--KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI---------KE 52

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---FSTSEVKCL 122
           I++L   +HP+++      ++D++ + +V+E  +  DL  +++  K+         V   
Sbjct: 53  IDLLKQLNHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
            +QL   ++++H   V+HRD+K +N+ +   GV+K+ D G+ R + S      SLV T +
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           Y +PE  +    Y+   D+WS+GC++ E+ A +  F G
Sbjct: 172 YMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 93.9 bits (233), Expect = 4e-22
 Identities = 60/217 (27%), Positives = 117/217 (53%), Gaps = 11/217 (5%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A +K +G+ VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--------FNEVVIMRDYHHEN 80

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V++    +   D +++VME++E      + +  +  +  ++  + L +L  + YLH+  
Sbjct: 81  VVDMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQG 138

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +    SLV T ++ APE ++    Y T
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGT 197

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
            VD+WS+G ++ E++  +P +     +  + +I   L
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.0 bits (231), Expect = 8e-22
 Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 53/299 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA+K++ +    K++ +        + EI ++ 
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--------INEILVMR 71

Query: 72  SFDHPSIVNVKEVVMDDH---DSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
              HP+IVN     +D +   D +++VMEY+      L + + +      ++  +  + L
Sbjct: 72  ENKHPNIVNY----LDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECL 125

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++   K Y   VD+WS+G +  E++  +P +     +  +  I  T GTP         E
Sbjct: 186 VVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP---------E 234

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
           L   +                         LS    D LNR L  D EKR +  + L H
Sbjct: 235 LQNPEK------------------------LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 92.1 bits (228), Expect = 2e-21
 Identities = 77/296 (26%), Positives = 140/296 (47%), Gaps = 47/296 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++ 
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMR 72

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLLEGV 130
              +P+IVN  +  +   D +++VMEY+      L + + +      ++  +  + L+ +
Sbjct: 73  ENKNPNIVNYLDSYLVG-DELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQAL 129

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           ++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE++ 
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         EL  
Sbjct: 190 -RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP---------EL-- 236

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                 + P  L      +A F           D LNR L  D EKR +  + L H
Sbjct: 237 ------QNPEKL------SAIFR----------DFLNRCLDMDVEKRGSAKELLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 91.2 bits (226), Expect = 3e-21
 Identities = 69/234 (29%), Positives = 122/234 (52%), Gaps = 29/234 (12%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVK----MNVGRKEDCLEYGFPISSLRE 66
           F+ EK  KI  G +  VYRA      + VALKKV+    M+   ++DC+         +E
Sbjct: 4   FQIEK--KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV---------KE 52

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---FSTSEVKCL 122
           I++L   +HP+++   +  ++D++ + +V+E  +  DL  +++  K+         V   
Sbjct: 53  IDLLKQLNHPNVIKYLDSFIEDNE-LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
            +QL   V+++H   V+HRD+K +N+ +   GV+K+ D G+ R + S      SLV T +
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--------KKPLFSGTTEVDQID 228
           Y +PE  +    Y+   D+WS+GC++ E+ A        K  LFS   +++Q D
Sbjct: 172 YMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 80/301 (26%), Positives = 140/301 (46%), Gaps = 47/301 (15%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  K SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 78

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +V +    +   D +++VME++E   L  ++   +   +  ++  + L +L+ +  LH  
Sbjct: 79  VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQ 135

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            V+HRD+K+ ++LL + G +K+ DFG   Q    +    SLV T ++ APEL+     Y 
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYG 194

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
             VD+WS+G ++ E++  +P +                        P L  +   + N  
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLP 233

Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
            +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P 
Sbjct: 234 PKLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280

Query: 317 S 317
            
Sbjct: 281 C 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.9 bits (225), Expect = 5e-21
 Identities = 61/227 (26%), Positives = 118/227 (51%), Gaps = 14/227 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA+K++ +    K++ +        + EI ++ 
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--------INEILVMR 71

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLLEGV 130
              +P+IVN  +  +   D +++VMEY+      L + + +      ++  +  + L+ +
Sbjct: 72  ENKNPNIVNYLDSYLVG-DELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQAL 128

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            +LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE++ 
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
             K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP
Sbjct: 189 -RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP 233

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 90.5 bits (224), Expect = 8e-21
 Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 12/208 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++G + A K ++    + E+ LE       + EI IL +
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELE-----DYMVEIEILAT 65

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP IV +      D     M+       +  +M  + +  +  +++ +  Q+LE ++Y
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL--- 189
           LH   ++HRDLK  N+LL   G +K+ DFG+S +    L+   S + T ++ APE++   
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 190 -LGAKKYSTAVDMWSVGCIMAELLAKKP 216
            +    Y    D+WS+G  + E+   +P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 33/216 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + E + ++  G YG+V + R   +G I+A+K+++  V  +E           L +++I +
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-------KRLLMDLDISM 54

Query: 72  -SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL---MLQLL 127
            S D P  V     +  + D V++ ME M+  L    + +     T     L    + ++
Sbjct: 55  RSVDCPYTVTFYGALFREGD-VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113

Query: 128 EGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL--------KPYTSLV 178
           + ++YLH    V+HRD+K SN+L+N  G +K+CDFG+S      +        KPY    
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYM--- 170

Query: 179 VTLWYRAPELL---LGAKKYSTAVDMWSVGCIMAEL 211
                 APE +   L  K Y    D+WS+G  M EL
Sbjct: 171 ------APERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 11  FEFEKL---NKISEGTYGIVYRAR----DKKSGEIVALKKVK-MNVGRKEDCLEYGFPIS 62
           FE   L    ++ EG +G V   R       +GE VA+K +      +     E      
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE------ 54

Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEH-DLKWLMESMKQPFSTSEVK 120
             REI IL + DH +IV  K V       S+ ++MEY+    L+  ++  +   +   + 
Sbjct: 55  --REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL 112

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR------QYGSPLKPY 174
               Q+ +G+ YL     +HRDL   N+L+ ++ ++KI DFG+++       Y    +P 
Sbjct: 113 LFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            S +   WY APE L    K+S+A D+WS G  + EL 
Sbjct: 173 ESPI--FWY-APECLR-TSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 66/234 (28%), Positives = 120/234 (51%), Gaps = 28/234 (11%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V  A  K  GE  A+K +K +V   +D +E      ++ E  +L L++++P 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVE-----CTMVEKRVLALAWENPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DL------KWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + ++        + ++ VME++   DL      K   +  +  F  +E+ C       G+
Sbjct: 58  LTHL-YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-------GL 109

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           ++LH   +++RDLK  N++L+  G +KI DFGM ++        ++   T  Y APE+L 
Sbjct: 110 QFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL--GTPTETIW 242
           G  KY+ +VD WS G ++ E+L  +  F G  E    D++F+++   TP    W
Sbjct: 170 G-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFESIRVDTPHYPRW 218

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 75/297 (25%), Positives = 137/297 (46%), Gaps = 43/297 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++E + ++  GTYG VY+AR+  +GE+ A+K +K+  G     ++        +EI ++ 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--------QEIFMVK 61

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV      +   + +++ MEY        +  +  P S  ++  +  + L+G+ 
Sbjct: 62  ECKHCNIVAYFGSYLS-REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL + G +K+ DFG++ +  + +    S + T ++ APE+   
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 192 AKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            K   Y+   D+W+VG    EL   +P                    P   + P  +   
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP--------------------PMFDLHPMRALFL 220

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
            +K+NF  QP  L  K   +++F     +S          LT +P+KR T +  L H
Sbjct: 221 MSKSNF--QPPKLKDKTKWSSTFHNFVKIS----------LTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.0 bits (220), Expect = 2e-20
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 12/208 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL +I +G++G VY+  D ++ E+VA+K + +     ED +E        +EI +L  
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIE-----DIQQEITVLSQ 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ-PFSTSEVKCLMLQLLEGVK 131
            D P I       +     ++++MEY+       ++ +K  P   + +  ++ ++L+G+ 
Sbjct: 59  CDSPYITRYYGSYLKG-TKLWIIMEYLGGGSA--LDLLKPGPLEETYIATILREILKGLD 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+ QG +K+ DFG++ Q         + V T ++ APE ++ 
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIK 174

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFS 219
              Y    D+WS+G    EL   +P  S
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 80/315 (25%), Positives = 136/315 (43%), Gaps = 53/315 (16%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMN--VGRKEDCLEYGFPISSLREINILLSFDHP 76
           I +G++G V + R + +  I ALK ++    V R E          +L E  +L   + P
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE-------VTHTLAERTVLAQVNCP 53

Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
            IV +K       + +Y+V+ ++     +     +  F  S  +    +LL  ++ LH  
Sbjct: 54  FIVPLK-FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF 112

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            V++RDLK  N+LL+ QG + +CDFG+ +          +   T  Y APELLLG   Y+
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYT 171

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
            AVD W++G ++ E+L   P F      + ++++++ +                      
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYD----ENVNEMYRKI---------------------L 206

Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV---DDALNHYWFHEVP 313
           ++P      RFP               DLL  LL+ DP +R+      +  NH +F ++ 
Sbjct: 207 QEPL-----RFPDG-------FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254

Query: 314 LPK--SKDFMPTFPP 326
             K   K   P F P
Sbjct: 255 WKKLLMKGIQPPFKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.1 bits (218), Expect = 3e-20
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E   + +I  G +G+V+     +  + VA+K ++     +ED +E         E  +++
Sbjct: 5   ELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIE---------EAQVMM 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP +V +  V  +    + +V E+MEH  L   + + +  FS   +  + L + EG+
Sbjct: 55  KLSHPKLVQLYGVCTE-RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRA 185
            YL  + V+HRDL   N L+    V+K+ DFGM+R     QY S     T     + + +
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS----TGTKFPVKWSS 169

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAK 214
           PE +    KYS+  D+WS G +M E+ ++
Sbjct: 170 PE-VFSFSKYSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 52/233 (22%)

Query: 19  ISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           + EG +G V+         +   E+VA+K +K       +     F     RE  +L +F
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLK---ETASNDARKDF----EREAELLTNF 65

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWL------------MESMKQPFSTSEV 119
            H +IV    V  +  D   MV EYMEH DL K+L             +S     + S++
Sbjct: 66  QHENIVKFYGVCTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
             + +Q+  G+ YL     +HRDL T N L+    V+KI DFGMSR        YT    
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YT---- 174

Query: 180 TLWYR------------APELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLF 218
           T +YR             PE ++  +K++T  D+WS G ++ E+    K+P +
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 87.7 bits (217), Expect = 4e-20
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 17/210 (8%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKM-NVGRKEDCLEYGFPISSLREINILLSFD 74
           +  + +G+YG V   R +  G+   +KK+ + N  R+E         ++ +E  +L    
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-------KAAEQEAQLLSQLK 57

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYME-----HDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           HP+IV  +E    +   +Y+VM + E     H LK   E   +    ++V    +Q+   
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK---EQKGKLLPENQVVEWFVQIAMA 114

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YLH+  +LHRDLKT N+ L    ++K+ D G++R   +     ++L+ T +Y +PE L
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-L 173

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFS 219
              K Y+   D+W++GC + E+   K  F+
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.2 bits (218), Expect = 4e-20
 Identities = 58/205 (28%), Positives = 108/205 (52%), Gaps = 12/205 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL KI +G++G V++  D ++ ++VA+K + +     ED +E        +EI +L  
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIE-----DIQQEITVLSQ 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVK 131
            D P +       + D   ++++MEY+       L+E    P   +++  ++ ++L+G+ 
Sbjct: 59  CDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLD 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+  G +K+ DFG++ Q         + V T ++ APE ++ 
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIK 174

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
              Y +  D+WS+G    EL   +P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 62/224 (27%), Positives = 118/224 (52%), Gaps = 12/224 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  + +G++G V  A  K + E+ A+K +K +V  ++D +E      ++ E  +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVE-----CTMVEKRVLA 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             D P  +          D +Y VMEY+   DL + ++ + + F   +      ++  G+
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGL 114

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            +LH   +++RDLK  N++L+++G +KI DFGM +++        +   T  Y APE ++
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE-II 173

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
             + Y  +VD W+ G ++ E+LA +P F G  E    D++F+++
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.8 bits (217), Expect = 5e-20
 Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 14/206 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL +I +G++G V++  D ++ ++VA+K + +     ED +E        +EI +L  
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIE-----DIQQEITVLSQ 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME--HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            D P +       +     ++++MEY+     L  L      PF   ++  ++ ++L+G+
Sbjct: 59  CDSPYVTKYYGSYLKG-TKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGL 114

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH    +HRD+K +N+LL+ QG +K+ DFG++ Q         + V T ++ APE ++
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VI 173

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKP 216
               Y +  D+WS+G    EL   +P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 88.4 bits (219), Expect = 6e-20
 Identities = 61/214 (28%), Positives = 112/214 (52%), Gaps = 10/214 (4%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V  A  K + E+ A+K +K +V  ++D ++      ++ E  IL L+  HP 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVD-----CTMTEKRILALAAKHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +  +        D ++ VMEY+   DL + ++  ++ F     +    ++   + +LH +
Sbjct: 58  LTAL-HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRH 115

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            V++RDLK  N+LL+ +G  K+ DFGM ++        T+   T  Y APE +L   +Y 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYG 174

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +VD W++G +M E++A +P F    E D  + I
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 81/319 (25%), Positives = 136/319 (42%), Gaps = 77/319 (24%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+  + +G  G V+  R K +G++ ALK +      K + ++       L E  IL +
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVK-----RVLTEQEILAT 57

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQP---FSTSEVKCLMLQLLE 128
            DHP +  +          + +VM+Y    +L  L++  +QP    S    +    ++L 
Sbjct: 58  LDHPFLPTL-YASFQTETYLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLL 114

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT------------- 175
            ++YLH   +++RDLK  N+LL+  G + + DF +S+Q      P +             
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 176 ----------------SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS 219
                           S V T  Y APE++ G   + +AVD W++G ++ E+L       
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEML------Y 227

Query: 220 GTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLS 279
           GTT                          P   +N  +   N+L+K     +F GSP +S
Sbjct: 228 GTT--------------------------PFKGSNRDETFSNILKKEV---TFPGSPPVS 258

Query: 280 ESGFDLLNRLLTYDPEKRI 298
            S  DL+ +LL  DP KR+
Sbjct: 259 SSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 65/230 (28%), Positives = 118/230 (51%), Gaps = 24/230 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  + +G++G V  A  K + E+ A+K +K +V  ++D +E      ++ E  +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVE-----CTMVEKRVLA 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESM---KQP---FSTSEVKCLML 124
               P  +          D +Y VMEY+   DL + ++ +   K+P   F  +E+     
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIA---- 111

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
               G+ +LH   +++RDLK  N++L+ +G +KI DFGM ++     K   +   T  Y 
Sbjct: 112 ---IGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYI 168

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
           APE++   + Y  +VD W+ G ++ E+LA +P F G  E    D++F+++
Sbjct: 169 APEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 8e-20
 Identities = 86/362 (23%), Positives = 139/362 (38%), Gaps = 92/362 (25%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE +  I  G +G V   + K +G I A+KK+     RK + LE         E +IL 
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-----RKSEMLEKEQVAHVRAERDILA 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVKCLMLQLLEG 129
             D+P +V +     D+ + +Y++MEY+   D+  L+  MK+  F+  E +  + + +  
Sbjct: 57  EADNPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIAETILA 113

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG---------------MSRQYGSPLKPY 174
           +  +H    +HRD+K  NLLL+ +G +K+ DFG               +           
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173

Query: 175 T-----------------------SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL 211
                                   S V T  Y APE+ L    Y+   D WS+G IM E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEM 232

Query: 212 LAKKPLFSGTTEVDQIDKIF---KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFP 268
           L   P F      +   KI    +TL  P         E+P                   
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPD--------EVP------------------- 265

Query: 269 AASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNHYWFHEVPLPKSKDFMPTFP 325
                    LS    DL+ RL   + E+R+    V++  +H +F  V     ++      
Sbjct: 266 ---------LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPII 315

Query: 326 PQ 327
           P+
Sbjct: 316 PE 317

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 45/301 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E+ K   + +G YG VY       G+++A+K+V+++        E  +      E+++L 
Sbjct: 1   EWTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNV-LAAEKEYE-KLQEEVDLLK 57

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           S  H +IV      +DD +++ + ME++       + +   P           Q+L+GV 
Sbjct: 58  SLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ------YGSPLKPYTSLVVTLWYRA 185
           YLH+N V+HRD+K +N++L   G++K+ DFG +R+      +G+      S+  T ++ A
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE ++    Y    D+WS+GC + E+   KP  +    +D++  +F         I    
Sbjct: 177 PE-VINESGYGRKSDIWSIGCTVFEMATGKPPLA---SMDRLAAMF--------YIGAHR 224

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
             +P    +F                       S +  D +   LT D  +R +    L 
Sbjct: 225 GLMPRLPDSF-----------------------SAAAIDFVTSCLTRDQHERPSALQLLR 261

Query: 306 H 306
           H
Sbjct: 262 H 262

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 40/233 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           E   L ++  G +G+V+    K  G+I VA+K ++     ++D +E         E  ++
Sbjct: 5   ELTFLKELGSGQFGVVHLG--KWRGKIDVAIKMIREGAMSEDDFIE---------EAKVM 53

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEG 129
           +   HP++V +  V       +++V EYM +  L   +   K    T  +  +   + E 
Sbjct: 54  MKLSHPNLVQLYGVCTK-QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS------PLKPYTSLV 178
           ++YL  N  +HRDL   N L+    V+K+ DFG++R     QY S      P+K      
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK------ 166

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPL--FSGTTEVDQI 227
               +  PE+   + ++S+  D+WS G +M E+    K P   FS +  V+ +
Sbjct: 167 ----WAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 35/235 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI-L 70
           + E L +I  GT G VY+ R KK+G ++A+K+++    ++E+          L ++++ L
Sbjct: 16  DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-------KRILMDLDVVL 68

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            S D P IV      + D D V++ ME M   L  L++ ++ P     +  + + +++ +
Sbjct: 69  KSHDCPYIVKCYGYFITDSD-VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 131 KYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMS----------RQYGSPLKPYTSLVV 179
            YL +   V+HRD+K SN+LL+  G +K+CDFG+S          R  G           
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA-------- 179

Query: 180 TLWYRAPELL---LGAKKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKI 230
              Y APE +       KY    D+WS+G  + EL   + P  +  TE + + KI
Sbjct: 180 ---YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 86.7 bits (214), Expect = 2e-19
 Identities = 86/317 (27%), Positives = 140/317 (44%), Gaps = 53/317 (16%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GT+G V   R+K SG+  A+K +K  V   +D + +     +L E  +L +  HP +
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAH-----TLTESRVLKNTRHPFL 57

Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
            ++K       D +  VMEY+     +   S ++ FS    +    +++  + YLH   +
Sbjct: 58  TSLK-YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116

Query: 139 LHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTA 198
           ++RDLK  NL+L+  G +KI DFG+ ++  +      +   T  Y APE +L    Y  A
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGRA 175

Query: 199 VDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
           VD W +G +M E++  + P ++   E     K+F+ +    E I                
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI--LMEDI---------------- 212

Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDA---LNHYWFHEV 312
                   +FP         LS     LL+ LL  DP KR+    DDA   + H +F  V
Sbjct: 213 --------KFPRT-------LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257

Query: 313 PLPK--SKDFMPTFPPQ 327
                  K  +P F PQ
Sbjct: 258 NWQDVYDKKLVPPFKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 16/202 (7%)

Query: 19  ISEGTYGIVYRARDKKSG--EI-VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V   R K  G  EI VA+K +K     K+      F    L E +I+  FDH
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ---RRDF----LSEASIMGQFDH 64

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I++++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 65  PNIIHLEGVVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + APE  + 
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182

Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G +M E+++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 42/215 (19%)

Query: 17  NKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
            ++  G +G V    Y  +  K  E VA+K +K          +  F    LRE +++  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQE---HIAAGKKEF----LREASVMAQ 52

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            DHP IV +  V   +   + +VME       LK+L +  ++    S++K L  Q+  G+
Sbjct: 53  LDHPCIVRLIGVCKGE--PLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGM 108

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS-------------PLKPYTSL 177
            YL     +HRDL   N+LL N+   KI DFGMSR  G+             PLK     
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----- 163

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
               WY APE +    K+S+  D+WS G  + E  
Sbjct: 164 ----WY-APECINYG-KFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.3 bits (211), Expect = 4e-19
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 25/212 (11%)

Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            +K+  + EG +G V    Y   +  +GE+VA+K +K   G++      G+     +EIN
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ---NTSGW----KKEIN 58

Query: 69  ILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQL 126
           IL +  H +IV  K    +     + ++MEY+   L  L + + K   + +++     Q+
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQI 116

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY------TSLVVT 180
            EG+ YLH    +HRDL   N+LL+N  ++KI DFG+++      + Y       S V  
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 174

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            WY A E  L   K+S A D+WS G  + ELL
Sbjct: 175 FWY-AVE-CLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 6e-19
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI +G +G VY+   K + E VA+K  +  +      L+  F    L+E  IL  +DHP+
Sbjct: 2   KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTL---PPDLKRKF----LQEAEILKQYDHPN 53

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE---GVKYLH 134
           IV +  V +     +Y+VME +      L+  +++  +   VK L+   L+   G++YL 
Sbjct: 54  IVKLIGVCVQKQ-PIYIVMELVPGGS--LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV--VTLWYRAPELLLGA 192
               +HRDL   N L+    VLKI DFGMSR+    +   +  +  + + + APE  L  
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNY 169

Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
            +Y++  D+WS G ++ E  + 
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 7e-19
 Identities = 58/215 (26%), Positives = 113/215 (52%), Gaps = 12/215 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + E ++ +  G  G V + +   +G ++A K V  ++G K    +       LRE+ I+ 
Sbjct: 6   DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV--HIGAKSSVRK-----QILRELQIMH 58

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
               P IV+     +++++ + M ME+M+      +     P     +  + + ++EG+ 
Sbjct: 59  ECRSPYIVSFYGAFLNENN-ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT 117

Query: 132 YLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           YL++ + ++HRD+K SN+L+N++G +K+CDFG+S +  + +    + V T  Y +PE + 
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQ 175

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD 225
           G  KY+   D+WS+G  + EL   K  F+ +   D
Sbjct: 176 G-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 25/213 (11%)

Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REI 67
            +++  + EG +G V    Y      +GE VA+K +K   G        G  I+ L +EI
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEI 57

Query: 68  NILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            IL +  H +IV  K +  +D    + ++ME++    LK  +   K   +  +     +Q
Sbjct: 58  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ 117

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT------SLVV 179
           + +G+ YL     +HRDL   N+L+ ++  +KI DFG+++   +  + YT      S V 
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV- 176

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             WY APE L+ +K Y  A D+WS G  + ELL
Sbjct: 177 -FWY-APECLIQSKFY-IASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 62/204 (30%), Positives = 109/204 (53%), Gaps = 18/204 (8%)

Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V R R K  G+    VA+K +K     K+      F    L E +I+  FDH
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ---RRDF----LSEASIMGQFDH 64

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I++++ VV      V ++ E+ME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 65  PNIIHLEGVVTKSR-PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV---VTLWYRAPELL 189
           +   +HRDL   N+L+N+  V K+ DFG+SR  +  +    YTS +   + + + APE  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE-A 182

Query: 190 LGAKKYSTAVDMWSVGCIMAELLA 213
           +  +K+++A D+WS G +M E+++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 80/317 (25%), Positives = 135/317 (42%), Gaps = 53/317 (16%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GT+G V   R+K +G   A+K     + RKE  +       ++ E  +L +  HP +
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMK-----ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
             +K      HD +  VMEY      +   S ++ F+    +    +++  ++YLH   V
Sbjct: 58  TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116

Query: 139 LHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTA 198
           ++RD+K  NL+L+  G +KI DFG+ ++  S      +   T  Y APE +L    Y  A
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRA 175

Query: 199 VDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
           VD W +G +M E++  + P ++   E     ++F+ +    E I                
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI--LMEEI---------------- 212

Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEV 312
                   RFP         LS     LL  LL  DP++R+        + + H +F  +
Sbjct: 213 --------RFPRT-------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257

Query: 313 PLPK--SKDFMPTFPPQ 327
                  K  +P F PQ
Sbjct: 258 NWQDVVQKKLLPPFKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 78/319 (24%), Positives = 144/319 (45%), Gaps = 55/319 (17%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V  AR K+SG + A+K +K +V  ++D +E      ++ E  IL L+ +HP 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVE-----CTMTEKRILSLARNHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +  +        D ++ VME++   DL + ++  ++ F  +  +    ++   + +LHD 
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDK 115

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            +++RDLK  N+LL+++G  K+ DFGM ++     K  ++   T  Y APE +L    Y 
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYG 174

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
            +VD W++G ++ E+L     F    E D  + I        E ++P             
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTW----------- 218

Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDA-----LNHYWFH 310
                                LS+   D+L   +T +P  R+ ++        L H +F 
Sbjct: 219 ---------------------LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257

Query: 311 EVPLPK--SKDFMPTFPPQ 327
           E+   K   +   P F P+
Sbjct: 258 ELDWEKLNRRQIEPPFRPR 276

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 87/320 (27%), Positives = 140/320 (43%), Gaps = 59/320 (18%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GT+G V   R+K +G+  A+K +K  V   +D + +     +L E  +L +  HP +
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAH-----TLTESRVLQNTRHPFL 57

Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
             +K      HD +  VMEY      +   S ++ FS    +    +++  + YLH   V
Sbjct: 58  TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116

Query: 139 LHRDLKTSNLLLNNQGVLKICDFGMSRQ---YGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           ++RDLK  NL+L+  G +KI DFG+ ++    G+ +K +     T  Y APE +L    Y
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TPEYLAPE-VLEDNDY 172

Query: 196 STAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
             AVD W +G +M E++  + P ++   E     K+F+ +          L E       
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI----------LME------- 210

Query: 255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDALN---HYWF 309
                      RFP         LS     LL  LL  DP++R+    +DA     H +F
Sbjct: 211 ---------EIRFPRT-------LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Query: 310 HEVPLPK--SKDFMPTFPPQ 327
             +       K   P F PQ
Sbjct: 255 ASINWQDVVQKKLEPPFKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 59/164 (35%), Positives = 90/164 (54%), Gaps = 8/164 (4%)

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQ--PFSTSEVKC 121
           E++ L + DH  IV   +    D D + ++MEY    DL K + + +K+  PF   EV  
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS--PLKPYTSLVV 179
           L  Q++  +  +H   ++HRDLK++N+ L   G++K+ DFG S+QY     L   +S   
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           T +Y APE L   K+YS   DMWS+G I+ ELL     F G ++
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276

Length = 478

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 22/207 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVG---RKEDCLEYGFPISSLREIN 68
           +FEKL ++  G  G+V +   + SG I+A K + + +    R +           +RE+ 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ----------IIRELK 51

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQL 126
           +L   + P IV        D + + + ME+M  D   L + +K+     E  +  + + +
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 127 LEGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           L G+ YL +   ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMS 166

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELL 212
           PE L G   Y+   D+WS+G  + E+ 
Sbjct: 167 PERLQGT-HYTVQSDIWSLGLSLVEMA 192

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 18  KISEGTYGIVYRARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           K+ +G++G+V R     SG     VA+K +K    +  D ++       L+E  I+ S D
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMD-----DFLKEAAIMHSLD 54

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FSTSEVKCLMLQLLEGV 130
           H +++ +  VV+     + MV E     L  L++ +++     F  S +    +Q+  G+
Sbjct: 55  HENLIRLYGVVLTH--PLMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS---LVVTLWYRAPE 187
           +YL     +HRDL   N+LL +   +KI DFG+ R        Y     L V   + APE
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 188 LLLGAKKYSTAVDMWSVGCIMAEL 211
             L  + +S A D+W  G  + E+
Sbjct: 171 -SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 75/315 (23%), Positives = 127/315 (40%), Gaps = 70/315 (22%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E L+++ +G YG VY+   + +G  +A+K++++        L+       + E++IL 
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-------LDESKFNQIIMELDILH 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSE--VKCLMLQLLE 128
               P IV+       +  +VYM MEYM+   L  L           E  ++ +   +++
Sbjct: 55  KAVSPYIVDFYGAFFIE-GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVK 113

Query: 129 GVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW----- 182
           G+K+L +   ++HRD+K +N+L+N  G +K+CDFG+S            LV +L      
Sbjct: 114 GLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----------LVASLAKTNIG 163

Query: 183 ---YRAPELL-----LGAKKYSTAVDMWSVGCIMAEL-LAKKPLFSGTTEVDQIDKIFKT 233
              Y APE +          Y+   D+WS+G  + E+ L + P    T        IF  
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQ 218

Query: 234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
           L    +   P L                                 S+   D + + L   
Sbjct: 219 LSAIVDGDPPTL-----------------------------PSGYSDDAQDFVAKCLNKI 249

Query: 294 PEKRITVDDALNHYW 308
           P +R T    L H W
Sbjct: 250 PNRRPTYAQLLEHPW 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE+++++  G  G+V + + K SG I+A K + + +       +       +RE+ +L 
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLH 58

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +L G
Sbjct: 59  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115

Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 173

Query: 189 LLGAKKYSTAVDMWSVGCIMAEL 211
           L G   YS   D+WS+G  + EL
Sbjct: 174 LQGT-HYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 70/254 (27%), Positives = 111/254 (43%), Gaps = 27/254 (10%)

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
           REI+IL +  H +I+N+         +V MVM   + DL   ++    P    +   +  
Sbjct: 135 REIDILKTISHRAIINLIHA-YRWKSTVCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQR 192

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG-SPLKPYT-SLVVTLW 182
           +LLE + YLH   ++HRD+KT N+ L+      + DFG + +    P  P       TL 
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSG--TTEVDQIDKIFKTLGTPTE 239
             +PELL     Y    D+WS G ++ E+  K   LF     +   Q+  I + +     
Sbjct: 253 TNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM----- 306

Query: 240 TIWPGLSELP-GAKANFAKQ--PYNLLRKRFPAASFTGSPVLSESGFD-----LLNRLLT 291
            + P   E P     N  K    Y +   R P   +T  PV+ + G       L+ ++LT
Sbjct: 307 QVHP--LEFPQNGSTNLCKHFKQYAI-VLRPP---YTIPPVIRKYGMHMDVEYLIAKMLT 360

Query: 292 YDPEKRITVDDALN 305
           +D E R +  D L+
Sbjct: 361 FDQEFRPSAQDILS 374

Length = 392

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 16/202 (7%)

Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V+R   K  G     VA+K +K     K+           L E +I+  F H
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-------QDFLSEASIMGQFSH 65

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
            +I+ ++ VV     ++ ++ EYME+  L   +      FS+ ++  ++  +  G+KYL 
Sbjct: 66  HNIIRLEGVVTKFKPAM-IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+    K+ DFG+SR     P   YT+    + + + APE  + 
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIA 183

Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G +M E+++
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EF    K+  G +G V+    K     VA+K +K +   K+   +        +E+  L 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQ--------KEVQALK 57

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H  ++++  V     + VY++ E ME    L +L     Q    + +  +  Q+ EG
Sbjct: 58  RLRHKHLISLFAVCSVG-EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR--APE 187
           + YL +   +HRDL   N+L+    V K+ DFG++R     +  Y S    + Y+  APE
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPE 174

Query: 188 LLLGAKKYSTAVDMWSVGCIMAEL 211
                  +ST  D+WS G ++ E+
Sbjct: 175 -AASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 28/268 (10%)

Query: 16  LNKISEGTYGIVYRAR---DKKSGEIVA---LKKVKMNVGRKEDCLEYGFPISSLREINI 69
           L  + +G YG V++ R      +G+I A   LKK  +   +K+          +  E NI
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA-------HTKAERNI 53

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML-QLLE 128
           L +  HP IV++          +Y+++EY+    +  M   ++     +  C  L ++  
Sbjct: 54  LEAVKHPFIVDLIYAFQTG-GKLYLILEYLSGG-ELFMHLEREGIFMEDTACFYLSEISL 111

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            +++LH   +++RDLK  N+LL+ QG +K+ DFG+ ++         +   T+ Y APE+
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L+ +  +  AVD WS+G +M ++L   P F+       IDKI K           G   L
Sbjct: 172 LMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-----------GKLNL 219

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSP 276
           P      A+     L KR P++     P
Sbjct: 220 PPYLTPEARDLLKKLLKRNPSSRLGAGP 247

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 59/226 (26%), Positives = 112/226 (49%), Gaps = 12/226 (5%)

Query: 16  LNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  + +G++G V+  R      +G++ A+K +K    +  D       + +  E +IL  
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD------RVRTKMERDILAE 54

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP IV +          +Y++++++     +   S +  F+  +VK  + +L   + +
Sbjct: 55  VNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 113

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH   +++RDLK  N+LL+ +G +K+ DFG+S++     K   S   T+ Y APE ++  
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNR 172

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT-LGTP 237
           + ++ + D WS G +M E+L     F G    + +  I K  LG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 65/233 (27%), Positives = 119/233 (51%), Gaps = 30/233 (12%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  + +G++G V  A  K + E+ A+K +K +V  ++D +E      ++ E  +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVE-----CTMVEKRVLA 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESM---KQP---FSTSEVKCLML 124
               P  +          D +Y VMEY+   DL + ++ +   K+P   F  +E+     
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI--- 112

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTL 181
               G+ +LH   +++RDLK  N++L+++G +KI DFGM ++    G   K +     T 
Sbjct: 113 ----GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG---TP 165

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
            Y APE ++  + Y  +VD W+ G ++ E+LA +  F G  E    D++F+++
Sbjct: 166 DYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 78/318 (24%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-----REI 67
           +E +  I +GTYG V++  +KK+G   A+K +               PI  +      E 
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--------------PIHDIDEEIEAEY 65

Query: 68  NILLSF-DHPSIVNV------KEVVMDDHDSVYMVMEYME----HDLKWLM----ESMKQ 112
           NIL +  DHP++V        K+V   + D +++V+E        DL        E M++
Sbjct: 66  NILKALSDHPNVVKFYGMYYKKDVK--NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123

Query: 113 PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK 172
           P     +  ++ + L G+++LH N  +HRD+K +N+LL  +G +K+ DFG+S Q  S   
Sbjct: 124 PI----IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 173 PYTSLVVTLWYRAPELLLGAKK----YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQID 228
              + V T ++ APE++   ++    Y    D+WS+G    EL        G  +     
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL--------GDGD----- 226

Query: 229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNR 288
                         P L++L   +A F K P N      P  +     + S    D + +
Sbjct: 227 --------------PPLADLHPMRALF-KIPRN------PPPTLHQPELWSNEFNDFIRK 265

Query: 289 LLTYDPEKRITVDDALNH 306
            LT D EKR TV D L H
Sbjct: 266 CLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 87/321 (27%), Positives = 143/321 (44%), Gaps = 60/321 (18%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GT+G V   ++K +G   A+K +K  V   +D + +     +L E  +L +  HP +
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-----TLTENRVLQNSRHPFL 57

Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNW 137
             +K      HD +  VMEY      +   S ++ FS    +    +++  + YLH +  
Sbjct: 58  TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLGAKK 194
           V++RDLK  NL+L+  G +KI DFG+ ++    G+ +K +     T  Y APE +L    
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG---TPEYLAPE-VLEDND 172

Query: 195 YSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           Y  AVD W +G +M E++  + P ++   E     K+F+ +    E I            
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI--LMEEI------------ 213

Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDA---LNHYW 308
                       RFP         LS     LL+ LL  DP++R+    DDA   + H +
Sbjct: 214 ------------RFPRT-------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254

Query: 309 FHEVPLPK--SKDFMPTFPPQ 327
           F  +       K  +P F PQ
Sbjct: 255 FAGIVWQDVYEKKLVPPFKPQ 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.5 bits (196), Expect = 5e-17
 Identities = 77/323 (23%), Positives = 137/323 (42%), Gaps = 62/323 (19%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKK-----VKMNVGRKEDCLEYGFPISSLREINILLSF 73
           + +G +G V   + K +G++ A KK     +K   G +           +L E  IL   
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQ----------MALNEKKILEKV 50

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVKCLMLQLLEGVK 131
               IV++     +  D + +VM  M   DLK+ + ++ +P F  +       Q++ G++
Sbjct: 51  SSRFIVSLA-YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   +++RDLK  N+LL++ G ++I D G++ +     K       T  Y APE+L G
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQG 168

Query: 192 AKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            + Y  +VD +++GC + E++A + P      +V++ +   +TL    E           
Sbjct: 169 -EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE----------- 216

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALN 305
                          +F           S    DL   LL  DPEKR+     + D+   
Sbjct: 217 ------------YPDKF-----------SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253

Query: 306 HYWFHEVPLPK--SKDFMPTFPP 326
           H  F ++   +  +    P F P
Sbjct: 254 HPLFKDLNWRRLEAGMLEPPFIP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 79.3 bits (195), Expect = 6e-17
 Identities = 71/250 (28%), Positives = 122/250 (48%), Gaps = 41/250 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-----REI 67
           +E +  I +GTYG VY+  +KK G + A+K +               PIS +      E 
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD--------------PISDVDEEIEAEY 69

Query: 68  NILLSF-DHPSIVNVKEVVMD-DH---DSVYMVMEY-----MEHDLKWLMESMKQPFSTS 117
           NIL S  +HP++V    +    D      +++V+E      +   +K L+    Q    +
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEA 128

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTS 176
            +  ++   L G+++LH+N ++HRD+K +N+LL  +G +K+ DFG+S Q  S  L+  TS
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 177 LVVTLWYRAPELLLGAKKYSTA----VDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKIF 231
           +    W  APE++   ++Y  +     D+WS+G    EL     PLF    ++  +  +F
Sbjct: 189 VGTPFWM-APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF----DMHPVKTLF 243

Query: 232 KTLGTPTETI 241
           K    P  T+
Sbjct: 244 KIPRNPPPTL 253

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 7e-17
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E +    I +G +G V     +  G+ VA+K +K +    +         + L E +++ 
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQ---------AFLAEASVMT 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
           +  HP++V +  VV+   + +Y+V EYM     + +L    +   + ++     L + EG
Sbjct: 56  TLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL +   +HRDL   N+L++   V K+ DFG++++  +     +  +   W  APE  
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE--ASQGQDSGKLPVKW-TAPE-A 170

Query: 190 LGAKKYSTAVDMWSVGCIMAELLA 213
           L  KK+ST  D+WS G ++ E+ +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 79.7 bits (196), Expect = 7e-17
 Identities = 60/203 (29%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG I+A K + + +       +       +RE+ +L 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLH 58

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 59  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 115

Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 116 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 173

Query: 189 LLGAKKYSTAVDMWSVGCIMAEL 211
           L G   YS   D+WS+G  + E+
Sbjct: 174 LQGT-HYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 23/226 (10%)

Query: 22  GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV 81
           G  G V  A+    GE  A+K V M    + D         +  E+  LL+ D  SIV  
Sbjct: 43  GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNR------AQAEVCCLLNCDFFSIVKC 96

Query: 82  KE--VVMDDHDS-----VYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGV 130
            E     D  +      + +V++Y    DL+  ++S     + F   E   L +Q+L  V
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT--SLVVTLWYRAPEL 188
            ++H   ++HRD+K++N+LL + G++K+ DFG S+ Y + +      +   T +Y APE+
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
               K YS   DM+S+G ++ ELL  K  F G    +  + + KTL
Sbjct: 217 WR-RKPYSKKADMFSLGVLLYELLTLKRPFDG---ENMEEVMHKTL 258

Length = 496

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.0 bits (192), Expect = 1e-16
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 44/220 (20%)

Query: 12  EFEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + ++  G +G+V    +RA+ K     VA+K +      +ED +E         E 
Sbjct: 5   ELTFMKELGSGQFGVVHLGKWRAQIK-----VAIKAINEGAMSEEDFIE---------EA 50

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ 125
            +++   HP +V +  V       +Y+V E+ME+   L +L +   +  S   +  +   
Sbjct: 51  KVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQD 108

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS------PLKPY 174
           + EG++YL  N  +HRDL   N L+++ GV+K+ DFGM+R     +Y S      P+K  
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-- 166

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
                   +  PE+     KYS+  D+WS G +M E+  +
Sbjct: 167 --------WSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 12/196 (6%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           +I  G +G V+  R +     VA+K  +       + L        L+E  IL  + HP+
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCR-------ETLPPDLKAKFLQEARILKQYSHPN 54

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           IV +  V       +Y+VME ++  D    + +        E+  ++     G++YL   
Sbjct: 55  IVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV--VTLWYRAPELLLGAKK 194
             +HRDL   N L+  + VLKI DFGMSR+    +   T  +  + + + APE  L   +
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGR 172

Query: 195 YSTAVDMWSVGCIMAE 210
           YS+  D+WS G ++ E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 84/336 (25%), Positives = 145/336 (43%), Gaps = 67/336 (19%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINI 69
            +FE +  IS G YG VY  R K++ +  A+KK+ K N+  +   ++  F      E +I
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-IQQVFV-----ERDI 54

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
           L   ++P +V++     +    + MVMEY+E  D   L++++         +    + + 
Sbjct: 55  LTFAENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVL 112

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---------QYGSPLKPYTSLVV 179
            ++YLH+  ++HRDLK  NLL+ + G +K+ DFG+S+          Y   ++  T   +
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 180 ------TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT 233
                 T  Y APE++L  + Y   VD W++G I+ E L     F G T  +   ++   
Sbjct: 173 DKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS- 230

Query: 234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
                +  WP   E   A A                              DL++RLL  +
Sbjct: 231 ----DDIEWPEGDEALPADAQ-----------------------------DLISRLLRQN 257

Query: 294 PEKRITVDDALN---HYWFHEVP----LPKSKDFMP 322
           P +R+    A     H +F  +     L +  +F+P
Sbjct: 258 PLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIP 293

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 80.6 bits (198), Expect = 1e-16
 Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 39/247 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINIL 70
           E+E + KI  G +G V+  + K++ E    K +    G KE         S L  E+N++
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR-GLKER------EKSQLVIEVNVM 66

Query: 71  LSFDHPSIVN-VKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM---LQ 125
               H +IV  +   +   +  +Y++ME+ +  DL   ++   + F   E   ++    Q
Sbjct: 67  RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126

Query: 126 LLEGVKYLHD-------NWVLHRDLKTSNLLL-----------------NNQGVLKICDF 161
           LL  + Y H+         VLHRDLK  N+ L                 N + + KI DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           G+S+  G     + S V T +Y +PELLL   K Y    DMW++GCI+ EL + K  F  
Sbjct: 187 GLSKNIGIESMAH-SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 221 TTEVDQI 227
                Q+
Sbjct: 246 ANNFSQL 252

Length = 1021

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.3 bits (190), Expect = 2e-16
 Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 16/196 (8%)

Query: 19  ISEGTYGIVYRA--RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           + +G +G V++   +DK     VA+K  K      ED L     I  L E  IL  +DHP
Sbjct: 3   LGKGNFGEVFKGTLKDKTP---VAVKTCK------ED-LPQELKIKFLSEARILKQYDHP 52

Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           +IV +  V       +Y+VME +   D    +   K    T ++    L    G+ YL  
Sbjct: 53  NIVKLIGVCTQ-RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL-VVTLWYRAPELLLGAKK 194
              +HRDL   N L+    VLKI DFGMSRQ    +   + L  + + + APE  L   +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYGR 170

Query: 195 YSTAVDMWSVGCIMAE 210
           YS+  D+WS G ++ E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 71/307 (23%), Positives = 139/307 (45%), Gaps = 49/307 (15%)

Query: 13  FEKLNKISEGTYGIVYRARD---KKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREIN 68
           FE L  +  G YG V+  R      +G++ A+K + K  + +K    E+     +  E  
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH-----TRTERQ 56

Query: 69  ILLSFDH-PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
           +L +    P +V +      D   ++++++Y+     +     ++ F+ SEV+  + +++
Sbjct: 57  VLEAVRRCPFLVTLHYAFQTD-TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV 115

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWYRAP 186
             + +LH   +++RD+K  N+LL+++G + + DFG+S+++ +  +    S   T+ Y AP
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 187 ELLLGAKK-YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           E++ G    +  AVD WS+G +  ELL     F+   E +   +I + +           
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--------- 226

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDD 302
                       +P       FP         +S    D + +LL  DP+KR+     D+
Sbjct: 227 -----------SKP------PFP-------KTMSAEARDFIQKLLEKDPKKRLGANGADE 262

Query: 303 ALNHYWF 309
             NH +F
Sbjct: 263 IKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 21/216 (9%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE +  +  GTYG VY+ R  K+G++ A+K + +    +E+            EIN+L  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---------EINMLKK 68

Query: 73  FDHPSIVN------VKEVVMDDHDSVYMVMEYM-EHDLKWLMESMK-QPFSTSEVKCLML 124
           + H   +       +K+      D +++VME+     +  L+++ K        +  +  
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           ++L G+ +LH + V+HRD+K  N+LL     +K+ DFG+S Q    +    + + T ++ 
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 185 APELLLGAKK----YSTAVDMWSVGCIMAELLAKKP 216
           APE++   +     Y    D+WS+G    E+    P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 56/212 (26%), Positives = 110/212 (51%), Gaps = 8/212 (3%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G+Y  V   R KK+  I A+K VK  +   ++ +++   + + + +    S +HP +
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDW---VQTEKHVFEQAS-NHPFL 58

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           V +      +   ++ V+EY+   DL + M+  ++       +    ++   + YLH+  
Sbjct: 59  VGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG 116

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           +++RDLK  N+LL+++G +K+ D+GM ++   P    ++   T  Y APE+L G + Y  
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
           +VD W++G +M E++A +  F      D  D+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 74/293 (25%), Positives = 137/293 (46%), Gaps = 45/293 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARD---KKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREI 67
            FE L  +  G YG V+  R      +G++ A+K + K  + +K   +E+     +  E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEH-----TRTER 55

Query: 68  NIL-LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
           N+L      P +V +      +   ++++++Y+     +     +  FS  EV+    ++
Sbjct: 56  NVLEHVRQSPFLVTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEI 114

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWYRA 185
           +  +++LH   +++RD+K  N+LL+++G + + DFG+S+++ S  K  T S   T+ Y A
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++ G   +  AVD WS+G ++ ELL     F+                          
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT-------------------------- 208

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
             L G +   ++    +L+   P  SF G P       DLL++LL  DP+KR+
Sbjct: 209 --LEGERNTQSEVSRRILKCDPPFPSFIG-PEAQ----DLLHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 91/341 (26%), Positives = 150/341 (43%), Gaps = 62/341 (18%)

Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGR--KEDCLEYGFPISSLRE 66
           S   F+ L+ + EGT+G V  A D+K  E  A+K V+ NV +  ++  +E  F +  +R+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKYTRDAKIEIQF-MEKVRQ 184

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVM-EYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
            +     D   ++ ++    ++   + +VM +Y    L W+M+    PFS   +  ++ Q
Sbjct: 185 ADPA---DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMK--HGPFSHRHLAQIIFQ 239

Query: 126 LLEGVKYLHDNW-VLHRDLKTSNLLLNNQGV----------------LKICDFG------ 162
               + Y H    ++H DLK  N+L+                     ++ICD G      
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299

Query: 163 MSRQYGSPLKPYTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELLAKKPLFSGT 221
            SR         T++V T  YR+PE++LG    YST  DMWS+GCI+ EL   K L+   
Sbjct: 300 HSR---------TAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTH 348

Query: 222 TEVDQIDKIFKTLGT-PTETIWPGLSELPGAKANF--------AKQPYNLLR--KRFPAA 270
             ++ +  + KTLG  P+E  W G      A+  +           P +L R  +  P  
Sbjct: 349 DNLEHLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVR 406

Query: 271 SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                 +L     DL+  LL YD +KR+       H +  +
Sbjct: 407 EVIRDDLLC----DLIYGLLHYDRQKRLNARQMTTHPYVLK 443

Length = 467

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.1 bits (189), Expect = 4e-16
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE +  +  GTYG VY+ R  K+G++ A+K + +    +E+  +         EIN+L  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---------EINMLKK 58

Query: 73  FDH--------PSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSE-VKCL 122
           + H         + +      MDD   +++VME+     +  L+++ K      E +  +
Sbjct: 59  YSHHRNIATYYGAFIKKNPPGMDDQ--LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             ++L G+ +LH + V+HRD+K  N+LL     +K+ DFG+S Q    +    + + T +
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 183 YRAPELLLGAKK----YSTAVDMWSVGCIMAELLAKKP 216
           + APE++   +     Y    D+WS+G    E+    P
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 36/229 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +  I +G  G VY A D      VALKK++ ++      L+  F    LRE  I   
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRF----LREAKIAAD 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME-----HDLK--WLMESMKQPFSTSE-VKCLM- 123
             HP IV V  +   D D VY  M Y+E       LK  W  ES+ +  +    V   + 
Sbjct: 59  LIHPGIVPVYSIC-SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 124 --LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG------------MSRQYGS 169
              ++   ++Y+H   VLHRDLK  N+LL   G + I D+G            +      
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 170 PLKPYTSLVV------TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
               Y+S+ +      T  Y APE LLG    S + D++++G I+ ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 5e-16
 Identities = 55/217 (25%), Positives = 108/217 (49%), Gaps = 18/217 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINIL 70
           F     + +G +G V   + + +G++ A KK+  K    RK + +       +L E  IL
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-------ALNEKQIL 54

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVKCLMLQLLE 128
              +   +V++     +  D++ +V+  M   DLK+ + +M  P F          ++  
Sbjct: 55  EKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAP 186
           G++ LH   +++RDLK  N+LL++ G ++I D G++ +   G  ++     V T+ Y AP
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR---GRVGTVGYMAP 170

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           E ++  ++Y+ + D W +GC++ E++  K  F    E
Sbjct: 171 E-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 15/196 (7%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
              +  G  G VY+A    +  I+A+K + +++      +E    I S  E+ IL   D 
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-----TVELQKQIMS--ELEILYKCDS 58

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+        + + + +  E+M+     +   + +      +  + + +++G+ YL  
Sbjct: 59  PYIIGFYGAFFVE-NRISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWS 113

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
             +LHRD+K SN+L+N +G +K+CDFG+S Q  + +    + V T  Y APE + G ++Y
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERISG-EQY 170

Query: 196 STAVDMWSVGCIMAEL 211
               D+WS+G    EL
Sbjct: 171 GIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 64/239 (26%), Positives = 122/239 (51%), Gaps = 20/239 (8%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           I  G +G VY  R   +G++ A+K     ++KM  G           ++    ++++ + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-------LALNERIMLSLVSTG 54

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           D P IV +        D +  +++ M   DL + + S    FS  E++    +++ G+++
Sbjct: 55  DCPFIVCMT-YAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEH 112

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H+ +V++RDLK +N+LL+  G ++I D G++  + S  KP+ S V T  Y APE+L   
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEVLQKG 170

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFS--GTTEVDQIDKIFKTLGTP-TETIWPGLSEL 248
             Y ++ D +S+GC++ +LL     F    T +  +ID++  T+     ++  P L  L
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSL 229

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.0 bits (187), Expect = 8e-16
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)

Query: 19  ISEGTYGIVYRARDKK--SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I +G +G V++AR       E   +  VKM        ++  F     RE  ++  FDHP
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEFDHP 68

Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEH-DL---------KWLMESM------------KQPF 114
           +IV +  V       + ++ EYM + DL         +                    P 
Sbjct: 69  NIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LK 172
           S +E  C+  Q+  G+ YL +   +HRDL T N L+    V+KI DFG+SR   S    K
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLFSGTTE 223
              +  + + +  PE +    +Y+T  D+W+ G ++ E+     +P +    E
Sbjct: 188 ASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 10/182 (5%)

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS----EVKC 121
           EI  L   +H +I+ ++E++  +  + YM+ +  + DL   M      +       + + 
Sbjct: 213 EILALGRLNHENILKIEEILRSE-ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRA 271

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
           +M QLL  V+Y+HD  ++HRD+K  N+ LN  G + + DFG +  +    + +    V T
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK--PLFSGTTEV-DQIDKIFKTLGTP 237
           +   +PE+L G   Y    D+WS G I+ ++L+    P+  G  +   Q+ KI  +L   
Sbjct: 332 VATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVC 390

Query: 238 TE 239
            E
Sbjct: 391 DE 392

Length = 501

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.7 bits (186), Expect = 8e-16
 Identities = 62/221 (28%), Positives = 113/221 (51%), Gaps = 24/221 (10%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  +++   H
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMKLSH 58

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       +Y+V EYM +   L +L E  K+ F  S++  +   + EG+ YL
Sbjct: 59  EKLVQLYGVCTKQR-PIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYL 116

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLL 190
                +HRDL   N L+++QG +K+ DFG+SR        YTS V + +   +  PE+LL
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLL 174

Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP--LFSGTTEVDQI 227
            + K+S+  D+W+ G +M E+  L K P   F+ +  V+++
Sbjct: 175 YS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 57/188 (30%), Positives = 89/188 (47%), Gaps = 33/188 (17%)

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMES-MKQPFSTSEVK 120
           L+E+ IL     P+I  +  V   D   + M+MEYME+ DL ++L +   +        K
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 121 -----CLM---LQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
                 L+    Q+  G++YL   N+V HRDL T N L+     +KI DFGMSR      
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFV-HRDLATRNCLVGKNYTIKIADFGMSRNL---- 180

Query: 172 KPYTSLVVTLWYRAP---------ELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSG 220
             Y+S    +  RAP          +LLG  K++T  D+W+ G  + E+  L ++  +  
Sbjct: 181 --YSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Query: 221 TTEVDQID 228
            T+   I+
Sbjct: 237 LTDQQVIE 244

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 82/325 (25%), Positives = 144/325 (44%), Gaps = 55/325 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L   + G  G  +   D K+ E V +K      G++           +  E +IL +
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIK-----AGQRG---------GTATEAHILRA 139

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HPSI+ +K     +  +  ++  Y + DL +   + K+  +  ++  +   +L  ++Y
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLILPRY-KTDL-YCYLAAKRNIAICDILAIERSVLRAIQY 197

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS---------RQYGSPLKPYTSLVVTLWY 183
           LH+N ++HRD+K  N+ +N+ G + + DFG +         + YG     +   + T   
Sbjct: 198 LHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG-----WAGTIAT--- 249

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAEL------LAKKPLFSGTTEVD-QIDKIFKTLGT 236
            APE LL    Y  AVD+WS G ++ E+      L +K    G  + D QI  I +  GT
Sbjct: 250 NAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308

Query: 237 PTETIWPGLSELP-GAKANFAKQPYNLLRK--RFPAASFTGSPVLSESGFD---LLNRLL 290
                    +E P  A+AN  +    L +K  R P +    +  L E   D   L+ ++L
Sbjct: 309 HP-------NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTN-LYELPIDLEYLICKML 360

Query: 291 TYDPEKRITVDDALNHYWFHEVPLP 315
            +D   R + +  L+   F ++P P
Sbjct: 361 AFDAHHRPSAEALLDFAAFQDIPDP 385

Length = 391

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 8/213 (3%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL-SFDHPS 77
           I +G++G V  A+ K  G+  A+K ++     K+   ++      + E N+LL +  HP 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKH-----IMAERNVLLKNVKHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +        D +Y V++Y+     +     ++ F     +    ++   + YLH   
Sbjct: 58  LVGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN 116

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           +++RDLK  N+LL++QG + + DFG+ ++     K  ++   T  Y APE+L   + Y  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDR 175

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            VD W +G ++ E+L   P F      +  D I
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)

Query: 14  EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN-ILLS 72
           + L +I  G +G V +   K SG I+A+K+++  V  KE           L +++ ++ S
Sbjct: 7   KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-------KRLLMDLDVVMRS 59

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL----KWLMESMKQPFSTSEVKCLMLQLLE 128
            D P IV     +  + D  ++ ME M+  L    K++ E +K       +  + +  ++
Sbjct: 60  SDCPYIVKFYGALFREGDC-WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 129 GVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL--------KPYTSLVV 179
            + YL +   ++HRD+K SN+LL+  G +K+CDFG+S Q    +        +PY     
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM---- 174

Query: 180 TLWYRAPELLL--GAKKYSTAVDMWSVGCIMAEL 211
                APE +       Y    D+WS+G  + E+
Sbjct: 175 -----APERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 37/260 (14%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           I  G +G VY  R   +G++ A+K     ++KM  G             +L E  I+LS 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET----------LALNE-RIMLSL 50

Query: 74  ----DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
               D P IV +        D +  +++ M   DL + + S    FS +E++    +++ 
Sbjct: 51  VSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIIL 108

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G++++H+ +V++RDLK +N+LL+  G ++I D G++  + S  KP+ S V T  Y APE+
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEV 166

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG--TTEVDQIDKIFKTLGTPTETIWPGLS 246
           L     Y ++ D +S+GC++ +LL     F    T +  +ID++       T T+     
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-------TLTMAV--- 216

Query: 247 ELPGAKANFAKQPYNLLRKR 266
           ELP + +   +     L +R
Sbjct: 217 ELPDSFSPELRSLLEGLLQR 236

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 20/198 (10%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
            I EG +G V +   + +G+ VA+K +K +V  +          + L E  ++    H +
Sbjct: 13  IIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQ----------AFLEETAVMTKLHHKN 60

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           +V +  V++  H+ +Y+VME M     + +L    +   S  ++    L + EG++YL  
Sbjct: 61  LVRLLGVIL--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
             ++HRDL   N+L++  GV K+ DFG++R     +    S +   W  APE  L  KK+
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKW-TAPE-ALKHKKF 174

Query: 196 STAVDMWSVGCIMAELLA 213
           S+  D+WS G ++ E+ +
Sbjct: 175 SSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 18/196 (9%)

Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           VY+ R K+    VA+K +K     K    E       +RE  I+   D+P IV +  V  
Sbjct: 15  VYKMRKKQID--VAIKVLKNE-NEKSVRDEM------MREAEIMHQLDNPYIVRMIGVC- 64

Query: 87  DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT 145
            + +++ +VME      L   +   K   + S V  LM Q+  G+KYL     +HRDL  
Sbjct: 65  -EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAA 123

Query: 146 SNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLLGAKKYSTAVDMW 202
            N+LL NQ   KI DFG+S+  G+    Y +     W   + APE +   +K+S+  D+W
Sbjct: 124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN-FRKFSSRSDVW 182

Query: 203 SVGCIMAELLA--KKP 216
           S G  M E  +  +KP
Sbjct: 183 SYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 17/163 (10%)

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----------HDLKWLMESMKQP 113
           L+EI I+     P+I+ +  V +   D + M+ EYME          H+ +   E     
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 114 F-STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSP 170
             S S +  +  Q+  G+KYL     +HRDL T N L+     +KI DFGMSR    G  
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 171 LKPYTSLVVTL-WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            +     V+ + W     +LLG  K++TA D+W+ G  + E+L
Sbjct: 186 YRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)

Query: 19  ISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           + +G++G+VY   A+    GE    VA+K V  N   +E  +E+      L E +++  F
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEF------LNEASVMKEF 66

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQ--------PFSTSEVKCLM 123
           +   +V +  VV        +VME M   DLK +L     +        P +  +   + 
Sbjct: 67  NCHHVVRLLGVVSTGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTL 181
            ++ +G+ YL     +HRDL   N ++     +KI DFGM+R        +     ++ +
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + APE L     ++T  D+WS G ++ E+  LA++P
Sbjct: 186 RWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 72.6 bits (178), Expect = 9e-15
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K +    E+          L+E  ++    HP
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---------FLKEAAVMKEIKHP 62

Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 63  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 180

Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 82/347 (23%), Positives = 124/347 (35%), Gaps = 89/347 (25%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F K+  I  G +G V   R   +  + A+K +     RK D L          E +IL  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL-----RKADVLMRNQAAHVKAERDILAE 57

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            D+  +V +     D  D++Y VM+Y+   D+  L+  +   F     +  + +L   ++
Sbjct: 58  ADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIE 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM---------SRQYGS------------- 169
            +H    +HRD+K  N+L++  G +K+ DFG+         S+ Y               
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 170 --------PLKPYT-------------SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIM 208
                    LKP               SLV T  Y APE+LL    Y+   D WSVG I+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 234

Query: 209 AELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFP 268
            E+L  +P F                 TP ET                      L     
Sbjct: 235 YEMLVGQPPFLAD--------------TPAETQLK------------VINWETTLH---- 264

Query: 269 AASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNHYWFHEV 312
                    LS    DL+ RL     E R+     D+   H +F  +
Sbjct: 265 ---IPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 31/215 (14%)

Query: 19  ISEGTYGIVYRARDKK-----SGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  G +G VY           SG I VA+K ++     +E           L+E +++ +
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-------KEFLKEAHLMSN 55

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFST-----SEVKCLMLQ 125
           F+HP+IV +  V + + +  Y++ME ME    L +L ++  + F        E+  + L 
Sbjct: 56  FNHPNIVKLLGVCLLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG-----VLKICDFGMSRQ-YGSPL--KPYTSL 177
           + +G  YL     +HRDL   N L++ +G     V+KI DFG++R  Y S    K    L
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           +   W  APE LL   K++T  D+WS G +M E+L
Sbjct: 175 LPVRWM-APESLLDG-KFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 8/201 (3%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL-SFDHPS 77
           I +G++G V  A+ K  G   A+K     V +K+  L+       + E N+LL +  HP 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVK-----VLQKKTILKKKEQNHIMAERNVLLKNLKHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +        + +Y V++Y+     +     ++ F     +    ++   + YLH   
Sbjct: 58  LVGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           +++RDLK  N+LL++QG + + DFG+ ++   P +  ++   T  Y APE +L  + Y  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDR 175

Query: 198 AVDMWSVGCIMAELLAKKPLF 218
            VD W +G ++ E+L   P F
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 53/206 (25%), Positives = 108/206 (52%), Gaps = 8/206 (3%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G+Y  V   R KK+ +I A+K VK  +   ++ +++   + + + +    S  +P +
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDW---VQTEKHVFEQAS-SNPFL 58

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           V +          +++V+EY+   DL + M+  ++       +    ++   + +LH+  
Sbjct: 59  VGLHSCFQTT-SRLFLVIEYVNGGDLMFHMQRQRK-LPEEHARFYAAEICIALNFLHERG 116

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           +++RDLK  N+LL+  G +K+ D+GM ++   P    ++   T  Y APE+L G ++Y  
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGF 175

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTE 223
           +VD W++G +M E++A +  F   T+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITD 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ EG +G VY+       ++ S   VA+K +K N   K   ++  F     +E  ++
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK---VQQEF----RQEAELM 62

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLM--------------ESMKQPF 114
               HP+IV +  V   +     M+ EY+ H DL ++L+              E++K   
Sbjct: 63  SDLQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL-- 171
             S+   + +Q+  G++YL  +  +HRDL   N L+     +KI DFG+SR  Y +    
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL 211
               SL+   W   PE +L   K++T  D+WS G ++ E+
Sbjct: 182 VQSKSLLPVRWM-PPEAILYG-KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 26/224 (11%)

Query: 18  KISEGTYGIVYRA--RDKKSGEI-VALKKVKMNVG--RKEDCLEYGFPISSLREINILLS 72
            I EG +G VY+      ++ +I VA+K  K       +E  L+         E  I+  
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ---------EAYIMRQ 63

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           FDHP IV +  V+ ++   V++VME     +L+  ++  K     + +     QL   + 
Sbjct: 64  FDHPHIVKLIGVITEN--PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---WYRAPEL 188
           YL     +HRD+   N+L+++   +K+ DFG+SR Y      Y +    L   W  APE 
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWM-APE- 178

Query: 189 LLGAKKYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
            +  +++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 67/230 (29%), Positives = 101/230 (43%), Gaps = 25/230 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           +F+ +  I  G +G V   R K S ++ A+K + K  + ++ D   +        E +I+
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFF------WEERDIM 97

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-----FSTSEVKCLML 124
              +   IV +     DD   +YMVMEYM   DL  LM +   P     F T+EV     
Sbjct: 98  AHANSEWIVQLHYAFQDDK-YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEV----- 151

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWY 183
             +  +  +H    +HRD+K  N+LL+  G LK+ DFG   +  +         V T  Y
Sbjct: 152 --VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209

Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 16  LNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + ++ +G +G V    Y      +GE+VA+KK++ +        E        REI IL 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--------REIEILK 60

Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ +VMEY+ +  L+  ++  ++     ++     Q+ +G
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKG 120

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ ++  +KI DFG++      ++Y    +P  S +   WY
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWY 178

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAEL 211
            APE  L   K+S A D+WS G ++ EL
Sbjct: 179 -APE-SLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 20/165 (12%)

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFST------ 116
           L+EI I+    +P+I+ +  V + D D + M+ EYME+ DL   + S ++  ST      
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD-DPLCMITEYMENGDLNQFL-SQREIESTFTHANN 122

Query: 117 ------SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS 169
                 + +  + +Q+  G+KYL     +HRDL T N L+ N   +KI DFGMSR  Y  
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182

Query: 170 PLKPYTSLVV--TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
                    V    W     +LLG  K++TA D+W+ G  + E+ 
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 12/216 (5%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK--KVKMNVGRKEDCLEYGFPISSLREINILL-SFDH 75
           I +G++G V  A+ K  G+  A+K  + K+ + RKE           + E N+LL +  H
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-------KHIMAERNVLLKNVKH 55

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P +V +        + +Y V++++     +     ++ F     +    ++   + YLH 
Sbjct: 56  PFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
             +++RDLK  N+LL++QG + + DFG+ ++  +     T+   T  Y APE++   + Y
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR-KQPY 173

Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
              VD W +G ++ E+L   P F      +  D I 
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 71/268 (26%), Positives = 112/268 (41%), Gaps = 56/268 (20%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F K+  +  G +G V  AR   +  + A+K +     RK+D L          E +IL  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTL-----RKKDVLLRNQVAHVKAERDILAE 57

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            D+  +V +      D D++Y VM+Y+   D+  L+  M   F     +  + +L   V+
Sbjct: 58  ADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVE 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM--------------------------SR 165
            +H    +HRD+K  N+L++  G +K+ DFG+                          S 
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 166 QYGSP--------LKPYT-------------SLVVTLWYRAPELLLGAKKYSTAVDMWSV 204
           ++G P        LKP               SLV T  Y APE+LL    Y+   D WSV
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSV 234

Query: 205 GCIMAELLAKKPLFSGTTEVDQIDKIFK 232
           G I+ E+L  +P F   T ++   K+  
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 19  ISEGTYGIVYRARDKKS----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           +  G +G V+ A+ K      GE + L K       +    E+       RE+++     
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR------RELDMFRKLS 66

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMK--------QPFSTSEVKCLMLQ 125
           H ++V +  +  +  +  YM++EY +  DLK  + + K         P ST +   L  Q
Sbjct: 67  HKNVVRLLGLCREA-EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTLWYR 184
           +  G+ +L +   +HRDL   N L+++Q  +K+    +S+  Y S      + ++ L + 
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAEL 211
           APE +     +ST  D+WS G +M E+
Sbjct: 186 APEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.0 bits (171), Expect = 9e-14
 Identities = 68/292 (23%), Positives = 131/292 (44%), Gaps = 44/292 (15%)

Query: 13  FEKLNKISEGTYGIVYRARD---KKSGEIVALKKVK-MNVGRKEDCLEYGFPISSLREIN 68
           FE L  +  G YG V+  R      SG++ A+K +K   + +K    E+     +  E  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEH-----TRTERQ 56

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           +L        +            ++++++Y+     +   S ++ F   EV+    +++ 
Sbjct: 57  VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSLVVTLWYRAPE 187
            +++LH   +++RD+K  N+LL++ G + + DFG+S+++    ++   S   T+ Y AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176

Query: 188 LLLGAKK-YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ++ G    +  AVD WS+G +M ELL     F+    VD                     
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT----VD--------------------- 211

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
              G K + A+    +L+   P      +  L++   D++ RLL  DP+KR+
Sbjct: 212 ---GEKNSQAEISRRILKSEPPYPQEMSA--LAK---DIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 8/214 (3%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL-SFDHPS 77
           I +G++G V  AR K   +  A+K     V +K+  L+       + E N+LL +  HP 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVK-----VLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +        D +Y V++Y+     +     ++ F     +    ++   + YLH   
Sbjct: 58  LVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 116

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           +++RDLK  N+LL++QG + + DFG+ ++        ++   T  Y APE +L  + Y  
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDR 175

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
            VD W +G ++ E+L   P F      +  D I 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 42/236 (17%)

Query: 18  KISEGTYGIVYRAR-----DKKSGEIVALKKVK-MNVGRKEDCLEYGFPISSLREINILL 71
           ++ EG +G V+ A        K   +VA+K +K   +  ++D           RE  +L 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---------FQREAELLT 62

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFST----- 116
           +  H  IV    V  D  D + MV EYM+H DL   + +           QP        
Sbjct: 63  NLQHEHIVKFYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 117 -SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP----L 171
            S++  +  Q+  G+ YL     +HRDL T N L+    ++KI DFGMSR   S     +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLFS-GTTEV 224
             +T L +   +  PE ++  +K++T  D+WS G I+ E+    K+P F    TEV
Sbjct: 182 GGHTMLPIR--WMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 14/160 (8%)

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL 122
           L+E  I+  F HP+++++  + +    S  +V+ YM+H DL+  + S         VK L
Sbjct: 44  LKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDL 100

Query: 123 M---LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPY 174
           +   LQ+ +G++YL     +HRDL   N +L+    +K+ DFG++R     +Y S     
Sbjct: 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
            + +   W  A E  L  +K++T  D+WS G ++ EL+ +
Sbjct: 161 GAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 58/231 (25%)

Query: 19  ISEGTYGIVYRA--RDKKSG--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS-- 72
           + EGT+G ++     D+K G  E V +K VK +              +S  ++ +LL   
Sbjct: 14  LQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--------------ASEIQVTLLLQES 59

Query: 73  -----FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK-------QPFSTSEV 119
                  H +I+ +  V ++D +  +++  YM   +LK  ++  +       Q  ST ++
Sbjct: 60  CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS----- 169
             + +Q+  G+ YLH   V+H+D+   N +++ +  +KI D  +SR      Y       
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179

Query: 170 --PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             P+K         W  A E L+  K+YS+A D+WS G ++ EL  L + P
Sbjct: 180 NRPVK---------WM-ALESLVN-KEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 48/157 (30%), Positives = 84/157 (53%), Gaps = 8/157 (5%)

Query: 58  GFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
           G+  SS+ E  +L    HP+++ + +V +    +  ++ +Y   DL   + +  +P   +
Sbjct: 202 GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLA 260

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC--DFGMS-RQYGSPLKP- 173
           +V  +  QLL  + Y+H   ++HRD+KT N+L+N  G   IC  DFG +    GS   P 
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN--GPEDICLGDFGAACFARGSWSTPF 318

Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAE 210
           +  +  T+   APE+L G   Y+ +VD+WS G ++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 22/165 (13%)

Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+ EF  +  IS G +G VY  R K + ++ A+K VK     K D +          E +
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-----KADMINKNMVHQVQAERD 56

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLM-------ESMKQPFSTSEVK 120
            L     P IV++    +   ++VY+VMEY+   D+K L+       E M      SEV 
Sbjct: 57  ALALSKSPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV-KYISEV- 113

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR 165
            L L       YLH + ++HRDLK  N+L++N+G +K+ DFG+S+
Sbjct: 114 ALALD------YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 20/218 (9%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G+Y  V     KK+  I A+K +K  +   ++ +++      + E     + +HP +
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET----ASNHPFL 58

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ------PFSTSEVKCLMLQLLEGVK 131
           V +      +   ++ V+E++   DL + M+  ++       F ++E+  L L       
Sbjct: 59  VGLHSCFQTE-SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEI-SLALN------ 110

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH+  +++RDLK  N+LL+ +G +K+ D+GM ++   P    ++   T  Y APE+L G
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
            + Y  +VD W++G +M E++A +  F      D  D+
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 11/219 (5%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +G +G V   + K +G++ A KK+     +K+          +L E  IL   + P I
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-----SGEKMALLEKEILEKVNSPFI 55

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDN 136
           VN+     +    + +VM  M   DLK+ + ++ +       V     Q+  G+ +LH  
Sbjct: 56  VNLA-YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            +++RD+K  N+LL++QG  ++ D G++ +     K  T    T  Y APE+L   + YS
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILK-EEPYS 172

Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTE-VDQIDKIFKTL 234
             VD +++GC + E++A +  F    E V + +   +TL
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 9e-13
 Identities = 57/217 (26%), Positives = 110/217 (50%), Gaps = 18/217 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINIL 70
           F +   + +G +G V   + + +G++ A K++  K    RK + +       +L E  IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM-------ALNEKQIL 54

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVKCLMLQLLE 128
              +   +VN+     +  D++ +V+  M   DLK+ + +M  P F          ++L 
Sbjct: 55  EKVNSQFVVNLA-YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC 113

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAP 186
           G++ LH    ++RDLK  N+LL++ G ++I D G++ +   G  ++     V T+ Y AP
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GRVGTVGYMAP 170

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           E +L  ++Y+ + D W +GC++ E++  +  F G  E
Sbjct: 171 E-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K       D     F    L E +++ 
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK------NDATAQAF----LAEASVMT 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM     + +L    +       +    L + E 
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL  N  +HRDL   N+L++   V K+ DFG++++  S     T  +   W  APE L
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL 171

Query: 190 LGAKKYSTAVDMWSVGCIMAEL 211
              KK+ST  D+WS G ++ E+
Sbjct: 172 R-EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 42/239 (17%)

Query: 18  KISEGTYGIVYRA--------RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           ++ EG +G V+ A        +DK    + ALK+   +   ++D           RE  +
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQD---------FQREAEL 60

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH------------DLKWLMESMKQP---F 114
           L    H  IV    V  +    + MV EYM H            D K L           
Sbjct: 61  LTVLQHQHIVRFYGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LK 172
           +  ++  +  Q+  G+ YL     +HRDL T N L+    V+KI DFGMSR   S    +
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLF--SGTTEVDQI 227
                ++ + +  PE +L  +K++T  D+WS G ++ E+    K+P +  S T  ++ I
Sbjct: 180 VGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 18/200 (9%)

Query: 18  KISEGTYGIVYRA--RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           ++  G +G V +   + KKS + VA+K +K       D  +       LRE N++   D+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILK------NDNNDPALKDELLREANVMQQLDN 55

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEGVKYL 133
           P IV +  +   + +S  +VME  E  L  L + +++    +E  +  L+ Q+  G+KYL
Sbjct: 56  PYIVRMIGIC--EAESWMLVMELAE--LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLL 190
            +   +HRDL   N+LL  Q   KI DFG+S+  G+    Y +     W   + APE  +
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-CM 170

Query: 191 GAKKYSTAVDMWSVGCIMAE 210
              K+S+  D+WS G +M E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 25  GIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV 84
            IV+ A+ K +  +VA+KK+ ++   KED           +EI       HP+I+     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLL------QQEIITSRQLQHPNILPYVTS 67

Query: 85  VMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLH 140
            + D + +Y+V   M +    DL  L     +      +  ++  +L  + Y+H    +H
Sbjct: 68  FIVDSE-LYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 141 RDLKTSNLLLNNQGVLKICDFGMSRQ-----------YGSPLKPYTSLVVTLWYRAPELL 189
           R +K S++LL+  G + +     S             +  P     S V  L + +PE+L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP----KSSVKNLPWLSPEVL 180

Query: 190 ----LGAKKYSTAVDMWSVGCIMAEL 211
                G   Y+   D++SVG    EL
Sbjct: 181 QQNLQG---YNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 45/266 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  I  G +G V   + K +G I A+K     + RK D LE         E +IL+
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMK-----ILRKADMLEKEQVAHIRAERDILV 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             D   +V +     D  + +Y++ME++       +   K   S    +  + + +  + 
Sbjct: 57  EADGAWVVKMFYSFQDKRN-LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS-------------------------RQ 166
            +H    +HRD+K  NLLL+ +G +K+ DFG+                          + 
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 167 YGSPLKPYT----------SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKP 216
             S  K  T          S V T  Y APE+ +    Y+   D WS+G IM E+L   P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 217 LFSGTTEVDQIDKIF---KTLGTPTE 239
            F   T  +   K+    +TL  P E
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPE 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 37/220 (16%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   + E+  K+  G +G V+      + + VA+K +K      E  L+         E 
Sbjct: 5   RESLKLER--KLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQ---------EA 52

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML--- 124
            I+    H  +V +  V  ++ + +Y+V EYM         S+     + E K L L   
Sbjct: 53  QIMKKLRHDKLVQLYAVCSEE-EPIYIVTEYMSKG------SLLDFLKSGEGKKLRLPQL 105

Query: 125 -----QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPY 174
                Q+ EG+ YL     +HRDL   N+L+    V KI DFG++R     +Y       
Sbjct: 106 VDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY----TAR 161

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
                 + + APE      +++   D+WS G ++ E++  
Sbjct: 162 EGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           E EK+  +  G +G VY+      GE     KVK+ V  K    E   P ++   L E  
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGE-----KVKIPVAIKV-LREETSPKANKEILDEAY 61

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM---LQ 125
           ++ S DHP +V +  + +     V ++ + M   L  L++ ++        + L+   +Q
Sbjct: 62  VMASVDHPHVVRLLGICLSS--QVQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQ 117

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY--TSLVVTLWY 183
           + +G+ YL +  ++HRDL   N+L+     +KI DFG+++      K Y      V + +
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKP 216
            A E +L  + Y+   D+WS G  + EL+    KP
Sbjct: 178 MALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 12/225 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE +  I  G +G V   + K +  I A+K     +  K + L+         E N+L+
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMK-----ILNKWEMLKRAETACFREERNVLV 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + D   I  +     D+ + +Y+VM+Y +  DL  L+   +        +  + +++  +
Sbjct: 57  NGDCQWITTLHYAFQDE-NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI 115

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELL 189
             +H    +HRD+K  N+LL+  G +++ DFG   +        +S+ V T  Y +PE+L
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 190 L----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
                G  KY    D WS+G  M E+L  +  F   + V+   KI
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 12/226 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  I  G +G V   + K + ++ A+K     +  K + L+         E ++L+
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMK-----ILNKWEMLKRAETACFREERDVLV 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + D+  I  +     D+ +++Y+VM+Y +  DL  L+   +        +  + +++  +
Sbjct: 57  NGDNQWITTLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELL 189
             +H    +HRD+K  N+L++  G +++ DFG   +        +S+ V T  Y +PE+L
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 190 L----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
                G  KY    D WS+G  M E+L  +  F   + V+   KI 
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 25/230 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           ++E +  I  G +G V   R K + ++ A+K + K  + ++ D   +        E +I+
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF------WEERDIM 97

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-----FSTSEVKCLML 124
              + P +V +     DD   +YMVMEYM   DL  LM +   P     F T+EV    +
Sbjct: 98  AFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV----V 152

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTSLVVTLWY 183
             L+ +   H    +HRD+K  N+LL+  G LK+ DFG   +     +    + V T  Y
Sbjct: 153 LALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 25/230 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           +++ +  I  G +G V   R K S ++ A+K + K  + ++ D   +        E +I+
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF------WEERDIM 97

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-----FSTSEVKCLML 124
              + P +V +     DD   +YMVMEYM   DL  LM +   P     F T+EV     
Sbjct: 98  AFANSPWVVQLFCAFQDD-KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV----- 151

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG-SPLKPYTSLVVTLWY 183
             +  +  +H   ++HRD+K  N+LL+  G LK+ DFG   +   + +    + V T  Y
Sbjct: 152 --VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209

Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 25/188 (13%)

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMES------------- 109
           L+E+ IL     P+I+ +  V +D+ D + M+ EYME+ DL   + S             
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 110 --MKQPFSTSEVKCLM---LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS 164
                         L+   LQ+  G+KYL     +HRDL T N L+     +KI DFGMS
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 165 RQY--GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSG 220
           R    G   +     V+ + + A E +L   K++TA D+W+ G  + E+L   K+  +  
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244

Query: 221 TTEVDQID 228
            T+   I+
Sbjct: 245 LTDEQVIE 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 69/267 (25%), Positives = 113/267 (42%), Gaps = 47/267 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINIL 70
           +FE L  I  G +G V   + K +G + A+K     + RK D LE    +  +R E +IL
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMK-----ILRKADMLEKE-QVGHIRAERDIL 55

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           +  D   +V +     D  + +Y++ME++       +   K   +  E +  + + +  +
Sbjct: 56  VEADSLWVVKMFYSFQDKLN-LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAI 114

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS-------------------------R 165
             +H    +HRD+K  NLLL+++G +K+ DFG+                          +
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 166 QYGSPLKPYT----------SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK 215
              S  K  T          S V T  Y APE+ +    Y+   D WS+G IM E+L   
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 216 PLFSGTTEVDQIDKIF---KTLGTPTE 239
           P F   T  +   K+    +TL  P E
Sbjct: 234 PPFCSETPQETYKKVMNWKETLIFPPE 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 19/171 (11%)

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK----------WLMESMKQP 113
           RE  +L +  H  IV    V ++  D + MV EYM+H DL            LM    +P
Sbjct: 56  REAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114

Query: 114 FSTSEVKCLML--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP- 170
              ++ + L +  Q+  G+ YL     +HRDL T N L+    ++KI DFGMSR   S  
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174

Query: 171 -LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLF 218
             +     ++ + +  PE ++  +K++T  D+WS+G ++ E+    K+P +
Sbjct: 175 YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 37/107 (34%), Positives = 59/107 (55%), Gaps = 7/107 (6%)

Query: 111 KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS 169
           K P +  ++ C   Q+  G+++L     +HRDL   N+LL+   V+KICDFG++R  Y  
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 170 PLKPYT---SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           P   Y    S  + L + APE +   K Y+T  D+WS G ++ E+ +
Sbjct: 228 P--DYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLM 123
           RE  +     HP+IV + +        ++ V EY+    L+ ++ +        E   LM
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA-DGALPAGETGRLM 85

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV---LKICDFGMS-------RQYGSPLKP 173
           LQ+L+ +   H+  ++HRDLK  N++++  GV    K+ DFG+            + L  
Sbjct: 86  LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145

Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT 233
            T ++ T  Y APE L G +  +   D+++ G I  E L  + +  G + V +I  +++ 
Sbjct: 146 TTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLTGQRVVQGAS-VAEI--LYQQ 201

Query: 234 LGTPTETIWPGLSELP 249
           L     ++ P ++  P
Sbjct: 202 LSPVDVSLPPWIAGHP 217

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L K+  G +G V+      +   VA+K +K      +D     F    L E  I+    H
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD-----F----LAEAQIMKKLRH 60

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P ++ +  V   + + +Y+V E M++   L++L     +     ++  +  Q+  G+ YL
Sbjct: 61  PKLIQLYAVCTLE-EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                +HRDL   N+L+    + K+ DFG++R     +  Y +       + + APE  L
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAAL 177

Query: 191 GAKKYSTAVDMWSVGCIMAELL 212
              ++S   D+WS G ++ E++
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.2 bits (151), Expect = 5e-11
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 41/207 (19%)

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q++ G+++LH   +++RDLK  N+LL+N G ++I D G++ +             T  + 
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           APELL G ++Y  +VD +++G  + E++A + P              F+  G   E    
Sbjct: 165 APELLQG-EEYDFSVDYFALGVTLYEMIAARGP--------------FRARGEKVEN--- 206

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI----- 298
                        K+    L++R    S T     S +       LL  DPEKR+     
Sbjct: 207 -------------KE----LKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDG 249

Query: 299 TVDDALNHYWFHEVPLPKSKDFMPTFP 325
             D    H  F ++   + +  M   P
Sbjct: 250 NCDGLRTHPLFRDLNWRQLEAGMLPPP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 7/107 (6%)

Query: 111 KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS 169
           K+  +  ++ C   Q+ +G+++L     +HRDL   N+LL+   V+KICDFG++R  Y  
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 170 PLKPYT---SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           P   Y       + L + APE +   + Y+   D+WS G ++ E+ +
Sbjct: 233 P--DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 72/278 (25%), Positives = 114/278 (41%), Gaps = 59/278 (21%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F K+  +  G +G V  A    +  + A+K +     RK+D L          E +IL  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTL-----RKKDVLNRNQVAHVKAERDILAE 57

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            D+  +V +      D D++Y VM+Y+   D+  L+  M + F     +  + +L   ++
Sbjct: 58  ADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIE 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM---------SRQY--------------- 167
            +H    +HRD+K  N+L++  G +K+ DFG+         S+ Y               
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 168 ----------GSPLKPYT-------------SLVVTLWYRAPELLLGAKKYSTAVDMWSV 204
                     G  LK                SLV T  Y APE+LL  K Y+   D WSV
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSV 234

Query: 205 GCIMAELLAKKPLFSGTTEVDQIDKIFK---TLGTPTE 239
           G I+ E+L  +P F   T  +   K+     TL  P +
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ 272

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 30/221 (13%)

Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 63

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R   +     K    L
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 183 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 12/225 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  I  G +G V   + K +G++ A+K   +N   K + L+         E ++L+
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKI--LN---KWEMLKRAETACFREERDVLV 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + D   I N+     D+ +++Y+VM+Y +  DL  L+   +        +  + +++  +
Sbjct: 57  NGDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELL 189
             +H    +HRD+K  N+LL+  G +++ DFG   +  +     +++ V T  Y +PE+L
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 190 L----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
                G  +Y    D WS+G  M E+L  +  F   + V+   KI
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 59/241 (24%), Positives = 117/241 (48%), Gaps = 18/241 (7%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINIL 70
           F     + +G +G V   + + +G++ A KK+  K    RK + +       +L E  IL
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-------ALNEKRIL 54

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVKCLMLQLLE 128
              +   +V++     +  D++ +V+  M   DLK+ + +M  P F          +L  
Sbjct: 55  EKVNSRFVVSLA-YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC 113

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAP 186
           G++ L    +++RDLK  N+LL+++G ++I D G++ Q   G  ++     V T+ Y AP
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR---GRVGTVGYMAP 170

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           E ++  +KY+ + D W +GC++ E++  +  F    E  + +++ + +    E      S
Sbjct: 171 E-VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS 229

Query: 247 E 247
           E
Sbjct: 230 E 230

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 17/211 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +F  +  +  G++G V  A  K      VA+K+ + +   K+  +++ F      E  IL
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-----SERKIL 85

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYM--EHDLKWLMESMKQPFSTSEVKCL-MLQLL 127
              +HP  VN+     D+   +Y+V+E++       +L  + + P   ++V C    Q++
Sbjct: 86  NYINHPFCVNLYGSFKDE-SYLYLVLEFVIGGEFFTFLRRNKRFP---NDVGCFYAAQIV 141

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
              +YL    +++RDLK  NLLL+  G +K+ DFG ++   +  + YT L  T  Y APE
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT-LCGTPEYIAPE 198

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
           +LL    +  A D W++G  + E+L   P F
Sbjct: 199 ILLNV-GHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 7/110 (6%)

Query: 108 ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ- 166
           E  K+P +  ++     Q+  G+++L     +HRDL   N+LL+   V+KICDFG++R  
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223

Query: 167 YGSPLKPYT---SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           Y  P   Y       + L + APE +   K Y+T  D+WS G ++ E+ +
Sbjct: 224 YKDP--DYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 32/219 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINIL 70
           F +   + +G +G V   + + +G++ A KK+  K    RK + +       +L E  IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-------ALNEKQIL 54

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP--------FSTSEVKC 121
              +   +V++     +  D++ +V+  M   DLK+ +  M +         F  +E+ C
Sbjct: 55  EKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVV 179
                  G++ LH   +++RDLK  N+LL++ G ++I D G++     G  +K     V 
Sbjct: 114 -------GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRVG 163

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
           T+ Y APE++   ++Y+ + D W++GC++ E++A +  F
Sbjct: 164 TVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 43/150 (28%), Positives = 80/150 (53%), Gaps = 21/150 (14%)

Query: 74  DHPSIVNVKEVVMDDHDSVY------MVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQL 126
           D+P+ + +       + SV       ++M+Y+ + DL  L++  +   S +EVK ++ QL
Sbjct: 67  DNPNFIKL-------YYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQL 118

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           +E +  LH + ++H D+K  N+L +  +  + +CD+G+ +  G+P    +    TL Y +
Sbjct: 119 VEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFS 174

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKK 215
           PE + G   Y  + D W+VG +  ELL  K
Sbjct: 175 PEKIKG-HNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 20/204 (9%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + K+  G +G V+      + + VA+K +K      E  LE         E  I+    H
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLE---------EAQIMKKLRH 60

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  VV    + +Y+V EYM     L +L +   +      +  +  Q+  G+ Y+
Sbjct: 61  DKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS---LVVTLWYRAPELLL 190
                +HRDL+++N+L+ +  V KI DFG++R        YT+       + + APE  L
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL 176

Query: 191 GAKKYSTAVDMWSVGCIMAELLAK 214
              +++   D+WS G ++ EL+ K
Sbjct: 177 YG-RFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)

Query: 14  EKLNKISEGTYGIVY----RARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
             L  +  G +G VY    R RD  + E+    K       ++D  ++      L E  I
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDF------LMEALI 62

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMES---MKQPFSTSEVKCLML 124
           +  F+H +IV +  V  +     ++++E M   DLK +L E+    ++P S +     M 
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLT-----MK 116

Query: 125 QLLE-------GVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQ-YGSPL-- 171
            LL        G KYL +N  +HRD+   N LL  +G   V KI DFGM+R  Y +    
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176

Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           K   +++   W   PE  L    +++  D+WS G ++ E+ +
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDG-IFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIV----ALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E +++  +  G +G VY+      GE V    A+K +    G K +       +  + E 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-------VEFMDEA 60

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ 125
            I+ S DHP +V +  V +    ++ +V + M H   L ++ E  K    +  +    +Q
Sbjct: 61  LIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQ 117

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWY 183
           + +G+ YL +  ++HRDL   N+L+ +   +KI DFG++R      K Y +    + + +
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            A E  +  +K++   D+WS G  + EL+
Sbjct: 178 MALE-CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 41/166 (24%), Positives = 82/166 (49%), Gaps = 26/166 (15%)

Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L E N++    HP +V +  VV    + +Y++ EYME+   + +L        + +
Sbjct: 45  PEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPEGIKLTIN 102

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---------QYG 168
           ++  +  Q+ EG+ ++     +HRDL+ +N+L++     KI DFG++R         + G
Sbjct: 103 KLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162

Query: 169 S--PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           +  P+K          + APE  +    ++   D+WS G ++ E++
Sbjct: 163 AKFPIK----------WTAPE-AINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 8/154 (5%)

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCL 122
           L E   L  FDH +IV + E V+   +++ +V EYM +  L   +   +      ++  +
Sbjct: 54  LAEALTLGQFDHSNIVRL-EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL---VV 179
           +  L  G+KYL +   +H+ L    +L+N+  V KI  F   ++  S    YT++     
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE-AIYTTMSGKSP 171

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            LW  APE  +    +S+A D+WS G +M E+++
Sbjct: 172 VLW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 56/226 (24%), Positives = 108/226 (47%), Gaps = 42/226 (18%)

Query: 16  LNKISEGTYGIVYRARDKKSG----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + ++ E  +G +Y+      G    ++VA+K +K ++   +   E+       +E +++ 
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQ------QEASLMA 62

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKC--------- 121
              HP+IV +  VV  +   V M+ EY+   DL   +  M+ P S  +V C         
Sbjct: 63  ELHHPNIVCLLGVVTQEQ-PVCMLFEYLNQGDLHEFL-IMRSPHS--DVGCSSDEDGTVK 118

Query: 122 ----------LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP- 170
                     + +Q+  G++YL  ++ +H+DL   N+L+  Q  +KI D G+SR+  S  
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 171 ---LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
              ++P  SL+   W     ++ G  K+S+  D+WS G ++ E+ +
Sbjct: 179 YYRVQP-KSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 29/233 (12%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           K+ +G +G V+      +   VA+K +K              P + L+E  ++    H  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEK 62

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFST----SEVKCLMLQLLEGVKYL 133
           +V +  VV ++   +Y+V EYM      L++ +K          ++  +  Q+  G+ Y+
Sbjct: 63  LVQLYAVVSEE--PIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS---LVVTLWYRAPELLL 190
                +HRDL+ +N+L+    V K+ DFG++R        YT+       + + APE  L
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL 176

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKIFKTLGTPTE 239
              +++   D+WS G ++ EL  K     P       +DQ+++ ++ +  P E
Sbjct: 177 YG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPE 227

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 61

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 62  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 118

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL +  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 179 ALESIL-HRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   + EK  K+  G +G V+ A   K  + VA+K +K      E  L          E 
Sbjct: 5   RESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA---------EA 52

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLM 123
           N++ +  H  +V +  VV    + +Y++ E+M      D     E  KQP    ++    
Sbjct: 53  NVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFS 108

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS------PLK 172
            Q+ EG+ ++     +HRDL+ +N+L++   V KI DFG++R     +Y +      P+K
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168

Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                     + APE  +    ++   D+WS G ++ E++ 
Sbjct: 169 ----------WTAPE-AINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 10/160 (6%)

Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  I+    H  +V +  VV ++   +Y+V E+M     L +L E   +     
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVPLYAVVSEE--PIYIVTEFMGKGSLLDFLKEGDGKYLKLP 102

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+ +G+ Y+     +HRDL+ +N+L+ +  V KI DFG++R        YT+ 
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED--NEYTAR 160

Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
                 + + APE  L   +++   D+WS G ++ EL+ K
Sbjct: 161 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 27/213 (12%)

Query: 19  ISEGTYGIVYRARDKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I EG +G V +AR KK G  +  A+K++K     K+D  ++   +  L ++       HP
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG-----HHP 68

Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMES--------------MKQPFSTSEVK 120
           +I+N+     +    +Y+ +EY  H   L +L +S                   S+ ++ 
Sbjct: 69  NIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
                +  G+ YL     +HRDL   N+L+    V KI DFG+SR     +K     +  
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            W       L    Y+T  D+WS G ++ E+++
Sbjct: 188 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 30/226 (13%)

Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 65

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL-----MLQL 126
           F+   +V +  VV     ++ ++ME M   DLK  + S++     + V+       M+Q+
Sbjct: 66  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124

Query: 127 L----EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSLVV 179
                +G+ YL+ N  +HRDL   N ++     +KI DFGM+R   +     K    L+ 
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTE 223
             W     L  G   ++T  D+WS G ++ E+  LA++P    + E
Sbjct: 185 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 27/219 (12%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +FE +  I EG +G V RA  KK G ++ A  K+      + D  ++   +  L ++   
Sbjct: 5   KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-- 60

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEY---------------MEHDLKWLME-SMKQPF 114
               HP+I+N+     ++   +Y+ +EY               +E D  +  E       
Sbjct: 61  ---HHPNIINLLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY 174
           ++ ++      +  G++YL +   +HRDL   N+L+      KI DFG+SR     +K  
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
              +   W       L    Y+T  D+WS G ++ E+++
Sbjct: 177 MGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 19  ISEGTYGIVYRAR---DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + +G +G V  A+   +  S + VA+K +K ++    D  E+      LRE   +  FDH
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEF------LREAACMKEFDH 60

Query: 76  PSIVNVKEVVMDDHDS----VYMV-MEYMEH-DLK--WLMESM-KQPFSTSEVKCL--ML 124
           P+++ +  V +         + MV + +M+H DL    LM  + ++PF+      +  M+
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLW 182
            +  G++YL     +HRDL   N +LN    + + DFG+S++   G   +   +  + + 
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
           + A E  L    Y+T  D+W+ G  M E++ +
Sbjct: 181 WLALE-SLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 54/266 (20%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  +  I +G +G V   + K +G+I A+K +  +   K+D L +        E ++L 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-----VKAERDVLA 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             D P +V++      D   +Y++ME++       M      FS    +  M + +  ++
Sbjct: 57  ESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY------------------GSPLKP 173
            +H    +HRD+K  N+L++  G +K+ DFG+S  +                   + +  
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175

Query: 174 YTSLVV-TLW----------------------------YRAPELLLGAKKYSTAVDMWSV 204
             S+ V ++                             Y APE+ L  + Y    D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL 234

Query: 205 GCIMAELLAKKPLFSGTTEVDQIDKI 230
           G IM E L   P F      +   KI
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKI 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 42/226 (18%)

Query: 19  ISEGTYGIVYRA-----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           + EG +G V +A     + +     VA+K +K N    E           L E N+L   
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-------LRDLLSEFNLLKQV 60

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMK-------------------- 111
           +HP ++ +      D   + +++EY ++  L+ +L ES K                    
Sbjct: 61  NHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 112 --QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---Q 166
             +  +  ++     Q+  G++YL +  ++HRDL   N+L+     +KI DFG+SR   +
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             S +K     +   W  A E L     Y+T  D+WS G ++ E++
Sbjct: 180 EDSYVKRSKGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 44/231 (19%)

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPF-STSEVKCLMLQLLEGVKY 132
           H +IVN+          + ++ EY  + DL   +   ++ F +  ++     Q+ +G+ +
Sbjct: 98  HENIVNLLGACTI-GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP----LKPYTSLVVTLWYRAPEL 188
           L     +HRDL   N+LL +  ++KICDFG++R   +     +K    L V   + APE 
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK--WMAPES 214

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           +     Y+   D+WS G ++ E                   IF     P    +PG+   
Sbjct: 215 IFNC-VYTFESDVWSYGILLWE-------------------IFSLGSNP----YPGMP-- 248

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
               + F    Y L+++ +  A    +P      +D++      DP KR T
Sbjct: 249 --VDSKF----YKLIKEGYRMAQPEHAP---AEIYDIMKTCWDADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 4/128 (3%)

Query: 90  DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL 149
           DSV++V+++ E    W   S         VK    +++  +  LH   ++ RDL  +N+L
Sbjct: 58  DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL 117

Query: 150 LNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMA 209
           L+++G +++  F    ++           V   Y APE + G  + + A D WS+G I+ 
Sbjct: 118 LDDRGHIQLTYFS---RWSEVEDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAILF 173

Query: 210 ELLAKKPL 217
           ELL  K L
Sbjct: 174 ELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 44/227 (19%)

Query: 15  KLNKI-SEGTYGIVYRAR---DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           KL KI  EG +G V   +   D  S   VA+K +K+++    +  E+      L E   +
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF------LSEAACM 55

Query: 71  LSFDHPSIVNVKEVVMDDHD-----SVYMVMEYMEH-DLKWLMESMK-----QPFSTSEV 119
             FDHP+++ +  V  +           +++ +M+H DL   +   +     +      +
Sbjct: 56  KDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL 115

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS---------- 169
              M+ +  G++YL +   +HRDL   N +L     + + DFG+S++  S          
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 170 --PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
             P+K         W  A E  L  + Y++  D+W+ G  M E+  +
Sbjct: 176 KMPVK---------WI-AIE-SLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.2 bits (127), Expect = 5e-08
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 19  ISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           I EG +G V +AR KK G  + A  K       K+D  ++   +  L ++       HP+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPN 57

Query: 78  IVNVKEVVMDDHDSVYMVMEY---------------MEHDLKWLME-SMKQPFSTSEVKC 121
           I+N+     +    +Y+ +EY               +E D  + +  S     S+ ++  
Sbjct: 58  IINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
               +  G+ YL     +HRDL   N+L+    V KI DFG+SR     +K     +   
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           W       L    Y+T  D+WS G ++ E+++
Sbjct: 177 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 19  ISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSL-REINILLS 72
           + EG +G V +A     D  +    VA+K +K +   K+        +S L  E+ ++  
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--------LSDLVSEMEMMKM 71

Query: 73  F-DHPSIVNVKEVVMDDHDSVYMVMEY----------------MEHDLKWLMESMKQPFS 115
              H +I+N+  V   +   +Y+V+EY                 E+         ++  +
Sbjct: 72  IGKHKNIINLLGVCTQE-GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKP 173
             ++     Q+  G+++L     +HRDL   N+L+    V+KI DFG++R   +    + 
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            T+  + + + APE L   + Y+   D+WS G ++ E+ 
Sbjct: 191 TTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 35/210 (16%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + K+  G +G V+      S + VA+K +K      +  LE         E N++ +  H
Sbjct: 11  VKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLE---------EANLMKTLQH 60

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  VV  + + +Y++ EYM     L +L           ++     Q+ EG+ Y+
Sbjct: 61  DKLVRLYAVVTKE-EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS------PLKPYTSLVVTLW 182
                +HRDL+ +N+L++   + KI DFG++R     +Y +      P+K          
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---------- 169

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           + APE  +    ++   D+WS G ++ E++
Sbjct: 170 WTAPE-AINFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 31/110 (28%), Positives = 57/110 (51%), Gaps = 3/110 (2%)

Query: 106 LMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR 165
           L +   +  +T ++     Q+  G+++L     +HRDL   N+LL    ++KICDFG++R
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285

Query: 166 Q--YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
              + S      S  + + + APE +     Y+T  D+WS G ++ E+ +
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 3/103 (2%)

Query: 112 QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP- 170
           +  +  ++     Q+  G++YL     +HRDL   N+L+    V+KI DFG++R   +  
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 171 -LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             K  T+  + + + APE L   + Y+   D+WS G +M E+ 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 19  ISEGTYGIVYRARDKKSGEI--VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           + EG +G V   +  +   I  VA+K +K+ +  + +  ++      L E   +  FDHP
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF------LSEAVCMKEFDHP 60

Query: 77  SIVNVKEVVM-----DDHDSVYMVMEYMEH-DL-KWLMESM--KQP--FSTSEVKCLMLQ 125
           +++ +  V +     + + S  +++ +M+H DL  +L+ S     P    T  +   M  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWY 183
           +  G++YL     +HRDL   N +LN    + + DFG+S++   G   +      + + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
            A E  L  + Y+T  D+WS G  M E+  +
Sbjct: 181 IAIE-SLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 32/110 (29%), Positives = 56/110 (50%), Gaps = 3/110 (2%)

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLW 182
           Q+  G++YL     +HRDL   N+L+    V+KI DFG++R   +    K  T+  + + 
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
           + APE L   + Y+   D+WS G ++ E+            V+++ K+ K
Sbjct: 202 WMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 31/218 (14%)

Query: 19  ISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFP--ISSLREINILLS 72
           + EG +G V  A     DK+    V    VKM    K D  E      IS +  + ++  
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKMI-- 80

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---------------FST 116
             H +I+N+      D   +Y+++EY    +L+  + + + P                S 
Sbjct: 81  GKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPY 174
            ++     Q+  G++YL     +HRDL   N+L+    V+KI DFG++R   +    K  
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           T+  + + + APE L   + Y+   D+WS G ++ E+ 
Sbjct: 200 TNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 77/329 (23%), Positives = 123/329 (37%), Gaps = 45/329 (13%)

Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           VY AR   +G +V ++   +     E+C E         E+ +   F HP+I+    V  
Sbjct: 16  VYLARHTPTGTLVTVRITDL-----ENCTEEHLKALQ-NEVVLSHFFRHPNIMTSWTVFT 69

Query: 87  DDH----DSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHR 141
                   S +M        LK +  E M    S + +  ++   L G+ YLH N  +HR
Sbjct: 70  TGSWLWVISPFMAYGSANSLLKTYFPEGM----SEALIGNILFGALRGLNYLHQNGYIHR 125

Query: 142 DLKTSNLLLNNQGVLKICDFGMSRQY-----GSPLK-----PYTSLVVTLWYRAPELL-L 190
           ++K S++L++  G++ +   G+S  Y     G   K     P  S  V  W  +PELL  
Sbjct: 126 NIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELLRQ 182

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLF-------------SGTTEVDQIDKIFKTLGTP 237
               Y+   D++SVG    EL   +  F              G          F    + 
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            +    G+    G     A     +  +R    S   S   S +  +L+   L  DPEKR
Sbjct: 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS---SKTFSPAFQNLVELCLQQDPEKR 299

Query: 298 ITVDDALNHYWFHEVPLPKSKDFMPTFPP 326
            +    L+H +F +V        +   PP
Sbjct: 300 PSASSLLSHAFFKQVKEQTQGSILSLLPP 328

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 37/221 (16%)

Query: 19  ISEGTYGIVYRAR----DKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSL-REINIL 70
           + EG +G V RA     DK   +    VA+K +K N   K+        ++ L  E+ ++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--------LADLISEMELM 71

Query: 71  LSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-----FSTSEVKCLM 123
                H +I+N+  V   +   +Y+++EY    +L+  + + + P     F  ++V    
Sbjct: 72  KLIGKHKNIINLLGVCTQE-GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130

Query: 124 L----------QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPL 171
           L          Q+  G++YL     +HRDL   N+L+    V+KI DFG++R        
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           K  ++  + + + APE L   + Y+   D+WS G +M E+ 
Sbjct: 191 KKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 49/209 (23%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E +K+  +  G +G VY+      GE     VA+K ++ N   K +          L E 
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-------KEILDEA 60

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ 125
            ++     P +  +  + +    +V +V + M +   L ++ E+ K    + ++    +Q
Sbjct: 61  YVMAGVGSPYVCRLLGICLTS--TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQ 117

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWY 183
           + +G+ YL +  ++HRDL   N+L+ +   +KI DFG++R        Y +    V + +
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            A E +L  ++++   D+WS G  + EL+
Sbjct: 178 MALESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLW 182
           Q+  G+++L     +HRDL   N+L+    ++KICDFG++R     S      S  + L 
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           + APE +     Y+T  D+WS G ++ E+ 
Sbjct: 307 WMAPESIFN-NLYTTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 9/111 (8%)

Query: 112 QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP- 170
            P    ++     Q+ +G+ +L     +HRD+   N+LL +  V KICDFG++R   +  
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 171 ---LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
              +K    L V   + APE +     Y+   D+WS G ++ E+  L K P
Sbjct: 267 NYVVKGNARLPVK--WMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 22/158 (13%)

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLM---------------ESMKQPFSTSE 118
           HP+IV +  VV  +   + M+  Y  H DL   +               +++K     ++
Sbjct: 67  HPNIVCLLGVVTKEQ-PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPY--T 175
              ++ Q+  G+++L  + V+H+DL T N+L+ ++  +KI D G+ R+ Y +        
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           SL+   W     ++ G  K+S   D+WS G ++ E+ +
Sbjct: 186 SLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---- 180
           Q+ +G+ +L     +HRDL   N+LL +  + KICDFG++R     ++  ++ VV     
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD----IRNDSNYVVKGNAR 277

Query: 181 --LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
             + + APE +     Y+   D+WS G ++ E+ +
Sbjct: 278 LPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 20/46 (43%), Positives = 31/46 (67%)

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS 164
           +K +M Q+L G++ LH   ++HRD+K  NLL+   G +KI DFG +
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 50/214 (23%), Positives = 102/214 (47%), Gaps = 27/214 (12%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEI----VALKKVKMNVGRK--EDCLEYGFPISSLR 65
           E  KL  +  G +G V++      G+     VA+K ++   GR+  ++  ++   + SL 
Sbjct: 8   ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL- 66

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM-- 123
                   DH  IV +  +      S+ +V +        L++ ++Q   + + + L+  
Sbjct: 67  --------DHAYIVRLLGIC--PGASLQLVTQLSPLGS--LLDHVRQHRDSLDPQRLLNW 114

Query: 124 -LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVT- 180
            +Q+ +G+ YL ++ ++HR+L   N+LL +  +++I DFG++   Y    K + S   T 
Sbjct: 115 CVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Query: 181 -LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
             W     +L G  +Y+   D+WS G  + E+++
Sbjct: 175 IKWMALESILFG--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 35/201 (17%)

Query: 30  ARDKKSGEIVALKKVKMNVGRKE--DCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD 87
           AR K +GE V ++++ +     E    L+    +S L        F+HP+IV  +   + 
Sbjct: 19  ARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKL--------FNHPNIVPYRATFIA 70

Query: 88  DHDSVYMVMEYMEH----DL--KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHR 141
           D++ +++V  +M +    DL     M+ M    S   +  ++  +L+ + Y+H    +HR
Sbjct: 71  DNE-LWVVTSFMAYGSAKDLICTHFMDGM----SELAIAYILQGVLKALDYIHHMGYVHR 125

Query: 142 DLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLK-----PYTSLVVTLWYRAPELL-L 190
            +K S++L++  G  K+   G+        +G  L+     P  S+ V  W  +PE+L  
Sbjct: 126 SVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL-SPEVLQQ 182

Query: 191 GAKKYSTAVDMWSVGCIMAEL 211
             + Y    D++SVG    EL
Sbjct: 183 NLQGYDAKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.8 bits (101), Expect = 9e-05
 Identities = 35/164 (21%), Positives = 64/164 (39%), Gaps = 17/164 (10%)

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
              +++    H  +V +  V + D +   MV EY++   L   +   K   S      + 
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA 107

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLL-------NNQGVLKICDFGMSRQYGSPLKPYTS 176
            QL   + YL D  ++H ++   N+L+            +K+ D G        +     
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG----IPITVLSREE 163

Query: 177 LVVTLWYRAPELL-LGAKKYSTAVDMWSVGCIMAELL--AKKPL 217
            V  + + APE +  G    + A D WS G  + E+    ++PL
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 55/270 (20%)

Query: 35  SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM 94
             EI  + KV ++   ++  L +    S +R+++      H  IV +  V + D +++ M
Sbjct: 30  EKEIKVILKV-LDPSHRDISLAFFETASMMRQVS------HKHIVLLYGVCVRDVENI-M 81

Query: 95  VMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ 153
           V E++E   L   M       +T     +  QL   + YL D  ++H ++ T N+LL  +
Sbjct: 82  VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE 141

Query: 154 GVLKICDFGMSRQYGSPLKPYTSL-----VVTLWYRAPELLLGAKKYSTAVDMWSVGCIM 208
           G+   C  G   +   P  P T L     V  + + APE +  +K  S A D WS G  +
Sbjct: 142 GIDGEC--GPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199

Query: 209 AELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFP 268
            E+      ++G  E+   DK               L+E                ++RF 
Sbjct: 200 WEI-----CYNG--EIPLKDKT--------------LAE----------------KERFY 222

Query: 269 AASFT-GSPVLSESGFDLLNRLLTYDPEKR 297
                  +P   E   DL+   + YDP +R
Sbjct: 223 EGQCMLVTPSCKELA-DLMTHCMNYDPNQR 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 46/178 (25%)

Query: 17  NKISEGTYGIVYRA-----RDKKSGEIVALKKVKMNVGRKEDCLEYG----FPISSLREI 67
            K+ EG +G+VY+A     + KK G+ V LKK            EYG    +    +R  
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYV-LKK----------ATEYGAVEIWMNERVRRA 186

Query: 68  --NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSE------ 118
             N    F +  +  V        D  ++V  Y  E  L  LM+S + P++         
Sbjct: 187 CPNSCADFVYGFLEPVSS---KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKV 243

Query: 119 -------------VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFG 162
                        ++ +M Q+L  +  LH   ++HRD+K  N++ +   G  KI D G
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 8/87 (9%)

Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
           V V  V   D D+  +VMEY+E +L      +K     +    L+ ++   V  LH   +
Sbjct: 61  VPVPIVYDVDPDNGLIVMEYIEGEL------LKDALEEARPD-LLREVGRLVGKLHKAGI 113

Query: 139 LHRDLKTSNLLLNNQGVLKICDFGMSR 165
           +H DL TSN++L+   +  I DFG+  
Sbjct: 114 VHGDLTTSNIILSGGRIYFI-DFGLGE 139

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.0 bits (97), Expect = 3e-04
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 7/88 (7%)

Query: 79  VNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           VNV  V   D ++  +VMEY+E   LK L+ S              +  L G   LH   
Sbjct: 61  VNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELE---LSREIGRLVGK--LHSAG 115

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR 165
           ++H DL TSN++L+   +  I DFG++ 
Sbjct: 116 IIHGDLTTSNMILSGGKIYLI-DFGLAE 142

Length = 211

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 25/143 (17%)

Query: 94  MVMEYMEH-DLKWLMES-------MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT 145
           +V+E+    DLK  + S       M Q      + C   ++  G+ +LH    +H DL  
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC---EVASGLLWLHQADFIHSDLAL 128

Query: 146 SNLLLNNQGVLKICDFGMS-RQYGSPLKPYTS---LVVTLWYRAPELL------LGAKKY 195
            N  L     +KI D+G++  QY  P   Y +     V L + APEL+      L  K  
Sbjct: 129 RNCQLTADLSVKIGDYGLALEQY--PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186

Query: 196 STAVDMWSVGCIMAEL--LAKKP 216
           +   ++WS+G  M EL   A +P
Sbjct: 187 TKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.2 bits (94), Expect = 7e-04
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 36/203 (17%)

Query: 35  SGEIVALKKVKMNVGRKE--DCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV 92
               V +K++K N   KE  + L+ G P   L+  NIL       +    E +       
Sbjct: 21  GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNIL-----QCLGQCVEAI-----PY 70

Query: 93  YMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQ-----LLEGVKYLHDNWVLHRDLKTS 146
            +V EY E  DLK  +   +     S++  L+LQ     +  GV ++H +  LH DL   
Sbjct: 71  LLVFEYCELGDLKSYLSQEQWHRRNSQL--LLLQRMACEIAAGVTHMHKHNFLHSDLALR 128

Query: 147 NLLLNNQGVLKICDFGM--SRQYGSPLKPYTSLVVTLWYRAPEL-------LLGAK--KY 195
           N  L +   +K+ D+G+  SR     ++      V L + APEL       L+ A+  K 
Sbjct: 129 NCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP 188

Query: 196 STAVDMWSVGCIMAELL--AKKP 216
           S   ++W++G  + EL   A +P
Sbjct: 189 S---NVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.5 bits (93), Expect = 8e-04
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 10/88 (11%)

Query: 79  VNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           VN   V   D D+  +VMEY+E   LK ++E               +  L G   LH   
Sbjct: 59  VNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGNDEL------LREIGRLVGK--LHKAG 110

Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR 165
           ++H DL TSN+++ +  +  I DFG+ +
Sbjct: 111 IVHGDLTTSNIIVRDDKLYLI-DFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 40/145 (27%), Positives = 57/145 (39%), Gaps = 35/145 (24%)

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           Y APELLLG K +  AVD W++G  + E L   P F+  T      ++F+          
Sbjct: 546 YLAPELLLG-KPHGPAVDWWALGVCLFEFLTGIPPFNDETP----QQVFQ---------- 590

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
                             N+L +  P     G   LS +  + +  LLT DP KR  + +
Sbjct: 591 ------------------NILNRDIPWPE--GEEKLSVNAQNAIEILLTMDPTKRAGLKE 630

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQ 327
              H  FH V     ++    F PQ
Sbjct: 631 LKQHPLFHGVDWENLQNQTMPFIPQ 655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.5 bits (90), Expect = 0.001
 Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 14/114 (12%)

Query: 103 LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG 162
           L  ++E   +P +  E+  + LQ L  ++ LH        L T + LL   G +      
Sbjct: 3   LADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPE 62

Query: 163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKP 216
            SR     +             APE++ G + Y+   D++S+G  + E L  + 
Sbjct: 63  QSRPDPYFM-------------APEVIQG-QSYTEKADIYSLGITLYEALDYEL 102

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 39/196 (19%)

Query: 39  VALKKVKMNVGRKEDC--LEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM 96
           V +K+++++   +E    LE   P  SL+  N+L       +    EV         +VM
Sbjct: 25  VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL-----QCLGQCTEVT-----PYLLVM 74

Query: 97  EYME-HDLKWLMESMK-------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNL 148
           E+    DLK  + S +        P +   + C   ++  G+ +LH N  +H DL   N 
Sbjct: 75  EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC---EIALGLLHLHKNNFIHSDLALRNC 131

Query: 149 LLNNQGVLKICDFGMSRQ------YGSPLKPYTSLVVTLWYRAPELL------LGAKKYS 196
           LL     +KI D+G+S        Y +P + +    V L + APEL+      L     +
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW----VPLRWIAPELVDEVHGNLLVVDQT 187

Query: 197 TAVDMWSVGCIMAELL 212
              ++WS+G  + EL 
Sbjct: 188 KESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 36/131 (27%), Positives = 58/131 (44%), Gaps = 22/131 (16%)

Query: 94  MVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN 152
           MV E++EH  L   +   K     +    +  QL   + YL D  ++H ++   N+LL  
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152

Query: 153 QGV-------LKICDFGMSRQYGSPLKPYTSL-----VVTLWYRAPELLLGAKKYSTAVD 200
            G+       +K+ D G+S         +T+L     V  + + APE + G    STA D
Sbjct: 153 LGLAEGTSPFIKLSDPGVS---------FTALSREERVERIPWIAPECVPGGNSLSTAAD 203

Query: 201 MWSVGCIMAEL 211
            WS G  + E+
Sbjct: 204 KWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	332
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG1243	690	consensus Protein kinase [General function predict	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
KOG3087	229	consensus Serine/threonine protein kinase [General	99.51
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.45
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.36
COG4248	637	Uncharacterized protein with protein kinase and he	99.35
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.16
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.05
PRK09902	216	hypothetical protein; Provisional	99.03
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.84
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.8
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.67
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.59
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.36
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.32
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.22
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
PLN02876	822	acyl-CoA dehydrogenase	98.08
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.07
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.05
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.93
KOG2270	520	consensus Serine/threonine protein kinase involved	97.9
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.79
PRK05231	319	homoserine kinase; Provisional	97.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.69
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.5
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.48
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.48
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.39
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.37
PLN02236	344	choline kinase	97.3
PRK12396	409	5-methylribose kinase; Reviewed	97.19
PLN02756	418	S-methyl-5-thioribose kinase	96.92
PTZ00384	383	choline kinase; Provisional	96.91
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.86
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.71
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.68
PRK10593	297	hypothetical protein; Provisional	96.61
PTZ00296	442	choline kinase; Provisional	96.44
PRK06148	1013	hypothetical protein; Provisional	96.24
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.11
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.42
PRK10271	188	thiK thiamine kinase; Provisional	95.24
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.05
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.5
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	94.39
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.68

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-60  Score=389.65  Aligned_cols=316  Identities=70%  Similarity=1.166  Sum_probs=294.2

Q ss_pred             cccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      +.||+++++|+.+..|++|.||.||+|+++.|++.||+|.++.....      ..+....++|+.+|.+++||||+.+..
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek------~GFPItsLREIniLl~~~H~NIV~vkE  142 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK------EGFPITSLREINILLKARHPNIVEVKE  142 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc------CCCcchhHHHHHHHHhcCCCCeeeeEE
Confidence            78999999999999999999999999999999999999999876532      234445689999999999999999999


Q ss_pred             eEEcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           84 VVMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        84 ~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +.+.. -+..|+|||||+.++...+.....+|.+.+++.+..|++.||+|||.+.|+|||||++|+|++..|.+||+|||
T Consensus       143 VVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  143 VVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             EEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccc
Confidence            98543 35699999999999999999888899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      +|+.++++...++....|.+|+|||.+.+...|+.+.|+||+||++.|++++.+.|.+....+.+.+|++.++.|.+..|
T Consensus       223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccc-cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 035861          243 PGLSELPGA-KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFM  321 (332)
Q Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~  321 (332)
                      |++..+++- +..+...+++.++..++...      ++....+|+..+|..||.+|.||+|.|+|+||.+.+.+..-..+
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~------lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~  376 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALS------LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMF  376 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccc------cchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhc
Confidence            999999987 58899999999998887654      67899999999999999999999999999999999999999999


Q ss_pred             CCCCCccccC
Q 035861          322 PTFPPQHARN  331 (332)
Q Consensus       322 ~~~~~~~~~~  331 (332)
                      |+||++...+
T Consensus       377 Pt~P~k~~~~  386 (419)
T KOG0663|consen  377 PTWPAKSEQQ  386 (419)
T ss_pred             CCCccccccc
Confidence            9999887654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-59  Score=388.80  Aligned_cols=283  Identities=33%  Similarity=0.482  Sum_probs=230.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..+.|.+.+.||+|+||.|-+|..+.|++.||||++.++....... +........+|+++|++|+||+|+++++++ +.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f-~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFF-EV  247 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeee-ec
Confidence            3457888999999999999999999999999999998765544322 222223457999999999999999999999 55


Q ss_pred             CCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcEEEeecccc
Q 035861           89 HDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMS  164 (332)
Q Consensus        89 ~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~~l~df~~~  164 (332)
                      ..+.|+||||++|+ +.+.+. .++.+.+...+.+++||+.|+.|||+.||+||||||+|||+..+   ..+||+|||+|
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             CCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            57889999999975 555554 48899999999999999999999999999999999999999877   68999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD-QIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~  241 (332)
                      +..+ ...-..+.|||+.|.|||++.+.+  .+..+.|+|||||++|-+++|.+||....... ..+++.++.-..-.. 
T Consensus       327 K~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~-  404 (475)
T KOG0615|consen  327 KVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL-  404 (475)
T ss_pred             hccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh-
Confidence            9875 445667899999999999997633  24458899999999999999999998865554 555565542222211 


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFM  321 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~  321 (332)
                                                      .+..+|.++++||.+||..||++|||+.|+|+||||+..+........
T Consensus       405 --------------------------------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~~~~l  452 (475)
T KOG0615|consen  405 --------------------------------QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSKQDIL  452 (475)
T ss_pred             --------------------------------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccchHHHH
Confidence                                            123389999999999999999999999999999999998855554444


Q ss_pred             CCCCCcc
Q 035861          322 PTFPPQH  328 (332)
Q Consensus       322 ~~~~~~~  328 (332)
                      ..+.|..
T Consensus       453 ~~~~~l~  459 (475)
T KOG0615|consen  453 KKLQPLS  459 (475)
T ss_pred             hhcCccc
Confidence            4444443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-58  Score=389.31  Aligned_cols=295  Identities=40%  Similarity=0.723  Sum_probs=257.3

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKE   83 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   83 (332)
                      +....+++|.++++||.|.||.||+|+...+++.||||.++.+-...+.+..       ++|+..|++++ ||||+++++
T Consensus         4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-------LREvksL~kln~hpniikL~E   76 (538)
T KOG0661|consen    4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-------LREVKSLRKLNPHPNIIKLKE   76 (538)
T ss_pred             eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-------HHHHHHHHhcCCCCcchhhHH
Confidence            4455788999999999999999999999999999999999988777666654       59999999998 999999999


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ++.+.+..+++||||++.++.+.+..+++.|++..+..|++||++||+|+|++|+.|||+||+|||+..+..+||+|||+
T Consensus        77 vi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   77 VIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             HhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccc
Confidence            99888669999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      |+...+ ..+++....|.||+|||++.....|+.+.|+|++||+++|+.+.++.|.+.+..+.+.+|..-++.|....|+
T Consensus       157 ARev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  157 AREVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cccccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            998754 4677888899999999999888999999999999999999999999999999999999999999999988776


Q ss_pred             CCCCCcc-ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          244 GLSELPG-AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       244 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      .-.++.. ....+.+.........+        +..+.++.+||.+|+++||.+||+|.++|+||||+.-.-.
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~--------p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLL--------PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhC--------cccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            5322211 22222222222222222        3378899999999999999999999999999999986533

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-56  Score=391.53  Aligned_cols=274  Identities=32%  Similarity=0.478  Sum_probs=240.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+....+....     ..+.+|+++-+.|.||||+.++++| ++..
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~r-----eKv~~EIeIHr~L~HpnIV~f~~~F-EDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQR-----EKVLNEIEIHRSLKHPNIVQFYHFF-EDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchH-----HHHHHHHHHHHhcCCCcEEeeeeEe-ecCC
Confidence            369999999999999999999999999999999987655443333     3577999999999999999999999 6669


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      +.|||+|.|..+.+..+.++.++++|.+++.+.+||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.....+
T Consensus        92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            99999999998777777778899999999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .....+.|||+-|.|||++.. ..++..+||||+||+||-|+.|++||...+..+++.++....-..|.           
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~-----------  239 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS-----------  239 (592)
T ss_pred             ccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc-----------
Confidence            777789999999999999986 77899999999999999999999999999999999998765332222           


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC-CCCCCCCCCcc
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS-KDFMPTFPPQH  328 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~-~~~~~~~~~~~  328 (332)
                                                .+|.++++||.+||+.||.+|||+++||.|+||++--.|+. ....-+..|.+
T Consensus       240 --------------------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~  292 (592)
T KOG0575|consen  240 --------------------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRF  292 (592)
T ss_pred             --------------------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcC
Confidence                                      37999999999999999999999999999999955454443 33444444443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-56  Score=352.63  Aligned_cols=293  Identities=45%  Similarity=0.854  Sum_probs=260.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|..++++|+|.||.||+|++..||+.||||.+.......      ++....++|++.|+.+.|+||+.+++++ ....
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F-~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVF-PHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhc-cCCC
Confidence            58999999999999999999999999999999998764332      3344678999999999999999999999 4447


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ...||+||++.++...+...+..++...+..++.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+++...++
T Consensus        75 ~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   75 NLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            78999999999999999988899999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .........|.+|+|||.+.+.+.|+...|+||.||++.|++.+.+.|.+.++.+.+..+++.++.|.+..||++..++.
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            77777778899999999999999999999999999999999999999999999999999999999999999999998876


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      ...-. ..+.......+        +..++++.+|+.+||..||.+|+++.|+|+|+||++.+.+..-.
T Consensus       235 Y~~~~-~~P~~~~~~lf--------~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~  294 (318)
T KOG0659|consen  235 YVKIQ-QFPKPPLNNLF--------PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPS  294 (318)
T ss_pred             HHHHh-cCCCCcccccc--------ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChh
Confidence            43222 33333333332        23678889999999999999999999999999999988666543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-56  Score=372.27  Aligned_cols=265  Identities=28%  Similarity=0.422  Sum_probs=225.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++.+.++.||+|+.|+||+++++.|++.+|+|++......   .    ..+++.+|+++++.++||+|+.+++.|..+
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~---~----~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP---A----LQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH---H----HHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            456889999999999999999999999999999999543221   1    123688999999999999999999999766


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....+|+||||+|+.++.+....+.++|..+..++.++++||.|||+ ++|+||||||+||||...|.|||+|||.+...
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            33699999999998888888777999999999999999999999995 99999999999999999999999999999887


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHcCCCCCCcc
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-----TEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ...  ...+..||..|||||.+.+ ..|+.++||||||+.++|+++|+.||...     ...+.+..|....++...   
T Consensus       230 vnS--~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP---  303 (364)
T KOG0581|consen  230 VNS--IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP---  303 (364)
T ss_pred             hhh--hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC---
Confidence            544  4567889999999999998 78999999999999999999999999874     333444444332111110   


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                                                      ....|+++++||..||++||.+||++.|+++|||+++...+..+
T Consensus       304 --------------------------------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  304 --------------------------------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             --------------------------------cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence                                            11389999999999999999999999999999999987765553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-56  Score=370.28  Aligned_cols=279  Identities=31%  Similarity=0.491  Sum_probs=243.7

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||+|++++.+.|++.+|+|++.+.......     .......|..+|.+++||+|++++..| +
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~-----e~~~~~~Er~IL~~v~hPFiv~l~ysF-Q   95 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK-----EVRHTKAERNILSKIKHPFIVKLIYSF-Q   95 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh-----hHHHHHHHHHHHHhCCCCcEeeeEEec-c
Confidence            4578999999999999999999999999999999999876554331     123567899999999999999999999 5


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +...+|+|+||+.|+-+.....+.+.+++..+..++..|+.||.|||++||+||||||+|||++.+|+++|+|||+|+..
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            55899999999998666666666899999999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      -.....-.+.+||+.|+|||++.. ..++.++|.||||+++|+|++|..||.+.+.....+++.+.-...          
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~----------  244 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL----------  244 (357)
T ss_pred             ccCCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC----------
Confidence            554455567899999999999998 689999999999999999999999999999999999887753111          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC----CHHHHhcCCCCCCCCCCCC--CCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI----TVDDALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~ell~hp~f~~~~~~~~--~~~~  321 (332)
                                                .+..++.++++||+++|..||++|.    ++++|-+||||..++|.+.  ....
T Consensus       245 --------------------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~  298 (357)
T KOG0598|consen  245 --------------------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLS  298 (357)
T ss_pred             --------------------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCC
Confidence                                      1222799999999999999999995    7999999999999999887  4577


Q ss_pred             CCCCCccc
Q 035861          322 PTFPPQHA  329 (332)
Q Consensus       322 ~~~~~~~~  329 (332)
                      |+|.|.-+
T Consensus       299 PpF~P~~~  306 (357)
T KOG0598|consen  299 PPFKPNVT  306 (357)
T ss_pred             CCeecCCC
Confidence            78887654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-55  Score=377.12  Aligned_cols=309  Identities=51%  Similarity=0.887  Sum_probs=266.6

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ++.+..+.|+.+++||+|.||.||+|++..+|+.||+|+++.........      ....+|+.+|++|.||||+++.++
T Consensus       111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~------~t~~REI~ILr~l~HpNIikL~ei  184 (560)
T KOG0600|consen  111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP------ITAIREIKILRRLDHPNIIKLEEI  184 (560)
T ss_pred             ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch------HHHHHHHHHHHhcCCCcccceeeE
Confidence            56677889999999999999999999999999999999998765433322      234699999999999999999999


Q ss_pred             EEcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +.+. ...+|+|+||++.+|...+....-.|++.+++.++.||+.||+|||++|++|||||.+||||+.+|.+||+|||+
T Consensus       185 vt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  185 VTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             EEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccc
Confidence            9776 578999999999999888877667899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          164 SRQYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      |++++... ..++....|.||+|||.+.+...|+.+.|+||.||||.||++|++.|.+.+..+.+..|++..+.|.+..|
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            99775443 34777888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccccccCCchh-hhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFM  321 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~  321 (332)
                      + ..+++..........+. .+++.+        ..++....+|+..||..||.+|.||.++|+|+||..-+.+-.-..+
T Consensus       345 ~-~~kLP~~~~~kp~~~y~r~l~E~~--------~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~L  415 (560)
T KOG0600|consen  345 P-VSKLPHATIFKPQQPYKRRLRETF--------KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSL  415 (560)
T ss_pred             c-cccCCcccccCCCCcccchHHHHh--------ccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccC
Confidence            8 66666433333333222 222222        2378899999999999999999999999999999776777767778


Q ss_pred             CCCCCcc
Q 035861          322 PTFPPQH  328 (332)
Q Consensus       322 ~~~~~~~  328 (332)
                      +.++|-+
T Consensus       416 p~y~~s~  422 (560)
T KOG0600|consen  416 PKYPPSH  422 (560)
T ss_pred             CCCCcch
Confidence            8777754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-56  Score=359.79  Aligned_cols=289  Identities=35%  Similarity=0.627  Sum_probs=243.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ++.|+.+.++|+|++|+||+++++.||+.||||++..+....      .+.+-.++|+++|+++.|+|++.++++| ...
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~------~VkKIAlREIrmLKqLkH~NLVnLiEVF-rrk   73 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP------VVKKIALREIRMLKQLKHENLVNLIEVF-RRK   73 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH------HHHHHHHHHHHHHHhcccchHHHHHHHH-Hhc
Confidence            468999999999999999999999999999999997654322      2223457999999999999999999999 555


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..+++|+|||+.+.++.+......+++..+..+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+....
T Consensus        74 rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   74 RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            88999999999999999999888999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      +...++...-|.||+|||.+.+..+|..+.|||++||++.||++|.+.|.+.++.+.+-.|.+.++........-+..-+
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            88888888999999999999998999999999999999999999999999999999999998887766544322221100


Q ss_pred             cccc--cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKA--NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      -...  --.......++.        .-+.++.-+.+|+.+||+.||++|++.+++|.||||.++-
T Consensus       234 ~F~Gv~lP~~~~~epLe~--------k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLER--------KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             ceeeeecCCCCCccchhh--------hcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            0000  000001111111        1244777889999999999999999999999999996653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-53  Score=343.42  Aligned_cols=272  Identities=31%  Similarity=0.499  Sum_probs=239.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|+.+..||.|+||.|.+++.+.+|..+|+|++.+...-+....+     ...+|..+|+.+.||+++.+.+.+ .
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQve-----H~~nEk~vL~~v~~PFlv~l~~t~-~  114 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVE-----HTHNEKRVLKAVSHPFLVKLYGTF-K  114 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHH-----HHhhHHHHHhhccCceeEEEEEee-c
Confidence            5788999999999999999999999999999999999876543322222     456899999999999999999999 5


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +..++|+||||++|+-+....++-+.+++..++.++.||+.||+|||+++|++|||||+|||+|++|.+||+|||+++..
T Consensus       115 d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  115 DNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            55899999999998766666666789999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...   --+.|||+.|+|||++.. +.++.++|.|+||+++|||+.|.+||.+.+...++.+|....-..|         
T Consensus       195 ~~r---T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP---------  261 (355)
T KOG0616|consen  195 SGR---TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP---------  261 (355)
T ss_pred             cCc---EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC---------
Confidence            543   357899999999999988 7899999999999999999999999999999999999987643322         


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDF  320 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~  320 (332)
                                                  +..++.+++||+++|+.|-.+|.     ..++|-.||||+.+.|..+  +..
T Consensus       262 ----------------------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i  313 (355)
T KOG0616|consen  262 ----------------------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI  313 (355)
T ss_pred             ----------------------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence                                        23799999999999999999993     6789999999999999887  557


Q ss_pred             CCCCCC
Q 035861          321 MPTFPP  326 (332)
Q Consensus       321 ~~~~~~  326 (332)
                      .+++-|
T Consensus       314 e~P~~p  319 (355)
T KOG0616|consen  314 EPPFEP  319 (355)
T ss_pred             cCCCCC
Confidence            777766

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-52  Score=344.97  Aligned_cols=294  Identities=47%  Similarity=0.902  Sum_probs=257.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC-eeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS-IVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~   88 (332)
                      +..|+.+++||+|++|+||+|+...+|+.||+|+++.....      ..+.....+|+.+++.++|+| |+.+++++..+
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~   83 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS   83 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence            66799999999999999999999999999999999876542      123335579999999999999 99999999776


Q ss_pred             CC-----eEEEEcccccccHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           89 HD-----SVYMVMEYMEHDLKWLMESMK---QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        89 ~~-----~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      ..     ..++|+|+++.++...+....   ..++...++.+++||+.||+|||++||+||||||.||+|+++|.+||+|
T Consensus        84 ~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   84 NNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence            53     899999999999988888766   4688899999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ||+|+...-+...+....+|.+|+|||++.+...|+...||||+||++.||+++...|.+..+.+....+++..+.|.+.
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999887777778888999999999999998899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCc-hhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQP-YNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      .||+...++..+..+.... .......        -+..+++..+++.+||+.+|..|.|++.+|+||||..+.....
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~--------~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSI--------LPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHh--------ccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence            9999998888776333222 2222222        2335578899999999999999999999999999999875544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.2e-53  Score=364.39  Aligned_cols=279  Identities=32%  Similarity=0.475  Sum_probs=237.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|+.+..||+|+||.||+|+.+.||..+|+|+++++.....     +.....+.|-.+|....++.|++++..| ++
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~-----~Qv~hV~aERdiL~~~ds~~vVKLyYsF-QD  212 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKK-----NQVEHVRAERDILAEVDSPWVVKLYYSF-QD  212 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhh-----hhHHHHHHHHHHhhhcCCCcEEEEEEEe-cC
Confidence            57899999999999999999999999999999999987654332     2233567899999999999999999999 66


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ..++||||||++|+-.--+..+.+.+++..+..++.+++.|+..||+.|++|+||||+|+|||..|++||+|||+|.-..
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            69999999999986555555568999999999999999999999999999999999999999999999999999975221


Q ss_pred             C-----------------------CCC-----C-------------------CccccccccccchhhhcCCCCCCchhHH
Q 035861          169 S-----------------------PLK-----P-------------------YTSLVVTLWYRAPELLLGAKKYSTAVDM  201 (332)
Q Consensus       169 ~-----------------------~~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~sDi  201 (332)
                      .                       ...     .                   ...-.|||.|+|||++.+ ..|+...|.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDw  371 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDW  371 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccH
Confidence            0                       000     0                   012368999999999998 669999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCch
Q 035861          202 WSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSES  281 (332)
Q Consensus       202 ~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      |||||++||||.|.+||.+.+..+++.++.+.....                                 .++....++++
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------------------------~fP~~~~~s~e  418 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------------------------KFPEEVDLSDE  418 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------------------------cCCCcCcccHH
Confidence            999999999999999999999999999998752111                                 11112237899


Q ss_pred             HHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCCCCCCCCCCCCCCCCcc
Q 035861          282 GFDLLNRLLTYDPEKRI---TVDDALNHYWFHEVPLPKSKDFMPTFPPQH  328 (332)
Q Consensus       282 ~~~li~~~l~~dp~~Rp---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~  328 (332)
                      ++|||.+||. ||+.|.   +++||-+||||+.+.|..+++-.++|.|+.
T Consensus       419 A~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v  467 (550)
T KOG0605|consen  419 AKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQV  467 (550)
T ss_pred             HHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCC
Confidence            9999999999 999998   499999999999999999999999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-53  Score=366.24  Aligned_cols=268  Identities=30%  Similarity=0.453  Sum_probs=233.4

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      -+..++|.+++.||.|+|++|++|+...+++.||||++.++-..++.-     ...+..|-..|.+| .||.|++++..|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K-----vkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK-----VKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc-----cchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            356789999999999999999999999999999999997654433222     22456788999999 899999999999


Q ss_pred             EcCCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       .++..+|+|+||++ |++++.+.+ -+.|++..++.++.+|+.||+|||++|||||||||+|||++++++++|+|||.+
T Consensus       144 -QD~~sLYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  144 -QDEESLYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             -ecccceEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccc
Confidence             55588999999998 567777766 689999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC-----------CC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 035861          165 RQYGSPL-----------KP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       165 ~~~~~~~-----------~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~  231 (332)
                      .......           ..  .....||..|.+||++.. ...++.+|+|+|||++|+|+.|.+||.+.+...++++|+
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~  300 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ  300 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence            8663211           11  145789999999999988 789999999999999999999999999999999999998


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      ...-..+                                     +..++.+++||+++|..||.+|+++++|-+||||..
T Consensus       301 ~l~y~fp-------------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  301 ALDYEFP-------------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             HhcccCC-------------------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            8643333                                     336899999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 035861          312 VPLPKSKD  319 (332)
Q Consensus       312 ~~~~~~~~  319 (332)
                      +.|.....
T Consensus       344 Vdw~nlw~  351 (604)
T KOG0592|consen  344 VDWENLWQ  351 (604)
T ss_pred             CChhhhhh
Confidence            99888644

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.6e-51  Score=352.27  Aligned_cols=286  Identities=38%  Similarity=0.755  Sum_probs=233.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+.+|++.+.||.|+||+||+|.+..++..||+|++........       ...+.+|+.++++++||||+++++++. .
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~-~   74 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKNLKHANIVTLHDIIH-T   74 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-------chhHHHHHHHHHhCCCCCEeeEEEEEc-C
Confidence            46789999999999999999999999999999999865432111       124568999999999999999999984 4


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....++|||+++|++.+.+......+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||.+....
T Consensus        75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            47899999999998888777766678999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..........++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.++...++.+...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            43333445577899999999877567899999999999999999999999999888888888888888887777665432


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .........       ...........+.++.++++||++||++||.+|||++|+|+||||
T Consensus       235 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFP-------QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccC-------ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            211110000       000011111234478899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-51  Score=359.94  Aligned_cols=262  Identities=31%  Similarity=0.449  Sum_probs=226.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVM   86 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   86 (332)
                      .....|.+.+.||+|+||+|+.|.+..+++.||+|++.........   ......+.+|+.++++++ ||||+++++++.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence            4667999999999999999999999999999999977654222111   112234558999999998 999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeecccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMS  164 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df~~~  164 (332)
                      .. ..+++||||+.| ++++.+.. .++++|..+..++.||+.|++|||++||+||||||+||+++.+ +++||+|||++
T Consensus        91 t~-~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   91 TP-TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             cC-CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            54 669999999996 77777777 8999999999999999999999999999999999999999999 99999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAK-KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .............+|++.|+|||++.+.. +...++|+||+|++||.|++|..||...+...+...+.+.....+     
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-----  243 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-----  243 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-----
Confidence            88744456678889999999999999866 557899999999999999999999999888888887655432222     


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCC-CchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVL-SESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                      ..+ |+++++|+++||..||.+|+++.+|++||||+.
T Consensus       244 --------------------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  244 --------------------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --------------------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                            225 899999999999999999999999999999997

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-50  Score=351.88  Aligned_cols=290  Identities=37%  Similarity=0.740  Sum_probs=227.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||.|+||+||+|++..+++.||+|++........       ...+.+|+.+++.++||||+.+++++.. .
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~-~   75 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-------PFTAIREASLLKGLKHANIVLLHDIIHT-K   75 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-------chhHHHHHHHHhhCCCCCcCeEEEEEec-C
Confidence            4689999999999999999999999999999999875432111       1145689999999999999999999854 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++||||+++++.+.+....+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||.+.....
T Consensus        76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          76 ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            78999999999999888887677899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-VDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .........++..|+|||++.+...++.++|+||||+++|+|++|..||....+ .+....+....+.+....++.....
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            333445567889999999987656789999999999999999999999987543 3445555555555555544443322


Q ss_pred             cccccc-ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          249 PGAKAN-FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       249 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +..... ............+.      ...++..+.+|+.+||+.||++|||++|+|+||||++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWN------KLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccccCCccHHHHhh------ccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            211100 00000000011111      112567889999999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-53  Score=337.67  Aligned_cols=261  Identities=28%  Similarity=0.441  Sum_probs=219.1

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee-e
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE-V   84 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~   84 (332)
                      |-..+.+|+++++||+|+||.||++++..+|..+|.|.+.-.......      ......|+.+|++|+||||+.+++ .
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~------rq~~v~Ei~lLkQL~HpNIVqYy~~~   87 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA------RQDCVKEISLLKQLNHPNIVQYYAHS   87 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH------HHHHHHHHHHHHhcCCchHHHHHHHh
Confidence            456778999999999999999999999999999999998733222211      225679999999999999999999 5


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccccCCCCCEEEcCCCcE
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMES----MKQPFSTSEVKCLMLQLLEGVKYLHD--NW--VLHRDLKTSNLLLNNQGVL  156 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~l~~~~~~~i~~~l~~~L~~lh~--~~--i~H~di~p~Nili~~~~~~  156 (332)
                      +.++...++||||+|+++-+..++.    ..+.++|..+|+++.|+|.||.++|.  ..  +.||||||.|||++.+|.|
T Consensus        88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv  167 (375)
T KOG0591|consen   88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV  167 (375)
T ss_pred             hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence            5556566999999999654444433    24569999999999999999999998  44  8899999999999999999


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      ||+|||+++...+...-.....|||.||+||.+.+ ..|+.+||||||||++|||+....||.+.+-.+...+|.++..+
T Consensus       168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP  246 (375)
T ss_pred             eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC
Confidence            99999999998776666677899999999999998 78999999999999999999999999999988888888776333


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +..                                   ...+|..+..||.-|+.+||+.||+.     +|++.++.
T Consensus       247 ~~p-----------------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  247 PLP-----------------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             CCc-----------------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence            222                                   12389999999999999999999985     44444444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-51  Score=341.93  Aligned_cols=266  Identities=32%  Similarity=0.483  Sum_probs=224.8

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +.....+|.+.+.||+|+|++||+|+++.++..||||.+.+........      ..+..|+++|+.++||||+.+++++
T Consensus         5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~------e~L~~Ei~iLkel~H~nIV~l~d~~   78 (429)
T KOG0595|consen    5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLV------ELLLSEIKILKELKHPNIVRLLDCI   78 (429)
T ss_pred             cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHH------HHHHHHHHHHHhcCCcceeeEEEEE
Confidence            4456789999999999999999999999999999999998765322211      1346899999999999999999998


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC------CcEEEe
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ------GVLKIC  159 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~------~~~~l~  159 (332)
                       +.+++.|+|||||.|+-+.......+.+++..++.++.||+.||++||+++|+||||||.|||++..      -.+||+
T Consensus        79 -~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   79 -EDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             -ecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence             5558999999999976555555557899999999999999999999999999999999999999875      469999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      |||+++.... .....+.+|++.|||||++.. .+|+-++|+||+|+++|++++|+.||...+..+....+.+.....+.
T Consensus       158 DFGfAR~L~~-~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~  235 (429)
T KOG0595|consen  158 DFGFARFLQP-GSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV  235 (429)
T ss_pred             ccchhhhCCc-hhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence            9999998853 345567899999999999987 78999999999999999999999999999988887766544222111


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                        .+..++....+|+...++.+|.+|.+.++-+.|++...-+.
T Consensus       236 ----------------------------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  236 ----------------------------------LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             ----------------------------------hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence                                              12226777779999999999999999999999999887653

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-51  Score=365.27  Aligned_cols=279  Identities=28%  Similarity=0.433  Sum_probs=244.0

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      ...+++|.+++.||+|+||+|+++..+.+++.+|||++++...-.....+     ..+.|.+++... +||.++.++..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve-----~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVE-----SLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHH-----HHHHHHHHHHHhccCCeEeeccccc
Confidence            34678999999999999999999999999999999999987655444443     567888888777 599999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       +...++|+||||+.|+.... ....+.+++..+..++..++.||.|||++||++||||.+|||+|.+|.+||+|||+|+
T Consensus       439 -QT~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  439 -QTKEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             -ccCCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence             55589999999999877332 2335789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..-.....-.+.+||+.|+|||++.+ ..|+.+.|.|||||+||||+.|..||.+.+..+..+.|.......|..     
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~-----  590 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF-----  590 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc-----
Confidence            76444455678899999999999998 789999999999999999999999999999999999998754333222     


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC--C
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS--K  318 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~--~  318 (332)
                                                      +|.++.++++++|..+|++|..     +++|.+||||..|+|.+.  +
T Consensus       591 --------------------------------ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r  638 (694)
T KOG0694|consen  591 --------------------------------LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNR  638 (694)
T ss_pred             --------------------------------ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhc
Confidence                                            7999999999999999999994     689999999999999988  5


Q ss_pred             CCCCCCCCcccc
Q 035861          319 DFMPTFPPQHAR  330 (332)
Q Consensus       319 ~~~~~~~~~~~~  330 (332)
                      ...|+|.|....
T Consensus       639 ~i~PPf~P~i~~  650 (694)
T KOG0694|consen  639 RIKPPFVPTIKG  650 (694)
T ss_pred             cCCCCCCcccCC
Confidence            688999998653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=359.15  Aligned_cols=259  Identities=28%  Similarity=0.472  Sum_probs=228.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ...|....+||+|+.|.||.+....+++.||||.+.........        -+++|+.+|+.+.|+||+.+++.+... 
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke--------LilnEi~Vm~~~~H~NiVnfl~Sylv~-  342 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE--------LLLNEILVMRDLHHPNIVNFLDSYLVG-  342 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh--------hhHHHHHHHHhccchHHHHHHHHhccc-
Confidence            34789999999999999999999999999999999887655533        467999999999999999999999766 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..+|+||||++|+.+..+.. ...++|.+++.|++++++||+|||.+||+|+|||.+|||++.+|.+||+|||+|.....
T Consensus       343 deLWVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  343 DELWVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             ceeEEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            77999999999876666665 44599999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      ....+.+..||++|||||++.. ..|+++.||||||+++.||+-|.+||-..+....+..+...-.+..           
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l-----------  489 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL-----------  489 (550)
T ss_pred             ccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc-----------
Confidence            7778889999999999999987 7899999999999999999999999998888777776655322221           


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                             ..+..+|+.+++|+.+||..|+++|+++.|||+||||+...
T Consensus       490 -----------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  490 -----------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             -----------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence                                   12334899999999999999999999999999999997654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-51  Score=338.05  Aligned_cols=296  Identities=37%  Similarity=0.642  Sum_probs=242.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc--
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD--   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   87 (332)
                      ...|..++.||.|++|.|..+.++.+|+.||||++...-.....+      ++.++|+.+|+.++|+||+.+.+++..  
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~a------kRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDA------KRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHH------HHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            346666899999999999999999999999999997322222111      246799999999999999999999855  


Q ss_pred             --CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 --DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 --~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                        +-...|+|+|.++.++...+.. +..+++..+..+++||+.||.|+|+.|++|||+||.|++++.+..+|++|||+|+
T Consensus        95 ~~~f~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   95 RDKFNDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ccccceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence              2356899999997776665554 6679999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..+..  ....+....|.+|+|||.+.....|+.+.||||+||++.||++|+..|.+.+....+..+....+.|.+....
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            87532  2333566779999999999888899999999999999999999999999999999999999999998877655


Q ss_pred             CCCCCcc--ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 035861          244 GLSELPG--AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       244 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~  320 (332)
                      .+..-.+  ......+.+.......        -+..++.+.+|+.+||..||.+|+|++|+|+||||..+.-++.+..
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~--------fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~  324 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSI--------FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV  324 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHH--------cCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence            4442111  1111112222222222        2347899999999999999999999999999999999998877763

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-51  Score=360.26  Aligned_cols=265  Identities=28%  Similarity=0.425  Sum_probs=233.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+.-|++++.||.|+.|.|-+|++..||+.+|||++.+.....+.     ....+.+|+-+|+.+.|||++.+++++ ++
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s-----~~~~IerEIviMkLi~HpnVl~LydVw-e~   83 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSS-----QPAGIEREIVIMKLIEHPNVLRLYDVW-EN   83 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccc-----cccchhhhhHHHHHhcCCCeeeeeeee-cc
Confidence            455789999999999999999999999999999999876422222     223677999999999999999999999 66


Q ss_pred             CCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...+|+|.||++|+ +.+.+. ..+++++.+++++++||+.|+.|||..+|+|+|+||+|+|++..+++||+|||.|...
T Consensus        84 ~~~lylvlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             CceEEEEEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            68999999999965 555555 4899999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      . +..-..+.||++.|++||++++..+.+.++||||.|++||.++||..||++.+-...+.++.++....|.        
T Consensus       163 ~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--------  233 (786)
T KOG0588|consen  163 V-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--------  233 (786)
T ss_pred             c-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--------
Confidence            3 3455667899999999999999888899999999999999999999999999999999988876544433        


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                                                   .+++++++||++||.+||+.|.+.+||++|||+......+..
T Consensus       234 -----------------------------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  234 -----------------------------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             -----------------------------cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                                         389999999999999999999999999999999998766655

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.2e-51  Score=353.73  Aligned_cols=257  Identities=32%  Similarity=0.555  Sum_probs=228.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+........      ..+.+|+++++.++||||+.+++.| +..
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l------~~l~~ev~i~r~lkHpniv~m~esf-Et~   73 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKEL------KNLRQEVRILRSLKHPNIVEMLESF-ETS   73 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHH------HHHHHHHHHHHhcCCcchhhHHHhh-ccc
Confidence            468999999999999999999999999999999998765544222      1467999999999999999999999 666


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...|+|+||+.|++...+. .++.++|+.+..++.++..||.|||+++|.|+|+||.||++...|.+|++|||+++..+.
T Consensus        74 ~~~~vVte~a~g~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   74 AHLWVVTEYAVGDLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             ceEEEEehhhhhhHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            8899999999997666555 489999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      +........||+.|||||.+.+ ..++..+|+|||||++||+++|++||....-.+..+.|......++.          
T Consensus       153 ~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----------  221 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----------  221 (808)
T ss_pred             CceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----------
Confidence            7777778899999999999986 89999999999999999999999999988877777777654332222          


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                 ..+..+.+|++.+|.+||..|.+..+++.|||++..
T Consensus       222 ---------------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  222 ---------------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ---------------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                                       279999999999999999999999999999999864

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-50  Score=336.33  Aligned_cols=285  Identities=37%  Similarity=0.647  Sum_probs=237.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .-.|...+.+|.|+||.||+|+...+++.||||.+-.+.....            +|+.+|+.+.||||+.+..++....
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn------------rEl~im~~l~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN------------RELQIMRKLDHPNIVRLLYFFSSST   90 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc------------HHHHHHHhcCCcCeeeEEEEEEecC
Confidence            3478999999999999999999999999999999876554332            7999999999999999998885432


Q ss_pred             ----CeEEEEcccccccHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeec
Q 035861           90 ----DSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDF  161 (332)
Q Consensus        90 ----~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df  161 (332)
                          -+..+||||++-++...+..   .+..++.-.++-+.+||+.||+|||+.||+||||||.|+|||.+ |.+||+||
T Consensus        91 ~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             CCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccC
Confidence                24668999999998877764   36789999999999999999999999999999999999999987 89999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |+|+....+ .+......+..|+|||.+.+...|+.+.||||.||++.||+.|.+.|.+.+..+.+..+++..+.|..+.
T Consensus       171 GSAK~L~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  171 GSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             CcceeeccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999988544 3445667788999999999999999999999999999999999999999999999999999999998775


Q ss_pred             ccCCCCC--ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          242 WPGLSEL--PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       242 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ...+..-  ..............          -....+++++.+|+.++|+.+|.+|.++.|++.||||..+..++.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~----------~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~  317 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHK----------VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT  317 (364)
T ss_pred             HhhcCcccccccCccccccccee----------ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence            5443321  00000010100000          123347899999999999999999999999999999999988744

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-49  Score=345.64  Aligned_cols=291  Identities=40%  Similarity=0.769  Sum_probs=235.8

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|.+++.||+|+||+||+|.+..+++.+|+|.+........       ...+.+|+.++++++|+||+++++.+..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIVHT   75 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-------chhHHHHHHHHHhCCCCCcceEEEEEee
Confidence            456789999999999999999999999999999999875432211       1135689999999999999999999854


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      + ...++||||+++++...+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+...
T Consensus        76 ~-~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          76 D-KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             C-CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence            4 789999999999988888776677899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+.+..+.+....++.+..
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            44333334456788999999987756789999999999999999999999999888888888888877777766655432


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ...... ..      .....+.......+.++.++++||.+||+.||.+|||++|+++||||+.+.
T Consensus       235 ~~~~~~-~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKN-YN------FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhh-hh------cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            211000 00      000001111122244788999999999999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-48  Score=339.72  Aligned_cols=306  Identities=62%  Similarity=1.078  Sum_probs=246.1

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .|+.+++|++.+.||.|++|.||+|.+..+++.||+|++........      ......+|+.++++++|+|++++++++
T Consensus         2 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (309)
T cd07845           2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVV   75 (309)
T ss_pred             CcccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEE
Confidence            46788999999999999999999999999999999999875432211      112345799999999999999999998


Q ss_pred             EcCC-CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~-~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .... ...++|+||+++++.+.+......+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        76 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          76 VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             ecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcccee
Confidence            5543 568999999999888887776678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..............++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            87654333334445677899999987656789999999999999999999999999998888888888777776666655


Q ss_pred             CCCCccc-cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 035861          245 LSELPGA-KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPT  323 (332)
Q Consensus       245 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~~~  323 (332)
                      +...+.. ..............        ..+..++.+.+||.+||+.||++||+++++++||||.+...+-....+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~  307 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKH--------KFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPT  307 (309)
T ss_pred             hhcccccccccccCCCCCchHH--------hccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCC
Confidence            4433221 01111111111110        11225888999999999999999999999999999999998876667776


Q ss_pred             CC
Q 035861          324 FP  325 (332)
Q Consensus       324 ~~  325 (332)
                      ||
T Consensus       308 ~~  309 (309)
T cd07845         308 FP  309 (309)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-49  Score=348.82  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=211.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||+|+||.||++++..+++.||+|++..........     ...+..|+.++++++||||+.+++.+. .....|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLQNTRHPFLTALKYSFQ-THDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHH-----HHHHHHHHHHHHhCCCCCCCCEEEEEE-cCCEEEEEE
Confidence            46899999999999999999999999997643221111     113568999999999999999999884 447899999


Q ss_pred             ccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcc
Q 035861           97 EYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS  176 (332)
Q Consensus        97 e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~  176 (332)
                      ||++|+.+......++.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++............
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          75 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            99998665555555778999999999999999999999999999999999999999999999999998754333333345


Q ss_pred             ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ..|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.....                     
T Consensus       155 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------  212 (323)
T cd05571         155 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------------  212 (323)
T ss_pred             eecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            678999999999976 6789999999999999999999999988776655554432211                     


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~  317 (332)
                                      ..+..++.++.+||.+||+.||++||     ++.++++||||..+.+...
T Consensus       213 ----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         213 ----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                            11223788999999999999999999     8999999999999875554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-49  Score=343.20  Aligned_cols=259  Identities=28%  Similarity=0.403  Sum_probs=215.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++..........     ...+.+|+.++++++||||+++++.+ .+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-----EQHVHNEKRVLKEVSHPFIIRLFWTE-HDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHH-----HHHHHHHHHHHHhCCCCcHhhhHhhh-ccCC
Confidence            47999999999999999999999999999999997543211111     12456899999999999999999988 4457


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||++|+.+.......+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            89999999987544444444678999999999999999999999999999999999999999999999999998765332


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                         .....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......              
T Consensus       155 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------------  216 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE--------------  216 (291)
T ss_pred             ---cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC--------------
Confidence               234568999999999876 66899999999999999999999999988776666665443111              


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPK  316 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~  316 (332)
                                             .+..++..+++||++||+.||.+|++     ++++++||||..+.+..
T Consensus       217 -----------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~  264 (291)
T cd05612         217 -----------------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD  264 (291)
T ss_pred             -----------------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence                                   11226888999999999999999995     99999999999887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-50  Score=337.13  Aligned_cols=261  Identities=30%  Similarity=0.454  Sum_probs=211.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .++...+.||+|+||+||++.+..+|+..|||.+.......        ...+.+|+.+|.+++||||++++|.......
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--------SESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--------HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            46899999999999999999999999999999998763222        2246799999999999999999997544433


Q ss_pred             -eEEEEcccccccHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEeeccccccc
Q 035861           91 -SVYMVMEYMEHDLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQY  167 (332)
Q Consensus        91 -~~~lv~e~~~~~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~df~~~~~~  167 (332)
                       .+++.|||++|+.+..+..+.+ .++++.+..+..|+++||+|||++|++|+||||+|||++. ++.+||+|||.+...
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence             7999999999765555544444 8999999999999999999999999999999999999999 799999999998876


Q ss_pred             CC---CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GS---PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..   .........||+.|+|||++..+.....++|||||||++.||+||..||... ...+....+......|      
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P------  242 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP------  242 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC------
Confidence            53   1122345789999999999986333446999999999999999999999873 3333333332221001      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                   ..+..+|+++++||++|+..||+.||||+++|+|||.++-..
T Consensus       243 -----------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  243 -----------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -----------------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                                         112338999999999999999999999999999999988554

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-49  Score=348.48  Aligned_cols=264  Identities=30%  Similarity=0.408  Sum_probs=218.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ....+++|++.+.||+|+||.||+|++..+++.||+|++.........     ....+.+|+.++++++||||+++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~   87 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK-----QVQHVAQEKSILMELSHPFIVNMMCSF   87 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh-----hHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            345678999999999999999999999999999999999764321111     112467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .. ....|+||||+.|+.+.......+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus        88 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         88 QD-ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             Ec-CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            54 47899999999876554444446789999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .....   .....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......         
T Consensus       167 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---------  233 (329)
T PTZ00263        167 KVPDR---TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK---------  233 (329)
T ss_pred             EcCCC---cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC---------
Confidence            65432   234578999999999987 66789999999999999999999999887776666555432111         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPK  316 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~  316 (332)
                                                  .+..++..+++||.+||+.||.+|++     ++++++||||.+..+..
T Consensus       234 ----------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~  281 (329)
T PTZ00263        234 ----------------------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK  281 (329)
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence                                        11226888999999999999999996     79999999999876543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-48  Score=338.25  Aligned_cols=291  Identities=39%  Similarity=0.755  Sum_probs=234.1

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...+++|.+.+.||.|++|.||+|.+..+++.||+|.+........       ...+.+|+..++.++|+||+++++.+.
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~nI~~~~~~~~   74 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIH   74 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-------hhHHHHHHHHHHhcCCCCcceEEEEEe
Confidence            3467899999999999999999999999999999999875432211       113568999999999999999999985


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      . ....++|+||+++++...+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~-~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          75 T-EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             c-CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            4 478999999999998888877677899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ............++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            54333333444668899999998775678899999999999999999999999888877777777777766666555432


Q ss_pred             CCccccc-cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          247 ELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       247 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ....... ....        ..........+.+++.+++||.+||+.||.+|||++|+|+||||+.+.
T Consensus       234 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         234 SNEEFKSYNYPK--------YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccccccccCc--------cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            2111000 0000        000111122345788999999999999999999999999999998876

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.3e-49  Score=338.53  Aligned_cols=286  Identities=36%  Similarity=0.618  Sum_probs=220.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|++|+||+++++.+++.+|+|++........      ....+.+|+.+++.++|+||+++++.+ ..+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE------VKETTLRELKMLRTLKQENIVELKEAF-RRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc------chhhHHHHHHHHHhCCCccccchhhhE-ecCC
Confidence            479999999999999999999999999999999975432211      122467899999999999999999988 4457


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||+++++++.+......+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          74 KLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            89999999999988877766678999999999999999999999999999999999999999999999999998765332


Q ss_pred             C-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          171 L-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      . .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+....+..+...+..+...+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             ccccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            1 22234568899999999977 568999999999999999999999999877766666655554444332222111100


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ...    ...... ..............+|.++.+||.+||+.||++|||++|+|+||||
T Consensus       233 ~~~----~~~~~~-~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         233 RFH----GLRFPA-VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hhc----ccccCc-ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000    000000 0000000001112378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-48  Score=345.44  Aligned_cols=294  Identities=36%  Similarity=0.613  Sum_probs=223.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC--
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH--   89 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   89 (332)
                      +|++.+.||+|+||.||+|++..++..||||++.........      ...+.+|+.+++.++||||+++++++....  
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD------ATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh------HHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            589999999999999999999999999999998643221111      124678999999999999999999875432  


Q ss_pred             --CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 --DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                        ...|+||||+++++.+.+.. ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+...
T Consensus        75 ~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          75 EFKDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             CCceEEEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence              35899999999888776654 567999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCC---CCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPL---KPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....   .......++..|+|||++.+. ..++.++|+||||+++|+|++|..||...+.......+....+.++.....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            2211   112345689999999998642 468899999999999999999999998887766666666655555443322


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      .+.....      ...........+.......+.+++.+.++|.+||+.||++||+++|+|+||||+++......
T Consensus       234 ~i~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~  302 (338)
T cd07859         234 RVRNEKA------RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE  302 (338)
T ss_pred             HhhhhhH------HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc
Confidence            2211000      00000000011111111223478889999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-49  Score=329.54  Aligned_cols=282  Identities=25%  Similarity=0.352  Sum_probs=236.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +.-.++.|++++.||.|.-|+||++....++..+|+|++.+.......     ...+...|.++|..+.||.+..++..+
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk-----Kl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK-----KLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh-----HHHHHHHHHHHHHhcCCCccchhhhee
Confidence            445577999999999999999999999999999999999876543322     223456899999999999999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESM--KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                       +.+.+.|++||||+|+-+..++.+  ++.+++..++.++..++.||+|||-.||++|||||+||||.++|+|.|+||.+
T Consensus       147 -et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  147 -ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             -eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccc
Confidence             555999999999998665555543  35699999999999999999999999999999999999999999999999988


Q ss_pred             ccccCC---------------------------------CCC-----------------------CCccccccccccchh
Q 035861          164 SRQYGS---------------------------------PLK-----------------------PYTSLVVTLWYRAPE  187 (332)
Q Consensus       164 ~~~~~~---------------------------------~~~-----------------------~~~~~~~~~~y~aPE  187 (332)
                      +.....                                 ...                       ......||-.|.|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            643210                                 000                       011235677899999


Q ss_pred             hhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhC
Q 035861          188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRF  267 (332)
Q Consensus       188 ~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ++.+ ...+.+.|+|+||+++|||+.|..||.+.+..+++.++.......+                             
T Consensus       306 vI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp-----------------------------  355 (459)
T KOG0610|consen  306 VIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP-----------------------------  355 (459)
T ss_pred             eeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC-----------------------------
Confidence            9998 5689999999999999999999999999999999988876432222                             


Q ss_pred             CCCccCCCCCCCchHHHHHHHhcCCCCCCCCC----HHHHhcCCCCCCCCCCCCCCCCCCCCCccc
Q 035861          268 PAASFTGSPVLSESGFDLLNRLLTYDPEKRIT----VDDALNHYWFHEVPLPKSKDFMPTFPPQHA  329 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  329 (332)
                            ..+.++..++|||+++|.+||.+|..    |.||=+||||..++|.-++..-|++.|+.-
T Consensus       356 ------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~  415 (459)
T KOG0610|consen  356 ------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV  415 (459)
T ss_pred             ------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence                  22348899999999999999999998    999999999999999999998888887653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-49  Score=332.66  Aligned_cols=275  Identities=24%  Similarity=0.374  Sum_probs=223.1

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ......++|++...||.|..++||+|+...+++.||||++.......+.       ..+.+|+..++.+.||||+.++..
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~l-------d~l~kE~~~msl~~HPNIv~~~~s   92 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDL-------DALRKEVQTMSLIDHPNIVTYHCS   92 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhH-------HHHHHHHHHhhhcCCCCcceEEEE
Confidence            3445667999999999999999999999999999999999876654431       257799999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      |+.+ ..+|+||.++.+ ++++.+... ...++|..+..|+++++.||.|||++|.+|||||+.||||+.+|.|+|+|||
T Consensus        93 Fvv~-~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   93 FVVD-SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             EEec-ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCce
Confidence            9666 889999999996 455555443 4569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCC----ccccccccccchhhh-cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          163 MSRQYGSPLKPY----TSLVVTLWYRAPELL-LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       163 ~~~~~~~~~~~~----~~~~~~~~y~aPE~~-~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      .+..........    ....|+++|+|||++ .....|+.++||||||++..|+++|..||........+..-.+  +.+
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~p  249 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDP  249 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCC
Confidence            776543222221    456899999999995 4446699999999999999999999999998877655443333  222


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +.....                         ....+....++.+++.+|..||.+||++|||++++|+|+||++...
T Consensus       250 p~~~t~-------------------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  250 PTLLTS-------------------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CCcccc-------------------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            221110                         1111122336789999999999999999999999999999999763

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-49  Score=345.92  Aligned_cols=278  Identities=30%  Similarity=0.463  Sum_probs=225.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||.||+|.+..+++.||||++..........     ...+..|+.++..++||||+++++.+. +..
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-----VRHVLTERDILTTTKSEWLVKLLYAFQ-DDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH-----HHHHHHHHHHHHhCCCCCCccEEEEEE-cCC
Confidence            47999999999999999999999999999999997653221111     124668999999999999999999884 457


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+..+....+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..... 
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            8999999998765555555577899999999999999999999999999999999999999999999999999876533 


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                        ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+...........         
T Consensus       154 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  221 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV---------  221 (333)
T ss_pred             --ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC---------
Confidence              2345578999999999987 5789999999999999999999999998877666655543211110000         


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCc
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQ  327 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~  327 (332)
                                          .......++.++.+||.+||..+|.+||+++++++||||.++.+.......+++.|.
T Consensus       222 --------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~~~~~~~~~~  278 (333)
T cd05600         222 --------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPE  278 (333)
T ss_pred             --------------------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHhhCCCCCCCC
Confidence                                000012368899999999999999999999999999999998876666555556554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6e-49  Score=345.87  Aligned_cols=274  Identities=25%  Similarity=0.350  Sum_probs=222.1

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCC-cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ...+++|++.+.||+|+||.||+|.+..++ ..||+|++..........     ...+.+|+.+++.++||||+++++.+
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-----VDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhh-----HHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            345679999999999999999999876554 689999987543222111     12456899999999999999999998


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+ ....|+||||++|+.+......++.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus       101 ~~-~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        101 KD-ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             Ee-CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            44 47899999999876555555557789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .....   .....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......        
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------  247 (340)
T PTZ00426        180 VVDTR---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF--------  247 (340)
T ss_pred             ecCCC---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--------
Confidence            65432   234578999999999976 668899999999999999999999999887766666654332111        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--C
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--K  318 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~  318 (332)
                                                   ++.+++.+.++|++||+.||++|+     +++++++||||.++.+...  .
T Consensus       248 -----------------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~  298 (340)
T PTZ00426        248 -----------------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHK  298 (340)
T ss_pred             -----------------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence                                         122688899999999999999995     8999999999999876554  2


Q ss_pred             CCCCCCCCc
Q 035861          319 DFMPTFPPQ  327 (332)
Q Consensus       319 ~~~~~~~~~  327 (332)
                      ....++.|+
T Consensus       299 ~~~~~~~p~  307 (340)
T PTZ00426        299 NVEVPYKPK  307 (340)
T ss_pred             CCCCCcCCC
Confidence            334455554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=293.05  Aligned_cols=288  Identities=43%  Similarity=0.806  Sum_probs=252.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|+..++||+|.+|+||++++..+++.||+|.++......      .+..+.++|+-+++.+.|.||++++++..++ .
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde------gvpssalreicllkelkhknivrl~dvlhsd-k   74 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLHDVLHSD-K   74 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC------CCcHHHHHHHHHHHHhhhcceeehhhhhccC-c
Confidence            47889999999999999999999999999999998765432      3334678999999999999999999998555 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ...+|+|+|..++.......++.++.+.+..++.|++.+|.++|++++.|+|+||.|.+|..+|.+|+.|||+++..+-+
T Consensus        75 kltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   75 KLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             eeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      ..-+.....|.+|++|.++.+.+-|+.+.|+||.|+++.|+.. |.+.|.+.+..+...+++..++.+.++.||++..++
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            7777777889999999999998899999999999999999987 888899999999999999999999999999999887


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .....-.-..-.....        .-|.++...++|++++|.-+|.+|+++++.|+||||.+..
T Consensus       235 dyk~yp~ypattswsq--------ivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQ--------IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCcccCCccccchHHH--------HhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            6543211111111111        1233667788999999999999999999999999999864

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.8e-49  Score=343.14  Aligned_cols=268  Identities=26%  Similarity=0.424  Sum_probs=215.6

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||+|+||.||++.+..++..||+|++..........     ...+.+|+.+++.++||||+.+++.+..+ ...|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----VAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH-----HHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEE
Confidence            46899999999999999999999999997643221111     11345799999999999999999988544 7899999


Q ss_pred             ccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcc
Q 035861           97 EYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS  176 (332)
Q Consensus        97 e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~  176 (332)
                      ||++|+.+.......+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        75 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          75 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            99998666555555678999999999999999999999999999999999999999999999999988754333333345


Q ss_pred             ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ..|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......                    
T Consensus       155 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--------------------  213 (323)
T cd05595         155 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--------------------  213 (323)
T ss_pred             ccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------------------
Confidence            678999999999876 67899999999999999999999999887766555544322111                    


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCC--CCCCCCCCcc
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSK--DFMPTFPPQH  328 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~--~~~~~~~~~~  328 (332)
                                       .+..+++++.+||.+||+.||.+|+     ++.++++||||....+....  ...+++.|+.
T Consensus       214 -----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~  275 (323)
T cd05595         214 -----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV  275 (323)
T ss_pred             -----------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence                             1123789999999999999999998     89999999999998755432  2334444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=336.64  Aligned_cols=273  Identities=32%  Similarity=0.484  Sum_probs=226.4

Q ss_pred             cccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCC------cchhHHHHHHhhCCCCC
Q 035861            4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP------ISSLREINILLSFDHPS   77 (332)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~------~~~~~e~~~l~~l~h~~   77 (332)
                      ..+...+++|+++..||+|.||.|-+|++..+++.||||++.+..............      ....+|+.+|++|.|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            356788999999999999999999999999999999999998766544433322221      25679999999999999


Q ss_pred             eeeeeeeEEcC-CCeEEEEcccccccHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc
Q 035861           78 IVNVKEVVMDD-HDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        78 i~~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~-l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~  155 (332)
                      |++++++..+. ....|+|+|||..+-...... +++ +++.+++.+++++..||+|||..||+||||||+|+|++.+|+
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            99999998332 356999999999665444333 455 999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCC-----CCCCCccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 035861          156 LKICDFGMSRQYGS-----PLKPYTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI  227 (332)
Q Consensus       156 ~~l~df~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~  227 (332)
                      |||+|||.+.....     .......-.||+.|+|||...++   ...+.+.|||||||+||.++.|..||.+....++.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            99999999876521     11122335799999999998773   34577899999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 035861          228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY  307 (332)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  307 (332)
                      .+|.+..-.                                   ++..+++.+.+++||.+||.+||+.|.++.+|-.||
T Consensus       329 ~KIvn~pL~-----------------------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  329 DKIVNDPLE-----------------------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHhcCccc-----------------------------------CCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            998764221                                   122234789999999999999999999999999999


Q ss_pred             CCCCC
Q 035861          308 WFHEV  312 (332)
Q Consensus       308 ~f~~~  312 (332)
                      |...-
T Consensus       374 wvt~~  378 (576)
T KOG0585|consen  374 WVTRD  378 (576)
T ss_pred             eeccC
Confidence            98763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-48  Score=336.89  Aligned_cols=275  Identities=22%  Similarity=0.352  Sum_probs=218.7

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|++.+.||+|+||+||++.+..+++.||+|.+..........     ...+.+|+.+++.++|++++.+.+.+.++ ..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-----EAMALNEKRILEKVNSRFVVSLAYAYETK-DA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhh-----HHHHHHHHHHHHhcCCCcEEEEEEEEccC-Ce
Confidence            3788999999999999999999999999999987543222111     12456899999999999999999988444 78


Q ss_pred             EEEEcccccccHHH-HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLKW-LMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~~-~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++|+||++|+.+. .+.. ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999999975443 4333 234689999999999999999999999999999999999999999999999999876532


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      . .......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+........           
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (285)
T cd05631         155 G-ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-----------  221 (285)
T ss_pred             C-CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------
Confidence            2 22334578999999999986 6789999999999999999999999987654333333322211110           


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCCC--CC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKSKDF--MP  322 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~~~~--~~  322 (332)
                                            ......++.++.+||++||+.||.+||+     ++++++||||.++++......  .+
T Consensus       222 ----------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~  279 (285)
T cd05631         222 ----------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEP  279 (285)
T ss_pred             ----------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCc
Confidence                                  1112237889999999999999999997     899999999999998777554  55


Q ss_pred             CCCCc
Q 035861          323 TFPPQ  327 (332)
Q Consensus       323 ~~~~~  327 (332)
                      ++.|.
T Consensus       280 ~~~~~  284 (285)
T cd05631         280 PFCPD  284 (285)
T ss_pred             CCCCC
Confidence            77664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-48  Score=343.13  Aligned_cols=269  Identities=29%  Similarity=0.444  Sum_probs=214.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||+|+||.||++.+..+++.||+|++..........     ...+.+|+.+++.+.||||+.+++.+. .....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLKNTRHPFLTSLKYSFQ-TKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhCCCCCCcceEEEEE-cCCEEEEEE
Confidence            36899999999999999999999999997643222111     124568999999999999999999884 447899999


Q ss_pred             ccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcc
Q 035861           97 EYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS  176 (332)
Q Consensus        97 e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~  176 (332)
                      ||++|+.+.........+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++............
T Consensus        75 Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          75 EYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            99997655555555678999999999999999999999999999999999999999999999999998754332233344


Q ss_pred             ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ..|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                     
T Consensus       155 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---------------------  212 (328)
T cd05593         155 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI---------------------  212 (328)
T ss_pred             ccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc---------------------
Confidence            578999999999876 6689999999999999999999999987766554443322110                     


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCCCCCCCCccc
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDFMPTFPPQHA  329 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~~~~~~~~~~  329 (332)
                                      ..+..++.++.+||.+||+.||++|+     ++.++++||||....+...  ....+++.|+.+
T Consensus       213 ----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~  276 (328)
T cd05593         213 ----------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVT  276 (328)
T ss_pred             ----------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC
Confidence                            11223788999999999999999997     8999999999998776543  223444444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-48  Score=339.59  Aligned_cols=268  Identities=27%  Similarity=0.432  Sum_probs=214.6

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|++..+++.||+|++..........     ...+..|..++..+ .||||+++++.+ .+....|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~iv~~~~~~-~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD-----VECTMTEKRILSLARNHPFLTQLYCCF-QTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccH-----HHHHHHHHHHHHhccCCCchhceeeEE-EcCCEEEEE
Confidence            46899999999999999999999999997643221111     11345777887766 799999999998 444789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...........
T Consensus        75 ~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             EcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999765555555567899999999999999999999999999999999999999999999999999875433333334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+......                   
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------------  214 (320)
T cd05590         155 TFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------------------  214 (320)
T ss_pred             ccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-------------------
Confidence            5678999999999876 67899999999999999999999999988877666655432111                   


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCCCCCCC--CCCCCCCCCc
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV------DDALNHYWFHEVPLPKS--KDFMPTFPPQ  327 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~hp~f~~~~~~~~--~~~~~~~~~~  327 (332)
                                        .+..++.++.+||++||+.||.+|+++      +++++||||..+.+...  +...+++.|.
T Consensus       215 ------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~  276 (320)
T cd05590         215 ------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPR  276 (320)
T ss_pred             ------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence                              112268899999999999999999998      99999999999876543  2233444444


Q ss_pred             c
Q 035861          328 H  328 (332)
Q Consensus       328 ~  328 (332)
                      .
T Consensus       277 ~  277 (320)
T cd05590         277 I  277 (320)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.9e-48  Score=339.39  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCC-CeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP-SIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~   90 (332)
                      +|++++.||+|+||.||+|++..+++.||+|++..........     ...+..|..++..+.|+ +|+.+++.+ .+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD-----VECTMVEKRVLALPGKPPFLTQLHSCF-QTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhcCCCCceeeeEEEE-EcCC
Confidence            5899999999999999999999999999999997643221111     12456788888888765 577777777 4457


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+.........+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            89999999987655545444678999999999999999999999999999999999999999999999999988654322


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......              
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--------------  219 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--------------  219 (324)
T ss_pred             CCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence            233345578999999999987 66899999999999999999999999888776666555432111              


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-----DDALNHYWFHEVPLPKS  317 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~f~~~~~~~~  317 (332)
                                             .+..++.++.+|+.+||..||.+|+++     +++++||||..+.+...
T Consensus       220 -----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~  268 (324)
T cd05587         220 -----------------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL  268 (324)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence                                   112378899999999999999999976     89999999999876544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-47  Score=329.74  Aligned_cols=283  Identities=47%  Similarity=0.901  Sum_probs=224.4

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++++.||.|++|.||+|.+..++..||+|++........      ....+.+|+.++++++|||++++++.+.. +..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   73 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG------VPSTAIREISLLKELQHPNIVCLQDVLMQ-ESR   73 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC------chHHHHHHHHHHHhcCCCCEeeeEEEEee-CCe
Confidence            58899999999999999999998999999999865432211      11245689999999999999999999854 478


Q ss_pred             EEEEcccccccHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++||||+++++.+.+....  ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 ~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          74 LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            99999999988877665433  5689999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+...++.++|+||||+++|++++|..||...........+....+.+....++......
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            43333444668889999998775667899999999999999999999999888777777776666555555554443332


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ............        ........+++++++||.+||+.||++||++.+|++||||
T Consensus       234 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKG--------SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcc--------hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            221111110000        0011123378999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.2e-48  Score=343.63  Aligned_cols=269  Identities=25%  Similarity=0.350  Sum_probs=214.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||+||++.+..+++.||+|++..........     ...+..|+.++.+++|++|+++++.+. +..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~E~~il~~~~~~~iv~~~~~~~-~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQ-----VGHIRAERDILVEADSLWVVKMFYSFQ-DKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH-----HHHHHHHHHHHHhCCCCCcceEEEEEe-cCC
Confidence            47999999999999999999999999999999997543211111     124568999999999999999999984 447


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+.......+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            89999999987655555555778999999999999999999999999999999999999999999999999998654211


Q ss_pred             CC-----------------------------------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Q 035861          171 LK-----------------------------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK  215 (332)
Q Consensus       171 ~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~  215 (332)
                      ..                                   ......||+.|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCC
Confidence            00                                   0123478999999999987 67889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          216 PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                      .||...+..+...++.......                                 ..+....+++++++||.+|+. +|.
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~p~~~~~s~~~~~li~~l~~-~~~  279 (363)
T cd05628         234 PPFCSETPQETYKKVMNWKETL---------------------------------IFPPEVPISEKAKDLILRFCC-EWE  279 (363)
T ss_pred             CCCCCCCHHHHHHHHHcCcCcc---------------------------------cCCCcCCCCHHHHHHHHHHcC-Chh
Confidence            9999887777666665421100                                 011112268899999999775 444


Q ss_pred             ---CCCCHHHHhcCCCCCCCCCCCCCCC
Q 035861          296 ---KRITVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       296 ---~Rps~~ell~hp~f~~~~~~~~~~~  320 (332)
                         .||+++||++||||+.+.+......
T Consensus       280 ~r~~r~~~~ei~~hp~f~~~~~~~~~~~  307 (363)
T cd05628         280 HRIGAPGVEEIKTNPFFEGVDWEHIRER  307 (363)
T ss_pred             hcCCCCCHHHHhCCCCCCCCCHHHHHhC
Confidence               4689999999999999887666443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-47  Score=330.24  Aligned_cols=283  Identities=44%  Similarity=0.789  Sum_probs=222.4

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||+|.+..+|+.+++|.+........      ....+.+|+..+++++|+|++++++.+.+ ...
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~   73 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLYDVLHS-DKK   73 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc------CccchhHHHHHHHhcCCCCeeeHHHHhcc-CCc
Confidence            58899999999999999999999999999999975432211      12245689999999999999999999854 478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++++||+++++.+.+....+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        74 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          74 LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             eEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            99999999999888877767789999999999999999999999999999999999999999999999999988665443


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF-SGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..|+ ...+..+....+.+..+.+....++.+...+.
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            44445567889999999887566799999999999999999998885 44555556666666655555444433322221


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..... ......       ......+.+++++++||.+||+.||.+|||++++++||||
T Consensus       234 ~~~~~-~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYP-MYPATT-------SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccC-CCCCcc-------hhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            10000 000000       0011123478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-50  Score=314.63  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=226.1

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...-++|++-+.||+|.|+.|+++.+..||+.+++|++.........      ...+.+|+.+-+.|+||||+.+...+ 
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~------~e~l~rEarIC~~LqHP~IvrL~~ti-   79 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD------FQKLEREARICRKLQHPNIVRLHDSI-   79 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc------HHHHHHHHHHHHhcCCCcEeehhhhh-
Confidence            44567999999999999999999999999999999999765544331      12567899999999999999999998 


Q ss_pred             cCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CCcEEEeecc
Q 035861           87 DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QGVLKICDFG  162 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~~~~l~df~  162 (332)
                      ++..+.|+|+|.++|+ +...+.. ..-++|..+-..+.||++||.|+|.+||+|+|+||.|+++-.   ..-+||+|||
T Consensus        80 ~~~~~~ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   80 QEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             cccceeEEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence            5558999999999985 4444444 366899999999999999999999999999999999999953   3469999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+.... ......+..|++.|+|||++.. .+++.++|||+-|+++|-++.|.+||.+.+....+++|+.+.-..+..  
T Consensus       159 vAi~l~-~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~--  234 (355)
T KOG0033|consen  159 LAIEVN-DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP--  234 (355)
T ss_pred             eEEEeC-CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc--
Confidence            999886 4455667789999999999987 789999999999999999999999999988888999988764333322  


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                     .++.+++++++||++||..||.+|+|+.|.|+|||+.+-.
T Consensus       235 -------------------------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  235 -------------------------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             -------------------------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence                                           2344899999999999999999999999999999998744

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-48  Score=345.94  Aligned_cols=276  Identities=29%  Similarity=0.469  Sum_probs=223.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|+||+||+|++..+++.||||++.........     ....+..|+.++..+.|+||+++++.+. +..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-----QIAHVRAERDILADADSPWIVKLYYSFQ-DEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhcc-----HHHHHHHHHHHHHhcCCCCccchhhhee-cCC
Confidence            4799999999999999999999999999999999764322211     1124568999999999999999999884 457


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||++|+.+.......+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            89999999986544444444578999999999999999999999999999999999999999999999999998765433


Q ss_pred             C-----------------------------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 035861          171 L-----------------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT  221 (332)
Q Consensus       171 ~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~  221 (332)
                      .                             .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            2                             12334568999999999987 57899999999999999999999999988


Q ss_pred             ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-H
Q 035861          222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-V  300 (332)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~  300 (332)
                      +......++......                                 ...+....+++++.+||.+||. ||.+|++ +
T Consensus       234 ~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~  279 (350)
T cd05573         234 TLQETYNKIINWKES---------------------------------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF  279 (350)
T ss_pred             CHHHHHHHHhccCCc---------------------------------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH
Confidence            876666655442110                                 0111122268999999999998 9999999 9


Q ss_pred             HHHhcCCCCCCCCCCCCCCCCCCCCCc
Q 035861          301 DDALNHYWFHEVPLPKSKDFMPTFPPQ  327 (332)
Q Consensus       301 ~ell~hp~f~~~~~~~~~~~~~~~~~~  327 (332)
                      +++++||||.++.+.......++..|.
T Consensus       280 ~~ll~hp~~~~~~~~~~~~~~~~~~~~  306 (350)
T cd05573         280 EEIKSHPFFKGIDWENLRETKPPFVPE  306 (350)
T ss_pred             HHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence            999999999999877666555554443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.3e-47  Score=329.65  Aligned_cols=281  Identities=41%  Similarity=0.747  Sum_probs=217.4

Q ss_pred             hcccccccccccCcEEEEEEEECC-CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeeeeeEE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVKEVVM   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~   86 (332)
                      .+|++++.||+|+||+||+|.+.. ++..||+|++.........      ...+.+|+..++.+   .||||+++++++.
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~hpniv~~~~~~~   74 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT   74 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence            379999999999999999999854 4678999998754332211      11344677666655   6999999999874


Q ss_pred             c----CCCeEEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           87 D----DHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        87 ~----~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      .    .....++|+|++++++.+.+... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          75 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             cccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            2    34568999999999887777654 345899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |.+...... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+....+....+.+....
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            998765432 22345568999999999876 6789999999999999999999999999988888888887766555443


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ++.....+...  .......        ......+.++..+++|+.+||+.||++||++.|+|+||||
T Consensus       233 ~~~~~~~~~~~--~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         233 WPRDVALPRQA--FHSKSAQ--------PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             chhhhcccchh--ccCCCCC--------CHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            33221111100  0000000        0011123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-48  Score=345.70  Aligned_cols=276  Identities=28%  Similarity=0.427  Sum_probs=219.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||.|+||+||++++..+++.||||++..........     ...+.+|+.+++.++|+||+.+++.+. +..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-----VAHVRAERDILAEADNPWVVKLYYSFQ-DEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhCCCCCCcceEEEEE-cCC
Confidence            47999999999999999999999999999999997643211111     123567999999999999999999984 458


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+.......+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            89999999987665555555678999999999999999999999999999999999999999999999999988654211


Q ss_pred             CC--------------------------------------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHH
Q 035861          171 LK--------------------------------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL  212 (332)
Q Consensus       171 ~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~ll  212 (332)
                      ..                                      ......||+.|+|||++.. ..++.++|+||||+++|+|+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhh
Confidence            10                                      0112358999999999876 67899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCC
Q 035861          213 AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY  292 (332)
Q Consensus       213 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  292 (332)
                      +|..||...+.......+......                                 ........+++++++||.+|+. 
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~~~~~~~s~~~~~li~~ll~-  279 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKET---------------------------------LQFPDEVPLSPEAKDLIKRLCC-  279 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCc---------------------------------cCCCCCCCCCHHHHHHHHHHcc-
Confidence            999999988776665555432110                                 0011111368899999999997 


Q ss_pred             CCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCCCCCc
Q 035861          293 DPEKRIT---VDDALNHYWFHEVPLPKSKDFMPTFPPQ  327 (332)
Q Consensus       293 dp~~Rps---~~ell~hp~f~~~~~~~~~~~~~~~~~~  327 (332)
                      +|.+|++   ++++++||||+.+.+.......+.+.|+
T Consensus       280 ~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~  317 (364)
T cd05599         280 EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPE  317 (364)
T ss_pred             CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence            8999998   9999999999998765544444444443

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-48  Score=337.14  Aligned_cols=252  Identities=28%  Similarity=0.433  Sum_probs=207.2

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||+|+||+||++.+..+++.||+|++..........     ...+..|+.++++++||||+++++.+. +....++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE-----VTHTLAERTVLAQVNCPFIVPLKFSFQ-SPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhCCCCcEeceeeEEe-cCCeEEEEEcC
Confidence            799999999999999999999999997543211111     124568999999999999999999884 44789999999


Q ss_pred             ccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 035861           99 MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV  178 (332)
Q Consensus        99 ~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  178 (332)
                      ++|+.+.......+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++..............
T Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          75 INGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99765544444467899999999999999999999999999999999999999999999999999875433323334557


Q ss_pred             ccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCC
Q 035861          179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQ  258 (332)
Q Consensus       179 ~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (332)
                      |++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                       
T Consensus       155 gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-----------------------  210 (312)
T cd05585         155 GTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-----------------------  210 (312)
T ss_pred             CCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----------------------
Confidence            8999999999987 6789999999999999999999999988776665555433211                       


Q ss_pred             chhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCCCC
Q 035861          259 PYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNHYWFHEVPL  314 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~f~~~~~  314 (332)
                                    ..+..+++.+.+||.+||+.||.+||   ++.++++||||.+..+
T Consensus       211 --------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         211 --------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             --------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence                          11223788999999999999999997   5899999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-49  Score=308.11  Aligned_cols=261  Identities=30%  Similarity=0.450  Sum_probs=230.1

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ..+..+++|++.+.||.|-||.||+|+.+.++-.||+|++.++..     ...++..++.+|+++-..|+||||++++++
T Consensus        16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-----~~~~v~~qlrREiEIqs~L~hpnilrlY~~   90 (281)
T KOG0580|consen   16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-----LKTQVEHQLRREIEIQSHLRHPNILRLYGY   90 (281)
T ss_pred             ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-----HHhcchhhhhheeEeecccCCccHHhhhhh
Confidence            456788999999999999999999999999999999999987653     333445578899999999999999999999


Q ss_pred             EEcCCCeEEEEccccc-ccHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           85 VMDDHDSVYMVMEYME-HDLKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +.++ ...|+++||.+ |++...+.. ....+++...+.++.|+|.||.|+|..+++||||||+|+|++.++.+|++|||
T Consensus        91 fhd~-~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   91 FHDS-KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             eecc-ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence            9666 88999999998 456555553 45679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      -+....  ...+.+.+||..|.|||...+ ...+...|+|++|++.||++.|..||......+++.++.+.....+    
T Consensus       170 wsV~~p--~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----  242 (281)
T KOG0580|consen  170 WSVHAP--SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----  242 (281)
T ss_pred             ceeecC--CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----
Confidence            987653  455678899999999999987 7789999999999999999999999999999899999877533222    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                       +.++.++++||.+|+.++|.+|.+..|++.|||+..
T Consensus       243 ---------------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  243 ---------------------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             ---------------------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                                             238999999999999999999999999999999865

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-47  Score=347.95  Aligned_cols=284  Identities=32%  Similarity=0.548  Sum_probs=219.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC--
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD--   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   88 (332)
                      .+|++++.||+|+||+||+|.+..+++.||||++.....            ...+|+.+++.++|+||+++++++...  
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------------YKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            479999999999999999999999999999998854321            124799999999999999998876321  


Q ss_pred             -----CCeEEEEcccccccHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEe
Q 035861           89 -----HDSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKIC  159 (332)
Q Consensus        89 -----~~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~  159 (332)
                           ...+++||||+++++.+.+..   ....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+
T Consensus       134 ~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             ccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence                 235779999999987665543   356799999999999999999999999999999999999999765 79999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      |||++...... .......+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+...++....+.+..
T Consensus       214 DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999865432 22234567899999999877567899999999999999999999999998888888888776665543


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      ..+..+...- ....+...........       .+...+.++++||.+||.+||.+|||+.|+|+||||..+..+
T Consensus       293 ~~~~~~~~~~-~~~~~~~~~~~~l~~~-------~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        293 DQLKEMNPNY-ADIKFPDVKPKDLKKV-------FPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHHHHhchhh-hcccCCccCchhHHHH-------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            3222111000 0000000000011111       123367899999999999999999999999999999987654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=333.25  Aligned_cols=255  Identities=26%  Similarity=0.365  Sum_probs=212.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcE-EEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~-v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...+..+.+.+|.|+||+||+|.+.  |.. ||||++.........      ...+.+|+.+|.+++||||+.++|++.+
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES------RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH------HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3556777888999999999999998  556 999999876544433      2367899999999999999999999966


Q ss_pred             CCCeEEEEcccccccHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCCCEEEcCCC-cEEEeeccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESM--KQPFSTSEVKCLMLQLLEGVKYLHDNW-VLHRDLKTSNLLLNNQG-VLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~i~~~l~~~L~~lh~~~-i~H~di~p~Nili~~~~-~~~l~df~~  163 (332)
                      ....++|||||++++++..+...  ...++...+..|+.||+.|+.|||+++ |+|+||||+|||++.++ ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            64479999999997665555443  688999999999999999999999999 99999999999999998 999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++.............||..|||||++.+ ...++.++||||+|+++|||+||..||......+....+......+.    
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~----  266 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP----  266 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence            9876543334445789999999999995 36899999999999999999999999999888666555554322221    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     .+..+++.+..|+.+||..||..||++.+++.-
T Consensus       267 -------------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~  299 (362)
T KOG0192|consen  267 -------------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSR  299 (362)
T ss_pred             -------------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence                                           112278899999999999999999999988754

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9e-48  Score=336.69  Aligned_cols=257  Identities=27%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||.||+|++..+++.||+|++...........     ..+..|.+++..+ .||+|+.+++.+.. ....|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDV-----DCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHH-----HHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEE
Confidence            469999999999999999999999999976432221111     1345788888766 89999999999844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...........
T Consensus        75 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99999765554444567899999999999999999999999999999999999999999999999999876433333344


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......                  
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~------------------  215 (321)
T cd05591         155 TFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY------------------  215 (321)
T ss_pred             ccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            5678999999999876 678999999999999999999999999888777666654422111                  


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-------CHHHHhcCCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-------TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~ell~hp~f~~~~~~~~  317 (332)
                                         +..++.++.+||.+||+.||++|+       +++++++||||..+.+...
T Consensus       216 -------------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         216 -------------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             -------------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence                               112688999999999999999999       9999999999998876544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-48  Score=339.68  Aligned_cols=268  Identities=28%  Similarity=0.428  Sum_probs=214.5

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||+|+||+||++.+..+++.||+|++..........     ...+..|+.+++.++||||+.+++.+. .....|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~-----~~~~~~e~~~l~~~~hp~i~~~~~~~~-~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-----VAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhCCCCCCCceEEEEE-cCCEEEEEE
Confidence            46899999999999999999999999997643222111     113467889999999999999999884 447899999


Q ss_pred             ccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           97 EYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        97 e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      ||++|+.+.........+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          75 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            999987665555556789999999999999999999997 8999999999999999999999999999875433223334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......                   
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~-------------------  214 (325)
T cd05594         155 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-------------------  214 (325)
T ss_pred             cccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC-------------------
Confidence            4578999999999976 67899999999999999999999999887765555444322111                   


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCC--CCCCCCCCcc
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSK--DFMPTFPPQH  328 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~--~~~~~~~~~~  328 (332)
                                        .+..+++++.+||.+||+.||++|+     ++.++++||||.++.+....  ...+++.|+.
T Consensus       215 ------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~  276 (325)
T cd05594         215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQV  276 (325)
T ss_pred             ------------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence                              1123788999999999999999997     99999999999987765442  2334444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-47  Score=338.22  Aligned_cols=300  Identities=33%  Similarity=0.533  Sum_probs=227.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||.||++.+..+++.||||++.........      ...+.+|+.+++.++||||+.+++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh------HHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            567999999999999999999999999999999998653221111      12456899999999999999999987433


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .     ...|+||||+++++...+..   .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus        96 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875          96 KSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             ccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            2     45799999999988776643   588999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+....+.+......
T Consensus       173 a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         173 ARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccccCCC-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9765432 22234568899999999987 678999999999999999999999999998888888887776665544333


Q ss_pred             CCCCCccccccc-cCCchhhhhhhCCCC----ccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANF-AKQPYNLLRKRFPAA----SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       244 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      .+.......... ............+..    ........+..+++||.+||+.||.+|||++++|+||||..+..+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~  330 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA  330 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence            222110000000 000000000111111    111122246688999999999999999999999999999987666554


Q ss_pred             C
Q 035861          319 D  319 (332)
Q Consensus       319 ~  319 (332)
                      .
T Consensus       331 ~  331 (364)
T cd07875         331 E  331 (364)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.7e-47  Score=327.24  Aligned_cols=291  Identities=76%  Similarity=1.275  Sum_probs=234.6

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ++.+++|++.+.||.|++|.||+|++..+++.+++|.+.......      .....+.+|+..+++++||||+++++++.
T Consensus         1 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   74 (293)
T cd07843           1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE------GFPITSLREINILLKLQHPNIVTVKEVVV   74 (293)
T ss_pred             CcchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc------cchhhHHHHHHHHHhcCCCCEEEEEEEEE
Confidence            356789999999999999999999999999999999997553321      11224568999999999999999999885


Q ss_pred             cCC-CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDH-DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~-~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+. ...|+|+||+++++.+.+......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          75 GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             ecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence            442 7799999999998878777656679999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .............++..|+|||.+.+...++.++|+||||+++|+|++|..||......+...++....+.+....++.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         155 EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             eccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            76554344445567888999999876556789999999999999999999999998888888888877777766666655


Q ss_pred             CCCcccc-ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          246 SELPGAK-ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       246 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..++... ..............++.      ..++..+.+||.+||+.+|++||++.|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPA------LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccc------cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            4433322 11111111111111111      1158889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-47  Score=338.95  Aligned_cols=298  Identities=34%  Similarity=0.544  Sum_probs=223.0

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++.+.||+|+||.||++.+..++..||+|++.........      ...+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH------AKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH------HHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            3568999999999999999999999999999999998654221111      1245689999999999999999998854


Q ss_pred             CC-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           88 DH-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        88 ~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      ..     ...|+||||+++++...+.   ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          92 QKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             CCCccccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence            32     3579999999998876653   358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....+.+.....
T Consensus       169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTN-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccC-ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            98754322 22234567899999999977 67899999999999999999999999988877777766666555443322


Q ss_pred             cCCCCCccc-cccccCCchhhhhhhCCC----CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          243 PGLSELPGA-KANFAKQPYNLLRKRFPA----ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      ..+...... ................+.    .........++.+++||.+||..||++|||+.|+|+||||+.+..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence            111100000 000000000000000111    01112223578899999999999999999999999999999765544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-47  Score=335.64  Aligned_cols=258  Identities=30%  Similarity=0.444  Sum_probs=209.8

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHH---hhCCCCCeeeeeeeEEcCC
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL---LSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~   89 (332)
                      |++++.||+|++|.||+|.+..+++.||||++...........     ..+..|+.++   +.++||||+++++.+. ..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-----ESLMCEKRIFETANSERHPFLVNLFACFQ-TE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-----HHHHHHHHHHHhccccCCCChhceeeEEE-cC
Confidence            7789999999999999999999999999999975432111111     1344555544   5668999999999884 44


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...|+||||++|+.+..... .+.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            78999999999866555443 46799999999999999999999999999999999999999999999999998875433


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+......             
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-------------  219 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-------------  219 (324)
T ss_pred             CCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence            2233345678999999999877 67899999999999999999999999988776666555432111             


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLP  315 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~  315 (332)
                                              .+..++..+.+||.+||+.||.+||     ++.++++||||.++.+.
T Consensus       220 ------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         220 ------------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             ------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                                    1123788899999999999999999     79999999999987644

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-49  Score=314.60  Aligned_cols=273  Identities=31%  Similarity=0.460  Sum_probs=231.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   88 (332)
                      ...|.-.+.+|.|..++|-++.++.+|..+++|++...........-.+....-..|+.+|+++ .||+|+.+.+++ +.
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-es   94 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-ES   94 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-cC
Confidence            4678899999999999999999999999999999987655443322333334556899999998 899999999999 55


Q ss_pred             CCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +.+.++|+|.++ |.+.+.+. ..-.+++....++++||+.++.|||.++|+|+||||+|||++++.+++|+|||++...
T Consensus        95 ~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             cchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            589999999999 45555554 4788999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCCCccccccccccchhhhcC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLG-----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      . +.......|||+.|.|||.+.+     ...|+...|+|++|++||.++.|.+||....+...+..++.+......+  
T Consensus       174 ~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp--  250 (411)
T KOG0599|consen  174 E-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP--  250 (411)
T ss_pred             C-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc--
Confidence            4 3455677899999999999864     2357889999999999999999999999988888888887764433322  


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                                                     .+.++|.+.++||++||+.||++|.|++|+|+||||.++.....+
T Consensus       251 -------------------------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  251 -------------------------------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             -------------------------------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence                                           344589999999999999999999999999999999877655544

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-47  Score=335.53  Aligned_cols=262  Identities=25%  Similarity=0.390  Sum_probs=212.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   90 (332)
                      +|++++.||+|+||.||+|.+..+++.||+|++...........     ..+..|..++..+ .|++|+.+++.+ .+..
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV-----ECTMVEKRVLALSGKPPFLTQLHSCF-QTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-----HHHHHHHHHHHhccCCCeEeeEEEEE-ecCC
Confidence            58899999999999999999999999999999976432221111     1345677777777 578888888887 4457


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||++|+.+.......+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            89999999986544444444678999999999999999999999999999999999999999999999999998754333


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........|++.|+|||++.. ..++.++|+||||+++|+|++|..||...+.......+.......             
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------------  220 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------------  220 (323)
T ss_pred             CCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence            333345678999999999987 678999999999999999999999999887776666554321111             


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~  317 (332)
                                              +..++.++.+|+.+||+.||++|++     ..++++||||..+.|...
T Consensus       221 ------------------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~  268 (323)
T cd05616         221 ------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  268 (323)
T ss_pred             ------------------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence                                    1237889999999999999999997     489999999998876554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-48  Score=343.72  Aligned_cols=276  Identities=28%  Similarity=0.390  Sum_probs=217.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||.|+||+||++.+..+++.||||++..........     ...+.+|+.+++.++||||+++++.+. +..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ-----LAHVKAERDVLAESDSPWVVSLYYSFQ-DAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHH-----HHHHHHHHHHHHhCCCCCcceEEEEEE-cCC
Confidence            47999999999999999999999999999999987543211111     124568999999999999999999985 447


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+.......+.+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            89999999987555444444678999999999999999999999999999999999999999999999999988532110


Q ss_pred             C-------------C----------------------------------CCccccccccccchhhhcCCCCCCchhHHHH
Q 035861          171 L-------------K----------------------------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWS  203 (332)
Q Consensus       171 ~-------------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s  203 (332)
                      .             .                                  ......||+.|+|||++.. ..++.++|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  233 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWS  233 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEe
Confidence            0             0                                  0012368999999999876 67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHH
Q 035861          204 VGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF  283 (332)
Q Consensus       204 lG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      ||+++|+|++|..||...+..+....+......                                 ...+....++.+++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~  280 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------------------------LYFPDDIHLSVEAE  280 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------------------------cCCCCCCCCCHHHH
Confidence            999999999999999887766655555432100                                 00111123688999


Q ss_pred             HHHHHhcCCCCCCC---CCHHHHhcCCCCCCCCCCCCCCCCCCCCCc
Q 035861          284 DLLNRLLTYDPEKR---ITVDDALNHYWFHEVPLPKSKDFMPTFPPQ  327 (332)
Q Consensus       284 ~li~~~l~~dp~~R---ps~~ell~hp~f~~~~~~~~~~~~~~~~~~  327 (332)
                      +||.+||. +|.+|   +++.++++||||+.+.+...+...+++.|+
T Consensus       281 dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~  326 (377)
T cd05629         281 DLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQ  326 (377)
T ss_pred             HHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHccCCCCcccC
Confidence            99999998 67665   599999999999998876666665555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-47  Score=333.01  Aligned_cols=267  Identities=27%  Similarity=0.475  Sum_probs=210.4

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhh-CCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS-FDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|.+..+++.||+|++...........     ..+..|..++.. ..||||+.+++.+. .....++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDV-----ECTMVERRVLALAWEHPFLTHLFCTFQ-TKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhH-----HHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEE
Confidence            469999999999999999999999999976432211111     123456666654 48999999999884 44789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99998765555555567899999999999999999999999999999999999999999999999999876433333344


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+......                   
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------------  214 (316)
T cd05592         155 TFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH-------------------  214 (316)
T ss_pred             cccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            5678999999999976 66899999999999999999999999988776655554322110                   


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH-HHHhcCCCCCCCCCCCC--CCCCCCCCCc
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-DDALNHYWFHEVPLPKS--KDFMPTFPPQ  327 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~ell~hp~f~~~~~~~~--~~~~~~~~~~  327 (332)
                                        .+..++.++.+||.+||+.||.+||++ .++++||||..+.+...  +...+.+.|+
T Consensus       215 ------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~  271 (316)
T cd05592         215 ------------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPK  271 (316)
T ss_pred             ------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence                              112268889999999999999999986 58999999998875433  2333444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.8e-48  Score=340.44  Aligned_cols=297  Identities=32%  Similarity=0.509  Sum_probs=233.6

Q ss_pred             cccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-C-----CC
Q 035861            4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-H-----PS   77 (332)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~   77 (332)
                      +.+...-.+|.|++.||+|+||+|.+|.+..|++.||||+++.......         +...|+.+|..++ |     -|
T Consensus       179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~---------Q~~~Ei~iL~~ln~~d~~~~~n  249 (586)
T KOG0667|consen  179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLR---------QAQIEIRILELLNKHDPDDKYN  249 (586)
T ss_pred             EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHH---------HHHHHHHHHHHHhccCCCCCee
Confidence            3344444589999999999999999999999999999999986543221         3458999999886 3     57


Q ss_pred             eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC--
Q 035861           78 IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG--  154 (332)
Q Consensus        78 i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~--  154 (332)
                      ++++++++ ...++.|||+|.++-+|.+.+..++ ..++...++.++.||+.||.+||+.||||+||||+|||+...+  
T Consensus       250 ~Vrm~d~F-~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  250 IVRMLDYF-YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             EEEeeecc-ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC
Confidence            99999999 5558899999999999999888754 5699999999999999999999999999999999999997544  


Q ss_pred             cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          155 VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      .|||+|||++......  .+ ..+.+..|+|||++.+ .+|+.+.|||||||++.||++|.+.|.+.+..+.+..|+..+
T Consensus       329 ~vKVIDFGSSc~~~q~--vy-tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQR--VY-TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL  404 (586)
T ss_pred             ceeEEecccccccCCc--ce-eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence            7999999999876432  22 6678899999999998 889999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccCCCCCccccc----------ccc-------CCchhh-----hhhhCCCCccCCCC----CCCchHHHHHHH
Q 035861          235 GTPTETIWPGLSELPGAKA----------NFA-------KQPYNL-----LRKRFPAASFTGSP----VLSESGFDLLNR  288 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~----------~~~-------~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~li~~  288 (332)
                      +.|+...+....+.-....          ...       ......     .....|.......+    .-...+.+||.+
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence            9888765554332111000          000       000010     11111211111111    223467899999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          289 LLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       289 ~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ||.+||.+|+|+.++|+||||+....
T Consensus       485 ~L~~dP~~R~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALNHPFLTGTSL  510 (586)
T ss_pred             HhccCchhcCCHHHHhcCcccccccc
Confidence            99999999999999999999996553

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-47  Score=339.30  Aligned_cols=279  Identities=24%  Similarity=0.329  Sum_probs=220.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++.+.||+|+||+||++++..+++.||+|++..........     ...+.+|+.+++.++||||+++++.+ .
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~il~~~~h~~iv~~~~~~-~  113 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD-----SAFFWEERDIMAHANSEWIVQLHYAF-Q  113 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhh-----HHHHHHHHHHHHhCCCCCcceEEEEE-e
Confidence            45679999999999999999999999999999999997533211111     11356899999999999999999988 4


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +....++||||++|+.+..+.. +..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+...
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMS-NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            5588999999998765544444 346899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCC-CCccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..... ......|++.|+|||.+.+.   ..++.++|+||||+++|+|++|..||...+.......+......       
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------  265 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS-------  265 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc-------
Confidence            43221 23355789999999998652   34788999999999999999999999988776666665432110       


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCC--CCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVPL--PKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~~--~~~~~  319 (332)
                                                ........++.++++||.+||+.+|.+  |++++++++||||++..+  ...+.
T Consensus       266 --------------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~~~~~~  319 (370)
T cd05596         266 --------------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRE  319 (370)
T ss_pred             --------------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhhHHhcC
Confidence                                      011112237899999999999999988  999999999999998543  33334


Q ss_pred             CCCCCCC
Q 035861          320 FMPTFPP  326 (332)
Q Consensus       320 ~~~~~~~  326 (332)
                      ..+++.|
T Consensus       320 ~~~~~~p  326 (370)
T cd05596         320 TVAPVVP  326 (370)
T ss_pred             CCcCccC
Confidence            4444444

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.8e-47  Score=333.07  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=207.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|.+..++..||+|++...........     ..+..|..+++.+ .||||+++++.+. +....|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~il~~~~~h~~i~~~~~~~~-~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV-----ECTMTEKRVLALAGKHPFLTQLHSCFQ-TKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHH-----HHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEE
Confidence            469999999999999999999999999986532211111     1345788888777 7999999999884 44789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.......+.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99998765555555567899999999999999999999999999999999999999999999999998865322223334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......                   
T Consensus       155 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~-------------------  214 (318)
T cd05570         155 TFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-------------------  214 (318)
T ss_pred             ceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            4568999999999987 67899999999999999999999999887766555544322110                   


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-----DDALNHYWFHEVPLP  315 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~f~~~~~~  315 (332)
                                        .+..++..+.+||.+||+.||.+||++     .++++||||+.+.+.
T Consensus       215 ------------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         215 ------------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             ------------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              112268899999999999999999999     999999999997653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.2e-47  Score=340.61  Aligned_cols=265  Identities=26%  Similarity=0.363  Sum_probs=210.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|++++.||+|+||+||+|++..+++.||+|++..........     ...+..|+.++++++|+||+++++.+.+ ...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~-----~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-----VAHVKAERDILAEADNEWVVKLYYSFQD-KDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH-----HHHHHHHHHHHHhcCCCCeeeeEEEEec-CCE
Confidence            6899999999999999999999999999999997643222111     1245689999999999999999999954 478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .|+||||++|+.+..+....+.+++..+..++.||+.||+|||+.||+|+||||+||+++.+++++|+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999876555455456789999999999999999999999999999999999999999999999999875321000


Q ss_pred             -----------------------------------------------CCCccccccccccchhhhcCCCCCCchhHHHHH
Q 035861          172 -----------------------------------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSV  204 (332)
Q Consensus       172 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl  204 (332)
                                                                     .......||..|+|||.+.+ ..++.++|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSl  234 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSV  234 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeeh
Confidence                                                           00123468999999999876 668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHH
Q 035861          205 GCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD  284 (332)
Q Consensus       205 G~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      |+++|+|++|..||...+.......+......                                 ........+++++++
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~~~~~~~s~~~~d  281 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------------------------LHIPPQVKLSPEAVD  281 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------------------------cCCCCCCCCCHHHHH
Confidence            99999999999999887766555544321110                                 001111237899999


Q ss_pred             HHHHhc--CCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          285 LLNRLL--TYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       285 li~~~l--~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      ||.+|+  ..++..|++++++++||||.++.+..
T Consensus       282 li~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         282 LITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence            999955  45555699999999999999877654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.4e-47  Score=332.12  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=205.9

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||.||+|.+..+++.||+|++..........     ......|..++... .||+|+++++.+.. ....|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD-----VECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcch-----HHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEE
Confidence            46999999999999999999999999997643211111     11345677777654 89999999999844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||+.|+.+.........+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...........
T Consensus        75 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             ECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99999755544444467899999999999999999999999999999999999999999999999998875433233334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......                  
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------  215 (316)
T cd05620         155 TFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY------------------  215 (316)
T ss_pred             ccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence            5678999999999987 678999999999999999999999998877665555443221110                  


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH-HHHhcCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-DDALNHYWFHEVPLPK  316 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~ell~hp~f~~~~~~~  316 (332)
                                         +..++.++++||.+||+.||++|+++ +++++||||..+.+..
T Consensus       216 -------------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~  258 (316)
T cd05620         216 -------------------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA  258 (316)
T ss_pred             -------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence                               11268899999999999999999997 5899999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-47  Score=326.03  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||+|+||+||++.+..+++.+|+|.+..........     ...+..|+.+++.+.|+||+.+.+.+ ......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG-----YEGAMVEKRILAKVHSRFIVSLAYAF-QTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHH-----HHHHHHHHHHHHhCCCCcEeeeeEEE-cCCCeEEEEEeC
Confidence            699999999999999999999999987543222111     12456799999999999999999888 444789999999


Q ss_pred             ccccHHH-HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC
Q 035861           99 MEHDLKW-LMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY  174 (332)
Q Consensus        99 ~~~~l~~-~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~  174 (332)
                      ++|+.+. .+..   .+..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  154 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT  154 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccc
Confidence            9875544 3322   34569999999999999999999999999999999999999999999999999987654433333


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN  254 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (332)
                      ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.......                 
T Consensus       155 ~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  216 (280)
T cd05608         155 KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-----------------  216 (280)
T ss_pred             cccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----------------
Confidence            45578899999999987 678899999999999999999999997654332222222111000                 


Q ss_pred             ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCC
Q 035861          255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~  318 (332)
                                      ....++.++..+.+|+.+||+.||++||     +++++++||||+++.+....
T Consensus       217 ----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  269 (280)
T cd05608         217 ----------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE  269 (280)
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHh
Confidence                            0111233788999999999999999999     88999999999998877553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=335.96  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=220.0

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|..++.||+|+||.||+|.++.+++.||+|++.......+..       .+.+|+.++.+++++||..+++.+..+ ..
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIe-------diqqei~~Ls~~~~~~it~yygsyl~g-~~   85 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIE-------DIQQEISVLSQCDSPNITEYYGSYLKG-TK   85 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhH-------HHHHHHHHHHhcCcchHHhhhhheeec-cc
Confidence            7888899999999999999999999999999998876544322       456899999999999999999999666 78


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      ++++||||.|+....+......+++..+..++++++.||.|||..+.+|+|||+.||++..+|.+||+|||.+.......
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999987766666656777999999999999999999999999999999999999999999999999999887665


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      ....+..||+.|||||++.. ..|+.++||||||++.+||++|.+|+....+......|       +...          
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~----------  227 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSA----------  227 (467)
T ss_pred             hccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCC----------
Confidence            66688999999999999995 78999999999999999999999999887652221111       1110          


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                         +......+|+.+++||..||.+||+.||+|.++|+|+|++...
T Consensus       228 -------------------PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  228 -------------------PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             -------------------CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                               1111114799999999999999999999999999999999843

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=321.20  Aligned_cols=280  Identities=29%  Similarity=0.446  Sum_probs=244.3

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|.||+|-+++.+.+++.||+|++++.........     ..-+.|-++|+..+||.+..+...+ +
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEV-----AHTlTE~RVL~~~~HPFLt~LKYsF-Q  238 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEV-----AHTLTENRVLQNCRHPFLTSLKYSF-Q  238 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHh-----hhhhhHHHHHHhccCcHHHHhhhhh-c
Confidence            357899999999999999999999999999999999987654333222     2346789999999999999988888 5


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....+|+||||+.|+-+.....+...+++...+.+...|..||.|||+++|+.+|||.+|.++|++|++||+|||+|+..
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            55889999999998755555555778999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      -.......+.|||+.|.|||++.. ..|..+.|.|.+|++||||++|+.||.+.+.......|....-..|..       
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~-------  390 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT-------  390 (516)
T ss_pred             ccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc-------
Confidence            555566778999999999999988 789999999999999999999999999998888887776543333222       


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDF  320 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~  320 (332)
                                                    ++++++.|+..+|.+||.+|.     .+.||.+|+||..++|.+.  ...
T Consensus       391 ------------------------------ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki  440 (516)
T KOG0690|consen  391 ------------------------------LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI  440 (516)
T ss_pred             ------------------------------CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence                                          799999999999999999998     6899999999999999988  669


Q ss_pred             CCCCCCccccC
Q 035861          321 MPTFPPQHARN  331 (332)
Q Consensus       321 ~~~~~~~~~~~  331 (332)
                      .|+|+|+-++.
T Consensus       441 ~PPfKPqVtSe  451 (516)
T KOG0690|consen  441 EPPFKPQVTSE  451 (516)
T ss_pred             CCCCCCCcccc
Confidence            99999998763

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.3e-48  Score=338.02  Aligned_cols=276  Identities=26%  Similarity=0.409  Sum_probs=221.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|+||+||++.+..+++.||+|++..........     ...+.+|+.+++.+.|+||+.+++.+.+ ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQET-----VSFFEEERDILSISNSPWIPQLQYAFQD-KD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhCCCCCCcceeeEEec-CC
Confidence            47999999999999999999999999999999998654311111     1235688999999999999999998844 47


Q ss_pred             eEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..++||||++| ++.+.+......+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            89999999976 45555555447899999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC-CCccccccccccchhhhcC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          170 PLK-PYTSLVVTLWYRAPELLLG-----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ... ......|++.|+|||++..     ...++.++|+||||+++|+|++|..||...+......++......       
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------  227 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF-------  227 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc-------
Confidence            222 1233468899999999863     356788999999999999999999999887776666655432110       


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPT  323 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~~~  323 (332)
                                                ...+..+.++..+.+||.+||. +|.+||+++++++||||..+.+.......++
T Consensus       228 --------------------------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~~~  280 (330)
T cd05601         228 --------------------------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPP  280 (330)
T ss_pred             --------------------------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCCCC
Confidence                                      0011123378899999999998 9999999999999999999887766655554


Q ss_pred             CCC
Q 035861          324 FPP  326 (332)
Q Consensus       324 ~~~  326 (332)
                      ..|
T Consensus       281 ~~~  283 (330)
T cd05601         281 FVP  283 (330)
T ss_pred             ccC
Confidence            444

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-47  Score=335.42  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=207.5

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHH-HHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN-ILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|++..+++.||+|++...........     ..+..|.. +++.++||||+++++.+.. ....++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-----KHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHH-----HHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEE
Confidence            468999999999999999999999999976432211111     12334444 4577899999999998844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.......+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          75 LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             EcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999765554545577899999999999999999999999999999999999999999999999999875433333334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....                     
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------------  212 (323)
T cd05575         155 TFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---------------------  212 (323)
T ss_pred             cccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            5578999999999877 678999999999999999999999998877666655554321                     


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV----DDALNHYWFHEVPLPKS  317 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~hp~f~~~~~~~~  317 (332)
                                      ....+.++..+.+||.+||+.||.+||++    .++++||||..+.+...
T Consensus       213 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~  262 (323)
T cd05575         213 ----------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDL  262 (323)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                            11123368899999999999999999987    69999999998876544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-47  Score=340.10  Aligned_cols=283  Identities=24%  Similarity=0.386  Sum_probs=213.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++++.||.|+||.||++.+..+++.||+|.....              .+.+|+.++++++||||+++++.+.. .
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~--------------~~~~E~~il~~l~HpnIv~~~~~~~~-~  155 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG--------------GTATEAHILRAINHPSIIQLKGTFTY-N  155 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh--------------hhHHHHHHHHhCCCCCCCCEeEEEEE-C
Confidence            35799999999999999999999999999999965321              34689999999999999999999854 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|+|++.+++...+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus       156 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        156 KFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             CeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            78899999999888777665 56789999999999999999999999999999999999999999999999999865322


Q ss_pred             -CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHcCCCCCCc
Q 035861          170 -PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT-------EVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~  241 (332)
                       .........||+.|+|||++.. ..++.++|+||||+++|+|++|..||....       .......+....+.++...
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             ccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence             1122334578999999999876 678999999999999999999998875432       2334455555544443322


Q ss_pred             ccCCCCCccccccccCCchhhhhhhC--CCC--ccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRF--PAA--SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      ......      ..............  +..  .+.....++.++.+||.+||+.||.+|||++|+|+||||++++.+
T Consensus       314 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        314 PIDAQA------NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             CcchhH------HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            110000      00000000000000  000  000011256789999999999999999999999999999987544

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-47  Score=332.15  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=208.7

Q ss_pred             cccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           16 LNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      ++.||+|+||.||+++..   .+++.||+|++..........    ....+..|+.+++.++||||+++++.+..+ ...
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK----DTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhh----hHHHHHHHHHHHHhCCCCchhceeeEEecC-CeE
Confidence            467999999999999864   468899999997543211111    012346899999999999999999998544 789


Q ss_pred             EEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC
Q 035861           93 YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK  172 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~  172 (332)
                      |+||||++|+.+.......+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999866655555577889999999999999999999999999999999999999999999999999875433333


Q ss_pred             CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccc
Q 035861          173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK  252 (332)
Q Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (332)
                      ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-----------------  217 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-----------------  217 (323)
T ss_pred             cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            3344578999999999876 5678999999999999999999999988777665555543211                 


Q ss_pred             ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 035861          253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPL  314 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~  314 (332)
                                          ..++.+++.+.+||.+||+.||++||     +++++++||||....+
T Consensus       218 --------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         218 --------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                                11233788999999999999999999     8999999999988654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-48  Score=333.59  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=229.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|.+++.+|+|+||.+++++++.++..+|+|.+...........      ....|+.+++++.||||+.+.+.+.+++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~------~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR------SAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH------HHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            5789999999999999999999999999999999987665443221      4568999999999999999999998887


Q ss_pred             CeEEEEcccccccHHHHHH-hcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEHDLKWLME-SMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~-~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...+|+|+||+|+.+.... ..+ ..++++.+..|+.|++.|+.|||+++|+|+|||+.|||+++++.|+|+|||+++..
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            7799999999986555444 333 56899999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........||+.|++||.+.+ .+|+.++|||||||++|||++.+.+|.+.+......++.+....|..        
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp--------  227 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP--------  227 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC--------
Confidence            766556677899999999999988 89999999999999999999999999999999999998887543332        


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                                  ..++.+++.+|..||+.+|..||++.++|.+|...
T Consensus       228 ----------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  228 ----------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             ----------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence                                        23899999999999999999999999999998877

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-47  Score=341.82  Aligned_cols=266  Identities=26%  Similarity=0.368  Sum_probs=211.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||+||++++..+++.||||++.........     ....+.+|+.++++++|+||+++++.+. +..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRN-----QAAHVKAERDILAEADNEWVVKLYYSFQ-DKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhh-----hHHHHHHHHHHHHhCCCCCcceEEEEEE-cCC
Confidence            4799999999999999999999999999999998654321111     1124568999999999999999999984 458


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+..+....+.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            89999999987655544444678999999999999999999999999999999999999999999999999987422100


Q ss_pred             -------------------------------------------CCCCccccccccccchhhhcCCCCCCchhHHHHHHHH
Q 035861          171 -------------------------------------------LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCI  207 (332)
Q Consensus       171 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~  207 (332)
                                                                 ........|++.|+|||++.. ..++.++|+||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi  233 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI  233 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccce
Confidence                                                       000113468999999999976 678999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHH
Q 035861          208 MAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLN  287 (332)
Q Consensus       208 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  287 (332)
                      +|+|++|..||...+..+....+......                                 ........+++++.+||.
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~~~~~~~s~~~~~li~  280 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWETT---------------------------------LHIPSQAKLSREASDLIL  280 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCcc---------------------------------ccCCCCCCCCHHHHHHHH
Confidence            99999999999887766555544321110                                 001112237889999999


Q ss_pred             HhcCCCCCCCC---CHHHHhcCCCCCCCCCCCC
Q 035861          288 RLLTYDPEKRI---TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       288 ~~l~~dp~~Rp---s~~ell~hp~f~~~~~~~~  317 (332)
                      +|+ .+|.+|+   ++.++++||||..+.+...
T Consensus       281 ~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         281 RLC-CGAEDRLGKNGADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             HHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence            987 5999999   9999999999998875554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-46  Score=322.05  Aligned_cols=280  Identities=43%  Similarity=0.779  Sum_probs=216.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeeeeeEEcC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVKEVVMDD   88 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~   88 (332)
                      +|++.+.||+|++|+||+|.+..+++.||+|.+.........      .....+|+..++.+   +||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            589999999999999999999999999999998754322111      11334677666655   799999999987432


Q ss_pred             ----CCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 ----HDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ----~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                          ....++++|++++++.+.+.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.
T Consensus        75 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          75 RTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             cCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCc
Confidence                34589999999998877766543 4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+...++....+.+....++
T Consensus       155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         155 ARIYSCQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccccCc-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8765422 22234567889999999976 668999999999999999999999999888877777777765555444333


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .....+...  ...        ..+.......+.++..+.+||.+||+.||++||+++|++.||||
T Consensus       233 ~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGA--FSP--------RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccc--cCC--------CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            211111000  000        00111112223478889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-46  Score=334.54  Aligned_cols=296  Identities=33%  Similarity=0.542  Sum_probs=222.4

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||.||++.+..+++.+|||++.........      ...+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH------HHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            3578999999999999999999999999999999998654322111      1245689999999999999999998854


Q ss_pred             CC-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           88 DH-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        88 ~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      ..     ...++||||+++++...+..   .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence            32     35799999999988766543   58999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....+.+.....
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99765432 22344578899999999976 67899999999999999999999999988877777777666554443322


Q ss_pred             cCCCCCcccc----ccccCCchh-hhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          243 PGLSELPGAK----ANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       243 ~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ..+.......    ......... .................+..+++||.+||+.||++|||+.|+|+||||..+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence            2211100000    000000000 00000001111122335678899999999999999999999999999987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-47  Score=340.34  Aligned_cols=275  Identities=25%  Similarity=0.382  Sum_probs=215.1

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|++++.||+|+||+||+|++..+++.||+|++..........     ...+.+|+.+++++.|+||+++++.+.+ ...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~-----~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-----VAHVKAERDILAEADNEWVVRLYYSFQD-KDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHH-----HHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCE
Confidence            6899999999999999999999999999999997543211111     1245689999999999999999999954 478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .|+||||++|+.+.......+.+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999875444444446779999999999999999999999999999999999999999999999999874321000


Q ss_pred             -----------------------------------------------CCCccccccccccchhhhcCCCCCCchhHHHHH
Q 035861          172 -----------------------------------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSV  204 (332)
Q Consensus       172 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl  204 (332)
                                                                     .......||+.|+|||++.+ ..++.++|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSl  234 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV  234 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEec
Confidence                                                           00112468999999999976 668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHH
Q 035861          205 GCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD  284 (332)
Q Consensus       205 G~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      |+++|+|++|..||...+..+....+......                                 ...+....+++++.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~  281 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------------------------LHIPPQAKLSPEASD  281 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------------------------cCCCCcccCCHHHHH
Confidence            99999999999999887766655554432110                                 011112337899999


Q ss_pred             HHHHhcCCCCCCCCC---HHHHhcCCCCCCCCCCCC-CCCCCCCCCc
Q 035861          285 LLNRLLTYDPEKRIT---VDDALNHYWFHEVPLPKS-KDFMPTFPPQ  327 (332)
Q Consensus       285 li~~~l~~dp~~Rps---~~ell~hp~f~~~~~~~~-~~~~~~~~~~  327 (332)
                      ||.+|+ .+|.+|++   ++++++||||+.+.+... ....+++.|.
T Consensus       282 li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~  327 (382)
T cd05625         282 LIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPK  327 (382)
T ss_pred             HHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHHHHhcCCCCccCc
Confidence            999987 49999997   999999999999876543 3334444443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-46  Score=323.71  Aligned_cols=283  Identities=47%  Similarity=0.907  Sum_probs=225.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++++.||.|++|.||+|++..++..|+||.+........      ....+.+|++.+++++||||+++++++. +...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   73 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG------VPSTAIREISLLKELNHPNIVKLLDVIH-TENK   73 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc------cchHHHHHHHHHHhcCCCCCcchhhhcc-cCCc
Confidence            48899999999999999999999999999998865432221      1225678999999999999999999984 4578


Q ss_pred             EEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .++||||+++++...+... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          74 LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             EEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999998877766543 356899999999999999999999999999999999999999999999999998765443


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+...++.++|+||||+++|+++||..||...+......++....+.+....++.....+.
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            33334445678899999887756678999999999999999999999998888877777777766666555554433322


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ......+........        ..+.++.+++++|.+||+.||++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSK--------VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHH--------HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            222221111111111        123378889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-46  Score=328.44  Aligned_cols=267  Identities=27%  Similarity=0.468  Sum_probs=210.5

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhh-CCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS-FDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|.+..+++.||+|++...........     .....|...+.. +.||||+++++.+.++ ...++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV-----ECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchH-----HHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEE
Confidence            469999999999999999999999999976532111111     134567777765 4899999999998544 789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99998755554444467799999999999999999999999999999999999999999999999999875432222334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|+..|+|||++.+ ..++.++|+||+|+++|+|++|..||...+..+....+......                   
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-------------------  214 (316)
T cd05619         155 TFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC-------------------  214 (316)
T ss_pred             eecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence            4568999999999876 67899999999999999999999999887766555544322110                   


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCCCCCCC--CCCCCCCCc
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD-DALNHYWFHEVPLPKSK--DFMPTFPPQ  327 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~hp~f~~~~~~~~~--~~~~~~~~~  327 (332)
                                        .+..++.++++||.+||+.||++||++. ++++||||..+.+....  ...+++.|.
T Consensus       215 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~  271 (316)
T cd05619         215 ------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPK  271 (316)
T ss_pred             ------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence                              0112688899999999999999999996 99999999998866442  234444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.7e-47  Score=336.69  Aligned_cols=290  Identities=38%  Similarity=0.652  Sum_probs=221.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC--
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH--   89 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   89 (332)
                      +|++++.||+|+||+||++.+..+++.||||.+.........      ...+.+|+.+++.++|+||+.+++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS------CKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHH------HHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            588999999999999999999989999999988543211111      124678999999999999999999985443  


Q ss_pred             --CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 --DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                        ...|+|+||+++++...+.. ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          75 PFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             ccceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence              26899999999887776654 668999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            3221 222344678899999999876668999999999999999999999999988888887777766554432211100


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .  ............   ..............++++.+||.+||+.||++|||+.|+|+||||....
T Consensus       234 ~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         234 E--GARAHILRGPHK---PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             H--HHHHHHHhCCCC---CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            0  000000000000   0000000112234688999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.9e-47  Score=332.41  Aligned_cols=265  Identities=25%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             cccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      +|++++.||+|+||+||+++..   .+++.||+|++..........    ....+..|+.+++.+ .|++|+.+++.+ .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAK----TVEHTRTERNVLEHVRQSPFLVTLHYAF-Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhh----HHHHHHHHHHHHHhccCCCCcccEEEEE-e
Confidence            5899999999999999999864   478899999997543211111    111356789999999 589999999888 4


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .....++||||++|+.+.........+++..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++...
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            44789999999997554444444678999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..... ......|+..|+|||.+.+...++.++||||||+++|+|++|..||...........+.....           
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------  224 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-----------  224 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-----------
Confidence            32221 223456899999999998755678999999999999999999999964322111111111100           


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPL  314 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~  314 (332)
                                            ......++.++..+.+||.+||+.||++||     +++++++||||++..+
T Consensus       225 ----------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         225 ----------------------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ----------------------cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                  000111233788999999999999999999     8899999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.2e-47  Score=331.92  Aligned_cols=257  Identities=23%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||.||++.+..+++.||+|++...........     ..+..|..++..+ +||||+.+++.+. +....|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~-----~~~~~e~~il~~~~~hp~Iv~~~~~~~-~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDI-----DWVQTEKHVFETASNHPFLVGLHSCFQ-TESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-----HHHHHHHHHHHhccCCCCCCceEEEEE-cCCEEEEE
Confidence            468999999999999999999999999976432221111     1355788888888 7999999999884 44789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.......+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99998755444444467899999999999999999999999999999999999999999999999999875322223334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHcCCCCCCcccCCCC
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV--------DQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||......        +...+...               
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------  218 (329)
T cd05588         155 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL---------------  218 (329)
T ss_pred             cccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------------
Confidence            5678999999999987 67889999999999999999999999632111        01111100               


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT------VDDALNHYWFHEVPLPK  316 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~hp~f~~~~~~~  316 (332)
                                           ......+..++..+.+||.+||+.||.+|++      ++++++||||..+.+..
T Consensus       219 ---------------------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~  272 (329)
T cd05588         219 ---------------------EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL  272 (329)
T ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence                                 0111122347889999999999999999997      78999999999876543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-46  Score=335.20  Aligned_cols=266  Identities=24%  Similarity=0.323  Sum_probs=212.6

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++.+.||+|+||.||++.+..+++.+|+|++..........     ...+.+|+.+++.++||||+++++.+. 
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~i~~~~~hp~iv~~~~~~~-  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD-----SAFFWEERDIMAFANSPWVVQLFCAFQ-  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh-----HHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence            34579999999999999999999999999999999997533221111     113568999999999999999999984 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +....|+||||++|+.+..+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~-~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            5588999999998754444444 346899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCC-CCccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..... ......||+.|+|||++...   ..++.++|+||||+++|+|++|..||...+......++.......      
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------  266 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL------  266 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc------
Confidence            43221 23456799999999998753   237889999999999999999999999887766666655421110      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVP  313 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~  313 (332)
                                                 ..+....++..+++++.+||..++.+  |++++|+++||||+...
T Consensus       267 ---------------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         267 ---------------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             ---------------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence                                       01111237889999999999866544  89999999999999844

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-46  Score=329.58  Aligned_cols=271  Identities=27%  Similarity=0.432  Sum_probs=215.4

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC-CCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~   90 (332)
                      +|++.+.||+|+||+||+|.+..+++.||+|++...........     ..+..|..++..+.| ++|+.+++.+ ....
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV-----ECTMVEKRVLALQDKPPFLTQLHSCF-QTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-----HHHHHHHHHHHhccCCCchhheeeEE-ecCC
Confidence            47889999999999999999999999999999976432211111     134578888888854 6677787777 4447


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+.......+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            89999999987655555555678999999999999999999999999999999999999999999999999998754332


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......              
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--------------  219 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--------------  219 (323)
T ss_pred             CccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence            223344568999999999876 67899999999999999999999999988776666655442111              


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCC--CCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKSK--DFMPT  323 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~~--~~~~~  323 (332)
                                             .+..++.++.+|+.+||+.+|.+|++     .+++++||||..+.+....  ...++
T Consensus       220 -----------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~  276 (323)
T cd05615         220 -----------------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPP  276 (323)
T ss_pred             -----------------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcC
Confidence                                   11236888999999999999999997     5799999999998865442  23444


Q ss_pred             CCC
Q 035861          324 FPP  326 (332)
Q Consensus       324 ~~~  326 (332)
                      +.|
T Consensus       277 ~~~  279 (323)
T cd05615         277 FKP  279 (323)
T ss_pred             ccC
Confidence            444

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=327.29  Aligned_cols=262  Identities=35%  Similarity=0.539  Sum_probs=226.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      .-..|++.+.||.|.||.||+++.+.||+.+|+|++.+.........     ..+.+|+.+|+++. ||||+.+++.+ +
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~-----~~v~~Ev~il~~l~~hpniv~l~~~~-e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDR-----EDVRREVAILQQLSGHPNIVQLKDAF-E  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccH-----HHHHHHHHHHHhccCCCCEEEEEEEE-E
Confidence            34479999999999999999999999999999999988766443311     24679999999998 99999999999 5


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC----CcEEEeecc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ----GVLKICDFG  162 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~----~~~~l~df~  162 (332)
                      +...+++|||+|.| .+.+.+...  .+++..+..++.|++.+++|||+.|++|+||||+|+|+...    +.++++|||
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            55789999999996 566666654  49999999999999999999999999999999999999643    479999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++..... .......+||+.|+|||++.. ..++...|+||+|+++|.|++|..||.+.+.......+......      
T Consensus       185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~------  256 (382)
T KOG0032|consen  185 LAKFIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD------  256 (382)
T ss_pred             CceEccC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC------
Confidence            9998765 556778899999999999986 68999999999999999999999999999988888877665332      


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                 +..+.++.++..+++||+.||..||..|+++.++|+|||+....
T Consensus       257 ---------------------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  257 ---------------------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             ---------------------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                                       23334555899999999999999999999999999999998864

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.1e-47  Score=337.03  Aligned_cols=269  Identities=27%  Similarity=0.393  Sum_probs=215.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||+||++.+..+++.||+|++.........     ....+..|+.++..++|++|+++++.+ .+..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-----QVAHIRAERDILVEADGAWVVKMFYSF-QDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhh-----hHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCC
Confidence            4799999999999999999999999999999999754321111     112456799999999999999999988 4558


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..|+||||++|+.+.......+.+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            89999999997655555555678999999999999999999999999999999999999999999999999988643211


Q ss_pred             C-----------------------------------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Q 035861          171 L-----------------------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK  215 (332)
Q Consensus       171 ~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~  215 (332)
                      .                                   .......||+.|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCC
Confidence            0                                   00113468999999999987 67899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          216 PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                      .||...+.......+......                                 ...+....++.++++||.+|+. ||.
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~li~~l~~-~p~  279 (360)
T cd05627         234 PPFCSETPQETYRKVMNWKET---------------------------------LVFPPEVPISEKAKDLILRFCT-DSE  279 (360)
T ss_pred             CCCCCCCHHHHHHHHHcCCCc---------------------------------eecCCCCCCCHHHHHHHHHhcc-Chh
Confidence            999888777666655432100                                 0011112268899999999875 999


Q ss_pred             CCC---CHHHHhcCCCCCCCCCCCCCCC
Q 035861          296 KRI---TVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       296 ~Rp---s~~ell~hp~f~~~~~~~~~~~  320 (332)
                      +|+   +++++++||||.+++|......
T Consensus       280 ~R~~~~~~~ei~~hp~f~~~~~~~~~~~  307 (360)
T cd05627         280 NRIGSNGVEEIKSHPFFEGVDWGHIRER  307 (360)
T ss_pred             hcCCCCCHHHHhcCCCCCCCCHHHHhcC
Confidence            998   4899999999999887665443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.6e-46  Score=327.19  Aligned_cols=296  Identities=24%  Similarity=0.367  Sum_probs=216.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|++|.||++++..++..+|+|++.......       ....+.+|++++++++||||+++++.+..+ 
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   75 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVGFYGAFYSD-   75 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHH-------HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-
Confidence            468999999999999999999999999999999987542111       112467899999999999999999998554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++|+.+..+......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            78999999999866665555567899999999999999999999986 69999999999999999999999999987653


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..  ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....+..................
T Consensus       156 ~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         156 DS--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             cc--ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence            32  2234568899999999987 66899999999999999999999999876654432221111000000000001000


Q ss_pred             ccc------cccccCCc----hhhhhhhCC-CCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          249 PGA------KANFAKQP----YNLLRKRFP-AASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       249 ~~~------~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      ...      ........    ......... .........+++++++||.+||+.||++||++++|++||||+......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~  311 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEE  311 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccccc
Confidence            000      00000000    000000000 111112234788999999999999999999999999999999876543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.7e-46  Score=321.06  Aligned_cols=293  Identities=45%  Similarity=0.835  Sum_probs=230.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++++.||.|++|.||+|.+..+++.|++|.+..........   .....+..|+..+++++|+||+++++++.+ ...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD---GINFTALREIKLLQELKHPNIIGLLDVFGH-KSN   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccc---hhhHHHHHHHHHHhhcCCCCChhhhheeec-CCE
Confidence            4889999999999999999999899999999997654331111   112245679999999999999999999955 578


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++||||+.|++...+......+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          77 INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             EEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            99999999777766665533479999999999999999999999999999999999999999999999999998765443


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......++..|+|||.+.+...++.++|+||||+++|++++|..||......+...++....+.+....++........
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence            33444456788999999876567899999999999999999998888888877777777766665555554443333221


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ..........         ........+..+.+||.+||++||++||++.|+++||||.+...+..
T Consensus       237 ~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         237 VEFKPFPPTP---------LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             ccccccCCcc---------hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence            1111111100         01112346788999999999999999999999999999999887764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-46  Score=343.10  Aligned_cols=290  Identities=24%  Similarity=0.354  Sum_probs=214.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC------CCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD------HPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~   83 (332)
                      .++|++++.||+|+||+||+|.+..+++.||||++.......         .....|+.++..+.      |.+++.+++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~---------~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT---------RDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhH---------HHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            368999999999999999999999999999999996422111         02234666665554      445888888


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCC--------
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQG--------  154 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~--------  154 (332)
                      ++..+...+|+||+++++++++.+.. .+.+++..+..++.||+.||+|||+ .||+|+||||+|||++.++        
T Consensus       199 ~~~~~~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        199 YFQNETGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             EEEcCCceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            88666678999999998888887765 5789999999999999999999997 5999999999999998765        


Q ss_pred             --------cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 035861          155 --------VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ  226 (332)
Q Consensus       155 --------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~  226 (332)
                              .+||+|||.+....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                    49999999876432   22345678999999999987 6789999999999999999999999998888877


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCcc-----ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPG-----AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD  301 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  301 (332)
                      ...+....+..+..+...+.....     ............................++.+.+||.+||++||.+|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            777777766665443321110000     000000000000000000000000111356788999999999999999999


Q ss_pred             HHhcCCCCCCCC
Q 035861          302 DALNHYWFHEVP  313 (332)
Q Consensus       302 ell~hp~f~~~~  313 (332)
                      |+|+||||.+..
T Consensus       434 e~L~Hp~~~~~~  445 (467)
T PTZ00284        434 QMTTHPYVLKYY  445 (467)
T ss_pred             HHhcCccccccC
Confidence            999999999854

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-47  Score=333.08  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=204.3

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeeeeeEEcCCCeEEEE
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      ||+|+||+||+|++..+++.||+|++...........     .....|..++..+   .||+|+.++..+.. ....|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~-----~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV-----AHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHH-----HHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEE
Confidence            7999999999999999999999999975432211111     1233566666554   69999999998844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.......+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             EcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99998765544444577899999999999999999999999999999999999999999999999999875433333344


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|+..|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+.......+                 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------  217 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-----------------  217 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-----------------
Confidence            567899999999997655689999999999999999999999988776665555433211110                 


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC----CHHHHhcCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI----TVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~ell~hp~f~~~~~~~  316 (332)
                                         ...++.++.+||.+||+.||.+||    +++++++||||.+..+..
T Consensus       218 -------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~  263 (330)
T cd05586         218 -------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL  263 (330)
T ss_pred             -------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence                               112688999999999999999998    799999999999876443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-45  Score=319.02  Aligned_cols=290  Identities=45%  Similarity=0.843  Sum_probs=229.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++.+.||.|++|+||+|.+..+++.||+|.+........      ....+.+|+..+++++|+|++++++.+.. .
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG------VPSTAIREISLLKEMQHGNIVRLQDVVHS-E   73 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc------chHHHHHHHHHHHhccCCCEeeEEEEEec-C
Confidence            4689999999999999999999998999999999865432111      11245689999999999999999999954 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~df~~~~~~  167 (332)
                      ...++||||+++++...+..... .+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        74 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         74 KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            78999999999988777765433 3688899999999999999999999999999999999985 457999999999765


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.+...++.++|+||+|+++|+++||..||......+...++....+.+....+.+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            43333334446688899999987756789999999999999999999999998888888888877777776666655444


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ++.........        .........+.+++++.++|.+||+.+|++||+++++++||||.++..
T Consensus       234 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDYKSAFPKW--------PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhhhhhcccC--------CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            33321111100        001111123447889999999999999999999999999999998653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=318.49  Aligned_cols=285  Identities=41%  Similarity=0.785  Sum_probs=221.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++.+.||.|++|.||+|++..+++.|++|.+........       ...+.+|+.+++.++|+||+++++++. +
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   74 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIH-T   74 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEe-c
Confidence            45789999999999999999999998999999999875432211       113468999999999999999999985 4


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....++||||+++++.+.+......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            47899999999998888777666788999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT-EVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ..........++..|+|||.+.+...++.++|+||+|+++|+|++|..||.... ..+....+.+....+....++....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            332333334567889999998765668899999999999999999999997765 4455555666555555555444432


Q ss_pred             CccccccccC-CchhhhhhhCCCCccCCCCCCC--chHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          248 LPGAKANFAK-QPYNLLRKRFPAASFTGSPVLS--ESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       248 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .......... .........        .+.++  ..+.+++.+||+.+|++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINH--------APRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHh--------CcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            2211111100 000001111        11233  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9e-46  Score=318.77  Aligned_cols=282  Identities=46%  Similarity=0.893  Sum_probs=225.7

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|+||+|++..++..||||++........       ...+.+|+.++++++|+|++++++.+... ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   72 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-------PSTAIREISLMKELKHENIVRLHDVIHTE-NK   72 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-------hHHHHHHHHHHHhhcCCCEeeeeeeEeeC-Cc
Confidence            58999999999999999999999999999999976432211       12456899999999999999999999555 77


Q ss_pred             EEEEcccccccHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++|+||+++++.+.+....  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        73 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          73 LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            89999999998877766543  5689999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+...++.++|+||||+++|++++|..||...+..+...++......+....+..+...+
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            33333445567889999998775667899999999999999999999999888888778777776666555554444332


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ................        ..+.++..++++|.+||+.||.+||+++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQ--------LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHH--------HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            2221111111111111        112368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-46  Score=329.75  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||++.+..+++.+|+|++...........     ..+..|+.++.++ +||||+.+++.+.. ....++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDI-----DWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHH-----HHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEE
Confidence            469999999999999999999999999986533221111     1345788887766 89999999998844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.......+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99999765555555567899999999999999999999999999999999999999999999999999875433333334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-----DQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||......     .....+...                 
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----------------  216 (329)
T cd05618         155 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-----------------  216 (329)
T ss_pred             cccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-----------------
Confidence            5678999999999987 67889999999999999999999999531100     000000000                 


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT------VDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~hp~f~~~~~~  315 (332)
                                      ........+..++..+.+||.+||+.||++||+      +.++++||||.++.+.
T Consensus       217 ----------------i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         217 ----------------ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             ----------------HhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                            000011122347888999999999999999998      5899999999988753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-46  Score=329.80  Aligned_cols=288  Identities=34%  Similarity=0.573  Sum_probs=221.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||.|+||+||+|.+..+++.||||++.........      ...+.+|+.++++++|+||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH------ARRTYRELRLLKHMKHENVIGLLDVFTPA   86 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHH------HHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence            456899999999999999999999999999999998653221111      11356899999999999999999887432


Q ss_pred             -----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 -----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 -----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                           ....|++++++++++...+.  ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          87 TSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccccccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence                 13478999999887765543  45799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +......   .....++..|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+....+.+......
T Consensus       165 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         165 ARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             ceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8865432   2345688999999999875678999999999999999999999999888777777776655544433222


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      .+......          .....++...    .......++.+.+||.+||..||.+|||+.|+|+||||..+..+..
T Consensus       242 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~  309 (343)
T cd07878         242 KISSEHAR----------KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED  309 (343)
T ss_pred             hcchhhHH----------HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence            11110000          0000000000    0011235677899999999999999999999999999999776553

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.4e-46  Score=332.25  Aligned_cols=280  Identities=24%  Similarity=0.317  Sum_probs=218.6

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ....++|++.+.||+|+||.||++.+..+++.+|+|++..........     ...+.+|+.+++.++||||+++++.+.
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~-----~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHH-----HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            344579999999999999999999999999999999987533211111     113568899999999999999999984


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       +....++||||++|+.+..+.. ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++..
T Consensus       114 -~~~~~~lv~Ey~~gg~L~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         114 -DDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             -cCCEEEEEEcCCCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence             4588999999998765554444 34689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC-CCCccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          167 YGSPL-KPYTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ..... .......||+.|+|||++...   ..++.++|+||||+++|+|++|..||...+.......+.......     
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----  266 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-----  266 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc-----
Confidence            54322 223456789999999998753   237889999999999999999999999888776666665421110     


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCC--CCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVP--LPKSK  318 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~--~~~~~  318 (332)
                                                  .......++..+++||.+||..++.+  |++++++++||||++..  +...+
T Consensus       267 ----------------------------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~  318 (371)
T cd05622         267 ----------------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLR  318 (371)
T ss_pred             ----------------------------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChhHHhcC
Confidence                                        01112347899999999999854443  78999999999998844  33444


Q ss_pred             CCCCCCCC
Q 035861          319 DFMPTFPP  326 (332)
Q Consensus       319 ~~~~~~~~  326 (332)
                      ...++..|
T Consensus       319 ~~~~~~~~  326 (371)
T cd05622         319 DTVAPVVP  326 (371)
T ss_pred             CCCCCCCC
Confidence            44444433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-45  Score=318.20  Aligned_cols=287  Identities=37%  Similarity=0.683  Sum_probs=221.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|.+.+.||+|++|.||+|.+..++..|++|++........       ...+.+|+..++.++|+||+.+.+++.. .
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~   75 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-------PFTAIREASLLKGLKHANIVLLHDIIHT-K   75 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-------cHHHHHHHHHHHhcCCCCEeEEEEEEec-C
Confidence            4689999999999999999999999999999999865432211       1135689999999999999999999854 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|+||+.++++..+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            78999999999998887776667789999999999999999999999999999999999999999999999998876543


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-VDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .........++..|+|||.+.+...++.++|+||||+++|++++|..||..... .+...++....+.+....++.+...
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            333334455788999999987655678899999999999999999999976543 3444555555555555555544443


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      +....................     .-..+..+.+++.+|+..||.+|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWK-----RLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchhhhcc-----ccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            332222111110000000000     00136788899999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-46  Score=320.97  Aligned_cols=267  Identities=22%  Similarity=0.374  Sum_probs=213.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|++.+.||+|+||+||++.+..+++.||+|++..........     ...+.+|+.+++.++|+||+++++.+.. ...
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-----EAMALNEKQILEKVNSRFVVSLAYAYET-KDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhh-----HHHHHHHHHHHHhcCCCCEeeeeeeecC-CCe
Confidence            4889999999999999999999899999999997543222111     1235679999999999999999998844 478


Q ss_pred             EEEEcccccccHH-HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLK-WLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~-~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++||||++|+.+ +.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999986544 444332 35699999999999999999999999999999999999999999999999999876532


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      . .......|+..|+|||++.+ ..++.++|+||+|+++|++++|..||...+.......+........           
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (285)
T cd05605         155 G-ETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-----------  221 (285)
T ss_pred             C-CccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-----------
Confidence            2 22234568899999999976 6788999999999999999999999987655443333322211000           


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~~  319 (332)
                                            ......++..+.+||.+||+.||++||     +++++++||||....+.....
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         222 ----------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             ----------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence                                  011223788999999999999999999     999999999999988776654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.8e-46  Score=324.53  Aligned_cols=284  Identities=38%  Similarity=0.714  Sum_probs=208.0

Q ss_pred             cccccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc-CCCeE
Q 035861           16 LNKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD-DHDSV   92 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   92 (332)
                      ..+||+|+||+||+|++.  .+++.+|+|.+......          ..+.+|+.++++++||||+++++.+.. .....
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   75 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKVFLSHADRKV   75 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence            568999999999999965  46789999988643211          135689999999999999999998854 34568


Q ss_pred             EEEcccccccHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE----cCCCcEEEee
Q 035861           93 YMVMEYMEHDLKWLMESM--------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICD  160 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~--------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili----~~~~~~~l~d  160 (332)
                      ++++|++++++.+.+...        ...+++..++.++.||+.||+|||+.||+|+||||+||++    +.++.+||+|
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          76 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            999999999887765432        1358999999999999999999999999999999999999    4557899999


Q ss_pred             cccccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 035861          161 FGMSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---------VDQID  228 (332)
Q Consensus       161 f~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---------~~~~~  228 (332)
                      ||++........   ......+++.|+|||++.+...++.++|+||+|+++|+|++|..||.....         .....
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  235 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence            999987643322   223457789999999998756789999999999999999999999965432         24455


Q ss_pred             HHHHHcCCCCCCcccCCCCCccccccccCCchhhh-hhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLL-RKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY  307 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  307 (332)
                      .+....+.+....+..+...+.............. ...............+..+.+||.+||+.||.+|||++|+|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            56666665555544443322211100000000000 00000000011122466789999999999999999999999999


Q ss_pred             CC
Q 035861          308 WF  309 (332)
Q Consensus       308 ~f  309 (332)
                      ||
T Consensus       316 ~f  317 (317)
T cd07868         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-46  Score=329.95  Aligned_cols=256  Identities=23%  Similarity=0.405  Sum_probs=206.3

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHH-HHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN-ILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||++++..+++.+|+|++...........     ..+..|.. +++.++||||+++++.+.. ....|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-----KHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-----HHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEE
Confidence            468999999999999999999999999976432211111     12344444 4677899999999998844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          75 LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99999865555555577899999999999999999999999999999999999999999999999999875433333344


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+....                     
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---------------------  212 (325)
T cd05604         155 TFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---------------------  212 (325)
T ss_pred             cccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            5678999999999987 668899999999999999999999998877666655554321                     


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV----DDALNHYWFHEVPLPK  316 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~hp~f~~~~~~~  316 (332)
                                      ....+.++..+.++|.+||+.+|.+||++    .++++||||....+..
T Consensus       213 ----------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~  261 (325)
T cd05604         213 ----------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD  261 (325)
T ss_pred             ----------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHH
Confidence                            01122368889999999999999999976    5999999999876544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.7e-46  Score=326.45  Aligned_cols=270  Identities=24%  Similarity=0.414  Sum_probs=210.5

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|+...+++.||+|++...........     ..+..|+.++.++ .|++|+.+++.+ .+....|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDI-----DWVQTEKHVFEQASSNPFLVGLHSCF-QTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-----HHHHHHHHHHHhhcCCCCEeeEEEEE-EeCCEEEEE
Confidence            469999999999999999999999999986533221111     1356788888887 699999999988 444789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.......+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99998765555555567899999999999999999999999999999999999999999999999999875433333334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE------VDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....      .+...+....                
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  217 (327)
T cd05617         155 TFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----------------  217 (327)
T ss_pred             cccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh----------------
Confidence            5678999999999976 6789999999999999999999999964211      1111111111                


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCCCCCCC--CCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT------VDDALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~hp~f~~~~~~~~--~~~~  321 (332)
                                          .....+..++..+.++|.+||+.||.+|++      ++++++||||..+.+...  ....
T Consensus       218 --------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~  277 (327)
T cd05617         218 --------------------KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVT  277 (327)
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCC
Confidence                                011112337888999999999999999997      579999999999886654  2344


Q ss_pred             CCCCCccc
Q 035861          322 PTFPPQHA  329 (332)
Q Consensus       322 ~~~~~~~~  329 (332)
                      ++++|..+
T Consensus       278 ~~~~~~~~  285 (327)
T cd05617         278 PPFKPQIT  285 (327)
T ss_pred             CCccCCCC
Confidence            45556543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-47  Score=318.27  Aligned_cols=255  Identities=31%  Similarity=0.529  Sum_probs=222.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|++.+.||.|.+|.|-++.....|+.||||.+++.....+....     .|.+|+++|..|+||||+.++++| ++.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlv-----hIRREIeIMSsLNHPhII~IyEVF-ENk  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLV-----HIRREIEIMSSLNHPHIIQIYEVF-ENK  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHH-----HHHHHHHHHhhcCCCceeehhhhh-cCC
Confidence            35899999999999999999999999999999999887765544433     578999999999999999999999 776


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....|||||..| .|.+.+.. .+.+++.++..+++||..|+.|+|+++++|+|||.+|||+|.++++||.|||++..+.
T Consensus       126 dKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            889999999986 56665555 7889999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      . ..-..+.||++.|.+||.+.+..+-.+..|.||||+++|.+..|..||++.+......+|.++....++         
T Consensus       205 ~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---------  274 (668)
T KOG0611|consen  205 D-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---------  274 (668)
T ss_pred             c-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---------
Confidence            3 344568899999999999998666788999999999999999999999999888887777665322222         


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                                   .+..+.-||++||.++|++|.++++|..|=|.+
T Consensus       275 -----------------------------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  275 -----------------------------TPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -----------------------------CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                         467778999999999999999999999996543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-46  Score=329.34  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             cccccccCcEEEEEEEE---CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           16 LNKISEGTYGIVYRARD---KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~---~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      ++.||+|+||+||++++   ..+++.+|+|++.........      ...+..|++++++++||||+++++.+.. ....
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~   73 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD------RVRTKMERDILAEVNHPFIVKLHYAFQT-EGKL   73 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhh------HHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEE
Confidence            36799999999999986   357899999999764322111      1134579999999999999999999854 4789


Q ss_pred             EEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC
Q 035861           93 YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK  172 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~  172 (332)
                      |+||||++|+.+.........+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          74 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            99999998654444444467799999999999999999999999999999999999999999999999999876543323


Q ss_pred             CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccc
Q 035861          173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK  252 (332)
Q Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (332)
                      ......|+..|+|||.+.. ..++.++|+||||+++|+|++|..||...+.......+.....                 
T Consensus       154 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-----------------  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-----------------  215 (318)
T ss_pred             ceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            3344578999999999876 6678999999999999999999999988776666555543211                 


Q ss_pred             ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 035861          253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLP  315 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~  315 (332)
                                          ..+..+++.+.+||++||+.||++||+     ++++++||||..+.+.
T Consensus       216 --------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         216 --------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence                                111237889999999999999999999     7889999999987644

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.9e-46  Score=328.89  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=206.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+.+|+.++.||.|+||+||++++..+++.||||++.......       ....+.+|+.+++.++|+||+++++++ ..
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~  143 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-------VRRQICREIEILRDVNHPNVVKCHDMF-DH  143 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH-------HHHHHHHHHHHHHhCCCCCcceeeeEe-cc
Confidence            4678999999999999999999999999999999986432111       112467899999999999999999998 45


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....++||||+.++.+..    ....++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       144 ~~~~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        144 NGEIQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             CCeEEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            578999999999865432    2346788889999999999999999999999999999999999999999999988664


Q ss_pred             CCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..........|+..|+|||.+..    ....+.++||||||+++|+|++|..||......+....+.....         
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---------  290 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM---------  290 (353)
T ss_pred             cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc---------
Confidence            43333445678999999998743    23456789999999999999999999974332221111111100         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                              .........++.++++||.+||+.||++||++.|+|+||||.+-...
T Consensus       291 ------------------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        291 ------------------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             ------------------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence                                    00011123378899999999999999999999999999999996433

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-46  Score=327.45  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=204.9

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHH-HHHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI-NILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||+|++..+++.||+|++...........     ..+..|. .+++.++||||+++++.+ .+....|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~~~l~~~~h~~iv~~~~~~-~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ-----NHIMAERNVLLKNLKHPFLVGLHYSF-QTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHH-----HHHHHHHHHHHHhCCCCCccceeeEE-EcCCEEEEE
Confidence            469999999999999999999999999975432111111     1233444 457788999999999888 444789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          75 LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99999765554445567899999999999999999999999999999999999999999999999999875433223334


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....                     
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------------------  212 (321)
T cd05603         155 TFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------------------  212 (321)
T ss_pred             cccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------------------
Confidence            5578999999999876 668899999999999999999999998877665555543221                     


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV----DDALNHYWFHEVPLPK  316 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~hp~f~~~~~~~  316 (332)
                                      ...++..+..+.++|.+||+.||.+|+++    .++++|+||..+.+..
T Consensus       213 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
T cd05603         213 ----------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD  261 (321)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHH
Confidence                            11122367889999999999999999975    5999999999877644

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-46  Score=325.59  Aligned_cols=279  Identities=24%  Similarity=0.355  Sum_probs=216.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||+||++++..+++.||+|++.........     ....+.+|..++..++|+||+.+++.+. +..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRA-----ETACFREERDVLVNGDRRWITNLHYAFQ-DEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh-----hHHHHHHHHHHHHhCCCCCCCceEEEEe-cCC
Confidence            4799999999999999999999999999999999753221111     1123567889999999999999999984 448


Q ss_pred             eEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..|+||||++| ++.+.+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            89999999976 45555554466799999999999999999999999999999999999999999999999999876533


Q ss_pred             CCC-CCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          170 PLK-PYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ... ......|++.|+|||++..    ...++.++|+||||+++|+|++|..||...+..+....+........      
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------  228 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ------  228 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc------
Confidence            222 1223468999999999863    24578899999999999999999999988776666555543211000      


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVPLPKSKDFMP  322 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~~~~~~~~~~  322 (332)
                                                .....+.++..+++||++||..++.+  |++++++++||||....+.......+
T Consensus       229 --------------------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~  282 (331)
T cd05597         229 --------------------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTA  282 (331)
T ss_pred             --------------------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhCCC
Confidence                                      00011237889999999998764444  78999999999999987655554444


Q ss_pred             CCCCc
Q 035861          323 TFPPQ  327 (332)
Q Consensus       323 ~~~~~  327 (332)
                      .+.|.
T Consensus       283 ~~~~~  287 (331)
T cd05597         283 PYVPE  287 (331)
T ss_pred             CccCc
Confidence            44443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.1e-47  Score=307.82  Aligned_cols=296  Identities=44%  Similarity=0.834  Sum_probs=242.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCc----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .+..|+.++.||+|.+|.||+|..+.++.    .+|||.+.....      ...++.+.-+|+.+++.+.|+|++.+..+
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------~tGiS~SAcREiaL~REl~h~nvi~Lv~V   95 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------GTGISMSACREIALLRELKHPNVISLVKV   95 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------CCCcCHHHHHHHHHHHHhcCCcchhHHHH
Confidence            45689999999999999999997654433    689998865432      22344466799999999999999999999


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC----CcE
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMESM----KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ----GVL  156 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~----~~~  156 (332)
                      +.+.+...++++||++.++...+.-.    ...++...++.+++||+.|++|||++-++||||||.||+|..+    |.|
T Consensus        96 fl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen   96 FLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             HhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence            98877999999999999998877542    2468999999999999999999999999999999999999988    899


Q ss_pred             EEeecccccccCCCCCCC---ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChH
Q 035861          157 KICDFGMSRQYGSPLKPY---TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT---------TEV  224 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~---------~~~  224 (332)
                      ||+|+|+++.+..+..+.   .....|.+|+|||.+.+...|+.+.|+|+.||++.||+|..+.|...         -..
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            999999999886654433   45567999999999999999999999999999999999999998642         345


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchh---h--hhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYN---L--LRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT  299 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  299 (332)
                      +...+|+..++.|.+..||++.+.+............   .  +....     .....-++...+|+.+||..||.+|.+
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~-----~~~k~k~~~a~~LL~klL~yDP~kRIt  330 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYY-----HKHKVKDPSALDLLQKLLTYDPIKRIT  330 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHH-----HHhcCCCchHHHHHHHHhccCchhhcc
Confidence            7789999999999999999999888753332222111   0  11111     111223566889999999999999999


Q ss_pred             HHHHhcCCCCCCCCCC
Q 035861          300 VDDALNHYWFHEVPLP  315 (332)
Q Consensus       300 ~~ell~hp~f~~~~~~  315 (332)
                      ++++|+|+||..-+.|
T Consensus       331 a~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  331 AEQALEHPYFTEDPLP  346 (438)
T ss_pred             HHHHhcccccccCCCC
Confidence            9999999999998665

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.1e-45  Score=319.45  Aligned_cols=290  Identities=48%  Similarity=0.926  Sum_probs=229.1

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .|+...++|++.+.||.|++|.||+|.+..+++.+++|.+.........      .....+|++.++.++|+||+++++.
T Consensus         2 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~   75 (311)
T cd07866           2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF------PITALREIKILKKLKHPNVVPLIDM   75 (311)
T ss_pred             CCCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc------chhHHHHHHHHHhcCCCCccchhhh
Confidence            5788899999999999999999999999999999999998754322211      1134689999999999999999998


Q ss_pred             EEcCC-------CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           85 VMDDH-------DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        85 ~~~~~-------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      +.+..       ...++|+||+++++...+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++
T Consensus        76 ~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~  155 (311)
T cd07866          76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK  155 (311)
T ss_pred             eecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            75433       34799999999988887776667899999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCC-----------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 035861          158 ICDFGMSRQYGSPLK-----------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ  226 (332)
Q Consensus       158 l~df~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~  226 (332)
                      |+|||.+........           ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+....
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~  235 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ  235 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999876532211           112234577899999987656689999999999999999999999998888888


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCccccc--cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPGAKA--NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      ...+......+....++.+...+....  ........ ...        ....+++.+.+||.+||+.||.+||++.+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-LEE--------RFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             HHHHHHHhCCCChhhchhhhhcccccccccCCCCCcc-HHH--------HcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            887777766665555544433332211  00000000 010        1123567889999999999999999999999


Q ss_pred             cCCCC
Q 035861          305 NHYWF  309 (332)
Q Consensus       305 ~hp~f  309 (332)
                      .||||
T Consensus       307 ~~~~f  311 (311)
T cd07866         307 EHPYF  311 (311)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-46  Score=327.24  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=206.7

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHH-HHHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI-NILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||+|+||+||++++..+++.||+|++...........     ..+..|. .+++.++|+||+.+++.+.. ....|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE-----KHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHH-----HHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEE
Confidence            469999999999999999999999999975432111110     1233343 34677899999999998844 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      |||++|+.+.........+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          75 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999866555555577899999999999999999999999999999999999999999999999999875433333344


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.....                    
T Consensus       155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--------------------  213 (325)
T cd05602         155 TFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------------------  213 (325)
T ss_pred             cccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--------------------
Confidence            5678999999999987 6789999999999999999999999998877666655543210                    


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH----HHhcCCCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD----DALNHYWFHEVPLPKS  317 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----ell~hp~f~~~~~~~~  317 (332)
                                       ...+.++..+.++|.+||+.||.+|+++.    ++++|+||..+.|.+.
T Consensus       214 -----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~  262 (325)
T cd05602         214 -----------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL  262 (325)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHH
Confidence                             11234788999999999999999999866    8999999988765443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-45  Score=315.75  Aligned_cols=282  Identities=48%  Similarity=0.925  Sum_probs=224.1

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      |++.+.||.|++|+||+|.++.+|..||+|++........      ....+.+|+..++.++|+|++++++.+.+ ....
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG------VPSTAIREISLLKELNHPNIVRLLDVVHS-ENKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc------chhHHHHHHHHHHhcCCCCccCHhheecc-CCeE
Confidence            6889999999999999999999999999999875432211      11245689999999999999999999854 4889


Q ss_pred             EEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           93 YMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      ++++||+++++.+.+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        74 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          74 YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            9999999888777665533 368999999999999999999999999999999999999999999999999987654433


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+......++.+....+....++.+...+..
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            33344456788999998876556789999999999999999999999988887777777776666655554444333322


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..........        ......+.++..+.++|.+||+.||++||+++|+++||||
T Consensus       234 ~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQ--------DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhccccccc--------chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            2111111111        1112234478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-45  Score=315.26  Aligned_cols=284  Identities=44%  Similarity=0.790  Sum_probs=226.0

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||+|.+..++..+++|++........      ....+.+|+..+++++|+|++++++.+.. ...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   73 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG------IPNQALREIKALQACQHPYVVKLLDVFPH-GSG   73 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch------hhHHHHHHHHHHHhCCCCCCcceeeEEec-CCe
Confidence            58999999999999999999998999999999876543221      11256789999999999999999999855 478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++|+|++++++.+.+......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        74 ~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          74 FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             eEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99999999667777776666789999999999999999999999999999999999999999999999999987664332


Q ss_pred             -CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          172 -KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       .......++..|+|||.+.+...++.++|+||||+++|++++|..||...........+......+....++.+..+..
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             1233456888999999987756679999999999999999999999988888777777777766665555554433222


Q ss_pred             ccc-cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          251 AKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       251 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                      ... ...........        ...+.++..+.+||.+||+.+|++||+++++|+||||.
T Consensus       234 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLE--------EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHH--------HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            100 00000000000        11234678999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.1e-45  Score=313.46  Aligned_cols=286  Identities=35%  Similarity=0.616  Sum_probs=217.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++........      ....+.+|+.++++++|+|++++++.+.. ..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV------IKKIALREIRMLKQLKHPNLVNLIEVFRR-KR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc------ccHHHHHHHHHHHhCCCCCEeeeeeEEee-CC
Confidence            479999999999999999999998999999999865432111      11235689999999999999999999854 47


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+||+++++++.+......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          74 KLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             EEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            88999999999988888776778999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+..............+..-. 
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ-  232 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc-
Confidence            3333445678889999998765668899999999999999999999998877666555554433222111000000000 


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..... ..+.  ..  .........+.++..+.+||.+||+.+|++||++.|++.||||
T Consensus       233 ~~~~~-~~~~--~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         233 FFKGL-SIPE--PE--TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccc-cCCC--cc--cccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000 0000  00  0000000113368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-46  Score=322.66  Aligned_cols=246  Identities=24%  Similarity=0.406  Sum_probs=209.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..+..++.||+|-||.||.|.++. ...||+|.+.......+         ++.+|+.+|++|+|++|+++++++..+ .
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~---------~f~~Ea~iMk~L~H~~lV~l~gV~~~~-~  274 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPE---------AFLREAQIMKKLRHEKLVKLYGVCTKQ-E  274 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChh---------HHHHHHHHHHhCcccCeEEEEEEEecC-C
Confidence            367889999999999999999984 33699999987543322         567999999999999999999999544 5


Q ss_pred             eEEEEccccc-ccHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           91 SVYMVMEYME-HDLKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        91 ~~~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      .+||||||++ |+|++.+.. ....+.....+.++.|||+|++||+++++|||||-..||||+.+..+||+|||+++...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            7999999998 677777776 45679999999999999999999999999999999999999999999999999999543


Q ss_pred             CC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      +. ........-++-|.|||++.. ..++.+|||||||++|||++| |+.||...+..+....+.++             
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-------------  420 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-------------  420 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-------------
Confidence            22 222333445677999999988 679999999999999999999 99999999998888887664             


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                                             .+.+.+..+++++.+++..||+.+|++|||++.+.
T Consensus       421 -----------------------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 -----------------------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -----------------------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                                   34445556899999999999999999999998664

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.7e-45  Score=314.51  Aligned_cols=261  Identities=25%  Similarity=0.359  Sum_probs=203.6

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||+|+||+||++....+++.||+|.+..........     ...+..|++++++++||||+++.+.+. +....++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~-----~~~~~~E~~il~~l~hp~i~~~~~~~~-~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG-----EKMALLEKEILEKVNSPFIVNLAYAFE-SKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchh-----hHHHHHHHHHHHhcCCCcEEEEEEEEe-cCCeEEEEEec
Confidence            799999999999999999999999997543221111     113456999999999999999999884 45789999999


Q ss_pred             ccccHH-HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcc
Q 035861           99 MEHDLK-WLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS  176 (332)
Q Consensus        99 ~~~~l~-~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~  176 (332)
                      ++|+.+ +.+... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~  153 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQ  153 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeec
Confidence            987544 444332 345899999999999999999999999999999999999999999999999998765432 22234


Q ss_pred             ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ..++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+.....                     
T Consensus       154 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------------------  211 (277)
T cd05607         154 RAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL---------------------  211 (277)
T ss_pred             cCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh---------------------
Confidence            568889999999987 5589999999999999999999999976543222222211100                     


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCCCCC
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV----DDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~hp~f~~~~~~~~~~  319 (332)
                                 ..........++.++++||.+||+.||++||++    +++++||||+.++++....
T Consensus       212 -----------~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~  267 (277)
T cd05607         212 -----------EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA  267 (277)
T ss_pred             -----------ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence                       000001112378899999999999999999999    7788999999998877764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.7e-45  Score=308.06  Aligned_cols=255  Identities=25%  Similarity=0.440  Sum_probs=208.7

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++++.||.|++|.||++++..+++.+++|.+.........      ...+..|+..+++++|+|++++++.+...+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE------RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHH------HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            589999999999999999999988999999998754332211      11356899999999999999999987555567


Q ss_pred             EEEEccccccc-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHD-LKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++++|+++++ +.+.+... ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            89999999864 54445442 34689999999999999999999999999999999999999999999999999877644


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+......             
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------------  220 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-------------  220 (257)
T ss_pred             cCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------------
Confidence            3333445567889999999877 67889999999999999999999999876655444443322110             


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                             ..+..+++.+.+|+.+||+.+|++||++.++++||||
T Consensus       221 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         221 -----------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -----------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                   1112378899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-45  Score=327.14  Aligned_cols=281  Identities=25%  Similarity=0.382  Sum_probs=207.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|++++.||+|+||.||+|++..+++.||+|+....              ....|+.++++++|+||+++++.+... .
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~~-~  130 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVSG-A  130 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEeC-C
Confidence            4799999999999999999999999999999974321              234799999999999999999998555 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+|++.+++.+.+......+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus       131 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             eeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            78999999999998888877788999999999999999999999999999999999999999999999999998753221


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-Ch---------HHHHHHHHHHcCCCCCC
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TE---------VDQIDKIFKTLGTPTET  240 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~---------~~~~~~~~~~~~~~~~~  240 (332)
                       .......|+..|+|||++.+ ..++.++|+||||+++|+|+++..|+... ..         ......+....+..+..
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             -cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence             22234568999999999877 67899999999999999999865554322 11         11222333333322222


Q ss_pred             cccCCC-CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          241 IWPGLS-ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      ...... ............    .+.............++..+.+||.+||+.||.+|||++|+|+||||+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASL----ERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cCCCCccHHHHHHHhhccc----CCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            110000 000000000000    00000000001112367788899999999999999999999999999874

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-45  Score=323.76  Aligned_cols=278  Identities=23%  Similarity=0.352  Sum_probs=216.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||+||+++...+++.+|+|++..........     ...+.+|+.++..+.|++|+.+++.+. +..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREERDVLVNGDNQWITTLHYAFQ-DEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhH-----HHHHHHHHHHHhhCCCCCEeeEEEEEe-cCC
Confidence            47999999999999999999999999999999986532211111     113567888999999999999999884 448


Q ss_pred             eEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..++||||++| ++.+.+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            89999999986 55555555467899999999999999999999999999999999999999999999999999875432


Q ss_pred             CCC-CCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          170 PLK-PYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ... ......|++.|+|||++..    ...++.++|+||||+++|+|++|..||...+..+....+........   +  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~--  229 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---F--  229 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc---C--
Confidence            211 2234578999999999862    34678899999999999999999999998877766666543211000   0  


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVPLPKSKDFMP  322 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~~~~~~~~~~  322 (332)
                                                 ......++.++++||++||..++.+  |++++++++||||..+.+........
T Consensus       230 ---------------------------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~  282 (332)
T cd05623         230 ---------------------------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEA  282 (332)
T ss_pred             ---------------------------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhCCC
Confidence                                       0011237899999999999765544  68999999999999988666554444


Q ss_pred             CCCC
Q 035861          323 TFPP  326 (332)
Q Consensus       323 ~~~~  326 (332)
                      ++.|
T Consensus       283 ~~~~  286 (332)
T cd05623         283 PYIP  286 (332)
T ss_pred             CccC
Confidence            4444

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-45  Score=317.12  Aligned_cols=275  Identities=22%  Similarity=0.385  Sum_probs=213.1

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|++.+.||+|+||+||++.+..+++.||+|.+..........     ...+..|+.++++++|++++++.+.+..+ ..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-----ESMALNEKQILEKVNSRFVVSLAYAYETK-DA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHH-----HHHHHHHHHHHHhCCCCCeeeeeEEEecC-CE
Confidence            4788899999999999999999999999999987543322111     11356799999999999999999998554 78


Q ss_pred             EEEEcccccccHH-HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLK-WLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~-~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++||||++|+.+ +.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            9999999986544 444332 34689999999999999999999999999999999999999999999999998875432


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      . .......|+..|+|||++.. ..++.++|+||+|+++|+|++|..||...................            
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------------  220 (285)
T cd05630         155 G-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------  220 (285)
T ss_pred             C-ccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh------------
Confidence            2 22234568899999999976 668999999999999999999999997654321111111100000            


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCC--CCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKSKD--FMP  322 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~~~--~~~  322 (332)
                                           .......+++++.+|+.+||+.||++|||     ++|+++||||+.+.+.....  ..+
T Consensus       221 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~  279 (285)
T cd05630         221 ---------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEP  279 (285)
T ss_pred             ---------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCC
Confidence                                 00012236888999999999999999999     99999999999877665433  445


Q ss_pred             CCCCc
Q 035861          323 TFPPQ  327 (332)
Q Consensus       323 ~~~~~  327 (332)
                      ++.|+
T Consensus       280 ~~~~~  284 (285)
T cd05630         280 PFKPD  284 (285)
T ss_pred             CCCCC
Confidence            66664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.5e-45  Score=318.36  Aligned_cols=282  Identities=39%  Similarity=0.736  Sum_probs=207.0

Q ss_pred             cccccccCcEEEEEEEECC--CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc-CCCeE
Q 035861           16 LNKISEGTYGIVYRARDKK--SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD-DHDSV   92 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   92 (332)
                      ..+||+|+||+||+|+...  ++..||+|.+......          ..+.+|+.+++.++||||+++++++.. .+...
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   75 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----------MSACREIALLRELKHPNVIALQKVFLSHSDRKV   75 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence            4679999999999999653  5688999988643211          135689999999999999999998854 34678


Q ss_pred             EEEcccccccHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE----cCCCcEEEee
Q 035861           93 YMVMEYMEHDLKWLMESM--------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICD  160 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~--------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili----~~~~~~~l~d  160 (332)
                      ++|+||+++++.+.+...        ...+++..++.++.||+.||.|||+.|++|+||||+||++    +.++.++|+|
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          76 WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            999999999887766431        2358899999999999999999999999999999999999    4567999999


Q ss_pred             cccccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 035861          161 FGMSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---------VDQID  228 (332)
Q Consensus       161 f~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---------~~~~~  228 (332)
                      ||++........   ......++..|+|||.+.+...++.++|+||||+++|+|+||..||.....         .....
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD  235 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence            999986543322   223456788999999998756789999999999999999999999975432         23344


Q ss_pred             HHHHHcCCCCCCcccCCCCCcccc---ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAK---ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      .+....+.+....+..+...+...   ..........  ..............+..+++||.+||+.||.+|||++|+|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYAN--SSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCC--chhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            555555555555544433322110   0000000000  00000011112235677899999999999999999999999


Q ss_pred             CCCC
Q 035861          306 HYWF  309 (332)
Q Consensus       306 hp~f  309 (332)
                      ||||
T Consensus       314 hp~f  317 (317)
T cd07867         314 DPYF  317 (317)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-44  Score=314.31  Aligned_cols=292  Identities=46%  Similarity=0.837  Sum_probs=230.2

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      +|.+..++|++.+.||.|++|+||+|.+..+++.|++|++........      ....+.+|+.++++++|||++++++.
T Consensus         1 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~   74 (302)
T cd07864           1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEI   74 (302)
T ss_pred             CchhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeehe
Confidence            366788999999999999999999999999999999999875432221      11245689999999999999999998


Q ss_pred             EEcCC---------CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc
Q 035861           85 VMDDH---------DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        85 ~~~~~---------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~  155 (332)
                      +.+..         ...++|+||+++++...+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             ecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc
Confidence            85442         378999999999888777765667999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          156 LKICDFGMSRQYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      ++|+|||.+....... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~  234 (302)
T cd07864         155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC  234 (302)
T ss_pred             EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999987654322 122333457789999998765567899999999999999999999999888888888887776


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      +.+....++.+...+...........       ..........++..+.++|.+||+.||++||++++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQY-------RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CCCChhhccccccccccccccccccc-------ccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            66666665554433221110000000       000001122368889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-44  Score=312.85  Aligned_cols=285  Identities=48%  Similarity=0.855  Sum_probs=222.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDH   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   89 (332)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.......      .....+.+|+.+++.+. |+||+++++.+....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE------GIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc------CCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            47999999999999999999999999999999986543221      11224568999999995 699999999885542


Q ss_pred             C----eEEEEcccccccHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEee
Q 035861           90 D----SVYMVMEYMEHDLKWLMESM----KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICD  160 (332)
Q Consensus        90 ~----~~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~d  160 (332)
                      .    ..|+||||+++++.+.+...    ...+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|
T Consensus        75 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          75 KNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             CCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEee
Confidence            2    37999999999887776543    245899999999999999999999999999999999999998 88999999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ||.+..............+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+......+...
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99987654433333444567889999998765668999999999999999999999999888888777777766655554


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                      .++.......... ....        .+.......+.++.++.+||.+||..||.+||+++|++.||||.
T Consensus       235 ~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         235 VWPGVSKLRDWHE-FPQW--------KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hCcchhhccchhh-cCcc--------cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            4443322211100 0000        00001111234789999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-44  Score=314.66  Aligned_cols=291  Identities=43%  Similarity=0.780  Sum_probs=222.0

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +..+++|++.+.||+|++|.||+|.+..+++.||||.+........      ......+|+..++++.||||+++++++.
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~   81 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICR   81 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC------chhHHHHHHHHHHhCCCCCccceEEEEe
Confidence            4467799999999999999999999999999999999865432211      1123457999999999999999999875


Q ss_pred             cCC-------CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           87 DDH-------DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        87 ~~~-------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                      ...       ...++|+||+++++.+.+......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          82 TKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             cccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence            432       3569999999998888777666689999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCC----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          160 DFGMSRQYGSPLK----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       160 df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      |||.+........    ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999876533211    112345678899999987655678899999999999999999999988777666666665555


Q ss_pred             CCCCCcccCCCCCccccc-cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          236 TPTETIWPGLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..+...++.......... ..............      .....+..+++||.+||..||.+||+++++|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERL------KPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhc------ccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            555554444332211100 00000000000000      111246778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.1e-45  Score=312.84  Aligned_cols=280  Identities=39%  Similarity=0.670  Sum_probs=215.8

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCC-C
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDH-D   90 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~   90 (332)
                      |++.+.||.|++|.||+|.+..++..+|+|.+.........       .....|+..+.++ .|+|++++++.+.++. .
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-------VNNLREIQALRRLSPHPNILRLIEVLFDRKTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-------hhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence            77899999999999999999999999999998654322111       1234788888888 4999999999985432 6


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+||++|++++.+......+++..++.++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+......
T Consensus        74 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          74 RLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            78999999999998888776678999999999999999999999999999999999999999 99999999998765332


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       .......++..|+|||.+.....++.++|+||||+++|+|++|..||...+..+....+....+.+.+.+.........
T Consensus       153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         153 -PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             -CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence             2223445788999999876656788999999999999999999999998887777777766555444432111100000


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .........        ........+.++.++.+||.+||+.+|++||+++++++||||
T Consensus       232 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKK--------GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccc--------cccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000000000        000011123468999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-46  Score=316.51  Aligned_cols=259  Identities=36%  Similarity=0.598  Sum_probs=208.7

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      |++++.||+|+||+||++++..+++.+|+|++...........      ....|+..+++++|+||+++++++.. ....
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~------~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEERE------ENIREIKILRRLRHPNIVQILDVFQD-DNYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHH------HHHHHHHHHHHHTBTTBCHEEEEEEE-SSEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccc------hhhhhhhccccccccccccccccccc-cccc
Confidence            7899999999999999999999999999999987654332211      12358999999999999999999955 4888


Q ss_pred             EEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           93 YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        93 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      ++|||++++ ++.+.+. ....+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        74 ~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   74 YIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             EEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999998 5555555 56789999999999999999999999999999999999999999999999999987643334


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......++..|+|||++......+.++|+||||+++|+|++|..||...+.......+............         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------
Confidence            44556678899999999884478999999999999999999999999987433333333222111100000         


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                           ......+..+.++|.+||+.||++||++.++++||||
T Consensus       224 ---------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 ---------------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             ---------------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ---------------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                                 0000023788999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6e-45  Score=314.56  Aligned_cols=260  Identities=32%  Similarity=0.453  Sum_probs=213.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||++.+..+++.+|+|++..........     ...+.+|++.++++.||||+++++.+.. ..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-----VEHVLNEKRILQSIRHPFLVNLYGSFQD-DS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhH-----HHHHHHHHHHHHhCCCCCccceeeEEEc-CC
Confidence            47999999999999999999999999999999987543211111     1245689999999999999999999854 47


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||++++.+.......+.+++..+..++.||+.||.+||+.|++|+||+|.||+++.++.++|+|||.+......
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            89999999965444444444678999999999999999999999999999999999999999999999999998765433


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                         .....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+.....               
T Consensus       155 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  215 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV---------------  215 (290)
T ss_pred             ---CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------------
Confidence               234567889999999876 5688999999999999999999999987775544444432111               


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~  317 (332)
                                            ..+..++..++++|.+||..||.+|+     +++|+++||||..+.+...
T Consensus       216 ----------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  265 (290)
T cd05580         216 ----------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL  265 (290)
T ss_pred             ----------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence                                  01122688899999999999999999     9999999999999986554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-45  Score=322.08  Aligned_cols=279  Identities=23%  Similarity=0.352  Sum_probs=217.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|+||+||++++..+++.||+|++.........     ....+.+|..++..+.|++|+.+++.+. +..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~l~~~~~-~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRA-----ETACFREERNVLVNGDCQWITTLHYAFQ-DEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCC
Confidence            4799999999999999999999999999999998753211111     0113567889999999999999999984 458


Q ss_pred             eEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..|+||||+.|+ +.+.+......+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            899999999865 5555554467899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-CCccccccccccchhhhcCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          170 PLK-PYTSLVVTLWYRAPELLLGA----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ... ......|++.|+|||++...    ..++.++|+||||+++|+|++|..||...+..+....+.........     
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----  229 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF-----  229 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC-----
Confidence            222 12235689999999998642    35788999999999999999999999887776666655432111000     


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVPLPKSKDFMP  322 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~~~~~~~~~~  322 (332)
                                             +    .....++.++++||.+||..++.+  |++++++++||||..+.|...+...+
T Consensus       230 -----------------------p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~  282 (331)
T cd05624         230 -----------------------P----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEA  282 (331)
T ss_pred             -----------------------C----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhCCC
Confidence                                   0    001226889999999999976654  46899999999999987766655554


Q ss_pred             CCCCc
Q 035861          323 TFPPQ  327 (332)
Q Consensus       323 ~~~~~  327 (332)
                      ++.|.
T Consensus       283 ~~~p~  287 (331)
T cd05624         283 PYIPD  287 (331)
T ss_pred             CccCC
Confidence            44444

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.9e-45  Score=321.89  Aligned_cols=298  Identities=35%  Similarity=0.571  Sum_probs=225.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|.||++.+..+++.||+|++.........      ...+.+|+.++++++|+||+++++.+...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH------AKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH------HHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            467899999999999999999999999999999998643221111      11345799999999999999999987433


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .     ...|+|+|++++++...+..   .+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.
T Consensus        88 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          88 KSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CCccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            2     35799999999988776654   289999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....+.++.....
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         165 ARTAGTSF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             ceeCCCCC-CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98654322 2234467888999999977 678999999999999999999999999888888788887776666554333


Q ss_pred             CCCCCccccccc-cCCchhhhhhh-----CCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANF-AKQPYNLLRKR-----FPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       244 ~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      .+.......... ...........     .+..........+..+++||.+||+.||++||++.|+|.||||..|-.++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence            322111100000 00000000011     111111113346778899999999999999999999999999987665444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-44  Score=317.75  Aligned_cols=294  Identities=24%  Similarity=0.374  Sum_probs=211.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||.|+||.||++.+..++..+|+|++.......       ....+.+|+++++.++|+||+++++.+.++ 
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   75 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVGFYGAFYSD-   75 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHH-------HHHHHHHHHHHHHHCCCCcccceeEEEEEC-
Confidence            468999999999999999999999999999999887542211       012467899999999999999999999554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++|+.+..+....+.+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            78999999998755554444467799999999999999999999975 79999999999999999999999999987553


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC-CCCCCcc-cCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG-TPTETIW-PGLS  246 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~  246 (332)
                      ..  ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||................. .+..... +...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         156 DS--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             hh--ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence            22  2234468889999999976 6689999999999999999999999987654333221111000 0000000 0000


Q ss_pred             CCccccccc---cCCc---hhhhhhhCCCCc-cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          247 ELPGAKANF---AKQP---YNLLRKRFPAAS-FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       247 ~~~~~~~~~---~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      .........   ....   ............ ......++.++++||.+||+.||++||+++|++.||||+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence            000000000   0000   000000011111 1111236788999999999999999999999999999988653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.7e-45  Score=315.00  Aligned_cols=266  Identities=25%  Similarity=0.427  Sum_probs=214.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      +.|++++.||.|++|.||+|.+..++..+++|.+.......        ...+.+|+..++.++|+|++++++.+..+ .
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--------LEDYMVEIEILATCNHPYIVKLLGAFYWD-G   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHH--------HHHHHHHHHHHHhCCCCcEeeeEEEEEeC-C
Confidence            57999999999999999999999999999999986542111        12456799999999999999999998554 7


Q ss_pred             eEEEEcccccccHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDLKWLM-ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~-~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..++||||++|+.+..+ ......+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            89999999998765544 44456799999999999999999999999999999999999999999999999998876433


Q ss_pred             CCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .........++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+......++.....  +       
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~-------  233 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P-------  233 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC--c-------
Confidence            3333345567889999998852    24568899999999999999999999987665444333322110  0       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                                               .......++.++.+||.+||..+|++||+++++++||||..+.+.+...
T Consensus       234 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~  282 (292)
T cd06644         234 -------------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR  282 (292)
T ss_pred             -------------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHH
Confidence                                     0011223678899999999999999999999999999999988877543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-44  Score=328.20  Aligned_cols=280  Identities=23%  Similarity=0.328  Sum_probs=208.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ...|.+.+.||.|+||.||++.+..+++.||||....              ..+.+|+.++++++|+||+++++++..+ 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVG-  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-
Confidence            3479999999999999999999999999999995321              1345899999999999999999988554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|++++.+++...+......+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus       233 ~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        233 GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            77899999999998888877667899999999999999999999999999999999999999999999999999876532


Q ss_pred             CCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHcCCCCCC
Q 035861          170 PLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT-------EVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~  240 (332)
                      ...  ......||..|+|||++.+ ..++.++||||||+++|+|++|..|+....       ......+++.........
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            211  1224568999999999987 678999999999999999999876653321       122333333332221111


Q ss_pred             cccCCCC-CccccccccCCchhhhhhhCCCCc---cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          241 IWPGLSE-LPGAKANFAKQPYNLLRKRFPAAS---FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       241 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      ....... +..   ...   ........+...   +.....++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       392 ~~~~~~~~l~~---~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        392 FPQHAGSRLVS---QYR---HRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCCcchHHHH---HHH---hhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            1000000 000   000   000000011111   1111246778999999999999999999999999999975

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=307.95  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=208.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      +.|++.+.||.|++|.||.+.+..+++.+++|.+...........   ....+.+|+..+++++||||+++++++..+ .
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKK---EVNALECEIQLLKNLQHERIVQYYGCLRDD-E   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHH---HHHHHHHHHHHHHhCCCCCeeeeEEEEccC-C
Confidence            479999999999999999999998999999999875433221110   112456899999999999999999999554 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+|+++|+.+.......+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            89999999987655544444678999999999999999999999999999999999999999999999999998755322


Q ss_pred             CCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          171 LKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...   .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.....            
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------  224 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------------  224 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC------------
Confidence            111   123457788999999987 5689999999999999999999999987655544443322111            


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                             ....+..++..+.++|.+||..+|.+||++.++++||||
T Consensus       225 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 -----------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                   011123378899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=315.94  Aligned_cols=272  Identities=29%  Similarity=0.437  Sum_probs=217.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|++.+.||+|++|+||++....+++.+|+|.+..........     ...+..|++.++.++|+||+++++.+.. ..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-----VKRVLTEQEILATLDHPFLPTLYASFQT-ET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHH-----HHHHHHHHHHHHhCCCCCchhheeeeec-CC
Confidence            37999999999999999999999999999999997653322111     1246789999999999999999999844 47


Q ss_pred             eEEEEccccccc-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           91 SVYMVMEYMEHD-LKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        91 ~~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ..|+||||+.|+ +.+.+... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            899999999874 44444332 3568999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCC-----------------------------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 035861          169 SPLK-----------------------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS  219 (332)
Q Consensus       169 ~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~  219 (332)
                      ....                             ......|+..|+|||.+.+ ..++.++|+||||+++|++++|..||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            2111                             1112356788999999976 568999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC
Q 035861          220 GTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT  299 (332)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  299 (332)
                      ..+.......+......                                   ......++..++++|.+||+.||++||+
T Consensus       234 ~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         234 GSNRDETFSNILKKEVT-----------------------------------FPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             CCchHHHHHHHhcCCcc-----------------------------------CCCccccCHHHHHHHHHHccCCHhHCCC
Confidence            77766555444321100                                   0011126889999999999999999999


Q ss_pred             ----HHHHhcCCCCCCCCCCCCCCCCCCC
Q 035861          300 ----VDDALNHYWFHEVPLPKSKDFMPTF  324 (332)
Q Consensus       300 ----~~ell~hp~f~~~~~~~~~~~~~~~  324 (332)
                          ++++|.||||+++.++.++-..++-
T Consensus       279 ~~~~~~~ll~~~~~~~~~~~~~~~~~~~~  307 (316)
T cd05574         279 SKRGAAEIKQHPFFRGVNWALIRHTTPPI  307 (316)
T ss_pred             chhhHHHHHcCchhhcCChhhcccCCCCC
Confidence                9999999999999998887744443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-44  Score=312.14  Aligned_cols=286  Identities=34%  Similarity=0.613  Sum_probs=218.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+.......      .....+.+|++.++.++|+||+++++.+ .+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK------MVKKIAMREIRMLKQLRHENLVNLIEVF-RRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc------hhhHHHHHHHHHHHhcCCcchhhHHHhc-ccCC
Confidence            47999999999999999999999889999999986543222      1112456899999999999999999998 4558


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+||+++++++.+......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          74 RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             eEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            89999999999888877766667999999999999999999999999999999999999999999999999998765443


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+...++.++|+||||+++|++++|..||......+....+..............+...+.
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            34344456788999999987656678899999999999999999999987766555555544332221110000000000


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .......      ............+.++..+.+|+.+||+.+|++||++.++++||||
T Consensus       234 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLP------EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccc------cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0000000      0000000111234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-45  Score=327.50  Aligned_cols=289  Identities=24%  Similarity=0.336  Sum_probs=213.8

Q ss_pred             hcccccccccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+|.+++.||.|++|.||++...  .++..|++|.+....             ...+|+.++++++||||+++++.+. .
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------------~~~~E~~il~~l~h~~iv~~~~~~~-~  157 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------------TPGREIDILKTISHRAIINLIHAYR-W  157 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------------cHHHHHHHHHhcCCCCccceeeeEe-e
Confidence            47999999999999999999764  356789999875421             2347999999999999999999884 4


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....|++||++.+++...+. ....+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....
T Consensus       158 ~~~~~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        158 KSTVCMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             CCEEEEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            47899999999998888774 46789999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCCCccc
Q 035861          169 SPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....  ......|+..|+|||.+.. ..++.++|+||||+++|+|++|..||.....   ...+..+.+..+..+.....
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             cccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            3222  1234568999999999976 6789999999999999999999999976532   33444454443332221110


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      ....  .......+... ..+.............++.++.+||.+||..||++||++.|+|.||||.+.++...+
T Consensus       316 ~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        316 NGST--NLCKHFKQYAI-VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLN  387 (392)
T ss_pred             ccch--hHHHHHHhhcc-cccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhc
Confidence            0000  00000000000 000000000001112357788999999999999999999999999999987766544

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=310.99  Aligned_cols=261  Identities=26%  Similarity=0.462  Sum_probs=211.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||.|++|+||++.+..++..+++|++........        ..+..|++++++++|+|++++++.+.. +
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   74 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL--------EDFMVEIDILSECKHPNIVGLYEAYFY-E   74 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHH--------HHHHHHHHHHHhCCCCceeEEEEEEec-C
Confidence            4689999999999999999999988899999999864322111        145689999999999999999999854 4


Q ss_pred             CeEEEEcccccccHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~-~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++++.+. .+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            7899999999985544 444445679999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..........++..|+|||.+..    ...++.++|+||||+++|+|++|..||...........+.....         
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  225 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP---------  225 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC---------
Confidence            43333445568889999999752    24577899999999999999999999987765544433322110         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               .....+..++.++.++|.+||+.+|.+||+++++++||||.+..
T Consensus       226 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 -------------------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             -------------------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                                     00111233688899999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-44  Score=304.32  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=208.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+.........      ...+..|+..++.++|||++++++.+.++ ..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~   73 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE------REEAIDEARVLAKLDSSYIIRYYESFLDK-GK   73 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHH------HHHHHHHHHHHHhcCCCCeehheeeeccC-CE
Confidence            588999999999999999999999999999998754332211      12466899999999999999999998554 78


Q ss_pred             EEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++|+||++| ++.+.+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            9999999986 454544443 46789999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......+            
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd08529         154 NTNFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP------------  220 (256)
T ss_pred             ccchhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence            4333345567889999999887 568899999999999999999999998877655544443221110            


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                              ....++.++.+++.+||+.+|++||++.++++|||+
T Consensus       221 ------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         221 ------------------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------------------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                                    011268899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=312.31  Aligned_cols=295  Identities=43%  Similarity=0.740  Sum_probs=226.8

Q ss_pred             hhcccc-cccccccCcEEEEEEEECCCCcEEEEEEeecccCCccc------ccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861           10 VFEFEK-LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKED------CLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus        10 ~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      -++|.. .+.||.|++|+||+|.+..+++.||||++.........      ..+......+.+|+.++++++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            347765 46799999999999999989999999999765433211      01111122467899999999999999999


Q ss_pred             eeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           83 EVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +++..+ ...++|||+++|++.+.+.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||
T Consensus        87 ~~~~~~-~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         87 DVYVEG-DFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEEecC-CcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            998554 78999999999988777654 5679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC--------------CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 035861          163 MSRQYGS--------------PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQID  228 (332)
Q Consensus       163 ~~~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~  228 (332)
                      .+.....              .........++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            8876541              11122233467789999998775667999999999999999999999999988888888


Q ss_pred             HHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                      .+....+.+....++.....+.........         +.......+..+..+.++|.+||+.+|++||+++++|.|||
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRK---------PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCC---------cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            777776666655444332221111000000         00001112236788999999999999999999999999999


Q ss_pred             CCCCCCC
Q 035861          309 FHEVPLP  315 (332)
Q Consensus       309 f~~~~~~  315 (332)
                      |+...-.
T Consensus       316 ~~~~~~~  322 (335)
T PTZ00024        316 FKSDPLP  322 (335)
T ss_pred             cCCCCCC
Confidence            9987544

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-44  Score=308.55  Aligned_cols=282  Identities=52%  Similarity=0.962  Sum_probs=228.4

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      |++.+.||+|++|.||+|+...+++.+++|++.......      .....+..|+..+++++|+|++++++++.+. ...
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE------GIPSTALREISLLKELKHPNIVKLLDVIHTE-RKL   73 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc------cccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-Cce
Confidence            677899999999999999999999999999998654211      1122456899999999999999999998544 789


Q ss_pred             EEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC
Q 035861           93 YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK  172 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~  172 (332)
                      ++|+|++++++.+.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        74 ~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          74 YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            99999999988877776556899999999999999999999999999999999999999999999999999887654433


Q ss_pred             CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccc
Q 035861          173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK  252 (332)
Q Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (332)
                      ......++..|+|||.+.+...++.++|+||||+++|++++|..||...+..+...++......+....++.+.......
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            44445567789999998875578999999999999999999999999988888888888777766666665554443222


Q ss_pred             ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .............        ..+.++..+.++|.+||..||++||++++++.||||
T Consensus       234 ~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEK--------VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHH--------hcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            2211111111111        122357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-44  Score=310.34  Aligned_cols=259  Identities=27%  Similarity=0.443  Sum_probs=212.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++++.||.|++|+||++.+..+++.|++|.+.......        ...+.+|+..++.++|+|++.+++.+.. .
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~   88 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--------KELIINEILVMKELKNPNIVNFLDSFLV-G   88 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--------HHHHHHHHHHHHhcCCCceeeeeeeEec-C
Confidence            357999999999999999999999999999999986543221        1245689999999999999999999854 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|+||++|+.+..... ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            78999999999876665554 45689999999999999999999999999999999999999999999999998876543


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+......             
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------  233 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-------------  233 (296)
T ss_pred             ccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-------------
Confidence            3333334567889999999876 66889999999999999999999999887665444333221100             


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                           ....+..+++.+.+||.+||..||++||++.+++.||||....
T Consensus       234 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         234 ---------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ---------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                                 0111233788899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.4e-44  Score=305.53  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=206.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||.|++|.||+|.+..+++.|++|++........        ..+.+|+..++.++||||+++++.+...
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF--------AVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHH--------HHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            34699999999999999999999999999999999875432111        1345799999999999999999998554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...++++||++++.+..+....+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          79 -DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             -CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence             7899999999976555555557789999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..........|+..|+|||.+.  ....++.++|+||||+++|++++|..||..................++        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------  229 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--------  229 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--------
Confidence            4333334557889999999874  224578899999999999999999999876544332222211100000        


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                                              .......++..+.++|.+||+.+|++||++++|++|||
T Consensus       230 ------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 ------------------------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ------------------------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                                    00011126778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.4e-44  Score=309.35  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=211.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ....+|++++.||+|++|.||+|++..++..+++|.+........        ..+.+|+.+++.+.|+|++++++.+..
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~--------~~~~~e~~~l~~~~h~~v~~~~~~~~~   88 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--------ELIINEILVMRENKNPNIVNYLDSYLV   88 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchH--------HHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence            345699999999999999999999998999999999875433221        145689999999999999999998855


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      + ...|+|+||++|+.+..+.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        89 ~-~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          89 G-DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             C-CEEEEeecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            4 78999999998755544443 456899999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||................ .+          
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~----------  234 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP----------  234 (296)
T ss_pred             cccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CC----------
Confidence            433333344568889999999876 667899999999999999999999997765433322221110 00          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                             ....+..++..+.+||.+||..+|++||+++++++||||.....
T Consensus       235 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         235 -----------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             -----------------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence                                   01112236788999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-44  Score=317.35  Aligned_cols=294  Identities=40%  Similarity=0.658  Sum_probs=224.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|.+.+.||.|++|+||++++..+++.||||.+.........      ...+..|+.+++.++|+||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID------AKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch------hHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            35899999999999999999999999999999998643211111      124568999999999999999999875432


Q ss_pred             ----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 ----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                          ...++++||+++++.+.+.. .+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        78 ~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          78 REAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             ccccCcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence                35799999999888776654 5789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .............++..|+|||.+.....++.++|+||||+++|+|++|..||...+.......+....+.+....+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65433233344567888999999876556899999999999999999999999887766666666665554444332211


Q ss_pred             CCCccccccccCCchhhhhhhCCCC-ccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAA-SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      .......       +.......+.. .....+.++..+++||.+||+.+|++||+++++++||||..++.+..
T Consensus       237 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         237 RNEKARR-------YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             CchhhhH-------HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            1100000       00000000000 01123457899999999999999999999999999999999876654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.6e-44  Score=308.52  Aligned_cols=260  Identities=25%  Similarity=0.455  Sum_probs=209.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      -|++.+.||.|++|.||++.+..++..+++|.+.......        ...+.+|+..++.++|+|++++++.+... ..
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~   76 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--------LEDYMVEIDILASCDHPNIVKLLDAFYYE-NN   76 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHH--------HHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CE
Confidence            3689999999999999999999999999999986432111        11456799999999999999999998554 78


Q ss_pred             EEEEcccccccHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYMEHDLKWLM-ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~-~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .++|+||++++.+... .....++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            9999999997665544 444567999999999999999999999999999999999999999999999999998765433


Q ss_pred             CCCCccccccccccchhhhc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          171 LKPYTSLVVTLWYRAPELLL----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ........++..|+|||.+.    ....++.++|+||+|+++|+|++|..||...+.......+.......         
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  227 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT---------  227 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC---------
Confidence            33334456788999999984    22457889999999999999999999998776555444443221100         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                               ...+..++..+.+||.+||+.||.+||+++++++||||.....
T Consensus       228 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         228 -------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             -------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence                                     0112236888999999999999999999999999999998544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=314.14  Aligned_cols=265  Identities=27%  Similarity=0.441  Sum_probs=234.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -.=|.+.+.||+|-|..|-++++-.||+.||||++.+........      ..+++|++.|+..+||||+++|+++ +.+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st------~hlfqEVRCMKLVQHpNiVRLYEVi-DTQ   89 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST------GHLFQEVRCMKLVQHPNIVRLYEVI-DTQ   89 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh------hHHHHHHHHHHHhcCcCeeeeeehh-ccc
Confidence            346899999999999999999999999999999998765433221      2567999999999999999999998 666


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc-CCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~-~~~~~~l~df~~~~~~  167 (332)
                      ..+|+|+|.=+| ++.+.+.+....+.++.+.+++.||+.|+.|+|+..++|+||||+|+.+. +-|-|||+|||++..+
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            889999999875 88888888888999999999999999999999999999999999999775 5689999999999877


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      . +.....+.+|+..|.|||++.+..+..++.||||||+++|.+.+|..||...++.+++..|+.+....          
T Consensus       170 ~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv----------  238 (864)
T KOG4717|consen  170 Q-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV----------  238 (864)
T ss_pred             C-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC----------
Confidence            3 45667788999999999999998888999999999999999999999999999999998888763322          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                                                 +..++.+.++||..||..||.+|.++++|..|+|++-+..+.+-.
T Consensus       239 ---------------------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~  283 (864)
T KOG4717|consen  239 ---------------------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA  283 (864)
T ss_pred             ---------------------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence                                       233799999999999999999999999999999999988776644

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.9e-44  Score=306.59  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=205.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|.||+|++..+++.+++|++........        ..+.+|+..+++++||||+++++.+...
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~--------~~~~~e~~~l~~~~h~~ii~~~~~~~~~   78 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF--------SLIQQEIFMVKECKHCNIVAYFGSYLSR   78 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchH--------HHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence            34589999999999999999999999999999999975432111        1356899999999999999999998554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...++|+||++++.+..+....+.+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||.+....
T Consensus        79 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          79 -EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence             7889999999976555544446789999999999999999999999999999999999999999999999999988664


Q ss_pred             CCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..........++..|+|||.+..  ...++.++|+||+|+++|+|++|..||...........+......+         
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  228 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP---------  228 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC---------
Confidence            43333344567889999998742  3457889999999999999999999996554332211111100000         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                                             ........++..+.+||.+||+.+|++||+++++|+|+|
T Consensus       229 -----------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         229 -----------------------PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -----------------------CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                                   000011236789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-44  Score=307.42  Aligned_cols=285  Identities=38%  Similarity=0.679  Sum_probs=219.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++.......      .....+.+|+..++.++|+||+++++.+.. ..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE------DVKKTALREVKVLRQLRHENIVNLKEAFRR-KG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc------cchhHHHHHHHHHHhcCCCCeeehhheEEE-CC
Confidence            37999999999999999999999999999999987543322      112356789999999999999999999955 47


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++++||++++++..+......+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          74 RLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            89999999999988877776777999999999999999999999999999999999999999999999999998876443


Q ss_pred             CC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          171 LK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .. ......++..|+|||.+.+...++.++|+||||+++|++++|..||...+..+....+....+..+...........
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            32 33445678889999999875478999999999999999999999998877666555554433322222111111000


Q ss_pred             cccc-cc-cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKA-NF-AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .... .. ...........       ....++.++++||.+||..+|++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         234 RFAGVAFPEPSQPESLERR-------YPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccccCCCCCcHHHHHh-------cCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0000 00 00000000000       122358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-44  Score=308.71  Aligned_cols=274  Identities=24%  Similarity=0.409  Sum_probs=214.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|+..+.||.|+||+||++.+..+++.+|+|.+..........     ...+.+|+.+++.++|++++.+.+.+..+ ..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG-----ESMALNEKQILEKVNSQFVVNLAYAYETK-DA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhH-----HHHHHHHHHHHHHcCCcCceeEEEEEecC-CE
Confidence            3778899999999999999999999999999987543222111     11346799999999999999999888544 78


Q ss_pred             EEEEcccccccHH-HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLK-WLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~-~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++++||++++.+ +.+... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            9999999997544 344332 34699999999999999999999999999999999999999999999999998876432


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      . .......|+..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+.........          
T Consensus       155 ~-~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~----------  222 (285)
T cd05632         155 G-ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE----------  222 (285)
T ss_pred             C-CcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc----------
Confidence            2 22234578999999999976 66899999999999999999999999877655443333322111100          


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCC--CCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKSK--DFMP  322 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~~--~~~~  322 (332)
                                             ...+.++.++.+|+.+||+.||++||+     ++++++|+||.+..+....  ...+
T Consensus       223 -----------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  279 (285)
T cd05632         223 -----------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP  279 (285)
T ss_pred             -----------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCC
Confidence                                   012236788999999999999999999     8999999999998766542  2334


Q ss_pred             CCCC
Q 035861          323 TFPP  326 (332)
Q Consensus       323 ~~~~  326 (332)
                      +|-|
T Consensus       280 ~~~~  283 (285)
T cd05632         280 PFVP  283 (285)
T ss_pred             CCCC
Confidence            4444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-44  Score=306.63  Aligned_cols=284  Identities=53%  Similarity=0.953  Sum_probs=225.2

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-CCe
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-HDS   91 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~   91 (332)
                      |++.+.||.|++|.||+|.+..+++.+++|.+.......      .....+.+|+..++.++|+|++++++.+... ...
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            678999999999999999999899999999998654111      1112467899999999999999999998554 378


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++|+||+++++...+......+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          75 IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             EEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            99999999998877776655689999999999999999999999999999999999999999999999999988664332


Q ss_pred             C-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          172 K-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      . ......++..|+|||.+.+...++.++|+||||+++|++++|..||...+.......+......+....++.+..+..
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence            1 223345678899999887656689999999999999999999999999888888888877766666665555444311


Q ss_pred             ccccc-cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANF-AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..... .............       ..++..+.+++.+||+.+|++||+++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFK-------HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            11100 0111111111111       1148899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-44  Score=329.77  Aligned_cols=262  Identities=28%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ...+|++.+.||+|+||+||++.+..+++.||||++.........      ...+.+|+..+..++|+|++.++..+...
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~------~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD------KNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH------HHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            346999999999999999999999999999999999765332211      11356889999999999999998876432


Q ss_pred             C-------CeEEEEcccccc-cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           89 H-------DSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        89 ~-------~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      .       ..+++||||+++ ++.+.+..   ....+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2       147899999986 55554433   235689999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          158 ICDFGMSRQYGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       158 l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      |+|||++......  ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999998765322  122334578999999999987 6789999999999999999999999988776655554433211


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .                                    ..++.+++++.+|+.+||+.||.+||++.++++|||++...
T Consensus       263 ~------------------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 D------------------------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             C------------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence            0                                    11233788999999999999999999999999999987643

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.1e-44  Score=310.25  Aligned_cols=264  Identities=27%  Similarity=0.445  Sum_probs=211.8

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ....+|++++.||.|++|.||++.+..+++.||+|.+........        ..+.+|+.+++.++|+|++++++.+..
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--------ELIINEILVMRENKNPNIVNYLDSYLV   87 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchH--------HHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            344799999999999999999999998999999999865432221        245689999999999999999999854


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      + ...++||||++|+.+..... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        88 ~-~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          88 G-DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             C-CEEEEeecccCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            4 78999999998765555544 456899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+... +.           
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~-----------  232 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-----------  232 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CC-----------
Confidence            443333344567889999999877 66889999999999999999999999765432221111100 00           


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                            .....+..++..+++|+.+||..+|++||+++++++||||.......
T Consensus       233 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         233 ----------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             ----------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence                                  00111223678899999999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.4e-44  Score=310.30  Aligned_cols=276  Identities=27%  Similarity=0.369  Sum_probs=218.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||.|++|.||++.+..+++.|++|.+..........     ...+.+|+.+++.++||||+++++.+. .+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-----IQQVFVERDILTFAENPFVVSMFCSFE-TKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHH-----HHHHHHHHHHHHhCCCCCeeeeEEEEe-cCC
Confidence            47999999999999999999999999999999987543211111     124568999999999999999999884 447


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|||+++|+.+.......+.+++..+..++.|++.||+|||++|++|+||+|.||+++.++.++|+|||.+......
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            89999999998655555555678999999999999999999999999999999999999999999999999987632100


Q ss_pred             C---------------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          171 L---------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       171 ~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      .               .......++..|+|||.+.. ..++.++|+||||+++|++++|..||.+....+..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  233 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            0               01112356778999999876 6689999999999999999999999987766555544433211


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT---VDDALNHYWFHEV  312 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~f~~~  312 (332)
                      ..+.                                  ....++..+.++|.+||+.||++||+   +.++|+||||...
T Consensus       234 ~~~~----------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         234 EWPE----------------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             CCCC----------------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            1110                                  01136888999999999999999997   7999999999998


Q ss_pred             CCCCCCCCCCCCCCc
Q 035861          313 PLPKSKDFMPTFPPQ  327 (332)
Q Consensus       313 ~~~~~~~~~~~~~~~  327 (332)
                      .+...-.....+.|+
T Consensus       280 ~~~~~~~~~~~~~~~  294 (305)
T cd05609         280 DWNGLLRQKAEFIPQ  294 (305)
T ss_pred             CHHHHhhcCCCCCCC
Confidence            877765555555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-44  Score=314.23  Aligned_cols=288  Identities=45%  Similarity=0.832  Sum_probs=214.0

Q ss_pred             cccccccccccCcEEEEEEEECC--CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-
Q 035861           12 EFEKLNKISEGTYGIVYRARDKK--SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-   88 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   88 (332)
                      +|++.+.||+|++|.||+|.+..  ++..||+|.+........     .....+.+|+.+++.++||||+++++.+... 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-----GISQSACREIALLRELKHENVVSLVEVFLEHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc-----CccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence            58899999999999999999987  899999999986432111     1122456899999999999999999998544 


Q ss_pred             CCeEEEEcccccccHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC----CCcEEEee
Q 035861           89 HDSVYMVMEYMEHDLKWLMESM----KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN----QGVLKICD  160 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~----~~~~~l~d  160 (332)
                      ....++|+|++++++.+.+...    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.    ++.++|+|
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            2679999999998887665432    236899999999999999999999999999999999999999    89999999


Q ss_pred             cccccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 035861          161 FGMSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV---------DQID  228 (332)
Q Consensus       161 f~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~---------~~~~  228 (332)
                      ||.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||......         ....
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876543322   2234467888999999877567899999999999999999999999765432         2334


Q ss_pred             HHHHHcCCCCCCcccCCCCCcccccc---ccCCch--hhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHH
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKAN---FAKQPY--NLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA  303 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  303 (332)
                      .+......+....+..+...+.....   ......  ......     .......+..+.+++.+||+.||++|||+.|+
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei  310 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKW-----MEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA  310 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHH-----HHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            44444444433333222222111110   000000  000000     00112467889999999999999999999999


Q ss_pred             hcCCCC
Q 035861          304 LNHYWF  309 (332)
Q Consensus       304 l~hp~f  309 (332)
                      ++||||
T Consensus       311 l~~~~f  316 (316)
T cd07842         311 LEHPYF  316 (316)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.5e-44  Score=313.62  Aligned_cols=293  Identities=19%  Similarity=0.245  Sum_probs=204.0

Q ss_pred             ccccccccc--CcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           14 EKLNKISEG--TYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        14 ~~~~~lg~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      ++++.||+|  ++++||++.+..+++.||+|++.........      ...+.+|+.+++.++||||+++++++..+ ..
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~   73 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEM------VTFLQGELHVSKLFNHPNIVPYRATFIAD-NE   73 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHH------HHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CE
Confidence            367889999  7899999999999999999998754332211      11355799999999999999999999555 78


Q ss_pred             EEEEcccccccHH-HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEHDLK-WLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~~l~-~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++|+||++++.+ +.+... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++||+.+.....
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999997544 444332 35689999999999999999999999999999999999999999999999986543311


Q ss_pred             CCC-------CCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----
Q 035861          170 PLK-------PYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP----  237 (332)
Q Consensus       170 ~~~-------~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~----  237 (332)
                      ...       ......++..|+|||++... ..++.++|+||||+++|++++|..||.................+.    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence            111       01123456779999998753 358899999999999999999999998766544433332211100    


Q ss_pred             ----CCCcccCCCCCccccccccCCchh-hhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          238 ----TETIWPGLSELPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       238 ----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                          ++...-.................. ................+++.+.+||.+||+.||++|||++++++||||+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                000000000000000000000000 000000011111233467899999999999999999999999999999986


Q ss_pred             C
Q 035861          313 P  313 (332)
Q Consensus       313 ~  313 (332)
                      .
T Consensus       314 ~  314 (327)
T cd08227         314 K  314 (327)
T ss_pred             c
Confidence            5

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-44  Score=315.11  Aligned_cols=290  Identities=39%  Similarity=0.671  Sum_probs=220.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|++.+.||+|++|.||+|++..+++.||+|++.......       ....+..|+.+++.++|+||+++++++....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-------FCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch-------hHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            358999999999999999999999999999999986422111       1124568999999999999999998874332


Q ss_pred             ----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 ----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                          ...++++|++++++...+.  ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        77 ~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          77 FESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             ccccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence                3579999999998776554  4579999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .......   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6533221   1233467889999998876567899999999999999999999999887776666666655554433322


Q ss_pred             cCCCCCccccccccCCchhhhhhh--CCCCc-cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKR--FPAAS-FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ..+.......         .....  .+... ....+.++.++.+||.+||+.+|++||++.++++||||.+..-+..
T Consensus       235 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~  303 (336)
T cd07849         235 NCIISLRARN---------YIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD  303 (336)
T ss_pred             HHhhchhhhh---------HHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence            2111100000         00000  00000 0112346888999999999999999999999999999999875543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-46  Score=325.62  Aligned_cols=262  Identities=24%  Similarity=0.422  Sum_probs=225.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      +-|.++..||.|+||.||++..+.++...|.|++........        .+++-|+++|..+.||+|+.+++.|.-+ +
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEEL--------EDylVEIeILa~CdHP~ivkLl~ayy~e-n  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEEL--------EDYLVEIEILAECDHPVIVKLLSAYYFE-N  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHH--------hhhhhhhhhhhcCCChHHHHHHHHHhcc-C
Confidence            357899999999999999999999999899999876543221        1457899999999999999999988444 7


Q ss_pred             eEEEEcccccccHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDLKWLM-ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~-~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++|..|+|+|+-.+.+ ......+.+.++..+++|++.||.|||+.+|+|+|||..|||++-+|.++|.|||.+.....
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence            79999999998866654 45577899999999999999999999999999999999999999999999999999887766


Q ss_pred             CCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ........+||++|||||+..+    ..+|++++||||||++|-+|+.+.+|-...+....+.++.+..++..       
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-------  255 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-------  255 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-------
Confidence            6667788999999999999864    35799999999999999999999999999888888777766533221       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                 ..++..+.++.+|+.+||.+||..||++.++|+||||+++++.
T Consensus       256 ---------------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  256 ---------------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             ---------------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence                                       1233468899999999999999999999999999999988754

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-43  Score=309.41  Aligned_cols=292  Identities=23%  Similarity=0.369  Sum_probs=212.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.......       ....+.+|++++++++||||+++++.+..+ .
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~   72 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-------IRNQIIRELKVLHECNSPYIVGFYGAFYSD-G   72 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-C
Confidence            47999999999999999999999999999999886432111       112467899999999999999999998554 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..++++||++|+.+..+....+.+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        73 ~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          73 EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             EEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            899999999976555555556789999999999999999999997 6999999999999999999999999998865432


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.... .............  +......
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~  226 (308)
T cd06615         153 S--MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEA--KESHRPV  226 (308)
T ss_pred             c--ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccc--cCCcccc
Confidence            2  1234567889999999876 5688999999999999999999999976553322 2222111000000  0000000


Q ss_pred             cccccccCC---chhhhhhhCCCC-ccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          250 GAKANFAKQ---PYNLLRKRFPAA-SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       250 ~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      .........   ............ ...+...++.++++|+.+||+.+|++||+++++++||||.++..++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  297 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE  297 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccccc
Confidence            000000000   000001001111 1111223788899999999999999999999999999999876554

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=320.87  Aligned_cols=257  Identities=29%  Similarity=0.494  Sum_probs=223.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      -|.-++.||.|+||.||-+++..+.+.||||.+.-+-.....     ...+|+.|+..|+++.|||++.+.|.|..+ ..
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~E-----KWqDIlKEVrFL~~l~HPntieYkgCyLre-~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----KWQDILKEVRFLRQLRHPNTIEYKGCYLRE-HT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHH-----HHHHHHHHHHHHHhccCCCcccccceeecc-ch
Confidence            477788999999999999999999999999999654321111     134789999999999999999999999666 77


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .|+|||||-|+-.+.+.-..+++-+.++..|+.+.+.||+|||+++.+|+|||..|||+++.|.|||+|||++....   
T Consensus       101 aWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            89999999998888888888999999999999999999999999999999999999999999999999999998753   


Q ss_pred             CCCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          172 KPYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                       +.....||++|||||++.  ..++|+-+.||||||++.-+++..++|+.+.+....+.-|....++..+          
T Consensus       178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq----------  246 (948)
T KOG0577|consen  178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----------  246 (948)
T ss_pred             -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC----------
Confidence             346789999999999983  5578999999999999999999999999999988887777654333322          


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               .+..|..+++||..||++-|.+|||++++|+|+|...=.
T Consensus       247 -------------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  247 -------------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             -------------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                                     233688999999999999999999999999999987633

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.2e-44  Score=327.95  Aligned_cols=257  Identities=28%  Similarity=0.413  Sum_probs=208.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCC-CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS-GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ...|.+.+.||+|++|.||+|....+ +..||+|.+.......        ...+..|+.+++.++||||+++++.+..+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~--------~~~~~~E~~~l~~l~Hpniv~~~~~~~~~  137 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ--------AAYARSELHCLAACDHFGIVKHFDDFKSD  137 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH--------HHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence            34599999999999999999998877 7788888764332111        11346799999999999999999998554


Q ss_pred             CCeEEEEccccccc-HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           89 HDSVYMVMEYMEHD-LKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        89 ~~~~~lv~e~~~~~-l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       ...|+||||++|+ +.+.+..   ...++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus       138 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        138 -DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             -CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence             7899999999864 4444332   2456899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          165 RQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ........  ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......+     
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-----  290 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-----  290 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----
Confidence            86543221  2334568999999999877 678999999999999999999999998877766555554321111     


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                     .+..++.++.+||.+||+.||++||++++++.|||++.+
T Consensus       291 -------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        291 -------------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                                           112378899999999999999999999999999998754

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.3e-44  Score=304.12  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=207.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcc-cccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKE-DCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      +|.+...||.|++|.||+|.+..++..+++|.+........ ..........+.+|+.++++++||||+++++.+.+. .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-D   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Confidence            47788999999999999999988899999998875543221 111111122466899999999999999999998554 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++++||++++.+.......+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            88999999987655555555678999999999999999999999999999999999999999999999999988765422


Q ss_pred             CC------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          171 LK------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       171 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..      ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+......++.....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  229 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---------  229 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---------
Confidence            11      1123457788999999876 5678899999999999999999999987665444333322100         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                 ...+..++..+.++|++||+.||.+||++.++++||||
T Consensus       230 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         230 ---------------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ---------------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                       01122378899999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-47  Score=306.01  Aligned_cols=258  Identities=28%  Similarity=0.503  Sum_probs=221.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      -|.++++||+|++|.||+++++.+|..+|||.+.....-.          .+..|+.++.++.++++++++|.++.. ..
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQ----------EIIKEISIMQQC~S~yVVKYYGSYFK~-sD  102 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQ----------EIIKEISIMQQCKSKYVVKYYGSYFKH-SD  102 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHH----------HHHHHHHHHHHcCCchhhhhhhhhccC-Cc
Confidence            4889999999999999999999999999999997654322          467999999999999999999999766 66


Q ss_pred             EEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      +|||||||+ |+..+.++.+++++++.++..++...+.+|+|||...-+|+|||..|||+..+|..||.|||.+...+..
T Consensus       103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            999999999 5677788888999999999999999999999999999999999999999999999999999999988776


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .....+.+||+.|+|||++.. -.|+..+||||||++.-||+.|++||.+-.....   ++.....|+..          
T Consensus       183 MAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPT----------  248 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPT----------  248 (502)
T ss_pred             HHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCC----------
Confidence            667788999999999999987 5689999999999999999999999987654322   22111111111          


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                           +..+...|.++.+||++||-+.|++|.++-++++|||+++...-
T Consensus       249 ---------------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  249 ---------------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             ---------------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence                                 11122268899999999999999999999999999999987643

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=301.76  Aligned_cols=257  Identities=30%  Similarity=0.469  Sum_probs=208.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||+|.+..+++.+++|++.......        ...+.+|+.++++++|||++++++.+..+ .
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--------FEIIQQEISMLKECRHPNIVAYFGSYLRR-D   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhh--------HHHHHHHHHHHHhCCCCChhceEEEEEeC-C
Confidence            57999999999999999999999889999999997543221        12567899999999999999999988554 7


Q ss_pred             eEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..+++|||++++.+..+.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            899999999986555544433 7899999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCCccccccccccchhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGA--KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      .........++..|+|||.+...  ..++.++|+||||+++|+|++|..||...........+......+.         
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  224 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP---------  224 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc---------
Confidence            33333455678889999998652  2678899999999999999999999987665544433322210000         


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                                             .......++.++.+|+.+||..+|.+||++.+++.|+|
T Consensus       225 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 -----------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -----------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                                   00011225778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-44  Score=306.04  Aligned_cols=282  Identities=49%  Similarity=0.889  Sum_probs=224.1

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      |++.+.||.|++|.||++.+..+++.+++|.+........      ....+..|+..+++++|++++++++.+..+ ...
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~   73 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG------IPKTALREIKLLKELNHPNIIKLLDVFRHK-GDL   73 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch------hHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCE
Confidence            6788999999999999999998999999999875443211      112456899999999999999999998544 789


Q ss_pred             EEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC
Q 035861           93 YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK  172 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~  172 (332)
                      ++|+||+++++.+.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        74 ~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          74 YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             EEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            99999999998888877667899999999999999999999999999999999999999999999999999877654432


Q ss_pred             CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccc
Q 035861          173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK  252 (332)
Q Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (332)
                      ......++..|+|||.+.+...++.++|+||||+++|++++|..||...+..+....+......+....++.+.......
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            33345678889999998875578999999999999999999999999888877777776665555444443332211100


Q ss_pred             -ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          253 -ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       253 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                       .....        ..........+.++..+++||.+||+.||.+||++++++.||||
T Consensus       234 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPK--------KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhcc--------ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence             00000        00000011223478899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-44  Score=313.91  Aligned_cols=293  Identities=40%  Similarity=0.661  Sum_probs=227.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC--
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH--   89 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   89 (332)
                      +|++.+.||.|++|.||+|++..+++.++||.+.......      .....+.+|+..++.++|+||+++.+++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL------IDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc------hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            5899999999999999999999889999999987543211      11225678999999999999999999985553  


Q ss_pred             --CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 --DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                        ...|++|||+++++...+.. ...+++..++.++.||+.||++||+.|++|+||||.||+++.++.++|+|||.+...
T Consensus        75 ~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          75 DFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             cccceEEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence              36899999999877666654 558999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          168 GSPL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       168 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ....   .......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            4432   1233456788899999998754789999999999999999999999999988888888877766555443321


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ......... .     ...............+.++..+.+||.+||+++|++||++++++.||||.++.-+..
T Consensus       234 ~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         234 ITSEKARNY-L-----KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             ccccchhhH-H-----hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence            111000000 0     000000000011112347889999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.5e-44  Score=315.11  Aligned_cols=292  Identities=39%  Similarity=0.693  Sum_probs=226.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (332)
                      .+|++.+.||.|++|.||+|.+..++..|++|++.......      .....+.+|+.++++++||||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP------TLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc------cchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            68999999999999999999999999999999986532211      112245689999999999999999987743   


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .....++|+||++|++.+.+.. ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          79 DFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             CCceEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            2356899999999877666654 567999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCC----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPLK----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .....    ......++..|+|||.+.....++.++|+||||+++|+|++|..||...+.......+....+.++...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            32211    11234678899999998765668999999999999999999999998887777766666666665544433


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      ........         ... ...+...    ....+.++..+.++|.+||+.+|++||++++++.||||.+.+.+....
T Consensus       238 ~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~  307 (334)
T cd07855         238 RIGSDRVR---------KYI-QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP  307 (334)
T ss_pred             hhchhhHH---------HHH-hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc
Confidence            22110000         000 0000000    011234688999999999999999999999999999999888766533

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=303.81  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=210.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+........       ...+.+|+..++.+.|+|++++.+.+.++ .
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   72 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-------IEDIQQEIQFLSQCRSPYITKYYGSFLKG-S   72 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH-------HHHHHHHHHHHHHcCCCCeeeeeEEEEEC-C
Confidence            479999999999999999999999999999999875432111       11356899999999999999999998655 8


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+|+++++.+...... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          73 KLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eEEEEEEeeCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            89999999987554444442 38999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.......             
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  217 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS-------------  217 (274)
T ss_pred             ccccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCC-------------
Confidence            333445567888999999987 558999999999999999999999997765443333222211000             


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                            .....++..+.+++.+||..+|++||+++++++||||.+...
T Consensus       218 ----------------------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         218 ----------------------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ----------------------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                                  001116788999999999999999999999999999988543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=340.64  Aligned_cols=279  Identities=26%  Similarity=0.380  Sum_probs=235.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|.+++.||+|+||.|.+++++.|++.||.|++.+-...+     +....-|++|-.+|.--+.+=|+.++..| +++
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-----r~~tA~F~EERDimv~~ns~Wiv~LhyAF-QD~  147 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-----RAETACFREERDIMVFGNSEWIVQLHYAF-QDE  147 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-----chhHHHHHHHhHHHHcCCcHHHHHHHHHh-cCc
Confidence            469999999999999999999999999999999997632221     12223567888888877888888888888 666


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      .++|+||||++| +++..+.+.. .+++..++.++..|..||..||+.|+|||||||+|||+|..|+++|.|||.|...+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            999999999986 5666666644 99999999999999999999999999999999999999999999999999998876


Q ss_pred             CCC-CCCccccccccccchhhhcC---C-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          169 SPL-KPYTSLVVTLWYRAPELLLG---A-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~---~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..+ -......|||.|.|||++..   + +.|+...|.|||||++|||+.|..||...+.-+++.+|++-..        
T Consensus       227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~--------  298 (1317)
T KOG0612|consen  227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE--------  298 (1317)
T ss_pred             CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh--------
Confidence            433 34566789999999999852   2 5789999999999999999999999999999999999886410        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT---VDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~f~~~~~~~~~~~  320 (332)
                                               ...++....+|.++++||.+++.. |+.|..   ++++-.||||.++.|..++..
T Consensus       299 -------------------------~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~iR~~  352 (1317)
T KOG0612|consen  299 -------------------------SLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNIRES  352 (1317)
T ss_pred             -------------------------hcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhhhhc
Confidence                                     011112234899999999998874 889998   999999999999999999999


Q ss_pred             CCCCCCccc
Q 035861          321 MPTFPPQHA  329 (332)
Q Consensus       321 ~~~~~~~~~  329 (332)
                      .|++-|-.-
T Consensus       353 ~pP~vPevs  361 (1317)
T KOG0612|consen  353 VPPVVPEVS  361 (1317)
T ss_pred             CCCCCCcCC
Confidence            999988643

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.2e-43  Score=302.03  Aligned_cols=255  Identities=24%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcC-
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDD-   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-   88 (332)
                      +.|++.+.||.|++|.||+|.+..+++.+|+|++.......         ..+..|+..++++ .|+|++++.+.+... 
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---------EEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccH---------HHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            46899999999999999999999999999999986543211         1356888999888 799999999998643 


Q ss_pred             ----CCeEEEEccccccc-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           89 ----HDSVYMVMEYMEHD-LKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        89 ----~~~~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                          ....++++||++++ +.+.+... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence                24689999999874 44444432 3468999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT  238 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  238 (332)
                      .+..............|+..|+|||++..    ...++.++|+||+|+++|+|++|..||...............     
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-----  231 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-----  231 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-----
Confidence            98765433333445678889999999863    235788999999999999999999999765443322221110     


Q ss_pred             CCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                    .........++..+.+|+.+||..+|.+||++.++++||||
T Consensus       232 ------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 ------------------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------------------------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                                          00011122367889999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-43  Score=312.10  Aligned_cols=288  Identities=36%  Similarity=0.611  Sum_probs=215.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC-
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH-   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   89 (332)
                      .+|.+.+.||.|++|.||+|.+..++..|++|.+.......        ...+.+|+.+++.++||||+++++.+.... 
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~--------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--------VKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch--------HHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            58999999999999999999999999999999986543211        124568999999999999999998764432 


Q ss_pred             ------------CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcE
Q 035861           90 ------------DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVL  156 (332)
Q Consensus        90 ------------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~  156 (332)
                                  ...++|+||+++++...+.  ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                        3578999999987766554  357999999999999999999999999999999999999985 4578


Q ss_pred             EEeecccccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 035861          157 KICDFGMSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT  233 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~  233 (332)
                      +++|||.+........   ......++..|+|||.+.....++.++|+||||+++|+|++|..||...+..+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999875432211   1122356788999998876567889999999999999999999999888877666666554


Q ss_pred             cCCCCCCcccCCCC-CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          234 LGTPTETIWPGLSE-LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      ...........+.. .+...........        .......+.++.++++||.+||+.||.+||+++++++||||+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPR--------RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccC--------CCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            33222211111000 0000000000000        00001123478899999999999999999999999999999987


Q ss_pred             CCCC
Q 035861          313 PLPK  316 (332)
Q Consensus       313 ~~~~  316 (332)
                      ..+.
T Consensus       307 ~~~~  310 (342)
T cd07854         307 SCPF  310 (342)
T ss_pred             cCCc
Confidence            6654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.9e-44  Score=313.65  Aligned_cols=308  Identities=36%  Similarity=0.642  Sum_probs=228.0

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      ....++|++.+.||+|++|.||+|.+..+++.+++|++.........      ...+..|+.+++++ +|+||+++++++
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~------~~~~~~E~~~l~~l~~h~ni~~~~~~~   76 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD------AQRTFREIMFLQELGDHPNIVKLLNVI   76 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh------hhhhhHHHHHHHHhcCCCCccceeeee
Confidence            34567999999999999999999999988999999988643211111      12345799999999 999999999988


Q ss_pred             EcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ... ....++|+|++++++...+.. . .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        77 ~~~~~~~~~lv~e~~~~~L~~~~~~-~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          77 KAENDKDIYLVFEYMETDLHAVIRA-N-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             ccCCCceEEEEecccccCHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            543 356899999999887666654 2 7899999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCC-----CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          165 RQYGSPL-----KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       165 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      .......     .......++..|+|||.+.....++.++|+||||+++|+|++|..||..........++....+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            7653221     12223457888999998876567889999999999999999999999888777777776665544433


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC-
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK-  318 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~-  318 (332)
                      ..+..+...      .....................+.++.++.+||.+||+.||++||++.++++||||+++..+... 
T Consensus       235 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         235 EDIESIKSP------FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             HHHHHHHhh------hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence            221111000      0000000000000001111223378899999999999999999999999999999998765443 


Q ss_pred             CCCCCCCCcc
Q 035861          319 DFMPTFPPQH  328 (332)
Q Consensus       319 ~~~~~~~~~~  328 (332)
                      ....+..|..
T Consensus       309 ~~~~~~~~~~  318 (337)
T cd07852         309 VLPYPITIPL  318 (337)
T ss_pred             CCCCCccCCc
Confidence            2334434443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-44  Score=308.05  Aligned_cols=262  Identities=26%  Similarity=0.466  Sum_probs=212.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .+.|.....||.|++|.||++.+..++..||||.+.......        ...+.+|+..++.++|+|++++++.+..+ 
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-   91 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--------RELLFNEVVIMRDYHHENVVDMYNSYLVG-   91 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHH--------HHHHHHHHHHHHhCCCCcHHHHHHheecC-
Confidence            356777888999999999999999899999999886432111        11456899999999999999999998554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|+||++++.+..+.. ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        92 ~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658          92 DELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            78899999999876665554 45689999999999999999999999999999999999999999999999998876543


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+ ..++.++|+||+|+++|++++|..||...........+........           
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  238 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-----------  238 (292)
T ss_pred             ccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-----------
Confidence            3333344567889999999876 6688999999999999999999999987766554443322211110           


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                             .....++..+.+++.+||..||.+||+++++++||||.....+.
T Consensus       239 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         239 -----------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             -----------------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                                   01122678899999999999999999999999999999977666

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-43  Score=299.55  Aligned_cols=253  Identities=30%  Similarity=0.519  Sum_probs=207.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||+|++..++..+++|.+.....          ...+.+|+..++.++|+|++++++.+..+ .
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------LQEIIKEISILKQCDSPYIVKYYGSYFKN-T   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----------HHHHHHHHHHHHhCCCCcEeeeeeeeecC-C
Confidence            589999999999999999999998899999999865432          12567899999999999999999999555 7


Q ss_pred             eEEEEcccccccH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..|+++|+++++. .+.+......+++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+.....
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            8999999999754 444444467789999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...                
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------  214 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----------------  214 (256)
T ss_pred             CccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----------------
Confidence            3333344557888999999877 57899999999999999999999999865543322211110                


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                        .......+..++..+.++|.+||+.||++||++.|+|+||||
T Consensus       215 ------------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 ------------------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ------------------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                              000111123367889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-43  Score=300.02  Aligned_cols=254  Identities=26%  Similarity=0.500  Sum_probs=208.7

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||+|++|++|.++...+++.+++|.+.........      ...+.+|+..+++++|+||+++.+.+ .+...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~   73 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE------REESRKEVAVLSNMKHPNIVQYQESF-EENGN   73 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH------HHHHHHHHHHHHhCCCCCeeeeEeee-cCCCe
Confidence            589999999999999999999999999999998754332211      12467899999999999999999988 45578


Q ss_pred             EEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++|+||+.+ ++.+.+.... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999986 5555554432 3589999999999999999999999999999999999999999999999999876644


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+ ..++.++|+||||+++|++++|..||......+....+......+            
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd08218         154 TVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP------------  220 (256)
T ss_pred             chhhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC------------
Confidence            3332334457888999999876 668899999999999999999999998777666555543321110            


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                              .+..++.++.++|.+||+.+|++||++.++++||||
T Consensus       221 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         221 ------------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ------------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                                    112368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-43  Score=335.04  Aligned_cols=270  Identities=27%  Similarity=0.418  Sum_probs=213.8

Q ss_pred             ccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861            3 MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus         3 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      ...|...+.+|.+++.||.|+||+||++++..++..+|+|++.........      ...+..|+.+++++.||||++++
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~------~~~~~~EI~IL~~L~HPNIVrl~   78 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE------KSQLVIEVNVMRELKHKNIVRYI   78 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHH------HHHHHHHHHHHHHcCCCCcCeEE
Confidence            446777889999999999999999999999999999999998754332211      12467899999999999999999


Q ss_pred             eeEEcC-CCeEEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccccCCCCCEEE
Q 035861           83 EVVMDD-HDSVYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDN-------WVLHRDLKTSNLLL  150 (332)
Q Consensus        83 ~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~-------~i~H~di~p~Nili  150 (332)
                      +.+... ...+||||||+++ +|...+...   ...+++..++.|+.||+.||+|||+.       +|+|+||||+||||
T Consensus        79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            988543 4678999999986 555544432   36799999999999999999999985       49999999999999


Q ss_pred             cC-----------------CCcEEEeecccccccCCCCCCCccccccccccchhhhcC-CCCCCchhHHHHHHHHHHHHH
Q 035861          151 NN-----------------QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELL  212 (332)
Q Consensus       151 ~~-----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~~ll  212 (332)
                      +.                 .+.++|+|||++....... ......|++.|+|||++.. ...++.++||||||+++|+|+
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence            64                 2359999999997654322 2234578999999999864 245789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCC
Q 035861          213 AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY  292 (332)
Q Consensus       213 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  292 (332)
                      +|..||...................                                    +.+.++..+.+||..||+.
T Consensus       238 TGk~PF~~~~~~~qli~~lk~~p~l------------------------------------pi~~~S~eL~dLI~~~L~~  281 (1021)
T PTZ00266        238 SGKTPFHKANNFSQLISELKRGPDL------------------------------------PIKGKSKELNILIKNLLNL  281 (1021)
T ss_pred             HCCCCCCcCCcHHHHHHHHhcCCCC------------------------------------CcCCCCHHHHHHHHHHhcC
Confidence            9999998765544333332211000                                    0122578899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCCC
Q 035861          293 DPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       293 dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      +|.+||++.++|.|||+..+..+
T Consensus       282 dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        282 SAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             ChhHCcCHHHHhccHHHhhcCCC
Confidence            99999999999999999987654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-43  Score=301.40  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=208.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|+||+|....++..+++|++........       ...+.+|+..++.++|+|++++++.+.. ..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   72 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-------VDELRKEVQAMSQCNHPNVVKYYTSFVV-GD   72 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchH-------HHHHHHHHHHHHhcCCCCEEEEEEEEee-CC
Confidence            479999999999999999999988899999999865432221       1246789999999999999999998854 47


Q ss_pred             eEEEEcccccccHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           91 SVYMVMEYMEHDLKWLMESMK---QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ..++++|+++|+.+.......   ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.++|+|||.+...
T Consensus        73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            899999999875544444332   46899999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCCC----CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPLKP----YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ......    .....++..|+|||.+.....++.++|+||||+++|+|++|..||...+......+...........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  229 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET---  229 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCC---
Confidence            433222    2334678899999998875578999999999999999999999998766554444433221100000   


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                  ......+++.+.+++.+||..||++||++++|++||||
T Consensus       230 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         230 ----------------------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ----------------------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                                        00012378889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-43  Score=302.66  Aligned_cols=261  Identities=26%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||.|+||+||++.+..+++.+++|.+..........     ...+..|+.++++++|||++++++.+. .....|+|+||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG-----EQMALNEKKILEKVSSRFIVSLAYAFE-TKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhh-----hHHHHHHHHHHHhCCCCCEeeeeeEEe-cCCeEEEEEec
Confidence            689999999999999999999999987543221111     124568999999999999999999884 44789999999


Q ss_pred             cccc-HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcc
Q 035861           99 MEHD-LKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS  176 (332)
Q Consensus        99 ~~~~-l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~  176 (332)
                      ++|+ +.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... ......
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~  153 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKG  153 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccc
Confidence            9975 444444422 3689999999999999999999999999999999999999999999999998875432 222234


Q ss_pred             ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ..++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+.....                     
T Consensus       154 ~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------  211 (277)
T cd05577         154 RAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL---------------------  211 (277)
T ss_pred             ccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc---------------------
Confidence            456778999999876 5589999999999999999999999976554222222211100                     


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCCCC
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~~~  320 (332)
                                  ......++.+++.+.++|.+||+.+|++||     ++.++++||||.++++......
T Consensus       212 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~  268 (277)
T cd05577         212 ------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAG  268 (277)
T ss_pred             ------------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcC
Confidence                        001112233688999999999999999999     8899999999999998777543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-44  Score=314.18  Aligned_cols=296  Identities=34%  Similarity=0.603  Sum_probs=228.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||.|++|+||+|++..++..||+|++........      ....+.+|+.+++.+.|+|++++.+.+...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI------HAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh------HHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            45689999999999999999999999999999998864321111      112456799999999999999999877443


Q ss_pred             CC-----eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 HD-----SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~~-----~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ..     ..++|+|++++++.+.+..  ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          87 SSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence            22     4899999998877666553  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +......   .....++..|+|||.+.+...++.++|+||||+++|++++|..||...+.......+....+.+++..+.
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            8865432   2344677889999998765578899999999999999999999999888877777777766555544333


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCC---c-cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAA---S-FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .+.....          .......+..   . ......++..+.+||.+||+.+|++||++.+|++||||.++.-+....
T Consensus       242 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~  311 (343)
T cd07851         242 KISSESA----------RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP  311 (343)
T ss_pred             hccchhH----------HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc
Confidence            3221000          0000000000   0 011123688999999999999999999999999999999988776555


Q ss_pred             CCCCCC
Q 035861          320 FMPTFP  325 (332)
Q Consensus       320 ~~~~~~  325 (332)
                      ..+.+.
T Consensus       312 ~~~~~~  317 (343)
T cd07851         312 VAPPYD  317 (343)
T ss_pred             cccccC
Confidence            444444

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.3e-43  Score=299.26  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=205.1

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||.|++|.||++++..+++.+++|++..........     ...+.+|+..++.++|+||+++++.+. +....++++||
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-----QEHIFSEKEILEECNHPFIVKLYRTFK-DKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhH-----HHHHHHHHHHHHhCCCCCEeeeeeeEE-cCCccEEEEec
Confidence            699999999999999999999999997654322111     124678999999999999999999884 44789999999


Q ss_pred             ccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 035861           99 MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV  178 (332)
Q Consensus        99 ~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  178 (332)
                      ++|+.+.........+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        75 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          75 CLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            9875555554446679999999999999999999999999999999999999999999999999988764332 223346


Q ss_pred             ccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT--EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       179 ~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ++..|+|||.+.. ..++.++|+||+|+++|++++|..||....  .......+......                    
T Consensus       154 ~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------  212 (262)
T cd05572         154 GTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK--------------------  212 (262)
T ss_pred             CCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC--------------------
Confidence            7888999999876 568899999999999999999999998766  43333333311100                    


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLP  315 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~  315 (332)
                                     ...+...+.++.++|.+||+.+|++||+     ++|+++||||+++.|.
T Consensus       213 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         213 ---------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence                           0111224788999999999999999999     9999999999998764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.9e-44  Score=305.25  Aligned_cols=260  Identities=21%  Similarity=0.358  Sum_probs=206.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|++|.||+|.+..++..||+|++........       ...+.+|+.++++++|||++++++.+... .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~   72 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL-------QKQIMSELEILYKCDSPYIIGFYGAFFVE-N   72 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHH-------HHHHHHHHHHHHhCCCCCeeeEEEEEEEC-C
Confidence            378999999999999999999999999999999865422111       12467899999999999999999999554 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+||++++.++..    ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 ~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          73 RISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             EEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            78999999998766543    35789999999999999999999999999999999999999999999999998765332


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHcCCCCCCcccCCCC
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ---IDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  247 (332)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........   ...........          
T Consensus       149 --~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  215 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----------  215 (279)
T ss_pred             --cccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----------
Confidence              2234578889999999876 5689999999999999999999999965322110   00111110000          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                           .........+++++++|+.+||+.+|++||+++++++||||.+.....
T Consensus       216 ---------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         216 ---------------------DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             ---------------------CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence                                 000011223678899999999999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.8e-43  Score=302.86  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=205.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ..++|++.+.||+|++|.||++....+++.+++|++.......         ..+..|+.+++++ +|||++++++++..
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~---------~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD---------EEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHH---------HHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            4568999999999999999999999999999999986432111         1345788888888 89999999999854


Q ss_pred             CC----CeEEEEcccccccHHH-HHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           88 DH----DSVYMVMEYMEHDLKW-LME---SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        88 ~~----~~~~lv~e~~~~~l~~-~~~---~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                      .+    ...++|+||++|+.+. .+.   .....+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence            32    4689999999875443 332   234678999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      |||.+..............++..|+|||.+....    .++.++|+||||+++|+|++|..||...........+.....
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            9999876543332333456788899999986432    368899999999999999999999987665544433322110


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                        +                                .......++..+.+||.+||+.+|++||++.++++||||+
T Consensus       251 --~--------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 --P--------------------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             --C--------------------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence              0                                0001122567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-43  Score=310.64  Aligned_cols=296  Identities=36%  Similarity=0.617  Sum_probs=226.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|++|+||++.+..++..||||++........      ....+.+|+.+++.++|+||+++++.+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchH------HHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            45689999999999999999999999999999999864321110      112456899999999999999999988544


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .     ..+++|++++++++...+.  ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          87 LSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccccceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            2     2468999999776655544  45799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +......   .....++..|+|||.+.+...++.++|+||||+++|++++|..||...+.......+.......+..+..
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         165 ARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8765332   2334568889999998765568899999999999999999999999887776666666654443333222


Q ss_pred             CCCCCccccccccCCchhhhhhhCCC----CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPA----ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .+....          ........+.    ......+.++..+.++|.+||+.||++||++.++++||||..+...+...
T Consensus       242 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~  311 (343)
T cd07880         242 KLQSED----------AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET  311 (343)
T ss_pred             hhcchh----------HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc
Confidence            221100          0000000111    11112345788899999999999999999999999999999987766655


Q ss_pred             CCCCCC
Q 035861          320 FMPTFP  325 (332)
Q Consensus       320 ~~~~~~  325 (332)
                      ..+++.
T Consensus       312 ~~~~~~  317 (343)
T cd07880         312 EAPPYD  317 (343)
T ss_pred             CCCCcc
Confidence            555444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.7e-43  Score=295.96  Aligned_cols=254  Identities=31%  Similarity=0.513  Sum_probs=209.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++++.||.|++|.||.++...+++.+++|.+.........      ...+.+|+.++++++|+||+++++.+.+. ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~   73 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE------RRDALNEIVILSLLQHPNIIAYYNHFMDD-NT   73 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH------HHHHHHHHHHHHhCCCCCeeEEEeEEecC-Ce
Confidence            589999999999999999999999999999998754432221      12456899999999999999999999554 78


Q ss_pred             EEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++++||++| ++.+.+... ...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 ~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            9999999986 454444443 35689999999999999999999999999999999999999999999999999887644


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|.|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+......+            
T Consensus       154 ~~~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd08221         154 EYSMAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP------------  220 (256)
T ss_pred             ccccccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence            3333345568899999999876 558899999999999999999999998877666555554321110            


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                              ....++..+.+++.+||+.+|++||+++++|+|||+
T Consensus       221 ------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         221 ------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                                    012368889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.9e-43  Score=298.21  Aligned_cols=259  Identities=26%  Similarity=0.415  Sum_probs=205.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|+||+||+|.. .+++.+|+|.+..........  ......+.+|++.+++++|+||+++.+.+.+. ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAA--EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhH--HHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-Ce
Confidence            588999999999999999987 468899999987543321111  01112467899999999999999999999554 88


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC-
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~-  170 (332)
                      .++++||++|+.+.........+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999998666665555678999999999999999999999999999999999999999999999999988754211 


Q ss_pred             -----CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          171 -----LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       171 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                           ........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.......        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM--------  227 (265)
T ss_pred             ccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC--------
Confidence                 111223457888999999876 568899999999999999999999998765444333322211110        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                ...+..++.++.++|.+||+.+|++||++.++++||||
T Consensus       228 --------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 --------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                      01123378899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-43  Score=309.41  Aligned_cols=291  Identities=36%  Similarity=0.615  Sum_probs=221.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|.+.+.||.|++|.||+|.+..+++.||+|++.......      .....+.+|+.+++.+.|+||+++++++....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE------IFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc------cchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            468999999999999999999999899999999886532111      11224678999999999999999999885432


Q ss_pred             -----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           90 -----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        90 -----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                           ..+++|+|++.+++....   ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          88 SGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             cCCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence                 347899999987654432   346899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      .....   ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+....+.+.......
T Consensus       165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         165 RHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             cCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            76432   223446688899999987655689999999999999999999999998887777777776655444433322


Q ss_pred             CCCCccccccccCCchhhhhhhCCC-CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPA-ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      +........ ..      .....+. ......+..+..+.+||.+||+.||.+||++++++.||||..+...+...
T Consensus       242 ~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~  310 (342)
T cd07879         242 LEDKAAKSY-IK------SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET  310 (342)
T ss_pred             hcccchHHH-Hh------hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence            221110000 00      0000000 00111234678899999999999999999999999999999987544433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-43  Score=312.63  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=194.7

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      -++|++.+.||.|+||.||+|.+.     .++..||+|++........       ...+.+|+.++..+ +||||+++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~niv~~~~   78 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE-------HKALMSELKILIHIGNHLNVVNLLG   78 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHH-------HHHHHHHHHHHHHhccCcceeeEEe
Confidence            358999999999999999999752     3456899999864322111       12467899999999 8999999999


Q ss_pred             eEEcCCCeEEEEccccccc-HHHHHHhc----------------------------------------------------
Q 035861           84 VVMDDHDSVYMVMEYMEHD-LKWLMESM----------------------------------------------------  110 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~----------------------------------------------------  110 (332)
                      .+.......++||||++|+ +.+.+...                                                    
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (338)
T cd05102          79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN  158 (338)
T ss_pred             EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence            8866666789999999864 44444321                                                    


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccc
Q 035861          111 ---------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVV  179 (332)
Q Consensus       111 ---------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~  179 (332)
                               ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........  ......+
T Consensus       159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                     12477888999999999999999999999999999999999999999999999876432211  1123345


Q ss_pred             cccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCC
Q 035861          180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQ  258 (332)
Q Consensus       180 ~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (332)
                      +..|+|||++.+ ..++.++||||||+++|+|++ |..||.................                       
T Consensus       239 ~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-----------------------  294 (338)
T cd05102         239 PLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-----------------------  294 (338)
T ss_pred             CccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-----------------------
Confidence            678999999876 678999999999999999997 9999977544332222221100                       


Q ss_pred             chhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          259 PYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                  ....+..+++.+.+|+.+||+.||++||++.++++
T Consensus       295 ------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 ------------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                        00112236888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.6e-43  Score=300.59  Aligned_cols=260  Identities=28%  Similarity=0.492  Sum_probs=209.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|...+.||.|++|.||++.+..+++.+++|++........        ..+.+|+.+++.+.|+|++.+++.+..+ .
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~   89 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR--------ELLFNEVVIMRDYQHPNIVEMYSSYLVG-D   89 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHH--------HHHHHHHHHHHHcCCCChheEEEEEEcC-C
Confidence            467777899999999999999988899999998864332111        1356899999999999999999988544 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++++|+++|+.+...... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          90 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             eEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            78999999987555554443 67999999999999999999999999999999999999999999999999987654333


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.......             
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------------  234 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-------------  234 (285)
T ss_pred             CcccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-------------
Confidence            222334568889999999876 568899999999999999999999998766555544433221000             


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                           ......++..+.+|+.+||+.+|++||++.++++||||.+...+
T Consensus       235 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         235 ---------------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             ---------------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                                 00112267889999999999999999999999999999996643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.7e-43  Score=297.58  Aligned_cols=255  Identities=29%  Similarity=0.481  Sum_probs=207.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc-CCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD-DHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   90 (332)
                      +|++++.||.|++|.||++.+..++..+++|++.........      ...+..|+..+++++|+|++++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE------KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH------HHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            589999999999999999999999999999998754332211      1245689999999999999999998754 345


Q ss_pred             eEEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           91 SVYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLH-----DNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh-----~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      ..++++||+++ ++.+.+...   ...+++..++.++.||+.||++||     +.+++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            68999999986 444444432   467999999999999999999999     889999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....      
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  227 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF------  227 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC------
Confidence            998876543332344568889999999877 5688999999999999999999999988765444333322110      


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                    ...+..++..+.+++.+||+.+|++||++++|++|||+
T Consensus       228 ------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 ------------------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                          01122367889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=300.59  Aligned_cols=257  Identities=28%  Similarity=0.449  Sum_probs=205.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   88 (332)
                      .++|++.+.||.|++|+||+|.+..+++.+++|++.......         ..+.+|+.+++++ .|+||+++++.+...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---------EEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhH---------HHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            478999999999999999999999889999999987543211         1456899999998 799999999998543


Q ss_pred             -----CCeEEEEcccccccHHHHHH-h---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           89 -----HDSVYMVMEYMEHDLKWLME-S---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        89 -----~~~~~lv~e~~~~~l~~~~~-~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                           ....++||||++++.+..+. .   .+..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence                 24589999999975444332 2   24679999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      |||.+..............++..|+|||.+...    ..++.++|+||||+++|++++|..||...........+.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            999987654443444456688899999987532    3467899999999999999999999976655444433322110


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                         .                               .......++..+++||.+||..||++|||++++++|||+
T Consensus       236 ---~-------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 ---P-------------------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ---C-------------------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence               0                               001112267889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.7e-43  Score=298.07  Aligned_cols=260  Identities=26%  Similarity=0.414  Sum_probs=203.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-C
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-H   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   89 (332)
                      .+|++.+.||+|++|.||++.+..++..|++|++...........   ....+.+|+.+++.++|+||+++++.+... .
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK---EVSALECEIQLLKNLQHERIVQYYGCLRDRAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHH---HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence            479999999999999999999999999999999875443221110   012456899999999999999999987543 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++++|+++++.+.......+.+++...+.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            67889999998754444444466799999999999999999999999999999999999999999999999998875432


Q ss_pred             CC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          170 PL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..   .......++..|+|||.+.+ ..++.++|+||+|+++|++++|..||................   ..       
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~~-------  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---TN-------  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---CC-------
Confidence            11   11223457888999999876 678999999999999999999999998765444333222110   00       


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                               ...+..+++.+++++ +||..+|++||+++||++||||+
T Consensus       228 -------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 -------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             -------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                     011123677888999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8e-43  Score=303.68  Aligned_cols=260  Identities=27%  Similarity=0.464  Sum_probs=211.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      -...|++.+.||+|++|+||+|+...+++.|++|++..........     ...+.+|+.+++.++|||++++.+.+..+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~-----~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK-----WQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHH-----HHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            3457999999999999999999999889999999986443222111     12467899999999999999999998554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...++|+||+.|++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        88 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          88 -HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             -CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence             7789999999999888877666789999999999999999999999999999999999999999999999999887643


Q ss_pred             CCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..    ....++..|+|||.+.+  ...++.++|+||||+++|++++|..||...+.......+.....  +.       
T Consensus       167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~-------  233 (307)
T cd06607         167 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PT-------  233 (307)
T ss_pred             CC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CC-------
Confidence            22    34467788999998742  35688899999999999999999999987765554333321100  00       


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                .....++..++++|.+||+.+|++||++.+++.||||..-.
T Consensus       234 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         234 --------------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             --------------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                                      00112577899999999999999999999999999998744

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.7e-43  Score=301.57  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc-
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD-   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-   87 (332)
                      .+.|++.+.||.|+||.||+|.+..+++.+++|++.......         ..+..|+..++++ .|+|++++++.+.. 
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~---------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---------EEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHH---------HHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            358999999999999999999999999999999986542211         1345788888888 79999999999853 


Q ss_pred             ----CCCeEEEEccccccc-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           88 ----DHDSVYMVMEYMEHD-LKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        88 ----~~~~~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                          .....+++|||++++ +.+.+... ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+||
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence                246789999999874 44444332 345889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |.+..............++..|+|||.+..    ...++.++|+||||+++|+|++|..||...........+....   
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---  242 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---  242 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---
Confidence            998765433333345568889999998753    2457889999999999999999999997655433322211110   


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                      ........++..+.+||.+||+.||.+||++.|||+||||
T Consensus       243 --------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 --------------------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                            0001112378899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.6e-43  Score=300.31  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=208.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|+.++.||.|++|.||+|.+..++..+|+|++........       ...+.+|+..++++.|+|++++++.+.++ .
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   75 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-------IEDIQQEITVLSQCDSPYVTKYYGSYLKG-T   75 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEEC-C
Confidence            468899999999999999999998899999999875432111       12466899999999999999999998554 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||++|+.+..... .+++++..+..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            8999999998755444444 457899999999999999999999999999999999999999999999999998765433


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+....  +             
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~-------------  218 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--P-------------  218 (277)
T ss_pred             ccccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--C-------------
Confidence            323334467888999999876 568999999999999999999999997665443332221100  0             


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                           ......++..+.+++.+||+.+|++||+++++++||||.+...
T Consensus       219 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         219 ---------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ---------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                                 0011225778899999999999999999999999999988654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-43  Score=303.35  Aligned_cols=260  Identities=27%  Similarity=0.483  Sum_probs=210.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|.....||.|+||.||++.+..++..||+|.+.......        ...+.+|+..++.+.|||++++++.+..+ .
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~   91 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--------RELLFNEVVIMRDYQHQNVVEMYKSYLVG-E   91 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch--------HHHHHHHHHHHHhCCCCchhhhhhheeeC-C
Confidence            45667778999999999999999899999999986533211        12456899999999999999999998554 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++++||++++.+..+.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        92 ~~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             eEEEEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            8999999999766555554 457899999999999999999999999999999999999999999999999998765433


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....   . .          
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~-~----------  235 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---P-P----------  235 (297)
T ss_pred             cccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---C-C----------
Confidence            333344568889999999976 568999999999999999999999998766554443332110   0 0          


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                          .......++..+.++|.+||+.+|++||+++++++||||.+...+
T Consensus       236 --------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         236 --------------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             --------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence                                001112367889999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=297.34  Aligned_cols=255  Identities=29%  Similarity=0.423  Sum_probs=200.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHH-HhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI-LLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      +.||.|++|.||+|.+..+++.||+|++...........     ..+..|... .....|+|++++++.+.. ....++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQV-----TNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHH-----HHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEE
Confidence            579999999999999998999999999865432111110     012334443 345589999999999854 4789999


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT  175 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~  175 (332)
                      +||++|+.+..+....+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....    ..
T Consensus        76 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999866565555567899999999999999999999999999999999999999999999999998875432    23


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF  255 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
                      ...++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.......+                 
T Consensus       152 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  213 (260)
T cd05611         152 KFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-----------------  213 (260)
T ss_pred             cCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC-----------------
Confidence            3457788999999877 4589999999999999999999999987776655544432211000                 


Q ss_pred             cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCCCCC
Q 035861          256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNHYWFHEVPLP  315 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~f~~~~~~  315 (332)
                                      ......++..+.++|.+||+.+|++||   +++|+++||||.+++|.
T Consensus       214 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         214 ----------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             ----------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence                            011123788999999999999999999   55799999999998763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.7e-43  Score=300.81  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ..++|++.+.||+|++|.||++.+..+++.+++|++.......         ..+..|+.+++.+ +|+|++++++.+..
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID---------EEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchH---------HHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4569999999999999999999999999999999875432111         1355788999898 79999999998742


Q ss_pred             ----CCCeEEEEcccccccHHH-HHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           88 ----DHDSVYMVMEYMEHDLKW-LME---SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        88 ----~~~~~~lv~e~~~~~l~~-~~~---~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                          +....++||||++|+.+. .+.   .....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                346789999999875443 332   234568999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      |||.+..............++..|+|||.+..    ...++.++|+||+|+++|+|++|..||...............  
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--  244 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--  244 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--
Confidence            99998765443333344568899999998853    244788999999999999999999999776543322221110  


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ..                                .....+..++..+.+||.+||+.||++||++.||++|+||
T Consensus       245 ~~--------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 PP--------------------------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CC--------------------------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            00                                0011112257789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-43  Score=302.01  Aligned_cols=263  Identities=24%  Similarity=0.407  Sum_probs=208.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++++.||+|++|.||++.+..++..+|+|.+....... .      ...+.+|+..+++++|+||+++++.+.. ..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-~------~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   72 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-K------FNQIIMELDILHKAVSPYIVDFYGAFFI-EG   72 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-H------HHHHHHHHHHHHhcCCCcHHhhhhheec-CC
Confidence            47999999999999999999999999999999886432111 0      1246789999999999999999998855 47


Q ss_pred             eEEEEcccccccHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           91 SVYMVMEYMEHDLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ..++|+||++|+.+..+...   ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+..
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            89999999998655555443   2378999999999999999999996 6999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAK-----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ....  ......++..|+|||.+.+..     .++.++|+||||+++|++++|..||...........+.......+   
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  227 (286)
T cd06622         153 LVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP---  227 (286)
T ss_pred             ccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC---
Confidence            5322  223345778899999985422     358899999999999999999999976544333333222111111   


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                                    ...++.++.++.+||.+||+.+|++||++++++.||||......+
T Consensus       228 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~  272 (286)
T cd06622         228 ------------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD  272 (286)
T ss_pred             ------------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCc
Confidence                                          111223788999999999999999999999999999999877553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-42  Score=304.05  Aligned_cols=292  Identities=34%  Similarity=0.609  Sum_probs=223.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|++.+.||.|++|.||++.+..+++.||+|++.......      .....+..|+.+++.++|||++++.+.+....
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            458999999999999999999999999999999886432211      11124568999999999999999999987666


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++++|++++++...+.  ...+++..+..++.|++.||++||+.|++|+||+|.||+++.++.++|+|||.+.....
T Consensus        83 ~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          83 EDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             CcEEEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            7789999999887655543  45688999999999999999999999999999999999999999999999998875432


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .   .....++..|+|||.+.+...++.++|+||||+++|++++|..||...........+.+..+.+++.+...+....
T Consensus       161 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         161 Q---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             C---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            2   2334567889999988765678999999999999999999999998877766666666665555544332221100


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      ....      ........+.......+.++..+.++|.+||+.+|++||++++++.||||..+..+..+
T Consensus       238 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         238 TLRF------VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             hHHH------HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            0000      00000000000001123468899999999999999999999999999999988877554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=307.09  Aligned_cols=295  Identities=34%  Similarity=0.580  Sum_probs=224.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||+|++|.||++.+..+++.||+|++.........      ...+.+|+.++++++|+||+++++.+....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH------AKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHH------HHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            46899999999999999999999989999999988653221110      124568999999999999999999874322


Q ss_pred             -----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           90 -----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        90 -----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                           ...|++++++++++.+.+.  ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        90 ~~~~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          90 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                 3478999998777755443  346999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      .....   ......++..|+|||.+.+...++.++|+||||+++|++++|..||...+.......+....+.++......
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         168 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            76432   223446788899999987656688999999999999999999999988877777777776665555544433


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCcc-CCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASF-TGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMP  322 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~~  322 (332)
                      +.......       +.......+.... ......++.+++||.+||+.||.+||++.++++||||+++..+.......
T Consensus       245 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~  316 (345)
T cd07877         245 ISSESARN-------YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD  316 (345)
T ss_pred             cccHhHHH-------HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC
Confidence            32211000       0000000011110 11123688899999999999999999999999999999988776655433

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=299.35  Aligned_cols=260  Identities=25%  Similarity=0.488  Sum_probs=208.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---CCCeeeeeeeEEcC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---HPSIVNVKEVVMDD   88 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   88 (332)
                      .|++.+.||.|++|.||+|.+..+++.+++|.+.........       ..+.+|+.+++++.   |||++++++.+.. 
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-   73 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-------SDIQREVALLSQLRQSQPPNITKYYGSYLK-   73 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhH-------HHHHHHHHHHHHhccCCCCCeeeEeeeeee-
Confidence            588999999999999999999999999999998654322111       13557888888886   9999999998854 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....++||||++|+.+..... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          74 GPRLWIIMEYAEGGSVRTLMK-AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            478999999998865555544 3479999999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..........|+..|+|||.+.+...++.++|+||||+++|+|++|..||...........+...  .+           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~-----------  219 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP-----------  219 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CC-----------
Confidence            44333444568889999999877566789999999999999999999999766543322211100  00           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                         +   ......++.++.+++.+||+.||++||++.++++||||++....
T Consensus       220 -------------------~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         220 -------------------P---RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             -------------------C---CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence                               0   00011267889999999999999999999999999999886643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-42  Score=301.82  Aligned_cols=266  Identities=26%  Similarity=0.446  Sum_probs=216.0

Q ss_pred             ccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861            3 MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus         3 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      +..+.....-|...+.||+|++|+||+|++..++..+++|++..........     ...+.+|+..++.++|+|+++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~   87 (313)
T cd06633          13 LFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK-----WQDIIKEVKFLQQLKHPNTIEYK   87 (313)
T ss_pred             HhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHH-----HHHHHHHHHHHHhCCCCCCccEE
Confidence            3445555566888889999999999999999999999999987543322111     11456899999999999999999


Q ss_pred             eeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           83 EVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +++.+. ...|+||||+.|++.+.+.....++++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||
T Consensus        88 ~~~~~~-~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633          88 GCYLKE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             EEEEeC-CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecC
Confidence            998554 7889999999999888887767789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      .+....    ......++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+.....  +  
T Consensus       167 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~--  238 (313)
T cd06633         167 SASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--P--  238 (313)
T ss_pred             CCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--C--
Confidence            886432    2234567888999999842  35688899999999999999999999987766555444432110  0  


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                     ....+.++..+++|+.+||+.+|.+||++.++++||||..-.
T Consensus       239 -------------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         239 -------------------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             -------------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                                           001122577899999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-43  Score=304.40  Aligned_cols=259  Identities=26%  Similarity=0.418  Sum_probs=207.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|+..+.||.|++|.||+|.+..++..||+|.+........       ...+.+|+..+++++|+||+++++.+.. ..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   75 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-------IEDIQQEITVLSQCDSPYITRYYGSYLK-GT   75 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHH-------HHHHHHHHHHHHcCCCCccHhhhccccc-CC
Confidence            468899999999999999999998899999998864432111       1246689999999999999999999854 47


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++|+||++++.+..... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ceEEEEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            8999999999765554443 457899999999999999999999999999999999999999999999999998765433


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+....                
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----------------  217 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS----------------  217 (277)
T ss_pred             chhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC----------------
Confidence            222334467888999999876 568899999999999999999999987654433222111100                


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                          .......++.++.++|.+||+.+|++||++.++++||||..+...
T Consensus       218 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06642         218 --------------------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK  262 (277)
T ss_pred             --------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence                                000112267889999999999999999999999999999876543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-43  Score=299.71  Aligned_cols=257  Identities=28%  Similarity=0.495  Sum_probs=206.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+........       ...+.+|++.++++.||||+++++.+..+ .
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   72 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-------QKQILRELDILHKCNSPYIVGFYGAFYNN-G   72 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHH-------HHHHHHHHHHHHHCCCCchhhhheeeecC-C
Confidence            478999999999999999999999999999999876532211       12467899999999999999999998555 8


Q ss_pred             eEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           91 SVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ..++++|+++| ++.+.+......+++..+..++.|++.||++||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus        73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            89999999995 4555444434789999999999999999999999 999999999999999999999999999887653


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHcCCCCCCccc
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT-----EVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....  ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||....     ..+....+...   ...    
T Consensus       153 ~~~~--~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~----  222 (265)
T cd06605         153 NSLA--KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPP----  222 (265)
T ss_pred             HHHh--hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CCC----
Confidence            2211  12567888999999877 578999999999999999999999997542     11111111110   000    


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                  ......++..++++|.+||..||++||++.+++.||||+..+
T Consensus       223 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         223 ----------------------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ----------------------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                                        000111688899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-43  Score=298.85  Aligned_cols=256  Identities=30%  Similarity=0.447  Sum_probs=207.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||++.+..++..+++|++..........     ...+.+|++.+++++||||+++++.+ .+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS-----VRNVLNERRILQELNHPFLVNLWYSF-QDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhH-----HHHHHHHHHHHHhCCCCChHHHHHhh-cCCCe
Confidence            5899999999999999999999899999999997644322111     12567899999999999999999988 45578


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++|+||+.|+.+........++++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999986655555545789999999999999999999999999999999999999999999999999887654321


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                       ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...... ....+......               
T Consensus       155 -~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~---------------  216 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET---------------  216 (258)
T ss_pred             -cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc---------------
Confidence             2344567888999999877 55899999999999999999999999876542 11111111100               


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH--HHHhcCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV--DDALNHYWF  309 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~ell~hp~f  309 (332)
                                        .....++.++..+.++|.+||+.||.+||++  .|+++||||
T Consensus       217 ------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                              0011122367899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.2e-43  Score=297.80  Aligned_cols=254  Identities=31%  Similarity=0.484  Sum_probs=204.9

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||.|++|.||++.+..+++.+++|++.........     ....+.+|+..+++++|+|++++++.+. .....|+++|+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKN-----QVDQVLTERDILSQAQSPYVVKLYYSFQ-GKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhh-----HHHHHHHHHHHHHhCCCcchhHHHHhee-cCcEEEEEEec
Confidence            68999999999999999999999998654332111     1225678999999999999999999884 45789999999


Q ss_pred             ccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC------
Q 035861           99 MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK------  172 (332)
Q Consensus        99 ~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~------  172 (332)
                      ++|+.+..+....+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........      
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          75 LPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            98755554444456899999999999999999999999999999999999999999999999998876433211      


Q ss_pred             --CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          173 --PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                        ......++..|+|||.... ...+.++|+||||+++|++++|..||...........+.......+            
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP------------  221 (265)
T ss_pred             cccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC------------
Confidence              2234567788999999877 5588999999999999999999999988776655544433111100            


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH---HHHhcCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV---DDALNHYWFHEVPL  314 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~hp~f~~~~~  314 (332)
                                             ....++..+.+++.+||+.+|.+||++   .++|+||||+++.|
T Consensus       222 -----------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         222 -----------------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             -----------------------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                                   001147889999999999999999999   99999999998865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=314.96  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=204.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+..+...||+|.||+||+|.|.++   ||||++.......+..      +.|.+|+..+++-+|.||+.+.|++... 
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~ql------qaFKnEVa~lkkTRH~NIlLFMG~~~~p-  460 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQL------QAFKNEVAVLKKTRHENILLFMGACMNP-  460 (678)
T ss_pred             HHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHH------HHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence            34677889999999999999999743   9999998876655422      2678999999999999999999999554 


Q ss_pred             CeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      .. .||+.+|+|+ |...+.-....|+......|+.|+++|+.|||.++|+|+|||..|||+.++++|||+|||++..-.
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            43 8999999995 555555556779999999999999999999999999999999999999999999999999987542


Q ss_pred             --CCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          169 --SPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       169 --~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                        ..........|...|+|||+++.  ..++++.|||||+|+++|||++|..||...+..+.+-.+-++...        
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~--------  611 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM--------  611 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC--------
Confidence              22334455678889999999863  357899999999999999999999999955544433333222111        


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                              .-......+++.++++|+..||.+++++||.+.+||.
T Consensus       612 ------------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  612 ------------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                    1112223346779999999999999999999999887

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-43  Score=297.41  Aligned_cols=263  Identities=28%  Similarity=0.469  Sum_probs=206.0

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|+..+.||+|++|.||++.+..+++.+++|++.........  .......+..|+..+++++|+|++++++.+. +...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSE--QEEVVEALRKEIRLMARLNHPHIIRMLGATC-EDSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchh--HHHHHHHHHHHHHHHHHcCCCceehhhceec-cCCe
Confidence            488899999999999999999999999999998754322111  1111235678999999999999999999984 4478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeecccccccCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~~~~~~  170 (332)
                      .++|+||+.|+.+..+....+++++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            899999999866655555567899999999999999999999999999999999999998776 6999999998765432


Q ss_pred             CC----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          171 LK----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       171 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..    ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+......          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----------  226 (268)
T ss_pred             cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc----------
Confidence            11    1123457888999999876 66889999999999999999999999754432222222111000          


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                            ......+..+++.+.+++.+||..+|++||++.++++||||.
T Consensus       227 ----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                  000111223688999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.7e-42  Score=304.77  Aligned_cols=294  Identities=37%  Similarity=0.663  Sum_probs=224.1

Q ss_pred             cccccccccccCcEEEEEEEECCC--CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc-
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKS--GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD-   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-   87 (332)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+........      ....+..|+..++++ .|+||+++++.... 
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   74 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI------LAKRALRELKLLRHFRGHKNITCLYDMDIVF   74 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch------hHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence            488999999999999999999887  88999999864321111      112456899999998 59999999987532 


Q ss_pred             --CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 --DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 --~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                        .....+++++++++++...+.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus        75 ~~~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          75 PGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             cccCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence              2245789999999888776654 6779999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLK----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .......    ......|+..|+|||.+.+...++.++|+||+|+++|++++|..||...+.......+....+.+++..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6532211    122346788999999887656789999999999999999999999999888888888887776655443


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCC-CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPA-ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      ...+.......       ........+. ......+.++..+++|+.+||+.||.+||++.+++.||||.+++-+....
T Consensus       234 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~  305 (332)
T cd07857         234 LSRIGSPKAQN-------YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEP  305 (332)
T ss_pred             HHhhhhhhHHH-------HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccc
Confidence            22221100000       0000000000 00112234688999999999999999999999999999999988665444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-42  Score=296.85  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHH---hhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL---LSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      .||+|+||.||++.+..+++.+|+|.+............     ...++...+   ....|++++.+++.+..+ +..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHH-----HHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEE
Confidence            489999999999999999999999998754332211110     122343333   334799999999888554 77899


Q ss_pred             EcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC
Q 035861           95 VMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY  174 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~  174 (332)
                      ||||++|+.+.......+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+......  ..
T Consensus        75 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~  152 (279)
T cd05633          75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (279)
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence            9999997666555555778999999999999999999999999999999999999999999999999998755332  22


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN  254 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (332)
                      ....++..|+|||.+..+..++.++|+||+|+++|++++|..||........ ..+.....                   
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~-------------------  212 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTL-------------------  212 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhh-------------------
Confidence            3346889999999987546688999999999999999999999975432111 11111000                   


Q ss_pred             ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 035861          255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~  317 (332)
                                    ......++.++.++.++|.+||..||++|+     ++.++++||||+.+++...
T Consensus       213 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         213 --------------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             --------------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence                          001112233788999999999999999999     6999999999999886655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-42  Score=298.46  Aligned_cols=258  Identities=26%  Similarity=0.443  Sum_probs=208.4

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      -|++.+.||.|+||.||+|.+..++..+|+|..........       ...+.+|+..+++++|+||+++++.+..+ ..
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~   76 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-------IEDIQQEITVLSQCDSPYVTKYYGSYLKD-TK   76 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHH-------HHHHHHHHHHHHhcCCCCEeEEEEEEEeC-Ce
Confidence            57899999999999999999988899999998764322111       12466899999999999999999999554 78


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++|+||++++.+..... ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          77 LWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999999865555544 4578999999999999999999999999999999999999999999999999887654332


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+....  .              
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------------  218 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--P--------------  218 (277)
T ss_pred             hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--C--------------
Confidence            22334467888999999876 567889999999999999999999997765444333321110  0              


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                          ......++.++.+++.+||+.+|.+||++.++++||||.+....
T Consensus       219 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         219 --------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence                                00112368889999999999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-42  Score=293.73  Aligned_cols=258  Identities=27%  Similarity=0.421  Sum_probs=206.7

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|+..+.||+|++|+||+|....++..|++|.+........   .......+..|+.+++.++|+|++++++.+. +...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---GQEAVKQLEQEIALLSKLQHPNIVQYLGTER-EEDN   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---chHHHHHHHHHHHHHHhcCCCCchheeeeEe-cCCe
Confidence            47888999999999999999988899999999875432111   0001124678999999999999999999884 4478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++++||++|+.+.........+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999976555555556779999999999999999999999999999999999999999999999999887653322


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                       ......++..|+|||.+.....++.++|+||||+++|++++|..||...........+......               
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  220 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------------  220 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------------
Confidence             2344567888999999876334899999999999999999999999876644433332221100               


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                          ...++.+++.+.+++.+||+.+|++||++++++.|||+
T Consensus       221 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 --------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             --------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                                01122368889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=289.37  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=206.3

Q ss_pred             chhccccc-ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEE
Q 035861            9 SVFEFEKL-NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVM   86 (332)
Q Consensus         9 ~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   86 (332)
                      ..++|.+- +.||-|-.|.|..+.++.|++++|+|++..+.             ..++|+++--.. .||||+.+++++.
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------------KARrEVeLHw~~s~h~~iV~IidVye  125 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------------KARREVELHWMASGHPHIVSIIDVYE  125 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------------HHHhHhhhhhhhcCCCceEEeehhhh
Confidence            45566654 46999999999999999999999999997543             223677765444 7999999999983


Q ss_pred             ---cCCCeEEEEccccccc-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcEEE
Q 035861           87 ---DDHDSVYMVMEYMEHD-LKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKI  158 (332)
Q Consensus        87 ---~~~~~~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~~l  158 (332)
                         .+...+.+|||.++|+ |...+..+ +..++|.++..|..||+.|+.|||+.+|+||||||+|+|.+..   ..+||
T Consensus       126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence               3456789999999975 44444432 3569999999999999999999999999999999999999754   47999


Q ss_pred             eecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHc
Q 035861          159 CDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV----DQIDKIFKTL  234 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~----~~~~~~~~~~  234 (332)
                      +|||+++....+ ....+.+.|+.|.|||++.. ..++...|+||+||+||-|++|.+||......    ....+|..+.
T Consensus       206 tDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  206 TDFGFAKETQEP-GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ  283 (400)
T ss_pred             cccccccccCCC-ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence            999999886543 34456788999999999977 66999999999999999999999999765432    2333443332


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ...+                                 -+.|..+|+..+++|+++|..+|++|.++++++.|||+++-+
T Consensus       284 y~FP---------------------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  284 YEFP---------------------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             ccCC---------------------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            2222                                 223455899999999999999999999999999999999855

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.4e-43  Score=302.68  Aligned_cols=260  Identities=27%  Similarity=0.452  Sum_probs=208.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|.||++.+..++..+++|.+.......        ...+.+|+.+++.++|||++++++.+..+
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   88 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--------KELIINEILVMRENKHPNIVNYLDSYLVG   88 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH--------HHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence            4579999999999999999999998889999999986432221        12456899999999999999999998554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...++|+||++++.+..... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        89 -~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          89 -DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             -CcEEEEEecCCCCcHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence             77899999998765555544 3468899999999999999999999999999999999999999999999999887654


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..........++..|+|||.+.. ..++.++|+||||+++|++++|..||...+.......+...  .            
T Consensus       167 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~--~------------  231 (293)
T cd06647         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--G------------  231 (293)
T ss_pred             ccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC--C------------
Confidence            43333344567888999999876 56889999999999999999999999765443221111100  0            


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                          ......+..++..+.++|.+||..+|++||++.+++.||||....
T Consensus       232 --------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         232 --------------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             --------------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                                000111223678899999999999999999999999999998755

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=299.41  Aligned_cols=281  Identities=43%  Similarity=0.768  Sum_probs=217.3

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCCCe
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   91 (332)
                      |++.+.||.|++|+||+|+...+++.++||.+..........       ...+|+..++++. |+|++++++.+.. ...
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~-------~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~   72 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC-------MNLREVKSLRKLNEHPNIVKLKEVFRE-NDE   72 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHH-------HHHHHHHHHHhccCCCCchhHHHHhhc-CCc
Confidence            678999999999999999999889999999987543321111       2346889999998 9999999999855 578


Q ss_pred             EEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .++|||+++|++.+.+.... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          73 LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            99999999888887776644 47899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       .......++..|+|||.+.....++.++|+||||+++|++++|..||......+....+....+.+....+........
T Consensus       153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         153 -PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             -CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence             2233456788899999987656789999999999999999999999988887777777776655555443322111110


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      ....       ......+.......+..+..+.+||.+||+.+|++||+++|++.||||
T Consensus       232 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGF-------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccc-------cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0000       000000000011112246789999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-42  Score=298.93  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=203.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHH-HhhCCCCCeeeeeeeEEcCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI-LLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.........       ..+..|... ++.+.|||++++++.+..+ 
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-   72 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-------KRLLMDLDISMRSVDCPYTVTFYGALFRE-   72 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-------HHHHHHHHHHHHHcCCCCeeeeeEEEecC-
Confidence            4799999999999999999999999999999998754322111       133455554 5666899999999998554 


Q ss_pred             CeEEEEcccccccHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ...++++||++|++.+.+..   ....+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+.
T Consensus        73 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          73 GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            77899999999987665543   245689999999999999999999997 99999999999999999999999999987


Q ss_pred             ccCCCCCCCccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTT-EVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~  241 (332)
                      ..... .......++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||.... ..+...........     
T Consensus       153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  226 (283)
T cd06617         153 YLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP-----  226 (283)
T ss_pred             ccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC-----
Confidence            65322 122334578889999988642   346889999999999999999999996532 22222222211000     


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                    ......++.++.+||.+||..+|++||++.++++||||......
T Consensus       227 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         227 ------------------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             ------------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence                                          00011268899999999999999999999999999999996544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=312.54  Aligned_cols=242  Identities=25%  Similarity=0.373  Sum_probs=202.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +..+..++.||+|+.|.||+|+..  ++.||||+++.-.               ..+++-|++|+|+||+.+.|+|... 
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk---------------ETdIKHLRkLkH~NII~FkGVCtqs-  184 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---------------ETDIKHLRKLKHPNIITFKGVCTQS-  184 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh---------------hhhHHHHHhccCcceeeEeeeecCC-
Confidence            345667889999999999999988  8899999886321               2578899999999999999999554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..+|||||||..+-+..+.+....+.......|..+||.+++|||.+.|+|+|||.-||||+.+..|||+|||.+.....
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            88999999999665666666688999999999999999999999999999999999999999999999999999887643


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      . ...-...||+.|||||++++ .+.+.+.|||||||+||||+||..||.+.+....+--+-.                 
T Consensus       265 ~-STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs-----------------  325 (904)
T KOG4721|consen  265 K-STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS-----------------  325 (904)
T ss_pred             h-hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC-----------------
Confidence            3 22335689999999999998 7899999999999999999999999987654332211100                 


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                        +..-+..+..++..++=||++||+-.|..|||+.+||.|
T Consensus       326 ------------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  326 ------------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ------------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence                              112234455588899999999999999999999999999

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-42  Score=296.51  Aligned_cols=266  Identities=29%  Similarity=0.448  Sum_probs=206.0

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc--cccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC--LEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +|.+.+.||.|++|.||+|....+++.+|+|.+..........  ........+..|+..++.++|+|++++++.+ ...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE-TTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe-ccC
Confidence            6889999999999999999998889999999986533222111  1111122456899999999999999999988 445


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|+||++|+.+.......+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            78899999998765555544457899999999999999999999999999999999999999999999999999876432


Q ss_pred             CCC--CCccccccccccchhhhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          170 PLK--PYTSLVVTLWYRAPELLLGAK-KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ...  ......++..|+|||.+.... .++.++|+||||+++|++++|..||..........+.......+         
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------  231 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP---------  231 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC---------
Confidence            211  122345788899999987633 47899999999999999999999997655443333222110000         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                            .......+.++..+.++|.+||..+|++||+++++|+||||
T Consensus       232 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         232 ----------------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                  00011123378899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-44  Score=284.14  Aligned_cols=300  Identities=42%  Similarity=0.780  Sum_probs=248.7

Q ss_pred             cccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      .+++...+.|....+||+|.||.||+|+...+++.|++|++.......      .+....++|+.+|..+.|+|++.+++
T Consensus        10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe------GfpitalreikiL~~lkHenv~nliE   83 (376)
T KOG0669|consen   10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIE   83 (376)
T ss_pred             CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc------CCcHHHHHHHHHHHHhcchhHHHHHH
Confidence            467788889999999999999999999999999999998876533211      22335679999999999999999998


Q ss_pred             eEEc-------CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcE
Q 035861           84 VVMD-------DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVL  156 (332)
Q Consensus        84 ~~~~-------~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~  156 (332)
                      +|-.       .....|+|+.+|+.++...+......++..++.+++.+++.||.|+|+..|+|+|+|+.|+||+++|.+
T Consensus        84 ic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   84 ICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             HHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceE
Confidence            8732       224589999999999888888777889999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCC----CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 035861          157 KICDFGMSRQYGSP----LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK  232 (332)
Q Consensus       157 ~l~df~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~  232 (332)
                      ||.|||+++....+    ...++....|.+|++||.+.+...++.+.|+|..||++.+|+|+.+.+.+.+....+..|..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            99999999655321    12234456699999999999989999999999999999999999999999999999999988


Q ss_pred             HcCCCCCCcccCCCCCcccccc----ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          233 TLGTPTETIWPGLSELPGAKAN----FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                      ..+....+.||.+.+++-...-    ..+.......+......      -++++.+|+.+||..||.+|+.+.++|.|.|
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~------kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYV------KDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhccccc------CChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence            8999999999988876643221    22222333333332222      3678889999999999999999999999999


Q ss_pred             CCCCCCC
Q 035861          309 FHEVPLP  315 (332)
Q Consensus       309 f~~~~~~  315 (332)
                      |..=++|
T Consensus       318 F~kdp~p  324 (376)
T KOG0669|consen  318 FWKDPMP  324 (376)
T ss_pred             hhcCCcc
Confidence            9887766

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.1e-42  Score=293.82  Aligned_cols=260  Identities=28%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-C
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-H   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   89 (332)
                      .+|++.+.||+|++|.||.+.+..++..|++|.+...........   ....+.+|+..++++.|+||+++++.+.+. .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK---EVNALECEIQLLKNLLHERIVQYYGCLRDPME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHH---HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence            579999999999999999999999999999999864332211110   012456799999999999999999987543 3


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++++||++|+.+.........+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            56889999998755554444456789999999999999999999999999999999999999999999999998875432


Q ss_pred             CC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          170 PL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..   .......++..|+|||.+.+ ..++.++|+||||+++|++++|..||..........+....   +..       
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-------  227 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ---PTN-------  227 (265)
T ss_pred             ccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC---CCC-------
Confidence            11   11233457888999999876 66899999999999999999999999776544433322211   100       


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                               ...++.++..+.++|.+|+. +|++||+++++++|||++
T Consensus       228 -------------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 -------------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             -------------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                     01122367788899999995 899999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-42  Score=294.90  Aligned_cols=258  Identities=29%  Similarity=0.484  Sum_probs=211.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||++++..+++.+++|++.......       ....+..|+..+.+++|+|++++++.+..+ .
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~   72 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-------FRKQLLRELKTLRSCESPYVVKCYGAFYKE-G   72 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchH-------HHHHHHHHHHHHHhcCCCCeeeEEEEEccC-C
Confidence            47899999999999999999999999999999987654321       112567899999999999999999998555 8


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..++|+||++++.+.........+++..++.++.|++.||++||+ .|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            899999999965555555546889999999999999999999999 9999999999999999999999999999887654


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCCCCCcccCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT---EVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .........++..|+|||.+.+ ..++.++|+||||+++|++++|..||....   ..+....+...   ..        
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~--------  220 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP--------  220 (264)
T ss_pred             CCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC--------
Confidence            4333335567889999999877 578999999999999999999999997764   22222222211   00        


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCC-CCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPV-LSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               ...... ++..+.++|.+||..+|++||+++++++||||++++
T Consensus       221 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 -------------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                                     011122 678899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-42  Score=298.50  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=207.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDH   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   89 (332)
                      ++|++.+.||+|++|.||+++...++..+++|++..........     ...+..|..+++++. |+||+++++.+ .+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-----VKYVKIEKEVLTRLNGHPGIIKLYYTF-QDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHH-----HHHHHHHHHHHHhcccCCCchhHHHHh-cCC
Confidence            47999999999999999999999999999999987643221111     124568899999998 99999999988 445


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...+++||+++++.+.......+.+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            78999999996544444444466899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC--------------------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 035861          170 PL--------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK  229 (332)
Q Consensus       170 ~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~  229 (332)
                      ..                    .......++..|+|||.+.. ..++.++|+||||++++++++|..||...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK  233 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            22                    11223356788999999876 5689999999999999999999999988776555554


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH----HHHhc
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV----DDALN  305 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~  305 (332)
                      +.....                                     ..+..+++.+.+||.+||+.+|.+||++    +++++
T Consensus       234 ~~~~~~-------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 ILKLEY-------------------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHhcCC-------------------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            432211                                     1112368889999999999999999999    99999


Q ss_pred             CCCC
Q 035861          306 HYWF  309 (332)
Q Consensus       306 hp~f  309 (332)
                      ||||
T Consensus       277 ~~~~  280 (280)
T cd05581         277 HPFF  280 (280)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.5e-42  Score=292.95  Aligned_cols=254  Identities=28%  Similarity=0.511  Sum_probs=205.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||++.++.++..+|+|.+.........      ...+.+|+..++.++|+|++++++.+ .....
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~   73 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE------KEASKKEVILLAKMKHPNIVTFFASF-QENGR   73 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh------hHHHHHHHHHHHhCCCCChhhhhhee-ccCCe
Confidence            588999999999999999999999999999998764322211      12456899999999999999999988 44578


Q ss_pred             EEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeecccccccC
Q 035861           92 VYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYG  168 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~~~~  168 (332)
                      .++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||.+....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            9999999986 4444444422 3579999999999999999999999999999999999999886 46999999887765


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..........++..|+|||.+.. ..++.++|+||||+++|++++|..||...+.......+.....             
T Consensus       154 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  219 (257)
T cd08225         154 DSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-------------  219 (257)
T ss_pred             CCcccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-------------
Confidence            44333344568888999999876 5688999999999999999999999987665544443322110             


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                             ....+.++..+.++|.+||..+|++||++.++++||||
T Consensus       220 -----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 -----------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                                   01122367889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-42  Score=296.36  Aligned_cols=249  Identities=17%  Similarity=0.180  Sum_probs=200.1

Q ss_pred             ccccc--ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc--
Q 035861           12 EFEKL--NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD--   87 (332)
Q Consensus        12 ~y~~~--~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   87 (332)
                      +++..  ..||+|+++.||+|...  |+.||||++..........     ...+.+|+.++++++||||+++++++.+  
T Consensus        19 ~i~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         19 DIDKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVL-----IDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             HcCCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHH-----HHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            44444  67999999999999985  8899999997543222111     1245689999999999999999999855  


Q ss_pred             C-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 D-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 ~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      + ....++||||++|+.+.......+.+++.....++.|++.||++||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence            2 35689999999987655555556789999999999999999999998 499999999999999999999999999987


Q ss_pred             ccCCCCCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      .....   .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||...+..+....+......++      
T Consensus       172 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------  242 (283)
T PHA02988        172 ILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------  242 (283)
T ss_pred             hhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence            65332   1234678899999998652 4689999999999999999999999998876666555543211111      


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                   .+..+++.+.+|+.+||+.||++|||+.++++
T Consensus       243 -----------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 -----------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -----------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                         11236889999999999999999999999985

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-42  Score=298.25  Aligned_cols=267  Identities=24%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   88 (332)
                      .++|+..+.||+|++|.||++.+..+++.+|+|.+........       ...+..|+..+.++. |+||+++++.+..+
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-------QKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHH-------HHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            4578899999999999999999999999999999875432211       124568999998985 99999999988554


Q ss_pred             CCeEEEEcccccccHHHHH---H-hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 HDSVYMVMEYMEHDLKWLM---E-SMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~---~-~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                       ...+++||++++++.+..   . .....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        76 -~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          76 -GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             -CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecch
Confidence             678899999987654332   1 224679999999999999999999997 4999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGA--KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      +....... ......++..|+|||.+.+.  ..++.++|+||+|+++|++++|..||.....  ....+.......+.  
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~--  229 (288)
T cd06616         155 SGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPP--  229 (288)
T ss_pred             hHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCC--
Confidence            87653321 22334578889999999764  3688999999999999999999999976542  12222111110000  


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                                 .........++.++.+||.+||+.+|++||++++|++||||.+..+.+
T Consensus       230 ---------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~  277 (288)
T cd06616         230 ---------------------------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN  277 (288)
T ss_pred             ---------------------------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcc
Confidence                                       000111123788999999999999999999999999999999866544

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.4e-42  Score=292.59  Aligned_cols=258  Identities=31%  Similarity=0.499  Sum_probs=205.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||+|++|.||++....+++.+++|.+.......      .....+.+|+..+++++|+||+++++... +...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~   73 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP------KTIKEIADEMKVLELLKHPNLVKYYGVEV-HREK   73 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccch------HHHHHHHHHHHHHHhCCCCChhheeeeEe-cCCE
Confidence            5899999999999999999998889999999987654331      11235679999999999999999999874 4478


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++|+||++++.+.........+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          74 VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999976666555556678999999999999999999999999999999999999999999999999987764332


Q ss_pred             CCC----ccccccccccchhhhcCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          172 KPY----TSLVVTLWYRAPELLLGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       172 ~~~----~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ...    ....++..|+|||.+....  ..+.++|+||||+++|++++|..||............... ...+       
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-------  225 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP-------  225 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC-------
Confidence            221    2346788999999987632  3788999999999999999999999765322221111111 1000       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                               ..+....++..+.+||.+||+.+|.+||++++++.|||+
T Consensus       226 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -------------------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -------------------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                                     011112258889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.1e-42  Score=293.15  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=203.4

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||++++..++..+++|.+........       ...+..|+..++++.|+|++++++.+ .+...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   72 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-------VEDSRKEAVLLAKMKHPNIVAFKESF-EADGH   72 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHH-------HHHHHHHHHHHHhCCCCCcceEEEEE-EECCE
Confidence            58899999999999999999999999999999865432111       12456899999999999999999998 44488


Q ss_pred             EEEEcccccc-cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEH-DLKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .++++||+++ ++.+.+.. ....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++++|||.+.....
T Consensus        73 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999986 45554443 234689999999999999999999999999999999999999999999999999876644


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......+            
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  219 (255)
T cd08219         153 PGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP------------  219 (255)
T ss_pred             cccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC------------
Confidence            3333344567888999999876 568999999999999999999999998776555444433221100            


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                              .+..++..+.+||.+||+.||++||++.++++-
T Consensus       220 ------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 ------------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                                    112267889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.1e-42  Score=294.98  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=200.5

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHH---HHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI---NILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      .||+|++|+||++.+..+++.||+|.+............     ....|.   ..++...||+++.+.+.+.. ....++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEE
Confidence            489999999999999989999999998764332211100     112333   34445689999999998844 478999


Q ss_pred             EcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC
Q 035861           95 VMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY  174 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~  174 (332)
                      |+||+.|+.+.......+.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+......  ..
T Consensus        75 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~  152 (278)
T cd05606          75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (278)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence            9999998766655555778999999999999999999999999999999999999999999999999988755332  22


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN  254 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (332)
                      ....|+..|+|||.+.+...++.++|+||+|+++|+|++|..||.......... ......                   
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~-------------------  212 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL-------------------  212 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhh-------------------
Confidence            345688999999999765568899999999999999999999997653221111 111000                   


Q ss_pred             ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCC
Q 035861          255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~  318 (332)
                                    ......+..++..+.+++.+||..+|.+||     ++.++++||||..+.+....
T Consensus       213 --------------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~  267 (278)
T cd05606         213 --------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF  267 (278)
T ss_pred             --------------ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhh
Confidence                          000111223688999999999999999999     99999999999998876663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-42  Score=291.70  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=205.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||++.+..++..+++|.+.........      ...+.+|+..+++++|+|++++++.+. ....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   73 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE------RLAAQNECQVLKLLSHPNIIEYYENFL-EDKA   73 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH------HHHHHHHHHHHhhCCCCchhheeeeEe-cCCE
Confidence            589999999999999999999999999999999754332211      125678999999999999999999884 4478


Q ss_pred             EEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeecccccccC
Q 035861           92 VYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYG  168 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~~~~  168 (332)
                      .++|+|+++| ++.+.+... ...+++..+..++.+++.+|++||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            9999999987 455555443 34589999999999999999999999999999999999998654 68999999998764


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ... ......++..|+|||.+.. ..++.++|+||+|+++|++++|..||...+.......+......+           
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd08220         154 SKS-KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-----------  220 (256)
T ss_pred             CCc-cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-----------
Confidence            332 2233467888999999876 568899999999999999999999998776655544443221110           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                               ....++..+.+++.+||+.+|++||++.|+++||||
T Consensus       221 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         221 -------------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -------------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                                     112268889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.2e-42  Score=291.46  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=209.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||++.+..++..+++|++.........      ...+.+|++.++.++|+|++++.+.+... ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~   73 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE------REDALNEVKILKKLNHPNIIKYYESFEEK-GK   73 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH------HHHHHHHHHHHHhcCCCChhheEEEEecC-CE
Confidence            588999999999999999999989999999999765432111      12456899999999999999999998555 88


Q ss_pred             EEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           92 VYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .++|+|+++| ++.+.+...   ...+++..+..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            9999999987 455555443   377999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.. ..++.++|+||+|+++|++++|..||.................            
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  220 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------  220 (258)
T ss_pred             ccCcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence            544333344577889999998876 5688999999999999999999999987765544444332110            


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                              ...+..++..+.+++.+||..+|++||+++++|+||||
T Consensus       221 ------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ------------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                                    01112378899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.4e-42  Score=296.69  Aligned_cols=260  Identities=28%  Similarity=0.467  Sum_probs=209.0

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|+-...||+|++|.||++....+++.+|+|.+.......        ...+.+|+..++.++|+|++++++.+..+ ..
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~   91 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVG-DE   91 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhH--------HHHHHHHHHHHHhcCCcchhheeeEEEeC-CE
Confidence            4455678999999999999999999999999875432111        12456899999999999999999998554 78


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .+++|||++++.+..+.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        92 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          92 LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             EEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            999999999876665554 4568999999999999999999999999999999999999999999999999887654332


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......++..|+|||.+.. ..++.++|+||+|+++|++++|..||......+....+........             
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------  236 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-------------  236 (292)
T ss_pred             ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-------------
Confidence            22334567888999998875 6678999999999999999999999987665544433322211000             


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                           .....++..+.+++.+||+.+|.+||+++++++||||...-.++
T Consensus       237 ---------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         237 ---------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence                                 00122678899999999999999999999999999999977543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=279.78  Aligned_cols=263  Identities=26%  Similarity=0.454  Sum_probs=218.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVM   86 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   86 (332)
                      ..+++.+.+..||.|+.|+|+++..+.+|...|||.++......+.       .+|+..+.++... .+|+|++++|+|+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~-------kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN-------KRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH-------HHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            3567888999999999999999999999999999999876543321       2566777777655 5899999999998


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+ ...+|.||.+..-....+....++++|..+-++...+..||.||. ++||+|+|+||+|||+|..|++||+|||.+.
T Consensus       162 ~n-~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsG  240 (391)
T KOG0983|consen  162 TN-TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISG  240 (391)
T ss_pred             eC-chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccc
Confidence            77 557788999987667777777889999999999999999999999 5789999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGA--KKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ..... .......|.+.|||||.+...  ..|+.++|+||||+.++|++||..||... .+.+.+..+.+..++      
T Consensus       241 rlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP------  313 (391)
T KOG0983|consen  241 RLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP------  313 (391)
T ss_pred             eeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC------
Confidence            76443 334556788899999998642  46888999999999999999999999874 566777777663321      


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                  .+......|+.+++|+..||.+|+.+||.-.++|+|||+..-+
T Consensus       314 ----------------------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  314 ----------------------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ----------------------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                                        1112223799999999999999999999999999999988755

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=293.90  Aligned_cols=279  Identities=44%  Similarity=0.810  Sum_probs=212.4

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeeeeeEEcCC
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVKEVVMDDH   89 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~   89 (332)
                      |++.+.||.|++|.||+|++..++..+|+|++........      ....+.+|+.+++++   .|+|++++++.+...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG------IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch------hhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            7889999999999999999998899999999975433211      111344677766655   6999999999986543


Q ss_pred             C----eEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           90 D----SVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        90 ~----~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .    ..++++|++++++.+.+.... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        75 ~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          75 TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             CCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            2    389999999998777665533 36899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+...++......+....++.
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         155 RIYSFEM-ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eeccCCc-ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7764332 2233456888999999977 6689999999999999999999999998888877777776544433222211


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .......          ..............+.++..+.++|.+||+.||.+||++++++.||||
T Consensus       233 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVSLPRS----------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             Ccccchh----------hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            1100000          000000011111123467888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-41  Score=297.49  Aligned_cols=258  Identities=28%  Similarity=0.472  Sum_probs=211.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|+..+.||+|+||.||++++..++..+++|.+..........     ...+..|+..++.++|+|++++++++..+ .
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~   98 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK-----WQDIIKEVKFLQRIKHPNSIEYKGCYLRE-H   98 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHH-----HHHHHHHHHHHHhCCCCCEEEEEEEEeeC-C
Confidence            45889999999999999999999899999999986542221111     12467899999999999999999998555 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||+.|++.+.+.....++++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        99 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635          99 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            7899999999988887776677899999999999999999999999999999999999999999999999998865432 


Q ss_pred             CCCCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          171 LKPYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                         .....++..|+|||.+.  ....++.++|+||||+++|+|++|..||...........+........          
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  244 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----------  244 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC----------
Confidence               23446788899999974  235688999999999999999999999987765555554443211110          


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               ....++..+++|+.+||+.+|.+||++.++++|+|+....
T Consensus       245 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         245 -------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             -------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                                     1122677899999999999999999999999999997644

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-42  Score=295.66  Aligned_cols=262  Identities=25%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|++|+||++.+..++..+++|++.......       ....+.+|+++++.++||||+++++.+... 
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   75 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-------VRKQILRELQIMHECRSPYIVSFYGAFLNE-   75 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch-------HHHHHHHHHHHHHHcCCCCcceEeeeEecC-
Confidence            468999999999999999999999999999999886532111       122567899999999999999999999555 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++|+||++++.++.+....+.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            7899999999987666665556789999999999999999999996 699999999999999999999999999886542


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HH---HHHHHcCCCCCCc
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ----ID---KIFKTLGTPTETI  241 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~----~~---~~~~~~~~~~~~~  241 (332)
                      ...  .....++..|+|||++.+ ..++.++|+||||+++|++++|..||........    ..   .........    
T Consensus       156 ~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  228 (284)
T cd06620         156 NSI--ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE----  228 (284)
T ss_pred             hhc--cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc----
Confidence            221  124468889999999876 5788999999999999999999999986543210    00   111100000    


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                 .........++..+.+|+.+||+.||++||++.|+++|+||.+-.
T Consensus       229 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         229 ---------------------------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             ---------------------------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                                       000000112677899999999999999999999999999997744

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.8e-42  Score=297.50  Aligned_cols=262  Identities=27%  Similarity=0.450  Sum_probs=212.1

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ..-...|+..+.||.|++|+||+|++..++..+++|.+..........     ...+.+|+..++.++|+|++++.+++.
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~   85 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-----WQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHH-----HHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence            334557999999999999999999999899999999986432211111     114568999999999999999999985


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .. ...++|+||+.|++.+.+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        86 ~~-~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          86 RE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             cC-CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            55 78899999999988887776677799999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ....    ....++..|+|||.+..  ....+.++|+||||+++|++++|..||...+.......+......        
T Consensus       165 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------  232 (308)
T cd06634         165 MAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------  232 (308)
T ss_pred             ecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--------
Confidence            5322    34457888999999752  245788999999999999999999999776544433333221100        


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                 ......++..+.+||.+||+.+|++||+++++++|||+..-.
T Consensus       233 ---------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         233 ---------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ---------------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                                       001223688899999999999999999999999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=288.42  Aligned_cols=254  Identities=30%  Similarity=0.522  Sum_probs=209.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||+|++|.||++++..+++.|++|.+.........      ...+.+|++.+++++|+|++++.+.+.+. ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~   73 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA------LKSIMQEIDLLKNLKHPNIVKYIGSIETS-DS   73 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHH------HHHHHHHHHHHHhCCCCCccEEEEEEEeC-CE
Confidence            588999999999999999999988999999999765432111      12567899999999999999999998554 78


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++++|+++++.+.........+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          74 LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999986555555556789999999999999999999999999999999999999999999999999998775544


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......++..|+|||.+.. ..++.++|+||||+++|++++|..||..........+.....                 
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  215 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-----------------  215 (254)
T ss_pred             ccccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-----------------
Confidence            43445677889999999876 458899999999999999999999997765443333322110                 


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                         ....+..++..+.+++.+||..+|++||++.+++.||||
T Consensus       216 -------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 -------------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                               001122368899999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-41  Score=290.61  Aligned_cols=250  Identities=23%  Similarity=0.393  Sum_probs=195.1

Q ss_pred             chhcccccccc--cccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKI--SEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~l--g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      ..++|++.+.+  |.|+||.||++....++..+++|.+.......             .|+.....+ +|+|++++++.+
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEE
Confidence            34577777777  99999999999999999999999987543211             122222222 799999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~  164 (332)
                      ..+ ...++||||++|+.+.........+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        79 ~~~-~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         79 TTL-KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             ecC-CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            555 68999999998654444444456899999999999999999999999999999999999999998 9999999988


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHcCCCCCCccc
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI-DKIFKTLGTPTETIWP  243 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  243 (332)
                      ......    ....++..|+|||++.. ..++.++|+||+|+++|++++|..||......... ........        
T Consensus       158 ~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  224 (267)
T PHA03390        158 KIIGTP----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--------  224 (267)
T ss_pred             eecCCC----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--------
Confidence            765432    23357888999999976 56889999999999999999999999755433211 11111110        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-VDDALNHYWFHE  311 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~hp~f~~  311 (332)
                                                ......+.+++.+.+||.+||+.+|.+||+ ++++|+||||.+
T Consensus       225 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        225 --------------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                                      001111237899999999999999999996 699999999974

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.9e-42  Score=291.16  Aligned_cols=255  Identities=30%  Similarity=0.429  Sum_probs=197.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .......||+|+||.||+|.+..++..|++|.+........        ..+.+|+.++++++|+||+++++.+..+ ..
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~   79 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV--------QPLHEEIALHSYLKHRNIVQYLGSDSEN-GF   79 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHH--------HHHHHHHHHHHhcCCCCeeeeeeeeccC-CE
Confidence            34445689999999999999998899999998865432111        1456899999999999999999998544 78


Q ss_pred             EEEEccccccc-HHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEeeccccccc
Q 035861           92 VYMVMEYMEHD-LKWLMESMKQPF--STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~~-l~~~~~~~~~~l--~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~df~~~~~~  167 (332)
                      .++++|+++|+ +.+.+......+  ++..+..++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999864 555554434556  88899999999999999999999999999999999986 679999999998765


Q ss_pred             CCCCCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ...........++..|+|||.+... ..++.++|+||+|+++|++++|..||................            
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~------------  227 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF------------  227 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh------------
Confidence            4322333344578899999998653 347889999999999999999999997543221111000000            


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                            ......+..+++++++|+.+||+.+|++||++.+++.||||
T Consensus       228 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 ----------------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ----------------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                                  00001122368889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.9e-42  Score=291.94  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=200.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++.+.||.|++|.||+|++..+++.||||.+..........     ...+.+|+..++.++|||++++++.+... 
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   74 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA-----RQDCVKEIDLLKQLNHPNVIKYLDSFIED-   74 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHH-----HHHHHHHHHHHHhCCCcceeeeeeeEEEC-
Confidence            358999999999999999999999999999999886533222111     12456899999999999999999998554 


Q ss_pred             CeEEEEccccccc-HHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEHD-LKWLME---SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~~-l~~~~~---~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ...++++||++++ +.+.+.   .....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            7889999999974 433332   234568999999999999999999999999999999999999999999999999887


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE--VDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.....  ......+ .....++     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~-----  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPP-----  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCC-----
Confidence            66443333334567889999999876 5688999999999999999999999865432  2222221 1111110     


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                   .....++..+.+++.+||+.+|++||+++++++.
T Consensus       228 -----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 -----------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -----------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                                         0112267889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.3e-42  Score=294.38  Aligned_cols=260  Identities=29%  Similarity=0.490  Sum_probs=211.8

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..-+.|++...||.|++|.||+|.+..++..+++|++..... .        ...+.+|++.+++++|+|++++++.+..
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-N--------KELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-h--------HHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            345679999999999999999999998899999999975433 0        1145689999999999999999999866


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      + ...++++||++| ++.+.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        87 ~-~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          87 G-DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             C-CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            5 889999999996 45555444333899999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ............++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+......          
T Consensus       166 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  234 (286)
T cd06614         166 LTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP----------  234 (286)
T ss_pred             hccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence            5443333344567788999999876 66899999999999999999999999876655444433221100          


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                              .......++..+.+||.+||+.+|.+||++.++++|+||.+.
T Consensus       235 ------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         235 ------------------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             ------------------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                                    011112267889999999999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.3e-42  Score=292.50  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=198.7

Q ss_pred             hhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.+........       ...+.+|+..+++++||||+++++.+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~   76 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-------RRGFLAEALTLGQFDHSNIVRLEGVIT   76 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH-------HHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence            468999999999999999999875   3466899999875422111       124678999999999999999999985


Q ss_pred             cCCCeEEEEcccccccHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLM-ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~-~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      . ....++||||++++.++.+ ......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++++|||.+.
T Consensus        77 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          77 R-GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             c-CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            4 4789999999998655544 4435679999999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....... ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+.....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------  226 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--------  226 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------
Confidence            4322111 1112234567999999876 678999999999999999775 9999988776655554432211        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  ...++.++..+.+++.+||+.+|++||++++|++
T Consensus       227 ----------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 ----------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                        1112336888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=300.60  Aligned_cols=278  Identities=25%  Similarity=0.393  Sum_probs=226.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..+.|.+.+.||+|+||.||-++.+.||+-||.|.+.+.......-     ..-.++|..+|.+++.+.|+.+-..+ +.
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g-----e~maLnEk~iL~kV~s~FiVslaYAf-eT  256 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG-----ETMALNEKQILEKVSSPFIVSLAYAF-ET  256 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh-----hHHhhHHHHHHHHhccCcEEEEeeee-cC
Confidence            4568889999999999999999999999999999997765543322     22356899999999999998887777 66


Q ss_pred             CCeEEEEcccccccHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ...+|+|+..++|+-+...+-+.  ..+++..+..++.+|+.||++||+.+|++||+||+|||+|+.|++.|+|+|+|..
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            68899999999986555444333  4699999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ... ..+.....||..|||||++.+ ..|+.+.|.|||||++|+|+.|..||.......-..++-+.....+.       
T Consensus       337 i~~-g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~-------  407 (591)
T KOG0986|consen  337 IPE-GKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE-------  407 (591)
T ss_pred             cCC-CCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh-------
Confidence            743 344556689999999999998 45999999999999999999999999876544333333222111111       


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCCC--
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSKD--  319 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~~--  319 (332)
                                                .-+...|+++++|.+.+|.+||.+|.     .+.++-+||||++++|.....  
T Consensus       408 --------------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagm  461 (591)
T KOG0986|consen  408 --------------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGM  461 (591)
T ss_pred             --------------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccC
Confidence                                      11233799999999999999999998     677999999999999998855  


Q ss_pred             CCCCCCCc
Q 035861          320 FMPTFPPQ  327 (332)
Q Consensus       320 ~~~~~~~~  327 (332)
                      ..|+|-|.
T Consensus       462 l~PPfiPd  469 (591)
T KOG0986|consen  462 LEPPFIPD  469 (591)
T ss_pred             CCCCCCCC
Confidence            55666553

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.3e-42  Score=294.70  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=200.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCC-----cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSG-----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      .+.+|++.+.||+|++|.||+|.....+     ..+++|.+.......       ....+.+|+..+++++||||+++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~-------~~~~~~~ei~~l~~l~h~~i~~~~~   75 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-------VQQEFRQEAELMSDLQHPNIVCLLG   75 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH-------HHHHHHHHHHHHHhcCCcccceEEE
Confidence            3568999999999999999999986554     679999886432111       1124678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      .+.. ....++++||+++ ++.+.+....               ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        76 ~~~~-~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N  154 (283)
T cd05048          76 VCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN  154 (283)
T ss_pred             EEcC-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence            9854 4778999999986 4544444321               458889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      |+++.++.++|+|||.+.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999987542211  12233456788999999876 568999999999999999998 99999887766


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +....+......                                    ..+..++.++.+|+.+||+.||.+||++.+|+
T Consensus       234 ~~~~~i~~~~~~------------------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~  277 (283)
T cd05048         234 EVIEMIRSRQLL------------------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIH  277 (283)
T ss_pred             HHHHHHHcCCcC------------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            555444322111                                    11223789999999999999999999999998


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      ++
T Consensus       278 ~~  279 (283)
T cd05048         278 TR  279 (283)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-41  Score=287.84  Aligned_cols=248  Identities=23%  Similarity=0.394  Sum_probs=198.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||+|+||.||++.++. +..+|+|.+.......         ..+.+|+..+++++||||+++++.+ ...
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   71 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSE---------EDFIEEAKVMMKLSHPKLVQLYGVC-TQQ   71 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccH---------HHHHHHHHHHHHCCCCCceeEEEEE-ccC
Confidence            5689999999999999999998864 5579999876432211         1466899999999999999999988 445


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++| ++.+.+....+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            789999999986 4555555445678999999999999999999999999999999999999999999999999887543


Q ss_pred             CCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .... ......++..|+|||.+.. ..++.++|+||+|+++|++++ |..||...+..+....+.......         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---------  221 (256)
T cd05114         152 DDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---------  221 (256)
T ss_pred             CCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------
Confidence            2211 1122234567999999876 678999999999999999999 899998877766666554321100         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 .+...+..+.+++.+||+.+|++||+++++++
T Consensus       222 ---------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         222 ---------------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                       11125678899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-42  Score=302.88  Aligned_cols=304  Identities=20%  Similarity=0.283  Sum_probs=209.4

Q ss_pred             ccccccc--CcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           16 LNKISEG--TYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        16 ~~~lg~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      ...||.|  ++|+||++++..+++.||+|++.........      ...+.+|+.+++.++||||+++++++..+ ...+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   75 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEH------LKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLW   75 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHH------HHHHHHHHHHHHhCCCCCcceEeeeEecC-CceE
Confidence            3567777  9999999999999999999998754322211      12466888999999999999999999554 7789


Q ss_pred             EEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           94 MVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        94 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      +|+|++.+ ++.+.+... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++++||+.+.......
T Consensus        76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            99999996 444444432 2458999999999999999999999999999999999999999999999997553321111


Q ss_pred             CC-------CccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          172 KP-------YTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       172 ~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..       .....++..|+|||++.+. ..++.++|+||||+++|++++|..||...................+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence            11       0112235569999998753 347899999999999999999999998776554444333321111110000


Q ss_pred             C-CCCCccccc--ccc-CCchhhhhh----hC--CCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          244 G-LSELPGAKA--NFA-KQPYNLLRK----RF--PAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       244 ~-~~~~~~~~~--~~~-~~~~~~~~~----~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      . .........  ... .........    ..  ..........++..+++||++||+.||++|||++|+|+||||.++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            0 000000000  000 000000000    00  0001111234678899999999999999999999999999999998


Q ss_pred             CCCCCCCCCCCCC
Q 035861          314 LPKSKDFMPTFPP  326 (332)
Q Consensus       314 ~~~~~~~~~~~~~  326 (332)
                      .....+++...||
T Consensus       316 ~~~~~~~~~~~~~  328 (328)
T cd08226         316 EQTQGSILSLLPP  328 (328)
T ss_pred             HhcccchhhcCCc
Confidence            8777767666654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-41  Score=292.52  Aligned_cols=263  Identities=29%  Similarity=0.445  Sum_probs=202.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-C
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-H   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   89 (332)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+....... .      ...+.+|++.+++++||||+++++.+... .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-L------QKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchH-H------HHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            47899999999999999999999899999999987543211 1      12467899999999999999999988543 3


Q ss_pred             CeEEEEccccccc-HHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEHD-LKWLM---ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~~-l~~~~---~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ...++||||++|+ +.+.+   ......+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            5689999999874 43332   2234568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHcCCCCCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-----VDQIDKIFKTLGTPTET  240 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~  240 (332)
                      ......  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....     .+....+....   ...
T Consensus       154 ~~~~~~--~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  227 (287)
T cd06621         154 ELVNSL--AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP---NPE  227 (287)
T ss_pred             cccccc--cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC---chh
Confidence            543221  123456788999999876 6789999999999999999999999976522     11111111100   000


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .                           ..........++.+.+||.+||+.+|++||++.|+++||||++.-
T Consensus       228 ~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         228 L---------------------------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             h---------------------------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            0                           000000112467889999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-42  Score=319.53  Aligned_cols=298  Identities=22%  Similarity=0.309  Sum_probs=200.8

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCC-cEEEEEEeecccCCcc---------cccccCCCcchhHHHHHHhhCCCCC
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKE---------DCLEYGFPISSLREINILLSFDHPS   77 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~---------~~~~~~~~~~~~~e~~~l~~l~h~~   77 (332)
                      ....+|++++.||+|+||+||++..+... ...++|.+........         ..........+.+|+.++++++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34578999999999999999998765322 2222221111000000         0000001124568999999999999


Q ss_pred             eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC
Q 035861           78 IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK----QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ  153 (332)
Q Consensus        78 i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~----~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~  153 (332)
                      |+.+++++... ...|++++++.+++...+....    .......+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus       225 Iv~l~~~~~~~-~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSE-ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEEC-CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            99999998444 7789999999988877665422    234567788899999999999999999999999999999999


Q ss_pred             CcEEEeecccccccCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CC--ChHHHHHH
Q 035861          154 GVLKICDFGMSRQYGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GT--TEVDQIDK  229 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~-~~--~~~~~~~~  229 (332)
                      +.+||+|||++........ ......|+..|+|||++.+ ..++.++||||||+++|+|++|..++. ..  .......+
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            9999999999976643322 2234578999999999987 678999999999999999999876543 22  33344444


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccc-cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANF-AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                      ++......... ++...   ....+. ............+.  +-....++..+.++|.+||+.||.+|||+.|+|+|||
T Consensus       383 ~~~~~~~~~~~-~p~~~---~~~~~~i~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        383 IIDSLSVCDEE-FPDPP---CKLFDYIDSAEIDHAGHSVPP--LIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHhcccChhh-cCCcH---HHHHHHhhhhhcccCccchhh--HHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            44433322211 11100   000000 00000000000000  0011125677889999999999999999999999999


Q ss_pred             CCCCC
Q 035861          309 FHEVP  313 (332)
Q Consensus       309 f~~~~  313 (332)
                      |....
T Consensus       457 f~~~~  461 (501)
T PHA03210        457 FSAEE  461 (501)
T ss_pred             hhcCC
Confidence            98865

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=316.24  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee-eEEcC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE-VVMDD   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~-~~~~~   88 (332)
                      .+++|.+.|.+|||+.||+|.+...+..||+|++.......        .+.+.+|+.+|++| .|+||+.+++ .....
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~--------L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEA--------LNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHH--------HHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            47889999999999999999999888999999997652111        12467999999999 5999999999 33221


Q ss_pred             -----CCeEEEEccccc-ccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCcEEEe
Q 035861           89 -----HDSVYMVMEYME-HDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        89 -----~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~~~l~  159 (332)
                           .-.++|.||||. |++.+.+..+ ...|++.++++|++|+|+|+++||...  |+|||||-+||||+.+|..|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence                 235789999999 6898888754 345999999999999999999999998  9999999999999999999999


Q ss_pred             ecccccccCCCCCC---------Cccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 035861          160 DFGMSRQYGSPLKP---------YTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQID  228 (332)
Q Consensus       160 df~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~  228 (332)
                      |||++...-.....         .-....|+.|+|||.+.  .+...+.++|||+|||+||.|+....||........  
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI--  266 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI--  266 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--
Confidence            99998754322211         11235689999999874  346789999999999999999999999987633221  


Q ss_pred             HHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC--
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH--  306 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--  306 (332)
                        .+                                   ..+.++..+.++..+++||+.||+.||++||++-+++.+  
T Consensus       267 --ln-----------------------------------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  267 --LN-----------------------------------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             --Ee-----------------------------------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence              11                                   223344445699999999999999999999999999876  


Q ss_pred             ------CCCCCCC
Q 035861          307 ------YWFHEVP  313 (332)
Q Consensus       307 ------p~f~~~~  313 (332)
                            +++.++.
T Consensus       310 ~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  310 ELANKPCPIPDIY  322 (738)
T ss_pred             HHhcCCCCccccc
Confidence                  5555555

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.8e-41  Score=286.38  Aligned_cols=249  Identities=23%  Similarity=0.386  Sum_probs=198.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++++.||+|++|+||.+.+.. +..+|+|.+.......         ..+.+|+..+++++||||+++++++. ..
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   71 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE---------DEFIEEAKVMMKLSHEKLVQLYGVCT-KQ   71 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccH---------HHHHHHHHHHhcCCCCCeeeEEEEEc-cC
Confidence            4689999999999999999998764 4459999886433211         14678999999999999999999984 44


Q ss_pred             CeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...+++|||+.++ +.+.+......+++..++.++.|++.||+|||+.|++|+||+|.||+++.++.++|+|||.+....
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence            6789999999865 555555444578999999999999999999999999999999999999999999999999887543


Q ss_pred             CCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .+.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.......         
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------  221 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY---------  221 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC---------
Confidence            2211 1112234567999999976 568899999999999999998 999998777665555543321111         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                 .....+..+++++.+||+.+|.+||++.+|+++
T Consensus       222 ---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         222 ---------------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                       011257889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-41  Score=291.11  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=200.7

Q ss_pred             chhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ..++|++.+.||+|++|.||+|....     .+..||+|.+........       ...+.+|+..++.++|+||+++++
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~   76 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-------RIEFLNEASVMKGFTCHHVVRLLG   76 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-------HHHHHHHHHHHHhCCCCCeeeEEE
Confidence            35689999999999999999997642     345799998754321111       114568999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ  153 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~  153 (332)
                      .+.+. ...++||||+++ ++.+.+....         ..++...+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus        77 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~  155 (288)
T cd05061          77 VVSKG-QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             EEcCC-CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence            88444 678999999985 5555554321         234667889999999999999999999999999999999999


Q ss_pred             CcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 035861          154 GVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~  230 (332)
                      +.++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999875432111  1122344667999999876 668999999999999999998 78888776655544433


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc-----
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN-----  305 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~-----  305 (332)
                      ......                                    .....+++.+.+++.+||+.||++||++.++++     
T Consensus       235 ~~~~~~------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 MDGGYL------------------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HcCCCC------------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            221100                                    011225788999999999999999999999988     


Q ss_pred             -CCCCCCCCC
Q 035861          306 -HYWFHEVPL  314 (332)
Q Consensus       306 -hp~f~~~~~  314 (332)
                       ||||..+.|
T Consensus       279 ~~~~~~~~~~  288 (288)
T cd05061         279 LHPSFPEVSF  288 (288)
T ss_pred             cCCCCCCCCC
Confidence             999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-41  Score=293.79  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=194.2

Q ss_pred             hcccccccccccCcEEEEEEEECC----------------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK----------------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD   74 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   74 (332)
                      ++|.+.+.||+|+||.||++.+..                ++..||+|++........       ...+.+|+..+.+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~   77 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA-------RNDFLKEVKILSRLK   77 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHH-------HHHHHHHHHHHhhcC
Confidence            589999999999999999998642                344799998865322110       124678999999999


Q ss_pred             CCCeeeeeeeEEcCCCeEEEEcccccc-cHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 035861           75 HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK------------------QPFSTSEVKCLMLQLLEGVKYLHD  135 (332)
Q Consensus        75 h~~i~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~l~~~~~~~i~~~l~~~L~~lh~  135 (332)
                      ||||+++++.+.+. ...++||||+++ ++.+.+....                  ..+++..++.++.||+.||+|||+
T Consensus        78 h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          78 DPNIIRLLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             CCCeeEEEEEEecC-CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999555 678999999986 4444443211                  246788899999999999999999


Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA  213 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt  213 (332)
                      .|++|+||||+||+++.++.++|+|||.+........  ......++..|+|||.+.. ..++.++|+||||+++|+|++
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999876532211  1122344678999999876 668999999999999999986


Q ss_pred             --CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcC
Q 035861          214 --KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLT  291 (332)
Q Consensus       214 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  291 (332)
                        +..||...+..+..............                             ......++.++..+.+|+.+||+
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~cl~  286 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGR-----------------------------QVYLFRPPPCPQGLYELMLQCWS  286 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccc-----------------------------cccccCCCCCCHHHHHHHHHHcc
Confidence              56788776655544443321110000                             00011123478899999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 035861          292 YDPEKRITVDDALN  305 (332)
Q Consensus       292 ~dp~~Rps~~ell~  305 (332)
                      .||++|||+++|.+
T Consensus       287 ~~p~~RPs~~~i~~  300 (304)
T cd05096         287 RDCRERPSFSDIHA  300 (304)
T ss_pred             CCchhCcCHHHHHH
Confidence            99999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=305.04  Aligned_cols=265  Identities=26%  Similarity=0.389  Sum_probs=228.8

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..+.+..|.++..||+|.|++|.++++..++..||||.+.+........      ..+.+|+++++.++||||++++.+.
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~------~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR------QKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH------HHHHHHHHHHHhcCCcceeeeeeee
Confidence            4456778999999999999999999999999999999998776544321      1357999999999999999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       .....+|+||||+.|+-+......++.+.+..+..++.|+..|++|||+++|+|+|||++||+++.+.++||+|||++.
T Consensus       125 -~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  125 -ETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             -eecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccce
Confidence             4448899999999876555555558888889999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .++. .....+.+|++.|.|||++.+..+..++.|+||||+++|-++.|..||.+.+-.....+.....-..+.      
T Consensus       204 ~~~~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~------  276 (596)
T KOG0586|consen  204 FFDY-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF------  276 (596)
T ss_pred             eecc-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc------
Confidence            8864 345567899999999999999888899999999999999999999999988766555554443222222      


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                     .++.+..+||+++|-.+|.+|++.+++.+|.|.......
T Consensus       277 -------------------------------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  277 -------------------------------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -------------------------------eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                                           278888999999999999999999999999999998876

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.3e-41  Score=285.33  Aligned_cols=257  Identities=31%  Similarity=0.517  Sum_probs=206.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC-C
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH-D   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   90 (332)
                      +|++.+.||+|++|.||+|.+..++..+++|++.........      ...+.+|+..+++++|+||+++++.+.... .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE------LEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHH------HHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            588899999999999999999989999999998765432111      124678999999999999999999985442 6


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++++|+++++.+.........+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            78999999976555555444568999999999999999999999999999999999999999999999999998876543


Q ss_pred             CC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          171 LK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..  ......++..|.|||.+.. ...+.++|+||||+++|++++|..||........  .......             
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-------------  218 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS-------------  218 (260)
T ss_pred             cccccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc-------------
Confidence            32  1345578889999999877 5589999999999999999999999987652211  1111100             


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                         .......+..++..+.+||.+|++.+|++||++.+++.||||
T Consensus       219 -------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 -------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                               000011122358899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-42  Score=297.48  Aligned_cols=263  Identities=29%  Similarity=0.430  Sum_probs=204.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDH   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   89 (332)
                      ..|++++.||.||.+.||++..... ..||+|.+.........      ...+.+|+.+|.+| .|.+|+.++++-+.+ 
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qt------l~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-  432 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQT------LDGYRNEIALLNKLKGHDKIIQLYDYEVTD-  432 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHH------HHHHHHHHHHHHHhcCCceEEEEeeeeccC-
Confidence            4899999999999999999998654 44666666544333322      22567999999999 699999999998665 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      +++|+|||+=+.+|...+......++.-.++.+..|++.|+.++|++||||.||||.|+|+-. |.+||+|||.|.....
T Consensus       433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  433 GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            999999999999998888886666666799999999999999999999999999999999876 8999999999987644


Q ss_pred             CCC--CCccccccccccchhhhcCC----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          170 PLK--PYTSLVVTLWYRAPELLLGA----------KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~----------~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      ...  .....+||+-||+||++...          ...+.+||||||||+||+|+.|+.||..-...  +.++.....+.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--~aKl~aI~~P~  589 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--IAKLHAITDPN  589 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--HHHHHhhcCCC
Confidence            333  34567899999999998531          12577999999999999999999999764321  12221111110


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      .+--++.++                               -..++.++++.||+.||.+||++.|+|+|||++-++.+
T Consensus       590 ~~Iefp~~~-------------------------------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~  636 (677)
T KOG0596|consen  590 HEIEFPDIP-------------------------------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP  636 (677)
T ss_pred             ccccccCCC-------------------------------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence            000111110                               01237899999999999999999999999999986654

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-41  Score=288.23  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .-.+|++++.||.|++|.||+|.+.. +..+++|++........        ..+..|+..++.++|+|++++++.+. +
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~--------~~~~~e~~~l~~l~~~~i~~~~~~~~-~   73 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQ--------QDFQKEVQALKRLRHKHLISLFAVCS-V   73 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhH--------HHHHHHHHHHhcCCCcchhheeeeEe-c
Confidence            44689999999999999999999987 88899999875432111        14568999999999999999999884 4


Q ss_pred             CCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....++||||+++ ++.+.+... ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence            4778999999987 555555442 34689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ............++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  223 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------  223 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------
Confidence            5433222333445678999999876 678999999999999999998 89999877766555555432111         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 ..+..++..+.+++.+||+.||++||++.++++
T Consensus       224 ---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ---------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       112237889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-41  Score=287.40  Aligned_cols=250  Identities=21%  Similarity=0.347  Sum_probs=199.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|.+.+.||.|++|.||+|.+..+++.+++|++.......         ..+.+|+..+++++|+||+++++.+.. +
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   74 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---------EEFLKEAAVMKEIKHPNLVQLLGVCTR-E   74 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHH---------HHHHHHHHHHHhCCCCChhheEEEEcC-C
Confidence            357999999999999999999999899999999886432111         145689999999999999999999844 4


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...+++|||+++ ++.+.+... ...+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            778999999986 455555443 345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCC-ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPLKPY-TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------  223 (263)
T cd05052         155 TGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR----------  223 (263)
T ss_pred             ccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------
Confidence            4322111 12233567999998876 678899999999999999998 9999987665554444322110          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                ...+..++.++.++|.+||+.+|++||++.++++.
T Consensus       224 --------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         224 --------------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence                                      01122378899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=285.26  Aligned_cols=249  Identities=20%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++.+.||+|++|.||++.+. ++..+++|++.......         ..+.+|+..++.++|+||+++++.+ ...
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~~~~~~-~~~   71 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---------DDFIEEAKVMMKLSHPNLVQLYGVC-TKQ   71 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---------HHHHHHHHHHHhCCCCCEEEEEEEE-cCC
Confidence            457999999999999999999886 46679999886433211         1456899999999999999999988 444


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++|+|+++| ++.+.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence            788999999986 4555555545678999999999999999999999999999999999999999999999999887653


Q ss_pred             CCCCC-CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLKP-YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+.....           
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------  219 (256)
T cd05059         152 DDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-----------  219 (256)
T ss_pred             cccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-----------
Confidence            22111 111223457999999876 678899999999999999999 8999987666555444332111           


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                               ...+..++.++.+++.+||+.+|++||++.++++.
T Consensus       220 -------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 -------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                     01112378899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.7e-41  Score=283.44  Aligned_cols=252  Identities=34%  Similarity=0.552  Sum_probs=204.7

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|.+.+.||+|++|.||++.+..++..+++|++.......        ...+.+|+..++.+.|++++.+.+.+..+ ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--------KEKIINEIQILKKCKHPNIVKYYGSYLKK-DE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhH--------HHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence            5889999999999999999999889999999997654311        12467899999999999999999988555 78


Q ss_pred             EEEEcccccccHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYMEHDLKWL-MESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~-~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .++++||++|..+.. +......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            899999999654444 4443368999999999999999999999999999999999999999999999999998776433


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .. .....++..|+|||.+.. ...+.++|+||||+++|++++|..||...+............  .+.           
T Consensus       152 ~~-~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-----------  216 (253)
T cd05122         152 KA-RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPG-----------  216 (253)
T ss_pred             cc-ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCC-----------
Confidence            21 345567888999999876 558899999999999999999999998765444333322210  000           


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW  308 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  308 (332)
                                           ......++..+.++|.+||+.||++||++.++++|||
T Consensus       217 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ---------------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ---------------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                                 0001114788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-41  Score=293.22  Aligned_cols=265  Identities=26%  Similarity=0.442  Sum_probs=208.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ..++|++.+.||+|++|.||+|.+..++..||||.+........       ...+..|+..+... .|+||+++++.+.+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-------NKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-------HHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            56799999999999999999999998899999999975432111       11345666666555 59999999999855


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      + ...+++||++++.+...+......+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+..
T Consensus        86 ~-~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          86 D-SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             C-CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            4 7899999999988777776666789999999999999999999997 6999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCCCcc
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-VDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  242 (332)
                      ..... ......++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||..... .+....+.......     
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  238 (296)
T cd06618         165 LVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-----  238 (296)
T ss_pred             ccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-----
Confidence            53321 12233567789999998653   2478899999999999999999999976432 22333222211000     


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                                   ......++.++.+|+.+||+.||.+||+++++++||||..+...+
T Consensus       239 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         239 -----------------------------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             -----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence                                         000112678899999999999999999999999999999866543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=285.06  Aligned_cols=247  Identities=32%  Similarity=0.510  Sum_probs=201.1

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||.|++|.||++.+..+++.+++|++..........     ...+..|+..+++++|+|++++++.+ +++...++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-----VEHTLTERNILSRINHPFIVKLHYAF-QTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHH-----HHHHHHHHHHHHHcCCCcHHHHHHHe-ecCCeeEEEEec
Confidence            699999999999999889999999987654322211     11456899999999999999999988 455889999999


Q ss_pred             ccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 035861           99 MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV  178 (332)
Q Consensus        99 ~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  178 (332)
                      ++++.+.........+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............
T Consensus        75 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          75 APGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            96544444444456799999999999999999999999999999999999999999999999999877644323344556


Q ss_pred             ccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCC
Q 035861          179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQ  258 (332)
Q Consensus       179 ~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (332)
                      ++..|+|||.+.+ ...+.++|+||||+++|++++|..||...........+...                         
T Consensus       155 ~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------------------  208 (250)
T cd05123         155 GTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-------------------------  208 (250)
T ss_pred             CCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-------------------------
Confidence            7888999999876 56889999999999999999999999877654444433321                         


Q ss_pred             chhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH---HHHhcCCCC
Q 035861          259 PYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV---DDALNHYWF  309 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~hp~f  309 (332)
                                  ....+..++..+.++|.+||..||++||++   +++++||||
T Consensus       209 ------------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 ------------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                        011122257889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=282.50  Aligned_cols=263  Identities=23%  Similarity=0.384  Sum_probs=210.6

Q ss_pred             hhcccc-cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861           10 VFEFEK-LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      .+-|++ .+.||+|+++.|-.+....++..||||++.+.......        ++.+|++.+.++ .|+||+.++++| +
T Consensus        76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~--------RvfREVe~f~~Cqgh~nilqLiefF-E  146 (463)
T KOG0607|consen   76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRS--------RVFREVETFYQCQGHKNILQLIEFF-E  146 (463)
T ss_pred             HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHH--------HHHHHHHHHHHhcCCccHHHHHHHh-c
Confidence            334444 35699999999999999999999999999877543322        567999999999 799999999999 6


Q ss_pred             CCCeEEEEcccccccH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---cEEEeeccc
Q 035861           88 DHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---~~~l~df~~  163 (332)
                      ++...|+|||.+.|+. +..+.. ...+++.++.++..+|+.||.|||.+||+|+|+||+|||-....   -|||+||.+
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence            6688999999999764 555444 78899999999999999999999999999999999999987654   599999987


Q ss_pred             ccccCCC-------CCCCccccccccccchhhhc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----------
Q 035861          164 SRQYGSP-------LKPYTSLVVTLWYRAPELLL----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT----------  222 (332)
Q Consensus       164 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~----~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~----------  222 (332)
                      ..-...+       .....+.+|+..|||||+..    ....|+.+.|.||||+++|-|++|.+||.+..          
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            6543211       11234567888899999863    33568899999999999999999999997532          


Q ss_pred             -----hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCC
Q 035861          223 -----EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR  297 (332)
Q Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  297 (332)
                           ....+..|..+....|+..                                 |..+|.+.++||+.+|..|+.+|
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkd---------------------------------WahIS~eakdlisnLlvrda~~r  352 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKD---------------------------------WAHISSEAKDLISNLLVRDAKQR  352 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhh---------------------------------hHHhhHHHHHHHHHHHhccHHhh
Confidence                 2233444444433333332                                 34489999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCC
Q 035861          298 ITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       298 ps~~ell~hp~f~~~~~~  315 (332)
                      .++.++++|||++.....
T Consensus       353 lsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  353 LSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             hhhhhccCCccccccchh
Confidence            999999999999987644

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-43  Score=292.68  Aligned_cols=275  Identities=27%  Similarity=0.427  Sum_probs=235.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   88 (332)
                      ..+|.++..||.|+||.|.++..+.+.+.||||++++.........+     --+.|-++|.... -|.++.++..+ +.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDve-----ctm~EKrvLAL~~kppFL~qlHScF-QT  421 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVE-----CTMVEKRVLALPGKPPFLVQLHSCF-QT  421 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCccc-----ceehhhhheecCCCCchHHHHHHHh-hh
Confidence            45899999999999999999999999999999999987765554444     2357888887774 55666666666 55


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      -+.+|+||||+.|+-+-..+..-+.+.++.+..++..|+-||-+||++||+++|||.+||+++.+|++||.|||.+...-
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence            57899999999986555555557889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .....-.+.+||+.|+|||.+.- .+|+.+.|.||+|++||||+.|..||.+.+..+....|....-..+..        
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--------  572 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--------  572 (683)
T ss_pred             cCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--------
Confidence            55555678899999999999887 789999999999999999999999999999999988887754333322        


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC--CCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~--~~~~  321 (332)
                                                   +|.++.++....|.+.|.+|..     -.+|-+||||..+.|...  ++..
T Consensus       573 -----------------------------lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiq  623 (683)
T KOG0696|consen  573 -----------------------------LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQ  623 (683)
T ss_pred             -----------------------------ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCC
Confidence                                         7999999999999999999984     468999999999999988  5589


Q ss_pred             CCCCCcc
Q 035861          322 PTFPPQH  328 (332)
Q Consensus       322 ~~~~~~~  328 (332)
                      |+|+|+.
T Consensus       624 PPfkPk~  630 (683)
T KOG0696|consen  624 PPFKPKI  630 (683)
T ss_pred             CCCCCcc
Confidence            9999987

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4e-41  Score=285.35  Aligned_cols=252  Identities=29%  Similarity=0.508  Sum_probs=205.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|++.+.||.|++|.||++++..+++.+++|.+.........      ...+.+|+..++.++|+||+++.+.+..+ ..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~   73 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE------REDAVNEIRILASVNHPNIISYKEAFLDG-NK   73 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH------HHHHHHHHHHHHhCCCCCchhhhhhhccC-CE
Confidence            588999999999999999999999999999998764432211      12456899999999999999999998555 88


Q ss_pred             EEEEccccccc-HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           92 VYMVMEYMEHD-LKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~~-l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .++|+|++++. +...+..   ....+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            99999999875 4443333   1356899999999999999999999999999999999999999999999999998776


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...  ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+......           
T Consensus       154 ~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  219 (256)
T cd08530         154 KKN--MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-----------  219 (256)
T ss_pred             ccC--CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------
Confidence            443  2334567889999999876 67888999999999999999999999877655443333221100           


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                               .....++.++++++.+||+.+|++||++.++++||++
T Consensus       220 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         220 -------------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -------------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                                     0112368889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-41  Score=288.21  Aligned_cols=254  Identities=28%  Similarity=0.433  Sum_probs=199.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++.+.||.|++|.||++.+..++..++||.+..........     ...+.+|+..++.+.|+||+++++.+.++ 
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-   74 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA-----RADCIKEIDLLKQLNHPNVIKYYASFIED-   74 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHH-----HHHHHHHHHHHHHccCCchhhhhheeEeC-
Confidence            368999999999999999999999899999999887543222111     12466899999999999999999998655 


Q ss_pred             CeEEEEccccccc-HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEHD-LKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~~-l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ...++++|+++|+ +.+.+..   ....+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            7889999999974 4444432   24568999999999999999999999999999999999999999999999999887


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV--DQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  243 (332)
                      .............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  .....+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD---------  224 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC---------
Confidence            65433333334567889999999876 56889999999999999999999999654322  1111111100         


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ........++..+.+++.+||+.||++|||+.+|++
T Consensus       225 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         225 --------------------------YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             --------------------------CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                                      000011236889999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.3e-41  Score=301.84  Aligned_cols=252  Identities=22%  Similarity=0.350  Sum_probs=193.6

Q ss_pred             hcccccccccccCcEEEEEEEE-----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      ++|++.+.||+|+||+||+|++     ..++..||||++........       ...+.+|+.++..+ +||||+++++.
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-------~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-------REALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-------HHHHHHHHHHHHHhcCCcceeeeeee
Confidence            4899999999999999999974     34567899999864322111       12467899999999 89999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcC----------------------------------------------------
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMK----------------------------------------------------  111 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------------------------------------  111 (332)
                      +.. ....++||||++| ++.+.+....                                                    
T Consensus       108 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         108 CTV-GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             ecc-CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            844 4778999999986 4444443211                                                    


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861          112 ----------------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus       112 ----------------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                                            ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                                  2478889999999999999999999999999999999999999999999999876533


Q ss_pred             CCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          170 PLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ...  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..........+.......          
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR----------  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence            211  1112234567999999977 678999999999999999998 88898765544333333221100          


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                               ...+...+.++.+|+.+||+.||++||++.+|++.
T Consensus       336 -------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 -------------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                     00112257789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.6e-41  Score=291.86  Aligned_cols=268  Identities=25%  Similarity=0.396  Sum_probs=205.4

Q ss_pred             cccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      .|++.+.||.|++|.||++...   .+|..||+|++..........    ....+.+|+.+++++ .|++|+.+++.+. 
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHYAFQ-   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcch----HHHHHHHHHHHHHhcccCCChhceeeEee-
Confidence            4889999999999999999874   478999999987533211111    112355799999999 5899999998884 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .+...++|+||++++.+.........+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            44788999999997554444444677999999999999999999999999999999999999999999999999988765


Q ss_pred             CCCC-CCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||.+... ..++.++|+||||+++|++++|..||...........+.......        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--------  227 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--------
Confidence            3321 122234578889999998652 346789999999999999999999996543222222222111000        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~  317 (332)
                                               ....+..+++.+.+++.+||+.||++||     +++++++||||..+++...
T Consensus       228 -------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         228 -------------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             -------------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence                                     0001223688899999999999999997     8999999999999997654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.8e-41  Score=295.10  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=197.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcE----EEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEI----VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..+|++.+.||+|+||+||+|++..++..    ||+|++........       ...+.+|+.+++.+.||||+++++.+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~g~~   78 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-------NKEILDEAYVMASVDNPHVCRLLGIC   78 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHH-------HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45899999999999999999998665554    88998864321111       12466899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ..+  ..+++++++.+ ++.+.+......+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus        79 ~~~--~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          79 LTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             cCC--CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence            543  46788999885 566666665667899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .........  .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+... +.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~------  228 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGE------  228 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCC------
Confidence            865432221  122234567999999876 678999999999999999998 999998766544322 222110      


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                   ....++.++.++.+++.+||+.+|++||++.+++.+
T Consensus       229 -----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 -----------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                         011122367889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.4e-41  Score=290.16  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=195.9

Q ss_pred             hcccccccccccCcEEEEEEEE-----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           11 FEFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ++|.+.+.||+|+||+||++..     ..++..+++|.+.......        ...+.+|+..+++++|+||+++++.+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA--------RKDFHREAELLTNLQHEHIVKFYGVC   76 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHH--------HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            4799999999999999999985     2345678899886432111        11467899999999999999999998


Q ss_pred             EcCCCeEEEEccccccc-HHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC
Q 035861           86 MDDHDSVYMVMEYMEHD-LKWLMESMK------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN  152 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~-l~~~~~~~~------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~  152 (332)
                      .. ....++|+||++++ +.+.+....            ..+++..++.++.|++.||+|||++|++|+||||+||+++.
T Consensus        77 ~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          77 VE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             ec-CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            54 47899999999864 444443221            24899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 035861          153 QGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDK  229 (332)
Q Consensus       153 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~  229 (332)
                      ++.++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~  234 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  234 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999875432211  1122334678999999876 678999999999999999998 8999987776665555


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      +.......                                    ....++.++.+|+.+||+.||.+||++.++++
T Consensus       235 i~~~~~~~------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         235 ITQGRVLQ------------------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHcCCcCC------------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            54321110                                    11226788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-41  Score=301.57  Aligned_cols=252  Identities=22%  Similarity=0.335  Sum_probs=193.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCC-----CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS-----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|+||.||+|++..+     +..||+|++........       ...+.+|+.+++.+ +|+||+++++
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-------REALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-------HHHHHHHHHHHHhhccCCceeeEee
Confidence            45799999999999999999986443     35799999975432211       12456899999999 8999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc----------------------------------------------------
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM----------------------------------------------------  110 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~----------------------------------------------------  110 (332)
                      .+... ...++||||+++ ++.+.+...                                                    
T Consensus       110 ~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         110 ACTHG-GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             EecCC-CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            98444 789999999986 444444321                                                    


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC-
Q 035861          111 -----------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK-  172 (332)
Q Consensus       111 -----------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~-  172 (332)
                                       ..++++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                             12478889999999999999999999999999999999999999999999999876532211 


Q ss_pred             -CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          173 -PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       ......++..|+|||++.. ..++.++|+||||+++|+|++ |..||..................              
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~--------------  333 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ--------------  333 (374)
T ss_pred             eeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC--------------
Confidence             1112234567999999876 678999999999999999997 99999765443333333221100              


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                           ...+..+++++.+++.+||+.||.+||++.+|++
T Consensus       334 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 ---------------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ---------------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 0011226889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.3e-41  Score=289.71  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=198.8

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ..+|.+.+.||+|++|.||+|....     ++..||+|.+........       ...+.+|+++++.+.|+||+++++.
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~   76 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA-------RKDFEREAELLTNFQHENIVKFYGV   76 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHH-------HHHHHHHHHHHHhcCCCCchheeeE
Confidence            4579999999999999999998743     457899999865432210       1256789999999999999999999


Q ss_pred             EEcCCCeEEEEcccccccH-HHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE
Q 035861           85 VMDDHDSVYMVMEYMEHDL-KWLMESM-------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL  150 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l-~~~~~~~-------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili  150 (332)
                      +..+ ...++||||++|+. .+.+...             ...+++..+..++.|++.||++||++|++|+||+|+||++
T Consensus        77 ~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili  155 (280)
T cd05049          77 CTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV  155 (280)
T ss_pred             EecC-CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE
Confidence            9555 78999999998654 4444332             2347899999999999999999999999999999999999


Q ss_pred             cCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 035861          151 NNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQI  227 (332)
Q Consensus       151 ~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~  227 (332)
                      +.++.++|+|||.+.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+..
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~  234 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI  234 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999887542211  11223345678999999877 678999999999999999998 99999877766655


Q ss_pred             HHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ..+......                                    .....++..+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQGRLL------------------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHcCCcC------------------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            544322111                                    111237889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=286.56  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=200.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|++.+.||+|+||+||+|.+..+   ...+++|.+........       ...+.+|+..+++++|+||+++++.+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-------RLDFLTEASIMGQFDHPNIIRLEGVVT   75 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHH-------HHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence            46899999999999999999998643   45799998864332111       124568999999999999999999885


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      . ....+++||++++ ++.+.+....+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        76 ~-~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          76 K-SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             c-CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence            4 4778999999987 5555555545679999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCC--ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLKPY--TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .........  ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+......+     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  228 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP-----  228 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            764211111  12234567999999876 668999999999999999998 999997766655554443221111     


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     .+..++..+.+|+.+||+.+|++||++++++++
T Consensus       229 -------------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 -------------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                           112368889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.6e-41  Score=283.89  Aligned_cols=244  Identities=24%  Similarity=0.428  Sum_probs=190.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||+|++|+||+|++..+++.+|+|.+.......       ....+.+|++++++++|+||+++++++.. ....++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   72 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-------LKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVM   72 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHH-------HHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEE
Confidence            46999999999999999899999999875432111       11246789999999999999999999844 47789999


Q ss_pred             cccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCC--
Q 035861           97 EYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--  173 (332)
Q Consensus        97 e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~--  173 (332)
                      ||++++ +.+.+......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            999864 45455444556899999999999999999999999999999999999999999999999998754321111  


Q ss_pred             CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccc
Q 035861          174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK  252 (332)
Q Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (332)
                      ......+..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+.....                 
T Consensus       153 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-----------------  214 (252)
T cd05084         153 GGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-----------------  214 (252)
T ss_pred             CCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------------
Confidence            111123456999999876 568999999999999999998 8888876655443333322110                 


Q ss_pred             ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                         ...+..++..+.+|+.+||+.+|++||++.++++
T Consensus       215 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               0112236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-42  Score=289.87  Aligned_cols=247  Identities=32%  Similarity=0.518  Sum_probs=192.7

Q ss_pred             cccccccccCcEEEEEEEEC----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           14 EKLNKISEGTYGIVYRARDK----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+........       ...+.+|++.+++++||||+++++++... 
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-   73 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE-------EEEFLNEIQILRKLRHPNIVKLYGFCIEN-   73 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH-------HHHHHHHHHHHHTHSBTTBE-EEEEEESS-
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc-------ceeeeeccccccccccccccccccccccc-
Confidence            46788999999999999988    4567899999954322111       12567999999999999999999999744 


Q ss_pred             CeEEEEccccc-ccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYME-HDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++|+||++ |++.+.+... ...+++..++.|+.||+.||+|||+++++|++|+++||+++.++.+||+|||.+...
T Consensus        74 ~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   74 EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            66899999998 5677777765 577999999999999999999999999999999999999999999999999998776


Q ss_pred             CCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          168 GSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...  ............|+|||.+.. ..++.++||||||+++||+++ |..||...+..+....+......+       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-------  225 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-------  225 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-------
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce-------
Confidence            221  111233446678999999987 558999999999999999999 789998887777666664332111       


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                   .+..++..+.++|.+||+.||++||++.+|++
T Consensus       226 -----------------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  226 -----------------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -----------------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -----------------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                         12236888999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.3e-41  Score=283.87  Aligned_cols=245  Identities=24%  Similarity=0.395  Sum_probs=197.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+.+|++.+.||+|++|.||++...  +..+++|.+.....          ...+.+|+..+++++|++++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   71 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch----------HHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence            4568999999999999999999876  77899998854321          11456899999999999999999987666


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....++++||+++ ++.+.+..... .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcccee
Confidence            6778999999986 55555554333 489999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .....   ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+....+.....          
T Consensus       152 ~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  217 (256)
T cd05082         152 ASSTQ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------  217 (256)
T ss_pred             ccccC---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------
Confidence            43221   23344567999999876 668899999999999999997 9999987665544444322110          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ....+.+++.+.+++.+||+.+|++||++.++++
T Consensus       218 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 --------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                      0112237889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-41  Score=297.41  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=195.8

Q ss_pred             hcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      ++|++.+.||.|+||.||+|....     +++.||+|++........       ...+..|+..+.++ .|+||+++++.
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~-------~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-------YKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH-------HHHHHHHHHHHHhhccCcchhheeee
Confidence            489999999999999999997543     457899998864322111       11356899999999 89999999998


Q ss_pred             EEcCCCeEEEEcccccccHH-HHHHhc-----------------------------------------------------
Q 035861           85 VMDDHDSVYMVMEYMEHDLK-WLMESM-----------------------------------------------------  110 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~-~~~~~~-----------------------------------------------------  110 (332)
                      +...+...++++||++|+.+ +.+...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            87776789999999997544 333321                                                     


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccc
Q 035861          111 -------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTL  181 (332)
Q Consensus       111 -------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~  181 (332)
                             ...+++..+..++.||+.||+|||++||+|+||||.||+++.++.++|+|||++........  ......++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                   12678999999999999999999999999999999999999999999999999976532211  112334567


Q ss_pred             cccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCch
Q 035861          182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPY  260 (332)
Q Consensus       182 ~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (332)
                      .|+|||++.+ ..++.++|+||||+++|++++ |..||......+..........                         
T Consensus       240 ~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------------  293 (337)
T cd05054         240 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-------------------------  293 (337)
T ss_pred             cccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-------------------------
Confidence            7999999877 678999999999999999998 9999976544333322222100                         


Q ss_pred             hhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          261 NLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                ....+..+++++.+++.+||+.+|++||+++|+++|
T Consensus       294 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         294 ----------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      000112367889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=283.68  Aligned_cols=259  Identities=26%  Similarity=0.412  Sum_probs=204.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-C
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-H   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   89 (332)
                      .+|++.+.||+|++|.||++.+..++..+++|.+..........   .....+.+|+..+++++|+||+++++.+.+. .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETS---KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhh---HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence            47999999999999999999999999999999886432211110   1112566899999999999999999988554 3


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..+++++|+++|+.+.......+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            56889999998765544444456799999999999999999999999999999999999999999999999999876532


Q ss_pred             CC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          170 PL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..   .......++..|+|||.+.+ ..++.++|+||||+++|++++|..||..........++..   .+..       
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-------  227 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK-------  227 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC-------
Confidence            11   11223457888999999877 5688999999999999999999999987655544433321   1111       


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                               ...+..+++.+.++|.+||. +|..||++.++++|||.
T Consensus       228 -------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 -------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             -------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                     11123378899999999999 47999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.8e-41  Score=283.91  Aligned_cols=249  Identities=21%  Similarity=0.347  Sum_probs=198.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|+++++||+|++|.||+|... ++..|++|.+......         ...+.+|+.+++.++|+||+++++.+ .+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   72 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMS---------VQAFLEEANLMKTLQHDKLVRLYAVV-TK   72 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchh---------HHHHHHHHHHHHhCCCCCeeeEEEEE-cC
Confidence            3578999999999999999999875 4567999987543211         12467899999999999999999988 44


Q ss_pred             CCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....++++|++++ ++.+.+... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  152 (261)
T cd05072          73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV  152 (261)
T ss_pred             CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCcccee
Confidence            5778999999976 555555432 35689999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... ......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...........+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (261)
T cd05072         153 IEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--------  223 (261)
T ss_pred             cCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            543221 1223345667999999876 668899999999999999998 99999877665555444322110        


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  .....++.++.+++.+||..+|++||+++++++
T Consensus       224 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 ----------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                        111236888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-40  Score=283.65  Aligned_cols=253  Identities=28%  Similarity=0.465  Sum_probs=200.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||.|++|.||+|....+++.+++|.+..........     ...+.+|++.+++++|++++.+++.+..+ .
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~-----~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA-----RQDCLKEIDLLKQLDHPNVIKYLASFIEN-N   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhh-----HHHHHHHHHHHHhCCCCCeeeeeeeeecC-C
Confidence            58999999999999999999999899999999987543222111     12567899999999999999999999655 7


Q ss_pred             eEEEEcccccc-cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           91 SVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ..++||||++| ++...+..   ....+++..++.++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~  155 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeee
Confidence            88999999986 45444432   235589999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE--VDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ............++..|.|||.+.+ ..++.++|+||||+++|++++|..||.....  .+....+.....         
T Consensus       156 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------  225 (267)
T cd08224         156 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY---------  225 (267)
T ss_pred             ccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC---------
Confidence            5443333344567888999999876 6689999999999999999999999965431  111111111000         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ...+.+.++..+.++|.+||..+|++||++.+|++
T Consensus       226 --------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         226 --------------------------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             --------------------------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                      00011236788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.5e-41  Score=316.93  Aligned_cols=255  Identities=26%  Similarity=0.343  Sum_probs=195.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.........     ....+.+|+.++++++||||+++++.+.+ .
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~-----~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~   74 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL-----LKKRFLREAKIAADLIHPGIVPVYSICSD-G   74 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHH-----HHHHHHHHHHHHHhCCCcCcCeEEEEEee-C
Confidence            46899999999999999999999999999999998754322111     11256789999999999999999999844 4


Q ss_pred             CeEEEEcccccccHH-HHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           90 DSVYMVMEYMEHDLK-WLMESM----------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~-~~~~~~----------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                      ...+++|||++|+.+ +.+...          ...++...+..++.||+.||+|||+.||+||||||+||+++.++.++|
T Consensus        75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEE
Confidence            789999999997544 433321          123566778899999999999999999999999999999999999999


Q ss_pred             eecccccccCCC------------------CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 035861          159 CDFGMSRQYGSP------------------LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG  220 (332)
Q Consensus       159 ~df~~~~~~~~~------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~  220 (332)
                      +|||.+......                  ........||+.|+|||.+.+ ..++.++|+||||+++|+|+||..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999998765110                  011123468999999999877 6789999999999999999999999976


Q ss_pred             CChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH
Q 035861          221 TTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV  300 (332)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  300 (332)
                      ..........  ....+                                ........+++.+.+++.+||+.||++|++.
T Consensus       234 ~~~~ki~~~~--~i~~P--------------------------------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        234 KKGRKISYRD--VILSP--------------------------------IEVAPYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             cchhhhhhhh--hccCh--------------------------------hhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence            4432221110  00000                                0001122478889999999999999999876


Q ss_pred             HHHhc
Q 035861          301 DDALN  305 (332)
Q Consensus       301 ~ell~  305 (332)
                      .+.+.
T Consensus       280 ~eeLl  284 (932)
T PRK13184        280 VQELK  284 (932)
T ss_pred             HHHHH
Confidence            55553

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6e-41  Score=289.34  Aligned_cols=268  Identities=24%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             cccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      +|++.+.||.|++|.||+++..   .+++.++||++.........    .....+..|+.++.++ .|++|+++.+.+ .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~----~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKA----KTAEHTRTERQVLEAVRRCPFLVTLHYAF-Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhh----hHHHHHHHHHHHHHhccCCcchhhhheee-e
Confidence            4889999999999999999864   36788999998754221111    1112456899999999 699999999888 4


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .....++||||++|+.+.........+++..+..++.|++.+|++||+.|++|+||+|.||+++.++.++|+|||.+...
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            44788999999987544444444567999999999999999999999999999999999999999999999999988764


Q ss_pred             CCCCC-CCccccccccccchhhhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGAK-KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..... ......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.....          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~----------  225 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL----------  225 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----------
Confidence            32211 112345788999999986532 368899999999999999999999964332211111111100          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT---VDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~f~~~~~~~~  317 (332)
                                             ......+..++..+.++|.+||+.||++|||   +.++|+||||+.+.|+..
T Consensus       226 -----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         226 -----------------------KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             -----------------------ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence                                   0001112236788999999999999999998   678899999999988655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=270.46  Aligned_cols=255  Identities=23%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (332)
                      ++|.+.+.||.|||+-||+++...+++.||+|++.........        ..++|++.-++++|||++++++....   
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e--------~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIE--------EALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHH--------HHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            4899999999999999999999999999999999876532221        45799999999999999999887643   


Q ss_pred             -CCCeEEEEccccc-ccHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCcEEEee
Q 035861           88 -DHDSVYMVMEYME-HDLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        88 -~~~~~~lv~e~~~-~~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~~~l~d  160 (332)
                       .....||+++|.. |++.+.+...   ...+++.+++.|+.+++.||.+||+..  ++|+||||.||++++++.+++.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence             3356899999986 6677777654   346999999999999999999999999  99999999999999999999999


Q ss_pred             cccccccCCCCCCC---------ccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 035861          161 FGMSRQYGSPLKPY---------TSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK  229 (332)
Q Consensus       161 f~~~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~  229 (332)
                      ||+++...-.....         .....|..|+|||.+..  ....+.++|||||||++|.|+.|..||..--.      
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------  246 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------  246 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------
Confidence            99998653222111         12234778999999864  24578899999999999999999999953210      


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                        .+  .   ..     .               +.-..+....+..+.+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       247 --~G--g---Sl-----a---------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  247 --QG--G---SL-----A---------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             --cC--C---eE-----E---------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence              00  0   00     0               00000111222233389999999999999999999999999864

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-40  Score=282.88  Aligned_cols=243  Identities=26%  Similarity=0.338  Sum_probs=191.4

Q ss_pred             cccccCcEEEEEEEE--CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           18 KISEGTYGIVYRARD--KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      .||+|+||.||+|.+  ..++..+|+|++........      ....+..|+.+++.+.|+||+++++.+ ++ ...++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~-~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA------LKDELLREANVMQQLDNPYIVRMIGIC-EA-ESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH------HHHHHHHHHHHHHhCCCCCcceEEEEE-cC-CCcEEE
Confidence            689999999999965  45678999998864432211      112467899999999999999999987 43 457899


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCC--
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--  173 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~--  173 (332)
                      ||+++++.+.........+++..+..++.|++.||++||++|++|+||||.||+++.++.++|+|||.+.........  
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999997654444444678999999999999999999999999999999999999999999999999998765433221  


Q ss_pred             -CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          174 -YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                       .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+.....                
T Consensus       154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~----------------  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER----------------  216 (257)
T ss_pred             ecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----------------
Confidence             122233578999998865 568889999999999999998 9999987766555444432211                


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                          ...+..+++++.+||.+||+.||++||++.+|..
T Consensus       217 --------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 --------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                                1112237899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-40  Score=283.27  Aligned_cols=247  Identities=22%  Similarity=0.385  Sum_probs=197.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|+++++||+|++|.||+|... +++.+|+|.+.......         ..+.+|+.++++++|+|++++++.+ .. 
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~-~~-   72 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSP---------EAFLAEANLMKQLQHPRLVRLYAVV-TQ-   72 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcH---------HHHHHHHHHHHhcCCcCeeeEEEEE-cc-
Confidence            358999999999999999999865 57789999986443221         1467899999999999999999887 33 


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++++|++.+ ++.+.+... ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            568999999975 555555432 346899999999999999999999999999999999999999999999999998765


Q ss_pred             CCC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ... ........++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+......         
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------  222 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---------  222 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---------
Confidence            421 112223345678999999876 568899999999999999999 99999877766555444322111         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 ..+..++.++.+++.+||+.+|++||+++++++
T Consensus       223 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ---------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                       111226788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-40  Score=286.11  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=196.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCc----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..+|++++.||.|++|+||+|++..++.    .||+|++........       ...+.+|+..++.+.|+||+.+++.+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-------NKEILDEAYVMAGVGSPYVCRLLGIC   78 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHH-------HHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            4589999999999999999999877666    478998864332111       12466899999999999999999988


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ..  ...+++++++++ ++.+.+....+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~--~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          79 LT--STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             cC--CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence            54  346789999985 566666555567999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .........  .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----  230 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-----  230 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-----
Confidence            765432221  122234567999999876 568999999999999999998 89998776554443322221110     


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ...+.++.++.+++.+||+.||++||++.+++..
T Consensus       231 -------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         231 -------------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             -------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                           1112367889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.8e-41  Score=285.13  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=199.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|.+.+.||+|++|+||++.+..++..+++|++.........   ......+..|+.+++.++|||++++++.+.+. ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLER-DA   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-Cc
Confidence            588999999999999999999877777777776542221110   00111345788999999999999999998444 67


Q ss_pred             EEEEcccccccHHH-HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           92 VYMVMEYMEHDLKW-LMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~~l~~-~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .++|+||++++.+. .+..   ....+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+...
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeec
Confidence            89999999874443 3332   3467999999999999999999999999999999999999975 67999999988766


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.. ..++.++|+||+|+++|++++|..||...........+......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----------  223 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP-----------  223 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC-----------
Confidence            443333344567888999999865 56788999999999999999999999776655544443321100           


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                               ..+..++.++.++|.+||..+|++||++.++++||||
T Consensus       224 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         224 -------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                     0112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-40  Score=286.19  Aligned_cols=252  Identities=22%  Similarity=0.361  Sum_probs=194.1

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      -++|++.+.||+|++|+||+|.+..     ++..+|+|++........       ...+.+|+.+++.++|+||+++++.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~iv~~~~~   77 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-------RIEFLNEASVMKEFNCHHVVRLLGV   77 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHH-------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            4689999999999999999998652     356799998754221111       1145689999999999999999999


Q ss_pred             EEcCCCeEEEEccccccc-HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC
Q 035861           85 VMDDHDSVYMVMEYMEHD-LKWLMESMK---------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~---------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~  154 (332)
                      + ......++||||++++ +.+.+....         ..++...+..++.|++.||+|||+.|++|+||||+||+++.++
T Consensus        78 ~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          78 V-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             E-cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence            8 4447889999999865 444443321         2357788999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 035861          155 VLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~  231 (332)
                      .++|+|||.+........  ......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+.......+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999998875432111  1122345678999999876 678999999999999999999 788988776655444333


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ......                                    .+..++..+.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EGGLLD------------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCcCC------------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            211100                                    112267789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.6e-41  Score=290.61  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=193.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEE--EEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v--~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      .+++|++.+.||+|+||.||+|.+..++..+  ++|.+.....  ...     ...+.+|+..+.++ +|+||+++++.+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~--~~~-----~~~~~~Ei~~l~~l~~h~~iv~~~~~~   77 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDD-----HRDFAGELEVLCKLGHHPNIINLLGAC   77 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC--HHH-----HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            4679999999999999999999987777654  5655542211  110     12456799999999 899999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                       ......++|+||+++ ++.+.+....               ..+++..++.++.|++.||+|||++|++|+||||+||+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil  156 (303)
T cd05088          78 -EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  156 (303)
T ss_pred             -CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence             444789999999986 5555544321               25789999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQID  228 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~  228 (332)
                      ++.++.++|+|||++...... .......++..|+|||.+.. ..++.++|+||||+++|+++| |..||...+..+...
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  234 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  234 (303)
T ss_pred             ecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence            999999999999988643211 11112233567999998866 568899999999999999998 999997766554433


Q ss_pred             HHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      .+....                                    ....+..+++.+.+|+.+||+.+|++||++++++.+
T Consensus       235 ~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQGY------------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcCC------------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            321100                                    000112267889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-40  Score=281.14  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=196.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|++|.||+|.+. ++..+++|.+.......         ..+.+|+.++++++|++++++++.+ ..
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---------~~~~~E~~~l~~l~~~~i~~~~~~~-~~   72 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---------ESFLEEAQIMKKLRHDKLVQLYAVV-SE   72 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---------HHHHHHHHHHHhcCCCceEEEEeEE-CC
Confidence            3568999999999999999999876 45669999987543221         1467899999999999999999987 33


Q ss_pred             CCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       ...+++|||+++ ++.+.+... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~  151 (260)
T cd05070          73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL  151 (260)
T ss_pred             -CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence             457899999986 455554432 34589999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+.....         
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  221 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR---------  221 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            533221 1122234567999998876 678999999999999999999 8999987766555554432111         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 ...+...+..+.+|+.+||..+|++|||+.++++
T Consensus       222 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 ---------------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ---------------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                       0112236788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-40  Score=286.54  Aligned_cols=253  Identities=22%  Similarity=0.388  Sum_probs=197.2

Q ss_pred             chhcccccccccccCcEEEEEEEEC----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .+++|++.+.||+|+||+||+|...    .++..+++|.+........       ...+.+|+.+++++.||||+++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~   75 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-------WGEFQQEASLMAELHHPNIVCLLGV   75 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHH-------HHHHHHHHHHHhhCCCCCeeeEEEE
Confidence            4578999999999999999999853    3567899999864322111       1145689999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESM----------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~----------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      +... ...|++|||+++ ++.+.+...                ...+++..+..++.|++.||+|||++|++|+||+|+|
T Consensus        76 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n  154 (283)
T cd05090          76 VTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN  154 (283)
T ss_pred             EecC-CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence            8554 778999999986 454444321                1247889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      |+++.++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ  233 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999987653221  11223345667999999876 568999999999999999998 99999776654


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      .....+.....                                    ...+..+++.+.+++.+||+.||++||++.+|+
T Consensus       234 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~  277 (283)
T cd05090         234 EVIEMVRKRQL------------------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH  277 (283)
T ss_pred             HHHHHHHcCCc------------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            44443322110                                    111223688999999999999999999999998


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      ++
T Consensus       278 ~~  279 (283)
T cd05090         278 TR  279 (283)
T ss_pred             HH
Confidence            65

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-40  Score=284.33  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=193.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcE----EEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEI----VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..+|++++.||.|+||+||+|.+..++..    +++|++.......       ....+..|+..++++.||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~~~~~l~~l~h~~iv~~~~~~   78 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ-------TFQEITDHMLAMGSLDHAYIVRLLGIC   78 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchH-------HHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            46899999999999999999999777764    6666654221110       112355677788999999999999987


Q ss_pred             EcCCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       .+ ...++++|+++ |++.+.+....+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        79 -~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          79 -PG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             -CC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence             33 44678899988 4666666665678999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ........  ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+..... +    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~----  230 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-L----  230 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-C----
Confidence            76532211  2233456678999999876 668999999999999999998 9999977654433222211110 0    


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ..+..++..+.+++.+||..||++||++.|+++.
T Consensus       231 -------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         231 -------------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             -------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                           0111256778899999999999999999999763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-40  Score=285.46  Aligned_cols=252  Identities=22%  Similarity=0.361  Sum_probs=196.3

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|++.+.||+|++|.||+|.+..     ++..|++|.+........       ...+..|+..++.++|+||+++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~   77 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-------ESDFLMEALIMSKFNHQNIVRLIGV   77 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHH-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3679999999999999999999976     678899998764322111       1146789999999999999999998


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMK------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---  154 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---  154 (332)
                      +.+. ...++||||++| ++.+.+....      ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++   
T Consensus        78 ~~~~-~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          78 SFER-LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             EccC-CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCc
Confidence            8554 678899999976 4555544322      2589999999999999999999999999999999999998765   


Q ss_pred             cEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 035861          155 VLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~  231 (332)
                      .++|+|||.+........  .......+..|+|||++.+ ..++.++|+||||+++|+|++ |..||...+.......+.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            699999999876532111  1112233567999999976 668999999999999999997 999998776655443332


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ....                                    ...+..++..+.+++.+||+.+|++||++.+|++|
T Consensus       236 ~~~~------------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         236 GGGR------------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCc------------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2100                                    01122368889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=281.45  Aligned_cols=248  Identities=22%  Similarity=0.381  Sum_probs=196.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++.+.||+|++|.||+|.+.. ++.||+|.+......         ...+.+|+..+++++|+|++++++++.. .
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD---------PKDFLAEAQIMKKLRHPKLIQLYAVCTL-E   73 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc---------HHHHHHHHHHHHHCCCCCccceeEEEec-C
Confidence            3579999999999999999999754 567999998653321         1246789999999999999999998844 4


Q ss_pred             CeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...+++||+++| ++.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            778999999965 5555554433 46899999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCCC-CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPLKP-YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ...... ......+..|+|||.+.. ..++.++|+||||+++|++++ |..||...+.......+......         
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------  223 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---------  223 (261)
T ss_pred             cCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            422111 111223457999998876 678999999999999999999 99999877666555544322110         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 .....++..+.+++.+||+.+|.+||++.++++
T Consensus       224 ---------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ---------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ---------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                       111236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-40  Score=314.60  Aligned_cols=151  Identities=29%  Similarity=0.423  Sum_probs=128.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||.|+||+||+|.+..+++.||||++..........     ...+..|+.+++.++|+||+++++.+. .
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~   75 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNM-----VHQVQAERDALALSKSPFIVHLYYSLQ-S   75 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHH-----HHHHHHHHHHHHhcCCCCcCeEEEEEE-E
Confidence            4679999999999999999999999999999999997543222111     124568999999999999999998884 4


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ....|+||||+.|+.+..+....+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus        76 ~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          76 ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            47899999999865444444446779999999999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-40  Score=281.25  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=195.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++.++||+|++|+||+|++..+ ..|++|.+.......         ..+.+|+..+++++|+||+++++.+ .. 
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~---------~~~~~E~~~l~~l~~~~i~~~~~~~-~~-   72 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---------EAFLQEAQVMKKLRHEKLVQLYAVV-SE-   72 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCH---------HHHHHHHHHHHhCCCCCcceEEEEE-CC-
Confidence            35799999999999999999998755 459999987533211         1456899999999999999999887 33 


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||+++ ++.+.+... ...+++..+..++.|++.||++||+.|++|+||+|.||+++.++.++|+|||.+...
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            457899999986 555555442 345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..... ......++..|+|||.... ..++.++|+||||+++|++++ |..||...........+.....          
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~----------  221 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  221 (262)
T ss_pred             cccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC----------
Confidence            43221 1123345677999998876 668999999999999999999 8889987766555444322110          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ......++..+.+|+.+|++.+|++||++.++++
T Consensus       222 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 --------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             --------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                      0111236888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=280.86  Aligned_cols=245  Identities=26%  Similarity=0.456  Sum_probs=199.5

Q ss_pred             ccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           17 NKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      +.||+|+||.||++.+...   +..+++|.+.......       ....+.+|+..++.++|+|++++++++.. ....+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~   72 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------ERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLY   72 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-------HHHHHHHHHHHHhhcCCCChheeeeeecC-CCceE
Confidence            4699999999999999866   8899999987654322       11256789999999999999999999855 58899


Q ss_pred             EEcccccc-cHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           94 MVMEYMEH-DLKWLMESM--------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        94 lv~e~~~~-~l~~~~~~~--------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ++|||+++ ++.+.+...        ...+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccc
Confidence            99999965 555555543        377999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .......  .......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+....       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------  224 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------  224 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            8764322  22334456788999999887 478999999999999999999 699998876655555443311       


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                   ....+..++.++.+++.+||+.+|++||++++++++
T Consensus       225 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 -----------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -----------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                         111122368899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=297.58  Aligned_cols=246  Identities=30%  Similarity=0.491  Sum_probs=203.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ...+|.+...+|.|+|+.|-.+.+..++...++|++.......            .+|+.++... .|+|++++.+++ .
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~------------~~e~~~~~~~~~h~niv~~~~v~-~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN------------QDEIPISLLVRDHPNIVKSHDVY-E  386 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccccc------------ccccchhhhhcCCCcceeeccee-c
Confidence            4668999999999999999999999999999999998763222            2566565555 899999999999 5


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE-cCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL-NNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili-~~~~~~~l~df~~~~~  166 (332)
                      +....|+|||.+.|+.+-..+.+.+.+. ..+..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||.+..
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            6689999999999876555555455445 8888899999999999999999999999999999 5889999999999987


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ....   ....+-|..|.|||++.. ..++.++|+||||++||+|++|..||......   ..+......+...      
T Consensus       466 ~~~~---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s------  532 (612)
T KOG0603|consen  466 LERS---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS------  532 (612)
T ss_pred             Cchh---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc------
Confidence            6433   445567888999999985 88999999999999999999999999887665   2222222111111      


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                                   ..+|.++++||++||+.||.+|+++.+++.||||.
T Consensus       533 -----------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  533 -----------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             -----------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence                                         23899999999999999999999999999999993

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-40  Score=286.50  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=195.8

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ..+|.+.+.||+|++|.||+|++..     ++..+++|.+........        ..+.+|+..+++++|+||+++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~   75 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--------KDFQREAELLTNLQHEHIVKFYGV   75 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHH--------HHHHHHHHHHhcCCCCCcceEEEE
Confidence            4579999999999999999998642     455688888754332111        145689999999999999999999


Q ss_pred             EEcCCCeEEEEccccccc-HHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCE
Q 035861           85 VMDDHDSVYMVMEYMEHD-LKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNL  148 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Ni  148 (332)
                      +.. ....++||||++++ +.+.+...               .+.+++..++.++.||+.||++||++|++|+||+|+||
T Consensus        76 ~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  154 (291)
T cd05094          76 CGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC  154 (291)
T ss_pred             Ecc-CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence            854 47789999999864 44444331               13489999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 035861          149 LLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVD  225 (332)
Q Consensus       149 li~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~  225 (332)
                      +++.++.++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+
T Consensus       155 l~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  233 (291)
T cd05094         155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE  233 (291)
T ss_pred             EEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999875433211  1223345778999999876 678999999999999999998 999998776655


Q ss_pred             HHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ....+......                                    .....++..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         234 VIECITQGRVL------------------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHhCCCCC------------------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            44433221100                                    011226788999999999999999999999976


Q ss_pred             C
Q 035861          306 H  306 (332)
Q Consensus       306 h  306 (332)
                      .
T Consensus       278 ~  278 (291)
T cd05094         278 I  278 (291)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-40  Score=285.48  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=197.5

Q ss_pred             chhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      .+.+|++.+.||.|+||.||+|.+..     ++..||+|++.......       ....+..|+.++..++||||+++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~~~~l~h~~iv~~~~   75 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-------LREEFKHEAMMRSRLQHPNIVCLLG   75 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH-------HHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            35689999999999999999998754     35789999987443211       1124568999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccccHH-HHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEHDLK-WLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~-~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      .+... ...++++||+.++.+ +.+...               ...+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        76 ~~~~~-~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N  154 (283)
T cd05091          76 VVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN  154 (283)
T ss_pred             EEcCC-CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence            98444 678999999986543 333211               2357888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      |+++.++.++|+|||.+........  ......+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||......
T Consensus       155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  233 (283)
T cd05091         155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  233 (283)
T ss_pred             eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999998875432211  1123345678999999876 568999999999999999998 88888877666


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +....+......+                                    ....++..+.+|+.+||+.+|++||++.+|+
T Consensus       234 ~~~~~i~~~~~~~------------------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~  277 (283)
T cd05091         234 DVIEMIRNRQVLP------------------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIH  277 (283)
T ss_pred             HHHHHHHcCCcCC------------------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            5555544321110                                    1123788899999999999999999999998


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      ..
T Consensus       278 ~~  279 (283)
T cd05091         278 SR  279 (283)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.3e-40  Score=288.19  Aligned_cols=288  Identities=20%  Similarity=0.242  Sum_probs=196.6

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      .+.+.+|.|  +.||.++...+++.||+|++.........      ...+.+|+..+++++|+||+++++.+..+ ...+
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~   75 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKED------LKLLQQEIITSRQLQHPNILPYVTSFIVD-SELY   75 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhH------HHHHHHHHHHHHhcCCcchhhhhheeecC-CeEE
Confidence            344444444  45566666668999999999764222211      12467899999999999999999998554 7789


Q ss_pred             EEcccccccHHH-HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           94 MVMEYMEHDLKW-LMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        94 lv~e~~~~~l~~-~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      ++|||++++.+. .+... ...+++..+..++.|++.||+|||++||+|+||+|+||+++.++.++++||+.+.......
T Consensus        76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            999999965444 44432 3568999999999999999999999999999999999999999999999999876542211


Q ss_pred             C-------CCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          172 K-------PYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       172 ~-------~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .       ......++..|+|||.+... ..++.++|+||+|+++|+|++|..||..........+......  +.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  233 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV--PCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--cccccc
Confidence            1       12234566789999998653 3578899999999999999999999987655443333222111  100000


Q ss_pred             CCCCCccccccccCCchhhhhh-hCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRK-RFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      .  ..+................ ............++.++.+|+.+||..||++||+++++|+||||+.+..
T Consensus       234 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         234 S--TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             C--chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence            0  0000000000000000000 0000011112225678889999999999999999999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-40  Score=283.96  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=194.7

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ..+|++.++||+|+||.||++...     .++..+++|.+.......        ...+.+|++.++.++|+||+++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~   75 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--------RQDFQREAELLTVLQHQHIVRFYGV   75 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHH--------HHHHHHHHHHHhcCCCCCCceEEEE
Confidence            358899999999999999999743     346678888876432111        1246789999999999999999998


Q ss_pred             EEcCCCeEEEEccccccc-HHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           85 VMDDHDSVYMVMEYMEHD-LKWLMESMK--------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~--------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      +... ...++++||++++ +.+.+....              ..+++..+..++.||+.||+|||+.|++|+||+|+||+
T Consensus        76 ~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil  154 (280)
T cd05092          76 CTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL  154 (280)
T ss_pred             EecC-CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEE
Confidence            8544 7789999999864 444444321              34889999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQ  226 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~  226 (332)
                      +++++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+.
T Consensus       155 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  233 (280)
T cd05092         155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA  233 (280)
T ss_pred             EcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence            99999999999998865422111  1122234678999999876 668999999999999999998 8999977766555


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ...+......                                    ..+..+++.+.+||.+||+.||++||++.+|++
T Consensus       234 ~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         234 IECITQGREL------------------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHcCccC------------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            4444322110                                    111237888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-40  Score=278.91  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|.+.+.||.|++|+||++... ++..+++|.+.......         ..+.+|+..+++++|+|++++++.+. .
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~-~   72 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSP---------EAFLQEAQIMKKLRHDKLVQLYAVCS-E   72 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCH---------HHHHHHHHHHhhCCCCCEeeeeeeee-c
Confidence            3468999999999999999999976 45779999887543221         24678999999999999999999984 4


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....+++||++++ ++.+.+.... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            4778999999986 4555554432 4689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... .......+..|+|||.+.+ ...+.++|+||||+++|++++ |..||...+.......+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM--------  223 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            542111 1112234567999999876 668999999999999999998 99999887766655554332111        


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  ..+...+.++.+++.+||+.+|++||+++++++
T Consensus       224 ----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 ----------------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                        111225788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-40  Score=278.18  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=198.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ...+|++.+.||.|++|.||++...  ++.+++|.+.....         ....+.+|+.+++.++|+|++++++.+.. 
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   71 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-   71 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC-
Confidence            3568999999999999999999886  78999999975432         01246789999999999999999999854 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....++|||++++ ++.+.+.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            5778999999996 5555554433 2689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .....   .....+..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+....           
T Consensus       152 ~~~~~---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  216 (256)
T cd05039         152 ASQGQ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-----------  216 (256)
T ss_pred             ccccc---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            53221   13344567999999876 578899999999999999997 999998776554433332210           


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                               ....+..+++.+.++|.+||..+|++||+++++++
T Consensus       217 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                                     00111236889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=283.07  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=197.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCC-----CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKS-----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ..++|++.+.||.|++|.||+|.+...     +..|++|.+........       ...+.+|+..++.++|+||+++++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~   76 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-------RIEFLNEASVMKEFNCHHVVRLLG   76 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH-------HHHHHHHHHHHHhCCCCceeEEEE
Confidence            356899999999999999999998643     47899999754321111       124568999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM---------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ  153 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~  153 (332)
                      ++..+ ...++||||+++ ++.+.+...         ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus        77 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~  155 (277)
T cd05032          77 VVSTG-QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED  155 (277)
T ss_pred             EEcCC-CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence            98554 788999999985 555544332         1246888999999999999999999999999999999999999


Q ss_pred             CcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 035861          154 GVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~  230 (332)
                      +.++|+|||.+.......  .......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+..+....+
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            999999999887543221  11233455778999999876 568999999999999999998 99999877665554443


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      .... .                                   ...+..++..+.+++.+||+.+|++||++.++++.
T Consensus       235 ~~~~-~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         235 IDGG-H-----------------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             hcCC-C-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            3110 0                                   01112257889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.8e-40  Score=281.33  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=193.1

Q ss_pred             ccccccccccCcEEEEEEEECCCCc--EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC--
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGE--IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD--   88 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   88 (332)
                      |.+.+.||+|++|.||+|++..++.  .+|+|.+.........      ...+..|+..++.++|+||+++++.+...  
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE------MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE   74 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH------HHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence            4578899999999999999877665  6899988654322211      12456899999999999999999987432  


Q ss_pred             ---CCeEEEEcccccc-cHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           89 ---HDSVYMVMEYMEH-DLKWLMES-----MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        89 ---~~~~~lv~e~~~~-~l~~~~~~-----~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                         ....++++||+.+ ++...+..     ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+
T Consensus        75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence               1346899999986 44444322     12458999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 035861          160 DFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       160 df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      |||.+........  ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+..... 
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  232 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-  232 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            9999886533221  1122345677999999876 678999999999999999999 7899977665554444332111 


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                         ....+.++..+.++|.+||+.||++|||+.+|+++
T Consensus       233 -----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                               01122367889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-40  Score=287.29  Aligned_cols=252  Identities=21%  Similarity=0.370  Sum_probs=197.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCC-----CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS-----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|++|.||++.....     ...+++|.+........       ...+.+|+..++++ +|+||+++++
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD-------LSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHH-------HHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            35899999999999999999997643     36799998865322111       11356899999999 8999999999


Q ss_pred             eEEcCCCeEEEEccccccc-HHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEHD-LKWLMES---------------MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~-l~~~~~~---------------~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      ++.. ....+++|||++++ +...+..               ....+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        84 ~~~~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          84 VCTQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEcC-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            8844 47799999999864 4444432               13468999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      |+++.++.++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+..
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            9999999999999999876533211  1122234567999999876 678999999999999999997 99999877766


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +....+.....                                    ...+..++..+.+|+.+||..||++|||+.+++
T Consensus       242 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil  285 (293)
T cd05053         242 ELFKLLKEGYR------------------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV  285 (293)
T ss_pred             HHHHHHHcCCc------------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            55544432210                                    011123678899999999999999999999998


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      ++
T Consensus       286 ~~  287 (293)
T cd05053         286 ED  287 (293)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-39  Score=277.47  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=195.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|.+.+.||.|++|+||++.+..+ ..+++|.+......         ...+.+|+.++++++|+|++++++.+ .. .
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---------PEAFLQEAQIMKKLRHDKLVPLYAVV-SE-E   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---------HHHHHHHHHHHHhCCCCCeeeEEEEE-cC-C
Confidence            5799999999999999999988654 45899987643221         12466899999999999999999887 33 4


Q ss_pred             eEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           91 SVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ..+++|||+++ ++.+.+.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            57899999986 5666665433 458999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ... .......++..|+|||.... ..++.++|+||||+++|++++ |..||......+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM----------  222 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            322 11222345677999998876 668999999999999999999 89999887665554443322110          


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ..+..++..+.+++.+||+.||++||+++++++
T Consensus       223 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 --------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             --------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                      011236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=299.29  Aligned_cols=251  Identities=29%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEcc
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVME   97 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e   97 (332)
                      .||+|.+|+||-|++..|...+|||-+..+....        .+-+.+|+.+-++++|.||+++.|.+ ..+++.-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~--------~QPLhEEIaLH~~LrHkNIVrYLGs~-senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE--------VQPLHEEIALHSTLRHKNIVRYLGSV-SENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchh--------hccHHHHHHHHHHHhhHhHHHHhhcc-CCCCeEEEEee
Confidence            4999999999999999999999999987544322        22467899999999999999999998 44488899999


Q ss_pred             cccccHHHHHHh-cCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEeecccccccCCCCCC
Q 035861           98 YMEHDLKWLMES-MKQPF--STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKP  173 (332)
Q Consensus        98 ~~~~~l~~~~~~-~~~~l--~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~df~~~~~~~~~~~~  173 (332)
                      -++|+.+..+.+ .=+++  ++..+..+..||++||.|||++.|+|+|||-+|+||.. .|.+||+|||.++....-...
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            999866555544 44788  89999999999999999999999999999999999975 689999999999887554444


Q ss_pred             CccccccccccchhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHcCCCCCCcccCCCCCccc
Q 035861          174 YTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI-DKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       174 ~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      -.+..||.-|||||++.. ...|..++|||||||++-||+||++||......+.. -++-.....               
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvH---------------  797 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVH---------------  797 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecC---------------
Confidence            456789999999999963 456899999999999999999999999765433322 111111000               


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                          .+-+..+|.+++.||.+|+.+||.+||++.++|.+||++.-
T Consensus       798 --------------------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  798 --------------------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --------------------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                                01122378889999999999999999999999999999875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=294.16  Aligned_cols=255  Identities=31%  Similarity=0.462  Sum_probs=216.5

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      -.+.||+|-||+||-|+++.+|+.||||++.+-........      .+++|+.+|..+.||.|+.+.-.+ +..+..++
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqes------qlR~EVaILq~l~HPGiV~le~M~-ET~ervFV  640 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQES------QLRNEVAILQNLHHPGIVNLECMF-ETPERVFV  640 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHH------HHHHHHHHHHhcCCCCeeEEEEee-cCCceEEE
Confidence            35789999999999999999999999999987766544332      467999999999999999998877 66688999


Q ss_pred             EcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcEEEeecccccccCCC
Q 035861           95 VMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSP  170 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~~l~df~~~~~~~~~  170 (332)
                      |||.+.|+.++.+... .+.+++..-+.++.||+.||.|||-+||+|+||||+|||+...   ..+||+|||+++..+..
T Consensus       641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9999999998888664 5789999999999999999999999999999999999999754   48999999999987543


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       .-.....||+.|.|||++.+ +.|+..-|+||+|+++|--++|..||....  +.-++|.+....              
T Consensus       721 -sFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFM--------------  782 (888)
T KOG4236|consen  721 -SFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFM--------------  782 (888)
T ss_pred             -hhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccc--------------
Confidence             33456789999999999998 779999999999999999999999996543  334444443211              


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                         .+..+|+++++++.+||..+|+..-.+|-|++.-|.|||+++-.
T Consensus       783 -------------------yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  783 -------------------YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             -------------------cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence                               12234566999999999999999999999999999999999854

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-40  Score=277.94  Aligned_cols=242  Identities=26%  Similarity=0.365  Sum_probs=190.0

Q ss_pred             ccccccCcEEEEEEEECCCC---cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           17 NKISEGTYGIVYRARDKKSG---EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      +.||+|+||.||+|++..++   ..+++|.+.......       ....+..|+..++++.|+|++++++++ .. ...+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~-~~~~   71 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-------GKKEFLREASVMAQLDHPCIVRLIGVC-KG-EPLM   71 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchH-------HHHHHHHHHHHHHhcCCCCeeeEEEEE-cC-CceE
Confidence            46999999999999876544   789999987554321       112467899999999999999999987 43 4578


Q ss_pred             EEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC
Q 035861           94 MVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK  172 (332)
Q Consensus        94 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~  172 (332)
                      +|||+++++ +.+.+.. ...+++..+..++.|++.||++||..|++|+||+|+||+++.++.++|+|||.+........
T Consensus        72 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          72 LVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             EEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            999999864 5554444 56899999999999999999999999999999999999999999999999999876543322


Q ss_pred             CC---ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          173 PY---TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       173 ~~---~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..   ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+.....             
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-------------  216 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-------------  216 (257)
T ss_pred             ccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-------------
Confidence            21   11223457999999876 668999999999999999998 9999987765544333322100             


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                             ...+..++..++++|.+||..+|++||++.++++
T Consensus       217 -----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                   0112236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-39  Score=276.00  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=197.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++.+.||.|++|.||++.+. ++..+++|.+.......         ..+..|++.+++++||+++++++.+ ...
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~~~~~~-~~~   71 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---------EDFIEEAQVMMKLSHPKLVQLYGVC-TER   71 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---------HHHHHHHHHHHhCCCCCeeeEEEEE-ccC
Confidence            458999999999999999999885 36789999886433221         1456899999999999999999988 444


Q ss_pred             CeEEEEcccccccHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~-~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++++||++++.+. .+....+.+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecc
Confidence            7789999999875544 444445678999999999999999999999999999999999999999999999999887543


Q ss_pred             CCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .... ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+.....           
T Consensus       152 ~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------  219 (256)
T cd05112         152 DDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-----------  219 (256)
T ss_pred             cCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-----------
Confidence            2211 1122334567999999876 678899999999999999998 9999987665554444322110           


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                               ...+...+..+.+|+.+||+.+|++||++.++++.
T Consensus       220 -------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 -------------------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                                     01112257889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-40  Score=280.79  Aligned_cols=251  Identities=20%  Similarity=0.322  Sum_probs=194.1

Q ss_pred             ccccccccccCcEEEEEEEECC---CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           13 FEKLNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      |++.+.||+|+||.||+|....   ++..||+|.+.........      ...+..|+..++.++|+|++++++.+....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE------IEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHH------HHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            6788999999999999998764   3478999998654322211      114568999999999999999999885443


Q ss_pred             C-----eEEEEccccccc-HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           90 D-----SVYMVMEYMEHD-LKWLMESM-----KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        90 ~-----~~~lv~e~~~~~-l~~~~~~~-----~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                      .     ..++++||++++ +...+...     ...+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEE
Confidence            2     478999999864 44333221     246899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCCCCC--ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 035861          159 CDFGMSRQYGSPLKPY--TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +|||.+..........  .....+..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+.....
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  233 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR  233 (273)
T ss_pred             CCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999987653322111  11234567999999866 678999999999999999999 8899987766555444432210


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                          ...+..++..+.+++.+||+.||.+||++.+++++
T Consensus       234 ------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ------------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ------------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                                01112368889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.4e-40  Score=284.08  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=193.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc--EEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE--IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ++|++.+.||.|+||.||+|....++.  .+++|.+........       ...+..|+..+.++ .||||+++++.+. 
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~E~~~l~~l~~hp~iv~~~~~~~-   73 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-------HRDFAGELEVLCKLGHHPNIINLLGACE-   73 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHH-------HHHHHHHHHHHHhhcCCCchhheEEEEc-
Confidence            589999999999999999999876664  467777753221111       11456899999999 7999999999884 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN  151 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~  151 (332)
                      +....++++||+++ ++.+.+....               ..+++..+..++.|++.||++||++|++|+||||+||+++
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~  153 (297)
T cd05089          74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence            44778999999985 5555554321               3588999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 035861          152 NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       152 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~  230 (332)
                      .++.++|+|||++....... .......+..|+|||.+.. ..++.++|+||||+++|+|++ |..||...........+
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~  231 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL  231 (297)
T ss_pred             CCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999886432111 1112223456999998876 668999999999999999997 99999877665554443


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      .....                                    ...+..++..+.+|+.+||+.+|.+||+++++++.
T Consensus       232 ~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         232 PQGYR------------------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             hcCCC------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22111                                    11122378899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6e-40  Score=280.01  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=197.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC---cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG---EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ..+|++.+.||.|+||.||+|.+..++   ..+++|.+........       ...+.+|+..+++++||||+++++.+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-------RRDFLSEASIMGQFDHPNIIHLEGVVT   75 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHH-------HHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            458999999999999999999986444   3789998864321111       124678999999999999999999985


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      . ....++|||+++| ++.+.+....+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        76 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          76 K-SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             c-CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence            4 4788999999986 4555555545678999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCC---ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLKPY---TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .........   ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-----  228 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-----
Confidence            654322111   11223457999999976 668999999999999999886 99999877665544444322110     


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                     .....++..+.+++.+|++.+|.+||++.++++
T Consensus       229 -------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 -------------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -------------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                           011236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-39  Score=276.78  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=189.4

Q ss_pred             cccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           18 KISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      .||+|+||.||+|.+.  .++..||+|++.......       ....+.+|+.++++++|+||+++++.+ +. ...++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~ii~~~~~~-~~-~~~~lv   72 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS-------VRDEMMREAEIMHQLDNPYIVRMIGVC-EA-EALMLV   72 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChH-------HHHHHHHHHHHHHhcCCCCeEEEEEEE-cC-CCeEEE
Confidence            4899999999999875  345579999886542211       112466899999999999999999987 43 568899


Q ss_pred             ccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCC-
Q 035861           96 MEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP-  173 (332)
Q Consensus        96 ~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~-  173 (332)
                      |||++|+ +.+.+......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......... 
T Consensus        73 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             EEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            9999865 44455445667999999999999999999999999999999999999999999999999998755332211 


Q ss_pred             --CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          174 --YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                        .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+.....               
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------  216 (257)
T cd05115         153 KARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR---------------  216 (257)
T ss_pred             eccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---------------
Confidence              112223567999999876 568999999999999999996 9999988776655444332211               


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                           ...++.+++++.++|.+||+.+|++||++.+|++
T Consensus       217 ---------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 1112336889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-42  Score=283.97  Aligned_cols=295  Identities=28%  Similarity=0.468  Sum_probs=218.0

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-C-CC----e
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-H-PS----I   78 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~~----i   78 (332)
                      .|.....+|.+.+.+|+|.||.|..+.++.++..||||+++.-....+         +.+-|++++.++. + |+    +
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYre---------Aa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYRE---------AALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhh---------HHHHHHHHHHHHHhcCCCCceEE
Confidence            455567899999999999999999999999999999999975433222         3457889998883 2 22    3


Q ss_pred             eeeeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-----
Q 035861           79 VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-----  152 (332)
Q Consensus        79 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-----  152 (332)
                      +.+.+++ +-.+..|||+|.++-++.+.+..++ .+++...+..|++||++++++||+.+++|-||||+||++..     
T Consensus       154 v~m~~wF-dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  154 VQMRDWF-DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             Eeeehhh-hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence            4444445 6668899999999988888887744 56899999999999999999999999999999999999842     


Q ss_pred             ---------------CCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 035861          153 ---------------QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL  217 (332)
Q Consensus       153 ---------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p  217 (332)
                                     +..|+|+|||+|+....   .......|..|+|||++.+ -.++.++|+||+||+|.|+.||...
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeecccee
Confidence                           23599999999987543   2356678999999999998 7799999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHcCCCCCCcccCCCCCc-c--ccccccCCchhh-----hhhhCCCCcc-CCCCCCCchHHHHHHH
Q 035861          218 FSGTTEVDQIDKIFKTLGTPTETIWPGLSELP-G--AKANFAKQPYNL-----LRKRFPAASF-TGSPVLSESGFDLLNR  288 (332)
Q Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~li~~  288 (332)
                      |....+.+.+.-+.+.+++.|......-.... -  ...++.......     .+...+-... .........+.+||++
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            99988888776666667765544322110000 0  000111000000     0000000000 0011123358899999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          289 LLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       289 ~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ||.+||.+|+|+.|+|.||||+...
T Consensus       389 mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  389 MLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHccCccccccHHHHhcCHHhhcCC
Confidence            9999999999999999999999864

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-41  Score=296.93  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=210.3

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC-CeE
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH-DSV   92 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   92 (332)
                      ++...||+|+|-+||+|.+..+|..||--.+......+...    -..++..|+.+|+.|+|+||++++..+.+.. ...
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~----~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPE----ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChH----HHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            45577999999999999999999888765544332222111    0125779999999999999999999997653 357


Q ss_pred             EEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCC-CcEEEeecccccccCC
Q 035861           93 YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGS  169 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~-~~~~l~df~~~~~~~~  169 (332)
                      -+|+|.+.++++...+++.+.++...++.|++||+.||.|||++.  |+|||||=+||||+++ |.|||+|+|+|+....
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            789999998877777777999999999999999999999999986  9999999999999865 8999999999998643


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .  .....+|||.|||||.+..  .|+...||||||++|+||+|+..||... +..+.++++..+..+..          
T Consensus       199 s--~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s----------  264 (632)
T KOG0584|consen  199 S--HAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA----------  264 (632)
T ss_pred             c--ccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH----------
Confidence            3  2344799999999999874  6899999999999999999999999876 55566677765532221          


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                               ....-++++++||.+||.. ..+|+|+.|+|.||||..-
T Consensus       265 -------------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 -------------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -------------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                     1222478999999999999 9999999999999999984

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-40  Score=289.88  Aligned_cols=254  Identities=21%  Similarity=0.387  Sum_probs=193.3

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||.|+||+||+|.+.     .+++.||||++........       ...+.+|+.++.++ .|+||+++++
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~niv~~~~   78 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------HRALMSELKILIHIGHHLNVVNLLG   78 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-------HHHHHHHHHHHHhccCCccHhhhcc
Confidence            358999999999999999999853     4577899999865432111       11466899999999 6899999999


Q ss_pred             eEEcCCCeEEEEccccccc-HHHHHHhcC---------------------------------------------------
Q 035861           84 VVMDDHDSVYMVMEYMEHD-LKWLMESMK---------------------------------------------------  111 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~---------------------------------------------------  111 (332)
                      .+.......+++|||++++ +.+.+....                                                   
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (343)
T cd05103          79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL  158 (343)
T ss_pred             eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence            8876667789999999964 444443211                                                   


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC--CC
Q 035861          112 ---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PY  174 (332)
Q Consensus       112 ---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~  174 (332)
                                     ..++...+..++.|++.||+|||++|++|+||||.||+++.++.++|+|||.+........  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                           2367788899999999999999999999999999999999999999999999876422111  11


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA  253 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (332)
                      ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.................                  
T Consensus       239 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------  299 (343)
T cd05103         239 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT------------------  299 (343)
T ss_pred             CCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC------------------
Confidence            22334567999999876 678999999999999999997 8899876543222222211100                  


Q ss_pred             cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                       ....+..+++++.+++.+||+.||++||++.+|++|
T Consensus       300 -----------------~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         300 -----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             000112257789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-39  Score=277.92  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=197.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|+..+.||+|++|.||+|....++.   .+++|.+........       ...+..|+..+++++|+|++++.+.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-------RQDFLSEASIMGQFSHHNIIRLEGVVT   76 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHH-------HHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence            4588999999999999999999875554   688988864322111       124568999999999999999999984


Q ss_pred             cCCCeEEEEcccccccHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~-~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       .....++|||+++++.+ +.+....+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          77 -KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             -cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence             44778999999997544 4444445679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCCc---cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLKPYT---SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ..........   ....+..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+......+    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~----  230 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP----  230 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----
Confidence            6532211111   1122456999999876 568999999999999999997 999998776655554443211100    


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                      ....++.++.+++.+||+.+|++||++.+|++
T Consensus       231 --------------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 --------------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             --------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                            11126788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.5e-40  Score=284.67  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             hcccccccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVK   82 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   82 (332)
                      ++|.+.+.||+|+||.||++.+..       +...+|+|.+........       ...+..|+.+++.+ +|+||++++
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-------LSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH-------HHHHHHHHHHHHHhcCCCCEeeEE
Confidence            689999999999999999998643       234699998865321111       11356799999999 799999999


Q ss_pred             eeEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCC
Q 035861           83 EVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTS  146 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~  146 (332)
                      +.+..+ ...++||||+++ ++.+.+....               ..+++..++.++.|++.||+|||++|++|+||+|+
T Consensus        91 ~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          91 GACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEecC-CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            998554 678999999986 5555554421               24788999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeecccccccCCCCCC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 035861          147 NLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTE  223 (332)
Q Consensus       147 Nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~  223 (332)
                      ||+++.++.++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            999999999999999998754321111  112233467999999876 668999999999999999998 8888877665


Q ss_pred             HHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHH
Q 035861          224 VDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA  303 (332)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  303 (332)
                      .+....+....                                    ....+..++.++.+|+.+||..+|++||++.++
T Consensus       249 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev  292 (307)
T cd05098         249 EELFKLLKEGH------------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  292 (307)
T ss_pred             HHHHHHHHcCC------------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            44433332110                                    001122368899999999999999999999999


Q ss_pred             hcC
Q 035861          304 LNH  306 (332)
Q Consensus       304 l~h  306 (332)
                      +++
T Consensus       293 l~~  295 (307)
T cd05098         293 VED  295 (307)
T ss_pred             HHH
Confidence            875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-39  Score=282.53  Aligned_cols=253  Identities=21%  Similarity=0.338  Sum_probs=196.3

Q ss_pred             chhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVK   82 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   82 (332)
                      ..++|.+.+.||+|+||.||++.+.     .++..+|+|.+........       ...+.+|+.+++++ +|+||++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-------REALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHH-------HHHHHHHHHHHHhccCCCCcceEE
Confidence            4458999999999999999999852     3456799998865432111       12456899999999 799999999


Q ss_pred             eeEEcCCCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           83 EVVMDDHDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      +.+... ...+++|||+.+ ++.+.+.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|
T Consensus       106 ~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         106 GACTIG-GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             EEEecC-CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence            988444 778999999986 4555554433 3489999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 035861          161 FGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       161 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      ||.+........  ......++..|+|||.+.+ ..++.++|+||+|+++|++++ |..||..........+......  
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~--  261 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--  261 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC--
Confidence            999875532211  1122345678999999877 568999999999999999998 9999977665444333322110  


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                       ....+...+..+.+|+.+||+.+|++||++.++++
T Consensus       262 ---------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 ---------------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                             00112236788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.4e-40  Score=281.03  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             hhcccccccccccCcEEEEEEEECC----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      -++|++.+.||+|+||.||+|.+..    ++..|++|++........       ...+.+|+..++.++|+|++++++++
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~   77 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-------VTLLLQESCLLYGLSHQNILPILHVC   77 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHH-------HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4689999999999999999999875    357888888753221111       12456899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMK-------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      ..+....+++++++++ ++.+.+....       ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++
T Consensus        78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence            7766788999999985 5555444321       4589999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc
Q 035861          158 ICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       158 l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  234 (332)
                      |+|||+++.......  ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+....
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  236 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY  236 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence            999999875432111  1122345667999999876 668999999999999999999 999998776655443332211


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      .                                    ......+++++.+++.+||+.||++||++.++++
T Consensus       237 ~------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 R------------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C------------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0                                    0111226788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.9e-40  Score=292.29  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=192.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCC-----CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS-----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   83 (332)
                      .++|.+++.||.|+||+||+|.+...     +..||||++........       ...+.+|+.+++++. ||||+++++
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-------~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE-------KQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHH-------HHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            35888999999999999999987432     34699999865432111       124678999999995 999999999


Q ss_pred             eEEcCCCeEEEEccccccc-HHHHHHhc----------------------------------------------------
Q 035861           84 VVMDDHDSVYMVMEYMEHD-LKWLMESM----------------------------------------------------  110 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~----------------------------------------------------  110 (332)
                      .+ .+....|+||||++++ +.+.+...                                                    
T Consensus       109 ~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         109 AC-TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EE-ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            98 4457899999999864 44433221                                                    


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861          111 -------------------------------------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus       111 -------------------------------------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                                                                 ...+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                       1247788889999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      |+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            9999999999999999876532211  1223345678999999876 668999999999999999997 89998765433


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      ...........                                   .......++..+.+++.+||+.||++||++.+|.
T Consensus       347 ~~~~~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  391 (400)
T cd05105         347 STFYNKIKSGY-----------------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS  391 (400)
T ss_pred             HHHHHHHhcCC-----------------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence            22222211100                                   0111223688899999999999999999999887


Q ss_pred             c
Q 035861          305 N  305 (332)
Q Consensus       305 ~  305 (332)
                      +
T Consensus       392 ~  392 (400)
T cd05105         392 D  392 (400)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=310.54  Aligned_cols=250  Identities=24%  Similarity=0.427  Sum_probs=208.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc-----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE-----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ...+..+.||+|+||.||.|.......     .||||.+.......+       ...+++|+.+|+.++||||++++|++
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-------~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-------VSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-------HHHHHHHHHHHhcCCCcceeeEEEee
Confidence            356788899999999999999765333     388888865432221       12678999999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESM------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                      .+ ....+|++||++| +|+..++..      ...++..+++.++.|||.|..||++++++|+||...|+|++....|||
T Consensus       765 l~-~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  765 LD-SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             cC-CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence            88 4788999999985 788888876      567999999999999999999999999999999999999999999999


Q ss_pred             eeccccccc-CCCCCCCcc-ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 035861          159 CDFGMSRQY-GSPLKPYTS-LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       159 ~df~~~~~~-~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +|||+|+.. +........ ..-...|||||.+.+ ..++.+||||||||++||++| |..||.+.+..+.......+  
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g--  920 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG--  920 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--
Confidence            999999943 211111111 123467999999998 789999999999999999999 89999999888777655443  


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                        .+++.++.++..+.+++.+||+.+|++||++..|++
T Consensus       921 ----------------------------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 ----------------------------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ----------------------------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                              355666779999999999999999999999999988

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=278.91  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCc----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..+|++.+.||+|+||+||+|.+..+++    .+++|.........       ....+.+|+..+++++|+|++++++++
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK-------ANKEILDEAYVMASVDHPHVVRLLGIC   78 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHH-------HHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            4589999999999999999999876654    58888876543211       112456899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ..  ...++|+|++++ ++.+.+......+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        79 ~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          79 LS--SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             ec--CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence            54  678899999985 566666655567999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCC--ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLKPY--TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ..........  ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------  229 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER------  229 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC------
Confidence            7654322211  12223567999999875 678999999999999999998 9999988766554444332211      


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                    ...+...+..+.+++.+||..+|.+||++.++++
T Consensus       230 ------------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ------------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                          1112225778899999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-39  Score=282.08  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC----------------cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG----------------EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF   73 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----------------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   73 (332)
                      ..+|++++.||+|+||.||++.+..++                ..||+|.+........       ...+.+|+..++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~-------~~~~~~e~~~l~~l   76 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA-------REDFLKEVKILSRL   76 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHH-------HHHHHHHHHHHHhc
Confidence            458999999999999999999876533                4578998865432211       12456899999999


Q ss_pred             CCCCeeeeeeeEEcCCCeEEEEccccccc-HHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 035861           74 DHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMK----------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRD  142 (332)
Q Consensus        74 ~h~~i~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~----------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~d  142 (332)
                      +|+|++++++.+..+ ...++++|+++++ +...+....          ..+++..++.++.|++.||+|||++|++|+|
T Consensus        77 ~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d  155 (296)
T cd05051          77 SDPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD  155 (296)
T ss_pred             CCCCEeEEEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence            999999999998555 7889999999864 444443322          2689999999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh--CCCCC
Q 035861          143 LKTSNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLF  218 (332)
Q Consensus       143 i~p~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt--g~~pf  218 (332)
                      |||+||+++.++.++|+|||.+.......  .......++..|+|||.+.. ..++.++|+||||+++|++++  +..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            99999999999999999999987543221  11223345678999999876 568999999999999999998  77888


Q ss_pred             CCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC
Q 035861          219 SGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI  298 (332)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  298 (332)
                      ...+..+.............                             ........+.++.++.+|+.+||+.||++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  285 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDG-----------------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRP  285 (296)
T ss_pred             CCcChHHHHHHHHhcccccc-----------------------------ccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence            77665555444432110000                             0000111233678999999999999999999


Q ss_pred             CHHHHhc
Q 035861          299 TVDDALN  305 (332)
Q Consensus       299 s~~ell~  305 (332)
                      ++.+|++
T Consensus       286 t~~el~~  292 (296)
T cd05051         286 TFREIHL  292 (296)
T ss_pred             CHHHHHH
Confidence            9999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-39  Score=273.17  Aligned_cols=244  Identities=27%  Similarity=0.444  Sum_probs=191.5

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||+|++|.||+|... ++..+|+|++........       ...+.+|+..++.+.||||+++++.+... ...++||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   71 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQEL-------KIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVM   71 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHH-------HHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEE
Confidence            46899999999999864 578899998864332110       11466899999999999999999998544 7789999


Q ss_pred             ccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC-
Q 035861           97 EYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY-  174 (332)
Q Consensus        97 e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~-  174 (332)
                      ||+++ ++.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        72 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          72 ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             ECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence            99986 4555555445678999999999999999999999999999999999999999999999999887543221111 


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA  253 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (332)
                      ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+.....                  
T Consensus       152 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------  212 (250)
T cd05085         152 GLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------------------  212 (250)
T ss_pred             CCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            12233567999999876 678999999999999999998 9999987766554444322110                  


Q ss_pred             cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                        ...+..++..+.+++.+||+.+|++||++.++++.
T Consensus       213 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         213 ------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                              01122368899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3e-40  Score=308.83  Aligned_cols=262  Identities=31%  Similarity=0.470  Sum_probs=202.9

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ++...+|+.+..||+||||.||+++++-+|+.||||++.... .....      ..+.+|+..+.+|+||||+.++..++
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~------skI~rEVk~LArLnHpNVVRYysAWV  547 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLY------SKILREVKLLARLNHPNVVRYYSAWV  547 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHH------HHHHHHHHHHhhcCCcceeeeehhhh
Confidence            467889999999999999999999999999999999998765 22222      25789999999999999999987653


Q ss_pred             cC------------------------------------------------------C-----------------------
Q 035861           87 DD------------------------------------------------------H-----------------------   89 (332)
Q Consensus        87 ~~------------------------------------------------------~-----------------------   89 (332)
                      ++                                                      .                       
T Consensus       548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg  627 (1351)
T KOG1035|consen  548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG  627 (1351)
T ss_pred             ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence            21                                                      0                       


Q ss_pred             -----------------------------------------CeEEEEcccccccHHHHHHhcCCCC-CHHHHHHHHHHHH
Q 035861           90 -----------------------------------------DSVYMVMEYMEHDLKWLMESMKQPF-STSEVKCLMLQLL  127 (332)
Q Consensus        90 -----------------------------------------~~~~lv~e~~~~~l~~~~~~~~~~l-~~~~~~~i~~~l~  127 (332)
                                                               ..+||=||||+.+++..+..++... ....+|+++++|+
T Consensus       628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREIL  707 (1351)
T ss_pred             cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHH
Confidence                                                     1247788999998888888766555 5888999999999


Q ss_pred             HHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc------------------CCCCCCCccccccccccchhhh
Q 035861          128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY------------------GSPLKPYTSLVVTLWYRAPELL  189 (332)
Q Consensus       128 ~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~------------------~~~~~~~~~~~~~~~y~aPE~~  189 (332)
                      .||+|+|+.||+||||||.|||++.++.|||+|||+++..                  +.+....+...||..|+|||.+
T Consensus       708 EGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  708 EGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            9999999999999999999999999999999999998762                  1122234567899999999999


Q ss_pred             cCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhh
Q 035861          190 LGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKR  266 (332)
Q Consensus       190 ~~~~--~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (332)
                      .+..  .|+.+.|+||||++++||+   .||...-.. ..+..+.+..-  +.+  +++                     
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~i--P~~--~~f---------------------  839 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSI--PEP--ADF---------------------  839 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCC--CCC--ccc---------------------
Confidence            7755  6999999999999999998   556543211 22222221111  100  000                     


Q ss_pred             CCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          267 FPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                             ..+ --+.-..+|++|++.||.+||||.|+|++.||.-
T Consensus       840 -------~~~-~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  840 -------FDP-EHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             -------ccc-cchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence                   001 1223348999999999999999999999999973

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-39  Score=280.46  Aligned_cols=249  Identities=22%  Similarity=0.371  Sum_probs=191.6

Q ss_pred             cccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           12 EFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +|++.+.||+|+||.||+|....     ....+++|.+........       ...+..|+..++.+.||||+++++.+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-------LRDLLSEFNLLKQVNHPHVIKLYGACS   73 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH-------HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            58899999999999999998753     235688887764332111       124568999999999999999999884


Q ss_pred             cCCCeEEEEccccccc-HHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 035861           87 DDHDSVYMVMEYMEHD-LKWLMESM-----------------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRD  142 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~-l~~~~~~~-----------------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~d  142 (332)
                      . ....++++||+.++ +.+.+...                       ...+++..++.++.|++.||++||++|++|+|
T Consensus        74 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~d  152 (290)
T cd05045          74 Q-DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRD  152 (290)
T ss_pred             c-CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhh
Confidence            4 47789999999964 44443321                       13478899999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 035861          143 LKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFS  219 (332)
Q Consensus       143 i~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~  219 (332)
                      |+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            999999999999999999999875432211  1122345668999999876 668999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC
Q 035861          220 GTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT  299 (332)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  299 (332)
                      ...............                                    ....+..++.++.+++.+||+.+|++||+
T Consensus       232 ~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~  275 (290)
T cd05045         232 GIAPERLFNLLKTGY------------------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPT  275 (290)
T ss_pred             CCCHHHHHHHHhCCC------------------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCC
Confidence            766554443322111                                    01112236889999999999999999999


Q ss_pred             HHHHhc
Q 035861          300 VDDALN  305 (332)
Q Consensus       300 ~~ell~  305 (332)
                      +.++++
T Consensus       276 ~~~i~~  281 (290)
T cd05045         276 FADISK  281 (290)
T ss_pred             HHHHHH
Confidence            999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=281.43  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=193.3

Q ss_pred             hcccccccccccCcEEEEEEEECCC--------------CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKS--------------GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP   76 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~--------------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~   76 (332)
                      .+|++.+.||+|+||.||++.+..+              ...||+|.+........       ...+.+|++.+++++|+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~ei~~l~~l~h~   77 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA-------RNDFLKEIKIMSRLKNP   77 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHH-------HHHHHHHHHHHHhCCCC
Confidence            4899999999999999999987543              23589998865322111       11466899999999999


Q ss_pred             CeeeeeeeEEcCCCeEEEEccccccc-HHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMK-----------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLK  144 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-----------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~  144 (332)
                      |++++++.+..+ ...++||||+.++ +.+.+....           ..+++..++.++.|++.||+|||++|++|+|||
T Consensus        78 ~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  156 (295)
T cd05097          78 NIIRLLGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA  156 (295)
T ss_pred             CcCeEEEEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence            999999999544 7789999999875 444333211           236888999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh--CCCCCCC
Q 035861          145 TSNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSG  220 (332)
Q Consensus       145 p~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt--g~~pf~~  220 (332)
                      |+||+++.++.++|+|||.+.......  .......++..|+|||.+.. ..++.++|+||||+++|+|++  +..||..
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999999999987542211  11122344678999999876 568999999999999999988  6778877


Q ss_pred             CChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH
Q 035861          221 TTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV  300 (332)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  300 (332)
                      .+..+..............                             ......++.+++.+.+|+.+||+.||++||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGR-----------------------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             cChHHHHHHHHHhhhhccc-----------------------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            6655544433221100000                             00011223368899999999999999999999


Q ss_pred             HHHhc
Q 035861          301 DDALN  305 (332)
Q Consensus       301 ~ell~  305 (332)
                      .+|++
T Consensus       287 ~~i~~  291 (295)
T cd05097         287 NKIHH  291 (295)
T ss_pred             HHHHH
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-39  Score=278.29  Aligned_cols=267  Identities=23%  Similarity=0.384  Sum_probs=194.6

Q ss_pred             hcccccccccccCcEEEEEEEE----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           11 FEFEKLNKISEGTYGIVYRARD----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .+|++++.||+|+||+||++..    ..++..|++|.+.......        ...+.+|+.++++++|||++++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~   75 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--------LRDFEREIEILKSLQHDNIVKYKGVCY   75 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHH--------HHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence            4789999999999999999974    4578899999986432111        114568999999999999999999874


Q ss_pred             c-CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           87 D-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        87 ~-~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      . +....++|+||+++ ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          76 SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccc
Confidence            3 34568999999985 555555554567999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..++...... ....+    ...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~----~~~~~~-  228 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMM----GNDKQG-  228 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhc----cccccc-
Confidence            865332211   111223456999999876 67899999999999999999988776443221 10000    000000 


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                    ......................++..+.+|+.+||+.+|++|||+.+|++.
T Consensus       229 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         229 --------------QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             --------------ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                          000000000000111122334578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.6e-39  Score=275.30  Aligned_cols=246  Identities=23%  Similarity=0.375  Sum_probs=187.2

Q ss_pred             ccccccCcEEEEEEEECC---CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           17 NKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      +.||+|+||+||+|.+..   +...+|+|.+........       ...+..|+..++.++|||++++++.+...+...+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-------VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL   73 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHH-------HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcE
Confidence            468999999999998643   345799998753221110       1245689999999999999999998766666788


Q ss_pred             EEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC-
Q 035861           94 MVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL-  171 (332)
Q Consensus        94 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~-  171 (332)
                      +++||+.+ ++.+.+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999985 5555555545567888889999999999999999999999999999999999999999999987543211 


Q ss_pred             ---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          172 ---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       172 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                         .......++..|+|||.+.. ..++.++|+||||+++|+|++| ..||...+..+....+.....            
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~------------  220 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR------------  220 (262)
T ss_pred             eeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC------------
Confidence               11123345668999999876 6789999999999999999995 556665555444333322110            


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                              ...+..++..+.+++.+||+.+|++||++.++++.
T Consensus       221 ------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         221 ------------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             ------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                    00112257789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-39  Score=276.14  Aligned_cols=239  Identities=21%  Similarity=0.270  Sum_probs=183.4

Q ss_pred             ccccccCcEEEEEEEECCC------------CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           17 NKISEGTYGIVYRARDKKS------------GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~------------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      +.||.|++|+||+|+...+            ...+++|++......        ....+.+|+..++.++||||++++++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--------~~~~~~~~~~~l~~l~hp~iv~~~~~   72 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD--------ISLAFFETASMMRQVSHKHIVLLYGV   72 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh--------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4689999999999986432            235888886543211        11245688899999999999999999


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc-------E
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------L  156 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~-------~  156 (332)
                      +..+ ...+++|||++++.++.... ....+++..++.++.||+.||+|||++|++|+||+|+||+++.++.       +
T Consensus        73 ~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          73 CVRD-VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             EecC-CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence            8554 67889999999765555444 3567999999999999999999999999999999999999987664       8


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHcC
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +++|||.+.....    .....++..|+|||.+.....++.++||||||+++|+|+ +|..||......+. ....... 
T Consensus       152 ~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~-  225 (262)
T cd05077         152 KLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ-  225 (262)
T ss_pred             EeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC-
Confidence            9999998865432    123456788999999876577899999999999999998 58888766543322 1111100 


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                          .......+.++.+||.+||+.||.+||++.+|+++
T Consensus       226 ------------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 ------------------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ------------------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                                00011145678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-39  Score=278.58  Aligned_cols=238  Identities=22%  Similarity=0.277  Sum_probs=182.8

Q ss_pred             cccccCcEEEEEEEECCC------------------------CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC
Q 035861           18 KISEGTYGIVYRARDKKS------------------------GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF   73 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~------------------------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   73 (332)
                      +||+|+||.||+|....+                        ...|++|++.......        ...+.+|+.+++.+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~--------~~~~~~~~~~~~~l   73 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDI--------ALAFFETASLMSQV   73 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHH--------HHHHHHHHHHHhcC
Confidence            699999999999985321                        2357888875432111        12456888999999


Q ss_pred             CCCCeeeeeeeEEcCCCeEEEEcccccccHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC
Q 035861           74 DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN  152 (332)
Q Consensus        74 ~h~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~  152 (332)
                      +||||+++++++.++ ...++||||++++.++.+. ...+.+++..+..++.|++.||+|||++|++|+||||+||+++.
T Consensus        74 ~h~niv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~  152 (274)
T cd05076          74 SHIHLAFVHGVCVRG-SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR  152 (274)
T ss_pred             CCCCeeeEEEEEEeC-CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence            999999999998555 6789999999987655554 34567899999999999999999999999999999999999986


Q ss_pred             CC-------cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChH
Q 035861          153 QG-------VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEV  224 (332)
Q Consensus       153 ~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~ll-tg~~pf~~~~~~  224 (332)
                      .+       .++++|||.+......    ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||......
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence            44       4899999987543221    23356778999999876567899999999999999985 689999766544


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +... ........                                     +...++.+.++|.+||+.+|++||++.++|
T Consensus       229 ~~~~-~~~~~~~~-------------------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il  270 (274)
T cd05076         229 EKER-FYEKKHRL-------------------------------------PEPSCKELATLISQCLTYEPTQRPSFRTIL  270 (274)
T ss_pred             HHHH-HHHhccCC-------------------------------------CCCCChHHHHHHHHHcccChhhCcCHHHHH
Confidence            3222 11110000                                     111456789999999999999999999998


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      ++
T Consensus       271 ~~  272 (274)
T cd05076         271 RD  272 (274)
T ss_pred             Hh
Confidence            75

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=292.42  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=205.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC----cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +++..+.++||+|+||.||+|.....+    ..||||...........     ....++.|++++++++||||+.++|+.
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~-----~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKE-----QIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHH-----HHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            457778899999999999999987542    23899988752211111     123578999999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ... .-+++|||+|.| +|.+.+....+.++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||++
T Consensus       231 ~~~-~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  231 VLE-EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             cCC-CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            555 778999999997 566666665567999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH-HcCCCCCCcc
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFK-TLGTPTETIW  242 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~  242 (332)
                      +....-........-+..|+|||.+.. ..++.++||||+|+++||+++ |..||.+.+..+...++.. ....+.    
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~----  384 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI----  384 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC----
Confidence            765311111112235678999999988 589999999999999999998 8899999999988888844 222221    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                      +...+..+..++.+|+..+|++||++.++.+-
T Consensus       385 --------------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~  416 (474)
T KOG0194|consen  385 --------------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK  416 (474)
T ss_pred             --------------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence                                            12257788899999999999999999888653

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-39  Score=282.55  Aligned_cols=252  Identities=22%  Similarity=0.355  Sum_probs=194.3

Q ss_pred             hhcccccccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNV   81 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   81 (332)
                      ..+|.+.+.||+|++|.||++++..       ....+|+|.+........       ...+..|+..++++ .||||+++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-------LADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH-------HHHHHHHHHHHHhccCCCCeeeE
Confidence            3589999999999999999998632       345689998764322111       11356899999999 69999999


Q ss_pred             eeeEEcCCCeEEEEccccccc-HHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861           82 KEVVMDDHDSVYMVMEYMEHD-LKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                      ++++. .....++++||++++ +.+.+...               ...+++..+..++.||+.||.|||++|++|+||||
T Consensus        84 ~~~~~-~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  162 (314)
T cd05099          84 LGVCT-QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA  162 (314)
T ss_pred             EEEEc-cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            99884 447789999999864 44444332               13488999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCCCC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +||+++.++.++|+|||.++........  .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999765321111  112233457999999876 678999999999999999999 889998776


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ..+....+.....                                    ...+..++.++++|+.+||+.+|++||++.+
T Consensus       242 ~~~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  285 (314)
T cd05099         242 VEELFKLLREGHR------------------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQ  285 (314)
T ss_pred             HHHHHHHHHcCCC------------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            6555544432110                                    0112236788999999999999999999999


Q ss_pred             HhcC
Q 035861          303 ALNH  306 (332)
Q Consensus       303 ll~h  306 (332)
                      +++.
T Consensus       286 ll~~  289 (314)
T cd05099         286 LVEA  289 (314)
T ss_pred             HHHH
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-39  Score=274.52  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=197.5

Q ss_pred             ccccccccccCcEEEEEEEECCCC----cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSG----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      +++++.||.|+||.||++++..++    ..+|+|++........       ...+..|+..++.++|+|++++++.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   73 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQ-------IEEFLREARIMRKLDHPNIVKLLGVCTEE   73 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHH-------HHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            467899999999999999998766    8899999865432211       12466899999999999999999998555


Q ss_pred             CCeEEEEccccccc-HHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEHD-LKWLMESMKQP-FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~~-l~~~~~~~~~~-l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       ...+++||+++++ +.+.+...... +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        74 -~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       74 -EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             -CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCcee
Confidence             7899999999874 44444443333 99999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCc-cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSPLKPYT-SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ......... ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------  223 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence            543211111 2236678999999865 678999999999999999998 78888776665555544332111        


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  .....++.++.+++.+||..||++|||+.++++
T Consensus       224 ----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      224 ----------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ----------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                        111226889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.8e-39  Score=275.32  Aligned_cols=257  Identities=26%  Similarity=0.476  Sum_probs=199.4

Q ss_pred             cccccccccccCcEEEEEEEECC-CCcEEEEEEeecccCCcccc--cccCCCcchhHHHHHHhh-CCCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDC--LEYGFPISSLREINILLS-FDHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~--~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~   87 (332)
                      .|++.+.||+|++|.||+|.+.. +++.+++|.+..........  ........+..|+..+.+ ++|+|++++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 67899999986543221100  000111234567777754 699999999999855


Q ss_pred             CCCeEEEEccccccc-HHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           88 DHDSVYMVMEYMEHD-LKWLM---ESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~-l~~~~---~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                       +...+++|||++|+ +.+.+   ......+++..++.++.|++.+|.+||+ .|++|+||+|.||+++.++.++|+|||
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence             47899999999874 43433   2334579999999999999999999996 789999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+....... ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+......+.    
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  233 (269)
T cd08528         160 LAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL----  233 (269)
T ss_pred             ceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC----
Confidence            987654332 3345567888999999986 6689999999999999999999999987766555444433211110    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ....++..+.++|.+||+.||++||++.|+.++
T Consensus       234 -------------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 -------------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                           011267889999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-39  Score=276.47  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=197.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ..+|++.+.||+|++|.||+|....+++   .|++|++.......  .     ...+..|+..++.+.||||+++++.+ 
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~e~~~l~~l~h~ni~~~~~~~-   74 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK--Q-----RRDFLSEASIMGQFDHPNIIHLEGVV-   74 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHH--H-----HHHHHHHHHHHHhCCCcCcceEEEEE-
Confidence            4679999999999999999999876654   59999886432111  1     12467899999999999999999998 


Q ss_pred             cCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+....++||||++++ +.+.+....+.+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          75 TKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             CCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccc
Confidence            4447789999999875 444554445678999999999999999999999999999999999999999999999999886


Q ss_pred             ccCCCCCC--Ccccc---ccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          166 QYGSPLKP--YTSLV---VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       166 ~~~~~~~~--~~~~~---~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      ........  .....   .+..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+.....    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~----  229 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR----  229 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----
Confidence            54322111  11111   2357999999876 678999999999999999886 9999987766555444422111    


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                      ......++..+.+++.+||+.+|++||++++|+..
T Consensus       230 --------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         230 --------------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             --------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                            11122367889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-39  Score=279.30  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=195.3

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|++++.||.|+||.||++.+..     ++..+++|++........       ...+.+|+..++++.|||++++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~ei~~l~~l~h~~iv~~~~~   76 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-------QADFQREAALMAEFDHPNIVKLLGV   76 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHH-------HHHHHHHHHHHHhcCCCchheEEEE
Confidence            5689999999999999999998743     678899998864322110       1246689999999999999999998


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMK---------------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRD  142 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~d  142 (332)
                      +. .....++++||+++ ++.+.+....                     ..+++..++.++.|++.||++||++|++|+|
T Consensus        77 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~d  155 (288)
T cd05050          77 CA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD  155 (288)
T ss_pred             Ec-CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            84 44678999999986 5555554321                     2478888999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 035861          143 LKTSNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFS  219 (332)
Q Consensus       143 i~p~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~  219 (332)
                      |+|+||+++.++.++|+|||.+.......  ........+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999887543211  11122234567999999876 678999999999999999997 888987


Q ss_pred             CCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC
Q 035861          220 GTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT  299 (332)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  299 (332)
                      .....+....+.....                                    ......++.++.+|+.+||+.+|++||+
T Consensus       235 ~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt  278 (288)
T cd05050         235 GMAHEEVIYYVRDGNV------------------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPS  278 (288)
T ss_pred             CCCHHHHHHHHhcCCC------------------------------------CCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence            7666554443322110                                    0111236788999999999999999999


Q ss_pred             HHHHhc
Q 035861          300 VDDALN  305 (332)
Q Consensus       300 ~~ell~  305 (332)
                      ++|+++
T Consensus       279 ~~el~~  284 (288)
T cd05050         279 FASINR  284 (288)
T ss_pred             HHHHHH
Confidence            999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-39  Score=274.43  Aligned_cols=243  Identities=24%  Similarity=0.412  Sum_probs=194.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|.||++..  +++.+++|.+.....          ...+.+|+..+++++|||++++++.+..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~----------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT----------AQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch----------HHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            357899999999999999999875  488899998854321          12467899999999999999999988543


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                        ..+++|||+.| ++.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        72 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          72 --GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             --CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence              36899999986 5655555433 3589999999999999999999999999999999999999999999999998875


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....   ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.....          
T Consensus       150 ~~~~---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  215 (254)
T cd05083         150 GSMG---VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR----------  215 (254)
T ss_pred             cccc---CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC----------
Confidence            4321   122334567999999876 678899999999999999998 9999987765544433322110          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ......++..+.+++.+||+.+|++||++.++++
T Consensus       216 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 --------------------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             --------------------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      0112236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-39  Score=278.48  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=194.6

Q ss_pred             hhcc-cccccccccCcEEEEEEEE----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEF-EKLNKISEGTYGIVYRARD----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y-~~~~~lg~g~~g~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++| ++++.||.|+||+||++..    ..++..||+|.+........       ...+.+|+..++.++||||+++++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~   74 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN-------TSGWKKEINILKTLYHENIVKYKGC   74 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHH-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3566 9999999999999988653    34678899999865422110       1245689999999999999999998


Q ss_pred             EEcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +... ....+++|||++++.+..... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          75 CSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             EecCCCceEEEEecCCCCCCHHHHHH-HcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccc
Confidence            7543 356899999999765554444 34699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          164 SRQYGSPLKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      +.........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+......  ..........  ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~--~~  228 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQG--QM  228 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccccc--cc
Confidence            8765432111   122345667999999876 66899999999999999999999998654321  1111100000  00


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                     ..  ...............+..++.++.+++.+||+.+|++||+++++++
T Consensus       229 ---------------~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         229 ---------------TV--VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ---------------ch--hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                           00  0000000011112223457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-39  Score=278.70  Aligned_cols=266  Identities=24%  Similarity=0.396  Sum_probs=193.4

Q ss_pred             cccccccccccCcEEEEEEEE----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARD----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      -|++++.||+|++|.||+++.    ..++..|++|.+........       ...+.+|+.+++.+.|+|++++.+.+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-------IADLKKEIEILRNLYHENIVKYKGICTE   77 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHH-------HHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            478999999999999999984    35688899999864432111       1246689999999999999999998855


Q ss_pred             C-CCeEEEEcccccccHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 D-HDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 ~-~~~~~lv~e~~~~~l~~-~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      . ....++||||++|+.+. .+......+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        78 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            4 35689999999865444 444434568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .......   ......++..|+|||.+.+ ..++.++|+||||+++|+++++..|......  ....   ..+...... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~---~~~~~~~~~-  230 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLK---MIGPTHGQM-  230 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hhhh---hcccccccc-
Confidence            6533221   1123455677999999876 5688999999999999999998766533211  0000   000000000 


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                 .    ...................++..+.+|+.+||+.+|++||++.++++.
T Consensus       231 -----------~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 -----------T----VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -----------c----HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                       0    000000000011112234478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-39  Score=281.08  Aligned_cols=253  Identities=21%  Similarity=0.351  Sum_probs=195.8

Q ss_pred             chhcccccccccccCcEEEEEEEEC-------CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK-------KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVN   80 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~   80 (332)
                      ...+|.+.+.||+|+||.||+++..       .++..+++|.+........       ...+.+|+..++.+ +||||++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-------LSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH-------HHHHHHHHHHHHhhccCCCchh
Confidence            4568999999999999999999753       2345789998864321111       11456899999999 8999999


Q ss_pred             eeeeEEcCCCeEEEEcccccc-cHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 035861           81 VKEVVMDDHDSVYMVMEYMEH-DLKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLK  144 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~  144 (332)
                      +++.+.. ....+++|||+++ ++.+.+...               ...++...+..++.||+.||+|||++|++|+|||
T Consensus        86 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk  164 (304)
T cd05101          86 LLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA  164 (304)
T ss_pred             eeEEEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999844 4788999999986 444444432               1347888899999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeecccccccCCCCCC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 035861          145 TSNLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGT  221 (332)
Q Consensus       145 p~Nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~  221 (332)
                      |+||+++.++.++|+|||.+.........  .....++..|+|||++.+ ..++.++|+||||+++|++++ |..||...
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999998765332111  122344567999999877 668999999999999999998 78888777


Q ss_pred             ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH
Q 035861          222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD  301 (332)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  301 (332)
                      +..+....+.....                                    ...+..++..+.+|+.+||+.+|.+||++.
T Consensus       244 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  287 (304)
T cd05101         244 PVEELFKLLKEGHR------------------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFK  287 (304)
T ss_pred             CHHHHHHHHHcCCc------------------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence            66555444322110                                    001123688999999999999999999999


Q ss_pred             HHhcC
Q 035861          302 DALNH  306 (332)
Q Consensus       302 ell~h  306 (332)
                      ++++.
T Consensus       288 e~l~~  292 (304)
T cd05101         288 QLVED  292 (304)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-39  Score=275.84  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=196.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|.+.+.||.|++|.||+|.+...   ...+++|..........       ...+.+|+..++++.|+|++++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~-------~~~~~~e~~~l~~~~h~~i~~~~~~~~   77 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-------REKFLQEAYIMRQFDHPHIVKLIGVIT   77 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHH-------HHHHHHHHHHHHhCCCCchhceeEEEc
Confidence            45789999999999999999987543   34688898865432111       124668999999999999999999874


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       + ...++|||++++ ++.+.+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        78 -~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          78 -E-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             -C-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceee
Confidence             3 456799999986 5555555545568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....... ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+.....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------  226 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER--------  226 (270)
T ss_pred             ecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc--------
Confidence            6533211 1112233467999998866 668999999999999999986 9999988776555444322111        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                  ...++.++.++.+++.+|+..+|++||++.+++..
T Consensus       227 ----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         227 ----------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        11123368899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-39  Score=272.02  Aligned_cols=243  Identities=27%  Similarity=0.456  Sum_probs=192.1

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +.||.|++|.||++.+.. ++.|++|.+........       ...+.+|+.+++++.|+||+.+++.+... ...++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~   71 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDL-------KRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVM   71 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHH-------HHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEE
Confidence            469999999999999987 89999998875433210       12467899999999999999999998544 7789999


Q ss_pred             cccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC-
Q 035861           97 EYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY-  174 (332)
Q Consensus        97 e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~-  174 (332)
                      |+++|+ +.+.+......+++..+..++.+++.||++||++|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence            999865 555555545678999999999999999999999999999999999999999999999999987653211111 


Q ss_pred             -ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccc
Q 035861          175 -TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK  252 (332)
Q Consensus       175 -~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (332)
                       .....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+.....                 
T Consensus       152 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-----------------  213 (251)
T cd05041         152 DGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-----------------  213 (251)
T ss_pred             cccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------
Confidence             11223556999999876 578999999999999999999 8888877665544443322110                 


Q ss_pred             ccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                         ...+..++..+.+++.+||..+|.+||+++|+++
T Consensus       214 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                               0111236788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.9e-40  Score=277.85  Aligned_cols=239  Identities=19%  Similarity=0.259  Sum_probs=183.2

Q ss_pred             ccccccCcEEEEEEEECCCCc-------EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           17 NKISEGTYGIVYRARDKKSGE-------IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~-------~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +.||.|+||+||+|.+..++.       .+++|.+.......        ...+.+|+.+++.+.|||++++++.+..+ 
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-   71 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNY--------SESFFEAASMMSQLSHKHLVLNYGVCVCG-   71 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHH--------HHHHHHHHHHHHhCCCCChhheeeEEEeC-
Confidence            469999999999999865443       37788775432111        12456899999999999999999999655 


Q ss_pred             CeEEEEcccccccHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc--------EEEee
Q 035861           90 DSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--------LKICD  160 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~-~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~--------~~l~d  160 (332)
                      ...++||||++++.+ ..+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.        ++++|
T Consensus        72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence            668899999987554 444444456899999999999999999999999999999999999987764        69999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHcCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      ||.+.....    .....++..|+|||++.+...++.++|+||||+++|++++|. .||.......... ......    
T Consensus       152 ~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~----  222 (258)
T cd05078         152 PGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH----  222 (258)
T ss_pred             cccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc----
Confidence            998765432    223457788999999987566899999999999999999985 5555444332221 111100    


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                       ..+...+.++.+|+.+||+.||++||+++++++.
T Consensus       223 ---------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         223 ---------------------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ---------------------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                             0111246778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=288.65  Aligned_cols=279  Identities=27%  Similarity=0.429  Sum_probs=237.5

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...+.+++.+..||-|+||.|-+++.+.....+|+|++++........     ...+..|-.+|..+++|.|++++..+ 
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ-----qeHv~sEr~Im~~~~s~fIvrLYrTf-  489 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ-----QEHVFSERNIMMECRSDFIVRLYRTF-  489 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH-----HHHHHhHHHHHHhcCchHHHHHHHHh-
Confidence            345678899999999999999999998665568999887654433221     12456899999999999999999999 


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .+..+.|+.||.|=|+-++.+.+..+.|++..+..++..+++|++|||++||+++||||+|.+++.+|.+||.|||+++.
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence            55589999999999887888887789999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ...... --+.+||+.|.|||++.+ +..+.+.|.||||+++||+++|.+||.+.++..++..|.++.....        
T Consensus       570 i~~g~K-TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--------  639 (732)
T KOG0614|consen  570 IGSGRK-TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--------  639 (732)
T ss_pred             hccCCc-eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--------
Confidence            866533 345799999999999988 6789999999999999999999999999999999999988642211        


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCC--
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKSKD--  319 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~~~--  319 (332)
                                                 -+..++..+.+||+++...+|.+|..     +.+|-+|-||..+.|...+.  
T Consensus       640 ---------------------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~  692 (732)
T KOG0614|consen  640 ---------------------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT  692 (732)
T ss_pred             ---------------------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence                                       12237889999999999999999985     89999999999999987743  


Q ss_pred             CCCCCCCcc
Q 035861          320 FMPTFPPQH  328 (332)
Q Consensus       320 ~~~~~~~~~  328 (332)
                      ..|++.|.-
T Consensus       693 L~pPi~~~v  701 (732)
T KOG0614|consen  693 LPPPIIPSV  701 (732)
T ss_pred             CCCCccccC
Confidence            555555543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=286.44  Aligned_cols=201  Identities=28%  Similarity=0.459  Sum_probs=167.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|.....||+|+||.||+|.... +..||||.+.......        ...+..|+..+.+++|||+++++|+|.+...
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~  145 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--------EREFLNEVEILSRLRHPNLVKLLGYCLEGGE  145 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--------hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence            577777899999999999999874 4889999776544321        1147899999999999999999999976644


Q ss_pred             eEEEEccccc-ccHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           91 SVYMVMEYME-HDLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNW---VLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        91 ~~~lv~e~~~-~~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~---i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ..++|+||++ |+|.+.+..... +++|..+.+|+.++|.||+|||...   |+||||||+|||+|.+.+.||+|||++.
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            6899999998 566666666555 8999999999999999999999754   9999999999999999999999999996


Q ss_pred             ccCCCCCCCccc-cccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 035861          166 QYGSPLKPYTSL-VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT  221 (332)
Q Consensus       166 ~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~  221 (332)
                      ............ .||..|++||+... +..+.++||||+|++++|++||+.+....
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            543211222222 78999999999987 78999999999999999999999887653

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.3e-39  Score=273.12  Aligned_cols=247  Identities=21%  Similarity=0.356  Sum_probs=194.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++.+.||+|++|.||++... .+..+++|.+......         ...+.+|+.++++++|+|++++++.+..  
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   72 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---------VEAFLAEANVMKTLQHDKLVKLHAVVTK--   72 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhH---------HHHHHHHHHHHHhcCCCCcceEEEEEcC--
Confidence            358999999999999999999865 4566999987643211         1145689999999999999999999854  


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...+++|||+++ ++.+.+... ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            567899999985 566655542 345788999999999999999999999999999999999999999999999988754


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+.....          
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------  221 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------  221 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC----------
Confidence            3221 11122334567999999876 668999999999999999998 8999987766555444322111          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ......++.++.+++.+||+.+|++||++.++++
T Consensus       222 --------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 --------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             --------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                      0111236788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.1e-39  Score=279.19  Aligned_cols=250  Identities=23%  Similarity=0.373  Sum_probs=194.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .+|+..+.||+|++|.||+|.+..++.    .+++|.+........       ...+.+|+.+++.+.|+||+++++.+.
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-------NVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHH-------HHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            488999999999999999999877776    467787754322111       113568999999999999999999885


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ..  ..+++++++++ ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+.
T Consensus        80 ~~--~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          80 SP--TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             CC--CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence            43  36789999985 5666666555678999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .......  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------  228 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE--------  228 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------
Confidence            6532221  1222345678999999876 678999999999999999997 899997765443332221110        


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                  .....+.++..+.+++.+||..+|++||+++++++.
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 ----------------------------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        011122367788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.9e-39  Score=271.89  Aligned_cols=229  Identities=24%  Similarity=0.353  Sum_probs=181.6

Q ss_pred             cCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEcccccc
Q 035861           22 GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH  101 (332)
Q Consensus        22 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  101 (332)
                      |.+|.||++.+..+++.+|+|.+.....             ...|...+....|||++++++.+... ...+++|||++|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------------~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------------YSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------------hhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCC
Confidence            8899999999999999999999976431             11344555556799999999998554 789999999997


Q ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccc
Q 035861          102 DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL  181 (332)
Q Consensus       102 ~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  181 (332)
                      +.+.........+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+......   .....++.
T Consensus        70 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~  146 (237)
T cd05576          70 GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN  146 (237)
T ss_pred             CCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence            544443334567999999999999999999999999999999999999999999999999987655332   12334566


Q ss_pred             cccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchh
Q 035861          182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYN  261 (332)
Q Consensus       182 ~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (332)
                      .|+|||.+.. ..++.++|+||+|+++|++++|..|+.......      .                             
T Consensus       147 ~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~-----------------------------  190 (237)
T cd05576         147 MYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N-----------------------------  190 (237)
T ss_pred             cccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c-----------------------------
Confidence            7999998865 567899999999999999999998875322100      0                             


Q ss_pred             hhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH-----HHHhcCCCC
Q 035861          262 LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-----DDALNHYWF  309 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~f  309 (332)
                            .......++.++..+++||.+||+.||++|+++     +++++||||
T Consensus       191 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         191 ------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                  000011123378899999999999999999985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.9e-39  Score=275.07  Aligned_cols=252  Identities=19%  Similarity=0.355  Sum_probs=195.3

Q ss_pred             hcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+|++++.||.|+||+||+|+...     +.+.+++|.+.......       ....+.+|++++++++|+|++++++.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~   77 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN-------LQSEFRRELDMFRKLSHKNVVRLLGLC   77 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchH-------HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence            589999999999999999999753     34678888875432210       011456899999999999999999988


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcE
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQ---------PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVL  156 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~---------~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~  156 (332)
                       .+....++||||++++.+........         .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          78 -REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             -CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence             44577899999999644443333233         68999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCC-CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc
Q 035861          157 KICDFGMSRQYGS-PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       157 ~l~df~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  234 (332)
                      +++|||.+..... .........++..|+|||.+.+ ...+.++|+||||+++|++++ |..||...........+....
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~  235 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK  235 (275)
T ss_pred             EEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence            9999998764322 1122233456778999999876 567899999999999999998 788997665544444332111


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ..                                   ......++..+.+++.+||+.+|++||++.++++.
T Consensus       236 ~~-----------------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 LE-----------------------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             cC-----------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            00                                   01112367899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.2e-39  Score=272.16  Aligned_cols=244  Identities=25%  Similarity=0.360  Sum_probs=193.3

Q ss_pred             ccccccCcEEEEEEEECC-CC--cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           17 NKISEGTYGIVYRARDKK-SG--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~-~~--~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      +.||+|++|+||+|.+.. .+  ..+|||.+......       .....+..|+..+++++|+||+++++.+..  ...+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   71 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLM   71 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEE
Confidence            468999999999999865 23  36899988765432       111256789999999999999999999855  7789


Q ss_pred             EEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           94 MVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        94 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      +++|++++ ++.+.+.... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence            99999975 5555555543 468999999999999999999999999999999999999999999999999987664322


Q ss_pred             CC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          172 KP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ..   .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+....+......           
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  219 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----------  219 (257)
T ss_pred             cceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----------
Confidence            11   112345678999999876 668999999999999999998 99999877666555544321100           


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                              ...+..++..+.+++.+||+.+|++||++.++++
T Consensus       220 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 ------------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                                    0011226788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.5e-39  Score=276.97  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=192.2

Q ss_pred             hcccccccccccCcEEEEEEEECC----------------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK----------------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD   74 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   74 (332)
                      ++|++.+.||+|+||+||++.+..                ++..+|+|++........       ...+.+|+..++.++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~-------~~~~~~E~~~l~~l~   77 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA-------RNDFLKEIKIMSRLK   77 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHH-------HHHHHHHHHHHHhCC
Confidence            479999999999999999986432                344688898864321110       124668999999999


Q ss_pred             CCCeeeeeeeEEcCCCeEEEEcccccc-cHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Q 035861           75 HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK----------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL  143 (332)
Q Consensus        75 h~~i~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di  143 (332)
                      |+||+++++.+..+ ...+++|||+++ ++.+.+....          ..+++..+..++.|++.||+|||+.|++|+||
T Consensus        78 ~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          78 DPNIIRLLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             CCCcceEEEEEecC-CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            99999999998554 678999999986 5544444321          23677899999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh--CCCCCC
Q 035861          144 KTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFS  219 (332)
Q Consensus       144 ~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt--g~~pf~  219 (332)
                      ||+||+++.++.++|+|||.+........  ......++..|++||.... ..++.++|+||||+++|+|++  |..||.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999876432211  1122334577999998776 568999999999999999998  778887


Q ss_pred             CCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC
Q 035861          220 GTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT  299 (332)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  299 (332)
                      ..+..+............                             ........+..++..+.+|+.+||+.||.+||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~  286 (296)
T cd05095         236 QLSDEQVIENTGEFFRDQ-----------------------------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS  286 (296)
T ss_pred             ccChHHHHHHHHHHHhhc-----------------------------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence            766554443322110000                             000001112336788999999999999999999


Q ss_pred             HHHHhc
Q 035861          300 VDDALN  305 (332)
Q Consensus       300 ~~ell~  305 (332)
                      +.+|++
T Consensus       287 ~~~i~~  292 (296)
T cd05095         287 FQEIHA  292 (296)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-38  Score=285.33  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=195.3

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   83 (332)
                      .++|.+.+.||+|+||.||+|++.     .+++.||+|++........       ...+..|+.++.++. ||||+++++
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-------~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-------KQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-------HHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            457889999999999999999964     3456899999975432211       124678999999997 999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcC---------------------------------------------------
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------------------------------------------  111 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------------------------------------------  111 (332)
                      .+... ...++|+||+.+ ++.+.+....                                                   
T Consensus       109 ~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         109 ACTKG-GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEccC-CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            98554 678999999986 4554443311                                                   


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861          112 ----------------------------------------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus       112 ----------------------------------------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                                                                    ..+++..+..++.||+.||+|||+.|++|+||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                          1356778889999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +||+++.++.++|+|||.+.......  .......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999987542211  11223356778999999876 668999999999999999998 889997655


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ..+..........                                   ....+..++.++.+|+.+||..+|.+||++.+
T Consensus       347 ~~~~~~~~~~~~~-----------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~e  391 (401)
T cd05107         347 MNEQFYNAIKRGY-----------------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ  391 (401)
T ss_pred             chHHHHHHHHcCC-----------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            4444333322110                                   01112336889999999999999999999999


Q ss_pred             HhcC
Q 035861          303 ALNH  306 (332)
Q Consensus       303 ll~h  306 (332)
                      |++.
T Consensus       392 ll~~  395 (401)
T cd05107         392 LVHL  395 (401)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.9e-39  Score=281.74  Aligned_cols=251  Identities=20%  Similarity=0.353  Sum_probs=194.0

Q ss_pred             hcccccccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVK   82 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   82 (332)
                      .+|++.+.||+|+||.||++.+..       ++..+++|.+........       ...+.+|+.+++++ +|+||++++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-------LSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHH-------HHHHHHHHHHHHhhcCCCCeeeee
Confidence            379999999999999999998643       223689998764321111       11456899999999 899999999


Q ss_pred             eeEEcCCCeEEEEcccccc-cHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCC
Q 035861           83 EVVMDDHDSVYMVMEYMEH-DLKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTS  146 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~  146 (332)
                      +.+..+ ...++++||+++ ++.+.+...               ...++...+..++.|++.||+|||++|++|+||+|+
T Consensus        85 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          85 GACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             EEEccC-CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            998544 778999999986 455544432               124778889999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 035861          147 NLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTE  223 (332)
Q Consensus       147 Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~  223 (332)
                      ||+++.++.++|+|||.++.......  ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...+.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999876532211  1122234567999999876 678899999999999999998 8899987766


Q ss_pred             HHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHH
Q 035861          224 VDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA  303 (332)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  303 (332)
                      .+....+.....                                    ......++.++.+|+.+||+.+|++||++.++
T Consensus       243 ~~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~el  286 (334)
T cd05100         243 EELFKLLKEGHR------------------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQL  286 (334)
T ss_pred             HHHHHHHHcCCC------------------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            555444432110                                    01112367889999999999999999999999


Q ss_pred             hcC
Q 035861          304 LNH  306 (332)
Q Consensus       304 l~h  306 (332)
                      +++
T Consensus       287 l~~  289 (334)
T cd05100         287 VED  289 (334)
T ss_pred             HHH
Confidence            987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.7e-40  Score=298.30  Aligned_cols=248  Identities=27%  Similarity=0.453  Sum_probs=206.9

Q ss_pred             hcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+.++.+.||+|+||.||+|+...     +...||||.++.......       .++|.+|++++..++||||++++|+|
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~-------~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQA-------RQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHH-------HHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            467889999999999999998642     345799999976543211       23678999999999999999999999


Q ss_pred             EcCCCeEEEEccccc-ccHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc
Q 035861           86 MDDHDSVYMVMEYME-HDLKWLMESMK-------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN  151 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~  151 (332)
                      .++ +.+|+|+||+. |+|.+.++.+.             .+++..+.+.|+.|||.|+.||-++.++|+||-..|+||.
T Consensus       559 ~~~-~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  559 REG-DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             ccC-CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            555 78999999998 67766665532             1278899999999999999999999999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCCCc---cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 035861          152 NQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQI  227 (332)
Q Consensus       152 ~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~  227 (332)
                      ++-.|||+|||+++..-+. +.+.   .-.-+++|||||.+.. +.++.+|||||+||+|||+++ |..||.+..+.+.+
T Consensus       638 e~l~VKIsDfGLsRdiYss-DYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSS-DYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             cceEEEecccccchhhhhh-hhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            9999999999999865322 2111   1233678999999998 789999999999999999998 99999999988888


Q ss_pred             HHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +.+..+                                    ..++.+..++.++.+|+..||+.+|.+||++.||=
T Consensus       716 e~i~~g------------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  716 ECIRAG------------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHcC------------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            877654                                    22555666999999999999999999999999873

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=271.64  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=185.5

Q ss_pred             ccccccCcEEEEEEEECCCCc--EEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEE
Q 035861           17 NKISEGTYGIVYRARDKKSGE--IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   93 (332)
                      +.||+|++|.||+|+...++.  .+++|.+........       ...+.+|+..+.++ .||||+++++.+.. ....+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~   72 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLY   72 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHH-------HHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCce
Confidence            368999999999999987775  457777753221111       11456899999999 79999999999844 47789


Q ss_pred             EEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           94 MVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        94 lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      ++|||+++ ++.+.+....               ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++
T Consensus        73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEE
Confidence            99999985 5555554321               2478999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      |+|||++...... ........+..|+|||++.. ..++.++|+||||+++|+|++ |..||...+..+....+....  
T Consensus       153 l~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--  228 (270)
T cd05047         153 IADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--  228 (270)
T ss_pred             ECCCCCccccchh-hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--
Confidence            9999988533211 11112233567999999876 678999999999999999997 999997765544443331110  


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                        .......++.++.+|+.+||+.+|.+||++.++++
T Consensus       229 ----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 ----------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ----------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                              00111236788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-38  Score=270.24  Aligned_cols=236  Identities=20%  Similarity=0.282  Sum_probs=182.8

Q ss_pred             ccccccCcEEEEEEEECCCC----------cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           17 NKISEGTYGIVYRARDKKSG----------EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +.||+|+||.||+|.+..++          ..+++|.+......         ...+.+|+..++.++|+||+++++.+.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---------SLAFFETASLMSQLSHKHLVKLYGVCV   71 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---------HHHHHHHHHHHHcCCCcchhheeeEEe
Confidence            46999999999999998766          34777776543221         125678999999999999999999885


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-------cEEE
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-------VLKI  158 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-------~~~l  158 (332)
                      .  ...++|+||++++.++...... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++       .++|
T Consensus        72 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          72 R--DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             c--CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence            5  5578999999976555554433 3799999999999999999999999999999999999999887       7999


Q ss_pred             eecccccccCCCCCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 035861          159 CDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      +|||.+.....    .....++..|+|||.+... ..++.++|+||||+++|++++ |..||.......... .......
T Consensus       150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~~~  224 (259)
T cd05037         150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHR  224 (259)
T ss_pred             CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcCCC
Confidence            99999876533    2233456779999998764 378999999999999999999 577776654222111 1111000


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      .                                     +......+.+++.+||..+|++||++.++++
T Consensus       225 ~-------------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 L-------------------------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             C-------------------------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0                                     0002367889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=312.99  Aligned_cols=264  Identities=28%  Similarity=0.436  Sum_probs=220.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ...+++....||.|.||.||.+.+..+|+..|+|-+......      ......+.+|..++..++|||++.++|+-+-.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecH
Confidence            344788899999999999999999999999999998876554      22334678999999999999999999998544


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...+|.||||.|+++..+....+..++.....+..|++.|++|||+.||+|+||||.||+++-+|.+|++|||.|....
T Consensus      1307 -ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1307 -EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             -HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence             6688999999998888888877788899999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCC----CccccccccccchhhhcCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCc
Q 035861          169 SPLKP----YTSLVVTLWYRAPELLLGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       169 ~~~~~----~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .+...    .....||+.|||||++.+.+  ...-++|||||||++.||+||+.||... +.++....+..+..+..+  
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-- 1463 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-- 1463 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc--
Confidence            54322    23457999999999997633  4567999999999999999999999864 555555555444322221  


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                        ..+|++.++||..||..||.+|.++.|||+|-|=+.-...
T Consensus      1464 ----------------------------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1464 ----------------------------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             ----------------------------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                                              1279999999999999999999999999999987664433

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=273.36  Aligned_cols=262  Identities=15%  Similarity=0.158  Sum_probs=186.9

Q ss_pred             hcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCccccc---ccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCL---EYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ++|++.+.||+|+||+||+|.+..+   +..+++|+............   ..........+...+..+.|++++.+++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999998877   66777776543221110000   00000111233344566789999999987


Q ss_pred             EEcCCC---eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           85 VMDDHD---SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        85 ~~~~~~---~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      ......   ..+++++++..++.+.+.. ....++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            643322   4578888887776655543 445688899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC-------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-H
Q 035861          162 GMSRQYGSPL-------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK-T  233 (332)
Q Consensus       162 ~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~-~  233 (332)
                      |+++......       .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.............. .
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            9987653211       11223468999999999876 6789999999999999999999999987633222111110 0


Q ss_pred             -cCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          234 -LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                       .......                               ....+..+..+.++++.|++.+|++||+..++++
T Consensus       250 ~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEG-------------------------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhhh-------------------------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             0000000                               0011225788999999999999999999999875

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-38  Score=270.56  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=188.4

Q ss_pred             ccccccCcEEEEEEEECCCC------cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           17 NKISEGTYGIVYRARDKKSG------EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      +.||.|++|.||+|+.....      ..+++|.+........       ...+.+|+..++.++||||+++++++... .
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   72 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-------KKEFLKEAHLMSNFNHPNIVKLLGVCLLN-E   72 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhh-------HHHHHHHHHHHHhcCCCCeeeEeeeecCC-C
Confidence            36899999999999986433      6799998754321111       12467899999999999999999998544 6


Q ss_pred             eEEEEcccccc-cHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-----cEEE
Q 035861           91 SVYMVMEYMEH-DLKWLMESM------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-----VLKI  158 (332)
Q Consensus        91 ~~~lv~e~~~~-~l~~~~~~~------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-----~~~l  158 (332)
                      ..++|+|+++| ++.+.+...      ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++     .+++
T Consensus        73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence            78999999986 555554431      23478899999999999999999999999999999999999887     8999


Q ss_pred             eecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 035861          159 CDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       159 ~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +|||++.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.... 
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  230 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-  230 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-
Confidence            9999987542211  11123345678999999977 668999999999999999998 999998776655444332110 


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                         ....+..++..+.+||.+||+.+|.+||++.++++
T Consensus       231 -----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -----------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -----------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                               00112236788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=264.76  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=207.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   90 (332)
                      +.+-++.||.|+||+|++..++.+|+..|||.++.....++.       .+++.|.+..++- ++|||++++|..+.+ +
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-------~rll~e~d~~mks~~cp~IVkfyGa~F~E-G  136 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-------KRLLMEHDTVMKSSNCPNIVKFYGALFSE-G  136 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-------HHHHHHHHHHHhhcCCcHHHHHhhhhhcC-C
Confidence            556778899999999999999999999999999876542221       2466777776655 799999999999776 6


Q ss_pred             eEEEEcccccccHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           91 SVYMVMEYMEHDLKWLME----SMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~----~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ..||-||.+.-++.....    ..+..++|..+-.|......||.||. +.+|+|||+||+|||++..|.+||+|||.+.
T Consensus       137 dcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  137 DCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             ceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence            688999999977644332    23567999999999999999999999 5689999999999999999999999999997


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCC-CCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKK-YSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..... -..+...|...|+|||.+..... ++.+||+||||++|||++||..||..- +..+.+..+..+.++.......
T Consensus       217 qLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~  295 (361)
T KOG1006|consen  217 QLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE  295 (361)
T ss_pred             hHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence            66332 22234467778999999976555 899999999999999999999999753 3334444443332211111100


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                     .-.++..++.+|..||.+|-..||.-.+++++||+..-...
T Consensus       296 -------------------------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  296 -------------------------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             -------------------------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence                                           11278899999999999999999999999999999876543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.9e-38  Score=268.47  Aligned_cols=250  Identities=20%  Similarity=0.306  Sum_probs=184.2

Q ss_pred             ccccccCcEEEEEEEECC--CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           17 NKISEGTYGIVYRARDKK--SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      +.||+|+||+||+|....  ....+++|.+........       ...+.+|+..++.++|+||+++++.+.. ....++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~l   72 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE-------QLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLL   72 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHH-------HHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEE
Confidence            369999999999997532  345688887654321111       1145689999999999999999998844 477899


Q ss_pred             Eccccccc-HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           95 VMEYMEHD-LKWLMESMK----QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        95 v~e~~~~~-l~~~~~~~~----~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ||||++++ +.+.+....    ...++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccccc
Confidence            99999864 544444422    2246788899999999999999999999999999999999999999999998865322


Q ss_pred             CC--CCCccccccccccchhhhcC------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          170 PL--KPYTSLVVTLWYRAPELLLG------AKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       170 ~~--~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ..  .......++..|+|||++..      ...++.++|+||||+++|+|++ |..||......+...............
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK  232 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence            11  11123345667999999753      2456889999999999999999 788888776665555443321111000


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ......++..+.+++..|+ .||++||++++|++-
T Consensus       233 -------------------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         233 -------------------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             -------------------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence                                           0012236788889999998 599999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.8e-38  Score=267.60  Aligned_cols=249  Identities=20%  Similarity=0.265  Sum_probs=183.7

Q ss_pred             ccccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           17 NKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      +.||+|+||.||+|...  .++..+++|.+........       ...+.+|+..+++++||||+++++.+. +....++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~l   72 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-------QMKFLEEAQPYRSLQHSNLLQCLGQCT-EVTPYLL   72 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-------HHHHHHHHHHHHhCCCCCEeeEEEEEc-CCCCcEE
Confidence            36899999999999864  3556799998765432111       114668999999999999999999884 4467899


Q ss_pred             Eccccccc-HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           95 VMEYMEHD-LKWLMESM----KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        95 v~e~~~~~-l~~~~~~~----~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ||||++++ +.+.+...    ....++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            99999964 44444432    12457778889999999999999999999999999999999999999999998865422


Q ss_pred             CCC--CCccccccccccchhhhcCC------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          170 PLK--PYTSLVVTLWYRAPELLLGA------KKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ...  ......++..|+|||++...      ..++.++|+||||+++|+|++ |..||......+.............. 
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  231 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP-  231 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC-
Confidence            211  12234567789999998542      135789999999999999996 99999876655443332221100000 


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                    ........+..+.++++.|+ .+|++||++++|+.
T Consensus       232 ------------------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         232 ------------------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ------------------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                                          00011225778889999998 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=264.88  Aligned_cols=281  Identities=23%  Similarity=0.414  Sum_probs=225.2

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      +..+++|.++..||+|++++|.++....|.+.||+|++++.-...+...+     ....|-.+..+- +||.++-++..+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedid-----wvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDID-----WVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccch-----hHHhhHHHHHhccCCCeEEehhhhh
Confidence            34577999999999999999999999999999999999876554443332     233566666554 799999999888


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       +.+..+++|.||++|+-+-....+...++++.+..+...|+.||.|||++||+.+|||.+|+|++..|++||+|+|.++
T Consensus       321 -qtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  321 -QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             -cccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence             5558899999999975433333447889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHH-HHcCCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG-------TTEVDQIDKIF-KTLGTP  237 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~-------~~~~~~~~~~~-~~~~~~  237 (332)
                      .--.+...-.+.+||+.|.|||.+++ ..|.++.|.|+||++|+||+.|+.||.-       .+..+.+-+++ ...-..
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence            76555566678899999999999998 7899999999999999999999999963       12222222221 111111


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC------CHHHHhcCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI------TVDDALNHYWFHE  311 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~ell~hp~f~~  311 (332)
                                                           +..+|-.+..+++..|.+||.+|.      .+.++-.|+||..
T Consensus       479 -------------------------------------prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  479 -------------------------------------PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             -------------------------------------cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence                                                 111566677899999999999997      5789999999999


Q ss_pred             CCCCCCC--CCCCCCCCccccC
Q 035861          312 VPLPKSK--DFMPTFPPQHARN  331 (332)
Q Consensus       312 ~~~~~~~--~~~~~~~~~~~~~  331 (332)
                      +.|.-.+  .-.|+|.|+.+.+
T Consensus       522 idwd~leqk~v~ppf~p~i~~d  543 (593)
T KOG0695|consen  522 IDWDLLEQKQVLPPFQPQITDD  543 (593)
T ss_pred             CCHHHHhhcccCCCCCCccccc
Confidence            9988764  4678888887653

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.4e-38  Score=268.77  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=191.3

Q ss_pred             ccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           13 FEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      |.+.+.||+|++|.||+|.+.   .++..+|||++..........      ..+.+|+..+++++|||++++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI------EEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHH------HHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            678899999999999999864   357899999996543222111      13568999999999999999999875432


Q ss_pred             -----CeEEEEcccccccH-HHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           90 -----DSVYMVMEYMEHDL-KWLMESM-----KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        90 -----~~~~lv~e~~~~~l-~~~~~~~-----~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                           ...+++++|+.++. ...+...     ...++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence                 12478889988644 3333221     124789999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 035861          159 CDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       159 ~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +|||.+........  ......++..|++||.+.. ..++.++|+||||+++|++++ |..||...+..+....+.....
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  233 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR  233 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999876532211  1122334567999999876 567889999999999999999 8899877665544443332110


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                          ....+..+..+.+++.+||+.+|++||++.+++.+
T Consensus       234 ------------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 ------------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                                01112367889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=276.36  Aligned_cols=272  Identities=27%  Similarity=0.396  Sum_probs=220.4

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      .+.++|-++..||+|||+.||++.+...++.||+|+-.......+. ...+..+...+|..+-+.|.||.|+++++++.-
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdE-KKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDE-KKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhH-hhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            3456899999999999999999999999999999998665443322 222233345689999999999999999999977


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcC---CCcEEEeecc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNN---QGVLKICDFG  162 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~---~~~~~l~df~  162 (332)
                      +....|-|+|||+|+-++...+.++.+++.++..|+.||..||.||.+..  |+|.||||.|||+-.   -|.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            77889999999999888888888899999999999999999999999765  999999999999854   3689999999


Q ss_pred             cccccCCCCCC-------CccccccccccchhhhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 035861          163 MSRQYGSPLKP-------YTSLVVTLWYRAPELLLGA---KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK  232 (332)
Q Consensus       163 ~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~  232 (332)
                      ++...+.....       -....||.||.|||.+.-+   ...+.+.||||+||++|.++.|+-||+.......+.   .
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL---q  695 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL---Q  695 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH---h
Confidence            99887543322       1235689999999998643   457889999999999999999999998764433222   1


Q ss_pred             HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      ......                            .....++..|.+++++++||++||++--++|..+.++..||||.-
T Consensus       696 eNTIlk----------------------------AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  696 ENTILK----------------------------ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhchhc----------------------------ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            111000                            012335556779999999999999999999999999999999975

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=262.79  Aligned_cols=292  Identities=35%  Similarity=0.545  Sum_probs=232.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ...+|.-++.+|.|.- .|..+.+.-++++|++|.+.........      ..+..+|..++..+.|+||+.++.++...
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~------akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH------AKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc------chhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            4568999999999999 8888989889999999998765332222      22456899999999999999999998432


Q ss_pred             -----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 -----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 -----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                           ....|+|||++.+++...+.   -.++-+.+..+++|++.|+.|||+.||+||||||+||++..++.+||.|||+
T Consensus        88 ~~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             ccHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence                 13479999999999877666   3478889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ++..+.. -..+....+..|+|||++.+ ..+....||||+||++.||++|...|.+....+.+.++...++.+....+.
T Consensus       165 ar~e~~~-~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  165 ARTEDTD-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hcccCcc-cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            9876443 35566788999999999988 459999999999999999999999999999999999999999988877655


Q ss_pred             CCCCCccccc-cccCCchhhhhhhCCCCccCC----CCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          244 GLSELPGAKA-NFAKQPYNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      .+........ ...+...-...+.+|+..+..    ++.-+..+++|+.+||..||++|.|+.++|+||||+-|
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence            4443222111 111111122233444443322    22345568899999999999999999999999999955

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-38  Score=270.06  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=195.5

Q ss_pred             hcccccccccccCcEEEEEEEEC----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDK----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .+|++.+.||+|+||.||++...    .++..+|+|++......       .....+.+|+..++.+.|+||+++++++.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~ei~~l~~l~~~~i~~~~~~~~   76 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------QHRSDFEREIEILRTLDHENIVKYKGVCE   76 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------HHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence            47889999999999999999864    34789999998754332       01124678999999999999999999874


Q ss_pred             c-CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           87 D-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        87 ~-~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      . +....+++|||+++ ++.+.+......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          77 KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             cCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            4 24578999999986 555555554456999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSPLKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.........  +.   +...   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~---~~~~---  227 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MI---GIAQ---  227 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc--cc---cccc---
Confidence            876422211   112234556999999876 57899999999999999999999998653221100  00   0000   


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                   .......................++.++.+|+.+||+.+|++||++.||++
T Consensus       228 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         228 -------------GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -------------ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                         000000000000011111222346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.1e-39  Score=252.56  Aligned_cols=286  Identities=26%  Similarity=0.480  Sum_probs=217.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      ..++|++++++|+|.++.||.|....++++++||+++.-..           +.+.+|+.+|..|. +|||+.+.++..+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-----------kKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-----------KKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-----------HHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            56799999999999999999999999999999999975332           14679999999995 9999999999854


Q ss_pred             C-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeeccccc
Q 035861           88 D-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSR  165 (332)
Q Consensus        88 ~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~  165 (332)
                      . .....+|+|+++..-...+   -..++...+..++.+|+.||.|+|+.||.|+|+||.|++|+... .++|+|||+|.
T Consensus       105 p~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence            3 2457899999987543333   34688999999999999999999999999999999999999654 79999999999


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHcCCCCCCcccC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      +.... ..+....-+..|.-||.+..-..++.+-|+|||||++..|+..+.||. +.+..+.+-++.+-++..--.  .-
T Consensus       182 FYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~--~Y  258 (338)
T KOG0668|consen  182 FYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY--AY  258 (338)
T ss_pred             hcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH--HH
Confidence            87543 444555667789999999988889999999999999999999888875 456666776666654422100  00


Q ss_pred             CCCCccccccccC--------CchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAK--------QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       245 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      +   .......+.        .+...-........   .--+++++.+|+.++|..|..+|+|+.|.+.||||..+....
T Consensus       259 l---~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n---~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  259 L---NKYQIDLDPQFEDILGRHSRKPWSRFINSEN---QHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             H---HHHccCCChhHhhHhhccccccHHHhCCccc---cccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence            0   000111111        11111111111111   111578999999999999999999999999999998766544


Q ss_pred             C
Q 035861          317 S  317 (332)
Q Consensus       317 ~  317 (332)
                      .
T Consensus       333 ~  333 (338)
T KOG0668|consen  333 S  333 (338)
T ss_pred             h
Confidence            3

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=289.28  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=218.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc--
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD--   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--   87 (332)
                      +.|++++.||.|.+|.||+++...+++..|+|++.......+         .+..|.++++.+ .|||++.+++++.-  
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---------EiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---------EIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---------HHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            478999999999999999999999999999999987654433         455788888887 79999999999853  


Q ss_pred             --CCCeEEEEcccccccHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           88 --DHDSVYMVMEYMEHDLKWLMESM--KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        88 --~~~~~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                        .++.+|+|||+|+|++...+.+.  ...+.|+.+..|++.++.||.|||.+.++|+|||-.|||++.++.|||.|||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence              34789999999998665555432  46699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAK----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      +...++......+..||++|||||++.+..    .++..+|+||||++..||.-|.+|+.+......+-.+-+   .   
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---N---  243 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---N---  243 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---C---
Confidence            999988888888999999999999997533    467799999999999999999999988766544333211   1   


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                  |...+..+...+..+-+||..||.+|-+.||+..++|+|||++.-
T Consensus       244 ----------------------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  244 ----------------------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ----------------------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                                        122223344578899999999999999999999999999999843

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-39  Score=281.83  Aligned_cols=276  Identities=25%  Similarity=0.381  Sum_probs=221.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|..++.||-|+||.|.++....|...||.|.+++..-     ..++.......|-.+|..-..+-|++++..| ++..+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySF-QDkdn  703 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDN  703 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-ccCCc
Confidence            68899999999999999999999999999999976432     2222233445788889888999999999999 66689


Q ss_pred             EEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      +|+||+|++| ++...++. -+-|.|..++.++..+..|+++.|+.|++|+||||+|||||.+|++||+|||+|+-+..-
T Consensus       704 LYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999997 45555555 678999999999999999999999999999999999999999999999999998632100


Q ss_pred             --------C-----C-----------------------------CCccccccccccchhhhcCCCCCCchhHHHHHHHHH
Q 035861          171 --------L-----K-----------------------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIM  208 (332)
Q Consensus       171 --------~-----~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l  208 (332)
                              .     +                             ......||+-|+|||++.. ..++...|.||.||+|
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHH
Confidence                    0     0                             0113467888999999987 5689999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHH
Q 035861          209 AELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNR  288 (332)
Q Consensus       209 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  288 (332)
                      |+|+.|..||-+....++..++++....                                 .-.....++|.+..+||.+
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~---------------------------------l~~~~~~~ls~e~~~li~k  908 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVINWRNF---------------------------------LHIPYQGNLSKEALDLIQK  908 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeeeehhhc---------------------------------cccccccccCHHHHHHHHH
Confidence            9999999999888776665555432110                                 0011122378999999998


Q ss_pred             hcCCCCCCCC---CHHHHhcCCCCCCCCCCCCCCCCCCCCCccc
Q 035861          289 LLTYDPEKRI---TVDDALNHYWFHEVPLPKSKDFMPTFPPQHA  329 (332)
Q Consensus       289 ~l~~dp~~Rp---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  329 (332)
                      ++. +++.|.   .+++|-.||||+.|.+.+.+....+|.|.++
T Consensus       909 Lc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~It  951 (1034)
T KOG0608|consen  909 LCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRIT  951 (1034)
T ss_pred             Hhc-ChhhhhcccchhhhhcCccccccchHhhhhccCCcCcccc
Confidence            765 467777   4778999999999999999999999999875

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=276.40  Aligned_cols=246  Identities=25%  Similarity=0.443  Sum_probs=201.8

Q ss_pred             cccccccccccCcEEEEEEEECCC--C--cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKS--G--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~--~--~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      .....+.||.|-||.||.|.....  |  -.||||+.+.......       ...|+.|+.+++.++||||++++|++.+
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            345667899999999999987532  3  3588888876443322       2268899999999999999999999943


Q ss_pred             CCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                        ...|||||.++ |.+...+..+...++...+..+++||+.||+|||+.+++||||-..||||.....|||+|||+++.
T Consensus       463 --~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  463 --QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             --cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence              45899999999 788888888888899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCcccc--ccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          167 YGSPLKPYTSLV--VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       167 ~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .+... .+....  -+.-|+|||.+.- ..++.+||+|.||++|||++. |..||.+....+.+..+             
T Consensus       541 ~ed~~-yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------------  605 (974)
T KOG4257|consen  541 LEDDA-YYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------------  605 (974)
T ss_pred             ccccc-hhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------------
Confidence            75432 222222  3556999999876 789999999999999999987 89999886655443322             


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                                             ....+++.++.+++.+..|+.+||+++|.+||.+.+|.
T Consensus       606 -----------------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  606 -----------------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             -----------------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                   23566777888999999999999999999999776653

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.1e-37  Score=260.50  Aligned_cols=249  Identities=21%  Similarity=0.301  Sum_probs=182.9

Q ss_pred             ccccccCcEEEEEEEECCC--CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           17 NKISEGTYGIVYRARDKKS--GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      +.||+|+||+||++.....  ...+++|.+........       ...+.+|+..++.++|||++++++.+.. ....++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~l   72 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-------QNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLL   72 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHH-------HHHHHHHHHHHhccCCcchhheEEEecC-CCccEE
Confidence            3699999999999975432  33466666654322111       1256789999999999999999999854 477899


Q ss_pred             Ecccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           95 VMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        95 v~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ||||+++ ++.+.+...   ....++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||.+......
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            9999996 444444432   234677788999999999999999999999999999999999999999999987543211


Q ss_pred             --CCCCccccccccccchhhhcC------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          171 --LKPYTSLVVTLWYRAPELLLG------AKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       171 --~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                        ........++..|+|||++..      ...++.++|+||||+++|+|++ +..||......+....+.........  
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--  230 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF--  230 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC--
Confidence              112234567888999998753      1235789999999999999997 57788777766655555433111100  


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 .  ......+++.+.+++..|+ .+|++||++++|++
T Consensus       231 ---------------------------~--~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         231 ---------------------------K--PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ---------------------------C--CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                                       0  0011226788899999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=277.12  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=215.3

Q ss_pred             hcccccccccccCcEEEEEEEECC---CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      .+....+.||+|+||.|++|.|+.   +...||||.+.......       ...+|++|+..|.+|+|+|++++||++.+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------IMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            466788899999999999999974   33479999998655432       22368899999999999999999999954


Q ss_pred             CCCeEEEEccccc-ccHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 DHDSVYMVMEYME-HDLKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                        .-.-+|+|.++ |+|++.+.+ ....|....+..++.|||.|+.||..+++||+||-..|+++-....|||+|||+.+
T Consensus       183 --qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 --QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             --chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence              44679999999 567777766 34668899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCcc---ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLKPYTS---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ..+.+...+..   ......|+|||.+.. ..++.+||+|++||+||||+| |..||.+....+.+.++-.         
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~---------  330 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA---------  330 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc---------
Confidence            88665554422   234567999999988 789999999999999999998 8899999988887776642         


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                 .+++..++.+++.+.+++.+||..+|++||++..|.+.-+.....
T Consensus       331 ---------------------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  331 ---------------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             ---------------------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence                                       344555666899999999999999999999999998776665543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.4e-37  Score=286.66  Aligned_cols=279  Identities=20%  Similarity=0.268  Sum_probs=177.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCC----CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKS----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ...++|++.+.||+|+||+||+|.+..+    +..||+|++.......           . ...+.++...+.++..+..
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----------~-~~~e~l~~~~~~~~~~~~~  196 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----------I-WMNERVRRACPNSCADFVY  196 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----------H-HHHHHHHhhchhhHHHHHH
Confidence            3567999999999999999999999988    8999999875321100           0 0111112222222222211


Q ss_pred             eE-----EcCCCeEEEEcccccccH-HHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCc
Q 035861           84 VV-----MDDHDSVYMVMEYMEHDL-KWLMESMKQP-------------------FSTSEVKCLMLQLLEGVKYLHDNWV  138 (332)
Q Consensus        84 ~~-----~~~~~~~~lv~e~~~~~l-~~~~~~~~~~-------------------l~~~~~~~i~~~l~~~L~~lh~~~i  138 (332)
                      .+     .......++|+||++++. .+.+......                   .....+..++.||+.||+|||++||
T Consensus       197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI  276 (566)
T PLN03225        197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI  276 (566)
T ss_pred             hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence            11     134467899999998754 4444322111                   1234567899999999999999999


Q ss_pred             ccccCCCCCEEEcC-CCcEEEeecccccccCCCC-CCCccccccccccchhhhcCCC---------------------CC
Q 035861          139 LHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPL-KPYTSLVVTLWYRAPELLLGAK---------------------KY  195 (332)
Q Consensus       139 ~H~di~p~Nili~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------------------~~  195 (332)
                      +|+||||+|||++. ++.+||+|||++....... .......+++.|+|||.+....                     .+
T Consensus       277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            99999999999986 5799999999997653221 2224557889999999764311                     13


Q ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCC
Q 035861          196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGS  275 (332)
Q Consensus       196 ~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      +.++||||||+++|+|+++..++.  .........+...+.....+......         ... ......     ....
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~---------~~~-~~~~~~-----~~~~  419 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEP---------RAS-PDLRRG-----FEVL  419 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhcc---------ccc-hhhhhh-----hhhc
Confidence            345699999999999998776543  22223333332221111111000000         000 000000     0000


Q ss_pred             CCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          276 PVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       276 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      ...+....+||.+||+.||++|||+.++|+||||......
T Consensus       420 d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        420 DLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            1123456699999999999999999999999999986654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=286.99  Aligned_cols=250  Identities=28%  Similarity=0.404  Sum_probs=194.4

Q ss_pred             ccccccccccCcEE-EEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCC
Q 035861           13 FEKLNKISEGTYGI-VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        13 y~~~~~lg~g~~g~-v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   90 (332)
                      |.-.+.+|.|+.|+ ||+|...  ++.||||.+-.....           -..+|+..++.. .||||+++++.- .++.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~-----------~A~rEi~lL~eSD~H~NviRyyc~E-~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFD-----------FAQREIQLLQESDEHPNVIRYYCSE-QDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHH-----------HHHHHHHHHHhccCCCceEEEEeec-cCCc
Confidence            34456789999986 8999887  889999998654321           234899999888 799999999987 6669


Q ss_pred             eEEEEcccccccHHHHHHhc--CCCC-CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---C--CcEEEeecc
Q 035861           91 SVYMVMEYMEHDLKWLMESM--KQPF-STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---Q--GVLKICDFG  162 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~--~~~l-~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~--~~~~l~df~  162 (332)
                      +.||..|.|..+|.+.+...  .... .....+.+..|++.||+|||+.+|+||||||.||||+.   +  .+++|+|||
T Consensus       577 F~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  577 FLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             eEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            99999999999999888773  1111 22556788999999999999999999999999999986   3  379999999


Q ss_pred             cccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCC
Q 035861          163 MSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPT  238 (332)
Q Consensus       163 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~  238 (332)
                      +|+.......   ...+..||..|+|||.+.. ..-+.+.|||||||++|+.++| .+||++.-..+.  .|......  
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~--  731 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYT--  731 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccc--
Confidence            9998854433   3456788999999999987 4457799999999999999996 999987643321  22211100  


Q ss_pred             CCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                    -..+  .+.-..++.+||.+|++++|..||+|.+||.||+|=+.+
T Consensus       732 ------------------------------L~~L--~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  732 ------------------------------LVHL--EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             ------------------------------eeee--ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence                                          0001  111122788999999999999999999999999996654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=283.38  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=214.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      +...+.+.||.|.||.|++|+.+..++   .||||.++.....++.       ..|+.|+.+|-++.||||+.+.|+. .
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekqr-------rdFL~EAsIMGQFdHPNIIrLEGVV-T  700 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQR-------RDFLSEASIMGQFDHPNIIRLEGVV-T  700 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHH-------hhhhhhhhhcccCCCCcEEEEEEEE-e
Confidence            356788899999999999999887664   6999999865443322       2678999999999999999999999 4


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ...-..||+||++. .|...++.+++.|+..++..|++.|+.|+.||-+.|++||||-..||||+.+-..|++|||+++.
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence            44778899999995 56667777788999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCC-CCCccc--cccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          167 YGSPL-KPYTSL--VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~~~-~~~~~~--~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ..+.. ..+++.  ..+.+|.|||.+.- ..++.+||+||+|++|||.++ |..||.+..+.+.++.+..+.        
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy--------  851 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY--------  851 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--------
Confidence            75443 223332  23578999999987 789999999999999999887 999999999999988887654        


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                  +++++.+++..+.+|+..||++|=.+||.+.+|+.+
T Consensus       852 ----------------------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  852 ----------------------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             ----------------------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                        344455589999999999999999999999999875

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=273.09  Aligned_cols=246  Identities=22%  Similarity=0.366  Sum_probs=208.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      ++....+||.|-+|.||.|.|+...-.||||.++.+....+         .|+.|+.+|+.+.|||+++++|+| ..+.-
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeve---------EFLkEAAvMKeikHpNLVqLLGVC-T~EpP  337 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------EFLKEAAVMKEIKHPNLVQLLGVC-THEPP  337 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHH---------HHHHHHHHHHhhcCccHHHHhhhh-ccCCC
Confidence            55677899999999999999999888999999976654333         578999999999999999999999 44467


Q ss_pred             EEEEccccc-ccHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYME-HDLKWLMESMKQP-FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~-~~l~~~~~~~~~~-l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      .|||+||+. |+|++.++.+++. ++...++.|+.||..|++||.+++++|+||-..|.||.++..||+.|||+++.+..
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            899999987 7999999988754 78888999999999999999999999999999999999999999999999998754


Q ss_pred             CC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          170 PL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      .. ....+....+-|.|||.+.- ..++.+||+|+||++|||++| |-.||.+-+..+.+..+.++              
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------------  482 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------------  482 (1157)
T ss_pred             CceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence            22 22223344667999999987 679999999999999999998 88999888776666655443              


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                                            .+-..+..+++.+.+|+++||++.|.+||++.|+-
T Consensus       483 ----------------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  483 ----------------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ----------------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                                  23333455899999999999999999999998874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-36  Score=253.15  Aligned_cols=242  Identities=42%  Similarity=0.666  Sum_probs=193.6

Q ss_pred             CcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEcccccc-
Q 035861           23 TYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-  101 (332)
Q Consensus        23 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~-  101 (332)
                      ++|.||+|.+..+++.+++|++........       ...+.+|+..+++++|++++++.+.+..+ ...++++|++++ 
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~   72 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGG   72 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCC
Confidence            589999999998899999999976543221       12567899999999999999999998554 788999999998 


Q ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccc
Q 035861          102 DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL  181 (332)
Q Consensus       102 ~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  181 (332)
                      ++...+.. ...+++..++.++.+++.++++||+.|++|+||+|.||+++.++.++++|||.+...... .......++.
T Consensus        73 ~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~  150 (244)
T smart00220       73 DLFDLLKK-RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG-GLLTTFVGTP  150 (244)
T ss_pred             CHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc-cccccccCCc
Confidence            55554443 445899999999999999999999999999999999999999999999999998876432 1334556788


Q ss_pred             cccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCch
Q 035861          182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPY  260 (332)
Q Consensus       182 ~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (332)
                      .|+|||.+.. ..++.++|+||||++++++++|..||... .................                      
T Consensus       151 ~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------  207 (244)
T smart00220      151 EYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP----------------------  207 (244)
T ss_pred             CCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc----------------------
Confidence            8999999875 56788999999999999999999999773 33333222221111000                      


Q ss_pred             hhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          261 NLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                  .....++.++.+++.+|+..+|++||++.++++||||
T Consensus       208 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      208 ------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ------------cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                        0001157889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=258.11  Aligned_cols=290  Identities=31%  Similarity=0.431  Sum_probs=207.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-----C---CCeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-----H---PSIVNVK   82 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~   82 (332)
                      .+|.+.++||.|-|+|||++.+..+.+.||+|+.+......+         ..+.|+++|++++     +   ..|++++
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtE---------aAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTE---------AALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHH---------HHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            599999999999999999999999999999999975544333         4568999999883     2   4588888


Q ss_pred             eeEE---cCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCC----
Q 035861           83 EVVM---DDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQ----  153 (332)
Q Consensus        83 ~~~~---~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~----  153 (332)
                      +.|.   .+..+.|+|+|+++.+|+..+..++ +.++...++.|++|++.||.||| +.||+|-||||+|||+..+    
T Consensus       149 D~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             ccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            8873   3457899999999999999998765 56999999999999999999999 5799999999999998300    


Q ss_pred             -------C------------------------------------------------------------------------
Q 035861          154 -------G------------------------------------------------------------------------  154 (332)
Q Consensus       154 -------~------------------------------------------------------------------------  154 (332)
                             +                                                                        
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                   0                                                                        


Q ss_pred             --------------------------------------------------------------------------------
Q 035861          155 --------------------------------------------------------------------------------  154 (332)
Q Consensus       155 --------------------------------------------------------------------------------  154 (332)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             ---cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC------CChHH
Q 035861          155 ---VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG------TTEVD  225 (332)
Q Consensus       155 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~------~~~~~  225 (332)
                         ++||.|||.|.-.   ...++..+.|.-|+|||++.+ ..|+..+||||++|+++||+||...|..      ..+.+
T Consensus       389 ~di~vKIaDlGNACW~---~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED  464 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWV---HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED  464 (590)
T ss_pred             cceeEEEeeccchhhh---hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence               0111222211100   011122233455999999998 6799999999999999999999999964      34667


Q ss_pred             HHHHHHHHcCCCCCCcccCCC---CCcccccccc---CCchhhhhhhC-CCCccCCCCCCCchHHHHHHHhcCCCCCCCC
Q 035861          226 QIDKIFKTLGTPTETIWPGLS---ELPGAKANFA---KQPYNLLRKRF-PAASFTGSPVLSESGFDLLNRLLTYDPEKRI  298 (332)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  298 (332)
                      .+..|+..++..|....-+-.   ++-+....+.   +-....+.+.+ ....  -+..-..++.+|+.-||+.+|++||
T Consensus       465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~--~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYE--WSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhC--CCHHHHHHHHHHHHHHHhcCccccc
Confidence            788888887776644322110   0111111110   00000000000 0000  0111245677999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCC
Q 035861          299 TVDDALNHYWFHEVPLP  315 (332)
Q Consensus       299 s~~ell~hp~f~~~~~~  315 (332)
                      ||.+.|+|||++.+..+
T Consensus       543 tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  543 TAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             cHHHHhcCccccCCCCC
Confidence            99999999999998876

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-37  Score=266.13  Aligned_cols=255  Identities=26%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      ...+.++||+|-||.|.++.-.. +.+||||+++.......       ..++.+|+++|.+|+||||+.++++|..+ +.
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~-------r~~F~kEIkiLsqLkhPNIveLvGVC~~D-eP  609 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNA-------RNDFLKEIKILSRLKHPNIVELLGVCVQD-DP  609 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhH-------HHHHHHHHHHHhccCCCCeeEEEeeeecC-Cc
Confidence            45688999999999999998863 68999999986554332       23688999999999999999999999777 77


Q ss_pred             EEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           92 VYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      +++|+||++. ++...+.+.. ..+......+|+.||+.|++||.+.+++||||.+.|+|+++++++||+|||.++..-+
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence            9999999995 5555555432 2346677788999999999999999999999999999999999999999999986532


Q ss_pred             CC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          170 PL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..  .......-+.+|+|||.+.. +.++.+||+|++|+++||+++  ...||....+.+..+..........       
T Consensus       690 g~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~-------  761 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG-------  761 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC-------
Confidence            21  11223344688999999987 789999999999999999875  7899988887776665544332222       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                            +...+..++.++..+.+|+-+||..|-.+||+++++-.
T Consensus       762 ----------------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  762 ----------------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ----------------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                                  22334455668999999999999999999999999854

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=276.79  Aligned_cols=205  Identities=31%  Similarity=0.472  Sum_probs=172.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC--
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD--   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   88 (332)
                      +-+.--+.||+|+||.||+|+++.+|+.||||+++........       .....|++++++++|+||++++++-.+.  
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~-------e~~~~EieilkKLnh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPR-------ERWCREIEILKKLNHPNIVKLFDIEETKFL   85 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchH-------HHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence            4567778899999999999999999999999999876533322       2456899999999999999999986322  


Q ss_pred             ---CCeEEEEcccccccHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC--CC--cEEE
Q 035861           89 ---HDSVYMVMEYMEHDLKWLMESMK---QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN--QG--VLKI  158 (332)
Q Consensus        89 ---~~~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~--~~--~~~l  158 (332)
                         .....+|||||.|+.+.......   ..+++.+.+.++.++..||.|||++||+||||||.||++..  +|  .-||
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence               13467999999986655554432   45999999999999999999999999999999999999853  33  5899


Q ss_pred             eecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 035861          159 CDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE  223 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~  223 (332)
                      +|||.|+..+.+. ......||+.|.+||.+...+.++...|.||+|+++|+++||..||-....
T Consensus       166 tDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  166 TDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9999999886553 678889999999999998668899999999999999999999999965433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1e-37  Score=268.75  Aligned_cols=294  Identities=28%  Similarity=0.420  Sum_probs=224.2

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC------CCe
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH------PSI   78 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i   78 (332)
                      .|-.+-.+|.|....|+|-||+|.+|.+..-|..||||++.....-.         +.-+.|+++|++|+.      -++
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---------KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---------KTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---------hhhhHHHHHHHHhhccCchhhhHH
Confidence            45556679999999999999999999999889999999997543211         133589999999953      467


Q ss_pred             eeeeeeEEcCCCeEEEEcccccccHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-Cc
Q 035861           79 VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GV  155 (332)
Q Consensus        79 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~  155 (332)
                      +.++..| ...+++|+|+|.+.-+|.+.+....  -.+....+..++.||+.||..|..+|++|.||||+||||... ..
T Consensus       497 lrl~r~F-~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  497 LRLFRHF-KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHHHHh-hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence            7777777 5558899999999999988887764  457889999999999999999999999999999999999875 47


Q ss_pred             EEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          156 LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +||||||+|.....+.  .+....+..|.|||++.+ -+|++.-|+||+||+|||+.||+..|.+.+..+++...+..-+
T Consensus       576 LKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  576 LKLCDFGSASFASENE--ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeeccCcccccccccc--ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            9999999998765432  244456778999999998 7899999999999999999999999999999999888887777


Q ss_pred             CCCCCcccCCCC-------Ccc-cccccc--------------CCchhhhhhhCCCCc-cCCCCCCCchHHHHHHHhcCC
Q 035861          236 TPTETIWPGLSE-------LPG-AKANFA--------------KQPYNLLRKRFPAAS-FTGSPVLSESGFDLLNRLLTY  292 (332)
Q Consensus       236 ~~~~~~~~~~~~-------~~~-~~~~~~--------------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  292 (332)
                      ..+......-.-       -.+ .....+              ............... ....+.+-..+++|+.+||..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            666443221110       000 000000              011111111111111 111223445788999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCC
Q 035861          293 DPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       293 dp~~Rps~~ell~hp~f~~  311 (332)
                      ||++|.++.++|+||||+.
T Consensus       733 dP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  733 DPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ChhhcCCHHHHhcCCcccC
Confidence            9999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=252.11  Aligned_cols=286  Identities=37%  Similarity=0.667  Sum_probs=225.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC--
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH--   89 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   89 (332)
                      +.+-.+.||.|+||.||.+.+..+|+.|++|++..-......+      +.+.+|+.++.-++|.|++...++.....  
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~------krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASC------KRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHH------HHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            5667789999999999999999999999999986433222111      24678999999999999999988873332  


Q ss_pred             --CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 --DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                        ...|+++|.+..++...+.. ...++...++-+.+||+.||.|||+.||.|+||||.|.+++.+..+||+|||+++..
T Consensus       128 fFqEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  128 FFQELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence              23678889998887665554 778999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          168 GSP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      +.. ....+....|..|+|||.+++...|+.+.||||.|+++.|++..+..|...+..+.++-+...++.|..+.+..  
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~--  284 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY--  284 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH--
Confidence            432 23445556788999999999999999999999999999999999999999999999999999888777553322  


Q ss_pred             CCccccccccCCchhhhhhhCCCCcc------CCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASF------TGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                             -.+......++.......+      .....-..+...++.+++..||+.|.+.++.+.|++.....
T Consensus       285 -------ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  285 -------ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             -------HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                   1122222222222111110      11112344677899999999999999999999999988765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=262.85  Aligned_cols=280  Identities=20%  Similarity=0.288  Sum_probs=183.4

Q ss_pred             cchhcccccccccccCcEEEEEEEEC----------------CCCcEEEEEEeecccCCcccc------cccCCCcchhH
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDK----------------KSGEIVALKKVKMNVGRKEDC------LEYGFPISSLR   65 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~~~------~~~~~~~~~~~   65 (332)
                      ...++|++.++||+|+||+||+|...                ..++.||||.+..........      ...........
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45679999999999999999999752                234679999986533211000      00111223345


Q ss_pred             HHHHHhhCCCCCe-----eeeeeeEEc-------CCCeEEEEccccccc-HHHHHHhcC---------------------
Q 035861           66 EINILLSFDHPSI-----VNVKEVVMD-------DHDSVYMVMEYMEHD-LKWLMESMK---------------------  111 (332)
Q Consensus        66 e~~~l~~l~h~~i-----~~~~~~~~~-------~~~~~~lv~e~~~~~-l~~~~~~~~---------------------  111 (332)
                      |+..+.++.|.++     +.+++++..       .....++|+||++++ +.+.+....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777766554     455565532       134689999999864 434333211                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC-CCccccccccccchhh
Q 035861          112 --QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK-PYTSLVVTLWYRAPEL  188 (332)
Q Consensus       112 --~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~  188 (332)
                        ..+++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence              1245677889999999999999999999999999999999999999999999865432211 1112234788999998


Q ss_pred             hcCCCC---------------------CCchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          189 LLGAKK---------------------YSTAVDMWSVGCIMAELLAKKP-LFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       189 ~~~~~~---------------------~~~~sDi~slG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      +.....                     .....|+||+|+++|+|+++.. ||.........   ..........+     
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~~~~~~-----  453 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDNDLNRW-----  453 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---HhhccchHHHH-----
Confidence            754211                     1124699999999999999886 66432211110   00000000000     


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCC---CCCCCHHHHhcCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP---EKRITVDDALNHYWFHE  311 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~ell~hp~f~~  311 (332)
                                      ................++..++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       454 ----------------r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        454 ----------------RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ----------------HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                            00000011122233478899999999999866   68999999999999964

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=264.19  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=209.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCc----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      +.+..+.||+|+||+||+|.+-..++    +||||++......+.       ..++++|+..|..++|||++++++++..
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-------s~e~LdeAl~masldHpnl~RLLgvc~~  769 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-------SIELLDEALRMASLDHPNLLRLLGVCML  769 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-------hHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence            45667889999999999999976665    688888876554332       2367899999999999999999999955


Q ss_pred             CCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      +.  .-||++|++ |.|++.++...+++-....+.|++||++|+.|||+.+++||||-..||||.....+|+.|||+++.
T Consensus       770 s~--~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  770 ST--LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             ch--HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            53  678999999 578888888889999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCCccccc--cccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          167 YGSPLKPYTSLVV--TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       167 ~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .......+....|  .+-|+|-|.+.. ..++.+|||||+||++||++| |..|+.+....+.-+.+..           
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-----------  915 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-----------  915 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-----------
Confidence            7655555544444  566999999887 789999999999999999999 9999988877665444332           


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                               ..++..++.++.++..++.+||..|+..||+++++.+
T Consensus       916 -------------------------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  916 -------------------------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -------------------------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                                     3446677889999999999999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=257.84  Aligned_cols=209  Identities=26%  Similarity=0.417  Sum_probs=181.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---CCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---HPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~   85 (332)
                      .+.+|..++.+|.|+||.|++++++.+...|+||.+.+.+.-.+...+....-.+..|+.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            455799999999999999999999999999999999887664444444333345678999999997   99999999999


Q ss_pred             EcCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       ++++++||+||..+.+ -+...+.....++|.++..|+.|++.|+++||+.||+|||||-+|++++.+|.+||+|||++
T Consensus       639 -Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  639 -EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             -ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence             7779999999998743 23344455788999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG  220 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~  220 (332)
                      ....+  .+.....||..|.|||++.+..+.....|||+||+++|.+.....||.+
T Consensus       718 a~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87643  5567889999999999999988889999999999999999999999853

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.2e-34  Score=285.14  Aligned_cols=254  Identities=18%  Similarity=0.230  Sum_probs=181.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|...+.||+|+||.||+|+...++..||||.+.....            ....|+..+++++||||+++++++.+. .
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~-~  756 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSE-K  756 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcC-C
Confidence            356677889999999999999988999999998864321            112578899999999999999999555 6


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH---DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh---~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ..++||||++|+.+..+..   .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++..++. ++.....
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            7899999999765554443   3899999999999999999999   6699999999999999998887765 5544322


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCCCcccCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..    .....++..|+|||++.+ ..++.++||||+|+++|||+||+.||...... ....+..+.....  .....+ 
T Consensus       833 ~~----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~-  904 (968)
T PLN00113        833 CT----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD--CHLDMW-  904 (968)
T ss_pred             cc----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc--cchhhe-
Confidence            11    123357889999999876 67899999999999999999999998532110 0011111100000  000000 


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                      ....... ..........++.+++.+||+.||++||+++|+++.
T Consensus       905 ----------------~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        905 ----------------IDPSIRG-DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ----------------eCccccC-CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                            0000000 000011123356789999999999999999999876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=6.3e-35  Score=246.20  Aligned_cols=292  Identities=30%  Similarity=0.525  Sum_probs=209.7

Q ss_pred             cchhcccccccccccCcEEEEEEEECC---CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      ...+.|.++.+||.|.|++||++.+..   ..+.||+|.+...+...          .+..|++.|..+ .+.||+++.+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~----------ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS----------RILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch----------HHHHHHHHHHHhccchhhhcchh
Confidence            345689999999999999999999876   78899999998776544          467999999999 6899999999


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeecc
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFG  162 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df~  162 (332)
                      .+ ..++..++|+||.+......+..   .++..++..+++.++.||+++|++||+|+||||.|++.+.. ++-.|+|||
T Consensus       103 ~~-rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  103 CF-RNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             hh-ccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEech
Confidence            88 55588999999999754444433   46799999999999999999999999999999999999864 688999999


Q ss_pred             cccccC----------------CC----------------------------CCCCccccccccccchhhhcCCCCCCch
Q 035861          163 MSRQYG----------------SP----------------------------LKPYTSLVVTLWYRAPELLLGAKKYSTA  198 (332)
Q Consensus       163 ~~~~~~----------------~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~  198 (332)
                      ++...+                .+                            ........||+.|+|||++.....-+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            976210                00                            0001123578999999999887888999


Q ss_pred             hHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCC--------CC--ccc--CCCCCccccccccCCc-hhhhh
Q 035861          199 VDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPT--------ET--IWP--GLSELPGAKANFAKQP-YNLLR  264 (332)
Q Consensus       199 sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~--------~~--~~~--~~~~~~~~~~~~~~~~-~~~~~  264 (332)
                      .|+||.|+++.-++++..||... ++.+.+..+....+...        ..  .+.  .+...+.....+.... .....
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999998654 33333333332211111        00  111  0111111112222221 11111


Q ss_pred             hhCCCCc-cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          265 KRFPAAS-FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       265 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ..-+... .......+..+.+|+++||..||.+|.|++++|+||||....
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            0111111 112233556889999999999999999999999999999655

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=261.20  Aligned_cols=261  Identities=30%  Similarity=0.463  Sum_probs=218.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|+.+..+|+|.+|.||++++..+++..|+|+++......-.        .+.+|+-+++.++||||+.+++.+... .
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~--------~iqqei~~~~dc~h~nivay~gsylr~-d   85 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS--------GIQQEIGMLRDCRHPNIVAYFGSYLRR-D   85 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccc--------ccccceeeeecCCCcChHHHHhhhhhh-c
Confidence            4899999999999999999999999999999999887654432        334799999999999999999999555 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..+|.||||+|+.+..+..-.+++++.++..+++..+++|+|||+.|-+|||||-.||+++..|.+|+.|||.+..++.-
T Consensus        86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            78999999999887777777899999999999999999999999999999999999999999999999999999888766


Q ss_pred             CCCCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          171 LKPYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .......+||+.|+|||+-.  ..+.+...+|+|++|+..-|+.....|-..........-+-+....++..        
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l--------  237 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL--------  237 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc--------
Confidence            66778889999999999863  23568999999999999999888777766555544443333322222211        


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                              ......++.+-+|++.+|.++|.+||+++-+|.|||..+-
T Consensus       238 ------------------------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  238 ------------------------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ------------------------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                                    1111257888899999999999999999999999998764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=217.68  Aligned_cols=214  Identities=27%  Similarity=0.465  Sum_probs=174.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDH   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   89 (332)
                      ++...+..||+|++|.|-+.++..+|...|+|.+..+...++.       ++.+.|+.+.++. .+|+++.++|.+... 
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-------~r~L~dldi~~r~~~CPf~V~FyGa~~re-  117 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-------KRLLMDLDIIMRTVDCPFTVHFYGALFRE-  117 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-------HHHHHhhhhhccCCCCCeEEEeehhhhcc-
Confidence            3566788999999999999999999999999999876653322       2456778777666 799999999988555 


Q ss_pred             CeEEEEcccccccHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEHDLKW---LMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~---~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ...+|.||.+.-++..   .....++.++|..+-+|+..+..||.|||+ ..++|||+||+||||+.+|+||+||||.+.
T Consensus       118 gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  118 GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            7789999999876543   334457889999999999999999999995 589999999999999999999999999987


Q ss_pred             ccCCCCCCCccccccccccchhhhcC---CCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHH
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLG---AKKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEVDQIDKIFKT  233 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l~~lltg~~pf~~-~~~~~~~~~~~~~  233 (332)
                      ...+.. ..+...|...|+|||.+..   ...|+-+||+||||+++.||++++.||.. .+..+.+.++...
T Consensus       198 ~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  198 YLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             eehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            664322 2233456777999999853   24689999999999999999999999975 5677777777654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=238.15  Aligned_cols=189  Identities=28%  Similarity=0.385  Sum_probs=152.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHH--hhCCCCCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL--LSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l--~~l~h~~i~~~~~~~~~   87 (332)
                      -.+..+.+.||+|.||.||+|.+.  |+.||||++......           +..+|.++.  .-|+|+||+.+++.-..
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~-----------SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER-----------SWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccchh-----------hhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            347889999999999999999999  899999999754321           234555555  44599999999887544


Q ss_pred             CCC---eEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCCEEEcCCCc
Q 035861           88 DHD---SVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN--------WVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        88 ~~~---~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~--------~i~H~di~p~Nili~~~~~  155 (332)
                      +.+   .+|+|++|.+ |+|.+.+..  ..++.+...+++..+|.||+|||..        .|+|||||+.||||.++|.
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence            433   4899999999 555555554  6899999999999999999999942        3999999999999999999


Q ss_pred             EEEeecccccccCCC----CCCCccccccccccchhhhcCCCCC-----CchhHHHHHHHHHHHHHh
Q 035861          156 LKICDFGMSRQYGSP----LKPYTSLVVTLWYRAPELLLGAKKY-----STAVDMWSVGCIMAELLA  213 (332)
Q Consensus       156 ~~l~df~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~-----~~~sDi~slG~~l~~llt  213 (332)
                      ..|+|+|+|......    ........||.+|||||++.+.-..     -..+||||||+++||++-
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            999999999877433    2345667899999999999753221     236899999999999974

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=256.33  Aligned_cols=247  Identities=25%  Similarity=0.419  Sum_probs=196.3

Q ss_pred             cccccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861           14 EKLNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      .+.+.||.|+||.|++|....       ....||||.+.......+.       ..+..|+++++.+ .|+|++.+.|.+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~-------~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEK-------KDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHH-------HHHHHHHHHHHHhcCCcchhhheeee
Confidence            556689999999999997541       1457999998766554221       2567999999999 699999999999


Q ss_pred             EcCCCeEEEEccccc-ccHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           86 MDDHDSVYMVMEYME-HDLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      .. .+..++|.||+. |+++..++.+.               ..++...+..++.|||.|++||++..++||||-..|||
T Consensus       372 t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  372 TQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL  450 (609)
T ss_pred             cc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence            55 588999999998 67777777655               34899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCCCCC-cccc--ccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC-hH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPLKPY-TSLV--VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT-EV  224 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~-~~  224 (332)
                      ++.+..+|++|||+++......... ....  -...|+|||.+.. ..++.+|||||+|+++||++| |..||.+-. ..
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9999999999999998643221111 1111  2455999999998 889999999999999999999 888998744 34


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +....+..+                                    .+...+..++.++.++++.||+.+|++||++.++.
T Consensus       530 ~l~~~l~~G------------------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  530 ELLEFLKEG------------------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HHHHHHhcC------------------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            443323222                                    22333444799999999999999999999998876


Q ss_pred             c
Q 035861          305 N  305 (332)
Q Consensus       305 ~  305 (332)
                      +
T Consensus       574 ~  574 (609)
T KOG0200|consen  574 E  574 (609)
T ss_pred             H
Confidence            5

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-33  Score=235.75  Aligned_cols=191  Identities=25%  Similarity=0.351  Sum_probs=152.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHH--hhCCCCCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL--LSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l--~~l~h~~i~~~~~~~~~   87 (332)
                      +...+.++.+|+|.||.||+|+..  ++.||||++......           ++..|-++.  -.++|+||+.+++.-.-
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kq-----------s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQ-----------SFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHH-----------HHHhHHHHHhccCccchhHHHhhchhcc
Confidence            456788999999999999999987  789999999765321           234454444  45589999999987521


Q ss_pred             ---CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCCCEEEcCCC
Q 035861           88 ---DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN---------WVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        88 ---~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~---------~i~H~di~p~Nili~~~~  154 (332)
                         ....++||+++.+. +|.+.+.  ...+++....+|+..++.||+|||+-         .|+|||||+.||||..|+
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence               13469999999985 5555554  35799999999999999999999963         499999999999999999


Q ss_pred             cEEEeecccccccCCCCCC--CccccccccccchhhhcCCCCCC-----chhHHHHHHHHHHHHHhCC
Q 035861          155 VLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYS-----TAVDMWSVGCIMAELLAKK  215 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~-----~~sDi~slG~~l~~lltg~  215 (332)
                      +..|+|||++..+......  .....||.+|||||++.+.-.+.     .+.||||+|.++||+++.-
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            9999999999887532221  22357899999999998754444     3689999999999999854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=6.2e-31  Score=215.69  Aligned_cols=213  Identities=42%  Similarity=0.686  Sum_probs=178.5

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccc
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEY   98 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~   98 (332)
                      ||.|++|.||++....+++.+++|++.......       ....+.+|+..++.+.|++++++++.+... ...++++|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~   72 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEY   72 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEec
Confidence            689999999999998889999999998654321       012467899999999999999999999554 788999999


Q ss_pred             ccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEeecccccccCCCCCCCcc
Q 035861           99 MEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYTS  176 (332)
Q Consensus        99 ~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~df~~~~~~~~~~~~~~~  176 (332)
                      ++| ++.+.+......++...+..++.+++.+|++||+.|++|+||+|.||+++. ++.++|+||+.+............
T Consensus        73 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          73 CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            995 555544443357999999999999999999999999999999999999999 899999999999876443222344


Q ss_pred             ccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccccc
Q 035861          177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA  256 (332)
Q Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
                      ..+...|.+||.+......+.++|+|++|++++++                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            56778899999987743788999999999999998                                             


Q ss_pred             CCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 035861          257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY  307 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  307 (332)
                                             ..+.+++.+|++.+|++||++.++++++
T Consensus       188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                   1224899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=223.52  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             cccccccccccCcEEEEEEEECCCC-----cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSG-----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +++....+-+|.||.||.|++....     +.|.+|++.......+       ...++.|...+....|||++++.++.+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQ-------v~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQ-------VNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHH-------HHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            5777788999999999999886433     3466666654322111       124567888888889999999999999


Q ss_pred             cCCCeEEEEccccc-ccHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           87 DDHDSVYMVMEYME-HDLKWLMESM-------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        87 ~~~~~~~lv~e~~~-~~l~~~~~~~-------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                      ++....++++.+.+ |++...+.-+       ...++..+...++.|++.|++|||++|++|.||-..|.+|++.-++||
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence            98888889999888 5665555422       234788889999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCCCCC--ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 035861          159 CDFGMSRQYGSPLKPY--TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +|=.+++..-.....+  .....+..||+||.+.+ ..++.+||+||||+++||++| |+.||..-++.+...-+.++  
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG--  514 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG--  514 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--
Confidence            9988887653322221  22344677999999998 789999999999999999998 89999888887766655443  


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                        .++..+-++++++..++.-||+.+|++||+++++..
T Consensus       515 ----------------------------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 ----------------------------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ----------------------------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                                              334455568999999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=217.55  Aligned_cols=259  Identities=23%  Similarity=0.339  Sum_probs=189.9

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      -....+.|.+.+.+|+|.||.+.++.+++++..+|+|.+........         ++.+|...--.| .|.||+.-+++
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~---------dF~rEfhY~~~Ls~H~hIi~tY~v   89 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQA---------DFVREFHYSFFLSPHQHIIDTYEV   89 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHH---------HHHHHhccceeeccchhhhHHHHH
Confidence            34566799999999999999999999999999999999976543222         355666655455 58999999998


Q ss_pred             EEcCCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC--CcEEEeec
Q 035861           85 VMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ--GVLKICDF  161 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~--~~~~l~df  161 (332)
                      ..+..+.+.+++|+++ |+|.+.+..  ..+-|.....++.|+++||.|||+++++|||||.+||||...  .+|||+||
T Consensus        90 aFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   90 AFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             HhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence            8888889999999999 566555443  568899999999999999999999999999999999999654  38999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCC
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGT  236 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~  236 (332)
                      |..+..+.-.   ........|.+||....    .-...+.+|+|.||+++|.++||..||...... ..+.+.....+.
T Consensus       168 G~t~k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  168 GLTRKVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             ccccccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence            9998765322   22233556889998643    223577899999999999999999999743211 111111111111


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCC---CCHHHHhcCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR---ITVDDALNHYW  308 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~hp~  308 (332)
                      ....                             .+.. =.-.++.+..++++-|..++.+|   -++.......|
T Consensus       245 k~~~-----------------------------~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  245 KNPA-----------------------------LPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             cCcc-----------------------------Cchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            1100                             0000 01168888899999999999998   34444444444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.7e-30  Score=211.09  Aligned_cols=203  Identities=41%  Similarity=0.633  Sum_probs=168.3

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      |.+.+.||.|++|+||++....+++.+++|.+......       .....+..|+..+++++|+|++++++.+... ...
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~   72 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPL   72 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecC-Cce
Confidence            67789999999999999999988999999999865433       0112566899999999999999999998544 778


Q ss_pred             EEEcccccc-cHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           93 YMVMEYMEH-DLKWLMESMKQP-FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        93 ~lv~e~~~~-~l~~~~~~~~~~-l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ++++|++++ ++.+.+.. ... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+......
T Consensus        73 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       73 YLVMEYCEGGDLFDYLRK-KGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEEEeccCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            999999998 55555444 444 899999999999999999999999999999999999999999999999988876433


Q ss_pred             C-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChH
Q 035861          171 L-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEV  224 (332)
Q Consensus       171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~-~~~~  224 (332)
                      . .......++..|++||.+.....++.++|+|+||++++++++|+.||.. .+..
T Consensus       152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            2 1223446677899999984436678899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=6.7e-31  Score=255.12  Aligned_cols=198  Identities=16%  Similarity=0.205  Sum_probs=140.5

Q ss_pred             CCeeeeeeeEE------cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           76 PSIVNVKEVVM------DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        76 ~~i~~~~~~~~------~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      .||..+++.+.      ......+.++|+++++|.+.+......+++..++.++.||+.||+|||++||+|+||||+|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL  112 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV  112 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence            35555555441      112457788999999888887665567999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEe-------------------ecccccccCCCC----------------CCCccccccccccchhhhcCCCC
Q 035861          150 LNNQGVLKIC-------------------DFGMSRQYGSPL----------------KPYTSLVVTLWYRAPELLLGAKK  194 (332)
Q Consensus       150 i~~~~~~~l~-------------------df~~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~  194 (332)
                      |+..+.++++                   |||+++......                .......||+.|+|||++.+ ..
T Consensus       113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~  191 (793)
T PLN00181        113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-SS  191 (793)
T ss_pred             EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-CC
Confidence            9765555555                   555443211000                00011357888999999887 66


Q ss_pred             CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCC
Q 035861          195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTG  274 (332)
Q Consensus       195 ~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ++.++|||||||++|||++|..|+....  .....+..... ++..                                  
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~~~----------------------------------  234 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PPQI----------------------------------  234 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-Chhh----------------------------------
Confidence            8999999999999999999888765321  11111111100 0000                                  


Q ss_pred             CCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          275 SPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       275 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                       ....+...+++.+||+++|.+||++.|+|+||||...
T Consensus       235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             -hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence             0013445689999999999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.6e-29  Score=200.83  Aligned_cols=167  Identities=22%  Similarity=0.298  Sum_probs=128.3

Q ss_pred             ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 035861          101 HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT  180 (332)
Q Consensus       101 ~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  180 (332)
                      |++.+.+......+++..++.++.|++.||+|||+.+      ||+||+++.++.+++  ||.+......     ...|+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            5677777765677999999999999999999999998      999999999999999  9988765432     22578


Q ss_pred             ccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCCCcccCCCCCccccccccCCc
Q 035861          181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQP  259 (332)
Q Consensus       181 ~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (332)
                      +.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+...........                  
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------  128 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------------  128 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------------
Confidence            99999999987 67899999999999999999999999765432 22223222211110000                  


Q ss_pred             hhhhhhhCCCCccCCCCCCCc--hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          260 YNLLRKRFPAASFTGSPVLSE--SGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                  ......++.  ++.++|.+||+.+|.+||++.++++|+|+..
T Consensus       129 ------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 ------------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ------------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                        000011233  6889999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.1e-28  Score=226.53  Aligned_cols=269  Identities=29%  Similarity=0.423  Sum_probs=195.9

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEE
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   93 (332)
                      .-...+|.|++|.|+.+......+....|.+.......+.....  ...+..|.-+-..+.|+|++.....+.+... .+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~--~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKY--NYNITSEFCIGSSLSHPNIIETLDIVQEIDG-IL  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHH--hhhhhhheeecccccCCchhhhHHHHhhccc-ch
Confidence            46678999999988888877666666666655321011111111  1125566666677899999887777745433 33


Q ss_pred             EEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC--
Q 035861           94 MVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL--  171 (332)
Q Consensus        94 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~--  171 (332)
                      -+||||++++ ..+....+.+...++..++.||+.|+.|+|+.|+.|+|+|++|+++..+|.+|++|||.+.....+.  
T Consensus       398 ~~mE~~~~Dl-f~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  398 QSMEYCPYDL-FSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hhhhcccHHH-HHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            4499999944 4444446789999999999999999999999999999999999999999999999999987653322  


Q ss_pred             --CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          172 --KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                        .......|+..|.|||++..........||||.|+++..|.+|+.||......+..........              
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~--------------  542 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD--------------  542 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc--------------
Confidence              2345678899999999999877778889999999999999999999976544322110000000              


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                        ....            ..........++.+.+.+|.+||++||.+|.++++|++++||+.+..
T Consensus       543 --~~~~------------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  543 --QRNI------------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --cccc------------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence              0000            00111112226778889999999999999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-26  Score=179.25  Aligned_cols=204  Identities=24%  Similarity=0.325  Sum_probs=171.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC-CCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~   88 (332)
                      ...|.++++||+|+||.+|+|....+|+.||||+-.......          .+..|..+.+.|++ ..|..+..+. .+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----------qL~yEskvY~iL~~g~GiP~i~~y~-~e   82 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----------QLLYESKVYRILQGGVGIPHIRHYG-TE   82 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----------chhHHHHHHHHhccCCCCchhhhhc-cc
Confidence            458999999999999999999999999999999987655443          34578888888865 4555555555 55


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~~l~df~~~~  165 (332)
                      ..+-.+||+.++.++.+...-+...++...++-++-|++.-++|+|.++++|+||||+|+|..-.   ..+.++|||+++
T Consensus        83 ~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   83 KDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             cccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence            57788999999999999999999999999999999999999999999999999999999998633   479999999998


Q ss_pred             ccCCCC-------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 035861          166 QYGSPL-------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD  225 (332)
Q Consensus       166 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~  225 (332)
                      .+.+..       .......||..|.+-.+..+ ..-+.+.|+-|+|.++.++.-|..||.+.....
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence            774322       22345678999999888776 556889999999999999999999998865443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-26  Score=187.05  Aligned_cols=201  Identities=23%  Similarity=0.352  Sum_probs=173.3

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   90 (332)
                      .|+|.++||.|+||..+.|++..++++||||.-...+.-.          .+..|.+..+.| ..++|..++.+. ....
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----------QLrdEYr~YKlL~g~~GIP~vYYFG-qeG~   97 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----------QLRDEYRTYKLLGGTEGIPQVYYFG-QEGK   97 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcc----------hHHHHHHHHHHHcCCCCCCceeeec-cccc
Confidence            7999999999999999999999999999999887655433          345777777777 578888877766 4447


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-----cEEEeeccccc
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-----VLKICDFGMSR  165 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-----~~~l~df~~~~  165 (332)
                      +-.+|+|.++.+|.+...-+...|+...++.++.|++.-++++|++.+|.+||||+|+||...+     .+.++|||+++
T Consensus        98 ~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   98 YNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            7789999999999999999999999999999999999999999999999999999999998654     59999999999


Q ss_pred             ccCCCCC-------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 035861          166 QYGSPLK-------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV  224 (332)
Q Consensus       166 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~  224 (332)
                      .+.++..       ......||.+||+-....+ ..-+.+.|+-|||.++++.+-|..||.+....
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            8754332       3456789999999988877 67799999999999999999999999875443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7.1e-25  Score=191.34  Aligned_cols=204  Identities=25%  Similarity=0.325  Sum_probs=165.5

Q ss_pred             cccccccccccCcEEEEEEEECCCC-cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC----CCCeeeeeeeEE
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD----HPSIVNVKEVVM   86 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~~   86 (332)
                      +|.+.+.||+|+||.||.+.+..++ ..+|+|+..........        .+..|..++..+.    .+++..++....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--------VLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--------cchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            8999999999999999999998764 67888888765433321        2346888888776    357778877774


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-----CcEEEee
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-----GVLKICD  160 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-----~~~~l~d  160 (332)
                      ....+.++||+.++.++.+...... +.++...+..++.|++.+|.+||+.|++||||||.|+.+...     ..+.|.|
T Consensus        91 ~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   91 STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            3457889999999999988776654 789999999999999999999999999999999999999865     3699999


Q ss_pred             ccccc--ccC-CC----CCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 035861          161 FGMSR--QYG-SP----LKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV  224 (332)
Q Consensus       161 f~~~~--~~~-~~----~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~  224 (332)
                      ||+++  ... ..    ...   .....||..|+++.+..+ ...+.+.|+||++.++.++..|..||......
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            99998  321 11    111   223459999999998887 77899999999999999999999999765543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-27  Score=207.80  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             cccccCcEEEEEEEE---CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCCCeEE
Q 035861           18 KISEGTYGIVYRARD---KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~---~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   93 (332)
                      .+|.|++|.|+++..   ...+.-++.|+.++.........      .-..|..++..++ ||.++.+...+ +.+...+
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyaf-qt~~kl~   73 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAF-QTDGKLY   73 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeee-ccccchh
Confidence            378999999998753   34577889998876554332211      2235777777775 99999998888 5558889


Q ss_pred             EEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCC
Q 035861           94 MVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP  173 (332)
Q Consensus        94 lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~  173 (332)
                      +++++..|+.+.........+.+.....+...++.++.++|+.|++|+|+|++||+++.+|.+++.|||.++..-...  
T Consensus        74 l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   74 LILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             HhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            999999986655555556678888999999999999999999999999999999999999999999999988653221  


Q ss_pred             CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccc
Q 035861          174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA  253 (332)
Q Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (332)
                        ..+|+..|+|||++.+   ...++|.||+|+++++++||..||..    ++...|.+.....+.              
T Consensus       152 --~~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--------------  208 (612)
T KOG0603|consen  152 --IACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--------------  208 (612)
T ss_pred             --hcccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--------------
Confidence              2289999999999873   58899999999999999999999988    555555553322222              


Q ss_pred             cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC--CCCCCCCCCCC
Q 035861          254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLP--KSKDFMPTFPP  326 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~--~~~~~~~~~~~  326 (332)
                                             ..+..+++++..++..+|..|..     +.|+.+|+||+.+.|.  ..+...+.|+|
T Consensus       209 -----------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp  265 (612)
T KOG0603|consen  209 -----------------------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKP  265 (612)
T ss_pred             -----------------------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence                                   26888999999999999999984     5799999999999999  55778888888


Q ss_pred             cccc
Q 035861          327 QHAR  330 (332)
Q Consensus       327 ~~~~  330 (332)
                      ..++
T Consensus       266 ~~~~  269 (612)
T KOG0603|consen  266 GSIT  269 (612)
T ss_pred             cccc
Confidence            7654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-26  Score=212.79  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=182.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|...+.||++.|=+|.++++.. |. |+||++.+...........    +-+.|++ ....++||.+++.-.. ..+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~----qrL~~ik-~~l~~~pn~lPfqk~~-~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFK----QRLEEIK-FALMKAPNCLPFQKVL-VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHH----HHHHHHH-HHhhcCCcccchHHHH-HhhHH
Confidence            78889999999999999999863 44 9999998765333221111    1234444 5566899999998876 44477


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC---
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG---  168 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~---  168 (332)
                      .|+|-+|...+|.+.+.. ...+...+.+.|+.||+.||..+|+.||+|||||.+||||+.-..+.|+||..-+-.-   
T Consensus        96 AylvRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            889999999999887765 5668899999999999999999999999999999999999999999999999765331   


Q ss_pred             CCCCCC----ccccccccccchhhhcCCC----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 035861          169 SPLKPY----TSLVVTLWYRAPELLLGAK----------KYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKT  233 (332)
Q Consensus       169 ~~~~~~----~~~~~~~~y~aPE~~~~~~----------~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~  233 (332)
                      ++...+    .+.....+|.|||.+....          ..+++-||||+||++.|+++ |++||.-..-    -...+.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~~  250 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRSG  250 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhcc
Confidence            111111    2233456899999985411          25779999999999999998 5677742211    111111


Q ss_pred             cCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ....++....                                ..-+..++.||..|++.||+.|.|+++.|+-
T Consensus       251 ~~~~~e~~Le--------------------------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 NADDPEQLLE--------------------------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CccCHHHHHH--------------------------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0000011100                                1135678899999999999999999999986

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=4e-25  Score=184.64  Aligned_cols=237  Identities=22%  Similarity=0.313  Sum_probs=150.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC----------CCeeee
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH----------PSIVNV   81 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~i~~~   81 (332)
                      .+...+.||.|+++.||.+++..|++.+++|++...........+     .+.+|.-....+.+          -.++..
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~-----~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYE-----QLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHH-----HHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHH-----HHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            677889999999999999999999999999999876632221111     23334433333221          122222


Q ss_pred             eeeE-EcC----------CC-----eEEEEcccccccHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHHCCcc
Q 035861           82 KEVV-MDD----------HD-----SVYMVMEYMEHDLKWLMES---MKQP---FSTSEVKCLMLQLLEGVKYLHDNWVL  139 (332)
Q Consensus        82 ~~~~-~~~----------~~-----~~~lv~e~~~~~l~~~~~~---~~~~---l~~~~~~~i~~~l~~~L~~lh~~~i~  139 (332)
                      ++.. +.+          ..     +.+++|+.+.+++.+.+..   ....   +.......+..|+++.+++||+.|++
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV  167 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV  167 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence            2221 111          01     2477888888887665432   2222   33444556779999999999999999


Q ss_pred             cccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCC-------CCCCchhHHHHHHHHHHHHH
Q 035861          140 HRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA-------KKYSTAVDMWSVGCIMAELL  212 (332)
Q Consensus       140 H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~sDi~slG~~l~~ll  212 (332)
                      |+||+|+|++++.+|.+.|+||+.....+...   .....+..|.|||.....       ..++.+.|.|+||+++|.|+
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999999887654321   113445779999977542       24788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCC
Q 035861          213 AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY  292 (332)
Q Consensus       213 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  292 (332)
                      ++..||...........                                         .+....++++.+++||..+|+.
T Consensus       245 C~~lPf~~~~~~~~~~~-----------------------------------------~f~~C~~~Pe~v~~LI~~lL~~  283 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-----------------------------------------DFSRCRDMPEPVQFLIRGLLQR  283 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-----------------------------------------GGTTSS---HHHHHHHHHHT-S
T ss_pred             HccCCCCCCCccccccc-----------------------------------------cchhcCCcCHHHHHHHHHHccC
Confidence            99999976533211000                                         1111124899999999999999


Q ss_pred             CCCCC
Q 035861          293 DPEKR  297 (332)
Q Consensus       293 dp~~R  297 (332)
                      +|.+|
T Consensus       284 ~~~~R  288 (288)
T PF14531_consen  284 NPEDR  288 (288)
T ss_dssp             SGGGS
T ss_pred             CcccC
Confidence            99987

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=5.5e-25  Score=191.70  Aligned_cols=170  Identities=18%  Similarity=0.148  Sum_probs=125.9

Q ss_pred             cchhcccccccccccCcEEEEEEEECC-CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...++|.+.+.||+|+||+||+|++.. ++..+|||+...........   .....+.+|++++++++|+|+++.+... 
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~---~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKP---LARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccH---HHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            456789999999999999999999876 67778999875321100000   0112467999999999999998643322 


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL-KTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di-~p~Nili~~~~~~~l~df~~~~  165 (332)
                         ...|+||||++|+.+....    ...   ...++.+++.+|.+||+.||+|||| ||+||+++.++.++|+|||+++
T Consensus        91 ---~~~~LVmE~~~G~~L~~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence               3479999999987655321    111   1467899999999999999999999 9999999999999999999998


Q ss_pred             ccCCCCCCC--------ccccccccccchhhhcC
Q 035861          166 QYGSPLKPY--------TSLVVTLWYRAPELLLG  191 (332)
Q Consensus       166 ~~~~~~~~~--------~~~~~~~~y~aPE~~~~  191 (332)
                      .........        ....++..|.+||.+..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            764322111        23456677899998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=4.5e-23  Score=181.00  Aligned_cols=268  Identities=36%  Similarity=0.574  Sum_probs=205.2

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCC-CeeeeeeeEEcCCCe
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP-SIVNVKEVVMDDHDS   91 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~   91 (332)
                      |.+...||.|+|+.||.+.+.   ..+++|.+........     .....+.+|+..+..+.|+ +++.+...+ .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFF-QDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCE
Confidence            778899999999999999997   6789999876654432     1122567899999999988 799999999 44466


Q ss_pred             EEEEcccccccHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeeccccccc
Q 035861           92 VYMVMEYMEHDLKWLMESMKQ---PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~---~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~~~  167 (332)
                      .+++++++.+..+........   .+++.....+..|++.++.++|+.|++|+|+||+||+++..+ .++++|||.+...
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            899999999765554444343   799999999999999999999999999999999999999998 7999999998755


Q ss_pred             CCCCC------CCccccccccccchhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCC
Q 035861          168 GSPLK------PYTSLVVTLWYRAPELLLGA--KKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTLGT  236 (332)
Q Consensus       168 ~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~~~~  236 (332)
                      .....      ......++..|++||.+...  ...+...|+||+|++++++++|..||.....   .............
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            43321      24667899999999999874  5789999999999999999999999877664   2333333332221


Q ss_pred             C--CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          237 P--TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +  .........                             ......+.+++..++..+|..|.+..+...+++......
T Consensus       233 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         233 PSLASPLSPSNP-----------------------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             cccccccCcccc-----------------------------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            1  000000000                             112356789999999999999999999999977776554


Q ss_pred             CCCC
Q 035861          315 PKSK  318 (332)
Q Consensus       315 ~~~~  318 (332)
                      ....
T Consensus       284 ~~~~  287 (384)
T COG0515         284 KESD  287 (384)
T ss_pred             cccc
Confidence            4443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=177.43  Aligned_cols=264  Identities=24%  Similarity=0.305  Sum_probs=176.1

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCc-----------------------------------EEEEEEeecccC
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGE-----------------------------------IVALKKVKMNVG   49 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----------------------------------~v~iK~~~~~~~   49 (332)
                      .+.-.+++|++.+.||+|+...||.+....++.                                   +.|||.+.....
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            344567799999999999999999997654221                                   356666654333


Q ss_pred             Cccccc-----------ccCCCcc---hhHHHHHH----hh-CCCCCeeeeeeeEEcC----------------------
Q 035861           50 RKEDCL-----------EYGFPIS---SLREINIL----LS-FDHPSIVNVKEVVMDD----------------------   88 (332)
Q Consensus        50 ~~~~~~-----------~~~~~~~---~~~e~~~l----~~-l~h~~i~~~~~~~~~~----------------------   88 (332)
                      ......           ..+.-..   .....+.+    .+ -+||||+.+.+.|+++                      
T Consensus       231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~  310 (598)
T KOG4158|consen  231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS  310 (598)
T ss_pred             CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence            221100           0000000   00000011    11 1599999999888542                      


Q ss_pred             ----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc--CCC--cEEEee
Q 035861           89 ----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN--NQG--VLKICD  160 (332)
Q Consensus        89 ----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~--~~~--~~~l~d  160 (332)
                          ....|+||...+.++...+..  ...+.....-++.|+++|+.|||++|++|+|+|++|||+.  +|+  .+.|.|
T Consensus       311 g~g~~~tlylvMkrY~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             ccCCCceEEEehhcchhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence                246899999999988777765  4567888888999999999999999999999999999984  333  689999


Q ss_pred             cccccccCCCC------CCCccccccccccchhhhcCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 035861          161 FGMSRQYGSPL------KPYTSLVVTLWYRAPELLLGAK-----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK  229 (332)
Q Consensus       161 f~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~  229 (332)
                      ||+|-.-+.-.      ......-|.-.-+|||+.....     -.-.++|.|+.|.+.||+++...||........-. 
T Consensus       389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-  467 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-  467 (598)
T ss_pred             cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-
Confidence            99886432211      1122345677899999986421     12458999999999999999999997632211000 


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH---HHHhc
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV---DDALN  305 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~  305 (332)
                                                    ....+..+|.    .+.-+++.+++|+..+|+.||++|+|+   .++|+
T Consensus       468 ------------------------------r~Yqe~qLPa----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  468 ------------------------------RTYQESQLPA----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ------------------------------hhhhhhhCCC----CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence                                          0011111221    122378899999999999999999984   45554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.9e-24  Score=169.96  Aligned_cols=149  Identities=28%  Similarity=0.297  Sum_probs=109.7

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc---c--ccCC-------------CcchhHHHHHHhhCCCC
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC---L--EYGF-------------PISSLREINILLSFDHP   76 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~---~--~~~~-------------~~~~~~e~~~l~~l~h~   76 (332)
                      +...||+|++|+||+|... +|+.||||+++.........   .  ...+             ......|+..+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999986 89999999998653221110   0  0000             01123488999999877


Q ss_pred             CeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCCCEEEcCCCc
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL-HDNWVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~l-h~~~i~H~di~p~Nili~~~~~  155 (332)
                      ++....... ..  ..+|||||++|+.+.........++...+..++.|++.+|.++ |+.||+|+||||+||+++ ++.
T Consensus        80 ~v~~p~~~~-~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          80 GIPCPEPIL-LK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCCCcEEE-ec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence            763322222 12  2379999999865433323356899999999999999999999 699999999999999998 478


Q ss_pred             EEEeecccccccC
Q 035861          156 LKICDFGMSRQYG  168 (332)
Q Consensus       156 ~~l~df~~~~~~~  168 (332)
                      ++|+|||++...+
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.7e-24  Score=169.95  Aligned_cols=246  Identities=20%  Similarity=0.253  Sum_probs=187.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+.+..++.+|.....|..|+|++.  |..+++|++..+.......      .++-+|...++-+.||||+++++.+ .
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~ris------rdfneefp~lrifshpnilpvlgac-n  257 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARIS------RDFNEEFPALRIFSHPNILPVLGAC-N  257 (448)
T ss_pred             cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhhc------chhhhhCcceeeecCCchhhhhhhc-c
Confidence            35677888899999999999999998  5578889887655433322      2456888999999999999999999 5


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCcEEEe--ec
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGVLKIC--DF  161 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~~~l~--df  161 (332)
                      ...+..++..|++. ++...+..... -.+..++.+++.+++.+++|||+..  |.-.-|++..++||++-+.+|+  |-
T Consensus       258 sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~  337 (448)
T KOG0195|consen  258 SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT  337 (448)
T ss_pred             CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence            55888999999995 44444444222 2688899999999999999999875  4556799999999998776654  32


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      .++..       ..+....+.|++||.+.....  .-.+.|+|||++++||+.|...||..-...+--.++.-       
T Consensus       338 kfsfq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------  403 (448)
T KOG0195|consen  338 KFSFQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------  403 (448)
T ss_pred             eeeee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------
Confidence            22222       134455788999999975322  34579999999999999999999988776655444421       


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                                                  ...+...+|.++..+..|+.-|+..||.+||.+..|+
T Consensus       404 ----------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ----------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ----------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                                        1223334566899999999999999999999877654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.2e-23  Score=170.63  Aligned_cols=178  Identities=15%  Similarity=0.117  Sum_probs=130.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccC-CCcchhHHHHHHhhCCCCCeeeeeeeEEcC-
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYG-FPISSLREINILLSFDHPSIVNVKEVVMDD-   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   88 (332)
                      ++|++++.+|.|+||.||++..  ++..+|||++.......+...+.- ....+.+|+..+.++.|++|.....++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            5899999999999999999755  366899999976554333221110 011245888899999999999988886433 


Q ss_pred             ------CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           89 ------HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        89 ------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                            ....+++|||++|..+....    .+++    ....+++.+|..+|+.|++|||++|.||+++.+| ++|+|||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence                  23588999999996554442    2333    2456999999999999999999999999999988 9999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHH
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL  212 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~ll  212 (332)
                      ..........            ....+.. ..+..++|+||||+++..+.
T Consensus       180 ~~~~~~e~~a------------~d~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKA------------KDRIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             Ccccccchhh------------HHHHHHH-hHhcccccccceeEeehHHH
Confidence            8865422110            0112223 45668999999999876543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.1e-23  Score=194.43  Aligned_cols=238  Identities=29%  Similarity=0.414  Sum_probs=177.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .-.+|+.++.|..|++|.||.++++.+.+++|.| +.++..             +++.  ++..-..|.           
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------------ilRn--ilt~a~npf-----------  133 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------------ILRN--ILTFAGNPF-----------  133 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------------hhhc--cccccCCcc-----------
Confidence            3468999999999999999999999988899884 332110             1111  111112222           


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                           .|     |+....+.. -++++-..        +.+++|||+.||+|+|+||+|.+|+.-|++|++|||++...-
T Consensus       134 -----vv-----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  134 -----VV-----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             -----ee-----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                 22     433332222 33444332        789999999999999999999999999999999999876431


Q ss_pred             CC---------------CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 035861          169 SP---------------LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT  233 (332)
Q Consensus       169 ~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~  233 (332)
                      -.               .-.....+||+.|.|||++.. ..|....|+|+||+++|+.+.|..||.+.+..+.+...+..
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd  273 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  273 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence            00               001234589999999999887 66899999999999999999999999999999998888776


Q ss_pred             cCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC---CHHHHhcCCCCC
Q 035861          234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI---TVDDALNHYWFH  310 (332)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~f~  310 (332)
                      ...-++..                                  ..+++++++++.++|+.+|..|-   .+.++-+|+||+
T Consensus       274 ~i~wpE~d----------------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~  319 (1205)
T KOG0606|consen  274 DIEWPEED----------------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQ  319 (1205)
T ss_pred             hccccccC----------------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhcccee
Confidence            44333331                                  12688999999999999999997   678999999999


Q ss_pred             CCCCCCCCCCCCCCCCc
Q 035861          311 EVPLPKSKDFMPTFPPQ  327 (332)
Q Consensus       311 ~~~~~~~~~~~~~~~~~  327 (332)
                      .+.|-..-+....|-|+
T Consensus       320 ~LDw~~llRqkaefvpq  336 (1205)
T KOG0606|consen  320 LLDWKSLLRQKAEFVPQ  336 (1205)
T ss_pred             ecccchhhhhhcccccc
Confidence            99988655555555443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.5e-22  Score=163.19  Aligned_cols=148  Identities=23%  Similarity=0.229  Sum_probs=111.1

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccccc-----ccCC-------------CcchhHHHHHHhhCCCC
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCL-----EYGF-------------PISSLREINILLSFDHP   76 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~-----~~~~-------------~~~~~~e~~~l~~l~h~   76 (332)
                      +.+.||+|++|+||+|.+. +|+.||||++...........     ...+             ......|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999987632111100     0000             01124688889899888


Q ss_pred             CeeeeeeeEEcCCCeEEEEcccccccH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCC
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~  154 (332)
                      ++.....+....   .++||||++|+. ..... ....++...+..++.|++.++.++|+ .|++|+||||+||+++ ++
T Consensus        80 ~i~~p~~~~~~~---~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          80 GVPVPEPILLKK---NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCCceEEEecC---CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence            874443333222   379999999863 22222 24568889999999999999999999 9999999999999999 79


Q ss_pred             cEEEeecccccccC
Q 035861          155 VLKICDFGMSRQYG  168 (332)
Q Consensus       155 ~~~l~df~~~~~~~  168 (332)
                      .++|+|||++....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.7e-21  Score=153.71  Aligned_cols=192  Identities=14%  Similarity=0.075  Sum_probs=138.3

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCCCe
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   91 (332)
                      ..+...|++|+||+||.+..  .+.+++.+.+...........    ...+.+|+++++++. ++++..++++     ..
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~----~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVA----WWLARREALALRQLDGLPRTPRLLHW-----DG   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHH----HHHHHHHHHHHHhcCCCCCCCEEEEE-----cC
Confidence            35678899999999997766  477888777765544222110    012468999999995 5778888774     23


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCCCEEEcCCCcEEEeecccccccCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL-KTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di-~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .+++|+|+.|..+.....      . ....++.|++.+|.++|+.||+|+|| ||.||+++.++.++|+|||++......
T Consensus        73 ~~lvmeyI~G~~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             EEEEEeeecCccHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            689999999976543221      1 12357889999999999999999999 799999999999999999999865433


Q ss_pred             CCCC-------------ccccccccccchhhhcCCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 035861          171 LKPY-------------TSLVVTLWYRAPELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTT  222 (332)
Q Consensus       171 ~~~~-------------~~~~~~~~y~aPE~~~~~~~~~-~~sDi~slG~~l~~lltg~~pf~~~~  222 (332)
                      ....             .....++.|++|+...--...+ ...+.++.|.-+|+++|+..+....+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            2110             0112356677777654322334 67788999999999999999876543

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=1.8e-20  Score=155.55  Aligned_cols=151  Identities=20%  Similarity=0.123  Sum_probs=111.4

Q ss_pred             cccccccccccCcEEEEEEE-ECCCCcEEEEEEeecccCCccccc-----ccC-----------CCcchhHHHHHHhhCC
Q 035861           12 EFEKLNKISEGTYGIVYRAR-DKKSGEIVALKKVKMNVGRKEDCL-----EYG-----------FPISSLREINILLSFD   74 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~-~~~~~~~v~iK~~~~~~~~~~~~~-----~~~-----------~~~~~~~e~~~l~~l~   74 (332)
                      -|.+.+.||.|++|.||+|. +..+|+.||+|++...........     ...           ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999998 667899999999986532111000     000           0112457999998886


Q ss_pred             CCC--eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCCCEEEc
Q 035861           75 HPS--IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW-VLHRDLKTSNLLLN  151 (332)
Q Consensus        75 h~~--i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~-i~H~di~p~Nili~  151 (332)
                      +..  +..+++.   .  ..++|||+++|..+.........+....+..++.|++.+|++||+.| ++|+||||+||+++
T Consensus       109 ~~~i~~p~~~~~---~--~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW---R--RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe---c--CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            532  3333332   2  24799999999654433323455667778899999999999999999 99999999999999


Q ss_pred             CCCcEEEeecccccccC
Q 035861          152 NQGVLKICDFGMSRQYG  168 (332)
Q Consensus       152 ~~~~~~l~df~~~~~~~  168 (332)
                       ++.++|+|||.+...+
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             7899999999887543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=4e-20  Score=175.40  Aligned_cols=191  Identities=24%  Similarity=0.309  Sum_probs=147.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---CCCeeeeeeeEEc
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---HPSIVNVKEVVMD   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~   87 (332)
                      ..|.|.+.||.|++|+||.|.... |+.||+|+-....... ..          --.+++.+|+   -+.|..+...++-
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fY----------I~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FY----------ICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-ee----------ehHHHHHhhchhhhcchHHHHHHHcc
Confidence            378999999999999999999977 9999999887654322 11          1123334444   2233333333322


Q ss_pred             CCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-------CCcEEEe
Q 035861           88 DHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-------QGVLKIC  159 (332)
Q Consensus        88 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-------~~~~~l~  159 (332)
                      . +..++|+||.+ |++++.+. ..+.+++.....++.|++..+.+||..+||||||||+|+++..       ..-++|+
T Consensus       766 ~-~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  766 Q-NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             C-CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            2 44679999999 56666555 5788999999999999999999999999999999999999963       2369999


Q ss_pred             ecccccccC--CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCC
Q 035861          160 DFGMSRQYG--SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKP  216 (332)
Q Consensus       160 df~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~  216 (332)
                      |||.+..+.  ..........+|-.+-.+|...+ ..|+++.|.|.|+.+++-|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            999987553  22344566778888999999887 899999999999999999998764

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=3.1e-19  Score=144.63  Aligned_cols=137  Identities=18%  Similarity=0.215  Sum_probs=101.4

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-----CCCCeeeeeeeEEc
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-----DHPSIVNVKEVVMD   87 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~   87 (332)
                      +.-.+.||+|++|.||.  +..++.. +||++.......        ...+.+|+..++.+     .||||+.+++++.+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~--------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGG--------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccch--------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            34567899999999995  5555555 799887643211        12567999999999     57999999999966


Q ss_pred             CC--Ce-EEEEccccc--c-cHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccCCCCCEEEcCC----CcE
Q 035861           88 DH--DS-VYMVMEYME--H-DLKWLMESMKQPFSTSEVKCLMLQLLEGV-KYLHDNWVLHRDLKTSNLLLNNQ----GVL  156 (332)
Q Consensus        88 ~~--~~-~~lv~e~~~--~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L-~~lh~~~i~H~di~p~Nili~~~----~~~  156 (332)
                      +.  +. +.+|+||.+  + ++.+.+ .. ..+++.  ..++.+++.++ +|||+++|+|+||||+||+++..    +.+
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l-~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFA-EQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHH-Hc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcE
Confidence            53  23 347899954  4 555555 42 346666  35678888777 99999999999999999999743    389


Q ss_pred             EEeecccc
Q 035861          157 KICDFGMS  164 (332)
Q Consensus       157 ~l~df~~~  164 (332)
                      +|+|++.+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=9.4e-20  Score=161.97  Aligned_cols=205  Identities=25%  Similarity=0.356  Sum_probs=154.2

Q ss_pred             HhhCCCCCeeeeeeeEEcCCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccccCCCCC
Q 035861           70 LLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV-LHRDLKTSN  147 (332)
Q Consensus        70 l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i-~H~di~p~N  147 (332)
                      |+.+.|.|+.+++|.++++ ...++|.++|. |++.+.+....-.++.-....+.++|+.||+|+|..-| +||.+++.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            3567899999999999777 88899999998 56777777667778999999999999999999998766 899999999


Q ss_pred             EEEcCCCcEEEeecccccccCC--CCCCCccccccccccchhhhcCCC------CCCchhHHHHHHHHHHHHHhCCCCCC
Q 035861          148 LLLNNQGVLKICDFGMSRQYGS--PLKPYTSLVVTLWYRAPELLLGAK------KYSTAVDMWSVGCIMAELLAKKPLFS  219 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~sDi~slG~~l~~lltg~~pf~  219 (332)
                      .+++....+|++|||+......  .............|.|||.+....      ..+.+.|+||+|++++|+++...||.
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            9999999999999999876632  111222223455699999987631      14678999999999999999999997


Q ss_pred             CCChH----HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          220 GTTEV----DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       220 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                      .....    +....+.+   .......|.+...                          . ...+++..++.+||..+|.
T Consensus       160 ~~~~~~~~~eii~~~~~---~~~~~~rP~i~~~--------------------------~-e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKK---GGSNPFRPSIELL--------------------------N-ELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             cccccCChHHHHHHHHh---cCCCCcCcchhhh--------------------------h-hcchHHHHHHHHhcccChh
Confidence            63322    22233222   1111122221110                          0 1455788999999999999


Q ss_pred             CCCCHHHHhc
Q 035861          296 KRITVDDALN  305 (332)
Q Consensus       296 ~Rps~~ell~  305 (332)
                      +||+++++-.
T Consensus       210 ~rPs~~~i~~  219 (484)
T KOG1023|consen  210 KRPSIEQIRS  219 (484)
T ss_pred             hCccHHHHHh
Confidence            9999987754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=4.4e-19  Score=145.85  Aligned_cols=143  Identities=22%  Similarity=0.208  Sum_probs=107.1

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      ++.||+|++|.||+|.+  .+..+++|+.....................+|+..+..+.|+++.....++... ...+++
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv   77 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIV   77 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEE
Confidence            35799999999999988  477899998764332221111100112356789999999888876665555343 567899


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      |||++|..+........   . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        78 ~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999855544443222   2 8889999999999999999999999999999999 78999999998875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.8e-18  Score=140.90  Aligned_cols=139  Identities=22%  Similarity=0.207  Sum_probs=100.5

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEcc
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVME   97 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e   97 (332)
                      .||+|++|.||+|.+.  +..+++|+...................+.+|+.++..+.++++.....+.... ...++|||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEE
Confidence            3899999999999864  78899998764332211110000012345799999999887654444333333 45689999


Q ss_pred             cccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           98 YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        98 ~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +++|..+.........       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9998655444332211       7899999999999999999999999999999 789999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=1.6e-19  Score=157.82  Aligned_cols=177  Identities=29%  Similarity=0.391  Sum_probs=129.7

Q ss_pred             CeEEEEcccccccHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           90 DSVYMVMEYMEHDLKWLMESMK---QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .+.||.|++|.-+.+..+..+.   ...+....+.++.|++.++.|   +|.+|+|++|.||+...++.++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            3578999999965555554323   346788899999999999999   9999999999999999999999999999877


Q ss_pred             cCCCC------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          167 YGSPL------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       167 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      .....      ...+...||.+|++||.+.+ ..++.++||||||++++|+++- ...+..    ......++....|+.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPPE  480 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCChH
Confidence            64322      24456789999999999998 7899999999999999999851 211111    111111111111111


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      .+                                  .+++.+ ..|+.+|+...|.+||++.+.-.|+|.
T Consensus       481 ~~----------------------------------~d~p~e-~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 FL----------------------------------QDYPEE-YTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             Hh----------------------------------hcCcHH-HHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            10                                  002222 389999999999999988888888775

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.7e-18  Score=139.58  Aligned_cols=145  Identities=19%  Similarity=0.199  Sum_probs=106.2

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccc--------------cCCCcchhHHHHHHhhCCCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLE--------------YGFPISSLREINILLSFDHPS   77 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~   77 (332)
                      .|.+.+.||.|++|.||++... +|+.+|||++............              .........|...+..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888999999999999999874 7999999998764321110000              000112456788888886664


Q ss_pred             --eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc
Q 035861           78 --IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        78 --i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~  155 (332)
                        +...++    . ...++||||++|..+..+..      ......++.+++.++.++|+.|++|+||+|.||+++.++.
T Consensus        95 i~v~~~~~----~-~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          95 FPVPKPID----W-NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCCceee----c-CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence              333322    1 34589999999865443321      1456778999999999999999999999999999999999


Q ss_pred             EEEeecccccccC
Q 035861          156 LKICDFGMSRQYG  168 (332)
Q Consensus       156 ~~l~df~~~~~~~  168 (332)
                      ++|+|||.+...+
T Consensus       164 ~~liDfg~~~~~~  176 (198)
T cd05144         164 IYIIDWPQMVSTD  176 (198)
T ss_pred             EEEEECCccccCC
Confidence            9999999996654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=6e-18  Score=157.53  Aligned_cols=144  Identities=19%  Similarity=0.131  Sum_probs=105.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|...+.||+|+||+||++.+.  +..+++|+...................+.+|++.++.++|++++....+.... ..
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~  410 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-EE  410 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-CC
Confidence            4466789999999999999876  34455555432221111100000112466899999999999988766655443 45


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .++||||++|..+.....        ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||.+...
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            689999999865544332        356799999999999999999999999999999 5789999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.5e-19  Score=166.37  Aligned_cols=263  Identities=23%  Similarity=0.342  Sum_probs=198.0

Q ss_pred             hhcccccccccccCcEEEEEEEECC-CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      ...|.+.+.||+|+++.|-...... +...++.|.+....  .....    ...+..|...-+.+. |.|++.+++.. .
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~----~~~i~~e~~~~~~~s~h~n~~~~~~~~-~   91 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDS----SEHIDTETDIQKKLSKHSNTVHMIEPS-S   91 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--Cccch----hhhcCccccccccccccccccccCCcc-C
Confidence            5589999999999999998887743 34455566555443  11111    113335666666665 99999999998 5


Q ss_pred             CCCeEEEEcccccccHHHHHH-hcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCCC-cEEEeeccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLME-SMKQ-PFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQG-VLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~-~~~~-~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~~-~~~l~df~~  163 (332)
                      +....++++++..|+.+.... ..+. ..+...+..++.|+..++.|+| ..++.|+||+|+|.+++..+ .+++.|||+
T Consensus        92 ~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   92 SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             CCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchh
Confidence            558889999998876544444 3343 6888899999999999999999 99999999999999999999 999999999


Q ss_pred             ccccCC-C--CCCCccccc-cccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          164 SRQYGS-P--LKPYTSLVV-TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       164 ~~~~~~-~--~~~~~~~~~-~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      ++.+.. .  .......+| ++.|.|||.+.+........|+||.|+++.-+++|..|+...........-...      
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~------  245 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS------  245 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc------
Confidence            987643 2  223345577 999999999887667788999999999999999999998765433210000000      


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                .-......++..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus       246 --------------------------~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  246 --------------------------NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             --------------------------cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                                      0001123344557888899999999999999999999999999999

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=3.2e-17  Score=132.09  Aligned_cols=141  Identities=22%  Similarity=0.205  Sum_probs=97.5

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccccccc----------------CCCcchhHHHHHHhhCCCCC-
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEY----------------GFPISSLREINILLSFDHPS-   77 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~-   77 (332)
                      +.+.||+|++|+||+|.+. +++.||||++.............                ........|...+.++.+.. 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999986 78999999987643221111100                00001124555555553332 


Q ss_pred             -eeeeeeeEEcCCCeEEEEccccccc-----HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEE
Q 035861           78 -IVNVKEVVMDDHDSVYMVMEYMEHD-----LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLL  150 (332)
Q Consensus        78 -i~~~~~~~~~~~~~~~lv~e~~~~~-----l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili  150 (332)
                       +...++.     ...++||||++|+     .+.....      ...+..++.+++.++.++|. .|++|+||+|+||++
T Consensus        80 ~~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~~------~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          80 PVPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVRL------LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCCceEec-----CCCEEEEEEeCCCCccChhhhhhhh------cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence             2333322     2358999999983     2222111      16788899999999999999 999999999999999


Q ss_pred             cCCCcEEEeecccccccC
Q 035861          151 NNQGVLKICDFGMSRQYG  168 (332)
Q Consensus       151 ~~~~~~~l~df~~~~~~~  168 (332)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=2e-17  Score=147.40  Aligned_cols=254  Identities=21%  Similarity=0.210  Sum_probs=196.8

Q ss_pred             hcccccccccc--cCcEEEEEEEE--CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861           11 FEFEKLNKISE--GTYGIVYRARD--KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus        11 ~~y~~~~~lg~--g~~g~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      ..+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-...........      .-.+|...-+.+ .|++.+..+..+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~------~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSK------RKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccc------cccchhhcccccCccccccccCccc
Confidence            46778889999  99999999998  78889999998544332221111      224677766666 588888877777


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccccCCCCCEEEcCC-CcEEEee
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE----GVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICD  160 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~----~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~d  160 (332)
                       ++.+..++=+|.|+.++..........+++..++..+.+..+    ||.++|..+++|.|++|.||+...+ ...+++|
T Consensus       188 -e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  188 -EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             -ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence             555888999999998888888877777999999999999999    9999999999999999999999999 7899999


Q ss_pred             cccccccCCCCCCCccc-----cccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHH
Q 035861          161 FGMSRQYGSPLKPYTSL-----VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT--TEVDQIDKIFKT  233 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~--~~~~~~~~~~~~  233 (332)
                      |+...............     .|...|++||...+  -++..+|+|+||.++.+..++..++...  ..+...+...  
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--  342 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--  342 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence            99988775544332222     67778999998875  6799999999999999999888777554  3332222111  


Q ss_pred             cCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                         .+.+.                                 ....+.++...+..|++.+|-.|+++..+++|++...
T Consensus       343 ---ip~e~---------------------------------~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 ---IPLEF---------------------------------CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             ---Cchhh---------------------------------hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence               00000                                 1114566667999999999999999999999999884

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.5e-16  Score=132.34  Aligned_cols=143  Identities=15%  Similarity=0.160  Sum_probs=100.7

Q ss_pred             cccc-ccCcEEEEEEEECCCCcEEEEEEeecccC-----CcccccccCCCcchhHHHHHHhhCCCCCe--eeeeeeEEcC
Q 035861           17 NKIS-EGTYGIVYRARDKKSGEIVALKKVKMNVG-----RKEDCLEYGFPISSLREINILLSFDHPSI--VNVKEVVMDD   88 (332)
Q Consensus        17 ~~lg-~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~   88 (332)
                      ..|| .|+.|+||.+...  +..++||.+.....     ...............+|+.++.++.|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8899999998876  77899998864221     00000001112346789999999988775  4555543332


Q ss_pred             CCe---EEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           89 HDS---VYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        89 ~~~---~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ...   .++|+|+++| ..+..+.. ...+++.    .+.+++.+|.+||+.||+|+||||.|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~-~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQ-EAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHh-cCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            222   3599999997 33433333 3455554    3578999999999999999999999999999999999999988


Q ss_pred             cc
Q 035861          165 RQ  166 (332)
Q Consensus       165 ~~  166 (332)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            75

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=2.3e-15  Score=116.75  Aligned_cols=132  Identities=23%  Similarity=0.251  Sum_probs=106.2

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC--CCeeeeeeeEEcCCCeE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH--PSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~   92 (332)
                      +++.||.|.++.||++...  +..+++|.......          ...+..|+..++.+.+  ..++.++... +..+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~-~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASG-ESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCcc
Confidence            4678999999999999986  46899998865432          1145688899988866  4777877766 444678


Q ss_pred             EEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           93 YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN---WVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        93 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~---~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ++++||++|..+...       +......++.+++.+|+.+|..   +++|+|++|.||+++..+.++++||+.+..
T Consensus        69 ~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          69 YLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999999998643322       5667778899999999999985   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.57  E-value=4.5e-14  Score=127.54  Aligned_cols=185  Identities=18%  Similarity=0.335  Sum_probs=133.0

Q ss_pred             cccccccccccCcEEEE-EEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVY-RARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~-~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      -|++ ...+-++.+ +| .|..+.++.+|.|..........        ...+.+-++.++.++||+|+.++..+.++ .
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~--------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-~   82 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEV--------TELAKRAVKRLKTLRHPNILSYLDTTEEE-G   82 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchh--------hHHHHHHHHHhhhccCchhhhhhhhhccc-C
Confidence            3554 444444444 44 46777889999999987665411        11345788999999999999999999444 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..|||+|.+..-. ..+..    +....+...+.||+.||.||| +.+++||+|+-..|+|+..|.+||++|..+.....
T Consensus        83 ~~ylvTErV~Pl~-~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~  157 (690)
T KOG1243|consen   83 TLYLVTERVRPLE-TVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG  157 (690)
T ss_pred             ceEEEeeccccHH-HHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence            8999999997511 11111    226777888999999999998 67899999999999999999999999998865433


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK  215 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~  215 (332)
                      ..........-..|..|+....   -....|.|.||+++++++.|.
T Consensus       158 ~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  158 FNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             CCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCcc
Confidence            2221222223334667765433   125679999999999999883

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=5.9e-14  Score=111.77  Aligned_cols=147  Identities=20%  Similarity=0.202  Sum_probs=100.2

Q ss_pred             cccccccCcEEEEEEEECC------CCcEEEEEEeecccCCccc---cc--ccC---------CCcch----hHHHHHHh
Q 035861           16 LNKISEGTYGIVYRARDKK------SGEIVALKKVKMNVGRKED---CL--EYG---------FPISS----LREINILL   71 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~---~~--~~~---------~~~~~----~~e~~~l~   71 (332)
                      ...||.|-.+.||.|....      .+..+|||+.+.....-..   ..  +..         ....+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998653      3578999999754321110   00  000         01122    27888888


Q ss_pred             hCCCC--CeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCCCE
Q 035861           72 SFDHP--SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL-HDNWVLHRDLKTSNL  148 (332)
Q Consensus        72 ~l~h~--~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~l-h~~~i~H~di~p~Ni  148 (332)
                      ++...  ++...+..     ...+||||+++++.+-.-.-.+..+++.....+..+++.+|..| |+.|++||||++.||
T Consensus        82 rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            88433  33333332     23479999998742111111133456667788899999999998 899999999999999


Q ss_pred             EEcCCCcEEEeecccccccC
Q 035861          149 LLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus       149 li~~~~~~~l~df~~~~~~~  168 (332)
                      +++ ++.+.|+||+.+...+
T Consensus       157 L~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE-CCcEEEEECCCceeCC
Confidence            997 4789999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=1e-14  Score=137.26  Aligned_cols=280  Identities=25%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..+.+.+.+.+-+|+++.++.+.-..++...++|+......-.....     .+++.+-..+-.-.+|.++.....+ ..
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~-----~s~r~~s~~~i~p~~P~v~~~~~s~-~~  875 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDY-----ESIRSKSNILITPRSPAVVRSFPSF-PC  875 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccc-----cccCCccCccccCCCCceecccCCC-CC
Confidence            56688888999999999999998888886666665543221111000     1122233332223345555444332 23


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....++++++++|+-+.....+.+..+++.+......+.+++++||...+.|+|++|.|+++..+|..++.||+.....+
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence            35678999999864333333335567888888888899999999999999999999999999999999999997432110


Q ss_pred             -------C------------------------CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 035861          169 -------S------------------------PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL  217 (332)
Q Consensus       169 -------~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p  217 (332)
                             .                        +........+++.|.+||...+ ......+|.|++|+++++.++|..|
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCC
Confidence                   0                        0011223467889999999887 6788899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCC
Q 035861          218 FSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR  297 (332)
Q Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  297 (332)
                      |.........+.+.+.....     +.                             .....+.++++++..++..+|.+|
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~-----p~-----------------------------g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPW-----PE-----------------------------GPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred             CCCcchhhhhhccccCCCCC-----CC-----------------------------CccccChhhhhhhhhhhccCchhc
Confidence            99988777665554321111     10                             112268889999999999999999


Q ss_pred             CCHH---HHhcCCCCCCCCCCCCCCCCCCCCCccc
Q 035861          298 ITVD---DALNHYWFHEVPLPKSKDFMPTFPPQHA  329 (332)
Q Consensus       298 ps~~---ell~hp~f~~~~~~~~~~~~~~~~~~~~  329 (332)
                      ..+.   ++-.|+||+...|.........|-|+..
T Consensus      1081 ~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1081 LGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred             cCcccccccccCCccCCCCccccccccCccCCCCC
Confidence            9888   9999999999999988777777777654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.51  E-value=1e-13  Score=106.16  Aligned_cols=150  Identities=24%  Similarity=0.241  Sum_probs=111.2

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      .+..+-+|+.+.|+++.+.  |+.++||.-..+.........+-...+-.+|++.+.++.--.|..-.-++++. ..-.|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-YGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-CCCeE
Confidence            6778899999999999887  88888887666555444444444445667899999888655554433334333 44579


Q ss_pred             Ecccccc--cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---cEEEeeccccccc
Q 035861           95 VMEYMEH--DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQY  167 (332)
Q Consensus        95 v~e~~~~--~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---~~~l~df~~~~~~  167 (332)
                      +||+++|  ++.+.+...- ..........++.+|-+.+.-||.++|+||||..+||++..++   .+.++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999999  5555555433 3334444478999999999999999999999999999998766   4689999988653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.2e-13  Score=106.18  Aligned_cols=140  Identities=24%  Similarity=0.213  Sum_probs=98.6

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEc
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      ..+++|+-+.+|.+.+.  |.++++|.=..+........+.-....-.+|+.++.++.--.+..-.-+.++. ....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-DNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCEEEE
Confidence            45789999999999875  65677776555444443333322233456899999888654443322222233 5567999


Q ss_pred             ccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           97 EYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        97 e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ||++|.++.......   .    ..++..+-..+.-||..||+||||.++||++...+ +.++|||++...
T Consensus        79 e~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          79 EYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999998877554433   2    44666666777789999999999999999999854 999999998754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=3.3e-14  Score=117.88  Aligned_cols=209  Identities=19%  Similarity=0.212  Sum_probs=142.5

Q ss_pred             HHHhhCCCCCeeeeeeeEEc----CCCeEEEEccccccc-H---HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 035861           68 NILLSFDHPSIVNVKEVVMD----DHDSVYMVMEYMEHD-L---KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--  137 (332)
Q Consensus        68 ~~l~~l~h~~i~~~~~~~~~----~~~~~~lv~e~~~~~-l---~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--  137 (332)
                      ..+-++-|.||++++.++.+    +.....++.||+..+ +   +.....+...+......+|+.||+.||.|||+..  
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            33445579999999999843    224578899999853 3   3333445677999999999999999999999886  


Q ss_pred             cccccCCCCCEEEcCCCcEEEeecccccccCC----CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh
Q 035861          138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS----PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA  213 (332)
Q Consensus       138 i~H~di~p~Nili~~~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt  213 (332)
                      |+||++.-+.|++..+|-+|++--........    .........+.+.|.+||.=.. ...+-++|||++|+...+|.-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHH
Confidence            99999999999999999888864322211100    0001112234567889986544 456789999999999999988


Q ss_pred             CCCCCCCCChH-HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCC
Q 035861          214 KKPLFSGTTEV-DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY  292 (332)
Q Consensus       214 g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  292 (332)
                      +..-....... ..-..+.+..-        ++                                -...-++++.+|++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~--------~l--------------------------------en~lqr~~i~kcl~~  317 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVII--------GL--------------------------------ENGLQRGSITKCLEG  317 (458)
T ss_pred             heeccCCCcceeehhhhhhhhee--------ec--------------------------------cCccccCcCcccccC
Confidence            77654332111 11111111000        00                                011123789999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          293 DPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       293 dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      .|..||++.+++.||-+-++++...
T Consensus       318 eP~~rp~ar~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  318 EPNGRPDARLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             CCCCCcchhhhhcCceeeecchHHH
Confidence            9999999999999999888775544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=2e-13  Score=123.34  Aligned_cols=149  Identities=19%  Similarity=0.215  Sum_probs=98.3

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc----------------c----------------ccCCCcch
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC----------------L----------------EYGFPISS   63 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~----------------~----------------~~~~~~~~   63 (332)
                      .+.||.|++|+||+|+.. +|+.||||+.+......-..                .                ....+.++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999875 68999999986543111000                0                00001134


Q ss_pred             hHHHHHHhhC----CCCCeeeeeeeEEcCCCeEEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 035861           64 LREINILLSF----DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLE-GVKYLHDNW  137 (332)
Q Consensus        64 ~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~-~L~~lh~~~  137 (332)
                      ..|+..+.++    .+.+-+.+..++.+-....++||||++|..+...... ....   ....++..++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            4566655555    2333344444443333456899999998654433321 1122   23456666665 467899999


Q ss_pred             cccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861          138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus       138 i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ++|+|++|.||+++.++.++++|||.+...+
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=3.1e-14  Score=127.18  Aligned_cols=257  Identities=21%  Similarity=0.236  Sum_probs=185.1

Q ss_pred             cccchhcccccccccccCcEEEEEEEEC-CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDK-KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      ..+...+|..+..||.|.|+.|+..... .++..|++|-............      .-+.|+.+...+ .|.+.+.+..
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di------~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI------FSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh------cchhhhhHhhHhhcccccCCCCC
Confidence            3456679999999999999999998766 6778899988765443322111      124566666655 5888888888


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeecc
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFG  162 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df~  162 (332)
                      .+.+. ...|+=.|+|+|............+++...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++||+
T Consensus       334 ~W~~~-r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  334 SWSQL-RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             Ccccc-ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence            77555 5566999999876655555545668999999999999999999999999999999999999987 788999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ..+....  ........+..|-..|.+.....+..+.|++|||+-+.+.+++...-.....+..+.              
T Consensus       413 ~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~--------------  476 (524)
T KOG0601|consen  413 CWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR--------------  476 (524)
T ss_pred             cccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee--------------
Confidence            8864321  111122223333135666665788999999999999999998876654443322111              


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                .......+.....+..+.+.++..++..||++.++..|.=|-.
T Consensus       477 --------------------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  477 --------------------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             --------------------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                                      0111112224466778889999999999999999998876644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.2e-13  Score=107.93  Aligned_cols=129  Identities=16%  Similarity=0.108  Sum_probs=93.0

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEE
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      ++.++.|..+.||++...  +..+++|+........         .....|+..++.+...++++-.-.+..  ...++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~---------~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv   69 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELL---------INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLI   69 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccc---------cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEE
Confidence            467899999999999876  7789999875442110         123578888888865554443323322  234799


Q ss_pred             cccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           96 MEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV-----LHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        96 ~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i-----~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ||+++|..+...        ......+..+++.+|+.||+.++     +|||++|.||+++ ++.++++||+.+..
T Consensus        70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999999653321        11123456899999999999885     9999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=9.2e-14  Score=127.03  Aligned_cols=152  Identities=18%  Similarity=0.171  Sum_probs=98.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCc--------------------c------------cccc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRK--------------------E------------DCLE   56 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------~------------~~~~   56 (332)
                      .+.+|+. +.||+|++|+||+|+.+.+|+.||||+.+......                    .            ....
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 89999999999999998889999999998542110                    0            0000


Q ss_pred             cCCCcchhHHHHHHhhCC----CCCeeeeeeeEEcCCCeEEEEcccccccHHHHHHh-cCCC-----CCHHHHHHHHHHH
Q 035861           57 YGFPISSLREINILLSFD----HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMES-MKQP-----FSTSEVKCLMLQL  126 (332)
Q Consensus        57 ~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~-----l~~~~~~~i~~~l  126 (332)
                      ...+.++..|+..+.++.    +...+.+..++.+-....++||||+.|..+..+.. ....     +.+..+..++.| 
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-  275 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-  275 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence            001123445555555552    44444555555333345689999999865443321 1122     233333333344 


Q ss_pred             HHHHHHHHHCCcccccCCCCCEEEcCCC----cEEEeecccccccC
Q 035861          127 LEGVKYLHDNWVLHRDLKTSNLLLNNQG----VLKICDFGMSRQYG  168 (332)
Q Consensus       127 ~~~L~~lh~~~i~H~di~p~Nili~~~~----~~~l~df~~~~~~~  168 (332)
                            +...|++|+|++|.||+++.+|    +++++|||.+...+
T Consensus       276 ------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 ------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  4469999999999999999988    99999999987653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.45  E-value=5.8e-12  Score=110.86  Aligned_cols=213  Identities=15%  Similarity=0.175  Sum_probs=155.7

Q ss_pred             CcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---CCCeEEEEcccc
Q 035861           23 TYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---DHDSVYMVMEYM   99 (332)
Q Consensus        23 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~lv~e~~   99 (332)
                      -..+.|++..+.+|..|++|.+...+....        .....-++.++++.|+|++++.+++..   ++..+++|++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc--------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            346799999999999999999943322111        122356888999999999999999853   346789999999


Q ss_pred             cc--cHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861          100 EH--DLKWLMESM--------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus       100 ~~--~l~~~~~~~--------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ++  +|.+.....              +...+|..+|.++.||..||.++|+.|++..-|.+.+|+++++.+++|+..|.
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence            86  455544321              23478899999999999999999999999999999999999999999998887


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHH-HHHHHHHcCCCCCCc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEVDQ-IDKIFKTLGTPTETI  241 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~-~~~~~~-~~~~~~~~~~~~~~~  241 (332)
                      ........            .  |-+..    -.+.|.=.||.++..+.||..--.. ...... ...+...        
T Consensus       440 ~Dvl~~d~------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~--------  493 (655)
T KOG3741|consen  440 MDVLQEDP------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTT--------  493 (655)
T ss_pred             eeeecCCC------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhh--------
Confidence            76654321            0  11222    3467999999999999999643211 111111 2222221        


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                          ++.+++++|.-+....+++ -++.+++.+
T Consensus       494 ------------------------------------yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  494 ------------------------------------YSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------------------------------hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                                                7888888999888888877 677777765

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=3.9e-13  Score=122.01  Aligned_cols=157  Identities=24%  Similarity=0.337  Sum_probs=114.5

Q ss_pred             HHHHHHH-HCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC----c-----cccccccccchhhhcCCCCCCc
Q 035861          128 EGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----T-----SLVVTLWYRAPELLLGAKKYST  197 (332)
Q Consensus       128 ~~L~~lh-~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~----~-----~~~~~~~y~aPE~~~~~~~~~~  197 (332)
                      .|+.++| +.+++|++|.|++|.++..+.+|++.|+++.....+....    .     .......|.|||.+.. ...+.
T Consensus       110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~~~  188 (700)
T KOG2137|consen  110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTNTP  188 (700)
T ss_pred             chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccccc
Confidence            8999999 4589999999999999999999999999887654322211    1     1122456999999987 77899


Q ss_pred             hhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCC
Q 035861          198 AVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSP  276 (332)
Q Consensus       198 ~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ++|+||+|+++|.+.. |..-+...+....+......                                 .......-+.
T Consensus       189 ~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---------------------------------~~~~~~~~s~  235 (700)
T KOG2137|consen  189 ASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---------------------------------LNAGAFGYSN  235 (700)
T ss_pred             cccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---------------------------------cccccccccc
Confidence            9999999999999984 55444444332222211110                                 0011111124


Q ss_pred             CCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          277 VLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       277 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      .+++++++=+.+++..++.-||++.+++..|||.+......+
T Consensus       236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKALR  277 (700)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhhh
Confidence            589999999999999999999999999999999997655443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.35  E-value=6.6e-11  Score=101.95  Aligned_cols=256  Identities=13%  Similarity=0.079  Sum_probs=159.5

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee-----EE-
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV-----VM-   86 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-----~~-   86 (332)
                      .....||+|+.+.+|-.-.   -...+.|++........           .+....|... .||-+..-+.+     +. 
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~-----------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~   79 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQ-----------AQKVAELAATPDAPLLNYRVAWPQATLHGG   79 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCchHH-----------HHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence            4567799999999997633   23356788765443221           1233333333 45533221111     11 


Q ss_pred             cCCCeEEEEccccccc--HHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           87 DDHDSVYMVMEYMEHD--LKWLMES-----MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~--l~~~~~~-----~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                      .......+.|..+.|-  .......     .-....+..+.++++.|+.+-+.||..|.+-||++++|+||++++.|.|.
T Consensus        80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence            1223378889998873  2222211     12347899999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHc
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~  234 (332)
                      |=.+-... .+.....+..|...|.+||...-    +..-+..+|.|.||+++++++.| ++||.+-....       ..
T Consensus       160 dsDsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~a  231 (637)
T COG4248         160 DSDSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DA  231 (637)
T ss_pred             cccceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CC
Confidence            86544333 44555667788899999998652    13346689999999999999886 99997632110       00


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhh--hhhhCCCCccCCCCCCCchHHHHHHHhcCCC--CCCCCCHHH
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNL--LRKRFPAASFTGSPVLSESGFDLLNRLLTYD--PEKRITVDD  302 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d--p~~Rps~~e  302 (332)
                      +.+.+..+           ......+..  .....+....-+...+++.+..|+.+|+..-  +.-||+++.
T Consensus       232 p~p~E~~I-----------a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         232 PNPLETDI-----------AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             CCcchhhh-----------hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            00000000           000000111  1111222233334557889999999999763  568998764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.19  E-value=1.9e-10  Score=91.35  Aligned_cols=134  Identities=25%  Similarity=0.282  Sum_probs=82.3

Q ss_pred             EEEEEEECCCCcEEEEEEeecccCCcccc------------------cccCCCcchhHHHHHHhhCCCCC--eeeeeeeE
Q 035861           26 IVYRARDKKSGEIVALKKVKMNVGRKEDC------------------LEYGFPISSLREINILLSFDHPS--IVNVKEVV   85 (332)
Q Consensus        26 ~v~~~~~~~~~~~v~iK~~~~~~~~~~~~------------------~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~   85 (332)
                      .||.|... ++..+|||+.+.....-...                  ..........+|.+.|.++...+  +...+.+ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            48888874 57799999997643211110                  00001123457999999997664  3444433 


Q ss_pred             EcCCCeEEEEccccc--ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           86 MDDHDSVYMVMEYME--HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY-LHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~-lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                       ..   .+|||||++  |..+..+...  .++......++.+++..+.. +|+.|++|||+++.||+++.+ .+.++|||
T Consensus        79 -~~---~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   79 -NR---NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             -ET---TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             -eC---CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence             22   269999999  7543333331  22255667788888885555 679999999999999999987 99999999


Q ss_pred             cccccC
Q 035861          163 MSRQYG  168 (332)
Q Consensus       163 ~~~~~~  168 (332)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=1.7e-10  Score=95.47  Aligned_cols=142  Identities=18%  Similarity=0.247  Sum_probs=100.0

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC--eeeeeeeEEcCC--Ce
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS--IVNVKEVVMDDH--DS   91 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~--~~   91 (332)
                      .+.|+.|..+.||++.... |+.+++|.........       ....+..|+..+..+.+.+  +..++.......  +.
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~-------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~   74 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLP-------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGT   74 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCc-------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCC
Confidence            3568999999999998753 5789999986543210       1124568999999886533  455555542221  25


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD------------------------------------  135 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~------------------------------------  135 (332)
                      .++|||+++|..+..... ...+++.....++.+++.+|+.||+                                    
T Consensus        75 ~~~v~e~i~G~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          75 PFYVMERVDGRVLRDRLL-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             ceEEEEEeCCEecCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            689999999865333221 1356777777777777777777773                                    


Q ss_pred             --------------------CCcccccCCCCCEEEcC--CCcEEEeecccccc
Q 035861          136 --------------------NWVLHRDLKTSNLLLNN--QGVLKICDFGMSRQ  166 (332)
Q Consensus       136 --------------------~~i~H~di~p~Nili~~--~~~~~l~df~~~~~  166 (332)
                                          ..++|||+++.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                23689999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=6.6e-10  Score=93.62  Aligned_cols=146  Identities=14%  Similarity=0.043  Sum_probs=93.2

Q ss_pred             ccccCcEEEEEEEECCCCcEEEEEEeecccCC---cccccccCCCcchhHHHHHHhhCCCCCee--eeeeeEEcC----C
Q 035861           19 ISEGTYGIVYRARDKKSGEIVALKKVKMNVGR---KEDCLEYGFPISSLREINILLSFDHPSIV--NVKEVVMDD----H   89 (332)
Q Consensus        19 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~~~~~~~e~~~l~~l~h~~i~--~~~~~~~~~----~   89 (332)
                      +.......|+++...  |+.|.||........   +.......-.....+|...+.+|...+|.  ...++....    .
T Consensus        30 v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         30 FRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333333446666554  778999977433211   00000000111355787777777433332  222222111    2


Q ss_pred             CeEEEEccccccc--HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-------CCcEEEe
Q 035861           90 DSVYMVMEYMEHD--LKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-------QGVLKIC  159 (332)
Q Consensus        90 ~~~~lv~e~~~~~--l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-------~~~~~l~  159 (332)
                      ...++|+|+++|.  +.+.+... ..+.+......++.+++..++.||..|++|+|+++.|||++.       ++.+.|+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            3578999999984  44444321 345677788899999999999999999999999999999985       4689999


Q ss_pred             ecccccc
Q 035861          160 DFGMSRQ  166 (332)
Q Consensus       160 df~~~~~  166 (332)
                      ||+.+..
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9998854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.16  E-value=1.9e-10  Score=94.08  Aligned_cols=145  Identities=21%  Similarity=0.214  Sum_probs=101.7

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc--------cc------cCCCcchhHHHHHHhhCCCC--
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC--------LE------YGFPISSLREINILLSFDHP--   76 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~--------~~------~~~~~~~~~e~~~l~~l~h~--   76 (332)
                      +.+...||-|--|.||.|... .|.++|||.-+....+-...        ..      .-......+|.+.|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346788999999999999986 68899999876432211100        00      00112345788888888543  


Q ss_pred             CeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcE
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVL  156 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~  156 (332)
                      .+..-++     .+...+|||+++|..+..     -+++.+....++..|+.-+..+-..|++|||+++-||+++++|.+
T Consensus       172 ~VP~P~~-----~nRHaVvMe~ieG~eL~~-----~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIA-----WNRHAVVMEYIEGVELYR-----LRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCccc-----cccceeeeehcccceeec-----ccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            3333322     245679999999954222     122456666777788887888889999999999999999999999


Q ss_pred             EEeecccccccC
Q 035861          157 KICDFGMSRQYG  168 (332)
Q Consensus       157 ~l~df~~~~~~~  168 (332)
                      .++||.-+...+
T Consensus       242 ~vIDwPQ~v~~~  253 (304)
T COG0478         242 VVIDWPQAVPIS  253 (304)
T ss_pred             EEEeCcccccCC
Confidence            999999876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=4.5e-09  Score=85.69  Aligned_cols=106  Identities=19%  Similarity=0.167  Sum_probs=77.0

Q ss_pred             chhHHHHHHhhCCCCCe--eeeeeeEEc---CCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 035861           62 SSLREINILLSFDHPSI--VNVKEVVMD---DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD  135 (332)
Q Consensus        62 ~~~~e~~~l~~l~h~~i--~~~~~~~~~---~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~  135 (332)
                      ...+|...+..|...+|  ...+++...   .....++|+|+++|. .+..+.......+......++.+++..++-||+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            45577777666643222  233333322   113468999999983 344444333347888889999999999999999


Q ss_pred             CCcccccCCCCCEEEcCCC---cEEEeeccccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQY  167 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~---~~~l~df~~~~~~  167 (332)
                      .|++|+|+++.|||++.++   .+.++||+.+...
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999987   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.03  E-value=5.8e-09  Score=83.47  Aligned_cols=143  Identities=12%  Similarity=0.118  Sum_probs=98.6

Q ss_pred             cccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe--eeee-eeEEc--CCCeEEE
Q 035861           20 SEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI--VNVK-EVVMD--DHDSVYM   94 (332)
Q Consensus        20 g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-~~~~~--~~~~~~l   94 (332)
                      |+||-|.|++....  |..+-+|.-.......-..  ..-...+.+|...+.++...++  .... +-...  ..-..+|
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~--P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L  102 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRY--PFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL  102 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccC--CCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence            56899999998765  4467788764222111110  1133467899999988853332  2222 11111  1234689


Q ss_pred             Ecccccc--cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc--EEEeecccccc
Q 035861           95 VMEYMEH--DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQ  166 (332)
Q Consensus        95 v~e~~~~--~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~--~~l~df~~~~~  166 (332)
                      |+|-++|  ++.+.+... -.+.++.....+..+++.+++-||+.|+.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9999986  555544332 235678888999999999999999999999999999999987777  99999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.84  E-value=2.1e-08  Score=80.53  Aligned_cols=145  Identities=20%  Similarity=0.161  Sum_probs=86.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCC-cchhHHHHHHhhC---CCCCeeeeeeeEE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP-ISSLREINILLSF---DHPSIVNVKEVVM   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~-~~~~~e~~~l~~l---~h~~i~~~~~~~~   86 (332)
                      ++|.+++.+-......|.+..-.  |+.+++|..+......+.....-+. ....+.+..+.++   .......++.+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46777777777777777766554  7889999887654332221110000 0112233323223   2333333222221


Q ss_pred             ----cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           87 ----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        87 ----~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                          .-....+++|||++|.-+....    .+++    .+...+.+++.-||+.|++|||.+|.|++++.+ .++++|++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~  179 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ  179 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence                1123466899999995432221    1233    245667788999999999999999999999965 59999998


Q ss_pred             cccc
Q 035861          163 MSRQ  166 (332)
Q Consensus       163 ~~~~  166 (332)
                      ....
T Consensus       180 ~k~~  183 (229)
T PF06176_consen  180 GKRM  183 (229)
T ss_pred             cccc
Confidence            6543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.80  E-value=2e-08  Score=81.55  Aligned_cols=145  Identities=20%  Similarity=0.163  Sum_probs=93.3

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc----------c------ccCCCcchhHHHHHHhhCCCCC--e
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC----------L------EYGFPISSLREINILLSFDHPS--I   78 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~----------~------~~~~~~~~~~e~~~l~~l~h~~--i   78 (332)
                      ..|++|-.+.||+|.. .++..+|+|++......-...          .      ...+......|...|+++...+  +
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3678888889999876 457889999997644322110          0      0001111235666666653332  2


Q ss_pred             eeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEE
Q 035861           79 VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        79 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~  157 (332)
                      ..-+.+.     .-.+|||+++....-.=.-.+-++...++..+..++++.+.-|-. .|++||||+..|||+. ++.+.
T Consensus       133 P~Pi~~~-----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFR-----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeec-----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            2222222     236999999864100000012234444788888999999999887 8999999999999999 78999


Q ss_pred             EeecccccccC
Q 035861          158 ICDFGMSRQYG  168 (332)
Q Consensus       158 l~df~~~~~~~  168 (332)
                      ++||+.+...+
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999887654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.67  E-value=8e-08  Score=87.85  Aligned_cols=149  Identities=19%  Similarity=0.230  Sum_probs=94.1

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc--------------------------------cccCCCcchh
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC--------------------------------LEYGFPISSL   64 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~--------------------------------~~~~~~~~~~   64 (332)
                      ..|+.++-|+||+|+... |+.||||+.+......-..                                .....+.++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578999999999999975 9999999986532211000                                0000112234


Q ss_pred             HHHHHHhhCC----CCCeeeeeeeEEcCCCeEEEEcccccccHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 035861           65 REINILLSFD----HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVL  139 (332)
Q Consensus        65 ~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~  139 (332)
                      .|+..+.+++    ...-+.+-.++.+-.....++|||++|.-.+.+. .....++...+.....++.  +..+-..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            5555554442    2333444455544334568999999994333332 2224456444444333322  3344568999


Q ss_pred             cccCCCCCEEEcCCCcEEEeecccccccC
Q 035861          140 HRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus       140 H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      |+|.+|.||+++.+|++.+.|||.....+
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCC
Confidence            99999999999999999999999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=2.3e-07  Score=76.66  Aligned_cols=134  Identities=16%  Similarity=0.161  Sum_probs=78.1

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe--eeeeeeEEcCCCeEEE
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI--VNVKEVVMDDHDSVYM   94 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~~l   94 (332)
                      ..||+|..+.||+.    .+..+++|........          ..+.+|.+.++.+..-++  ...+.+. +.....++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~----------~~i~~E~~~l~~l~~~glpvP~~~~~~-~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDK----------ETIKREFDASRKVFSLGIPTPHPFDLV-EDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCH----------HHHHHHHHHHHHHHHcCCCCCceEEEE-ecCCeeee
Confidence            56899999999984    2456888988643211          134688888888754333  4445544 44466789


Q ss_pred             EcccccccH-HH---------------HHHh----cC----CCCCHHHH-HHHHH----------HHHHH-HHHHH----
Q 035861           95 VMEYMEHDL-KW---------------LMES----MK----QPFSTSEV-KCLML----------QLLEG-VKYLH----  134 (332)
Q Consensus        95 v~e~~~~~l-~~---------------~~~~----~~----~~l~~~~~-~~i~~----------~l~~~-L~~lh----  134 (332)
                      |||+++|.. ..               .+..    -+    ...+.... ..+..          .+... ..+|.    
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999999841 11               0000    00    01111110 01100          01111 11222    


Q ss_pred             HCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       135 ~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ...++|||+.|.||++++++ +.++||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            12368999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=8e-07  Score=68.48  Aligned_cols=132  Identities=23%  Similarity=0.261  Sum_probs=93.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      ..++.+.|+.|.+|.||++.+.  |..+|+|+-+.++...          .+..|++++..+.-.++.+-...+..+   
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~----------~l~kEakiLeil~g~~~~p~vy~yg~~---   87 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRR----------NLEKEAKILEILAGEGVTPEVYFYGED---   87 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchh----------hHHHHHHHHHHhhhcCCCceEEEechh---
Confidence            4467788999999999999998  7789999887655433          456899999988877776655555233   


Q ss_pred             EEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC-CCCEEEcCCCcEEEeeccccccc
Q 035861           92 VYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLK-TSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~-p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       .+.|||+.| .+.+.....    +...    ...++++---|-..||-|+.|+ |..+++.+++.+.|+||..|+.-
T Consensus        88 -~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          88 -FIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             -hhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence             466999999 443332211    2233    3344455444778899999986 56666666679999999999843

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=4.1e-07  Score=75.75  Aligned_cols=139  Identities=21%  Similarity=0.258  Sum_probs=75.5

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC--eeeeeeeEE--cCCCe
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS--IVNVKEVVM--DDHDS   91 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~--~~~~~   91 (332)
                      ++.++.|..+.||++....  ..+++|......  ..        ..+..|..+++.+....  +..++....  .....
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~--~~--------~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPD--AA--------ERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHH--HH--------HHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCC--CH--------HHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            4678999999999999874  589999976541  00        13457777777774332  334444221  22245


Q ss_pred             EEEEcccccccHHHH--------------------HHhcC---CCCCHHH---------HHHH------------HHHHH
Q 035861           92 VYMVMEYMEHDLKWL--------------------MESMK---QPFSTSE---------VKCL------------MLQLL  127 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~--------------------~~~~~---~~l~~~~---------~~~i------------~~~l~  127 (332)
                      .+++|++++|.....                    +....   ..+....         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            789999998843222                    01110   1111000         0000            11122


Q ss_pred             H-HHHHHHH-------CCcccccCCCCCEEEc-CCCcEEEeecccccc
Q 035861          128 E-GVKYLHD-------NWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQ  166 (332)
Q Consensus       128 ~-~L~~lh~-------~~i~H~di~p~Nili~-~~~~~~l~df~~~~~  166 (332)
                      . .+..+++       ..++|||+.|.||+++ +++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2 3333332       3589999999999999 667778999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=7.3e-08  Score=87.62  Aligned_cols=245  Identities=17%  Similarity=0.127  Sum_probs=159.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC-eeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS-IVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~   90 (332)
                      -|.....+++++++++++.+...+...+ .+.+...             ....-++++|.+++||| .+..++.+ +.+.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~  307 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDY-DGED  307 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------------hhhHHHHHHHHHccCCCCcccccccC-Cccc
Confidence            4667778899999999999887655544 5555432             13357899999999999 55555555 4557


Q ss_pred             eEEEEccccccc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           91 SVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        91 ~~~lv~e~~~~~--l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ..++.++++.++  ....+....-.+...+...+.+.-+.+|+++|+.--+|+|    ||+... +..+..+|+....++
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence            788999999875  2221111122344445556667777899999988778887    666655 788999999887764


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .. .......+++.++|||+... ..+....|.|++|.---++.-|.+|-....               ......+... 
T Consensus       383 ~~-~~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~---------------~~~~~~g~~p-  444 (829)
T KOG0576|consen  383 RT-MKPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP---------------AVLPMIGNGP-  444 (829)
T ss_pred             cc-cccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCc---------------cccCCCCCCC-
Confidence            33 24566788999999998876 678888999999986666666666654411               0000000000 


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHH-HHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF-DLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                       +                  ...+......++... ++...|+...|..|+....++-|.+|..-+
T Consensus       445 -~------------------s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  445 -N------------------SPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             -C------------------ccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence             0                  000000000011111 467788888999999999998888887644

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=2.1e-06  Score=78.42  Aligned_cols=146  Identities=21%  Similarity=0.196  Sum_probs=91.8

Q ss_pred             ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcc-----------------------------cccccCCCcchhHHH
Q 035861           17 NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKE-----------------------------DCLEYGFPISSLREI   67 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----------------------------~~~~~~~~~~~~~e~   67 (332)
                      +.||.-+.|+||+|+.+. |+.||||+-+......-                             .....-.+.++..|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999976 99999999755322110                             000011122344555


Q ss_pred             HHHhhC----CCCC---eeeeeeeEEcCCCeEEEEccccccc---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHC
Q 035861           68 NILLSF----DHPS---IVNVKEVVMDDHDSVYMVMEYMEHD---LKWLMESMKQPFSTSEVKCLMLQLLEGVKY-LHDN  136 (332)
Q Consensus        68 ~~l~~l----~h~~---i~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~-lh~~  136 (332)
                      +...++    .|-+   -+.+-.++.+-.....++|||++|.   -++.+.+  ..++...+   +..+.++... +-..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i---~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDI---LNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHH---HHHHHHHHHHHHHhc
Confidence            444333    3444   2224444433334578999999983   2344443  34666544   3444443333 4468


Q ss_pred             CcccccCCCCCEEEcC----CCcEEEeecccccccC
Q 035861          137 WVLHRDLKTSNLLLNN----QGVLKICDFGMSRQYG  168 (332)
Q Consensus       137 ~i~H~di~p~Nili~~----~~~~~l~df~~~~~~~  168 (332)
                      |++|+|-+|.||+++.    ++.+.+-|||+.....
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            8999999999999994    5689999999987654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.34  E-value=4.2e-06  Score=81.39  Aligned_cols=202  Identities=20%  Similarity=0.211  Sum_probs=134.0

Q ss_pred             HHHHHHhhCCCCCeeeeeeeEEcCCCe---EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 035861           65 REINILLSFDHPSIVNVKEVVMDDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHR  141 (332)
Q Consensus        65 ~e~~~l~~l~h~~i~~~~~~~~~~~~~---~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~  141 (332)
                      .|.+.+....|+|+..++.+..+....   ..+..+++.+..+......-+.++....+.+..++..+|+++|+....|.
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v  310 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHV  310 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcccee
Confidence            466777778999999999888665221   12334556554333344446778999999999999999999999866665


Q ss_pred             cCCCC---CEEEcCCCcEEEe--ecccccccCCCCCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCC
Q 035861          142 DLKTS---NLLLNNQGVLKIC--DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKK  215 (332)
Q Consensus       142 di~p~---Nili~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~  215 (332)
                      -+...   +.-++..+.+..+  ||+.+........ ......+..+.++|..... .......|+|++|.+...+..|.
T Consensus       311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~  389 (1351)
T KOG1035|consen  311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE  389 (1351)
T ss_pred             EEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence            55554   4445566667766  8887776543322 2223344557777766541 12233479999999999998877


Q ss_pred             CCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          216 PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                      .+-........   ....                                          . ...+..+++.+|+.-+++
T Consensus       390 ~i~~~~~~~~~---~l~~------------------------------------------~-~~~~~~d~~~~~~~~~~~  423 (1351)
T KOG1035|consen  390 DISEKSAVPVS---LLDV------------------------------------------L-STSELLDALPKCLDEDSE  423 (1351)
T ss_pred             cccccccchhh---hhcc------------------------------------------c-cchhhhhhhhhhcchhhh
Confidence            65433211110   0000                                          0 111567899999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q 035861          296 KRITVDDALNHYWFHEVP  313 (332)
Q Consensus       296 ~Rps~~ell~hp~f~~~~  313 (332)
                      +|+++.+++.|+|.+--.
T Consensus       424 ~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  424 ERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hccchhhhhhchhccccc
Confidence            999999999999987543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.32  E-value=6.5e-06  Score=69.09  Aligned_cols=72  Identities=18%  Similarity=0.176  Sum_probs=45.5

Q ss_pred             cccccCc-EEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCCCeEEEE
Q 035861           18 KISEGTY-GIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDHDSVYMV   95 (332)
Q Consensus        18 ~lg~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv   95 (332)
                      .|..|.. +.||++...  +..+++|+.....  .         .....|+..++.+. +--+..++... ...+..++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~---------~~~~~E~~~l~~l~~~~~vP~v~~~~-~~~~~~~lv   70 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--T---------YELEREAERLRWLAGKLPVPEVIDYG-SDDGRAWLL   70 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--c---------cchHHHHHHHHHHHhcCCCCeEEEEE-ecCCccEEE
Confidence            3445555 789999764  4678888875432  0         13457888887773 33344555544 333567899


Q ss_pred             cccccccH
Q 035861           96 MEYMEHDL  103 (332)
Q Consensus        96 ~e~~~~~l  103 (332)
                      |++++|..
T Consensus        71 ~e~i~G~~   78 (244)
T cd05150          71 TSAVPGVP   78 (244)
T ss_pred             EEeeCCcc
Confidence            99999854

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.22  E-value=2.5e-05  Score=62.26  Aligned_cols=134  Identities=22%  Similarity=0.248  Sum_probs=89.9

Q ss_pred             hcccccccccccCc-EEEEEEEECCCCcEEEEEEeecccCCccc-----ccc--------cCCCcchhHHHHHHhhCC--
Q 035861           11 FEFEKLNKISEGTY-GIVYRARDKKSGEIVALKKVKMNVGRKED-----CLE--------YGFPISSLREINILLSFD--   74 (332)
Q Consensus        11 ~~y~~~~~lg~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-----~~~--------~~~~~~~~~e~~~l~~l~--   74 (332)
                      .+++.++.||.|.- |.||++...  |..||+|++..-......     ...        ......+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            58999999999999 999999987  789999994321111110     000        012235667777777774  


Q ss_pred             -CCCe--eeeeeeEEcC-----------------CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 035861           75 -HPSI--VNVKEVVMDD-----------------HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH  134 (332)
Q Consensus        75 -h~~i--~~~~~~~~~~-----------------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh  134 (332)
                       +.++  ++++|+..-+                 ...+.||.|++....         .+...    -+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence             4455  8888887322                 112456777665532         23333    3456666677899


Q ss_pred             HCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861          135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus       135 ~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      +.||+-+|+++.|..     .=+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999998     3368899865

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.11  E-value=1.4e-05  Score=67.53  Aligned_cols=135  Identities=21%  Similarity=0.288  Sum_probs=74.7

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEcc
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVME   97 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e   97 (332)
                      .+..|-.+.+|+...  ++..+++|...........        ....|..+++.+...++.+-.-.. ..   -++|+|
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~--------~r~~E~~~l~~l~~~g~~P~~i~~-~~---~~~v~e   68 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGV--------DRQREYQILQALSALGLAPKPILV-NE---HWLLVE   68 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccC--------cHHHHHHHHHHHHhcCCCCceEEE-eC---CEEEEE
Confidence            456788889998874  3668889876432211100        124788888888544443322222 12   268999


Q ss_pred             cccccHHHH-----------H----H---hcC---CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCc
Q 035861           98 YMEHDLKWL-----------M----E---SMK---QPFSTS-EVKCLMLQL---------LEGVKYLHD--------NWV  138 (332)
Q Consensus        98 ~~~~~l~~~-----------~----~---~~~---~~l~~~-~~~~i~~~l---------~~~L~~lh~--------~~i  138 (332)
                      |++|.....           +    .   ...   .+++.. .+..+..++         ...+..+-.        ..+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            998843210           1    0   001   112211 111211111         112222222        248


Q ss_pred             ccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861          139 LHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus       139 ~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +|+|+.|.||++++++ +.|+||..+...
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            9999999999999877 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=2.3e-05  Score=65.42  Aligned_cols=30  Identities=30%  Similarity=0.437  Sum_probs=25.6

Q ss_pred             CcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      +++|||+.+.||++++++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999999765567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.08  E-value=3.1e-05  Score=76.30  Aligned_cols=81  Identities=19%  Similarity=0.276  Sum_probs=51.8

Q ss_pred             ccccccccCcEEEEEEEECCCC--cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCe--eeeeeeEEcC-
Q 035861           15 KLNKISEGTYGIVYRARDKKSG--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSI--VNVKEVVMDD-   88 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~-   88 (332)
                      .++.++.|.++.+|+......+  ..+++|+.........       ...+.+|..+++.+. |.++  ..++.++.+. 
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~  114 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS  114 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence            3567889999999998765322  4677877643321111       013568999998884 6654  5555555222 


Q ss_pred             -CCeEEEEccccccc
Q 035861           89 -HDSVYMVMEYMEHD  102 (332)
Q Consensus        89 -~~~~~lv~e~~~~~  102 (332)
                       .+..|+|||+++|.
T Consensus       115 v~G~~flVME~v~G~  129 (822)
T PLN02876        115 VIGTAFYIMEYLEGR  129 (822)
T ss_pred             cCCCceEEEEecCCc
Confidence             14578999999884

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.07  E-value=4.8e-05  Score=63.44  Aligned_cols=73  Identities=10%  Similarity=0.213  Sum_probs=44.7

Q ss_pred             cccccccCcEEEEEEEECC-CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee-eeeeEEcCCCeEE
Q 035861           16 LNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN-VKEVVMDDHDSVY   93 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~   93 (332)
                      ++.|..|-.+.+|++.... .++.|++|+.......   ..      .-..|+.++..+...++.+ ++... ++    .
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~------d~~~E~~~~~~l~~~gl~P~v~~~~-~~----~   68 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---II------DRERELRIHKLLSKHGLAPKLYATF-QN----G   68 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---ee------cHHHHHHHHHHHHhCCCCCeEEEEe-CC----c
Confidence            4567888889999997543 3567999976532211   11      1236888888775444433 33322 22    3


Q ss_pred             EEccccccc
Q 035861           94 MVMEYMEHD  102 (332)
Q Consensus        94 lv~e~~~~~  102 (332)
                      +++||++|.
T Consensus        69 ~l~e~i~G~   77 (235)
T cd05157          69 LIYEFIPGR   77 (235)
T ss_pred             EEEEeeCCC
Confidence            799999873

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.05  E-value=9.4e-05  Score=59.46  Aligned_cols=140  Identities=17%  Similarity=0.207  Sum_probs=90.5

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccc--------ccccCCCcchhHHHHHHhhCC------CCCeee
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKED--------CLEYGFPISSLREINILLSFD------HPSIVN   80 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~--------~~~~~~~~~~~~e~~~l~~l~------h~~i~~   80 (332)
                      -...||+|+.-.||.--   .+...+||+..........        ...........+|+.....+.      +.+|..
T Consensus         5 ~~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            34579999999998653   3556899999876510000        000111224556776666665      788999


Q ss_pred             eeeeEEcCCCeEEEEccccc---cc---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC
Q 035861           81 VKEVVMDDHDSVYMVMEYME---HD---LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~---~~---l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~  154 (332)
                      ++|...++ .-..+|+|.+.   |.   ++..... .+.+++ ...   ..+-+...+|-+++|+.+|++|.||++..+.
T Consensus        82 ~~G~veT~-~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   82 FYGFVETN-LGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EeEEEecC-CceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            99999555 66788888875   21   2333333 445666 333   3444555678899999999999999997543


Q ss_pred             ----cEEEee-ccc
Q 035861          155 ----VLKICD-FGM  163 (332)
Q Consensus       155 ----~~~l~d-f~~  163 (332)
                          .+.|+| ||.
T Consensus       156 ~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  156 SGEFRLVLIDGLGE  169 (199)
T ss_pred             CCceEEEEEeCCCC
Confidence                578887 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=0.0001  Score=58.90  Aligned_cols=97  Identities=20%  Similarity=0.204  Sum_probs=75.9

Q ss_pred             HHHHHHhhCCC-CCeeeeeeeEEcCCCeEEEEccccccc-HHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 035861           65 REINILLSFDH-PSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWL---MESMKQPFSTSEVKCLMLQLLEGVKYLHD---N  136 (332)
Q Consensus        65 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~lv~e~~~~~-l~~~---~~~~~~~l~~~~~~~i~~~l~~~L~~lh~---~  136 (332)
                      .|.-+++.+++ +++++++|.|    +. +++.|+.+.+ +...   +.. -...++..+.+|+.++++.+.+|+.   .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~-~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GR-FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CC-EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            57778888865 6899999998    22 4688998853 3211   111 1346899999999999999999997   3


Q ss_pred             CcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .+.-.|++++|+-++++|++|++|.......
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            4788999999999999999999999876554

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.93  E-value=6.4e-06  Score=69.76  Aligned_cols=145  Identities=16%  Similarity=0.191  Sum_probs=94.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccc------cC--------CCcchhHHHHHHhhCC-CC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLE------YG--------FPISSLREINILLSFD-HP   76 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~------~~--------~~~~~~~e~~~l~~l~-h~   76 (332)
                      -+.++..||-|--+.+|.+-+. .|.+.++|.-+....+-.....      ..        -..+..+|...|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3678899999999999999874 5888899876543321111000      00        0112346777776663 32


Q ss_pred             CeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcE
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVL  156 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~  156 (332)
                      .=++  ..+  +.+..++|||.+.|-.+..+..      ......+...+...+--|-.+|++|||.+--||+|+.++.+
T Consensus       172 fpVP--kpi--D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVP--KPI--DHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCC--Ccc--cccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            2122  111  2256789999998854332221      11223455666667777889999999999999999999999


Q ss_pred             EEeeccccccc
Q 035861          157 KICDFGMSRQY  167 (332)
Q Consensus       157 ~l~df~~~~~~  167 (332)
                      +++||.-+...
T Consensus       242 ~vIDFPQmvS~  252 (465)
T KOG2268|consen  242 VVIDFPQMVST  252 (465)
T ss_pred             EEeechHhhcc
Confidence            99999876554

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.90  E-value=5.5e-05  Score=65.30  Aligned_cols=150  Identities=25%  Similarity=0.251  Sum_probs=98.7

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCc---ccc--cccC-------------CCcchhHHHHHHhhCCC
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRK---EDC--LEYG-------------FPISSLREINILLSFDH   75 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~--~~~~-------------~~~~~~~e~~~l~~l~h   75 (332)
                      .+-.+|..|--+.||.+... +|..+|||++..+...-   +..  .++.             +......|++-|+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            35577889999999998875 57789999986432210   000  0000             11122357777777765


Q ss_pred             CCeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCCC
Q 035861           76 PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        76 ~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~~  154 (332)
                      ..| ++...+.-  ....|||++++++---.=.-.+..++...+..+-.+++.-+.-|. .++++|.||+--|+|+.. |
T Consensus       226 aGI-P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  226 AGI-PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             cCC-CCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C
Confidence            553 32222211  224699999985321111112556888888888888888888876 678999999999999986 8


Q ss_pred             cEEEeecccccccC
Q 035861          155 VLKICDFGMSRQYG  168 (332)
Q Consensus       155 ~~~l~df~~~~~~~  168 (332)
                      .+.++|.+-+...+
T Consensus       302 ~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  302 KLYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEEccccccCC
Confidence            99999998776553

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.81  E-value=0.00043  Score=61.79  Aligned_cols=82  Identities=21%  Similarity=0.202  Sum_probs=48.9

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--CC-CeeeeeeeEEcCCCeE
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--HP-SIVNVKEVVMDDHDSV   92 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~   92 (332)
                      .+.||.|..+.||++.....++.++||.-........... .........|.+.|+.+.  .| .+..++.+   +....
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~---D~~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHY---DEELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEE---CCCCC
Confidence            4679999999999999864335899998642211100000 000113456778887762  23 34444444   23456


Q ss_pred             EEEcccccc
Q 035861           93 YMVMEYMEH  101 (332)
Q Consensus        93 ~lv~e~~~~  101 (332)
                      ++|||++++
T Consensus       107 ~lVME~L~~  115 (401)
T PRK09550        107 VTVMEDLSD  115 (401)
T ss_pred             EEEEecCCC
Confidence            899999865

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.79  E-value=0.00026  Score=61.61  Aligned_cols=141  Identities=16%  Similarity=0.137  Sum_probs=77.6

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC--eeeeeee-----EE
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS--IVNVKEV-----VM   86 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~   86 (332)
                      ..++.++.|....+|++...  +..+++|+........          .+..|..++..|...+  +..++..     +.
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~----------~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~   92 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAE----------ELPFFLALTTHLAARGLPVPKPVKSRDGRQLS   92 (307)
T ss_pred             eeccccCCccccceEEEEeC--CCcEEEEEecCCCCHH----------HHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence            34667788888899998643  4468889775421111          2235566665553222  2222221     11


Q ss_pred             cCCCeEEEEcccccccH-----HH----------HHHhcCCCCCH-------HHHH----------------HHHHHHHH
Q 035861           87 DDHDSVYMVMEYMEHDL-----KW----------LMESMKQPFST-------SEVK----------------CLMLQLLE  128 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l-----~~----------~~~~~~~~l~~-------~~~~----------------~i~~~l~~  128 (332)
                      ...+..++++++++|..     ..          .+......++.       ...+                .....+..
T Consensus        93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~  172 (307)
T TIGR00938        93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK  172 (307)
T ss_pred             hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence            22355789999988721     00          01110111100       0000                01112333


Q ss_pred             HHHHHHH-------CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          129 GVKYLHD-------NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       129 ~L~~lh~-------~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .++++..       .+++|||+++.||++++++.+.|+||+.+..
T Consensus       173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            4555542       5799999999999999988778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.79  E-value=0.0004  Score=60.81  Aligned_cols=31  Identities=26%  Similarity=0.365  Sum_probs=26.5

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .+++|||+.|.||+++++...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3799999999999999765668999998753

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.77  E-value=0.00016  Score=62.85  Aligned_cols=30  Identities=33%  Similarity=0.435  Sum_probs=26.6

Q ss_pred             CcccccCCCCCEEEcCC----CcEEEeecccccc
Q 035861          137 WVLHRDLKTSNLLLNNQ----GVLKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~----~~~~l~df~~~~~  166 (332)
                      +++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            57999999999999985    8899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.69  E-value=0.0002  Score=61.98  Aligned_cols=139  Identities=14%  Similarity=0.106  Sum_probs=78.3

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC--eeeeeee-----EEc
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS--IVNVKEV-----VMD   87 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~   87 (332)
                      -++.+..|....+|+....  +..+++|+....  ...         .+..|+.++..+...+  +.+.+..     +..
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~--~~~---------~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEKV--SAE---------ELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCCC--ChH---------hccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            3667888888899998654  457899987541  111         2346777776663322  2232221     112


Q ss_pred             CCCeEEEEcccccccHH---------------HHHHhcCCCCC--------HHHHH------------HHHHHHHHHHHH
Q 035861           88 DHDSVYMVMEYMEHDLK---------------WLMESMKQPFS--------TSEVK------------CLMLQLLEGVKY  132 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~---------------~~~~~~~~~l~--------~~~~~------------~i~~~l~~~L~~  132 (332)
                      ..+..++++++++|...               ..+......+.        .....            .....+..++..
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            23456889999987321               00110000000        00000            011112334444


Q ss_pred             HHH-------CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          133 LHD-------NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       133 lh~-------~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      +.+       .+++|||+.|.||++++++.+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            443       4699999999999999987788999997754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.50  E-value=0.00023  Score=64.19  Aligned_cols=173  Identities=20%  Similarity=0.278  Sum_probs=106.0

Q ss_pred             chhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 035861           62 SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHR  141 (332)
Q Consensus        62 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~  141 (332)
                      +++.....++.+.|+|...+..+.-.......+|+|+++-++.+.....+  +-.....                  +|+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~------------------~~~   87 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL------------------AHG   87 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc------------------ccc
Confidence            45677888999999999999988755556688999999999888776643  2111111                  222


Q ss_pred             cCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 035861          142 DLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT  221 (332)
Q Consensus       142 di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~  221 (332)
                       +.+.|++..       +| ..+...                  |      ....+++||||+|.++.++..|...+...
T Consensus        88 -~~~~~~~~~-------td-~~~t~~------------------~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   88 -VLHLNIIYI-------TD-HFLTKY------------------P------SPIGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             -cceehhhhc-------cc-cccccC------------------C------CCCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence             122233322       22 111110                  1      11124999999999999999988777665


Q ss_pred             ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH
Q 035861          222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD  301 (332)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  301 (332)
                      ...+....+.+...-+.....-                 ......    .    -.++....++..+|+-..|..||...
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~-----------------a~e~~~----~----~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLST-----------------AMEHLI----Q----LLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHH-----------------HHHHHH----H----HhhhHhHHHHhccCCccccccccchh
Confidence            5444444443322111110000                 000000    0    01566778999999999999999999


Q ss_pred             HHhcCCCCCCC
Q 035861          302 DALNHYWFHEV  312 (332)
Q Consensus       302 ell~hp~f~~~  312 (332)
                      ++.+++-|...
T Consensus       190 ~~~k~~i~~ev  200 (725)
T KOG1093|consen  190 ELSKRCSFTEV  200 (725)
T ss_pred             HHhcCccHHHH
Confidence            99999888654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.48  E-value=0.0011  Score=57.29  Aligned_cols=32  Identities=16%  Similarity=0.311  Sum_probs=28.6

Q ss_pred             CcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      .++|||+++.|+++++.+-+-|+||+.+..-+
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            38999999999999999999999999987643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.48  E-value=0.0023  Score=56.11  Aligned_cols=77  Identities=19%  Similarity=0.226  Sum_probs=47.6

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCC-c---ccccccCCCcchhHHHHHHhhCC--CCCeeeeeeeEEcCCCe
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGR-K---EDCLEYGFPISSLREINILLSFD--HPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~---~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~   91 (332)
                      .||.|....||++.....++.++||.-...... .   ....     .+..-|.+.|+...  .|..++-+..+  +...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~-----~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTL-----DRARIESSALIRQGEHVPHLVPRIFHF--DTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCc-----cHHHHHHHHHHHhhccCccccCeEEEE--cccc
Confidence            589999999999997543367999986543321 1   1111     13446777776653  35444433333  3355


Q ss_pred             EEEEcccccc
Q 035861           92 VYMVMEYMEH  101 (332)
Q Consensus        92 ~~lv~e~~~~  101 (332)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            6799999853

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.39  E-value=0.00091  Score=57.10  Aligned_cols=30  Identities=17%  Similarity=0.400  Sum_probs=25.3

Q ss_pred             CcccccCCCCCEEEcCCCc-EEEeecccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGV-LKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~-~~l~df~~~~~  166 (332)
                      .++|||+++.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3799999999999997565 46999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.37  E-value=0.0016  Score=57.19  Aligned_cols=30  Identities=37%  Similarity=0.542  Sum_probs=26.0

Q ss_pred             cccccCCCCCEEEcC-CCcEEEeeccccccc
Q 035861          138 VLHRDLKTSNLLLNN-QGVLKICDFGMSRQY  167 (332)
Q Consensus       138 i~H~di~p~Nili~~-~~~~~l~df~~~~~~  167 (332)
                      ++|+|+.+.||++++ ++.++++||..|...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            789999999999975 478999999988653

>PLN02236 choline kinase

Probab=97.30  E-value=0.0014  Score=57.95  Aligned_cols=138  Identities=13%  Similarity=0.169  Sum_probs=76.5

Q ss_pred             ccccccccCcEEEEEEEECC----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCee-eeeeeEEcCC
Q 035861           15 KLNKISEGTYGIVYRARDKK----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIV-NVKEVVMDDH   89 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~   89 (332)
                      -+..+..|-...+|++....    +++.+++|+.....   +....+      ..|..+++.+...++. ++++.+ .+ 
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR------~~E~~~~~~l~~~gl~P~~~~~~-~~-  108 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR------DDEIRTFECMSRHGQGPRLLGRF-PN-  108 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech------HHHHHHHHHHHHcCCCCceEEEE-CC-
Confidence            34556668888999987532    24679999886542   121111      3688888877544443 344443 33 


Q ss_pred             CeEEEEcccccccHHH-----------HH-------HhcCC-----CCCHHHHHHHHHHH-----------------HHH
Q 035861           90 DSVYMVMEYMEHDLKW-----------LM-------ESMKQ-----PFSTSEVKCLMLQL-----------------LEG  129 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~-----------~~-------~~~~~-----~l~~~~~~~i~~~l-----------------~~~  129 (332)
                      .   .|.+|++|..+.           .+       .....     ......+..+..++                 ...
T Consensus       109 g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~  185 (344)
T PLN02236        109 G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE  185 (344)
T ss_pred             c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence            2   467777652211           11       00010     11122222332111                 111


Q ss_pred             HHHHH--------HCCcccccCCCCCEEEcC-CCcEEEeecccccc
Q 035861          130 VKYLH--------DNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQ  166 (332)
Q Consensus       130 L~~lh--------~~~i~H~di~p~Nili~~-~~~~~l~df~~~~~  166 (332)
                      +..|.        ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22221        225899999999999986 46899999998764

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.19  E-value=0.004  Score=55.33  Aligned_cols=81  Identities=19%  Similarity=0.169  Sum_probs=50.2

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--CCCeeeeeeeEEcCCCeEE
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--HPSIVNVKEVVMDDHDSVY   93 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~   93 (332)
                      .+.||.|.-+.||++.+...++.++||.-.......+...  -...+..-|.+.|+.+.  .|..++-+..+  +.....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swp--L~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFK--LSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCC--CChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhh
Confidence            5689999999999999853356799998654333211100  01123456778887663  45555544444  335567


Q ss_pred             EEccccc
Q 035861           94 MVMEYME  100 (332)
Q Consensus        94 lv~e~~~  100 (332)
                      +|||+++
T Consensus       110 ~vMEdL~  116 (409)
T PRK12396        110 CVMEDLS  116 (409)
T ss_pred             HHHHhCc
Confidence            8999885

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.92  E-value=0.016  Score=51.88  Aligned_cols=81  Identities=14%  Similarity=0.139  Sum_probs=48.7

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--C-CCeeeeeeeEEcCCCe
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--H-PSIVNVKEVVMDDHDS   91 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h-~~i~~~~~~~~~~~~~   91 (332)
                      ..+.||.|....||++...  +..++||.-........... .....+...|+..|+.+.  . ..+.+++.+. +  ..
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~w-pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-e--d~  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESW-PMTKERAYFEATALREHGRLCPDHVPEVYHFD-R--TM  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccc-cCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-C--CC
Confidence            4678899999999999874  45699998763332111000 000113345677776653  2 3555666655 2  33


Q ss_pred             EEEEcccccc
Q 035861           92 VYMVMEYMEH  101 (332)
Q Consensus        92 ~~lv~e~~~~  101 (332)
                      .+++||++++
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            5788999965

>PTZ00384 choline kinase; Provisional

Probab=96.91  E-value=0.0079  Score=53.77  Aligned_cols=30  Identities=27%  Similarity=0.237  Sum_probs=24.9

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ...+|+|+-+.||+.++ +.+.++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            45799999999998764 5699999988764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.86  E-value=0.016  Score=50.47  Aligned_cols=30  Identities=17%  Similarity=0.182  Sum_probs=27.5

Q ss_pred             CcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      +++|||+.+.|+++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999997754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.71  E-value=0.0073  Score=52.55  Aligned_cols=90  Identities=18%  Similarity=0.239  Sum_probs=66.0

Q ss_pred             CCCCCeeeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEc
Q 035861           73 FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLN  151 (332)
Q Consensus        73 l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~  151 (332)
                      ...++....+-+-.++..+.|++|++.++.+..     -.....+++..++.+.+..++-+..+ ..-|+|+.-.||+|+
T Consensus       282 ~g~~~~e~~~vv~~de~~y~yl~~kdhgt~is~-----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId  356 (488)
T COG5072         282 CGSVFLETLKVVSLDETLYLYLHFKDHGTPISI-----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID  356 (488)
T ss_pred             ccchhhhcceEEecCCceEEEEEEecCCceeee-----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence            344444443333334446778888888775421     23346788889999999988888854 578999999999999


Q ss_pred             CCCcEEEeecccccccC
Q 035861          152 NQGVLKICDFGMSRQYG  168 (332)
Q Consensus       152 ~~~~~~l~df~~~~~~~  168 (332)
                       +|+|.|+||.+++...
T Consensus       357 -~GnvtLIDfklsRl~~  372 (488)
T COG5072         357 -EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             -cCceEEEEeeeeeccc
Confidence             8999999999998543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.68  E-value=0.00045  Score=69.86  Aligned_cols=153  Identities=12%  Similarity=0.009  Sum_probs=105.0

Q ss_pred             HHHHHhhCCCCCeeeeeeeEEcC-CCeEEEEccccccc-HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC-C--
Q 035861           66 EINILLSFDHPSIVNVKEVVMDD-HDSVYMVMEYMEHD-LKWLMESMKQ---PFSTSEVKCLMLQLLEGVKYLHDN-W--  137 (332)
Q Consensus        66 e~~~l~~l~h~~i~~~~~~~~~~-~~~~~lv~e~~~~~-l~~~~~~~~~---~l~~~~~~~i~~~l~~~L~~lh~~-~--  137 (332)
                      |...++...|+++...+.-.... ....++.++++.++ +.+.+.+...   .++...+.....+...+..-+|+. |  
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            33444555788877766655332 24467889998864 4555544322   344444444444446666666643 2  


Q ss_pred             --cccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Q 035861          138 --VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK  215 (332)
Q Consensus       138 --i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~  215 (332)
                        .+|.++++.|.+|..+.+++++++|+.+.............+++.|+.|+.... -.++.++|+|..|+.+|...-|.
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhccc
Confidence              689999999999999999999999999843333333445566778888887655 56777899999999999998777


Q ss_pred             CCCC
Q 035861          216 PLFS  219 (332)
Q Consensus       216 ~pf~  219 (332)
                      .+|.
T Consensus      1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred             HHHH
Confidence            7764

>PRK10593 hypothetical protein; Provisional

Probab=96.61  E-value=0.014  Score=50.49  Aligned_cols=108  Identities=14%  Similarity=0.069  Sum_probs=70.0

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC---CCeeeeeeeEEc-
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH---PSIVNVKEVVMD-   87 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~-   87 (332)
                      ...-.+.||.|..+.||+....  +..+++|..+.... ..         .+..|+..++.+..   ..+..+++.+.. 
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~-~~---------~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~   82 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFST-PG---------VAQQEAWKLSMLARSGTVRMPTVYGVMTHE   82 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC--CCCEEEEEeccccc-ch---------HHHHHHHHHHHHccCCCCCcCcEEEEeccC
Confidence            4455678999999999998654  33577787532111 11         34588888887743   346666665532 


Q ss_pred             -CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 035861           88 -DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN  136 (332)
Q Consensus        88 -~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~  136 (332)
                       ..+..++|||+++|.....     ...+......+..+++.+|+.||+.
T Consensus        83 ~~~g~~~LVmE~i~G~~~~~-----~~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         83 QSPGPDVLLLERLRGVSVEA-----PARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CcCCCeEEEEeccCCEecCC-----CCCCHHHHHHHHHHHHHHHHHHhCC
Confidence             2355899999999864322     1123444566777888888888874

>PTZ00296 choline kinase; Provisional

Probab=96.44  E-value=0.021  Score=52.14  Aligned_cols=29  Identities=31%  Similarity=0.508  Sum_probs=24.3

Q ss_pred             CcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .++|+|+.+.||+.+.+ .+.|+||..|..
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence            47899999999987654 499999988754

>PRK06148 hypothetical protein; Provisional

Probab=96.24  E-value=0.06  Score=54.61  Aligned_cols=31  Identities=26%  Similarity=0.489  Sum_probs=26.4

Q ss_pred             CCcccccCCCCCEEEcCCC--cEE-Eeecccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQG--VLK-ICDFGMSRQ  166 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~--~~~-l~df~~~~~  166 (332)
                      .+++|+|+++.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  555 999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.11  E-value=0.085  Score=45.25  Aligned_cols=75  Identities=17%  Similarity=0.188  Sum_probs=42.9

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---CCCeeeeeeeEEcCC
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---HPSIVNVKEVVMDDH   89 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~   89 (332)
                      .+-.+.++.|..+.+|+..  .+++.+.||+-..... .          .+..|+.-|+.|.   .-.+.+.+++.... 
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~-~----------~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-   84 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR-D----------MFEGEAEGLKALAEANPIRVPKVIAWGEYD-   84 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC-C----------HHHHHHHHHHHHCHTTTSBS--EEEEEE-S-
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhH-H----------HHHHHHHHHHHHHhcCCCCCCeEEEEEeec-
Confidence            4556779999999999988  4588899998872211 1          3457887777773   33455556555333 


Q ss_pred             CeEEEEcccccc
Q 035861           90 DSVYMVMEYMEH  101 (332)
Q Consensus        90 ~~~~lv~e~~~~  101 (332)
                      ...++|+|+++.
T Consensus        85 ~~~fLlle~l~~   96 (288)
T PF03881_consen   85 DDAFLLLEFLEM   96 (288)
T ss_dssp             SCCEEEEE----
T ss_pred             CCceEEEEeecC
Confidence            445899999864

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.42  E-value=0.036  Score=48.24  Aligned_cols=29  Identities=24%  Similarity=0.391  Sum_probs=25.7

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+++|||+++.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999998 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.24  E-value=0.018  Score=45.70  Aligned_cols=29  Identities=28%  Similarity=0.488  Sum_probs=25.7

Q ss_pred             cccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861          138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus       138 i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .+|+|+.|.||++++++ ++|+||+.+...
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            68999999999998877 899999988754

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.05  E-value=0.039  Score=46.84  Aligned_cols=46  Identities=24%  Similarity=0.343  Sum_probs=34.6

Q ss_pred             HHHHHHHHHHHHHHC--CcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861          122 LMLQLLEGVKYLHDN--WVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus       122 i~~~l~~~L~~lh~~--~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .+..+-.++.-.+..  -++|+|+.|.|++.++.+.+.|+||..|...
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            334444444444433  4889999999999999999999999988653

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.50  E-value=0.073  Score=43.45  Aligned_cols=30  Identities=33%  Similarity=0.575  Sum_probs=21.3

Q ss_pred             CcccccCCCCCEEE-cCCCcEEEeecccccc
Q 035861          137 WVLHRDLKTSNLLL-NNQGVLKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili-~~~~~~~l~df~~~~~  166 (332)
                      .++|+|+.+.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48899999999999 8889999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=94.39  E-value=0.0057  Score=55.18  Aligned_cols=81  Identities=22%  Similarity=0.388  Sum_probs=64.1

Q ss_pred             CcccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee
Q 035861            1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN   80 (332)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   80 (332)
                      |+++.-++..+++..+.++|.|+||+|+.+....++-.+|||.+.........       .+.+++...+..+.|++++.
T Consensus        39 ~~~~~~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~-------~rvl~~~~s~a~feh~g~~~  111 (516)
T KOG1033|consen   39 NKRVITSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESR-------SRVLREVSSLAEFEHPGIKR  111 (516)
T ss_pred             hhhhhhhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhh-------hhhhccccchhhhcccchhh
Confidence            35555677788999999999999999999999887878999998765433222       24567888899999999999


Q ss_pred             eeeeEEcC
Q 035861           81 VKEVVMDD   88 (332)
Q Consensus        81 ~~~~~~~~   88 (332)
                      +...+...
T Consensus       112 ~~ha~~~~  119 (516)
T KOG1033|consen  112 YFHAWYER  119 (516)
T ss_pred             heeceecC
Confidence            88877544

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.68  E-value=0.15  Score=45.38  Aligned_cols=60  Identities=15%  Similarity=0.080  Sum_probs=41.0

Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNN  152 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~  152 (332)
                      ..++-+|..|-......+ ....+++...+++.-...||--+- --+++|.|++|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            456667777744333333 344566677777777777766654 568999999999999963

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	332
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-74
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-74
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-74
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-74
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-74
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-74
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-74
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-74
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-74
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-74
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-74
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-74
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-74
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-74
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-74
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-74
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-74
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-74
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-74
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-74
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-74
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-74
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-74
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-74
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-74
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-74
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-74
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-74
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-74
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-74
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-73
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-73
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-73
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-73
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-73
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-72
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-72
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-69
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-69
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-69
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-65
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-64
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-63
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-62
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-60
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-60
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-60
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-60
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-59
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-59
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-58
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-57
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-57
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-57
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-57
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-57
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-56
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-51
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-48
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-48
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-48
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-47
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-47
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-47
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-47
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-47
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-47
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-47
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-47
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-47
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-47
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-47
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-47
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-47
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-47
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-47
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-47
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-47
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-47
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-47
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-47
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-47
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-47
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-47
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-47
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-46
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-46
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-46
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-44
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-43
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-43
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-42
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-42
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-42
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-42
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-42
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-42
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-41
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-41
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-41
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-41
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-41
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-41
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-41
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-41
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-41
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-41
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-41
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-41
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-41
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-41
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-41
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-41
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-41
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-41
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-41
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-41
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-41
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-41
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-41
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-41
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-41
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-41
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-41
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-41
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-41
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-41
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-41
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-41
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-41
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-41
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-41
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-41
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-41
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-41
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-41
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-41
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-41
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-41
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-41
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-41
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-41
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-41
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-41
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-41
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-41
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-41
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-41
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-41
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-41
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-41
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-41
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-40
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-40
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-40
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-40
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-40
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-40
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-40
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-40
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-40
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-40
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-40
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-40
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-40
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-40
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-40
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-40
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-40
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-40
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-40
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-40
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-40
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-40
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-40
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-40
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-40
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-40
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-40
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-40
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-40
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-39
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-38
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-38
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-38
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-38
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-38
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-38
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-38
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-38
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-38
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-38
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-38
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-38
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-38
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-38
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-38
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-38
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-38
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-38
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-37
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-37
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-37
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-37
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-37
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-37
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-37
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-37
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-37
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-37
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-37
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-36
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-36
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-36
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-36
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-34
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-34
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-27
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-27
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-27
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-27
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-27
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-27
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-26
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-26
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-26
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-26
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-25
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-25
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-25
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-25
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-25
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-25
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-24
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-24
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-24
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-24
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-24
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-24
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-24
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-24
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-24
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-24
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-24
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-24
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-24
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-24
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-24
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-24
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-24
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-24
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-24
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-24
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-23
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-23
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-23
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-23
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-23
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-23
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-23
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-23
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-23
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-23
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-23
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-23
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-23
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-23
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-23
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-23
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-22
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-22
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-22
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-22
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-22
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-21
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-20
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-20
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-20
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-20
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-20
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-20
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-20
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-20
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-20
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-20
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-19
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-19
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-19
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-19
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-19
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-19
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-19
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-19
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-19
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-19
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-19
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-19
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-19
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-19
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-19
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-19
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-18
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-18
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-18
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-18
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-18
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-18
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-18
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-18
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-17
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-17
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-17
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-17
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-16
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-14
3soa_A	444	Full-Length Human Camkii Length = 444		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-08
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		4e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-08

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 137/308 (44%), Positives = 203/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 55
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 56  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 286
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 287 FFQDVTKP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 58
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 59  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 238 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 312 VPLP 315
           V  P
Sbjct: 290 VTKP 293

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 58
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 59  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 238 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 312 VPLP 315
           V  P
Sbjct: 290 VTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 65
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 66  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 245 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296
Query: 312 VPLP 315
           V  P
Sbjct: 297 VTKP 300

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 65
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 66  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 245 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296
Query: 312 VPLP 315
           V  P
Sbjct: 297 VTKP 300

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 137/304 (45%), Positives = 203/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 58
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 59  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K      R+ F        P L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 238 KPSFPKWA----RQDFSKV----VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 312 VPLP 315
           V  P
Sbjct: 290 VTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 57
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 62
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 63  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 242 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293
Query: 312 VPLP 315
           V  P
Sbjct: 294 VTKP 297

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 137/304 (45%), Positives = 203/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 58
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 59  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K      R+ F        P L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 238 KPSFPKWA----RQDFSKV----VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 312 VPLP 315
           V  P
Sbjct: 290 VTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 137/304 (45%), Positives = 203/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 57
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K      R+ F        P L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWA----RQDFSKV----VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  275 bits (703), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 137/311 (44%), Positives = 203/311 (65%), Gaps = 16/311 (5%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           G  S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++R
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIR 54
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLML 124
           EI++L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLF 113
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           QLL+G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           ++ +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAAL 285
Query: 305 NHYWFHEVPLP 315
            H +F +V  P
Sbjct: 286 AHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  275 bits (703), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 57
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDVIHTE-NKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 137/311 (44%), Positives = 203/311 (65%), Gaps = 16/311 (5%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           G  S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++R
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIR 54
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLML 124
           EI++L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           QLL+G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           ++ +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAAL 285
Query: 305 NHYWFHEVPLP 315
            H +F +V  P
Sbjct: 286 AHPFFQDVTKP 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  275 bits (702), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 137/311 (44%), Positives = 204/311 (65%), Gaps = 16/311 (5%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           G  S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++R
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIR 54
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLML 124
           EI++L   +HP+IV + +V+  + + +Y+V E+++ DLK  M+ S         +K  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTE-NKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           QLL+G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           ++ +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAAL 285
Query: 305 NHYWFHEVPLP 315
            H +F +V  P
Sbjct: 286 AHPFFQDVTKP 296

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  274 bits (701), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 55
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 56  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 286
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 287 FFQDVTKP 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  274 bits (701), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 56
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 57  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 287
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 288 FFQDVTKP 295

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 57
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 58  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 289 FFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 56
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 57  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 287
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 288 FFQDVTKP 295

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 54
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 55  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 285
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 286 FFQDVTKP 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 56
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 57  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 287
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 288 FFQDVTKP 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 137/308 (44%), Positives = 204/308 (66%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 54
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 55  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K      R+ F        P L E G  LL+++L YDP KRI+   AL H 
Sbjct: 234 MPDYKPSFPKWA----RQDFSKV----VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 285
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 286 FFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 58
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 59  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 238 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 289
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 290 FFQDVTKP 297

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  273 bits (699), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 135/304 (44%), Positives = 200/304 (65%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VAL K+++      D    G P +++REI++L  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL------DTETEGVPSTAIREISLLKE 58
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 59  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 238 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 312 VPLP 315
           V  P
Sbjct: 290 VTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  273 bits (699), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 135/304 (44%), Positives = 200/304 (65%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VAL K+++      D    G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL------DTETEGVPSTAIREISLLKE 57
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  273 bits (699), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 55
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 56  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 286
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 287 FFQDVTKP 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  273 bits (699), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 54
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 55  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 285
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 286 FFQDVTKP 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  273 bits (699), Expect = 8e-74,   Method: Compositional matrix adjust.
 Identities = 136/304 (44%), Positives = 202/304 (66%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 57
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K      R+ F        P L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWA----RQDFSKV----VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  273 bits (698), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 54
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 55  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 285
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 286 FFQDVTKP 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  273 bits (698), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 135/304 (44%), Positives = 200/304 (65%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 57
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  273 bits (698), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 135/304 (44%), Positives = 200/304 (65%), Gaps = 16/304 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI++L  
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLKE 59
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 60  LNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE+LLG
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 239 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290
Query: 312 VPLP 315
           V  P
Sbjct: 291 VTKP 294

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  273 bits (697), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 55
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 56  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 286
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 287 FFQDVTKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  273 bits (697), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 57
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 58  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 289 FFQDVTKP 296

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  272 bits (696), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 56
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 57  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 287
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 288 FFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  272 bits (695), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 136/308 (44%), Positives = 202/308 (65%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 57
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 58  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K       K  P         L E G  LL+++L YDP KRI+   AL H 
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 308 WFHEVPLP 315
           +F +V  P
Sbjct: 289 FFQDVTKP 296

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  271 bits (693), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 135/304 (44%), Positives = 202/304 (66%), Gaps = 16/304 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  F+K+ KI EGTYG+VY+AR+K +GE+VALKK+++      D    G P +++REI+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREIS 54
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLL 127
           +L   +HP+IV + +V+  + + +Y+V E++  DLK  M+ S         +K  + QLL
Sbjct: 55  LLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ Y   VVTLWYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +LLG K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  K +F K      R+ F        P L E G  LL+++L YDP KRI+   AL H 
Sbjct: 234 MPDYKPSFPKWA----RQDFSKV----VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 285
Query: 308 WFHE 311
           +F +
Sbjct: 286 FFQD 289

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  267 bits (683), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 132/301 (43%), Positives = 203/301 (67%), Gaps = 15/301 (4%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +++KL K+ EGTYG+VY+A+D + G IVALK++++      D  + G P +++REI++L 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRL------DAEDEGIPSTAIREISLLK 74
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+IV++ +V+  +   + +V E+ME DLK +++  K     S++K  + QLL GV 
Sbjct: 75  ELHHPNIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + +LHRDLK  NLL+N+ G LK+ DFG++R +G P++ YT  VVTLWYRAP++L+G
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +KKYST+VD+WS+GCI AE++  KPLF G T+ DQ+ KIF  LGTP    WP + ELP  
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K    ++ + +  K+ P +S    P   + G DLL+ +L +DP KRI+  DA+NH +F +
Sbjct: 254 K----QRTFQVFEKK-PWSSII--PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 312 V 312
           +
Sbjct: 307 L 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 132/301 (43%), Positives = 203/301 (67%), Gaps = 15/301 (4%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +++KL K+ EGTYG+VY+A+D + G IVALK++++      D  + G P +++REI++L 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRL------DAEDEGIPSTAIREISLLK 74
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+IV++ +V+  +   + +V E+ME DLK +++  K     S++K  + QLL GV 
Sbjct: 75  ELHHPNIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + +LHRDLK  NLL+N+ G LK+ DFG++R +G P++ YT  VVTLWYRAP++L+G
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +KKYST+VD+WS+GCI AE++  KPLF G T+ DQ+ KIF  LGTP    WP + ELP  
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K    ++ + +  K+ P +S    P   + G DLL+ +L +DP KRI+  DA+NH +F +
Sbjct: 254 K----QRTFQVFEKK-PWSSII--PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 312 V 312
           +
Sbjct: 307 L 307

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 136/300 (45%), Positives = 191/300 (63%), Gaps = 16/300 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++  L KI EGTYG+VY+A++   GE  ALKK+++    KED    G P +++REI+IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL---EKED---EGIPSTTIREISILK 55
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+      V +V E+++ DLK L++  +    +   K  +LQLL G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLV-LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y HD  VLHRDLK  NLL+N +G LKI DFG++R +G P++ YT  VVTLWYRAP++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +KKYST +D+WSVGCI AE++   PLF G +E DQ+ +IF+ LGTP    WP ++ELP  
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             NF       + +  P  SF     L ESG DLL+++L  DP +RIT   AL H +F E
Sbjct: 235 DPNFT------VYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 136/300 (45%), Positives = 191/300 (63%), Gaps = 16/300 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++  L KI EGTYG+VY+A++   GE  ALKK+++    KED    G P +++REI+IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL---EKED---EGIPSTTIREISILK 55
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+      V +V E+++ DLK L++  +    +   K  +LQLL G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLV-LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y HD  VLHRDLK  NLL+N +G LKI DFG++R +G P++ YT  VVTLWYRAP++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +KKYST +D+WSVGCI AE++   PLF G +E DQ+ +IF+ LGTP    WP ++ELP  
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             NF       + +  P  SF     L ESG DLL+++L  DP +RIT   AL H +F E
Sbjct: 235 DPNFT------VYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 135/300 (45%), Positives = 191/300 (63%), Gaps = 16/300 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++  L KI EGTYG+VY+A++   GE  ALKK+++    KED    G P +++REI+IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL---EKED---EGIPSTTIREISILK 55
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+      V +V E+++ DLK L++  +    +   K  +LQLL G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLV-LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y HD  VLHRDLK  NLL+N +G LKI DFG++R +G P++ YT  +VTLWYRAP++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +KKYST +D+WSVGCI AE++   PLF G +E DQ+ +IF+ LGTP    WP ++ELP  
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             NF       + +  P  SF     L ESG DLL+++L  DP +RIT   AL H +F E
Sbjct: 235 DPNFT------VYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  243 bits (621), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 132/307 (42%), Positives = 192/307 (62%), Gaps = 20/307 (6%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EKL KI EGTYG V++A+++++ EIVALK+V++      D  + G P S+LREI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLK 56
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+  D   + +V E+ + DLK   +S         VK  + QLL+G+ 
Sbjct: 57  ELKHKNIVRLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H   VLHRDLK  NLL+N  G LK+ DFG++R +G P++ Y++ VVTLWYR P++L G
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 192 AKKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           AK YST++DMWS GCI AEL  A +PLF G    DQ+ +IF+ LGTPTE  WP +++LP 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 251 AKANFAKQPYNLLRKRFPAAS--FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
            K      PY +    +PA +      P L+ +G DLL  LL  +P +RI+ ++AL H +
Sbjct: 236 YK------PYPM----YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 309 FHEVPLP 315
           F +   P
Sbjct: 286 FSDFCPP 292

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  241 bits (615), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 131/307 (42%), Positives = 192/307 (62%), Gaps = 20/307 (6%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EKL KI EGTYG V++A+++++ EIVALK+V++      D  + G P S+LREI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLK 56
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+  D   + +V E+ + DLK   +S         VK  + QLL+G+ 
Sbjct: 57  ELKHKNIVRLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H   VLHRDLK  NLL+N  G LK+ +FG++R +G P++ Y++ VVTLWYR P++L G
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 192 AKKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           AK YST++DMWS GCI AEL  A +PLF G    DQ+ +IF+ LGTPTE  WP +++LP 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 251 AKANFAKQPYNLLRKRFPAAS--FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
            K      PY +    +PA +      P L+ +G DLL  LL  +P +RI+ ++AL H +
Sbjct: 236 YK------PYPM----YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 309 FHEVPLP 315
           F +   P
Sbjct: 286 FSDFCPP 292

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 124/304 (40%), Positives = 184/304 (60%), Gaps = 13/304 (4%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +EKL+ + EG +  VY+ARDK + +IVA+KK+K+  G + +  + G   ++LREI +L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL--GHRSEAKD-GINRTALREIKLLQ 67
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ + +       ++ +V ++ME DL+ +++      + S +K  ML  L+G++
Sbjct: 68  ELSHPNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH +W+LHRDLK +NLLL+  GVLK+ DFG+++ +GSP + Y   VVT WYRAPELL G
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFG 186
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           A+ Y   VDMW+VGCI+AELL + P   G +++DQ+ +IF+TLGTPTE  WP +  LP  
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
              F   P   L   F AA         +   DL+  L  ++P  RIT   AL   +F  
Sbjct: 247 -VTFKSFPGIPLHHIFSAA--------GDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
Query: 312 VPLP 315
            P P
Sbjct: 298 RPGP 301

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  234 bits (597), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 121/308 (39%), Positives = 195/308 (63%), Gaps = 16/308 (5%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S  +F++L K+  GTY  VY+  +K +G  VALK+VK++        E G P +++REI+
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-------EEGTPSTAIREIS 55
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-----QPFSTSEVKCLM 123
           ++    H +IV + +V+  + + + +V E+M++DLK  M+S       +    + VK   
Sbjct: 56  LMKELKHENIVRLYDVIHTE-NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            QLL+G+ + H+N +LHRDLK  NLL+N +G LK+ DFG++R +G P+  ++S VVTLWY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAP++L+G++ YST++D+WS GCI+AE++  KPLF GT + +Q+  IF  +GTP E++WP
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            +++LP    N  ++P   LR+       T  P L  +  D L+ LL  +P+ R++   A
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVL--QPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 304 LNHYWFHE 311
           L+H WF E
Sbjct: 292 LHHPWFAE 299

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  229 bits (585), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 128/321 (39%), Positives = 184/321 (57%), Gaps = 24/321 (7%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C  V ++EKL KI +GT+G V++AR +K+G+ VALKKV M    KE     GFPI++LRE
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKE-----GFPITALRE 67
Query: 67  INILLSFDHPSIVNVKEVVMDDHD-------SVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           I IL    H ++VN+ E+             S+Y+V ++ EHDL  L+ ++   F+ SE+
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----GSPLKPYT 175
           K +M  LL G+ Y+H N +LHRD+K +N+L+   GVLK+ DFG++R +     S    Y 
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + VVTLWYR PELLLG + Y   +D+W  GCIMAE+  + P+  G TE  Q+  I +  G
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 247
Query: 236 TPTETIWPGLSELP-GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           + T  +WP +       K    K     ++ R  A       V      DL+++LL  DP
Sbjct: 248 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY------VRDPYALDLIDKLLVLDP 301
Query: 295 EKRITVDDALNHYWFHEVPLP 315
            +RI  DDALNH +F   P+P
Sbjct: 302 AQRIDSDDALNHDFFWSDPMP 322

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 128/321 (39%), Positives = 184/321 (57%), Gaps = 24/321 (7%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C  V ++EKL KI +GT+G V++AR +K+G+ VALKKV M    KE     GFPI++LRE
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKE-----GFPITALRE 67
Query: 67  INILLSFDHPSIVNVKEVVMDDHD-------SVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           I IL    H ++VN+ E+             S+Y+V ++ EHDL  L+ ++   F+ SE+
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----GSPLKPYT 175
           K +M  LL G+ Y+H N +LHRD+K +N+L+   GVLK+ DFG++R +     S    Y 
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + VVTLWYR PELLLG + Y   +D+W  GCIMAE+  + P+  G TE  Q+  I +  G
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 247
Query: 236 TPTETIWPGLSELP-GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           + T  +WP +       K    K     ++ R  A       V      DL+++LL  DP
Sbjct: 248 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY------VRDPYALDLIDKLLVLDP 301
Query: 295 EKRITVDDALNHYWFHEVPLP 315
            +RI  DDALNH +F   P+P
Sbjct: 302 AQRIDSDDALNHDFFWSDPMP 322

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 128/321 (39%), Positives = 185/321 (57%), Gaps = 24/321 (7%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C  V ++EKL KI +GT+G V++AR +K+G+ VALKKV M    KE     GFPI++LRE
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKE-----GFPITALRE 67
Query: 67  INILLSFDHPSIVNVKEVVMDDHD-------SVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           I IL    H ++VN+ E+             S+Y+V ++ EHDL  L+ ++   F+ SE+
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----GSPLKPYT 175
           K +M  LL G+ Y+H N +LHRD+K +N+L+   GVLK+ DFG++R +     S    Y 
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + VVTLWYR PELLLG + Y   +D+W  GCIMAE+  + P+  G TE  Q+  I +  G
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 247
Query: 236 TPTETIWPGLSELP-GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           + T  +WP +       K    K     ++ R  A  +   P       DL+++LL  DP
Sbjct: 248 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA--YVRDPY----ALDLIDKLLVLDP 301
Query: 295 EKRITVDDALNHYWFHEVPLP 315
            +RI  DDALNH +F   P+P
Sbjct: 302 AQRIDSDDALNHDFFWSDPMP 322

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  229 bits (583), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 128/321 (39%), Positives = 184/321 (57%), Gaps = 24/321 (7%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C  V ++EKL KI +GT+G V++AR +K+G+ VALKKV M    KE     GFPI++LRE
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKE-----GFPITALRE 66
Query: 67  INILLSFDHPSIVNVKEVVMDDHD-------SVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           I IL    H ++VN+ E+             S+Y+V ++ EHDL  L+ ++   F+ SE+
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----GSPLKPYT 175
           K +M  LL G+ Y+H N +LHRD+K +N+L+   GVLK+ DFG++R +     S    Y 
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + VVTLWYR PELLLG + Y   +D+W  GCIMAE+  + P+  G TE  Q+  I +  G
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 236 TPTETIWPGLSELP-GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           + T  +WP +       K    K     ++ R  A       V      DL+++LL  DP
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY------VRDPYALDLIDKLLVLDP 300
Query: 295 EKRITVDDALNHYWFHEVPLP 315
            +RI  DDALNH +F   P+P
Sbjct: 301 AQRIDSDDALNHDFFWSDPMP 321

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 177/295 (60%), Gaps = 15/295 (5%)
Query: 15  KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           KL+K+ EGTY  VY+ + K +  +VALK++++         E G P +++RE+++L    
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-------EEGAPCTAIREVSLLKDLK 58
Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           H +IV + +++  +  S+ +V EY++ DLK  ++      +   VK  + QLL G+ Y H
Sbjct: 59  HANIVTLHDIIHTE-KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
              VLHRDLK  NLL+N +G LK+ DFG++R    P K Y + VVTLWYR P++LLG+  
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
           YST +DMW VGCI  E+   +PLF G+T  +Q+  IF+ LGTPTE  WPG+       +N
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL------SN 231
Query: 255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              + YN  + R   A  + +P L   G DLL +LL ++   RI+ +DA+ H +F
Sbjct: 232 EEFKTYNYPKYR-AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  226 bits (575), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 121/307 (39%), Positives = 186/307 (60%), Gaps = 22/307 (7%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+  + ++ K+ EGTYG VY+A D  + E VA+K++++      +  E G P +++RE++
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL------EHEEEGVPGTAIREVS 85
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
           +L    H +I+ +K V+  +H  ++++ EY E+DLK  M+  K P  S   +K  + QL+
Sbjct: 86  LLKELQHRNIIELKSVIHHNH-RLHLIFEYAENDLKKYMD--KNPDVSMRVIKSFLYQLI 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLN-----NQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
            GV + H    LHRDLK  NLLL+        VLKI DFG++R +G P++ +T  ++TLW
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YR PE+LLG++ YST+VD+WS+ CI AE+L K PLF G +E+DQ+ KIF+ LG P +T W
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           PG++ LP  K +F K     L++   A        L  +       +L  DP KRI+  +
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTA-------MLEMDPVKRISAKN 315
Query: 303 ALNHYWF 309
           AL H +F
Sbjct: 316 ALEHPYF 322

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  220 bits (560), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 123/315 (39%), Positives = 192/315 (60%), Gaps = 27/315 (8%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           CR+  ++E + +I EG YG V++ARD K  G  VALK+V++  G      E G P+S++R
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIR 60
Query: 66  EINILL---SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQP-FSTS 117
           E+ +L    +F+HP++V + +V      D    + +V E+++ DL   ++ + +P   T 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +K +M QLL G+ +LH + V+HRDLK  N+L+ + G +K+ DFG++R Y   +   TS+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSV 179
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVTLWYRAPE+LL +  Y+T VD+WSVGCI AE+  +KPLF G+++VDQ+ KI   +G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E  WP    LP       +Q ++  +   P   F     + E G DLL + LT++P KR
Sbjct: 239 GEEDWPRDVALP-------RQAFH-SKSAQPIEKFVTD--IDELGKDLLLKCLTFNPAKR 288
Query: 298 ITVDDALNHYWFHEV 312
           I+   AL+H +F ++
Sbjct: 289 ISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 123/315 (39%), Positives = 192/315 (60%), Gaps = 27/315 (8%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           CR+  ++E + +I EG YG V++ARD K  G  VALK+V++  G      E G P+S++R
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIR 60
Query: 66  EINILL---SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQP-FSTS 117
           E+ +L    +F+HP++V + +V      D    + +V E+++ DL   ++ + +P   T 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +K +M QLL G+ +LH + V+HRDLK  N+L+ + G +K+ DFG++R Y   +   TS+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSV 179
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVTLWYRAPE+LL +  Y+T VD+WSVGCI AE+  +KPLF G+++VDQ+ KI   +G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E  WP    LP       +Q ++  +   P   F     + E G DLL + LT++P KR
Sbjct: 239 GEEDWPRDVALP-------RQAFH-SKSAQPIEKFVTD--IDELGKDLLLKCLTFNPAKR 288
Query: 298 ITVDDALNHYWFHEV 312
           I+   AL+H +F ++
Sbjct: 289 ISAYSALSHPYFQDL 303

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  219 bits (557), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 124/307 (40%), Positives = 179/307 (58%), Gaps = 26/307 (8%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL- 71
           +E + +I  G YG VY+ARD  SG  VALK V++  G      E G PIS++RE+ +L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG------EEGLPISTVREVALLRR 59
Query: 72  --SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE-VKCLML 124
             +F+HP++V + +V      D    V +V E+++ DL+  ++    P   +E +K LM 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q L G+ +LH N ++HRDLK  N+L+ + G +K+ DFG++R Y   +     +VVTLWYR
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVVTLWYR 178
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LL +  Y+T VDMWSVGCI AE+  +KPLF G +E DQ+ KIF  +G P E  WP 
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
              LP  +  F          R P    +  P + ESG  LL  +LT++P KRI+   AL
Sbjct: 238 DVSLP--RGAFP--------PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 305 NHYWFHE 311
            H + H+
Sbjct: 288 QHSYLHK 294

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  219 bits (557), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 124/307 (40%), Positives = 180/307 (58%), Gaps = 26/307 (8%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL- 71
           +E + +I  G YG VY+ARD  SG  VALK V++  G      E G PIS++RE+ +L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG------EEGLPISTVREVALLRR 59
Query: 72  --SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE-VKCLML 124
             +F+HP++V + +V      D    V +V E+++ DL+  ++    P   +E +K LM 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q L G+ +LH N ++HRDLK  N+L+ + G +K+ DFG++R Y   +  +  +VVTLWYR
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF-PVVVTLWYR 178
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LL +  Y+T VDMWSVGCI AE+  +KPLF G +E DQ+ KIF  +G P E  WP 
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
              LP  +  F          R P    +  P + ESG  LL  +LT++P KRI+   AL
Sbjct: 238 DVSLP--RGAFP--------PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 305 NHYWFHE 311
            H + H+
Sbjct: 288 QHSYLHK 294

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  219 bits (557), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 123/313 (39%), Positives = 190/313 (60%), Gaps = 27/313 (8%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           CR+  ++E + +I EG YG V++ARD K  G  VALK+V++  G      E G P+S++R
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIR 60
Query: 66  EINILL---SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQP-FSTS 117
           E+ +L    +F+HP++V + +V      D    + +V E+++ DL   ++ + +P   T 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +K +M QLL G+ +LH + V+HRDLK  N+L+ + G +K+ DFG++R Y   +   TS+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSV 179
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVTLWYRAPE+LL +  Y+T VD+WSVGCI AE+  +KPLF G+++VDQ+ KI   +G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E  WP    LP       +Q ++  +   P   F     + E G DLL + LT++P KR
Sbjct: 239 GEEDWPRDVALP-------RQAFH-SKSAQPIEKFVTD--IDELGKDLLLKCLTFNPAKR 288
Query: 298 ITVDDALNHYWFH 310
           I+   AL+H +F 
Sbjct: 289 ISAYSALSHPYFQ 301

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  218 bits (556), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 124/307 (40%), Positives = 179/307 (58%), Gaps = 26/307 (8%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL- 71
           +E + +I  G YG VY+ARD  SG  VALK V++  G      E G PIS++RE+ +L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG------EEGLPISTVREVALLRR 59
Query: 72  --SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE-VKCLML 124
             +F+HP++V + +V      D    V +V E+++ DL+  ++    P   +E +K LM 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q L G+ +LH N ++HRDLK  N+L+ + G +K+ DFG++R Y   +     +VVTLWYR
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWYR 178
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+LL +  Y+T VDMWSVGCI AE+  +KPLF G +E DQ+ KIF  +G P E  WP 
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
              LP  +  F          R P    +  P + ESG  LL  +LT++P KRI+   AL
Sbjct: 238 DVSLP--RGAFP--------PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 305 NHYWFHE 311
            H + H+
Sbjct: 288 QHSYLHK 294

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 124/314 (39%), Positives = 180/314 (57%), Gaps = 23/314 (7%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           G  +   +E + +I  G YG VY+ARD  SG  VALK V++           G PIS++R
Sbjct: 4   GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVR 60
Query: 66  EINILL---SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE 118
           E+ +L    +F+HP++V + +V      D    V +V E+++ DL+  ++    P   +E
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 119 -VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +K LM Q L G+ +LH N ++HRDLK  N+L+ + G +K+ DFG++R Y   +   T +
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPV 179
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVTLWYRAPE+LL +  Y+T VDMWSVGCI AE+  +KPLF G +E DQ+ KIF  +G P
Sbjct: 180 VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E  WP    LP  +  F          R P    +  P + ESG  LL  +LT++P KR
Sbjct: 239 PEDDWPRDVSLP--RGAFP--------PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR 288
Query: 298 ITVDDALNHYWFHE 311
           I+   AL H + H+
Sbjct: 289 ISAFRALQHSYLHK 302

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  198 bits (504), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 126/349 (36%), Positives = 191/349 (54%), Gaps = 57/349 (16%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLRE 66
            +FE+E   K+  GTYG VY+A+ K   +    ALK+++            G  +S+ RE
Sbjct: 20  DLFEYEGC-KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----------GISMSACRE 68
Query: 67  INILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLME------SMKQPFSTSE- 118
           I +L    HP+++++++V +   D  V+++ +Y EHDL  +++      + K+P      
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 119 -VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----VLKICDFGMSRQYGSPLKP 173
            VK L+ Q+L+G+ YLH NWVLHRDLK +N+L+  +G     +KI D G +R + SPLKP
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 174 YTSL---VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE------- 223
              L   VVT WYRAPELLLGA+ Y+ A+D+W++GCI AELL  +P+F    E       
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 224 --VDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVL--- 278
              DQ+D+IF  +G P +  W  + ++P          ++ L K F   ++T   ++   
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMP---------EHSTLMKDFRRNTYTNCSLIKYM 299
Query: 279 -------SESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDF 320
                      F LL +LLT DP KRIT + A+   +F E PLP S  F
Sbjct: 300 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVF 348

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/307 (37%), Positives = 173/307 (56%), Gaps = 24/307 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           + +L  I EG YG+V  A D      VA+KK+      +  C        +LREI ILL 
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYCQR------TLREIQILLR 97
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +++ +++++    ++    VY+V + ME DL  L++S  Q  S   +   + Q+L 
Sbjct: 98  FRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS--QQLSNDHICYFLYQILR 155
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLL+N    LKICDFG++R    P   +T      V T WYR
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYR 214
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE---D 271
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           L+ +   KA    Q      K   A  F   P       DLL+R+LT++P KRITV++AL
Sbjct: 272 LNCIINMKARNYLQSLPSKTKVAWAKLF---PKSDSKALDLLDRMLTFNPNKRITVEEAL 328
Query: 305 NHYWFHE 311
            H +  +
Sbjct: 329 AHPYLEQ 335

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 116/323 (35%), Positives = 170/323 (52%), Gaps = 23/323 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E+E +  I  G YG+V  AR + +G+ VA+KK+        +         +LRE+ IL 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKR------TLRELKILK 108
Query: 72  SFDHPSIVNVKEVVM-----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
            F H +I+ +K+++       +  SVY+V++ ME DL  ++ S  QP +   V+  + QL
Sbjct: 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQL 167
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----TSLVVTLW 182
           L G+KY+H   V+HRDLK SNLL+N    LKI DFGM+R   +    +    T  V T W
Sbjct: 168 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPEL+L   +Y+ A+D+WSVGCI  E+LA++ LF G   V Q+  I   LGTP+    
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS---- 283
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P + +  GA+    +     L  R P    T  P        LL R+L ++P  RI+   
Sbjct: 284 PAVIQAVGAER--VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341
Query: 303 ALNHYWFHEVPLPKSK-DFMPTF 324
           AL H +  +   P  + D  P F
Sbjct: 342 ALRHPFLAKYHDPDDEPDCAPPF 364

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 114/323 (35%), Positives = 167/323 (51%), Gaps = 23/323 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E+E +  I  G YG+V  AR + +G+ VA+KK+        +         +LRE+ IL 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKR------TLRELKILK 109
Query: 72  SFDHPSIVNVKEVVM-----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
            F H +I+ +K+++       +  SVY+V++ ME DL  ++ S  QP +   V+  + QL
Sbjct: 110 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQL 168
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----TSLVVTLW 182
           L G+KY+H   V+HRDLK SNLL+N    LKI DFGM+R   +    +    T  V T W
Sbjct: 169 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           YRAPEL+L   +Y+ A+D+WSVGCI  E+LA++ LF G   V Q+  I   LGTP+  + 
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV- 287
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
                +    A   +     L  R P    T  P        LL R+L ++P  RI+   
Sbjct: 288 -----IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 342
Query: 303 ALNHYWFHEVPLPKSK-DFMPTF 324
           AL H +  +   P  + D  P F
Sbjct: 343 ALRHPFLAKYHDPDDEPDCAPPF 365

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/307 (37%), Positives = 171/307 (55%), Gaps = 34/307 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLA 79
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 137
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 196
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 257 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 305
Query: 300 VDDALNH 306
           V+ AL H
Sbjct: 306 VEQALAH 312

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 77
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 135
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 194
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 303
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 304 VEQALAHPYLEQ 315

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 117/311 (37%), Positives = 174/311 (55%), Gaps = 42/311 (13%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLA 79
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 137
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 196
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT-ETIWP 243
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P+ E +  
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 244 GLS--------ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
           G++         LP       K P+N L   FP A             DLL+++LT++P 
Sbjct: 257 GINLKARNYLLSLPHKN----KVPWNRL---FPNA--------DSKALDLLDKMLTFNPH 301
Query: 296 KRITVDDALNH 306
           KRI V+ AL H
Sbjct: 302 KRIEVEQALAH 312

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 79
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 137
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 196
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 257 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 305
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 306 VEQALAHPYLEQ 317

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 77
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 135
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 194
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 303
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 304 VEQALAHPYLEQ 315

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 97
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 155
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 214
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 275 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 323
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 324 VEQALAHPYLEQ 335

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 77
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 135
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 194
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 303
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 304 VEQALAHPYLEQ 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 171/312 (54%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D        L KV++ + +        +   +LREI ILL 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDN-------LNKVRVAIKKISPFEHQTYXQRTLREIKILLR 81
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 139
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 307
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 308 VEQALAHPYLEQ 319

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 81
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 139
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYR 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 307
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 308 VEQALAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 82
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 140
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYR 199
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 260 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 308
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 309 VEQALAHPYLEQ 320

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 85
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 202
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 262
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 263 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 311
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 312 VEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 77
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 135
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 194
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 303
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 304 VEQALAHPYLEQ 315

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 75
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 133
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 192
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 252
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 253 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 301
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 302 VEQALAHPYLEQ 313

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 81
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 139
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 307
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 308 VEQALAHPYLEQ 319

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 82
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 140
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 199
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 260 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 308
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 309 VEQALAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 83
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 141
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 200
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 260
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 261 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 309
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 310 VEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 74
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 132
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 191
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 251
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 252 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 300
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 301 VEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 172/312 (55%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 81
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 139
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 307
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 308 VEQALAHPYLEQ 319

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 171/312 (54%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D        L KV++ + +        +   +LREI ILL 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDN-------LNKVRVAIRKISPFEHQTYCQRTLREIKILLR 81
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 139
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 307
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 308 VEQALAHPYLEQ 319

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 171/312 (54%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 81
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L++   Q  S   +   + Q+L 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC--QHLSNDHICYFLYQILR 139
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 307
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 308 VEQALAHPYLEQ 319

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 117/330 (35%), Positives = 170/330 (51%), Gaps = 30/330 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+  + + EG YG+V  A  K +GEIVA+KK+       E   +  F + +LREI IL 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREIKILK 64
Query: 72  SFDHPSIVNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            F H +I+ +  +   D     + VY++ E M+ DL  ++ +  Q  S   ++  + Q L
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTL 122
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR----------QYGSPLKPYTSL 177
             VK LH + V+HRDLK SNLL+N+   LK+CDFG++R          +        T  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           V T WYRAPE++L + KYS A+D+WS GCI+AEL  ++P+F G     Q+  IF  +GTP
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGS-PVLSESGFDLLNRLLTYDPEK 296
                    E P A+      P       +PAA      P ++  G DLL R+L +DP K
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPM------YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTFPP 326
           RIT  +AL H +      P  +      PP
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEPEGEPIPP 326

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 117/330 (35%), Positives = 170/330 (51%), Gaps = 30/330 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+  + + EG YG+V  A  K +GEIVA+KK+       E   +  F + +LREI IL 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREIKILK 64
Query: 72  SFDHPSIVNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            F H +I+ +  +   D     + VY++ E M+ DL  ++ +  Q  S   ++  + Q L
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTL 122
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR----------QYGSPLKPYTSL 177
             VK LH + V+HRDLK SNLL+N+   LK+CDFG++R          +        T  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           V T WYRAPE++L + KYS A+D+WS GCI+AEL  ++P+F G     Q+  IF  +GTP
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGS-PVLSESGFDLLNRLLTYDPEK 296
                    E P A+      P       +PAA      P ++  G DLL R+L +DP K
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPM------YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTFPP 326
           RIT  +AL H +      P  +      PP
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEPEGEPIPP 326

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 114/312 (36%), Positives = 171/312 (54%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 75
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 133
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WYR
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYR 192
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P +     
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNC 252
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 253 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 301
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 302 VEQALAHPYLEQ 313

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 117/330 (35%), Positives = 171/330 (51%), Gaps = 30/330 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+  + + EG YG+V  A  K +GEIVA+KK+       E   +  F + +LREI IL 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREIKILK 64
Query: 72  SFDHPSIVNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            F H +I+ +  +   D     + VY++ E M+ DL  ++ +  Q  S   ++  + Q L
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTL 122
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-------QYGSPLKPYTSLV-- 178
             VK LH + V+HRDLK SNLL+N+   LK+CDFG++R           P    + +V  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 179 -VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
             T WYRAPE++L + KYS A+D+WS GCI+AEL  ++P+F G     Q+  IF  +GTP
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGS-PVLSESGFDLLNRLLTYDPEK 296
                    E P A+      P       +PAA      P ++  G DLL R+L +DP K
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPM------YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTFPP 326
           RIT  +AL H +      P  +      PP
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEPEGEPIPP 326

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 113/313 (36%), Positives = 170/313 (54%), Gaps = 34/313 (10%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILL 96
Query: 72  SFDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            F H +I+ + +++    ++    VY+V   M  DL  L+++  Q  S   +   + Q+L
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQIL 154
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWY 183
            G+KY+H   VLHRDLK SNLLLN    LKICDFG++R    P   +T      V T WY
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWY 213
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAPE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++    
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 273
Query: 244 GLSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
            +  L       +     K P+N L   FP A             DLL+++LT++P KRI
Sbjct: 274 CIINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRI 322
Query: 299 TVDDALNHYWFHE 311
            V+ AL H +  +
Sbjct: 323 EVEQALAHPYLEQ 335

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 113/312 (36%), Positives = 171/312 (54%), Gaps = 34/312 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L+ I EG YG+V  A D  +   VA+KK+      +  C        +LREI ILL 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQR------TLREIKILLR 77
Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   +   + Q+L 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILR 135
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL----VVTLWYR 184
           G+KY+H   VLHRDLK SNLLLN    LKI DFG++R    P   +T      V T WYR
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEYVATRWYR 194
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P++     
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 245 LSELPGAKANFA-----KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
           +  L       +     K P+N L   FP A             DLL+++LT++P KRI 
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRL---FPNA--------DSKALDLLDKMLTFNPHKRIE 303
Query: 300 VDDALNHYWFHE 311
           V+ AL H +  +
Sbjct: 304 VEQALAHPYLEQ 315

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 120/357 (33%), Positives = 193/357 (54%), Gaps = 58/357 (16%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++E + K+ +G YGIV+++ D+++GE+VA+KK+        D         + REI IL 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR------TFREIMILT 63
Query: 72  SFD-HPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMES-MKQPFSTSEVKCLMLQLLE 128
               H +IVN+  V+  D+D  VY+V +YME DL  ++ + + +P     V   + QL++
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV---VYQLIK 120
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS--------PL--------- 171
            +KYLH   +LHRD+K SN+LLN +  +K+ DFG+SR + +        PL         
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 172 ---KPY-TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
              +P  T  V T WYRAPE+LLG+ KY+  +DMWS+GCI+ E+L  KP+F G++ ++Q+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 228 DKIFKTLGTPT------------ETIWPGLSELPGAKANFAKQPY----NLLRKRFPAAS 271
           ++I   +  P+            +T+   L E    + +  +  +    NLL K  P A 
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 272 FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW---FHEVPLPKSKDFMPTFP 325
                  +E   DLL++LL ++P KRI+ +DAL H +   FH      + D + T P
Sbjct: 301 ------CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIP 351

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 101/303 (33%), Positives = 164/303 (54%), Gaps = 13/303 (4%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           +S+ ++E L  + EG+YG+V + R+K +G IVA+KK   +   K           ++REI
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM------VKKIAMREI 75
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +L    H ++VN+ EV        Y+V E+++H +   +E          V+  + Q++
Sbjct: 76  KLLKQLRHENLVNLLEVC-KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+ + H + ++HRD+K  N+L++  GV+K+CDFG +R   +P + Y   V T WYRAPE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           LL+G  KY  AVD+W++GC++ E+   +PLF G +++DQ+  I   LG     + P   E
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG----NLIPRHQE 250
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           L      FA      +++R P       P LSE   DL  + L  DP+KR    + L+H 
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLER--RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308
Query: 308 WFH 310
           +F 
Sbjct: 309 FFQ 311

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 103/307 (33%), Positives = 170/307 (55%), Gaps = 25/307 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EK+ KI EG+YG+V++ R++ +G+IVA+KK    +  ++D +       +LREI +L 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPV---IKKIALREIRMLK 57
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP++VN+ EV       +++V EY +H +   ++  ++      VK +  Q L+ V 
Sbjct: 58  QLKHPNLVNLLEVFRRKR-RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H +  +HRD+K  N+L+    V+K+CDFG +R    P   Y   V T WYR+PELL+G
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
             +Y   VD+W++GC+ AELL+  PL+ G ++VDQ+  I KTLG     + P   ++   
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG----DLIPRHQQVFST 232
Query: 252 KANFAK----QPYNL--LRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
              F+      P ++  L  +FP  S+   P L      LL   L  DP +R+T +  L+
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISY---PALG-----LLKGCLHMDPTERLTCEQLLH 284
Query: 306 HYWFHEV 312
           H +F  +
Sbjct: 285 HPYFENI 291

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/305 (34%), Positives = 160/305 (52%), Gaps = 22/305 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L  +  G YG V  A D ++G  VA+KK+      +       F   + RE+ +L  
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLLKH 80
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +DD    Y+VM +M  DL  LM+  K       ++ L+ Q+L
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQML 138
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G++Y+H   ++HRDLK  NL +N    LKI DFG++RQ  S +      VVT WYRAPE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---XGXVVTRWYRAPE 195
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L   +Y+  VD+WSVGCIMAE++  K LF G+  +DQ+ +I K  GTP       L  
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                 N+ K    L +K F +     SP+      +LL ++L  D E+R+T  +AL H 
Sbjct: 256 --DEAKNYMKGLPELEKKDFASILTNASPL----AVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 308 WFHEV 312
           +F  +
Sbjct: 310 YFESL 314

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 109/334 (32%), Positives = 177/334 (52%), Gaps = 36/334 (10%)
Query: 4   LQGCRSVFEFEKLNK--------------ISEGTYGIVYRARDKKSGEIVALKKVKMNVG 49
           + G R+ F  ++LNK              +  G YG V  A D +  + VA+KK+     
Sbjct: 7   MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKL----S 62
Query: 50  RKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLK 104
           R    L +     + RE+ +L    H +++ + +V      ++D   VY+V   M  DL 
Sbjct: 63  RPFQSLIHAR--RTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLN 120
Query: 105 WLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS 164
            +++S  Q  S   V+ L+ QLL G+KY+H   ++HRDLK SN+ +N    L+I DFG++
Sbjct: 121 NIVKS--QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA 178
Query: 165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
           RQ    +  Y   V T WYRAPE++L    Y+  VD+WSVGCIMAELL  K LF G+  +
Sbjct: 179 RQADEEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235
Query: 225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD 284
           DQ+ +I + +GTP+  +   L+++    A    Q    + ++  ++ F G+  L+    D
Sbjct: 236 DQLKRIMEVVGTPSPEV---LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLA---ID 289
Query: 285 LLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK 318
           LL R+L  D ++R++  +AL H +F +   P+ +
Sbjct: 290 LLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE 323

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/308 (34%), Positives = 167/308 (54%), Gaps = 22/308 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  + D KSG  +A+KK+     R    + +     + RE+ +L  
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKL----SRPFQSIIHA--KRTYRELRLLKH 106
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 164
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 221
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  ++Q+ +I +  GTP  ++   +S 
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASV---ISR 278
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +P  +A         + KR  A  F G+  L+    DLL ++L  D +KRIT  +AL H 
Sbjct: 279 MPSHEARNYINSLPQMPKRNFADVFIGANPLA---VDLLEKMLVLDTDKRITASEALAHP 335
Query: 308 WFHEVPLP 315
           +F +   P
Sbjct: 336 YFSQYHDP 343

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 164/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L A  Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 158/297 (53%), Gaps = 25/297 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  G YG V  A DK+SGE VA+KK+      +       F   + RE+ +L    H ++
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------IFAKRAYRELLLLKHMQHENV 103
Query: 79  VNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           + + +V      + +    Y+VM +M+ DL+ +M      FS  +++ L+ Q+L+G+KY+
Sbjct: 104 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYI 160
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
           H   V+HRDLK  NL +N    LKI DFG++R   + +   T  VVT WYRAPE++L   
Sbjct: 161 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVILSWM 217
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y+  VD+WSVGCIMAE+L  K LF G   +DQ+ +I K  G P       L++   AK+
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND-KAAKS 276
Query: 254 NFAKQPYNLLRKRFPAASFTG-SPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                P      + P   FT   P  S    DLL ++L  D +KR+T   AL H +F
Sbjct: 277 YIQSLP------QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  167 bits (423), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 108/297 (36%), Positives = 160/297 (53%), Gaps = 25/297 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  G YG V  A DK+SGE VA+KK+      +       F   + RE+ +L    H ++
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------IFAKRAYRELLLLKHMQHENV 85
Query: 79  VNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           + + +V      + +    Y+VM +M+ DL+ +M  +K  FS  +++ L+ Q+L+G+KY+
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-GLK--FSEEKIQYLVYQMLKGLKYI 142
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
           H   V+HRDLK  NL +N    LKI DFG++R   + +   T  VVT WYRAPE++L   
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVILSWM 199
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y+  VD+WSVGCIMAE+L  K LF G   +DQ+ +I K  G P       L++   AK+
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND-KAAKS 258
Query: 254 NFAKQPYNLLRKRFPAASFTG-SPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                P      + P   FT   P  S    DLL ++L  D +KR+T   AL H +F
Sbjct: 259 YIQSLP------QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++S K   +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK--LTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG+ R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 166/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 97
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 155
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 212
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 273 --ESARNYIQSLAQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 326
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 327 YFAQYHDPDDE 337

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/320 (33%), Positives = 166/320 (51%), Gaps = 25/320 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSKDFMPTFPPQ 327
           +F +   P   D  P   PQ
Sbjct: 307 YFAQYHDP---DDEPVADPQ 323

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 166/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 96
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 154
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 211
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 272 --ESARNYIQSLAQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 325
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 326 YFAQYHDPDDE 336

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 83
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 141
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 198
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 259 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 313 YFAQYHDPDDE 323

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 108/334 (32%), Positives = 176/334 (52%), Gaps = 36/334 (10%)
Query: 4   LQGCRSVFEFEKLNK--------------ISEGTYGIVYRARDKKSGEIVALKKVKMNVG 49
           + G R+ F  ++LNK              +  G YG V  A D +  + VA+KK+     
Sbjct: 7   MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKL----S 62
Query: 50  RKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLK 104
           R    L +     + RE+ +L    H +++ + +V      ++D   VY+V   M  DL 
Sbjct: 63  RPFQSLIHAR--RTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLN 120
Query: 105 WLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS 164
            +++   Q  S   V+ L+ QLL G+KY+H   ++HRDLK SN+ +N    L+I DFG++
Sbjct: 121 NIVKC--QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA 178
Query: 165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
           RQ    +  Y   V T WYRAPE++L    Y+  VD+WSVGCIMAELL  K LF G+  +
Sbjct: 179 RQADEEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235
Query: 225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD 284
           DQ+ +I + +GTP+  +   L+++    A    Q    + ++  ++ F G+  L+    D
Sbjct: 236 DQLKRIMEVVGTPSPEV---LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLA---ID 289
Query: 285 LLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK 318
           LL R+L  D ++R++  +AL H +F +   P+ +
Sbjct: 290 LLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE 323

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 73
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 131
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 249 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 303 YFAQYHDPDDE 313

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 73
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK--LTDDHVQFLIYQIL 131
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 249 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 303 YFAQYHDPDDE 313

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  166 bits (420), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 84
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPE 199
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 260 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 314 YFAQYHDPDDE 324

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ I  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 82
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 140
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPE 197
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 258 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 312 YFAQYHDPDDE 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 84
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPE 199
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 260 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 314 YFAQYHDPDDE 324

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 83
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 141
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAPE 198
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 259 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 313 YFAQYHDPDDE 323

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 84
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPE 199
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 260 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 314 YFAQYHDPDDE 324

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAPE 194
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 255 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 309 YFAQYHDPDDE 319

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 87
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 145
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 146 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 202
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 262
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 263 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 316
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 317 YFAQYHDPDDE 327

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 166/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 97
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 155
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 212
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 273 --ESARNYIQSLTQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 326
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 327 YFAQYHDPDDE 337

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 83
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 141
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 198
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 259 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 313 YFAQYHDPDDE 323

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 82
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 140
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPE 197
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 258 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 312 YFAQYHDPDDE 322

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 168/311 (54%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
            + L  +  G YG V  A D +  + VA+KK+     R    L +     + RE+ +L  
Sbjct: 22  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKL----SRPFQSLIHAR--RTYRELRLLKH 75
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      ++D   VY+V   M  DL  +++   Q  S   V+ L+ QLL
Sbjct: 76  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLL 133
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SN+ +N    L+I DFG++RQ    +  Y   V T WYRAPE
Sbjct: 134 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY---VATRWYRAPE 190
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  K LF G+  +DQ+ +I + +GTP+  +   L++
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAK 247
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +    A    Q    + ++  ++ F G+  L+    DLL R+L  D ++R++  +AL H 
Sbjct: 248 ISSEHARTYIQSLPPMPQKDLSSIFRGANPLA---IDLLGRMLVLDSDQRVSAAEALAHA 304
Query: 308 WFHEVPLPKSK 318
           +F +   P+ +
Sbjct: 305 YFSQYHDPEDE 315

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 84
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 199
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 260 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 314 YFAQYHDPDDE 324

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 166/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 96
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 154
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 211
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 272 --ESARNYIQSLTQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 325
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 326 YFAQYHDPDDE 336

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 166/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 88
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 146
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPE 203
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 264 --ESARNYIQSLTQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 317
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 318 YFAQYHDPDDE 328

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 100
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 158
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VATRWYRAPE 215
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 276 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 329
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 330 YFAQYHDPDDE 340

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 74
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 132
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 189
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 250 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 303
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 304 YFAQYHDPDDE 314

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 194
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 255 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 309 YFAQYHDPDDE 319

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 82
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 140
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 197
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 258 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 312 YFAQYHDPDDE 322

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 76
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 134
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 135 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 191
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 251
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 252 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 305
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 306 YFAQYHDPDDE 316

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 83
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 141
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 198
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 259 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 313 YFAQYHDPDDE 323

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 82
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 140
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 197
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 258 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 312 YFAQYHDPDDE 322

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 194
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 255 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 309 YFAQYHDPDDE 319

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 89
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 147
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 204
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 265 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 318
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 319 YFAQYHDPDDE 329

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 89
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 147
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 204
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 265 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 318
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 319 YFAQYHDPDDE 329

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 194
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 255 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 309 YFAQYHDPDDE 319

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +   T  V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 88
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 146
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 203
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 264 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 317
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 318 YFAQYHDPDDE 328

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +      V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---AGFVATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 73
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 131
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +      V T WYRAPE
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---AGFVATRWYRAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 249 --ESARNYIQSLAQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 303 YFAQYHDPDDE 313

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 73
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 131
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 249 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 303 YFAQYHDPDDE 313

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 121/366 (33%), Positives = 176/366 (48%), Gaps = 83/366 (22%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E  + I  G+YG V  A DK    +VA+KK+        DC         LREI IL  
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI------LREIAILNR 108
Query: 73  FDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQL 126
            +H  +V V ++V+    +  D +Y+V+E  + D K L    + P   +E  +K L+  L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF---RTPVYLTELHIKTLLYNL 165
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS---PLKP----- 173
           L GVKY+H   +LHRDLK +N L+N    +K+CDFG++R     + G+   P+ P     
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 174 --------------YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA------ 213
                          T  VVT WYRAPEL+L  + Y+ A+D+WS+GCI AELL       
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 214 -----KKPLFSGTT--------------------EVDQIDKIFKTLGTPTETIWPGLSEL 248
                + PLF G++                      DQ++ IF  LGTP+E     L + 
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345
Query: 249 PGAK--ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
              +    F K+    L +RFPA+        S     LL R+L ++P KRIT+++ L H
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPAS--------SADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 307 YWFHEV 312
            +F EV
Sbjct: 398 PFFKEV 403

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 75
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 133
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 134 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 190
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 250
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 251 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 304
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 305 YFAQYHDPDDE 315

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 166/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 100
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 158
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 215
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 276 --ESARNYIQSLTQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 329
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 330 YFAQYHDPDDE 340

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +      V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---AGFVATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 74
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 132
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T WYRAPE
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPE 189
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 250 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 303
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 304 YFAQYHDPDDE 314

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 103/318 (32%), Positives = 162/318 (50%), Gaps = 36/318 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-------R 65
           ++ L+ +  G YG V  A D K+G  VA+KK+               P  S+       R
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-------------PFQSIIHAKRTYR 82
Query: 66  EINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVK 120
           E+ +L    H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQ 140
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
            L+ Q+L G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   V T
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VAT 197
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            WYRAPE++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
           +   +S    +  N+ +    + +  F       +P+      DLL ++L  D +KRIT 
Sbjct: 258 LLKKISS--ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITA 311
Query: 301 DDALNHYWFHEVPLPKSK 318
             AL H +F +   P  +
Sbjct: 312 AQALAHAYFAQYHDPDDE 329

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 165/311 (53%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 97
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++  K   +   V+ L+ Q+L
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQIL 155
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +      V T WYRAPE
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVATRWYRAPE 212
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F A  F G+  L+    DLL ++L  D +KRIT   AL H 
Sbjct: 273 --ESARNYIQSLAQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHA 326
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 327 YFAQYHDPDDE 337

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 163/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI D+G++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 117/361 (32%), Positives = 177/361 (49%), Gaps = 77/361 (21%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G+YG VY A DK + + VA+KKV        DC         LREI IL       I
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI------LREITILNRLKSDYI 87
Query: 79  VNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEGVKY 132
           + + ++++ D     D +Y+V+E  + DLK L    K P   +E  +K ++  LL G  +
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEEHIKTILYNLLLGENF 144
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL--------------------- 171
           +H++ ++HRDLK +N LLN    +K+CDFG++R   S                       
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 172 -KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL-----------AKKPLFS 219
            K  TS VVT WYRAPEL+L  + Y+ ++D+WS GCI AELL            + PLF 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 220 GT-----------------TEVDQIDKIFKTLGTPTETIWPGLSE---LPGAKANFAKQP 259
           G+                 +  DQ++ IF  +GTPTE     +++   +   K    ++P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 260 YNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD 319
            NL +K          P +S+ G +LL  +L ++P KRIT+D AL+H +  +V   K ++
Sbjct: 325 INLKQK---------YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLEN 375
Query: 320 F 320
           F
Sbjct: 376 F 376

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 159/298 (53%), Gaps = 14/298 (4%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNV--GRKEDCLEYGFPISS-LREINILLSFDH 75
           IS G+YG V    D + G  VA+K+V   V  GR  + L   F     LREI +L  F H
Sbjct: 30  ISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 76  PSIVNVKEVVMDDHD----SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           P+I+ ++++ +   +     +Y+V E M  DL  ++   +   S   ++  M  +L G+ 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
            LH+  V+HRDL   N+LL +   + ICDF ++R+  +     T  V   WYRAPEL++ 
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHRWYRAPELVMQ 207
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K ++  VDMWS GC+MAE+  +K LF G+T  +Q++KI + +GTP        S  P A
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS-PSA 266
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           +        N+  + + A   T  PV      DL+ ++L ++P++RI+ + AL H +F
Sbjct: 267 RDYLRNSLSNVPARAWTAVVPTADPV----ALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 159/298 (53%), Gaps = 14/298 (4%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNV--GRKEDCLEYGFPISS-LREINILLSFDH 75
           IS G+YG V    D + G  VA+K+V   V  GR  + L   F     LREI +L  F H
Sbjct: 30  ISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 76  PSIVNVKEVVMDDHD----SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           P+I+ ++++ +   +     +Y+V E M  DL  ++   +   S   ++  M  +L G+ 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
            LH+  V+HRDL   N+LL +   + ICDF ++R+  +     T  V   WYRAPEL++ 
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHRWYRAPELVMQ 207
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K ++  VDMWS GC+MAE+  +K LF G+T  +Q++KI + +GTP        S  P A
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS-PSA 266
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           +        N+  + + A   T  PV      DL+ ++L ++P++RI+ + AL H +F
Sbjct: 267 RDYLRNSLSNVPARAWTAVVPTADPV----ALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI DF ++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 108/320 (33%), Positives = 163/320 (50%), Gaps = 45/320 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV      K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SELPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           +E   A       P+  + R R P  +             L +RLL Y P  R+T  +A 
Sbjct: 255 TEF--AFPQIKAHPWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLEAC 301
Query: 305 NHYWFHE-----VPLPKSKD 319
            H +F E     V LP  +D
Sbjct: 302 AHSFFDELRDPNVKLPNGRD 321

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI  FG++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 166/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV      K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 255 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 299
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRD 321

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 108/320 (33%), Positives = 163/320 (50%), Gaps = 45/320 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV      K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SELPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           +E   A       P+  + R R P  +             L +RLL Y P  R+T  +A 
Sbjct: 255 TEF--AFPQIKAHPWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLEAC 301
Query: 305 NHYWFHE-----VPLPKSKD 319
            H +F E     V LP  +D
Sbjct: 302 AHSFFDELRDPNVKLPNGRD 321

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 111
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 172 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 230
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 290
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 291 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 335
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 336 ACAHSFFDELRDPNVKLPNGRD 357

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 87
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 206
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 266
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 267 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 311
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 312 ACAHSFFDELRDPNVKLPNGRD 333

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 113
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 174 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 232
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 292
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 293 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 337
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 338 ACAHSFFDELRDPNVKLPNGRD 359

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 109
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 228
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 289 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 333
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 334 ACAHSFFDELRDPNVKLPNGRD 355

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI D G++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 103
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 164 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 222
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 282
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 283 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 327
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 328 ACAHSFFDELRDPNVKLPNGRD 349

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 83
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 144 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 202
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 262
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 263 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 307
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 308 ACAHSFFDELRDPNVKLPNGRD 329

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 154
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 215 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 273
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 333
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 334 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 378
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 379 ACAHSFFDELRDPNVKLPNGRD 400

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 80
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 141 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 199
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 259
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 260 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 304
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 305 ACAHSFFDELRDPNVKLPNGRD 326

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 94
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 155 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 213
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 273
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 274 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 318
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 319 ACAHSFFDELRDPNVKLPNGRD 340

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 109
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 228
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 289 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 333
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 334 ACAHSFFDELRDPNVKLPNGRD 355

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 87
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 206
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 266
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 267 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 311
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 312 ACAHSFFDELRDPNVKLPNGRD 333

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 79
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 140 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 198
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 258
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 259 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 303
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 304 ACAHSFFDELRDPNVKLPNGRD 325

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 255 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 299
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRD 321

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI D G++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 255 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 299
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRD 321

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 22/311 (7%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L+ +  G YG V  A D K+G  VA+KK+     R    + +     + RE+ +L  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHA--KRTYRELRLLKH 77
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +++ + VY+V   M  DL  +++   Q  +   V+ L+ Q+L
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+KY+H   ++HRDLK SNL +N    LKI D G++R     +  Y   V T WYRAPE
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VATRWYRAPE 192
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP   +   +S 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
              +  N+ +    + +  F       +P+      DLL ++L  D +KRIT   AL H 
Sbjct: 253 --ESARNYIQSLTQMPKMNFANVFIGANPL----AVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 308 WFHEVPLPKSK 318
           +F +   P  +
Sbjct: 307 YFAQYHDPDDE 317

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 76
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 137 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 195
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 255
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 256 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 300
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 301 ACAHSFFDELRDPNVKLPNGRD 322

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 255 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 299
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRD 321

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 88
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 149 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 207
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 208 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 267
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 268 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 312
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 313 ACAHSFFDELRDPNVKLPNGRD 334

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 167/322 (51%), Gaps = 49/322 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+   DH +I
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIMRKLDHCNI 75
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V ++       +  D VY+  V++Y+   +  +       KQ      VK  M QL   +
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT----ETIWPGL 245
            GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT      + P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 246 SE--LPGAKANFAKQPYN-LLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           +E   P  KA+    P+  + R R P  +             L +RLL Y P  R+T  +
Sbjct: 255 TEFKFPQIKAH----PWTKVFRPRTPPEAIA-----------LCSRLLEYTPTARLTPLE 299
Query: 303 ALNHYWFHE-----VPLPKSKD 319
           A  H +F E     V LP  +D
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRD 321

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 163/315 (51%), Gaps = 36/315 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L  +  G  G+V+ A D    + VA+KK+ +   +            +LREI I+  
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--------HALREIKIIRR 64
Query: 73  FDHPSIVNVKEVV-------------MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
            DH +IV V E++             + + +SVY+V EYME DL  ++E  + P      
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHA 122
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSR---QYGSPLKPYT 175
           +  M QLL G+KY+H   VLHRDLK +NL +N +  VLKI DFG++R    + S     +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
             +VT WYR+P LLL    Y+ A+DMW+ GCI AE+L  K LF+G  E++Q+  I +++ 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 236 -TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
               E     LS +P    N   +P+  L +  P         +S    D L ++LT+ P
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG--------ISREAVDFLEQILTFSP 294
Query: 295 EKRITVDDALNHYWF 309
             R+T ++AL+H + 
Sbjct: 295 MDRLTAEEALSHPYM 309

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/320 (32%), Positives = 167/320 (52%), Gaps = 36/320 (11%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G++G+V++A+  +S E VA+KKV  +   K             RE+ I+    HP++
Sbjct: 48  IGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------------RELQIMRIVKHPNV 94
Query: 79  VNVKEVVM---DDHDSVYM--VMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGV 130
           V++K       D  D V++  V+EY+   +         +KQ      +K  M QLL  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 KYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            Y+H   + HRD+K  NLLL+   GVLK+ DFG ++   +  +P  S + + +YRAPEL+
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSXICSRYYRAPELI 213
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            GA  Y+T +D+WS GC+MAEL+  +PLF G + +DQ+ +I K LGTP+        ++ 
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR------EQIK 267
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
               N+ +  +  +R    +  F   P       DL++RLL Y P  R+T  +AL H +F
Sbjct: 268 TMNPNYMEHKFPQIRPHPFSKVF--RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
Query: 310 HEV-----PLPKSKDFMPTF 324
            E+      +P  ++  P F
Sbjct: 326 DELRTGEARMPNGRELPPLF 345

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 253 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKX 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 253 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 108/327 (33%), Positives = 167/327 (51%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 72
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQML 129
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+     T  VVT +YRAPE
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L  
Sbjct: 189 VILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 246
Query: 248 LPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITV 300
            P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI+V
Sbjct: 247 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           DDAL H     W+     E P P+  D
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYD 332

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 107/327 (32%), Positives = 168/327 (51%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +++L  I  G  GIV  A D   G  VA+KK+      +           + RE+ +L  
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR------AYRELVLLKC 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + +        +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R   +   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y+  VD+WSVGCIM EL+    +F GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 252
Query: 246 S-ELPGAKANFAKQPYNLLRKRFPAASFTGSP----VLSESGFDLLNRLLTYDPEKRITV 300
              +     N  K P     + FP   F        + +    DLL+++L  DP+KRI+V
Sbjct: 253 QPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 312
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           D+AL H     W+     E P P+  D
Sbjct: 313 DEALRHPYITVWYDPAEAEAPPPQIYD 339

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 117
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 174
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 231
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 232 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 291 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 349 SVDDALQHPYINVWYDPAEVEAPPPQIYD 377

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 253 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 108/327 (33%), Positives = 167/327 (51%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 73
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 130
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+     T  VVT +YRAPE
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 189
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L  
Sbjct: 190 VILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 247
Query: 248 LPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITV 300
            P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI+V
Sbjct: 248 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           DDAL H     W+     E P P+  D
Sbjct: 307 DDALQHPYINVWYDPAEVEAPPPQIYD 333

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 108/327 (33%), Positives = 167/327 (51%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 73
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 130
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+     T  VVT +YRAPE
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 189
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L  
Sbjct: 190 VILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 247
Query: 248 LPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITV 300
            P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI+V
Sbjct: 248 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           DDAL H     W+     E P P+  D
Sbjct: 307 DDALQHPYINVWYDPAEVEAPPPQIYD 333

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 106/327 (32%), Positives = 166/327 (50%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +++L  I  G  GIV  A D   G  VA+KK+      +           + RE+ +L  
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR------AYRELVLLKC 77
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + +        +  L+ Q+L
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQML 134
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R   +   + PY   VVT +YRA
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPY---VVTRYYRA 191
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM EL+    +F GT  +DQ +K+ + LGTP+      L
Sbjct: 192 PEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 250
Query: 246 S-ELPGAKANFAKQPYNLLRKRFPAASFTGSP----VLSESGFDLLNRLLTYDPEKRITV 300
              +     N    P     + FP   F        + +    DLL+++L  DP+KRI+V
Sbjct: 251 QPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 310
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           D+AL H     W+     E P P+  D
Sbjct: 311 DEALRHPYITVWYDPAEAEAPPPQIYD 337

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 117
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 174
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 231
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 232 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 291 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 349 SVDDALQHPYINVWYDPAEVEAPPPQIYD 377

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 253 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 311 SVDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 108/327 (33%), Positives = 167/327 (51%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 72
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 129
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+     T  VVT +YRAPE
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L  
Sbjct: 189 VILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 246
Query: 248 LPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITV 300
            P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI+V
Sbjct: 247 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           DDAL H     W+     E P P+  D
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYD 332

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 80
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 194
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 195 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 253
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 254 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 311
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 312 SVDDALQHPYINVWYDPAEVEAPPPQIYD 340

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 78
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 135
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 136 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 192
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 193 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 251
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 252 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 309
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 310 SVDDALQHPYINVWYDPAEVEAPPPQIYD 338

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 114/355 (32%), Positives = 171/355 (48%), Gaps = 78/355 (21%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G+YG VY A DK + + VA+KKV        DC         LREI IL       I
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRI------LREITILNRLKSDYI 89
Query: 79  VNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEGVKY 132
           + + ++++ +     D +Y+V+E  + DLK L    K P   +E  VK ++  LL G K+
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEQHVKTILYNLLLGEKF 146
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP---------------------- 170
           +H++ ++HRDLK +N LLN    +KICDFG++R   S                       
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 171 ---LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL-----------AKKP 216
               K  TS VVT WYRAPEL+L  + Y+ ++D+WS GCI AELL            + P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 217 LFSGT-----------------TEVDQIDKIFKTLGTPTETIWPGLSELPGAK--ANFAK 257
           LF G+                 +  DQ++ IF  +GTP E     +++    K    F  
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPT 326
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
           +    L K++ +        +S+ G DLL  +L ++ +KRIT+D AL+H +  +V
Sbjct: 327 RDGIDLSKKYSS--------ISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDV 373

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 37/329 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 80
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 194
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 195 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 253
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 254 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 311
Query: 299 TVDDALNH----YWFH----EVPLPKSKD 319
           +VDDAL H     W+     E P P+  D
Sbjct: 312 SVDDALQHPYINVWYDPAEVEAPPPQIYD 340

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 104/308 (33%), Positives = 162/308 (52%), Gaps = 29/308 (9%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKX 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 253 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 299 TVDDALNH 306
           +VDDAL H
Sbjct: 311 SVDDALQH 318

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 104/308 (33%), Positives = 162/308 (52%), Gaps = 29/308 (9%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKX 79
Query: 73  FDHPSIVNVKEV-----VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP-YNLLR--KRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRI 298
              P  +     +P Y  L   K FP + F      + + +    DLL+++L  DP KRI
Sbjct: 253 Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 299 TVDDALNH 306
           +VDDAL H
Sbjct: 311 SVDDALQH 318

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 167/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKV 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L  +++          +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 167/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L  +++          +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 167/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKV 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L  +++          +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 167/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L  +++          +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 167/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 80
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 137
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 194
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP       L
Sbjct: 195 PEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 254 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 311 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 340

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 73
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 130
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 187
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 188 PEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 246
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 247 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 303
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 304 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 333

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 107/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 84
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 141
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 142 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 198
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 199 PEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 257
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 258 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 314
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 315 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 344

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 106/328 (32%), Positives = 164/328 (50%), Gaps = 35/328 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+     T  VVT +YRAPE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPEVVTRYYRAPE 195
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP       L  
Sbjct: 196 VILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ- 253
Query: 248 LPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRIT 299
            P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KRI+
Sbjct: 254 -PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRIS 311
Query: 300 VDDALNH----YWFH----EVPLPKSKD 319
           VD+AL H     W+     E P PK  D
Sbjct: 312 VDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 106/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKV 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L  +++          +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVG IM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 104/327 (31%), Positives = 161/327 (49%), Gaps = 33/327 (10%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 81
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 138
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+        VVT +YRAPE
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MVPFVVTRYYRAPE 197
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP       L  
Sbjct: 198 VILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ- 255
Query: 248 LPGAKANFAKQPYNL---LRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITV 300
            P  +     +P        K FP   F      + + +    DLL+++L  D  KRI+V
Sbjct: 256 -PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 314
Query: 301 DDALNH----YWFH----EVPLPKSKD 319
           D+AL H     W+     E P PK  D
Sbjct: 315 DEALQHPYINVWYDPSEAEAPPPKIPD 341

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 106/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKV 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L  +++          +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY   VVT +YRA
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVG IM E++    LF GT  +DQ +K+ + LGTP+      L
Sbjct: 194 PEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 106/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   ++P    VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 106/330 (32%), Positives = 166/330 (50%), Gaps = 39/330 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +           + RE+ ++  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------AYRELVLMKC 79
Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+ +  V      +++   VY+VME M+ +L    + ++       +  L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQML 136
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRA 185
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   ++P    VVT +YRA
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE---VVTRYYRA 193
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L
Sbjct: 194 PEVILGM-GYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKL 252
Query: 246 SELPGAKANFAKQP----YNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKR 297
              P  +     +P    Y+   K FP   F      + + +    DLL+++L  D  KR
Sbjct: 253 Q--PTVRNYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 298 ITVDDALNH----YWFH----EVPLPKSKD 319
           I+VD+AL H     W+     E P PK  D
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD 339

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 102/325 (31%), Positives = 165/325 (50%), Gaps = 39/325 (12%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI- 69
           F+ E++    +GT+G V   ++K +G  VA+KKV  +            P    RE+ I 
Sbjct: 25  FQVERM--AGQGTFGTVQLGKEKSTGMSVAIKKVIQD------------PRFRNRELQIM 70
Query: 70  --LLSFDHPSIVNVKEVVMD----DHDSVYM--VMEYMEHDLKWLMESMKQPFSTSE--- 118
             L    HP+IV ++         D   +Y+  VMEY+   L     +  +         
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 119 VKCLMLQLLEGVKYLH--DNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYT 175
           +K  + QL+  +  LH     V HRD+K  N+L+N   G LK+CDFG +++  SP +P  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNV 189
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + + + +YRAPEL+ G + Y+TAVD+WSVGCI AE++  +P+F G     Q+ +I + LG
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSES--GFDLLNRLLTYD 293
            P+  +   L+      ++     YN   K  P ++      L ++   +DLL+ LL Y 
Sbjct: 250 CPSREVLRKLN-----PSHTDVDLYN--SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 294 PEKRITVDDALNHYWFHEVPLPKSK 318
           PE+R+   +AL H +F E+  P +K
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATK 327

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/338 (29%), Positives = 169/338 (50%), Gaps = 74/338 (21%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  G++GIV    D +SG+  ALKKV  +   K             RE++I+   DH +I
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------------RELDIMKVLDHVNI 62
Query: 79  VNV-----------------------------------KEVVMDDHDSVYM--VMEYMEH 101
           + +                                   K V+++   + Y+  +MEY+  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 102 DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLK 157
            L  +++S     +    + +   + QL   V ++H   + HRD+K  NLL+N++   LK
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182
Query: 158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL 217
           +CDFG +++   P +P  + + + +YRAPEL+LGA +Y+ ++D+WS+GC+  EL+  KPL
Sbjct: 183 LCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241
Query: 218 FSGTTEVDQIDKIFKTLGTPTET----IWPGLSEL--PGAKANFAKQPYNLLRKRFPAAS 271
           FSG T +DQ+ +I + +GTPT+     + P  +E+  P  KA          RK  P   
Sbjct: 242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD-------WRKILPE-- 292
Query: 272 FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             G+P L+    DLL ++L Y+P+ RI   +A+ H +F
Sbjct: 293 --GTPSLA---IDLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 143/302 (47%), Gaps = 49/302 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++++ K+  G YG V   +DK +G   A+K +K     K          + L E+ +L  
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK-----KSSVTTTSNSGALLDEVAVLKQ 77
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            DHP+I+ + E   +D  + Y+VME       +    ++Q FS  +   +M Q+L G  Y
Sbjct: 78  LDHPNIMKLYEF-FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 136
Query: 133 LHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPE 187
           LH + ++HRDLK  NLLL ++    ++KI DFG+S  +  G  +K       T +Y APE
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG---TAYYIAPE 193
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +L   KKY    D+WS G I+  LL   P F G T+ + + ++                 
Sbjct: 194 VL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV----------------- 234
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
               K  F+  P +  +             +S+    L+  +LTY+P KRI+ ++ALNH 
Sbjct: 235 ---EKGKFSFDPPDWTQ-------------VSDEAKQLVKLMLTYEPSKRISAEEALNHP 278
Query: 308 WF 309
           W 
Sbjct: 279 WI 280

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 146/297 (49%), Gaps = 49/297 (16%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           + +G++G V   +DK +G+  A+K + K  V +K D        S LRE+ +L   DHP+
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPN 93
Query: 78  IVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           I+ + E   +D    Y+V E Y   +L   + S K+ FS  +   ++ Q+L G+ Y+H N
Sbjct: 94  IMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKN 151
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            ++HRDLK  NLLL ++     ++I DFG+S  + +  K     + T +Y APE+L G  
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 209
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D+WS G I+  LL+  P F+G  E D + K+ K   T          ELP  K 
Sbjct: 210 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---------FELPQWKK 259
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                                   +SES  DL+ ++LTY P  RI+  DAL+H W  
Sbjct: 260 ------------------------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 146/297 (49%), Gaps = 49/297 (16%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           + +G++G V   +DK +G+  A+K + K  V +K D        S LRE+ +L   DHP+
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPN 111
Query: 78  IVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           I+ + E   +D    Y+V E Y   +L   + S K+ FS  +   ++ Q+L G+ Y+H N
Sbjct: 112 IMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKN 169
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            ++HRDLK  NLLL ++     ++I DFG+S  + +  K     + T +Y APE+L G  
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 227
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D+WS G I+  LL+  P F+G  E D + K+ K   T          ELP  K 
Sbjct: 228 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---------FELPQWKK 277
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                                   +SES  DL+ ++LTY P  RI+  DAL+H W  
Sbjct: 278 ------------------------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 143/302 (47%), Gaps = 49/302 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++++ K+  G YG V   +DK +G   A+K +K     K          + L E+ +L  
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK-----KSSVTTTSNSGALLDEVAVLKQ 60
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            DHP+I+ + E   +D  + Y+VME       +    ++Q FS  +   +M Q+L G  Y
Sbjct: 61  LDHPNIMKLYEF-FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 119
Query: 133 LHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPE 187
           LH + ++HRDLK  NLLL ++    ++KI DFG+S  +  G  +K       T +Y APE
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG---TAYYIAPE 176
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +L   KKY    D+WS G I+  LL   P F G T+ + + ++                 
Sbjct: 177 VL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV----------------- 217
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
               K  F+  P +  +             +S+    L+  +LTY+P KRI+ ++ALNH 
Sbjct: 218 ---EKGKFSFDPPDWTQ-------------VSDEAKQLVKLMLTYEPSKRISAEEALNHP 261
Query: 308 WF 309
           W 
Sbjct: 262 WI 263

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 146/297 (49%), Gaps = 49/297 (16%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           + +G++G V   +DK +G+  A+K + K  V +K D        S LRE+ +L   DHP+
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPN 110
Query: 78  IVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           I+ + E   +D    Y+V E Y   +L   + S K+ FS  +   ++ Q+L G+ Y+H N
Sbjct: 111 IMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKN 168
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            ++HRDLK  NLLL ++     ++I DFG+S  + +  K     + T +Y APE+L G  
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 226
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D+WS G I+  LL+  P F+G  E D + K+ K   T          ELP  K 
Sbjct: 227 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---------FELPQWKK 276
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                                   +SES  DL+ ++LTY P  RI+  DAL+H W  
Sbjct: 277 ------------------------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 146/297 (49%), Gaps = 49/297 (16%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           + +G++G V   +DK +G+  A+K + K  V +K D        S LRE+ +L   DHP+
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPN 87
Query: 78  IVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           I+ + E   +D    Y+V E Y   +L   + S K+ FS  +   ++ Q+L G+ Y+H N
Sbjct: 88  IMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKN 145
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            ++HRDLK  NLLL ++     ++I DFG+S  + +  K     + T +Y APE+L G  
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 203
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D+WS G I+  LL+  P F+G  E D + K+ K   T          ELP  K 
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---------FELPQWKK 253
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                                   +SES  DL+ ++LTY P  RI+  DAL+H W  
Sbjct: 254 ------------------------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 143/297 (48%), Gaps = 49/297 (16%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           + +G++G V   +DK +G+  A+K + K  V +K D        S LRE+ +L   DHP+
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPN 87
Query: 78  IVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           I  + E   +D    Y+V E Y   +L   + S K+ FS  +   ++ Q+L G+ Y H N
Sbjct: 88  IXKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYXHKN 145
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            ++HRDLK  NLLL ++     ++I DFG+S  + +  K     + T +Y APE+L G  
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKXKDKIGTAYYIAPEVLHGT- 203
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D+WS G I+  LL+  P F+G  E D + K+ K   T          ELP  K 
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---------FELPQWKK 253
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                                   +SES  DL+ + LTY P  RI+  DAL+H W  
Sbjct: 254 ------------------------VSESAKDLIRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 105/340 (30%), Positives = 155/340 (45%), Gaps = 50/340 (14%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
            + +E L  I +G++G V +A D K  + VALK V+          E  F   +  EI I
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---------EKRFHRQAAEEIRI 146
Query: 70  LLSF---DHPSIVNVKEVVMDD--HDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLM 123
           L      D  + +NV  ++ +    + + M  E +  +L  L++  K Q FS   V+   
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTL 181
             +L+ +  LH N ++H DLK  N+LL  QG   +K+ DFG S       + YT  + + 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTX-IQSR 263
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +YRAPE++LGA+ Y   +DMWS+GCI+AELL   PL  G  E DQ+  + + LG P++ +
Sbjct: 264 FYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 242 WPGLSELPGAKANFAKQPYN--------------LLRKRFPAASFTGSPVLSESG----- 282
              L     AK   + + Y               L   R       G P   E G     
Sbjct: 323 ---LDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 283 ------FDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
                  D L + L +DP  R+T   AL H W     LPK
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR-LPK 418

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 102/333 (30%), Positives = 152/333 (45%), Gaps = 49/333 (14%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
            + +E L  I +G++G V +A D K  + VALK V+          E  F   +  EI I
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---------EKRFHRQAAEEIRI 146
Query: 70  LLSF---DHPSIVNVKEVVMDD--HDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLM 123
           L      D  + +NV  ++ +    + + M  E +  +L  L++  K Q FS   V+   
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTL 181
             +L+ +  LH N ++H DLK  N+LL  QG   +K+ DFG S       + YT  + + 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTX-IQSR 263
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +YRAPE++LGA+ Y   +DMWS+GCI+AELL   PL  G  E DQ+  + + LG P++ +
Sbjct: 264 FYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 242 WPGLSELPGAKANFAKQPYN--------------LLRKRFPAASFTGSPVLSESG----- 282
              L     AK   + + Y               L   R       G P   E G     
Sbjct: 323 ---LDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 283 ------FDLLNRLLTYDPEKRITVDDALNHYWF 309
                  D L + L +DP  R+T   AL H W 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 12/206 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK+  +  +  +  +       ++E+  L  
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQK 110
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  +   + +H + ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 111 LRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL+  G++K+ DFG +    S + P    V T ++ APE++L  
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANXFVGTPYWMAPEVILAM 225
Query: 193 K--KYSTAVDMWSVGCIMAELLAKKP 216
              +Y   VD+WS+G    EL  +KP
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 12/206 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK+  +  +  +  +       ++E+  L  
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQK 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  +   + +H + ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 72  LRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL+  G++K+ DFG +    S + P    V T ++ APE++L  
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANXFVGTPYWMAPEVILAM 186
Query: 193 K--KYSTAVDMWSVGCIMAELLAKKP 216
              +Y   VD+WS+G    EL  +KP
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 105/345 (30%), Positives = 152/345 (44%), Gaps = 60/345 (17%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
            + +E L  I +G +G V +A D K  + VALK V+          E  F   +  EI I
Sbjct: 96  AYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRN---------EKRFHRQAAEEIRI 146
Query: 70  LLSF---DHPSIVNVKEVVMDD--HDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLM 123
           L      D  + +NV  ++ +    + + M  E +  +L  L++  K Q FS   V+   
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMS-----RQYGSPLKPYTS 176
             +L+ +  LH N ++H DLK  N+LL  QG   +K+ DFG S     R Y         
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--------X 258
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
            + + +YRAPE++LGA+ Y   +DMWS+GCI+AELL   PL  G  E DQ+  + + LG 
Sbjct: 259 XIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317
Query: 237 PTETIWPGLSELPGAKANFAKQPYN--------------LLRKRFPAASFTGSPVLSESG 282
           P + +   L     AK   + + Y               L   R       G P   E G
Sbjct: 318 PXQKL---LDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374
Query: 283 -----------FDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
                       D L + L +DP  R+T   AL H W     LPK
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR-LPK 418

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 56/308 (18%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSG---EIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           ++++ K+  G YG V   RDK +     I  ++K  ++       LE         E+ +
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE---------EVAV 89
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVME-YMEHDL-KWLMESMKQPFSTSEVKCLMLQLL 127
           L   DHP+I+ + +   +D  + Y+VME Y   +L   ++  MK  F+  +   ++ Q+L
Sbjct: 90  LKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVL 146
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
            GV YLH + ++HRDLK  NLLL ++    ++KI DFG+S  + +  K     + T +Y 
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYI 205
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+L   KKY    D+WS+G I+  LLA  P F G T+ + + K+ K   T     W  
Sbjct: 206 APEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           +SE  GAK                               DL+ ++L +D ++RI+   AL
Sbjct: 264 VSE--GAK-------------------------------DLIKQMLQFDSQRRISAQQAL 290
Query: 305 NHYWFHEV 312
            H W  E+
Sbjct: 291 EHPWIKEM 298

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 15  KLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEY--GFPISSLREINI 69
           K+ K+  G YG V   ++K       I  +KK + + GR  D  +    F      EI++
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           L S DHP+I+ + +V  +D    Y+V E+ E    +     +  F   +   +M Q+L G
Sbjct: 100 LKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVL---KICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           + YLH + ++HRD+K  N+LL N+  L   KI DFG+S  +    K    L  T +Y AP
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-GTAYYIAP 217
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           E+L   KKY+   D+WS G IM  LL   P F G  + D I K+ K              
Sbjct: 218 EVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-------------- 261
Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                K  F                F     +S+   +L+  +LTYD  KR T ++ALN 
Sbjct: 262 ----GKYYF---------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302
Query: 307 YW 308
            W
Sbjct: 303 RW 304

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 100/326 (30%), Positives = 158/326 (48%), Gaps = 46/326 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I +G++G V +A D+   E VA+K +K    +K    +    +  L  +N   +     I
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 99
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLH--D 135
           V++K   M   + + +V E + ++L  L+ +   +  S +  +    Q+   + +L   +
Sbjct: 100 VHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE 158
Query: 136 NWVLHRDLKTSNLLLNN--QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
             ++H DLK  N+LL N  +  +KI DFG S Q G  +      + + +YR+PE+LLG  
Sbjct: 159 LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQXIQSRFYRSPEVLLGMP 215
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y  A+DMWS+GCI+ E+   +PLFSG  EVDQ++KI + LG P   I   L + P A+ 
Sbjct: 216 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI---LDQAPKARK 271
Query: 254 NFAKQP---YNLLRKRFPAASF---------------TGSP---VLSESGF--------- 283
            F K P   +NL + +     +               TG P      ESG          
Sbjct: 272 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 331
Query: 284 DLLNRLLTYDPEKRITVDDALNHYWF 309
           DL+ R+L YDP+ RI    AL H +F
Sbjct: 332 DLILRMLDYDPKTRIQPYYALQHSFF 357

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 100/326 (30%), Positives = 158/326 (48%), Gaps = 46/326 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I +G++G V +A D+   E VA+K +K    +K    +    +  L  +N   +     I
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLH--D 135
           V++K   M   + + +V E + ++L  L+ +   +  S +  +    Q+   + +L   +
Sbjct: 119 VHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE 177
Query: 136 NWVLHRDLKTSNLLLNN--QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
             ++H DLK  N+LL N  +  +KI DFG S Q G  +      + + +YR+PE+LLG  
Sbjct: 178 LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQXIQSRFYRSPEVLLGMP 234
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y  A+DMWS+GCI+ E+   +PLFSG  EVDQ++KI + LG P   I   L + P A+ 
Sbjct: 235 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI---LDQAPKARK 290
Query: 254 NFAKQP---YNLLRKRFPAASF---------------TGSP---VLSESGF--------- 283
            F K P   +NL + +     +               TG P      ESG          
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350
Query: 284 DLLNRLLTYDPEKRITVDDALNHYWF 309
           DL+ R+L YDP+ RI    AL H +F
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 143
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 202
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 203 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 262
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 263 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 313
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 314 AMTHPYFQQV 323

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 142
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 201
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 261
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 262 PQLEALVG---RHSRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 312
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 313 AMTHPYFQQV 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 141
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 200
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 261 PQLEALVG---RHSRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 311
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 312 AMTHPYFQQV 321

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 141
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 200
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 261 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 311
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 312 AMTHPYFQQV 321

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 100/326 (30%), Positives = 158/326 (48%), Gaps = 46/326 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I +G++G V +A D+   E VA+K +K    +K    +    +  L  +N   +     I
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLH--D 135
           V++K   M   + + +V E + ++L  L+ +   +  S +  +    Q+   + +L   +
Sbjct: 119 VHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE 177
Query: 136 NWVLHRDLKTSNLLLNN--QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
             ++H DLK  N+LL N  +  +KI DFG S Q G  +      + + +YR+PE+LLG  
Sbjct: 178 LSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRI---YQXIQSRFYRSPEVLLGMP 234
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y  A+DMWS+GCI+ E+   +PLFSG  EVDQ++KI + LG P   I   L + P A+ 
Sbjct: 235 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI---LDQAPKARK 290
Query: 254 NFAKQP---YNLLRKRFPAASF---------------TGSP---VLSESGF--------- 283
            F K P   +NL + +     +               TG P      ESG          
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350
Query: 284 DLLNRLLTYDPEKRITVDDALNHYWF 309
           DL+ R+L YDP+ RI    AL H +F
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 141
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 200
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 261 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 311
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 312 AMTHPYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 141
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 200
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 261 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 311
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 312 AMTHPYFQQV 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 142
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 201
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 261
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 262 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 312
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 313 AMTHPYFQQV 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 141
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 200
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 261 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 311
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 312 AMTHPYFQQV 321

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 136/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 141
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 200
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT    ++         
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 261 PQLEALVGRH---SRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 311
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 312 AMTHPYFQQV 321

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 142/309 (45%), Gaps = 45/309 (14%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+  N + +G++  VYRA    +G  VA+K +      K+   + G       E+ I  
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID-----KKAMYKAGMVQRVQNEVKIHC 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HPSI+ +     +D + VY+V+E   + ++   +++  +PFS +E +  M Q++ G+
Sbjct: 67  QLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH + +LHRDL  SNLLL     +KI DFG++ Q   P + + +L  T  Y +PE+  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            +  +    D+WS+GC+   LL  +P F   T  + ++K+                    
Sbjct: 186 RS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------------- 225
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                              A +     LS    DL+++LL  +P  R+++   L+H +  
Sbjct: 226 ------------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
Query: 311 EVPLPKSKD 319
                KSKD
Sbjct: 268 RNSSTKSKD 276

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 165/316 (52%), Gaps = 41/316 (12%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVA---LKKVKMNVGRKEDCLEYGFPISSLREIN 68
           +++ + K+  G Y  V+ A +  + E V    LK VK N  +              REI 
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK--------------REIK 83
Query: 69  ILLSF-DHPSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
           IL +    P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M +
Sbjct: 84  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYE 139
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           +L+ + Y H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFK 198
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            PELL+  + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++ 
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYD 256
Query: 244 GLSELPGAKANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEK 296
            +      K N    P +N +     RKR+     +    ++S    D L++LL YD + 
Sbjct: 257 YID-----KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 297 RITVDDALNHYWFHEV 312
           R+T  +A+ H +F+ V
Sbjct: 312 RLTAREAMEHPYFYTV 327

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 89
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 90  HLRHPNILRLY-GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 206
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 207 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 237 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 135/250 (54%), Gaps = 27/250 (10%)
Query: 76  PSIVNVKEVVMDDHDSV-YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + ++V D H     ++ EY+ + D K L  ++    +  +++  + +LL+ + Y 
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL----TDYDIRYYIYELLKALDYC 162
Query: 134 HDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P K Y   V + +++ PELL+  
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL 221
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW--------- 242
           + Y  ++DMWS+GC+ A ++ +K P F G    DQ+ KI K LGT     +         
Sbjct: 222 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELD 281
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
           P L  L G     +++P+     +F  A      ++S    D L++LL YD ++R+T  +
Sbjct: 282 PQLEALVG---RHSRKPW----LKFMNAD--NQHLVSPEAIDFLDKLLRYDHQERLTALE 332
Query: 303 ALNHYWFHEV 312
           A+ H +F +V
Sbjct: 333 AMTHPYFQQV 342

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 68
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 69  HLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 185
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 186 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 215
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 216 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA+K   K K  +G      E    ++   EI IL   +H
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 74
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 75  PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 187
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 232
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 233 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274
Query: 306 HYWFHE 311
           H W  +
Sbjct: 275 HPWLQD 280

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 62
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 63  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 179
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 180 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 209
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 210 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA+K   K K  +G      E    ++   EI IL   +H
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 73
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 74  PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 131
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 132 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 186
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 187 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 231
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 232 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 273
Query: 306 HYWFHE 311
           H W  +
Sbjct: 274 HPWLQD 279

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 67  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 184 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 213
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 214 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA+K   K K  +G      E    ++   EI IL   +H
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 80
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 81  PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 138
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 139 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 193
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 194 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 238
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 239 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 280
Query: 306 HYWFHE 311
           H W  +
Sbjct: 281 HPWLQD 286

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA+K   K K  +G      E    ++   EI IL   +H
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 74
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 75  PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 187
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 232
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 233 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274
Query: 306 HYWFHE 311
           H W  +
Sbjct: 275 HPWLQD 280

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 68
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 69  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 185
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 186 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 215
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 216 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 13  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 67
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 68  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 184
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 185 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 214
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 215 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 68
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 69  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE + G
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEXIEG 185
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 186 -RXHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 215
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 216 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 26  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 80
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 81  HLRHPNILRLY-GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 198 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 227
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 228 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA+K   K K  +G      E    ++   EI IL   +H
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 74
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 75  PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 187
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 232
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 233 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274
Query: 306 HYWFHE 311
           H W  +
Sbjct: 275 HPWLQD 280

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 67  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 184 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 213
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 214 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTELCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTXLCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 132/242 (54%), Gaps = 36/242 (14%)
Query: 94  MVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN 152
           +V EY+ + D K L     Q  +  +++  M +LL+ + Y H   ++HRD+K  N+++++
Sbjct: 117 LVFEYINNTDFKQLY----QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 172
Query: 153 QGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL 211
           Q   L++ D+G++  Y  P + Y   V + +++ PELL+  + Y  ++DMWS+GC++A +
Sbjct: 173 QQKKLRLIDWGLAEFY-HPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 231
Query: 212 LAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW-----------PGLSELPGAKANFAKQP 259
           + ++ P F G    DQ+ +I K LGT  E ++           P  +++ G  +      
Sbjct: 232 IFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHIDLDPHFNDILGQHS------ 283
Query: 260 YNLLRKRFPAASFTGSP---VLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
               RKR+   +F  S    ++S    DLL++LL YD ++R+T  +A+ H +F+ V   +
Sbjct: 284 ----RKRW--ENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQ 337
Query: 317 SK 318
           S+
Sbjct: 338 SQ 339

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 68
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 69  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEG 185
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 186 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 215
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 216 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 64
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEG 181
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 211
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 212 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 64
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCH--APSSRRTTLSGTLDYLPPEMIEG 181
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 211
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 212 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 132/242 (54%), Gaps = 36/242 (14%)
Query: 94  MVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN 152
           +V EY+ + D K L     Q  +  +++  M +LL+ + Y H   ++HRD+K  N+++++
Sbjct: 112 LVFEYINNTDFKQLY----QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 167
Query: 153 QGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL 211
           Q   L++ D+G++  Y  P + Y   V + +++ PELL+  + Y  ++DMWS+GC++A +
Sbjct: 168 QQKKLRLIDWGLAEFY-HPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226
Query: 212 LAKK-PLFSGTTEVDQIDKIFKTLGTPTETIW-----------PGLSELPGAKANFAKQP 259
           + ++ P F G    DQ+ +I K LGT  E ++           P  +++ G  +      
Sbjct: 227 IFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHIDLDPHFNDILGQHS------ 278
Query: 260 YNLLRKRFPAASFTGSP---VLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
               RKR+   +F  S    ++S    DLL++LL YD ++R+T  +A+ H +F+ V   +
Sbjct: 279 ----RKRW--ENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQ 332
Query: 317 SK 318
           S+
Sbjct: 333 SQ 334

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  I  G +G+    RDK+S E+VA+K ++    R E   E     +  REI    S
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE----RGEKIDE-----NVKREIINHRS 70
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV  KEV++     + +VMEY      +        FS  E +    QL+ GV Y
Sbjct: 71  LRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 133 LHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            H   V HRDLK  N LL+      LKICDFG S+      +P  S V T  Y APE+LL
Sbjct: 130 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 188
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      D+WS G  +  +L     F                            E P 
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPF----------------------------EDPE 220
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              NF K  + +L  ++    +     +S     L++R+   DP KRI++ +  NH WF
Sbjct: 221 EPKNFRKTIHRILNVQYAIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 128/301 (42%), Gaps = 48/301 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS--LREINIL 70
           +E +  I  G +G+    RDK+S E+VA+K +           E G  I++   REI   
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYI-----------ERGEKIAANVKREIINH 69
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            S  HP+IV  KEV++     + +VMEY      +        FS  E +    QL+ GV
Sbjct: 70  RSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            Y H   V HRDLK  N LL+      LKICDFG S+      +P  S V T  Y APE+
Sbjct: 129 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 187
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           LL  +      D+WS G  +  +L     F                            E 
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPF----------------------------ED 219
Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           P    NF K  + +L  ++    +     +S     L++R+   DP KRI++ +  NH W
Sbjct: 220 PEEPKNFRKTIHRILNVQYAIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEW 276
Query: 309 F 309
           F
Sbjct: 277 F 277

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA++   K K  +G      E    ++   EI IL   +H
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 213
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 214 PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 271
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 272 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 326
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 327 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 371
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 372 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 413
Query: 306 HYWFHE 311
           H W  +
Sbjct: 414 HPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 141/306 (46%), Gaps = 56/306 (18%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G  G V  A ++K+ + VA++   K K  +G      E    ++   EI IL   +H
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR---EADPALNVETEIEILKKLNH 199
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P I+ +K     D +  Y+V+E ME    +      +    +  K    Q+L  V+YLH+
Sbjct: 200 PCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLW----YRAPEL 188
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G      TSL+ TL     Y APE+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEV 312
Query: 189 L--LGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGL 245
           L  +G   Y+ AVD WS+G I+   L+  P FS   T+V   D+I               
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------------- 357
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 K NF  + +                 +SE   DL+ +LL  DP+ R T ++AL 
Sbjct: 358 ---TSGKYNFIPEVW---------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 306 HYWFHE 311
           H W  +
Sbjct: 400 HPWLQD 405

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 67  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P     +L  TL Y  PE++ G
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRAALCGTLDYLPPEMIEG 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 184 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 213
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 214 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 67  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI +FG S    +P    T+L  TL Y  PE++ G
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 184 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 213
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 214 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P     +L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRAALCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 65
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 66  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI +FG S    +P    T+L  TL Y  PE++ G
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 182
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 183 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 212
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 213 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+   I+ALK     V  K    + G      RE+ I  
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 61  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 120 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 178 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 207
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 208 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 64
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P     +L  TL Y  PE++ G
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRDTLCGTLDYLPPEMIEG 181
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 211
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 212 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 123/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 89
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 90  HLRHPNILRLY-GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P      L  TL Y  PE++ G
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 207 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 236
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 237 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 123/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 68
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 69  HLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P      L  TL Y  PE++ G
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRXXLXGTLDYLPPEMIEG 185
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 186 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 215
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 216 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 133/246 (54%), Gaps = 19/246 (7%)
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P+I+ + ++V D       ++   EH      + ++Q  +  +++  M ++L+ + Y H 
Sbjct: 92  PNIITLADIVKDPVSRTPALV--FEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCHS 149
Query: 136 NWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
             ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  + 
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 195 YSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      K 
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID-----KY 261
Query: 254 NFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
           N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 307 YWFHEV 312
            +F+ V
Sbjct: 322 PYFYTV 327

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 123/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 67  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P      L  TL Y  PE++ G
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRDDLCGTLDYLPPEMIEG 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 184 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 213
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 214 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 123/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P      L  TL Y  PE++ G
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRXXLCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 210
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 211 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 123/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K S  I+ALK     V  K    + G      RE+ I  
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKNSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +     D    VY+++EY      +        F        + +L   + 
Sbjct: 64  HLRHPNILRLYGYFHDS-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P     +L  TL Y  PE++ G
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRAALCGTLDYLPPEMIEG 180
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T  D                          
Sbjct: 181 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTY------------------------ 215
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                        KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 216 -------------KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 123/298 (41%), Gaps = 46/298 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 65
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 66  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P      L  TL Y  PE++ G
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRXXLCGTLDYLPPEMIEG 182
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 183 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 212
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 213 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 123/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I  
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQS 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 67  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P      L  TL Y  PE++ G
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRXXLCGTLDYLPPEMIEG 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T                             
Sbjct: 184 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------------------- 213
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    KR     FT    ++E   DL++RLL ++P +R  + + L H W
Sbjct: 214 --------YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N+L++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 127/299 (42%), Gaps = 44/299 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  I  G +G+    RDK+S E+VA+K ++    R E   E     +  REI    S
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE----RGEKIDE-----NVKREIINHRS 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV  KEV++     + +VMEY      +        FS  E +    QL+ GV Y
Sbjct: 72  LRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 133 LHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            H   V HRDLK  N LL+      LKIC FG S+      +P  S V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      D+WS G  +  +L     F                            E P 
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----------------------------EDPE 221
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              NF K  + +L  ++    +     +S     L++R+   DP KRI++ +  NH WF
Sbjct: 222 EPKNFRKTIHRILNVQYAIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 141/254 (55%), Gaps = 23/254 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEVPLPKSK 318
            H +F+ V   +S+
Sbjct: 320 EHPYFYPVVKEQSQ 333

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 146
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 205
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 258
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 319 EHPYFYTV 326

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 146
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 205
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 258
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 319 EHPYFYTV 326

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 152
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 211
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 264
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 265 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 324
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 325 EHPYFYTV 332

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 145
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 204
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 257
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 318 EHPYFYTV 325

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 138/248 (55%), Gaps = 23/248 (9%)
Query: 76  PSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+I+ + ++V D    +  +V E++ + D K L +++    +  +++  M ++L+ + Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC 147
Query: 134 HDNWVLHRDLKTSNLLLNNQGV-LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 206
Query: 193 KKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LG  TE ++  +      
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYID----- 259
Query: 252 KANFAKQP-YNLL-----RKRFPAASFT-GSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           K N    P +N +     RKR+     +    ++S    D L++LL YD + R+T  +A+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 320 EHPYFYTV 327

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 139/296 (46%), Gaps = 46/296 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +G++G V + +D+ + +  A+K +     + +D        + LRE+ +L   DHP+I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNI 83
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
           + + E+ ++D  S Y+V E       +     ++ FS  +   ++ Q+  G+ Y+H + +
Sbjct: 84  MKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 139 LHRDLKTSNLLLNNQGV---LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           +HRDLK  N+LL ++     +KI DFG+S  +    K     + T +Y APE+L G   Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRGT--Y 199
Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF 255
               D+WS G I+  LL+  P F G  E D + ++        ET               
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ET--------------- 236
Query: 256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
            K  ++L + R           +S+   DL+ ++LT+ P  RIT    L H W  +
Sbjct: 237 GKYAFDLPQWR----------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 127/299 (42%), Gaps = 44/299 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  I  G +G+    RDK+S E+VA+K ++    R E   E     +  REI    S
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE----RGEKIDE-----NVKREIINHRS 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV  KEV++     + +VMEY      +        FS  E +    QL+ GV Y
Sbjct: 72  LRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 133 LHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            H   V HRDLK  N LL+      LKIC FG S+      +P  + V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLL 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      D+WS G  +  +L     F                            E P 
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----------------------------EDPE 221
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              NF K  + +L  ++    +     +S     L++R+   DP KRI++ +  NH WF
Sbjct: 222 EPKNFRKTIHRILNVQYAIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GTYGIVY  RD  +   +A+K++     R      Y  P+    EI +     H +I
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR------YSQPLH--EEIALHKHLKHKNI 81
Query: 79  VNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSE--VKCLMLQLLEGVKYLHD 135
           V        ++  + + ME +    L  L+ S   P   +E  +     Q+LEG+KYLHD
Sbjct: 82  VQYLGS-FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 136 NWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYT-SLVVTLWYRAPELL-LGA 192
           N ++HRD+K  N+L+N   GVLKI DFG S++    + P T +   TL Y APE++  G 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTETFTGTLQYMAPEIIDKGP 199
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLF 218
           + Y  A D+WS+GC + E+   KP F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+ L K+ EG+YG VY+A  K++G+IVA+K+V +    +E           ++EI+I+  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE----------IIKEISIMQQ 80
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            D P +V        + D +++VMEY     +  ++    +  +  E+  ++   L+G++
Sbjct: 81  CDSPHVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL-- 189
           YLH    +HRD+K  N+LLN +G  K+ DFG++ Q    +     ++ T ++ APE++  
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           +G   Y+   D+WS+G    E+   KP ++   ++  +  IF                  
Sbjct: 200 IG---YNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMI---------------- 237
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                    P N      P  +F    + S++  D + + L   PE+R T    L H
Sbjct: 238 ---------PTN------PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 46/296 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +G++G V + +D+ + +  A+K +     + +D        + LRE+ +L   DHP+I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNI 83
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
           + + E+ ++D  S Y+V E       +     ++ FS  +   ++ Q+  G+ Y+H + +
Sbjct: 84  MKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 139 LHRDLKTSNLLLNNQGV---LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           +HRDLK  N+LL ++     +KI DFG+S  +    K     + T +Y APE+L G   Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRGT--Y 199
Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF 255
               D+WS G I+  LL+  P F G  E D    I K + T                   
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVET------------------- 236
Query: 256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
            K  ++L + R           +S+   DL+ ++LT+ P  RIT    L H W  +
Sbjct: 237 GKYAFDLPQWR----------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +GTYGIVY  RD  +   +A+K++     R      Y  P+    EI +     H +I
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR------YSQPLH--EEIALHKHLKHKNI 67
Query: 79  VNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSE--VKCLMLQLLEGVKYLHD 135
           V        ++  + + ME +    L  L+ S   P   +E  +     Q+LEG+KYLHD
Sbjct: 68  VQYLGS-FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 136 NWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYT-SLVVTLWYRAPELL-LGA 192
           N ++HRD+K  N+L+N   GVLKI DFG S++    + P T +   TL Y APE++  G 
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTETFTGTLQYMAPEIIDKGP 185
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLF 218
           + Y  A D+WS+GC + E+   KP F
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+    + +G +G VY AR+++S  I+ALK     V  K    + G      RE+ I  
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALK-----VLFKTQLEKAGVEHQLRREVEIQS 67
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 68  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 184
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L   P F   T                             
Sbjct: 185 -RMHDEKVDLWSLGVLCYEFLVGMPPFEAHT----------------------------- 214
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    +R     FT    ++E   DL++RLL ++  +R+T+ + L H W
Sbjct: 215 --------YQETYRRISRVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 124/229 (54%), Gaps = 16/229 (6%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV---KMNVGRKEDCLEYGFPISSL 64
           +S+ ++ +L KI EG++G     +  + G    +K++   +M+   +E+         S 
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE---------SR 71
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVKCL 122
           RE+ +L +  HP+IV  +E   +++ S+Y+VM+Y E  DL   + + K   F   ++   
Sbjct: 72  REVAVLANMKHPNIVQYRES-FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
            +Q+   +K++HD  +LHRD+K+ N+ L   G +++ DFG++R   S ++   + + T +
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
           Y +PE+    K Y+   D+W++GC++ EL   K  F   +  + + KI 
Sbjct: 191 YLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 50/306 (16%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
           R +++F  +  +  G +  V  A DK++ ++VA+K + K  +  KE  +E         E
Sbjct: 17  RDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--------NE 66
Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
           I +L    HP+IV + ++  +    +Y++M+ +     +     K  ++  +   L+ Q+
Sbjct: 67  IAVLHKIKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 127 LEGVKYLHDNWVLHRDLKTSNLL---LNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           L+ VKYLHD  ++HRDLK  NLL   L+    + I DFG+S+    P    ++   T  Y
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGY 184
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE +L  K YS AVD WS+G I   LL   P F    +    ++I K         W 
Sbjct: 185 VAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 243
Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
                                             +S+S  D +  L+  DPEKR T + A
Sbjct: 244 D---------------------------------ISDSAKDFIRHLMEKDPEKRFTCEQA 270
Query: 304 LNHYWF 309
           L H W 
Sbjct: 271 LQHPWI 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 127/299 (42%), Gaps = 44/299 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  I  G +G+    RDK++ E+VA+K ++    R E   E     +  REI    S
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIE----RGEKIDE-----NVKREIINHRS 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV  KEV++     + +VMEY      +        FS  E +    QL+ GV Y
Sbjct: 72  LRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 133 LHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            H   V HRDLK  N LL+      LKI DFG S+      +P  S V T  Y APE+LL
Sbjct: 131 AHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP-KSAVGTPAYIAPEVLL 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      D+WS G  +  +L     F                            E P 
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----------------------------EDPE 221
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              NF K  + +L  ++    +     +S     L++R+   DP KRI++ +  NH WF
Sbjct: 222 EPKNFRKTIHRILNVQYAIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 139/307 (45%), Gaps = 48/307 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           +E    I +G + +V R  ++++G+  A+K V +           G     L RE +I  
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSP----GLSTEDLKREASICH 81
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKW-LMESMKQPFSTSEVKC--LMLQLL 127
              HP IV + E    D   +YMV E+M+  DL + +++     F  SE      M Q+L
Sbjct: 82  MLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 128 EGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           E ++Y HDN ++HRD+K  N+LL    N   +K+ DFG++ Q G         V T  + 
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE ++  + Y   VD+W  G I+  LL+    F GT E     ++F+ +          
Sbjct: 201 APE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGI---------- 244
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                  K  +   P                  +SES  DL+ R+L  DP +RITV +AL
Sbjct: 245 ------IKGKYKMNPRQWSH-------------ISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 305 NHYWFHE 311
           NH W  E
Sbjct: 286 NHPWLKE 292

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 46/296 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +G++G V + +D+ + +  A+K +     + +D        + LRE+ +L   DHP+I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT------STILREVELLKKLDHPNI 83
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
           + + E+ ++D  S Y+V E       +     ++ FS  +   ++ Q+  G+ Y+H + +
Sbjct: 84  MKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 139 LHRDLKTSNLLLNNQGV---LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           +HRDLK  N+LL ++     +KI DFG+S  +    K     + T +Y APE+L G   Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRGT--Y 199
Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF 255
               D+WS G I+  LL+  P F G  E D    I K + T                   
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVET------------------- 236
Query: 256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
            K  ++L + R           +S+   DL+ ++LT+ P  RIT    L H W  +
Sbjct: 237 GKYAFDLPQWR----------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 50/309 (16%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISS 63
           +  R +++F  +  +  G +  V  A DK++ ++VA+K + K  +  KE  +E       
Sbjct: 14  EDIRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME------- 64
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
             EI +L    HP+IV + ++  +    +Y++M+ +     +     K  ++  +   L+
Sbjct: 65  -NEIAVLHKIKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLL---LNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+L+ VKYLHD  ++HRDLK  NLL   L+    + I DFG+S+    P    ++   T
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGT 181
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE +L  K YS AVD WS+G I   LL   P F    +    ++I K        
Sbjct: 182 PGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            W                                   +S+S  D +  L+  DPEKR T 
Sbjct: 241 YWDD---------------------------------ISDSAKDFIRHLMEKDPEKRFTC 267
Query: 301 DDALNHYWF 309
           + AL H W 
Sbjct: 268 EQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 50/309 (16%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISS 63
           +  R +++F  +  +  G +  V  A DK++ ++VA+K + K  +  KE  +E       
Sbjct: 14  EDIRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME------- 64
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
             EI +L    HP+IV + ++  +    +Y++M+ +     +     K  ++  +   L+
Sbjct: 65  -NEIAVLHKIKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLL---LNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+L+ VKYLHD  ++HRDLK  NLL   L+    + I DFG+S+    P    ++   T
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGT 181
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE +L  K YS AVD WS+G I   LL   P F    +    ++I K        
Sbjct: 182 PGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            W                                   +S+S  D +  L+  DPEKR T 
Sbjct: 241 YWDD---------------------------------ISDSAKDFIRHLMEKDPEKRFTC 267
Query: 301 DDALNHYWF 309
           + AL H W 
Sbjct: 268 EQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 50/309 (16%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISS 63
           +  R +++F  +  +  G +  V  A DK++ ++VA+K + K  +  KE  +E       
Sbjct: 14  EDIRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME------- 64
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
             EI +L    HP+IV + ++  +    +Y++M+ +     +     K  ++  +   L+
Sbjct: 65  -NEIAVLHKIKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLL---LNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+L+ VKYLHD  ++HRDLK  NLL   L+    + I DFG+S+    P    ++   T
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGT 181
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE +L  K YS AVD WS+G I   LL   P F    +    ++I K        
Sbjct: 182 PGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            W                                   +S+S  D +  L+  DPEKR T 
Sbjct: 241 YWDD---------------------------------ISDSAKDFIRHLMEKDPEKRFTC 267
Query: 301 DDALNHYWF 309
           + AL H W 
Sbjct: 268 EQALQHPWI 276

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 121/209 (57%), Gaps = 14/209 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++  + A K +  +   +E+  +Y      + EI+IL S
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDY------MVEIDILAS 90
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP+IV + +    +++ +++++E+     +  +M  +++P + S+++ +  Q L+ + 
Sbjct: 91  CDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLHDN ++HRDLK  N+L    G +K+ DFG+S +    ++   S + T ++ APE+++ 
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 192 A----KKYSTAVDMWSVGCIMAELLAKKP 216
                + Y    D+WS+G  + E+   +P
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 121/209 (57%), Gaps = 14/209 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++  + A K +  +   +E+  +Y      + EI+IL S
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDY------MVEIDILAS 90
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP+IV + +    +++ +++++E+     +  +M  +++P + S+++ +  Q L+ + 
Sbjct: 91  CDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLHDN ++HRDLK  N+L    G +K+ DFG+S +    ++   S + T ++ APE+++ 
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMC 209
Query: 192 A----KKYSTAVDMWSVGCIMAELLAKKP 216
                + Y    D+WS+G  + E+   +P
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+    + +G +G VY AR+++S  I+ALK     V  K    + G      RE+ I  
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALK-----VLFKTQLEKAGVEHQLRREVEIQS 67
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +      D   VY+++EY      +        F        + +L   + 
Sbjct: 68  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P     +L  TL Y  PE++ G
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVH--APSSRRDTLCGTLDYLPPEMIEG 184
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L   P F   T                             
Sbjct: 185 -RMHDEKVDLWSLGVLCYEFLVGMPPFEAHT----------------------------- 214
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                   Y    +R     FT    ++E   DL++RLL ++  +R+T+ + L H W
Sbjct: 215 --------YQETYRRISRVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 7/217 (3%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++L   R++  + +   + +G +   Y   D  + E+ A K V  ++  K    E     
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
               EI I  S D+P +V       DD D VY+V+E         +   ++  +  E + 
Sbjct: 88  KMSTEIAIHKSLDNPHVVGFHGFFEDD-DFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            M Q ++GV+YLH+N V+HRDLK  NL LN+   +KI DFG++ +     +   +L  T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
            Y APE+L   K +S  VD+WS+GCI+  LL  KP F
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 149/321 (46%), Gaps = 50/321 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL- 70
           +FE    + +G++G V+ A  KK+ +  A+K +K +V   +D +E      ++ E  +L 
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLS 73
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           L+++HP + ++        ++++ VMEY+   DL + ++S  + F  S       +++ G
Sbjct: 74  LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILG 131
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           +++LH   +++RDLK  N+LL+  G +KI DFGM ++             T  Y APE+L
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           LG +KY+ +VD WS G ++ E+L  +  F G  E +    I   +  P    W       
Sbjct: 192 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRW------- 241
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-DDALNHYW 308
                                       L +   DLL +L   +PEKR+ V  D   H  
Sbjct: 242 ----------------------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 273
Query: 309 FHEVPLP--KSKDFMPTFPPQ 327
           F E+     + K+  P F P+
Sbjct: 274 FREINWEELERKEIDPPFRPK 294

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 120/209 (57%), Gaps = 14/209 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++  + A K +  +   +E+  +Y      + EI+IL S
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDY------MVEIDILAS 90
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP+IV + +    +++ +++++E+     +  +M  +++P + S+++ +  Q L+ + 
Sbjct: 91  CDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLHDN ++HRDLK  N+L    G +K+ DFG+S +    ++     + T ++ APE+++ 
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMC 209
Query: 192 A----KKYSTAVDMWSVGCIMAELLAKKP 216
                + Y    D+WS+G  + E+   +P
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 7/217 (3%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++L   R++  + +   + +G +   Y   D  + E+ A K V  ++  K    E     
Sbjct: 17  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----- 71
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
               EI I  S D+P +V       DD D VY+V+E         +   ++  +  E + 
Sbjct: 72  KMSTEIAIHKSLDNPHVVGFHGFFEDD-DFVYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            M Q ++GV+YLH+N V+HRDLK  NL LN+   +KI DFG++ +     +    L  T 
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
            Y APE+L   K +S  VD+WS+GCI+  LL  KP F
Sbjct: 191 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 7/217 (3%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++L   R++  + +   + +G +   Y   D  + E+ A K V  ++  K    E     
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
               EI I  S D+P +V       DD D VY+V+E         +   ++  +  E + 
Sbjct: 88  KMSTEIAIHKSLDNPHVVGFHGFFEDD-DFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            M Q ++GV+YLH+N V+HRDLK  NL LN+   +KI DFG++ +     +    L  T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
            Y APE+L   K +S  VD+WS+GCI+  LL  KP F
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 7/217 (3%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++L   R++  + +   + +G +   Y   D  + E+ A K V  ++  K    E     
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE----- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
               EI I  S D+P +V       DD D VY+V+E         +   ++  +  E + 
Sbjct: 88  KMSTEIAIHKSLDNPHVVGFHGFFEDD-DFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            M Q ++GV+YLH+N V+HRDLK  NL LN+   +KI DFG++ +     +    L  T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
            Y APE+L   K +S  VD+WS+GCI+  LL  KP F
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 130/298 (43%), Gaps = 48/298 (16%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           N I  G++G V  A  K +    A KK+        D  +        +EI I+ S DHP
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--------QEIEIMKSLDHP 83
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +I+ + E   D+ D +Y+VME       +     K+ F  S+   +M  +L  V Y H  
Sbjct: 84  NIIRLYETFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 137 WVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            V HRDLK  N L    +    LK+ DFG++ ++  P K   + V T +Y +P++L G  
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLEGL- 200
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D WS G +M  LL   P FS  T+ + + KI +   T  E  W  +S  P A++
Sbjct: 201 -YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS--PQAES 257
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                                          L+ RLLT  P++RIT   AL H WF +
Sbjct: 258 -------------------------------LIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 146/314 (46%), Gaps = 50/314 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + +G++G V+ A  KK+ +  A+K +K +V   +D +E      ++ E  +L L+++HP 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLSLAWEHPF 79
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           + ++        ++++ VMEY+   DL + ++S  + F  S       +++ G+++LH  
Sbjct: 80  LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK 137
Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            +++RDLK  N+LL+  G +KI DFGM ++             T  Y APE+LLG +KY+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYN 196
Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
            +VD WS G ++ E+L  +  F G  E +    I   +  P    W              
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRW-------------- 240
Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-DDALNHYWFHEVPLP 315
                                L +   DLL +L   +PEKR+ V  D   H  F E+   
Sbjct: 241 ---------------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279
Query: 316 --KSKDFMPTFPPQ 327
             + K+  P F P+
Sbjct: 280 ELERKEIDPPFRPK 293

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 130/298 (43%), Gaps = 48/298 (16%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           N I  G++G V  A  K +    A KK+        D  +        +EI I+ S DHP
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--------QEIEIMKSLDHP 66
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +I+ + E   D+ D +Y+VME       +     K+ F  S+   +M  +L  V Y H  
Sbjct: 67  NIIRLYETFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 137 WVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            V HRDLK  N L    +    LK+ DFG++ ++  P K   + V T +Y +P++L G  
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLEGL- 183
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y    D WS G +M  LL   P FS  T+ + + KI +   T  E  W  +S  P A++
Sbjct: 184 -YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS--PQAES 240
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                                          L+ RLLT  P++RIT   AL H WF +
Sbjct: 241 -------------------------------LIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 141/305 (46%), Gaps = 58/305 (19%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINILLSFDHP 76
           K+  G +G V+   ++ SG    L++V   + +    +    P+  +  EI +L S DHP
Sbjct: 29  KLGSGAFGDVHLVEERSSG----LERVIKTINKDRSQV----PMEQIEAEIEVLKSLDHP 80
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSE--VKCLMLQLLEGVKY 132
           +I+ + EV  D H+ +Y+VME  E    L+ ++ +  +  + SE  V  LM Q++  + Y
Sbjct: 81  NIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 133 LHDNWVLHRDLKTSNLLLNN---QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            H   V+H+DLK  N+L  +      +KI DFG++  + S  +  T+   T  Y APE+ 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVF 198
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT--EVDQIDKIFKTLGTPTETIWPGLSE 247
              +  +   D+WS G +M  LL     F+GT+  EV Q                     
Sbjct: 199 --KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ--------------------- 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
               KA + K+P   +  R           L+    DLL ++LT DPE+R +    L+H 
Sbjct: 236 ----KATY-KEPNYAVECR----------PLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 308 WFHEV 312
           WF + 
Sbjct: 281 WFKQA 285

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           ++ +F+ +  + +G +G VY AR+K++  I+ALK +  +   KE     G      REI 
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-----GVEHQLRREIE 66
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           I     HP+I+ +      D   +Y+++E+      +        F        M +L +
Sbjct: 67  IQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            + Y H+  V+HRD+K  NLL+  +G LKI DFG S    +P      +  TL Y  PE+
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRXMCGTLDYLPPEM 183
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           + G K +   VD+W  G +  E L   P F   +               TET        
Sbjct: 184 IEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------------TET-------- 220
Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                           +R         P LS+   DL+++LL Y P +R+ +   + H W
Sbjct: 221 ---------------HRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 15/226 (6%)
Query: 13  FEKLNKISEGTYGIVYRAR---DKKSGEIVALKKVK--MNVGRKEDCLEYGFPISSLREI 67
           FE L  + +G YG V++ R      +G+I A+K +K  M V   +D         +  E 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH------TKAER 72
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML-QL 126
           NIL    HP IV++          +Y+++EY+    +  M+  ++     +  C  L ++
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAEI 130
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
              + +LH   +++RDLK  N++LN+QG +K+ DFG+ ++         +   T+ Y AP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
           E+L+ +  ++ AVD WS+G +M ++L   P F+G      IDKI K
Sbjct: 191 EILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKED------------ 53
           C  + ++   ++I +G+YG+V  A ++      A+K + K  + R+              
Sbjct: 9   CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 54  ----CLEYGFPISSL-REINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEHDLKWLM 107
               C++   PI  + +EI IL   DHP++V + EV+ D + D +YMV E +       +
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 108 ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY 167
            ++K P S  + +     L++G++YLH   ++HRD+K SNLL+   G +KI DFG+S ++
Sbjct: 129 PTLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKY--STAVDMWSVGCIMAELLAKKPLFSGTTEVD 225
                  ++ V T  + APE L   +K     A+D+W++G  +   +  +  F       
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF------- 240
Query: 226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDL 285
            +D+    L +  ++                            A  F   P ++E   DL
Sbjct: 241 -MDERIMCLHSKIKS---------------------------QALEFPDQPDIAEDLKDL 272
Query: 286 LNRLLTYDPEKRITVDDALNHYW 308
           + R+L  +PE RI V +   H W
Sbjct: 273 ITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 15/226 (6%)
Query: 13  FEKLNKISEGTYGIVYRAR---DKKSGEIVALKKVK--MNVGRKEDCLEYGFPISSLREI 67
           FE L  + +G YG V++ R      +G+I A+K +K  M V   +D         +  E 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH------TKAER 72
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML-QL 126
           NIL    HP IV++          +Y+++EY+    +  M+  ++     +  C  L ++
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAEI 130
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
              + +LH   +++RDLK  N++LN+QG +K+ DFG+ ++             T+ Y AP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
           E+L+ +  ++ AVD WS+G +M ++L   P F+G      IDKI K
Sbjct: 191 EILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 144/300 (48%), Gaps = 47/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  AR+K SG  VA+K + +   ++ + L          E+ I+  + H +
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--------FNEVVIMRDYQHFN 103
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +V + +  +   + ++++ME+++   L  ++  ++   +  ++  +   +L+ + YLH  
Sbjct: 104 VVEMYKSYLVGEE-LWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQ 160
Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            V+HRD+K+ ++LL   G +K+ DFG   Q    +     LV T ++ APE ++    Y+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYA 219
Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
           T VD+WS+G ++ E++  +P +   + V  + +               L + P  K    
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---------------LRDSPPPKLK-- 262
Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
                         S   SPVL     D L R+L  DP++R T  + L+H +  +  LP+
Sbjct: 263 -------------NSHKVSPVLR----DFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 137/307 (44%), Gaps = 48/307 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           +E    I +G + +V R  ++++G+  A+K V +           G     L RE +I  
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP----GLSTEDLKREASICH 83
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKW-LMESMKQPFSTSEVKC--LMLQLL 127
              HP IV + E    D   +YMV E+M+  DL + +++     F  SE      M Q+L
Sbjct: 84  MLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           E ++Y HDN ++HRD+K   +LL    N   +K+  FG++ Q G         V T  + 
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE ++  + Y   VD+W  G I+  LL+    F GT E     ++F+ +          
Sbjct: 203 APE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGI---------- 246
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                  K  +   P                  +SES  DL+ R+L  DP +RITV +AL
Sbjct: 247 ------IKGKYKMNPRQWSH-------------ISESAKDLVRRMLMLDPAERITVYEAL 287
Query: 305 NHYWFHE 311
           NH W  E
Sbjct: 288 NHPWLKE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 137/307 (44%), Gaps = 48/307 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           +E    I +G + +V R  ++++G+  A+K V +           G     L RE +I  
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP----GLSTEDLKREASICH 81
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKW-LMESMKQPFSTSEVKC--LMLQLL 127
              HP IV + E    D   +YMV E+M+  DL + +++     F  SE      M Q+L
Sbjct: 82  MLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 128 EGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           E ++Y HDN ++HRD+K   +LL    N   +K+  FG++ Q G         V T  + 
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE ++  + Y   VD+W  G I+  LL+    F GT E     ++F+ +          
Sbjct: 201 APE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGI---------- 244
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                  K  +   P                  +SES  DL+ R+L  DP +RITV +AL
Sbjct: 245 ------IKGKYKMNPRQWSH-------------ISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 305 NHYWFHE 311
           NH W  E
Sbjct: 286 NHPWLKE 292

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/320 (28%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  I  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEYM     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           ++ +F+    + +G +G VY AR+K++  I+ALK +  +   KE     G      REI 
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-----GVEHQLRREIE 67
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           I     HP+I+ +      D   +Y+++E+      +        F        M +L +
Sbjct: 68  IQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 126
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            + Y H+  V+HRD+K  NLL+  +G LKI DFG S    +P      +  TL Y  PE+
Sbjct: 127 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRXMCGTLDYLPPEM 184
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           + G K +   VD+W  G +  E L   P F   +               TET        
Sbjct: 185 IEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------------TET-------- 221
Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                           +R         P LS+   DL+++LL Y P +R+ +   + H W
Sbjct: 222 ---------------HRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/320 (28%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  I  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEYM     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 122/299 (40%), Gaps = 44/299 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +  I  G +G+    RDK + E+VA+K ++      E+           REI    S
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---------REIINHRS 72
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV  KEV++     + ++MEY      +        FS  E +    QLL GV Y
Sbjct: 73  LRHPNIVRFKEVILTP-THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 133 LHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            H   + HRDLK  N LL+      LKICDFG S+      +P  S V T  Y APE+LL
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 190
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      D+WS G  +  +L     F                            E P 
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPF----------------------------EDPE 222
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              ++ K    +L  ++   S      +S     L++R+   DP  RI++ +   H WF
Sbjct: 223 EPRDYRKTIQRILSVKY---SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 133/266 (50%), Gaps = 16/266 (6%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A +K +G+ VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--------FNEVVIMRDYHHDN 103
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V++    +   D +++VME++E      + +  +  +  ++  + L +L  + YLH+  
Sbjct: 104 VVDMYSSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQG 161
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APE ++    Y T
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGT 220
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG-AKANFA 256
            VD+WS+G ++ E++  +P +     +  + +I  +L    + +    S L G       
Sbjct: 221 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLV 280
Query: 257 KQPYNLLRKRFPAASFTGSPVLSESG 282
           ++P     +R  A    G P L  +G
Sbjct: 281 REP----SQRATAQELLGHPFLKLAG 302

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 140/317 (44%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 110
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 111 NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T +L  T  Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGATWTLCGTPEY 225
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 259
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 260 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 301
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 302 FGNLKNGVNDIKNHKWF 318

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 50/265 (18%)
Query: 66  EINILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPF-STSEVKCLM 123
           EI ILL +  HP+I+ +K+V  DD   VY+V E M    + L + ++Q F S  E   ++
Sbjct: 70  EIEILLRYGQHPNIITLKDV-YDDGKHVYLVTELMRGG-ELLDKILRQKFFSEREASFVL 127
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
             + + V+YLH   V+HRDLK SN+L      N   L+ICDFG ++Q    L+    L++
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ----LRAENGLLM 183
Query: 180 TLWYRA----PELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTL 234
           T  Y A    PE+L   + Y    D+WS+G ++  +LA   P  +G +  D  ++I   +
Sbjct: 184 TPCYTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRI 240
Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           G+       G   L G   N                       +SE+  DL++++L  DP
Sbjct: 241 GS-------GKFTLSGGNWN----------------------TVSETAKDLVSKMLHVDP 271
Query: 295 EKRITVDDALNHYWF-HEVPLPKSK 318
            +R+T    L H W   +  LP+S+
Sbjct: 272 HQRLTAKQVLQHPWVTQKDKLPQSQ 296

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 50/265 (18%)
Query: 66  EINILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPF-STSEVKCLM 123
           EI ILL +  HP+I+ +K+V  DD   VY+V E M    + L + ++Q F S  E   ++
Sbjct: 70  EIEILLRYGQHPNIITLKDV-YDDGKHVYLVTELMRGG-ELLDKILRQKFFSEREASFVL 127
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
             + + V+YLH   V+HRDLK SN+L      N   L+ICDFG ++Q    L+    L++
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ----LRAENGLLM 183
Query: 180 TLWYRA----PELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTL 234
           T  Y A    PE+L   + Y    D+WS+G ++  +LA   P  +G +  D  ++I   +
Sbjct: 184 TPCYTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRI 240
Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           G+       G   L G   N                       +SE+  DL++++L  DP
Sbjct: 241 GS-------GKFTLSGGNWN----------------------TVSETAKDLVSKMLHVDP 271
Query: 295 EKRITVDDALNHYWF-HEVPLPKSK 318
            +R+T    L H W   +  LP+S+
Sbjct: 272 HQRLTAKQVLQHPWVTQKDKLPQSQ 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 142/302 (47%), Gaps = 53/302 (17%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++ 
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMR 72
Query: 72  SFDHPSIVNVKEVVMDDH---DSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
              +P+IVN     +D +   D +++VMEY+      L + + +      ++  +  + L
Sbjct: 73  ENKNPNIVNY----LDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECL 126
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++   K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         E
Sbjct: 187 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP---------E 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           L        + P  L      +A F           D LNR L  D EKR +  + L H 
Sbjct: 236 L--------QNPEKL------SAIFR----------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 308 WF 309
           + 
Sbjct: 272 FL 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 90
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 91  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 239
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 240 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 281
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 282 FGNLKNGVNDIXNHKWF 298

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  I  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLAGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 114/223 (51%), Gaps = 19/223 (8%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVK----MNVGRKEDCLEYGFPI 61
           G  ++  F    KI  G +  VYRA     G  VALKKV+    M+   + DC+      
Sbjct: 27  GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI------ 80
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---FSTS 117
              +EI++L   +HP+++      ++D++ + +V+E  +  DL  +++  K+        
Sbjct: 81  ---KEIDLLKQLNHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            V    +QL   ++++H   V+HRD+K +N+ +   GV+K+ D G+ R + S      SL
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           V T +Y +PE  +    Y+   D+WS+GC++ E+ A +  F G
Sbjct: 197 VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 140/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGVFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 74  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 188
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 225
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 226 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 140/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKDGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLPNGVNDIKNHKWF 297

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 74  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 188
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 225
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 226 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 140/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKDGVNDIKNHKWF 297

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/327 (25%), Positives = 139/327 (42%), Gaps = 51/327 (15%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R  F F  +  +  G +  V+  + + +G++ ALK +K +   ++  LE         EI
Sbjct: 8   RKTFIF--MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--------NEI 57
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +L    H +IV ++++  +     Y+VM+ +     +     +  ++  +   ++ Q+L
Sbjct: 58  AVLKKIKHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL 116
Query: 128 EGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
             VKYLH+N ++HRDLK  NLL         + I DFG+S+   + +   ++   T  Y 
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYV 174
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE +L  K YS AVD WS+G I   LL   P F   TE    +KI +         W  
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233
Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                                            +SES  D +  LL  DP +R T + AL
Sbjct: 234 ---------------------------------ISESAKDFICHLLEKDPNERYTCEKAL 260
Query: 305 NHYWFHEVPLPKSKDFMPTFPPQHARN 331
           +H W  +      +D  P+   Q  +N
Sbjct: 261 SHPWI-DGNTALHRDIYPSVSLQIQKN 286

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 146/316 (46%), Gaps = 54/316 (17%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHP 76
           ++  G + +V +   K +G+  A K +K    R +DC         L EI +L L+   P
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKR-RRGQDC-----RAEILHEIAVLELAKSCP 89
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
            ++N+ EV  ++   + +++EY          +  + +  S ++V  L+ Q+LEGV YLH
Sbjct: 90  RVINLHEV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 135 DNWVLHRDLKTSNLLLNN---QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
            N ++H DLK  N+LL++    G +KI DFGMSR+ G   +    ++ T  Y APE +L 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPE-ILN 206
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
               +TA DMW++G I   LL     F               +G   +  +  +S++   
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPF---------------VGEDNQETYLNISQV--- 248
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             +++++ ++                +S+   D +  LL  +PEKR T +  L+H W  +
Sbjct: 249 NVDYSEETFS---------------SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
Query: 312 VPLPKSKDFMPTFPPQ 327
                  DF   F P+
Sbjct: 294 W------DFENLFHPE 303

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 110
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 111 NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 225
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 259
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 260 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 301
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 302 FGNLKNGVNDIKNHKWF 318

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNYE-----FEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLXGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 141/302 (46%), Gaps = 53/302 (17%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++ 
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMR 72
Query: 72  SFDHPSIVNVKEVVMDDH---DSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
              +P+IVN     +D +   D +++VMEY+      L + + +      ++  +  + L
Sbjct: 73  ENKNPNIVNY----LDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECL 126
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        + +V T ++ APE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE 186
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++   K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         E
Sbjct: 187 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP---------E 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           L        + P  L      +A F           D LNR L  D EKR +  + L H 
Sbjct: 236 L--------QNPEKL------SAIFR----------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 308 WF 309
           + 
Sbjct: 272 FL 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  + SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 209
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +    +   D +++VME++E      + +  +  +  ++  + L +L+ +  LH   
Sbjct: 210 VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG 267
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APEL+     Y  
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 326
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
            VD+WS+G ++ E++  +P +                        P L  +   + N   
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLPP 365
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P S
Sbjct: 366 RLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 412

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 141/302 (46%), Gaps = 53/302 (17%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++ 
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMR 72
Query: 72  SFDHPSIVNVKEVVMDDH---DSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
              +P+IVN     +D +   D +++VMEY+      L + + +      ++  +  + L
Sbjct: 73  ENKNPNIVNY----LDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECL 126
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        + +V T ++ APE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE 186
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++   K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         E
Sbjct: 187 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP---------E 235
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           L        + P  L      +A F           D LNR L  D EKR +  + L H 
Sbjct: 236 L--------QNPEKL------SAIFR----------DFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 308 WF 309
           + 
Sbjct: 272 FL 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 90
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 91  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 239
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 240 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 281
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 282 FGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 90
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 91  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 239
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 240 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 281
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 282 FGNLKNGVNDIKNHKWF 298

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V +++E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNYE-----FEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 90
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 91  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 239
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 240 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 281
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 282 FGNLKNGVNDIKNHKWF 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 76
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 77  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 135
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 191
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 192 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 225
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 226 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 267
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 268 FGNLKNGVNDIKNHKWF 284

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE  +++  G   IVYR + K + +  ALK +K  V +K              EI +LL 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK----------IVRTEIGVLLR 104
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+I+ +KE+  +    + +V+E +     +     K  +S  +    + Q+LE V Y
Sbjct: 105 LSHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 133 LHDNWVLHRDLKTSNLLLNN---QGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPE 187
           LH+N ++HRDLK  NLL         LKI DFG+S+  ++   +K   ++  T  Y APE
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCGTPGYCAPE 220
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           +L G   Y   VDMWSVG I   LL   +P +      DQ                    
Sbjct: 221 ILRGC-AYGPEVDMWSVGIITYILLCGFEPFYD--ERGDQF------------------- 258
Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF---DLLNRLLTYDPEKRITVDDA 303
                          + R+      +  SP   E      DL+ +L+  DP+KR+T   A
Sbjct: 259 ---------------MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
Query: 304 LNHYW 308
           L H W
Sbjct: 304 LQHPW 308

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  + SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 87
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +    +   D +++VME++E      + +  +  +  ++  + L +L+ +  LH   
Sbjct: 88  VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG 145
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APEL+     Y  
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 204
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
            VD+WS+G ++ E++  +P +                        P L  +   + N   
Sbjct: 205 EVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLPP 243
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P S
Sbjct: 244 RLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 290

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 82
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 83  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 141
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 197
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 198 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 231
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 232 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 273
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 274 FGNLKNGVNDIKNHKWF 290

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  + SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 89
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +    +   D +++VME++E      + +  +  +  ++  + L +L+ +  LH   
Sbjct: 90  VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG 147
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APEL+     Y  
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 206
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
            VD+WS+G ++ E++  +P +                        P L  +   + N   
Sbjct: 207 EVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLPP 245
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P S
Sbjct: 246 RLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 292

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 90
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY      +        FS    +    
Sbjct: 91  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG +++    +K  T  L  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 239
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 240 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 281
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 282 FGNLKNGVNDIKNHKWF 298

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  + SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 78
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +    +   D +++VME++E      + +  +  +  ++  + L +L+ +  LH   
Sbjct: 79  VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG 136
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APEL+     Y  
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 195
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
            VD+WS+G ++ E++  +P +                        P L  +   + N   
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLPP 234
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P S
Sbjct: 235 RLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 281

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  + SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 132
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +    +   D +++VME++E      + +  +  +  ++  + L +L+ +  LH   
Sbjct: 133 VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG 190
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APEL+     Y  
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 249
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
            VD+WS+G ++ E++  +P +                        P L  +   + N   
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLPP 288
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P S
Sbjct: 289 RLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 335

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI EG+ GIV  A  + SG++VA+KK+ +   ++ + L          E+ I+  + H +
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--------FNEVVIMRDYQHEN 82
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +V +    +   D +++VME++E      + +  +  +  ++  + L +L+ +  LH   
Sbjct: 83  VVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG 140
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST 197
           V+HRD+K+ ++LL + G +K+ DFG   Q    +     LV T ++ APEL+     Y  
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 199
Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
            VD+WS+G ++ E++  +P +                        P L  +   + N   
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFNE---------------------PPLKAMKMIRDNLPP 238
Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  NL +          SP L   GF  L+RLL  DP +R T  + L H +  +   P S
Sbjct: 239 RLKNLHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 285

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 52/307 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +  + EG++G V  A    +G+ VALK +   V  K D           REI+ L  
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-----MQGRIEREISYLRL 70
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP I+ + +V+    D + MV+EY  ++L  ++++  +   S  E +    Q++  V+
Sbjct: 71  LRHPHIIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVE 127
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELL 189
           Y H + ++HRDLK  NLLL+    +KI DFG+S     G+ LK       +  Y APE++
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 184
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            G       VD+WS G I+  +L ++  F      + I  +FK +     T+   LS  P
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----ESIPVLFKNISNGVYTLPKFLS--P 238
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           GA                                 L+ R+L  +P  RI++ + +   WF
Sbjct: 239 GAAG-------------------------------LIKRMLIVNPLNRISIHEIMQDDWF 267
Query: 310 HEVPLPK 316
            +V LP+
Sbjct: 268 -KVDLPE 273

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 52/307 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +  + EG++G V  A    +G+ VALK +   V  K D           REI+ L  
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-----MQGRIEREISYLRL 60
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP I+ + +V+    D + MV+EY  ++L  ++++  +   S  E +    Q++  V+
Sbjct: 61  LRHPHIIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVE 117
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELL 189
           Y H + ++HRDLK  NLLL+    +KI DFG+S     G+ LK       +  Y APE++
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 174
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            G       VD+WS G I+  +L ++  F      + I  +FK +     T+   LS  P
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----ESIPVLFKNISNGVYTLPKFLS--P 228
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           GA                                 L+ R+L  +P  RI++ + +   WF
Sbjct: 229 GAAG-------------------------------LIKRMLIVNPLNRISIHEIMQDDWF 257
Query: 310 HEVPLPK 316
            +V LP+
Sbjct: 258 -KVDLPE 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 140/310 (45%), Gaps = 54/310 (17%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S+ +F+ L  +  G++G V+  R + +G   A+K +K  +  +   +E+        +  
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH------TNDER 57
Query: 69  ILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
           ++LS   HP I+ +     D    ++M+M+Y+E    + +    Q F     K    ++ 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
             ++YLH   +++RDLK  N+LL+  G +KI DFG ++    P   Y  L  T  Y APE
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY-XLCGTPDYIAPE 173
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            ++  K Y+ ++D WS G ++ E+LA    F  +  +   +KI               +E
Sbjct: 174 -VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------------AE 219
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDD 302
           L                 RFP       P  +E   DLL+RL+T D  +R+       +D
Sbjct: 220 L-----------------RFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255
Query: 303 ALNHYWFHEV 312
             NH WF EV
Sbjct: 256 VKNHPWFKEV 265

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 52/307 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +  + EG++G V  A    +G+ VALK +   V  K D           REI+ L  
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-----MQGRIEREISYLRL 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP I+ + +V+    D + MV+EY  ++L  ++++  +   S  E +    Q++  V+
Sbjct: 70  LRHPHIIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVE 126
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELL 189
           Y H + ++HRDLK  NLLL+    +KI DFG+S     G+ LK       +  Y APE++
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 183
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            G       VD+WS G I+  +L ++  F      + I  +FK +     T+   LS  P
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----ESIPVLFKNISNGVYTLPKFLS--P 237
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           GA                                 L+ R+L  +P  RI++ + +   WF
Sbjct: 238 GAAG-------------------------------LIKRMLIVNPLNRISIHEIMQDDWF 266
Query: 310 HEVPLPK 316
            +V LP+
Sbjct: 267 -KVDLPE 272

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 52/307 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +  + EG++G V  A    +G+ VALK +   V  K D           REI+ L  
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-----MQGRIEREISYLRL 64
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP I+ + +V+    D + MV+EY  ++L  ++++  +   S  E +    Q++  V+
Sbjct: 65  LRHPHIIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVE 121
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELL 189
           Y H + ++HRDLK  NLLL+    +KI DFG+S     G+ LK       +  Y APE++
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 178
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            G       VD+WS G I+  +L ++  F      + I  +FK +     T+   LS  P
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----ESIPVLFKNISNGVYTLPKFLS--P 232
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           GA                                 L+ R+L  +P  RI++ + +   WF
Sbjct: 233 GAAG-------------------------------LIKRMLIVNPLNRISIHEIMQDDWF 261
Query: 310 HEVPLPK 316
            +V LP+
Sbjct: 262 -KVDLPE 267

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 141/302 (46%), Gaps = 53/302 (17%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++ 
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMR 73
Query: 72  SFDHPSIVNVKEVVMDDH---DSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
              +P+IVN     +D +   D +++VMEY+      L + + +      ++  +  + L
Sbjct: 74  ENKNPNIVNY----LDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECL 127
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        + +V T ++ APE
Sbjct: 128 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE 187
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++   K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         E
Sbjct: 188 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP---------E 236
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           L        + P  L      +A F           D LNR L  D EKR +  + + H 
Sbjct: 237 L--------QNPEKL------SAIFR----------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 308 WF 309
           + 
Sbjct: 273 FL 274

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ ++ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 44/305 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           +E   ++  G + IV + R K +G+  A K +K    R+      G     + RE+NIL 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKK---RRLSSSRRGVSREEIEREVNILR 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ + ++  +  D V +++E +     +   + K+  +  E    + Q+L+GV 
Sbjct: 64  EIRHPNIITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           YLH   + H DLK  N++L ++ V    +K+ DFG++ +  +    + ++  T  + APE
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPE 181
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            ++  +      DMWS+G I   LL+    F G T+ + +                    
Sbjct: 182 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------------------- 220
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                 N +   Y+     F    F+ +   SE   D + RLL  DP++R+T+  +L H 
Sbjct: 221 -----TNISAVNYD-----FDEEYFSNT---SELAKDFIRRLLVKDPKRRMTIAQSLEHS 267
Query: 308 WFHEV 312
           W   +
Sbjct: 268 WIKAI 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F+    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 140/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 88
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 89  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T +L  T
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGT 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 239
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 240 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 278
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 279 TKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 140/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 18  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 73
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 74  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 131
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T +L  T
Sbjct: 132 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGT 187
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 188 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 224
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 225 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 263
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 264 TKRFGNLKDGVNDIKNHKWF 283

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 39/244 (15%)
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI+I  S  H  +V       +D+D V++V+E         +   ++  +  E +  + Q
Sbjct: 67  EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 125
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +   +L  T  Y A
Sbjct: 126 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIA 185
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE +L  K +S  VD+WS+GCIM  LL  KP                    P ET     
Sbjct: 186 PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET----- 219
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           S L        K  Y++ +   P A+             L+ ++L  DP  R T+++ LN
Sbjct: 220 SCLKETYLRIKKNEYSIPKHINPVAA------------SLIQKMLQTDPTARPTINELLN 267
Query: 306 HYWF 309
             +F
Sbjct: 268 DEFF 271

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 39/244 (15%)
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI+I  S  H  +V       +D+D V++V+E         +   ++  +  E +  + Q
Sbjct: 71  EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 129
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +   +L  T  Y A
Sbjct: 130 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIA 189
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE +L  K +S  VD+WS+GCIM  LL  KP                    P ET     
Sbjct: 190 PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET----- 223
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           S L        K  Y++ +   P A+             L+ ++L  DP  R T+++ LN
Sbjct: 224 SCLKETYLRIKKNEYSIPKHINPVAA------------SLIQKMLQTDPTARPTINELLN 271
Query: 306 HYWF 309
             +F
Sbjct: 272 DEFF 275

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 110
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F     +    
Sbjct: 111 NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 169
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 225
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 259
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 260 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 301
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 302 FGNLKNGVNDIKNHKWF 318

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 39/244 (15%)
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI+I  S  H  +V       +D+D V++V+E         +   ++  +  E +  + Q
Sbjct: 67  EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 125
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +   +L  T  Y A
Sbjct: 126 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIA 185
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE +L  K +S  VD+WS+GCIM  LL  KP                    P ET     
Sbjct: 186 PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET----- 219
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           S L        K  Y++ +   P A+             L+ ++L  DP  R T+++ LN
Sbjct: 220 SCLKETYLRIKKNEYSIPKHINPVAA------------SLIQKMLQTDPTARPTINELLN 267
Query: 306 HYWF 309
             +F
Sbjct: 268 DEFF 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 48/298 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + +V + R+K +G   A K +K    R+      G     + RE++IL    HP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + EV  +  D V ++ E +     +   + K+  +  E    + Q+L GV YLH  
Sbjct: 75  NVITLHEVYENKTD-VILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            + H DLK  N++L ++ V    +KI DFG++ +  +G+  K   ++  T  + APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE-IV 189
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 226
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
             AN +   Y      F    F+ +  L++   D + RLL  DP+KR+T+ D+L H W
Sbjct: 227 --ANVSAVNY-----EFEDEYFSNTSALAK---DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 145/315 (46%), Gaps = 60/315 (19%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E    I  G+Y +  R   K +    A+K +  +   K D  E         EI ILL 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRDPTE---------EIEILLR 71
Query: 73  F-DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPF-STSEVKCLMLQLLEGV 130
           +  HP+I+ +K+V  DD   VY+V E M+   + L + ++Q F S  E   ++  + + V
Sbjct: 72  YGQHPNIITLKDV-YDDGKYVYVVTELMKGG-ELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 131 KYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR-- 184
           +YLH   V+HRDLK SN+L      N   ++ICDFG ++Q    L+    L++T  Y   
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ----LRAENGLLMTPCYTAN 185
Query: 185 --APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             APE +L  + Y  A D+WS+G ++  +L     F+   + D  ++I   +G+      
Sbjct: 186 FVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGS------ 237
Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
            G   L G   N                       +S++  DL++++L  DP +R+T   
Sbjct: 238 -GKFSLSGGYWN----------------------SVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 303 ALNHYWF-HEVPLPK 316
            L H W  H   LP+
Sbjct: 275 VLRHPWIVHWDQLPQ 289

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 131/320 (40%), Gaps = 66/320 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA+K   K ++N    +            RE+ I+  
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF---------REVRIMKV 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 70  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +     +  Y APEL  
Sbjct: 129 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---SPPYAAPELFQ 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K     VD+WS+G I+  L++    F G                              
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG------------------------------ 215
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF- 309
                  Q    LR+R     +     +S    +LL + L  +P KR T++  +   W  
Sbjct: 216 -------QNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMN 268
Query: 310 --HE--------VPLPKSKD 319
             HE         PLP  KD
Sbjct: 269 VGHEDDELKPYVAPLPDYKD 288

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 138/311 (44%), Gaps = 54/311 (17%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F     +   +KI             
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSG---------- 253
Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI----- 298
                               + RFP+         S    DLL  LL  D  KR      
Sbjct: 254 --------------------KVRFPSH-------FSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 299 TVDDALNHYWF 309
            V+D  NH WF
Sbjct: 287 GVNDIKNHKWF 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/317 (26%), Positives = 139/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NL+++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE+++ +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 117/224 (52%), Gaps = 12/224 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  + +G++G V  A  K + E+ A+K +K +V  ++D +E      ++ E  +L 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVE-----CTMVEKRVLA 74
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             D P  +          D +Y VMEY+   DL + ++ + + F   +      ++  G+
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISIGL 133
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            +LH   +++RDLK  N++L+++G +KI DFGM +++            T  Y APE ++
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPE-II 192
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
             + Y  +VD W+ G ++ E+LA +P F G  E    D++F+++
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSI 232

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKDGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F     +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           ++ +FE    + +G +G VY AR+KKS  IVALK +  +   KE     G      REI 
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKE-----GVEHQLRREIE 75
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           I     HP+I+ +     D    +Y+++EY      +        F       +M +L +
Sbjct: 76  IQAHLHHPNILRLYNYFYDRR-RIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELAD 134
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            + Y H   V+HRD+K  NLLL  +G LKI DFG S    +P     ++  TL Y  PE+
Sbjct: 135 ALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVH--APSLRRKTMCGTLDYLPPEM 192
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           + G + ++  VD+W +G +  ELL   P F   +  +   +I K                
Sbjct: 193 IEG-RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK---------------- 235
Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                         +  +FPA+  TG+        DL+++LL ++P +R+ +     H W
Sbjct: 236 --------------VDLKFPASVPTGAQ-------DLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F     +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F     +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 132/306 (43%), Gaps = 61/306 (19%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPS 77
           + EG++ I  +   KKS +  A+K +   +             ++ +EI  L L   HP+
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRM-----------EANTQKEITALKLCEGHPN 67
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           IV + EV   D    ++VME +     +     K+ FS +E   +M +L+  V ++HD  
Sbjct: 68  IVKLHEV-FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 138 VLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
           V+HRDLK  NLL    N+   +KI DFG +R      +P  +   TL Y APE LL    
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNG 185
Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSG-------TTEVDQIDKIFKTLGTPTETIWPGLSE 247
           Y  + D+WS+G I+  +L+ +  F         T+ V+ + KI                 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI----------------- 228
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSP--VLSESGFDLLNRLLTYDPEKRITVDDALN 305
               K +F               SF G     +S+   DL+  LLT DP KR+ +     
Sbjct: 229 ---KKGDF---------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
Query: 306 HYWFHE 311
           + W  +
Sbjct: 271 NEWLQD 276

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 88
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 89  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 239
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 240 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 278
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 279 TKRFGNLKNGVNDIKNHKWF 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKDGVNDIKNHKWF 297

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 109/244 (44%), Gaps = 39/244 (15%)
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI+I  S  H  +V       +D+D V++V+E         +   ++  +  E +  + Q
Sbjct: 65  EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +    L  T  Y A
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE +L  K +S  VD+WS+GCIM  LL  KP                    P ET     
Sbjct: 184 PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET----- 217
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           S L        K  Y++ +   P A+             L+ ++L  DP  R T+++ LN
Sbjct: 218 SCLKETYLRIKKNEYSIPKHINPVAA------------SLIQKMLQTDPTARPTINELLN 265
Query: 306 HYWF 309
             +F
Sbjct: 266 DEFF 269

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY      +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG++++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 84
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F     +    
Sbjct: 85  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 143
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 199
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 200 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 233
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 234 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 275
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 276 FGNLKNGVNDIKNHKWF 292

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 142/302 (47%), Gaps = 53/302 (17%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++ 
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMR 73
Query: 72  SFDHPSIVNVKEVVMDDH---DSVYMVMEYMEHDLKWLMESMKQP-FSTSEVKCLMLQLL 127
              +P+IVN     +D +   D +++VMEY+      L + + +      ++  +  + L
Sbjct: 74  ENKNPNIVNY----LDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECL 127
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HR++K+ N+LL   G +K+ DFG   Q        +++V T ++ APE
Sbjct: 128 QALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 187
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++   K Y   VD+WS+G +  E++  +P +     +  +  +  T GTP         E
Sbjct: 188 VVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP---------E 236
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           L        + P  L      +A F           D LNR L  D EKR +  + + H 
Sbjct: 237 L--------QNPEKL------SAIFR----------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 308 WF 309
           + 
Sbjct: 273 FL 274

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 138/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY      +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 82
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        F     +    
Sbjct: 83  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 141
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 197
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 198 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 231
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 232 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 273
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 274 FGNLKNGVNDIKNHKWF 290

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 114/209 (54%), Gaps = 14/209 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++G + A K ++    + E+ LE       + EI IL +
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELE-----DYIVEIEILAT 64
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP IV +      D   +++++E+     +  +M  + +  +  +++ +  Q+LE + 
Sbjct: 65  CDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 123
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   ++HRDLK  N+L+  +G +++ DFG+S +    L+   S + T ++ APE+++ 
Sbjct: 124 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 192 A----KKYSTAVDMWSVGCIMAELLAKKP 216
                  Y    D+WS+G  + E+   +P
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            AP ++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 114/209 (54%), Gaps = 14/209 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++G + A K ++    + E+ LE       + EI IL +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELE-----DYIVEIEILAT 72
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP IV +      D   +++++E+     +  +M  + +  +  +++ +  Q+LE + 
Sbjct: 73  CDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   ++HRDLK  N+L+  +G +++ DFG+S +    L+   S + T ++ APE+++ 
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 192 A----KKYSTAVDMWSVGCIMAELLAKKP 216
                  Y    D+WS+G  + E+   +P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 109/244 (44%), Gaps = 39/244 (15%)
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI+I  S  H  +V       +D+D V++V+E         +   ++  +  E +  + Q
Sbjct: 91  EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +    L  T  Y A
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE +L  K +S  VD+WS+GCIM  LL  KP                    P ET     
Sbjct: 210 PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET----- 243
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           S L        K  Y++ +   P A+             L+ ++L  DP  R T+++ LN
Sbjct: 244 SCLKETYLRIKKNEYSIPKHINPVAA------------SLIQKMLQTDPTARPTINELLN 291
Query: 306 HYWF 309
             +F
Sbjct: 292 DEFF 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 109/244 (44%), Gaps = 39/244 (15%)
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI+I  S  H  +V       +D+D V++V+E         +   ++  +  E +  + Q
Sbjct: 89  EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 147
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +    L  T  Y A
Sbjct: 148 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 207
Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE +L  K +S  VD+WS+GCIM  LL  KP                    P ET     
Sbjct: 208 PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET----- 241
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           S L        K  Y++ +   P A+             L+ ++L  DP  R T+++ LN
Sbjct: 242 SCLKETYLRIKKNEYSIPKHINPVAA------------SLIQKMLQTDPTARPTINELLN 289
Query: 306 HYWF 309
             +F
Sbjct: 290 DEFF 293

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 121/233 (51%), Gaps = 15/233 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-L 71
           FE +  + +G++G V  AR K++G++ A+K +K +V  ++D +E      ++ E  IL L
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE-----CTMTEKRILSL 79
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + +HP +  +        D ++ VME++   DL + ++  ++ F  +  +    +++  +
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISAL 137
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            +LHD  +++RDLK  N+LL+++G  K+ DFGM ++         +   T  Y APE +L
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-IL 196
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
               Y  AVD W++G ++ E+L     F    E D  + I        E ++P
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYP 244

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 131/320 (40%), Gaps = 66/320 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA+K   K ++N    +            RE+ I+  
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF---------REVRIMKV 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 70  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +     +  Y APEL  
Sbjct: 129 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---SPPYAAPELFQ 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K     VD+WS+G I+  L++    F G                              
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG------------------------------ 215
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF- 309
                  Q    LR+R     +     +S    +LL + L  +P KR T++  +   W  
Sbjct: 216 -------QNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMN 268
Query: 310 --HE--------VPLPKSKD 319
             HE         PLP  KD
Sbjct: 269 VGHEDDELKPYVEPLPDYKD 288

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 130/320 (40%), Gaps = 66/320 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA+K   K ++N    +            RE+ I+  
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF---------REVRIMKV 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 70  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +        Y APEL  
Sbjct: 129 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---APPYAAPELFQ 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K     VD+WS+G I+  L++    F G                              
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG------------------------------ 215
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF- 309
                  Q    LR+R     +     +S    +LL + L  +P KR T++  +   W  
Sbjct: 216 -------QNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMN 268
Query: 310 --HE--------VPLPKSKD 319
             HE         PLP  KD
Sbjct: 269 VGHEDDELKPYVEPLPDYKD 288

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 117/227 (51%), Gaps = 12/227 (5%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            APE++L +K Y+ AVD W++G ++ E+ A  P F     +   +KI
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 114/214 (53%), Gaps = 10/214 (4%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ ++K+  G    VY A D      VA+K + +    KE+ L+  F     RE++    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FE----REVHNSSQ 67
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             H +IV++ +V  +D D  Y+VMEY+E   L   +ES   P S         Q+L+G+K
Sbjct: 68  LSHQNIVSMIDVDEED-DCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIK 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG-SPLKPYTSLVVTLWYRAPELLL 190
           + HD  ++HRD+K  N+L+++   LKI DFG+++    + L     ++ T+ Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
           G +      D++S+G ++ E+L  +P F+G T V
Sbjct: 186 G-EATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 123/255 (48%), Gaps = 15/255 (5%)
Query: 13  FEKLNKISEGTYGIVYRARD---KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           FE L  + +G++G V+  R      SG + A+K +K    +  D       + +  E +I
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDR------VRTKMERDI 83
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           L   +HP +V +          +Y++++++     +   S +  F+  +VK  + +L  G
Sbjct: 84  LADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALG 142
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           + +LH   +++RDLK  N+LL+ +G +K+ DFG+S++     K   S   T+ Y APE +
Sbjct: 143 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-V 201
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT-LGTPTETIWPGLSEL 248
           +  + +S + D WS G +M E+L     F G    + +  I K  LG P        S L
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLL 261
Query: 249 PGAKANFAKQPYNLL 263
              +A F + P N L
Sbjct: 262 ---RALFKRNPANRL 273

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 137/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +FE++  +  G++G V   + K++G   A+K +      K   +E+     +L
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-----TL 90
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  I  + + P +V + E    D+ ++YMV+EY      +        FS    +    
Sbjct: 91  NEKRIQQAVNFPFLVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +K+ DFG +++    +K  T  L  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGTPEY 205
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 239
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 240 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 281
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 282 FGNLKNGVNDIKNHKWF 298

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K ++  V   +D + +     ++ E  +L 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S      +   T  Y APE +L 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 178
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 139/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY      +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +++ DFG++++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 138/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY      +        FS    + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 138/317 (43%), Gaps = 66/317 (20%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           Q    + +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TL 89
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
            E  IL + + P +V + E    D+ ++YMVMEY+     +        FS    +    
Sbjct: 90  NEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEA 204
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++L +K Y+ AVD W++G ++ E+ A  P F                         
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF------------------------- 238
Query: 244 GLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
                      FA QP  +  K      RFP+         S    DLL  LL  D  KR
Sbjct: 239 -----------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKR 280
Query: 298 I-----TVDDALNHYWF 309
                  V+D  NH WF
Sbjct: 281 FGNLKNGVNDIKNHKWF 297

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K ++  V   +D + +     ++ E  +L 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 64  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S      +   T  Y APE +L 
Sbjct: 123 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 181
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 214

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K     + RKE  +       ++ E  +L 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMK-----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S      +   T  Y APE +L 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 178
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 131/320 (40%), Gaps = 66/320 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA++   K ++N    +            RE+ I+  
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF---------REVRIMKV 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 70  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +     +  Y APEL  
Sbjct: 129 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---SPPYAAPELFQ 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K     VD+WS+G I+  L++    F G                              
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG------------------------------ 215
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF- 309
                  Q    LR+R     +     +S    +LL + L  +P KR T++  +   W  
Sbjct: 216 -------QNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMN 268
Query: 310 --HE--------VPLPKSKD 319
             HE         PLP  KD
Sbjct: 269 VGHEDDELKPYVEPLPDYKD 288

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 135/301 (44%), Gaps = 44/301 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           +E   ++  G + IV + R K +G+  A K +K    R+      G     + RE+NIL 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKK---RRLSSSRRGVSREEIEREVNILR 70
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ + ++  +  D V +++E +     +   + K+  +  E    + Q+L+GV 
Sbjct: 71  EIRHPNIITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           YLH   + H DLK  N++L ++ V    +K+ DFG++ +  +    + ++  T  + APE
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPE 188
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            ++  +      DMWS+G I   LL+    F G T+ + +                    
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------------------- 227
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                 N +   Y+     F    F+ +   SE   D + RLL  DP++R+ +  +L H 
Sbjct: 228 -----TNISAVNYD-----FDEEYFSNT---SELAKDFIRRLLVKDPKRRMXIAQSLEHS 274
Query: 308 W 308
           W
Sbjct: 275 W 275

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 131/320 (40%), Gaps = 66/320 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA++   K ++N    +            RE+ I+  
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF---------REVRIMKV 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 70  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +     +  Y APEL  
Sbjct: 129 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---SPPYAAPELFQ 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K     VD+WS+G I+  L++    F G                              
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG------------------------------ 215
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF- 309
                  Q    LR+R     +     +S    +LL + L  +P KR T++  +   W  
Sbjct: 216 -------QNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMN 268
Query: 310 --HE--------VPLPKSKD 319
             HE         PLP  KD
Sbjct: 269 VGHEDDELKPYVEPLPDYKD 288

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 138/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 88
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        F     + 
Sbjct: 89  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 239
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 240 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 278
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 279 TKRFGNLKNGVNDIKNHKWF 298

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 137/320 (42%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 88
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +  + E    D+ ++YMVMEY      +        FS    + 
Sbjct: 89  -TLNEKRILQAVNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGT 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 239
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 240 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 278
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 279 TKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 137/320 (42%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 88
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +  + E    D+ ++YMVMEY      +        FS    + 
Sbjct: 89  -TLNEKRILQAVNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGT 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 239
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 240 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 278
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 279 TKRFGNLKNGVNDIKNHKWF 298

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 138/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        F     + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 122/297 (41%), Gaps = 49/297 (16%)
Query: 22  GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV 81
           GT+G V   + + +G  VA+K +     R  D +         REI  L  F HP I+ +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG-----KIRREIQNLKLFRHPHIIKL 81
Query: 82  KEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHR 141
            +V+    D ++MVMEY+     +            E + L  Q+L GV Y H + V+HR
Sbjct: 82  YQVISTPSD-IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140
Query: 142 DLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAV 199
           DLK  N+LL+     KI DFG+S     G  L+       +  Y APE++ G       V
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCG---SPNYAAPEVISGRLYAGPEV 197
Query: 200 DMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQP 259
           D+WS G I+  LL     F      D +  +FK        I  G+              
Sbjct: 198 DIWSSGVILYALLCGTLPFDD----DHVPTLFK-------KICDGI-------------- 232
Query: 260 YNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK 316
                       F     L+ S   LL  +L  DP KR T+ D   H WF +  LPK
Sbjct: 233 ------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-DLPK 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 137/305 (44%), Gaps = 44/305 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           +E   ++  G + IV + R K +G+  A K +K    R+      G     + RE+NIL 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKK---RRLXSSRRGVSREEIEREVNILR 84
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ + ++  +  D V +++E +     +   + K+  +  E    + Q+L+GV 
Sbjct: 85  EIRHPNIITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           YLH   + H DLK  N++L ++ V    +K+ DFG++ +  +    + ++  T  + APE
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPE 202
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            ++  +      DMWS+G I   LL+    F G T+ + +                    
Sbjct: 203 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------------------- 241
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                 N +   Y+     F    F+ +  L++   D + RLL  DP++R+ +  +L H 
Sbjct: 242 -----TNISAVNYD-----FDEEYFSNTSELAK---DFIRRLLVKDPKRRMXIAQSLEHS 288
Query: 308 WFHEV 312
           W   +
Sbjct: 289 WIKAI 293

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 138/320 (43%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY+     +        F     + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NLL++ QG +++ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 131/320 (40%), Gaps = 66/320 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA+K   K ++N    +            RE+ I+  
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF---------REVRIMKV 62
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 63  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY 121
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +     +  Y APEL  
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---SPPYAAPELFQ 178
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K     VD+WS+G I+  L++    F G                              
Sbjct: 179 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG------------------------------ 208
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF- 309
                  Q    LR+R     +     +S    +LL + L  +P KR T++  +   W  
Sbjct: 209 -------QNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMN 261
Query: 310 --HE--------VPLPKSKD 319
             HE         PLP  KD
Sbjct: 262 VGHEDDELKPYVEPLPDYKD 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 137/320 (42%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 87
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +V + E    D+ ++YMVMEY      +        F     + 
Sbjct: 88  -TLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF 145
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGT 201
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 238
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 239 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 277
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWF 297

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL KI +G++G V++  D ++ ++VA+K + +     E            +EI +L  
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-------DIQQEITVLSQ 81
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVK 131
            D P +       + D   ++++MEY+       L+E    P   +++  ++ ++L+G+ 
Sbjct: 82  CDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLD 138
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+  G +K+ DFG++ Q         + V T ++ APE ++ 
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIK 197
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
              Y +  D+WS+G    EL   +P
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEP 222

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K ++  V   +D + +     ++ E  +L 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S          T  Y APE +L 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLE 178
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL KI +G++G V++  D ++ ++VA+K + +     E            +EI +L  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-------DIQQEITVLSQ 61
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVK 131
            D P +       + D   ++++MEY+       L+E    P   +++  ++ ++L+G+ 
Sbjct: 62  CDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLD 118
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+  G +K+ DFG++ Q         + V T ++ APE ++ 
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIK 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
              Y +  D+WS+G    EL   +P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEP 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISS---LREINILLS 72
           I +G +  V  AR   +G  VA+K   K ++N            P S     RE+ I+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLN------------PTSLQKLFREVRIMKI 70
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+VMEY      +            E +    Q++  V+Y
Sbjct: 71  LNHPNIVKLFEVI-ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 129
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S ++  G+ L  +     +  Y APEL  
Sbjct: 130 CHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG---SPPYAAPELFQ 186
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           G K     VD+WS+G I+  L++    F G
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K ++  V   +D + +     ++ E  +L 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S          T  Y APE +L 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLE 178
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 23/246 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EFE L  + +GT+G V   ++K +G   A+K +K  V   +D + +     +L E  +L 
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-----TLTENRVLQ 64
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ FS    +    +++  + 
Sbjct: 65  NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 132 YLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPE 187
           YLH +  V++RDLK  NL+L+  G +KI DFG+ ++    G+ +K +     T  Y APE
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG---TPEYLAPE 180
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE-------VDQIDKIFKTLGTPTE 239
            +L    Y  AVD W +G +M E++  + P ++   E       +++I +  +TLG   +
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAK 238
Query: 240 TIWPGL 245
           ++  GL
Sbjct: 239 SLLSGL 244

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 23/246 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EFE L  + +GT+G V   ++K +G   A+K +K  V   +D + +     +L E  +L 
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-----TLTENRVLQ 65
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ FS    +    +++  + 
Sbjct: 66  NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 132 YLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPE 187
           YLH +  V++RDLK  NL+L+  G +KI DFG+ ++    G+ +K +     T  Y APE
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG---TPEYLAPE 181
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE-------VDQIDKIFKTLGTPTE 239
            +L    Y  AVD W +G +M E++  + P ++   E       +++I +  +TLG   +
Sbjct: 182 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAK 239
Query: 240 TIWPGL 245
           ++  GL
Sbjct: 240 SLLSGL 245

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 23/246 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EFE L  + +GT+G V   ++K +G   A+K +K  V   +D + +     +L E  +L 
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-----TLTENRVLQ 63
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ FS    +    +++  + 
Sbjct: 64  NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 132 YLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPE 187
           YLH +  V++RDLK  NL+L+  G +KI DFG+ ++    G+ +K +     T  Y APE
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG---TPEYLAPE 179
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE-------VDQIDKIFKTLGTPTE 239
            +L    Y  AVD W +G +M E++  + P ++   E       +++I +  +TLG   +
Sbjct: 180 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAK 237
Query: 240 TIWPGL 245
           ++  GL
Sbjct: 238 SLLSGL 243

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K ++  V   +D + +     ++ E  +L 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 65
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 66  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 124
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S          T  Y APE +L 
Sbjct: 125 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLE 183
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 216

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 8/213 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K     + RKE  +       ++ E  +L 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMK-----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S          T  Y APE +L 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLE 178
Query: 192 AKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE 223
              Y  AVD W +G +M E++  + P ++   E
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 120/243 (49%), Gaps = 17/243 (6%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EFE L  + +GT+G V   ++K +G   A+K +K  V   +D + +     +L E  +L 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-----TLTENRVLQ 203
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ FS    +    +++  + 
Sbjct: 204 NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 132 YLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           YLH +  V++RDLK  NL+L+  G +KI DFG+ ++         +   T  Y APE +L
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VL 321
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE-------VDQIDKIFKTLGTPTETIW 242
               Y  AVD W +G +M E++  + P ++   E       +++I +  +TLG   +++ 
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLL 380
Query: 243 PGL 245
            GL
Sbjct: 381 SGL 383

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL KI +G++G V++  D ++ ++VA+K + +     E            +EI +L  
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-------DIQQEITVLSQ 76
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVK 131
            D P +       + D   ++++MEY+       L+E    P   +++  ++ ++L+G+ 
Sbjct: 77  CDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLD 133
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+  G +K+ DFG++ Q           V T ++ APE ++ 
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIK 192
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFS 219
              Y +  D+WS+G    EL   +P  S
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHS 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS-----LRE 66
           ++E L  I  G+YG   + R K  G+I+  K+           L+YG    +     + E
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE-----------LDYGSMTEAEKQMLVSE 55
Query: 67  INILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKC 121
           +N+L    HP+IV   + ++D  + ++Y+VMEY E  DL  ++      +Q      V  
Sbjct: 56  VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 122 LMLQLLEGVKYLH-----DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS 176
           +M QL   +K  H      + VLHRDLK +N+ L+ +  +K+ DFG++R          +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            V T +Y +PE  +    Y+   D+WS+GC++ EL A  P F+  ++ +   KI
Sbjct: 176 FVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 18  KISEGTYGIVYRARDKKSG-EIVA--LKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           ++  G + IV + R+K +G E  A  +KK +    R+  C E        RE++IL    
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE-----EIEREVSILRQVL 73
Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           HP+I+ + +V  +  D V +++E +     +   + K+  S  E    + Q+L+GV YLH
Sbjct: 74  HPNIITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 135 DNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
              + H DLK  N++L ++ +    +K+ DFG++ +    ++ + ++  T  + APE ++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPE-IV 190
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             +      DMWS+G I   LL+    F G T+ + +                       
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------------- 227
Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             AN     Y+   + F           SE   D + +LL  +  KR+T+ +AL H W 
Sbjct: 228 --ANITAVSYDFDEEFFSQT--------SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL KI +G++G V++  D ++ ++VA+K + +     E            +EI +L  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-------DIQQEITVLSQ 61
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVK 131
            D P +       + D   ++++MEY+       L+E    P   +++  ++ ++L+G+ 
Sbjct: 62  CDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLD 118
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+  G +K+ DFG++ Q           V T ++ APE ++ 
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIK 177
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
              Y +  D+WS+G    EL   +P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEP 202

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS-----LRE 66
           ++E L  I  G+YG   + R K  G+I+  K+           L+YG    +     + E
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE-----------LDYGSMTEAEKQMLVSE 55
Query: 67  INILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKC 121
           +N+L    HP+IV   + ++D  + ++Y+VMEY E  DL  ++      +Q      V  
Sbjct: 56  VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 122 LMLQLLEGVKYLH-----DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS 176
           +M QL   +K  H      + VLHRDLK +N+ L+ +  +K+ DFG++R          +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 175
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            V T +Y +PE  +    Y+   D+WS+GC++ EL A  P F+  ++ +   KI
Sbjct: 176 FVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 120/243 (49%), Gaps = 17/243 (6%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EFE L  + +GT+G V   ++K +G   A+K +K  V   +D + +     +L E  +L 
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-----TLTENRVLQ 206
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ FS    +    +++  + 
Sbjct: 207 NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 265
Query: 132 YLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           YLH +  V++RDLK  NL+L+  G +KI DFG+ ++         +   T  Y APE +L
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VL 324
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTE-------VDQIDKIFKTLGTPTETIW 242
               Y  AVD W +G +M E++  + P ++   E       +++I +  +TLG   +++ 
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLL 383
Query: 243 PGL 245
            GL
Sbjct: 384 SGL 386

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 11/234 (4%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE L  I +G++G V   +   + ++ A+K +      K+ C+E     +  +E+ I+  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-----KQKCVERNEVRNVFKELQIMQG 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP +VN+     D+ D   +V   +  DL++ ++     F    VK  + +L+  + Y
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDY 130
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           L +  ++HRD+K  N+LL+  G + I DF ++       +  T++  T  Y APE+    
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSR 189
Query: 193 K--KYSTAVDMWSVGCIMAELL-AKKPL-FSGTTEVDQIDKIFKTLGTPTETIW 242
           K   YS AVD WS+G    ELL  ++P     +T   +I   F+T      + W
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 50/309 (16%)
Query: 5   QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISS 63
           +  + +FEF++   +  G +  V  A +K +G++ A+K + K  +  KE  +E       
Sbjct: 18  EDIKKIFEFKET--LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE------- 68
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
             EI +L    H +IV + E + +  + +Y+VM+ +     +     K  ++  +   L+
Sbjct: 69  -NEIAVLRKIKHENIVAL-EDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLI 126
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+L+ V YLH   ++HRDLK  NLL  +Q     + I DFG+S+  G      ++   T
Sbjct: 127 RQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTACGT 185
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE +L  K YS AVD WS+G I   LL   P F    +    ++I K        
Sbjct: 186 PGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            W                                   +S+S  D +  L+  DP KR T 
Sbjct: 245 YWDD---------------------------------ISDSAKDFIRNLMEKDPNKRYTC 271
Query: 301 DDALNHYWF 309
           + A  H W 
Sbjct: 272 EQAARHPWI 280

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 58/272 (21%)
Query: 65  REINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCL 122
           +EI +L    H +++ + +V+ ++    +YMVMEY    ++ +++S+ ++ F   +    
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY 114
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV--- 179
             QL++G++YLH   ++H+D+K  NLLL   G LKI   G++      L P+ +      
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA----LHPFAADDTCRT 170
Query: 180 ---TLWYRAPELLLGAKKYST-AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
              +  ++ PE+  G   +S   VD+WS G  +  +      F G    D I K+F+ +G
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIG 226
Query: 236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
                   G   +PG                         P LS    DLL  +L Y+P 
Sbjct: 227 K-------GSYAIPG----------------------DCGPPLS----DLLKGMLEYEPA 253
Query: 296 KRITVDDALNHYWFHE--------VPLPKSKD 319
           KR ++     H WF +        VP+P S D
Sbjct: 254 KRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 139/311 (44%), Gaps = 52/311 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E    I  G+Y +  R   K +    A+K +  +   K D  E         EI ILL 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKS---KRDPTE---------EIEILLR 71
Query: 73  F-DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPF-STSEVKCLMLQLLEGV 130
           +  HP+I+ +K+V  DD   VY+V E +    + L + ++Q F S  E   ++  + + V
Sbjct: 72  YGQHPNIITLKDV-YDDGKYVYVVTE-LXKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 131 KYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           +YLH   V+HRDLK SN+L      N   ++ICDFG ++Q  +      +   T  + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAP 189
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           E +L  + Y  A D+WS+G ++   L     F+   + D  ++I   +G+       G  
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGS-------GKF 240
Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
            L G   N                       +S++  DL+++ L  DP +R+T    L H
Sbjct: 241 SLSGGYWN----------------------SVSDTAKDLVSKXLHVDPHQRLTAALVLRH 278
Query: 307 YWF-HEVPLPK 316
            W  H   LP+
Sbjct: 279 PWIVHWDQLPQ 289

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 136/320 (42%), Gaps = 66/320 (20%)
Query: 2   NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           N  Q    + +FE++  +  G++G V   +  ++G   A+K +      K   +E+    
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH---- 88
Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            +L E  IL + + P +  + E    D+ ++YMVMEY      +        F     + 
Sbjct: 89  -TLNEKRILQAVNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF 146
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVT 180
              Q++   +YLH   +++RDLK  NL+++ QG +K+ DFG +++    +K  T  L  T
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGT 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y APE++L +K Y+ AVD W++G ++ E+ A  P F                      
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF---------------------- 239
Query: 241 IWPGLSELPGAKANFAKQPYNLLRK------RFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                         FA QP  +  K      RFP+         S    DLL  LL  D 
Sbjct: 240 --------------FADQPIQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDL 278
Query: 295 EKRI-----TVDDALNHYWF 309
            KR       V+D  NH WF
Sbjct: 279 TKRFGNLKNGVNDIKNHKWF 298

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 117/242 (48%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 34  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 86
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 87  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGCLLKYIRKIGS--FDETCTRFYTAEIVS 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K     S V T  Y +P
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K  S + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 204 ELLT-EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 262
Query: 247 EL 248
           +L
Sbjct: 263 DL 264

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 47/300 (15%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPS 77
           I  G   +V R   + +G   A+K +++   R           ++ RE +IL     HP 
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 78  IVNVKEVVMDDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           I+     ++D ++S   +++V + M     +   + K   S  E + +M  LLE V +LH
Sbjct: 162 II----TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
            N ++HRDLK  N+LL++   +++ DFG S  +  P +    L  T  Y APE+L  +  
Sbjct: 218 ANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLAPEILKCSMD 276
Query: 195 -----YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
                Y   VD+W+ G I+  LLA  P F    ++  +  I +     +   W       
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD----- 331
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                                        S +  DL++RLL  DPE R+T + AL H +F
Sbjct: 332 ----------------------------RSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L  I +G +  V  AR   +G+ VA+K   K ++N    +            RE+ I   
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF---------REVRIXKV 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            +HP+IV + EV+ +   ++Y+V EY      +            E +    Q++  V+Y
Sbjct: 70  LNHPNIVKLFEVI-ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQY 128
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ--YGSPLKPYTSLVVTLWYRAPELLL 190
            H  +++HRDLK  NLLL+    +KI DFG S +  +G+ L  +        Y APEL  
Sbjct: 129 CHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCG---APPYAAPELFQ 185
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           G K     VD+WS+G I+  L++    F G
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 116/214 (54%), Gaps = 17/214 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 78
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 79  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 135
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 136 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 193
Query: 189 LLGAKKYSTAVDMWSVGCIMAEL-LAKKPLFSGT 221
           L G   YS   D+WS+G  + E+ + + P+ SG+
Sbjct: 194 LQGT-HYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL++I +G++G VY+  D  + E+VA+K + +     E            +EI +L  
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIE-------DIQQEITVLSQ 73
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVK 131
            D P I       +     ++++MEY+       ++ +K  P   + +  ++ ++L+G+ 
Sbjct: 74  CDSPYITRYFGSYLKS-TKLWIIMEYLGGGSA--LDLLKPGPLEETYIATILREILKGLD 130
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH    +HRD+K +N+LL+ QG +K+ DFG++ Q           V T ++ APE ++ 
Sbjct: 131 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIK 189
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
              Y    D+WS+G    EL   +P
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEP 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 123/303 (40%), Gaps = 61/303 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISS---LREINI 69
           L  I +G +  V  AR   +G  VA+K   K ++N            P S     RE+ I
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN------------PTSLQKLFREVRI 64
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           +   +HP+IV + EV+ +   ++Y++MEY      +            E +    Q++  
Sbjct: 65  MKILNHPNIVKLFEVI-ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 123
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPE 187
           V+Y H   ++HRDLK  NLLL+    +KI DFG S ++  G  L  +     +  Y APE
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG---SPPYAAPE 180
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           L  G K     VD+WS+G I+  L++    F G                           
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--------------------------- 213
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                     Q    LR+R     +     +S    +LL R L  +P KR T++  +   
Sbjct: 214 ----------QNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 263
Query: 308 WFH 310
           W +
Sbjct: 264 WIN 266

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/347 (25%), Positives = 149/347 (42%), Gaps = 47/347 (13%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  + EGT+G V    D   G+     K+  NVG+  +        ++  EIN+L  
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE--------AARLEINVLKK 72
Query: 73  FDHPSIVN-VKEVVMDD----HDSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQL 126
                  N    V+M D    H  + +  E + ++  ++L E+  QP+    V+ +  QL
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFGMSRQY 167
              +++LH+N + H DLK  N+L  N                      +++ DFG +   
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--- 189
Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
               + +T++V T  YR PE++L    ++   D+WS+GCI+ E      LF      + +
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 228 DKIFKTLG-TPTETIWPGLSELPGAKANFAKQPYNLLRKRF------PAASFTGSPVLSE 280
             + K LG  P+  I     +    K        N    R+      P  S+     L  
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE-NSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 281 SG-FDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPP 326
              FDL+ R+L +DP +RIT+ +AL H +F  +  P+ + F  +  P
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT-PEERSFHTSRNP 353

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS-----LRE 66
           ++E L  I  G+YG   + R K  G+I+  K+           L+YG    +     + E
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE-----------LDYGSMTEAEKQMLVSE 55
Query: 67  INILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKC 121
           +N+L    HP+IV   + ++D  + ++Y+VMEY E  DL  ++      +Q      V  
Sbjct: 56  VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 122 LMLQLLEGVKYLH-----DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS 176
           +M QL   +K  H      + VLHRDLK +N+ L+ +  +K+ DFG++R           
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE 175
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            V T +Y +PE  +    Y+   D+WS+GC++ EL A  P F+  ++ +   KI
Sbjct: 176 FVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 122/303 (40%), Gaps = 61/303 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISS---LREINI 69
           L  I +G +  V  AR   +G  VA+K   K ++N            P S     RE+ I
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN------------PTSLQKLFREVRI 67
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           +   +HP+IV + EV+ +   ++Y++MEY      +            E +    Q++  
Sbjct: 68  MKILNHPNIVKLFEVI-ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPE 187
           V+Y H   ++HRDLK  NLLL+    +KI DFG S ++  G  L  +        Y APE
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---APPYAAPE 183
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           L  G K     VD+WS+G I+  L++    F G                           
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--------------------------- 216
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                     Q    LR+R     +     +S    +LL R L  +P KR T++  +   
Sbjct: 217 ----------QNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 308 WFH 310
           W +
Sbjct: 267 WIN 269

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE+++++  G  G+V + + + SG I+A K + + +       +       +RE+ +L 
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLH 69
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +L G
Sbjct: 70  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y APE 
Sbjct: 127 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMAPER 184
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + EL   +
Sbjct: 185 LQGT-HYSVQSDIWSMGLSLVELAVGR 210

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 139/300 (46%), Gaps = 52/300 (17%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + EG++G V  A   K+ + VALK +   + +K D       +   REI+ L    HP I
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD-----MHMRVEREISYLKLLRHPHI 71
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           + + +V+    D V MV+EY   +L  +++E  K+  +  E +    Q++  ++Y H + 
Sbjct: 72  IKLYDVITTPTDIV-MVIEYAGGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           ++HRDLK  NLLL++   +KI DFG+S     G+ LK       +  Y APE++ G    
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVINGKLYA 185
Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF 255
              VD+WS G ++  +L  +  F      + I  +FK + +    +   LS  PGA++  
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDD----EFIPNLFKKVNSCVYVMPDFLS--PGAQS-- 237
Query: 256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP 315
                                        L+ R++  DP +RIT+ +     WF+ V LP
Sbjct: 238 -----------------------------LIRRMIVADPMQRITIQEIRRDPWFN-VNLP 267

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 114/227 (50%), Gaps = 6/227 (2%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  + +G++G V+  +     +   L  +K+    K+  L+    + +  E +IL+
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV---LKKATLKVRDRVRTKMERDILV 81
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             +HP IV +          +Y++++++     +   S +  F+  +VK  + +L   + 
Sbjct: 82  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   +++RDLK  N+LL+ +G +K+ DFG+S++     K   S   T+ Y APE ++ 
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVN 199
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT-LGTP 237
            + ++ + D WS G +M E+L     F G    + +  I K  LG P
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/330 (25%), Positives = 142/330 (43%), Gaps = 46/330 (13%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  + EGT+G V    D   G+     K+  NVG+  +        ++  EIN+L  
Sbjct: 30  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE--------AARLEINVLKK 81
Query: 73  FDHPSIVN-VKEVVMDD----HDSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQL 126
                  N    V+M D    H  + +  E + ++  ++L E+  QP+    V+ +  QL
Sbjct: 82  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 141
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFGMSRQY 167
              +++LH+N + H DLK  N+L  N                      +++ DFG +   
Sbjct: 142 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--- 198
Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
               + +T++V T  YR PE++L    ++   D+WS+GCI+ E      LF      + +
Sbjct: 199 TFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257
Query: 228 DKIFKTLG-TPTETIWPGLSELPGAKANFAKQPYNLLRKRF------PAASFTGSPVLSE 280
             + K LG  P+  I     +    K        N    R+      P  S+     L  
Sbjct: 258 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE-NSSDGRYVKENCKPLKSYMLQDSLEH 316
Query: 281 SG-FDLLNRLLTYDPEKRITVDDALNHYWF 309
              FDL+ R+L +DP +RIT+ +AL H +F
Sbjct: 317 VQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 35  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 87
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 88  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 144
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K     S V T  Y +P
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 205 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 263
Query: 247 EL 248
           +L
Sbjct: 264 DL 265

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL +I +G++G V++  D ++ ++VA+K + +     E            +EI +L  
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-------QEITVLSQ 77
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            D   +       +     ++++MEY+     L  L      PF   ++  ++ ++L+G+
Sbjct: 78  CDSSYVTKYYGSYLKG-SKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGL 133
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH    +HRD+K +N+LL+ QG +K+ DFG++ Q         + V T ++ APE++ 
Sbjct: 134 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 193
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKP 216
            +  Y +  D+WS+G    EL   +P
Sbjct: 194 QS-AYDSKADIWSLGITAIELAKGEP 218

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 114/227 (50%), Gaps = 6/227 (2%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  + +G++G V+  +     +   L  +K+    K+  L+    + +  E +IL+
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV---LKKATLKVRDRVRTKMERDILV 81
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             +HP IV +          +Y++++++     +   S +  F+  +VK  + +L   + 
Sbjct: 82  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   +++RDLK  N+LL+ +G +K+ DFG+S++     K   S   T+ Y APE ++ 
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVN 199
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT-LGTP 237
            + ++ + D WS G +M E+L     F G    + +  I K  LG P
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/330 (25%), Positives = 142/330 (43%), Gaps = 46/330 (13%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  + EGT+G V    D   G+     K+  NVG+  +        ++  EIN+L  
Sbjct: 53  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE--------AARLEINVLKK 104
Query: 73  FDHPSIVN-VKEVVMDD----HDSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQL 126
                  N    V+M D    H  + +  E + ++  ++L E+  QP+    V+ +  QL
Sbjct: 105 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 164
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFGMSRQY 167
              +++LH+N + H DLK  N+L  N                      +++ DFG +   
Sbjct: 165 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--- 221
Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
               + +T++V T  YR PE++L    ++   D+WS+GCI+ E      LF      + +
Sbjct: 222 TFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280
Query: 228 DKIFKTLG-TPTETIWPGLSELPGAKANFAKQPYNLLRKRF------PAASFTGSPVLSE 280
             + K LG  P+  I     +    K        N    R+      P  S+     L  
Sbjct: 281 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE-NSSDGRYVKENCKPLKSYMLQDSLEH 339
Query: 281 SG-FDLLNRLLTYDPEKRITVDDALNHYWF 309
              FDL+ R+L +DP +RIT+ +AL H +F
Sbjct: 340 VQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 114/227 (50%), Gaps = 6/227 (2%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  + +G++G V+  +     +   L  +K+    K+  L+    + +  E +IL+
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV---LKKATLKVRDRVRTKMERDILV 82
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             +HP IV +          +Y++++++     +   S +  F+  +VK  + +L   + 
Sbjct: 83  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH   +++RDLK  N+LL+ +G +K+ DFG+S++     K   S   T+ Y APE ++ 
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVN 200
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT-LGTP 237
            + ++ + D WS G +M E+L     F G    + +  I K  LG P
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 121
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 122 ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 178
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 179 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 236
Query: 189 LLGAKKYSTAVDMWSVGCIMAEL 211
           L G   YS   D+WS+G  + E+
Sbjct: 237 LQGT-HYSVQSDIWSMGLSLVEM 258

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/335 (24%), Positives = 146/335 (43%), Gaps = 56/335 (16%)
Query: 13  FEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +E ++ + EGT+G V +  D ++ G  VALK +K NV + ++        ++  EIN+L 
Sbjct: 35  YEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIK-NVEKYKE--------AARLEINVLE 85
Query: 72  SFDHPSIVNVKEVV-----MDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQ 125
             +     N    V      D H  + +  E +      +L ++   P+   +V+ +  Q
Sbjct: 86  KINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG-------------------VLKICDFGMSRQ 166
           L + VK+LHDN + H DLK  N+L  N                      +++ DFG +  
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA-- 203
Query: 167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ 226
                + ++++V T  YRAPE++L    +S   D+WS+GCI+ E      LF      + 
Sbjct: 204 -TFDHEHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREH 261
Query: 227 IDKIFKTLG-TPTETIWPGLSEL-----------PGAKANFAKQPYNLLRKRFPAASFTG 274
           +  + + LG  P+  I     +              +   + ++    LR+       T 
Sbjct: 262 LAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRR-----YLTS 316
Query: 275 SPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   FDL+  +L Y+P KR+T+ +AL H +F
Sbjct: 317 EAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFF 351

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 18/212 (8%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLR 65
           S  + EK+  I  G +G V   R K  G+    VA+K +K     K+      F    L 
Sbjct: 29  SCIKIEKV--IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDF----LS 79
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLML 124
           E +I+  FDHP+I++++ VV      V ++ EYME+  L   +      F+  ++  ++ 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 138
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTL 181
            +  G+KYL D   +HRDL   N+L+N+  V K+ DFGMSR     P   YT+    + +
Sbjct: 139 GIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            + APE  +  +K+++A D+WS G +M E+++
Sbjct: 199 RWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 134/312 (42%), Gaps = 53/312 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G +G+V+R  ++ +G   A K V       ++ +         +EI  +    HP+
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--------KEIQTMSVLRHPT 215
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +VN+ +   DD++ V M+ E+M   +L   +       S  E    M Q+ +G+ ++H+N
Sbjct: 216 LVNLHDAFEDDNEMV-MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 137 WVLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLLG 191
             +H DLK  N++   +    LK+ DFG++      L P  S+ VT     + APE+  G
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPEVAEG 330
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K      DMWSVG +   LL+    F G  + + +                        
Sbjct: 331 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------------------------ 365
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             N     +N+       ++F+G   +SE G D + +LL  DP  R+T+  AL H W   
Sbjct: 366 -RNVKSCDWNM-----DDSAFSG---ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416
Query: 312 VPLPKSKDFMPT 323
              P     +P+
Sbjct: 417 GNAPGRDSQIPS 428

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 31  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 83
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 84  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 140
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG--SPLKPYTSLVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++     S      S V T  Y +P
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 201 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 259
Query: 247 EL 248
           +L
Sbjct: 260 DL 261

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 59
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 60  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + E+   +
Sbjct: 175 LQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 53/312 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G +G+V+R  ++ +G   A K V       ++ +         +EI  +    HP+
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--------KEIQTMSVLRHPT 109
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +VN+ +   DD++ V M+ E+M   +L   +       S  E    M Q+ +G+ ++H+N
Sbjct: 110 LVNLHDAFEDDNEMV-MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 137 WVLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLLG 191
             +H DLK  N++   +    LK+ DFG++      L P  S+ VT     + APE+  G
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPEVAEG 224
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K      DMWSVG +   LL+    F G  + +       TL       W         
Sbjct: 225 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDW--------- 267
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                             ++F+G   +SE G D + +LL  DP  R+T+  AL H W   
Sbjct: 268 --------------NMDDSAFSG---ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 310
Query: 312 VPLPKSKDFMPT 323
              P     +P+
Sbjct: 311 GNAPGRDSQIPS 322

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 129/298 (43%), Gaps = 52/298 (17%)
Query: 22  GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV 81
           G  G V     +++G+  ALK            L Y  P +     +   +   P IV +
Sbjct: 21  GVNGKVLECFHRRTGQKCALK------------LLYDSPKARQEVDHHWQASGGPHIVCI 68
Query: 82  KEVVMDDHDS---VYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
            +V  + H     + ++ME ME       + E   Q F+  E   +M  +   +++LH +
Sbjct: 69  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 128
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            + HRD+K  NLL  ++    VLK+ DFG +++  +      +   T +Y APE+L G +
Sbjct: 129 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVL-GPE 185
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           KY  + DMWS+G IM  LL   P F   T                + I PG+        
Sbjct: 186 KYDKSCDMWSLGVIMYILLCGFPPFYSNT---------------GQAISPGM-------- 222
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
              K+   L +  FP   ++    +SE    L+  LL  DP +R+T+   +NH W ++
Sbjct: 223 ---KRRIRLGQYGFPNPEWSE---VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 59
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 60  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + E+   +
Sbjct: 175 LQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 86
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 87  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 201
Query: 189 LLGAKKYSTAVDMWSVGCIMAEL 211
           L G   YS   D+WS+G  + E+
Sbjct: 202 LQGT-HYSVQSDIWSMGLSLVEM 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 32  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 84
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 85  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 141
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K     + V T  Y +P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 202 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 260
Query: 247 EL 248
           +L
Sbjct: 261 DL 262

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 11  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 63
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 64  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 120
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 121 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 181 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 239
Query: 247 EL 248
           +L
Sbjct: 240 DL 241

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 129/298 (43%), Gaps = 52/298 (17%)
Query: 22  GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV 81
           G  G V     +++G+  ALK            L Y  P +     +   +   P IV +
Sbjct: 40  GVNGKVLECFHRRTGQKCALK------------LLYDSPKARQEVDHHWQASGGPHIVCI 87
Query: 82  KEVVMDDHDS---VYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
            +V  + H     + ++ME ME       + E   Q F+  E   +M  +   +++LH +
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 137 WVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            + HRD+K  NLL  ++    VLK+ DFG +++  +      +   T +Y APE+L G +
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVL-GPE 204
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           KY  + DMWS+G IM  LL   P F   T                + I PG+        
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNT---------------GQAISPGM-------- 241
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
              K+   L +  FP   ++    +SE    L+  LL  DP +R+T+   +NH W ++
Sbjct: 242 ---KRRIRLGQYGFPNPEWSE---VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 18/214 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V   R K  G+    VA+K +K+    K+           L E +I+  FDH
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR-------RDFLGEASIMGQFDH 82
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I++++ VV      V +V EYME+  L   ++     F+  ++  ++  +  G+KYL 
Sbjct: 83  PNIIHLEGVVTKSK-PVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLS 141
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + APE  + 
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 200
Query: 192 AKKYSTAVDMWSVGCIMAELLA--KKPLFSGTTE 223
            +K+++A D+WS G +M E+++  ++P +  T +
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQ 234

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 59
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 60  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + E+   +
Sbjct: 175 LQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 12  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 64
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 65  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 121
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 122 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 182 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 240
Query: 247 EL 248
           +L
Sbjct: 241 DL 242

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 92/343 (26%), Positives = 143/343 (41%), Gaps = 72/343 (20%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSG-EIVALKKVK-----MNVGRKE----DCLEYGFPIS 62
           +E ++ + EG +G V    D K+G   VA+K VK         R E    + L    P S
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKC 121
           + R + +L  F+H             H  + +V E +      ++ E+   PF    ++ 
Sbjct: 76  TFRCVQMLEWFEH-------------HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFG 162
           +  Q+ + V +LH N + H DLK  N+L                         +K+ DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT 222
            S  Y    + +++LV T  YRAPE++L A  +S   D+WS+GCI+ E      +F    
Sbjct: 183 -SATYDD--EHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 223 EVDQIDKIFKTLG-TPTETI---------------WPGLSELPGAKANFAKQPYNLLRKR 266
             + +  + + LG  P   I               W   S   G   + A +P     K 
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS-AGRYVSRACKPL----KE 293
Query: 267 FPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           F         V  E  FDL+ ++L YDP KRIT+ +AL H +F
Sbjct: 294 F----MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 35  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 87
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 88  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 144
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 205 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 263
Query: 247 EL 248
           +L
Sbjct: 264 DL 265

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 34  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 86
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 87  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 204 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 262
Query: 247 EL 248
           +L
Sbjct: 263 DL 264

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 52/296 (17%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 37  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 89
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 90  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 146
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 147 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K              
Sbjct: 207 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------- 251
Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
                           L   FPAA F  +        DL+ +LL  D  KR+  ++
Sbjct: 252 ----------------LEYDFPAAFFPKAR-------DLVEKLLVLDATKRLGCEE 284

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 10  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 62
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 63  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 119
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 180 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 247 EL 248
           +L
Sbjct: 239 DL 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 34  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 86
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 87  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 204 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 262
Query: 247 EL 248
           +L
Sbjct: 263 DL 264

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 34  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 86
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 87  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 204 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 262
Query: 247 EL 248
           +L
Sbjct: 263 DL 264

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 39  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 91
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 92  SRLDHPFFVKLYFCFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 148
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 149 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 209 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 267
Query: 247 EL 248
           +L
Sbjct: 268 DL 269

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 9   FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 61
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 62  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 118
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 119 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 179 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 237
Query: 247 EL 248
           +L
Sbjct: 238 DL 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 32  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 84
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 85  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 141
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 202 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 260
Query: 247 EL 248
           +L
Sbjct: 261 DL 262

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 18/212 (8%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLR 65
           S  + EK+  I  G +G V   R K  G+    VA+K +K     K+      F    L 
Sbjct: 8   SCIKIEKV--IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDF----LS 58
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLML 124
           E +I+  FDHP+I++++ VV      V ++ EYME+  L   +      F+  ++  ++ 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 117
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTL 181
            +  G+KYL D   +HRDL   N+L+N+  V K+ DFGMSR     P   YT+    + +
Sbjct: 118 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            + APE  +  +K+++A D+WS G +M E+++
Sbjct: 178 RWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVG---RKEDCLEYGFPISSLREINI 69
           +E   ++  G +G V R   + +GE VA+K+ +  +    R+  CLE          I I
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE----------IQI 66
Query: 70  LLSFDHPSIVNVKEV-----VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSE--VKC 121
           +   +HP++V+ +EV      +  +D   + MEY E  DL+  +   +      E  ++ 
Sbjct: 67  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 126
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLN---NQGVLKICDFGMSRQYGSPLKPYTSLV 178
           L+  +   ++YLH+N ++HRDLK  N++L     + + KI D G +++     +  T  V
Sbjct: 127 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 185
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            TL Y APE LL  KKY+  VD WS G +  E + 
Sbjct: 186 GTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 59
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 60  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + E+   +
Sbjct: 175 LQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 59
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 60  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + E+   +
Sbjct: 175 LQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 32  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 84
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 85  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 141
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 202 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 260
Query: 247 EL 248
           +L
Sbjct: 261 DL 262

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVG---RKEDCLEYGFPISSLREINI 69
           +E   ++  G +G V R   + +GE VA+K+ +  +    R+  CLE          I I
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE----------IQI 65
Query: 70  LLSFDHPSIVNVKEV-----VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSE--VKC 121
           +   +HP++V+ +EV      +  +D   + MEY E  DL+  +   +      E  ++ 
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLN---NQGVLKICDFGMSRQYGSPLKPYTSLV 178
           L+  +   ++YLH+N ++HRDLK  N++L     + + KI D G +++     +  T  V
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 184
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            TL Y APE LL  KKY+  VD WS G +  E + 
Sbjct: 185 GTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 138/318 (43%), Gaps = 48/318 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYG-FPISSLREINILL 71
           +E    +  G   +V R   K + +  A+K + +  G      E      ++L+E++IL 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 72  SFD-HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               HP+I+ +K+   + +   ++V + M+    +   + K   S  E + +M  LLE +
Sbjct: 79  KVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
             LH   ++HRDLK  N+LL++   +K+ DFG S Q   P +   S+  T  Y APE++ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIE 196
Query: 191 GAKK-----YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
            +       Y   VDMWS G IM  LLA  P F                           
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------------------------- 229
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPV---LSESGFDLLNRLLTYDPEKRITVDD 302
                    + ++   +LR         GSP     S++  DL++R L   P+KR T ++
Sbjct: 230 ---------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 303 ALNHYWFHEVPLPKSKDF 320
           AL H +F +  + + + F
Sbjct: 281 ALAHPFFQQYVVEEVRHF 298

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 18/212 (8%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLR 65
           S  + EK+  I  G +G V   R K  G+    VA+K +K     K+      F    L 
Sbjct: 14  SCIKIEKV--IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDF----LS 64
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLML 124
           E +I+  FDHP+I++++ VV      V ++ EYME+  L   +      F+  ++  ++ 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 123
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTL 181
            +  G+KYL D   +HRDL   N+L+N+  V K+ DFGMSR     P   YT+    + +
Sbjct: 124 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            + APE  +  +K+++A D+WS G +M E+++
Sbjct: 184 RWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 193
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 194 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 232
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 233 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 207
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 208 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 246
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 247 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 80  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 139
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 140 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 197
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 198 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 236
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 237 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 75  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 134
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 135 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 192
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 193 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 231
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 232 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 16  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 68
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 69  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 125
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 126 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 186 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 244
Query: 247 EL 248
           +L
Sbjct: 245 DL 246

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 74  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 133
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 191
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 192 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 230
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 231 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 82  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 141
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 142 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 199
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 200 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 238
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 239 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 237
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 276
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 277 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 31  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 83
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 84  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 140
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 201 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 259
Query: 247 EL 248
           +L
Sbjct: 260 DL 261

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 126 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 185
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 186 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 243
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 244 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 282
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 283 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 81  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 140
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 141 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 198
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 199 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 237
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 238 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 193
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 194 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 232
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 233 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 117/295 (39%), Gaps = 44/295 (14%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           + +  GT+G V     + +G  VA+K +     R  D +         REI  L  F HP
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG-----KIKREIQNLKLFRHP 71
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
            I+ + +V+    D  +MVMEY+     +            E + L  Q+L  V Y H +
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYS 196
            V+HRDLK  N+LL+     KI DFG+S          TS   +  Y APE++ G     
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-CGSPNYAAPEVISGRLYAG 189
Query: 197 TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFA 256
             VD+WS G I+  LL       GT                          LP     F 
Sbjct: 190 PEVDIWSCGVILYALLC------GT--------------------------LP-----FD 212
Query: 257 KQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
            +    L K+     F     L+ S   LL  +L  DP KR T+ D   H WF +
Sbjct: 213 DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 8/219 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  I  G+Y  V   R KK+  I A+K VK  +   ++ +++   + + + +    
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW---VQTEKHVFEQA 66
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           S +HP +V +      +   ++ V+EY+   DL + M+  ++       +    ++   +
Sbjct: 67  S-NHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLAL 123
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH+  +++RDLK  N+LL+++G +K+ D+GM ++   P    +    T  Y APE+L 
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
           G + Y  +VD W++G +M E++A +  F      D  D+
Sbjct: 184 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 34  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 86
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 87  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 204 ELLT-EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR 262
Query: 247 EL 248
           +L
Sbjct: 263 DL 264

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 34  FKFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 86
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 87  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 143
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 204 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR 262
Query: 247 EL 248
           +L
Sbjct: 263 DL 264

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 8/219 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  I  G+Y  V   R KK+  I A+K VK  +   ++ +++   + + + +    
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW---VQTEKHVFEQA 62
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           S +HP +V +      +   ++ V+EY+   DL + M+  ++       +    ++   +
Sbjct: 63  S-NHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLAL 119
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH+  +++RDLK  N+LL+++G +K+ D+GM ++   P    +    T  Y APE+L 
Sbjct: 120 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
           G + Y  +VD W++G +M E++A +  F      D  D+
Sbjct: 180 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + IV + R+K +G   A K +K    R+      G     + RE++IL    H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKK---RQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + +V  +  D V +++E +     +   + K+  S  E    + Q+L+GV YLH  
Sbjct: 76  NVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            + H DLK  N++L ++ +    +K+ DFG++ +    ++ + ++  T  + APE ++  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPE-IVNY 192
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +      DMWS+G I   LL+    F G T+ + +                         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------------------- 227
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           AN     Y+   + F           SE   D + +LL  +  KR+T+ +AL H W
Sbjct: 228 ANITSVSYDFDEEFFSHT--------SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 60/309 (19%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINI 69
           E++   ++ +G + +V R     +G+  A K +  K    R    LE        RE  I
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE--------REARI 56
Query: 70  LLSFDHPSIVNVKEVVMDDHDSV------YMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
                HP+IV +       HDS+      Y+V + +     +     ++ +S ++    +
Sbjct: 57  CRLLKHPNIVRL-------HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 109
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+LE V + H N ++HRDLK  NLLL ++     +K+ DFG++ +     + +     T
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y +PE+L     Y   VDMW+ G I+  LL   P F    + DQ  +++       + 
Sbjct: 170 PGYLSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPF---WDEDQ-HRLY-------QQ 217
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
           I  G  + P  + +                       ++    DL+N++LT +P KRIT 
Sbjct: 218 IKAGAYDFPSPEWD----------------------TVTPEAKDLINKMLTINPAKRITA 255
Query: 301 DDALNHYWF 309
            +AL H W 
Sbjct: 256 SEALKHPWI 264

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 74  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 133
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T    T +Y APE +LG 
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTEPCYTPYYVAPE-VLGP 191
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 192 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 230
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 231 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + IV + R+K +G   A K +K    R+      G     + RE++IL    H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + +V  +  D V +++E +     +   + K+  S  E    + Q+L+GV YLH  
Sbjct: 76  NVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            + H DLK  N++L ++ +    +K+ DFG++ +    ++ + ++  T  + APE ++  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPE-IVNY 192
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +      DMWS+G I   LL+    F G T+ + +                         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------------------- 227
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           AN     Y+   + F           SE   D + +LL  +  KR+T+ +AL H W
Sbjct: 228 ANITAVSYDFDEEFFSQT--------SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 114/219 (52%), Gaps = 8/219 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  I  G+Y  V   R KK+  I A++ VK  +   ++ +++   + + + +    
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW---VQTEKHVFEQA 109
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           S +HP +V +      +   ++ V+EY+   DL + M+  ++       +    ++   +
Sbjct: 110 S-NHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLAL 166
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH+  +++RDLK  N+LL+++G +K+ D+GM ++   P    ++   T  Y APE+L 
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
           G + Y  +VD W++G +M E++A +  F      D  D+
Sbjct: 227 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 60/309 (19%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINI 69
           E++   ++ +G + +V R     +G+  A K +  K    R    LE        RE  I
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE--------REARI 56
Query: 70  LLSFDHPSIVNVKEVVMDDHDSV------YMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
                HP+IV +       HDS+      Y+V + +     +     ++ +S ++    +
Sbjct: 57  CRLLKHPNIVRL-------HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 109
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+LE V + H N ++HRDLK  NLLL ++     +K+ DFG++ +     + +     T
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y +PE+L     Y   VDMW+ G I+  LL   P F    + DQ  +++       + 
Sbjct: 170 PGYLSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPF---WDEDQ-HRLY-------QQ 217
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
           I  G  + P  + +                       ++    DL+N++LT +P KRIT 
Sbjct: 218 IKAGAYDFPSPEWD----------------------TVTPEAKDLINKMLTINPAKRITA 255
Query: 301 DDALNHYWF 309
            +AL H W 
Sbjct: 256 SEALKHPWI 264

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + IV + R+K +G   A K +K    R+      G     + RE++IL    H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + +V  +  D V +++E +     +   + K+  S  E    + Q+L+GV YLH  
Sbjct: 76  NVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            + H DLK  N++L ++ +    +K+ DFG++ +    ++ + ++  T  + APE ++  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPE-IVNY 192
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +      DMWS+G I   LL+    F G T+ + +                         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------------------- 227
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           AN     Y+   + F           SE   D + +LL  +  KR+T+ +AL H W
Sbjct: 228 ANITAVSYDFDEEFFSQT--------SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 133/296 (44%), Gaps = 44/296 (14%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + IV + R+K +G   A K +K    R+      G     + RE++IL    H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + +V  +  D V +++E +     +   + K+  S  E    + Q+L+GV YLH  
Sbjct: 76  NVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            + H DLK  N++L ++ +    +K+ DFG++ +    ++ + ++  T  + APE ++  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPE-IVNY 192
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +      DMWS+G I   LL+    F G T+ + +                         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------------------- 227
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           AN     Y+     F    F+ +   SE   D + +LL  +  KR+T+ +AL H W
Sbjct: 228 ANITSVSYD-----FDEEFFSHT---SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +       +       +RE+ +L 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLH 62
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEG 129
             + P IV        D + + + ME+M  D   L + +K+     E  +  + + +++G
Sbjct: 63  ECNSPYIVGFYGAFYSDGE-ISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKG 119
Query: 130 VKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +      V T  Y +PE 
Sbjct: 120 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA--NEFVGTRSYMSPER 177
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK 215
           L G   YS   D+WS+G  + E+   +
Sbjct: 178 LQGT-HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDHP 76
           ++  G + IV + R+K +G   A K +K    R+      G     + RE++IL    H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +++ + +V  +  D V +++E +     +   + K+  S  E    + Q+L+GV YLH  
Sbjct: 76  NVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 137 WVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            + H DLK  N++L ++ +    +K+ DFG++ +    ++ + ++  T  + APE ++  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPE-IVNY 192
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +      DMWS+G I   LL+    F G T+ + +                         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------------------- 227
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
           AN     Y+   + F           SE   D + +LL  +  KR+T+ +AL H W
Sbjct: 228 ANITSVSYDFDEEFFSHT--------SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 8/219 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  I  G+Y  V   R KK+  I A+K VK  +   ++ +++   + + + +    
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW---VQTEKHVFEQA 77
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           S +HP +V +      +   ++ V+EY+   DL + M+  ++       +    ++   +
Sbjct: 78  S-NHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLAL 134
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH+  +++RDLK  N+LL+++G +K+ D+GM ++   P    +    T  Y APE+L 
Sbjct: 135 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
           G + Y  +VD W++G +M E++A +  F      D  D+
Sbjct: 195 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 232

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 91/343 (26%), Positives = 142/343 (41%), Gaps = 72/343 (20%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSG-EIVALKKVK-----MNVGRKE----DCLEYGFPIS 62
           +E ++ + EG +G V    D K+G   VA+K VK         R E    + L    P S
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKC 121
           + R + +L  F+H             H  + +V E +      ++ E+   PF    ++ 
Sbjct: 76  TFRCVQMLEWFEH-------------HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFG 162
           +  Q+ + V +LH N + H DLK  N+L                         +K+ DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT 222
            S  Y    + +++LV    YRAPE++L A  +S   D+WS+GCI+ E      +F    
Sbjct: 183 -SATYDD--EHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 223 EVDQIDKIFKTLG-TPTETI---------------WPGLSELPGAKANFAKQPYNLLRKR 266
             + +  + + LG  P   I               W   S   G   + A +P     K 
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS-AGRYVSRACKPL----KE 293
Query: 267 FPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           F         V  E  FDL+ ++L YDP KRIT+ +AL H +F
Sbjct: 294 F----MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 138/308 (44%), Gaps = 54/308 (17%)
Query: 9   SVFEF-EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL--- 64
           SV+++ + L ++  G +G+V+R  +K +G +   K +              +P+      
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-----------PYPLDKYTVK 96
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
            EI+I+    HP ++N+ +   D ++ V +++E++   +L   + +     S +EV   M
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMV-LILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTL 181
            Q  EG+K++H++ ++H D+K  N++   +    +KI DFG++ +  +P +       T 
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATA 214
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
            + APE ++  +      DMW++G +   LL+    F+G  +++       TL       
Sbjct: 215 EFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCD 266
Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           W                        F   +F+    +S    D +  LL  +P KR+TV 
Sbjct: 267 W-----------------------EFDEDAFSS---VSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 302 DALNHYWF 309
           DAL H W 
Sbjct: 301 DALEHPWL 308

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 115/242 (47%), Gaps = 15/242 (6%)
Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+F K+  + EG++     AR+  +    A+K ++     KE+ + Y       RE +++
Sbjct: 32  FKFGKI--LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 84
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
              DHP  V +     DD + +Y  + Y ++   LK++ +     F  +  +    +++ 
Sbjct: 85  SRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS 141
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRAP 186
            ++YLH   ++HRDLK  N+LLN    ++I DFG ++      K   +   V T  Y +P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ELL   K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P   
Sbjct: 202 ELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 260
Query: 247 EL 248
           +L
Sbjct: 261 DL 262

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 118/297 (39%), Gaps = 48/297 (16%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           + +  GT+G V     + +G  VA+K +     R  D +         REI  L  F HP
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG-----KIKREIQNLKLFRHP 71
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
            I+ + +V+    D  +MVMEY+     +            E + L  Q+L  V Y H +
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELLLGAKK 194
            V+HRDLK  N+LL+     KI DFG+S     G  L+       +  Y APE++ G   
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCG---SPNYAAPEVISGRLY 187
Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN 254
               VD+WS G I+  LL       GT                          LP     
Sbjct: 188 AGPEVDIWSCGVILYALLC------GT--------------------------LP----- 210
Query: 255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           F  +    L K+     F     L+ S   LL  +L  DP KR T+ D   H WF +
Sbjct: 211 FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/318 (25%), Positives = 137/318 (43%), Gaps = 48/318 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYG-FPISSLREINILL 71
           +E    +  G   +V R   K + +  A+K + +  G      E      ++L+E++IL 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 72  SFD-HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               HP+I+ +K+   + +   ++V + M+    +   + K   S  E + +M  LLE +
Sbjct: 79  KVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
             LH   ++HRDLK  N+LL++   +K+ DFG S Q   P +    +  T  Y APE++ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIE 196
Query: 191 GAKK-----YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
            +       Y   VDMWS G IM  LLA  P F                           
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------------------------- 229
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPV---LSESGFDLLNRLLTYDPEKRITVDD 302
                    + ++   +LR         GSP     S++  DL++R L   P+KR T ++
Sbjct: 230 ---------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 303 ALNHYWFHEVPLPKSKDF 320
           AL H +F +  + + + F
Sbjct: 281 ALAHPFFQQYVVEEVRHF 298

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           V+ ARD +    VA+K ++ ++ R     +  F +   RE     + +HP+IV V +   
Sbjct: 28  VHLARDLRDHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82
Query: 87  DDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL 143
            +  +    Y+VMEY++      +   + P +      ++    + + + H N ++HRD+
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 144 KTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVD 200
           K +N+L++    +K+ DFG++R     G+ +    +++ T  Y +PE   G        D
Sbjct: 143 KPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG-DSVDARSD 201
Query: 201 MWSVGCIMAELLAKKPLFSGTTEV 224
           ++S+GC++ E+L  +P F+G + V
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEIXI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 112/212 (52%), Gaps = 18/212 (8%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLR 65
           S  + E++  I  G +G V   R K  G+    VA+K +K+    K+           L 
Sbjct: 43  SCIKIERV--IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR-------RDFLC 93
Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLML 124
           E +I+  FDHP++V+++ VV      V +V+E+ME+  L   +      F+  ++  ++ 
Sbjct: 94  EASIMGQFDHPNVVHLEGVVTRGK-PVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTL 181
            +  G++YL D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + +
Sbjct: 153 GIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            + APE +   +K+++A D+WS G +M E+++
Sbjct: 213 RWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMS 243

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEIXI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEIXI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 56
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 106
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 107 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 201
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 202 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 248
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 249 SARITIPDIKKDRWYNK-PLKKG 270

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 133/309 (43%), Gaps = 48/309 (15%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYG-FPISSLREINILL 71
           +E    +  G   +V R   K + +  A+K + +  G      E      ++L+E++IL 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 72  SFD-HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               HP+I+ +K+   + +   ++V + M+    +   + K   S  E + +M  LLE +
Sbjct: 66  KVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 124
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
             LH   ++HRDLK  N+LL++   +K+ DFG S Q   P +    +  T  Y APE++ 
Sbjct: 125 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIE 183
Query: 191 GAKK-----YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
            +       Y   VDMWS G IM  LLA  P F                           
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------------------------- 216
Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPV---LSESGFDLLNRLLTYDPEKRITVDD 302
                    + ++   +LR         GSP     S++  DL++R L   P+KR T ++
Sbjct: 217 ---------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 267
Query: 303 ALNHYWFHE 311
           AL H +F +
Sbjct: 268 ALAHPFFQQ 276

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 251 SARITIPDIKKDRWYNK-PLKKG 272

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 12  EFEKLNKISEGTYGIVYRA----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + +I  G +G+V+      +DK     VA+K ++     +ED +E         E 
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIE---------EA 53
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQL 126
            +++   HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L +
Sbjct: 54  EVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 112
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTL 181
            EG+ YL +  V+HRDL   N L+    V+K+ DFGM+R     QY S     T     +
Sbjct: 113 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 168
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL 217
            + +PE +    +YS+  D+WS G +M E+ ++  +
Sbjct: 169 KWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           V+ ARD +    VA+K ++ ++ R     +  F +   RE     + +HP+IV V +   
Sbjct: 28  VHLARDLRDHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82
Query: 87  DDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL 143
            +  +    Y+VMEY++      +   + P +      ++    + + + H N ++HRD+
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 144 KTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVD 200
           K +N++++    +K+ DFG++R     G+ +    +++ T  Y +PE   G        D
Sbjct: 143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSD 201
Query: 201 MWSVGCIMAELLAKKPLFSGTTEV 224
           ++S+GC++ E+L  +P F+G + V
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 12  EFEKLNKISEGTYGIVYRA----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + +I  G +G+V+      +DK     VA+K ++     +ED +E         E 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIE---------EA 51
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQL 126
            +++   HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L +
Sbjct: 52  EVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTL 181
            EG+ YL +  V+HRDL   N L+    V+K+ DFGM+R     QY S     T     +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 166
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
            + +PE +    +YS+  D+WS G +M E+ ++
Sbjct: 167 KWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSE 198

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 12  EFEKLNKISEGTYGIVYRA----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + +I  G +G+V+      +DK     VA+K ++     +ED +E         E 
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIE---------EA 56
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQL 126
            +++   HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L +
Sbjct: 57  EVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 115
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTL 181
            EG+ YL +  V+HRDL   N L+    V+K+ DFGM+R     QY S     T     +
Sbjct: 116 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 171
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL 217
            + +PE +    +YS+  D+WS G +M E+ ++  +
Sbjct: 172 KWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 103
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 104 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 162
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 221
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 222 YRKFTSASDVWSYGIVLWEVMS 243

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 12  EFEKLNKISEGTYGIVYRA----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + +I  G +G+V+      +DK     VA+K ++     +ED +E         E 
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIE---------EA 53
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQL 126
            +++   HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L +
Sbjct: 54  EVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 112
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTL 181
            EG+ YL +  V+HRDL   N L+    V+K+ DFGM+R     QY S     T     +
Sbjct: 113 CEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 168
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL 217
            + +PE +    +YS+  D+WS G +M E+ ++  +
Sbjct: 169 KWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 93
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 94  PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 152
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 211
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 76
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 77  PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 194
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMS 216

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 12  EFEKLNKISEGTYGIVYRA----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + +I  G +G+V+      +DK     VA+K ++     +ED +E         E 
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIE---------EA 54
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQL 126
            +++   HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L +
Sbjct: 55  EVMMKLSHPKLVQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTL 181
            EG+ YL +  V+HRDL   N L+    V+K+ DFGM+R     QY S     T     +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 169
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL 217
            + +PE +    +YS+  D+WS G +M E+ ++  +
Sbjct: 170 KWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 140/317 (44%), Gaps = 70/317 (22%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 58
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 108
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 203
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 204 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 250
Query: 295 EKRITVDDALNHYWFHE 311
             RIT+ D     W+++
Sbjct: 251 SARITIPDIKKDRWYNK 267

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 140/317 (44%), Gaps = 70/317 (22%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHE 311
             RIT+ D     W+++
Sbjct: 250 SARITIPDIKKDRWYNK 266

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 140/317 (44%), Gaps = 70/317 (22%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHE 311
             RIT+ D     W+++
Sbjct: 250 SARITIPDIKKDRWYNK 266

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 18/204 (8%)
Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V R R K  G+    VA+K +K     ++   E+      L E +I+  F+H
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REF------LSEASIMGQFEH 74
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV +    V ++ E+ME+  L   +      F+  ++  ++  +  G++YL 
Sbjct: 75  PNIIRLEGVVTNSM-PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV---VTLWYRAPELL 189
           +   +HRDL   N+L+N+  V K+ DFG+SR  +  S    YTS +   + + + APE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE-A 192
Query: 190 LGAKKYSTAVDMWSVGCIMAELLA 213
           +  +K+++A D WS G +M E+++
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 140/317 (44%), Gaps = 70/317 (22%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG YG V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHE 311
             RIT+ D     W+++
Sbjct: 250 SARITIPDIKKDRWYNK 266

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 22  GTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV 81
           G    V+ ARD +    VA+K ++ ++ R     +  F +   RE     + +HP+IV V
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 82  KEVVMDDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWV 138
            +    +  +    Y+VMEY++      +   + P +      ++    + + + H N +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 139 LHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           +HRD+K +N++++    +K+ DFG++R     G+ +    +++ T  Y +PE   G    
Sbjct: 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSV 196
Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTT 222
               D++S+GC++ E+L  +P F+G +
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG++R     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 12  EFEKLNKISEGTYGIVYRA----RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E   + +I  G +G+V+      +DK     VA+K +K     ++D +E         E 
Sbjct: 28  ELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIKEGSMSEDDFIE---------EA 73
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQL 126
            +++   HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L +
Sbjct: 74  EVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 132
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTL 181
            EG+ YL +  V+HRDL   N L+    V+K+ DFGM+R     QY S     T     +
Sbjct: 133 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 188
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
            + +PE +    +YS+  D+WS G +M E+ ++
Sbjct: 189 KWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSE 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           V+ ARD +    VA+K ++ ++ R     +  F +   RE     + +HP+IV V +   
Sbjct: 28  VHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82
Query: 87  DDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL 143
            +  +    Y+VMEY++      +   + P +      ++    + + + H N ++HRD+
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 144 KTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVD 200
           K +N++++    +K+ DFG++R     G+ +    +++ T  Y +PE   G        D
Sbjct: 143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSD 201
Query: 201 MWSVGCIMAELLAKKPLFSGTTEV 224
           ++S+GC++ E+L  +P F+G + V
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 29/225 (12%)
Query: 6   GCRSVFEFEK-----LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLE 56
           G R   +FE+     L ++ +G +G V   R       +GE+VA+KK++ +        E
Sbjct: 1   GSRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE 60
Query: 57  YGFPISSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPF 114
                   REI IL S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+  
Sbjct: 61  --------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 112
Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYG 168
              ++     Q+ +G++YL     +HR+L T N+L+ N+  +KI DFG++      ++Y 
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYY 172
Query: 169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
              +P  S +   WY APE L  + K+S A D+WS G ++ EL  
Sbjct: 173 KVKEPGESPI--FWY-APESLTES-KFSVASDVWSFGVVLYELFT 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 121/231 (52%), Gaps = 18/231 (7%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           + + E L ++  GT G V++ R +K+G ++A+K+++ +  ++E+          L ++++
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-------KRILMDLDV 76
Query: 70  LL-SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           +L S D P IV      + + D V++ ME M    + L + M+ P     +  + + +++
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 129 GVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMS-RQYGSPLKPYTSLVVTLWYRAP 186
            + YL + + V+HRD+K SN+LL+ +G +K+CDFG+S R      K  ++      Y AP
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA--YMAP 193
Query: 187 ELL----LGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFK 232
           E +         Y    D+WS+G  + EL   + P  +  T+ + + K+ +
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 88/154 (57%), Gaps = 6/154 (3%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL 122
           L E +I+  FDHP+I+ ++ VV     ++ +V EYME+  L   + +    F+  ++  +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VV 179
           +  +  G++YL D   +HRDL   N+L+++  V K+ DFG+SR     P   YT+    +
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            + + APE  +  + +S+A D+WS G +M E+LA
Sbjct: 217 PIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+ R     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE +  +  GTYG VY+ R  K+G++ A+K + +    +E+  +         EIN+L  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---------EINMLKK 76
Query: 73  FDH--------PSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSE-VKCL 122
           + H         + +      MDD   +++VME+     +  L+++ K      E +  +
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQ--LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             ++L G+ +LH + V+HRD+K  N+LL     +K+ DFG+S Q    +    + + T +
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 183 YRAPELLLGAKK----YSTAVDMWSVGCIMAELLAKKP 216
           + APE++   +     Y    D+WS+G    E+    P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV---KE 83
           V+ ARD +    VA+K ++ ++ R     +  F +   RE     + +HP+IV V    E
Sbjct: 28  VHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYATGE 82
Query: 84  VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL 143
                    Y+VMEY++      +   + P +      ++    + + + H N ++HRD+
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142
Query: 144 KTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVD 200
           K +N++++    +K+ DFG++R     G+ +    +++ T  Y +PE   G        D
Sbjct: 143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSD 201
Query: 201 MWSVGCIMAELLAKKPLFSGTTEV 224
           ++S+GC++ E+L  +P F+G + V
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V     K  G+    VA+K +K     K+      F    L E +I+  FDH
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ---RRDF----LSEASIMGQFDH 93
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P++++++ VV      V ++ E+ME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 94  PNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV---VTLWYRAPELL 189
           D   +HRDL   N+L+N+  V K+ DFG+SR  +  +    YTS +   + + + APE  
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE-A 211
Query: 190 LGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGTTEVDQIDKI 230
           +  +K+++A D+WS G +M E+++  ++P +  T + D I+ I
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAI 253

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           V+ ARD +    VA+K ++ ++ R     +  F +   RE     + +HP+IV V +   
Sbjct: 45  VHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGE 99
Query: 87  DDHDSV---YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDL 143
            +  +    Y+VMEY++      +   + P +      ++    + + + H N ++HRD+
Sbjct: 100 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 159
Query: 144 KTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVD 200
           K +N++++    +K+ DFG++R     G+ +    +++ T  Y +PE   G        D
Sbjct: 160 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSD 218
Query: 201 MWSVGCIMAELLAKKPLFSGTTEV 224
           ++S+GC++ E+L  +P F+G + V
Sbjct: 219 VYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           I  G +G VY  R   +G++ A+K     ++KM  G           ++    ++++ + 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-------LALNERIMLSLVSTG 248
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           D P IV +        D +  +++ M   DL + + S    FS ++++    +++ G+++
Sbjct: 249 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 306
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H+ +V++RDLK +N+LL+  G ++I D G++  + S  KP+ S V T  Y APE+L   
Sbjct: 307 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEVLQKG 364
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSG--TTEVDQIDKIFKTLGT 236
             Y ++ D +S+GC++ +LL     F    T +  +ID++  T+  
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 410

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           I  G +G VY  R   +G++ A+K     ++KM  G           ++    ++++ + 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-------LALNERIMLSLVSTG 249
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           D P IV +        D +  +++ M   DL + + S    FS ++++    +++ G+++
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 307
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H+ +V++RDLK +N+LL+  G ++I D G++  + S  KP+ S V T  Y APE+L   
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSG--TTEVDQIDKIFKTLGT 236
             Y ++ D +S+GC++ +LL     F    T +  +ID++  T+  
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V E ME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           I  G +G VY  R   +G++ A+K     ++KM  G           ++    ++++ + 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-------LALNERIMLSLVSTG 249
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           D P IV +        D +  +++ M   DL + + S    FS ++++    +++ G+++
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 307
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H+ +V++RDLK +N+LL+  G ++I D G++  + S  KP+ S V T  Y APE+L   
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSG--TTEVDQIDKIFKTLGT 236
             Y ++ D +S+GC++ +LL     F    T +  +ID++  T+  
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           I  G +G VY  R   +G++ A+K     ++KM  G           ++    ++++ + 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-------LALNERIMLSLVSTG 249
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           D P IV +        D +  +++ M   DL + + S    FS ++++    +++ G+++
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 307
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +H+ +V++RDLK +N+LL+  G ++I D G++  + S  KP+ S V T  Y APE+L   
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSG--TTEVDQIDKIFKTLGT 236
             Y ++ D +S+GC++ +LL     F    T +  +ID++  T+  
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 66
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      +++    +P  S +   WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI--FWY 184
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 185 -APESLTES-KFSVASDVWSFGVVLYELFT 212

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 135/317 (42%), Gaps = 60/317 (18%)
Query: 3   MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFP 60
           M    R   +++   ++ +G + +V R   K   +  A K +  K    R    LE    
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE---- 78
Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDHDSV------YMVMEYMEHDLKWLMESMKQPF 114
               RE  I     HP+IV +       HDS+      Y+V + +     +     ++ +
Sbjct: 79  ----REARICRLLKHPNIVRL-------HDSISEEGFHYLVFDLVTGGELFEDIVAREYY 127
Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPL 171
           S ++    + Q+LE V ++H + ++HRDLK  NLLL ++     +K+ DFG++ +     
Sbjct: 128 SEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ 187
Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
           + +     T  Y +PE+L     Y   VD+W+ G I+  LL   P F    + DQ  K++
Sbjct: 188 QAWFGFAGTPGYLSPEVLR-KDPYGKPVDIWACGVILYILLVGYPPF---WDEDQ-HKLY 242
Query: 232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLT 291
                  + I  G  + P  + +                       ++    +L+N++LT
Sbjct: 243 -------QQIKAGAYDFPSPEWD----------------------TVTPEAKNLINQMLT 273
Query: 292 YDPEKRITVDDALNHYW 308
            +P KRIT D AL H W
Sbjct: 274 INPAKRITADQALKHPW 290

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 38/252 (15%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
             R   +FE++  + +G +G V +AR+       A+KK++      E+ L      + L 
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLS-----TILS 51
Query: 66  EINILLSFDHPSIVNVKEVVMDDHD------------SVYMVMEYMEHDLKW-LMESMKQ 112
           E+ +L S +H  +V      ++  +            ++++ MEY E+   + L+ S   
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENL 111
Query: 113 PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL- 171
                E   L  Q+LE + Y+H   ++HRDLK  N+ ++    +KI DFG+++     L 
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 172 -------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
                           TS + T  Y A E+L G   Y+  +DM+S+G I  E++   P  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFS 229
Query: 219 SGTTEVDQIDKI 230
           +G   V+ + K+
Sbjct: 230 TGMERVNILKKL 241

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 5   QGCRSVFEFEK-----LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCL 55
           +G  ++ +FE+     L ++ +G +G V   R       +GE+VA+KK++ +        
Sbjct: 17  RGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 76
Query: 56  EYGFPISSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQP 113
           E        REI IL S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+ 
Sbjct: 77  E--------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 128
Query: 114 FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQY 167
               ++     Q+ +G++YL     +HRDL T N+L+ N+  +KI DFG++      ++ 
Sbjct: 129 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
               +P  S +   WY APE L  + K+S A D+WS G ++ EL  
Sbjct: 189 XKVKEPGESPI--FWY-APESLTES-KFSVASDVWSFGVVLYELFT 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 38/252 (15%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
             R   +FE++  + +G +G V +AR+       A+KK++      E+ L      + L 
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLS-----TILS 51
Query: 66  EINILLSFDHPSIVNVKEVVMDDHD------------SVYMVMEYMEHDLKW-LMESMKQ 112
           E+ +L S +H  +V      ++  +            ++++ MEY E+   + L+ S   
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 113 PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL- 171
                E   L  Q+LE + Y+H   ++HRDLK  N+ ++    +KI DFG+++     L 
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 172 -------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
                           TS + T  Y A E+L G   Y+  +DM+S+G I  E++   P  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFS 229
Query: 219 SGTTEVDQIDKI 230
           +G   V+ + K+
Sbjct: 230 TGMERVNILKKL 241

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 115/227 (50%), Gaps = 18/227 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  + +G++G V  +  K + E+ A+K +K +V  ++D +E      ++ E  +L 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-----CTMVEKRVLA 75
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               P  +          D +Y VMEY+   DL + ++ + + F          ++  G+
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGL 134
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAPE 187
            +L    +++RDLK  N++L+++G +KI DFGM ++    G   K +     T  Y APE
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCG---TPDYIAPE 191
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
            ++  + Y  +VD W+ G ++ E+LA +  F G  E    D++F+++
Sbjct: 192 -IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSI 233

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            +K+  + EG +G V    Y   +  +GE+VA+K +K   G +   L  G+     REI 
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ---LRSGWQ----REIE 63
Query: 69  ILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQL 126
           IL +  H  IV  K    D  + SV +VMEY+   L  L + + +     +++     Q+
Sbjct: 64  ILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV--PLGSLRDYLPRHCVGLAQLLLFAQQI 121
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTLW 182
            EG+ YLH    +HR L   N+LL+N  ++KI DFG+++      + Y           W
Sbjct: 122 CEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 181
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           Y APE L   K Y  A D+WS G  + ELL 
Sbjct: 182 Y-APECLKECKFY-YASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            +K+  + EG +G V    Y   +  +GE+VA+K +K   G +   L  G+     REI 
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ---LRSGWQ----REIE 62
Query: 69  ILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQL 126
           IL +  H  IV  K    D  + SV +VMEY+   L  L + + +     +++     Q+
Sbjct: 63  ILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV--PLGSLRDYLPRHCVGLAQLLLFAQQI 120
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTLW 182
            EG+ YLH    +HR L   N+LL+N  ++KI DFG+++      + Y           W
Sbjct: 121 CEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 180
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           Y APE L   K Y  A D+WS G  + ELL 
Sbjct: 181 Y-APECLKECKFY-YASDVWSFGVTLYELLT 209

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 5   QGCRSVFEFEK-----LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCL 55
           +G  ++ +FE+     L ++ +G +G V   R       +GE+VA+KK++ +        
Sbjct: 17  RGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 76
Query: 56  EYGFPISSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQP 113
           E        REI IL S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+ 
Sbjct: 77  E--------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 128
Query: 114 FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQY 167
               ++     Q+ +G++YL     +HRDL T N+L+ N+  +KI DFG++      ++ 
Sbjct: 129 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
               +P  S +   WY APE L  + K+S A D+WS G ++ EL  
Sbjct: 189 XKVKEPGESPI--FWY-APESLTES-KFSVASDVWSFGVVLYELFT 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R + +FE +  +  G +G+V+ A++K      A+K++++    +E   E       +RE+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL--PNRELARE-----KVMREV 54
Query: 68  NILLSFDHPSIV---------NVKEVVMDDHDSVYMVMEYM---EHDLKWLMESMKQPFS 115
             L   +HP IV         N  E +      VY+ ++     + +LK  M        
Sbjct: 55  KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 116 TSEVKCL--MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM---------S 164
                CL   LQ+ E V++LH   ++HRDLK SN+      V+K+ DFG+          
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 165 RQYGSPLKPY---TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           +   +P+  Y   T  V T  Y +PE + G   YS  VD++S+G I+ ELL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 142/323 (43%), Gaps = 71/323 (21%)
Query: 10  VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI 69
           V +++ +  + EG  G V  A ++ + E VA+K V M   R  DC     P +  +EI I
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK--RAVDC-----PENIKKEICI 57
Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEY---------MEHDLKWLMESMKQPFSTSEVK 120
               +H ++V       + +   Y+ +EY         +E D+      M +P    + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI-----GMPEP----DAQ 107
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV 178
               QL+ GV YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            TL Y APELL   + ++  VD+WS G ++  +LA                         
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA------------------------- 202
Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKR----FPAASFTGSPVLSESGFDLLNRLLTYDP 294
                   ELP  + + + Q Y+  +++     P      +P+       LL+++L  +P
Sbjct: 203 -------GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------LLHKILVENP 249
Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
             RIT+ D     W+++ PL K 
Sbjct: 250 SARITIPDIKKDRWYNK-PLKKG 271

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 19  ISEGTYGIVYRARDKKSG---EI-VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD 74
           I  G +G VY+   K S    E+ VA+K +K     K+        +  L E  I+  F 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-------VDFLGEAGIMGQFS 104
Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           H +I+ + E V+  +  + ++ EYME+  L   +      FS  ++  ++  +  G+KYL
Sbjct: 105 HHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLL 190
            +   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + APE  +
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE-AI 222
Query: 191 GAKKYSTAVDMWSVGCIMAELL 212
             +K+++A D+WS G +M E++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 112/224 (50%), Gaps = 12/224 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  + +G++G V  +  K + E+ A+K +K +V  ++D +E      ++ E  +L 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-----CTMVEKRVLA 396
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               P  +          D +Y VMEY+   DL + ++ + + F          ++  G+
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGL 455
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            +L    +++RDLK  N++L+++G +KI DFGM ++             T  Y APE ++
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE-II 514
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
             + Y  +VD W+ G ++ E+LA +  F G  E    D++F+++
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSI 554

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 97
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 215
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 216 -APESLTES-KFSVASDVWSFGVVLYELFT 243

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 105
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V E ME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 223
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 19  ISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  G +G V   R K   K    VA+K +K+    K+      F    L E +I+  FDH
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----LGEASIMGQFDH 76
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV      V +V E ME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 77  PNIIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSL--VVTLWYRAPELLLG 191
           D   +HRDL   N+L+N+  V K+ DFG+SR     P   YT+    + + + +PE  + 
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIA 194
Query: 192 AKKYSTAVDMWSVGCIMAELLA 213
            +K+++A D+WS G ++ E+++
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMS 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 22  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 73
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 191
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 192 -APESLTES-KFSVASDVWSFGVVLYELFT 219

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI-L 70
           + E + ++  G YG+V + R   SG+I+A+K+++  V  +E           L +++I +
Sbjct: 52  DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ-------KRLLMDLDISM 104
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM---KQPFSTSEVKCLMLQLL 127
            + D P  V     +  + D V++ ME M+  L    + +    Q      +  + + ++
Sbjct: 105 RTVDCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 128 EGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMS--------RQYGSPLKPYTSLV 178
           + +++LH    V+HRD+K SN+L+N  G +K+CDFG+S        +   +  KPY    
Sbjct: 164 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM--- 220
Query: 179 VTLWYRAPELL---LGAKKYSTAVDMWSVGCIMAEL 211
                 APE +   L  K YS   D+WS+G  M EL
Sbjct: 221 ------APERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 21  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 72
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 190
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 191 -APESLTES-KFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 66
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 184
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 185 -APESLTES-KFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 19  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 70
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 188
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 189 -APESLTES-KFSVASDVWSFGVVLYELFT 216

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 18/204 (8%)
Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V R R K  G+    VA+K +K     ++   E+      L E +I+  F+H
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REF------LSEASIMGQFEH 76
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P+I+ ++ VV +    V ++ E+ME+  L   +      F+  ++  ++  +  G++YL 
Sbjct: 77  PNIIRLEGVVTNSM-PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA 135
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSL--VVTLWYRAPELL 189
           +   +HRDL   N+L+N+  V K+ DFG+SR   +  S     +SL   + + + APE  
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE-A 194
Query: 190 LGAKKYSTAVDMWSVGCIMAELLA 213
           +  +K+++A D WS G +M E+++
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 69
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 187
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 188 -APESLTES-KFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 20  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 71
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 189
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 190 -APESLTES-KFSVASDVWSFGVVLYELFT 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            +K+  + EG +G V    Y   +  +GE+VA+K +K + G +      G+     +EI+
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH---RSGWK----QEID 85
Query: 69  ILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQL 126
           IL +  H  I+  K    D    S+ +VMEY+   L  L + + +     +++     Q+
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP--LGSLRDYLPRHSIGLAQLLLFAQQI 143
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTLW 182
            EG+ YLH    +HRDL   N+LL+N  ++KI DFG+++      + Y           W
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           Y APE L   K Y  A D+WS G  + ELL
Sbjct: 204 Y-APECLKEYKFY-YASDVWSFGVTLYELL 231

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 65
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 183
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 184 -APESLTES-KFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 64
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 182
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 183 -APESLTES-KFSVASDVWSFGVVLYELFT 210

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 131/302 (43%), Gaps = 51/302 (16%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINIL 70
           FE+L K   G + +V R     +G+  A K +  K    R    LE        RE  I 
Sbjct: 27  FEELGK---GAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE--------REARIC 75
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               HP+IV + + + ++    Y++ + +     +     ++ +S ++    + Q+LE V
Sbjct: 76  RLLKHPNIVRLHDSISEEGHH-YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 134
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            + H   V+HRDLK  NLLL ++     +K+ DFG++ +     + +     T  Y +PE
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 194
Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +L     Y   VD+W+ G I+  LL   P F    + DQ  +++       + I  G  +
Sbjct: 195 VLR-KDPYGKPVDLWACGVILYILLVGYPPF---WDEDQ-HRLY-------QQIKAGAYD 242
Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
            P  + +                       ++    DL+N++LT +P KRIT  +AL H 
Sbjct: 243 FPSPEWD----------------------TVTPEAKDLINKMLTINPSKRITAAEALKHP 280
Query: 308 WF 309
           W 
Sbjct: 281 WI 282

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 66
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q+ +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 184
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 185 -APESLTES-KFSVASDVWSFGVVLYELFT 212

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 142/318 (44%), Gaps = 56/318 (17%)
Query: 5   QGC-RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           QG   S +   K   +  G +G V++  +  +G  +A K +K    + ++ ++       
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK------- 134
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL- 122
             EI+++   DH +++ + +     +D + +VMEY++   +     + + ++ +E+  + 
Sbjct: 135 -NEISVMNQLDHANLIQLYDAFESKND-IVLVMEYVDGG-ELFDRIIDESYNLTELDTIL 191
Query: 123 -MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVV 179
            M Q+ EG++++H  ++LH DLK  N+L  N+    +KI DFG++R+Y    KP   L V
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY----KPREKLKV 247
Query: 180 TLW---YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
                 + APE ++     S   DMWSVG I   LL+    F G  + + ++ I      
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--- 303
Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                                  ++L  + F          +SE   + +++LL  +   
Sbjct: 304 ----------------------RWDLEDEEFQD--------ISEEAKEFISKLLIKEKSW 333
Query: 297 RITVDDALNHYWFHEVPL 314
           RI+  +AL H W  +  L
Sbjct: 334 RISASEALKHPWLSDHKL 351

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 34/238 (14%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI-L 70
           + E + ++  G YG+V + R   SG+I+A+K+++  V  +E           L +++I +
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-------RLLMDLDISM 60
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM---KQPFSTSEVKCLMLQLL 127
            + D P  V     +  + D V++ ME M+  L    + +    Q      +  + + ++
Sbjct: 61  RTVDCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 128 EGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMS--------RQYGSPLKPYTSLV 178
           + +++LH    V+HRD+K SN+L+N  G +K+CDFG+S        +   +  KPY    
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM--- 176
Query: 179 VTLWYRAPELL---LGAKKYSTAVDMWSVGCIMAEL-LAKKPLFSGTTEVDQIDKIFK 232
                 APE +   L  K YS   D+WS+G  M EL + + P  S  T   Q+ ++ +
Sbjct: 177 ------APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 18  LRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 69
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++ME++ +  L+  ++  K+     ++     Q+ +G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 187
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 188 -APESLTES-KFSVASDVWSFGVVLYELFT 215

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL 122
           L E +I+  FDHP+I+ ++ VV     ++ +V EYME+  L   + +    F+  ++  +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG---SPLKPYTSLVV 179
           +  +  G++YL D   +HRDL   N+L+++  V K+ DFG+SR            T   +
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            + + APE  +  + +S+A D+WS G +M E+LA
Sbjct: 217 PIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            +K+  + EG +G V    Y   +  +GE+VA+K +K + G +      G+     +EI+
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH---RSGWK----QEID 68
Query: 69  ILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQL 126
           IL +  H  I+  K    D  + S+ +VMEY+   L  L + + +     +++     Q+
Sbjct: 69  ILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP--LGSLRDYLPRHSIGLAQLLLFAQQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTLW 182
            EG+ YLH    +HR+L   N+LL+N  ++KI DFG+++      + Y           W
Sbjct: 127 CEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           Y APE L   K Y  A D+WS G  + ELL 
Sbjct: 187 Y-APECLKEYKFY-YASDVWSFGVTLYELLT 215

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 136/317 (42%), Gaps = 54/317 (17%)
Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGE-----IVALKKVKMNVGRKEDCL 55
           M  +   R   E++   ++ +G + +V R     +G+     I+  KK+     R    L
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS---ARDHQKL 57
Query: 56  EYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFS 115
           E        RE  I     HP+IV + + + ++    Y++ + +     +     ++ +S
Sbjct: 58  E--------REARICRLLKHPNIVRLHDSISEEGHH-YLIFDLVTGGELFEDIVAREYYS 108
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLK 172
            ++    + Q+LE V + H   V+HR+LK  NLLL ++     +K+ DFG++ +     +
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
            +     T  Y +PE+L     Y   VD+W+ G I+  LL   P F    + DQ  +++ 
Sbjct: 169 AWFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPF---WDEDQ-HRLY- 222
Query: 233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
                 + I  G  + P  + +                       ++    DL+N++LT 
Sbjct: 223 ------QQIKAGAYDFPSPEWD----------------------TVTPEAKDLINKMLTI 254
Query: 293 DPEKRITVDDALNHYWF 309
           +P KRIT  +AL H W 
Sbjct: 255 NPSKRITAAEALKHPWI 271

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 16  LNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           L ++ +G +G V   R       +GE+VA+KK++ +        E        REI IL 
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--------REIEILK 69
Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           S  H +IV  K V       ++ ++MEY+ +  L+  +++  +     ++     Q+ +G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKPYTSLVVTLWY 183
           ++YL     +HRDL T N+L+ N+  +KI DFG++      ++     +P  S +   WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI--FWY 187
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            APE L  + K+S A D+WS G ++ EL  
Sbjct: 188 -APESLTES-KFSVASDVWSFGVVLYELFT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
            +K+  + EG +G V    Y   +  +GE+VA+K +K + G +      G+     +EI+
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH---RSGWK----QEID 68
Query: 69  ILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQL 126
           IL +  H  I+  K    D  + S+ +VMEY+   L  L + + +     +++     Q+
Sbjct: 69  ILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP--LGSLRDYLPRHSIGLAQLLLFAQQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTLW 182
            EG+ YLH    +HR+L   N+LL+N  ++KI DFG+++      + Y           W
Sbjct: 127 CEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           Y APE L   K Y  A D+WS G  + ELL 
Sbjct: 187 Y-APECLKEYKFY-YASDVWSFGVTLYELLT 215

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 31/249 (12%)
Query: 83  EVVMDDHDSVYMVMEYMEHD--LKW------LMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           E ++ ++D VY++ EYME+D  LK+      L ++         +KC++  +L    Y+H
Sbjct: 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168
Query: 135 DNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
           +   + HRD+K SN+L++  G +K+ DFG S +Y    K   S   T  +  PE      
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSR-GTYEFMPPEFFSNES 226
Query: 194 KYSTA-VDMWSVG-CIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            Y+ A VD+WS+G C+        P     + V+  + I       T+ I     E P  
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI------RTKNI-----EYPLD 275
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           + +F    Y L  K+    S   +  LS    D L   L  +P +RIT +DAL H W  +
Sbjct: 276 RNHFL---YPLTNKK----STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
Query: 312 VPLPKSKDF 320
             +   ++F
Sbjct: 329 TNIEDLREF 337

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 21/223 (9%)
Query: 19  ISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I  G +G V     K  G+    VA+K +K     K+      F    L E +I+  FDH
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ---RRDF----LSEASIMGQFDH 67
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P++++++ VV      V ++ E+ME+  L   +      F+  ++  ++  +  G+KYL 
Sbjct: 68  PNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLV---VTLWYRAPELL 189
           D   +HR L   N+L+N+  V K+ DFG+SR  +  +    YTS +   + + + APE  
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE-A 185
Query: 190 LGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGTTEVDQIDKI 230
           +  +K+++A D+WS G +M E+++  ++P +  T + D I+ I
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAI 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 8/220 (3%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F  L  I +G++G V  AR K      A+K     V +K+  L+       + E N+LL
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVK-----VLQKKAILKKKEEKHIMSERNVLL 93
Query: 72  -SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +  HP +V +        D +Y V++Y+     +     ++ F     +    ++   +
Sbjct: 94  KNVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            YLH   +++RDLK  N+LL++QG + + DFG+ ++        ++   T  Y APE +L
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
             + Y   VD W +G ++ E+L   P F      +  D I
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 78
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 79  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                LHRDL   N L+N+QGV+K+ DFG+SR        YTS V +   + +  PE+L+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLM 194
Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + K+S+  D+W+ G +M E+  L K P
Sbjct: 195 YS-KFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 20  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 69
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 70  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 127
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                LHRDL   N L+N+QGV+K+ DFG+SR        YTS V +   + +  PE+L+
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLM 185
Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + K+S+  D+W+ G +M E+  L K P
Sbjct: 186 YS-KFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 58
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 59  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                LHRDL   N L+N+QGV+K+ DFG+SR        YTS V +   + +  PE+L+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLM 174
Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + K+S+  D+W+ G +M E+  L K P
Sbjct: 175 YS-KFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 13  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 62
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 63  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 120
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                LHRDL   N L+N+QGV+K+ DFG+SR        YTS V +   + +  PE+L+
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLM 178
Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + K+S+  D+W+ G +M E+  L K P
Sbjct: 179 YS-KFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 63
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 64  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                LHRDL   N L+N+QGV+K+ DFG+SR        YTS V +   + +  PE+L+
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLM 179
Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + K+S+  D+W+ G +M E+  L K P
Sbjct: 180 YS-KFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
            +I  G +G V+  R +    +VA+K  +       + L        L+E  IL  + HP
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-------ETLPPDLKAKFLQEARILKQYSHP 172
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           +IV +  V       +Y+VME ++  D    + +         +  ++     G++YL  
Sbjct: 173 NIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV--VTLWYRAPELLLGAK 193
              +HRDL   N L+  + VLKI DFGMSR+    +   +  +  V + + APE  L   
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE-ALNYG 290
Query: 194 KYSTAVDMWSVGCIMAELLA 213
           +YS+  D+WS G ++ E  +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   +F+++  I  G +G V++A+ +  G+   +K+VK N  + E  ++    ++ L  +
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK---ALAKLDHV 64
Query: 68  NILL------SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL--KWLMESMKQPFSTSEV 119
           NI+        FD+    + K         +++ ME+ +     +W+ +   +       
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
             L  Q+ +GV Y+H   +++RDLK SN+ L +   +KI DFG+     +  K   S   
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS-KG 183
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           TL Y +PE  + ++ Y   VD++++G I+AELL
Sbjct: 184 TLRYMSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 135/311 (43%), Gaps = 49/311 (15%)
Query: 13  FEKLNKISEGTYGIVYRAR---DKKSGEIVALKKVK-MNVGRKEDCLEYGFPISSLREIN 68
           FE L  +  G YG V+  R      +G++ A+K +K   + +K    E+     +  E  
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-----TRTERQ 110
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           +L        +            ++++++Y+     +   S ++ F+  EV+  + +++ 
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSLVVTLWYRAPE 187
            +++LH   +++RD+K  N+LL++ G + + DFG+S+++     +       T+ Y AP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 188 LLLGAKK-YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ++ G    +  AVD WS+G +M ELL     F+                           
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--------------------------- 263
Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVD 301
            + G K + A+    +L+   P         +S    DL+ RLL  DP+KR+       D
Sbjct: 264 -VDGEKNSQAEISRRILKSEPPYPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDAD 317
Query: 302 DALNHYWFHEV 312
           +   H +F ++
Sbjct: 318 EIKEHLFFQKI 328

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EI 67
            +++  + EG +G V    Y      +GE VA+K +K   G        G  I+ L+ EI
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEI 74
Query: 68  NILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQ 125
            IL +  H +IV  K +  +D  + + ++ME++    LK  +   K   +  +     +Q
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTL 181
           + +G+ YL     +HRDL   N+L+ ++  +KI DFG+++   +  +  T          
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF 194
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           WY APE L+ +K Y  A D+WS G  + ELL 
Sbjct: 195 WY-APECLMQSKFY-IASDVWSFGVTLHELLT 224

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +V E ++       + +   Q F+  E   +   + E ++YLH 
Sbjct: 120 IVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS 179
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++  S     T+   T +Y APE +LG 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE-VLGP 237
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + D WS+G I   LL   P F                         GL+  PG K
Sbjct: 238 EKYDKSCDXWSLGVIXYILLCGYPPFYSNH---------------------GLAISPGXK 276
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                  Y      FP   ++    +SE    L+  LL  +P +R T+ +  NH W  +
Sbjct: 277 TRIRXGQYE-----FPNPEWSE---VSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQ 327

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPS 77
           ++EG +  VY A+D  SG   ALK++  N   K   +        ++E+  +     HP+
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--------IQEVCFMKKLSGHPN 87
Query: 78  IVNV-------KEVVMDDHDSVYMVMEYMEHDLKWLMESM--KQPFSTSEVKCLMLQLLE 128
           IV         KE          ++ E  +  L   ++ M  + P S   V  +  Q   
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 129 GVKYLHDNW--VLHRDLKTSNLLLNNQGVLKICDFGM------------SRQYGSPLKPY 174
            V+++H     ++HRDLK  NLLL+NQG +K+CDFG             S Q  + ++  
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 175 TSLVVTLWYRAPELL-------LGAKKYSTAVDMWSVGCIM 208
            +   T  YR PE++       +G K+     D+W++GCI+
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQ-----DIWALGCIL 243

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
            +I  G +G V+  R +    +VA+K  +       + L        L+E  IL  + HP
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-------ETLPPDLKAKFLQEARILKQYSHP 172
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           +IV +  V       +Y+VME ++  D    + +         +  ++     G++YL  
Sbjct: 173 NIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV--VTLWYRAPELLLGAK 193
              +HRDL   N L+  + VLKI DFGMSR+    +   +  +  V + + APE  L   
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYG 290
Query: 194 KYSTAVDMWSVGCIMAELLA 213
           +YS+  D+WS G ++ E  +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 13  FEKLNKISEGTYGIV----YRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EI 67
            +++  + EG +G V    Y      +GE VA+K +K   G        G  I+ L+ EI
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEI 62
Query: 68  NILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQ 125
            IL +  H +IV  K +  +D  + + ++ME++    LK  +   K   +  +     +Q
Sbjct: 63  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT----SLVVTL 181
           + +G+ YL     +HRDL   N+L+ ++  +KI DFG+++   +  +  T          
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF 182
Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           WY APE L+ +K Y  A D+WS G  + ELL 
Sbjct: 183 WY-APECLMQSKFY-IASDVWSFGVTLHELLT 212

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 21/238 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + + L +I  G YG V +   K SG+I+A+K+++  V  KE           L ++++++
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-------KQLLMDLDVVM 75
Query: 72  -SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL----KWLMESMKQPFSTSEVKCLMLQL 126
            S D P IV     +  + D  ++ ME M        K++   +        +  + L  
Sbjct: 76  RSSDCPYIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 127 LEGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ + +L +N  ++HRD+K SN+LL+  G +K+CDFG+S Q    +   T       Y A
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMA 193
Query: 186 PELL---LGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTE 239
           PE +      + Y    D+WS+G  + EL   + P     +  DQ+ ++ K  G P +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQ 249

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G++G V+R +DK++G   A+KKV++ V R E             E+        P 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------------ELVACAGLSSPR 111
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL--MLQLLEGVKYLHD 135
           IV +   V +    V + ME +E     L + +KQ     E + L  + Q LEG++YLH 
Sbjct: 112 IVPLYGAVREG-PWVNIFMELLEGGS--LGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 136 NWVLHRDLKTSNLLLNNQGV-LKICDFGMS-----RQYGSPLKPYTSLVVTLWYRAPELL 189
             +LH D+K  N+LL++ G    +CDFG +        G  L     +  T  + APE++
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
           +G K     VD+WS  C+M  +L
Sbjct: 229 MG-KPCDAKVDIWSSCCMMLHML 250

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 25/203 (12%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G++G V+R  DK++G   A+KKV++ V R E             E+        P 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------------ELMACAGLTSPR 146
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL--MLQLLEGVKYLHD 135
           IV +   V +    V + ME +E     L + +K+     E + L  + Q LEG++YLH 
Sbjct: 147 IVPLYGAVREG-PWVNIFMELLEGGS--LGQLVKEQGCLPEDRALYYLGQALEGLEYLHS 203
Query: 136 NWVLHRDLKTSNLLLNNQGV-LKICDFGMS-----RQYGSPLKPYTSLVVTLWYRAPELL 189
             +LH D+K  N+LL++ G    +CDFG +        G  L     +  T  + APE++
Sbjct: 204 RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVV 263
Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
           LG +     VD+WS  C+M  +L
Sbjct: 264 LG-RSCDAKVDVWSSCCMMLHML 285

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G++G V+R +DK++G   A+KKV++ V R E             E+        P 
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------------ELVACAGLSSPR 127
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL--MLQLLEGVKYLHD 135
           IV +   V +    V + ME +E     L + +KQ     E + L  + Q LEG++YLH 
Sbjct: 128 IVPLYGAVREG-PWVNIFMELLEGGS--LGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 184
Query: 136 NWVLHRDLKTSNLLLNNQGV-LKICDFGMS-----RQYGSPLKPYTSLVVTLWYRAPELL 189
             +LH D+K  N+LL++ G    +CDFG +        G  L     +  T  + APE++
Sbjct: 185 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
           +G K     VD+WS  C+M  +L
Sbjct: 245 MG-KPCDAKVDIWSSCCMMLHML 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 25/203 (12%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G++G V+R  DK++G   A+KKV++ V R E             E+        P 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------------ELMACAGLTSPR 127
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL--MLQLLEGVKYLHD 135
           IV +   V +    V + ME +E     L + +K+     E + L  + Q LEG++YLH 
Sbjct: 128 IVPLYGAVREG-PWVNIFMELLEGGS--LGQLVKEQGCLPEDRALYYLGQALEGLEYLHS 184
Query: 136 NWVLHRDLKTSNLLLNNQGV-LKICDFGMS-----RQYGSPLKPYTSLVVTLWYRAPELL 189
             +LH D+K  N+LL++ G    +CDFG +        G  L     +  T  + APE++
Sbjct: 185 RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVV 244
Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
           LG +     VD+WS  C+M  +L
Sbjct: 245 LG-RSCDAKVDVWSSCCMMLHML 266

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 94/191 (49%), Gaps = 16/191 (8%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           VYR R K+    VA+K +K     K D  E       +RE  I+   D+P IV +  V  
Sbjct: 30  VYRMRKKQID--VAIKVLKQGT-EKADTEEM------MREAQIMHQLDNPYIVRLIGVC- 79
Query: 87  DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT 145
              +++ +VME      L   +   ++    S V  L+ Q+  G+KYL +   +HRDL  
Sbjct: 80  -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138
Query: 146 SNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLLGAKKYSTAVDMW 202
            N+LL N+   KI DFG+S+  G+    YT+     W   + APE  +  +K+S+  D+W
Sbjct: 139 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVW 197
Query: 203 SVGCIMAELLA 213
           S G  M E L+
Sbjct: 198 SYGVTMWEALS 208

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           ++  G++G V+R +DK++G   A+KKV++ V R E             E+        P 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------------ELVACAGLSSPR 125
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCL--MLQLLEGVKYLHD 135
           IV +   V +    V + ME +E     L + +KQ     E + L  + Q LEG++YLH 
Sbjct: 126 IVPLYGAVREG-PWVNIFMELLEGGS--LGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 182
Query: 136 NWVLHRDLKTSNLLLNNQGV-LKICDFGMS-----RQYGSPLKPYTSLVVTLWYRAPELL 189
             +LH D+K  N+LL++ G    +CDFG +        G  L     +  T  + APE++
Sbjct: 183 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
           +G K     VD+WS  C+M  +L
Sbjct: 243 MG-KPCDAKVDIWSSCCMMLHML 264

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 60/308 (19%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINI 69
           E++    I +G + +V R     +G   A K +  K    R    LE        RE  I
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE--------REARI 56
Query: 70  LLSFDHPSIVNVKEVVMDDHDSV------YMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
                H +IV +       HDS+      Y+V + +     +     ++ +S ++    +
Sbjct: 57  CRLLKHSNIVRL-------HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 109
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+LE V + H   V+HRDLK  NLLL ++     +K+ DFG++ +     + +     T
Sbjct: 110 QQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             Y +PE+L   + Y   VD+W+ G I+  LL   P F    + DQ  K++       + 
Sbjct: 170 PGYLSPEVLR-KEAYGKPVDIWACGVILYILLVGYPPF---WDEDQ-HKLY-------QQ 217
Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
           I  G  + P  + +                       ++    +L+N++LT +P KRIT 
Sbjct: 218 IKAGAYDFPSPEWD----------------------TVTPEAKNLINQMLTINPAKRITA 255
Query: 301 DDALNHYW 308
            +AL H W
Sbjct: 256 HEALKHPW 263

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   +F+++  I  G +G V++A+ +  G+   +++VK N  + E            RE+
Sbjct: 9   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE------------REV 56
Query: 68  NILLSFDHPSIV----------------------------NVKEVVMDDHDSVYMVMEYM 99
             L   DH +IV                            N K         +++ ME+ 
Sbjct: 57  KALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFC 116
Query: 100 EHDL--KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK 157
           +     +W+ +   +         L  Q+ +GV Y+H   ++HRDLK SN+ L +   +K
Sbjct: 117 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVK 176
Query: 158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           I DFG+     +  K  T    TL Y +PE  + ++ Y   VD++++G I+AELL
Sbjct: 177 IGDFGLVTSLKNDGKR-TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 63
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 64  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT---LWYRAPELLL 190
                LHRDL   N L+N+QGV+K+ DFG+SR        YTS   +   + +  PE+L+
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSRGSKFPVRWSPPEVLM 179
Query: 191 GAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            + K+S+  D+W+ G +M E+  L K P
Sbjct: 180 YS-KFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 94/191 (49%), Gaps = 16/191 (8%)
Query: 27  VYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM 86
           VYR R K+    VA+K +K     K D  E       +RE  I+   D+P IV +  V  
Sbjct: 356 VYRMRKKQID--VAIKVLKQGT-EKADTEEM------MREAQIMHQLDNPYIVRLIGVC- 405
Query: 87  DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT 145
              +++ +VME      L   +   ++    S V  L+ Q+  G+KYL +   +HR+L  
Sbjct: 406 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 146 SNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPELLLGAKKYSTAVDMW 202
            N+LL N+   KI DFG+S+  G+    YT+     W   + APE  +  +K+S+  D+W
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVW 523
Query: 203 SVGCIMAELLA 213
           S G  M E L+
Sbjct: 524 SYGVTMWEALS 534

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L ++  G +G+V   + +   + VA+K +K     +++ +E         E  ++++  H
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE---------EAKVMMNLSH 78
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
             +V +  V       ++++ EYM +   L +L E M+  F T ++  +   + E ++YL
Sbjct: 79  EKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR-APELLLGA 192
                LHRDL   N L+N+QGV+K+ DFG+SR Y    +  +S+      R +P  +L  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMY 195
Query: 193 KKYSTAVDMWSVGCIMAEL--LAKKP 216
            K+S+  D+W+ G +M E+  L K P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 38/252 (15%)
Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
             R   +FE++  + +G +G V +AR+       A+KK++      E+ L      + L 
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLS-----TILS 51
Query: 66  EINILLSFDHPSIVNVKEVVMDDHD------------SVYMVMEYMEHDLKW-LMESMKQ 112
           E+ +L S +H  +V      ++  +            ++++  EY E+   + L+ S   
Sbjct: 52  EVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL 111
Query: 113 PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL- 171
                E   L  Q+LE + Y+H   ++HR+LK  N+ ++    +KI DFG+++     L 
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 172 -------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
                           TS + T  Y A E+L G   Y+  +D +S+G I  E +   P  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFS 229
Query: 219 SGTTEVDQIDKI 230
           +G   V+ + K+
Sbjct: 230 TGXERVNILKKL 241

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 67
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y+++E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 68  NLVQLLGVCTRE-PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYN 185
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 186 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDP 216
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 217 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 254

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E    +  G +G+V +A  K   + VA+K+++    RK          + + E+  L 
Sbjct: 9   EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK----------AFIVELRQLS 56
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLE 128
             +HP+IV +    ++    V +VMEY E    + +    +P   ++ +      LQ  +
Sbjct: 57  RVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 129 GVKYLHD---NWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           GV YLH      ++HRDLK  NLLL   G VLKICDFG +    + +   T+   +  + 
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWM 170
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
           APE+  G+  YS   D++S G I+ E++ ++  F
Sbjct: 171 APEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 67
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 68  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE-SLAYN 185
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 186 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDP 216
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 217 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 254

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 69
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y+++E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 70  NLVQLLGVCTRE-PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 218
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 219 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E    +  G +G+V +A  K   + VA+K+++    RK          + + E+  L 
Sbjct: 10  EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK----------AFIVELRQLS 57
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLE 128
             +HP+IV +    ++    V +VMEY E    + +    +P   ++ +      LQ  +
Sbjct: 58  RVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 129 GVKYLHD---NWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           GV YLH      ++HRDLK  NLLL   G VLKICDFG +    + +   T+   +  + 
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWM 171
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF 218
           APE+  G+  YS   D++S G I+ E++ ++  F
Sbjct: 172 APEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 69
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y+++E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 70  NLVQLLGVCTRE-PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 218
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 219 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 256

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 74
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R   +     K    L
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL 193
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 194 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 143/329 (43%), Gaps = 57/329 (17%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R  +E +++  I  G   +V  A      E VA+K++ +     E C      +  L+EI
Sbjct: 14  RDDYELQEV--IGSGATAVVQAAYCAPKKEKVAIKRINL-----EKCQTSMDEL--LKEI 64
Query: 68  NILLSFDHPSIVN--VKEVVMDDHDSVYMVMEYMEHD-----LKWLM---ESMKQPFSTS 117
             +    HP+IV+     VV D+   +++VM+ +        +K ++   E        S
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPL---K 172
            +  ++ ++LEG++YLH N  +HRD+K  N+LL   G ++I DFG+S     G  +   K
Sbjct: 122 TIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
              + V T  + APE++   + Y    D+WS G    EL      +    +   +  +  
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH---KYPPMKVLML 238
Query: 233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
           TL     ++  G+            Q   +L+K              +S   +++  L  
Sbjct: 239 TLQNDPPSLETGV------------QDKEMLKK------------YGKSFRKMISLCLQK 274
Query: 293 DPEKRITVDDALNHYWFHEVPLPKSKDFM 321
           DPEKR T  + L H +F +    K+K+F+
Sbjct: 275 DPEKRPTAAELLRHKFFQKA---KNKEFL 300

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 69
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 70  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 218
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 219 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 256

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 19  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 71
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 72  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R   +     K    L
Sbjct: 131 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL 190
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 191 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 229

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 74
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R   +     K    L
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL 193
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 194 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 75  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 192
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 69
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 70  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 188 KFSIKSDVWAFGVLLWEI 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y+++E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 75  NLVQLLGVCTRE-PPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 192
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 193 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 223
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 224 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 261

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           NK+ EG +G+VY+     +   VA+KK+   V    + L+  F     +EI ++    H 
Sbjct: 37  NKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD----QEIKVMAKCQHE 90
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ-LLEGVKYL 133
           ++V +      D D + +V  YM +   L  L      P  +  ++C + Q    G+ +L
Sbjct: 91  NLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY--TSLVVTLWYRAPELLLG 191
           H+N  +HRD+K++N+LL+     KI DFG++R      +    + +V T  Y APE L G
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG 209
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
             + +   D++S G ++ E++   P
Sbjct: 210 --EITPKSDIYSFGVVLLEIITGLP 232

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 74
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R   +     K    L
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGL 193
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 194 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 13  FEKLNKISEGTYGIVYRARDKK--SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
            E +  I EG +G V++AR       E   +  VKM        ++  F     RE  ++
Sbjct: 49  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ----REAALM 104
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ----------------- 112
             FD+P+IV +  V       + ++ EYM + DL   + SM                   
Sbjct: 105 AEFDNPNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 113 ------PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
                 P S +E  C+  Q+  G+ YL +   +HRDL T N L+    V+KI DFG+SR 
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 167 YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
             S    K   +  + + +  PE +    +Y+T  D+W+ G ++ E+ +
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFS 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 70
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y+++E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 71  NLVQLLGVCTRE-PPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYN 188
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 189 KFSIKSDVWAFGVLLWEI 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 4   LQGCRSVFE-----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYG 58
            QG    FE      E + ++  G YG+V + R   SG+I A+K+++  V  +E      
Sbjct: 22  FQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQ----- 76
Query: 59  FPISSLREINI-LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM---KQPF 114
                L +++I   + D P  V     +  + D V++  E  +  L    + +    Q  
Sbjct: 77  --KRLLXDLDISXRTVDCPFTVTFYGALFREGD-VWICXELXDTSLDKFYKQVIDKGQTI 133
Query: 115 STSEVKCLMLQLLEGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMS--------R 165
               +  + + +++ +++LH    V+HRD+K SN+L+N  G +K CDFG+S        +
Sbjct: 134 PEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK 193
Query: 166 QYGSPLKPYTSLVVTLWYRAPELL---LGAKKYSTAVDMWSVGCIMAEL 211
              +  KPY          APE +   L  K YS   D+WS+G    EL
Sbjct: 194 DIDAGCKPYX---------APERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R  +E +++  I  G   +V  A      E VA+K++ +     E C      +  L+EI
Sbjct: 9   RDDYELQEV--IGSGATAVVQAAYCAPKKEKVAIKRINL-----EKCQTSMDEL--LKEI 59
Query: 68  NILLSFDHPSIVN--VKEVVMDDHDSVYMVMEYMEHD-----LKWLM---ESMKQPFSTS 117
             +    HP+IV+     VV D+   +++VM+ +        +K ++   E        S
Sbjct: 60  QAMSQCHHPNIVSYYTSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 116
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPL---K 172
            +  ++ ++LEG++YLH N  +HRD+K  N+LL   G ++I DFG+S     G  +   K
Sbjct: 117 TIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL 211
              + V T  + APE++   + Y    D+WS G    EL
Sbjct: 177 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 75  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYN 192
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 193 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 223
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 224 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 261

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 69
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 70  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 218
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 219 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 256

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 21  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 73
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 74  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R  Y +    K    L
Sbjct: 133 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 192
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 193 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 231

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 73
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 74  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 191
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 192 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 222
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 223 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 260

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 74
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSL 177
            +  ++ +G+ YL+    +HRDL   N ++ +   +KI DFGM+R  Y +    K    L
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 193
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 194 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 75  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 192
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 193 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 223
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 224 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 261

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 49/297 (16%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKV--KMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           ++ +G + +V R   K +G   A K +  K    R    LE        RE  I     H
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--------REARICRKLQH 64
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           P+IV + + + ++    Y+V + +     +     ++ +S ++    + Q+LE + Y H 
Sbjct: 65  PNIVRLHDSIQEESFH-YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           N ++HR+LK  NLLL ++     +K+ DFG++ +     + +     T  Y +PE +L  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE-VLKK 181
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
             YS  VD+W+ G I+  LL   P F    + DQ  +++  +         G  + P  +
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPF---WDEDQ-HRLYAQIKA-------GAYDYPSPE 230
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
            +                       ++     L++ +LT +P+KRIT D AL   W 
Sbjct: 231 WD----------------------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 69
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 70  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 218
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 219 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 256

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K       D     F    L E +++ 
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK------NDATAQAF----LAEASVMT 241
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM     + +L    +       +    L + E 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL  N  +HRDL   N+L++   V K+ DFG++++  S     T  +   W  APE L
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL 358
Query: 190 LGAKKYSTAVDMWSVGCIMAEL 211
              KK+ST  D+WS G ++ E+
Sbjct: 359 R-EKKFSTKSDVWSFGILLWEI 379

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           NK+ EG +G+VY+     +   VA+KK+   V    + L+  F     +EI ++    H 
Sbjct: 37  NKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD----QEIKVMAKCQHE 90
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ-LLEGVKYL 133
           ++V +      D D + +V  YM +   L  L      P  +  ++C + Q    G+ +L
Sbjct: 91  NLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY--TSLVVTLWYRAPELLLG 191
           H+N  +HRD+K++N+LL+     KI DFG++R      +      +V T  Y APE L G
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG 209
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
             + +   D++S G ++ E++   P
Sbjct: 210 --EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 18  KISEGTYGIVYRARDKKSG-----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G + +V R   K +G     +I+  KK+     +K   LE        RE  I   
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LE--------REARICRK 60
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV + + + ++    Y+V + +     +     ++ +S ++    + Q+LE + Y
Sbjct: 61  LQHPNIVRLHDSIQEESFH-YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 133 LHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            H N ++HR+LK  NLLL ++     +K+ DFG++ +     + +     T  Y +PE +
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE-V 177
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           L    YS  VD+W+ G I+  LL   P F    + DQ  +++  +         G  + P
Sbjct: 178 LKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQ-HRLYAQIKA-------GAYDYP 226
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             + +                       ++     L++ +LT +P+KRIT D AL   W 
Sbjct: 227 SPEWD----------------------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           NK+ EG +G+VY+     +   VA+KK+   V    + L+  F     +EI ++    H 
Sbjct: 31  NKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD----QEIKVMAKCQHE 84
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ-LLEGVKYL 133
           ++V +      D D + +V  YM +   L  L      P  +  ++C + Q    G+ +L
Sbjct: 85  NLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPELLLG 191
           H+N  +HRD+K++N+LL+     KI DFG++R  +  +       +V T  Y APE L G
Sbjct: 144 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG 203
Query: 192 AKKYSTAVDMWSVGCIMAELLAKKP 216
             + +   D++S G ++ E++   P
Sbjct: 204 --EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G +G VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 67
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 68  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYN 185
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 186 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDP 216
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 217 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 254

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K       D     F    L E +++ 
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK------NDATAQAF----LAEASVMT 69
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM     + +L    +       +    L + E 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL  N  +HRDL   N+L++   V K+ DFG++++  S     T  +   W  APE L
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL 186
Query: 190 LGAKKYSTAVDMWSVGCIMAEL 211
              KK+ST  D+WS G ++ E+
Sbjct: 187 R-EKKFSTKSDVWSFGILLWEI 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 71
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 72  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 189
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 190 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 220
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 221 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 258

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 276
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   ++YL 
Sbjct: 277 NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HR+L   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 394
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 395 KFSIKSDVWAFGVLLWEI 412

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 132/300 (44%), Gaps = 55/300 (18%)
Query: 18  KISEGTYGIVYRARDKKSG-----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G + +V R   K +G     +I+  KK+     +K   LE        RE  I   
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LE--------REARICRK 84
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV + + + ++    Y+V + +     +     ++ +S ++    + Q+LE + Y
Sbjct: 85  LQHPNIVRLHDSIQEESFH-YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 133 LHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            H N ++HR+LK  NLLL ++     +K+ DFG++ +     + +     T  Y +PE +
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE-V 201
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           L    YS  VD+W+ G I+  LL   P F    + DQ  +++                  
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQ-HRLY------------------ 239
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
              A      Y+     +P+  +     ++     L++ +LT +P+KRIT D AL   W 
Sbjct: 240 ---AQIKAGAYD-----YPSPEWD---TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 74
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 75  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 192
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 193 KFSIKSDVWAFGVLLWEI 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 71
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 72  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 189
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 190 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 220
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 221 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 258

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 90/363 (24%), Positives = 155/363 (42%), Gaps = 79/363 (21%)
Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKED-CLEYGFPISSLREI 67
           +VF+ E  +KI EGT+  VY            L   ++ VG +E   L++  P S    I
Sbjct: 21  NVFKIE--DKIGEGTFSSVY------------LATAQLQVGPEEKIALKHLIPTS--HPI 64
Query: 68  NILLSFDHPSIVNVKEVVMD------DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC 121
            I       ++   ++ VM        +D V + M Y+EH+  +L   +    S  EV+ 
Sbjct: 65  RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE-SFL--DILNSLSFQEVRE 121
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSR--------------- 165
            ML L + +K +H   ++HRD+K SN L N +     + DFG+++               
Sbjct: 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 166 --QYGSPLKPYTSLVV-----------TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             Q     +   S+ +           T  +RAPE+L      +TA+DMWS G I   LL
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 213 AKK-PLFSGTTEVDQIDKIF------------KTLG--------TPTETIWPGLSELPGA 251
           + + P +  + ++  + +I             KT G         P + +      L G 
Sbjct: 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301
Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
            ++  K   ++   +  A +  G   + +  +DLL++LL  +P  RIT ++AL H +F +
Sbjct: 302 DSSTPKLTSDI---QGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358
Query: 312 VPL 314
           + L
Sbjct: 359 MSL 361

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 18  KISEGTYGIVYRARDKKSG-----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G + +V R   K +G     +I+  KK+     +K   LE        RE  I   
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LE--------REARICRK 61
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+IV + + + ++    Y+V + +     +     ++ +S ++    + Q+LE + Y
Sbjct: 62  LQHPNIVRLHDSIQEESFH-YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 133 LHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            H N ++HR+LK  NLLL ++     +K+ DFG++ +     + +     T  Y +PE +
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE-V 178
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           L    YS  VD+W+ G I+  LL   P F    + DQ  +++  +         G  + P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPF---WDEDQ-HRLYAQIKA-------GAYDYP 227
Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
             + +                       ++     L++ +LT +P+KRIT D AL   W 
Sbjct: 228 SPEWD----------------------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 82
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 83  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 141
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 200
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 201 KFSIKSDVWAFGVLLWEI 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K       D     F    L E +++ 
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK------NDATAQAF----LAEASVMT 54
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM     + +L    +       +    L + E 
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL  N  +HRDL   N+L++   V K+ DFG++++  S     T  +   W  APE L
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL 171
Query: 190 LGAKKYSTAVDMWSVGCIMAEL 211
              KK+ST  D+WS G ++ E+
Sbjct: 172 R-EKKFSTKSDVWSFGILLWEI 192

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 77
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 78  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R        Y       V   + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 194 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 67
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 68  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R        Y       V   + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 184 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 9/219 (4%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F++L+++  G+YG V++ R K+ G + A+K+        +D       + S  ++     
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG---- 114
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP  V + E   ++   +Y+  E     L+   E+       ++V   +   L  + +
Sbjct: 115 -QHPCCVRL-EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH   ++H D+K +N+ L  +G  K+ DFG+  + G+             Y APELL G+
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGDPRYMAPELLQGS 231
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
             Y TA D++S+G  + E+     L  G     Q+ + +
Sbjct: 232 --YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 72  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R        Y       V   + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 188 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 72  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R        Y       V   + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 188 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 67
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 68  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT---SLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R        Y       V   + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 184 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 30  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 203
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTR 225

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 315
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 316 NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HR+L   N L+    ++K+ DFG+SR   G     +      + + APE  L   
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 433
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 434 KFSIKSDVWAFGVLLWEI 451

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 56  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 229
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTR 251

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 211
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 209
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTR 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 35  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 208
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTR 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 37  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 210
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTR 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 57  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 230
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTR 252

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 33  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 206
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR 228

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 77
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 78  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R   Q            V   + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 194 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 16  LNKISEGTYGIVYRAR-DKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           L K+ +G++G+V R   D  SG+ V  A+K +K +V  + + ++       +RE+N + S
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVNAMHS 67
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEG 129
            DH +++ +  VV+     + MV E     L  L++ +++    F    +    +Q+ EG
Sbjct: 68  LDHRNLIRLYGVVLTP--PMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSLVVTLWYRAP 186
           + YL     +HRDL   NLLL  + ++KI DFG+ R   Q            V   + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL--AKKPL--FSGTTEVDQIDKIFKTLGTPTE 239
           E  L  + +S A D W  G  + E+    ++P    +G+  + +IDK  + L  P +
Sbjct: 184 E-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     +Y S      + +   W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 211
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E   +I +G +G+V++ R  K   +VA+K + +     E  +   F     RE+ I+ 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMS 78
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + +HP+IV +  ++   H+   MVME++   DL   +     P   S    LML +  G+
Sbjct: 79  NLNHPNIVKLYGLM---HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 131 KYLHDNW--VLHRDLKTSNLLL-----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           +Y+ +    ++HRDL++ N+ L     N     K+ DFG+S+Q    +   + L+    +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQW 192
Query: 184 RAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLF 218
            APE  +GA++  Y+   D +S   I+  +L  +  F
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 23  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 75
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 76  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSL 177
            +  ++ +G+ YL+    +HR+L   N ++ +   +KI DFGM+R  Y +    K    L
Sbjct: 135 QMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 194
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 195 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 233

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 16  LNKISEGTYGIVYR--ARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           L ++ +G++G+VY   ARD   GE    VA+K V  +   +E        I  L E +++
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-------IEFLNEASVM 74
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------PFSTSEVK 120
             F    +V +  VV     ++ +VME M H DLK  + S++          P +  E+ 
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSL 177
            +  ++ +G+ YL+    +HR+L   N ++ +   +KI DFGM+R  Y +    K    L
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 193
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +   W  APE L     ++T+ DMWS G ++ E+  LA++P
Sbjct: 194 LPVRWM-APESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 88
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y+V EYM +   L +L E  ++  +   +  +  Q+   ++YL 
Sbjct: 89  NLVQLLGVCTLE-PPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    V+K+ DFG+SR   G     +      + + APE  L   
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 206
Query: 194 KYSTAVDMWSVGCIMAEL 211
            +S   D+W+ G ++ E+
Sbjct: 207 TFSIKSDVWAFGVLLWEI 224

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 4   LQGCRSVF--EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           L  C   +  ++  ++ +  G +G V+ A DK+  + V +K +K      EDC      +
Sbjct: 15  LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE-KVLEDCWIEDPKL 73
Query: 62  SSLR-EINILLSFDHPSIVNVKEV---------VMDDHDSVYMVMEYMEHDLKWLMESMK 111
             +  EI IL   +H +I+ V ++         VM+ H S   +  +++   +     + 
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----LD 128
Query: 112 QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
           +P ++     +  QL+  V YL    ++HRD+K  N+++     +K+ DFG S  Y    
Sbjct: 129 EPLASY----IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERG 183
Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           K + +   T+ Y APE+L+G       ++MWS+G  +  L+ ++  F    E
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 49/284 (17%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 71
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 72  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G            + + APE  L   
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE-SLAYN 189
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
           K+S   D+W+ G ++ E+                                G+S  PG   
Sbjct: 190 KFSIKSDVWAFGVLLWEIATY-----------------------------GMSPYPGIDL 220
Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           +   Q Y LL K +      G P   E  ++L+     ++P  R
Sbjct: 221 S---QVYELLEKDYRMERPEGCP---EKVYELMRACWQWNPSDR 258

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           NK  EG +G+VY+     +   VA+KK+   V    + L+  F     +EI +     H 
Sbjct: 28  NKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD----QEIKVXAKCQHE 81
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK----QPFSTSEVKCLMLQ-LLEGVK 131
           ++V +     D  D   + + Y+      L++ +      P  +   +C + Q    G+ 
Sbjct: 82  NLVELLGFSSDGDD---LCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGIN 138
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPELL 189
           +LH+N  +HRD+K++N+LL+     KI DFG++R  +  +     + +V T  Y APE L
Sbjct: 139 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKP 216
            G  + +   D++S G ++ E++   P
Sbjct: 199 RG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 37  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+KYL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR----QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
            +HRDL   N +L+ +  +K+ DFG++R    +    +   T   + + + A E  L  +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE-SLQTQ 211
Query: 194 KYSTAVDMWSVGCIMAELLAK 214
           K++T  D+WS G ++ EL+ +
Sbjct: 212 KFTTKSDVWSFGVLLWELMTR 232

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           +K+  G YG VY    KK    VA+K +K      ED +E       L+E  ++    HP
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVE---EFLKEAAVMKEIKHP 70
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           ++V +  V   +    Y++ E+M +   L +L E  +Q  +   +  +  Q+   ++YL 
Sbjct: 71  NLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRDL   N L+    ++K+ DFG+SR   G            + + APE  L   
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE-SLAYN 188
Query: 194 KYSTAVDMWSVGCIMAEL 211
           K+S   D+W+ G ++ E+
Sbjct: 189 KFSIKSDVWAFGVLLWEI 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K       D     F    L E +++ 
Sbjct: 13  ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK------NDATAQAF----LAEASVMT 60
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM     + +L    +       +    L + E 
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL  N  +HRDL   N+L++   V K+ DFG++++  S     T  +   W  APE L
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL 177
Query: 190 LGAKKYSTAVDMWSVGCIMAEL 211
             A  +ST  D+WS G ++ E+
Sbjct: 178 REA-AFSTKSDVWSFGILLWEI 198

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E   +I +G +G+V++ R  K   +VA+K + +     E  +   F     RE+ I+ 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMS 78
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + +HP+IV +  ++   H+   MVME++   DL   +     P   S    LML +  G+
Sbjct: 79  NLNHPNIVKLYGLM---HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 131 KYLHDNW--VLHRDLKTSNLLL-----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           +Y+ +    ++HRDL++ N+ L     N     K+ DFG S+Q    +   + L+    +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---SVHSVSGLLGNFQW 192
Query: 184 RAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLF 218
            APE  +GA++  Y+   D +S   I+  +L  +  F
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI  G++G V+RA  +  G  VA+K +       E   E+      LRE+ I+    HP+
Sbjct: 44  KIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEF------LREVAIMKRLRHPN 95
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLM---ESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           IV     V    + + +V EY+     + +      ++         +   + +G+ YLH
Sbjct: 96  IVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 135 DNW--VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +    ++HR+LK+ NLL++ +  +K+CDFG+SR   S      S   T  + APE+L   
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 193 KKYSTAVDMWSVGCIMAEL 211
                + D++S G I+ EL
Sbjct: 215 PSNEKS-DVYSFGVILWEL 232

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 25/230 (10%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           +++ +  I  G +G V   R K S ++ A+K + K  + ++ D   +        E +I+
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF------WEERDIM 129
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP-----FSTSEVKCLML 124
              + P +V +     DD   +YMVMEYM   DL  LM +   P     F T+EV     
Sbjct: 130 AFANSPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV----- 183
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG-SPLKPYTSLVVTLWY 183
             +  +  +H   ++HRD+K  N+LL+  G LK+ DFG   +   + +    + V T  Y
Sbjct: 184 --VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 211
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI  G++G V+RA  +  G  VA+K +       E   E+      LRE+ I+    HP+
Sbjct: 44  KIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEF------LREVAIMKRLRHPN 95
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLM---ESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           IV     V    + + +V EY+     + +      ++         +   + +G+ YLH
Sbjct: 96  IVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 135 DNW--VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           +    ++HRDLK+ NLL++ +  +K+CDFG+SR   S          T  + APE+L   
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 193 KKYSTAVDMWSVGCIMAEL 211
                + D++S G I+ EL
Sbjct: 215 PSNEKS-DVYSFGVILWEL 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L  
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 209
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTR 231

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 25/230 (10%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           ++E +  I  G +G V   R K + ++ A+K + K  + ++ D   +        E +I+
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF------WEERDIM 128
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP-----FSTSEVKCLML 124
              + P +V +     DD   +YMVMEYM   DL  LM +   P     F T+EV     
Sbjct: 129 AFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV----- 182
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTSLVVTLWY 183
             +  +  +H    +HRD+K  N+LL+  G LK+ DFG   +     +    + V T  Y
Sbjct: 183 --VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 39  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L  
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQT 212
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTR 234

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 25/230 (10%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           ++E +  I  G +G V   R K + ++ A+K + K  + ++ D   +        E +I+
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF------WEERDIM 123
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP-----FSTSEVKCLML 124
              + P +V +     DD   +YMVMEYM   DL  LM +   P     F T+EV     
Sbjct: 124 AFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV----- 177
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTSLVVTLWY 183
             +  +  +H    +HRD+K  N+LL+  G LK+ DFG   +     +    + V T  Y
Sbjct: 178 --VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 43  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L  
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 216
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTR 238

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 211
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 25/230 (10%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINIL 70
           ++E +  I  G +G V   R K + ++ A+K + K  + ++ D   +        E +I+
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF------WEERDIM 128
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP-----FSTSEVKCLML 124
              + P +V +     DD   +YMVMEYM   DL  LM +   P     F T+EV     
Sbjct: 129 AFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV----- 182
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTSLVVTLWY 183
             +  +  +H    +HRD+K  N+LL+  G LK+ DFG   +     +    + V T  Y
Sbjct: 183 --VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 184 RAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
            +PE+L    G   Y    D WSVG  + E+L     F   + V    KI
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           I  G +G VY      +      KK+   V       + G     L E  I+  F HP++
Sbjct: 39  IGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLLGA 192
            +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L  
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 212
Query: 193 KKYSTAVDMWSVGCIMAELLAK 214
           +K++T  D+WS G ++ EL+ +
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTR 234

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 19  ISEGTYGIVYRAR--DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I  G +G VY     D         KK+   V       + G     L E  I+  F HP
Sbjct: 97  IGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           +++++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+L  
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRAPELLL 190
              +HRDL   N +L+ +  +K+ DFG++R     ++ S      + +   W       L
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--L 268
Query: 191 GAKKYSTAVDMWSVGCIMAELLAK 214
             +K++T  D+WS G ++ EL+ +
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTR 292

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 12/225 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE L  I  G +G V   + K + ++ A+K     +  K + L+         E ++L+
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMK-----ILNKWEMLKRAETACFREERDVLV 129
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + D   I  +     DD +++Y+VM+Y +  DL  L+   +        +  + +++  +
Sbjct: 130 NGDSKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELL 189
             +H    +HRD+K  N+L++  G +++ DFG   +        +S+ V T  Y +PE+L
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 190 L----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
                G  +Y    D WS+G  M E+L  +  F   + V+   KI
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/211 (21%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + +G +G   +   +++GE++ +K++     R ++  +  F    L+E+ ++   +HP++
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELI----RFDEETQRTF----LKEVKVMRCLEHPNV 69
Query: 79  VNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +    V+  D   +  + EY++   L+ +++SM   +  S+       +  G+ YLH   
Sbjct: 70  LKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 138 VLHRDLKTSNLLLNNQGVLKICDFGMSR----QYGSP----------LKPYTSLVVTLWY 183
           ++HRDL + N L+     + + DFG++R    +   P           K   ++V   ++
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
            APE++ G + Y   VD++S G ++ E++ +
Sbjct: 189 MAPEMING-RSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 57/237 (24%)
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           IV+V E +      + +VME ++       + +   Q F+  E   +M  + E ++YLH 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 136 NWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
             + HRD+K  NLL  ++    +LK+ DFG +++                          
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-----------------------TTG 172
Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           +KY  + DMWS+G IM  LL   P F                         GL+  PG K
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---------------------GLAISPGMK 211
Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                  Y      FP   ++    +SE    L+  LL  +P +R+T+ + +NH W 
Sbjct: 212 TRIRMGQYE-----FPNPEWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 87/335 (25%), Positives = 142/335 (42%), Gaps = 56/335 (16%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + K+  G +  V+ A+D  +   VA+K V+ +    E   +    I  L+ +N   +   
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 76  PSIVNVKEVVMDDHDS--------VYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQL 126
            S+     + + DH +        V MV E +  +L  L++  + +      VK +  QL
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 127 LEGVKYLHDN-WVLHRDLKTSNLLLN------NQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           L G+ Y+H    ++H D+K  N+L+       N   +KI D G +  Y    + YT+ + 
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQ 197
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF------SGTTEVDQIDKIFKT 233
           T  YR+PE+LLGA  +    D+WS  C++ EL+    LF      S T + D I +I + 
Sbjct: 198 TREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 234 LGTPTETIWPGLSELPG---AKANFAKQPYN---LLRKRFPAASFTGSPVLSESG----- 282
           LG           ELP        + +  +N   LLR       +    VL+E       
Sbjct: 257 LG-----------ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 283 -----FDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
                 D L+ +L  DP KR      +NH W  + 
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 87/335 (25%), Positives = 142/335 (42%), Gaps = 56/335 (16%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + K+  G +  V+ A+D  +   VA+K V+ +    E   +    I  L+ +N   +   
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 76  PSIVNVKEVVMDDHDS--------VYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQL 126
            S+     + + DH +        V MV E +  +L  L++  + +      VK +  QL
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 127 LEGVKYLHDN-WVLHRDLKTSNLLLN------NQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           L G+ Y+H    ++H D+K  N+L+       N   +KI D G +  Y    + YT+ + 
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQ 197
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF------SGTTEVDQIDKIFKT 233
           T  YR+PE+LLGA  +    D+WS  C++ EL+    LF      S T + D I +I + 
Sbjct: 198 TREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 234 LGTPTETIWPGLSELPG---AKANFAKQPYN---LLRKRFPAASFTGSPVLSESG----- 282
           LG           ELP        + +  +N   LLR       +    VL+E       
Sbjct: 257 LG-----------ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 283 -----FDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
                 D L+ +L  DP KR      +NH W  + 
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E   +I +G +G+V++ R  K   +VA+K + +     E  +   F     RE+ I+ 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMS 78
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + +HP+IV +  ++   H+   MVME++   DL   +     P   S    LML +  G+
Sbjct: 79  NLNHPNIVKLYGLM---HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 131 KYLHDNW--VLHRDLKTSNLLL-----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           +Y+ +    ++HRDL++ N+ L     N     K+ DF +S+Q    +   + L+    +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ---SVHSVSGLLGNFQW 192
Query: 184 RAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLF 218
            APE  +GA++  Y+   D +S   I+  +L  +  F
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/345 (22%), Positives = 126/345 (36%), Gaps = 94/345 (27%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR---EINILLSFDH 75
           I +G+YG+V  A + ++  I A+K +  N  R+ +      P    R   E+ ++    H
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN------PKDVERIKTEVRLMKKLHH 87
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKC-------------- 121
           P+I  + EV  +D   + +VME        L++ +      S  KC              
Sbjct: 88  PNIARLYEV-YEDEQYICLVMELCHGG--HLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 122 ----------------------------LMLQLLEGVKYLHDNWVLHRDLKTSNLLL--N 151
                                       +M Q+   + YLH+  + HRD+K  N L   N
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 152 NQGVLKICDFGMSRQY----GSPLKPYTSLVVTLWYRAPELL-LGAKKYSTAVDMWSVGC 206
               +K+ DFG+S+++           T+   T ++ APE+L    + Y    D WS G 
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 207 IMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKR 266
           ++  LL     F G  + D I ++                     K  F    YN     
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNK------------------KLCFENPNYN----- 301
Query: 267 FPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                     VLS    DLL+ LL  + ++R     AL H W  +
Sbjct: 302 ----------VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINILLSFDHPS 77
           I  G +G VYRA     G+ VA+K  + +    ED  +    I ++R E  +     HP+
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHD--PDEDISQT---IENVRQEAKLFAMLKHPN 67
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           I+ ++ V + + + + +VME+     L  ++   + P     +    +Q+  G+ YLHD 
Sbjct: 68  IIALRGVCLKEPN-LCLVMEFARGGPLNRVLSGKRIPPDI--LVNWAVQIARGMNYLHDE 124
Query: 137 WV---LHRDLKTSNLL---------LNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
            +   +HRDLK+SN+L         L+N+ +LKI DFG++R++    K   S      + 
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNK-ILKITDFGLAREWHRTTK--MSAAGAYAWM 181
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           APE++  A  +S   D+WS G ++ ELL  +  F G
Sbjct: 182 APEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +S G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 76
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 77  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 133
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 194 ALESIL-HRIYTHQSDVWSYGVTVWELM 220

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 95/371 (25%), Positives = 151/371 (40%), Gaps = 86/371 (23%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  + K+  G +  V+ + D +  + VA+K VK      E         ++L EI +L S
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---------TALDEIRLLKS 89
Query: 73  FDH--PSIVNVKEVV--MDDHD-------SVYMVMEYMEHDL-KWLMESMKQPFSTSEVK 120
             +  P+  N + VV  +DD          + MV E + H L KW+++S  Q      VK
Sbjct: 90  VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 121 CLMLQLLEGVKYLHDNW-VLHRDLKTSNLLL--NNQGVLKICDFGMSRQYG--------- 168
            ++ Q+L+G+ YLH    ++H D+K  N+LL  N Q + ++       Q           
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 169 -------------SPLKP----------------------YTSLVVTLWYRAPELLLGAK 193
                        +PL+P                      +T  + T  YR+ E+L+G+ 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS- 268
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLF---SG---TTEVDQIDKIFKTLG-TPTETIWPG-- 244
            Y+T  D+WS  C+  EL     LF   SG   T + D I  I + LG  P + I  G  
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 245 LSELPGAKANFAK----QPYNLLRKRFPAASFTGSPVLSESGF-DLLNRLLTYDPEKRIT 299
             E    K +       +P+ L         ++       +GF D L  +L   PEKR T
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEA---AGFTDFLLPMLELIPEKRAT 385
Query: 300 VDDALNHYWFH 310
             + L H W +
Sbjct: 386 AAECLRHPWLN 396

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 95/371 (25%), Positives = 151/371 (40%), Gaps = 86/371 (23%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  + K+  G +  V+ + D +  + VA+K VK      E         ++L EI +L S
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---------TALDEIRLLKS 73
Query: 73  FDH--PSIVNVKEVV--MDDHD-------SVYMVMEYMEHDL-KWLMESMKQPFSTSEVK 120
             +  P+  N + VV  +DD          + MV E + H L KW+++S  Q      VK
Sbjct: 74  VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 133
Query: 121 CLMLQLLEGVKYLHDNW-VLHRDLKTSNLLL--NNQGVLKICDFGMSRQYG--------- 168
            ++ Q+L+G+ YLH    ++H D+K  N+LL  N Q + ++       Q           
Sbjct: 134 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 193
Query: 169 -------------SPLKP----------------------YTSLVVTLWYRAPELLLGAK 193
                        +PL+P                      +T  + T  YR+ E+L+G+ 
Sbjct: 194 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS- 252
Query: 194 KYSTAVDMWSVGCIMAELLAKKPLF---SG---TTEVDQIDKIFKTLG-TPTETIWPG-- 244
            Y+T  D+WS  C+  EL     LF   SG   T + D I  I + LG  P + I  G  
Sbjct: 253 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 312
Query: 245 LSELPGAKANFAK----QPYNLLRKRFPAASFTGSPVLSESGF-DLLNRLLTYDPEKRIT 299
             E    K +       +P+ L         ++       +GF D L  +L   PEKR T
Sbjct: 313 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE---EAAGFTDFLLPMLELIPEKRAT 369
Query: 300 VDDALNHYWFH 310
             + L H W +
Sbjct: 370 AAECLRHPWLN 380

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 23/181 (12%)
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMES-------------- 109
           RE  +L +  H  IV    V   D D + MV EYM+H DL   + +              
Sbjct: 66  REAELLTNLQHEHIVKFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 110 -MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG 168
             K     S++  +  Q+  G+ YL     +HRDL T N L+    ++KI DFGMSR   
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 169 SP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLFS-GTTE 223
           S    +     ++ + +  PE ++  +K++T  D+WS G I+ E+    K+P F    TE
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 224 V 224
           V
Sbjct: 244 V 244

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS-SLREINILLSFDHPS 77
           + +G    V+R R KK+G++ A+K          + + +  P+   +RE  +L   +H +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--------NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 78  IVN---VKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLML--QLLEGVK 131
           IV    ++E     H    ++ME+     L  ++E     +   E + L++   ++ G+ 
Sbjct: 69  IVKLFAIEEETTTRHK--VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 132 YLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +L +N ++HR++K  N++     + Q V K+ DFG +R+     + + SL  T  Y  P+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPD 185
Query: 188 LLLGA-------KKYSTAVDMWSVGC 206
           +   A       KKY   VD+WS+G 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 19  ISEGTYGIVYRARDKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I +G +G+VY       GE +  A  +++  +       E     + LRE  ++   +HP
Sbjct: 29  IGKGHFGVVYH------GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           +++ +  +++      ++++ YM H DL   + S ++  +  ++    LQ+  G++YL +
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMS-----RQYGSPLKPYTSLVVTLWYRAPELLL 190
              +HRDL   N +L+    +K+ DFG++     R+Y S  +   + +   W       L
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES--L 200
Query: 191 GAKKYSTAVDMWSVGCIMAELLAK 214
              +++T  D+WS G ++ ELL +
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 9   SVFEFEKLNKISE---GTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++FE   L  IS+   G +G V   R       +G +VA+K+++ +   ++   +     
Sbjct: 6   TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ----- 60
Query: 62  SSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEV 119
              REI IL +     IV  + V       S+ +VMEY+    L+  ++  +     S +
Sbjct: 61  ---REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 117
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKP 173
                Q+ +G++YL     +HRDL   N+L+ ++  +KI DFG++      + Y    +P
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             S +   WY APE  L    +S   D+WS G ++ EL 
Sbjct: 178 GQSPI--FWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 9   SVFEFEKLNKISE---GTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++FE   L  IS+   G +G V   R       +G +VA+K+++ +   ++   +     
Sbjct: 5   TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ----- 59
Query: 62  SSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEV 119
              REI IL +     IV  + V       S+ +VMEY+    L+  ++  +     S +
Sbjct: 60  ---REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 116
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKP 173
                Q+ +G++YL     +HRDL   N+L+ ++  +KI DFG++      + Y    +P
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             S +   WY APE  L    +S   D+WS G ++ EL 
Sbjct: 177 GQSPI--FWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 70
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 71  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPELLLGA 192
               +HRD+   N+L+++   +K+ DFG+SR  +  +  K     +   W  APE  +  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-APE-SINF 186
Query: 193 KKYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           +++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 9   SVFEFEKLNKISE---GTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++FE   L  IS+   G +G V   R       +G +VA+K+++ +   ++   +     
Sbjct: 18  TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ----- 72
Query: 62  SSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEV 119
              REI IL +     IV  + V       S+ +VMEY+    L+  ++  +     S +
Sbjct: 73  ---REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS------RQYGSPLKP 173
                Q+ +G++YL     +HRDL   N+L+ ++  +KI DFG++      + Y    +P
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             S +   WY APE  L    +S   D+WS G ++ EL 
Sbjct: 190 GQSPI--FWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 70
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 71  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 187
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 98
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 99  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 215
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 216 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 253

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 12/225 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE +  I  G +G V   + K +  I A+K     +  K + L+         E ++L+
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMK-----ILNKWEMLKRAETACFREERDVLV 129
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + D   I  +      D + +Y+VM+Y +  DL  L+   +        +  + +++  +
Sbjct: 130 NGDCQWITAL-HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 188
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELL 189
             +H    +HRD+K  N+LL+  G +++ DFG   +        +S+ V T  Y +PE+L
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 190 L----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
                G  KY    D WS+G  M E+L  +  F   + V+   KI
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/313 (23%), Positives = 122/313 (38%), Gaps = 41/313 (13%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           FE + ++ E   G    AR +    ++  ++  + +  K+     G   S + RE+ +L 
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLY 65
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
                  V       ++ D  Y+V E M           ++ F+  E   ++  +   + 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 132 YLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVT-------- 180
           +LH+  + HRDLK  N+L    N    +KICDFG+    G  L    S + T        
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGS--GIKLNGDCSPISTPELLTPCG 183
Query: 181 -LWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
              Y APE++      A  Y    D+WS+G I+  LL+  P F G    D          
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD---------- 233
Query: 236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
                 W      P  + N   +     +  FP   +     +S +  DL+++LL  D +
Sbjct: 234 ----CGWDRGEACPACQ-NMLFESIQEGKYEFPDKDWAH---ISCAAKDLISKLLVRDAK 285
Query: 296 KRITVDDALNHYW 308
           +R++    L H W
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 94/371 (25%), Positives = 147/371 (39%), Gaps = 90/371 (24%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  + K+  G +  V+   D +    VA+K VK      E  L+    +  +RE +    
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESD---- 88
Query: 73  FDHPSIVNVKEVV--MDDHD-------SVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCL 122
              PS  N   VV  +DD          V MV E + H L KW+++S  Q      VK +
Sbjct: 89  ---PSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSI 145
Query: 123 MLQLLEGVKYLHDNW-VLHRDLKTSNLLL--NNQGVLKICDFGMSRQYG----------- 168
           + Q+L+G+ YLH    ++H D+K  N+L+  ++  V ++       Q             
Sbjct: 146 IRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVS 205
Query: 169 ---------SPLKP----------------------YTSLVVTLWYRAPELLLGAKKYST 197
                    +PL P                      +T  + T  YR+ E+L+GA  YST
Sbjct: 206 TAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEVLIGA-GYST 264
Query: 198 AVDMWSVGCIMAELLAKKPLF---SG---TTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
             D+WS  C+  EL     LF   SG   + + D I  I + LG+      P    L G 
Sbjct: 265 PADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSI-----PRHFALSG- 318
Query: 252 KANFAKQPYNL------LRKRFPAASFT------GSPVLSESGF-DLLNRLLTYDPEKRI 298
              ++++ +N       + K  P + F       G P    + F D L  +L   PEKR 
Sbjct: 319 --KYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRA 376
Query: 299 TVDDALNHYWF 309
           +  + L H W 
Sbjct: 377 SAGECLRHPWL 387

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 67
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 68  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 184
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 222

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 75
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 76  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 192
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 70
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 71  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 187
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 73
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 74  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 130
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 131 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 191 ALESIL-HRIYTHQSDVWSYGVTVWELM 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 12/225 (5%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE +  I  G +G V   + K +  I A+K     +  K + L+         E ++L+
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMK-----ILNKWEMLKRAETACFREERDVLV 145
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + D   I  +      D + +Y+VM+Y +  DL  L+   +        +  + +++  +
Sbjct: 146 NGDCQWITAL-HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 204
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELL 189
             +H    +HRD+K  N+LL+  G +++ DFG   +        +S+ V T  Y +PE+L
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 190 L----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI 230
                G  KY    D WS+G  M E+L  +  F   + V+   KI
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 309

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 72
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 73  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 189
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 190 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 227

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 73
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 74  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 190
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 191 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 228

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 71
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 72  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 128
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 189 ALESIL-HRIYTHQSDVWSYGVTVWELM 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P S L E  I+    H  +V +  VV    + +Y+V EYM     L +L +   +     
Sbjct: 48  PESFLEEAQIMKKLKHDKLVQLYAVV--SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLP 105
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTS 176
            +  +  Q+  G+ Y+     +HRDL+++N+L+ N  + KI DFG++R    +       
Sbjct: 106 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG 165
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKIFK 232
               + + APE  L   +++   D+WS G ++ EL+ K     P  +    ++Q+++ ++
Sbjct: 166 AKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 450
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 451 PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 567
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 70
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 71  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGXLLDYVREH-KDNIGSQYLLNWCVQI 127
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 128 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 188 ALESIL-HRIYTHQSDVWSYGVTVWELM 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 72
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 73  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 129
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 190 ALESIL-HRIYTHQSDVWSYGVTVWELM 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 69
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 70  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 70
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 71  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 127
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 128 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 188 ALESIL-HRIYTHQSDVWSYGVTVWELM 214

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+VMEYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 126/294 (42%), Gaps = 48/294 (16%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  G +GIV+R  +  S +    K VK+  G  +  ++        +EI+IL    H +I
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVK--------KEISILNIARHRNI 63
Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           +++ E   +  + + M+ E++   D+   + +     +  E+   + Q+ E +++LH + 
Sbjct: 64  LHLHES-FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 138 VLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKY 195
           + H D++  N++   +    +KI +FG +RQ   P   +  L     Y APE+       
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVH-QHDVV 180
Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANF 255
           STA DMWS+G ++  LL+    F   T    I+ I                    A+  F
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM------------------NAEYTF 222
Query: 256 AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
            ++ +                 +S    D ++RLL  + + R+T  +AL H W 
Sbjct: 223 DEEAF---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 66
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 67  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 123
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            EG+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 124 AEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 184 ALESIL-HRIYTHQSDVWSYGVTVWELM 210

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 19/172 (11%)
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK----------WLMESMKQP 113
           RE  +L +  H  IV    V ++  D + MV EYM+H DL            LM     P
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122
Query: 114 FSTSEVKCLML--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP- 170
              ++ + L +  Q+  G+ YL     +HRDL T N L+    ++KI DFGMSR   S  
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 171 -LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLFS 219
             +     ++ + +  PE ++  +K++T  D+WS+G ++ E+    K+P + 
Sbjct: 183 YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +S G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 76
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 77  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 133
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 194 ALESIL-HRIYTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +S G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 69
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 70  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 450
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 451 PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L++    +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 509 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 567
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS-SLREINILLSFDHPS 77
           + +G    V+R R KK+G++ A+K          + + +  P+   +RE  +L   +H +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--------NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 78  IVN---VKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLML--QLLEGVK 131
           IV    ++E     H    ++ME+     L  ++E     +   E + L++   ++ G+ 
Sbjct: 69  IVKLFAIEEETTTRHK--VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 132 YLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +L +N ++HR++K  N++     + Q V K+ DFG +R+     + +  L  T  Y  P+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVXLYGTEEYLHPD 185
Query: 188 LLLGA-------KKYSTAVDMWSVG 205
           +   A       KKY   VD+WS+G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIG 210

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 71
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 72  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 128
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG ++  G+  K Y +    V + + 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 189 ALESIL-HRIYTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 73
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 74  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 130
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG ++  G+  K Y +    V + + 
Sbjct: 131 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 191 ALESIL-HRIYTHQSDVWSYGVTVWELM 217

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 19  ISEGTYGIVYRA---RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I EG +G V++      +     VA+K  K       +C         L+E   +  FDH
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDH 70
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   + YL 
Sbjct: 71  PHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-QYGSPLKPYTSLVVTLWYRAPELLLGAK 193
               +HRD+   N+L++    +K+ DFG+SR    S     +   + + + APE  +  +
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFR 187
Query: 194 KYSTAVDMWSVGCIMAELL--AKKPLFSGTTEVDQIDKI 230
           ++++A D+W  G  M E+L    KP F G    D I +I
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 60/107 (56%), Gaps = 7/107 (6%)
Query: 111 KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS 169
           K+P +  ++     Q+  G+++L     +HRDL   N+LL+   V+KICDFG++R  Y +
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 170 P---LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           P    K  T L   L + APE +   K YST  D+WS G ++ E+ +
Sbjct: 253 PDYVRKGDTRL--PLKWMAPESIFD-KIYSTKSDVWSYGVLLWEIFS 296

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 23/186 (12%)
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMES-------------- 109
           RE  +L    H  IV    V  +    + MV EYM H DL   + S              
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 110 MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS 169
              P    ++  +  Q+  G+ YL     +HRDL T N L+    V+KI DFGMSR   S
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 170 P--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLF--SGTTE 223
               +     ++ + +  PE +L  +K++T  D+WS G ++ E+    K+P +  S T  
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 224 VDQIDK 229
           +D I +
Sbjct: 270 IDCITQ 275

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 71
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++M+ M     L ++ E  K    +  +    +Q+
Sbjct: 72  VMASVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 128
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG ++  G+  K Y +    V + + 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 189 ALESIL-HRIYTHQSDVWSYGVTVWELM 215

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 14  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 74  DHPSIVNVKEVVM-DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            + +   +  V    +  S+Y  +  +E             F   ++  +  Q  +G+ Y
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGMDY 119
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAPEL 188
           LH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + APE+
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAPEV 177
Query: 189 LLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           +    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 30  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            + +   +            +V ++ E   L   + + +  F   ++  +  Q   G+ Y
Sbjct: 87  GYSTAPQLA-----------IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAPEL 188
           LH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + APE+
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAPEV 193
Query: 189 --LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
             +  +  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 18  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            + +              + +V ++ E   L   + + +  F   ++  +  Q   G+ Y
Sbjct: 75  GYST-----------KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAPEL 188
           LH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + APE+
Sbjct: 124 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAPEV 181
Query: 189 --LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
             +  +  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 222

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 418 LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 473
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 474 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSG--TTEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 534 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 591
Query: 235 GTPT 238
           G P 
Sbjct: 592 GCPA 595

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 419 LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 474
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 475 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSG--TTEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 535 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 592
Query: 235 GTPT 238
           G P 
Sbjct: 593 GCPA 596

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 19  ISEGTYGIVYRARDKKSG--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I EG +G V +AR KK G     A+K++K     K+D  ++   +  L ++       HP
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG-----HHP 86
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMES--------------MKQPFSTSEVK 120
           +I+N+     +    +Y+ +EY  H   L +L +S                   S+ ++ 
Sbjct: 87  NIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
                +  G+ YL     +HRDL   N+L+    V KI DFG+SR     +K     +  
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            W     L      Y+T  D+WS G ++ E+++
Sbjct: 206 RWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 236

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 1/99 (1%)
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q++ G+++LH   +++RDLK  N+LL++ G ++I D G++ +  +          T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           APELLLG ++Y  +VD +++G  + E++A +  F    E
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 1/99 (1%)
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q++ G+++LH   +++RDLK  N+LL++ G ++I D G++ +  +          T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           APELLLG ++Y  +VD +++G  + E++A +  F    E
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 1/99 (1%)
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q++ G+++LH   +++RDLK  N+LL++ G ++I D G++ +  +          T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           APELLLG ++Y  +VD +++G  + E++A +  F    E
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 19  ISEGTYGIVYRARDKKSG--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I EG +G V +AR KK G     A+K++K     K+D  ++   +  L ++       HP
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG-----HHP 76
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMES--------------MKQPFSTSEVK 120
           +I+N+     +    +Y+ +EY  H   L +L +S                   S+ ++ 
Sbjct: 77  NIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
                +  G+ YL     +HRDL   N+L+    V KI DFG+SR     +K     +  
Sbjct: 136 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 195
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            W     L      Y+T  D+WS G ++ E+++
Sbjct: 196 RWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 226

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V+EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 32/252 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L 
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQ 68
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVK 131
                I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V 
Sbjct: 69  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 125
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRA 185
            +H + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV      T+ Y  
Sbjct: 126 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGTVNYMP 180
Query: 186 PELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           PE +              K S   D+WS+GCI+  +   K  F     ++QI K+   + 
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIID 238
Query: 236 TPTETIWPGLSE 247
              E  +P + E
Sbjct: 239 PNHEIEFPDIPE 250

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 23/186 (12%)
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMES-------------- 109
           RE  +L    H  IV    V  +    + MV EYM H DL   + S              
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 121
Query: 110 MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS 169
              P    ++  +  Q+  G+ YL     +HRDL T N L+    V+KI DFGMSR   S
Sbjct: 122 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 181
Query: 170 P--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLF--SGTTE 223
               +     ++ + +  PE +L  +K++T  D+WS G ++ E+    K+P +  S T  
Sbjct: 182 TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 240
Query: 224 VDQIDK 229
           +D I +
Sbjct: 241 IDCITQ 246

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 1/99 (1%)
Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           Q++ G+++LH   +++RDLK  N+LL++ G ++I D G++ +  +          T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
           APELLLG ++Y  +VD +++G  + E++A +  F    E
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 32/252 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQ 84
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVK 131
                I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V 
Sbjct: 85  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 141
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRA 185
            +H + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV      T+ Y  
Sbjct: 142 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGTVNYMP 196
Query: 186 PELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           PE +              K S   D+WS+GCI+  +   K  F     ++QI K+   + 
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIID 254
Query: 236 TPTETIWPGLSE 247
              E  +P + E
Sbjct: 255 PNHEIEFPDIPE 266

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 14  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 71  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 117
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAP 175
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 32/252 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQ 112
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVK 131
                I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V 
Sbjct: 113 QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 169
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRA 185
            +H + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV      T+ Y  
Sbjct: 170 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGTVNYMP 224
Query: 186 PELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           PE +              K S   D+WS+GCI+  +   K  F     ++QI K+   + 
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIID 282
Query: 236 TPTETIWPGLSE 247
              E  +P + E
Sbjct: 283 PNHEIEFPDIPE 294

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 34  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 91  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 137
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 138 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAP 195
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 238

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V+EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTS 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R    +       
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKIFK 232
               + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ ++
Sbjct: 175 AKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 32/249 (12%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L    
Sbjct: 61  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQQHS 115
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
             I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V  +H
Sbjct: 116 DKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRAPEL 188
            + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV      T+ Y  PE 
Sbjct: 173 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 189 L----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
           +              K S   D+WS+GCI+  +   K  F     ++QI K+   +    
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIIDPNH 285
Query: 239 ETIWPGLSE 247
           E  +P + E
Sbjct: 286 EIEFPDIPE 294

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 30  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            + +              + +V ++ E   L   + + +  F   ++  +  Q   G+ Y
Sbjct: 87  GYST-----------KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAPEL 188
           LH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + APE+
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAPEV 193
Query: 189 --LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
             +  +  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 14  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 71  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 117
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAP 175
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 23/186 (12%)
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMES-------------- 109
           RE  +L    H  IV    V  +    + MV EYM H DL   + S              
Sbjct: 69  REAELLTMLQHQHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 127
Query: 110 MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS 169
              P    ++  +  Q+  G+ YL     +HRDL T N L+    V+KI DFGMSR   S
Sbjct: 128 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 187
Query: 170 P--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--AKKPLF--SGTTE 223
               +     ++ + +  PE +L  +K++T  D+WS G ++ E+    K+P +  S T  
Sbjct: 188 TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 246
Query: 224 VDQIDK 229
           +D I +
Sbjct: 247 IDCITQ 252

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 32/252 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L 
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQ 64
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVK 131
                I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V 
Sbjct: 65  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 121
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRA 185
            +H + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV      T+ Y  
Sbjct: 122 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGTVNYMP 176
Query: 186 PELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           PE +              K S   D+WS+GCI+  +   K  F     ++QI K+   + 
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIID 234
Query: 236 TPTETIWPGLSE 247
              E  +P + E
Sbjct: 235 PNHEIEFPDIPE 246

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIV----ALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E +++  +  G +G VY+      GE V    A+K +    G K +       +  + E 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-------VEFMDEA 68
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ 125
            I+ S DHP +V +  V +    ++ +V + M H   L+++ E  K    +  +    +Q
Sbjct: 69  LIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLEYVHEH-KDNIGSQLLLNWCVQ 125
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           + +G+ YL +  ++HRDL   N+L+ +   +KI DFG++R      K Y +    +  + 
Sbjct: 126 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 186 PEL-LLGAKKYSTAVDMWSVGCIMAELLA 213
             L  +  +K++   D+WS G  + EL+ 
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 32/252 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQ 65
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVK 131
                I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V 
Sbjct: 66  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 122
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRA 185
            +H + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV      T+ Y  
Sbjct: 123 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGTVNYMP 177
Query: 186 PELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           PE +              K S   D+WS+GCI+  +   K  F     ++QI K+   + 
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIID 235
Query: 236 TPTETIWPGLSE 247
              E  +P + E
Sbjct: 236 PNHEIEFPDIPE 247

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 42  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 99  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 145
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAP 203
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIV----ALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E +++  +  G +G VY+      GE V    A+K +    G K +       +  + E 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-------VEFMDEA 91
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQ 125
            I+ S DHP +V +  V +    ++ +V + M H   L+++ E  K    +  +    +Q
Sbjct: 92  LIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLEYVHEH-KDNIGSQLLLNWCVQ 148
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           + +G+ YL +  ++HRDL   N+L+ +   +KI DFG++R      K Y +    +  + 
Sbjct: 149 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 186 PEL-LLGAKKYSTAVDMWSVGCIMAELLA 213
             L  +  +K++   D+WS G  + EL+ 
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 60  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 115
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 176 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 233
Query: 235 GTPT 238
           G P 
Sbjct: 234 GCPA 237

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 19  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 76  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 122
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAP 180
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 41  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 98  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 144
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 145 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAP 202
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 42  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 99  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 145
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAP 203
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 72
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 73  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 129
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 190 ALESIL-HRIYTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 71
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 72  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 128
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 189 ALESIL-HRIYTHQSDVWSYGVTVWELM 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 75
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 76  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 132
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 133 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 193 ALESIL-HRIYTHQSDVWSYGVTVWELM 219

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 19  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 76  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 122
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAP 180
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 17  NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSF 73
            +I  G++G VY+   K  G+ VA+K + +     +    +   +  LR+   +NILL  
Sbjct: 16  QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 74  DH---PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            +   P +  V +    +  S+Y  +  +E             F   ++  +  Q  +G+
Sbjct: 73  GYSTKPQLAIVTQWC--EGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGM 119
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPLKPYTSLVVTLWYRAP 186
            YLH   ++HRDLK++N+ L+    +KI DFG+    SR  GS    +  L  ++ + AP
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAP 177
Query: 187 ELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           E++    K  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 178 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 94
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 95  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 151
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 152 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLA 213
           A E +L  + Y+   D+WS G  + EL+ 
Sbjct: 212 ALESIL-HRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 72
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 73  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 129
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 190 ALESIL-HRIYTHQSDVWSYGVTVWELM 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 69
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 70  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGXLLDYVREH-KDNIGSQYLLNWCVQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 62/301 (20%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + K+ EG +  V        G   ALK++         C E      + RE ++   F+H
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRIL--------CHEQQDREEAQREADMHRLFNH 85
Query: 76  PSIVNVKEVVMDDHDS---VYMVMEYMEHDLKW-LMESMKQP---FSTSEVKCLMLQLLE 128
           P+I+ +    + +  +    ++++ + +    W  +E +K      +  ++  L+L +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-----GS----PLKPYTSLVV 179
           G++ +H     HRDLK +N+LL ++G   + D G   Q      GS     L+ + +   
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 180 TLWYRAPELLLGAKK--YSTAVDMWSVGCIM-AELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           T+ YRAPEL             D+WS+GC++ A +  + P           D +F+    
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----------YDMVFQK--- 252
Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                        G     A Q  N L       S   SP  S + + LLN ++T DP +
Sbjct: 253 -------------GDSVALAVQ--NQL-------SIPQSPRHSSALWQLLNSMMTVDPHQ 290
Query: 297 R 297
           R
Sbjct: 291 R 291

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 72
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 73  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 129
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 190 ALESIL-HRIYTHQSDVWSYGVTVWELM 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKIRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 69
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 70  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 76
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 77  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 133
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 194 ALESIL-HRIYTHQSDVWSYGVTVWELM 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 79
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 80  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 136
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 137 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLA 213
           A E +L  + Y+   D+WS G  + EL+ 
Sbjct: 197 ALESIL-HRIYTHQSDVWSYGVTVWELMT 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 74  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 129
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 190 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 247
Query: 235 GTPT 238
           G P 
Sbjct: 248 GCPA 251

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 48  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 105
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 106 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 163
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 164 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 222
Query: 231 FK 232
           ++
Sbjct: 223 YR 224

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 46  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 103
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 104 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 161
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 162 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 220
Query: 231 FK 232
           ++
Sbjct: 221 YR 222

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 86/161 (53%), Gaps = 9/161 (5%)
Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVK 120
           +L E  IL   +   +V++     +  D++ +V+  M   DLK+ +  M Q  F  +   
Sbjct: 231 ALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLV 178
               ++  G++ LH   +++RDLK  N+LL++ G ++I D G++     G  +K     V
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV 346
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS 219
            T+ Y APE++   ++Y+ + D W++GC++ E++A +  F 
Sbjct: 347 GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/311 (22%), Positives = 122/311 (39%), Gaps = 37/311 (11%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILL 71
           FE + ++ E   G    AR +    ++  ++  + +  K+     G   S + RE+ +L 
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLY 65
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
                  V       ++ D  Y+V E M           ++ F+  E   ++  +   + 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 132 YLHDNWVLHRDLKTSNLLL---NNQGVLKICDF--GMSRQYGSPLKPYTSLVV-----TL 181
           +LH+  + HRDLK  N+L    N    +KICDF  G   +      P ++  +     + 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 182 WYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
            Y APE++      A  Y    D+WS+G I+  LL+  P F G    D            
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD------------ 233
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
               W      P  + N   +     +  FP   +     +S +  DL+++LL  D ++R
Sbjct: 234 --CGWDRGEACPACQ-NMLFESIQEGKYEFPDKDWAH---ISCAAKDLISKLLVRDAKQR 287
Query: 298 ITVDDALNHYW 308
           ++    L H W
Sbjct: 288 LSAAQVLQHPW 298

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 9   SVFEFEKLNKISE---GTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPI 61
           ++FE   L  IS+   G +G V   R       +G +VA+K+++ +   ++   +     
Sbjct: 2   TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ----- 56
Query: 62  SSLREINILLSFDHPSIVNVKEVVMD-DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEV 119
              REI IL +     IV  + V        + +VMEY+    L+  ++  +     S +
Sbjct: 57  ---REIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRL 113
Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
                Q+ +G++YL     +HRDL   N+L+ ++  +KI DFG+++    PL     +V 
Sbjct: 114 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDXXVVR 171
Query: 180 ------TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
                   WY APE  L    +S   D+WS G ++ EL 
Sbjct: 172 EPGQSPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 117
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT 175
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R        YT
Sbjct: 118 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYT 175
Query: 176 S---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           +       + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 176 AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 66  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 121
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 182 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 239
Query: 235 GTPT 238
           G P 
Sbjct: 240 GCPA 243

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV ++   +Y+V EYM     L +L   M +     
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGEMGKYLRLP 281
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG+ R        YT+ 
Sbjct: 282 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIED--NEYTAR 339
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 340 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 398
Query: 231 FK 232
           ++
Sbjct: 399 YR 400

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 76  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 131
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 192 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 249
Query: 235 GTPT 238
           G P 
Sbjct: 250 GCPA 253

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 76  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 131
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 192 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 249
Query: 235 GTPT 238
           G P 
Sbjct: 250 GCPA 253

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 60  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 115
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 176 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 233
Query: 235 GTPT 238
           G P 
Sbjct: 234 GCPA 237

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 57  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 112
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT 175
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R        YT
Sbjct: 113 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYT 170
Query: 176 S---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           +       + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 171 AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 113
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT 175
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R        YT
Sbjct: 114 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYT 171
Query: 176 S---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           +       + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 172 AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 86/161 (53%), Gaps = 9/161 (5%)
Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP-FSTSEVK 120
           +L E  IL   +   +V++     +  D++ +V+  M   DLK+ +  M Q  F  +   
Sbjct: 231 ALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLV 178
               ++  G++ LH   +++RDLK  N+LL++ G ++I D G++     G  +K     V
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV 346
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS 219
            T+ Y APE++   ++Y+ + D W++GC++ E++A +  F 
Sbjct: 347 GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 63
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 64  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 120
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLA 213
           A E +L  + Y+   D+WS G  + EL+ 
Sbjct: 181 ALESIL-HRIYTHQSDVWSYGVTVWELMT 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 84/160 (52%), Gaps = 14/160 (8%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 47  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 102
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT 175
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R        YT
Sbjct: 103 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYT 160
Query: 176 S---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           +       + + APE  +    ++   D+WS G ++ E++
Sbjct: 161 AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIV 199

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 69
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 70  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 54  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 109
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 110 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 170 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 227
Query: 235 GTPT 238
           G P 
Sbjct: 228 GCPA 231

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 107
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAR 167
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
                 + + APE  +    ++   D+WS G ++ E++
Sbjct: 168 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIV 204

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           L E N++   D+P IV +  + + + +S  +VME  E  L  L + ++Q     +   + 
Sbjct: 56  LAEANVMQQLDNPYIVRM--IGICEAESWMLVMEMAE--LGPLNKYLQQNRHVKDKNIIE 111
Query: 124 L--QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           L  Q+  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +     
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 182 W---YRAPELLLGAKKYSTAVDMWSVGCIMAELLA--KKPLFSGT--TEVDQIDKIFKTL 234
           W   + APE  +   K+S+  D+WS G +M E  +  +KP + G   +EV  + +  + +
Sbjct: 172 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERM 229
Query: 235 GTPT 238
           G P 
Sbjct: 230 GCPA 233

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 115
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 116 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 175
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 176 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E   L ++  G +G+V   + K   + VA+K +K     +++  +         E   ++
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQ---------EAQTMM 58
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP +V    V   ++  +Y+V EY+ +  L   + S  +    S++  +   + EG+
Sbjct: 59  KLSHPKLVKFYGVCSKEY-PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW---YRAPE 187
            +L  +  +HRDL   N L++    +K+ DFGM+R        Y S V T +   + APE
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPE 175
Query: 188 LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP--LFSGTT---EVDQIDKIFK---TLGTP 237
            +    KYS+  D+W+ G +M E+  L K P  L++ +    +V Q  ++++      T 
Sbjct: 176 -VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234
Query: 238 TETIWPGLSELPGAKANFAK 257
            + ++    ELP  +  F +
Sbjct: 235 YQIMYSCWHELPEKRPTFQQ 254

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 113
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 114 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 173
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 174 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 107
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT 175
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R        YT
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYT 165
Query: 176 S---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           +       + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 166 AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 61  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 116
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 117 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 176
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 177 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 107
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 167
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 168 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 19  ISEGTYGIVYRARDKKSG--EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
           I EG +G V +AR KK G     A+K++K     K+D  ++   +  L ++       HP
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG-----HHP 83
Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMES--------------MKQPFSTSEVK 120
           +I+N+     +    +Y+ +EY  H   L +L +S                   S+ ++ 
Sbjct: 84  NIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
                +  G+ YL     +HR+L   N+L+    V KI DFG+SR     +K     +  
Sbjct: 143 HFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 202
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            W     L      Y+T  D+WS G ++ E+++
Sbjct: 203 RWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 233

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 54  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 109
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 110 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 169
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 170 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 107
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 167
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 168 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 53  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 108
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPY 174
            +++  +  Q+ EG+ ++ +   +HRDL+ +N+L+++    KI DFG++R    +     
Sbjct: 109 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR 168
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                 + + APE  +    ++   D+WS G ++ E++ 
Sbjct: 169 EGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 71
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 72  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 128
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG ++  G+  K Y +    V + + 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 189 ALESIL-HRIYTHQSDVWSYGVTVWELM 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L   M +     
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL  +N+L+    V K+ DFG++R        YT+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIED--NEYTAR 172
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 173 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 231 FK 232
           ++
Sbjct: 232 YR 233

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 125/311 (40%), Gaps = 54/311 (17%)
Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPS 77
           + EG Y  V  A   ++G+  A+K ++   G               RE+  L     + +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS--------RVFREVETLYQCQGNKN 72
Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           I+ + E   DD    Y+V E ++          ++ F+  E   ++  +   + +LH   
Sbjct: 73  ILELIEFFEDD-TRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 138 VLHRDLKTSNLLLNNQ---GVLKICDF--GMSRQYGSPLKPYTSLVVT-----LWYRAPE 187
           + HRDLK  N+L  +      +KICDF  G   +  +   P T+  +T       Y APE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 188 LLL----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD------QIDKIFKTLGTP 237
           ++      A  Y    D+WS+G ++  +L+  P F G    D      ++ ++ +     
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN--KL 249
Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E+I  G  E P    ++A                     +S    DL+++LL  D ++R
Sbjct: 250 FESIQEGKYEFP--DKDWAH--------------------ISSEAKDLISKLLVRDAKQR 287
Query: 298 ITVDDALNHYW 308
           ++    L H W
Sbjct: 288 LSAAQVLQHPW 298

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV ++   +Y+V EYM     L +L     +     
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLP 363
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 364 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 421
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 422 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
Query: 231 FK 232
           ++
Sbjct: 481 YR 482

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 76
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 77  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 133
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG ++  G+  K Y +    V + + 
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 194 ALESIL-HRIYTHQSDVWSYGVTVWELM 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V  KE   E   P ++   L E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKE-LREATSPKANKEILDEAY 69
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 70  VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 126
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG ++  G+  K Y +    V + + 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELL 212
           A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 32/249 (12%)
Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L    
Sbjct: 61  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQQHS 115
Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
             I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V  +H
Sbjct: 116 DKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRAPEL 188
            + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P T+ VV       + Y  PE 
Sbjct: 173 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 189 L----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
           +              K S   D+WS+GCI+  +   K  F     ++QI K+   +    
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIIDPNH 285
Query: 239 ETIWPGLSE 247
           E  +P + E
Sbjct: 286 EIEFPDIPE 294

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE-INIL 70
           +FE L  I  G +  V   + K++G++ A+K     +  K D L+ G  +S  RE  ++L
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMK-----IMNKWDMLKRG-EVSCFREERDVL 115
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEY-MEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           ++ D   I  +      D + +Y+VMEY +  DL  L+    +       +  + +++  
Sbjct: 116 VNGDRRWITQL-HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPEL 188
           +  +H    +HRD+K  N+LL+  G +++ DFG   +  +     + + V T  Y +PE+
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 189 LLGAKKYSTA------VDMWSVGCIMAELL-AKKPLFSGTT 222
           L                D W++G    E+   + P ++ +T
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 32/252 (12%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L +I  G    V++  ++K  +I A+K V +     +    Y   I+ L +    L 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNK----LQ 84
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLEGVK 131
                I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE V 
Sbjct: 85  QHSDKIIRLYDYEITDQ-YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVH 141
Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------TLWYRA 185
            +H + ++H DLK +N L+ + G+LK+ DFG++ Q    ++P    VV      T+ Y  
Sbjct: 142 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ----MQPDXXXVVKDSQVGTVNYMP 196
Query: 186 PELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           PE +              K S   D+WS+GCI+  +   K  F     ++QI K+   + 
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIID 254
Query: 236 TPTETIWPGLSE 247
              E  +P + E
Sbjct: 255 PNHEIEFPDIPE 266

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 78
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 79  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R   +     K    L+ 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 198 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 234

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 16  LNKI-SEGTYGIVYRARDKKSGEIVALKKVKMNVGRK---EDCLEYGFPISSLREINILL 71
           LN+I  EG +G VY       G     K  K+NV  K   +DC         + E  I+ 
Sbjct: 28  LNRILGEGFFGEVYE------GVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMK 80
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + DHP IV +  ++  + +  +++ME Y   +L   +E  K       +    LQ+ + +
Sbjct: 81  NLDHPHIVKLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 138
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL--WYRAPEL 188
            YL     +HRD+   N+L+ +   +K+ DFG+SR Y      Y + V  L   + +PE 
Sbjct: 139 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPE- 196
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLA--KKPLF 218
            +  ++++TA D+W     M E+L+  K+P F
Sbjct: 197 SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 16  LNKI-SEGTYGIVYRARDKKSGEIVALKKVKMNVGRK---EDCLEYGFPISSLREINILL 71
           LN+I  EG +G VY       G     K  K+NV  K   +DC         + E  I+ 
Sbjct: 12  LNRILGEGFFGEVY------EGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMK 64
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + DHP IV +  ++  + +  +++ME Y   +L   +E  K       +    LQ+ + +
Sbjct: 65  NLDHPHIVKLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 122
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL--WYRAPEL 188
            YL     +HRD+   N+L+ +   +K+ DFG+SR Y      Y + V  L   + +PE 
Sbjct: 123 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPE- 180
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLA--KKPLF 218
            +  ++++TA D+W     M E+L+  K+P F
Sbjct: 181 SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 16  LNKI-SEGTYGIVYRARDKKSGEIVALKKVKMNVGRK---EDCLEYGFPISSLREINILL 71
           LN+I  EG +G VY       G     K  K+NV  K   +DC         + E  I+ 
Sbjct: 16  LNRILGEGFFGEVYE------GVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMK 68
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVME-YMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + DHP IV +  ++  + +  +++ME Y   +L   +E  K       +    LQ+ + +
Sbjct: 69  NLDHPHIVKLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL--WYRAPEL 188
            YL     +HRD+   N+L+ +   +K+ DFG+SR Y      Y + V  L   + +PE 
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPE- 184
Query: 189 LLGAKKYSTAVDMWSVGCIMAELLA--KKPLF 218
            +  ++++TA D+W     M E+L+  K+P F
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 69
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 70  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 128
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR---QYGSPLKPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R   +     K    L+ 
Sbjct: 129 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 189 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 225

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 84/160 (52%), Gaps = 14/160 (8%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQP----FS 115
           P + L E N++    H  +V +  VV    + +Y++ EYME+    L++ +K P     +
Sbjct: 48  PDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS--LVDFLKTPSGIKLT 103
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT 175
            +++  +  Q+ EG+ ++ +   +HR+L+ +N+L+++    KI DFG++R        YT
Sbjct: 104 INKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIED--NEYT 161
Query: 176 S---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           +       + + APE  +    ++   D+WS G ++ E++
Sbjct: 162 AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIV 200

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 18/121 (14%)
Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM---------SRQYGSPLK 172
           + +Q+ E V++LH   ++HRDLK SN+      V+K+ DFG+          +   +P+ 
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 173 PYTS---LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
            Y +    V T  Y +PE + G   YS  VD++S+G I+ EL     L+S +T+++++  
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFEL-----LYSFSTQMERVRI 282
Query: 230 I 230
           I
Sbjct: 283 I 283

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV ++   +Y+V EYM     L +L     +     
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 338
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 339 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 231 FK 232
           ++
Sbjct: 398 YR 399

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV ++   +Y+V EYM     L +L     +     
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 338
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 339 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 231 FK 232
           ++
Sbjct: 398 YR 399

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L     +     
Sbjct: 50  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 107
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 108 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 165
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 166 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 224
Query: 231 FK 232
           ++
Sbjct: 225 YR 226

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   + EK  K+  G +G V+ A   K  + VA+K +K      E         + L E 
Sbjct: 181 RESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---------AFLAEA 228
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLM 123
           N++ +  H  +V +  VV    + +Y++ E+M      D     E  KQP    ++    
Sbjct: 229 NVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFS 284
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS-PLKPYTSLVVTLW 182
            Q+ EG+ ++     +HRDL+ +N+L++   V KI DFG++R     P+K          
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK---------- 334
Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           + APE  +    ++   D+WS G ++ E++
Sbjct: 335 WTAPE-AINFGSFTIKSDVWSFGILLMEIV 363

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 90  DSVYMVMEYMEHDLKWLMESMKQPFSTSE--VKCLMLQLLEGVKYLHDNWVLHRDLKTSN 147
           DS  +++E ME  ++ L + + +  +  E   +    Q+LE V++ H+  VLHRD+K  N
Sbjct: 86  DSFVLILERME-PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 144
Query: 148 LLLN-NQGVLKICDFGMSRQYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSV 204
           +L++ N+G LK+ DFG     G+ LK   YT    T  Y  PE +   + +  +  +WS+
Sbjct: 145 ILIDLNRGELKLIDFGS----GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 200
Query: 205 GCIMAELLAKKPLFSGTTEVDQIDKIFK 232
           G ++ +++     F    E+ +    F+
Sbjct: 201 GILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREIN 68
           EF+K+  +  G +G VY+      GE     KVK+ V   E   E   P ++   L E  
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIME-LREATSPKANKEILDEAY 103
Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQL 126
           ++ S D+P +  +  + +    +V ++ + M     L ++ E  K    +  +    +Q+
Sbjct: 104 VMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 160
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL--VVTLWYR 184
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + 
Sbjct: 161 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLA 213
           A E +L  + Y+   D+WS G  + EL+ 
Sbjct: 221 ALESIL-HRIYTHQSDVWSYGVTVWELMT 248

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 42/228 (18%)
Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE---INILLSFD 74
           +I  G++G VY+   K  G+ VA+K +K+     E    +   ++ LR+   +NILL   
Sbjct: 43  RIGSGSFGTVYKG--KWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL------- 127
           + +            D++ +V ++ E        S+ +     E K  M QL+       
Sbjct: 100 YMT-----------KDNLAIVTQWCEGS------SLYKHLHVQETKFQMFQLIDIARQTA 142
Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM----SRQYGSPL--KPYTSLVVTL 181
           +G+ YLH   ++HRD+K++N+ L+    +KI DFG+    SR  GS    +P  S+   L
Sbjct: 143 QGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV---L 199
Query: 182 WYRAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           W  APE++       +S   D++S G ++ EL+  +  +S     DQI
Sbjct: 200 WM-APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 84
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 85  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 143
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 204 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 240

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L     +     
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP 111
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 112 QLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 169
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 170 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 228
Query: 231 FK 232
           ++
Sbjct: 229 YR 230

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 84
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 85  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 204 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 240

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV ++   +Y+V EYM     L +L     +     
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVGEYMSKGSLLDFLKGETGKYLRLP 280
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS- 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+ 
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTAR 338
Query: 177 --LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKI 230
                 + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ 
Sbjct: 339 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 231 FK 232
           ++
Sbjct: 398 YR 399

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 190 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 249
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 250 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 297

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 75
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 76  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 134
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 135 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 195 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 231

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 78
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 79  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 198 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 234

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 72  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 191 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 77
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 78  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 197 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 233

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 188 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 247
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 248 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 295

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 74
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 75  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 133
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 134 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 194 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 230

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 181 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 240
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 241 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 288

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 106
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 107 FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 165
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 166 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 226 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 262

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 243 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 290

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 77
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 78  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +    K    L+ 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 197 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 233

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + +Y+V EYM     L +L     +     
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP 111
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTS 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R    +       
Sbjct: 112 QLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKIFK 232
               + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ ++
Sbjct: 172 AKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 230

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 189 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 140 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 199
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 200 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 189 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 198 IYKDPDXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 198 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 175 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 234
Query: 167 -YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            Y  P  ++   + +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 235 IYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 282

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   + EK  K+  G +G V+ A   K  + VA+K +K      E         + L E 
Sbjct: 14  RESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---------AFLAEA 61
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLM 123
           N++ +  H  +V +  VV    + +Y++ E+M      D     E  KQP    ++    
Sbjct: 62  NVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFS 117
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS---LVVT 180
            Q+ EG+ ++     +HRDL+ +N+L++   V KI DFG++R        YT+       
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFP 175
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           + + APE  +    ++   D+WS G ++ E++
Sbjct: 176 IKWTAPE-AINFGSFTIKSDVWSFGILLMEIV 206

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 12  EFEKLNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           ++E    I+ G  G +Y A D+  +G  V LK + ++ G  E           L E+   
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVV-- 137
Query: 71  LSFDHPSIVNVKEVV--MDDH-DSV-YMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
               HPSIV +   V   D H D V Y+VMEY+    + L  S  Q    +E    +L++
Sbjct: 138 ----HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG--QSLKRSKGQKLPVAEAIAYLLEI 191
Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           L  + YLH   +++ DLK  N++L  +  LK+ D G   +  S    +  L  T  ++AP
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS----FGYLYGTPGFQAP 246
Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           E++      + A D+++VG  +A L    P  +G
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNG 278

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 112 ARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 167
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 172
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R   + EK  K+  G +G V+ A   K  + VA+K +K      E         + L E 
Sbjct: 187 RESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---------AFLAEA 234
Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLM 123
           N++ +  H  +V +  VV    + +Y++ E+M      D     E  KQP    ++    
Sbjct: 235 NVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFS 290
Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS---LVVT 180
            Q+ EG+ ++     +HRDL+ +N+L++   V KI DFG++R        YT+       
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFP 348
Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           + + APE  +    ++   D+WS G ++ E++
Sbjct: 349 IKWTAPE-AINFGSFTIKSDVWSFGILLMEIV 379

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSP--LKPYTSL 177
           C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R  Y  P  ++   + 
Sbjct: 148 CYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           +   W  APE +   + Y+   D+WS G ++ E+ +
Sbjct: 208 LPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 115 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 170
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 171 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 227

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 171
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 172
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 172
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 18  KISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ +G++G+VY    K     +    VA+K V      +E        I  L E +++  
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNEASVMKE 71
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCL 122
           F+   +V +  VV     ++ ++ME M   DLK  + S++          P S S++  +
Sbjct: 72  FNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPL--KPYTSLVV 179
             ++ +G+ YL+ N  +HRDL   N  +     +KI DFGM+R  Y +    K    L+ 
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W     L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 191 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 227

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 167
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 186
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 187
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 187
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 187
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 214
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 139 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 194
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 186
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 206
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 214
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 199
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 164 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 219
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 220 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 167
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 214
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+ +    F+
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 8   RSVFEFEKLNKISEGTYGIVYRARD---KKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
           R   EF K+  +  G +G V  A      K+G  + +  VKM +  K D  E    +S L
Sbjct: 44  RENLEFGKV--LGSGAFGKVMNATAYGISKTGVSIQVA-VKM-LKEKADSSEREALMSEL 99
Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVK--- 120
           + +  L S  H +IVN+          +Y++ EY  + DL   + S ++ FS  E++   
Sbjct: 100 KMMTQLGS--HENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 121 -------------------CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF 161
                              C   Q+ +G+++L     +HRDL   N+L+ +  V+KICDF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 162 GMSRQYGSP----LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           G++R   S     ++    L V   + APE L     Y+   D+WS G ++ E+ +
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVK--WMAPESLFEG-IYTIKSDVWSYGILLWEIFS 269

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 199
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 200
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 200
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 200
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 200
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 199
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKP--YT 175
            +    Q+LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG     G+ LK   YT
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYT 199
Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
               T  Y  PE +   + +  +  +WS+G ++ +++     F    E+
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 19  ISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFP--ISSLREINILLS 72
           + EG +G V  A     DK     V    VKM    K D  E      IS +  + ++  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKMI-- 90
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP---------------FST 116
             H +I+N+      D   +Y+++EY  + +L+  +++ + P                S+
Sbjct: 91  GKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPY 174
            ++     Q+  G++YL     +HRDL   N+L+    V+KI DFG++R   +    K  
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           T+  + + + APE L   + Y+   D+WS G ++ E+ 
Sbjct: 210 TNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 71  LSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---FSTSEVKCLMLQ 125
           LSF  HP +V++     D+ + + ++ +YME+ +LK  +     P    S  +   + + 
Sbjct: 89  LSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV--TLWY 183
              G+ YLH   ++HRD+K+ N+LL+   V KI DFG+S++     + +   VV  TL Y
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKK 215
             PE  +   + +   D++S G ++ E+L  +
Sbjct: 208 IDPEYFIKG-RLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  +  G +G VY  +     +  S   VA+K +   V  ++D L++      L E  I+
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDF------LMEALII 87
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLE 128
             F+H +IV    V +      +++ME M   DLK +L E+  +P   S +   ML LL 
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLA--MLDLLH 144
Query: 129 -------GVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQY--GSPLKPYTS 176
                  G +YL +N  +HRD+   N LL   G   V KI DFGM+R     S  +    
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            ++ + +  PE  +    +++  D WS G ++ E+ +
Sbjct: 205 AMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFS 240

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 167 YGSPLKPYT--SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                         + L + APE +   + Y+   D+WS G ++ E+ +
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  +  G +G VY  +     +  S   VA+K +   V  ++D L++      L E  I+
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDF------LMEALII 128
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLE- 128
             F+H +IV    V +       ++      DLK +L E+  +P   S +   ML LL  
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA--MLDLLHV 186
Query: 129 ------GVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSR---QYGSPLKPYTS 176
                 G +YL +N  +HRD+   N LL   G   V KI DFGM+R   + G   K   +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           ++   W      + G   +++  D WS G ++ E+ +
Sbjct: 247 MLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFS 281

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 167 YGSPLKPYT--SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                         + L + APE +   + Y+   D+WS G ++ E+ +
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 167 YGSPLKPYT--SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                         + L + APE +   + Y+   D+WS G ++ E+ +
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  +  G +G VY  +     +  S   VA+K +   V  ++D L++      L E  I+
Sbjct: 50  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDF------LMEALII 102
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLE 128
             F+H +IV    V +      +++ME M   DLK +L E+  +P   S +   ML LL 
Sbjct: 103 SKFNHQNIVRCIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLA--MLDLLH 159
Query: 129 -------GVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQY--GSPLKPYTS 176
                  G +YL +N  +HRD+   N LL   G   V KI DFGM+R     S  +    
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            ++ + +  PE  +    +++  D WS G ++ E+ +
Sbjct: 220 AMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 108 ESMKQPFSTSE-VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
           E + + F T E + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 167 YGSPLKPYT--SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
                         + L + APE +   + Y+   D+WS G ++ E+ +
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  +  G +G VY  +     +  S   VA+K +   V  ++D L++      L E  I+
Sbjct: 53  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDF------LMEALII 105
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLK-WLMESMKQPFSTSEVKCLMLQLLE- 128
             F+H +IV    V +       ++      DLK +L E+  +P   S +   ML LL  
Sbjct: 106 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA--MLDLLHV 163
Query: 129 ------GVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSR---QYGSPLKPYTS 176
                 G +YL +N  +HRD+   N LL   G   V KI DFGM+R   + G   K   +
Sbjct: 164 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           ++   W      + G   +++  D WS G ++ E+ +
Sbjct: 224 MLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFS 258

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 19  ISEGTYGIVYRA------RDK-KSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINIL 70
           + EG +G V  A      +DK K    VA+K +K +   K+        +S L  E+ ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--------LSDLVSEMEMM 94
Query: 71  -LSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP--------------- 113
            +   H +I+N+      D   +Y+++EY  + +L+  + + + P               
Sbjct: 95  KMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 114 FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS--PL 171
            +  ++     QL  G++YL     +HRDL   N+L+    V+KI DFG++R   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           K  T+  + + + APE L   + Y+   D+WS G +M E+  
Sbjct: 214 KKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 19  ISEGTYGIVYRA------RDK-KSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINIL 70
           + EG +G V  A      +DK K    VA+K +K +   K+        +S L  E+ ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--------LSDLVSEMEMM 94
Query: 71  -LSFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP--------------- 113
            +   H +I+N+      D   +Y+++EY  + +L+  + + + P               
Sbjct: 95  KMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 114 FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS--PL 171
            +  ++     QL  G++YL     +HRDL   N+L+    V+KI DFG++R   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           K  T+  + + + APE L   + Y+   D+WS G +M E+  
Sbjct: 214 KKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 71  LSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---FSTSEVKCLMLQ 125
           LSF  HP +V++     D+ + + ++ +YME+ +LK  +     P    S  +   + + 
Sbjct: 89  LSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV--TLWY 183
              G+ YLH   ++HRD+K+ N+LL+   V KI DFG+S++     + +   VV  TL Y
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKK 215
             PE  +   + +   D++S G ++ E+L  +
Sbjct: 208 IDPEYFIKG-RLTEKSDVYSFGVVLFEVLCAR 238

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 60  PISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTS 117
           P + L+E  ++    H  +V +  VV    + + +V EYM     L +L     +     
Sbjct: 47  PEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLP 104
Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTS 176
           ++  +  Q+  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R    +       
Sbjct: 105 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK----PLFSGTTEVDQIDKIFK 232
               + + APE  L   +++   D+WS G ++ EL  K     P       +DQ+++ ++
Sbjct: 165 AKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 223

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 39/280 (13%)
Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGF--PISSLREINIL 70
           F    KI  G +G +   ++  + E VA+K   M     +  LEY F   + S   I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             F      N             MV+E +   L+ L +   + FS   V  + +QL+  +
Sbjct: 71  YYFGPCGKYNA------------MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 131 KYLHDNWVLHRDLKTSNLLLNNQG-----VLKICDFGMSRQYGS-------PLKPYTSLV 178
           +Y+H   +++RD+K  N L+   G     V+ I DFG++++Y         P + + SL 
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLT 178
Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG--- 235
            T  Y +    LG K+ S   D+ ++G +    L     + G  + D + + ++ +G   
Sbjct: 179 GTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQG-LKADTLKERYQKIGDTK 236
Query: 236 --TPTETIWPGLSELPG-----AKANFAKQP-YNLLRKRF 267
             TP E +     E+        + +F ++P Y+ LRK F
Sbjct: 237 RATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLF 276

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 19  ISEGTYGIVYRA------RDK-KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + EG +G V  A      +DK K    VA+K +K +   +ED  +    +  ++ I    
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEEDLSDLVSEMEMMKMIG--- 98
Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP---------------FS 115
              H +I+N+      D   +Y+++EY  + +L+  + + + P                +
Sbjct: 99  --KHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKP 173
             ++     QL  G++YL     +HRDL   N+L+    V+KI DFG++R   +    K 
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
            T+  + + + APE L   + Y+   D+WS G +M E+  
Sbjct: 216 TTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 19  ISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFP--ISSLREINILLS 72
           + EG +G V  A     DK     V    VKM    K D  E      IS +  + ++  
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKMI-- 131
Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYM-EHDLKWLMESMKQP---------------FST 116
             H +I+N+      D   +Y+++EY  + +L+  +++ + P                S+
Sbjct: 132 GKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPY 174
            ++     Q+  G++YL     +HRDL   N+L+    V+KI DFG++R   +    K  
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           T+  + + + APE L   + Y+   D+WS G ++ E+  
Sbjct: 251 TNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 288

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/128 (24%), Positives = 60/128 (46%), Gaps = 3/128 (2%)
Query: 111 KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGS 169
           K P      +C   Q++  +++ H   V+HRD+K  N+L++  +G  K+ DFG       
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192
Query: 170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
             +PYT    T  Y  PE +   + ++    +WS+G ++ +++     F    E+ + + 
Sbjct: 193 --EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250
Query: 230 IFKTLGTP 237
            F    +P
Sbjct: 251 HFPAHVSP 258

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 19  ISEGTYGIVYRA------RDK-KSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINIL 70
           + EG +G V  A      +DK K    VA+K +K +   K+        +S L  E+ ++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--------LSDLVSEMEMM 140
Query: 71  -LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP--------------- 113
            +   H +I+N+      D   +Y+++EY    +L+  + + + P               
Sbjct: 141 KMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 114 FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--L 171
            +  ++     QL  G++YL     +HRDL   N+L+    V+KI DFG++R   +    
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA 213
           K  T+  + + + APE L   + Y+   D+WS G +M E+  
Sbjct: 260 KKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 300
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	332
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	0.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	0.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	0.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-180
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-179
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-179
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-178
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-178
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-177
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-177
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-176
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-170
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-169
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-162
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-117
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-117
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-111
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-106
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-106
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-104
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-100
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-99
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-99
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-99
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-99
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-98
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-96
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-70
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-68
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-67
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-66
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-66
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-65
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-65
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-64
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-63
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-63
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-62
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-62
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-61
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-61
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-61
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-61
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-61
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-60
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-60
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-60
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-60
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-60
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-60
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-60
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-60
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-59
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-59
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-59
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-59
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-59
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-58
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-58
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-58
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-58
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-58
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-58
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-57
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-57
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-57
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-57
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-57
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-57
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-57
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-56
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-56
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-56
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-56
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-55
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-55
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-55
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-54
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-54
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-54
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-54
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-54
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-53
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-53
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-52
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-52
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-51
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-51
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-51
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-50
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-49
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-49
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-48
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-48
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-47
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-47
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-46
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-45
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-45
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-45
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-44
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-44
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-44
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-43
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-43
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-43
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-43
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-43
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-43
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-42
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-42
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-42
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-42
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-41
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-41
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-40
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-40
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-38
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-37
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-37
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-36
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-35
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-35
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-34
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-34
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-33
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-33
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-33
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-32
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-32
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-32
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-31
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-31
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-28
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-26
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-18
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-17
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  527 bits (1359), Expect = 0.0
 Identities = 127/337 (37%), Positives = 186/337 (55%), Gaps = 24/337 (7%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
              C  V ++EKL KI +GT+G V++AR +K+G+ VALKKV M    KE     GFPI++
Sbjct: 10  CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKE-----GFPITA 63

Query: 64  LREINILLSFDHPSIVNVKEVVMDD-------HDSVYMVMEYMEHDLKWLMESMKQPFST 116
           LREI IL    H ++VN+ E+             S+Y+V ++ EHDL  L+ ++   F+ 
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123

Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK---- 172
           SE+K +M  LL G+ Y+H N +LHRD+K +N+L+   GVLK+ DFG++R +         
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 173 PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK 232
            YT+ VVTLWYR PELLLG + Y   +D+W  GCIMAE+  + P+  G TE  Q+  I +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243

Query: 233 TLGTPTETIWPGLSELPGAK-ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLT 291
             G+ T  +WP +      +     K     ++ R        + V      DL+++LL 
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLV 297

Query: 292 YDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQH 328
            DP +RI  DDALNH +F   P+P     M +     
Sbjct: 298 LDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTS 334

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  525 bits (1354), Expect = 0.0
 Identities = 126/332 (37%), Positives = 186/332 (56%), Gaps = 14/332 (4%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           M +         +EKL+ + EG +  VY+ARDK + +IVA+KK+K+         + G  
Sbjct: 1   MAL-DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGIN 56

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVK 120
            ++LREI +L    HP+I+ + +       ++ +V ++ME DL+ +++      + S +K
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMETDLEVIIKDNSLVLTPSHIK 115

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT 180
             ML  L+G++YLH +W+LHRDLK +NLLL+  GVLK+ DFG+++ +GSP + YT  VVT
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            WYRAPELL GA+ Y   VDMW+VGCI+AELL + P   G +++DQ+ +IF+TLGTPTE 
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            WP +  LP     F   P   L   F A          +   DL+  L  ++P  RIT 
Sbjct: 236 QWPDMCSLPDYV-TFKSFPGIPLHHIFSA--------AGDDLLDLIQGLFLFNPCARITA 286

Query: 301 DDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
             AL   +F   P P     +P         K
Sbjct: 287 TQALKMKYFSNRPGPTPGCQLPRPNCPVETLK 318

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  516 bits (1331), Expect = 0.0
 Identities = 121/325 (37%), Positives = 198/325 (60%), Gaps = 16/325 (4%)

Query: 9   SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           S  +F++L K+  GTY  VY+  +K +G  VALK+VK++    E+    G P +++REI+
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD---SEE----GTPSTAIREIS 55

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMES-----MKQPFSTSEVKCLM 123
           ++    H +IV + +V+  + + + +V E+M++DLK  M+S       +    + VK   
Sbjct: 56  LMKELKHENIVRLYDVIHTE-NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            QLL+G+ + H+N +LHRDLK  NLL+N +G LK+ DFG++R +G P+  ++S VVTLWY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAP++L+G++ YST++D+WS GCI+AE++  KPLF GT + +Q+  IF  +GTP E++WP
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            +++LP    N  ++P   LR+     +      L  +  D L+ LL  +P+ R++   A
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 304 LNHYWFHEVPLPKSKDFMPTFPPQH 328
           L+H WF E     S     +    H
Sbjct: 292 LHHPWFAEYYHHASMGGSRSHHHHH 316

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  498 bits (1285), Expect = e-179
 Identities = 125/341 (36%), Positives = 198/341 (58%), Gaps = 28/341 (8%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKS-GEIVALKKVKMNVGRKEDCLEYGF 59
           M     CR+  ++E + +I EG YG V++ARD K+ G  VALK+V++         E G 
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGM 54

Query: 60  PISSLREINILL---SFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQ 112
           P+S++RE+ +L    +F+HP++V + +V      D    + +V E+++ DL   ++ + +
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 114

Query: 113 PF-STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
           P   T  +K +M QLL G+ +LH + V+HRDLK  N+L+ + G +K+ DFG++R Y   +
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174

Query: 172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF 231
              TS+VVTLWYRAPE+LL +  Y+T VD+WSVGCI AE+  +KPLF G+++VDQ+ KI 
Sbjct: 175 A-LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

Query: 232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLT 291
             +G P E  WP    LP  +  F  +    + K            + E G DLL + LT
Sbjct: 233 DVIGLPGEEDWPRDVALP--RQAFHSKSAQPIEKFVTD--------IDELGKDLLLKCLT 282

Query: 292 YDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           ++P KRI+   AL+H +F ++   K ++     PP    ++
Sbjct: 283 FNPAKRISAYSALSHPYFQDLERCK-ENLDSHLPPSQNTSE 322

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  498 bits (1285), Expect = e-179
 Identities = 121/320 (37%), Positives = 189/320 (59%), Gaps = 20/320 (6%)

Query: 1   MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFP 60
           ++      S+  + ++ K+ EGTYG VY+A D  + E VA+K++++      +  E G P
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL------EHEEEGVP 77

Query: 61  ISSLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVK 120
            +++RE+++L    H +I+ +K V+  +   ++++ EY E+DLK  M+      S   +K
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLIFEYAENDLKKYMDKNP-DVSMRVIK 135

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-----NQGVLKICDFGMSRQYGSPLKPYT 175
             + QL+ GV + H    LHRDLK  NLLL+        VLKI DFG++R +G P++ +T
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
             ++TLWYR PE+LLG++ YST+VD+WS+ CI AE+L K PLF G +E+DQ+ KIF+ LG
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255

Query: 236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
            P +T WPG++ LP  K +F K     L++           +L + G DLL  +L  DP 
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG-------ALLDDEGLDLLTAMLEMDPV 308

Query: 296 KRITVDDALNHYWFHEVPLP 315
           KRI+  +AL H +F      
Sbjct: 309 KRISAKNALEHPYFSHNDFD 328

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  495 bits (1276), Expect = e-178
 Identities = 131/311 (42%), Positives = 196/311 (63%), Gaps = 17/311 (5%)

Query: 4   LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           L     + +++KL K+ EGTYG+VY+A+D   G IVALK++++      D  + G P ++
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRL------DAEDEGIPSTA 66

Query: 64  LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLM 123
           +REI++L    HP+IV++ +V+  +   + +V E+ME DLK +++  K     S++K  +
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSE-RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            QLL GV + H + +LHRDLK  NLL+N+ G LK+ DFG++R +G P++ YT  VVTLWY
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAP++L+G+KKYST+VD+WS+GCI AE++  KPLF G T+ DQ+ KIF  LGTP    WP
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245

Query: 244 GLSELPGAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
            + ELP  K   F            P           + G DLL+ +L +DP KRI+  D
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPG--------FCQEGIDLLSNMLCFDPNKRISARD 297

Query: 303 ALNHYWFHEVP 313
           A+NH +F ++ 
Sbjct: 298 AMNHPYFKDLD 308

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  494 bits (1273), Expect = e-178
 Identities = 121/320 (37%), Positives = 179/320 (55%), Gaps = 24/320 (7%)

Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           G  +   +E + +I  G YG VY+ARD  SG  VALK V++           G PIS++R
Sbjct: 4   GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVR 60

Query: 66  EINILL---SFDHPSIVNVKEVVMDDH----DSVYMVMEYMEHDLKWLMESMKQP-FSTS 117
           E+ +L    +F+HP++V + +V           V +V E+++ DL+  ++    P     
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +K LM Q L G+ +LH N ++HRDLK  N+L+ + G +K+ DFG++R Y   +   T +
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPV 179

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVTLWYRAPE+LL +  Y+T VDMWSVGCI AE+  +KPLF G +E DQ+ KIF  +G P
Sbjct: 180 VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E  WP    LP  +  F  +    ++   P         + ESG  LL  +LT++P KR
Sbjct: 239 PEDDWPRDVSLP--RGAFPPRGPRPVQSVVPE--------MEESGAQLLLEMLTFNPHKR 288

Query: 298 ITVDDALNHYWFHEV-PLPK 316
           I+   AL H + H+    P+
Sbjct: 289 ISAFRALQHSYLHKDEGNPE 308

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  492 bits (1268), Expect = e-177
 Identities = 127/305 (41%), Positives = 185/305 (60%), Gaps = 16/305 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EKL KI EGTYG V++A+++++ EIVALK+V++      D  + G P S+LREI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLK 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+  D   + +V E+ + DLK   +S         VK  + QLL+G+ 
Sbjct: 57  ELKHKNIVRLHDVLHSD-KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H   VLHRDLK  NLL+N  G LK+ +FG++R +G P++ Y++ VVTLWYR P++L G
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 192 AKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           AK YST++DMWS GCI AEL    +PLF G    DQ+ +IF+ LGTPTE  WP +++LP 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
            K          L    P         L+ +G DLL  LL  +P +RI+ ++AL H +F 
Sbjct: 236 YKPYPMYPATTSLVNVVPK--------LNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

Query: 311 EVPLP 315
           +   P
Sbjct: 288 DFCPP 292

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  492 bits (1270), Expect = e-177
 Identities = 119/324 (36%), Positives = 181/324 (55%), Gaps = 19/324 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            + KL+K+ EGTY  VY+ + K +  +VALK++++     E+    G P +++RE+++L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEE----GAPCTAIREVSLLK 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +++  +  S+ +V EY++ DLK  ++      +   VK  + QLL G+ 
Sbjct: 56  DLKHANIVTLHDIIHTE-KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   VLHRDLK  NLL+N +G LK+ DFG++R    P K Y + VVTLWYR P++LLG
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +  YST +DMW VGCI  E+   +PLF G+T  +Q+  IF+ LGTPTE  WPG+      
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234

Query: 252 KA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
           K  N+ K     L    P         L   G DLL +LL ++   RI+ +DA+ H +F 
Sbjct: 235 KTYNYPKYRAEALLSHAPR--------LDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

Query: 311 EVPLPKSK--DFMPTFPPQHARNK 332
            +     K  D    F  +  + +
Sbjct: 287 SLGERIHKLPDTTSIFALKEIQLQ 310

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  489 bits (1261), Expect = e-176
 Identities = 128/301 (42%), Positives = 185/301 (61%), Gaps = 16/301 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++  L KI EGTYG+VY+A++   GE  ALKK+++      +  + G P +++REI+IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL------EKEDEGIPSTTIREISILK 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              H +IV + +V+      + +V E+++ DLK L++  +    +   K  +LQLL G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y HD  VLHRDLK  NLL+N +G LKI DFG++R +G P++ YT  +VTLWYRAP++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           +KKYST +D+WSVGCI AE++   PLF G +E DQ+ +IF+ LGTP    WP ++ELP  
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             NF                      L ESG DLL+++L  DP +RIT   AL H +F E
Sbjct: 235 DPNFTVYEPLPWESFLKG--------LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

Query: 312 V 312
            
Sbjct: 287 N 287

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  474 bits (1223), Expect = e-170
 Identities = 98/325 (30%), Positives = 165/325 (50%), Gaps = 17/325 (5%)

Query: 6   GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
             +S+ ++E L  + EG+YG+V + R+K +G IVA+KK   +    +D         ++R
Sbjct: 20  YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDD---KMVKKIAMR 73

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           EI +L    H ++VN+ EV        Y+V E+++H +   +E          V+  + Q
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKK-KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ G+ + H + ++HRD+K  N+L++  GV+K+CDFG +R   +P + Y   V T WYRA
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PELL+G  KY  AVD+W++GC++ E+   +PLF G +++DQ+  I   LG          
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252

Query: 246 SELPGAKA-NFAK-QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
           ++ P        + +    L +R+P         LSE   DL  + L  DP+KR    + 
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPK--------LSEVVIDLAKKCLHIDPDKRPFCAEL 304

Query: 304 LNHYWFHEVPLPKSKDFMPTFPPQH 328
           L+H +F      +          Q 
Sbjct: 305 LHHDFFQMDGFAERFSQELQLKVQK 329

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  472 bits (1218), Expect = e-169
 Identities = 100/319 (31%), Positives = 164/319 (51%), Gaps = 17/319 (5%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++EK+ KI EG+YG+V++ R++ +G+IVA+KK   +   ++D         +LREI +L 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDD---PVIKKIALREIRMLK 57

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP++VN+ EV       +++V EY +H +   ++  ++      VK +  Q L+ V 
Sbjct: 58  QLKHPNLVNLLEVFRRK-RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H +  +HRD+K  N+L+    V+K+CDFG +R    P   Y   V T WYR+PELL+G
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
             +Y   VD+W++GC+ AELL+  PL+ G ++VDQ+  I KTLG          S     
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236

Query: 252 KA-NFAK-QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                   +    L  +FP         +S     LL   L  DP +R+T +  L+H +F
Sbjct: 237 SGVKIPDPEDMEPLELKFPN--------ISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

Query: 310 HEVPLPKSKDFMPTFPPQH 328
             +   +        P ++
Sbjct: 289 ENIREIEDLAKEHDKPAEN 307

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  457 bits (1178), Expect = e-162
 Identities = 123/352 (34%), Positives = 182/352 (51%), Gaps = 39/352 (11%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
              +FE+E   K+  GTYG VY+A+ K  K  +  ALK+++            G  +S+ 
Sbjct: 18  VEDLFEYEGC-KVGRGTYGHVYKAKRKDGKDDKDYALKQIE----------GTGISMSAC 66

Query: 65  REINILLSFDHPSIVNVKEVVMDDHD-SVYMVMEYMEHDLKWLMESMKQ--------PFS 115
           REI +L    HP+++++++V +   D  V+++ +Y EHDL  +++  +            
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPL 171
              VK L+ Q+L+G+ YLH NWVLHRDLK +N+L+      +G +KI D G +R + SPL
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186

Query: 172 KPYTSL---VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV---- 224
           KP   L   VVT WYRAPELLLGA+ Y+ A+D+W++GCI AELL  +P+F    E     
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246

Query: 225 -----DQIDKIFKTLGTPTETIWPGLSELPGAKANFAK-QPYNLLRKRFPAASFTGSPVL 278
                DQ+D+IF  +G P +  W  + ++P         +                    
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306

Query: 279 SESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHAR 330
               F LL +LLT DP KRIT + A+   +F E PLP S  F     P   R
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKR 358

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  343 bits (882), Expect = e-117
 Identities = 102/326 (31%), Positives = 163/326 (50%), Gaps = 36/326 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +     I  G++G+V++A+  +S E VA+KKV  +   K             RE+ I+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK------------NRELQIMRI 88

Query: 73  FDHPSIVNVKEVVM-----DDHDSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLML 124
             HP++V++K          D   + +V+EY+   +         +KQ      +K  M 
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           QLL  + Y+H   + HRD+K  NLLL+   GVLK+ DFG ++      +P  S + + +Y
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRYY 207

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAPEL+ GA  Y+T +D+WS GC+MAEL+  +PLF G + +DQ+ +I K LGTP+     
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            ++     +  F +   +   K F        P       DL++RLL Y P  R+T  +A
Sbjct: 268 TMNPNY-MEHKFPQIRPHPFSKVFR-------PRTPPDAIDLISRLLEYTPSARLTAIEA 319

Query: 304 LNHYWFHEVP-----LPKSKDFMPTF 324
           L H +F E+      +P  ++  P F
Sbjct: 320 LCHPFFDELRTGEARMPNGRELPPLF 345

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  343 bits (883), Expect = e-117
 Identities = 103/326 (31%), Positives = 161/326 (49%), Gaps = 35/326 (10%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +     I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+  
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------------NRELQIMRK 103

Query: 73  FDHPSIVNVKEVVMDDHDS-----VYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLML 124
            DH +IV ++       +      + +V++Y+   +  +       KQ      VK  M 
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           QL   + Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + +Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYY 222

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           RAPEL+ GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT     
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            ++     +  F +   +   K F        P        L +RLL Y P  R+T  +A
Sbjct: 283 EMNPNY-TEFKFPQIKAHPWTKVFR-------PRTPPEAIALCSRLLEYTPTARLTPLEA 334

Query: 304 LNHYWFHE-----VPLPKSKDFMPTF 324
             H +F E     V LP  +D    F
Sbjct: 335 CAHSFFDELRDPNVKLPNGRDTPALF 360

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  325 bits (836), Expect = e-111
 Identities = 95/326 (29%), Positives = 154/326 (47%), Gaps = 29/326 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+      +GT+G V   ++K +G  VA+KKV  +   +            L+ +  L  
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAV 75

Query: 73  FDHPSIVNVKEVVM----DDHDSVY--MVMEYMEHDLKWLMES---MKQPFSTSEVKCLM 123
             HP+IV ++         D   +Y  +VMEY+   L     +    +       +K  +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 124 LQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVT 180
            QL+  +  LH     V HRD+K  N+L+N   G LK+CDFG +++  SP +P  + + +
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYICS 194

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            +YRAPEL+ G + Y+TAVD+WSVGCI AE++  +P+F G     Q+ +I + LG P+  
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
           +   L+       +            F       S   ++  +DLL+ LL Y PE+R+  
Sbjct: 255 VLRKLNP-SHTDVDLYNSKGIPWSNVFSDH----SLKDAKEAYDLLSALLQYLPEERMKP 309

Query: 301 DDALNHYWFHEVPLPKSKDFMPTFPP 326
            +AL H +F E  L      +P    
Sbjct: 310 YEALCHPYFDE--LHDPATKLPNNKD 333

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  315 bits (809), Expect = e-106
 Identities = 91/340 (26%), Positives = 156/340 (45%), Gaps = 62/340 (18%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +     +  G++GIV    D +SG+  ALKKV  +   K             RE++I+  
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------------NRELDIMKV 56

Query: 73  FDHPSIVNVKEVVMDDHDS-------------------------------------VYMV 95
            DH +I+ + +      D                                      + ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 96  MEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN- 151
           MEY+   L  +++S     +    + +   + QL   V ++H   + HRD+K  NLL+N 
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 152 NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL 211
               LK+CDFG +++   P +P  + + + +YRAPEL+LGA +Y+ ++D+WS+GC+  EL
Sbjct: 177 KDNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 212 LAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAAS 271
           +  KPLFSG T +DQ+ +I + +GTPT+     ++     +  F        RK  P  +
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP-HYTEVRFPTLKAKDWRKILPEGT 294

Query: 272 FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                       DLL ++L Y+P+ RI   +A+ H +F  
Sbjct: 295 -------PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  312 bits (801), Expect = e-106
 Identities = 76/308 (24%), Positives = 148/308 (48%), Gaps = 27/308 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ + K+  G Y  V+ A +  + E V +K +K  V +K+            REI IL +
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKK----------IKREIKILEN 86

Query: 73  F-DHPSIVNVKEVVMDDHDS--VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
               P+I+ + ++V D        +       D K L     Q  +  +++  M ++L+ 
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKA 142

Query: 130 VKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + Y H   ++HRD+K  N++++     L++ D+G++  +  P + Y   V + +++ PEL
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPEL 201

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWP---G 244
           L+  + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LGT     +     
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           +   P       +       +   + +     ++S    D L++LL YD + R+T  +A+
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQ---HLVSPEALDFLDKLLRYDHQSRLTAREAM 318

Query: 305 NHYWFHEV 312
            H +F+ V
Sbjct: 319 EHPYFYTV 326

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  312 bits (801), Expect = e-104
 Identities = 118/368 (32%), Positives = 170/368 (46%), Gaps = 81/368 (22%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E  + I  G+YG V  A DK    +VA+KK+ + V               LREI IL  
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDL-----IDCKRILREIAILNR 108

Query: 73  FDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            +H  +V V ++V+    +  D +Y+V+E  + D K L  +     +   +K L+  LL 
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLV 167

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--------------- 173
           GVKY+H   +LHRDLK +N L+N    +K+CDFG++R    P                  
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 174 ------------YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL--------- 212
                        T  VVT WYRAPEL+L  + Y+ A+D+WS+GCI AELL         
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 213 --AKKPLFSGT--------------------TEVDQIDKIFKTLGTPTETIWPGLSELPG 250
              + PLF G+                       DQ++ IF  LGTP+E     L +   
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK-ED 346

Query: 251 AKA---NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           AK     F K+    L +RFPA+        S     LL R+L ++P KRIT+++ L H 
Sbjct: 347 AKRYIRIFPKREGTDLAERFPAS--------SADAIHLLKRMLVFNPNKRITINECLAHP 398

Query: 308 WFHEVPLP 315
           +F EV + 
Sbjct: 399 FFKEVRIA 406

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  298 bits (765), Expect = e-100
 Identities = 96/325 (29%), Positives = 156/325 (48%), Gaps = 28/325 (8%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS---LREINI 69
           +     IS G+YG V    D + G  VA+K+V   V                  LREI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 70  LLSFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           L  F HP+I+ ++++ +         +Y+V E M  DL  ++   +   S   ++  M  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           +L G+  LH+  V+HRDL   N+LL +   + ICDF ++R+  +     T  V   WYRA
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED-TADANKTHYVTHRWYRA 201

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PEL++  K ++  VDMWS GC+MAE+  +K LF G+T  +Q++KI + +GTP        
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261

Query: 246 SELPGA----KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           S  P A    + + +  P        P A             DL+ ++L ++P++RI+ +
Sbjct: 262 SS-PSARDYLRNSLSNVPARAWTAVVPTA--------DPVALDLIAKMLEFNPQRRISTE 312

Query: 302 DALNHYWF------HEVPLPKSKDF 320
            AL H +F       ++    S+ F
Sbjct: 313 QALRHPYFESLFDPLDLTEGLSERF 337

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  296 bits (761), Expect = 2e-99
 Identities = 113/321 (35%), Positives = 173/321 (53%), Gaps = 36/321 (11%)

Query: 7   CRSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
              VF+    +  L+ I EG YG+V  A D  +   VA+KK+      +  C        
Sbjct: 19  RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQ------R 71

Query: 63  SLREINILLSFDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSE 118
           +LREI ILL F H +I+ + +++    ++    VY+V + ME DL  L+++  Q  S   
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDH 129

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL- 177
           +   + Q+L G+KY+H   VLHRDLK SNLLLN    LKICDFG++R           L 
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 178 --VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
             V T WYRAPE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249

Query: 236 TPTETIWPGLSELPGAKA-----NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLL 290
           +P++     L+ +   KA     +   +      + FP A             DLL+++L
Sbjct: 250 SPSQED---LNCIINLKARNYLLSLPHKNKVPWNRLFPNA--------DSKALDLLDKML 298

Query: 291 TYDPEKRITVDDALNHYWFHE 311
           T++P KRI V+ AL H +  +
Sbjct: 299 TFNPHKRIEVEQALAHPYLEQ 319

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  296 bits (759), Expect = 2e-99
 Identities = 105/319 (32%), Positives = 161/319 (50%), Gaps = 37/319 (11%)

Query: 7   CRSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
            ++ +E    +     +  G YG V  A DK+SGE VA+KK+      +           
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR------ 69

Query: 63  SLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
           + RE+ +L    H +++ + +V      + +    Y+VM +M+ DL+ +M      FS  
Sbjct: 70  AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEE 126

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
           +++ L+ Q+L+G+KY+H   V+HRDLK  NL +N    LKI DFG++R   + +  Y   
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--- 183

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVT WYRAPE++L    Y+  VD+WSVGCIMAE+L  K LF G   +DQ+ +I K  G P
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 238 TETIWPGLSELPGAKA-----NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
                  + +L    A     +  + P     + FP A        S    DLL ++L  
Sbjct: 244 GTEF---VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA--------SPQAADLLEKMLEL 292

Query: 293 DPEKRITVDDALNHYWFHE 311
           D +KR+T   AL H +F  
Sbjct: 293 DVDKRLTAAQALTHPFFEP 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  294 bits (754), Expect = 5e-99
 Identities = 106/312 (33%), Positives = 158/312 (50%), Gaps = 36/312 (11%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L  +  G  G+V+ A D    + VA+KK+ +     +          +LREI I+  
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKH------ALREIKIIRR 64

Query: 73  FDHPSIVNVKEVV-------------MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
            DH +IV V E++             + + +SVY+V EYME DL  ++E    P      
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHA 122

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKPYTSL- 177
           +  M QLL G+KY+H   VLHRDLK +NL +N +  VLKI DFG++R           L 
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 178 --VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
             +VT WYR+P LLL    Y+ A+DMW+ GCI AE+L  K LF+G  E++Q+  I +++ 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 236 TPT-ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
               E     LS +P    N   +P+  L +  P          S    D L ++LT+ P
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI--------SREAVDFLEQILTFSP 294

Query: 295 EKRITVDDALNH 306
             R+T ++AL+H
Sbjct: 295 MDRLTAEEALSH 306

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  294 bits (756), Expect = 6e-99
 Identities = 111/316 (35%), Positives = 162/316 (51%), Gaps = 34/316 (10%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+  + + EG YG+V  A  K +GEIVA+KK++    +    L       +LREI IL  
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFAL------RTLREIKILKH 65

Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
           F H +I+ +  +      ++ + VY++ E M+ DL  ++ +  Q  S   ++  + Q L 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLR 123

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----------TSLV 178
            VK LH + V+HRDLK SNLL+N+   LK+CDFG++R                      V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            T WYRAPE++L + KYS A+D+WS GCI+AEL  ++P+F G     Q+  IF  +GTP 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 239 ETIWPGLSELPGAKA---NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
                   E P A+    +    P   L K FP          +  G DLL R+L +DP 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV--------NPKGIDLLQRMLVFDPA 295

Query: 296 KRITVDDALNHYWFHE 311
           KRIT  +AL H +   
Sbjct: 296 KRITAKEALEHPYLQT 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  295 bits (756), Expect = 1e-98
 Identities = 101/317 (31%), Positives = 157/317 (49%), Gaps = 32/317 (10%)

Query: 7   CRSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
            ++ +E    +  L  +  G YG V  A D ++G  VA+KK+      +           
Sbjct: 17  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR------ 70

Query: 63  SLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
           + RE+ +L    H +++ + +V      +DD    Y+VM +M  DL  LM+   +     
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGED 128

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            ++ L+ Q+L+G++Y+H   ++HRDLK  NL +N    LKI DFG++RQ  S +  Y   
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 185

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVT WYRAPE++L   +Y+  VD+WSVGCIMAE++  K LF G+  +DQ+ +I K  GTP
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245

Query: 238 TETIWPGLSELPGAKA---NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                  L     AK       +            A        S    +LL ++L  D 
Sbjct: 246 PAEFVQRLQS-DEAKNYMKGLPELEKKDFASILTNA--------SPLAVNLLEKMLVLDA 296

Query: 295 EKRITVDDALNHYWFHE 311
           E+R+T  +AL H +F  
Sbjct: 297 EQRVTAGEALAHPYFES 313

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  293 bits (752), Expect = 4e-98
 Identities = 102/317 (32%), Positives = 161/317 (50%), Gaps = 32/317 (10%)

Query: 7   CRSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
            ++++E    ++ L+ +  G YG V  A D K+G  VA+KK+                  
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR------ 74

Query: 63  SLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
           + RE+ +L    H +++ + +V      +++ + VY+V   M  DL  +++   Q  +  
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDD 132

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            V+ L+ Q+L G+KY+H   ++HRDLK SNL +N    LKI DFG++R     +  Y   
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           V T WYRAPE++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 238 TETIWPGLSELPGAKA---NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
              +   +S    A+    +  + P       F  A        +    DLL ++L  D 
Sbjct: 250 GAELLKKISS-ESARNYIQSLTQMPKMNFANVFIGA--------NPLAVDLLEKMLVLDS 300

Query: 295 EKRITVDDALNHYWFHE 311
           +KRIT   AL H +F +
Sbjct: 301 DKRITAAQALAHAYFAQ 317

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  290 bits (743), Expect = 1e-96
 Identities = 104/340 (30%), Positives = 160/340 (47%), Gaps = 35/340 (10%)

Query: 7   CRSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
             S F     ++ L  I  G  GIV  A D      VA+KK+      +           
Sbjct: 17  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR------ 70

Query: 63  SLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
           + RE+ ++   +H +I+ +  V      +++   VY+VME M+ +L  ++   +      
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHE 127

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +  L+ Q+L G+K+LH   ++HRDLK SN+++ +   LKI DFG++R         T  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPY 186

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVT +YRAPE++LG   Y   VD+WSVGCIM E++    LF GT  +DQ +K+ + LGTP
Sbjct: 187 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245

Query: 238 TETIWPGLSELPGAKA---NFAKQPYNLLRKRFPAASFT----GSPVLSESGFDLLNRLL 290
                  L   P  +    N  K       K FP   F      + + +    DLL+++L
Sbjct: 246 CPEFMKKLQ--PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303

Query: 291 TYDPEKRITVDDALNHYWFH------EVPLPKSKDFMPTF 324
             D  KRI+VD+AL H + +      E   P  K      
Sbjct: 304 VIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQL 343

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  290 bits (743), Expect = 2e-96
 Identities = 101/332 (30%), Positives = 173/332 (52%), Gaps = 41/332 (12%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + K+ +G YGIV+++ D+++GE+VA+KK+        D         + REI IL  
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ------RTFREIMILTE 64

Query: 73  F-DHPSIVNVKEVVMDDHDS-VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              H +IVN+  V+  D+D  VY+V +YME DL  ++ +          + ++ QL++ +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVI 122

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL------------- 177
           KYLH   +LHRD+K SN+LLN +  +K+ DFG+SR + +  +   ++             
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 178 --------VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK 229
                   V T WYRAPE+LLG+ KY+  +DMWS+GCI+ E+L  KP+F G++ ++Q+++
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242

Query: 230 IFKTLGTPT---------ETIWPGLSELPG-AKANFAKQPYNLLRKRFPAASFTGSPVLS 279
           I   +  P+               +  L    +   + +     + +            +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

Query: 280 ESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           E   DLL++LL ++P KRI+ +DAL H +   
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  290 bits (745), Expect = 8e-96
 Identities = 105/323 (32%), Positives = 164/323 (50%), Gaps = 33/323 (10%)

Query: 7   CRSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS 62
             S F     ++ L  I  G  GIV  A D      VA+KK+      +           
Sbjct: 54  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------ 107

Query: 63  SLREINILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTS 117
           + RE+ ++   +H +I+++  V      +++   VY+VME M+ +L  ++   +      
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHE 164

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYT 175
            +  L+ Q+L G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+   + PY 
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 223

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
             VVT +YRAPE++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LG
Sbjct: 224 --VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280

Query: 236 TPTETIWPGLSELPGAKA---NFAKQPYNLLRKRFPAASFT----GSPVLSESGFDLLNR 288
           TP       L   P  +    N  K       K FP + F      + + +    DLL++
Sbjct: 281 TPCPEFMKKLQ--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338

Query: 289 LLTYDPEKRITVDDALNHYWFHE 311
           +L  DP KRI+VDDAL H + + 
Sbjct: 339 MLVIDPAKRISVDDALQHPYINV 361

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  286 bits (733), Expect = 2e-94
 Identities = 108/359 (30%), Positives = 170/359 (47%), Gaps = 77/359 (21%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +   + I  G+YG VY A DK + + VA+KKV        DC         LREI IL  
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK------RILREITILNR 81

Query: 73  FDHPSIVNVKEVV----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLE 128
                I+ + +++    +   D +Y+V+E  + DLK L ++     +   +K ++  LL 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLL 140

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY-------------- 174
           G  ++H++ ++HRDLK +N LLN    +K+CDFG++R   S                   
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 175 --------TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-----------KK 215
                   TS VVT WYRAPEL+L  + Y+ ++D+WS GCI AELL            + 
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 216 PLFSGTTE-----------------VDQIDKIFKTLGTPTETIWPGLSELPGAKA----- 253
           PLF G++                   DQ++ IF  +GTPTE     L  +   +      
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD---LKNINKPEVIKYIK 317

Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV 312
            F  +    L++++P+         S+ G +LL  +L ++P KRIT+D AL+H +  +V
Sbjct: 318 LFPHRKPINLKQKYPSI--------SDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  221 bits (564), Expect = 2e-70
 Identities = 76/327 (23%), Positives = 127/327 (38%), Gaps = 60/327 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +  L +I  G    V++  ++   +I A+K V +     +    Y        EI  L 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSY------RNEIAYLN 81

Query: 72  SFDHPS--IVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLE 128
                S  I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE
Sbjct: 82  KLQQHSDKIIRLYDYEITD-QYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLE 138

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAP 186
            V  +H + ++H DLK +N L+ + G+LK+ DFG++   Q  +      S V T+ Y  P
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

Query: 187 ELLLGA----------KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           E +              K S   D+WS+GCI+  +   K  F      +QI K+   +  
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAIIDP 255

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
             E  +P                                 +  +   D+L   L  DP++
Sbjct: 256 NHEIEFP--------------------------------DIPEKDLQDVLKCCLKRDPKQ 283

Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPT 323
           RI++ + L H +      P ++    T
Sbjct: 284 RISIPELLAHPYVQIQTHPVNQMAKGT 310

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  214 bits (548), Expect = 8e-68
 Identities = 76/327 (23%), Positives = 127/327 (38%), Gaps = 60/327 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +  L +I  G    V++  ++   +I A+K V +     +    Y        EI  L 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSY------RNEIAYLN 62

Query: 72  SFDHPS--IVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLE 128
                S  I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE
Sbjct: 63  KLQQHSDKIIRLYDYEITD-QYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLE 119

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAP 186
            V  +H + ++H DLK +N L+ + G+LK+ DFG++ Q    +      S V T+ Y  P
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 187 ELLLG----------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           E +              K S   D+WS+GCI+  +   K  F      +QI K+   +  
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAIIDP 236

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
             E  +P                                 +  +   D+L   L  DP++
Sbjct: 237 NHEIEFP--------------------------------DIPEKDLQDVLKCCLKRDPKQ 264

Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPT 323
           RI++ + L H +      P ++    T
Sbjct: 265 RISIPELLAHPYVQIQTHPVNQMAKGT 291

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  211 bits (539), Expect = 6e-67
 Identities = 72/325 (22%), Positives = 124/325 (38%), Gaps = 71/325 (21%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE++  + +G +G V +AR+       A+KK++      E+ L      + L E+ +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLS-----TILSEVMLLA 57

Query: 72  SFDHPSIVNVKEVVMDDHDS------------VYMVMEYME-HDLKWLMESMKQPFSTSE 118
           S +H  +V      ++  +             +++ MEY E   L  L+ S        E
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY---- 174
              L  Q+LE + Y+H   ++HRDLK  N+ ++    +KI DFG+++     L       
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 175 ----------TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
                     TS + T  Y A E+L G   Y+  +DM+S+G I  E++   P  +G   V
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERV 235

Query: 225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD 284
           + + K+                     K                                
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKM--KVEK-------------------------------K 262

Query: 285 LLNRLLTYDPEKRITVDDALNHYWF 309
           ++  L+ +DP KR      LN  W 
Sbjct: 263 IIRLLIDHDPNKRPGARTLLNSGWL 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  213 bits (543), Expect = 2e-66
 Identities = 75/329 (22%), Positives = 126/329 (38%), Gaps = 60/329 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +  L +I  G    V++  ++   +I A+K V +     +    Y        EI  L 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSY------RNEIAYLN 109

Query: 72  SFDHPS--IVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLE 128
                S  I+ + +  + D   +YMVME    DL  WL +  K+     E K     +LE
Sbjct: 110 KLQQHSDKIIRLYDYEITD-QYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLE 166

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAP 186
            V  +H + ++H DLK +N L+ + G+LK+ DFG++ Q    +      S V  + Y  P
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

Query: 187 ELLLGA----------KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           E +              K S   D+WS+GCI+  +   K  F      +QI K+   +  
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAIIDP 283

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
             E  +P                                 +  +   D+L   L  DP++
Sbjct: 284 NHEIEFP--------------------------------DIPEKDLQDVLKCCLKRDPKQ 311

Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTFP 325
           RI++ + L H +      P ++    T  
Sbjct: 312 RISIPELLAHPYVQIQTHPVNQMAKGTTE 340

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  210 bits (536), Expect = 6e-66
 Identities = 72/300 (24%), Positives = 136/300 (45%), Gaps = 46/300 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++ +L KI EG++G     +  + G    +K++ ++        E      S RE+ +L 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS-RMSSKERE-----ESRREVAVLA 78

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEG 129
           +  HP+IV  +E   ++  S+Y+VM+Y E  DL   + + K   F   ++    +Q+   
Sbjct: 79  NMKHPNIVQYRESFEEN-GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           +K++HD  +LHRD+K+ N+ L   G +++ DFG++R   S ++   + + T +Y +PE+ 
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
              K Y+   D+W++GC++ EL   K  F   +  + + KI                   
Sbjct: 198 EN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------------------- 237

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                        +   FP  S   S  L      L+++L   +P  R +V+  L   + 
Sbjct: 238 -------------ISGSFPPVSLHYSYDLR----SLVSQLFKRNPRDRPSVNSILEKGFI 280

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  208 bits (532), Expect = 1e-65
 Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 49/299 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            F++L+++  G+YG V++ R K+ G + A+K+        +D          L E+    
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR------KLAEVGSHE 111

Query: 72  S-FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
               HP  V +++   +    +Y+  E     L+   E+       ++V   +   L  +
Sbjct: 112 KVGQHPCCVRLEQAWEEG-GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            +LH   ++H D+K +N+ L  +G  K+ DFG+  + G+             Y APELL 
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELLQ 229

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G   Y TA D++S+G  + E+     L  G     Q+ + +                   
Sbjct: 230 G--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------------------- 268

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                       L   F          LS     +L  +L  DP+ R T +  L     
Sbjct: 269 ------------LPPEFT-------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  205 bits (525), Expect = 4e-65
 Identities = 75/310 (24%), Positives = 133/310 (42%), Gaps = 53/310 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++E L  I  G+YG   + R K  G+I+  K++       E   +       + E+N+L 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG-SMTEAEKQ-----MLVSEVNLLR 60

Query: 72  SFDHPSIVNVKEVVMDDHD-SVYMVMEYMEH-DLKWLMESMKQ---PFSTSEVKCLMLQL 126
              HP+IV   + ++D  + ++Y+VMEY E  DL  ++    +         V  +M QL
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 127 LEGVKYLHD-----NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
              +K  H      + VLHRDLK +N+ L+ +  +K+ DFG++R          + V T 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +Y +PE +     Y+   D+WS+GC++ EL A  P F+  ++ +   KI           
Sbjct: 181 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------- 228

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
                                   +F    +  S  L+    +++ R+L      R +V+
Sbjct: 229 ---------------------REGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVE 263

Query: 302 DALNHYWFHE 311
           + L +    E
Sbjct: 264 EILENPLILE 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  203 bits (519), Expect = 9e-64
 Identities = 74/303 (24%), Positives = 127/303 (41%), Gaps = 48/303 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            F    KI  G +  VYRA     G  VALKKV++                 ++EI++L 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-----DCIKEIDLLK 87

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---PFSTSEVKCLMLQLL 127
             +HP+++      ++D + + +V+E  +  DL  +++  K+         V    +QL 
Sbjct: 88  QLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
             ++++H   V+HRD+K +N+ +   GV+K+ D G+ R + S      SLV T +Y +PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEVDQ-IDKIFKTLGTPTETIWPGL 245
            +     Y+   D+WS+GC++ E+ A +  F G    +     KI               
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--------------- 250

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                 + ++   P               S   SE    L+N  +  DPEKR  V    +
Sbjct: 251 -----EQCDYPPLP---------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290

Query: 306 HYW 308
              
Sbjct: 291 VAK 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  205 bits (522), Expect = 1e-63
 Identities = 48/327 (14%), Positives = 89/327 (27%), Gaps = 68/327 (20%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  G   +V+  RD +  E  ALK   M        LE                    S 
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE-----RLHEATFAAARLLGESP 124

Query: 79  V---------------------NVKEVVMDDHD----SVYMVMEYMEHDLKWLMESMKQ- 112
                                    ++     D    +  ++M     DL+ L  ++   
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184

Query: 113 -----PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY 167
                      +  L  QL+     L    ++H      NL +   G L + D     + 
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAK-KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ 226
           G+      +  V + Y   E L  +   ++ A++ W +G  +  +      F   T   +
Sbjct: 245 GTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLL 286
                 +L  P                                  F     L +    L+
Sbjct: 302 GSWKRPSLRVPGTDSLA----------------------------FGSCTPLPDFVKTLI 333

Query: 287 NRLLTYDPEKRITVDDALNHYWFHEVP 313
            R L +D  +R+   +A+    F ++ 
Sbjct: 334 GRFLNFDRRRRLLPLEAMETPEFLQLQ 360

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  202 bits (515), Expect = 4e-63
 Identities = 66/317 (20%), Positives = 115/317 (36%), Gaps = 37/317 (11%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINI 69
             +   + + +G    V+R R KK+G++ A+K    ++  R  D           RE  +
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--------REFEV 60

Query: 70  LLSFDHPSIVNVKEVV-MDDHDSVYMVMEYMEH-DL-KWLMESMKQ-PFSTSEVKCLMLQ 125
           L   +H +IV +  +          ++ME+     L   L E         SE   ++  
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           ++ G+ +L +N ++HR++K  N++     + Q V K+ DFG +R+     + + SL  T 
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTE 179

Query: 182 WYRAPELLLGA-------KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK-- 232
            Y  P++   A       KKY   VD+WS+G            F       +  ++    
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
             G P+  I        G        P +             S  L      +L  +L  
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSL----------SRGLQVLLTPVLANILEA 289

Query: 293 DPEKRITVDDALNHYWF 309
           D EK    D        
Sbjct: 290 DQEKCWGFDQFFAETSD 306

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  199 bits (509), Expect = 1e-62
 Identities = 66/315 (20%), Positives = 117/315 (37%), Gaps = 72/315 (22%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+++  I  G +G V++A+ +  G+   +K+VK N    E            RE+  L 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAE---------REVKALA 59

Query: 72  SFDHPSIVNVKEVVMDDHDS---------------VYMVMEYMEH-DL-KWLMESMKQPF 114
             DH +IV+                          +++ ME+ +   L +W+ +   +  
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY 174
                  L  Q+ +GV Y+H   +++RDLK SN+ L +   +KI DFG+     +  K  
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-R 178

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
           T    TL Y +PE +   + Y   VD++++G I+AELL        T++      +    
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKF--FTDL---- 231

Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                                                     +  +    LL +LL+  P
Sbjct: 232 ----------------------------RDGIIS-------DIFDKKEKTLLQKLLSKKP 256

Query: 295 EKRITVDDALNHYWF 309
           E R    + L     
Sbjct: 257 EDRPNTSEILRTLTV 271

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  199 bits (508), Expect = 2e-62
 Identities = 82/326 (25%), Positives = 134/326 (41%), Gaps = 56/326 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              +E ++   +  G   +V R   K + +  A+K            E+  E       L
Sbjct: 16  YENYEPKE--ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT--L 71

Query: 65  REINILLSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEV 119
           +E++IL     HP+I+ +K+   + +   ++V + M+     D  +L E  K   S  E 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFD--YLTE--KVTLSEKET 126

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV 179
           + +M  LLE +  LH   ++HRDLK  N+LL++   +K+ DFG S Q   P +    +  
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCG 185

Query: 180 TLWYRAPELLLGA-----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
           T  Y APE++  +       Y   VDMWS G IM  LLA  P F    ++  +  I    
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                  W   S+    K                               DL++R L   P
Sbjct: 246 YQFGSPEWDDYSD--TVK-------------------------------DLVSRFLVVQP 272

Query: 295 EKRITVDDALNHYWFHEVPLPKSKDF 320
           +KR T ++AL H +F +  + + + F
Sbjct: 273 QKRYTAEEALAHPFFQQYVVEEVRHF 298

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  200 bits (511), Expect = 2e-61
 Identities = 86/308 (27%), Positives = 137/308 (44%), Gaps = 46/308 (14%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
            +  G  G V  A ++K+ + VA++ +           E    ++   EI IL   +HP 
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
           I+ +K     D +  Y+V+E ME  +L   ++    +    +  K    Q+L  V+YLH+
Sbjct: 202 IIKIKNFF--DAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE 257

Query: 136 NWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           N ++HRDLK  N+LL++Q    ++KI DFG S+  G       +L  T  Y APE+L+  
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSV 316

Query: 193 --KKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEVDQIDKIFKTLGTPTETIWPGLSELP 249
               Y+ AVD WS+G I+   L+  P FS   T+V   D+I          +W  +SE  
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-- 374

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
            A                                DL+ +LL  DP+ R T ++AL H W 
Sbjct: 375 KAL-------------------------------DLVKKLLVVDPKARFTTEEALRHPWL 403

Query: 310 HEVPLPKS 317
            +  + + 
Sbjct: 404 QDEDMKRK 411

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  195 bits (498), Expect = 5e-61
 Identities = 84/318 (26%), Positives = 140/318 (44%), Gaps = 55/318 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
             + +F+  N + +G++  VYRA    +G  VA+K   K  M        ++        
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ-------- 59

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ---PFSTSEVKC 121
            E+ I     HPSI+ +     +D + VY+V+E   +    +   +K    PFS +E + 
Sbjct: 60  NEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHN--GEMNRYLKNRVKPFSENEARH 116

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            M Q++ G+ YLH + +LHRDL  SNLLL     +KI DFG++ Q   P + + +L  T 
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP 176

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
            Y +PE+      +    D+WS+GC+   LL  +P F   T  + ++K+           
Sbjct: 177 NYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---------- 225

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
                      A++            P         LS    DL+++LL  +P  R+++ 
Sbjct: 226 ----------LADY----------EMP-------SFLSIEAKDLIHQLLRRNPADRLSLS 258

Query: 302 DALNHYWFHEVPLPKSKD 319
             L+H +       KSKD
Sbjct: 259 SVLDHPFMSRNSSTKSKD 276

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  201 bits (512), Expect = 7e-61
 Identities = 92/311 (29%), Positives = 146/311 (46%), Gaps = 59/311 (18%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
              ++ ++   + +G++G V   +DK +G+  A+K + K  V +K D        S LRE
Sbjct: 25  SDRYKGQR--VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLRE 76

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM---EHDLKWLMESM--KQPFSTSEVKC 121
           + +L   DHP+I+ + E   +D    Y+V E     E     L + +  ++ FS  +   
Sbjct: 77  VQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGE-----LFDEIISRKRFSEVDAAR 130

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLV 178
           ++ Q+L G+ Y+H N ++HRDLK  NLLL ++     ++I DFG+S  +    K     +
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI 189

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            T +Y APE+L G   Y    D+WS G I+  LL+  P F+G  E D + K+ K   T  
Sbjct: 190 GTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
              W  +SE   AK                               DL+ ++LTY P  RI
Sbjct: 248 LPQWKKVSE--SAK-------------------------------DLIRKMLTYVPSMRI 274

Query: 299 TVDDALNHYWF 309
           +  DAL+H W 
Sbjct: 275 SARDALDHEWI 285

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  201 bits (513), Expect = 7e-61
 Identities = 91/315 (28%), Positives = 143/315 (45%), Gaps = 64/315 (20%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
             +++  K  K+  G YG V   RDK +    A+K   K  ++       L         
Sbjct: 36  SEMYQRVK--KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL--------- 84

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM---EHDLKWLMESM--KQPFSTSEV 119
            E+ +L   DHP+I+ + +   +D  + Y+VME     E     L + +  +  F+  + 
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGE-----LFDEIIHRMKFNEVDA 138

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTS 176
             ++ Q+L GV YLH + ++HRDLK  NLLL ++    ++KI DFG+S  +    K    
Sbjct: 139 AVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKE 197

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
            + T +Y APE+L   KKY    D+WS+G I+  LLA  P F G T+ + + K+ K   T
Sbjct: 198 RLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                W  +SE  GAK                               DL+ ++L +D ++
Sbjct: 256 FDSPEWKNVSE--GAK-------------------------------DLIKQMLQFDSQR 282

Query: 297 RITVDDALNHYWFHE 311
           RI+   AL H W  E
Sbjct: 283 RISAQQALEHPWIKE 297

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  201 bits (513), Expect = 7e-61
 Identities = 87/317 (27%), Positives = 134/317 (42%), Gaps = 57/317 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK-----KVKMNVGRKEDCLEYGFPIS 62
              +   +  K+  G YG V   ++K      A+K     +        ++     F   
Sbjct: 35  GESYFKVR--KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92

Query: 63  SLREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM---EHDLKWLMESM--KQPFSTS 117
              EI++L S DHP+I+ + +V  +D    Y+V E+    E     L E +  +  F   
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGE-----LFEQIINRHKFDEC 146

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPY 174
           +   +M Q+L G+ YLH + ++HRD+K  N+LL N+     +KI DFG+S  + S     
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKL 205

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
              + T +Y APE+L    KY+   D+WS G IM  LL   P F G  + D I K+ K  
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263

Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                  W  +S    AK                               +L+  +LTYD 
Sbjct: 264 YYFDFNDWKNIS--DEAK-------------------------------ELIKLMLTYDY 290

Query: 295 EKRITVDDALNHYWFHE 311
            KR T ++ALN  W  +
Sbjct: 291 NKRCTAEEALNSRWIKK 307

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  194 bits (496), Expect = 1e-60
 Identities = 79/312 (25%), Positives = 135/312 (43%), Gaps = 56/312 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
             +F F++  K+  G +G V+   ++ SG    +K + K       + +E         E
Sbjct: 21  DDLFIFKR--KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--------AE 70

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCL 122
           I +L S DHP+I+ + EV  +D+ ++Y+VME  E     +     ++  +  S   V  L
Sbjct: 71  IEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVV 179
           M Q++  + Y H   V+H+DLK  N+L  +      +KI DFG++  +    +  T+   
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAG 188

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           T  Y APE+    +  +   D+WS G +M  LL     F+GT+  +   K          
Sbjct: 189 TALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------- 239

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
                       + N+A +                   L+    DLL ++LT DPE+R +
Sbjct: 240 -----------KEPNYAVECRP----------------LTPQAVDLLKQMLTKDPERRPS 272

Query: 300 VDDALNHYWFHE 311
               L+H WF +
Sbjct: 273 AAQVLHHEWFKQ 284

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  194 bits (496), Expect = 1e-60
 Identities = 70/332 (21%), Positives = 125/332 (37%), Gaps = 72/332 (21%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE +  +  G +G+V+ A++K      A+K++++    +E   E       +RE+  L 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELARE-----KVMREVKALA 58

Query: 72  SFDHPSIVNVKEVVMDDHDS-----------VYMVMEYMEH-DLKWLMESMKQPFSTSEV 119
             +HP IV      ++ + +           +Y+ M+     +LK  M            
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 120 KCL--MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ----------- 166
            CL   LQ+ E V++LH   ++HRDLK SN+      V+K+ DFG+              
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 167 -YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD 225
                   +T  V T  Y +PE + G   YS  VD++S+G I+ ELL   P  +    V 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVR 235

Query: 226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDL 285
            +  +                                   +FP       P        +
Sbjct: 236 TLTDV--------------------------------RNLKFPPLFTQKYPCEY----VM 259

Query: 286 LNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
           +  +L+  P +R    + + +  F ++  P  
Sbjct: 260 VQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  195 bits (498), Expect = 2e-60
 Identities = 90/333 (27%), Positives = 143/333 (42%), Gaps = 50/333 (15%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R  +   K   +  G  G V  A ++K+ + VA+K +           E    ++   EI
Sbjct: 9   RDEYIMSK--TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQ 125
            IL   +HP I+ +K     D +  Y+V+E ME  +L   ++    +    +  K    Q
Sbjct: 67  EILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQ 122

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           +L  V+YLH+N ++HRDLK  N+LL++Q    ++KI DFG S+  G       +L  T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 181

Query: 183 YRAPELLLGA--KKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEVDQIDKIFKTLGTPTE 239
           Y APE+L+      Y+ AVD WS+G I+   L+  P FS   T+V   D+I         
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
            +W  +SE   A                                DL+ +LL  DP+ R T
Sbjct: 242 EVWAEVSE--KAL-------------------------------DLVKKLLVVDPKARFT 268

Query: 300 VDDALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
            ++AL H W  +  +   + F      ++    
Sbjct: 269 TEEALRHPWLQDEDM--KRKFQDLLSEENESTA 299

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  194 bits (496), Expect = 2e-60
 Identities = 80/328 (24%), Positives = 134/328 (40%), Gaps = 61/328 (18%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
           RS   + +   + +G +   +   D  + E+ A K   K  +    + + +         
Sbjct: 12  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------- 63

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ--PFSTSEVKCL 122
            EI+I  S  H  +V       +D+D V++V+E      + L+E  K+    +  E +  
Sbjct: 64  MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRR--RSLLELHKRRKALTEPEARYY 120

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           + Q++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +    L  T  
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           Y APE+L   K +S  VD+WS+GCIM  LL  KP F  +   +   +I            
Sbjct: 181 YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK----------- 228

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
                    K  +            P         ++     L+ ++L  DP  R T+++
Sbjct: 229 ---------KNEY----------SIP-------KHINPVAASLIQKMLQTDPTARPTINE 262

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQHAR 330
            LN  +F       +  ++P   P    
Sbjct: 263 LLNDEFF-------TSGYIPARLPITCL 283

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  199 bits (509), Expect = 2e-60
 Identities = 78/313 (24%), Positives = 132/313 (42%), Gaps = 64/313 (20%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              +       + +G++G V + +D+ + +  A+K   K           L         
Sbjct: 21  AERYNIVC--MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL--------- 69

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM---EHDLKWLMESM--KQPFSTSEV 119
           RE+ +L   DHP+I+ + E++ +D  S Y+V E     E     L + +  ++ FS  + 
Sbjct: 70  REVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGE-----LFDEIIKRKRFSEHDA 123

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTS 176
             ++ Q+  G+ Y+H + ++HRDLK  N+LL ++     +KI DFG+S  +         
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
            + T +Y APE+L G   Y    D+WS G I+  LL+  P F G  E D + ++      
Sbjct: 183 RIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                W  +S+   AK                               DL+ ++LT+ P  
Sbjct: 241 FDLPQWRTISD--DAK-------------------------------DLIRKMLTFHPSL 267

Query: 297 RITVDDALNHYWF 309
           RIT    L H W 
Sbjct: 268 RITATQCLEHPWI 280

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  193 bits (494), Expect = 2e-60
 Identities = 92/315 (29%), Positives = 133/315 (42%), Gaps = 66/315 (20%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
              +  E    I  G++G V  A  K +    A KK+ K  V   +            +E
Sbjct: 8   NQYYTLEN--TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---------QE 56

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYM---EHDLKWLMESM--KQPFSTSEVKC 121
           I I+ S DHP+I+ + E   +D+  +Y+VME     E     L E +  K+ F  S+   
Sbjct: 57  IEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGGE-----LFERVVHKRVFRESDAAR 110

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLV 178
           +M  +L  V Y H   V HRDLK  N L         LK+ DFG++ ++  P K   + V
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKV 169

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            T +Y +P++L     Y    D WS G +M  LL   P FS  T+ + + KI +  GT T
Sbjct: 170 GTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--GTFT 225

Query: 239 --ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
             E  W  +S    A+                                L+ RLLT  P++
Sbjct: 226 FPEKDWLNVSP--QAE-------------------------------SLIRRLLTKSPKQ 252

Query: 297 RITVDDALNHYWFHE 311
           RIT   AL H WF +
Sbjct: 253 RITSLQALEHEWFEK 267

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  193 bits (493), Expect = 3e-60
 Identities = 76/317 (23%), Positives = 131/317 (41%), Gaps = 68/317 (21%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              +       + +G++G V + +D+ + +  A+K   K                    L
Sbjct: 21  AERYNIVC--MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST---------IL 69

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-----HDLKWLMESMKQPFSTSEV 119
           RE+ +L   DHP+I+ + E+ ++D  S Y+V E         ++       ++ FS  + 
Sbjct: 70  REVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDA 123

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTS 176
             ++ Q+  G+ Y+H + ++HRDLK  N+LL ++     +KI DFG+S  +         
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKD 182

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
            + T +Y APE+L     Y    D+WS G I+  LL+  P F G  E D + ++    G 
Sbjct: 183 RIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GK 238

Query: 237 PT--ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                  W  +S+   AK                               DL+ ++LT+ P
Sbjct: 239 YAFDLPQWRTISD--DAK-------------------------------DLIRKMLTFHP 265

Query: 295 EKRITVDDALNHYWFHE 311
             RIT    L H W  +
Sbjct: 266 SLRITATQCLEHPWIQK 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  194 bits (496), Expect = 4e-60
 Identities = 80/328 (24%), Positives = 134/328 (40%), Gaps = 61/328 (18%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
           RS   + +   + +G +   +   D  + E+ A K   K  +    + + +         
Sbjct: 38  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------- 89

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQ--PFSTSEVKCL 122
            EI+I  S  H  +V       +D+D V++V+E      + L+E  K+    +  E +  
Sbjct: 90  MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRR--RSLLELHKRRKALTEPEARYY 146

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           + Q++ G +YLH N V+HRDLK  NL LN    +KI DFG++ +     +    L  T  
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           Y APE+L   K +S  VD+WS+GCIM  LL  KP F  +   +   +I            
Sbjct: 207 YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK----------- 254

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
                    K  +            P         ++     L+ ++L  DP  R T+++
Sbjct: 255 ---------KNEY----------SIP-------KHINPVAASLIQKMLQTDPTARPTINE 288

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQHAR 330
            LN  +F       +  ++P   P    
Sbjct: 289 LLNDEFF-------TSGYIPARLPITCL 309

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  191 bits (488), Expect = 4e-59
 Identities = 84/307 (27%), Positives = 135/307 (43%), Gaps = 54/307 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R  F F +   +  G +  V+  + + +G++ ALK +K +   ++  LE         EI
Sbjct: 8   RKTFIFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--------NEI 57

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQ 125
            +L    H +IV ++++  +     Y+VM+ +   +L   ++E  +  ++  +   ++ Q
Sbjct: 58  AVLKKIKHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQ 114

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           +L  VKYLH+N ++HRDLK  NLL         + I DFG+S+   +     ++   T  
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPG 172

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           Y APE+L   K YS AVD WS+G I   LL   P F   TE    +KI +         W
Sbjct: 173 YVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW 231

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
             +SE   AK                               D +  LL  DP +R T + 
Sbjct: 232 DDISE--SAK-------------------------------DFICHLLEKDPNERYTCEK 258

Query: 303 ALNHYWF 309
           AL+H W 
Sbjct: 259 ALSHPWI 265

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  190 bits (485), Expect = 5e-59
 Identities = 69/312 (22%), Positives = 128/312 (41%), Gaps = 57/312 (18%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              ++ ++  ++ +G + +V R   K +G   A K     K++    +            
Sbjct: 5   SDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--------- 53

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCL 122
           RE  I     HP+IV + +  + +    Y+V + +   +L + ++   ++ +S ++    
Sbjct: 54  REARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHC 110

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVV 179
           + Q+LE + Y H N ++HR+LK  NLLL ++     +K+ DFG++ +     + +     
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAG 169

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           T  Y +PE+L     YS  VD+W+ G I+  LL   P F    +     +I         
Sbjct: 170 TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
             W  ++    AK                                L++ +LT +P+KRIT
Sbjct: 229 PEWDTVTP--EAK-------------------------------SLIDSMLTVNPKKRIT 255

Query: 300 VDDALNHYWFHE 311
            D AL   W   
Sbjct: 256 ADQALKVPWICN 267

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  193 bits (492), Expect = 7e-59
 Identities = 66/316 (20%), Positives = 115/316 (36%), Gaps = 37/316 (11%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINI 69
             +   + + +G    V+R R KK+G++ A+K    ++  R  D           RE  +
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--------REFEV 60

Query: 70  LLSFDHPSIVNVKEVV-MDDHDSVYMVMEYMEH-DL-KWLMESMKQ-PFSTSEVKCLMLQ 125
           L   +H +IV +  +          ++ME+     L   L E         SE   ++  
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           ++ G+ +L +N ++HR++K  N++     + Q V K+ DFG +R+     + + SL  T 
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTE 179

Query: 182 WYRAPELLLGA-------KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK-- 232
            Y  P++   A       KKY   VD+WS+G            F       +  ++    
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
             G P+  I        G        P +             S  L      +L  +L  
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSL----------SRGLQVLLTPVLANILEA 289

Query: 293 DPEKRITVDDALNHYW 308
           D EK    D       
Sbjct: 290 DQEKCWGFDQFFAETS 305

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  192 bits (489), Expect = 8e-59
 Identities = 90/343 (26%), Positives = 143/343 (41%), Gaps = 66/343 (19%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
             V+E  +   I +G + +V R  ++++G+  A+K V +    K             RE 
Sbjct: 23  EDVYELCE--VIGKGPFSVVRRCINRETGQQFAVKIVDV---AKFTSSPGLSTEDLKREA 77

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLM 123
           +I     HP IV + E        +YMV E+M+                 +S +     M
Sbjct: 78  SICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVT 180
            Q+LE ++Y HDN ++HRD+K   +LL ++     +K+  FG++ Q G         V T
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK--TLGTPT 238
             + APE++   + Y   VD+W  G I+  LL+    F GT E     ++F+    G   
Sbjct: 197 PHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYK 250

Query: 239 --ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                W  +SE   AK                               DL+ R+L  DP +
Sbjct: 251 MNPRQWSHISE--SAK-------------------------------DLVRRMLMLDPAE 277

Query: 297 RITVDDALNHYWFHE-------VPLPKSKDFMPTFPPQHARNK 332
           RITV +ALNH W  E       + LP++ + +  F   +AR K
Sbjct: 278 RITVYEALNHPWLKERDRYAYKIHLPETVEQLRKF---NARRK 317

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  192 bits (490), Expect = 8e-59
 Identities = 81/312 (25%), Positives = 130/312 (41%), Gaps = 51/312 (16%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
              ++ +    I  G   +V R   + +G   A+K +++   R           ++ RE 
Sbjct: 93  YQKYDPKD--VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150

Query: 68  NILLS-FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLML 124
           +IL     HP I+ + +   +    +++V + M   +L  +L E  K   S  E + +M 
Sbjct: 151 HILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMR 207

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
            LLE V +LH N ++HRDLK  N+LL++   +++ DFG S     P +    L  T  Y 
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYL 266

Query: 185 APELLLGA-----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT- 238
           APE+L  +       Y   VD+W+ G I+  LLA  P F    ++  +  I +  G    
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME--GQYQF 324

Query: 239 -ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
               W   S     K                               DL++RLL  DPE R
Sbjct: 325 SSPEWDDRSS--TVK-------------------------------DLISRLLQVDPEAR 351

Query: 298 ITVDDALNHYWF 309
           +T + AL H +F
Sbjct: 352 LTAEQALQHPFF 363

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  191 bits (487), Expect = 1e-58
 Identities = 74/354 (20%), Positives = 124/354 (35%), Gaps = 92/354 (25%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
           +  +  +    I +G+YG+V  A + ++  I A+K   K K+     +D           
Sbjct: 25  QKKYHLKG--AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE------RIK 76

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME------------------------ 100
            E+ ++    HP+I  + EV  +D   + +VME                           
Sbjct: 77  TEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 101 ----------------HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLK 144
                             +    ES+        +  +M Q+   + YLH+  + HRD+K
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195

Query: 145 TSNLLL--NNQGVLKICDFGMSRQYGSP----LKPYTSLVVTLWYRAPELLLGA-KKYST 197
             N L   N    +K+ DFG+S+++           T+   T ++ APE+L    + Y  
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 198 AVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAK 257
             D WS G ++  LL     F G  + D I ++                     K  F  
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN------------------KKLCFEN 297

Query: 258 QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             Y                VLS    DLL+ LL  + ++R     AL H W  +
Sbjct: 298 PNY---------------NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  189 bits (482), Expect = 1e-58
 Identities = 77/315 (24%), Positives = 137/315 (43%), Gaps = 58/315 (18%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              +E  +  ++  G + IV + R K +G+  A K   K +++  R+    E        
Sbjct: 4   EDHYEMGE--ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE-----EIE 56

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVK 120
           RE+NIL    HP+I+ + ++  ++   V +++E +      D  +L E  K+  +  E  
Sbjct: 57  REVNILREIRHPNIITLHDI-FENKTDVVLILELVSGGELFD--FLAE--KESLTEDEAT 111

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTS 176
             + Q+L+GV YLH   + H DLK  N++L ++ V    +K+ DFG++ +       + +
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKN 170

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           +  T  + APE++   +      DMWS+G I   LL+    F G T+ + +  I      
Sbjct: 171 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------ 223

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                         +  N+           F    F      SE   D + RLL  DP++
Sbjct: 224 --------------SAVNY----------DFDEEYF---SNTSELAKDFIRRLLVKDPKR 256

Query: 297 RITVDDALNHYWFHE 311
           R+T+  +L H W   
Sbjct: 257 RMTIAQSLEHSWIKA 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  188 bits (481), Expect = 2e-58
 Identities = 85/307 (27%), Positives = 129/307 (42%), Gaps = 48/307 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE    + +G +G VY AR+K+S  I+ALK     V  K    + G      RE+ I   
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQSH 65

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP+I+ +      D   VY+++EY     +   ++ +   F        + +L   + 
Sbjct: 66  LRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALS 123

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T L  TL Y  PE++ G
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEG 181

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T  +   +I                     
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------------------- 220

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           +  F           FP         ++E   DL++RLL ++P +R  + + L H W   
Sbjct: 221 RVEF----------TFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

Query: 312 VPLPKSK 318
                S 
Sbjct: 264 NSSKPSN 270

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (482), Expect = 3e-58
 Identities = 63/323 (19%), Positives = 124/323 (38%), Gaps = 60/323 (18%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  + K+ EG +  V        G   ALK+  +    ++D  E      + RE ++   
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKR--ILCHEQQDREE------AQREADMHRL 82

Query: 73  FDHPSIVNVKEVVMDDHDS---VYMVMEYMEH-DLKWLMESMKQ---PFSTSEVKCLMLQ 125
           F+HP+I+ +    + +  +    ++++ + +   L   +E +K      +  ++  L+L 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV------ 179
           +  G++ +H     HRDLK +N+LL ++G   + D G   Q    ++     +       
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 180 ---TLWYRAPELLLGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
              T+ YRAPEL             D+WS+GC++  ++  +  +    +           
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ----------- 251

Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
                    G S     +               P      SP  S + + LLN ++T DP
Sbjct: 252 --------KGDSVALAVQNQL----------SIPQ-----SPRHSSALWQLLNSMMTVDP 288

Query: 295 EKRITVDDALNHYWFHEVPLPKS 317
            +R  +   L+     + P P  
Sbjct: 289 HQRPHIPLLLSQLEALQPPAPGQ 311

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  191 bits (488), Expect = 7e-58
 Identities = 96/330 (29%), Positives = 146/330 (44%), Gaps = 45/330 (13%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-- 70
           +E L  I +G++G V +A D K  + VALK V+ N  R        F   +  EI IL  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKR--------FHRQAAEEIRILEH 149

Query: 71  LSFDHPS----IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQ 125
           L          ++++ E      + + M  E +  +L  L++  K Q FS   V+     
Sbjct: 150 LRKQDKDNTMNVIHMLENFTF-RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG--VLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           +L+ +  LH N ++H DLK  N+LL  QG   +K+ DFG S      +  Y   + + +Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY---IQSRFY 265

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI-- 241
           RAPE++LGA+ Y   +DMWS+GCI+AELL   PL  G  E DQ+  + + LG P++ +  
Sbjct: 266 RAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 242 ----------------WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESG--- 282
                           +  ++ L               + R P  S      L       
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 283 -FDLLNRLLTYDPEKRITVDDALNHYWFHE 311
             D L + L +DP  R+T   AL H W   
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  188 bits (480), Expect = 8e-58
 Identities = 69/331 (20%), Positives = 129/331 (38%), Gaps = 56/331 (16%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
              +   +   +  G +GIV+R  +  S +    K VK+    +             +EI
Sbjct: 4   YEKYMIAE--DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---------KEI 52

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLM 123
           +IL    H +I+++ E   +  + + M+ E++      +   +  S     +  E+   +
Sbjct: 53  SILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFE--RINTS-AFELNEREIVSYV 108

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            Q+ E +++LH + + H D++  N++   +    +KI +FG +RQ   P   +  L    
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAP 167

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
            Y APE+       STA DMWS+G ++  LL+    F   T    I+ I           
Sbjct: 168 EYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------- 215

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
                      A +           F   +F     +S    D ++RLL  + + R+T  
Sbjct: 216 ---------MNAEYT----------FDEEAF---KEISIEAMDFVDRLLVKERKSRMTAS 253

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           +AL H W  +     S   + T   +   + 
Sbjct: 254 EALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  189 bits (482), Expect = 1e-57
 Identities = 71/315 (22%), Positives = 131/315 (41%), Gaps = 47/315 (14%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
            S +   K   +  G +G V++  +  +G  +A K +K    R     E         EI
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK---TRGMKDKE-----EVKNEI 137

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQL 126
           +++   DH +++ + +   +  + + +VMEY++  +L   +       +  +    M Q+
Sbjct: 138 SVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQG--VLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
            EG++++H  ++LH DLK  N+L  N+    +KI DFG++R+Y  P +       T  + 
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFL 255

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE++      S   DMWSVG I   LL+    F G  + + ++ I        +  +  
Sbjct: 256 APEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
           +SE   AK                               + +++LL  +   RI+  +AL
Sbjct: 315 ISEE--AK-------------------------------EFISKLLIKEKSWRISASEAL 341

Query: 305 NHYWFHEVPLPKSKD 319
            H W  +  L     
Sbjct: 342 KHPWLSDHKLHSRLS 356

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  187 bits (478), Expect = 2e-57
 Identities = 72/323 (22%), Positives = 132/323 (40%), Gaps = 58/323 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              ++  +  ++  G + IV + R+K +G   A K   K +    R+    E        
Sbjct: 11  EDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE-----EIE 63

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVK 120
           RE++IL    H +++ + +V  ++   V +++E +      D  +L +  K+  S  E  
Sbjct: 64  REVSILRQVLHHNVITLHDV-YENRTDVVLILELVSGGELFD--FLAQ--KESLSEEEAT 118

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTS 176
             + Q+L+GV YLH   + H DLK  N++L         +K+ DFG++ +       + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN 177

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           +  T  + APE++   +      DMWS+G I   LL+    F G T+ + +  I      
Sbjct: 178 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------ 230

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                            ++           F    F      SE   D + +LL  +  K
Sbjct: 231 --------------TSVSY----------DFDEEFF---SHTSELAKDFIRKLLVKETRK 263

Query: 297 RITVDDALNHYWFHEVPLPKSKD 319
           R+T+ +AL H W   V   ++  
Sbjct: 264 RLTIQEALRHPWITPVDNQQAMV 286

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  188 bits (479), Expect = 2e-57
 Identities = 64/338 (18%), Positives = 124/338 (36%), Gaps = 43/338 (12%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-------- 64
           +  +  +++G +  +      K  +  ALKK + ++  K+                    
Sbjct: 33  YRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 65  -REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME--------HDLKWLMESMKQPFS 115
             E+ I+    +   +  + + + ++D VY++ EYME             L ++      
Sbjct: 91  KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 116 TSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY 174
              +KC++  +L    Y+H+   + HRD+K SN+L++  G +K+ DFG S          
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI-- 207

Query: 175 TSLVVTLWYRAPELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQI-DKIFK 232
                T  +  PE       Y+   VD+WS+G  +  +      FS    + ++ + I  
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267

Query: 233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTY 292
                                 +     + L       S   +  LS    D L   L  
Sbjct: 268 ------------------KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309

Query: 293 DPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHAR 330
           +P +RIT +DAL H W  +  +   ++F      +  +
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKK 347

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  190 bits (486), Expect = 2e-57
 Identities = 68/314 (21%), Positives = 127/314 (40%), Gaps = 60/314 (19%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              ++  +  ++ +G + +V R     +G+  A       K++    +            
Sbjct: 10  TEEYQLFE--ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE--------- 58

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCL 122
           RE  I     HP+IV + +  + +    Y++ + +   +L + ++   ++ +S ++    
Sbjct: 59  REARICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHC 115

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVV 179
           + Q+LE V + H   V+HR+LK  NLLL ++     +K+ DFG++ +     + +     
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT- 238
           T  Y +PE+L     Y   VD+W+ G I+  LL   P F    +     +I    G    
Sbjct: 176 TPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--GAYDF 232

Query: 239 -ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
               W  ++    AK                               DL+N++LT +P KR
Sbjct: 233 PSPEWDTVTP--EAK-------------------------------DLINKMLTINPSKR 259

Query: 298 ITVDDALNHYWFHE 311
           IT  +AL H W   
Sbjct: 260 ITAAEALKHPWISH 273

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  187 bits (477), Expect = 3e-57
 Identities = 80/312 (25%), Positives = 132/312 (42%), Gaps = 63/312 (20%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
            +E    I  G+Y +  R   K +    A+K +      K D            EI ILL
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPT---------EEIEILL 70

Query: 72  SF-DHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLE 128
            +  HP+I+ +K+V  DD   VY+V E M+    L  ++   ++ FS  E   ++  + +
Sbjct: 71  RYGQHPNIITLKDV-YDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITK 127

Query: 129 GVKYLHDNWVLHRDLKTSNLLL----NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
            V+YLH   V+HRDLK SN+L      N   ++ICDFG ++Q  +      +   T  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT-----PTE 239
           APE+L   + Y  A D+WS+G ++  +L     F+   +    ++I   +G+        
Sbjct: 188 APEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEILARIGSGKFSLSGG 245

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
             W  +S+   AK                               DL++++L  DP +R+T
Sbjct: 246 -YWNSVSD--TAK-------------------------------DLVSKMLHVDPHQRLT 271

Query: 300 VDDALNHYWFHE 311
               L H W   
Sbjct: 272 AALVLRHPWIVH 283

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  186 bits (474), Expect = 7e-57
 Identities = 75/328 (22%), Positives = 136/328 (41%), Gaps = 58/328 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              ++  +  ++  G + +V + R+K +G   A K   K +    R+    E        
Sbjct: 10  DDYYDTGE--ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE-----DIE 62

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVK 120
           RE++IL    HP+++ + EV  ++   V +++E +      D  +L E  K+  +  E  
Sbjct: 63  REVSILKEIQHPNVITLHEV-YENKTDVILILELVAGGELFD--FLAE--KESLTEEEAT 117

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ----GVLKICDFGMSRQYGSPLKPYTS 176
             + Q+L GV YLH   + H DLK  N++L ++      +KI DFG++ +       + +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKN 176

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
           +  T  + APE++   +      DMWS+G I   LL+    F G T+ + +  +      
Sbjct: 177 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------ 229

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                         +  N+           F    F      S    D + RLL  DP+K
Sbjct: 230 --------------SAVNY----------EFEDEYF---SNTSALAKDFIRRLLVKDPKK 262

Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTF 324
           R+T+ D+L H W       ++     + 
Sbjct: 263 RMTIQDSLQHPWIKPKDTQQALSRKASA 290

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  187 bits (476), Expect = 7e-57
 Identities = 69/312 (22%), Positives = 128/312 (41%), Gaps = 57/312 (18%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSL 64
              ++ ++  ++ +G + +V R   K +G   A K     K++    +            
Sbjct: 28  SDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--------- 76

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCL 122
           RE  I     HP+IV + +  + +    Y+V + +   +L + ++   ++ +S ++    
Sbjct: 77  REARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHC 133

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVV 179
           + Q+LE + Y H N ++HR+LK  NLLL ++     +K+ DFG++ +     + +     
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAG 192

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE 239
           T  Y +PE+L     YS  VD+W+ G I+  LL   P F    +     +I         
Sbjct: 193 TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251

Query: 240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT 299
             W  ++    AK                                L++ +LT +P+KRIT
Sbjct: 252 PEWDTVTP--EAK-------------------------------SLIDSMLTVNPKKRIT 278

Query: 300 VDDALNHYWFHE 311
            D AL   W   
Sbjct: 279 ADQALKVPWICN 290

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  186 bits (474), Expect = 2e-56
 Identities = 74/321 (23%), Positives = 136/321 (42%), Gaps = 54/321 (16%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-RE 66
              ++  +  ++  G + IV + R+K +G   A K +K    R+      G     + RE
Sbjct: 11  EDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVCREEIERE 65

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCL 122
           ++IL    HP+I+ + +V  ++   V +++E +      D  +L +  K+  S  E    
Sbjct: 66  VSILRQVLHPNIITLHDV-YENRTDVVLILELVSGGELFD--FLAQ--KESLSEEEATSF 120

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ----GVLKICDFGMSRQYGSPLKPYTSLV 178
           + Q+L+GV YLH   + H DLK  N++L ++      +K+ DFG++ +       + ++ 
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIF 179

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            T  + APE++   +      DMWS+G I   LL+    F G T+ + +  I        
Sbjct: 180 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-------- 230

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
                          ++           F    F      SE   D + +LL  +  KR+
Sbjct: 231 ------------TAVSY----------DFDEEFF---SQTSELAKDFIRKLLVKETRKRL 265

Query: 299 TVDDALNHYWFHEVPLPKSKD 319
           T+ +AL H W   V   ++  
Sbjct: 266 TIQEALRHPWITPVDTQQAMV 286

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  183 bits (468), Expect = 2e-56
 Identities = 82/317 (25%), Positives = 132/317 (41%), Gaps = 54/317 (17%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+    + +G +G VY AR+K++  I+ALK     V  K    + G      REI I   
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALK-----VLFKSQLEKEGVEHQLRREIEIQSH 70

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLLEGV 130
             HP+I+ +      D   +Y+++E+    +L K L +     F        M +L + +
Sbjct: 71  LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADAL 127

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
            Y H+  V+HRD+K  NLL+  +G LKI DFG S    +P     ++  TL Y  PE++ 
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLDYLPPEMIE 185

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
           G K +   VD+W  G +  E L   P F   +  +   +I                    
Sbjct: 186 G-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV------------------- 225

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
              +           +FP       P LS+   DL+++LL Y P +R+ +   + H W  
Sbjct: 226 -NVDL----------KFP-------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

Query: 311 EVPLPKSKDFMPTFPPQ 327
                 S+  +P     
Sbjct: 268 A----NSRRVLPPVYQS 280

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  185 bits (471), Expect = 2e-56
 Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 58/301 (19%)

Query: 22  GTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PS 77
           G + +V +   K +G+  A K   K +     + + L          EI +L      P 
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL---------HEIAVLELAKSCPR 90

Query: 78  IVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           ++N+ EV  ++   + +++EY            +  + +  S ++V  L+ Q+LEGV YL
Sbjct: 91  VINLHEVY-ENTSEIILILEYAAGGEIFS--LCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 134 HDNWVLHRDLKTSNLLLNNQ---GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           H N ++H DLK  N+LL++    G +KI DFGMSR+ G        ++ T  Y APE+L 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILN 206

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
                +TA DMW++G I   LL     F G    +    I                    
Sbjct: 207 Y-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-------------------- 245

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
           ++ N            +   +F     +S+   D +  LL  +PEKR T +  L+H W  
Sbjct: 246 SQVNV----------DYSEETF---SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

Query: 311 E 311
           +
Sbjct: 293 Q 293

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  186 bits (475), Expect = 2e-56
 Identities = 65/308 (21%), Positives = 130/308 (42%), Gaps = 51/308 (16%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
              ++  +  ++  G +G+V+R  +K +G +   K +       K              E
Sbjct: 50  YDYYDILE--ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---------NE 98

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
           I+I+    HP ++N+ +   +D   + +++E++   +L   + +     S +EV   M Q
Sbjct: 99  ISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG--VLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
             EG+K++H++ ++H D+K  N++   +    +KI DFG++ +   P +       T  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEF 216

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++   +      DMW++G +   LL+    F+G  +++ +  + +      E  + 
Sbjct: 217 AAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            +S    AK                               D +  LL  +P KR+TV DA
Sbjct: 276 SVSPE--AK-------------------------------DFIKNLLQKEPRKRLTVHDA 302

Query: 304 LNHYWFHE 311
           L H W   
Sbjct: 303 LEHPWLKG 310

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  183 bits (466), Expect = 1e-55
 Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 69/311 (22%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HP 76
            + EG++ I  +   KKS +  A+K +     R E   +        +EI  L   + HP
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQ--------KEITALKLCEGHP 66

Query: 77  SIVNVKEVVMDDHDSVYMVMEYME-----HDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +IV + EV   D    ++VME +        +K      K+ FS +E   +M +L+  V 
Sbjct: 67  NIVKLHEV-FHDQLHTFLVMELLNGGELFERIK-----KKKHFSETEASYIMRKLVSAVS 120

Query: 132 YLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           ++HD  V+HRDLK  NLL  ++     +KI DFG +R      +P  +   TL Y APE 
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE- 179

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTLGT-----PTET 240
           LL    Y  + D+WS+G I+  +L+ +  F             +I K +         E 
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
            W  +S+   AK                               DL+  LLT DP KR+ +
Sbjct: 240 -WKNVSQ--EAK-------------------------------DLIQGLLTVDPNKRLKM 265

Query: 301 DDALNHYWFHE 311
                + W  +
Sbjct: 266 SGLRYNEWLQD 276

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  181 bits (462), Expect = 2e-55
 Identities = 63/319 (19%), Positives = 114/319 (35%), Gaps = 74/319 (23%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           EF +L KI  G +G V++   +  G I A+K+ K  +    D        ++LRE+    
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE------QNALREVYAHA 65

Query: 72  S-FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLMLQL 126
               H  +V       +D D + +  EY       D       +   F  +E+K L+LQ+
Sbjct: 66  VLGQHSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVL-------------------KICDFGMSRQY 167
             G++Y+H   ++H D+K SN+ ++   +                    KI D G   + 
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
            SP            + A E+L     +    D++++   +      +PL     +  +I
Sbjct: 185 SSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240

Query: 228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLN 287
            +               L  +P                           VLS+   +LL 
Sbjct: 241 RQGR-------------LPRIPQ--------------------------VLSQEFTELLK 261

Query: 288 RLLTYDPEKRITVDDALNH 306
            ++  DPE+R +    + H
Sbjct: 262 VMIHPDPERRPSAMALVKH 280

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  182 bits (464), Expect = 2e-55
 Identities = 74/309 (23%), Positives = 121/309 (39%), Gaps = 72/309 (23%)

Query: 21  EGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIV 79
            G  G V     +++G+  ALK +                    +E++        P IV
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---------QEVDHHWQASGGPHIV 85

Query: 80  NVKEVVMDDH---DSVYMVMEYME------HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            + +V  + H     + ++ME ME           + E   Q F+  E   +M  +   +
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSR----IQERGDQAFTEREAAEIMRDIGTAI 141

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           ++LH + + HRD+K  NLL  ++    VLK+ DFG +++         +   T +Y APE
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPE 199

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT-----PTETIW 242
            +LG +KY  + DMWS+G IM  LL   P F   T       + + +       P    W
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-W 257

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
             +SE   AK                                L+  LL  DP +R+T+  
Sbjct: 258 SEVSE--DAK-------------------------------QLIRLLLKTDPTERLTITQ 284

Query: 303 ALNHYWFHE 311
            +NH W ++
Sbjct: 285 FMNHPWINQ 293

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  182 bits (463), Expect = 1e-54
 Identities = 95/336 (28%), Positives = 148/336 (44%), Gaps = 50/336 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVK-----MNVGRKEDCLEYGFPISSLREI 67
           +E  + I +G++G V +A D+   E VA+K +K     +N  + E        +  L  +
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE--------VRLLELM 107

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQL 126
           N   +     IV++K       + + +V E + ++L   L  +  +  S +  +    Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHF-MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 127 LEGVKYLHDNW--VLHRDLKTSNLLLNNQG--VLKICDFGMSRQYGSPLKPYTSLVVTLW 182
              + +L      ++H DLK  N+LL N     +KI DFG S Q G  +  Y   + + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRF 223

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI- 241
           YR+PE+LLG   Y  A+DMWS+GCI+ E+   +PLFSG  EVDQ++KI + LG P   I 
Sbjct: 224 YRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 242 -----------------WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESG-- 282
                            W       G +         L           G     ESG  
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 283 -------FDLLNRLLTYDPEKRITVDDALNHYWFHE 311
                   DL+ R+L YDP+ RI    AL H +F +
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  186 bits (474), Expect = 1e-54
 Identities = 72/322 (22%), Positives = 129/322 (40%), Gaps = 55/322 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
              ++  +  ++  G +G+V+R  ++ +G   A K V   +   KE            +E
Sbjct: 156 LDHYDIHE--ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---------KE 204

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQ 125
           I  +    HP++VN+ +   +D + + M+ E+M   +L   +       S  E    M Q
Sbjct: 205 IQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           + +G+ ++H+N  +H DLK  N++   +    LK+ DFG++     P +       T  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEF 322

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT--ETI 241
            APE+  G K      DMWSVG +   LL+    F G  + + +  +          ++ 
Sbjct: 323 AAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--CDWNMDDSA 379

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           + G+SE    K                               D + +LL  DP  R+T+ 
Sbjct: 380 FSGISED--GK-------------------------------DFIRKLLLADPNTRMTIH 406

Query: 302 DALNHYWFHEVPLPKSKDFMPT 323
            AL H W      P     +P+
Sbjct: 407 QALEHPWLTPGNAPGRDSQIPS 428

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  181 bits (461), Expect = 4e-54
 Identities = 72/308 (23%), Positives = 122/308 (39%), Gaps = 69/308 (22%)

Query: 21  EGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIV 79
            G  G V +  +K++ E  ALK ++                   RE+ +       P IV
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---------REVELHWRASQCPHIV 118

Query: 80  NVKEV---VMDDHDSVYMVMEYME------HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            + +V   +      + +VME ++           + +   Q F+  E   +M  + E +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSR----IQDRGDQAFTEREASEIMKSIGEAI 174

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +YLH   + HRD+K  NLL  ++    +LK+ DFG +++  +     T+   T +Y APE
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPE 233

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK--TLGTPT--ETIWP 243
            +LG +KY  + DMWS+G IM  LL   P F     +     +     +G        W 
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            +SE    K                                L+  LL  +P +R+T+ + 
Sbjct: 293 EVSE--EVK-------------------------------MLIRNLLKTEPTQRMTITEF 319

Query: 304 LNHYWFHE 311
           +NH W  +
Sbjct: 320 MNHPWIMQ 327

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  180 bits (459), Expect = 4e-54
 Identities = 80/355 (22%), Positives = 135/355 (38%), Gaps = 63/355 (17%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL----- 70
           + K+  G +  V+ A+D  +   VA+K V+             +  ++  EI +L     
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKV--------YTEAAEDEIKLLQRVND 74

Query: 71  LSFDHPSIVNVKEVV-MDDH--------DSVYMVMEYMEHDL-KWLMESMKQPFSTSEVK 120
                   +    ++ + DH          V MV E +  +L   + +   +      VK
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134

Query: 121 CLMLQLLEGVKYLHDNW-VLHRDLKTSNLLLN------NQGVLKICDFGMSRQYGSPLKP 173
            +  QLL G+ Y+H    ++H D+K  N+L+       N   +KI D G +  Y      
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG------TTEVDQI 227
               + T  YR+PE+LLGA  +    D+WS  C++ EL+    LF        T + D I
Sbjct: 195 S---IQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250

Query: 228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYN---LLRKRFPAASFTGSPVLSESG-- 282
            +I + LG     +             + +  +N   LLR       +    VL+E    
Sbjct: 251 AQIIELLGELPSYLL--------RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302

Query: 283 --------FDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHA 329
                    D L+ +L  DP KR      +NH W  +  L   +  +P      +
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT-LGMEEIRVPDRELYGS 356

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  181 bits (461), Expect = 7e-54
 Identities = 56/311 (18%), Positives = 110/311 (35%), Gaps = 59/311 (18%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
             F   + +  G  G +   R       VA+K++        +C        + RE+ +L
Sbjct: 24  ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL------PECFS-----FADREVQLL 71

Query: 71  LSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
              D HP+++       D     Y+ +E     L+  +E         E   L+ Q   G
Sbjct: 72  RESDEHPNVIRYFCTEKDR-QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQG-----VLKICDFGMSRQYG---SPLKPYTSLVVTL 181
           + +LH   ++HRDLK  N+L++           I DFG+ ++           + +  T 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 182 WYRAPELLLGA--KKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPT 238
            + APE+L     +  +  VD++S GC+   ++++    F  + +      +        
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDC 249

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
                    +  A+                               +L+ +++  DP+KR 
Sbjct: 250 LHPEKHEDVI--AR-------------------------------ELIEKMIAMDPQKRP 276

Query: 299 TVDDALNHYWF 309
           +    L H +F
Sbjct: 277 SAKHVLKHPFF 287

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  176 bits (449), Expect = 3e-53
 Identities = 66/323 (20%), Positives = 118/323 (36%), Gaps = 64/323 (19%)

Query: 21  EGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLS-FDHPSI 78
           EG +  V    +  + +  A+K + K     +             RE+ +L     H ++
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---------REVEMLYQCQGHRNV 73

Query: 79  VNVKEVVMDDHDSVYMVMEYME------HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
           + + E   ++ D  Y+V E M       H  K      ++ F+  E   ++  +   + +
Sbjct: 74  LELIEF-FEEEDRFYLVFEKMRGGSILSHIHK------RRHFNELEASVVVQDVASALDF 126

Query: 133 LHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQY-------GSPLKPYTSLVVTLW 182
           LH+  + HRDLK  N+L  +      +KICDF +                   +   +  
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 183 YRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
           Y APE++      A  Y    D+WS+G I+  LL+  P F G    D      +      
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSP--VLSESGFDLLNRLLTYDPEK 296
             +             F      +   ++    F       +S +  DL+++LL  D ++
Sbjct: 247 NML-------------FES----IQEGKY---EFPDKDWAHISCAAKDLISKLLVRDAKQ 286

Query: 297 RITVDDALNHYWFH----EVPLP 315
           R++    L H W      E  LP
Sbjct: 287 RLSAAQVLQHPWVQGCAPENTLP 309

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  183 bits (466), Expect = 6e-53
 Identities = 77/337 (22%), Positives = 135/337 (40%), Gaps = 39/337 (11%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
           ++   +E   ++  G +G V R   + +GE VA+K+  +    +  +            E
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC--------LE 62

Query: 67  INILLSFDHPSIVNVKEVV-----MDDHDSVYMVMEYMEH-DL-KWLMESMKQ-PFSTSE 118
           I I+   +HP++V+ +EV      +  +D   + MEY E  DL K+L +           
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQY--GSPLKP 173
           ++ L+  +   ++YLH+N ++HRDLK  N++L     + + KI D G +++   G     
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT- 181

Query: 174 YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT 233
               V TL Y APELL   KKY+  VD WS G +  E +     F    +  Q     + 
Sbjct: 182 --EFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
                  ++  L+      ++    P +L            S +L+      L  +L + 
Sbjct: 239 KSNEHIVVYDDLTG-AVKFSSVLPTPNHL------------SGILAGKLERWLQCMLMWH 285

Query: 294 PEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQHAR 330
             +R T     N   F  +    S   +        R
Sbjct: 286 QRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGR 322

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  175 bits (447), Expect = 1e-52
 Identities = 92/336 (27%), Positives = 139/336 (41%), Gaps = 64/336 (19%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
              FE E   ++  G   IVYR + K + +  ALK +K      +  +          EI
Sbjct: 52  SDFFEVES--ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVR--------TEI 99

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQ 125
            +LL   HP+I+ +KE+  +    + +V+E +   +L   ++E  K  +S  +    + Q
Sbjct: 100 GVLLRLSHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQ 156

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLW 182
           +LE V YLH+N ++HRDLK  NLL         LKI DFG+S+          ++  T  
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPG 215

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG-TTEVDQIDKIFKTLGTPTETI 241
           Y APE+L G   Y   VDMWSVG I   LL     F     +     +I           
Sbjct: 216 YCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           W  +S    AK                               DL+ +L+  DP+KR+T  
Sbjct: 275 WDEVSL--NAK-------------------------------DLVRKLIVLDPKKRLTTF 301

Query: 302 DALNHYWF-----HEVPLPKSKDFMPTFPPQHARNK 332
            AL H W      + V +  ++  +  F   +AR K
Sbjct: 302 QALQHPWVTGKAANFVHMDTAQKKLQEF---NARRK 334

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  174 bits (442), Expect = 2e-52
 Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 48/303 (15%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
            E      + +GTYGIVY  RD  +   +A+K++     R    L          EI + 
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--------EEIALH 73

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSE--VKCLMLQLL 127
               H +IV       ++   + + ME +    L  L+ S   P   +E  +     Q+L
Sbjct: 74  KHLKHKNIVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           EG+KYLHDN ++HRD+K  N+L+N   GVLKI DFG S++         +   TL Y AP
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

Query: 187 ELLLGAKK-YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           E++    + Y  A D+WS+GC + E+   KP F    E      +FK        + P  
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFK---VGMFKVHP-- 245

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
            E+P +                          +S      + +    DP+KR   +D L 
Sbjct: 246 -EIPES--------------------------MSAEAKAFILKCFEPDPDKRACANDLLV 278

Query: 306 HYW 308
             +
Sbjct: 279 DEF 281

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  174 bits (443), Expect = 6e-52
 Identities = 45/347 (12%), Positives = 103/347 (29%), Gaps = 87/347 (25%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK--------------KVKMNVGRKEDCLEYGFPISSL 64
           + +        A D+++GE   +               ++K  V R            + 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 65  REINILLSFD---HPSIVNVKEVVMDDHD----SVYMVMEYMEHDLKWLMESMKQ----- 112
             +  +  FD    P    +  V +D+ D    S + +   M+ +L+   E +       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 113 -PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
                     L LQ++  +  LH   ++H  L+  +++L+ +G + +  F    + G+  
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-- 258

Query: 172 KPYTSLVVTLWYRAPELL----------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT 221
                  V+  +  PEL                 + + D W++G ++  +       +  
Sbjct: 259 --RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316

Query: 222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSES 281
             +   + IF++           +      +                             
Sbjct: 317 AALGGSEWIFRS--------CKNIP--QPVR----------------------------- 337

Query: 282 GFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQH 328
              LL   L Y  E R+    A+    + ++        +    P +
Sbjct: 338 --ALLEGFLRYPKEDRLLPLQAMETPEYEQLR-----TELSAALPLY 377

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  171 bits (434), Expect = 6e-51
 Identities = 65/319 (20%), Positives = 113/319 (35%), Gaps = 67/319 (21%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
                ++  G++G V+R +DK++G   A+KKV+               +  + E+     
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-------------LEVFRVEELVACAG 106

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQ--PFSTSEVKCLMLQL 126
              P IV +   V +    V + ME +E      L      +KQ            + Q 
Sbjct: 107 LSSPRIVPLYGAVREG-PWVNIFMELLEGGSLGQL------IKQMGCLPEDRALYYLGQA 159

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVL-KICDFGMSRQ-----YGSPLKPYTSLVVT 180
           LEG++YLH   +LH D+K  N+LL++ G    +CDFG +        G  L     +  T
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
             + APE+++G K     VD+WS  C+M  +L     ++   +  +     K    P   
Sbjct: 220 ETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT---QYFRGPLCLKIASEPPPI 275

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
                 E+P +                           +      +   L  +P  R + 
Sbjct: 276 R-----EIPPS--------------------------CAPLTAQAIQEGLRKEPVHRASA 304

Query: 301 DDALNHYWFHEVPLPKSKD 319
            +           +   K 
Sbjct: 305 MELRRKVGKALQEVGGLKS 323

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  173 bits (440), Expect = 7e-51
 Identities = 67/333 (20%), Positives = 124/333 (37%), Gaps = 78/333 (23%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           +++   EK   +  G+ G V   +    G  VA+K++        D  +      +L EI
Sbjct: 14  KNLVVSEK--ILGYGSSGTVV-FQGSFQGRPVAVKRML------IDFCD-----IALMEI 59

Query: 68  NILL-SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL------KWLMESMKQPFSTSEVK 120
            +L  S DHP+++            +Y+ +E    +L      K + +   +        
Sbjct: 60  KLLTESDDHPNVIRYYCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------LKICDFGMSRQY 167
            L+ Q+  GV +LH   ++HRDLK  N+L++                 + I DFG+ ++ 
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 168 G----SPLKPYTSLVVTLWYRAPELLLGA------KKYSTAVDMWSVGCIMAELLAK-KP 216
                S      +   T  +RAPELL  +      ++ + ++D++S+GC+   +L+K K 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 217 LFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSP 276
            F    +  +   I +                                            
Sbjct: 239 PFGD--KYSRESNIIR------------------------------GIFSLDEMKCLHDR 266

Query: 277 VLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
            L     DL+++++ +DP KR T    L H  F
Sbjct: 267 SLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  171 bits (436), Expect = 7e-51
 Identities = 65/342 (19%), Positives = 127/342 (37%), Gaps = 64/342 (18%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-- 70
           F  + K+ +GT+G V   +   + +  A+K V+ N+ +        +  S+  E +IL  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKK--------YTRSAKIEADILKK 87

Query: 71  LSFDHPSIVNVKEVVMDDH----DSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQ 125
           +  D  +  N+  V         D + ++ E +   L + +  +    F   ++K   ++
Sbjct: 88  IQNDDINNNNI--VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIE 145

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------------LKICD 160
           +L+ + YL    + H DLK  N+LL++                            +K+ D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           FG +             + T  YRAPE++L    +  + DMWS GC++AEL     LF  
Sbjct: 206 FGCATFKSDYHGSI---INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRT 261

Query: 221 TTEVDQIDKIFKTLGTPTETI-------------WPGLSELPGAKANFAKQPYNLLRKRF 267
              ++ +  +   +    + +                  +L   +   +      ++K  
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321

Query: 268 PAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
           P        +      D L  +L  DP  R +  + L H + 
Sbjct: 322 PLYKIIKHELF----CDFLYSILQIDPTLRPSPAELLKHKFL 359

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  169 bits (430), Expect = 1e-50
 Identities = 66/310 (21%), Positives = 110/310 (35%), Gaps = 88/310 (28%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHP 76
            +  G  G V +  +K++ E  ALK ++                   RE+ +       P
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---------REVELHWRASQCP 71

Query: 77  SIVNVKEV---VMDDHDSVYMVMEYME-----HDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            IV + +V   +      + +VME ++       +    +   Q F+  E   +M  + E
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGE 128

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
            ++YLH   + HRD+K  NLL  ++    +LK+ DFG                      A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------A 167

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK--TLGTPT--ETI 241
            E     +KY  + DMWS+G IM  LL   P F     +     +     +G        
Sbjct: 168 KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
           W  +SE    K                                L+  LL  +P +R+T+ 
Sbjct: 226 WSEVSE--EVK-------------------------------MLIRNLLKTEPTQRMTIT 252

Query: 302 DALNHYWFHE 311
           + +NH W  +
Sbjct: 253 EFMNHPWIMQ 262

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  166 bits (423), Expect = 1e-49
 Identities = 82/313 (26%), Positives = 135/313 (43%), Gaps = 59/313 (18%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSL------------- 64
           I +G+YG+V  A ++      A+K + K  + R+        P  +              
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 65  ----REINILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEHDLKWLME-SMKQPFSTSE 118
               +EI IL   DHP++V + EV+ D + D +YMV E +      +ME    +P S  +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ--GPVMEVPTLKPLSEDQ 138

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV 178
            +     L++G++YLH   ++HRD+K SNLL+   G +KI DFG+S ++       ++ V
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198

Query: 179 VTLWYRAPELLLGAKK-YS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT 236
            T  + APE L   +K +S  A+D+W++G  +   +  +  F     +    KI      
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK----- 253

Query: 237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
                                Q        FP       P ++E   DL+ R+L  +PE 
Sbjct: 254 --------------------SQAL-----EFPD-----QPDIAEDLKDLITRMLDKNPES 283

Query: 297 RITVDDALNHYWF 309
           RI V +   H W 
Sbjct: 284 RIVVPEIKLHPWV 296

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  166 bits (423), Expect = 4e-49
 Identities = 81/358 (22%), Positives = 143/358 (39%), Gaps = 67/358 (18%)

Query: 13  FEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +E +  + EGT+G V    D  +    VALK ++ NVG+        +  ++  EIN+L 
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVGK--------YREAARLEINVLK 71

Query: 72  S------FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLML 124
                   +    V + +   + H  + +  E +  +  ++L E+  QP+    V+ +  
Sbjct: 72  KIKEKDKENKFLCVLMSDWF-NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY 130

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFGMSR 165
           QL   +++LH+N + H DLK  N+L  N                      +++ DFG + 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190

Query: 166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD 225
                       V T  YR PE++L    ++   D+WS+GCI+ E      LF      +
Sbjct: 191 FDHEHHTTI---VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 226 QIDKIFKTLGTPTETI----------------WPGLSELPGAKANFAKQPYNLLRKRFPA 269
            +  + K LG     +                W   S        + K+    L+     
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS----DGRYVKENCKPLKSYMLQ 302

Query: 270 ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFPPQ 327
                  +     FDL+ R+L +DP +RIT+ +AL H +F  +  P+ + F  +  P 
Sbjct: 303 -----DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT-PEERSFHTSRNPS 354

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  165 bits (421), Expect = 6e-49
 Identities = 84/343 (24%), Positives = 137/343 (39%), Gaps = 58/343 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +E ++ + EG +G V    D K+G   VA+K VK NV R        +  ++  EI +L 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDR--------YCEAARSEIQVLE 66

Query: 72  ------SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLML 124
                        V + E   + H  + +V E +      ++ E+   PF    ++ +  
Sbjct: 67  HLNTTDPNSTFRCVQMLEWF-EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAY 125

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-------------------LKICDFGMSR 165
           Q+ + V +LH N + H DLK  N+L                         +K+ DFG + 
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185

Query: 166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD 225
                       V T  YRAPE++L    +S   D+WS+GCI+ E      +F      +
Sbjct: 186 YDDEHHSTL---VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

Query: 226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLL-----RKRFPAAS------FTG 274
            +  + + LG   + +   + +    K  F     +        +    A          
Sbjct: 242 HLAMMERILGPLPKHM---IQKTRKRK-YFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297

Query: 275 SPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS 317
             V  E  FDL+ ++L YDP KRIT+ +AL H +F    L KS
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD--LLKKS 338

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  163 bits (415), Expect = 1e-48
 Identities = 64/308 (20%), Positives = 122/308 (39%), Gaps = 55/308 (17%)

Query: 13  FEKLNK-ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR-EINIL 70
           F K +  I  G++  VY+  D ++   VA  +++     K +           + E  +L
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-------RQRFKEEAEML 79

Query: 71  LSFDHPSIVN---VKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQL 126
               HP+IV      E  +     + +V E M    LK  ++  K       ++    Q+
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQI 138

Query: 127 LEGVKYLHDN--WVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           L+G+++LH     ++HRDLK  N+ +    G +KI D G++    +      +++ T  +
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEF 196

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE+    +KY  +VD+++ G  M E+   +  +S      QI +   T G    +   
Sbjct: 197 MAPEM--YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGVKPASFDK 253

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
                P  K                               +++   +  + ++R ++ D 
Sbjct: 254 VAI--PEVK-------------------------------EIIEGCIRQNKDERYSIKDL 280

Query: 304 LNHYWFHE 311
           LNH +F E
Sbjct: 281 LNHAFFQE 288

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  165 bits (418), Expect = 7e-48
 Identities = 42/327 (12%), Positives = 97/327 (29%), Gaps = 73/327 (22%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLE--------------YGFPISSL 64
           + +        A D+++GE   +           + ++                    + 
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 65  REINILLSFD---HPSIVNVKEVVMDDHD----SVYMVMEYMEHDLKWLMESMKQ----- 112
             +  +  FD    P    +  V +D+ D    S + +   M+ +L+   E +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 113 -PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
                     L LQ++  +  LH   ++H  L+  +++L+ +G + +  F    + G+  
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265

Query: 172 K-PYTSLVVTLWYRAPELLLGAK----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ 226
             P           A  +L   +      + A D W++G  +  +       +    +  
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325

Query: 227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLL 286
            + IF++           + +                    P                LL
Sbjct: 326 SEWIFRS--------CKNIPQ--------------------PVR-------------ALL 344

Query: 287 NRLLTYDPEKRITVDDALNHYWFHEVP 313
              L Y  E R+    A+    + ++ 
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQLR 371

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  162 bits (411), Expect = 1e-47
 Identities = 65/324 (20%), Positives = 122/324 (37%), Gaps = 60/324 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +++    +  G +G VY          VA+K V+ +       L  G  +    E+ +L 
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLK 101

Query: 72  SFDH--PSIVNVKEVVMDDHDSVYMVMEYMEH--DL-KWLMESMKQPFSTSEVKCLMLQL 126
                   ++ + +   +  DS  +++E  E   DL  ++ E  +        +    Q+
Sbjct: 102 KVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQV 158

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           LE V++ H+  VLHRD+K  N+L++ N+G LK+ DFG           YT    T  Y  
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 216

Query: 186 PELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           PE +    +Y   +  +WS+G ++ +++     F      +  ++I              
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEII------------- 256

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                  +              F          +S     L+   L   P  R T ++  
Sbjct: 257 -------RGQV----------FFR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQ 292

Query: 305 NHYWFHEVPLPK--SKDFMPTFPP 326
           NH W  +V LP+  ++  + +  P
Sbjct: 293 NHPWMQDVLLPQETAEIHLHSLSP 316

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  161 bits (408), Expect = 5e-47
 Identities = 66/348 (18%), Positives = 116/348 (33%), Gaps = 75/348 (21%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
                 ++EG +  VY A+D  SG   ALK+  +    +E           ++E+  +  
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEEKNRA------IIQEVCFMKK 81

Query: 73  -FDHPSIV-------NVKEVVMDDHDSVYMVMEYMEHDLKWLMESM--KQPFSTSEVKCL 122
              HP+IV         KE          ++ E  +  L   ++ M  + P S   V  +
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 123 MLQLLEGVKYLHDN--WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV- 179
             Q    V+++H     ++HRDLK  NLLL+NQG +K+CDFG +           S    
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 180 -----------TLWYRAPEL--LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ 226
                      T  YR PE+  L          D+W++GCI+  L  ++  F    ++  
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259

Query: 227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLL 286
             +I                        +            P                L+
Sbjct: 260 --RIV--------------------NGKY----------SIPP-----HDTQYTVFHSLI 282

Query: 287 NRLLTYDPEKRITVDDALNHYWF--HEVPLPKSKDFMPTFPPQHARNK 332
             +L  +PE+R+++ + ++          +                  
Sbjct: 283 RAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGS 330

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  159 bits (405), Expect = 7e-47
 Identities = 72/331 (21%), Positives = 130/331 (39%), Gaps = 71/331 (21%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           + EG+YG V    D ++    A+K + K  + R  +        +  +EI +L    H +
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEA-----NVKKEIQLLRRLRHKN 67

Query: 78  IVNVKEVVMDDHDS-VYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHD 135
           ++ + +V+ ++    +YMVMEY    ++ +++S+ ++ F   +      QL++G++YLH 
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127

Query: 136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-------------GSPLKPYTSLVVTLW 182
             ++H+D+K  NLLL   G LKI   G++                GSP            
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA----------- 176

Query: 183 YRAPELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           ++ PE+  G   +S   VD+WS G  +  +        G                     
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITT------GL-------------------- 210

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
                  P     F       L +     S+           DLL  +L Y+P KR ++ 
Sbjct: 211 ------YP-----FEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIR 259

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
               H WF     P ++  +P  P    +++
Sbjct: 260 QIRQHSWF-RKKHPPAEAPVPIPPSPDTKDR 289

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  158 bits (401), Expect = 5e-46
 Identities = 63/322 (19%), Positives = 124/322 (38%), Gaps = 56/322 (17%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  ++ +  G +G V+ A DK+  + V +K +K     ++  +E         EI IL  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH--DL-KWLMESMKQPFSTSEVKCLMLQLLEG 129
            +H +I+ V ++  ++     +VME      DL  ++               +  QL+  
Sbjct: 86  VEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSA 142

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPE 187
           V YL    ++HRD+K  N+++     +K+ DFG +     G      T    T+ Y APE
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TF-CGTIEYCAPE 199

Query: 188 LLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           +L+G   Y    ++MWS+G  +  L+ ++  F       ++++  +              
Sbjct: 200 VLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE-------------- 238

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                                  A+     ++S+    L++ LL   PE+R T++  +  
Sbjct: 239 -----------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275

Query: 307 YWFHEVPLPKSKDFMPTFPPQH 328
            W  +        +   F    
Sbjct: 276 PWVTQPVNLADYTWEEVFRVNK 297

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  157 bits (400), Expect = 1e-45
 Identities = 76/301 (25%), Positives = 133/301 (44%), Gaps = 57/301 (18%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK+  +  +  +  +       ++E+  L  
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQK 110

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  +   + +H   ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 111 LRHPNTIQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL+  G++K+ DFG +      + P  S V T ++ APE++L  
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVILAM 225

Query: 193 KK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            +  Y   VD+WS+G I    LA+                      P     P L  +  
Sbjct: 226 DEGQYDGKVDVWSLG-ITCIELAE--------------------RKP-----P-LFNMNA 258

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGF-----DLLNRLLTYDPEKRITVDDALN 305
             A +       + +         SP L    +     + ++  L   P+ R T +  L 
Sbjct: 259 MSALY------HIAQN-------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305

Query: 306 H 306
           H
Sbjct: 306 H 306

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  155 bits (395), Expect = 2e-45
 Identities = 61/326 (18%), Positives = 113/326 (34%), Gaps = 61/326 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL- 70
           E+     + +G +G V+          VA+K +  N       L          E+ +L 
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP--LEVALLW 89

Query: 71  ---LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH--DL-KWLMESMKQPFSTSEVKCLML 124
                  HP ++ + +   +  +   +V+E      DL  ++ E  K P      +C   
Sbjct: 90  KVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFG 146

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           Q++  +++ H   V+HRD+K  N+L++  +G  K+ DFG         +PYT    T  Y
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVY 204

Query: 184 RAPELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
             PE +    +Y      +WS+G ++ +++     F      ++  +I            
Sbjct: 205 SPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPF------ERDQEIL----------- 246

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD 302
                    +A             FP         +S     L+ R L   P  R ++++
Sbjct: 247 ---------EAEL----------HFP-------AHVSPDCCALIRRCLAPKPSSRPSLEE 280

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQH 328
            L   W    P            P  
Sbjct: 281 ILLDPWMQT-PAEDVPLNPSKGGPAP 305

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  155 bits (395), Expect = 4e-45
 Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 61/299 (20%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           I +G +  V  AR   +G  VA+K   K ++N    +            RE+ I+   +H
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---------REVRIMKILNH 73

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P+IV + EV ++   ++Y++MEY    ++  +L+          E +    Q++  V+Y 
Sbjct: 74  PNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYC 130

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELLLG 191
           H   ++HRDLK  NLLL+    +KI DFG S ++  G  L           Y APEL  G
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD--AF-CGAPPYAAPELFQG 187

Query: 192 AKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            KKY    VD+WS+G I+  L++    F G                              
Sbjct: 188 -KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---------------------------- 218

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                       LR+R     +     +S    +LL R L  +P KR T++  +   W 
Sbjct: 219 ---------LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  154 bits (390), Expect = 3e-44
 Identities = 71/307 (23%), Positives = 134/307 (43%), Gaps = 21/307 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + + +  K            +RE+ +L 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRN-----QIIRELQVLH 86

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             + P IV        D + + + ME+M+   L  +++          +  + + +++G+
Sbjct: 87  ECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGL 144

Query: 131 KYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
            YL +   ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE L
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL 202

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKP--LFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            G   YS   D+WS+G  + E+   +         E++ +               P    
Sbjct: 203 QG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF-----DLLNRLLTYDPEKRITVDD 302
            P  K     +P   + +          P L    F     D +N+ L  +P +R  +  
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 303 ALNHYWF 309
            + H + 
Sbjct: 322 LMVHAFI 328

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  153 bits (388), Expect = 3e-44
 Identities = 66/366 (18%), Positives = 118/366 (32%), Gaps = 105/366 (28%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMN--VGRKEDCLEYGFPISSLREINI 69
           +FE +  +  G +G+V+ A++K      A+K++++      +E  +     ++ L    I
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 70  L-----------------------------------------------LSFDHPSIVNVK 82
           +                                               +          +
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 83  EVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL--MLQLLEGVKYLHDNWVL 139
                    +Y+ M+     +LK  M             CL   +Q+ E V++LH   ++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 140 HRDLKTSNLLLNNQGVLKICDFGMSR------------QYGSPLKPYTSLVVTLWYRAPE 187
           HRDLK SN+      V+K+ DFG+                      +T  V T  Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            + G   YS  VD++S+G I+ ELL     FS   E  +I                    
Sbjct: 247 QIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRI-------------------- 282

Query: 248 LPGAKANFAKQPYNLLRK-RFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                          +R  +FP       P        ++  +L+  P +R    D + +
Sbjct: 283 ------------ITDVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPTERPEATDIIEN 326

Query: 307 YWFHEV 312
             F  +
Sbjct: 327 AIFENL 332

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  153 bits (388), Expect = 7e-44
 Identities = 80/305 (26%), Positives = 124/305 (40%), Gaps = 56/305 (18%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINI 69
           ++ +  I  G +G+    RDK + E+VA+K   +        +            REI  
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ------------REIIN 69

Query: 70  LLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLL 127
             S  HP+IV  KEV +     + ++MEY    +L + +       FS  E +    QLL
Sbjct: 70  HRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLL 126

Query: 128 EGVKYLHDNWVLHRDLKTSNLLL--NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
            GV Y H   + HRDLK  N LL  +    LKICDFG S+      +P ++ V T  Y A
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 185

Query: 186 PELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           PE+LL  ++Y     D+WS G  +  +L     F    E  +  + ++      + I   
Sbjct: 186 PEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPRDYRKT---IQRI--- 234

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                     +            P         +S     L++R+   DP  RI++ +  
Sbjct: 235 ------LSVKY----------SIPDDIR-----ISPECCHLISRIFVADPATRISIPEIK 273

Query: 305 NHYWF 309
            H WF
Sbjct: 274 THSWF 278

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  151 bits (384), Expect = 1e-43
 Identities = 75/309 (24%), Positives = 124/309 (40%), Gaps = 54/309 (17%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+    + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVMSR 86

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP  V +     DD + +Y  + Y ++ +L   +  +   F  +  +    +++  ++
Sbjct: 87  LDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALE 144

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT--SLVVTLWYRAPELL 189
           YLH   ++HRDLK  N+LLN    ++I DFG ++      K     S V T  Y +PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
              K    + D+W++GCI+ +L+A  P F    E     KI                   
Sbjct: 205 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------- 244

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT------VDDA 303
                  K  Y      FP               DL+ +LL  D  KR+           
Sbjct: 245 ------IKLEY-----DFP-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 286

Query: 304 LNHYWFHEV 312
             H +F  V
Sbjct: 287 KAHPFFESV 295

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  149 bits (379), Expect = 2e-43
 Identities = 84/304 (27%), Positives = 120/304 (39%), Gaps = 70/304 (23%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           +  GT+G V     + +G  VA+K +      ++            REI  L  F HP I
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN-----RQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 79  VNVKEVVMDDHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           + + +V +      +MVMEY+   +L  ++ +         E + L  Q+L  V Y H +
Sbjct: 74  IKLYQV-ISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----------GSPLKPYTSLVVTLWYRAP 186
            V+HRDLK  N+LL+     KI DFG+S             GSP            Y AP
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-----------YAAP 179

Query: 187 ELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           E++ G + Y+   VD+WS G I+  LL       GT                        
Sbjct: 180 EVISG-RLYAGPEVDIWSCGVILYALLC------GT------------------------ 208

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
             LP     F  +    L K+     F     L+ S   LL  +L  DP KR T+ D   
Sbjct: 209 --LP-----FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

Query: 306 HYWF 309
           H WF
Sbjct: 262 HEWF 265

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  151 bits (383), Expect = 2e-43
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 75/306 (24%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           + EG++G V  A   K+ + VALK   +  +        +E        REI+ L    H
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--------REISYLKLLRH 68

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P I+ + +V +     + MV+EY   +L  +++E  K+  +  E +    Q++  ++Y H
Sbjct: 69  PHIIKLYDV-ITTPTDIVMVIEYAGGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCH 125

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----------GSPLKPYTSLVVTLWYR 184
            + ++HRDLK  NLLL++   +KI DFG+S             GSP            Y 
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YA 174

Query: 185 APELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
           APE++ G K Y+   VD+WS G ++  +L       G                       
Sbjct: 175 APEVING-KLYAGPEVDVWSCGIVLYVMLV------GR---------------------- 205

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
               LP     F  +    L K+  +  +     LS     L+ R++  DP +RIT+ + 
Sbjct: 206 ----LP-----FDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEI 256

Query: 304 LNHYWF 309
               WF
Sbjct: 257 RRDPWF 262

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  149 bits (378), Expect = 4e-43
 Identities = 74/300 (24%), Positives = 133/300 (44%), Gaps = 57/300 (19%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           + +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++  
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMRE 73

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQ-PFSTSEVKCLMLQLL 127
             +P+IVN  +  +   + +++VMEY+      D+      + +      ++  +  + L
Sbjct: 74  NKNPNIVNYLDSYLVGDE-LWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECL 126

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + +++LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 188 LLLGAKKYSTAVDMWSVGCIMA-ELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ++   K Y   VD+WS+G IMA E++  +P                    P         
Sbjct: 187 VVTR-KAYGPKVDIWSLG-IMAIEMIEGEP--------------------P-------YL 217

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                +A +      L+              LS    D LNR L  D EKR +  + L H
Sbjct: 218 NENPLRALY------LIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  149 bits (378), Expect = 6e-43
 Identities = 70/319 (21%), Positives = 133/319 (41%), Gaps = 66/319 (20%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++G + A K ++     + +            EI IL +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI--------VEIEILAT 72

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            DHP IV +      D   +++++E+        +   M  + +  +  +++ +  Q+LE
Sbjct: 73  CDHPYIVKLLGAYYHDGK-LWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVVCRQMLE 128

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            + +LH   ++HRDLK  N+L+  +G +++ DFG+S +    L+   S + T ++ APE+
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188

Query: 189 LLGA----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           ++        Y    D+WS+G I    +A+                      P     P 
Sbjct: 189 VMCETMKDTPYDYKADIWSLG-ITLIEMAQ--------------------IEP-----P- 221

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESG-----F-DLLNRLLTYDPEKRI 298
             EL   +          + K  P       P L         F D L   L  +PE R 
Sbjct: 222 HHELNPMRVLL------KIAKSDP-------PTLLTPSKWSVEFRDFLKIALDKNPETRP 268

Query: 299 TVDDALNHYWFHEVPLPKS 317
           +    L H +   +   K+
Sbjct: 269 SAAQLLEHPFVSSITSNKA 287

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  149 bits (378), Expect = 8e-43
 Identities = 76/300 (25%), Positives = 135/300 (45%), Gaps = 57/300 (19%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
            +   KI EG+ GIV  AR+K SG  VA+K + +   ++ + L          E+ I+  
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--------FNEVVIMRD 98

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQ-PFSTSEVKCLMLQLL 127
           + H ++V + +  +   + ++++ME+++     D+      + Q   +  ++  +   +L
Sbjct: 99  YQHFNVVEMYKSYLVGEE-LWVLMEFLQGGALTDI------VSQVRLNEEQIATVCEAVL 151

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           + + YLH   V+HRD+K+ ++LL   G +K+ DFG   Q    +    SLV T ++ APE
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211

Query: 188 LLLGAKKYSTAVDMWSVGCIMA-ELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           ++     Y+T VD+WS+G IM  E++  +P                    P         
Sbjct: 212 VISR-SLYATEVDIWSLG-IMVIEMVDGEP--------------------P-------YF 242

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                +A         LR   P      S  +S    D L R+L  DP++R T  + L+H
Sbjct: 243 SDSPVQAMK------RLRDS-PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  149 bits (378), Expect = 3e-42
 Identities = 60/321 (18%), Positives = 120/321 (37%), Gaps = 34/321 (10%)

Query: 13  FEKLNKISEG--TYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +E L  I +G      V  AR K +GE V ++++ +     E             E+++ 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL------QGELHVS 80

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLMLQL 126
             F+HP+IV  +   + D++ +++V  +M      DL  +        +   +  ++  +
Sbjct: 81  KLFNHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGV 137

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK-------PYTSLVV 179
           L+ + Y+H    +HR +K S++L++  G + +     +    S  +            V 
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 180 TLWYRAPELLL-GAKKYSTAVDMWSVGCIMA-ELLAKKPLFSGTTEVDQIDKIFK----T 233
            L + +PE+L    + Y    D++SVG I A EL      F        + +        
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

Query: 234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF-----DLLNR 288
           L   +      L+  P      +    +L       ++           F       + +
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 289 LLTYDPEKRITVDDALNHYWF 309
            L  +P+ R +    LNH +F
Sbjct: 317 CLQRNPDARPSASTLLNHSFF 337

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  146 bits (371), Expect = 4e-42
 Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 62/302 (20%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + EG YG V  A ++ + E VA+K   +++ R  DC E     +  +EI I    +H ++
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI--VDMKRAVDCPE-----NIKKEICINKMLNHENV 67

Query: 79  VNVKEVVMDDHDSVYMVMEYM---EHDLKWLME--SMKQPFSTSEVKCLMLQLLEGVKYL 133
           V        + +  Y+ +EY    E     L +           + +    QL+ GV YL
Sbjct: 68  VKFYGH-RREGNIQYLFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELLLG 191
           H   + HRD+K  NLLL+ +  LKI DFG++  +   +  +    +  TL Y APELL  
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 192 AKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            +++    VD+WS G ++  +LA      G                          ELP 
Sbjct: 182 -REFHAEPVDVWSCGIVLTAMLA------G--------------------------ELP- 207

Query: 251 AKANF--AKQPYNLLRKRFPAA-SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
               +                         +  +   LL+++L  +P  RIT+ D     
Sbjct: 208 ----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263

Query: 308 WF 309
           W+
Sbjct: 264 WY 265

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  147 bits (372), Expect = 4e-42
 Identities = 78/312 (25%), Positives = 136/312 (43%), Gaps = 60/312 (19%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F KL KI +G++G V++  D ++ ++VA+K   +++   ED +E        +EI +L  
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--IDLEEAEDEIE-----DIQQEITVLSQ 76

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMK-QPFSTSEVKCLMLQLL 127
            D P +       + D   ++++MEY+      DL      ++  P   +++  ++ ++L
Sbjct: 77  CDSPYVTKYYGSYLKDTK-LWIIMEYLGGGSALDL------LEPGPLDETQIATILREIL 129

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G+ YLH    +HRD+K +N+LL+  G +K+ DFG++ Q         + V T ++ APE
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++     Y +  D+WS+G I A  LA+                    G P     P  SE
Sbjct: 190 VIKQ-SAYDSKADIWSLG-ITAIELAR--------------------GEP-----P-HSE 221

Query: 248 LPGAKANF--AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
           L   K  F   K     L   +       S  L     + +   L  +P  R T  + L 
Sbjct: 222 LHPMKVLFLIPKNNPPTLEGNY-------SKPLK----EFVEACLNKEPSFRPTAKELLK 270

Query: 306 HYWFHEVPLPKS 317
           H +        S
Sbjct: 271 HKFILRNAKKTS 282

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  147 bits (372), Expect = 8e-42
 Identities = 70/326 (21%), Positives = 132/326 (40%), Gaps = 74/326 (22%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE +  +  GTYG VY+ R  K+G++ A+K + +    +E+           +EIN+L  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---------QEINMLKK 76

Query: 73  F-DHPSIVN-----VKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCL 122
           +  H +I       +K+      D +++VME+       DL  +  +         +  +
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYI 134

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             ++L G+ +LH + V+HRD+K  N+LL     +K+ DFG+S Q    +    + + T +
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 183 YRAPELLLGAKK----YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
           + APE++   +     Y    D+WS+G I A  +A+                    G P 
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAE--------------------GAP- 232

Query: 239 ETIWPGLSELPGAKANF--AKQPYNLLRKRFPAASFTGSPVLSESGF-----DLLNRLLT 291
               P L ++   +A F   + P               +P L    +       +   L 
Sbjct: 233 ----P-LCDMHPMRALFLIPRNP---------------APRLKSKKWSKKFQSFIESCLV 272

Query: 292 YDPEKRITVDDALNHYWFHEVPLPKS 317
            +  +R   +  + H +  + P  + 
Sbjct: 273 KNHSQRPATEQLMKHPFIRDQPNERQ 298

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  146 bits (371), Expect = 9e-42
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 62/302 (20%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI 78
           + EG YG V  A ++ + E VA+K   +++ R  DC E     +  +EI I    +H ++
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI--VDMKRAVDCPE-----NIKKEICINKMLNHENV 67

Query: 79  VNVKEVVMDDHDSVYMVMEYM---EHDLKWLME--SMKQPFSTSEVKCLMLQLLEGVKYL 133
           V        + +  Y+ +EY    E     L +           + +    QL+ GV YL
Sbjct: 68  VKFYGH-RREGNIQYLFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELLLG 191
           H   + HRD+K  NLLL+ +  LKI DFG++  +   +  +    +  TL Y APELL  
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 192 AKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            +++    VD+WS G ++  +LA                                 ELP 
Sbjct: 182 -REFHAEPVDVWSCGIVLTAMLA--------------------------------GELP- 207

Query: 251 AKANF--AKQPYNLLRKRFPAASFTGSPV-LSESGFDLLNRLLTYDPEKRITVDDALNHY 307
               +                 ++      +  +   LL+++L  +P  RIT+ D     
Sbjct: 208 ----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263

Query: 308 WF 309
           W+
Sbjct: 264 WY 265

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  146 bits (370), Expect = 1e-41
 Identities = 79/299 (26%), Positives = 141/299 (47%), Gaps = 55/299 (18%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+ L K+ EG+YG VY+A  K++G+IVA+K+V +    +E        I  ++EI+I+  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--------I--IKEISIMQQ 80

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME----HDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            D P +V        + D +++VMEY       D+   +    +  +  E+  ++   L+
Sbjct: 81  CDSPHVVKYYGSYFKNTD-LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLK 136

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G++YLH    +HRD+K  N+LLN +G  K+ DFG++ Q    +    +++ T ++ APE+
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196

Query: 189 LLGAKKYSTAVDMWSVGCIMA-ELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +     Y+   D+WS+G I A E+   KP                    P        ++
Sbjct: 197 IQE-IGYNCVADIWSLG-ITAIEMAEGKP--------------------P-------YAD 227

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
           +   +A F      ++    P  +F    + S++  D + + L   PE+R T    L H
Sbjct: 228 IHPMRAIF------MIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  146 bits (370), Expect = 2e-41
 Identities = 75/308 (24%), Positives = 131/308 (42%), Gaps = 51/308 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + + L +I  G YG V +   K SG+I+A+K+++  V   E   +       L ++++++
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQK-----QLLMDLDVVM 75

Query: 72  -SFDHPSIVNVKEVVMDDHDSVYMVMEYM----EHDLKWLMESMKQPFSTSEVKCLMLQL 126
            S D P IV     +  + D  ++ ME M    +   K++   +        +  + L  
Sbjct: 76  RSSDCPYIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134

Query: 127 LEGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           ++ + +L +N  ++HRD+K SN+LL+  G +K+CDFG+S Q    +   T       Y A
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMA 193

Query: 186 PELLLG---AKKYSTAVDMWSVGCIMAEL-LAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           PE +      + Y    D+WS+G  + EL   + P     +  DQ+ ++ K  G P    
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP---- 247

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
            P LS     +                          S S  + +N  LT D  KR    
Sbjct: 248 -PQLSNSEEREF-------------------------SPSFINFVNLCLTKDESKRPKYK 281

Query: 302 DALNHYWF 309
           + L H + 
Sbjct: 282 ELLKHPFI 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  144 bits (366), Expect = 2e-41
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 16/218 (7%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E   +I +G +G+V++ R  K   +VA+K + +     E  +   F     RE+ I+ 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF-QEFQREVFIMS 78

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + +HP+IV +  ++    +   MVME++   DL   +     P   S    LML +  G+
Sbjct: 79  NLNHPNIVKLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 131 KYLHDN--WVLHRDLKTSNLLLNNQG-----VLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           +Y+ +    ++HRDL++ N+ L +         K+ DFG+S+Q    +   + L+    +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQW 192

Query: 184 RAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSG 220
            APE +    + Y+   D +S   I+  +L  +  F  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  146 bits (371), Expect = 3e-41
 Identities = 74/321 (23%), Positives = 134/321 (41%), Gaps = 48/321 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE L  I +G++G V   +   + ++ A+K        K+ C+E     +  +E+ I+  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMK-----YMNKQKCVERNEVRNVFKELQIMQG 71

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            +HP +VN+     D+ D ++MV++ +   DL++ ++     F    VK  + +L+  + 
Sbjct: 72  LEHPFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALD 129

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL- 190
           YL +  ++HRD+K  N+LL+  G + I DF ++          T++  T  Y APE+   
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYMAPEMFSS 188

Query: 191 -GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
                YS AVD WS+G    ELL  +  +   +      +I                   
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVH----------------- 230

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDALNHYW 308
                F           +P          S+    LL +LL  +P++R   + D  N  +
Sbjct: 231 ----TFETTVV-----TYP-------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

Query: 309 FHEVPLPK--SKDFMPTFPPQ 327
            +++       K  +P F P 
Sbjct: 275 MNDINWDAVFQKRLIPGFIPN 295

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  147 bits (372), Expect = 5e-41
 Identities = 70/326 (21%), Positives = 124/326 (38%), Gaps = 50/326 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE L  I  G +  V   + K++G++ A+K +      K D L+ G       E ++L++
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN-----KWDMLKRGEVSCFREERDVLVN 117

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            D   I  +     D+ + +Y+VMEY    DL  L+    +       +  + +++  + 
Sbjct: 118 GDRRWITQLHFAFQDE-NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELLL 190
            +H    +HRD+K  N+LL+  G +++ DFG   +  +     + + V T  Y +PE+L 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 191 G------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
                     Y    D W++G    E+   +  F   +  +   KI              
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH------------ 284

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                  K +             P         + E   D + RLL   PE R+    A 
Sbjct: 285 ------YKEHL----------SLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAG 323

Query: 305 ---NHYWFHEVPLPKSKDFMPTFPPQ 327
               H +F  +     +D +P F P 
Sbjct: 324 DFRTHPFFFGLDWDGLRDSVPPFTPD 349

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  147 bits (372), Expect = 1e-40
 Identities = 86/309 (27%), Positives = 122/309 (39%), Gaps = 80/309 (25%)

Query: 19  ISEGTYGIVYRARDKKSGEIVALK---KVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           +  GT+G V   + + +G  VA+K   + K+        +         REI  L  F H
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--------REIQNLKLFRH 75

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH----DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           P I+ + +V +     ++MVMEY+      D  ++ +         E + L  Q+L GV 
Sbjct: 76  PHIIKLYQV-ISTPSDIFMVMEYVSGGELFD--YICK--NGRLDEKESRRLFQQILSGVD 130

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY----------GSPLKPYTSLVVTL 181
           Y H + V+HRDLK  N+LL+     KI DFG+S             GSP           
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---------- 180

Query: 182 WYRAPELLLGAKKYS-TAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET 240
            Y APE++ G + Y+   VD+WS G I+  LL       GT                   
Sbjct: 181 -YAAPEVISG-RLYAGPEVDIWSSGVILYALLC------GT------------------- 213

Query: 241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
                  LP     F       L K+     F     L+ S   LL  +L  DP KR T+
Sbjct: 214 -------LP-----FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATI 261

Query: 301 DDALNHYWF 309
            D   H WF
Sbjct: 262 KDIREHEWF 270

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  142 bits (361), Expect = 2e-40
 Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 52/313 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++E    I  G   +V  A      E VA+K+  +N+ + +  ++       L+EI  + 
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKR--INLEKCQTSMD-----ELLKEIQAMS 68

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME--------HDLKWLMESMKQPFSTSEVKCLM 123
              HP+IV+     +   + +++VM+ +           +    E        S +  ++
Sbjct: 69  QCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-----YGSPLKPYTSLV 178
            ++LEG++YLH N  +HRD+K  N+LL   G ++I DFG+S         +  K   + V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            T  + APE++   + Y    D+WS G I A  LA                     G   
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFG-ITAIELAT--------------------GAA- 225

Query: 239 ETIWPGLSELPGAKANF--AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
               P   + P  K      +     L                +S   +++  L  DPEK
Sbjct: 226 ----P-YHKYPPMKVLMLTLQNDPPSLET--GVQDKEMLKKYGKSFRKMISLCLQKDPEK 278

Query: 297 RITVDDALNHYWF 309
           R T  + L H +F
Sbjct: 279 RPTAAELLRHKFF 291

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  146 bits (369), Expect = 2e-40
 Identities = 71/324 (21%), Positives = 131/324 (40%), Gaps = 48/324 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           FE L  I  G +G V   + K + ++ A+K +      K + L+         E ++L++
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-----KWEMLKRAETACFREERDVLVN 130

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            D   I  +     DD +++Y+VM+Y    DL  L+   +        +  + +++  + 
Sbjct: 131 GDSKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELLL 190
            +H    +HRD+K  N+L++  G +++ DFG   +        +S+ V T  Y +PE+L 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 191 ----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
               G  +Y    D WS+G  M E+L  +  F   + V+   KI                
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------------- 295

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL-- 304
                K  F          +FP         +SE+  DL+ RL+    E R+  +     
Sbjct: 296 ----HKERF----------QFPTQ----VTDVSENAKDLIRRLIC-SREHRLGQNGIEDF 336

Query: 305 -NHYWFHEVPLPKSKDFMPTFPPQ 327
             H +F  +     ++    + P+
Sbjct: 337 KKHPFFSGIDWDNIRNCEAPYIPE 360

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  142 bits (360), Expect = 2e-40
 Identities = 70/312 (22%), Positives = 128/312 (41%), Gaps = 63/312 (20%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + E + ++  G YG+V + R   SG+I+A+K+++  V  +E           L +++I +
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ-------KRLLMDLDISM 60

Query: 72  -SFDHPSIVNVKEVVMDDHDSVYMVMEYME---HDLKWLMESMKQPFSTSEVKCLMLQLL 127
            + D P  V     +  + D V++ ME M+         +    Q      +  + + ++
Sbjct: 61  RTVDCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 128 EGVKYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           + +++LH    V+HRD+K SN+L+N  G +K+CDFG+S      +           Y AP
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAP 178

Query: 187 ELLLG---AKKYSTAVDMWSVGCIMAEL-LAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           E +      K YS   D+WS+G  M EL + + P  S  T   Q+ ++ +          
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE---------- 228

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF-----DLLNRLLTYDPEKR 297
                                           SP L    F     D  ++ L  + ++R
Sbjct: 229 ------------------------------EPSPQLPADKFSAEFVDFTSQCLKKNSKER 258

Query: 298 ITVDDALNHYWF 309
            T  + + H +F
Sbjct: 259 PTYPELMQHPFF 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  140 bits (356), Expect = 1e-39
 Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 31/248 (12%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E E    +  G +G+V +A+ +   + VA+K+++    RK       F    + E+  L 
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKA------F----IVELRQLS 56

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL--MLQLLE 128
             +HP+IV +    ++    V +VMEY E   L  ++   +     +    +   LQ  +
Sbjct: 57  RVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 129 GVKYLHD---NWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           GV YLH      ++HRDLK  NLLL   G VLKICDFG +    + +   T+   +  + 
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWM 170

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG--TTEVDQIDKIFKTLGTPT--ET 240
           APE+  G   YS   D++S G I+ E++ ++  F          +  +      P   + 
Sbjct: 171 APEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLIKN 228

Query: 241 IWPGLSEL 248
           +   +  L
Sbjct: 229 LPKPIESL 236

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  141 bits (357), Expect = 2e-39
 Identities = 42/272 (15%), Positives = 86/272 (31%), Gaps = 42/272 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
                + + EG +  VY A      +    +K  + V +  +  E+       + +  L 
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY---IGTQLMERLK 122

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK----QPFSTSEVKCLMLQL 126
                  +      +   +   +V E   +  L   +   K    +      V    +++
Sbjct: 123 PSMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQ-----------GVLKICDFGMSRQYGSPLKPYT 175
           L  ++ +HD  ++H D+K  N +L N              L + D G S      L P  
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK--LFPKG 239

Query: 176 SLVVTLW----YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT--------- 222
           ++         ++  E+L   K ++  +D + V   +  +L    +              
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 223 -----EVDQIDKIFKT-LGTPTETIWPGLSEL 248
                 +D  ++ F   L  P     P L  L
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  142 bits (359), Expect = 3e-39
 Identities = 74/325 (22%), Positives = 116/325 (35%), Gaps = 52/325 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E +  I  G +G V   R K + ++ A+K +      K     +        E +I+  
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-----FWEERDIMAF 125

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            + P +V +     DD   +YMVMEYM   DL  LM            +    +++  + 
Sbjct: 126 ANSPWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALD 182

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWYRAPELLL 190
            +H    +HRD+K  N+LL+  G LK+ DFG   +          + V T  Y +PE+L 
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 191 ---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
              G   Y    D WSVG  + E+L     F   + V    KI                 
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---------------- 286

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL--- 304
                    K         FP         +S+   +L+   LT D E R+  +      
Sbjct: 287 -------NHKNSL-----TFP-----DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 328

Query: 305 NHYWFHEVP--LPKSKDFMPTFPPQ 327
            H +F          +D +    P 
Sbjct: 329 RHLFFKNDQWAWETLRDTVAPVVPD 353

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  138 bits (349), Expect = 1e-38
 Identities = 68/305 (22%), Positives = 127/305 (41%), Gaps = 50/305 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + E L ++  GT G V++ R +K+G ++A+K+++ +  ++E+          L +++++L
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-------KRILMDLDVVL 78

Query: 72  -SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            S D P IV      + + D V++ ME M    + L + M+ P     +  + + +++ +
Sbjct: 79  KSHDCPYIVQCFGTFITNTD-VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 131 KYLHDNW-VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE-- 187
            YL +   V+HRD+K SN+LL+ +G +K+CDFG+S +                Y APE  
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSAGCAAYMAPERI 196

Query: 188 --LLLGAKKYSTAVDMWSVGCIMAEL-LAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
                    Y    D+WS+G  + EL   + P  +  T+ + + K+ +            
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ------------ 244

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                                        G    S      +   LT D  KR   +  L
Sbjct: 245 ----------------------EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282

Query: 305 NHYWF 309
            H + 
Sbjct: 283 EHSFI 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  137 bits (346), Expect = 4e-38
 Identities = 45/224 (20%), Positives = 104/224 (46%), Gaps = 25/224 (11%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +      + +G +G   +   +++GE++ +K++     R ++  +  F    L+E+ ++ 
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI----RFDEETQRTF----LKEVKVMR 62

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
             +HP+++    V+  D   +  + EY++   L+ +++SM   +  S+       +  G+
Sbjct: 63  CLEHPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--------------QYGSPLKPYTS 176
            YLH   ++HRDL + N L+     + + DFG++R                    K   +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           +V   ++ APE++ G + Y   VD++S G ++ E++ +      
Sbjct: 182 VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  140 bits (354), Expect = 1e-37
 Identities = 68/328 (20%), Positives = 134/328 (40%), Gaps = 55/328 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F     +  G +G V+  + K +G++ A KK+     +K    +      ++ E  IL  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG-----AMVEKKILAK 241

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---FSTSEVKCLMLQLLE 128
                IV++     +    + +VM  M   D+++ + ++ +    F          Q++ 
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G+++LH   +++RDLK  N+LL++ G ++I D G++ +  +          T  + APEL
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           LLG ++Y  +VD +++G  + E++A +  F    E  +  ++ +                
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---------------- 403

Query: 249 PGAKANFAKQPYNLLRK--RFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVD 301
                        +L +   +P          S +  D    LL  DPEKR+     + D
Sbjct: 404 ------------RVLEQAVTYP-------DKFSPASKDFCEALLQKDPEKRLGFRDGSCD 444

Query: 302 DALNHYWFHEVPLPK--SKDFMPTFPPQ 327
               H  F ++   +  +    P F P 
Sbjct: 445 GLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  134 bits (339), Expect = 2e-37
 Identities = 45/247 (18%), Positives = 96/247 (38%), Gaps = 24/247 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +   L K++E   G +++ R +  G  + +K +K+         ++        E   L 
Sbjct: 11  QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDF------NEECPRLR 62

Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLMLQLLE 128
            F HP+++ V             ++  +M +  L   L E        S+     L +  
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122

Query: 129 GVKYLH--DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           G+ +LH  +  +    L + +++++     +I    +   + S        +    + AP
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAP 177

Query: 187 ELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI-FKTLGTPT--ETI 241
           E L          + DMWS   ++ EL+ ++  F+  + ++   K+  + L  PT    I
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-RPTIPPGI 236

Query: 242 WPGLSEL 248
            P +S+L
Sbjct: 237 SPHVSKL 243

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  134 bits (340), Expect = 2e-37
 Identities = 49/221 (22%), Positives = 100/221 (45%), Gaps = 16/221 (7%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +     +I  G++G VY+ +    G+ VA+K + +     +    +        E+ +L 
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWH--GD-VAVKMLNVTAPTPQQLQAF------KNEVGVLR 75

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              H +I+            + +V ++ E   L   + + +  F   ++  +  Q   G+
Sbjct: 76  KTRHVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPEL 188
            YLH   ++HRDLK++N+ L+    +KI DFG++      S    +  L  ++ + APE+
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 189 LLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
           +    +  YS   D+++ G ++ EL+  +  +S     DQI
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  134 bits (339), Expect = 3e-37
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 15/214 (7%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +     KI  G++G V+RA     G  VA+K +       E   E+      LRE+ I+ 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEF------LREVAIMK 89

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLM--ESMKQPFSTSEVKCLMLQLLE 128
              HP+IV     V     ++ +V EY+    L  L+     ++         +   + +
Sbjct: 90  RLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148

Query: 129 GVKYLHDN--WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           G+ YLH+    ++HR+LK+ NLL++ +  +K+CDFG+SR   S      S   T  + AP
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           E+L   +  +   D++S G I+ EL   +  +  
Sbjct: 209 EVLRD-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  138 bits (350), Expect = 4e-37
 Identities = 62/325 (19%), Positives = 134/325 (41%), Gaps = 52/325 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F +   + +G +G V   + + +G++ A KK++    +K           +L E  IL  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-----ALNEKQILEK 240

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKW-LMESMKQPFSTSEVKCLMLQLLEGV 130
            +   +V++     +  D++ +V+  M   DLK+ +    +  F  +       ++  G+
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           + LH   +++RDLK  N+LL++ G ++I D G++       +     V T+ Y APE++ 
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVK 358

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIF-KTLGTPTETIWPGLSELP 249
             ++Y+ + D W++GC++ E++A +  F    +  + +++       P            
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------------ 405

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDAL 304
                          + +           S     L ++LL  DP +R+     +  +  
Sbjct: 406 ---------------EEYS-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443

Query: 305 NHYWFHEVPLPK--SKDFMPTFPPQ 327
            H  F ++   +  +    P F P 
Sbjct: 444 EHPLFKKLNFKRLGAGMLEPPFKPD 468

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  134 bits (339), Expect = 8e-37
 Identities = 79/307 (25%), Positives = 137/307 (44%), Gaps = 54/307 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+++  +  G++G V   + K+SG   A+K     +  K+  ++      +L E  IL 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMK-----ILDKQKVVKLKQIEHTLNEKRILQ 96

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           + + P +V ++    D+  ++YMVMEY+   ++   +  + + FS    +    Q++   
Sbjct: 97  AVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           +YLH   +++RDLK  NLL++ QG +++ DFG +++     + +T L  T    APE++L
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWT-LCGTPEALAPEIIL 211

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
             K Y+ AVD W++G ++ E+ A  P F     +   +KI                    
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------------- 253

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALN 305
                        + RFP          S    DLL  LL  D  KR       V+D  N
Sbjct: 254 -------------KVRFP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293

Query: 306 HYWFHEV 312
           H WF   
Sbjct: 294 HKWFATT 300

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  134 bits (339), Expect = 3e-35
 Identities = 69/331 (20%), Positives = 127/331 (38%), Gaps = 54/331 (16%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL- 71
           F     I  G +G VY  R   +G++ A+K +     + +          +L E  +L  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL-----ALNERIMLSL 245

Query: 72  --SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
             + D P IV +        D +  +++ M   DL + +      FS ++++    +++ 
Sbjct: 246 VSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIIL 303

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G++++H+ +V++RDLK +N+LL+  G ++I D G++    S  KP+   V T  Y APE+
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHA-SVGTHGYMAPEV 361

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L     Y ++ D +S+GC++ +LL     F      D+ +    TL              
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----------- 410

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDA 303
                              P          S     LL  LL  D  +R+        + 
Sbjct: 411 ----------------VELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447

Query: 304 LNHYWFHEVPLPK--SKDFMPTFPPQHARNK 332
               +F  +       + + P   P      
Sbjct: 448 KESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 478

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  129 bits (327), Expect = 3e-35
 Identities = 83/325 (25%), Positives = 135/325 (41%), Gaps = 55/325 (16%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F++ KL  + +GT+G V   R+K +G   A+K     + RKE  +       ++ E  +L
Sbjct: 7   FDYLKL--LGKGTFGKVILVREKATGRYYAMK-----ILRKEVIIAKDEVAHTVTESRVL 59

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
            +  HP +  +K      HD +  VMEY    +L + +   +  F+    +    +++  
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSA 117

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S      +   T  Y APE+L
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
                Y  AVD W +G +M E++  +  F         + I                E+ 
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------EEI- 222

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDAL--- 304
                           RFP         LS     LL  LL  DP++R+     DA    
Sbjct: 223 ----------------RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259

Query: 305 NHYWFHEVPLPK--SKDFMPTFPPQ 327
            H +F  +       K  +P F PQ
Sbjct: 260 EHRFFLSINWQDVVQKKLLPPFKPQ 284

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  128 bits (324), Expect = 7e-35
 Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 54/306 (17%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+ L  +  G++G V+  R + +G   A+K     V +KE  +       +  E  +L  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMK-----VLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP I+ +     D    ++M+M+Y+E  +L  L+   ++ F     K    ++   ++
Sbjct: 63  VTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALE 120

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   +++RDLK  N+LL+  G +KI DFG ++        YT L  T  Y APE++  
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT-LCGTPDYIAPEVVST 177

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K Y+ ++D WS G ++ E+LA    F  +  +   +KI                     
Sbjct: 178 -KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------------ 218

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNH 306
                         RFP       P  +E   DLL+RL+T D  +R+       +D  NH
Sbjct: 219 ------------ELRFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259

Query: 307 YWFHEV 312
            WF EV
Sbjct: 260 PWFKEV 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 1e-34
 Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 25/223 (11%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + E    I +G +G VY  R    GE VA++ + +    ++    +       RE+    
Sbjct: 34  QLEIGELIGKGRFGQVYHGRWH--GE-VAIRLIDIERDNEDQLKAF------KREVMAYR 84

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              H ++V      M     + ++    +   L  ++   K     ++ + +  ++++G+
Sbjct: 85  QTRHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLVVTLWYRA 185
            YLH   +LH+DLK+ N+  +N G + I DFG+       Q G            L + A
Sbjct: 144 GYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 186 PELL--------LGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
           PE++             +S   D++++G I  EL A++  F  
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (318), Expect = 2e-34
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E      I  G +G VYRA     G+ VA+K  + +                 +E  +  
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENV----RQEAKLFA 61

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP+I+ ++ V +    ++ +VME+     L  ++   + P     +    +Q+  G+
Sbjct: 62  MLKHPNIIALRGVCLK-EPNLCLVMEFARGGPLNRVLSGKRIPPDI--LVNWAVQIARGM 118

Query: 131 KYLHDN---WVLHRDLKTSNLLLNNQG--------VLKICDFGMSRQYGSPLKPYTSLVV 179
            YLHD     ++HRDLK+SN+L+  +         +LKI DFG++R++        S   
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAAG 176

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG 220
              + APE++     +S   D+WS G ++ ELL  +  F G
Sbjct: 177 AYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  126 bits (319), Expect = 6e-34
 Identities = 81/322 (25%), Positives = 141/322 (43%), Gaps = 52/322 (16%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F   K+  + +G++G V+ A  KK+ +  A+K       +K+  L       ++ E  +L
Sbjct: 19  FILHKM--LGKGSFGKVFLAEFKKTNQFFAIK-----ALKKDVVLMDDDVECTMVEKRVL 71

Query: 71  -LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
            L+++HP + ++        ++++ VMEY+   DL + +      F  S       +++ 
Sbjct: 72  SLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIIL 129

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G+++LH   +++RDLK  N+LL+  G +KI DFGM ++         +   T  Y APE+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           LLG +KY+ +VD WS G ++ E+L  +  F G  E +    I                  
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------DNP 235

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDALNHY 307
                             +P         L +   DLL +L   +PEKR+    D   H 
Sbjct: 236 -----------------FYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271

Query: 308 WFHEVPLPK--SKDFMPTFPPQ 327
            F E+   +   K+  P F P+
Sbjct: 272 LFREINWEELERKEIDPPFRPK 293

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  128 bits (323), Expect = 7e-34
 Identities = 85/327 (25%), Positives = 137/327 (41%), Gaps = 58/327 (17%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           FE+ KL  + +GT+G V   ++K +G   A+K +K     KE  +       +L E  +L
Sbjct: 150 FEYLKL--LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTENRVL 202

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
            +  HP +  +K      HD +  VMEY    +L + + S ++ FS    +    +++  
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSA 260

Query: 130 VKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + YLH +  V++RDLK  NL+L+  G +KI DFG+ ++         +   T  Y APE+
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L     Y  AVD W +G +M E++  +  F         + I                E+
Sbjct: 321 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------EEI 366

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDAL-- 304
                            RFP         L      LL+ LL  DP++R+    +DA   
Sbjct: 367 -----------------RFP-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI 402

Query: 305 -NHYWFHEV---PLPKSKDFMPTFPPQ 327
             H +F  +    +   K   P F PQ
Sbjct: 403 MQHRFFAGIVWQHV-YEKKLSPPFKPQ 428

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  130 bits (327), Expect = 1e-33
 Identities = 68/326 (20%), Positives = 134/326 (41%), Gaps = 56/326 (17%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F F  +  + +G++G V  +  K + E+ A+K     + +K+  ++      ++ E  +L
Sbjct: 343 FNFLMV--LGKGSFGKVMLSERKGTDELYAVK-----ILKKDVVIQDDDVECTMVEKRVL 395

Query: 71  -LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
            L    P +  +        D +Y VMEY+   DL + ++ + + F          ++  
Sbjct: 396 ALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAI 453

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           G+ +L    +++RDLK  N++L+++G +KI DFGM ++         +   T  Y APE+
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 513

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           +   + Y  +VD W+ G ++ E+LA +  F G  E +    I +               +
Sbjct: 514 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------------HNV 559

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDAL-- 304
                             +P         +S+    +   L+T  P KR+    +     
Sbjct: 560 -----------------AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595

Query: 305 -NHYWFHEVPLPK--SKDFMPTFPPQ 327
             H +F  +   K   K+  P + P+
Sbjct: 596 KEHAFFRYIDWEKLERKEIQPPYKPK 621

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  122 bits (309), Expect = 6e-33
 Identities = 66/214 (30%), Positives = 114/214 (53%), Gaps = 10/214 (4%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ ++K+  G    VY A D      VA+K + +    KE+ L+  F     RE++    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-F----EREVHNSSQ 67

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             H +IV++ +V  ++ D  Y+VMEY+E   L   +ES   P S         Q+L+G+K
Sbjct: 68  LSHQNIVSMIDVD-EEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIK 125

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELLL 190
           + HD  ++HRD+K  N+L+++   LKI DFG+++         T+ V+ T+ Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
           G +      D++S+G ++ E+L  +P F+G T V
Sbjct: 186 G-EATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  123 bits (311), Expect = 6e-33
 Identities = 80/329 (24%), Positives = 141/329 (42%), Gaps = 59/329 (17%)

Query: 11  FEFEKLNKISEGTYGIVYRAR---DKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
           FE  ++  + +G YG V++ R      +G+I A+K + K  + R      +     +  E
Sbjct: 19  FELLRV--LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-----TKAE 71

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            NIL    HP IV++          +Y+++EY+   +L   +   +  F        + +
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAE 129

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           +   + +LH   +++RDLK  N++LN+QG +K+ DFG+ ++         +   T+ Y A
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE+L+    ++ AVD WS+G +M ++L   P F+G      IDKI K             
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK------------- 235

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDA 303
            +L                   P       P L++   DLL +LL  +   R+     DA
Sbjct: 236 CKL-----------------NLP-------PYLTQEARDLLKKLLKRNAASRLGAGPGDA 271

Query: 304 L---NHYWFHEVPLPK--SKDFMPTFPPQ 327
                H +F  +   +  ++   P F P 
Sbjct: 272 GEVQAHPFFRHINWEELLARKVEPPFKPL 300

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  125 bits (314), Expect = 7e-33
 Identities = 88/370 (23%), Positives = 140/370 (37%), Gaps = 90/370 (24%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL--LSF 73
           + K+  G +  V+ + D +  + VA+K VK      E         ++L EI +L  +  
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---------TALDEIRLLKSVRN 92

Query: 74  DHPSIVNVKEVV--MD--DHDSVY-----MVMEYMEHDL-KWLMESMKQPFSTSEVKCLM 123
             P+  N + VV  +D      V      MV E + H L KW+++S  Q      VK ++
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 124 LQLLEGVKYLH-DNWVLHRDLKTSNLLLN------------------------------- 151
            Q+L+G+ YLH    ++H D+K  N+LL+                               
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 152 ------------------NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
                              +  +KI D G +       K +T  + T  YR+ E+L+G+ 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGSG 269

Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSG------TTEVDQIDKIFKTLGT-PTETI--WPG 244
            Y+T  D+WS  C+  EL     LF        T + D I  I + LG  P + I     
Sbjct: 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328

Query: 245 LSELPGAKANFAK----QPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV 300
             E    K +       +P+ L         ++          D L  +L   PEKR T 
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEA--AGFTDFLLPMLELIPEKRATA 386

Query: 301 DDALNHYWFH 310
            + L H W +
Sbjct: 387 AECLRHPWLN 396

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (320), Expect = 9e-33
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 18  KISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP 76
            I+ G  G +Y A D+  +G  V LK   +      +          + E   L    HP
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAM-A----MAERQFLAEVVHP 139

Query: 77  SIVNVKEVVMDDHDS----VYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           SIV +   V           Y+VMEY+    LK    S  Q    +E    +L++L  + 
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYLLEILPALS 196

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELLL 190
           YLH   +++ DLK  N++L  + + K+ D G   +  S        +  T  ++APE++ 
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS-----FGYLYGTPGFQAPEIVR 250

Query: 191 GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT 222
                + A D+++VG  +A L    P  +G  
Sbjct: 251 TGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  123 bits (310), Expect = 1e-32
 Identities = 65/315 (20%), Positives = 128/315 (40%), Gaps = 66/315 (20%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F F  +  + +G++G V  +  K + E+ A+K     + +K+  ++      ++ E  +L
Sbjct: 22  FNFLMV--LGKGSFGKVMLSERKGTDELYAVK-----ILKKDVVIQDDDVECTMVEKRVL 74

Query: 71  -LSFDHPSIVNVKEVVMDDH------DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL 122
            L    P +  +       H      D +Y VMEY+   DL + ++ + + F        
Sbjct: 75  ALPGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFY 126

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             ++  G+ +L    +++RDLK  N++L+++G +KI DFGM ++         +   T  
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
           Y APE++   + Y  +VD W+ G ++ E+LA +  F G  E +    I +          
Sbjct: 187 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---------- 235

Query: 243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TV 300
                +                  +P         +S+    +   L+T  P KR+    
Sbjct: 236 ---HNV-----------------AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGP 268

Query: 301 DDAL---NHYWFHEV 312
           +       H +F  +
Sbjct: 269 EGERDIKEHAFFRYI 283

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  122 bits (309), Expect = 2e-32
 Identities = 77/332 (23%), Positives = 142/332 (42%), Gaps = 67/332 (20%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           FEF ++  + +G++G V  AR K++G++ A+K     V +K+  L+      ++ E  IL
Sbjct: 25  FEFIRV--LGKGSFGKVMLARVKETGDLYAVK-----VLKKDVILQDDDVECTMTEKRIL 77

Query: 71  -LSFDHPSIVNVK-----EVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
            L+ +HP +  +             D ++ VME++   DL + ++  ++ F  +  +   
Sbjct: 78  SLARNHPFLTQLFCCFQTP------DRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYA 130

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
            +++  + +LHD  +++RDLK  N+LL+++G  K+ DFGM ++         +   T  Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE+L     Y  AVD W++G ++ E+L     F    E D  + I             
Sbjct: 191 IAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----------- 238

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI----- 298
              E+                  +P         L E    +L   +T +P  R+     
Sbjct: 239 --DEV-----------------VYP-------TWLHEDATGILKSFMTKNPTMRLGSLTQ 272

Query: 299 -TVDDALNHYWFHEVPLPK--SKDFMPTFPPQ 327
                 L H +F E+   +   +   P F P+
Sbjct: 273 GGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  122 bits (308), Expect = 2e-32
 Identities = 72/329 (21%), Positives = 137/329 (41%), Gaps = 61/329 (18%)

Query: 11  FEFEKLNKISEGTYGIVYRAR---DKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
           FE  K+  + +G++G V+  +      + ++ A+K + K  +  ++        + +  E
Sbjct: 26  FELLKV--LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-------VRTKME 76

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            +IL+  +HP IV +          +Y++++++   DL   +      F+  +VK  + +
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAE 134

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRA 185
           L   + +LH   +++RDLK  N+LL+ +G +K+ DFG+S++     K   S   T+ Y A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
           PE++   + ++ + D WS G +M E+L     F G    + +  I K             
Sbjct: 195 PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK------------- 240

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI--TVDDA 303
           ++L                   P         LS     LL  L   +P  R+    D  
Sbjct: 241 AKL-----------------GMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGV 276

Query: 304 L---NHYWFHEVPLPK--SKDFMPTFPPQ 327
                H +F  +   K   ++  P F P 
Sbjct: 277 EEIKRHSFFSTIDWNKLYRREIHPPFKPA 305

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  121 bits (305), Expect = 6e-32
 Identities = 74/334 (22%), Positives = 145/334 (43%), Gaps = 61/334 (18%)

Query: 11  FEFEKLNKISEGTYGIVYRAR---DKKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLRE 66
           FE  K+  +  G YG V+  R      +G++ A+K + K  + +K    E+     +  E
Sbjct: 56  FELLKV--LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-----TRTE 108

Query: 67  INILLSFDH-PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLML 124
             +L      P +V +          ++++++Y+   +L   + S ++ F+  EV+  + 
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYVG 166

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT-SLVVTLWY 183
           +++  +++LH   +++RD+K  N+LL++ G + + DFG+S+++ +           T+ Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226

Query: 184 RAPELLLGAKK-YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW 242
            AP+++ G    +  AVD WS+G +M ELL     F+   E +   +I +          
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276

Query: 243 PGLSELPGAKANFAKQPYNLLRK--RFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-- 298
                              +L+    +P         +S    DL+ RLL  DP+KR+  
Sbjct: 277 ------------------RILKSEPPYP-------QEMSALAKDLIQRLLMKDPKKRLGC 311

Query: 299 TVDDAL---NHYWFHEVPLPK--SKDFMPTFPPQ 327
              DA     H +F ++      +K     F P 
Sbjct: 312 GPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 345

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  121 bits (306), Expect = 8e-32
 Identities = 78/325 (24%), Positives = 133/325 (40%), Gaps = 55/325 (16%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F F K+  I +G++G V  AR K      A+K     V +K+  L+       + E N+L
Sbjct: 40  FHFLKV--IGKGSFGKVLLARHKAEEVFYAVK-----VLQKKAILKKKEEKHIMSERNVL 92

Query: 71  L-SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLE 128
           L +  HP +V +        D +Y V++Y+   +L + ++  +  F     +    ++  
Sbjct: 93  LKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIAS 150

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
            + YLH   +++RDLK  N+LL++QG + + DFG+ ++        ++   T  Y APE+
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L   + Y   VD W +G ++ E+L   P F      +  D I                 L
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------KPL 256

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDAL--- 304
                            +         P ++ S   LL  LL  D  KR+   DD +   
Sbjct: 257 -----------------QLK-------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292

Query: 305 NHYWFHEVPLPK--SKDFMPTFPPQ 327
           +H +F  +      +K   P F P 
Sbjct: 293 SHVFFSLINWDDLINKKITPPFNPN 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (299), Expect = 1e-31
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
             + L ++ +G +G V   R       +GE+VA+KK++ +                 REI
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--------EREI 62

Query: 68  NILLSFDHPSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            IL S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           + +G++YL     +HRDL T N+L+ N+  +KI DFG+++      + +           
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           WY APE L    K+S A D+WS G ++ EL 
Sbjct: 183 WY-APESLT-ESKFSVASDVWSFGVVLYELF 211

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  118 bits (299), Expect = 2e-31
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
             +++  + EG +G V   R       +GE VA+K +K   G               +EI
Sbjct: 22  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-------IADLKKEI 74

Query: 68  NILLSFDHPSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            IL +  H +IV  K +  +D  + + ++ME++    LK  +   K   +  +     +Q
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           + +G+ YL     +HRDL   N+L+ ++  +KI DFG+++   +  + YT          
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           WY APE L+   K+  A D+WS G  + ELL
Sbjct: 195 WY-APECLM-QSKFYIASDVWSFGVTLHELL 223

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (299), Expect = 2e-31
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
             + L ++ +G +G V   R       +GE+VA+KK++ +                 REI
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--------EREI 93

Query: 68  NILLSFDHPSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            IL S  H +IV  K V       ++ ++MEY+ +  L+  ++  K+     ++     Q
Sbjct: 94  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           + +G++YL     +HRDL T N+L+ N+  +KI DFG+++      + Y           
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           WY APE L    K+S A D+WS G ++ EL 
Sbjct: 214 WY-APESLT-ESKFSVASDVWSFGVVLYELF 242

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  118 bits (299), Expect = 4e-31
 Identities = 78/340 (22%), Positives = 137/340 (40%), Gaps = 74/340 (21%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+  ++  I  G+Y  V   R KK+  I A+K     V +KE   +         E ++ 
Sbjct: 11  FDLLRV--IGRGSYAKVLLVRLKKTDRIYAMK-----VVKKELVNDDEDIDWVQTEKHVF 63

Query: 71  -LSFDHPSIVNVKEVVMDDH------DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL 122
             + +HP +V +       H        ++ V+EY+   DL + M   ++       +  
Sbjct: 64  EQASNHPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFY 115

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             ++   + YLH+  +++RDLK  N+LL+++G +K+ D+GM ++   P    ++   T  
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 175

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-----DQIDKIFKTLGTP 237
           Y APE+L G + Y  +VD W++G +M E++A +  F           +  D +F+     
Sbjct: 176 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----- 229

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRK--RFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
                                   +L K  R P         LS     +L   L  DP+
Sbjct: 230 -----------------------VILEKQIRIP-------RSLSVKAASVLKSFLNKDPK 259

Query: 296 KRI------TVDDALNHYWFHEVPLPK--SKDFMPTFPPQ 327
           +R+         D   H +F  V       K  +P F P 
Sbjct: 260 ERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  119 bits (300), Expect = 6e-31
 Identities = 73/323 (22%), Positives = 133/323 (41%), Gaps = 72/323 (22%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           F+  ++  I  G+Y  V   R KK+  I A++     V +KE   +         E ++ 
Sbjct: 54  FDLLRV--IGRGSYAKVLLVRLKKTDRIYAMR-----VVKKELVNDDEDIDWVQTEKHVF 106

Query: 71  -LSFDHPSIVNVKEVVMDDH------DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCL 122
             + +HP +V +       H        ++ V+EY+   DL + M+  ++       +  
Sbjct: 107 EQASNHPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFY 158

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLW 182
             ++   + YLH+  +++RDLK  N+LL+++G +K+ D+GM ++   P    ++   T  
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 218

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-----DQIDKIFKTLGTP 237
           Y APE+L G + Y  +VD W++G +M E++A +  F           +  D +F+     
Sbjct: 219 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----- 272

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRK--RFPAASFTGSPVLSESGFDLLNRLLTYDPE 295
                                   +L K  R P         LS     +L   L  DP+
Sbjct: 273 -----------------------VILEKQIRIP-------RSLSVKAASVLKSFLNKDPK 302

Query: 296 KRI------TVDDALNHYWFHEV 312
           +R+         D   H +F  V
Sbjct: 303 ERLGCHPQTGFADIQGHPFFRNV 325

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  116 bits (292), Expect = 3e-30
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 20/211 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
             + ++++ +G +G V   R       +G +VA+K+++ +   ++            REI
Sbjct: 24  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--------QREI 75

Query: 68  NILLSFDHPSIVNVKEVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
            IL +     IV  + V       S+ +VMEY+    L+  ++  +     S +     Q
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           + +G++YL     +HRDL   N+L+ ++  +KI DFG+++        Y           
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           WY APE L     +S   D+WS G ++ EL 
Sbjct: 196 WY-APESLS-DNIFSRQSDVWSFGVVLYELF 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  118 bits (298), Expect = 4e-30
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 22/213 (10%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R+    +   K+  G YG VY    KK    VA+K +K +    E+     F    L+E 
Sbjct: 219 RTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----F----LKEA 267

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQ 125
            ++    HP++V +  V   +    Y++ E+M + +L  +L E  +Q  S   +  +  Q
Sbjct: 268 AVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           +   ++YL     +HR+L   N L+    ++K+ DFG+SR        YT+         
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIK 384

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
           W  APE L    K+S   D+W+ G ++ E+   
Sbjct: 385 WT-APESLA-YNKFSIKSDVWAFGVLLWEIATY 415

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  115 bits (290), Expect = 5e-30
 Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 42/226 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + + + +I +G YG V+  + +  GE VA+K             E         EI   +
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-EEASWFRE--------TEIYQTV 86

Query: 72  SFDHPSIVNVKEVVMDDHDSV---YMVMEYMEH-----DLKWLMESMKQPFSTSEVKCLM 123
              H +I+      +    S    Y++ +Y E+      LK              +  L 
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLA 140

Query: 124 LQLLEGVKYLHDNW--------VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--- 172
              + G+ +LH           + HRDLK+ N+L+   G   I D G++ ++ S      
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200

Query: 173 -PYTSLVVTLWYRAPELLLGA-----KKYSTAVDMWSVGCIMAELL 212
            P  + V T  Y  PE+L  +      +     DM+S G I+ E+ 
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (288), Expect = 5e-30
 Identities = 49/222 (22%), Positives = 81/222 (36%), Gaps = 34/222 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +   L  + +G YG V+R   +  GE VA+K        K    E         E+   +
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR-DEKSWFRE--------TELYNTV 57

Query: 72  SFDHPSIVNVKEVVMDDHDS---VYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
              H +I+      M    S   ++++  Y E   L   +        T     ++L + 
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115

Query: 128 EGVKYLHDNW--------VLHRDLKTSNLLLNNQGVLKICDFGMSR----QYGSPLKPYT 175
            G+ +LH           + HRDLK+ N+L+   G   I D G++               
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 176 SLVVTLWYRAPELLLGA-----KKYSTAVDMWSVGCIMAELL 212
             V T  Y APE+L              VD+W+ G ++ E+ 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (287), Expect = 1e-29
 Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 10/207 (4%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
            +  G  G VY A D     IVALK +   +                RE         P 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-M----QREARTAGRLQEPH 95

Query: 78  IVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
           +V + +    D   +Y+ M  +   DL  ++   + P +      ++ Q+   +   H  
Sbjct: 96  VVPIHDFGEID-GQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV-TLWYRAPELLLGAKKY 195
              HRD+K  N+L++      + DFG++              V TL+Y APE        
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHA 212

Query: 196 STAVDMWSVGCIMAELLAKKPLFSGTT 222
           +   D++++ C++ E L   P + G  
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQ 239

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  114 bits (288), Expect = 1e-29
 Identities = 48/233 (20%), Positives = 89/233 (38%), Gaps = 34/233 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
                  I +G +G V+R + +  GE VA+K        +    E         EI   +
Sbjct: 43  TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-EERSWFRE--------AEIYQTV 91

Query: 72  SFDHPSIVNVKEVVMDDHDSV---YMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
              H +I+        D+ +    ++V +Y EH  L   +   +   +   +  L L   
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTA 149

Query: 128 EGVKYLHDNW--------VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK----PYT 175
            G+ +LH           + HRDLK+ N+L+   G   I D G++ ++ S          
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 176 SLVVTLWYRAPELLLGA-----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTE 223
             V T  Y APE+L  +      +     D++++G +  E+  +  +     +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (285), Expect = 2e-29
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 20/207 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +    +K+  G YG VY    KK    VA+K +K +    E+     F    L+E  ++ 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----F----LKEAAVMK 64

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLEG 129
              HP++V +  V   +    Y++ E+M + +L  +L E  +Q  S   +  +  Q+   
Sbjct: 65  EIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRA 185
           ++YL     +HRDL   N L+    ++K+ DFG+SR        YT+         W  A
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT-A 180

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELL 212
           PE L    K+S   D+W+ G ++ E+ 
Sbjct: 181 PESLA-YNKFSIKSDVWAFGVLLWEIA 206

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (286), Expect = 2e-29
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
             +K+  + EG +G V        +  +GE+VA+K +K + G +             +EI
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-------RSGWKQEI 84

Query: 68  NILLSFDHPSIVNVKEVVMDDH-DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
           +IL +  H  I+  K    D    S+ +VMEY+    L+  +   +     +++     Q
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQ 142

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           + EG+ YLH    +HRDL   N+LL+N  ++KI DFG+++      + Y           
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           WY APE L    K+  A D+WS G  + ELL
Sbjct: 203 WY-APECLK-EYKFYYASDVWSFGVTLYELL 231

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (285), Expect = 3e-29
 Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 14/219 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E    +  G    V+ ARD +    VA+K ++ ++ R        F     RE     +
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-F----RREAQNAAA 68

Query: 73  FDHPSIVNV---KEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLE 128
            +HP+IV V    E         Y+VMEY++   L+ ++ + + P +      ++    +
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQ 127

Query: 129 GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP--YTSLVV-TLWYRA 185
            + + H N ++HRD+K +N++++    +K+ DFG++R           T+ V+ T  Y +
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV 224
           PE   G        D++S+GC++ E+L  +P F+G + V
Sbjct: 188 PEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  111 bits (281), Expect = 5e-29
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K +   +       F    L E +++ 
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA------F----LAEASVMT 69

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM    L  +L    +       +    L + E 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS--PLKPYTSLVVTLW 182
           ++YL  N  +HRDL   N+L++   V K+ DFG+++     Q     P+K         W
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------W 180

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
             APE L   KK+ST  D+WS G ++ E+ 
Sbjct: 181 T-APEALR-EKKFSTKSDVWSFGILLWEIY 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  113 bits (285), Expect = 1e-28
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K +   +       F    L E +++ 
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA------F----LAEASVMT 241

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM    L  +L    +       +    L + E 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS--PLKPYTSLVVTLW 182
           ++YL  N  +HRDL   N+L++   V K+ DFG+++     Q     P+K         W
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------W 352

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
             APE L   KK+ST  D+WS G ++ E+ + 
Sbjct: 353 T-APEALR-EKKFSTKSDVWSFGILLWEIYSF 382

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  113 bits (284), Expect = 2e-28
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
                 K+ +G +G V+      +   VA+K +K      E      F    L+E  ++ 
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA-----F----LQEAQVMK 234

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLEG 129
              H  +V +  VV ++   +Y+V EYM    L  +L     +     ++  +  Q+  G
Sbjct: 235 KLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRA 185
           + Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+         W  A
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWT-A 349

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAK 214
           PE  L   +++   D+WS G ++ EL  K
Sbjct: 350 PEAAL-YGRFTIKSDVWSFGILLTELTTK 377

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  113 bits (285), Expect = 3e-28
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           R     E   K+ +G +G V+      +   VA+K +K      E      F    L+E 
Sbjct: 266 RESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA-----F----LQEA 313

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQ 125
            ++    H  +V +  VV ++   +Y+V EYM    L  +L     +     ++  +  Q
Sbjct: 314 QVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---- 181
           +  G+ Y+     +HRDL+ +N+L+    V K+ DFG++R        YT+         
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIK 429

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK 214
           W  APE  L   +++   D+WS G ++ EL  K
Sbjct: 430 WT-APEAAL-YGRFTIKSDVWSFGILLTELTTK 460

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (283), Expect = 3e-28
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             +   K+  G +G V+ A   K  + VA+K +K      E      F    L E N++ 
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA-----F----LAEANVMK 238

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
           +  H  +V +  VV  +   +Y++ E+M     L +L           ++     Q+ EG
Sbjct: 239 TLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRA 185
           + ++     +HRDL+ +N+L++   V KI DFG++R        YT+         W  A
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWT-A 353

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELL 212
           PE +     ++   D+WS G ++ E++
Sbjct: 354 PEAIN-FGSFTIKSDVWSFGILLMEIV 379

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (277), Expect = 4e-28
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 21/229 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
                  I  G  G V   R +  G+    VA+K +K     ++      F    L E +
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ---RRDF----LSEAS 102

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
           I+  FDHP+I+ ++ VV        +V EYME+  L   + +    F+  ++  ++  + 
Sbjct: 103 IMGQFDHPNIIRLEGVVTRG-RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WY 183
            G++YL D   +HRDL   N+L+++  V K+ DFG+SR          +         W 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTEVDQIDKI 230
            APE +   + +S+A D+WS G +M E+    ++P +   T  D I  +
Sbjct: 222 -APEAIA-FRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  109 bits (274), Expect = 6e-28
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 20/212 (9%)

Query: 16  LNKISEGTYGIVYRARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
              I  G +G VY      +       A+K +       E           L E  I+  
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-------VSQFLTEGIIMKD 82

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           F HP+++++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K
Sbjct: 83  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTL---WYRAP 186
           YL     +HRDL   N +L+ +  +K+ DFG++R          +      L   W  A 
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-AL 201

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           E L   +K++T  D+WS G ++ EL      P
Sbjct: 202 ESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  110 bits (277), Expect = 9e-28
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 34/220 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +     +I  G +G V+  R +    +VA+K  +  +               L+E  IL 
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL-------KAKFLQEARILK 167

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            + HP+IV +  V       +Y+VME ++  D    + +         +  ++     G+
Sbjct: 168 QYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGS-------PLKPYTSLV 178
           +YL     +HRDL   N L+  + VLKI DFGMSR      Y +       P+K      
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK------ 280

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
              W  APE L    +YS+  D+WS G ++ E   L   P
Sbjct: 281 ---WT-APEALN-YGRYSSESDVWSFGILLWETFSLGASP 315

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (271), Expect = 9e-28
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 20/206 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E   + +I  G +G+V+        + VA+K ++     +ED     F    + E  +++
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED-----F----IEEAEVMM 58

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L + EG+
Sbjct: 59  KLSHPKLVQLYGVCLEQ-APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRAP 186
            YL +  V+HRDL   N L+    V+K+ DFGM+R        YTS   T     W  +P
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWA-SP 174

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELL 212
           E+     +YS+  D+WS G +M E+ 
Sbjct: 175 EVFS-FSRYSSKSDVWSFGVLMWEVF 199

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  110 bits (276), Expect = 1e-27
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 23/233 (9%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSL 64
            +    +K   +  G +G V   R K   +    VA+K +K+    K+      F    L
Sbjct: 44  ATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDF----L 94

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
            E +I+  FDHP+I+ ++ VV      V +V EYME+  L   +      F+  ++  ++
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL-- 181
             +  G+KYL D   +HRDL   N+L+N+  V K+ DFG+ R      +   +       
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 182 --WYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTEVDQIDKI 230
             W  +PE +   +K+++A D+WS G ++ E+    ++P +   +  D I  +
Sbjct: 214 IRWT-SPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  109 bits (274), Expect = 1e-27
 Identities = 56/229 (24%), Positives = 83/229 (36%), Gaps = 41/229 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             + L  I  G YG VY+         VA+K       R+    E        + I  + 
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA-NRQNFINE--------KNIYRVP 62

Query: 72  SFDHPSIVN----VKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQL 126
             +H +I       + V  D      +VMEY  +  L   +              L   +
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120

Query: 127 LEGVKYLHDNW---------VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY--- 174
             G+ YLH            + HRDL + N+L+ N G   I DFG+S +           
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 175 -----TSLVVTLWYRAPELLLGA------KKYSTAVDMWSVGCIMAELL 212
                 S V T+ Y APE+L GA      +     VDM+++G I  E+ 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  108 bits (271), Expect = 1e-27
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 22/212 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +   L ++  G +G+V   + +   + VA+K +K     +++     F    + E  +++
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE-----F----IEEAKVMM 74

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           +  H  +V +  V       ++++ EYM +  L   +  M+  F T ++  +   + E +
Sbjct: 75  NLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRAP 186
           +YL     LHRDL   N L+N+QGV+K+ DFG+SR        YTS V +     W   P
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWS-PP 190

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           E+L+   K+S+  D+W+ G +M E+  L K P
Sbjct: 191 EVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  107 bits (270), Expect = 2e-27
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E   L ++  G +G+V   + K   + VA+K +K     +++     F     +E   ++
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDE-----F----FQEAQTMM 58

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP +V    V   +   +Y+V EY+ +  L   + S  +    S++  +   + EG+
Sbjct: 59  KLSHPKLVKFYGVCSKE-YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRAP 186
            +L  +  +HRDL   N L++    +K+ DFGM+R        Y S V T     W  AP
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWS-AP 174

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTEVDQIDKI 230
           E+     KYS+  D+W+ G +M E+  L K P +   T  + + K+
Sbjct: 175 EVFH-YFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (269), Expect = 2e-27
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 18  KISEGTYGIVYRARDKKSGEI--VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           ++  G +G V +   +   +   VA+K +K    + +           +RE  I+   D+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------TEEMMREAQIMHQLDN 69

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V   +  ++ +VME      L   +   ++    S V  L+ Q+  G+KYL 
Sbjct: 70  PYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRAPELLL 190
           +   +HRDL   N+LL N+   KI DFG+S+  G+    YT+         WY APE + 
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECIN 186

Query: 191 GAKKYSTAVDMWSVGCIMAELL 212
             +K+S+  D+WS G  M E L
Sbjct: 187 -FRKFSSRSDVWSYGVTMWEAL 207

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  108 bits (271), Expect = 3e-27
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR---DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREI 67
           EF+K+  +  G +G VY+     + +  +I VA+K+++     K            L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEI----LDEA 68

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQL 126
            ++ S D+P +  +  + +    +V ++ + M    L   +   K    +  +    +Q+
Sbjct: 69  YVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---WY 183
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    +   W 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 -ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (268), Expect = 4e-27
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             + + ++  G +G V+        + VA+K +K      +      F    L E N++ 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA-----F----LAEANLMK 63

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQLLEG 129
              H  +V +  VV  +   +Y++ EYME+  L  +L        + +++  +  Q+ EG
Sbjct: 64  QLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRA 185
           + ++ +   +HRDL+ +N+L+++    KI DFG++R        YT+         W  A
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWT-A 178

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           PE +     ++   D+WS G ++ E+    + P
Sbjct: 179 PEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  107 bits (268), Expect = 8e-27
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 22/230 (9%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEI----VALKKVKMNVGRKEDCLEYGFPISSLREI 67
              +   I  G +G VY+   K S       VA+K +K     K+      F    L E 
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDF----LGEA 97

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQL 126
            I+  F H +I+ ++ V+      + ++ EYME+  L   +      FS  ++  ++  +
Sbjct: 98  GIMGQFSHHNIIRLEGVISKY-KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----W 182
             G+KYL +   +HRDL   N+L+N+  V K+ DFG+SR      +   +         W
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTEVDQIDKI 230
             APE +   +K+++A D+WS G +M E+    ++P +   +  + +  I
Sbjct: 217 T-APEAIS-YRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (274), Expect = 9e-27
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 18  KISEGTYGIVYRAR-DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           ++  G +G V +     +  +I VA+K +K    + +           +RE  I+   D+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------TEEMMREAQIMHQLDN 395

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P IV +  V     +++ +VME        K+L+   ++    S V  L+ Q+  G+KYL
Sbjct: 396 PYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL 452

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRAPELL 189
            +   +HR+L   N+LL N+   KI DFG+S+  G+    YT+         WY APE +
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECI 511

Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
              +K+S+  D+WS G  M E L
Sbjct: 512 N-FRKFSSRSDVWSYGVTMWEAL 533

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 1e-26
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 20/212 (9%)

Query: 16  LNKISEGTYGIVYRARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
              I  G +G VY      +       A+K +       E           L E  I+  
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-------VSQFLTEGIIMKD 146

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           F HP+++++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTL----WYRAP 186
           +L     +HRDL   N +L+ +  +K+ DFG++R  Y        +         W  A 
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-AL 265

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           E L   +K++T  D+WS G ++ EL      P
Sbjct: 266 ESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  105 bits (265), Expect = 1e-26
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 20/203 (9%)

Query: 18  KISEGTYGIVYRA--RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           ++  G +G V +   + KK  + VA+K +K          E       L E N++   D+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL------LAEANVMQQLDN 77

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
           P IV +  +   +  S  +VME  E     K+L ++  +      +  L+ Q+  G+KYL
Sbjct: 78  PYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 133

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WYRAPELL 189
            ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y +         WY APE +
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 192

Query: 190 LGAKKYSTAVDMWSVGCIMAELL 212
               K+S+  D+WS G +M E  
Sbjct: 193 N-YYKFSSKSDVWSFGVLMWEAF 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (264), Expect = 1e-26
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 12  EFEKLNKISEGTYGIVYRA--RDKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           +   L K+ +G++G+V R          + VA+K +K +V  + + ++  F    +RE+N
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DF----IREVN 73

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
            + S DH +++ +  VV+     + MV E      L   +   +  F    +    +Q+ 
Sbjct: 74  AMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WY 183
           EG+ YL     +HRDL   NLLL  + ++KI DFG+ R        Y           W 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            APE L   + +S A D W  G  + E+ 
Sbjct: 192 -APESLK-TRTFSHASDTWMFGVTLWEMF 218

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =  105 bits (263), Expect = 3e-26
 Identities = 39/276 (14%), Positives = 81/276 (29%), Gaps = 58/276 (21%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C    + ++  KI EG +G V++         VA+K + +      +          L E
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73

Query: 67  INILLSF---------DHPSIVNVKEVVM-----------------------------DD 88
           I I                  + +  V                                 
Sbjct: 74  IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 89  HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW-VLHRDLKTSN 147
            D +++V+E+    +  L +   +  S +  K ++ QL   +     +    HRDL   N
Sbjct: 134 DDQLFIVLEFEFGGID-LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 148 LLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCI 207
           +LL    + K+      +    P       ++               Y+ +        +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID--------------YTLSRLERDGIVV 238

Query: 208 MAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
             ++   + LF+G  + D    I++ +       W 
Sbjct: 239 FCDVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWG 272

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (260), Expect = 5e-26
 Identities = 41/229 (17%), Positives = 82/229 (35%), Gaps = 43/229 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEI-------VALKKVKMNVGRKEDCLEYGFPISSL 64
           +      + +GT+  +++   ++ G+        V LK +       +    Y    S  
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD------KAHRNY--SESFF 60

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
              +++    H  +V    V +   D   +V E+++   L   ++  K   +      + 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCG-DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLN--------NQGVLKICDFGMSRQ------YGS 169
            QL   + +L +N ++H ++   N+LL         N   +K+ D G+S           
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179

Query: 170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            +          W   PE +   K  + A D WS G  + E+     KP
Sbjct: 180 RIP---------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  104 bits (260), Expect = 7e-26
 Identities = 50/237 (21%), Positives = 96/237 (40%), Gaps = 35/237 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             + L   + G +G V++A+     E VA+K   +   ++    E         E+  L 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSWQNE--------YEVYSLP 73

Query: 72  SFDHPSIVNVKEVVMDDHDSV---YMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLMLQL 126
              H +I+                +++  + E   L  +L        S +E+  +   +
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAETM 130

Query: 127 LEGVKYLHDNW----------VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY-- 174
             G+ YLH++           + HRD+K+ N+LL N     I DFG++ ++ +       
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 175 TSLVVTLWYRAPELLLGA----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI 227
              V T  Y APE+L GA    +     +DM+++G ++ EL ++     G  +   +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  103 bits (258), Expect = 9e-26
 Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 24/229 (10%)

Query: 12  EFEKLNKISEGTYGIVYRA--RDKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           +      + EG +G VY     + K  +I VA+K  K +                + E  
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-------KEKFMSEAV 65

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
           I+ + DHP IV +  ++ ++    +++ME   + +L   +E  K       +    LQ+ 
Sbjct: 66  IMKNLDHPHIVKLIGIIEEE--PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL----WY 183
           + + YL     +HRD+   N+L+ +   +K+ DFG+SR      + Y    VT     W 
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKWM 181

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTEVDQIDKI 230
            +PE +   ++++TA D+W     M E+    K+P F      D I  +
Sbjct: 182 -SPESIN-FRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVL 227

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  102 bits (257), Expect = 1e-25
 Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 30/232 (12%)

Query: 12  EFEKLNKISEGTYGIVYRA--RDKKSGEI-VALKKVK---MNVGRKEDCLEYGFPISSLR 65
             E    I EG +G V++      ++  + VA+K  K    +  R++      F    L+
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------F----LQ 65

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLML 124
           E   +  FDHP IV +  V+ ++   V+++ME     +L+  ++  K     + +     
Sbjct: 66  EALTMRQFDHPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL--- 181
           QL   + YL     +HRD+   N+L+++   +K+ DFG+SR        Y          
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKGKLPI 181

Query: 182 -WYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKPLFSGTTEVDQIDKI 230
            W  APE +   +++++A D+W  G  M E+     KP F G    D I +I
Sbjct: 182 KWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  102 bits (257), Expect = 2e-25
 Identities = 50/220 (22%), Positives = 100/220 (45%), Gaps = 20/220 (9%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRA--RDKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSL 64
                      I +G +G+VY     D+    I  A+K +      ++         + L
Sbjct: 18  HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-------VEAFL 70

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
           RE  ++   +HP+++ +  +++      ++++ YM H DL   + S ++  +  ++    
Sbjct: 71  REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR-----QYGSPLKPYTSLV 178
           LQ+  G++YL +   +HRDL   N +L+    +K+ DFG++R     +Y S  +   + +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
              W  A E L    +++T  D+WS G ++ EL      P
Sbjct: 191 PVKWT-ALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (258), Expect = 2e-25
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 12  EFEKLNKISEGTYGIVYRAR---DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREI 67
           EF+K+  +  G +G VY+     + +  +I VA+K+++     K            L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEI----LDEA 68

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQL 126
            ++ S D+P +  +  + +    +V ++ + M    L   +   K    +  +    +Q+
Sbjct: 69  YVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL---WY 183
            +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    +   W 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELL 212
            A E +L  + Y+   D+WS G  + EL+
Sbjct: 187 -ALESIL-HRIYTHQSDVWSYGVTVWELM 213

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  102 bits (255), Expect = 2e-25
 Identities = 30/223 (13%), Positives = 54/223 (24%), Gaps = 38/223 (17%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           L           ++A D      VAL  V       +D         +L     L   D 
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD-----VLQETLSRTLRLSRIDK 90

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P +  V +VV        +V E++    L+ + ++   P         M  L       H
Sbjct: 91  PGVARVLDVV-HTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAH 146

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK 194
              V       S + ++  G + +              P                     
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPA----TMPDANPQD------------------- 183

Query: 195 YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
                D+  +G  +  LL  +           +    +     
Sbjct: 184 -----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  102 bits (256), Expect = 3e-25
 Identities = 47/218 (21%), Positives = 92/218 (42%), Gaps = 37/218 (16%)

Query: 12  EFEKLNKISEGTYGIVYRAR---DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREI 67
           E  KL  +  G +G V++     + +S +I V +K ++   GR+          +    +
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------FQAVTDHM 66

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQL 126
             + S DH  IV +  +      S+ +V +Y+    L   +   +       +    +Q+
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS------------PLKPY 174
            +G+ YL ++ ++HR+L   N+LL +   +++ DFG++                 P+K  
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-- 182

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
                  W  A E +    KY+   D+WS G  + EL+
Sbjct: 183 -------WM-ALESIH-FGKYTHQSDVWSYGVTVWELM 211

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (260), Expect = 7e-25
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 25/219 (11%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSL 64
           R   E  +   I EG +G V++            VA+K  K             F    L
Sbjct: 389 RERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKF----L 439

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLM 123
           +E   +  FDHP IV +  V+ ++   V+++ME     +L+  ++  K     + +    
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL-- 181
            QL   + YL     +HRD+   N+L+++   +K+ DFG+SR        Y         
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKGKLP 555

Query: 182 --WYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
             W  APE +   +++++A D+W  G  M E+     KP
Sbjct: 556 IKWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGVKP 592

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (251), Expect = 2e-24
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 50/231 (21%)

Query: 16  LNKISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
             ++ +G++G+VY        K   E  VA+K V      +E        I  L E +++
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-------RIEFLNEASVM 82

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------WLMESMKQPFSTSEVK 120
             F+   +V +  VV        ++ME M   DLK              +  P S S++ 
Sbjct: 83  KEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS---------- 169
            +  ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R  Y +          
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 170 -PLKPYTSLVVTLWYRAPE-LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            P++         W  +PE L  G   ++T  D+WS G ++ E+  LA++P
Sbjct: 202 LPVR---------WM-SPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQP 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  100 bits (250), Expect = 2e-24
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 45/229 (19%)

Query: 16  LNKISEGTYGIVYRA--RDKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
              + +G +G V  A  + +    + VA+K +K ++    D  E+      LRE   +  
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF------LREAACMKE 81

Query: 73  FDHPSIVNVKEVVMDD-----HDSVYMVMEYMEH-DLK-WLMES----MKQPFSTSEVKC 121
           FDHP +  +  V +            +++ +M+H DL  +L+ S             +  
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 122 LMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS----------- 169
            M+ +  G++YL     +HRDL   N +L     + + DFG+SR+ Y             
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           P+K         W  A E L     Y+   D+W+ G  M E+    + P
Sbjct: 202 PVK---------WL-ALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 44/228 (19%)

Query: 16  LNKISEGTYGIVYRARDKKSGEI---VALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
              + EG +G V     K+       VA+K +K++   + +  E+      L E   +  
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF------LSEAACMKD 92

Query: 73  FDHPSIVNVKEVVMDDH----DSVYMVMEYMEH-DLK-WL----MESMKQPFSTSEVKCL 122
           F HP+++ +  V ++          +++ +M++ DL  +L    +E+  +      +   
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS-----------P 170
           M+ +  G++YL +   LHRDL   N +L +   + + DFG+S++ Y             P
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           +K         W  A E L   + Y++  D+W+ G  M E+      P
Sbjct: 213 VK---------WI-AIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.5 bits (241), Expect = 2e-23
 Identities = 52/237 (21%), Positives = 92/237 (38%), Gaps = 56/237 (23%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           + ++ E  +G VY+         +  + VA+K +K             F      E  + 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL---REEF----RHEAMLR 66

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK--------WLMESMKQPFSTSEVKC 121
               HP++V +  VV  D   + M+  Y  H DL                    T +   
Sbjct: 67  ARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 122 LMLQLL-------EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS---- 169
                +        G++YL  + V+H+DL T N+L+ ++  +KI D G+ R+ Y +    
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 170 -------PLKPYTSLVVTLWYRAPE-LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                  P++         W  APE ++ G  K+S   D+WS G ++ E+     +P
Sbjct: 186 LLGNSLLPIR---------WM-APEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 56/236 (23%)

Query: 16  LNKISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
             ++ EG +G V+ A       +  ++ VA+K +K     +    ++       RE  +L
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDF------QREAELL 97

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK--------------WLMESMKQPFS 115
               H  IV    V  +    + MV EYM H DL                  +    P  
Sbjct: 98  TMLQHQHIVRFFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGS----- 169
             ++  +  Q+  G+ YL     +HRDL T N L+    V+KI DFGMSR  Y +     
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216

Query: 170 ------PLKPYTSLVVTLWYRAPE-LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                 P++         W   PE +L    K++T  D+WS G ++ E+    K+P
Sbjct: 217 GGRTMLPIR---------WM-PPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 95.8 bits (239), Expect = 5e-23
 Identities = 65/230 (28%), Positives = 95/230 (41%), Gaps = 43/230 (18%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
             ++ EG +G V+ A        K   +VA+K +K             F     RE  +L
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDF----QREAELL 71

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------------WLMESMKQPF 114
            +  H  IV    V  D  D + MV EYM+H DL                      K   
Sbjct: 72  TNLQHEHIVKFYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKP 173
             S++  +  Q+  G+ YL     +HRDL T N L+    ++KI DFGMSR  Y +    
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-- 188

Query: 174 YTSLVVTL----WYRAPE-LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
           Y     T+    W   PE ++    K++T  D+WS G I+ E+    K+P
Sbjct: 189 YRVGGHTMLPIRWM-PPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 50/231 (21%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  +  G +G VY  +     +  S   VA+K +      ++        +  L E  I+
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-------ELDFLMEALII 87

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMES-----MKQPFSTSEVKCLM 123
             F+H +IV    V +      +++ME M   DLK +L E+          +  ++  + 
Sbjct: 88  SKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVT 180
             +  G +YL +N  +HRD+   N LL   G   V KI DFGM+R           +   
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD----------IYRA 196

Query: 181 LWYR------------APE-LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            +YR             PE  + G   +++  D WS G ++ E+  L   P
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMP 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 50/231 (21%)

Query: 16  LNKISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  +  G +G VY  +          + VA+K +      ++        +  L E  I+
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-------ELDFLMEALII 128

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-WLMES-----MKQPFSTSEVKCLM 123
             F+H +IV    V +      ++++E M   DLK +L E+          +  ++  + 
Sbjct: 129 SKFNHQNIVRCIGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 124 LQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSPLKPYTSLVVT 180
             +  G +YL +N  +HRD+   N LL   G   V KI DFGM+R           +   
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD----------IYRA 237

Query: 181 LWYR------------APE-LLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            +YR             PE  + G   +++  D WS G ++ E+  L   P
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMP 286

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 49/230 (21%)

Query: 17  NKISEGTYGIVYRARDKKSGE--IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF- 73
           + I EG +G V +AR KK G     A+K++K    + +             E+ +L    
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLG 83

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------------WLMESMKQPFSTS 117
            HP+I+N+          +Y+ +EY  H +L                 +  S     S+ 
Sbjct: 84  HHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ---YGS----- 169
           ++      +  G+ YL     +HRDL   N+L+    V KI DFG+SR    Y       
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202

Query: 170 -PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
            P++         W  A E L     Y+T  D+WS G ++ E+  L   P
Sbjct: 203 LPVR---------WM-AIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 64/245 (26%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +  I EG +G V++AR       +   +VA+K +K          +  F     RE  ++
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADF----QREAALM 104

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-----------------------WL 106
             FD+P+IV +  V       + ++ EYM + DL                         +
Sbjct: 105 AEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 107 MESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
                 P S +E  C+  Q+  G+ YL +   +HRDL T N L+    V+KI DFG+SR 
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 167 -YGS-----------PLKPYTSLVVTLWYRAPE-LLLGAKKYSTAVDMWSVGCIMAEL-- 211
            Y +           P++         W   PE +     +Y+T  D+W+ G ++ E+  
Sbjct: 224 IYSADYYKADGNDAIPIR---------WM-PPESIFYN--RYTTESDVWAYGVVLWEIFS 271

Query: 212 LAKKP 216
              +P
Sbjct: 272 YGLQP 276

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 62/244 (25%)

Query: 16  LNKISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
              + EG +G V +A       ++G   VA+K +K N    E           L E N+L
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-------LRDLLSEFNVL 80

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-----------------------WL 106
              +HP ++ +      D   + +++EY ++  L+                        L
Sbjct: 81  KQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 107 MESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
               ++  +  ++     Q+ +G++YL +  ++HRDL   N+L+     +KI DFG+SR 
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 167 -YGS-----------PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL--L 212
            Y             P+K         W  A E L     Y+T  D+WS G ++ E+  L
Sbjct: 200 VYEEDSYVKRSQGRIPVK---------WM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTL 248

Query: 213 AKKP 216
              P
Sbjct: 249 GGNP 252

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.1 bits (219), Expect = 4e-20
 Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 54/237 (22%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
              +  G +G V  A         +   VA+K +K      E           + E+ IL
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRAL----MSELKIL 84

Query: 71  LSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------------WLMESMKQP 113
           +    H ++VN+          + +++E+ +  +L                   +  K  
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 114 FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP 173
            +   + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R        
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-------- 196

Query: 174 YTSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
              +     Y             APE +   + Y+   D+WS G ++ E+  L   P
Sbjct: 197 --DIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP 250

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 52/239 (21%), Positives = 86/239 (35%), Gaps = 57/239 (23%)

Query: 16  LNKISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
              +  G +G V  A      K    + VA+K +K +    E         + + E+ +L
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------REALMSELKVL 80

Query: 71  LSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK----------WLMESMKQPFSTSE 118
               +H +IVN+            ++ EY  + DL              ++        E
Sbjct: 81  SYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 119 VKCLMLQLL-------EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
           +   +  LL       +G+ +L     +HRDL   N+LL +  + KICDFG++R      
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD----- 194

Query: 172 KPYTSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                +     Y             APE +     Y+   D+WS G  + EL  L   P
Sbjct: 195 -----IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 52/239 (21%), Positives = 93/239 (38%), Gaps = 57/239 (23%)

Query: 16  LNKISEGTYGIVYRAR-------DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
              + EG +G V  A          K    VA+K +K +   K+           + E+ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-------LSDLVSEME 92

Query: 69  ILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------------WLMESMK 111
           ++     H +I+N+      D   +Y+++EY    +L+                +    +
Sbjct: 93  MMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 112 QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
           +  +  ++     QL  G++YL     +HRDL   N+L+    V+KI DFG++R      
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD----- 206

Query: 172 KPYTSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                +    +Y+            APE L   + Y+   D+WS G +M E+  L   P
Sbjct: 207 -----INNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 85.9 bits (213), Expect = 3e-19
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 35/273 (12%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI  G +G +   ++  + E VA+K   M     +  LEY       R    L S D   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEY-------RFYKQLGSGDG-- 66

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           I  V            MV+E +   L+ L +   + FS   V  + +QL+  ++Y+H   
Sbjct: 67  IPQVYYFGPCG-KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 138 VLHRDLKTSNLLL-----NNQGVLKICDFGMSRQYGS-------PLKPYTSLVVTLWYRA 185
           +++RD+K  N L+       Q V+ I DF ++++Y         P + + SL  T  Y +
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPL----FSGTTEVDQIDKIFKT-LGTPTET 240
               LG K+ S   D+ ++G +    L +  L        T  ++  KI  T   TP E 
Sbjct: 186 INTHLG-KEQSRRDDLEALGHMFMYFL-RGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243

Query: 241 IWPGLSELPG----AKA-NFAKQP-YNLLRKRF 267
           +     E+       +  +F ++P Y+ LRK F
Sbjct: 244 LCENFPEMATYLRYVRRLDFFEKPDYDYLRKLF 276

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 52/239 (21%), Positives = 91/239 (38%), Gaps = 57/239 (23%)

Query: 16  LNKISEGTYGIVYRAR-------DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
              + EG +G V  A          K    VA+K +K +   K+           + E+ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD---LSDL----VSEME 138

Query: 69  ILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------------WLMESMK 111
           ++     H +I+N+      D   +Y+++EY    +L+                +    +
Sbjct: 139 MMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 112 QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
           +  +  ++     QL  G++YL     +HRDL   N+L+    V+KI DFG++R      
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------ 251

Query: 172 KPYTSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                      Y+            APE L   + Y+   D+WS G +M E+  L   P
Sbjct: 252 DINNIDY----YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP 305

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 84.8 bits (210), Expect = 8e-19
 Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 14/162 (8%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEY----------GFPISSLREI 67
           KI  G +G++Y A      E  A   VK+   ++   L               I    E 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             L     P                +MVME +  DL+ +       F  S V  L +++L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-FKKSTVLQLGIRML 161

Query: 128 EGVKYLHDNWVLHRDLKTSNLLL--NNQGVLKICDFGMSRQY 167
           + ++Y+H+N  +H D+K +NLLL   N   + + D+G+S +Y
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 55/278 (19%), Positives = 105/278 (37%), Gaps = 44/278 (15%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-P 76
           +I EG++G+++   +  + + VA+K                       E           
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----------QLRDEYRTYKLLAGCT 66

Query: 77  SIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN 136
            I NV     +      +V++ +   L+ L++   + FS   V     Q+L  V+ +H+ 
Sbjct: 67  GIPNVYYFGQEG-LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 137 WVLHRDLKTSNLLL-----NNQGVLKICDFGMSRQYGSPLK----PYT---SLVVTLWYR 184
            +++RD+K  N L+      N  ++ + DFGM + Y  P+     PY    +L  T  Y 
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPL----FSGTTEVDQIDKIFKT-LGTPTE 239
           +    LG ++ S   D+ ++G +    L +  L        T   + ++I +    TP  
Sbjct: 186 SINTHLG-REQSRRDDLEALGHVFMYFL-RGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 240 TIWPGLSELPGA---------KANFAKQP-YNLLRKRF 267
            +    +  P              F   P Y+ L+  F
Sbjct: 244 EL---CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 20/176 (11%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS 77
           KI  G++G +Y   + ++ E VA+K   +     +   E        R +          
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI----YRILQ-----GGTG 64

Query: 78  IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW 137
           I NV+   ++  D   +VM+ +   L+ L     +  S   V  L  Q++  V+++H   
Sbjct: 65  IPNVRWFGVEG-DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 138 VLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGS-------PLKPYTSLVVTLWY 183
            LHRD+K  N L+        + I DFG++++Y         P +   +L  T  Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 38/274 (13%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL-REINILLSFDH- 75
           KI  G++G +Y   D  +GE VA+K   +                 L  E  I       
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGG 64

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD 135
             I  ++    +  D   MVME +   L+ L     + FS   V  L  Q++  ++Y+H 
Sbjct: 65  VGIPTIRWCGAEG-DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 136 NWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLK----PYT---SLVVTLWYRA 185
              +HRD+K  N L+       ++ I DFG++++Y         PY    +L  T  Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPL----FSGTTEVDQIDKIFKT-LGTPTET 240
               LG  + S   D+ S+G ++        L        T+  + ++I +  + TP E 
Sbjct: 184 INTHLG-IEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241

Query: 241 IWPGL-SELPG-----AKANFAKQP-YNLLRKRF 267
           +  G  SE            F  +P Y+ LR+ F
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 52/236 (22%), Positives = 84/236 (35%), Gaps = 55/236 (23%)

Query: 16  LNKISEGTYGIVYRAR----DKKSGEI-VALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
              +  G +G V  A      K+   + VA+K +K      E         + + E+ I+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-------KEALMSELKIM 103

Query: 71  LSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK-------------WLMESMKQPFS 115
                H +IVN+          V ++ EY  + DL                        S
Sbjct: 104 SHLGQHENIVNLLGACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 116 TSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPY 174
           T ++     Q+ +G+ +L     +HRD+   N+LL N  V KI DFG++R          
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---- 218

Query: 175 TSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                   Y             APE +     Y+   D+WS G ++ E+  L   P
Sbjct: 219 -------NYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 50/239 (20%), Positives = 93/239 (38%), Gaps = 57/239 (23%)

Query: 16  LNKISEGTYGIVYRAR-------DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
              + EG +G V  A               VA+K +K +   K+           + E+ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-------LSDLISEME 126

Query: 69  ILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK---------------WLMESMK 111
           ++     H +I+N+      D   +Y+++EY    +L+                   + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 112 QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL 171
           +  S+ ++     Q+  G++YL     +HRDL   N+L+    V+KI DFG++R      
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD----- 240

Query: 172 KPYTSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--LAKKP 216
                +    +Y+            APE L   + Y+   D+WS G ++ E+  L   P
Sbjct: 241 -----IHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 46/286 (16%), Positives = 96/286 (33%), Gaps = 37/286 (12%)

Query: 17  NKISEGTYGIVYRARDKKSG--------EIVALK--KVKMNVGRKEDCLEYGFPISSLRE 66
           +  +    GI+Y A    +         +  +LK       +  +++  +       + +
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQ 125
              L S    +I       +      ++V+  +   L+  ++   K   S   V  +  +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLL--NNQGVLKICDFGMSRQYGSPLK--PY-----TS 176
           LL+ +++LH+N  +H ++   N+ +   +Q  + +  +G + +Y    K   Y     + 
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227

Query: 177 LVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL----FSGTTEVDQIDKI-F 231
               L + + +L  G    S   D+ S+G  M + L    L        TE     K  F
Sbjct: 228 HEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWL-YGFLPWTNCLPNTEDIMKQKQKF 285

Query: 232 KTLGTPTETIWPGLSELPGAKANFAK---------QP-YNLLRKRF 267
                P                 + K         +P Y +LR   
Sbjct: 286 VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 53/244 (21%), Positives = 90/244 (36%), Gaps = 62/244 (25%)

Query: 16  LNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
              +  G +G V  A             VA+K +K      E         + + E+ ++
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-------REALMSELKMM 102

Query: 71  LSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLK--------------WLMESMKQPF 114
                H +IVN+          +Y++ EY  + DL                  E+ K+  
Sbjct: 103 TQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 115 STSEVKCL-MLQLL-------EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ 166
              ++  L    LL       +G+++L     +HRDL   N+L+ +  V+KICDFG++R 
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 167 YGSPLKPYTSLVVTLWYR------------APELLLGAKKYSTAVDMWSVGCIMAEL--L 212
                     ++    Y             APE L     Y+   D+WS G ++ E+  L
Sbjct: 222 ----------IMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSL 270

Query: 213 AKKP 216
              P
Sbjct: 271 GVNP 274

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 54/287 (18%), Positives = 104/287 (36%), Gaps = 41/287 (14%)

Query: 18  KISEGTYGIVYRARDKKSGEI-----VALKKVKMNVGRKEDCLEYGF-----PISSLREI 67
            I +G +G +Y A    S  +       +K    + G      E  F         +++ 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQIQKW 99

Query: 68  NILLSFDHPSIVNVK---EVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLML 124
                  +  +           +     +M+M+    DL+ + E+  + FS   V  L L
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLN--NQGVLKICDFGMSRQYGS-------PLKPYT 175
           ++L+ ++Y+H++  +H D+K SNLLLN  N   + + D+G++ +Y            P  
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL----FSGTTEVDQIDKI- 230
               T+ + + +   G    S   D+  +G  M + L    L         +  +  KI 
Sbjct: 220 CHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWL-TGHLPWEDNLKDPKYVRDSKIR 277

Query: 231 FKTLGTPTETIWPGLSELPGAKAN---------FAKQP-YNLLRKRF 267
           ++             +  PG  A          + ++P Y  LR   
Sbjct: 278 YRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 28/187 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNV--GRKEDCLEYGFPISSLREINIL 70
           F+    I  G +G VY+    + G  VALK+       G +E      F      EI  L
Sbjct: 41  FDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE------F----ETEIETL 89

Query: 71  LSFDHPSIVNVKEVVM----DDHDSVYMVMEYMEH-DLK-WLMESMKQPFSTSEVKCLML 124
               HP +V+     +    D+ + + ++ +YME+ +LK  L  S     S S  + L +
Sbjct: 90  SFCRHPHLVS-----LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 125 QL--LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV--T 180
            +    G+ YLH   ++HRD+K+ N+LL+   V KI DFG+S++     + + S VV  T
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 181 LWYRAPE 187
           L Y  PE
Sbjct: 205 LGYIDPE 211

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 68.3 bits (168), Expect = 3e-13
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 54/230 (23%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNV------GRKEDCLEYGFPI 61
                    NK+ EG +G+VY+     +   VA+KK+   V       +++      F  
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQ------F-- 77

Query: 62  SSLREINILLSFDHPSIVNVKEVVMDDHDS--VYMVMEYMEHD--LKWLMESMKQPFSTS 117
              +EI ++    H ++V +     D  D   VY    YM +   L  L      P    
Sbjct: 78  --DQEIKVMAKCQHENLVELLGFSSDGDDLCLVY---VYMPNGSLLDRLSCLDGTP---- 128

Query: 118 EVKCLMLQLLE-------------GVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS 164
                    L              G+ +LH+N  +HRD+K++N+LL+     KI DFG++
Sbjct: 129 --------PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 165 RQYGSPLKPYTSLVV--TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELL 212
           R      +   +  +  T  Y APE L G  + +   D++S G ++ E++
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEII 228

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.1 bits (144), Expect = 4e-10
 Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 35/222 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F   N +  G +G VY+ R    G +VA+K++K    +  + L++        E+ ++  
Sbjct: 32  FSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGE-LQF------QTEVEMISM 83

Query: 73  FDHPSIVNVKEVVMDDHDS--VYMVMEYMEHD--LKWLMESMKQ--PFSTSEVKCLMLQL 126
             H +++ ++   M   +   VY    YM +      L E  +   P    + + + L  
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVY---PYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140

Query: 127 LEGVKYLHDNW---VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY------TSL 177
             G+ YLHD+    ++HRD+K +N+LL+ +    + DFG+++     L  Y      T++
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAV 195

Query: 178 VVTLWYRAPE-LLLGAKKYSTAVDMWSVGCIMAELLA-KKPL 217
             T+ + APE L  G  K S   D++  G ++ EL+  ++  
Sbjct: 196 RGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAF 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 23/139 (16%)

Query: 85  VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLK 144
                  V         + +   +  K   +   + C   Q+ +G+++L     +HRDL 
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 220

Query: 145 TSNLLLNNQGVLKICDFGMSRQYGS------------PLKPYTSLVVTLWYRAPELLLGA 192
             N+LL+ + V+KICDFG++R                PLK         W  APE +   
Sbjct: 221 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK---------WM-APETIFD- 269

Query: 193 KKYSTAVDMWSVGCIMAEL 211
           + Y+   D+WS G ++ E+
Sbjct: 270 RVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 35/217 (16%), Positives = 72/217 (33%), Gaps = 32/217 (14%)

Query: 11  FEF--EKL---NKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFP 60
           +EF  ++L     +  G +G V  A         +   VA+K +K      E        
Sbjct: 17  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL---- 72

Query: 61  ISSLREINILLSFD-HPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSE 118
              + E+ IL+    H ++VN+          + +++E+ +  +L   + S +  F    
Sbjct: 73  ---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF--VP 127

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV 178
            K    +  +G  Y+     +  DLK     + +        F   +      +      
Sbjct: 128 YKTKGARFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK 215
           +   +   E L+           + V   M  L ++K
Sbjct: 185 LYKDFLTLEHLICY--------SFQVAKGMEFLASRK 213

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 4e-05
 Identities = 58/361 (16%), Positives = 105/361 (29%), Gaps = 104/361 (28%)

Query: 53  DC---LEYGFPISSLREINILLSFDHP--SIVNVKEVVMDDHDSVY--MVMEYMEHDLKW 105
           DC    +    I S  EI+ ++         + +   ++   + +    V E +  + K+
Sbjct: 34  DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF 93

Query: 106 LMESMK------------------------QPFSTSEV--KCLMLQLLEGVKYL--HDNW 137
           LM  +K                        Q F+   V      L+L + +  L    N 
Sbjct: 94  LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153

Query: 138 VLHRDL---KTS--NLLLNNQGVLKICDFGM----SRQYGSP---LKPYTSLVVTL---- 181
           ++   L   KT     +  +  V    DF +     +   SP   L+    L+  +    
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213

Query: 182 ----------------WYRAPELLLGAKKYSTAV----DMWSVGCIMAELLAKKPLFSGT 221
                                  LL +K Y   +    ++ +     A  L+ K L   T
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL--T 271

Query: 222 TE----VDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPY-NLLRKRFPAASFTGSP 276
           T      D +     T     +     L+     K+   K  Y +   +  P    T +P
Sbjct: 272 TRFKQVTDFLSAA-TTTHISLDHHSMTLTP-DEVKSLLLK--YLDCRPQDLPREVLTTNP 327

Query: 277 -VLSESGFDLLNRLLTYDPEKRITVD----------DALN------HYW----FHE-VPL 314
             LS     + + L T+D  K +  D          + L        +     F     +
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387

Query: 315 P 315
           P
Sbjct: 388 P 388

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	332
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.98
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.68
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.51
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.32
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.86
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.63
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.41
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.28
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.26
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.23
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.17
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.9
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.45
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.29
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.42
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.38
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.63

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.4e-65  Score=436.57  Aligned_cols=268  Identities=26%  Similarity=0.390  Sum_probs=230.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||+||+|++..+++.||||++.+.......     ....+.+|+.++++++||||+++++++. 
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~-  102 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSRLDHPFFVKLYFTFQ-  102 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            3467899999999999999999999999999999999864322111     1225679999999999999999999994 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ++..+|||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            55889999999987 55555544 67899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ....  .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+...++.+.....       
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------  253 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF-------  253 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            6432  233456789999999999987 678999999999999999999999999998888888887643221       


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH------HhcCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD------ALNHYWFHEVPLPKSK  318 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------ll~hp~f~~~~~~~~~  318 (332)
                                                    +..+|+++++||.+||++||++|||++|      |++||||++++|...+
T Consensus       254 ------------------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          254 ------------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             ------------------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             ------------------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence                                          1237999999999999999999999988      6899999999999886


Q ss_pred             CC
Q 035861          319 DF  320 (332)
Q Consensus       319 ~~  320 (332)
                      ..
T Consensus       304 ~~  305 (311)
T 4aw0_A          304 QQ  305 (311)
T ss_dssp             GS
T ss_pred             CC
Confidence            54

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-64  Score=425.28  Aligned_cols=260  Identities=28%  Similarity=0.446  Sum_probs=208.2

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +..+++|++++.||+|+||+||+|++..+++.||||++.+........     ...+.+|+.++++++||||+++++++.
T Consensus         9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A            9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDM-----QGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------C-----HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHH-----HHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            445789999999999999999999999999999999997654332221     225779999999999999999999994


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       ++...|+||||++|++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        84 -~~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           84 -SKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             -CSSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             -ECCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence             5588999999999999888776 67899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .... ......+||+.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+.......         
T Consensus       162 ~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~---------  231 (275)
T 3hyh_A          162 MTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL---------  231 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------
T ss_pred             cCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            5432 334567899999999999885556789999999999999999999999988877777766542211         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                  +..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus       232 ----------------------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          232 ----------------------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----------------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                                        1237999999999999999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-63  Score=432.34  Aligned_cols=260  Identities=27%  Similarity=0.464  Sum_probs=223.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|+++++||+|+||+||+|++..+|+.||||++.......        ...+.+|+.+++.++||||+++++++.++ .
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVG-D  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEET-T
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-C
Confidence            46999999999999999999999999999999997654322        12567999999999999999999999554 8


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .+|||||||+|+.+..+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus       145 ~~~ivmEy~~gg~L~~~l~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEEEeCCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            8999999999754444444 357999999999999999999999999999999999999999999999999999887655


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.........           
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~-----------  291 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK-----------  291 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS-----------
T ss_pred             CCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC-----------
Confidence            555667899999999999977 67899999999999999999999999998888877776553221111           


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                             .+..+|+++++||.+||+.||++|||++|+|+||||++...+
T Consensus       292 -----------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          292 -----------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             -----------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             -----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence                                   112379999999999999999999999999999999986543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-64  Score=431.44  Aligned_cols=271  Identities=26%  Similarity=0.446  Sum_probs=222.3

Q ss_pred             hhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|++++.||+|+||+||+|++.   .+++.||||++.........      ...+.+|+.++++++||||+++++++.
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEEEEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            468999999999999999999874   46789999999765432211      124568999999999999999999995


Q ss_pred             cCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      + +..+|+|||||+|+ |.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus        97 ~-~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A           97 T-EGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             E-TTEEEEEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             E-CCEEEEEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence            4 48899999999964 445444 46789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ............+||+.|+|||++.+ ..++.++|+|||||++|+|+||..||.+.+..+....+.+.....        
T Consensus       175 ~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------  245 (304)
T 3ubd_A          175 ESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--------  245 (304)
T ss_dssp             C-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             eccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------
Confidence            76544455567789999999999987 678999999999999999999999999998888888776542211        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC--C
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS--K  318 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~--~  318 (332)
                                                   ++.+|+++++||.+||+.||++|||     ++|+++||||++++|...  +
T Consensus       246 -----------------------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~  296 (304)
T 3ubd_A          246 -----------------------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRR  296 (304)
T ss_dssp             -----------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred             -----------------------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhC
Confidence                                         1237999999999999999999998     589999999999988765  3


Q ss_pred             CCCCCCCC
Q 035861          319 DFMPTFPP  326 (332)
Q Consensus       319 ~~~~~~~~  326 (332)
                      +..|+|.|
T Consensus       297 ~~~pP~~P  304 (304)
T 3ubd_A          297 EIHPPFKP  304 (304)
T ss_dssp             CSCCSSCC
T ss_pred             CCCcCcCC
Confidence            45566655

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4e-62  Score=433.61  Aligned_cols=260  Identities=27%  Similarity=0.463  Sum_probs=224.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|+++++||+|+||+||+|++..+|+.||||++.......        ...+.+|+.+|+.++||||+++++++.++ .
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVG-D  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEET-T
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEEC-C
Confidence            46999999999999999999999999999999997653222        12567999999999999999999999555 8


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .+|||||||+|+.+..+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus       222 ~~~iVmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEEEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            8999999999755554544 457999999999999999999999999999999999999999999999999999887655


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........            
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~------------  367 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL------------  367 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------------
T ss_pred             CccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC------------
Confidence            556677899999999999987 6789999999999999999999999999888887777655322111            


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                            .....+|+++++||.+||..||++|||++|+|+||||++...+
T Consensus       368 ----------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          368 ----------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             ----------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             ----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence                                  1123379999999999999999999999999999999985543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-63  Score=433.10  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=216.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||+||+|++..+|+.||||++.........      ...+.+|+.++++++||||+++++++.+ 
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIV~~~~~~~~-   94 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE------REESRREVAVLANMKHPNIVQYRESFEE-   94 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH------HHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH------HHHHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence            467999999999999999999999999999999999865433221      1256799999999999999999999954 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      +..+|||||||+| +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence            4889999999986 6666665433 4579999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++.....++.        
T Consensus       175 ~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~--------  245 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV--------  245 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             ecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--------
Confidence            6432222345679999999999987 6789999999999999999999999999998888888776432211        


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                  +..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       246 ----------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          246 ----------------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ----------------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                                        2237999999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-61  Score=416.62  Aligned_cols=261  Identities=25%  Similarity=0.318  Sum_probs=215.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..+.|++.++||+|+||+||+|++..+|+.||||++.....             ..+|+.+++.++||||+++++++.+ 
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~-  121 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVRE-  121 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEE-
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence            34578899999999999999999999999999999975321             2379999999999999999999954 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~~~  167 (332)
                      +..+|||||||+|+.+..+....+.+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+..
T Consensus       122 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            488999999999744444444467899999999999999999999999999999999999999988 6999999999876


Q ss_pred             CCCCC-----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          168 GSPLK-----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       168 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .....     .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......      
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------  274 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP------  274 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG------
T ss_pred             cCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC------
Confidence            43211     1234579999999999987 67899999999999999999999999887666555555543110      


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHH-------------hcCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA-------------LNHYWF  309 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el-------------l~hp~f  309 (332)
                                                  ....++.+++.+.+||.+||++||.+|||+.|+             |+|||+
T Consensus       275 ----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~  326 (336)
T 4g3f_A          275 ----------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK  326 (336)
T ss_dssp             ----------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred             ----------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence                                        011234489999999999999999999999998             689999


Q ss_pred             CCCCCCCCC
Q 035861          310 HEVPLPKSK  318 (332)
Q Consensus       310 ~~~~~~~~~  318 (332)
                      .+...|+.+
T Consensus       327 ~~~~~Pr~n  335 (336)
T 4g3f_A          327 GEYKEPRGN  335 (336)
T ss_dssp             SSCCCCCC-
T ss_pred             CCCCCCCCC
Confidence            998877654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=423.55  Aligned_cols=291  Identities=37%  Similarity=0.653  Sum_probs=236.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (332)
                      ++|++++.||+|+||+||+|++..+|+.||||++.........      ...+.+|+.+|+.++||||+.+++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN------AKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH------HHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH------HHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            4799999999999999999999999999999999654332211      1246789999999999999999998743   


Q ss_pred             --CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 --DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 --~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                        +....|||||||+|++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       128 ~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          128 YGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence              3367899999999998777765 6789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC----CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSP----LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .....    .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.++...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65322    22345678999999999998867789999999999999999999999999999999999999888887665


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      +..........          ....++...    ....+.+++++++||.+||.+||.+|||++|+|+||||++.+.++.
T Consensus       287 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~  356 (398)
T 4b99_A          287 IQAVGAERVRA----------YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD  356 (398)
T ss_dssp             TC-----CHHH----------HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhh----------hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence            54432211100          000000000    0112347899999999999999999999999999999999886654


Q ss_pred             C
Q 035861          318 K  318 (332)
Q Consensus       318 ~  318 (332)
                      .
T Consensus       357 ~  357 (398)
T 4b99_A          357 E  357 (398)
T ss_dssp             S
T ss_pred             c
Confidence            4

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-60  Score=406.40  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             cc-cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---
Q 035861           12 EF-EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---   87 (332)
Q Consensus        12 ~y-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (332)
                      +| ++.++||+|+||+||+|.+..++..||+|++.........      ...+.+|+.++++++||||+++++++.+   
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   99 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH------HHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH------HHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence            44 6778899999999999999999999999999865433221      1257799999999999999999998843   


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcC-CCcEEEeecccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNN-QGVLKICDFGMS  164 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~-~~~~~l~df~~~  164 (332)
                      +...+|||||||+|+.+..+....+.+++..+..++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|
T Consensus       100 ~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            24568999999997544444445778999999999999999999999999  999999999999985 789999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      +....  ......+||+.|+|||++.+  .++.++||||||+++|+|+||..||..........+.......+.      
T Consensus       180 ~~~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~------  249 (290)
T 3fpq_A          180 TLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------  249 (290)
T ss_dssp             GGCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------
T ss_pred             EeCCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC------
Confidence            86433  33456789999999999875  589999999999999999999999987655444333322111110      


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                  ..++.+++++++||.+||+.||++|||++|+|+||||++
T Consensus       250 ----------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 ----------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                        011236889999999999999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.1e-59  Score=399.40  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=194.9

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      +.+.+|++++.||+|+||+||+|+++.+++.||||++.......  .     ...+.+|+.++++++||||+++++.+.+
T Consensus         2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~-----~~~~~~E~~il~~l~HpnIV~~~~~~~~   74 (299)
T 4g31_A            2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--A-----REKVMREVKALAKLEHPGIVRYFNAWLE   74 (299)
T ss_dssp             HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH--H-----HHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH--H-----HHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            45779999999999999999999999999999999997543211  1     1256799999999999999999999864


Q ss_pred             CC-----------CeEEEEcccccccHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC
Q 035861           88 DH-----------DSVYMVMEYMEHDLKWLMESMKQP---FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ  153 (332)
Q Consensus        88 ~~-----------~~~~lv~e~~~~~l~~~~~~~~~~---l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~  153 (332)
                      .+           ...|+|||||+|+.+..+......   .++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred             cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC
Confidence            43           247999999987544444443433   4556788999999999999999999999999999999999


Q ss_pred             CcEEEeecccccccCCCCC------------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 035861          154 GVLKICDFGMSRQYGSPLK------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT  221 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~  221 (332)
                      +.+||+|||+|+.......            .....+||+.|+|||++.+ ..++.++|||||||++|+|++   ||...
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            9999999999987643211            1234579999999999987 679999999999999999995   77543


Q ss_pred             ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH
Q 035861          222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD  301 (332)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  301 (332)
                      ..  ....+...........                                 .+..++.+.+||.+||+.||++|||+.
T Consensus       231 ~~--~~~~~~~~~~~~~p~~---------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~  275 (299)
T 4g31_A          231 ME--RVRTLTDVRNLKFPPL---------------------------------FTQKYPCEYVMVQDMLSPSPMERPEAI  275 (299)
T ss_dssp             HH--HHHHHHHHHTTCCCHH---------------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cH--HHHHHHHHhcCCCCCC---------------------------------CcccCHHHHHHHHHHcCCChhHCcCHH
Confidence            22  2222221111000000                                 011466778999999999999999999


Q ss_pred             HHhcCCCCCCCCCCC
Q 035861          302 DALNHYWFHEVPLPK  316 (332)
Q Consensus       302 ell~hp~f~~~~~~~  316 (332)
                      |+|+||||+++++|.
T Consensus       276 eil~h~~~~~~~~p~  290 (299)
T 4g31_A          276 NIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHTSGGGCCC----
T ss_pred             HHhcCHhhCCCCCCC
Confidence            999999999988765

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-57  Score=421.46  Aligned_cols=279  Identities=21%  Similarity=0.364  Sum_probs=224.7

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...+++|++++.||+|+||+||+|++..+|+.||||++.+...........  ......++.+++.++||||+.+++.+ 
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~--~~~E~~~l~ll~~~~HP~IV~l~~~f-  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDCPFIVCMSYAF-  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHH--HHHHHHHHHHHSSSCCTTBCCEEEEE-
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHH--HHHHHHHHHHHhhCCCCCEeEEEEEE-
Confidence            457889999999999999999999999999999999997643211111000  00112345667778999999999999 


Q ss_pred             cCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ++...+|+|||||+|+ |.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EECCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence            4458899999999974 555544 46789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  242 (332)
                      .....  .....+||+.|+|||++..+..++.++|+|||||++|+|++|..||.+.+.   ......+.....       
T Consensus       341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-------  411 (689)
T 3v5w_A          341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------  411 (689)
T ss_dssp             ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-------
T ss_pred             ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-------
Confidence            76443  234568999999999997656799999999999999999999999975432   222222222111       


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~  317 (332)
                                                    ..+..+|+++++||.+||+.||.+|++     ++||++||||++++|...
T Consensus       412 ------------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          412 ------------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             ------------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             ------------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence                                          112338999999999999999999998     799999999999999876


Q ss_pred             --CCCCCCCCCcc
Q 035861          318 --KDFMPTFPPQH  328 (332)
Q Consensus       318 --~~~~~~~~~~~  328 (332)
                        +...++|.|..
T Consensus       462 ~~~~~~pP~~P~~  474 (689)
T 3v5w_A          462 FLQKYPPPLIPPR  474 (689)
T ss_dssp             HTTCSCCSCCCCT
T ss_pred             HcCCCCcCccCCC
Confidence              45677888754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-56  Score=394.27  Aligned_cols=290  Identities=28%  Similarity=0.433  Sum_probs=210.4

Q ss_pred             chhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      .-++|++++.||+|+||+||+|+++   .+++.||||.+......          ..+.+|+.+++.+ .||||+.++++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~----------~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP----------IRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH----------HHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH----------HHHHHHHHHHHHhcCCCCCceEEEE
Confidence            3467999999999999999999874   46789999998654221          1456899999988 69999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeecc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFG  162 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df~  162 (332)
                      +.+ ....|+||||++| ++.+.+    +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus        89 ~~~-~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           89 FRK-NDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEE-TTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEE-CCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            954 4889999999986 555544    359999999999999999999999999999999999999877 799999999


Q ss_pred             cccccCCCC----------------------------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhC
Q 035861          163 MSRQYGSPL----------------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK  214 (332)
Q Consensus       163 ~~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg  214 (332)
                      +|+......                            ......+||+.|+|||++.+...++.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997543211                            1123457999999999998766789999999999999999999


Q ss_pred             CCCCCC-CChHHHHHHHHHHcCCCCCCcccC-C-------CCCcccc--------ccccCCchhhhhh-hCCCCccCCCC
Q 035861          215 KPLFSG-TTEVDQIDKIFKTLGTPTETIWPG-L-------SELPGAK--------ANFAKQPYNLLRK-RFPAASFTGSP  276 (332)
Q Consensus       215 ~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~-~-------~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~  276 (332)
                      +.||.. .+..+.+..+....+.+....... .       ...+...        ............. .........+.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            999954 455566666665443221100000 0       0000000        0000000000000 00011123345


Q ss_pred             CCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          277 VLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       277 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .+|+++++||++||..||++|+|++|+|+||||++++
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            6899999999999999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-56  Score=382.48  Aligned_cols=255  Identities=21%  Similarity=0.248  Sum_probs=201.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.++||+|+||+||+|++..   .||||+++......+.      ...+.+|+.++++++||||+++++++ .+ 
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~l~g~~-~~-  103 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQ------FQAFRNEVAVLRKTRHVNILLFMGYM-TK-  103 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHH------HHHHHHHHHHHTTCCCTTBCCEEEEE-CS-
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHH------HHHHHHHHHHHHhCCCCCEeeEEEEE-EC-
Confidence            4688899999999999999998753   5999998754332221      12578999999999999999999987 44 


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...+||||||+| +|.+.+......+++..+..++.|||.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            457899999995 5666666666789999999999999999999999999999999999999999999999999997653


Q ss_pred             CC--CCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          169 SP--LKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       169 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..  ........||+.|+|||++..  ...++.++||||||+++|||+||..||...+.......+.......+.     
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-----  258 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-----  258 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----
Confidence            22  223345689999999999964  246899999999999999999999999887665555444432111110     


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                ....++.+++++.+|+.+||+.||++|||+.||+++
T Consensus       259 --------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          259 --------------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             --------------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             --------------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                      011233478999999999999999999999987644

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.9e-56  Score=415.01  Aligned_cols=269  Identities=25%  Similarity=0.415  Sum_probs=230.0

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++........        ..+.+|+.+|+.++||||+++++++ .
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~--------~~~~~Ei~il~~l~hpnIv~l~~~~-~  224 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--------ETVRKEIQTMSVLRHPTLVNLHDAF-E  224 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH--------HHHHHHHHHHHHTCCTTBCCEEEEE-E
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhH--------HHHHHHHHHHHhCCCCCCCeEEEEE-E
Confidence            456899999999999999999999999999999999975432111        2467899999999999999999999 4


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC--CcEEEeecccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ--GVLKICDFGMS  164 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~--~~~~l~df~~~  164 (332)
                      +...+|||||||+| +|.+.+....+.+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++
T Consensus       225 ~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             CSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             ECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccce
Confidence            55889999999986 6667666666789999999999999999999999999999999999999854  89999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+...   
T Consensus       305 ~~~~~~-~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---  379 (573)
T 3uto_A          305 AHLDPK-QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---  379 (573)
T ss_dssp             EECCTT-SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG---
T ss_pred             eEccCC-CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc---
Confidence            887433 33455689999999999987 6789999999999999999999999999998888887766533222221   


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~  320 (332)
                                                    .+.+|+++++||.+||+.||.+||++.|+|+||||+..+++.....
T Consensus       380 ------------------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~  425 (573)
T 3uto_A          380 ------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ  425 (573)
T ss_dssp             ------------------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCE
T ss_pred             ------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhh
Confidence                                          2237999999999999999999999999999999999888765543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-56  Score=382.88  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=207.4

Q ss_pred             chhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ..++|.+.+.||+|+||+||+|++.     .++..||||++.....   ..     ...+.+|+.++++++||||+++++
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~-----~~~f~~E~~il~~l~HpnIV~l~g   82 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NA-----RKDFHREAELLTNLQHEHIVKFYG   82 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH---HH-----HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh---HH-----HHHHHHHHHHHHhCCCCCCccEEE
Confidence            3468999999999999999999875     3578899999964321   11     125789999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL  150 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili  150 (332)
                      ++.+ ....|||||||+| +|.+.+...            ...+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus        83 ~~~~-~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl  161 (299)
T 4asz_A           83 VCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  161 (299)
T ss_dssp             EECS-SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EEee-CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence            9954 4789999999985 566655442            2469999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 035861          151 NNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQI  227 (332)
Q Consensus       151 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~  227 (332)
                      +.++.+||+|||+++.......  ......||+.|+|||++.+ ..++.++||||||+++|||+| |+.||...+..+..
T Consensus       162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  240 (299)
T 4asz_A          162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  240 (299)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999976533211  1233468999999999987 679999999999999999999 89999998888777


Q ss_pred             HHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 035861          228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY  307 (332)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  307 (332)
                      ..+......+                                    .++.+++++.+|+.+||+.||++|||+.+|+  +
T Consensus       241 ~~i~~~~~~~------------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~  282 (299)
T 4asz_A          241 ECITQGRVLQ------------------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--T  282 (299)
T ss_dssp             HHHHHTCCCC------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--H
T ss_pred             HHHHcCCCCC------------------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--H
Confidence            7776542111                                    1233789999999999999999999999994  4


Q ss_pred             CCCCC
Q 035861          308 WFHEV  312 (332)
Q Consensus       308 ~f~~~  312 (332)
                      |+.++
T Consensus       283 ~L~~~  287 (299)
T 4asz_A          283 LLQNL  287 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            55443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-55  Score=382.86  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=200.5

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|.+.++||+|+||+||+|++.     .++..||||++.....   ..     ...+.+|+.++++++||||++++++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~-----~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SA-----RQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH---HH-----HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH---HH-----HHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            357888999999999999999875     3678999999964321   11     1257899999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESM--------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      +.+ ....|||||||+| +|.+.+...              .+++++..+..++.|++.||+|||+++|+||||||+|||
T Consensus       112 ~~~-~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL  190 (329)
T 4aoj_A          112 CTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL  190 (329)
T ss_dssp             ECS-SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEE-CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence            954 4789999999996 555555432              246999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQ  226 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~  226 (332)
                      ++.++.+||+|||+++......  .......||+.|+|||++.+ ..++.++||||||+++|||+| |+.||...+..+.
T Consensus       191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~  269 (329)
T 4aoj_A          191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA  269 (329)
T ss_dssp             EETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred             ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999998653221  22234578999999999987 779999999999999999999 8999999888877


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ...+......                                    ..++.+++++.+|+.+||+.||++|||+.||+++
T Consensus       270 ~~~i~~g~~~------------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          270 IDCITQGREL------------------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHTCCC------------------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHcCCCC------------------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            7776554211                                    1123478999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.5e-55  Score=375.55  Aligned_cols=290  Identities=42%  Similarity=0.752  Sum_probs=240.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.........      ...+.+|+.++++++||||+++++++.++ 
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   73 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSD-   73 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH------HHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc------chHHHHHHHHHhcCCCCCEeeEEeEEEeC-
Confidence            46899999999999999999999999999999999765432211      12456899999999999999999999544 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++||||++|++++.+...++.+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus        74 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           74 KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            88999999999999999888788999999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL-FSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .........+++.|+|||++.+...++.++|+||||+++|+|++|..| |...+..+....+....+.+....++.+...
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            555556678899999999998766689999999999999999988777 5666777778888888888877776665544


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +........        ..........+.++.++++||.+||+.||++|||++|+|+||||+++..
T Consensus       234 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          234 PDYKPYPMY--------PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             TTCCCCCCC--------CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccccccc--------cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence            332211100        0011112233458999999999999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-55  Score=378.58  Aligned_cols=253  Identities=22%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             chhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ...+++++++||+|+||+||+|.+.     .+++.||||++.......       ....+.+|+.++++++||||+++++
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~-------~~~~f~~E~~il~~l~HpNIV~l~g   96 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-------LREEFRHEAMLRARLQHPNVVCLLG   96 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH-------HHHHHHHHHHHHHhCCCCCCCCcce
Confidence            3568889999999999999999864     357889999986432211       1235789999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      ++.+ ....+||||||++ +|.+.+...               ...+++..+..++.|||.||+|||+++|+||||||+|
T Consensus        97 ~~~~-~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N  175 (308)
T 4gt4_A           97 VVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN  175 (308)
T ss_dssp             EECS-SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEE-CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence            9954 4778999999986 566665432               2458999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      ||++.++.+||+|||+++.....  ........||+.|+|||++.+ ..++.++||||||+++|||+| |..||.+.+..
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999765322  223345678999999999987 679999999999999999998 89999998887


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +....+......                                    +.++.+++++.+|+.+||+.||++|||+.||+
T Consensus       255 ~~~~~i~~~~~~------------------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~  298 (308)
T 4gt4_A          255 DVVEMIRNRQVL------------------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIH  298 (308)
T ss_dssp             HHHHHHHTTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHcCCCC------------------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            777666543211                                    12234789999999999999999999999998


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      ++
T Consensus       299 ~~  300 (308)
T 4gt4_A          299 SR  300 (308)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-54  Score=375.52  Aligned_cols=294  Identities=43%  Similarity=0.790  Sum_probs=237.8

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +....++|++++.||+|+||+||+|++. +++.||+|++.........      ...+.+|+.++++++||||+++++++
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI------PSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CH------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchh------hHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            4456789999999999999999999985 5899999999754322211      12456899999999999999999998


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       .+....++||||++|++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||.+.
T Consensus        89 -~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           89 -HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             -CCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             -ccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence             4557899999999999999888877789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .............+++.|+|||++.+...++.++|+||||+++|+|++|..||......+....+....+.+....++.+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            77655555566688999999999987677899999999999999999999999998888888888888877777666655


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ..++...........       ........+.+++++.+||.+||+.||++|||++|+|+||||++++.
T Consensus       248 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          248 QELPLWKQRTFQVFE-------KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             TTSHHHHSCCCCCCC-------CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hccchhhhccccccc-------CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            443321111100000       00001112347889999999999999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.9e-54  Score=369.22  Aligned_cols=287  Identities=45%  Similarity=0.833  Sum_probs=230.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||+||+|++ .+++.||+|++.......      .....+.+|+.++++++||||+++++++... 
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   72 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHTK-   72 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc------ccchhHHHHHHHHHhcCCCCEeeeeeEEccC-
Confidence            36899999999999999999998 678999999996543211      1123567899999999999999999999544 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++|||++++++.+.+....+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||.+.....
T Consensus        73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           73 KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            78999999999999888887778899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........+++.|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....++.....+
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence            44444556789999999999875678999999999999999999999999999888888888887777666655544333


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      ..........        +.........+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       233 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          233 KYDPNFTVYE--------PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCTTCCCCC--------CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccc--------CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            2211111100        000111223478999999999999999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.3e-54  Score=377.76  Aligned_cols=277  Identities=27%  Similarity=0.436  Sum_probs=231.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||+||+|++..+++.||+|++........     .....+.+|+.+++.++||||+++++.+.. 
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-   76 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFLTALKYAFQT-   76 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh-----hHHHHHHHHHHHHHhCCCCcCcceEEEEEe-
Confidence            46799999999999999999999999999999999976432111     111246789999999999999999999954 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++....
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            47899999999875444444446789999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .........+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......           
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----------  224 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-----------  224 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred             cCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence            44444566789999999999977 678999999999999999999999999888777766665432111           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~~  321 (332)
                                                +..+++++++||.+||+.||++||     +++|+++||||..+.|...  +...
T Consensus       225 --------------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~  278 (337)
T 1o6l_A          225 --------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL  278 (337)
T ss_dssp             --------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             --------------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCC
Confidence                                      123789999999999999999999     8999999999999987765  4466


Q ss_pred             CCCCCccc
Q 035861          322 PTFPPQHA  329 (332)
Q Consensus       322 ~~~~~~~~  329 (332)
                      +++.|...
T Consensus       279 pp~~p~~~  286 (337)
T 1o6l_A          279 PPFKPQVT  286 (337)
T ss_dssp             CSCCCCCS
T ss_pred             CCCCCCCC
Confidence            77777654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.4e-54  Score=373.50  Aligned_cols=300  Identities=39%  Similarity=0.754  Sum_probs=227.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.......       ....+.+|+.++++++||||+++++++ ..
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~   74 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-------TPSTAIREISLMKELKHENIVRLYDVI-HT   74 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTC-------SCHHHHHHHHHHTTCCBTTBCCEEEEE-CC
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc-------cHHHHHHHHHHHHhcCCCCcceEEEEE-EE
Confidence            3568999999999999999999999999999999997543211       122467899999999999999999998 45


Q ss_pred             CCeEEEEcccccccHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMK-----QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~-----~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ....++||||++|++.+.+....     ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||.
T Consensus        75 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           75 ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             CCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            58899999999999888776542     4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +..............+++.|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....++
T Consensus       155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            98765544445566789999999999875678999999999999999999999999999999999998888888777776


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .....+...................   ......++.++.+||.+||+.||++|||++|+|+||||++...+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~  307 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQ---PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMG  307 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHG---GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-----
T ss_pred             hhhhhhhcccccccccchhHHHhhc---ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhcc
Confidence            6554433222221111111111110   111234789999999999999999999999999999999988665533

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.4e-54  Score=375.38  Aligned_cols=297  Identities=40%  Similarity=0.779  Sum_probs=232.0

Q ss_pred             cccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ..+...+++|++++.||+|+||+||+|.+..+++.||||++........      ....+.+|+.++++++||||+++++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~  100 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG------VPGTAIREVSLLKELQHRNIIELKS  100 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEE
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc------cchhHHHHHHHHHHcCCCCcceEEE
Confidence            4566788999999999999999999999999999999999975432221      1224678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc-----CCCcEEE
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-----NQGVLKI  158 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~-----~~~~~~l  158 (332)
                      ++..+ ...++||||++|++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++     .++.++|
T Consensus       101 ~~~~~-~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          101 VIHHN-HRLHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             EEEET-TEEEEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             EEecC-CEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEE
Confidence            99544 88999999999988887766 56799999999999999999999999999999999999995     4456999


Q ss_pred             eecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 035861          159 CDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT  238 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  238 (332)
                      +|||.+..............++..|+|||++.+...++.++||||||+++|+|++|..||......+....+....+.+.
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             CCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            99999987765545556667899999999998766789999999999999999999999999999999999998888887


Q ss_pred             CCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      ...++.+...+..................       ...+++++++||.+||+.||++|||++|+|+||||++..+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVL-------GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHH-------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            77666554433322222111111111111       12268899999999999999999999999999999998765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-53  Score=372.92  Aligned_cols=291  Identities=39%  Similarity=0.744  Sum_probs=232.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||+||+|.+..+++.||+|++........       ...+.+|+.++++++||||+++++++.. .
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~   72 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIHT-E   72 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-S
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-------chhHHHHHHHHHhcCCCCCCeeeeEEee-C
Confidence            4689999999999999999999999999999999965432211       1134579999999999999999999954 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++||||++|++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus        73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           73 KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            78999999999999998888777899999999999999999999999999999999999999999999999999987655


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........+++.|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....++.+....
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            44455566789999999999876778999999999999999999999999999999999999988888877766543321


Q ss_pred             cccc-cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          250 GAKA-NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       250 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      .... .....        .........+.+++++.+||.+||+.||++|||++|+|+||||.++....
T Consensus       233 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          233 EFKTYNYPKY--------RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHHHTCCCCC--------CCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             hhcccccccc--------cchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence            1100 00000        00111122345789999999999999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.5e-53  Score=369.49  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=223.7

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ....+++|++++.||+|+||+||+|.+..+++.||||++..........      ..+.+|+.+++.++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~E~~~l~~l~hpnIv~l~~~~   83 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL------QKLFREVRIMKILNHPNIVKLFEVI   83 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHH------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHH------HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456789999999999999999999999999999999997654332211      2467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      . .....|+||||++| ++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        84 ~-~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  161 (328)
T 3fe3_A           84 E-TEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS  161 (328)
T ss_dssp             E-CSSEEEEEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred             E-ECCEEEEEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence            4 45889999999976 55555544 678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... .......|++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+.......+      
T Consensus       162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------  234 (328)
T 3fe3_A          162 NEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP------  234 (328)
T ss_dssp             GGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             eecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            766432 3345668999999999998855556899999999999999999999999888777776665422111      


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                                     ..+++++.+||.+||+.||.+|||++|+++||||+....+.
T Consensus       235 -------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  275 (328)
T 3fe3_A          235 -------------------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED  275 (328)
T ss_dssp             -------------------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred             -------------------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence                                           22789999999999999999999999999999999866443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-54  Score=381.10  Aligned_cols=277  Identities=26%  Similarity=0.420  Sum_probs=225.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      .+++|++++.||+|+||+||+|++..+++.||||++.........     ....+..|..+++.+ +||||+.+++.+. 
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~-----~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-   94 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-----DVECTMTEKRILSLARNHPFLTQLFCCFQ-   94 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHT-----THHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchh-----HHHHHHHHHHHHHhccCCCceeeEEEEEE-
Confidence            467999999999999999999999999999999999764321111     112456899999888 7999999999994 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +....|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++...
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            44789999999997444444444678999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ..........+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......+         
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p---------  244 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP---------  244 (353)
T ss_dssp             CC---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             ccCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence            444444556789999999999976 6689999999999999999999999999988888887766432221         


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCCCCCCC--CC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV------DDALNHYWFHEVPLPKS--KD  319 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~hp~f~~~~~~~~--~~  319 (332)
                                                  ..++..+.+||.+||+.||.+||++      +|+++||||+++.|...  +.
T Consensus       245 ----------------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~  296 (353)
T 3txo_A          245 ----------------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQ  296 (353)
T ss_dssp             ----------------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTC
T ss_pred             ----------------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCc
Confidence                                        2278999999999999999999998      89999999999987765  44


Q ss_pred             CCCCCCCccc
Q 035861          320 FMPTFPPQHA  329 (332)
Q Consensus       320 ~~~~~~~~~~  329 (332)
                      ..++|.|...
T Consensus       297 ~~~p~~p~~~  306 (353)
T 3txo_A          297 IEPPFRPRIK  306 (353)
T ss_dssp             SCCSCCCCCC
T ss_pred             CCCCccCCCC
Confidence            6677777643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.8e-54  Score=377.69  Aligned_cols=254  Identities=21%  Similarity=0.379  Sum_probs=205.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCC-----CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC-CCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS-----GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~   83 (332)
                      .++|++++.||+|+||+||+|.+..+     ++.||||++........       ...+.+|+.+++++.| |||+++++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-------~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------HRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-------HHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            36899999999999999999998654     35799999865432211       1256789999999976 89999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      ++.++...++||||||+| +|.+.+...               ...+++..+..++.|||.||+|||+++|+||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            996666778999999995 566655442               2348999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      ||++.++.+||+|||+|+.......  ......||+.|+|||++.+ ..++.++||||||+++|||+| |..||.+.+..
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986543222  2234578999999999987 679999999999999999998 89999886654


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +...+.......                                   ...+..+++++.+||.+||+.||++|||+.||+
T Consensus       295 ~~~~~~i~~g~~-----------------------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil  339 (353)
T 4ase_A          295 EEFCRRLKEGTR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  339 (353)
T ss_dssp             HHHHHHHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHcCCC-----------------------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence            444443332111                                   111233789999999999999999999999999


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      +|
T Consensus       340 ~~  341 (353)
T 4ase_A          340 EH  341 (353)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.6e-53  Score=377.08  Aligned_cols=278  Identities=24%  Similarity=0.405  Sum_probs=225.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVM   86 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   86 (332)
                      ..+++|++++.||+|+||+||+|++..+++.||+|++.+........     ...+..|..++.++ +||||+++++.+.
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~-----~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED-----IDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH-----HHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            45779999999999999999999999999999999998754332221     22466888888776 8999999999984


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       +....|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       124 -~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          124 -TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             -ECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence             4488999999998754444444467899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHcCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---------VDQIDKIFKTLGTP  237 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---------~~~~~~~~~~~~~~  237 (332)
                      ...........+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.....         ......+....   
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---  278 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  278 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred             cccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence            4444445566789999999999987 6789999999999999999999999964321         11222222211   


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV------DDALNHYWFHE  311 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~hp~f~~  311 (332)
                                                        ...+..++.++++||.+||+.||.+||++      +||++||||++
T Consensus       279 ----------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          279 ----------------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             ----------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             ----------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence                                              11223379999999999999999999985      89999999999


Q ss_pred             CCCCCC--CCCCCCCCCccc
Q 035861          312 VPLPKS--KDFMPTFPPQHA  329 (332)
Q Consensus       312 ~~~~~~--~~~~~~~~~~~~  329 (332)
                      ++|...  +...++|.|...
T Consensus       325 i~w~~l~~~~~~pp~~p~~~  344 (396)
T 4dc2_A          325 VDWDMMEQKQVVPPFKPNIS  344 (396)
T ss_dssp             CCHHHHHTTCSCCSCCCCCC
T ss_pred             CCHHHHHcCCCCCCCcCCCC
Confidence            998765  446678887654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-52  Score=366.86  Aligned_cols=299  Identities=40%  Similarity=0.753  Sum_probs=238.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||+||+|.+..+++.||||++........   .......+.+|+.+++.++||||+++++++ .
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA---KDGINRTALREIKLLQELSHPNIIGLLDAF-G   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh---hhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-e
Confidence            356799999999999999999999999999999999975433221   111223567999999999999999999998 4


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      .....++||||+++++...+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           83 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            45788999999999988888776678999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+...++....+.+....++....
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            55555556678899999999998756789999999999999999999999999999999999998888887777766554


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .+........... ...        ...+.++.++++||.+||+.||++|||++|+|+||||++...+....
T Consensus       243 ~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~  305 (346)
T 1ua2_A          243 LPDYVTFKSFPGI-PLH--------HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC  305 (346)
T ss_dssp             STTCCCCCCCCCC-CHH--------HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred             CcccccccccCCC-ChH--------HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcc
Confidence            3322111000000 000        01234789999999999999999999999999999999987766543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-53  Score=366.85  Aligned_cols=275  Identities=28%  Similarity=0.446  Sum_probs=229.0

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|+||+||++++..+++.||+|++.........     ....+.+|..+++.++||||+++++.+. 
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-   76 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-----QVEHTNDERLMLSIVTHPFIIRMWGTFQ-   76 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHSCCBTTBCCEEEEEE-
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh-----HHHHHHHHHHHHhhCCCCCCceEeEEEE-
Confidence            3578999999999999999999999999999999999764321111     1124568999999999999999999994 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +....|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+|+||||+||+++.+|.+||+|||++...
T Consensus        77 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           77 DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            44889999999987444444444678999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...   .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......          
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  222 (318)
T 1fot_A          157 PDV---TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----------  222 (318)
T ss_dssp             SSC---BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC----------
T ss_pred             CCc---cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            432   245678999999999987 678999999999999999999999999988877777776532111          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDF  320 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~  320 (332)
                                                 ++.+++++++||.+||+.||++||     +++++++||||+++.|...  +..
T Consensus       223 ---------------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~  275 (318)
T 1fot_A          223 ---------------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI  275 (318)
T ss_dssp             ---------------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred             ---------------------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCC
Confidence                                       123789999999999999999999     9999999999999987765  345


Q ss_pred             CCCCCCccc
Q 035861          321 MPTFPPQHA  329 (332)
Q Consensus       321 ~~~~~~~~~  329 (332)
                      .+++.|...
T Consensus       276 ~~p~~p~~~  284 (318)
T 1fot_A          276 ETPYEPPIQ  284 (318)
T ss_dssp             CCSCCCCC-
T ss_pred             CCCCCCCcC
Confidence            566666543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-53  Score=371.94  Aligned_cols=276  Identities=25%  Similarity=0.410  Sum_probs=230.3

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVM   86 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   86 (332)
                      ..+++|++++.||+|+||+||+|++..+++.||+|++.........     ....+..|..++..+ .||+|+.+++.+.
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~-----~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-----DVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcch-----HHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            3567999999999999999999999999999999999764321111     112456888999887 8999999999984


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       +....|+||||++| ++.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++.
T Consensus        92 -~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           92 -TMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             -cCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence             44889999999987 5555544 35679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ............+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......        
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------  240 (353)
T 2i0e_A          170 ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------  240 (353)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             ccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            65444444556789999999999987 678999999999999999999999999988887777776532111        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--C
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--K  318 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~  318 (332)
                                                   +..++.++++||.+||+.||.+||     ++++|++||||+.+.|...  +
T Consensus       241 -----------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~  291 (353)
T 2i0e_A          241 -----------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK  291 (353)
T ss_dssp             -----------------------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTT
T ss_pred             -----------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhC
Confidence                                         123789999999999999999999     4799999999999998776  5


Q ss_pred             CCCCCCCCcc
Q 035861          319 DFMPTFPPQH  328 (332)
Q Consensus       319 ~~~~~~~~~~  328 (332)
                      ...++|.|..
T Consensus       292 ~~~~p~~p~~  301 (353)
T 2i0e_A          292 EIQPPYKPKA  301 (353)
T ss_dssp             CSCCSCCCCC
T ss_pred             CCCCCcCCCC
Confidence            5677787764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.2e-52  Score=359.08  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=221.9

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+...++|++++.||+|+||+||+|.+..+++.||||++........        ..+.+|+.+++.++||||+++++.+
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~E~~~l~~l~hp~iv~~~~~~   86 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--------ELIINEILVMRENKNPNIVNYLDSY   86 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH--------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH--------HHHHHHHHHHhcCCCCCCCeEeEEE
Confidence            34566799999999999999999999999999999999976543322        2467899999999999999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ..+ ...++||||++|+.+..+.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        87 ~~~-~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           87 LVG-DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (297)
T ss_dssp             EET-TEEEEEEECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEC-CEEEEEEECCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence            555 78999999997644444443 2469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .............|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+........       
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  236 (297)
T 3fxz_A          165 QITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------  236 (297)
T ss_dssp             ECCSTTCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-------
T ss_pred             ecCCcccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            77655555566789999999999987 6789999999999999999999999998887766665554322111       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                 ..+..++..+.+||.+||+.||++|||++|+|+||||+...
T Consensus       237 ---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 ---------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             ---------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ---------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                                       11223788999999999999999999999999999999754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-52  Score=368.35  Aligned_cols=276  Identities=26%  Similarity=0.394  Sum_probs=225.9

Q ss_pred             CcccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee
Q 035861            1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN   80 (332)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   80 (332)
                      |.........++|++++.||+|+||+||+|.+..+|+.||+|++..........  ......+.+|+.+++++.||||++
T Consensus         2 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~   79 (361)
T 2yab_A            2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIIT   79 (361)
T ss_dssp             --CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCc
Confidence            344556667788999999999999999999999999999999998755432110  001124679999999999999999


Q ss_pred             eeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC----cE
Q 035861           81 VKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----VL  156 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~----~~  156 (332)
                      +++++. +....++||||++|+.+.......+.+++..++.++.||+.||+|||++||+|+||||+||+++.++    .+
T Consensus        80 l~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           80 LHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             EEEEEE-CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             EEEEEE-eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCE
Confidence            999994 4588999999997644444444467899999999999999999999999999999999999998877    79


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      +|+|||++...... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus       159 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  236 (361)
T 2yab_A          159 KLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD  236 (361)
T ss_dssp             EECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             EEEecCCceEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence            99999999876442 33455679999999999976 67899999999999999999999999998888777776554222


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      .+...                                 ++.++..+++||.+||..||.+|||++|+|+||||+.+.+
T Consensus       237 ~~~~~---------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          237 FDEEF---------------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             CCHHH---------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             CCchh---------------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            11111                                 1237899999999999999999999999999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=378.69  Aligned_cols=270  Identities=25%  Similarity=0.391  Sum_probs=223.9

Q ss_pred             CcccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee
Q 035861            1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN   80 (332)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   80 (332)
                      |..+.+....++|++++.||+|+||+||+|.+..+++.+|+|++.........      ...+.+|+.+++.++||||++
T Consensus         1 M~~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~------~~~~~~E~~il~~l~hpnIv~   74 (444)
T 3soa_A            1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD------HQKLEREARICRLLKHPNIVR   74 (444)
T ss_dssp             ------CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH------HHHHHHHHHHHHHCCBTTBCC
T ss_pred             CCccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCcCCCe
Confidence            67788888999999999999999999999999999999999999765432211      124678999999999999999


Q ss_pred             eeeeEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc---CCCcE
Q 035861           81 VKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN---NQGVL  156 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~---~~~~~  156 (332)
                      +++++. +....|+||||++| ++.+.+.. .+.+++..+..++.||+.||+|||++||+|+||||+||+++   .++.+
T Consensus        75 l~~~~~-~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~v  152 (444)
T 3soa_A           75 LHDSIS-EEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV  152 (444)
T ss_dssp             EEEEEE-CSSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred             EEEEEE-ECCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcE
Confidence            999984 55889999999987 55555554 67899999999999999999999999999999999999998   45789


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      ||+|||++..............||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+......
T Consensus       153 kL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  231 (444)
T 3soa_A          153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD  231 (444)
T ss_dssp             EECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred             EEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC
Confidence            99999999877655555566789999999999977 67899999999999999999999999998888877777665332


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      .+..                                 .++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       232 ~~~~---------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 FPSP---------------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             CCTT---------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             CCcc---------------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            2222                                 123378999999999999999999999999999999753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-53  Score=373.62  Aligned_cols=277  Identities=29%  Similarity=0.459  Sum_probs=223.9

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      ...+++|++++.||+|+||+||+|++..+++.||||++.........     ....+..|..++..+ +||||+++++.+
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-----DVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhh-----hHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            34678999999999999999999999999999999999764321111     112356788888776 999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .+ ....|+||||++| ++.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+||+++.+|.++|+|||++
T Consensus        88 ~~-~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           88 QT-KENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EC-SSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             Ee-CCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            44 4789999999986 5555444 4578999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      .............+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......       
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------  237 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-------  237 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            865433344556789999999999987 678999999999999999999999999888877777665432111       


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCCCCCC--CCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD-DALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~hp~f~~~~~~~~--~~~~  321 (332)
                                                    +..+++++++||.+||..||++||++. +|++||||+.+.|...  ....
T Consensus       238 ------------------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~  287 (345)
T 1xjd_A          238 ------------------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID  287 (345)
T ss_dssp             ------------------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred             ------------------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCC
Confidence                                          122789999999999999999999998 9999999999987665  3456


Q ss_pred             CCCCCcc
Q 035861          322 PTFPPQH  328 (332)
Q Consensus       322 ~~~~~~~  328 (332)
                      +++.|..
T Consensus       288 ~p~~p~~  294 (345)
T 1xjd_A          288 PPFRPKV  294 (345)
T ss_dssp             C------
T ss_pred             CCcCCCC
Confidence            6666653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-52  Score=367.50  Aligned_cols=275  Identities=27%  Similarity=0.450  Sum_probs=222.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      .+++|++++.||+|+||+||+|++..+++.||+|++...........     ..+..|..+++++ +||||+++++.+.+
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~E~~~l~~~~~hp~iv~l~~~~~~   81 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI-----DWVQTEKHVFEQASNHPFLVGLHSCFQT   81 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHH-----HHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHH-----HHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence            56799999999999999999999999999999999986543322211     1356889999887 89999999999844


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       ....|+||||++| ++...+. ..+.+++..++.++.||+.||+|||++||+|+||||+||+++.+|.++|+|||++..
T Consensus        82 -~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           82 -ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             -CCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence             4889999999986 4544444 467899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHcCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT---------EVDQIDKIFKTLGTP  237 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~---------~~~~~~~~~~~~~~~  237 (332)
                      ...........+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||....         .......+....   
T Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---  235 (345)
T 3a8x_A          160 GLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  235 (345)
T ss_dssp             SCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred             ccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence            4433344556789999999999987 678999999999999999999999996521         111222222111   


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV------DDALNHYWFHE  311 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~hp~f~~  311 (332)
                                                        ...+..++.++++||.+||+.||.+||++      +|+++||||++
T Consensus       236 ----------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          236 ----------------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             ----------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             ----------------------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence                                              11123478999999999999999999995      89999999999


Q ss_pred             CCCCCC--CCCCCCCCCcc
Q 035861          312 VPLPKS--KDFMPTFPPQH  328 (332)
Q Consensus       312 ~~~~~~--~~~~~~~~~~~  328 (332)
                      +.|...  ....++|.|..
T Consensus       282 ~~w~~~~~~~~~~p~~p~~  300 (345)
T 3a8x_A          282 VDWDMMEQKQVVPPFKPNI  300 (345)
T ss_dssp             CCHHHHHTTCSCCSCCCCC
T ss_pred             CCHHHHHhCCCCCCcCCCC
Confidence            987654  34556676654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.8e-52  Score=365.53  Aligned_cols=301  Identities=41%  Similarity=0.745  Sum_probs=240.8

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+..+++|++++.||+|+||+||+|++..+++.||||++........      ....+.+|+.+++.++||||+++++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~   85 (351)
T 3mi9_A           12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEIC   85 (351)
T ss_dssp             TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS------SCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc------chHHHHHHHHHHHhccCCCcccHhhee
Confidence            34578899999999999999999999999999999999865543221      122467899999999999999999998


Q ss_pred             EcC-------CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           86 MDD-------HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        86 ~~~-------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                      ...       ....++||||++|++...+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           86 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             EEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred             eccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEE
Confidence            653       3568999999999999988887788999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC----CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          159 CDFGMSRQYGS----PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       159 ~df~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      +|||.+.....    .........|++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+....
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999976542    12233455789999999999876678999999999999999999999999999988888888887


Q ss_pred             CCCCCCcccCCCCCccccccc-cCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANF-AKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +..+...++.+.......... ...........+..      ...++.+.+||.+||+.||++|||++|+|+||||++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA------YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHH------HHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhh------ccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            777776666543322110000 00000000000000      01367889999999999999999999999999999988


Q ss_pred             CCCCC
Q 035861          314 LPKSK  318 (332)
Q Consensus       314 ~~~~~  318 (332)
                      .+...
T Consensus       320 ~~~~~  324 (351)
T 3mi9_A          320 MPSDL  324 (351)
T ss_dssp             CCCCS
T ss_pred             Ccccc
Confidence            77653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-52  Score=381.80  Aligned_cols=278  Identities=28%  Similarity=0.429  Sum_probs=224.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||.||+|.+..+++.||||++..........     ...+.+|+.+++.++||||+.+++++...
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-----VAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEET
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHH-----HHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            4678999999999999999999999999999999997643211111     12456899999999999999999999554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ...++||||++|+.+.........+++..+..++.||+.||+|||+ .||+|+||||+|||++.++.+||+|||++...
T Consensus       221 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          221 -DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             -TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             -CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence             7899999999875444444446789999999999999999999998 99999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......          
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------  368 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----------  368 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred             cCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            444444566789999999999987 678999999999999999999999999888877777665432211          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDF  320 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~  320 (332)
                                                 +..+++++.+||.+||+.||.+||     +++|+++||||+.+.|...  ...
T Consensus       369 ---------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~  421 (446)
T 4ejn_A          369 ---------------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL  421 (446)
T ss_dssp             ---------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             ---------------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcC
Confidence                                       123789999999999999999999     9999999999999987665  456


Q ss_pred             CCCCCCcccc
Q 035861          321 MPTFPPQHAR  330 (332)
Q Consensus       321 ~~~~~~~~~~  330 (332)
                      .++|.|+...
T Consensus       422 ~pp~~p~~~~  431 (446)
T 4ejn_A          422 SPPFKPQVTS  431 (446)
T ss_dssp             CCSCCCSCSS
T ss_pred             CCCccCCCCC
Confidence            7778887653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=357.26  Aligned_cols=293  Identities=41%  Similarity=0.739  Sum_probs=229.0

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVK   82 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~   82 (332)
                      |....++|++++.||+|+||+||+|++..+++.||||++.........   ........+|+..++++   .||||++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG---GGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS---SCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc---cccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            455678999999999999999999999999999999999765432211   11112445777777666   499999999


Q ss_pred             eeEEcCCC----eEEEEcccccccHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           83 EVVMDDHD----SVYMVMEYMEHDLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        83 ~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      +++.....    ..++|||+++|++.+.+..... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred             eeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence            99865433    5899999999998888776443 399999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |+|||.+...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+....+.+
T Consensus       161 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          161 LADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             ECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EeeCccccccCCC-cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999866432 33455678999999999987 668999999999999999999999999999999999999888887


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +...++.....+.....  .        ..+.......+.+++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFP--P--------RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CTTTSCSSCSSCGGGSC--C--------CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ChhhccchhhccccccC--C--------CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            77766544332211100  0        001111112345889999999999999999999999999999999854

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-52  Score=373.59  Aligned_cols=280  Identities=25%  Similarity=0.343  Sum_probs=230.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|++..+++.||+|++.......     ......+.+|+.+++.++||||+++++.+. +
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~  140 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-----RSDSAFFWEERDIMAFANSPWVVQLFYAFQ-D  140 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----TCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-----hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-E
Confidence            4568999999999999999999999999999999997633211     111235678999999999999999999995 4


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....|+||||++| ++.+.+.  ...+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++...
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            5889999999976 5555443  356999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC-CCccccccccccchhhhcCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGAK---KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ..... .....+||+.|+|||++....   .++.++|+||||+++|+|++|..||...+......++.......      
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------  292 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------  292 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc------
Confidence            43221 234668999999999997632   27889999999999999999999999998888888776532100      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCC--CCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVPLP--KSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~~~--~~~~  319 (332)
                                                 ..+....++.++++||.+||..+|.+  ||+++||++||||+++.|.  ..+.
T Consensus       293 ---------------------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~  345 (410)
T 3v8s_A          293 ---------------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD  345 (410)
T ss_dssp             ---------------------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGG
T ss_pred             ---------------------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcc
Confidence                                       01112237999999999999999988  9999999999999997654  4466


Q ss_pred             CCCCCCCccc
Q 035861          320 FMPTFPPQHA  329 (332)
Q Consensus       320 ~~~~~~~~~~  329 (332)
                      ..+++.|...
T Consensus       346 ~~~p~~p~~~  355 (410)
T 3v8s_A          346 TVAPVVPDLS  355 (410)
T ss_dssp             SCCSCCCCCS
T ss_pred             cCCCCCCcCC
Confidence            7888888754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.2e-52  Score=375.50  Aligned_cols=283  Identities=23%  Similarity=0.366  Sum_probs=235.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|++..+++.||+|++.......     ......+.+|..++..++||||+++++.+.+ 
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-  145 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-----RAETACFREERDVLVNGDSKWITTLHYAFQD-  145 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-----TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-----HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            3568999999999999999999999999999999997532211     1112346789999999999999999999944 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....|+||||++| ++.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            4889999999975 666666655678999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCC-CCccccccccccchhhhc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLL----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~----~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ..... ......||+.|+|||++.    +...++.++|+||||+++|+|++|..||...+..+...++........    
T Consensus       226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----  301 (437)
T 4aw2_A          226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----  301 (437)
T ss_dssp             CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC----
T ss_pred             ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc----
Confidence            43322 223467999999999986    235689999999999999999999999999988888887765321000    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK--RITVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~hp~f~~~~~~~~~~~  320 (332)
                                              ++    .....+++++++||++||..+|++  |++++|+++||||+++.|...+..
T Consensus       302 ------------------------~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~  353 (437)
T 4aw2_A          302 ------------------------FP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNC  353 (437)
T ss_dssp             ------------------------CC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGS
T ss_pred             ------------------------CC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhC
Confidence                                    00    001237999999999999998888  999999999999999999999888


Q ss_pred             CCCCCCccc
Q 035861          321 MPTFPPQHA  329 (332)
Q Consensus       321 ~~~~~~~~~  329 (332)
                      .+++.|...
T Consensus       354 ~~p~~P~~~  362 (437)
T 4aw2_A          354 EAPYIPEVS  362 (437)
T ss_dssp             CCSCCCCCS
T ss_pred             CCCCCCcCC
Confidence            888888754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-52  Score=367.19  Aligned_cols=274  Identities=28%  Similarity=0.426  Sum_probs=229.3

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...+++|++++.||+|+||+||+|++..+++.||+|++.........     ....+.+|+.+++.++||||+++++.+.
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34678999999999999999999999999999999999764321111     1124678999999999999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      + ....|+||||++| ++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++.
T Consensus       112 ~-~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          112 D-NSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             C-SSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             c-CCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence            4 4889999999976 55555544 5779999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .....   .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......        
T Consensus       190 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------  257 (350)
T 1rdq_E          190 RVKGR---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------  257 (350)
T ss_dssp             ECSSC---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             eccCC---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            76432   245679999999999987 678999999999999999999999999988877777776542111        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC--C
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS--K  318 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~--~  318 (332)
                                                   +..++.++.+||.+||+.||.+||+     +++|++||||+.+.|...  +
T Consensus       258 -----------------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~  308 (350)
T 1rdq_E          258 -----------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR  308 (350)
T ss_dssp             -----------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred             -----------------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhc
Confidence                                         1237899999999999999999998     999999999999887654  3


Q ss_pred             CCCCCCCCcc
Q 035861          319 DFMPTFPPQH  328 (332)
Q Consensus       319 ~~~~~~~~~~  328 (332)
                      ...+++.|..
T Consensus       309 ~~~~p~~p~~  318 (350)
T 1rdq_E          309 KVEAPFIPKF  318 (350)
T ss_dssp             CSCCSCCCCC
T ss_pred             cCCCCCCCCC
Confidence            4555666643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-52  Score=369.98  Aligned_cols=277  Identities=25%  Similarity=0.396  Sum_probs=224.6

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHH-HhhCCCCCeeeeeeeEE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI-LLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~   86 (332)
                      ...++|++++.||+|+||+||+|++..+++.||+|++..........     ...+..|... ++.++||||+++++.+.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~-----~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-----EKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH-----HHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            45679999999999999999999999999999999998654322211     1134456665 46789999999999995


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      + ....|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       110 ~-~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          110 T-ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             C-SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             e-CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            4 488999999998754444444467899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ...........+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......          
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------  257 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----------  257 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC----------
T ss_pred             cccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC----------
Confidence            5444444566789999999999987 67899999999999999999999999998888777777653211          


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCCC--CCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV----DDALNHYWFHEVPLPKS--KDF  320 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~hp~f~~~~~~~~--~~~  320 (332)
                                                 .++.++.++++||.+||+.||.+||++    +++++||||+.+.|...  +..
T Consensus       258 ---------------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~  310 (373)
T 2r5t_A          258 ---------------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI  310 (373)
T ss_dssp             ---------------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCC
Confidence                                       122378999999999999999999986    69999999999998776  445


Q ss_pred             CCCCCCcc
Q 035861          321 MPTFPPQH  328 (332)
Q Consensus       321 ~~~~~~~~  328 (332)
                      .++|.|..
T Consensus       311 ~pp~~p~~  318 (373)
T 2r5t_A          311 TPPFNPNV  318 (373)
T ss_dssp             CCSCCCSC
T ss_pred             CCCCCCCC
Confidence            67777754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-52  Score=371.68  Aligned_cols=282  Identities=23%  Similarity=0.341  Sum_probs=232.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||++++..+++.||+|++.+.......     ....+.+|..++..+.||||+++++.+. +
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~-----~~~~~~~E~~il~~~~hp~Iv~l~~~~~-~  132 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG-----EVSCFREERDVLVNGDRRWITQLHFAFQ-D  132 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHG-----GGCCHHHHHHHHHHSCTTTBCCEEEEEE-C
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHH-----HHHHHHHHHHHHHhcCCCCeeeEEEEEe-e
Confidence            457999999999999999999999999999999999753321111     1225678999999999999999999994 4


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....|+||||++| ++.+.+......+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++...
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            4889999999965 666666665568999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC-CCccccccccccchhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLG------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ..... .....+||+.|+|||++..      ...++.++|+||||+++|+|++|..||...+..+...++......... 
T Consensus       213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-  291 (412)
T 2vd5_A          213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL-  291 (412)
T ss_dssp             CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-
T ss_pred             cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC-
Confidence            43322 2234589999999999872      256899999999999999999999999998888887777643110000 


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCC---CCHHHHhcCCCCCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR---ITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~hp~f~~~~~~~~  317 (332)
                                                 +    .....+++++++||.+||. +|.+|   |+++|+++||||+.+.|...
T Consensus       292 ---------------------------p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          292 ---------------------------P----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             ---------------------------C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             ---------------------------C----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                                       0    0012379999999999999 99998   59999999999999999999


Q ss_pred             CCCCCCCCCccc
Q 035861          318 KDFMPTFPPQHA  329 (332)
Q Consensus       318 ~~~~~~~~~~~~  329 (332)
                      +...++|.|...
T Consensus       340 ~~~~~p~~p~~~  351 (412)
T 2vd5_A          340 RDSVPPFTPDFE  351 (412)
T ss_dssp             TTSCCSCCCC--
T ss_pred             hhcCCCCCCcCC
Confidence            888888888653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-52  Score=370.96  Aligned_cols=303  Identities=33%  Similarity=0.630  Sum_probs=226.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEV   84 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~   84 (332)
                      +....++|++++.||+|+||+||+|.+..+++.||||++..........      ....+|+..++.+. ||||++++++
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~   77 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA------QRTFREIMILTELSGHENIVNLLNV   77 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHH------HHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHH------HHHHHHHHHHHhccCCCCCCeeeeE
Confidence            3456789999999999999999999999999999999986443222111      14568999999996 9999999999


Q ss_pred             EEcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +..+ ....|+||||++|++...+..  ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           78 LRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            8644 347899999999998777765  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---------------------CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 035861          164 SRQYGSP---------------------LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT  222 (332)
Q Consensus       164 ~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~  222 (332)
                      +......                     ........||+.|+|||++.+...++.++||||||+++|+|++|..||.+.+
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9764321                     1122345789999999999876789999999999999999999999999999


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccc------------cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhc
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKA------------NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLL  290 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  290 (332)
                      .......+....+.+....+..+........            ..............  ........+++++.+||.+||
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL--LKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHH--HHHCTTCCCCHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhc--ccccccccCCHHHHHHHHHhh
Confidence            9999999988877776654433322100000            00000000000000  001122357899999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          291 TYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       291 ~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      +.||++|||++|+|+||||+.+..+...
T Consensus       314 ~~dP~~R~t~~e~l~Hp~~~~~~~~~~~  341 (388)
T 3oz6_A          314 QFNPNKRISANDALKHPFVSIFHNPNEE  341 (388)
T ss_dssp             CSSGGGSCCHHHHTTSTTTTTTCCGGGC
T ss_pred             ccCcccCCCHHHHhCCHHHHHhcCCccC
Confidence            9999999999999999999988755443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-52  Score=360.66  Aligned_cols=295  Identities=33%  Similarity=0.573  Sum_probs=222.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|++|+||+|.+..+++.||+|++.........      ...+.+|+..+++++||||+++++++.. .
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   74 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI------KKIALREIRMLKQLKHPNLVNLLEVFRR-K   74 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHH------HHHHHHHHHHHHHCCCTTBCCEEEEEEE-T
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHH------HHHHHHHHHHHHhCCCCCccchhheeec-C
Confidence            56899999999999999999999999999999998654332211      1245689999999999999999999954 4


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++||||++++++..+....+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           75 RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            78999999999998888887788899999999999999999999999999999999999999999999999999987655


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........++..|+|||.+.+...++.++|+||||+++|+|++|..||......+....+....+.........+....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            44445566889999999999876778999999999999999999999999988888777776655443322111000000


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ..........      ..........+.++.++.+||.+||+.||++|||++|+|+||||+++.....
T Consensus       235 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          235 YFSGVKIPDP------EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             GGTTCCCCCC------SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             ccccCcCCCc------cccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            0000000000      0000000011347889999999999999999999999999999999876654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.9e-52  Score=361.75  Aligned_cols=276  Identities=28%  Similarity=0.452  Sum_probs=217.3

Q ss_pred             cchhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ...++|++++.||+|+||+||++++.   .+++.||+|++..........    ....+.+|+.+++.++||||+++++.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK----DTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhh----HHHHHHHHHHHHHhCCCCCccceeEE
Confidence            45679999999999999999999985   689999999997643211111    11245689999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +.. ....|+||||++| ++.+.+. ..+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||+
T Consensus        90 ~~~-~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           90 FQT-GGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEC-SSCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEc-CCEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            954 4789999999986 4545444 467899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +..............|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.......      
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~------  240 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL------  240 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------
T ss_pred             ccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            8765433333455678999999999977 678999999999999999999999999888877777766532111      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC-
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS-  317 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~-  317 (332)
                                                     ++.++.++.+||.+||+.||++||     +++|+++||||+.+.|... 
T Consensus       241 -------------------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~  289 (327)
T 3a62_A          241 -------------------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELL  289 (327)
T ss_dssp             -------------------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHH
T ss_pred             -------------------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHh
Confidence                                           123789999999999999999999     8999999999999886544 


Q ss_pred             -CCCCCCCCCc
Q 035861          318 -KDFMPTFPPQ  327 (332)
Q Consensus       318 -~~~~~~~~~~  327 (332)
                       +...+++.|.
T Consensus       290 ~~~~~~p~~p~  300 (327)
T 3a62_A          290 ARKVEPPFKPL  300 (327)
T ss_dssp             TTCSCCSCCCC
T ss_pred             hccCCCCCCCC
Confidence             3344555554

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.6e-53  Score=370.15  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=216.8

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .+...+++|.+.+.||+|+||+||+|.+..+++.||||++........     .....+.+|+..++.++||||++++++
T Consensus         3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~   77 (336)
T 3h4j_B            3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS-----DMHMRVEREISYLKLLRHPHIIKLYDV   77 (336)
T ss_dssp             -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch-----hHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            455678899999999999999999999999999999999975432111     112356799999999999999999999


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      +.. ....++||||++|++.+.+.. .+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~-~~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s  155 (336)
T 3h4j_B           78 ITT-PTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS  155 (336)
T ss_dssp             EEC-SSEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred             EEe-CCEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccc
Confidence            954 478999999999998888776 567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... ......+|++.|+|||++.+....+.++|+||||+++|+|++|..||..........               .
T Consensus       156 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~  219 (336)
T 3h4j_B          156 NIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------K  219 (336)
T ss_dssp             BTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------C
T ss_pred             eeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------H
Confidence            865432 233456799999999999875445789999999999999999999997643211100               0


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                            ........+..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       220 ----------------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 ----------------------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ----------------------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ----------------------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                                  001111223447899999999999999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.2e-52  Score=367.45  Aligned_cols=278  Identities=24%  Similarity=0.411  Sum_probs=225.3

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +...+++|++++.||+|+||+||++.+..+++.||+|++........     .....+.+|+.+++.++||||+++++.+
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-----NEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccH-----HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            44567899999999999999999999999999999999976432111     1122567899999999999999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+. ...|+||||+.|+.+.........+++..++.++.||+.||+|||++||+|+||||+||+++.+|.++|+|||++.
T Consensus        85 ~~~-~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           85 QDE-EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             ECS-SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EeC-CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence            544 7899999999876555555557789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHcCCCCCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV---DQIDKIFKTLGTPTET  240 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~---~~~~~~~~~~~~~~~~  240 (332)
                      ..... .......||+.|+|||++..  ...++.++|+||||+++|+|++|..||......   .....+....      
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------  236 (384)
T 4fr4_A          164 MLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------  236 (384)
T ss_dssp             ECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------
T ss_pred             eccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------
Confidence            76432 33456789999999999864  245889999999999999999999999754322   2222222111      


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCCCCCCCC--
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-VDDALNHYWFHEVPLPKS--  317 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~hp~f~~~~~~~~--  317 (332)
                                                     ...+..++..+.+||.+||+.||.+||+ ++++++||||+++.|...  
T Consensus       237 -------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~  285 (384)
T 4fr4_A          237 -------------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQ  285 (384)
T ss_dssp             -------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHT
T ss_pred             -------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHh
Confidence                                           1112237899999999999999999998 999999999999997665  


Q ss_pred             CCCCCCCCCc
Q 035861          318 KDFMPTFPPQ  327 (332)
Q Consensus       318 ~~~~~~~~~~  327 (332)
                      ....++|.|.
T Consensus       286 ~~~~p~~~p~  295 (384)
T 4fr4_A          286 KRLIPGFIPN  295 (384)
T ss_dssp             TCSCCCCCCS
T ss_pred             CCCCCCCCCC
Confidence            3355555554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.9e-51  Score=369.00  Aligned_cols=298  Identities=36%  Similarity=0.616  Sum_probs=228.2

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ......++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.++++++|+||++++++
T Consensus        20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID------CKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHH------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHH------HHHHHHHHHHHHHcCCCCcceEEEE
Confidence            3445667999999999999999999999999999999999753222111      1256799999999999999999999


Q ss_pred             EEcCC----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           85 VMDDH----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        85 ~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      +....    ...|+|||+++|++.+.+.. ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             EecCCCCcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEcc
Confidence            85543    56899999999988777664 67799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCC----------------------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCC--
Q 035861          161 FGMSRQYGSPLK----------------------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKP--  216 (332)
Q Consensus       161 f~~~~~~~~~~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~--  216 (332)
                      ||++........                      ......||+.|+|||++.....++.++||||||+++|+|++|..  
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            999987643221                      23556789999999998665789999999999999999998543  


Q ss_pred             ---------CCCCCC-----------------hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCC-
Q 035861          217 ---------LFSGTT-----------------EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPA-  269 (332)
Q Consensus       217 ---------pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  269 (332)
                               +|.+.+                 ..+....+....+.++...+..+......          ......+. 
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~----------~~~~~~~~~  322 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI----------KYIKLFPHR  322 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHH----------HHHHTSCCC
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHH----------HHHHhCCCC
Confidence                     343332                 24556666777776665544333221100          00000000 


Q ss_pred             ---CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          270 ---ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       270 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                         ......+.+++++.+||.+||+.||++|||++|+|+||||+++.++....
T Consensus       323 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             CCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCc
Confidence               00111244899999999999999999999999999999999998877654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-51  Score=375.45  Aligned_cols=294  Identities=38%  Similarity=0.636  Sum_probs=215.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.+++.++||||+++++++...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID------CKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH------HHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH------HHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            346899999999999999999999999999999999653222111      12467899999999999999999998543


Q ss_pred             ----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           89 ----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        89 ----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                          ....|+|||+++|++...+.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CcccCceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence                256899999999998777765 678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC---------------------------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh----
Q 035861          165 RQYGSPL---------------------------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA----  213 (332)
Q Consensus       165 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt----  213 (332)
                      .......                           .......||+.|+|||++.....++.++||||||+++|+|++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            8754221                           123445779999999988665779999999999999999998    


Q ss_pred             -------CCCCCCCCC--------------------hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhh
Q 035861          214 -------KKPLFSGTT--------------------EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKR  266 (332)
Q Consensus       214 -------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (332)
                             |..+|.+..                    ..+....+....+.++...+..+.....          ......
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~----------~~~~~~  353 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA----------KRYIRI  353 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHH----------HHHHTT
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHH----------HHHHHh
Confidence                   666675543                    2345566666666666554333322100          000000


Q ss_pred             C----CCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          267 F----PAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       267 ~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      +    ........+.+++++.+||.+||..||++|||++|+|+||||+++.++..+.
T Consensus       354 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~  410 (458)
T 3rp9_A          354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVET  410 (458)
T ss_dssp             SCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCC
T ss_pred             cCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCC
Confidence            0    0111122345789999999999999999999999999999999998776543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-51  Score=376.23  Aligned_cols=297  Identities=34%  Similarity=0.554  Sum_probs=225.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.+++.++||||+++++++...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHH------HHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHH------HHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            457899999999999999999999999999999999754322211      12467899999999999999999998543


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .     ...|+||||+++++...+.   ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CccccCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            2     4689999999999877664   3599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....+.+....+.
T Consensus       211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          211 ARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             C-----C-CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeecCCC-cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9876432 23455688999999999987 678999999999999999999999999999999999999988877665544


Q ss_pred             CCCCCcccccc-ccCCchhhhhhhCCCCccCCCC----CCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          244 GLSELPGAKAN-FAKQPYNLLRKRFPAASFTGSP----VLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       244 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      .+......... ............++........    ..++++++||.+||..||++|||++|+|+||||+.+..+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  366 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA  366 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence            33211000000 0000000001111111111000    0256789999999999999999999999999999876443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=354.05  Aligned_cols=270  Identities=25%  Similarity=0.380  Sum_probs=221.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .....+.|++.+.||+|+||+||+|.+..+++.||+|++..........  ......+.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A            6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3455678999999999999999999999999999999998654332111  00112467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC----cEEEeec
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----VLKICDF  161 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~----~~~l~df  161 (332)
                      .. ....++||||++|+.+.......+.+++..++.++.||+.||+|||++|++|+||||+||+++.++    .++|+||
T Consensus        84 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           84 EN-KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EC-SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             Ee-CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            54 478999999998644444444467899999999999999999999999999999999999999887    8999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |++...... .......|++.|+|||++.. ..++.++|+||||+++|+|++|..||......+....+.......+...
T Consensus       163 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (326)
T 2y0a_A          163 GLAHKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  240 (326)
T ss_dssp             TTCEECCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             CCCeECCCC-CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence            999876432 23345678999999999976 6789999999999999999999999998887777666654322111110


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                       .+.++..+.+||.+||+.||++|||++|+|+||||+...
T Consensus       241 ---------------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          241 ---------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             ---------------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             ---------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence                                             123788999999999999999999999999999998765

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-51  Score=362.01  Aligned_cols=293  Identities=33%  Similarity=0.570  Sum_probs=226.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.........      ...+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF------AKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHH------HHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHH------HHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            346899999999999999999999999999999998654322111      12467899999999999999999998544


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .     ..+|+|||++++++.+.+..  ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            2     34699999997777766654  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +......   .....+|+.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.++.....
T Consensus       175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9876432   3456789999999999876779999999999999999999999999999999999999888877766544


Q ss_pred             CCCCCccccccccCCchhhhhhhCCC----CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPA----ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .+......          .....++.    ......+.+++.+.+||.+||..||.+|||++|+|+||||+++..+....
T Consensus       252 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  321 (367)
T 1cm8_A          252 RLQSDEAK----------NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP  321 (367)
T ss_dssp             TCSCHHHH----------HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred             HhhhHHHH----------HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCC
Confidence            33221100          00000110    01112244789999999999999999999999999999999988766544


Q ss_pred             CCC
Q 035861          320 FMP  322 (332)
Q Consensus       320 ~~~  322 (332)
                      ...
T Consensus       322 ~~~  324 (367)
T 1cm8_A          322 QVQ  324 (367)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=354.62  Aligned_cols=269  Identities=28%  Similarity=0.456  Sum_probs=212.9

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc------------------cccCCCcchhHHHH
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC------------------LEYGFPISSLREIN   68 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~------------------~~~~~~~~~~~e~~   68 (332)
                      +..+++|++.+.||+|+||+||+|++..+++.||||++..........                  ........+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            445789999999999999999999999999999999997654322110                  00112245789999


Q ss_pred             HHhhCCCCCeeeeeeeEEcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           69 ILLSFDHPSIVNVKEVVMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        69 ~l~~l~h~~i~~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      ++++++||||+++++++... ....++||||++++.+..+.. ...+++..++.++.||+.||+|||++|++|+||||+|
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            99999999999999998653 478999999998754443332 4679999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVD  225 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~sDi~slG~~l~~lltg~~pf~~~~~~~  225 (332)
                      |+++.++.++|+|||++..............|++.|+|||.+.+...  .+.++|+||||+++|+|++|..||.......
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999876544333455678999999999876332  4789999999999999999999998877665


Q ss_pred             HHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ....+......                                   ....+.+++.+.+||.+||+.||++||++.|+++
T Consensus       248 ~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQALE-----------------------------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCCCC-----------------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcccCC-----------------------------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            55544332111                                   1112347899999999999999999999999999


Q ss_pred             CCCCCC
Q 035861          306 HYWFHE  311 (332)
Q Consensus       306 hp~f~~  311 (332)
                      ||||++
T Consensus       293 hp~~~~  298 (298)
T 2zv2_A          293 HPWVTR  298 (298)
T ss_dssp             CHHHHC
T ss_pred             CccccC
Confidence            999963

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.5e-51  Score=360.34  Aligned_cols=263  Identities=25%  Similarity=0.410  Sum_probs=219.4

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +....++|++.+.||+|+||+||+|.+..+++.||+|++..........      ..+.+|+.+++.++||||+++++++
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~------~~~~~E~~il~~l~hpnIv~~~~~~   97 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF------QKLEREARICRKLQHPNIVRLHDSI   97 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHH------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHH------HHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3445568999999999999999999999999999999997654322111      2467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---cEEEeec
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDF  161 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---~~~l~df  161 (332)
                      . +....|+||||++| ++.+.+. ....+++..++.++.||+.||+|||++||+|+||||+||+++.++   .+||+||
T Consensus        98 ~-~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A           98 Q-EESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             E-CSSEEEEEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             E-eCCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence            5 44889999999987 4545444 467899999999999999999999999999999999999998654   5999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |++...... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......+...
T Consensus       176 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (362)
T 2bdw_A          176 GLAIEVNDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE  253 (362)
T ss_dssp             TTCBCCTTC-CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG
T ss_pred             CcceEecCC-cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            999876432 33445679999999999977 6789999999999999999999999998888777777665432222111


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                       +..+++++++||.+||+.||++||++.++|+||||..
T Consensus       254 ---------------------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          254 ---------------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             ---------------------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             ---------------------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                                             1237899999999999999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-51  Score=358.40  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=220.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|++.......         ..+.+|+.+++.++||||+++++++.+ 
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---------~~~~~E~~~l~~l~hpnIv~~~~~~~~-   72 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---------VLVKKEISILNIARHRNILHLHESFES-   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH---------HHHHHHHHHHHHSCCTTBCCEEEEEEE-
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccH---------HHHHHHHHHHHhCCCCCCCeEeEEEec-
Confidence            4579999999999999999999999999999999986432111         135689999999999999999999954 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC--CCcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN--QGVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~--~~~~~l~df~~~~  165 (332)
                      ....++||||++| ++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.  ++.++|+|||.+.
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            4789999999986 666666554567999999999999999999999999999999999999997  7899999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......+...    
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----  226 (321)
T 1tki_A          153 QLKPG-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----  226 (321)
T ss_dssp             ECCTT-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH----
T ss_pred             ECCCC-CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh----
Confidence            76432 33345678999999999987 5689999999999999999999999999888887777766433222111    


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                   .+.++.++.+||.+||..||.+|||+.|+|+||||++..
T Consensus       227 -----------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          227 -----------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             -----------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             -----------------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                                         123789999999999999999999999999999998753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.7e-51  Score=359.42  Aligned_cols=271  Identities=27%  Similarity=0.414  Sum_probs=216.8

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      ....++|++.+.||+|+||+||++.+..+++.||||++.....            ...+|++.+.++ +||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~   85 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVY   85 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEE
Confidence            3456789999999999999999999999999999999975432            234788888887 799999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC----CcEEEee
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ----GVLKICD  160 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~----~~~~l~d  160 (332)
                       .+....|+||||++| ++.+.+. ..+.+++..+..++.||+.||+|||++||+|+||||+||++..+    +.+||+|
T Consensus        86 -~~~~~~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           86 -DDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             -EcCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence             455889999999986 5555554 46789999999999999999999999999999999999998543    3599999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHcCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT---TEVDQIDKIFKTLGTP  237 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~---~~~~~~~~~~~~~~~~  237 (332)
                      ||++..............|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...   ...+....+.......
T Consensus       164 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          164 FGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL  242 (342)
T ss_dssp             CTTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred             CCCcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence            9999876554444556688999999999876 55789999999999999999999999763   3333444443321111


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      +                                 ...++.+++++++||.+||..||++||+++++++||||.++.....
T Consensus       243 ~---------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~  289 (342)
T 2qr7_A          243 S---------------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ  289 (342)
T ss_dssp             C---------------------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCC
T ss_pred             C---------------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccccc
Confidence            1                                 1112348999999999999999999999999999999988754444


Q ss_pred             CCCCCCCC
Q 035861          318 KDFMPTFP  325 (332)
Q Consensus       318 ~~~~~~~~  325 (332)
                      ....+++.
T Consensus       290 ~~~~~~~~  297 (342)
T 2qr7_A          290 YQLNRQDA  297 (342)
T ss_dssp             SCCCCCCC
T ss_pred             ccCCCccc
Confidence            44433443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-50  Score=353.78  Aligned_cols=264  Identities=26%  Similarity=0.385  Sum_probs=212.6

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|+||+||+|.+..+++.||||++........       ...+.+|+.+++.++||||+++++++. 
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~-   75 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-------PENIKKEICINKMLNHENVVKFYGHRR-   75 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch-------HHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            356799999999999999999999999999999999975433211       125679999999999999999999985 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +....++||||++|+.+.........+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             CSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            44889999999987544444444667999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ...  ........|++.|+|||++.+....+.++||||||+++|+|++|..||.................          
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------  225 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------  225 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC----------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc----------
Confidence            321  22234567899999999998755568899999999999999999999987654322222211110          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                              ........++..+.+||.+||+.||++|||++|+++||||++..
T Consensus       226 ------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          226 ------------------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             ------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ------------------------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                                    00111233789999999999999999999999999999998754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.8e-51  Score=386.99  Aligned_cols=277  Identities=24%  Similarity=0.382  Sum_probs=232.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      .+++|++++.||+|+||+||+|++..+++.||||++........     .....+..|..++..+ .||+|+.+++.+ +
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----DDVECTMVEKRVLALPGKPPFLTQLHSCF-Q  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHT-----TTTHHHHHHHHHHTCTTCCTTBCCEEEEC-B
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccH-----HHHHHHHHHHHHHHhccCCCeEEEEEEEE-E
Confidence            46789999999999999999999999999999999986432111     1122456888999887 799999999988 5


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      +...+|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            55889999999987444444444578999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.......          
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----------  561 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----------  561 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC----------
T ss_pred             ccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            444445566789999999999977 678999999999999999999999999988888877776532211          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCCCCC--CCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-----DDALNHYWFHEVPLPKS--KDF  320 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~f~~~~~~~~--~~~  320 (332)
                                                 +..++.++++||++||+.||++||++     +||++||||+.+.|...  +..
T Consensus       562 ---------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~  614 (674)
T 3pfq_A          562 ---------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI  614 (674)
T ss_dssp             ---------------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCS
T ss_pred             ---------------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCC
Confidence                                       12379999999999999999999997     99999999999998766  446


Q ss_pred             CCCCCCccc
Q 035861          321 MPTFPPQHA  329 (332)
Q Consensus       321 ~~~~~~~~~  329 (332)
                      .++|.|...
T Consensus       615 ~pp~~p~~~  623 (674)
T 3pfq_A          615 QPPYKPKAS  623 (674)
T ss_dssp             CCSCCCBCC
T ss_pred             CCCCCCcCC
Confidence            778888653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-50  Score=359.47  Aligned_cols=292  Identities=33%  Similarity=0.575  Sum_probs=228.3

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .|.....+|.+++.||+|+||+||+|++..++. +|+|++.....            ...+|+.+++.++||||++++++
T Consensus        34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~  100 (394)
T 4e7w_A           34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAF  100 (394)
T ss_dssp             SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEE
Confidence            344556689999999999999999999987666 88888764321            12379999999999999999999


Q ss_pred             EEcCC-----CeEEEEcccccccHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc-CCCc
Q 035861           85 VMDDH-----DSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGV  155 (332)
Q Consensus        85 ~~~~~-----~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~-~~~~  155 (332)
                      +....     ...++||||+++++...+..   ....+++..++.++.||+.||+|||++||+||||||+||+++ .++.
T Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~  180 (394)
T 4e7w_A          101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV  180 (394)
T ss_dssp             EEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred             EEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc
Confidence            85432     34889999999987665543   357899999999999999999999999999999999999999 7899


Q ss_pred             EEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          156 LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +||+|||++...... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+....+.+..+
T Consensus       181 ~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  259 (394)
T 4e7w_A          181 LKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG  259 (394)
T ss_dssp             EEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999999876332 2334557899999999998766799999999999999999999999999999988888888777


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      .+....+......- ..............       ....+.+++++.+||.+||+.||.+|||+.|+++||||+++..+
T Consensus       260 ~p~~~~~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          260 TPSREQIKTMNPNY-MEHKFPQIRPHPFS-------KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             CCCHHHHHHHCGGG-SSSCCCCCCCCCHH-------HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             CCCHHHHHhhChhh-hhhccccccCCcHH-------HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            66544322111000 00000000000000       11123478999999999999999999999999999999998876


Q ss_pred             CCC
Q 035861          316 KSK  318 (332)
Q Consensus       316 ~~~  318 (332)
                      ...
T Consensus       332 ~~~  334 (394)
T 4e7w_A          332 EAR  334 (394)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-50  Score=349.44  Aligned_cols=260  Identities=27%  Similarity=0.473  Sum_probs=217.9

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|+..+.||+|+||+||+|++..+|+.||||++.......        ...+.+|+..+++++||||+++++++..+ ..
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~  116 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--------RELLFNEVVIMRDYQHFNVVEMYKSYLVG-EE  116 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--------HHHHHHHHHHHTTCCCTTBCCEEEEEEET-TE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCcceEEEEEEEC-CE
Confidence            4778889999999999999999899999999997543221        12466899999999999999999999555 78


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .++||||++|+.+..+.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus       117 ~~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          117 LWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             EEEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence            999999998765555544 4579999999999999999999999999999999999999999999999999988765544


Q ss_pred             CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc
Q 035861          172 KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA  251 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (332)
                      .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+........             
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  261 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-------------  261 (321)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-------------
T ss_pred             cccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-------------
Confidence            44456689999999999977 6789999999999999999999999998877766655543211110             


Q ss_pred             cccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                           .....+++.+.+||.+||+.||++|||+.++++||||.+...+.
T Consensus       262 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          262 ---------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             ---------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             ---------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence                                 01122688999999999999999999999999999999876544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.3e-51  Score=358.93  Aligned_cols=292  Identities=33%  Similarity=0.585  Sum_probs=224.6

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.++++++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV------KKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHH------HHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHH------HHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            4678999999999999999999999999999999998754332211      1135689999999999999999999954


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ....++||||++|+++..+......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        96 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           96 -KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             -TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             -CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence             4889999999999998888777788999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.+...++.++|+||||+++|+|++|..||......+....+....+.........+..
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            55444455667899999999998756789999999999999999999999999988888777776654433221110000


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      .+...    .......  ..........+.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       255 ~~~~~----~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          255 NPVFA----GVRLPEI--KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CGGGT----TCCCCCC--SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccc----cccCccc--cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            00000    0000000  00000011123478999999999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.4e-50  Score=349.76  Aligned_cols=275  Identities=25%  Similarity=0.364  Sum_probs=224.3

Q ss_pred             cccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeee
Q 035861            2 NMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV   81 (332)
Q Consensus         2 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   81 (332)
                      .-..+....++|++.+.||+|+||+||+|.+..+++.||+|++..........  ......+.+|+.+++++.||||+++
T Consensus         3 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~   80 (321)
T 2a2a_A            3 EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITL   80 (321)
T ss_dssp             CCCBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceE
Confidence            33456667789999999999999999999999999999999998654432111  0012246789999999999999999


Q ss_pred             eeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC----cEE
Q 035861           82 KEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----VLK  157 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~----~~~  157 (332)
                      ++++.+ ....++|||+++|+.+.........+++..++.++.|++.||+|||+.|++|+||+|+||+++.++    .++
T Consensus        81 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           81 HDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EEEEEC-SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEec-CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence            999844 488999999998644444444467899999999999999999999999999999999999999888    799


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |+|||.+...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.......
T Consensus       160 l~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  237 (321)
T 2a2a_A          160 LIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF  237 (321)
T ss_dssp             ECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             EccCccceecCcc-ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence            9999999876432 23345578999999999976 678999999999999999999999999888777666655432111


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +..                                 ..+.++..+.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       238 ~~~---------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          238 DEE---------------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             CHH---------------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             Chh---------------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            110                                 01237889999999999999999999999999999998653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-50  Score=368.96  Aligned_cols=264  Identities=29%  Similarity=0.413  Sum_probs=222.1

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .|....++|.+++.||+|+||+||+|++..+|+.||||++........     .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~   84 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL-----DVVGKIRREIQNLKLFRHPHIIKLYQV   84 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHT-----TTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            456678899999999999999999999999999999999976432111     112256789999999999999999999


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      +.. ....++||||++|+.+......++.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++
T Consensus        85 ~~~-~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a  163 (476)
T 2y94_A           85 IST-PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS  163 (476)
T ss_dssp             EEC-SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEE-CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccch
Confidence            954 4789999999976544444455778999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... ......+|++.|+|||++.+....+.++|+||||+++|+|++|..||...+.......+.......       
T Consensus       164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------  235 (476)
T 2y94_A          164 NMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT-------  235 (476)
T ss_dssp             EECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC-------
T ss_pred             hhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC-------
Confidence            876432 334456799999999999875556889999999999999999999999888777766665432111       


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                    +..+++++.+||.+||+.||.+|||++|+++||||++-
T Consensus       236 ------------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          236 ------------------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ------------------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                          12378899999999999999999999999999999873

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=363.80  Aligned_cols=302  Identities=38%  Similarity=0.695  Sum_probs=219.8

Q ss_pred             cchhccccc-ccccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            8 RSVFEFEKL-NKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         8 ~~~~~y~~~-~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      +..+.|++. ++||+|+||+||+|++.  .+++.||||++......          ..+.+|+.++++++||||++++++
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~   86 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKV   86 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------HHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------HHHHHHHHHHHhcCCCCeeeEeeE
Confidence            344567774 47999999999999965  57889999998643221          246789999999999999999999


Q ss_pred             EEc-CCCeEEEEcccccccHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE----c
Q 035861           85 VMD-DHDSVYMVMEYMEHDLKWLMESM--------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----N  151 (332)
Q Consensus        85 ~~~-~~~~~~lv~e~~~~~l~~~~~~~--------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili----~  151 (332)
                      +.. .....++||||++|++.+.+...        ...+++..++.++.||+.||+|||++||+|+||||+||++    +
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             EEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST
T ss_pred             EecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC
Confidence            864 45789999999999988776532        1249999999999999999999999999999999999999    6


Q ss_pred             CCCcEEEeecccccccCCCC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----
Q 035861          152 NQGVLKICDFGMSRQYGSPL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-----  223 (332)
Q Consensus       152 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-----  223 (332)
                      .++.+||+|||++.......   .......||+.|+|||++.+...++.++||||||+++|+|++|..||.....     
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            77899999999998764322   2234567899999999998766799999999999999999999999976543     


Q ss_pred             ----HHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhh-CCCCccCCCCCCCchHHHHHHHhcCCCCCCCC
Q 035861          224 ----VDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKR-FPAASFTGSPVLSESGFDLLNRLLTYDPEKRI  298 (332)
Q Consensus       224 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  298 (332)
                          .+....++...+.+....++.+...+................. ............++.+.+||.+||+.||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                4677888888888888777665544332111100000000000 00000011222478899999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCCCCCC
Q 035861          299 TVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       299 s~~ell~hp~f~~~~~~~~~~  319 (332)
                      |++|+|+||||++.+++....
T Consensus       327 ta~e~L~hp~f~~~~~~~~~~  347 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLPTSDV  347 (405)
T ss_dssp             CHHHHHTSGGGTSSSCCCSST
T ss_pred             CHHHHhcChhhccCCCCcccc
Confidence            999999999999988776543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.8e-51  Score=359.60  Aligned_cols=264  Identities=30%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ....++|++++.||+|+||+||++++..+++.||||++.......         ..+.+|+..++.++||||+++++++.
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~~~~~   86 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---------ENVQREIINHRSLRHPNIVRFKEVIL   86 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---------HHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---------HHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            445679999999999999999999999999999999997543222         24568999999999999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc--EEEeeccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LKICDFGM  163 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~--~~l~df~~  163 (332)
                      .. ...++||||++| ++.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||+
T Consensus        87 ~~-~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~  164 (361)
T 3uc3_A           87 TP-THLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  164 (361)
T ss_dssp             CS-SEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred             eC-CEEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence            54 789999999976 5555444 3668999999999999999999999999999999999999987765  99999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......||+.|+|||++.+....+.++||||||+++|+|++|..||...................      
T Consensus       165 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~------  237 (361)
T 3uc3_A          165 SKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV------  237 (361)
T ss_dssp             C----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT------
T ss_pred             ccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC------
Confidence            8754222 223455789999999999875544556999999999999999999998754432222222211000      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               .........+++++++||.+||+.||++|||+.|+++||||.+..
T Consensus       238 -------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          238 -------------------------KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             -------------------------CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             -------------------------CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence                                     011111223789999999999999999999999999999997643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.4e-50  Score=343.29  Aligned_cols=268  Identities=25%  Similarity=0.398  Sum_probs=223.0

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +...++|++.+.||+|+||+||+|.+..+++.||+|++..........      ..+.+|+.++++++||||+++++++.
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF------QKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHH------HHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHH------HHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            456679999999999999999999999999999999998655432221      24568999999999999999999984


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc---EEEeecc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV---LKICDFG  162 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~---~~l~df~  162 (332)
                       .....++|||+++| ++.+.+.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.   ++|+|||
T Consensus        76 -~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           76 -EESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             -cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence             44788999999987 45455544 577999999999999999999999999999999999999987665   9999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.......+..  
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  229 (284)
T 3kk8_A          154 LAIEVNDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--  229 (284)
T ss_dssp             TCEECCSS-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             eeEEcccC-ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch--
Confidence            99766432 33345678999999999987 678999999999999999999999999888877777665543222211  


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                     ....+++++.+||.+||+.||++|||++|+|+||||++......
T Consensus       230 -------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          230 -------------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             -------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             -------------------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                                           12237899999999999999999999999999999998664443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-50  Score=347.38  Aligned_cols=264  Identities=31%  Similarity=0.467  Sum_probs=217.8

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...+++|++.+.||+|++|+||+|.+..++..||+|++........     .....+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-----GVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHH-----TCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchh-----hHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            4567899999999999999999999999999999999975432111     11225678999999999999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      + ....++||||+++ ++.+.+.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        80 ~-~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           80 D-ATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             C-SSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             c-CCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            4 4789999999996 45454444 5779999999999999999999999999999999999999999999999999886


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .....  ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.......        
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  226 (279)
T 3fdn_A          158 HAPSS--RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------  226 (279)
T ss_dssp             CC----------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--------
T ss_pred             cCCcc--cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC--------
Confidence            54332  2345578999999999877 678999999999999999999999999888777666655432211        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                   +..++..+.+||.+||+.||.+||+++|+++||||+.......
T Consensus       227 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          227 -----------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             -----------------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             -----------------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence                                         1227889999999999999999999999999999998765543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-50  Score=357.10  Aligned_cols=265  Identities=23%  Similarity=0.403  Sum_probs=220.1

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+...++|++++.||+|+||+||+|.+..+++.+|+|++........        ..+.+|+.+++.++||||+++++++
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--------~~~~~E~~il~~l~hpnIv~~~~~~  117 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--------YTVKNEISIMNQLHHPKLINLHDAF  117 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH--------HHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhH--------HHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            34566799999999999999999999999999999999975421111        1466899999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC--CCcEEEeecc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN--QGVLKICDFG  162 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~--~~~~~l~df~  162 (332)
                      . +....++||||++| ++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.  ++.++|+|||
T Consensus       118 ~-~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          118 E-DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             E-CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             E-eCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecc
Confidence            4 45889999999986 555555554557999999999999999999999999999999999999974  4689999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+.........   
T Consensus       197 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---  271 (387)
T 1kob_A          197 LATKLNPD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE---  271 (387)
T ss_dssp             TCEECCTT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS---
T ss_pred             cceecCCC-cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---
Confidence            99876432 22344578999999999987 67899999999999999999999999998877777666543221111   


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                    .....+++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus       272 ------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          272 ------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             ------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                                          112337899999999999999999999999999999997654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-51  Score=353.84  Aligned_cols=253  Identities=21%  Similarity=0.247  Sum_probs=185.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC-
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH-   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   89 (332)
                      .+|.+.+.||+|+||+||+|+++  |+.||||++.......   .      ....|+..+.+++||||+++++++.++. 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~---~------~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS---W------FREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHH---H------HHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhh---H------HHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            47889999999999999999985  8899999986432110   0      1124556667889999999999996553 


Q ss_pred             --CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCCEEEcCCCcEEE
Q 035861           90 --DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN--------WVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        90 --~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~--------~i~H~di~p~Nili~~~~~~~l  158 (332)
                        ..+||||||++| +|.+.+.  ...++++.+..++.|++.||+|||++        +|+||||||+|||++.++++||
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHH--HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEEecCCCCCcHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence              258999999996 5555544  35699999999999999999999987        9999999999999999999999


Q ss_pred             eecccccccCCCCC----CCccccccccccchhhhcCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----
Q 035861          159 CDFGMSRQYGSPLK----PYTSLVVTLWYRAPELLLGAK-----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-----  224 (332)
Q Consensus       159 ~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-----  224 (332)
                      +|||+++.......    ......||+.|+|||++.+..     .++.++||||||+++|||+||..||......     
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            99999987643322    123457999999999997532     3677999999999999999998877543211     


Q ss_pred             ---------HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCc-cCCCCCCCchHHHHHHHhcCCCC
Q 035861          225 ---------DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAAS-FTGSPVLSESGFDLLNRLLTYDP  294 (332)
Q Consensus       225 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp  294 (332)
                               ............                              .|..+ .......+..+.+|+.+||+.||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~------------------------------rp~~p~~~~~~~~~~~l~~li~~cl~~dP  279 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKL------------------------------RPNIPNRWQSCEALRVMAKIMRECWYANG  279 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCC------------------------------CCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred             hcccccchHHHHHHHHhcccC------------------------------CCCCCccccchHHHHHHHHHHHHHcccCH
Confidence                     011111000000                              00000 00011133467899999999999


Q ss_pred             CCCCCHHHHhcC
Q 035861          295 EKRITVDDALNH  306 (332)
Q Consensus       295 ~~Rps~~ell~h  306 (332)
                      ++|||+.||++.
T Consensus       280 ~~RPt~~ei~~~  291 (303)
T 3hmm_A          280 AARLTALRIKKT  291 (303)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.7e-50  Score=353.93  Aligned_cols=298  Identities=31%  Similarity=0.530  Sum_probs=223.1

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ...+++|++.+.||+|+||+||+|++..+++.||||++.......         ....+++..+..++||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---------CHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---------HHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            346779999999999999999999999999999999986533211         24557788888889999999999985


Q ss_pred             cCC------CeEEEEcccccccHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCCCEEEcC-CC
Q 035861           87 DDH------DSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLH--DNWVLHRDLKTSNLLLNN-QG  154 (332)
Q Consensus        87 ~~~------~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh--~~~i~H~di~p~Nili~~-~~  154 (332)
                      ...      ...++||||++|++...+..   ....+++..++.++.|++.||.|||  +.||+|+||||+||+++. ++
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             ccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            432      23789999999987665543   4677999999999999999999999  999999999999999997 89


Q ss_pred             cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          155 VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      .++|+|||++...... .......|++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+.+..
T Consensus       170 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            9999999999876432 233455789999999999775668999999999999999999999999999999998888877


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +.++...+..+................ ....++    .....++.++.+||.+||+.||.+|||+.|+|+||||+++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIP-WSNVFS----DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCC-HHHHTT----TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             CCCCHHHHHhcccchhhccccccccCC-cccccc----hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            776655433222111100000000000 011111    112236788999999999999999999999999999999887


Q ss_pred             CCCCC
Q 035861          315 PKSKD  319 (332)
Q Consensus       315 ~~~~~  319 (332)
                      +....
T Consensus       324 ~~~~~  328 (360)
T 3e3p_A          324 PATKL  328 (360)
T ss_dssp             TTCCC
T ss_pred             ccccC
Confidence            66543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.9e-50  Score=345.79  Aligned_cols=270  Identities=28%  Similarity=0.378  Sum_probs=225.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ......+|.+.+.||+|+||+||++.+..+++.+|+|++...........     ..+.+|+.+++.++|+||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-----EKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHH-----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHH-----HHHHHHHHHHHhCCCCCEeeeeeee
Confidence            44567799999999999999999999999999999999976543322211     2466899999999999999999998


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .. ....++|||+++|+.+.........+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           85 ED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EC-SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cc-CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            54 47899999999965444444446789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .............|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+.....          
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  232 (294)
T 2rku_A          164 KVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------  232 (294)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------
T ss_pred             ecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----------
Confidence            76544444555678999999999976 6689999999999999999999999988877665555433211          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                                                 ..+..++..+.+||.+||+.||++||+++++++||||.+...+....
T Consensus       233 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~  279 (294)
T 2rku_A          233 ---------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP  279 (294)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCC
T ss_pred             ---------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCC
Confidence                                       11223788999999999999999999999999999999987766543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-50  Score=357.46  Aligned_cols=284  Identities=31%  Similarity=0.567  Sum_probs=223.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.....            ...+|+.+++.++||||+++++++...
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence            34689999999999999999999999999999999864322            123799999999999999999988432


Q ss_pred             -------------------------------------CCeEEEEcccccccHHHHHH---hcCCCCCHHHHHHHHHHHHH
Q 035861           89 -------------------------------------HDSVYMVMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLE  128 (332)
Q Consensus        89 -------------------------------------~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~~l~~  128 (332)
                                                           ....++||||++|++.+.+.   .....+++..++.++.||+.
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~  152 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR  152 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence                                                 23488999999998665554   44678999999999999999


Q ss_pred             HHHHHHHCCcccccCCCCCEEEc-CCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHH
Q 035861          129 GVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCI  207 (332)
Q Consensus       129 ~L~~lh~~~i~H~di~p~Nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~  207 (332)
                      ||+|||++||+|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+...++.++|+||||++
T Consensus       153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999999999999999999998 6889999999999876432 333455779999999999876679999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHH
Q 035861          208 MAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLN  287 (332)
Q Consensus       208 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  287 (332)
                      +|+|++|..||...+..+....+....+.+....+......-. ..............       ..+..+++++.+||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT-EVRFPTLKAKDWRK-------ILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC---CCCCCCCCCCHHH-------HSCTTCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc-cccCCccCcccHHh-------hCCCCCCHHHHHHHH
Confidence            9999999999999999999999888777665442221110000 00000000000000       112347889999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          288 RLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       288 ~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +||+.||.+|||+.|+|+||||+++.
T Consensus       304 ~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             HHccCChhhCCCHHHHhcCHHHHHHH
Confidence            99999999999999999999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-50  Score=358.73  Aligned_cols=292  Identities=34%  Similarity=0.563  Sum_probs=218.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   88 (332)
                      .++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.+++.++||||+++++++... 
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH------AKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHH------HHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHH------HHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            46899999999999999999999999999999998653322111      12456899999999999999999998543 


Q ss_pred             ----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           89 ----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        89 ----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                          ....|+|+|++++++.+.+..  ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++
T Consensus       102 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          102 SLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             SGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             ccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence                255799999998877665543  67999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ......   .....+|..|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+.+..+.+....+..
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            865432   34567899999999998767789999999999999999999999999999999999998888777665544


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDF  320 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~  320 (332)
                      +......          .....++...    ....+.+++.+.+||.+||+.||.+|||++|+|+||||.++..+.....
T Consensus       257 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~  326 (367)
T 2fst_X          257 ISSESAR----------NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV  326 (367)
T ss_dssp             CCCHHHH----------HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCC
T ss_pred             hhhHHHH----------HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCC
Confidence            3321100          0000000000    0011346889999999999999999999999999999999887765543


Q ss_pred             CC
Q 035861          321 MP  322 (332)
Q Consensus       321 ~~  322 (332)
                      ..
T Consensus       327 ~~  328 (367)
T 2fst_X          327 AD  328 (367)
T ss_dssp             CC
T ss_pred             CC
Confidence            33

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-49  Score=359.22  Aligned_cols=286  Identities=34%  Similarity=0.587  Sum_probs=224.2

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC--
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD--   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   88 (332)
                      .+|++++.||+|+||+||+|++..+++.||||++.....            ...+|+.+++.++|+||+++++++...  
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~E~~il~~l~hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------------hHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence            479999999999999999999999999999999864321            123799999999999999999988432  


Q ss_pred             ---CCeEEEEcccccccHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeec
Q 035861           89 ---HDSVYMVMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDF  161 (332)
Q Consensus        89 ---~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df  161 (332)
                         ..+.++||||+++++...+.   .....+++..++.++.||+.||+|||++||+|+||||+|||++.+ +.+||+||
T Consensus       122 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             TTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence               23477999999998766554   345789999999999999999999999999999999999999965 57899999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |++...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+.+.++++..+.+....
T Consensus       202 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          202 GSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             TTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             hhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999875432 2234557899999999998756799999999999999999999999999998888888888776665432


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      +..+...- ...............       ...+.+++++++||.+||..||.+||++.|+++||||.++..+..
T Consensus       281 ~~~~~~~~-~~~~~p~~~~~~~~~-------~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          281 IREMNPNY-TEFKFPQIKAHPWTK-------VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             HHHHCSCC-CCCCCCCCCCCCHHH-------HSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             HHhhChhh-hhhccCccCCCCHHH-------hcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence            22110000 000000000000000       012347899999999999999999999999999999998876554

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.7e-50  Score=355.08  Aligned_cols=287  Identities=38%  Similarity=0.653  Sum_probs=230.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC-
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH-   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   89 (332)
                      .+|++++.||+|+||+||+|.+..++..||||++.......  .     ...+.+|+.++++++||||+++++++.... 
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT--Y-----CQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH--H-----HHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH--H-----HHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            58999999999999999999999999999999996432111  1     124678999999999999999999985432 


Q ss_pred             ---CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           90 ---DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        90 ---~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                         ...++|||+++|++.+.+..  ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+..
T Consensus       100 ~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          100 EQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             TTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence               46899999999998877754  5699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          167 YGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ......   ......|++.|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....+.
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            543211   12445789999999998776778999999999999999999999999999888888888877776655433


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      .+........          ....+...    ....+.+++++.+||.+||+.||++|||++|+|+||||+++..+.
T Consensus       258 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          258 CIINLKARNY----------LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             TCCCHHHHHH----------HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HhhhhhHHHH----------HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence            3222111000          00000000    011234789999999999999999999999999999999975443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-50  Score=352.81  Aligned_cols=262  Identities=30%  Similarity=0.459  Sum_probs=192.2

Q ss_pred             cccchhccccc---ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeee
Q 035861            6 GCRSVFEFEKL---NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNV   81 (332)
Q Consensus         6 ~~~~~~~y~~~---~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~   81 (332)
                      .+....+|++.   +.||+|+||+||+|.+..+++.||||++.....           ....+|+..++.+. ||||+++
T Consensus         3 ~~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~e~~~l~~l~~h~niv~~   71 (325)
T 3kn6_A            3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----------ANTQKEITALKLCEGHPNIVKL   71 (325)
T ss_dssp             CCHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH-----------HHHHHHHHHHHHTTTCTTBCCE
T ss_pred             CCcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhh-----------hhHHHHHHHHHHhcCCCCeeEE
Confidence            34456778876   789999999999999999999999999965321           13458999999996 9999999


Q ss_pred             eeeEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---cEE
Q 035861           82 KEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLK  157 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---~~~  157 (332)
                      ++++. +....|+||||++| ++.+.+.. .+.+++..++.++.||+.||+|||++||+|+||||+||+++.++   .++
T Consensus        72 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~k  149 (325)
T 3kn6_A           72 HEVFH-DQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIK  149 (325)
T ss_dssp             EEEEE-CSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEE
T ss_pred             EEEEE-cCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEE
Confidence            99994 44889999999987 55555544 67899999999999999999999999999999999999998766   899


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHH
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-------VDQIDKI  230 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-------~~~~~~~  230 (332)
                      |+|||++..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.       .+....+
T Consensus       150 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i  228 (325)
T 3kn6_A          150 IIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI  228 (325)
T ss_dssp             ECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred             EeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence            9999999876554445556678999999999876 6789999999999999999999999976433       2222222


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                      ........                                 ...++.+++++++||.+||+.||.+|||++|+++||||+
T Consensus       229 ~~~~~~~~---------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          229 KKGDFSFE---------------------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             TTTCCCCC---------------------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             HcCCCCCC---------------------------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence            21111000                                 001123789999999999999999999999999999999


Q ss_pred             CCCC
Q 035861          311 EVPL  314 (332)
Q Consensus       311 ~~~~  314 (332)
                      +...
T Consensus       276 ~~~~  279 (325)
T 3kn6_A          276 DGSQ  279 (325)
T ss_dssp             TTCC
T ss_pred             cCcc
Confidence            8543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.4e-50  Score=351.46  Aligned_cols=259  Identities=28%  Similarity=0.467  Sum_probs=219.3

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ..|++++.||+|+||+||+|.+..+++.||||++...........     ..+.+|+.++++++||||+++++++..+ .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~-~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEVRFLQKLRHPNTIQYRGCYLRE-H  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHH-----HHHHHHHHHHHHCCCTTBCCEEEEEEET-T
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHH-----HHHHHHHHHHHhCCCCCEeeEEEEEEEC-C
Confidence            469999999999999999999999999999999976433222111     2467899999999999999999999555 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      ..++||||+.|++.+.+......+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..... 
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            8999999999999888877778899999999999999999999999999999999999999999999999999976532 


Q ss_pred             CCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          171 LKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                         .....|++.|+|||++..  ...++.++||||||+++|+|++|..||...+.......+.......           
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------  272 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-----------  272 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Confidence               234578999999999852  3578999999999999999999999998887776665554432111           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                              .....++..+.+||.+||+.||++|||++++++||||.....
T Consensus       273 ------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          273 ------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence                                    012237889999999999999999999999999999987543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.4e-50  Score=350.97  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=213.9

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +...++|++++.||+|+||+||+|.+..+++.||||++..................+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34567999999999999999999999999999999999876543332222223346678999999999999999999994


Q ss_pred             cCCCeEEEEcccccc--cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           87 DDHDSVYMVMEYMEH--DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       +....++|||++.+  ++.+. ......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus       100 -~~~~~~lv~e~~~~g~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          100 -NQGFFQLVMEKHGSGLDLFAF-IDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             -CSSEEEEEEECCTTSCBHHHH-HHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -eCCEEEEEEEeCCCCccHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence             45889999999864  44444 444678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... .......|++.|+|||++.+....+.++||||||+++|+|++|..||......                    
T Consensus       178 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------  236 (335)
T 3dls_A          178 AYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------  236 (335)
T ss_dssp             EECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred             eECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence            876433 33345678999999999987555589999999999999999999999652210                    


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                             .......+..+++++.+||.+||+.||++|||++++++||||++.
T Consensus       237 -----------------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 -----------------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----------------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----------------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                                   000111223378999999999999999999999999999999873

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-50  Score=371.12  Aligned_cols=277  Identities=24%  Similarity=0.381  Sum_probs=225.3

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|.+++.||+|+||+||+|++..+++.||+|++.........     ....+..|+.++++++||||+.+++.+. 
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~-----~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-  255 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK-----GYQGAMVEKKILAKVHSRFIVSLAYAFE-  255 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhH-----HHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence            4567999999999999999999999999999999999764322111     1124678999999999999999999984 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +....|+||||++| ++...+...   ...+++..++.++.||+.||+|||++||+|+||||+||+++.+|.+||+|||+
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecce
Confidence            44889999999986 454554432   34699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHcCCCCC
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT----EVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~----~~~~~~~~~~~~~~~~~  239 (332)
                      +..............||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+    .......+.....    
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~----  410 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV----  410 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC----
T ss_pred             eeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc----
Confidence            9876544444445689999999999987 678999999999999999999999998753    2333333332211    


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPL  314 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~  314 (332)
                                                       ..++.+++.+++||.+||+.||++||+     +++|++||||+++.|
T Consensus       411 ---------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          411 ---------------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ---------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ---------------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                                             112337999999999999999999995     589999999999987


Q ss_pred             CCCC--CCCCCCCCcc
Q 035861          315 PKSK--DFMPTFPPQH  328 (332)
Q Consensus       315 ~~~~--~~~~~~~~~~  328 (332)
                      ....  ...++|.|..
T Consensus       458 ~~l~~~~~~pp~~P~~  473 (543)
T 3c4z_A          458 RQLEAGMLTPPFVPDS  473 (543)
T ss_dssp             HHHHTTCSCCSCCCCS
T ss_pred             HHHHcCCCCCCCCCCc
Confidence            7653  3566676653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-50  Score=360.38  Aligned_cols=307  Identities=33%  Similarity=0.539  Sum_probs=223.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~   96 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIIGLLNVFTPQ   96 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHH------HHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHH------HHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence            467999999999999999999999999999999999754322211      12456899999999999999999998544


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .     ...|+||||++|++.+.+.   ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A           97 KSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cccccccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            3     3789999999999877764   4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+....+.+....+.
T Consensus       174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          174 ARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ccccccc-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432 22345678999999999987 678999999999999999999999999999888888888776665544333


Q ss_pred             CCCCCccccc-cccCCchhhhhhhCCCCccCCC----CCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKA-NFAKQPYNLLRKRFPAASFTGS----PVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      .+........ ..............+.......    ...+..+++||.+||+.||++|||++|+|+||||+.+..+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~  331 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA  331 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcccc
Confidence            2211000000 0000000000111111111100    1125678999999999999999999999999999987765544


Q ss_pred             CCCCCCCC
Q 035861          319 DFMPTFPP  326 (332)
Q Consensus       319 ~~~~~~~~  326 (332)
                      ...++..|
T Consensus       332 ~~~~~~~~  339 (371)
T 2xrw_A          332 EAPPPKIP  339 (371)
T ss_dssp             TCCCCCCC
T ss_pred             CCCCCCCC
Confidence            44444433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-50  Score=355.03  Aligned_cols=265  Identities=31%  Similarity=0.422  Sum_probs=213.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|++.+.||+|+||+||+|.+..+++.||||++..........   .....+.+|+.+++.++||||+++++++.+ .
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~   98 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG---LSTEDLKREASICHMLKHPHIVELLETYSS-D   98 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSS---CCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-T
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccccc---chHHHHHHHHHHHHhCCCCCCCcEEEEEEe-C
Confidence            458999999999999999999999999999999997543211100   011246799999999999999999999855 4


Q ss_pred             CeEEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc---EEEeecc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV---LKICDFG  162 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~---~~l~df~  162 (332)
                      ...|+||||++| ++.+.+...   ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.   ++|+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            889999999985 555555432   345899999999999999999999999999999999999987654   9999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++..............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... ......+..........  
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~--  254 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR--  254 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH--
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc--
Confidence            99877554444456689999999999987 668999999999999999999999998753 33444443322111110  


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                     ..+.++.++++||.+||+.||++||++.|+|+||||++..
T Consensus       255 -------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          255 -------------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -------------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -------------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                                           0123789999999999999999999999999999998743

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=350.53  Aligned_cols=261  Identities=31%  Similarity=0.415  Sum_probs=200.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|++..+++.||||++......          ..+.+|+.++++++||||+++++++.. 
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~-  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----------KIVRTEIGVLLRLSHPNIIKLKEIFET-  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEEC-
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhH----------HHHHHHHHHHHhCCCCCCcceeeeEec-
Confidence            345799999999999999999999999999999999754321          135689999999999999999999954 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CCcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QGVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~~~~l~df~~~~  165 (332)
                      ....++||||++|+.+.......+.+++..++.++.||+.||+|||+.||+|+||||+||+++.   ++.++|+|||++.
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            4789999999986444434444677999999999999999999999999999999999999975   7899999999988


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHcCCCCCCcccC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD-QIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... ....+.........     
T Consensus       200 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~-----  272 (349)
T 2w4o_A          200 IVEHQ-VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS-----  272 (349)
T ss_dssp             --------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT-----
T ss_pred             ccCcc-cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC-----
Confidence            65432 22345678999999999987 678999999999999999999999997765544 33444332111111     


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                  ...+.++.++.+||.+||+.||++||++.|+|+||||......
T Consensus       273 ----------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          273 ----------------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             ----------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             ----------------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence                                        1123478999999999999999999999999999999986543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.5e-49  Score=350.05  Aligned_cols=304  Identities=37%  Similarity=0.598  Sum_probs=234.1

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .+....++|++.+.||+|+||+||+|.+..+++.||||++.......  .     ...+.+|+.++++++||||++++++
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~E~~~l~~l~h~~iv~~~~~   77 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL--F-----ALRTLREIKILKHFKHENIITIFNI   77 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHH--H-----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccch--H-----HHHHHHHHHHHHhCcCCCcCCeeee
Confidence            44556679999999999999999999999999999999996432111  1     1145689999999999999999998


Q ss_pred             EEcC----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           85 VMDD----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        85 ~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      +..+    ....++|||+++|++.+.+..  +.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|
T Consensus        78 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           78 QRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             CCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             ecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEe
Confidence            7443    267899999999988777665  5799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCC----------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 035861          161 FGMSRQYGSPLK----------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       161 f~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~  230 (332)
                      ||.+........          ......|++.|+|||++.....++.++|+||||+++|+|++|..||...+..+....+
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            999986542211          1223467999999999876678999999999999999999999999999888877777


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCC----ccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAA----SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ....+.+............         .........+..    .....+.+++++.+||.+||+.||++|||++|+|+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESP---------RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCH---------HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCchhccccccccc---------hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            7766555432111100000         000000000000    011123589999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCCCCC
Q 035861          307 YWFHEVPLPKSKDFMPTFPP  326 (332)
Q Consensus       307 p~f~~~~~~~~~~~~~~~~~  326 (332)
                      |||+.+..+.......+.+|
T Consensus       307 p~~~~~~~~~~~~~~~~~~~  326 (353)
T 2b9h_A          307 PYLQTYHDPNDEPEGEPIPP  326 (353)
T ss_dssp             GGGTTTCCTTSSCCCCCCCG
T ss_pred             ccccccCCcccccccCCCCc
Confidence            99999988776554444444

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-49  Score=353.78  Aligned_cols=289  Identities=35%  Similarity=0.591  Sum_probs=228.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.+++.++||||+++++++...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF------AKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHH------HHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhH------HHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            346899999999999999999999999999999999754322211      12467899999999999999999999544


Q ss_pred             CC-----eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 HD-----SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~~-----~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ..     ..++|||++++++.+.+   ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.
T Consensus       114 ~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             SSSTTCCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             CCcccceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            32     24999999999876654   34599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...+..   .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.++.....
T Consensus       191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            9865432   3455789999999999876788999999999999999999999999999999999988887777665444


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .+.....          .......+...    ....+.+++.+.+||.+||+.||++|||++|+|+||||+.+..+....
T Consensus       268 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~  337 (371)
T 4exu_A          268 KLNDKAA----------KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEET  337 (371)
T ss_dssp             TCSCHHH----------HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCC
T ss_pred             Hhhhhhh----------hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccc
Confidence            3322110          00000000000    111234789999999999999999999999999999999987665543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-49  Score=349.87  Aligned_cols=268  Identities=28%  Similarity=0.384  Sum_probs=224.2

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ......+|.+.+.||+|+||.||++.+..+++.+|+|++...........     ..+.+|+.+++.++|+||+++++++
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-----EKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHH-----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHH-----HHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34556799999999999999999999999999999999976543222111     2467899999999999999999999


Q ss_pred             EcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           86 MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+ ....++||||++|+.+..+......+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||.+.
T Consensus       111 ~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          111 ED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             EC-SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ec-CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            54 47899999999965444444446789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .............|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+......         
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  259 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS---------  259 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------
T ss_pred             ecccCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC---------
Confidence            76544444556678999999999987 66899999999999999999999999888776665555443211         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                  .+..++..+.+||.+||+.||++||+++|+|+||||.+...+..
T Consensus       260 ----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~  303 (335)
T 2owb_A          260 ----------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  303 (335)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             ----------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence                                        11237889999999999999999999999999999998765543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.7e-50  Score=342.44  Aligned_cols=264  Identities=32%  Similarity=0.411  Sum_probs=219.9

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +...++|++.+.||+|+||+||+|.+..++..+|+|++........        ..+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--------DRFKQEIEIMKSLDHPNIIRLYETFE   76 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCH--------HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchH--------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3456789999999999999999999999999999999976543221        24678999999999999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEEeecc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFG  162 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l~df~  162 (332)
                       +....++||||++| ++.+.+.. ...+++..++.++.|++.||+|||++|++|+||+|+||++   +.++.++|+|||
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           77 -DNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             -cCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence             44889999999987 55454444 6779999999999999999999999999999999999999   778899999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+...... .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||...+..+....+.......+... 
T Consensus       155 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  230 (277)
T 3f3z_A          155 LAARFKPG-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-  230 (277)
T ss_dssp             TCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-
T ss_pred             cceeccCc-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-
Confidence            99776432 33345678999999999875  489999999999999999999999999888777777665433222211 


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                                      ...+++.+.+||.+||+.||++||++.++|+||||++.-...
T Consensus       231 --------------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          231 --------------------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             --------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             --------------------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence                                            112789999999999999999999999999999998754433

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.9e-50  Score=358.16  Aligned_cols=302  Identities=20%  Similarity=0.241  Sum_probs=213.2

Q ss_pred             chhccccccccccc--CcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            9 SVFEFEKLNKISEG--TYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         9 ~~~~y~~~~~lg~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ..++|++++.||+|  +||+||+|++..+++.||||++.........      ...+.+|+.++++++||||+++++++.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM------VTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHH------HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHH------HHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            45699999999999  9999999999999999999999865433221      124568999999999999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ++ ...++||||++| ++.+.+... ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+
T Consensus        97 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           97 AD-NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             ET-TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EC-CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            54 789999999986 555555442 267999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-------CCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          165 RQYGSP-------LKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       165 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      ......       ........|+..|+|||++.+. ..++.++||||||+++|+|++|..||...+.......+......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            543211       1122334788999999999764 56899999999999999999999999887665554443322111


Q ss_pred             CC--------CCcccCCCCCccccccccCCchhhhh-hhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 035861          237 PT--------ETIWPGLSELPGAKANFAKQPYNLLR-KRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY  307 (332)
Q Consensus       237 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  307 (332)
                      ..        .........................+ .............+++.+++||.+||+.||++|||++|+|+||
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            00        00000000000000000000000000 0000011123345889999999999999999999999999999


Q ss_pred             CCCCCCCCCC
Q 035861          308 WFHEVPLPKS  317 (332)
Q Consensus       308 ~f~~~~~~~~  317 (332)
                      ||+++.....
T Consensus       336 ~f~~~~~~~~  345 (389)
T 3gni_B          336 FFKQIKRRAS  345 (389)
T ss_dssp             GGGGC---CC
T ss_pred             HHHHHhhcch
Confidence            9999876544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-48  Score=342.01  Aligned_cols=303  Identities=39%  Similarity=0.718  Sum_probs=232.6

Q ss_pred             ccchhcccccccccccCcEEEEEEEEC-CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDK-KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVK   82 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~   82 (332)
                      +...++|++++.||+|+||+||+|.+. .+++.||+|++.........      ...+.+|+..++.+   .||||++++
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeee
Confidence            445679999999999999999999995 67889999999765432211      12455777777665   899999999


Q ss_pred             eeEEc----CCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           83 EVVMD----DHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        83 ~~~~~----~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      +++..    .....++|||+++|++.+.+.... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEE
Confidence            99851    446789999999999888877643 4599999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |+|||.+...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+....+.+
T Consensus       161 l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          161 LADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             ECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EecCcccccccCC-CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999998765322 22345578999999999987 678999999999999999999999999999888888888877766


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ....++.....+......          ..........+.++..+++||.+||+.||++||++.|+|+||||+++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHS----------KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCC----------CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             CcccCccccccchhhhcc----------cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            655544322221111000          0001111223458899999999999999999999999999999999875543


Q ss_pred             CCCCCCCCCcc
Q 035861          318 KDFMPTFPPQH  328 (332)
Q Consensus       318 ~~~~~~~~~~~  328 (332)
                       ......+|.+
T Consensus       309 -~~~~~~~~~~  318 (326)
T 1blx_A          309 -NLDSHLPPSQ  318 (326)
T ss_dssp             -C---------
T ss_pred             -hhccCCCCcc
Confidence             3333344443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.5e-50  Score=370.14  Aligned_cols=275  Identities=23%  Similarity=0.387  Sum_probs=221.9

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||.||+|++..+++.||+|++.........     ....+.+|+.+++.++||||+++++.+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~-----~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-----GEAMALNEKQILEKVNSRFVVSLAYAYET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhH-----HHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence            4567899999999999999999999999999999999764321111     11245689999999999999999999844


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       ....|+||||++| ++.+.+.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.+|.+||+|||++.
T Consensus       256 -~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          256 -KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence             4889999999986 5555554432 349999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE----VDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~  241 (332)
                      ..... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.....    ......+... .      
T Consensus       335 ~~~~~-~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~------  405 (576)
T 2acx_A          335 HVPEG-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P------  405 (576)
T ss_dssp             ECCTT-CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C------
T ss_pred             ecccC-ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c------
Confidence            76432 23345689999999999987 6689999999999999999999999987542    2222222211 0      


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~  316 (332)
                                                    ...+..+++++++||.+||+.||.+||     +++|+++||||+++.|..
T Consensus       406 ------------------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~  455 (576)
T 2acx_A          406 ------------------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR  455 (576)
T ss_dssp             ------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred             ------------------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence                                          011233799999999999999999999     899999999999998766


Q ss_pred             CC--CCCCCCCCc
Q 035861          317 SK--DFMPTFPPQ  327 (332)
Q Consensus       317 ~~--~~~~~~~~~  327 (332)
                      ..  ...++|.|.
T Consensus       456 l~~~~~~pp~~p~  468 (576)
T 2acx_A          456 LGAGMLEPPFKPD  468 (576)
T ss_dssp             HHTTCSCCSCCCC
T ss_pred             HhcCCCCCCCCCC
Confidence            53  355666665

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=343.92  Aligned_cols=263  Identities=30%  Similarity=0.506  Sum_probs=192.1

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++.+.||+|+||+||+|.+..+++.||+|++........     .....+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA-----GMVQRVQNEVKIHCQLKHPSILELYNYFED   82 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhh-----hHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence            467899999999999999999999999999999999975432111     112256789999999999999999999854


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       ....++|||++++ ++.+.+......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           83 -SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             -SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             -CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence             4889999999976 56666665557899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.               
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------  225 (278)
T 3cok_A          162 LKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---------------  225 (278)
T ss_dssp             CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC---------------
T ss_pred             ccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh---------------
Confidence            6544344445678999999999876 678999999999999999999999997654332221110               


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                            ......+..++.++.+||.+||+.||++||+++++++||||.+...
T Consensus       226 ----------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          226 ----------------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             ----------------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             ----------------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence                                  0001122347899999999999999999999999999999988553

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.4e-50  Score=342.34  Aligned_cols=262  Identities=29%  Similarity=0.490  Sum_probs=218.2

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ......++|++.+.||+|++|+||+|.+..++..||+|++........     .....+.+|+.++++++||||++++++
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-----GVEHQLRREIEIQSHLRHPNILRMYNY   82 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchH-----HHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            445677899999999999999999999999999999999975432111     111246789999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +.. ....++|||++++ ++.+.+.. .+.+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           83 FHD-RKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             EEC-SSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEc-CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccc
Confidence            954 4789999999986 56555554 56799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +.....  .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+.....        
T Consensus       161 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  229 (284)
T 2vgo_A          161 SVHAPS--LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------  229 (284)
T ss_dssp             CEECSS--SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------
T ss_pred             cccCcc--cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--------
Confidence            876533  22345578999999999987 6789999999999999999999999998877666555543211        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                   ..++.++..+++||.+||+.||.+||+++++++||||+...
T Consensus       230 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 -----------------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             -----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             -----------------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                                         11223789999999999999999999999999999998643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-49  Score=338.49  Aligned_cols=261  Identities=30%  Similarity=0.425  Sum_probs=210.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+...++|.+.+.||+|+||+||++.+..++..+|+|++........       ...+.+|+.++++++||||+++++++
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~   89 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIKIFEVF   89 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-------HHHHHHHHHHHHhCCCchHHhHHHhe
Confidence            34567899999999999999999999999999999999976543221       12467899999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEE
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKI  158 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l  158 (332)
                      . +....++||||++| ++.+.+..   ....+++..++.++.||+.||+|||+.|++|+||||+||++   +.++.++|
T Consensus        90 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           90 E-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             E-CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             e-cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence            4 44789999999986 66665543   24789999999999999999999999999999999999999   45578999


Q ss_pred             eecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 035861          159 CDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT  238 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  238 (332)
                      +|||.+...... .......+++.|+|||.+.  ..++.++|+||||+++|+|++|..||....................
T Consensus       169 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (285)
T 3is5_A          169 IDFGLAELFKSD-EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA  245 (285)
T ss_dssp             CCCCCCCC-----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EeeecceecCCc-ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc
Confidence            999999765432 2334557899999999986  4589999999999999999999999998876665554433211111


Q ss_pred             CCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      .                                  ....+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus       246 ~----------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 V----------------------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C------------------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             c----------------------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            0                                  11226889999999999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.4e-50  Score=367.75  Aligned_cols=267  Identities=32%  Similarity=0.503  Sum_probs=221.8

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ....++|++.+.||+|+||+||+|++..+++.||||++..........     ...+.+|+.++++++||||+++++++.
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~   96 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLLREVQLLKQLDHPNIMKLYEFFE   96 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC-----HHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH-----HHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345578999999999999999999999999999999997654322211     125679999999999999999999994


Q ss_pred             cCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEEeecc
Q 035861           87 DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFG  162 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l~df~  162 (332)
                       +....++|||++.|+ +.+.+. ..+.+++..++.++.||+.||+|||++||+|+||||+||++   +.++.++|+|||
T Consensus        97 -~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A           97 -DKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             -eCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence             458899999999864 545444 46789999999999999999999999999999999999999   467899999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++...... .......|++.|+|||++.+  .++.++||||||+++|+|++|..||...+..+....+..........  
T Consensus       175 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  249 (484)
T 3nyv_A          175 LSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP--  249 (484)
T ss_dssp             HHHHBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG--
T ss_pred             eeEEcccc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc--
Confidence            99876433 33345678999999999975  58999999999999999999999999998888777776543222211  


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                                                     .++.+++++++||.+||+.||.+|||++|+|+||||+......
T Consensus       250 -------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~  292 (484)
T 3nyv_A          250 -------------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ  292 (484)
T ss_dssp             -------------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred             -------------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence                                           1123789999999999999999999999999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-49  Score=352.80  Aligned_cols=294  Identities=23%  Similarity=0.324  Sum_probs=224.6

Q ss_pred             ccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-----CCC
Q 035861            3 MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-----HPS   77 (332)
Q Consensus         3 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~   77 (332)
                      ...|...-++|++++.||+|+||+||+|++..+++.||||++.......         .....|+.+++.+.     |||
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---------RSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHH---------HHHHHHHHHHHHTCCCSTTGGG
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhh---------hhhHHHHHHHHHhcccCCCCCC
Confidence            3456667789999999999999999999999999999999996422111         13457889998886     999


Q ss_pred             eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC----
Q 035861           78 IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN----  152 (332)
Q Consensus        78 i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~----  152 (332)
                      |+++++.+... ...++|||++++++.+.+.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.    
T Consensus        98 iv~~~~~~~~~-~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A           98 IVKYHGKFMYY-DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             BCCEEEEEEET-TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             eecccceeeEC-CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            99999999555 7899999999888888777644 45999999999999999999999999999999999999975    


Q ss_pred             ---------------------CCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHH
Q 035861          153 ---------------------QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAEL  211 (332)
Q Consensus       153 ---------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~l  211 (332)
                                           ++.++|+|||++......   .....|++.|+|||++.+ ..++.++||||||+++|+|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHH
Confidence                                 789999999999865432   245678999999999987 6789999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc--------ccCC-chhhhhhhCCCCccCCCCCCCchH
Q 035861          212 LAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN--------FAKQ-PYNLLRKRFPAASFTGSPVLSESG  282 (332)
Q Consensus       212 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ++|..||...+..+....+.......+................        +... ....................++.+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999999999888888888777666554432211111000000        0000 000000000000000011245778


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          283 FDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       283 ~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                      .+||.+||+.||++|||+.|+|+||||+
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            8999999999999999999999999996

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-49  Score=365.26  Aligned_cols=266  Identities=28%  Similarity=0.496  Sum_probs=220.4

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+...++|++++.||+|+||+||+|.+..+++.||||++.........      ...+.+|+.++++++||||+++++++
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~   90 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEIL   90 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH------HHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence            345678999999999999999999999999999999999754322211      12467999999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc---CCCcEEEeec
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN---NQGVLKICDF  161 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~---~~~~~~l~df  161 (332)
                      . +....|+||||+.| ++.+.+.. .+.+++..++.++.||+.||+|||++||+|+||||+||+++   .++.+||+||
T Consensus        91 ~-~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           91 E-DSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             E-CSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             E-cCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            4 45889999999986 55555554 57899999999999999999999999999999999999995   4567999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |++...... .......|++.|+|||++.+  .++.++||||||+++|+|++|..||...+..+....+.......... 
T Consensus       169 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  244 (486)
T 3mwu_A          169 GLSTCFQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP-  244 (486)
T ss_dssp             SCTTTBCCC-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG-
T ss_pred             CcCeECCCC-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-
Confidence            999866433 33345679999999999875  48999999999999999999999999988888777776543222211 


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                      .+..+++++++||.+||+.||.+|||+.++|+||||++....
T Consensus       245 --------------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          245 --------------------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             --------------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             --------------------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence                                            112378999999999999999999999999999999987644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-49  Score=358.23  Aligned_cols=293  Identities=30%  Similarity=0.461  Sum_probs=224.0

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC------CCCCeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF------DHPSIVN   80 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~   80 (332)
                      ....++|++++.||+|+||+||+|.+..+++.||||++.......         ..+.+|+.+++.+      +|+||+.
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~---------~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---------RQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHH---------HHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchH---------HHHHHHHHHHHHHhhccccCCcCEEE
Confidence            345568999999999999999999999999999999996432111         1344677777666      5779999


Q ss_pred             eeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc--EE
Q 035861           81 VKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV--LK  157 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~--~~  157 (332)
                      +++.+... ...++|||++++++.+.+.... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.  +|
T Consensus       164 ~~~~~~~~-~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vk  242 (429)
T 3kvw_A          164 MLENFTFR-NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK  242 (429)
T ss_dssp             EEEEEEET-TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEE
T ss_pred             EEeecccC-CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceE
Confidence            99998544 8899999999999988887654 45999999999999999999999999999999999999999987  99


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |+|||++......   .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+....+.+
T Consensus       243 L~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          243 VIDFGSSCYEHQR---VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             ECCCTTCEETTCC---CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EeecccceecCCc---ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999765432   345578999999999987 678999999999999999999999999999999998888887777


Q ss_pred             CCCcccCCCCCccccccccCCch-------------hhhhhhC---------CCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPY-------------NLLRKRF---------PAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                      +..++.................+             .......         ...........++.+.+||.+||++||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence            76543322111000000000000             0000000         0000011223578899999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q 035861          296 KRITVDDALNHYWFHEVP  313 (332)
Q Consensus       296 ~Rps~~ell~hp~f~~~~  313 (332)
                      +|||++|+|+||||++..
T Consensus       399 ~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             TSCCHHHHHTSTTTC---
T ss_pred             hCCCHHHHhCChhhccCC
Confidence            999999999999999854

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=342.09  Aligned_cols=271  Identities=24%  Similarity=0.388  Sum_probs=218.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      +..++|++++.||+|+||.||++.+..++..||+|++.........    .....+.+|+..+++++||||+++++++..
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIP----NGEANVKKEIQLLRRLRHKNVIQLVDVLYN   77 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHST----THHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccc----hhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            4567999999999999999999999999999999999764321110    011256789999999999999999999853


Q ss_pred             -CCCeEEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 -DHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 -~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                       +....++||||+++++.+.+... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence             34678999999999977766653 4569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC--CCCCccccccccccchhhhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSP--LKPYTSLVVTLWYRAPELLLGAK-KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .....  ........|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+.......+......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------  231 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA------  231 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC------
Confidence            65422  22233456899999999987632 3478999999999999999999999988777666655443111      


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                                                     .+..+++.+.+||.+||+.||.+||+++|+++||||++...+....
T Consensus       232 -------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~  277 (305)
T 2wtk_C          232 -------------------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP  277 (305)
T ss_dssp             -------------------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCC
T ss_pred             -------------------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCC
Confidence                                           1223788999999999999999999999999999999977665443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=345.75  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++...........      ....|+..+..+ .|+||+++++++.+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA------RKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHH------HHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHH------HHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            34689999999999999999999999999999998765433222111      233455555444 99999999999954


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ....++|||++++++.+.+......+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus       129 -~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          129 -GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             -CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence             4889999999999999988887788999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||......   ..+....  .+         
T Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~--~~---------  270 (311)
T 3p1a_A          208 GTA-GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGY--LP---------  270 (311)
T ss_dssp             C-------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTC--CC---------
T ss_pred             ccC-CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccC--CC---------
Confidence            432 23345568999999999875  5899999999999999999997776543222   1111100  00         


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                              ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       271 ------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 ------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                                    0011237899999999999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=346.93  Aligned_cols=294  Identities=35%  Similarity=0.593  Sum_probs=220.4

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .|....++|++++.||+|++|+||+|.+..+++.||+|++......   .     ...+.+|+.++++++||||++++++
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~-----~~~~~~e~~~l~~l~h~~iv~~~~~   76 (320)
T 2i6l_A            5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---S-----VKHALREIKIIRRLDHDNIVKVFEI   76 (320)
T ss_dssp             -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH---H-----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH---H-----HHHHHHHHHHHHhcCCCCeeEEEEe
Confidence            5666778999999999999999999999999999999998754211   1     1246789999999999999999998


Q ss_pred             EEc-------------CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc
Q 035861           85 VMD-------------DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN  151 (332)
Q Consensus        85 ~~~-------------~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~  151 (332)
                      +..             .....++||||++|++.+.+.  .+.+++..++.++.||+.||+|||++|++|+||||+||+++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN  154 (320)
T ss_dssp             ECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred             ccccccccccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence            732             336789999999998877664  46799999999999999999999999999999999999997


Q ss_pred             -CCCcEEEeecccccccCCC---CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 035861          152 -NQGVLKICDFGMSRQYGSP---LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI  227 (332)
Q Consensus       152 -~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~  227 (332)
                       .++.++|+|||.+......   ........++..|+|||.+.....++.++|+||||+++|+|++|..||...+..+..
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             5679999999999865422   122334567889999999877678899999999999999999999999999888887


Q ss_pred             HHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCC---CCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFP---AASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      ..+....+.........+...          ..........   .......+.++.++.+||.+||+.||++||+++|+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  304 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSV----------IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL  304 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTT----------SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             HHHHHhcCCCchhhhhhhhhc----------CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence            777766543332211110000          0000000000   000111234899999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCC
Q 035861          305 NHYWFHEVPLPKSK  318 (332)
Q Consensus       305 ~hp~f~~~~~~~~~  318 (332)
                      +||||+...++..+
T Consensus       305 ~hp~~~~~~~p~~~  318 (320)
T 2i6l_A          305 SHPYMSIYSFPMDE  318 (320)
T ss_dssp             TSHHHHTTCC----
T ss_pred             CCcccccccCccCC
Confidence            99999998887654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.2e-49  Score=351.58  Aligned_cols=266  Identities=28%  Similarity=0.424  Sum_probs=216.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   88 (332)
                      ..+|++.+.||.|++|+||+|.+..+|+.||||++..................+.+|+.+++++ +||||+.+++++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            4579999999999999999999998999999999976543221111111122466899999998 89999999999844 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....++||||++| ++.+.+. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            4889999999997 4545444 4678999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCCCCccccccccccchhhhcC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLG-----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ... .......|++.|+|||++.+     ...++.++|+||||+++|+|++|..||...+.......+........... 
T Consensus       251 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  328 (365)
T 2y7j_A          251 EPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE-  328 (365)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH-
T ss_pred             CCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc-
Confidence            432 33345678999999999863     23578899999999999999999999998877776666654322211110 


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                      +..++..+.+||.+||+.||++||+++++|+||||++
T Consensus       329 --------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 --------------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             --------------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --------------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                                            1236889999999999999999999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-49  Score=339.95  Aligned_cols=263  Identities=29%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .|....++|++.+.||+|++|+||+|.+..+++.||||++........     .....+.+|+..++.++||||++++++
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL-----DVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccch-----hHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            456677899999999999999999999999999999999975432111     112256789999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +.. ....++|||+++| ++.+.+.. .+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           80 IST-PTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EEC-SSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             Eec-CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence            854 4789999999986 55555544 56799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+......       
T Consensus       158 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  229 (276)
T 2h6d_A          158 SNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-------  229 (276)
T ss_dssp             GGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             ccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-------
Confidence            8775432 22334568899999999987544578999999999999999999999887776665555432111       


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                    .+..++..+.+||.+||+.||++|||++++++||||++.
T Consensus       230 ------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          230 ------------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ------------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                          112268899999999999999999999999999999873

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-49  Score=352.17  Aligned_cols=302  Identities=31%  Similarity=0.524  Sum_probs=225.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccccc---ccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCL---EYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..++|++.+.||+|+||+||+|.+.. +..||||++...........   .......+.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            45689999999999999999999865 89999999976544322110   000113567999999999999999999998


Q ss_pred             EcC----CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           86 MDD----HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        86 ~~~----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      ...    ....|+|||+++|++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+||
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            542    2468999999999999988877778999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |.+...... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....
T Consensus       179 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          179 NLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             Ccccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999754322 2334557889999999998767789999999999999999999999999998888888887766554332


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                      ...+........ .    ................+.+++.+.+||.+||+.||++|||++|+|+||||+++..+..
T Consensus       258 ~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          258 VVMFSSPSARDY-L----RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHHTSCHHHHHH-T----TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhccchhhhHH-H----HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            211110000000 0    0000000000001112347889999999999999999999999999999999865544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.6e-49  Score=341.99  Aligned_cols=263  Identities=30%  Similarity=0.436  Sum_probs=216.7

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ++....++|.+.+.||+|+||+||++++..+++.||+|++........        ..+.+|+..++.++||||++++++
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~   74 (304)
T 2jam_A            3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--------SSLENEIAVLKKIKHENIVTLEDI   74 (304)
T ss_dssp             ---CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccch--------HHHHHHHHHHHhCCCCCeeehhhh
Confidence            455677899999999999999999999999999999999975432211        246689999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEEee
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICD  160 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l~d  160 (332)
                      +. +....++|||+++| ++.+.+.. .+.+++..++.++.|++.||+|||++|++|+||+|+||++   +.++.++|+|
T Consensus        75 ~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           75 YE-STTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             EE-CSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             cc-cCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEcc
Confidence            84 44789999999986 55555544 5679999999999999999999999999999999999999   7788999999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ||.+.....  .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.......+. 
T Consensus       153 fg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-  228 (304)
T 2jam_A          153 FGLSKMEQN--GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES-  228 (304)
T ss_dssp             CSTTCCCCC--BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT-
T ss_pred             CCcceecCC--CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-
Confidence            999875432  22334568999999999876 67899999999999999999999999988877766666553221111 


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                      .....++.++.+||.+||+.||++||+++++|+||||....
T Consensus       229 --------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          229 --------------------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             --------------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             --------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                                            11234789999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.9e-49  Score=344.53  Aligned_cols=266  Identities=29%  Similarity=0.425  Sum_probs=215.5

Q ss_pred             hhccccc-ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861           10 VFEFEKL-NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      -++|.+. +.||+|+||+||+|.+..+++.||+|++.........      ...+.+|+..++.+ .||||+++++++. 
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~~iv~~~~~~~-   99 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC------RAEILHEIAVLELAKSCPRVINLHEVYE-   99 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC------HHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH------HHHHHHHHHHHHhccCCCCEEEEEEEEE-
Confidence            3467776 8899999999999999999999999999865433221      12467899999999 5699999999994 


Q ss_pred             CCCeEEEEccccccc-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CCcEEEeecc
Q 035861           88 DHDSVYMVMEYMEHD-LKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QGVLKICDFG  162 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~-l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~~~~l~df~  162 (332)
                      +....++||||++|+ +.+.+.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.   ++.++|+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            458899999999875 4443332 2367999999999999999999999999999999999999998   7899999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.......+..  
T Consensus       180 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  255 (327)
T 3lm5_A          180 MSRKIGHA-CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE--  255 (327)
T ss_dssp             GCEEC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             cccccCCc-cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch--
Confidence            99876432 22344578999999999976 678999999999999999999999999888877776665543322221  


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                     ..+.++..+.+||.+||+.||++|||++++|+||||+++.+...
T Consensus       256 -------------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          256 -------------------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             -------------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             -------------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence                                           12337889999999999999999999999999999999987655

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-49  Score=364.27  Aligned_cols=263  Identities=32%  Similarity=0.518  Sum_probs=215.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ++...++|++++.||+|+||+||+|++..++..||+|++.........      ...+.+|+.+++.++||||+++++++
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~  105 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS------NSKLLEEVAVLKLLDHPNIMKLYDFF  105 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT------THHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH------HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            344566899999999999999999999999999999999765432221      22567999999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcEEEeec
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDF  161 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~~l~df  161 (332)
                      . +....|+||||++| ++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++..   +.+||+||
T Consensus       106 ~-~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          106 E-DKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             E-CSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             E-eCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            4 45889999999987 55555544 5779999999999999999999999999999999999999764   45999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      |++...... .......||+.|+|||++..  .++.++||||||+++|+|++|..||...+..+....+.......+...
T Consensus       184 G~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  260 (494)
T 3lij_A          184 GLSAVFENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE  260 (494)
T ss_dssp             TTCEECBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred             CCCeECCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence            999876433 33445679999999999864  589999999999999999999999999888887777766533322221


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                       ++.+++.+++||.+||+.||.+|||+.|+|+||||++.
T Consensus       261 ---------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          261 ---------------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ---------------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ---------------------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                             12378999999999999999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.1e-49  Score=339.12  Aligned_cols=275  Identities=27%  Similarity=0.396  Sum_probs=219.6

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc-cccCCCcchhHHHHHHhhCC-CCCeeeeeeeE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC-LEYGFPISSLREINILLSFD-HPSIVNVKEVV   85 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~   85 (332)
                      ...++|++.+.||+|++|.||+|.+..+++.||||++.......... ........+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45679999999999999999999999999999999997654221100 00111124568999999995 99999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       ......++|||+++| ++.+.+.. ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        94 -~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           94 -ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             -ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             -ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence             445889999999986 55555544 678999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccccchhhhc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLL-----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      ...... .......++..|+|||.+.     ....++.++|+||||+++|+|++|..||...+.......+.......+.
T Consensus       172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            776432 2334567899999999985     2356789999999999999999999999988877766666554222111


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      .                                 ..+.++..+.+||.+||+.||++||++.|+|+||||++..+...+
T Consensus       251 ~---------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          251 P---------------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             T---------------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred             c---------------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence            1                                 112378899999999999999999999999999999998776654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=351.96  Aligned_cols=258  Identities=24%  Similarity=0.400  Sum_probs=210.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      +|...+.||+|+||+||+|.+..+++.||+|++.......        ...+.+|+.++++++||||+++++++.. ...
T Consensus        90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~  160 (373)
T 2x4f_A           90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--------KEEVKNEISVMNQLDHANLIQLYDAFES-KND  160 (373)
T ss_dssp             EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH--------HHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc--------HHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCE
Confidence            3344678999999999999999999999999997543211        1246789999999999999999999954 478


Q ss_pred             EEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE--cCCCcEEEeecccccccC
Q 035861           92 VYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL--NNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        92 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili--~~~~~~~l~df~~~~~~~  168 (332)
                      .++||||++| ++.+.+......+++..++.++.||+.||+|||+.||+|+||||+||++  +.++.++|+|||++....
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            9999999986 6666666656679999999999999999999999999999999999999  566799999999998764


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .. .......|++.|+|||++.. ..++.++|+||||+++|+|++|..||...+..+....+.......+..        
T Consensus       241 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------  310 (373)
T 2x4f_A          241 PR-EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE--------  310 (373)
T ss_dssp             TT-CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG--------
T ss_pred             Cc-cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh--------
Confidence            32 23345578999999999876 678999999999999999999999999988888777776543222111        


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               ..+.+++++++||.+||+.||.+||++.|+|+||||.+..
T Consensus       311 -------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          311 -------------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                                     1123789999999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.2e-49  Score=343.40  Aligned_cols=268  Identities=22%  Similarity=0.353  Sum_probs=202.5

Q ss_pred             cccchhccccc-ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861            6 GCRSVFEFEKL-NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus         6 ~~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      +++..+.|++. +.||+|+||+||+|.+..+++.||||++.......        ...+.+|+..+.++ +||||+++++
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~~~~h~~i~~~~~   78 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--------RSRVFREVEMLYQCQGHRNVLELIE   78 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC--------HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh--------HHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            34556789985 78999999999999999999999999997543211        12467899999885 7999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc---EEEe
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV---LKIC  159 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~---~~l~  159 (332)
                      ++..+ ...++||||++| ++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.   ++|+
T Consensus        79 ~~~~~-~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           79 FFEEE-DRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             EEEET-TEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             EEeeC-CEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEE
Confidence            99554 789999999985 55555554 578999999999999999999999999999999999999998775   9999


Q ss_pred             ecccccccCCCC-------CCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----
Q 035861          160 DFGMSRQYGSPL-------KPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV----  224 (332)
Q Consensus       160 df~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~----  224 (332)
                      |||++.......       .......|++.|+|||.+..    ...++.++||||||+++|+|++|..||......    
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  236 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW  236 (316)
T ss_dssp             CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred             EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence            999987543211       11223468999999999864    134788999999999999999999999765421    


Q ss_pred             -----------HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCC
Q 035861          225 -----------DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD  293 (332)
Q Consensus       225 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  293 (332)
                                 .....+.......+                                 ....+.++..+++||.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~d  283 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEGKYEFP---------------------------------DKDWAHISCAAKDLISKLLVRD  283 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHCCCCCC---------------------------------HHHHTTSCHHHHHHHHHHSCSS
T ss_pred             cccccchhHHHHHHHHHhccCcccC---------------------------------chhcccCCHHHHHHHHHHhhCC
Confidence                       11222221110000                                 0011237889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCCC
Q 035861          294 PEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       294 p~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      |.+|||++|+|+||||++.....
T Consensus       284 P~~Rps~~e~l~hp~~~~~~~~~  306 (316)
T 2ac3_A          284 AKQRLSAAQVLQHPWVQGCAPEN  306 (316)
T ss_dssp             TTTSCCHHHHHHSTTCC------
T ss_pred             hhhCCCHHHHhcChhhcCCCCcc
Confidence            99999999999999999875443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.6e-49  Score=363.36  Aligned_cols=272  Identities=31%  Similarity=0.472  Sum_probs=219.5

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccc-----cccCCCcchhHHHHHHhhCCCCCee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDC-----LEYGFPISSLREINILLSFDHPSIV   79 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~   79 (332)
                      .++...++|++++.||+|+||+||+|.+..++..||+|++..........     ........+.+|+.++++++||||+
T Consensus        30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            34556789999999999999999999999999999999998654322110     0011223567899999999999999


Q ss_pred             eeeeeEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---c
Q 035861           80 NVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---V  155 (332)
Q Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---~  155 (332)
                      ++++++. +....|+||||++| ++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++   .
T Consensus       110 ~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          110 KLFDVFE-DKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             CEEEEEE-CSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             eEEEEEE-cCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            9999994 55889999999986 55555554 57799999999999999999999999999999999999999876   6


Q ss_pred             EEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          156 LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      ++|+|||++...... .......|++.|+|||++..  .++.++||||||+++|+|++|..||...+..+....+.....
T Consensus       188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  264 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY  264 (504)
T ss_dssp             EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999999876433 23445679999999999874  589999999999999999999999999888887777765432


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ..+..                                 .++.+++++++||.+||+.||.+|||++|+|+||||++...
T Consensus       265 ~~~~~---------------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          265 YFDFN---------------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCHH---------------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCcc---------------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            21111                                 11237899999999999999999999999999999988654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=347.23  Aligned_cols=287  Identities=36%  Similarity=0.600  Sum_probs=226.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++.........      ...+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF------AKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHH------HHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHH------HHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            46899999999999999999999999999999999754322211      124568999999999999999999985543


Q ss_pred             C-----eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           90 D-----SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        90 ~-----~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .     ..++|||++++++.+.+   ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             SGGGCCCCEEEEECCSEEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             ccccceeEEEEeccccCCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence            2     35999999998765543   345999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ......   .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.++......
T Consensus       174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            765432   23457899999999998767789999999999999999999999999998888888888777666554433


Q ss_pred             CCCCccccccccCCchhhhhhhCC----CCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFP----AASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSK  318 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~  318 (332)
                      +......         ... ...+    .......+.+++.+.+||.+||+.||++|||++++|+||||+.+..+..+
T Consensus       251 ~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          251 LNDKAAK---------SYI-QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             CSCHHHH---------HHH-HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HhhHHHH---------HHH-HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence            3221000         000 0000    01112234579999999999999999999999999999999998766554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.6e-49  Score=345.93  Aligned_cols=261  Identities=23%  Similarity=0.354  Sum_probs=202.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +++.+++|++++.||+|+||+||+|++..+++.||||++........       ...+.+|+.++++++||||+++++.+
T Consensus         1 ~s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~   73 (332)
T 3qd2_B            1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-------REKVMREVKALAKLEHPGIVRYFNAW   73 (332)
T ss_dssp             CCHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-------HHHHHHHHHHHTSCCCTTBCCEEEEE
T ss_pred             CchhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35678899999999999999999999999999999999975432211       12467999999999999999999988


Q ss_pred             EcCC--------------------------------------------------------CeEEEEcccccccHHHHHHh
Q 035861           86 MDDH--------------------------------------------------------DSVYMVMEYMEHDLKWLMES  109 (332)
Q Consensus        86 ~~~~--------------------------------------------------------~~~~lv~e~~~~~l~~~~~~  109 (332)
                      .+..                                                        ...++||||++|+.+..+..
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  153 (332)
T 3qd2_B           74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN  153 (332)
T ss_dssp             EECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHH
T ss_pred             EEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHh
Confidence            5442                                                        24899999999754444444


Q ss_pred             cCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC------------CCC
Q 035861          110 MKQ---PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL------------KPY  174 (332)
Q Consensus       110 ~~~---~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~------------~~~  174 (332)
                      ...   ..++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......            ...
T Consensus       154 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             TCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             cccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            333   35666789999999999999999999999999999999999999999999998765432            223


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN  254 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (332)
                      ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..|+....  .........   .....             
T Consensus       234 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~---~~~~~-------------  294 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNL---KFPLL-------------  294 (332)
T ss_dssp             CSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTT---CCCHH-------------
T ss_pred             cccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhcc---CCCcc-------------
Confidence            44578999999999987 678999999999999999999877652211  111111110   00000             


Q ss_pred             ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                          ....++.+.+||.+||+.||.+||+++|+|+||||+++
T Consensus       295 --------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          295 --------------------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             --------------------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             --------------------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                                01146778899999999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-48  Score=337.75  Aligned_cols=265  Identities=24%  Similarity=0.436  Sum_probs=212.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++.......        ...+.+|+..++.++||||+++++++..
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--------LEDYIVEIEILATCDHPYIVKLLGAYYH   87 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH--------HHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence            34568999999999999999999999999999999986543211        1246789999999999999999999955


Q ss_pred             CCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      + ...++|||+++|+ +.+.+......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        88 ~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           88 D-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             C--CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             C-CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            4 7889999999874 5555555567899999999999999999999999999999999999999999999999998754


Q ss_pred             cCCCCCCCccccccccccchhhhc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLL----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ............|+..|+|||.+.    ....++.++|+||||+++|+|++|..||...+.......+........    
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  242 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL----  242 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----
Confidence            322112223456899999999984    336789999999999999999999999998877766555544321110    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                    ..+..++..+.+||.+||+.||.+|||+.++++||||.++.+.
T Consensus       243 ------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          243 ------------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             ------------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             ------------------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence                                          1112368899999999999999999999999999999987653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-49  Score=356.70  Aligned_cols=269  Identities=30%  Similarity=0.432  Sum_probs=203.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++..................+.+|+.++++++||||+++++++ +.
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DA  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-ES
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-ec
Confidence            35689999999999999999999999999999999987543322222222233577999999999999999999997 44


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---cEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---~~~l~df~~~~  165 (332)
                       ...++||||++|+.+.......+.+++..++.++.||+.||+|||++||+|+||||+||+++.++   .+||+|||++.
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence             45789999998754444444467899999999999999999999999999999999999997654   59999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHcCCCCCCcc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK-IFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~  242 (332)
                      ..... .......|++.|+|||++..  ...++.++|+||||+++|+|++|..||........... +........    
T Consensus       291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~----  365 (419)
T 3i6u_A          291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI----  365 (419)
T ss_dssp             SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC----
T ss_pred             ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC----
Confidence            76432 23345678999999999853  35678899999999999999999999976543322222 221111000    


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                   ....+.+++.+.+||.+||+.||++||+++|+|+||||++..
T Consensus       366 -----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          366 -----------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             -----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             -----------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence                                         001123789999999999999999999999999999998743

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=337.42  Aligned_cols=261  Identities=27%  Similarity=0.477  Sum_probs=213.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.....          ...+.+|+..++.++||||+++++.+..+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            44689999999999999999999999999999999975432          12467899999999999999999999554


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ...++||||++| ++.+.+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        97 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           97 -TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             -TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence             788999999987 666666556788999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......           
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  243 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-----------  243 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------
T ss_pred             hhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-----------
Confidence            554444456678999999999987 56899999999999999999999999887765544433222110           


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                             ....+..++..+.+||.+||+.||.+||++.++++||||++....
T Consensus       244 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          244 -----------------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             -----------------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             -----------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence                                   001122268899999999999999999999999999999987643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-48  Score=333.96  Aligned_cols=264  Identities=26%  Similarity=0.381  Sum_probs=212.8

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|++|+||+|.+..+++.||+|++........       ...+.+|+..++.++||||+++++++.+
T Consensus         4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (276)
T 2yex_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-------PENIKKEICINKMLNHENVVKFYGHRRE   76 (276)
T ss_dssp             HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH-------HHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh-------hHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence            356799999999999999999999999999999999976543211       1246789999999999999999999854


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ....++|||+++|+.+.........+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           77 -GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             -TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence             4788999999987444444444667999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCCCCCcccC
Q 035861          168 GSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ-IDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  244 (332)
                      ...  ........|+..|+|||.+.+....+.++|+||||+++|+|++|..||........ .........         
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  226 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT---------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc---------
Confidence            321  12234557899999999998755558899999999999999999999987654322 222211100         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                .......++..+.+||.+||+.||.+|||++|+++||||++...
T Consensus       227 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          227 --------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             --------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             --------------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence                                      00111237899999999999999999999999999999998543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-49  Score=345.69  Aligned_cols=274  Identities=21%  Similarity=0.315  Sum_probs=215.3

Q ss_pred             ccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861            3 MLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus         3 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      |.......++|++.+.||+|+||+||++.+..+++.||||++...........     ..+.+|+..+++++||||++++
T Consensus         4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~hp~iv~~~   78 (311)
T 3ork_A            4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFY-----LRFRREAQNAAALNHPAIVAVY   78 (311)
T ss_dssp             CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHH-----HHHHHHHTTCCCCCCTTBCCEE
T ss_pred             CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHH-----HHHHHHHHHHHcCCCCCcceEE
Confidence            45566778899999999999999999999999999999999976543222111     2467899999999999999999


Q ss_pred             eeEEcCC---CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEe
Q 035861           83 EVVMDDH---DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        83 ~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~  159 (332)
                      +++....   ...|+||||++|+.+..+....+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred             EeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEe
Confidence            9885432   2359999999864444444446789999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          160 DFGMSRQYGSPL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       160 df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      |||.+.......   .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..................
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~  237 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  237 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence            999997654322   12234568999999999987 67899999999999999999999999988877666555543222


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      ++..                                 ..+.++.++.+||.+||+.||++||++.++|.|+|+......
T Consensus       238 ~~~~---------------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          238 PPSA---------------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             CHHH---------------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             Cccc---------------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            2111                                 122378999999999999999999999999999999865433

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-49  Score=348.25  Aligned_cols=267  Identities=25%  Similarity=0.384  Sum_probs=211.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.........   ......+.+|+.++++++||||+++++++.+ ..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  101 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN---PKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQ  101 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccC---HHHHHHHHHHHHHHHhCCCCCcceeehhhcc-CC
Confidence            5899999999999999999999999999999999764321100   0111256789999999999999999999944 58


Q ss_pred             eEEEEccccccc-HHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 035861           91 SVYMVMEYMEHD-LKWLMESM---------------------------------------KQPFSTSEVKCLMLQLLEGV  130 (332)
Q Consensus        91 ~~~lv~e~~~~~-l~~~~~~~---------------------------------------~~~l~~~~~~~i~~~l~~~L  130 (332)
                      ..++||||++|+ +.+.+...                                       ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            899999999864 44443210                                       11246788899999999999


Q ss_pred             HHHHHCCcccccCCCCCEEEcCCC--cEEEeecccccccCCCC----CCCccccccccccchhhhcCC-CCCCchhHHHH
Q 035861          131 KYLHDNWVLHRDLKTSNLLLNNQG--VLKICDFGMSRQYGSPL----KPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWS  203 (332)
Q Consensus       131 ~~lh~~~i~H~di~p~Nili~~~~--~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~s  203 (332)
                      +|||+.|++|+||||+||+++.++  .++|+|||.+.......    .......|++.|+|||.+.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998776  89999999997653211    123456789999999998642 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHH
Q 035861          204 VGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGF  283 (332)
Q Consensus       204 lG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      ||+++|+|++|..||...+..+....+...........                                 ...+++.+.
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~  308 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN---------------------------------YNVLSPLAR  308 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG---------------------------------GGGSCHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc---------------------------------cccCCHHHH
Confidence            99999999999999999888877777765432222111                                 122688999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          284 DLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       284 ~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +||.+||+.||.+||++.++|+||||+++..
T Consensus       309 ~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          309 DLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            9999999999999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-49  Score=337.67  Aligned_cols=269  Identities=26%  Similarity=0.413  Sum_probs=216.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|++++.||+|+||+||++.+..+++.||+|++...........  .....+.+|+.++++++||||+++++++.. .
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG--VSREEIEREVNILREIRHPNIITLHDIFEN-K   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccc--hHHHHHHHHHHHHHhCCCCCeeehhheecC-C
Confidence            4689999999999999999999999999999999986544322110  012256789999999999999999999954 4


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC----cEEEeecccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----VLKICDFGMS  164 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~----~~~l~df~~~  164 (332)
                      ...++|||+++| ++.+.+. ....+++..++.++.||+.||++||++|++|+||+|+||+++.++    .++|+|||.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CeEEEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            789999999975 5555544 467899999999999999999999999999999999999999877    8999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+.......+..    
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  233 (283)
T 3bhy_A          160 HKIEAG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE----  233 (283)
T ss_dssp             EECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH----
T ss_pred             eeccCC-CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch----
Confidence            875432 22344568999999999876 678999999999999999999999999887776665554322111100    


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                   ..+.++..+.+||.+||+.||++||++.++++||||+.+.....
T Consensus       234 -----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          234 -----------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             -----------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred             -----------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence                                         01236889999999999999999999999999999998765443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.7e-49  Score=343.04  Aligned_cols=275  Identities=31%  Similarity=0.434  Sum_probs=208.9

Q ss_pred             CcccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee
Q 035861            1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN   80 (332)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   80 (332)
                      |++.. ....++|++.+.||+|+||.||+|.+..+++.||||++..................+.+|+.++++++||||++
T Consensus         1 M~~~~-~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            1 MSVYP-KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             -CCCC-HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             Cccch-hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            44433 34567999999999999999999999999999999999765432211111122235679999999999999999


Q ss_pred             eeeeEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc---E
Q 035861           81 VKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV---L  156 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~---~  156 (332)
                      +++++..+  ..++||||++| ++.+.+ .....+++..++.++.||+.||+|||++|++|+||||+||+++.++.   +
T Consensus        80 ~~~~~~~~--~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           80 IKNFFDAE--DYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             EEEEEESS--SEEEEEECCTTEETHHHH-STTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCE
T ss_pred             EeeEEcCC--ceEEEEecCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeE
Confidence            99998443  38999999986 554444 44678999999999999999999999999999999999999987664   9


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHH
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQID-KIFKT  233 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~-~~~~~  233 (332)
                      +|+|||.+...... .......|++.|+|||++.  ....++.++|+||||+++|+|++|..||.......... .+...
T Consensus       157 kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (322)
T 2ycf_A          157 KITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  235 (322)
T ss_dssp             EECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred             EEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence            99999999875432 1123456899999999974  33668999999999999999999999997654332222 22221


Q ss_pred             cCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ......                                 .....++..+.+||.+||+.||++||+++++|+||||++..
T Consensus       236 ~~~~~~---------------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          236 KYNFIP---------------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             CCCCCH---------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             ccccCc---------------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            110000                                 00123789999999999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-48  Score=335.97  Aligned_cols=262  Identities=24%  Similarity=0.372  Sum_probs=199.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++..........      ..+.++...++.++||||+++++++..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK------RLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHH------HHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHH------HHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            4579999999999999999999999999999999997543222111      1233455557788999999999999554


Q ss_pred             CCeEEEEcccccccHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       ...++||||++|++.+.+..   ....+++..++.++.||+.||+|||++ |++|+||||+||+++.++.++|+|||.+
T Consensus        79 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           79 -GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             -SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             -CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence             77899999999987665543   467899999999999999999999998 9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~  240 (332)
                      ...... .......|++.|+|||.+.   ....++.++|+||||+++|+|++|..||... ................   
T Consensus       158 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  233 (290)
T 3fme_A          158 GYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---  233 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC---
T ss_pred             cccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC---
Confidence            765432 2233446899999999973   3467899999999999999999999999863 3333333333221100   


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                      .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       234 --------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          234 --------------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             --------------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             --------------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                            11123788999999999999999999999999999998643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=345.56  Aligned_cols=277  Identities=25%  Similarity=0.426  Sum_probs=214.9

Q ss_pred             chhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      ..++|++++.||+|+||+||++++.   .+++.||||++.........    .....+.+|+.+++.+ .||||+.+++.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----hHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            3579999999999999999999984   47899999998754321111    1112455799999999 69999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +..+ ...++||||++| ++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus       128 ~~~~-~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          128 FQTE-TKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEET-TEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             EeeC-ceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            8554 789999999987 55555544 56899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-CCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHcCCC
Q 035861          164 SRQYGSP-LKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTE----VDQIDKIFKTLGTP  237 (332)
Q Consensus       164 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~----~~~~~~~~~~~~~~  237 (332)
                      +...... ........||+.|+|||++.+. ..++.++||||||+++|+|++|..||.....    ......+.....  
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  283 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--  283 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--
Confidence            8765321 1222345789999999999752 4578999999999999999999999975432    222222221110  


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEV  312 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~  312 (332)
                                                         ..+..++..+.+||.+||+.||.+||     +++|+++||||+++
T Consensus       284 -----------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          284 -----------------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             -----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             -----------------------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence                                               11233788999999999999999999     99999999999998


Q ss_pred             CCCCCC--CCCCCCCCcc
Q 035861          313 PLPKSK--DFMPTFPPQH  328 (332)
Q Consensus       313 ~~~~~~--~~~~~~~~~~  328 (332)
                      ++....  ...+++.|..
T Consensus       329 ~~~~l~~~~~~~p~~p~~  346 (355)
T 1vzo_A          329 NWDDLAAKKVPAPFKPVI  346 (355)
T ss_dssp             CHHHHHTTCSCCSCCCCC
T ss_pred             ChhHhhhccCCCCCCCcc
Confidence            876553  3445555543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-48  Score=347.93  Aligned_cols=295  Identities=30%  Similarity=0.453  Sum_probs=222.2

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CC-----Ce
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HP-----SI   78 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i   78 (332)
                      .|....++|++.+.||+|+||+||+|.+..+++.||||++......         ......|+.+++.+. |+     ++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~~~~~~~~~~i  118 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF---------LNQAQIEVRLLELMNKHDTEMKYYI  118 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHH---------HHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHH---------HHHHHHHHHHHHHHHhcccccceeE
Confidence            3455678999999999999999999999999999999999643211         013456777777774 44     48


Q ss_pred             eeeeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCCCEEEc--CC
Q 035861           79 VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLH--DNWVLHRDLKTSNLLLN--NQ  153 (332)
Q Consensus        79 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh--~~~i~H~di~p~Nili~--~~  153 (332)
                      +.+.+.+... ...|+|||+++|++.+.+.... ..+++..++.++.|++.||+|||  +.||+|+||||+||+++  .+
T Consensus       119 v~~~~~~~~~-~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          119 VHLKRHFMFR-NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             CCEEEEEEET-TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred             EEeeeeeccC-CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence            8898888554 7899999999999988887654 56999999999999999999999  57999999999999995  46


Q ss_pred             CcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 035861          154 GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT  233 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~  233 (332)
                      +.+||+|||++......   .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...
T Consensus       198 ~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~  273 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV  273 (382)
T ss_dssp             CCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CcEEEEeccCceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            78999999999876432   345678999999999987 57899999999999999999999999999999999998888


Q ss_pred             cCCCCCCcccCCCCCccccccc-----------------cCCchhhhhhhCCC------CccCCCCC----CCchHHHHH
Q 035861          234 LGTPTETIWPGLSELPGAKANF-----------------AKQPYNLLRKRFPA------ASFTGSPV----LSESGFDLL  286 (332)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~------~~~~~~~~----~~~~~~~li  286 (332)
                      .+.++....+............                 ...........+..      ........    .++++++||
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli  353 (382)
T 2vx3_A          274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI  353 (382)
T ss_dssp             HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred             hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence            7777655443322110000000                 00000000000000      00000000    113789999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          287 NRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       287 ~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .+||++||++|||++|+|+||||++..
T Consensus       354 ~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          354 LRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             HHhcCCChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999999999854

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.7e-49  Score=344.63  Aligned_cols=289  Identities=24%  Similarity=0.440  Sum_probs=213.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.....           ..+.+|+.++++++ ||||+.+++++..
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----------KKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch-----------HHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            45689999999999999999999999999999999863221           24678999999996 9999999999965


Q ss_pred             C-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeeccccc
Q 035861           88 D-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSR  165 (332)
Q Consensus        88 ~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~  165 (332)
                      . ....++|||+++++.+..+..   .+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||.+.
T Consensus       103 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          103 PVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             TTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            3 467899999999765554443   489999999999999999999999999999999999999777 89999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCc-cc
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETI-WP  243 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~-~~  243 (332)
                      ..... .......++..|+|||.+.+...++.++||||||+++|+|++|..||... ...+....+....+.+.... ..
T Consensus       180 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          180 FYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             ECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             EcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            65432 33445678999999999987677999999999999999999999999543 44444444333222110000 00


Q ss_pred             C--CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          244 G--LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       244 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      .  ....+................   .........+++++++||.+||+.||++|||++|+|+||||+++...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWER---FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGG---GCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             Hhccccccchhhhhhhccccchhh---hccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence            0  000000000000000000000   00111123378999999999999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.3e-48  Score=331.53  Aligned_cols=256  Identities=23%  Similarity=0.337  Sum_probs=207.5

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (332)
                      ..|++.+.||+|+||+||+|.+..++..||+|++.........      ...+.+|+.++++++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH------HHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH------HHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            3688999999999999999999999999999999865443322      1246789999999999999999998743   


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEc-CCCcEEEeeccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLN-NQGVLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~-~~~~~~l~df~~  163 (332)
                      +....++||||++| ++.+.+ ...+.+++..++.++.||+.||+|||+.|  ++|+||||+||+++ .++.++|+|||.
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCceEEEEEEecCCCCHHHHH-HHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            34668999999987 555544 44678999999999999999999999999  99999999999998 788999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +.....  .......|++.|+|||.+.+  .++.++|+||||+++|+|++|..||..................+      
T Consensus       179 ~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  248 (290)
T 1t4h_A          179 ATLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------  248 (290)
T ss_dssp             GGGCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------
T ss_pred             cccccc--cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------
Confidence            976433  23345578999999998874  58999999999999999999999998765544433322211000      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                  .......++++.+||.+||+.||.+|||++++|+||||++
T Consensus       249 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 ----------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                        0011225788999999999999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.1e-48  Score=330.71  Aligned_cols=257  Identities=24%  Similarity=0.322  Sum_probs=206.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      .++..++|++++.||+|++|+||+|.+..+++.||+|++..........      ..+.+|+..+..+ +||||++++++
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~e~~~~~~l~~h~~iv~~~~~   79 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE------QNALREVYAHAVLGQHSHVVRYFSA   79 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHH------HHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHH------HHHHHHHHHHHHhCCCCCeeeeeee
Confidence            4456789999999999999999999999999999999997654322221      2456889999888 99999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-------
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-------  153 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-------  153 (332)
                      +.++ ...++||||++| ++.+.+...   ...+++..++.++.||+.||+|||++||+|+||||+||+++.+       
T Consensus        80 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           80 WAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             EEET-TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             eecC-CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence            8554 789999999986 666655543   2679999999999999999999999999999999999999844       


Q ss_pred             ------------CcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 035861          154 ------------GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT  221 (332)
Q Consensus       154 ------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~  221 (332)
                                  ..++|+|||.+......    ....|+..|+|||.+.+...++.++||||||+++|+|++|..|+...
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                        47999999999876432    23458999999999987557788999999999999999999887554


Q ss_pred             ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH
Q 035861          222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD  301 (332)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  301 (332)
                      ...   ..+.....                                    ...+..+++.+.+||.+||+.||++|||+.
T Consensus       235 ~~~---~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  275 (289)
T 1x8b_A          235 DQW---HEIRQGRL------------------------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAM  275 (289)
T ss_dssp             HHH---HHHHTTCC------------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHH---HHHHcCCC------------------------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence            322   22221100                                    111234789999999999999999999999


Q ss_pred             HHhcCCCCCCC
Q 035861          302 DALNHYWFHEV  312 (332)
Q Consensus       302 ell~hp~f~~~  312 (332)
                      ++++||||++.
T Consensus       276 ~ll~h~~~~~~  286 (289)
T 1x8b_A          276 ALVKHSVLLSA  286 (289)
T ss_dssp             HHHTCTTC---
T ss_pred             HHhhChHhhhh
Confidence            99999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.2e-48  Score=333.27  Aligned_cols=265  Identities=28%  Similarity=0.500  Sum_probs=217.8

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +...++|++++.||+|++|+||+|.+..+++.||+|++.........      ...+.+|+..+++++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH------HHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            44567999999999999999999999999999999999765432211      125678999999999999999999985


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcEEEeecc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVLKICDFG  162 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~~l~df~  162 (332)
                      . ....++|+|+++| ++.+.+.. ...+++..++.++.||+.||++||++|++|+||+|+||+++.+   +.++|+|||
T Consensus        92 ~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           92 D-SSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             C-SSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             C-CCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence            4 4789999999976 55555554 5679999999999999999999999999999999999999764   479999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .+...... .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||...+..+....+.........   
T Consensus       170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  243 (287)
T 2wei_A          170 LSTCFQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---  243 (287)
T ss_dssp             GGGTBCCC-SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---
T ss_pred             cceeecCC-CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---
Confidence            98866432 22344568899999999875  4899999999999999999999999988877766665543211111   


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                    .....++.++.+||.+||+.||++|||+.|+|+||||+++.+.
T Consensus       244 ------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          244 ------------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             ------------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             ------------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence                                          1112378999999999999999999999999999999986553

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.7e-48  Score=333.48  Aligned_cols=258  Identities=25%  Similarity=0.429  Sum_probs=215.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -..|++++.||+|+||+||+|.+..+++.||||++........       ...+.+|+.+++.+.||||+++++.+..+ 
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   92 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-------IEDIQQEITVLSQCDSPYVTKYYGSYLKD-   92 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-------HHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-------HHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            3579999999999999999999999999999999976543221       12567899999999999999999999554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...++||||++|+.+..+.. .+.+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             CeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            78999999998754444444 46799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......             
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  237 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP-------------  237 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------------
T ss_pred             cccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC-------------
Confidence            4444456678999999999987 67889999999999999999999999887766555444332110             


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                             .....++..+.+||.+||+.||.+||+++++++||||....
T Consensus       238 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          238 -----------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             -----------------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             -----------------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence                                   11223788999999999999999999999999999997643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-48  Score=348.38  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=200.7

Q ss_pred             ccchhccccc-ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHH-hhCCCCCeeeeeee
Q 035861            7 CRSVFEFEKL-NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPSIVNVKEV   84 (332)
Q Consensus         7 ~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~   84 (332)
                      ...+++|.+. +.||.|+||+||++.+..+++.||||++....             ...+|+.++ +..+||||++++++
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------~~~~E~~~~~~~~~hp~iv~l~~~  123 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------------KARREVELHWRASQCPHIVRIVDV  123 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-------------HHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch-------------hHHHHHHHHHHhcCCCCcceEeEE
Confidence            4466788887 68999999999999999999999999986321             345788876 44589999999998


Q ss_pred             EEc---CCCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CCcE
Q 035861           85 VMD---DHDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QGVL  156 (332)
Q Consensus        85 ~~~---~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~~~  156 (332)
                      +..   +....|+||||++| ++.+.+.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.   ++.+
T Consensus       124 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCE
T ss_pred             EeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccE
Confidence            743   34678999999986 6666665432 46999999999999999999999999999999999999998   7899


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHH
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD----QIDKIFK  232 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~----~~~~~~~  232 (332)
                      ||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......    ....+..
T Consensus       204 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          204 KLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             EECCCTTCEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             EEEecccccccCCC-CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            99999999865432 23345678999999999876 678999999999999999999999997654321    1222221


Q ss_pred             HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      ....                                 .....+..++.++++||.+||+.||++|||++|+++||||.+.
T Consensus       282 ~~~~---------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          282 GQYE---------------------------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TCCC---------------------------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             Cccc---------------------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            1110                                 1111223489999999999999999999999999999999864


Q ss_pred             C
Q 035861          313 P  313 (332)
Q Consensus       313 ~  313 (332)
                      .
T Consensus       329 ~  329 (400)
T 1nxk_A          329 T  329 (400)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-48  Score=336.83  Aligned_cols=262  Identities=23%  Similarity=0.400  Sum_probs=208.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   87 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.......         ..+.+|+..++++ .||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---------EEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT---------HHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH---------HHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            4568999999999999999999999999999999997543221         2467899999998 89999999999865


Q ss_pred             C-----CCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           88 D-----HDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        88 ~-----~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      .     ....++||||++| ++.+.+... ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence            3     4678999999987 666665543 35799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      ||.+..............|+..|+|||.+..    ...++.++|+||||+++|+|++|..||...+.......+......
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            9998876543333455678999999999862    356889999999999999999999999887766555444332110


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                         ......++..+.+||.+||+.||.+||+++++++||||++...
T Consensus       253 -----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          253 -----------------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             -----------------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             -----------------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence                                               0112337899999999999999999999999999999998653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-48  Score=332.57  Aligned_cols=260  Identities=28%  Similarity=0.434  Sum_probs=213.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc-
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD-   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   87 (332)
                      ..++|++++.||+|++|+||++.+..+++.||+|++.........      ...+.+|+..+++++||||+++++.+.. 
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE------KQMLVSEVNLLRELKHPNIVRYYDRIIDR   77 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH------HHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH------HHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence            467999999999999999999999999999999999765432211      1246789999999999999999998753 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCCCEEEcCCCcEEE
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESM---KQPFSTSEVKCLMLQLLEGVKYLHDNW-----VLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~i~~~l~~~L~~lh~~~-----i~H~di~p~Nili~~~~~~~l  158 (332)
                      .....++||||++| ++.+.+...   ...+++..++.++.|++.||+|||+.|     ++|+||+|+||+++.++.++|
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence            45789999999986 666655442   345999999999999999999999999     999999999999999999999


Q ss_pred             eecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 035861          159 CDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT  238 (332)
Q Consensus       159 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  238 (332)
                      +|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-  235 (279)
T 2w5a_A          158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-  235 (279)
T ss_dssp             CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-
T ss_pred             ecCchheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-
Confidence            999999876433222234568899999999987 578999999999999999999999999887766665554432111 


Q ss_pred             CCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                         .+..++.++.+||.+||+.||++||++.|+|+|+|++.
T Consensus       236 -----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          236 -----------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -----------------------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                                               11237899999999999999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.1e-48  Score=333.69  Aligned_cols=275  Identities=24%  Similarity=0.344  Sum_probs=214.3

Q ss_pred             cccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            4 LQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      +.|...-++|++++.||+|+||+||++.+..++..||+|++...........     ..+.+|+..+++++||||+++++
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~l~~l~hp~iv~~~~   78 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-----KRFEREVHNSSQLSHQNIVSMID   78 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHH-----HHHHHHHHHHTTCCBTTBCCEEE
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHH-----HHHHHHHHHHhcCCCCCCceEEE
Confidence            3456667799999999999999999999999999999999976544332221     24678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ++ ......++||||++|+.+.......+++++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.
T Consensus        79 ~~-~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  157 (294)
T 4eqm_A           79 VD-EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI  157 (294)
T ss_dssp             EE-ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred             ee-eeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence            98 45588999999998744444444467899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          164 SRQYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      +....... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............       
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------  229 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-------  229 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-------
T ss_pred             ccccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-------
Confidence            97654322 22334568999999999987 6789999999999999999999999998877665544432211       


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                               +.......+.+++.+.++|.+||+.||.+||+..+.+.++|..-+.....
T Consensus       230 -------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          230 -------------------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             -------------------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             -------------------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence                                     01111123347899999999999999999997666667766655544433

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-48  Score=347.88  Aligned_cols=289  Identities=26%  Similarity=0.374  Sum_probs=218.4

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--------CC
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--------HP   76 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~   76 (332)
                      .|....++|++++.||+|+||+||+|++..+++.||||++......         ...+.+|+.+++.+.        |+
T Consensus        31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~~~~~~  101 (397)
T 1wak_A           31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY---------TETALDEIRLLKSVRNSDPNDPNRE  101 (397)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---------HHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred             hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcc---------hHHHHHHHHHHHHHhhcCCCCCCcc
Confidence            3444567899999999999999999999999999999999643211         114568999998885        78


Q ss_pred             CeeeeeeeEEc---CCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEc
Q 035861           77 SIVNVKEVVMD---DHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLN  151 (332)
Q Consensus        77 ~i~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~  151 (332)
                      ||+.+++.+..   +....++|||++++++++.+.... ..+++..++.++.||+.||+|||++ ||+|+||||+|||++
T Consensus       102 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~  181 (397)
T 1wak_A          102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS  181 (397)
T ss_dssp             GBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred             eeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence            89999998852   446799999999999988887654 6799999999999999999999998 999999999999999


Q ss_pred             CCC-------------------------------------------------cEEEeecccccccCCCCCCCcccccccc
Q 035861          152 NQG-------------------------------------------------VLKICDFGMSRQYGSPLKPYTSLVVTLW  182 (332)
Q Consensus       152 ~~~-------------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~  182 (332)
                      .++                                                 .++|+|||.+......   .....||..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~  258 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQ  258 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGG
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCc
Confidence            775                                                 7999999999876432   345578999


Q ss_pred             ccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHcCCCCCCcccCCC----------
Q 035861          183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT------EVDQIDKIFKTLGTPTETIWPGLS----------  246 (332)
Q Consensus       183 y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~----------  246 (332)
                      |+|||++.+ ..++.++||||||+++|+|++|..||...+      .......+....+.++...+....          
T Consensus       259 y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          259 YRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             ccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            999999987 568999999999999999999999997654      344555565555554432211000          


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      ...................     .......++..+++||.+||+.||++|||++|+|+||||++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVE-----KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHH-----TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccccCCcchhHhhhh-----hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000000000000000000     01112234667889999999999999999999999999974

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.1e-48  Score=334.75  Aligned_cols=260  Identities=24%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|.+.  +..||||++..........      ..+.+|+.++++++||||+++++++ .+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~------~~~~~E~~~l~~l~hp~iv~~~~~~-~~  105 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERV------NEFLREVAIMKRLRHPNIVLFMGAV-TQ  105 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHH------HHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred             ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHH------HHHHHHHHHHHhCCCCCEeeEEEEE-EE
Confidence            4569999999999999999999885  8899999997554322211      2467899999999999999999999 44


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCcEEEeecc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQ---PFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~---~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      ....++||||++| ++.+.+.. .+   .+++..++.++.||+.||+|||+.|  ++|+||||+||+++.++.++|+|||
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHS-TTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             CCceEEEEecCCCCcHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            4778999999987 55554443 33   3999999999999999999999999  9999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++..............|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.....       
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------  256 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------  256 (309)
T ss_dssp             -----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------
T ss_pred             CCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Confidence            99765544444456678999999999987 6689999999999999999999999998877666555432211       


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN--HYWFHEVPL  314 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~f~~~~~  314 (332)
                                                  ....+..+++.+.+||.+||+.||.+|||+.++++  .+++++...
T Consensus       257 ----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          257 ----------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             ----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             ----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence                                        11122347899999999999999999999999998  466665443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-48  Score=346.11  Aligned_cols=300  Identities=24%  Similarity=0.356  Sum_probs=217.0

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      |....++|++++.||+|+||+||++.+..++..||+|++.......  .     ...+.+|+.++++++||||+++++++
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--~-----~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--I-----RNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHH--H-----HHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHH--H-----HHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            3445679999999999999999999999999999999997643211  1     12467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      ..+ ...++||||++| ++.+.+. ..+.+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.
T Consensus       101 ~~~-~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          101 YSD-GEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EET-TEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEC-CEEEEEEECCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence            554 789999999987 5555544 466899999999999999999999985 999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +......  ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+............+
T Consensus       179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          179 SGQLIDS--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             CHHHHHH--C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             Ccccccc--cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            8654221  1234578999999999987 678999999999999999999999998876655433221111100000000


Q ss_pred             CCCCC--cccc----ccccCCchhhhhhhC-CCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          244 GLSEL--PGAK----ANFAKQPYNLLRKRF-PAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       244 ~~~~~--~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      .....  ....    ............... ..........++.++.+||.+||+.||++|||++|+|+||||++.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence            00000  0000    000000001111111 1111222344788999999999999999999999999999999876544


Q ss_pred             C
Q 035861          317 S  317 (332)
Q Consensus       317 ~  317 (332)
                      .
T Consensus       336 ~  336 (360)
T 3eqc_A          336 V  336 (360)
T ss_dssp             C
T ss_pred             h
Confidence            3

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-48  Score=336.84  Aligned_cols=276  Identities=24%  Similarity=0.333  Sum_probs=193.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .....++|++.+.||+|++|+||+|.+..+++.||||++.......       ....+.+|+..+++++||||+++++++
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-------SMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch-------hHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            3445679999999999999999999998889999999986543211       112456899999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMES-------MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      ... ...++||||++| ++.+.+..       ....+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++
T Consensus        83 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           83 VVK-DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             ESS-SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             eec-CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence            555 678999999976 55555543       245699999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCC-----CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 035861          158 ICDFGMSRQYGSPL-----KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK  232 (332)
Q Consensus       158 l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~  232 (332)
                      |+|||.+.......     .......|++.|+|||.+.....++.++|+||||+++|+|++|..||..............
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            99999987653221     1223456899999999987545689999999999999999999999988766554443332


Q ss_pred             HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                      .........                           .........++.++.+||.+||+.||.+||++.++++||||++.
T Consensus       242 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          242 NDPPSLETG---------------------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             SSCCCTTC--------------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             cCCCccccc---------------------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            211110000                           00011123478899999999999999999999999999999987


Q ss_pred             CCCC
Q 035861          313 PLPK  316 (332)
Q Consensus       313 ~~~~  316 (332)
                      ....
T Consensus       295 ~~~~  298 (303)
T 2vwi_A          295 KNKE  298 (303)
T ss_dssp             ----
T ss_pred             CCCc
Confidence            6543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=336.73  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC--CCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH--PSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~   87 (332)
                      -.+|++++.||+|+||+||++.+. +++.||||++..........      ..+.+|+.+++.+.|  +||+.+++++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~------~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHH------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHH------HHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            357999999999999999999884 58899999997654322211      245789999999976  999999999855


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      + ...++|||+.++++.+.+.. .+.+++..++.++.||+.||+|||++||+|+||||+||+++ ++.+||+|||++...
T Consensus        81 ~-~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           81 D-QYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             S-SEEEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             C-CEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            4 78999999888888877766 67899999999999999999999999999999999999997 689999999999866


Q ss_pred             CCCCC--CCccccccccccchhhhcC----------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHc
Q 035861          168 GSPLK--PYTSLVVTLWYRAPELLLG----------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTL  234 (332)
Q Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~----------~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~  234 (332)
                      .....  ......||+.|+|||++.+          ...++.++||||||+++|+|++|..||...... .....+... 
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-  236 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-  236 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC-
Confidence            43222  2235578999999999853          256899999999999999999999999764332 222222211 


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                        ......+...+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       237 ----------------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          237 ----------------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             ----------------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ----------------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence                                              111112223577899999999999999999999999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.9e-50  Score=355.56  Aligned_cols=253  Identities=17%  Similarity=0.227  Sum_probs=197.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHH---HHHhhCCCCCeeeee----
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI---NILLSFDHPSIVNVK----   82 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~----   82 (332)
                      .++|++.+.||+|+||+||+|++..+++.||||++...........     ..+.+|+   ..+++++||||++++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI-----KQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHH-----HHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHH-----HHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            4689999999999999999999998999999999985433222111     2466888   555666899999988    


Q ss_pred             ---eeEEcCCC----------------eEEEEcccccccHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHHC
Q 035861           83 ---EVVMDDHD----------------SVYMVMEYMEHDLKWLMESMKQPFS-------TSEVKCLMLQLLEGVKYLHDN  136 (332)
Q Consensus        83 ---~~~~~~~~----------------~~~lv~e~~~~~l~~~~~~~~~~l~-------~~~~~~i~~~l~~~L~~lh~~  136 (332)
                         +++.....                ..|+||||++|++.+.+... +.++       +..++.++.||+.||+|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence               55432211                37899999999888877653 3344       488889999999999999999


Q ss_pred             CcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCC----------CCCCchhHHHHHHH
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA----------KKYSTAVDMWSVGC  206 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~sDi~slG~  206 (332)
                      ||+|+||||+|||++.++.+||+|||++...+.   ......| +.|+|||++.+.          ..++.++||||||+
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999999999999999999986432   2344566 899999999873          26899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHH
Q 035861          207 IMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLL  286 (332)
Q Consensus       207 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  286 (332)
                      ++|+|++|..||...+.......+                                         ....+.+++++.+||
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~li  340 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI-----------------------------------------FRSCKNIPQPVRALL  340 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG-----------------------------------------GSSCCCCCHHHHHHH
T ss_pred             HHHHHHHCCCCCcccccccchhhh-----------------------------------------hhhccCCCHHHHHHH
Confidence            999999999999654321110000                                         011134789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          287 NRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       287 ~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .+||+.||++||++.|+++||||+++.
T Consensus       341 ~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          341 EGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999999999999999999999998753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.3e-47  Score=339.54  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=203.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--CCCeeeeeeeEEcC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--HPSIVNVKEVVMDD   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~   88 (332)
                      .+|++++.||+|+||+||++.+.. ++.||||++.........      ...+.+|+.+++.+.  ||||+.+++++..+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~------~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQT------LDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHH------HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHH------HHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            369999999999999999999865 889999999765432211      124678999999996  59999999998555


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...|+|||+.++++.+.+.. ...+++..++.++.||+.||+|||+.||+|+||||+|||++ ++.+||+|||++....
T Consensus       129 -~~~~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          129 -QYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             -SEEEEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             -CEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence             77999999777788777765 56899999999999999999999999999999999999995 5899999999998664


Q ss_pred             CCCC--CCccccccccccchhhhcC----------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcC
Q 035861          169 SPLK--PYTSLVVTLWYRAPELLLG----------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTLG  235 (332)
Q Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~----------~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~  235 (332)
                      ....  ......||+.|+|||++.+          ...++.++||||||+++|+|++|..||...... .....+.... 
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~-  284 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-  284 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT-
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc-
Confidence            3221  2345679999999999864          236899999999999999999999999765432 2333322110 


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                        .....+...+..+.+||.+||+.||.+||++.|+|+||||+....
T Consensus       285 ----------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          285 ----------------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             ----------------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             ----------------------------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence                                              011112225778999999999999999999999999999986543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-47  Score=336.63  Aligned_cols=295  Identities=25%  Similarity=0.410  Sum_probs=222.8

Q ss_pred             ccccchhcccccccccccCcEEEEEEEE-CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCC------C
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARD-KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP------S   77 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~   77 (332)
                      .|....++|++++.||+|+||+||+|.+ ..+++.||||++......         ...+.+|+.+++.++|+      +
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~~~~~~~~~~   78 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY---------CEAARSEIQVLEHLNTTDPNSTFR   78 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHH---------HHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCch---------hHHHHHHHHHHHHhhhcCCCCcee
Confidence            4555667999999999999999999998 567899999998643211         11356788888887655      4


Q ss_pred             eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC----
Q 035861           78 IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN----  152 (332)
Q Consensus        78 i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~----  152 (332)
                      ++.+++++..+ ...++|||++++++.+.+.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.    
T Consensus        79 i~~~~~~~~~~-~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           79 CVQMLEWFEHH-GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             BCCEEEEEEET-TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred             eEeeecccccC-CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence            89999988444 7899999999889888877644 36899999999999999999999999999999999999987    


Q ss_pred             ---------------CCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 035861          153 ---------------QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL  217 (332)
Q Consensus       153 ---------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p  217 (332)
                                     ++.++|+|||.+......   .....|++.|+|||++.+ ..++.++|+||||+++|+|++|..|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCC
Confidence                           668999999999865432   345578999999999987 6789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc---ccccccCCchh--hhhhhCCC--CccCCCCCCCchHHHHHHHhc
Q 035861          218 FSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG---AKANFAKQPYN--LLRKRFPA--ASFTGSPVLSESGFDLLNRLL  290 (332)
Q Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  290 (332)
                      |...+..+....+....+..+............   ....+......  ........  .........++.+.+||.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            999888877777777666555443222211000   00000000000  00000000  011122335678899999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCC
Q 035861          291 TYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       291 ~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +.||.+|||+.|+++||||+.+.
T Consensus       314 ~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          314 EYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             CSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             CcCcccccCHHHHhcCHHHHHHh
Confidence            99999999999999999999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.4e-47  Score=329.08  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=202.5

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      +..++|++++.||+|+||+||+|++..+++.||||++......         ...+.+|+.++++++||||+++++.+.+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---------LSTILSEVMLLASLNHQYVVRYYAAWLE   73 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHH---------HHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHH---------HHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence            4567999999999999999999999999999999999643211         1246789999999999999999998754


Q ss_pred             C------------CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC
Q 035861           88 D------------HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        88 ~------------~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~  154 (332)
                      .            ....++||||++| ++.+.+......+++..++.++.|++.||+|||++|++|+||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC
Confidence            2            3568999999986 77777766566789999999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCC--------------CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 035861          155 VLKICDFGMSRQYGSP--------------LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG  220 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~  220 (332)
                      .++|+|||.+......              ........|+..|+|||.+.+...++.++|+||||+++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            9999999998765321              1222345688999999999875678999999999999999998   5543


Q ss_pred             CChH-HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC
Q 035861          221 TTEV-DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT  299 (332)
Q Consensus       221 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  299 (332)
                      .... .....+......                                 .+......++..+.+||.+||+.||.+|||
T Consensus       231 ~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  277 (303)
T 1zy4_A          231 GMERVNILKKLRSVSIE---------------------------------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPG  277 (303)
T ss_dssp             HHHHHHHHHHHHSTTCC---------------------------------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred             chhHHHHHHhccccccc---------------------------------cCccccccchHHHHHHHHHHHhcCcccCcC
Confidence            2222 222222111100                                 011112336778999999999999999999


Q ss_pred             HHHHhcCCCCCCCC
Q 035861          300 VDDALNHYWFHEVP  313 (332)
Q Consensus       300 ~~ell~hp~f~~~~  313 (332)
                      +.++++||||....
T Consensus       278 ~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          278 ARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHSSCSCCCC
T ss_pred             HHHHhCCCCcCCCC
Confidence            99999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-47  Score=338.59  Aligned_cols=296  Identities=24%  Similarity=0.389  Sum_probs=224.4

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCC-cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC------
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSG-EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS------   77 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------   77 (332)
                      .|....++|++++.||+|+||+||+|.+..++ ..||+|++.......         ..+.+|+.+++.+.|++      
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~~~~~~~~~~   83 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR---------EAARLEINVLKKIKEKDKENKFL   83 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHH---------HHHHHHHHHHHHHHHHCTTSCSC
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccch---------hHHHHHHHHHHHHhhcCCCCcee
Confidence            45566789999999999999999999998776 689999986432111         13557888888887655      


Q ss_pred             eeeeeeeEEcCCCeEEEEcccccccHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE------
Q 035861           78 IVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL------  150 (332)
Q Consensus        78 i~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili------  150 (332)
                      ++.+.+.+. .....++|||++++++++.+.... ..+++..++.++.||+.||+|||++||+|+||||+||++      
T Consensus        84 ~~~~~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           84 CVLMSDWFN-FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             BCCEEEEEE-ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred             EEEeeeeee-eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence            788888774 447899999999999988887654 579999999999999999999999999999999999999      


Q ss_pred             -------------cCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 035861          151 -------------NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL  217 (332)
Q Consensus       151 -------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p  217 (332)
                                   +.++.++|+|||++......   .....|++.|+|||++.+ ..++.++|+||||+++|+|++|..|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCC
Confidence                         66789999999999865432   245578999999999987 6789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHcCCCCCCcccCCCCCccc---cccccCCch--hhhhhhCCC--CccCCCCCCCchHHHHHHHhc
Q 035861          218 FSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA---KANFAKQPY--NLLRKRFPA--ASFTGSPVLSESGFDLLNRLL  290 (332)
Q Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  290 (332)
                      |......+....+....+..+.............   ...+.....  .........  .........+..+.+||.+||
T Consensus       239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            9998888877777776666554432221110000   000000000  000000000  001112224568899999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          291 TYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       291 ~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      +.||++|||+.|+|+||||+++..
T Consensus       319 ~~dP~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          319 EFDPAQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred             cCChhhCcCHHHHhcChhhcCCCh
Confidence            999999999999999999999764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.1e-48  Score=340.54  Aligned_cols=288  Identities=22%  Similarity=0.360  Sum_probs=217.7

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccccccc---------CCCcchhHHHHHHhhCCCC
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEY---------GFPISSLREINILLSFDHP   76 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~   76 (332)
                      +....++|++++.||+|+||.||+|.+  +++.||||++.............         .....+.+|+.++++++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            445568999999999999999999999  79999999998654332211100         0003577999999999999


Q ss_pred             CeeeeeeeEEcCCCeEEEEcccccc-cHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCC
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWL------MESM-KQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSN  147 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~N  147 (332)
                      ||+++++++..+ ...++||||++| ++.+.      +... ...+++..++.++.||+.||+|||+ .|++|+||+|+|
T Consensus       104 ~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          104 YCLTCEGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TBCCCSEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CcceEEEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            999999999554 789999999997 44333      2221 5679999999999999999999999 999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYST-AVDMWSVGCIMAELLAKKPLFSGTTE-VD  225 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~sDi~slG~~l~~lltg~~pf~~~~~-~~  225 (332)
                      |+++.++.++|+|||.+......  ......++..|+|||.+.+...++. ++|+||||+++|+|++|..||..... .+
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999999875432  3345678999999999987545655 99999999999999999999988766 44


Q ss_pred             HHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ....+.......+... ..+                 ...............++.++.+||.+||+.||.+||+++|+++
T Consensus       261 ~~~~i~~~~~~~~~~~-~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDR-NHF-----------------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSS-SSS-----------------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccch-hhh-----------------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            4444433211111100 000                 0000000111122458999999999999999999999999999


Q ss_pred             CCCCCCCCCCC
Q 035861          306 HYWFHEVPLPK  316 (332)
Q Consensus       306 hp~f~~~~~~~  316 (332)
                      ||||++.++..
T Consensus       323 hp~f~~~~~~~  333 (348)
T 2pml_X          323 HEWLADTNIED  333 (348)
T ss_dssp             SGGGTTCCHHH
T ss_pred             CccccCCCHHH
Confidence            99999876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.7e-47  Score=325.24  Aligned_cols=261  Identities=28%  Similarity=0.398  Sum_probs=203.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|.....||+|+||+||+|.+..++..||||++.......        ...+.+|+.+++.++||||+++++++... 
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   91 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY--------SQPLHEEIALHKHLKHKNIVQYLGSFSEN-   91 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------HHHHHHHHHHHTCCCTTBCCEEEEEEET-
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH--------HHHHHHHHHHHHhCCCCCEeeEeeEEEeC-
Confidence            345555569999999999999999999999999987543211        12567899999999999999999999544 


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-CCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQ--PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-QGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~--~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-~~~~~l~df~~~~  165 (332)
                      ...++|||+++| ++.+.+.....  .+++..++.++.|++.||+|||++|++|+||+|+||+++. ++.++|+|||.+.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            789999999975 55555554333  4678999999999999999999999999999999999998 8999999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      .............|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||.................         
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------  242 (295)
T 2clq_A          172 RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK---------  242 (295)
T ss_dssp             ESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC---------
T ss_pred             ccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc---------
Confidence            765433334456789999999998753 2378999999999999999999999976443322111111100         


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               .....+..++.++.+||.+||+.||++||+++++|+||||+...
T Consensus       243 -------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          243 -------------------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             -------------------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             -------------------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                                     00111234789999999999999999999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.2e-48  Score=344.37  Aligned_cols=268  Identities=19%  Similarity=0.239  Sum_probs=195.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHH---HHHhhCCCCCeeeee----
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREI---NILLSFDHPSIVNVK----   82 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~----   82 (332)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++............     .+.+|+   ..++. +||||+.++    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE-----RLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHH-----HHHHHHHHHHHHHC-----------CBC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHH-----HHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            34699999999999999999999999999999999875432221111     345664   45555 799987754    


Q ss_pred             ---eeEEcCC----------------CeEEEEcccccccHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCC
Q 035861           83 ---EVVMDDH----------------DSVYMVMEYMEHDLKWLMESMKQPFSTSEV------KCLMLQLLEGVKYLHDNW  137 (332)
Q Consensus        83 ---~~~~~~~----------------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~------~~i~~~l~~~L~~lh~~~  137 (332)
                         +++....                ...|+||||++|++.+.+...+..+++..+      ..++.||+.||+|||++|
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~  214 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG  214 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence               3332211                348999999999998888876556666666      788899999999999999


Q ss_pred             cccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcC-CCCCCchhHHHHHHHHHHHHHhCCC
Q 035861          138 VLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELLAKKP  216 (332)
Q Consensus       138 i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~~lltg~~  216 (332)
                      |+|+||||+|||++.++.+||+|||++...+..   .....+++.|+|||++.+ ...++.++||||||+++|+|++|..
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999876432   114456699999999964 2468999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC
Q 035861          217 LFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK  296 (332)
Q Consensus       217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  296 (332)
                      ||........             ..+....               ..............+.+++.+.+||.+||+.||++
T Consensus       292 Pf~~~~~~~~-------------~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  343 (371)
T 3q60_A          292 PFGLVTPGIK-------------GSWKRPS---------------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR  343 (371)
T ss_dssp             STTBCCTTCT-------------TCCCBCC---------------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTT
T ss_pred             CCCCcCcccc-------------cchhhhh---------------hhhccccccchhhccCCCHHHHHHHHHHcCCChhh
Confidence            9976532100             0000000               00000011122223458999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCC
Q 035861          297 RITVDDALNHYWFHEVPL  314 (332)
Q Consensus       297 Rps~~ell~hp~f~~~~~  314 (332)
                      ||++.++|+||||+++.+
T Consensus       344 Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          344 RLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             CCCHHHHTTSHHHHHHHH
T ss_pred             CCCHHHHhcCHHHHHHHH
Confidence            999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=331.10  Aligned_cols=282  Identities=22%  Similarity=0.317  Sum_probs=211.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      +...-++|++.+.||+|+||+||+|.+..+++.||||++........       ...+.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (319)
T 4euu_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIE   76 (319)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCcceEEEEe
Confidence            45566799999999999999999999999999999999975432211       12456899999999999999999998


Q ss_pred             EcCC-CeEEEEcccccc-cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE----cCCCcEE
Q 035861           86 MDDH-DSVYMVMEYMEH-DLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVLK  157 (332)
Q Consensus        86 ~~~~-~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili----~~~~~~~  157 (332)
                      .... ...++||||++| ++.+.+....  ..+++..++.++.||+.||+|||+.||+|+||||+||++    +.++.+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             ECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred             ecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEE
Confidence            6543 378999999985 5555555432  239999999999999999999999999999999999999    7778899


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHH
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG-------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE----VDQ  226 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~----~~~  226 (332)
                      |+|||.+...... .......|++.|+|||++..       ...++.++||||||+++|+|++|..||.....    .+.
T Consensus       157 L~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  235 (319)
T 4euu_A          157 LTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (319)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred             EccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence            9999999876443 23345678999999999862       36789999999999999999999999975332    333


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ...+....   +...+..+.........+...        . .........++..+.+||.+||+.||++|||++|+|+|
T Consensus       236 ~~~~~~~~---p~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h  303 (319)
T 4euu_A          236 MYKIITGK---PSGAISGVQKAENGPIDWSGD--------M-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (319)
T ss_dssp             HHHHHHHC---CTTCCEEEECSTTCCEEEESS--------C-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHHHhcCC---CcccchhhhcccCCccccCcc--------C-CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence            34444332   222222222211111111000        0 00111223356688899999999999999999999999


Q ss_pred             C
Q 035861          307 Y  307 (332)
Q Consensus       307 p  307 (332)
                      |
T Consensus       304 ~  304 (319)
T 4euu_A          304 T  304 (319)
T ss_dssp             H
T ss_pred             c
Confidence            6

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-46  Score=328.71  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=213.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--CCCeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--HPSIVNVKE   83 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~   83 (332)
                      +....++|++.+.||+|+||+||+|.+..+++.||||++..........  ......+..|+.+++++.  |+||+++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh--hhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            3445678999999999999999999999999999999998765432111  112235678999999996  599999999


Q ss_pred             eEEcCCCeEEEEccccc--ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc-CCCcEEEee
Q 035861           84 VVMDDHDSVYMVMEYME--HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICD  160 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~-~~~~~~l~d  160 (332)
                      ++... ...++|+|++.  +++.+.+.. .+.+++..++.++.||+.||+|||+.||+|+||||+||+++ .++.++|+|
T Consensus       116 ~~~~~-~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          116 WFERP-DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEECS-SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEecC-CcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            99544 78999999997  566666655 67899999999999999999999999999999999999999 778999999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ||++......  ......|++.|+|||.+.+....+.++|+||||+++|+|++|..||.....      +....      
T Consensus       194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~------  259 (320)
T 3a99_A          194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ------  259 (320)
T ss_dssp             CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC------
T ss_pred             Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccc------
Confidence            9999876432  234456899999999998755557899999999999999999999965321      11110      


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                     ......+++++.+||.+||+.||++||+++++++||||+++..+..
T Consensus       260 -------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~  305 (320)
T 3a99_A          260 -------------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE  305 (320)
T ss_dssp             -------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred             -------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccc
Confidence                                           0011237899999999999999999999999999999999876544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=327.43  Aligned_cols=263  Identities=25%  Similarity=0.414  Sum_probs=196.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||+||+|.+..+++.||||++..........      ..+.++..+++.++||||+++++++..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK------RILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHH------HHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHH------HHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            4679999999999999999999999999999999997653222111      1223445567788999999999999554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ...++|||++++.+..........+++..++.++.||+.||+|||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus        97 -~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 -TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             -SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             -CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence             78999999997666666665578899999999999999999999985 9999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccccchhhhc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCCCcc
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLL----GAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ... .......+++.|+|||.+.    ....++.++|+||||+++|+|++|..||... ...+....+.......     
T Consensus       176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  249 (318)
T 2dyl_A          176 VDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-----  249 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-----
T ss_pred             cCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-----
Confidence            332 2234457899999999985    2356889999999999999999999999874 3444444443321110     


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                   ......++.++.+||.+||+.||.+||+++++++||||++..
T Consensus       250 -----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          250 -----------------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -----------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                                         111223789999999999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-46  Score=319.77  Aligned_cols=249  Identities=23%  Similarity=0.407  Sum_probs=207.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|+||+||+|.+. ++..||+|++.......         ..+.+|+.++++++||||+++++++ .+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   77 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---------EDFIEEAEVMMKLSHPKLVQLYGVC-LEQ   77 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---------HHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---------HHHHHHHHHHHhCCCCCEeeEEEEE-ecC
Confidence            469999999999999999999986 47789999997543322         1467899999999999999999998 444


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++| ++.+.+......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            779999999986 5666665656779999999999999999999999999999999999999999999999999997653


Q ss_pred             CCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.......         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---------  227 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------  227 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---------
T ss_pred             ccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---------
Confidence            221 12234456778999999976 678999999999999999999 999999888777666654432111         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                 .+..+++.+.+|+.+||+.||++||++.++++|
T Consensus       228 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          228 ---------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                       122368899999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-46  Score=328.06  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=206.4

Q ss_pred             CcccccccchhcccccccccccCcEEEEEEEECCCCcE----EEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCC
Q 035861            1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEI----VALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP   76 (332)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~   76 (332)
                      |+.+......++|++++.||+|+||+||+|.+..+++.    |++|.+.......       ....+.+|+..+++++||
T Consensus         3 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~-------~~~~~~~e~~~l~~l~h~   75 (325)
T 3kex_A            3 MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-------SFQAVTDHMLAIGSLDHA   75 (325)
T ss_dssp             -CCCCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS-------CBCSCCHHHHHHHTCCCT
T ss_pred             hHHHHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH-------HHHHHHHHHHHHhcCCCC
Confidence            34444555667999999999999999999999888776    6666664332111       122456899999999999


Q ss_pred             CeeeeeeeEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc
Q 035861           77 SIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        77 ~i~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~  155 (332)
                      ||+++++++ .+ ...++|+||+.+ ++.+.+....+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.
T Consensus        76 ~iv~~~~~~-~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~  153 (325)
T 3kex_A           76 HIVRLLGLC-PG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ  153 (325)
T ss_dssp             TBCCEEEEE-CB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC
T ss_pred             CcCeEEEEE-cC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe
Confidence            999999988 44 568899999985 666666665578999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 035861          156 LKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFK  232 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~  232 (332)
                      ++|+|||++........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+..
T Consensus       154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  232 (325)
T 3kex_A          154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK  232 (325)
T ss_dssp             EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred             EEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence            99999999987643322  2344567788999999986 668999999999999999999 9999988776655554433


Q ss_pred             HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ...                                    ...+..++.++.+||.+||+.||.+||++.+++++
T Consensus       233 ~~~------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          233 GER------------------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TCB------------------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCC------------------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            211                                    11122367788899999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5e-47  Score=331.29  Aligned_cols=268  Identities=22%  Similarity=0.347  Sum_probs=190.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..++|++++.||+|+||+||+|.+..++.   .||||++.........      ...+.+|+.++++++||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD------IEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH------HHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH------HHHHHHHHHHHHHCCCCceehhhcee
Confidence            34589999999999999999999887665   8999999754332221      12467999999999999999999998


Q ss_pred             EcCCCe-----EEEEcccccc-cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC
Q 035861           86 MDDHDS-----VYMVMEYMEH-DLKWLMESMK-----QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        86 ~~~~~~-----~~lv~e~~~~-~l~~~~~~~~-----~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~  154 (332)
                      ......     .++||||++| ++.+.+....     ..+++..++.++.||+.||+|||++|++|+||||+||+++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            655322     3899999987 5555554321     2599999999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 035861          155 VLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~  231 (332)
                      .++|+|||.+.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            99999999997653322  12233456778999999987 678999999999999999999 999998887776666554


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-------HHHHh
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-------VDDAL  304 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~ell  304 (332)
                      ....                                    ....+.+++++.+||.+||+.||++|||       +++++
T Consensus       254 ~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          254 GGNR------------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             TTCC------------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC------------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4321                                    1122347899999999999999999999       89999


Q ss_pred             cCCCCCCCCCCCCCC
Q 035861          305 NHYWFHEVPLPKSKD  319 (332)
Q Consensus       305 ~hp~f~~~~~~~~~~  319 (332)
                      +|||+......+...
T Consensus       298 ~~~~~~~~~~~pl~~  312 (323)
T 3qup_A          298 GHLSVLSTSQDPLYI  312 (323)
T ss_dssp             HC-------------
T ss_pred             HHhhhcCCCCCCCCC
Confidence            999999976555543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=328.67  Aligned_cols=266  Identities=20%  Similarity=0.335  Sum_probs=199.4

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC----CCCCeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF----DHPSIVNVK   82 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----~h~~i~~~~   82 (332)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++...........  .....+.+|+..+.++    +|+||++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL--SDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccc--hhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3455689999999999999999999999999999999976543221111  1122456899999888    899999999


Q ss_pred             eeEEcCCCeEEEEccc-cc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc-CCCcEEEe
Q 035861           83 EVVMDDHDSVYMVMEY-ME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKIC  159 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~-~~~~~~l~  159 (332)
                      +++... ...++|+|+ +. +++.+.+.. .+.+++..++.++.||+.||+|||++|++|+||+|+||+++ .++.++|+
T Consensus       105 ~~~~~~-~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          105 DWFETQ-EGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EEC------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEecC-CeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence            998444 677899998 55 466665554 66799999999999999999999999999999999999999 78999999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      |||.+......  ......|+..|+|||.+.+....+.++|+||||+++|+|++|..||....      .+....     
T Consensus       183 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~-----  249 (312)
T 2iwi_A          183 DFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE-----  249 (312)
T ss_dssp             CCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTC-----
T ss_pred             EcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhc-----
Confidence            99998876432  23455689999999998764555679999999999999999999996532      111110     


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                                                      ......++..+.+||.+||+.||++||+++|+++||||+.....-...
T Consensus       250 --------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~  297 (312)
T 2iwi_A          250 --------------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN  297 (312)
T ss_dssp             --------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--------
T ss_pred             --------------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccccc
Confidence                                            011233788999999999999999999999999999999865443333


Q ss_pred             CC
Q 035861          320 FM  321 (332)
Q Consensus       320 ~~  321 (332)
                      ..
T Consensus       298 ~~  299 (312)
T 2iwi_A          298 PS  299 (312)
T ss_dssp             --
T ss_pred             cc
Confidence            33

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=323.58  Aligned_cols=256  Identities=21%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..-..++|.+.+.||+|+||+||+|.+..+++.||+|++.......        ...+.+|+.++++++||||+++++++
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~   76 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET--------QRTFLKEVKVMRCLEHPNVLKFIGVL   76 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHH--------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHH--------HHHHHHHHHHHHhCCCcCcccEEEEE
Confidence            3445789999999999999999999999999999999885422111        12567899999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .++ ...++||||++| ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        77 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           77 YKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EET-TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             ecC-CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence            554 789999999986 666666665788999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCC--------------CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 035861          165 RQYGSPLKP--------------YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       165 ~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~  230 (332)
                      .........              .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~----  230 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM----  230 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT----
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH----
Confidence            765332221              114578999999999987 7789999999999999999999999865321100    


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                             ............       ..++.+++.+.+||.+||+.||++|||+.++++
T Consensus       231 -----------------------~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          231 -----------------------DFGLNVRGFLDR-------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -----------------------TSSBCHHHHHHH-------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------HHhhhhhccccc-------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                   000000000000       112347899999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.7e-46  Score=318.09  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=207.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+. ++..||+|++.......         ..+.+|+..+++++||||+++++++ .+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~-~~   74 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---------DEFFQEAQTMMKLSHPKLVKFYGVC-SK   74 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---------HHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---------HHHHHHHHHHHhCCCCCEeeEEEEE-cc
Confidence            3469999999999999999999886 46679999997544322         1467899999999999999999998 55


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....++|||+++| ++.+.+......+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence            5789999999975 566666665667999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.......        
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------  225 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY--------  225 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC--------
Confidence            4322 12233445678999999976 568999999999999999999 999998888776666554332111        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                  .+..+++.+.+||.+||+.||++|||+.+++++
T Consensus       226 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          226 ----------------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        122268899999999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=327.30  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=206.4

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ...++|++.+.||+|+||+||+|.+..++.   .||||++........       ...+.+|+.++++++||||++++++
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~  118 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-------RRDFLSEASIMGQFDHPNIIRLEGV  118 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHH-------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHH-------HHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            345789999999999999999999976554   599999975322111       1246789999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      + .+....++||||++| ++.+.+......+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||+
T Consensus       119 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          119 V-TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             E-CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             E-EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence            8 444778999999976 66666666567899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          164 SRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      +........   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+......+  
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--  274 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--  274 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--
Confidence            987643322   1223345678999999976 578999999999999999999 999999888777766665432111  


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                        .+..+++.+.+||.+||+.||.+||++.+|++.
T Consensus       275 ----------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 ----------------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ----------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                              123378999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5e-46  Score=318.94  Aligned_cols=250  Identities=23%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||++.+. ++..||+|++.......         ..+.+|+.++++++|+||+++++++ .+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~-~~   90 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---------DEFIEEAKVMMNLSHEKLVQLYGVC-TK   90 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---------HHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---------HHHHHHHHHHhcCCCCCEeeEEEEE-ec
Confidence            3569999999999999999999886 57789999997543322         1467899999999999999999998 55


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....++||||++| ++.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            5789999999975 566666655678999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+........       
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------  242 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------  242 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------
T ss_pred             cccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------
Confidence            321 112233456778999999986 568999999999999999998 9999998887777666654322111       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                   +..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       243 -----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          243 -----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                         22268899999999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.7e-46  Score=319.72  Aligned_cols=257  Identities=18%  Similarity=0.218  Sum_probs=208.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      +...-++|++.+.||+|++|+||+|.+..+++.||||++......          ..+.+|+..++.+ .|++++.++++
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~   74 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYF   74 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----------HHHHHHHHHHHHHhcCCCCCeEEee
Confidence            344556899999999999999999999999999999998643321          2467899999999 89999999998


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc-----EEEe
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-----LKIC  159 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~-----~~l~  159 (332)
                      +. .....++|||++++++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.     ++|+
T Consensus        75 ~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           75 GQ-EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             EE-ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             cC-CCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            84 44889999999988888888776677999999999999999999999999999999999999987775     9999


Q ss_pred             ecccccccCCCCC-------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHH
Q 035861          160 DFGMSRQYGSPLK-------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT---EVDQIDK  229 (332)
Q Consensus       160 df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~---~~~~~~~  229 (332)
                      |||++........       ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....   .......
T Consensus       154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             ECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            9999987643322       2345578999999999987 678999999999999999999999998743   3333333


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      +.......+.                                ....+.+++++.+||.+||+.||++||++++|++.
T Consensus       233 ~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          233 IGEKKQSTPL--------------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHHHSCH--------------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHhhccCccH--------------------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            3322110100                                00112378999999999999999999999998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-46  Score=333.94  Aligned_cols=290  Identities=26%  Similarity=0.385  Sum_probs=212.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-----------CCCe
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-----------HPSI   78 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i   78 (332)
                      ..+|++++.||+|+||+||+|++..+++.||||++.......         ..+.+|+.+++++.           |+||
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~e~~~l~~l~~~~~~~~~~~~~~~i   88 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---------EAAEDEIKLLQRVNDADNTKEDSMGANHI   88 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH---------HHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccch---------hhhhHHHHHHHHhhcccccchhccccchH
Confidence            468999999999999999999999999999999986432111         13457888888775           8999


Q ss_pred             eeeeeeEEcC---CCeEEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcC-
Q 035861           79 VNVKEVVMDD---HDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNN-  152 (332)
Q Consensus        79 ~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~-  152 (332)
                      +++++.+...   ....++|||++++++.+.+... ...+++..++.++.||+.||+|||++ ||+|+||||+||+++. 
T Consensus        89 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           89 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            9999998543   2378999999988888887764 35699999999999999999999998 9999999999999953 


Q ss_pred             -----CCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----
Q 035861          153 -----QGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT-----  222 (332)
Q Consensus       153 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~-----  222 (332)
                           .+.++|+|||++......   .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....     
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                 348999999999876432   234578999999999987 668999999999999999999999998654     


Q ss_pred             -hHHHHHHHHHHcCCCCCCcccCCCCC------ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          223 -EVDQIDKIFKTLGTPTETIWPGLSEL------PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                       .......+....+..+...+......      ................... ......+..++.++.+||.+||+.||+
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL-TEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH-HHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh-hhcccCCcchHHHHHHHHHHHhccCcc
Confidence             44455566665555443221110000      0000000000000000000 001112233577899999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q 035861          296 KRITVDDALNHYWFHEVP  313 (332)
Q Consensus       296 ~Rps~~ell~hp~f~~~~  313 (332)
                      +|||++|+|+||||++..
T Consensus       324 ~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          324 KRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             TCBCHHHHHTCGGGTTCT
T ss_pred             ccCCHHHHhhChhhhccc
Confidence            999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.8e-46  Score=326.01  Aligned_cols=251  Identities=22%  Similarity=0.226  Sum_probs=204.3

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   88 (332)
                      -.+|++.+.||+|+||+||+|++..+++.||||++......          ..+..|+.+++++ .||||+.+++++..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            35899999999999999999999999999999998754321          2467899999999 999999999998554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc-----EEEeeccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-----LKICDFGM  163 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~-----~~l~df~~  163 (332)
                       ...++|||++++++.+.+......+++..++.++.||+.||+|||+.||+|+||||+||+++.++.     ++|+|||+
T Consensus        78 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           78 -KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             -CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence             789999999977888888776788999999999999999999999999999999999999998887     99999999


Q ss_pred             ccccCCCCC-------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Q 035861          164 SRQYGSPLK-------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKT  233 (332)
Q Consensus       164 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~  233 (332)
                      +........       ......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.   .+....+...
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            986543222       1245678999999999987 6789999999999999999999999987433   2333333222


Q ss_pred             cCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ....+..                                .....++ ++.+||.+||+.||.+||++++|++
T Consensus       236 ~~~~~~~--------------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          236 KRATPIE--------------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHSCHH--------------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCCHH--------------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1100000                                0001134 8999999999999999999998876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.4e-46  Score=332.54  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=206.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++.......  .     ...+.+|+.++++++||||+++++++ ...
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~-----~~~~~~E~~~l~~l~hpniv~~~~~~-~~~  184 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--L-----KAKFLQEARILKQYSHPNIVRLIGVC-TQK  184 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHH--H-----HTTTTHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHH--H-----HHHHHHHHHHHHhCCCCCEEEEEEEE-ecC
Confidence            468999999999999999999999899999999987432111  1     12467999999999999999999999 444


Q ss_pred             CeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++ |++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++....
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            77899999997 46777776656679999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          169 SPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....  ......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+.....          
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------  333 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR----------  333 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC----------
T ss_pred             CCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            2211  1122345678999999986 568999999999999999998 9999988877665554433211          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ...+..+++++.+||.+||+.||++|||++++++
T Consensus       334 --------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 --------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                      1112337889999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-45  Score=317.84  Aligned_cols=255  Identities=20%  Similarity=0.207  Sum_probs=207.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|+||+|++..+++.||||++......          ..+.+|+.+++.+.|++++..+..+...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence            456899999999999999999999999999999998654322          1467899999999999888877777677


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l~df~~~~  165 (332)
                      ....++|||++++++.+.+......+++..++.++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+.
T Consensus        77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            78899999999888888887667889999999999999999999999999999999999999   478899999999998


Q ss_pred             ccCCCCC-------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcC
Q 035861          166 QYGSPLK-------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTLG  235 (332)
Q Consensus       166 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~~~  235 (332)
                      .......       ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....   ......+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            7644322       2345678999999999987 6689999999999999999999999976432   122222222110


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ..+                                .....+.+++++.+||.+||+.||++||+++++++.
T Consensus       236 ~~~--------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          236 STP--------------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HSC--------------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             CCc--------------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            000                                000112378999999999999999999999998864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-46  Score=330.36  Aligned_cols=253  Identities=21%  Similarity=0.361  Sum_probs=204.4

Q ss_pred             chhcccccccccccCcEEEEEEEEC-------CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK-------KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVN   80 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~   80 (332)
                      ..++|++.+.||+|+||+||+|.+.       .++..||||++.......  .     ...+.+|+.+++++ +||||++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~--~-----~~~~~~E~~~l~~l~~hpnIv~  151 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--D-----LSDLVSEMEMMKMIGKHKNIIN  151 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHH--H-----HHHHHHHHHHHHHSCCCTTBCC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHH--H-----HHHHHHHHHHHHHhcCCCCEee
Confidence            3468999999999999999999874       345679999997542111  1     12467899999999 8999999


Q ss_pred             eeeeEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 035861           81 VKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLK  144 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~  144 (332)
                      +++++. .....|+||||++| ++.+.+....               ..+++..++.++.||+.||+|||++||+|+|||
T Consensus       152 ~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  230 (370)
T 2psq_A          152 LLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  230 (370)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEEc-cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            999984 44778999999986 6666665432               348999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 035861          145 TSNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGT  221 (332)
Q Consensus       145 p~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~  221 (332)
                      |+||+++.++.+||+|||++.......  .......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||...
T Consensus       231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999998654322  12234456788999999987 678999999999999999999 99999887


Q ss_pred             ChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH
Q 035861          222 TEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD  301 (332)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  301 (332)
                      ...+....+.....                                    ...+..++..+.+||.+||+.||++||++.
T Consensus       310 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  353 (370)
T 2psq_A          310 PVEELFKLLKEGHR------------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFK  353 (370)
T ss_dssp             CGGGHHHHHHTTCC------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CHHHHHHHHhcCCC------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            76655554433211                                    112233788999999999999999999999


Q ss_pred             HHhcC
Q 035861          302 DALNH  306 (332)
Q Consensus       302 ell~h  306 (332)
                      |++++
T Consensus       354 ell~~  358 (370)
T 2psq_A          354 QLVED  358 (370)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=333.12  Aligned_cols=257  Identities=20%  Similarity=0.336  Sum_probs=207.2

Q ss_pred             hhcccccccccccCcEEEEEEEE-----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|++++.||+|+||+||+|++     ..++..||||++........       ...+.+|+.++++++||||++++++
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-------ELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh-------HHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            46899999999999999999994     45678899999864322111       1146689999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC---
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMK------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG---  154 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~---  154 (332)
                      +.. ....++||||++| ++.+.+....      ..+++..++.++.||+.||+|||++||+||||||+||+++.++   
T Consensus       143 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          143 SLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ECS-SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             Eec-CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence            844 4778999999975 6666665543      3589999999999999999999999999999999999999655   


Q ss_pred             cEEEeecccccccC--CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 035861          155 VLKICDFGMSRQYG--SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       155 ~~~l~df~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~  231 (332)
                      .+||+|||++....  ..........+++.|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            59999999997542  11223344567889999999976 678999999999999999998 999999888777666655


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      .....                                    ..+..++..+.+||.+||+.||++||++.+|+++.++..
T Consensus       301 ~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGRM------------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCC------------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            43211                                    112337889999999999999999999999999977654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-46  Score=331.79  Aligned_cols=254  Identities=21%  Similarity=0.381  Sum_probs=204.2

Q ss_pred             hhcccccccccccCcEEEEEEE-----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++++.||+|+||.||+|.     ...+++.||||++........       ...+.+|+.++.++ .||||+++++
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------HRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH-------HHHHHHHHHHHHhhcCCcceeeeee
Confidence            4689999999999999999999     455678999999975432111       12467899999999 7899999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCC--------------------------------------------------
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQ--------------------------------------------------  112 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------------------------------------  112 (332)
                      ++.+.....++||||++| ++.+.+.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            997766678999999986 55555544321                                                  


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC--CCCc
Q 035861          113 ---------------PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL--KPYT  175 (332)
Q Consensus       113 ---------------~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~--~~~~  175 (332)
                                     .+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  ....
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                           18999999999999999999999999999999999999999999999999997653322  1234


Q ss_pred             cccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc
Q 035861          176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN  254 (332)
Q Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (332)
                      ...++..|+|||++.+ ..++.++||||||+++|+|++ |..||...................                 
T Consensus       254 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  315 (359)
T 3vhe_A          254 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  315 (359)
T ss_dssp             -CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred             ccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence            4567889999999986 678999999999999999998 999998776554444443332111                 


Q ss_pred             ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                        ..+..+++++.++|.+||+.||.+||++.|+++|
T Consensus       316 ------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                              1122378899999999999999999999999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1e-45  Score=314.95  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=194.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|.+.  ++.+|||++.........    .....+.+|+..++.++||||+++++++. .
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   77 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDIS----QTIENVRQEAKLFAMLKHPNIIALRGVCL-K   77 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-C
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHH----HHHHHHHHHHHHHHhcCCCCEeeEEEEEe-c
Confidence            4579999999999999999999986  889999998764332211    11124678999999999999999999984 4


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCCCEEEcC--------CCcEE
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW---VLHRDLKTSNLLLNN--------QGVLK  157 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~---i~H~di~p~Nili~~--------~~~~~  157 (332)
                      ....++||||++|+.+..+.. ...+++..++.++.|++.||+|||+.|   ++|+||||+||+++.        ++.++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            477899999998765555554 568999999999999999999999999   889999999999986        67899


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |+|||.+.......  .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............  
T Consensus       157 l~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--  231 (271)
T 3dtc_A          157 ITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL--  231 (271)
T ss_dssp             ECCCCC---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC--
T ss_pred             EccCCccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC--
Confidence            99999997654322  234578999999999986 6789999999999999999999999998776665554433211  


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                       ....+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus       232 ---------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          232 ---------------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                             111223478899999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-45  Score=316.83  Aligned_cols=254  Identities=20%  Similarity=0.216  Sum_probs=203.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.......          .+..|+.+++.++|++++..+..+...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----------QLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC----------CHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch----------HHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            4468999999999999999999999999999999876543222          467899999999999888888887777


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l~df~~~~  165 (332)
                      ....++|||++++++.+.+......+++..++.++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+.
T Consensus        77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            78899999999888888887767789999999999999999999999999999999999999   788999999999998


Q ss_pred             ccCCCCC-------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHcC
Q 035861          166 QYGSPLK-------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV---DQIDKIFKTLG  235 (332)
Q Consensus       166 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~---~~~~~~~~~~~  235 (332)
                      .......       ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            7643322       2335678999999999987 67899999999999999999999999764322   12222211100


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ..+                                .......+++++.+||.+||+.||++||++.++++
T Consensus       236 ~~~--------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 STP--------------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSC--------------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cch--------------------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            000                                00011236899999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-45  Score=319.56  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--CCCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--HPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~   87 (332)
                      -.+|++++.||+|+||.||++.+. +++.||||++.........      ...+.+|+..++++.  |+||+++++++..
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQT------LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHH------HHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccc------hHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            457999999999999999999985 4889999999765432211      124578999999997  5999999999855


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      + ...++|||+.++++.+.+.. ...+++..++.++.||+.||+|||++|++|+||||+||++++ +.++|+|||.+...
T Consensus       100 ~-~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          100 D-QYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             S-SEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             C-CEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            4 78999999877888877766 568999999999999999999999999999999999999965 89999999999865


Q ss_pred             CCCCC--CCccccccccccchhhhcC----------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHc
Q 035861          168 GSPLK--PYTSLVVTLWYRAPELLLG----------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV-DQIDKIFKTL  234 (332)
Q Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~----------~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~  234 (332)
                      .....  ......|++.|+|||.+.+          ...++.++|+||||+++|+|++|..||...... .....+... 
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-  255 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-  255 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc-
Confidence            43221  2234568999999999864          146889999999999999999999999765432 222222211 


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                                                        ......+...+..+.+||.+||+.||.+||++.|+|+||||+....
T Consensus       256 ----------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          256 ----------------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             ----------------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             ----------------------------------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence                                              0111112235788999999999999999999999999999987543


Q ss_pred             C
Q 035861          315 P  315 (332)
Q Consensus       315 ~  315 (332)
                      +
T Consensus       302 ~  302 (313)
T 3cek_A          302 P  302 (313)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-46  Score=324.92  Aligned_cols=265  Identities=26%  Similarity=0.401  Sum_probs=188.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHH-HHhhCCCCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREIN-ILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.........       ..+..|+. .++.++||||+++++++..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-------KQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHH-------HHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHH-------HHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            346899999999999999999999999999999999754321111       12334554 6677899999999999955


Q ss_pred             CCCeEEEEcccccccHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCEEEcCCCcEEEeecc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMES----MKQPFSTSEVKCLMLQLLEGVKYLHDN-WVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~----~~~~l~~~~~~~i~~~l~~~L~~lh~~-~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      + ...++|||+++|++.+.+..    ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||
T Consensus        93 ~-~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 E-GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             S-SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             C-CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            5 78999999999987766553    257799999999999999999999998 99999999999999999999999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLL---GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      .+...... .......|+..|+|||.+.   ....++.++|+||||+++|+|++|..||.......  ..+...    ..
T Consensus       172 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~  244 (327)
T 3aln_A          172 ISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQV----VK  244 (327)
T ss_dssp             SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC----CC
T ss_pred             Cceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHH----hc
Confidence            99765432 2223446899999999984   23568999999999999999999999997643211  000000    00


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                               ...+.........+++.+.+||.+||+.||++||++.++++||||.+..
T Consensus       245 -------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          245 -------------------------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------------------------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------------------------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                                     0001111112234789999999999999999999999999999998754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-46  Score=329.22  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=182.5

Q ss_pred             cccchhcccccc-cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            6 GCRSVFEFEKLN-KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         6 ~~~~~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .....++|++++ .||+|+||+||+|.+..+++.||||++.....            ...+....++.+.||||++++++
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~e~~~~~~~~~h~~i~~~~~~   90 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------------ARQEVDHHWQASGGPHIVCILDV   90 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH------------HHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH------------HHHHHHHHHHhcCCCChHHHHHH
Confidence            344667999966 59999999999999999999999999864311            11133344567799999999999


Q ss_pred             EEc---CCCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---CcE
Q 035861           85 VMD---DHDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---GVL  156 (332)
Q Consensus        85 ~~~---~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---~~~  156 (332)
                      +..   +....++||||++| ++.+.+.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.+   +.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence            854   23568999999987 6666665543 469999999999999999999999999999999999999864   459


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGT  236 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  236 (332)
                      +|+|||.+.....  .......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||..................
T Consensus       171 kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          171 KLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             EECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             EEeccccceeccc--cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            9999999986543  22345578999999999866 67889999999999999999999999765543322111110000


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                   ............++.++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       248 -----------------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          248 -----------------------------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             --------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             -----------------------------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                                         000111112234799999999999999999999999999999998743

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-46  Score=318.09  Aligned_cols=248  Identities=17%  Similarity=0.223  Sum_probs=199.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCC-------cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSG-------EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV   81 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   81 (332)
                      ..++|++.+.||+|+||+||+|.+..++       ..||+|++.......        ...+.+|+..+++++||||+++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~   77 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--------SESFFEAASMMSKLSHKHLVLN   77 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG--------HHHHHHHHHHHHTSCCTTBCCE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH--------HHHHHHHHHHHHhCCCCCEeEE
Confidence            4569999999999999999999998776       469999986543211        1256789999999999999999


Q ss_pred             eeeEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc-----
Q 035861           82 KEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV-----  155 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~-----  155 (332)
                      ++++.. ....++||||++| ++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.     
T Consensus        78 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           78 YGVCVC-GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             EEEECC-TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             EEEEEe-CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence            999954 4678899999985 666666665556999999999999999999999999999999999999998887     


Q ss_pred             ---EEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 035861          156 ---LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK  232 (332)
Q Consensus       156 ---~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~  232 (332)
                         ++|+|||.+.....    .....++..|+|||.+.+...++.++||||||+++|+|++|..|+..............
T Consensus       157 ~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             CCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence               99999999865432    23446788899999998766789999999999999999996555444333333333222


Q ss_pred             HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ....                                     .+...+.++.+||.+||+.||.+|||+.+++++
T Consensus       233 ~~~~-------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          233 DRHQ-------------------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTCC-------------------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccCC-------------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2111                                     112257889999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=336.62  Aligned_cols=255  Identities=21%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   90 (332)
                      +|.+.+.||+|+||+|+. ....+++.||||++.....           ....+|+.+++.+ +||||+++++.+. +..
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~~~-~~~   91 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCTEK-DRQ   91 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEEEE-ETT
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEEEe-cCC
Confidence            699999999999999653 3345689999999864321           1245899999999 8999999999984 458


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-----CCcEEEeeccccc
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-----QGVLKICDFGMSR  165 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-----~~~~~l~df~~~~  165 (332)
                      ..|+|||+++|++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.     ...++|+|||++.
T Consensus        92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            89999999999999988876667777788899999999999999999999999999999953     2368899999998


Q ss_pred             ccCCCC---CCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          166 QYGSPL---KPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      ......   .......||+.|+|||++.+  ...++.++||||||+++|+|++ |..||.......... ...   ....
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~---~~~~  247 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLG---ACSL  247 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTT---CCCC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-Hhc---cCCc
Confidence            764322   22344678999999999874  3567889999999999999999 999997654433221 110   0000


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      .                              ........+..+.+||.+||+.||.+|||++++++||||..+.
T Consensus       248 ~------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          248 D------------------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             T------------------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             c------------------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            0                              0000111355678999999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-45  Score=312.05  Aligned_cols=250  Identities=23%  Similarity=0.416  Sum_probs=207.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|+||++.+. ++..||+|++.......         ..+.+|+..+++++||||+++++++.. 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~-   74 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---------EDFIEEAEVMMKLSHPKLVQLYGVCLE-   74 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---------HHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---------HHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence            3468999999999999999999986 57789999997644322         146789999999999999999999844 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ....++|||+++| ++.+.+......+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            4778999999985 666666665677999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ... ........++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......         
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---------  224 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------  224 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred             ccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------
Confidence            321 112233456778999999976 568999999999999999999 89999888777666655433111         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                 ..+..++..+.+|+.+||+.||++||++.+++++
T Consensus       225 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          225 ---------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                       1122368899999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.2e-45  Score=317.31  Aligned_cols=259  Identities=29%  Similarity=0.437  Sum_probs=194.7

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      |...+.+|++.+.||+|+||.||+|.+..+++.||||++...........     ..+.+|+..+++++||||+++++.+
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR-----ADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHH-----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHH-----HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45677899999999999999999999999999999999975433221111     2467899999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      ..+ ...++|||++++ ++.+.+..   ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+||
T Consensus       102 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          102 IED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             EET-TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EcC-CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence            655 789999999987 55554432   3567999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHcCCCCC
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT--EVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~  239 (332)
                      |.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....  .......+.... .   
T Consensus       181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---  255 (310)
T 2wqm_A          181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-Y---  255 (310)
T ss_dssp             ------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-S---
T ss_pred             cceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-C---
Confidence            998776544333445678999999999987 678999999999999999999999997543  222222222110 0   


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     .......++.++.+||.+||+.||.+||++.+++++
T Consensus       256 -------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          256 -------------------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             -------------------------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                           001123378899999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.5e-45  Score=333.12  Aligned_cols=245  Identities=24%  Similarity=0.398  Sum_probs=203.3

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|.+.  ++.||||++.....          ...+.+|+.++++++||||+++++++.+.
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT----------SHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH----------HHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            3568999999999999999999987  77999999965321          22577999999999999999999998777


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....++||||+++ ++.+.+..... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            6689999999986 67776665443 379999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....   .....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...+..+....+.....          
T Consensus       339 ~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  404 (450)
T 1k9a_A          339 ASST---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------  404 (450)
T ss_dssp             CC---------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC----------
T ss_pred             cccc---ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            4322   123356788999999987 679999999999999999998 9999987766555554433211          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                ...+..+++.+.+||.+||+.||++|||+.++++
T Consensus       405 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 --------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                      1122347899999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=326.60  Aligned_cols=252  Identities=21%  Similarity=0.353  Sum_probs=205.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCC-------CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS-------GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNV   81 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   81 (332)
                      .++|.+.+.||+|+||+||+|.+..+       +..||||++........       ...+.+|+.+++++ +||||+++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-------LSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHH-------HHHHHHHHHHHHHhcCCchhhhh
Confidence            36899999999999999999997533       35799999975432111       12467899999999 99999999


Q ss_pred             eeeEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861           82 KEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                      ++++. .....++||||++| ++.+.+....               ..+++..++.++.||+.||+|||+.||+|+||||
T Consensus       141 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          141 LGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEC-SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             eeeec-cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            99984 44778999999986 6666665533               3599999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +||+++.++.+||+|||++.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998654322  22334456788999999987 678999999999999999999 999998887


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ..+....+......                                    ..+..+++++.+||.+||+.||++||++.|
T Consensus       299 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  342 (382)
T 3tt0_A          299 VEELFKLLKEGHRM------------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  342 (382)
T ss_dssp             HHHHHHHHHTTCCC------------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHcCCCC------------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            76665555432111                                    112337899999999999999999999999


Q ss_pred             HhcC
Q 035861          303 ALNH  306 (332)
Q Consensus       303 ll~h  306 (332)
                      ++++
T Consensus       343 ll~~  346 (382)
T 3tt0_A          343 LVED  346 (382)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-45  Score=318.87  Aligned_cols=259  Identities=20%  Similarity=0.275  Sum_probs=195.3

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+..+++|++.+.||+|+||+||+|.+..+++.||+|++..........     ...+.+|+..+++++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~hp~iv~~~~~~  103 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-----RTRMQREARTAGRLQEPHVVPIHDFG  103 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHH-----HHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            4456789999999999999999999999999999999997543322111     12467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .. ....++|+|+++| ++.+.+. ..+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus       104 ~~-~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          104 EI-DGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EE-TTEEEEEEECCCCEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             ee-CCeEEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            55 4789999999987 5555444 4678999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          165 RQYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.... ..........      
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~------  253 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPR------  253 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCC------
T ss_pred             ccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCC------
Confidence            7654321 22334578999999999876 6789999999999999999999999987655422 2222211111      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-CHHHHhcC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDALNH  306 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~h  306 (332)
                                                 .....+.++..+.+||.+||+.||++|| +++++++.
T Consensus       254 ---------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~  290 (309)
T 2h34_A          254 ---------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA  290 (309)
T ss_dssp             ---------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             ---------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHH
Confidence                                       0112234789999999999999999999 78887754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-45  Score=315.13  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=194.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..++|++.+.||+|+||+||+|.+..+   +..||+|++.......  .     ...+.+|+..+++++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--V-----REKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH--H-----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHH--H-----HHHHHHHHHHHHhCCCCccceEEEEE
Confidence            356899999999999999999998653   4569999886432111  1     12467899999999999999999987


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       .+ ...++||||+++ ++.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        86 -~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           86 -TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             -CS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             -cc-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence             43 557899999986 666666665567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          165 RQYGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ........ ......+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+.....       
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-------  235 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred             cccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-------
Confidence            76543221 2233456778999999976 678999999999999999996 9999988777666555543211       


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                   ...++.+++.+.+||.+||+.||++||++.+++++
T Consensus       236 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 -----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                         11223478999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-45  Score=318.19  Aligned_cols=270  Identities=23%  Similarity=0.348  Sum_probs=201.3

Q ss_pred             ccchhcccccccccccCcEEEEEEE----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      ....++|++++.||+|+||+||+|.    +..+++.||||++.......        ...+.+|+.++++++||||++++
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~   77 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--------LRDFEREIEILKSLQHDNIVKYK   77 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH--------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH--------HHHHHHHHHHHHhCCCCCEeeEE
Confidence            3456799999999999999999998    56689999999986432111        11467899999999999999999


Q ss_pred             eeEEcC-CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           83 EVVMDD-HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        83 ~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      +++... ....++||||++| ++.+.+......+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|
T Consensus        78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             EEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence            988443 3558999999975 67777766566799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          161 FGMSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       161 f~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      ||++........   ......++..|+|||.+.+ ..++.++||||||+++|+|++|..|+......  .....   ...
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~---~~~  231 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMI---GND  231 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHH---CTT
T ss_pred             CcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhh---cCc
Confidence            999986543221   2233456778999999987 67899999999999999999999998653221  11110   000


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ...               ...................+..+++++.+||.+||+.||++|||+.|+++
T Consensus       232 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          232 KQG---------------QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CCT---------------HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccc---------------chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000               00000011111122223334558999999999999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=325.09  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=205.8

Q ss_pred             cchhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      ...++|++++.||+|+||.||+|++.     .+++.||||++.......  .     ...+.+|+.++++++||||++++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~-----~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--M-----QADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--H-----HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH--H-----HHHHHHHHHHHHhCCCCCEEEEE
Confidence            34579999999999999999999987     345889999997543211  1     12467899999999999999999


Q ss_pred             eeEEcCCCeEEEEcccccc-cHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 035861           83 EVVMDDHDSVYMVMEYMEH-DLKWLMESMK-----------------------QPFSTSEVKCLMLQLLEGVKYLHDNWV  138 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~l~~~~~~~i~~~l~~~L~~lh~~~i  138 (332)
                      +++. .....++||||++| ++.+.+....                       ..+++..++.++.||+.||+|||++|+
T Consensus       117 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i  195 (343)
T 1luf_A          117 GVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  195 (343)
T ss_dssp             EEEC-SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEc-cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            9984 45778999999986 6666655432                       579999999999999999999999999


Q ss_pred             ccccCCCCCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CC
Q 035861          139 LHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KK  215 (332)
Q Consensus       139 ~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~  215 (332)
                      +|+||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCC
Confidence            999999999999999999999999987653221  22234567889999999886 568999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCC
Q 035861          216 PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPE  295 (332)
Q Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  295 (332)
                      .||...+..+....+......                                    ..+..++..+.+||.+||+.||+
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~~p~  318 (343)
T 1luf_A          275 QPYYGMAHEEVIYYVRDGNIL------------------------------------ACPENCPLELYNLMRLCWSKLPA  318 (343)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             CcCCCCChHHHHHHHhCCCcC------------------------------------CCCCCCCHHHHHHHHHHcccCcc
Confidence            999988777666555432111                                    11223788999999999999999


Q ss_pred             CCCCHHHHhcC
Q 035861          296 KRITVDDALNH  306 (332)
Q Consensus       296 ~Rps~~ell~h  306 (332)
                      +||++.+++++
T Consensus       319 ~Rps~~~~~~~  329 (343)
T 1luf_A          319 DRPSFCSIHRI  329 (343)
T ss_dssp             GSCCHHHHHHH
T ss_pred             cCCCHHHHHHH
Confidence            99999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-45  Score=320.36  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=197.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEE----EEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIV----ALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ..++|++++.||+|+||+||+|++..+++.+    |+|.+.......       ....+.+|+.++++++||||++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~   85 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-------ANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHH-------HHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            4568999999999999999999998777655    666664322111       11256789999999999999999999


Q ss_pred             EEcCCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +..+ . .++|++++. |++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||+
T Consensus        86 ~~~~-~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           86 CLTS-T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EESS-S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EecC-C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence            9554 3 667788877 577777777678899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          164 SRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      +........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.......+.....     
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----  237 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-----  237 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred             eeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-----
Confidence            987643322  2233456778999999987 678999999999999999999 9999988776655444433211     


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ...++.++..+.+|+.+||+.||.+||++.+++++
T Consensus       238 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 -------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -------------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                           11223378899999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-45  Score=316.05  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=207.4

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++.+.||+|++|+||+|.+..++..||+|++.......         ..+.+|+.++++++||||+++++++ .
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~-~   79 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---------EEFLKEAAVMKEIKHPNLVQLLGVC-T   79 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHH---------HHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHH---------HHHHHHHHHHHhCCCCCEeeEEEEE-c
Confidence            34568999999999999999999999999999999996533211         1467899999999999999999998 5


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      +....++|||+++| ++.+.+... ...+++..++.++.||+.||++||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence            55779999999985 666666553 3559999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------  230 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------  230 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------
T ss_pred             eccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------
Confidence            764332 22234456778999999986 578999999999999999999 9999988776655554433211        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  ...+..+++.+.+||.+||+.||.+||++.++++
T Consensus       231 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ----------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                                        1112337899999999999999999999999976

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-45  Score=320.10  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             chhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||||++........       ...+.+|+.++++++||||+++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-------LRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHH-------HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHH-------HHHHHHHHHHHhhCCCCceeeEEE
Confidence            3468999999999999999999873     4558899999975332111       124678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMK-----------------------QPFSTSEVKCLMLQLLEGVKYLHDNWVL  139 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~  139 (332)
                      ++ ......++||||++| ++.+.+....                       ..+++..++.++.||+.||+|||++|++
T Consensus        94 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           94 AC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             EE-CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EE-ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            98 444778999999985 6666555422                       2389999999999999999999999999


Q ss_pred             cccCCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 035861          140 HRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKP  216 (332)
Q Consensus       140 H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~  216 (332)
                      |+||||+||+++.++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999976543222  2234456788999999976 668999999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC
Q 035861          217 LFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK  296 (332)
Q Consensus       217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  296 (332)
                      ||...+.......+.....                                    ...+..+++.+.+||.+||+.||++
T Consensus       252 p~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~  295 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHR------------------------------------MERPDNCSEEMYRLMLQCWKQEPDK  295 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCCCHHHHHHHhhcCCc------------------------------------CCCCccCCHHHHHHHHHHccCChhh
Confidence            9988776655544432211                                    1112337899999999999999999


Q ss_pred             CCCHHHHhcC
Q 035861          297 RITVDDALNH  306 (332)
Q Consensus       297 Rps~~ell~h  306 (332)
                      ||++.+++++
T Consensus       296 Rps~~~l~~~  305 (314)
T 2ivs_A          296 RPVFADISKD  305 (314)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.2e-45  Score=311.70  Aligned_cols=256  Identities=24%  Similarity=0.335  Sum_probs=205.3

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++........... ......+.+|+.++++++||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM-IEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH-HCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH-HHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            445799999999999999999999999999999999976544322111 1112356789999999999999999999843


Q ss_pred             CCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCc-----EEEe
Q 035861           88 DHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGV-----LKIC  159 (332)
Q Consensus        88 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~-----~~l~  159 (332)
                      . .  ++||||++ |++.+.+......+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.     ++|+
T Consensus        95 ~-~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 P-P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             T-T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             C-C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            3 3  69999998 5777777776778999999999999999999999999  999999999999988776     9999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHcCC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG-AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQ--IDKIFKTLGT  236 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~--~~~~~~~~~~  236 (332)
                      |||.+.....   ......|++.|+|||.+.. ...++.++|+||||+++|+|++|..||........  ...+... ..
T Consensus       172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~  247 (287)
T 4f0f_A          172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL  247 (287)
T ss_dssp             CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC
T ss_pred             CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC
Confidence            9999875432   3345678999999999843 34578999999999999999999999987554332  2222111 11


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                        ....+..+++.+.+||.+||+.||.+||+++++++
T Consensus       248 ----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 ----------------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                              11122347899999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=318.11  Aligned_cols=252  Identities=22%  Similarity=0.362  Sum_probs=197.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEE----EEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIV----ALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ..++|++++.||+|+||+||+|.+..+++.+    ++|.+......       .....+.+|+.++++++||||++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~   85 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------KANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-------CCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-------HHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            4568999999999999999999998888766    55554322211       112256789999999999999999999


Q ss_pred             EEcCCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +..+ . .++|++++. |++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus        86 ~~~~-~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           86 CLTS-T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EESS-S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EecC-C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            9554 3 667788877 477777777678899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          164 SRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      +........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....     
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-----  237 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-----  237 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred             eeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            986543222  2233456778999999987 678999999999999999999 9999988776655544433221     


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ...++.++.++.+||.+||+.||.+||++.|+++.
T Consensus       238 -------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          238 -------------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                           11223378899999999999999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.4e-45  Score=326.33  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=194.4

Q ss_pred             chhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ...+|++.+.||+|+||+||+|++.   .++..||||++.......  .     ...+.+|+.++++++||||+++++++
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--Q-----RRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH--H-----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH--H-----HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3458999999999999999999886   467789999997542111  1     12467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      . .....++||||++| ++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++
T Consensus       116 ~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          116 T-KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             C-SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             e-eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            4 44778999999975 666666665567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          165 RQYGSPLKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      .........   .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||......+....+......    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~----  269 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL----  269 (373)
T ss_dssp             -------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC----
T ss_pred             cccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            866432211   122234678999999986 678999999999999999998 99999888776665555432111    


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                      ..+..++..+.+||.+||+.||.+||++.++++
T Consensus       270 --------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 --------------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                            112237889999999999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2e-45  Score=320.99  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|++.+.||+|+||+||+|.+.     .++..||+|++........       ...+.+|+.+++.++||||++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-------RIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-------HHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHH-------HHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            468999999999999999999876     3578899999874322111       1146689999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~  154 (332)
                      + .+....++|||+++| ++.+.+....         ..+++..++.++.||+.||+|||++|++|+||||+||+++.++
T Consensus        97 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           97 V-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             E-CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             E-ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            8 444778999999986 6666554421         4679999999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 035861          155 VLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~  231 (332)
                      .++|+|||++.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            99999999987653221  12233456888999999886 668999999999999999999 899998887766655554


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC-----
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH-----  306 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h-----  306 (332)
                      ....                                    ......++..+.+||.+||+.||.+||++.|++++     
T Consensus       255 ~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          255 EGGL------------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             TTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             cCCc------------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            3211                                    11122378899999999999999999999999997     


Q ss_pred             -CCCCCCCCCCCC
Q 035861          307 -YWFHEVPLPKSK  318 (332)
Q Consensus       307 -p~f~~~~~~~~~  318 (332)
                       ++|..+.+.-..
T Consensus       299 ~~~~~~~~~~~~~  311 (322)
T 1p4o_A          299 EPGFREVSFYYSE  311 (322)
T ss_dssp             CTTHHHHCSTTST
T ss_pred             ccCCccccccccc
Confidence             888776655543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.1e-45  Score=312.39  Aligned_cols=251  Identities=25%  Similarity=0.293  Sum_probs=199.2

Q ss_pred             hhcccccc-cccccCcEEEEEEEE--CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLN-KISEGTYGIVYRARD--KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~-~lg~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|++.+ .||+|+||+||+|.+  ..+++.||||++.........      ...+.+|+.+++.++||||+++++++ 
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL------KDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHH------HHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHH------HHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            45899998 999999999999954  566789999999754322111      12467899999999999999999998 


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .. ...++|||+++|+.+.......+.+++..++.++.||+.||++||++|++|+||||+||+++.++.++|+|||.+..
T Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 EA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             ES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CC-CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            44 56889999998644444444467799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCC---CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          167 YGSPLKP---YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      .......   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.....       
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------  238 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------  238 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred             eccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            6432221   122345688999999976 568899999999999999999 9999998877665554433211       


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                   ...+..+++.+.++|.+||+.||.+||++.++++
T Consensus       239 -----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 -----------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -----------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                         1112337899999999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7e-45  Score=314.12  Aligned_cols=256  Identities=21%  Similarity=0.338  Sum_probs=201.6

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      .....+|++.+.||+|+||+||+|.+..+   ...+|+|.+........       ...+.+|+.++++++||||+++++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~   93 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-------VSQFLTEGIIMKDFSHPNVLSLLG   93 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHH-------HHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHH-------HHHHHHHHHHHHhCCCCCEeeeee
Confidence            33456899999999999999999997543   33588888864322111       124678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      ++.+.+...++|||+++| ++.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        94 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A           94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             EECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             EEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccc
Confidence            976777788999999987 6666666556779999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC----CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 035861          163 MSRQYGSP----LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       163 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      .+......    ........+++.|+|||.+.+ ..++.++|+||||+++|+|++ +.+||...+..+....+...... 
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-  251 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-  251 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-
Confidence            99765322    122334466788999999976 678999999999999999999 66677666655554444332211 


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                         ..+..++..+.++|.+||+.||.+||++.++++.
T Consensus       252 -----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          252 -----------------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             -----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                               1122368899999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-45  Score=321.70  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             hhcccccccccccCcEEEEEEEE-----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|+||+||+|.+     ..++..||||++.......       ....+.+|+.+++++ +||||+++++
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-------EREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-------HHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            46899999999999999999997     3456789999997543211       123567999999999 8999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQ----------------------PFSTSEVKCLMLQLLEGVKYLHDNWVLH  140 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------~l~~~~~~~i~~~l~~~L~~lh~~~i~H  140 (332)
                      ++.. ....++||||++| ++.+.+.....                      .+++..++.++.||+.||+|||++||+|
T Consensus       117 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          117 ACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EECS-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEee-CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9844 4778999999976 66666655332                      3799999999999999999999999999


Q ss_pred             ccCCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 035861          141 RDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPL  217 (332)
Q Consensus       141 ~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~p  217 (332)
                      +||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|+| |..|
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999976533221  2234456788999999876 678999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCC
Q 035861          218 FSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR  297 (332)
Q Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  297 (332)
                      |.................                                   ....+..+++++.+||.+||+.||.+|
T Consensus       275 ~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R  319 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGF-----------------------------------KMDQPFYATEEIYIIMQSCWAFDSRKR  319 (344)
T ss_dssp             STTCCCSHHHHHHHHTTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             cccCCcHHHHHHHHhcCC-----------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence            988765544444433211                                   111123378999999999999999999


Q ss_pred             CCHHHHhcCC
Q 035861          298 ITVDDALNHY  307 (332)
Q Consensus       298 ps~~ell~hp  307 (332)
                      |++.+++++.
T Consensus       320 ps~~~l~~~l  329 (344)
T 1rjb_A          320 PSFPNLTSFL  329 (344)
T ss_dssp             CCHHHHHHHH
T ss_pred             cCHHHHHHHH
Confidence            9999999873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.2e-45  Score=313.14  Aligned_cols=245  Identities=23%  Similarity=0.392  Sum_probs=195.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|++|+||++.+.  ++.||+|++.....          ...+.+|+..+++++||||+++++++.+.
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhH----------HHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            4579999999999999999999886  88999999864321          12567899999999999999999998666


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ....++|||+++| ++.+.+.... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence            6678999999986 6666665432 2389999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+....           
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-----------  231 (278)
T 1byg_A          167 ASST---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------  231 (278)
T ss_dssp             ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------
T ss_pred             cccc---ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            5432   223456788999999976 678999999999999999998 999998776655544432211           


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                               ....+..+++.+.++|.+||+.||++||++.++++
T Consensus       232 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 -------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                                     11122347899999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-44  Score=315.11  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=204.7

Q ss_pred             hhcccccccccccCcEEEEEEEE-----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|+||+||+|.+     ..+++.||+|++........       ...+.+|+..++++ +||||+++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------REALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH-------HHHHHHHHHHHhhcccCCCeeeEEE
Confidence            35899999999999999999985     45678999999975432111       12467899999999 9999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQ-----------------PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                      ++. .....++|||+++| ++.+.+.....                 .+++..++.++.||+.||+|||++|++|+||||
T Consensus        95 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           95 ACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEC-SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEe-cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            984 44778999999986 66666655332                 489999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +||+++.++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999999999999999999987643322  1234456788999999876 678999999999999999999 999998876


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ...............                                   ..+..++..+.+||.+||+.||.+|||+.|
T Consensus       253 ~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          253 VDSKFYKMIKEGFRM-----------------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             SSHHHHHHHHHTCCC-----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             chhHHHHHhccCCCC-----------------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            555444444331111                                   112237889999999999999999999999


Q ss_pred             HhcC
Q 035861          303 ALNH  306 (332)
Q Consensus       303 ll~h  306 (332)
                      ++++
T Consensus       298 ll~~  301 (313)
T 1t46_A          298 IVQL  301 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-44  Score=310.27  Aligned_cols=256  Identities=20%  Similarity=0.305  Sum_probs=193.7

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..-++|++.+.||+|+||+||+|++..   .+|+|++.........      ...+.+|+.++++++||||+.++++. .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ------LQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHH------HHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHH------HHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            344689999999999999999998753   4999999765432221      12467899999999999999999965 3


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      . ...++||||++| ++.+.+......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus        91 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           91 A-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             S-SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             C-CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence            3 567899999985 56666656667899999999999999999999999999999999999999999999999999875


Q ss_pred             cCC--CCCCCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          167 YGS--PLKPYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~--~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ...  .........|++.|+|||.+.  ....++.++|+||||+++|+|++|..||...................+.   
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  246 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD---  246 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC---
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc---
Confidence            432  122334457899999999986  2356889999999999999999999999887666555555443211111   


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  .......+++.+.+||.+||+.||.+||++.++++
T Consensus       247 ----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 ----------------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ----------------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                        01112347899999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=316.58  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=198.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC----cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..+|.+.+.||+|+||+||+|.+..++    ..||||++........       ...+.+|+.++++++||||+++++++
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-------RVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHH-------HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            457889999999999999999986543    3599999875432111       12467899999999999999999998


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                       ......++|||+++| ++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       116 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          116 -SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             -CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             -ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence             555789999999986 666666665678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          165 RQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----  269 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----  269 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----
T ss_pred             hhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC----
Confidence            86543221   1122345778999999986 678999999999999999999 99999888776665555432111    


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                      ..+..++..+.+||.+||+.||++||++.+++++
T Consensus       270 --------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 --------------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             --------------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --------------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                            1122378899999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.3e-45  Score=319.03  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=203.2

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEE--EEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIV--ALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v--~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      ....++|++.+.||+|+||+||+|++..++..+  ++|.+.......       ....+.+|+.+++++ +||||+++++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-------DHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-------HHHHHHHHHHHHHhccCCCchhhhce
Confidence            345679999999999999999999998888765  888886432211       122567899999999 8999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      ++.. ....++|||+++| ++.+.+....               ..+++..++.++.||+.||+|||++|++|+||||+|
T Consensus        94 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N  172 (327)
T 1fvr_A           94 ACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  172 (327)
T ss_dssp             EEEE-TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             eeee-CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence            9954 4789999999976 6666655432               479999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQ  226 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~  226 (332)
                      |+++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+.
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~  250 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  250 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             EEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence            99999999999999998753221 22234456788999999876 568999999999999999998 9999988876665


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ...+....                                    ....+..+++.+.+||.+||+.||.+||++++++++
T Consensus       251 ~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          251 YEKLPQGY------------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHGGGTC------------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcCC------------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            54442221                                    111223478999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.7e-45  Score=322.55  Aligned_cols=268  Identities=18%  Similarity=0.195  Sum_probs=200.0

Q ss_pred             hcccccccccccCcEEEEEEEECCC-----CcEEEEEEeecccCCccc---ccccCCCcchhHHHHHHhhCCCCCeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKS-----GEIVALKKVKMNVGRKED---CLEYGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      ++|++.+.||+|+||+||+|.+..+     ++.||||++.........   ............|+..++.++|+||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999998764     578999998754321100   00011112334566677788999999999


Q ss_pred             eeEEcC---CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc--CCCcEE
Q 035861           83 EVVMDD---HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN--NQGVLK  157 (332)
Q Consensus        83 ~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~--~~~~~~  157 (332)
                      +++...   ....++||||+++++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++  .++.+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k  194 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY  194 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred             eeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence            998553   255899999997788877777668899999999999999999999999999999999999999  889999


Q ss_pred             EeecccccccCCCC-------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 035861          158 ICDFGMSRQYGSPL-------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       158 l~df~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~  230 (332)
                      |+|||++.......       .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||............
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~  273 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD  273 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence            99999997653221       11234459999999999987 66899999999999999999999999863322222211


Q ss_pred             HH-HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          231 FK-TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      .. ....                     .........+      ....++.++.+|+..||+.||.+||++.+|++.
T Consensus       274 ~~~~~~~---------------------~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          274 SKIRYRE---------------------NIASLMDKCF------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHHH---------------------CHHHHHHHHS------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhhh---------------------hHHHHHHHhc------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            11 1000                     0001111111      113378999999999999999999999988753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.4e-45  Score=311.03  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=202.4

Q ss_pred             ccchhcccccccccccCcEEEEEEEECC---CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ....++|.+.+.||+|+||+||+|.+..   ++..||+|++........       ...+.+|+..++.++||||+++++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~   80 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-------KEKFMSEAVIMKNLDHPHIVKLIG   80 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHH-------HHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchH-------HHHHHHHHHHHHhCCCCCcceEEE
Confidence            3456799999999999999999998653   344699999875432111       124678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      ++ .+ ...++|||+++| ++.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        81 ~~-~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           81 II-EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EE-CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EE-cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            87 44 346899999985 6666666666779999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          163 MSRQYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      .+....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......+   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---  234 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---  234 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---
T ss_pred             CCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---
Confidence            987654322 12234456788999999976 678999999999999999998 999998776665555444322111   


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                       .+..+++.+.+||.+||+.||++||++.|++++
T Consensus       235 ---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 ---------------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                             122378899999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-44  Score=309.29  Aligned_cols=252  Identities=20%  Similarity=0.328  Sum_probs=199.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..|++.+.||+|+||+||+|.+..++.   .+|+|++........       ...+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~   93 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-------VEAFLREGLLMRGLNHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH-------HHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH-------HHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            367778999999999999999755444   799999864322111       1246789999999999999999999976


Q ss_pred             CCCeEEEEccccc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYME-HDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .+...++|+|++. |++.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+..
T Consensus        94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            6566689999996 567666666567899999999999999999999999999999999999999999999999999975


Q ss_pred             cCC----CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCCCc
Q 035861          167 YGS----PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL-FSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       167 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ...    .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..| |...+..+....+.....      
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~------  246 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------  246 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC------
T ss_pred             ccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC------
Confidence            432    1223344567889999999987 6789999999999999999995555 555554444443333211      


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                    ...+..++..+.+||.+||+.||.+|||+.++++.
T Consensus       247 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          247 ------------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                          11123378899999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-44  Score=306.43  Aligned_cols=251  Identities=18%  Similarity=0.236  Sum_probs=204.0

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      ....++|++.+.||+|+||+||+|++.  +..||+|++..........      ..+.+|+..+++++||||+++++++.
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKS------RDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHH------HHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHH------HHHHHHHHHHHhcCCCchhheEEEEc
Confidence            346789999999999999999999996  8899999997654322211      24678999999999999999999985


Q ss_pred             cC-CCeEEEEcccccc-cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCcEEEeec
Q 035861           87 DD-HDSVYMVMEYMEH-DLKWLMESMKQ-PFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        87 ~~-~~~~~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      .. ....++||||++| ++.+.+..... .+++..++.++.||+.||+|||++|  ++|+||||+||+++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence            44 2678999999986 66666654333 5899999999999999999999999  999999999999999999999988


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      ++......     ....+++.|+|||.+.+..  .++.++|+||||+++|+|++|..||...+.......+......+  
T Consensus       158 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  230 (271)
T 3kmu_A          158 DVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--  230 (271)
T ss_dssp             GSCCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--
T ss_pred             cceeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--
Confidence            87754322     3456789999999997632  23448999999999999999999999887776655554432111  


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                       ..+..+++.+.+||.+||+.||++|||++++++
T Consensus       231 ---------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ---------------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ---------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                             112337899999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=319.48  Aligned_cols=250  Identities=24%  Similarity=0.422  Sum_probs=185.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEE---
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVM---   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---   86 (332)
                      .+|++.+.||+|+||+||+|++..+++.||||++.......        ...+.+|+..++++. ||||+++++++.   
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK--------NRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHH--------HHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHH--------HHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            38999999999999999999999999999999985442111        114568999999995 999999999984   


Q ss_pred             ----cCCCeEEEEcccccccHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEcCCCcEEE
Q 035861           87 ----DDHDSVYMVMEYMEHDLKWLMES--MKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        87 ----~~~~~~~lv~e~~~~~l~~~~~~--~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~~~~~~~l  158 (332)
                          ......+++||+++|++.+.+..  ..+.+++..++.++.||+.||+|||+.|  ++|+||||+||+++.++.++|
T Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                34456899999999998887754  3567999999999999999999999999  999999999999999999999


Q ss_pred             eecccccccCCCCC------------CCccccccccccchhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 035861          159 CDFGMSRQYGSPLK------------PYTSLVVTLWYRAPELLL--GAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV  224 (332)
Q Consensus       159 ~df~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~--~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~  224 (332)
                      +|||.+........            ......+++.|+|||++.  ....++.++||||||+++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99999986543211            111445889999999984  3367899999999999999999999999754332


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      ......                                       .........+..+.+||.+||+.||.+||++.|++
T Consensus       260 ~~~~~~---------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l  300 (337)
T 3ll6_A          260 RIVNGK---------------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV  300 (337)
T ss_dssp             ---------------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HhhcCc---------------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHH
Confidence            211100                                       01111233678899999999999999999999999


Q ss_pred             cCC
Q 035861          305 NHY  307 (332)
Q Consensus       305 ~hp  307 (332)
                      ++-
T Consensus       301 ~~l  303 (337)
T 3ll6_A          301 HQL  303 (337)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            883

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.9e-45  Score=317.11  Aligned_cols=254  Identities=21%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             hhcccccccccccCcEEEEEEEE-----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||++........       ...+.+|+..++++ .||||+++++
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------HRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHH-------HHHHHHHHHHHHhcccCCCeeeEEE
Confidence            46899999999999999999985     35678999999975432111       11467899999999 7899999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMKQ---------------PFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      ++.......++||||++| ++.+.+.....               .+++..++.++.||+.||+|||+.|++|+||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            986666678999999986 56555554322               28999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~  224 (332)
                      |+++.++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            9999999999999999976543222  1234467888999999976 678999999999999999998 99999876644


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      ............                                   ...+..+++.+.++|.+||+.||.+|||+.+++
T Consensus       258 ~~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  302 (316)
T 2xir_A          258 EEFCRRLKEGTR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  302 (316)
T ss_dssp             HHHHHHHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHhccCcc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            443333332111                                   111223788999999999999999999999999


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      +|
T Consensus       303 ~~  304 (316)
T 2xir_A          303 EH  304 (316)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=309.80  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             hhcccccc-cccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLN-KISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~-~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|.+.+ .||+|+||+||+|.+.  .++..||||++.......  .     ...+.+|+.++++++||||+++++++ 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~-----~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--D-----TEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH--H-----HHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchh--H-----HHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            45788887 9999999999999864  467889999997542111  1     12467899999999999999999998 


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .. ...++|||+++| ++.+.+......+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        80 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           80 QA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             ES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cC-CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence            44 558999999987 5655565556779999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          166 QYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .......   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.....      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~------  231 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------  231 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC------
T ss_pred             eeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc------
Confidence            7643222   1233456788999999976 568999999999999999998 9999988777665555433211      


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY  307 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  307 (332)
                                                    ...++.+++.+.+||.+||+.||++||++.+++++.
T Consensus       232 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          232 ------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ------------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                                          111234789999999999999999999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-44  Score=318.01  Aligned_cols=252  Identities=21%  Similarity=0.362  Sum_probs=202.5

Q ss_pred             hhcccccccccccCcEEEEEEEEC-------CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-------KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNV   81 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   81 (332)
                      .++|++.+.||+|+||+||+|.+.       .++..||||++........       ...+.+|+.+++++ +||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-------LSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHH-------HHHHHHHHHHHHHhhcCCCEeeE
Confidence            368999999999999999999975       3567899999975432111       12467899999999 89999999


Q ss_pred             eeeEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861           82 KEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                      ++++ ......++||||++| ++.+.+....               ..+++..++.++.||+.||+|||++|++|+||||
T Consensus       107 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          107 LGAC-TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEE-CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEE-ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            9998 444788999999986 6666555432               2489999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +||+++.++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            999999999999999999986543221  2233456788999999876 568999999999999999999 999998887


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ..+....+......                                    ..+..++..+.+||.+||+.||.+||++.+
T Consensus       265 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  308 (334)
T 2pvf_A          265 VEELFKLLKEGHRM------------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQ  308 (334)
T ss_dssp             HHHHHHHHHHTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHhcCCCC------------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            76665555443211                                    112237889999999999999999999999


Q ss_pred             HhcC
Q 035861          303 ALNH  306 (332)
Q Consensus       303 ll~h  306 (332)
                      ++++
T Consensus       309 ll~~  312 (334)
T 2pvf_A          309 LVED  312 (334)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.8e-45  Score=317.97  Aligned_cols=267  Identities=21%  Similarity=0.300  Sum_probs=204.7

Q ss_pred             hhcccccccccccCcEEEEEEE----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .++|++++.||+|+||+||++.    +..+++.||||++........        ..+.+|+.++++++|+||+++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--------RDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHH--------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHH--------HHHHHHHHHHHhcCCCceeEEEEEE
Confidence            4699999999999999999999    467889999999865421111        1467899999999999999999988


Q ss_pred             Ec-CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           86 MD-DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        86 ~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .. +....++||||++| ++.+.+......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence            64 45678999999965 66666666566799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          164 SRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      +........   ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........  ..   ..  
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~---~~--  245 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GC---ER--  245 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C--------
T ss_pred             ceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--cc---cc--
Confidence            987643322   2234467888999999876 5689999999999999999999999975432211000  00   00  


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                    ....................++.+++.+.+||.+||+.||.+|||+.+++++
T Consensus       246 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          246 --------------DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ---------------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          0000000011111122233345589999999999999999999999999655

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=320.19  Aligned_cols=255  Identities=16%  Similarity=0.173  Sum_probs=200.3

Q ss_pred             hcccccccccccCcEEEEEEEECCC--------CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee--
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKS--------GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN--   80 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--   80 (332)
                      ++|++.+.||+|+||+||+|.+..+        ++.||+|++...             ..+.+|+.++++++||||+.  
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~~~  108 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVNKW  108 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHHHH
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhhhh
Confidence            6999999999999999999999873        889999998743             14668999999999999887  


Q ss_pred             -------------eeeeEEcCCCeEEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCC
Q 035861           81 -------------VKEVVMDDHDSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTS  146 (332)
Q Consensus        81 -------------~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~  146 (332)
                                   +++++.......++||||++++|.+.+... ...+++..++.++.||+.||+|||++||+|+||||+
T Consensus       109 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             HHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             hhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                         566665556889999999977777777654 377999999999999999999999999999999999


Q ss_pred             CEEEcCCC--cEEEeecccccccCCCC-------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 035861          147 NLLLNNQG--VLKICDFGMSRQYGSPL-------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL  217 (332)
Q Consensus       147 Nili~~~~--~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p  217 (332)
                      ||+++.++  .++|+|||++.......       .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999998  99999999997653221       12234578999999999987 6789999999999999999999999


Q ss_pred             CCCCC-hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC
Q 035861          218 FSGTT-EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK  296 (332)
Q Consensus       218 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  296 (332)
                      |.... ...............+.....                           ....+..++.++.+||.+||+.||++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~  320 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVG---------------------------PCGHWIRPSETLQKYLKVVMALTYEE  320 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEEC---------------------------TTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhh---------------------------hccccCCCcHHHHHHHHHHHhCChhh
Confidence            98753 222222222211111111000                           00011236899999999999999999


Q ss_pred             CCCHHHHhcC
Q 035861          297 RITVDDALNH  306 (332)
Q Consensus       297 Rps~~ell~h  306 (332)
                      ||+++++++.
T Consensus       321 Rps~~~l~~~  330 (352)
T 2jii_A          321 KPPYAMLRNN  330 (352)
T ss_dssp             CCCHHHHHHH
T ss_pred             CCCHHHHHHH
Confidence            9999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-44  Score=314.57  Aligned_cols=255  Identities=19%  Similarity=0.287  Sum_probs=195.6

Q ss_pred             chhcccccccccccCcEEEEEEEECC---CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..++|.+.+.||+|+||+||+|....   ++..||+|++..........      ..+.+|+..+++++||||+++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI------EEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHH------HHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHH------HHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34689999999999999999998764   45689999997654322211      2467899999999999999999998


Q ss_pred             EcCCC----eEEEEcccccc-cHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc
Q 035861           86 MDDHD----SVYMVMEYMEH-DLKWLMES-----MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV  155 (332)
Q Consensus        86 ~~~~~----~~~lv~e~~~~-~l~~~~~~-----~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~  155 (332)
                      .....    ..++|||++++ ++.+.+..     ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            65432    46999999986 55555532     2456999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 035861          156 LKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFK  232 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~  232 (332)
                      ++|+|||.+.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence            9999999987653321  12234456788999999987 678999999999999999999 8999988777666555543


Q ss_pred             HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          233 TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ....                                    ..+..+++.+.+||.+||+.||.+||++.+++++
T Consensus       265 ~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 GHRL------------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCC------------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCC------------------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2111                                    1123378899999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.4e-45  Score=334.20  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      ..+|++.+.||+|+||.||+|.+..++..||||++......         ...+.+|+.++++++||||+++++++. ..
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  288 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLGVCT-RE  288 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---------hHHHHHHHHHHHhcCCCCEeeEEEEEe-cC
Confidence            45899999999999999999999988999999999754321         125679999999999999999999984 44


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||+++ ++.+.+... ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            778999999984 677766653 356899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||++.. ..++.++||||||+++|+|++ |..||...+..+....+....           
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  436 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------  436 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            4321 12233445778999999986 568999999999999999999 999998877665554443221           


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                               ....+..+++.+.+||.+||+.||++||++.+|++.
T Consensus       437 -------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          437 -------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                                     111223478999999999999999999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.8e-45  Score=318.76  Aligned_cols=258  Identities=20%  Similarity=0.335  Sum_probs=202.4

Q ss_pred             chhcccccccccccCcEEEEEEE-----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      ..++|++++.||+|+||+||+|+     ...++..||||++........       ...+.+|+.++++++||||+++++
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~  100 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-------ELDFLMEALIISKFNHQNIVRCIG  100 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH-------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh-------HHHHHHHHHHHhhCCCCCCCeEEE
Confidence            45699999999999999999999     456788999999964321111       114678999999999999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC---
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESMK------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ---  153 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~---  153 (332)
                      ++.. ....++||||++| ++.+.+....      ..+++..++.++.||+.||+|||++|++|+||||+||+++.+   
T Consensus       101 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          101 VSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             EECS-SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             EEcC-CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence            9854 4678999999965 6666665533      348999999999999999999999999999999999999944   


Q ss_pred             CcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 035861          154 GVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~  230 (332)
                      ..++|+|||.+.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            469999999987543221  22234567889999999876 678999999999999999998 99999888776665555


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                      ......                                    .....++..+.+||.+||+.||.+||++.+++++.|+.
T Consensus       259 ~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGGRM------------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCC------------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            432111                                    11233788999999999999999999999999998865


Q ss_pred             C
Q 035861          311 E  311 (332)
Q Consensus       311 ~  311 (332)
                      .
T Consensus       303 ~  303 (327)
T 2yfx_A          303 T  303 (327)
T ss_dssp             H
T ss_pred             h
Confidence            4

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.8e-45  Score=320.04  Aligned_cols=264  Identities=20%  Similarity=0.261  Sum_probs=192.8

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|++.  ++.||||++.......         .....|+..+++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS---------WQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHH---------HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHH---------HHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            3468999999999999999999987  7899999996542111         1234688889999999999999998654


Q ss_pred             C---CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccccCCCCCEEEcCCC
Q 035861           89 H---DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN----------WVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        89 ~---~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~----------~i~H~di~p~Nili~~~~  154 (332)
                      .   ...++||||+++ ++.+.+..  ..+++..++.++.|++.||+|||+.          ||+|+||||+||+++.++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            2   347999999987 55555543  4599999999999999999999999          999999999999999999


Q ss_pred             cEEEeecccccccCCCCC--CCccccccccccchhhhcCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 035861          155 VLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGA----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQID  228 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~  228 (332)
                      .+||+|||++........  ......|++.|+|||++.+.    ..++.++||||||+++|+|++|..||..........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999976543222  23345789999999999763    245668899999999999999999997643211000


Q ss_pred             HHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCcc-C-----CCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASF-T-----GSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ........+.                    .............. .     .....+.++.+||.+||+.||++|||+.|
T Consensus       249 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          249 FEEEIGQHPS--------------------LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             THHHHCSSCC--------------------HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhhhccCCc--------------------hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            0000000000                    00000000000000 0     00112345899999999999999999999


Q ss_pred             Hhc
Q 035861          303 ALN  305 (332)
Q Consensus       303 ll~  305 (332)
                      +++
T Consensus       309 ll~  311 (322)
T 3soc_A          309 VGE  311 (322)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-44  Score=310.24  Aligned_cols=268  Identities=23%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             chhcccccccccccCcEEEEEEE----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .-..|++++.||+|+||.||+|.    +..+++.||+|++........       ...+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~   91 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-------IADLKKEIEILRNLYHENIVKYKGI   91 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-------HHHHHHHHHHHHhCCCCCeeeeeeE
Confidence            34579999999999999999999    567899999999975432211       1246789999999999999999999


Q ss_pred             EEcCC-CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           85 VMDDH-DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +.... ...++||||++| ++.+.+......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||
T Consensus        92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            86542 568999999986 6777766667789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          163 MSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       163 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      .+........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.....  .....   ......
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~---~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMA--LFLKM---IGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HHHHH---HCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhh--HHhhc---cCCccc
Confidence            9987654322   2334567888999999977 5688999999999999999999998643211  11111   000000


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      .                ..................++.+++.+.+||.+||+.||.+|||+.++++
T Consensus       246 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 Q----------------MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             G----------------GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             c----------------cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0                0000001111112223334558999999999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=329.80  Aligned_cols=282  Identities=22%  Similarity=0.327  Sum_probs=207.6

Q ss_pred             ccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            5 QGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         5 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .+...-++|++.+.||+|+||+||+|.+..+++.||||++........       ...+.+|+.++++++||||++++++
T Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~   75 (396)
T 4eut_A            3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAI   75 (396)
T ss_dssp             EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCCCeEEEe
Confidence            345566799999999999999999999999999999999975432211       1245689999999999999999999


Q ss_pred             EEcCC-CeEEEEcccccc-cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE----cCCCcE
Q 035861           85 VMDDH-DSVYMVMEYMEH-DLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL----NNQGVL  156 (332)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili----~~~~~~  156 (332)
                      +.... ...++||||++| ++.+.+....  ..+++..++.++.||+.||+|||++||+|+||||+||++    +.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence            86543 368999999986 5555544322  239999999999999999999999999999999999999    777789


Q ss_pred             EEeecccccccCCCCCCCccccccccccchhhhcCC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHH
Q 035861          157 KICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA-------KKYSTAVDMWSVGCIMAELLAKKPLFSGTT----EVD  225 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~sDi~slG~~l~~lltg~~pf~~~~----~~~  225 (332)
                      ||+|||.+...... .......|++.|+|||++...       ..++.++|+||||+++|+|++|..||....    ..+
T Consensus       156 kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~  234 (396)
T 4eut_A          156 KLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (396)
T ss_dssp             EECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred             EEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence            99999999876432 233456789999999998641       356789999999999999999999997532    233


Q ss_pred             HHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ...++...   .+...+..+.........+...        . .........++..+.+||.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~---~p~~~~~~~~~~~~~~~~~~~~--------~-~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          235 VMYKIITG---KPSGAISGVQKAENGPIDWSGD--------M-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHHS---CCTTCCEEEECSTTCCEEEESS--------C-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHHHhcC---CCcccchhheeccCCCcccCcc--------C-CcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            33333332   2222222222211111111100        0 0011112335667889999999999999999999855


Q ss_pred             C
Q 035861          306 H  306 (332)
Q Consensus       306 h  306 (332)
                      +
T Consensus       303 ~  303 (396)
T 4eut_A          303 E  303 (396)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-44  Score=308.09  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|+||+||+|.+. ++..||+|++.......         ..+.+|+.+++.++||||+++++++. + 
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~~-~-   79 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---------DAFLAEANLMKQLQHQRLVRLYAVVT-Q-   79 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---------HHHHHHHHHHHHCCCTTBCCEEEEEC-S-
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccH---------HHHHHHHHHHHhCCCcCcceEEEEEc-C-
Confidence            368999999999999999999976 46789999987543221         24678999999999999999999884 3 


Q ss_pred             CeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++|||+++| ++.+.+.... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            457899999976 5555443322 26999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+......         
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------  229 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---------  229 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             cCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---------
Confidence            4322 12233456778999999976 568999999999999999999 99999888777665555432111         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                 ..+..++..+.+||.+||+.||++|||+.++++
T Consensus       230 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 ---------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                       112237899999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4e-44  Score=327.10  Aligned_cols=264  Identities=19%  Similarity=0.197  Sum_probs=210.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.......          .+..|+.+++.+.|++.+..+..+...
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----------~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----------QLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----------CHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----------HHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            4569999999999999999999999999999999876543322          467899999999886655555555566


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEE---cCCCcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili---~~~~~~~l~df~~~~  165 (332)
                      ....++||||+++++.+.+......+++..++.++.||+.||+|||++||+|+||||+||||   +.++.+||+|||++.
T Consensus        75 ~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            68899999999888888888777889999999999999999999999999999999999999   688999999999998


Q ss_pred             ccCCCCC-------CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcC
Q 035861          166 QYGSPLK-------PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTLG  235 (332)
Q Consensus       166 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~~~  235 (332)
                      .......       ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.....   ...+..+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            7643322       1235678999999999987 6789999999999999999999999987543   222332222110


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc----------
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN----------  305 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~----------  305 (332)
                      ..                                ........++.++.+||.+||+.||++||++.+|++          
T Consensus       234 ~~--------------------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          234 AT--------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HS--------------------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cc--------------------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            00                                000001236889999999999999999999988765          


Q ss_pred             CCCCCCCCCC
Q 035861          306 HYWFHEVPLP  315 (332)
Q Consensus       306 hp~f~~~~~~  315 (332)
                      ++|+..+.|.
T Consensus       282 ~~~~~~~dW~  291 (483)
T 3sv0_A          282 FQFDYVFDWT  291 (483)
T ss_dssp             CCCSSCCHHH
T ss_pred             CCccCCcCch
Confidence            5666555543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-44  Score=328.37  Aligned_cols=253  Identities=22%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||+|+||+||+|.+.. +..||||++......         ...+.+|+.++++++||||+++++++ .. 
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~-~~-  254 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS---------VEAFLAEANVMKTLQHDKLVKLHAVV-TK-  254 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC---------HHHHHHHHHHHTTCCCTTBCCEEEEE-CS-
T ss_pred             hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc---------HHHHHHHHHHHhhCCCCCEeeEEEEE-eC-
Confidence            4589999999999999999999864 678999999754321         12577999999999999999999988 43 


Q ss_pred             CeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||+.+ ++.+.+.... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            568899999985 6666665332 36899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||++.. ..++.++||||||+++|+|++ |..||...+..+....+......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------  405 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------  405 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred             CCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3211 11233446778999999976 678999999999999999999 999999888777766665432111        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC--CCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH--YWFHE  311 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--p~f~~  311 (332)
                                                  .+..+++++.+||.+||+.||++|||+++|++.  .++..
T Consensus       406 ----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          406 ----------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                                        122378999999999999999999999999763  44443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-45  Score=322.65  Aligned_cols=253  Identities=21%  Similarity=0.339  Sum_probs=193.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC---cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG---EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      -..|++.+.||+|+||+||+|.+..++   ..||+|.+........       ...+.+|+.++++++||||+++++++.
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~  160 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-------VSQFLTEGIIMKDFSHPNVLSLLGICL  160 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-------HHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-------HHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            346888999999999999999975432   4688888864322111       124678999999999999999999986


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      +.+...++||||++| ++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.
T Consensus       161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          161 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             cCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccc
Confidence            666788999999986 6666666556678999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC----CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          166 QYGSPL----KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       166 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ......    .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.....     
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-----  314 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-----  314 (373)
T ss_dssp             -----------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-----
T ss_pred             cccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-----
Confidence            653221    11233456788999999986 678999999999999999999 6778876655544444332211     


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                     ...+..++..+.++|.+||+.||++||++.+++++
T Consensus       315 -------------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 -------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                           11123378899999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=318.30  Aligned_cols=266  Identities=18%  Similarity=0.178  Sum_probs=196.2

Q ss_pred             hcccccccccccCcEEEEEEEECC---CCcEEEEEEeecccCCccc---ccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKK---SGEIVALKKVKMNVGRKED---CLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ++|++.+.||+|+||+||+|.+..   ++..+|+|++.........   .........+.+|+..++.++||||+.++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            589999999999999999999987   7889999999765321100   0011112245678888999999999999999


Q ss_pred             EEcC---CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC--cEEEe
Q 035861           85 VMDD---HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG--VLKIC  159 (332)
Q Consensus        85 ~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~--~~~l~  159 (332)
                      +...   ....++|||++++++.+.+.. .+.+++..++.++.||+.||+|||++||+|+||||+||+++.++  .++|+
T Consensus       117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECEEEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            8652   578999999996666665544 45899999999999999999999999999999999999999887  99999


Q ss_pred             ecccccccCCC-------CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH
Q 035861          160 DFGMSRQYGSP-------LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGT-TEVDQIDKIF  231 (332)
Q Consensus       160 df~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~-~~~~~~~~~~  231 (332)
                      |||++......       ........|+..|+|||++.+ ..++.++||||||+++|+|++|..||... ..........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            99999765321       111245578999999999987 67899999999999999999999999652 2222222221


Q ss_pred             H-HcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          232 K-TLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       232 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      . .....+..                      .....      ....++.++.+||.+||+.||++||++++|++.
T Consensus       275 ~~~~~~~~~~----------------------~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          275 TNLLDELPQS----------------------VLKWA------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHTTTHH----------------------HHHHS------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HhhcccccHH----------------------HHhhc------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            1 11111100                      00000      111378999999999999999999999998875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-45  Score=319.81  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++.+.||+|+||+||+|.+. +++.||||++.......        ...+.+|+..++.++||||+++++++ .
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~-~  105 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQG--------IEEFETEIETLSFCRHPHLVSLIGFC-D  105 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSH--------HHHHHHHHHGGGSCCCTTBCCEEEEC-C
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHH--------HHHHHHHHHHHHhCCCCCEeeEEEEE-c
Confidence            35579999999999999999999964 68899999886543211        12467899999999999999999998 4


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMK---QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .....++||||++| ++.+.+....   ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            45778999999986 4444443322   3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHH--HcCC
Q 035861          164 SRQYGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK---IFK--TLGT  236 (332)
Q Consensus       164 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~---~~~--~~~~  236 (332)
                      +......  ........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....   ...  ....
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             ccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            8764322  122334568999999999876 5689999999999999999999999976432211000   000  0000


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      .....                         .+.......+.++..+.+++.+||+.||++|||+.|++++
T Consensus       265 ~~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          265 LEQIV-------------------------DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CCSSS-------------------------SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhc-------------------------ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00000                         0011111122356778899999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.6e-45  Score=328.78  Aligned_cols=258  Identities=26%  Similarity=0.358  Sum_probs=190.0

Q ss_pred             chhc-ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeEE
Q 035861            9 SVFE-FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVVM   86 (332)
Q Consensus         9 ~~~~-y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   86 (332)
                      .+.+ |.+.+.||+|+||+||.+. ..+|+.||||++.....           ..+.+|+.+++++ +||||+++++.+ 
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~~~~~~-   78 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC-----------DIALMEIKLLTESDDHPNVIRYYCSE-   78 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGH-----------HHHHHHHHHHHHHTTSTTBCCEEEEE-
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEEE-
Confidence            3444 4456889999999998653 45699999999865321           1345899999876 899999999988 


Q ss_pred             cCCCeEEEEcccccccHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-------
Q 035861           87 DDHDSVYMVMEYMEHDLKWLMESMKQP------FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-------  153 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~~l~~~~~~~~~~------l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-------  153 (332)
                      .+....|+|||+++|++.+.+......      .++..++.++.||+.||+|||++||+|+||||+||+++.+       
T Consensus        79 ~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           79 TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             ECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             ecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence            445889999999999888877653221      1334567899999999999999999999999999999754       


Q ss_pred             ------CcEEEeecccccccCCCCC----CCccccccccccchhhhcC------CCCCCchhHHHHHHHHHHHHHh-CCC
Q 035861          154 ------GVLKICDFGMSRQYGSPLK----PYTSLVVTLWYRAPELLLG------AKKYSTAVDMWSVGCIMAELLA-KKP  216 (332)
Q Consensus       154 ------~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~~llt-g~~  216 (332)
                            +.++|+|||++........    ......||+.|+|||++.+      ...++.++||||||+++|+|++ |..
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  4899999999987644322    1234578999999999865      2568999999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCC
Q 035861          217 LFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK  296 (332)
Q Consensus       217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  296 (332)
                      ||.......  ..+..........                              .......+++++.+||.+||+.||.+
T Consensus       239 Pf~~~~~~~--~~i~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~  286 (434)
T 2rio_A          239 PFGDKYSRE--SNIIRGIFSLDEM------------------------------KCLHDRSLIAEATDLISQMIDHDPLK  286 (434)
T ss_dssp             TTCSTTTHH--HHHHHTCCCCCCC------------------------------TTCCCHHHHHHHHHHHHHHTCSSGGG
T ss_pred             CCCCchhhH--HHHhcCCCCcccc------------------------------cccccccchHHHHHHHHHHhhCChhh
Confidence            997654432  2222221111000                              00001125678999999999999999


Q ss_pred             CCCHHHHhcCCCCCC
Q 035861          297 RITVDDALNHYWFHE  311 (332)
Q Consensus       297 Rps~~ell~hp~f~~  311 (332)
                      ||++.++++||||..
T Consensus       287 Rps~~eil~hp~f~~  301 (434)
T 2rio_A          287 RPTAMKVLRHPLFWP  301 (434)
T ss_dssp             SCCHHHHHTSGGGSC
T ss_pred             CCCHHHHHhCCccCC
Confidence            999999999999964

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.3e-44  Score=306.93  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=205.1

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .....+|++++.||+|+||.||+|.+..+++.||+|++....            ..+.+|+..+++++||||+++++++.
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWD   74 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence            345579999999999999999999999999999999997532            13568999999999999999999874


Q ss_pred             c---------------CCCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           87 D---------------DHDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        87 ~---------------~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      .               .....++||||+++ ++.+.+... ...+++..++.++.||+.||+|||++|++|+||+|+||+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil  154 (284)
T 2a19_B           75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF  154 (284)
T ss_dssp             EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence            3               13458999999997 666666543 367999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDK  229 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~  229 (332)
                      ++.++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|+....  .....
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~  230 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTD  230 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHH
T ss_pred             EcCCCCEEECcchhheecccc-ccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHH
Confidence            999999999999998876433 22344568999999999987 678999999999999999999998874321  11111


Q ss_pred             HHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          230 IFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                      +...                                       .....++..+.+||.+||+.||.+||++.|++++.+.
T Consensus       231 ~~~~---------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          231 LRDG---------------------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             HHTT---------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhcc---------------------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1110                                       0112378899999999999999999999999999776


Q ss_pred             CC
Q 035861          310 HE  311 (332)
Q Consensus       310 ~~  311 (332)
                      -.
T Consensus       272 ~~  273 (284)
T 2a19_B          272 WK  273 (284)
T ss_dssp             HT
T ss_pred             Hh
Confidence            55

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=309.17  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=193.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||++++.  ++.||||++.....          ...+.+|+..+++++||||+++++.+. +
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~hp~iv~~~~~~~-~   72 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESE----------RKAFIVELRQLSRVNHPNIVKLYGACL-N   72 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTH----------HHHHHHHHHHHHHCCCTTBCCEEEBCT-T
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhH----------HHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            4569999999999999999999986  78899999853211          124678999999999999999999873 2


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCCCCEEEcCCCc-EEEeec
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHD---NWVLHRDLKTSNLLLNNQGV-LKICDF  161 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~---~~i~H~di~p~Nili~~~~~-~~l~df  161 (332)
                        ..++||||++| ++.+.+....  ..+++..++.++.|++.||+|||+   +|++|+||||+||+++.++. +||+||
T Consensus        73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence              36899999986 5555554432  247899999999999999999999   89999999999999998886 799999


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHcCCCCC
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVD--QIDKIFKTLGTPTE  239 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~  239 (332)
                      |.+......   .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......  ........  .   
T Consensus       151 g~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~---  221 (307)
T 2eva_A          151 GTACDIQTH---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--T---  221 (307)
T ss_dssp             CC---------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--C---
T ss_pred             ccccccccc---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--C---
Confidence            998765322   234468999999999987 678999999999999999999999997643322  11111111  0   


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC-----CCCCCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH-----YWFHEVPL  314 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h-----p~f~~~~~  314 (332)
                                                     .......++..+.+||.+||+.||++|||+++++++     .++.....
T Consensus       222 -------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          222 -------------------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             -------------------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             -------------------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence                                           011123378899999999999999999999999984     56655444


Q ss_pred             CCC
Q 035861          315 PKS  317 (332)
Q Consensus       315 ~~~  317 (332)
                      +..
T Consensus       271 ~~~  273 (307)
T 2eva_A          271 PLQ  273 (307)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.3e-44  Score=314.77  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=203.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCc-----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGE-----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|+||+||+|.+..++.     .||+|++........       ...+.+|+.+++.+ +||||+++++
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-------KEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHH-------HHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4589999999999999999999976654     799999875432111       12467899999999 8999999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM-------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      ++ ......++||||+++ ++.+.+...             ...+++..++.++.||+.||+|||+.|++|+||||+||+
T Consensus       118 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          118 AC-THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EE-CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EE-ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            98 444778999999986 666655442             346899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQ  226 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~  226 (332)
                      ++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            99999999999999976532221  2234456788999999886 678999999999999999998 9999987765555


Q ss_pred             HHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ...........                                   ..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       276 ~~~~~~~~~~~-----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          276 FYKLVKDGYQM-----------------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC-----------------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            54444432111                                   1122368899999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.7e-44  Score=309.31  Aligned_cols=256  Identities=25%  Similarity=0.347  Sum_probs=196.4

Q ss_pred             cchhcccccccccccCcEEEEEEEECC-CCc--EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKK-SGE--IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ...++|++++.||+|+||+||+|.+.. ++.  .||||++..........     ...+.+|+..+++++||||++++++
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~   89 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA-----MDDFIREVNAMHSLDHRNLIRLYGV   89 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHH-----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHH-----HHHHHHHHHHHHhCCCCCcccEEEE
Confidence            345689999999999999999998643 333  68999987543322111     1256789999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +..+  ..++|+|++++ ++.+.+......+++..++.++.||+.||++||++|++|+||||+||+++.++.++|+|||.
T Consensus        90 ~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           90 VLTP--PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             ECSS--SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             EccC--CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence            8544  37899999984 77777776667899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          164 SRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      +........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.......  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--  244 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--  244 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--
Confidence            887643322   1223456778999999976 568899999999999999999 999999888776665554321111  


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                       .....++..+.++|.+||+.||++||++.+++++
T Consensus       245 ---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          245 ---------------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             ---------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                             1123378999999999999999999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.7e-44  Score=325.89  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||+|+||+||+|.+.. +..||||++.......         ..+.+|+.++++++||||+++++++. + 
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hp~iv~~~~~~~-~-  250 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP---------EAFLQEAQVMKKLRHEKLVQLYAVVS-E-  250 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCH---------HHHHHHHHHHHHCCCTTBCCEEEEEC-S-
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCH---------HHHHHHHHHHHhCCCCCEeeEEEEEc-C-
Confidence            4579999999999999999999975 4669999997543221         24679999999999999999999984 4 


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||+++ ++.+.+... ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++...
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            567899999986 666666542 356999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+.....          
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  399 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  399 (452)
T ss_dssp             ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             CCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            3321 22233456788999999986 678999999999999999999 9999998877766665543311          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC--CCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH--YWFHEV  312 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--p~f~~~  312 (332)
                                                ...++.+++.+.+||.+||+.||++|||+++|++.  .++...
T Consensus       400 --------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          400 --------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                                      11123478999999999999999999999999874  666553

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.8e-46  Score=345.88  Aligned_cols=296  Identities=25%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +...++|++.+.||+|+||+||+|.+..+++.||||++........       ...+.+|+.++++++||||+++++++.
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~-------~~~~~~Ei~iL~~L~HpnIV~l~~v~~   82 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN-------RERWCLEIQIMKKLNHPNVVSAREVPD   82 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHH-------HHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHH-------HHHHHHHHHHHHhCCCCCCCceeeeec
Confidence            4456899999999999999999999999999999999865321111       124678999999999999999999873


Q ss_pred             c-----CCCeEEEEcccccc-cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCc---
Q 035861           87 D-----DHDSVYMVMEYMEH-DLKWLMESMK--QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGV---  155 (332)
Q Consensus        87 ~-----~~~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~---  155 (332)
                      .     .....++||||++| ++.+.+....  ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.   
T Consensus        83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCE
T ss_pred             ccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCcee
Confidence            3     24678999999976 5555554422  26999999999999999999999999999999999999997764   


Q ss_pred             EEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          156 LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      ++|+|||.+...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.................
T Consensus       163 vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~  240 (676)
T 3qa8_A          163 HKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS  240 (676)
T ss_dssp             EEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---
T ss_pred             EEEcccccccccccc-cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhccc
Confidence            999999999876433 23345678999999999876 6789999999999999999999999977544322111000000


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      ..........   ...          ..............+.++..+.+||.+||.+||++|||+.++++||||+.+...
T Consensus       241 ~~~~~~~~~l---~g~----------~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          241 NEHIVVYDDL---TGA----------VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             ---CCSCCCC---SSS----------CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             chhhhhhhhh---ccc----------cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence            0000000000   000          000000011112233467889999999999999999999999999999987644


Q ss_pred             CCCCCCCCC
Q 035861          316 KSKDFMPTF  324 (332)
Q Consensus       316 ~~~~~~~~~  324 (332)
                      -.......|
T Consensus       308 L~~kil~~f  316 (676)
T 3qa8_A          308 LSLKLLSVM  316 (676)
T ss_dssp             HCCCEEECC
T ss_pred             Hhccccccc
Confidence            333333333

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-44  Score=314.66  Aligned_cols=269  Identities=20%  Similarity=0.254  Sum_probs=198.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|... +++.||||++........       ...+.+|+.+++.++||||+++++++.. 
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   98 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNLLRLRGFCMT-   98 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C-------CCHHHHHHHGGGTCCCTTBCCCCEEECC-
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH-------HHHHHHHHHHHHhccCCCccceEEEEec-
Confidence            4568999999999999999999854 688999999975432221       1246789999999999999999999944 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCCCEEEcCCCcEEEeec
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMK---QPFSTSEVKCLMLQLLEGVKYLHDN---WVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~i~~~l~~~L~~lh~~---~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      ....++||||++| ++.+.+....   ..+++..++.++.|++.||+|||+.   |++|+||||+||+++.++.++|+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            4778899999987 5555554432   3499999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHcCC
Q 035861          162 GMSRQYGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT----EVDQIDKIFKTLGT  236 (332)
Q Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~----~~~~~~~~~~~~~~  236 (332)
                      |++........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....    ............. 
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  256 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL-  256 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT-
T ss_pred             ccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh-
Confidence            99987643222 2334458999999999976 568999999999999999999999995211    0000111111000 


Q ss_pred             CCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          237 PTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                       .......+.                    .........+..+..+.+|+.+||+.||.+|||+.|+++|-.-
T Consensus       257 -~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          257 -KEKKLEALV--------------------DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             -SSCCSTTSS--------------------CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             -hchhhhhhc--------------------ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence             000000000                    0000011112245678999999999999999999999998543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=313.27  Aligned_cols=252  Identities=22%  Similarity=0.378  Sum_probs=195.9

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc---
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD---   87 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (332)
                      ++|++++.||+|+||+||++.+..+++.||||++.......        ...+.+|+.+++.++||||+++++++..   
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--------REEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHH--------HHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHH--------HHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            58999999999999999999999999999999986532111        1246689999999999999999999853   


Q ss_pred             CCCeEEEEcccccc-cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .....++|+||+++ ++.+.+..   ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            33578999999997 66555544   357799999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCC---------CccccccccccchhhhcCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Q 035861          164 SRQYGSPLKP---------YTSLVVTLWYRAPELLLGAK--KYSTAVDMWSVGCIMAELLAKKPLFSGTTEV--DQIDKI  230 (332)
Q Consensus       164 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~~l~~lltg~~pf~~~~~~--~~~~~~  230 (332)
                      +.........         .....|++.|+|||.+....  .++.++||||||+++|+|++|..||......  .....+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            8754211110         11234688999999987532  3688999999999999999999999531100  000111


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ..                                    .......+.++..+.+||.+||+.||.+||++.+++++
T Consensus       261 ~~------------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          261 QN------------------------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HC------------------------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hc------------------------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            00                                    11111223478999999999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.5e-44  Score=308.87  Aligned_cols=254  Identities=23%  Similarity=0.311  Sum_probs=190.7

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhh--CCCCCeeeeeeeE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS--FDHPSIVNVKEVV   85 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~   85 (332)
                      ...++|++++.||+|+||+||+|++.  ++.||||++.....           .....|.+++..  ++||||+++++.+
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----------~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE-----------KSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGGGH-----------HHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccccc-----------hhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            45679999999999999999999984  88999999864321           123456666665  7999999999986


Q ss_pred             Ec---CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCCCEEEcCC
Q 035861           86 MD---DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH--------DNWVLHRDLKTSNLLLNNQ  153 (332)
Q Consensus        86 ~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh--------~~~i~H~di~p~Nili~~~  153 (332)
                      ..   .....++||||+++ ++.+.+ . ...+++..++.++.|++.||+|||        +.|++|+||||+||+++.+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l-~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYL-Q-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHH-T-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             ccccCCCceeEEehhhccCCCHHHHH-h-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence            44   23568999999987 555554 3 467999999999999999999999        9999999999999999999


Q ss_pred             CcEEEeecccccccCCCCCC----CccccccccccchhhhcCCC-----CCCchhHHHHHHHHHHHHHhC----------
Q 035861          154 GVLKICDFGMSRQYGSPLKP----YTSLVVTLWYRAPELLLGAK-----KYSTAVDMWSVGCIMAELLAK----------  214 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~~l~~lltg----------  214 (332)
                      +.+||+|||++.........    .....||+.|+|||.+.+..     .++.++||||||+++|+|++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            99999999998765332221    23347899999999998643     344799999999999999999          


Q ss_pred             CCCCCCCC----hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhc
Q 035861          215 KPLFSGTT----EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLL  290 (332)
Q Consensus       215 ~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  290 (332)
                      ..||....    ...............+..                           +.  ......++..+.+||.+||
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~--~~~~~~~~~~l~~li~~cl  280 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNI---------------------------PN--RWFSDPTLTSLAKLMKECW  280 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCC---------------------------CG--GGGGSHHHHHHHHHHHHHC
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCC---------------------------Ch--hhccCccHHHHHHHHHHHh
Confidence            77775432    112222221111100000                           00  0001114567899999999


Q ss_pred             CCCCCCCCCHHHHhc
Q 035861          291 TYDPEKRITVDDALN  305 (332)
Q Consensus       291 ~~dp~~Rps~~ell~  305 (332)
                      +.||++|||+.++++
T Consensus       281 ~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          281 YQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             hcChhhCCCHHHHHH
Confidence            999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.7e-44  Score=307.43  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=189.6

Q ss_pred             ccccchhccccc-ccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHH-hhCCCCCeeeee
Q 035861            5 QGCRSVFEFEKL-NKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL-LSFDHPSIVNVK   82 (332)
Q Consensus         5 ~~~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~   82 (332)
                      .....+++|.++ +.||+|+||+||++.+..+++.||+|++....             ...+|+..+ +.++||||++++
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~e~~~~~~~~~h~~i~~~~   77 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------------KARREVELHWRASQCPHIVRIV   77 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-------------HHHHHHHHHHHHTTSTTBCCEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-------------HHHHHHHHHHHhccCCCchhHH
Confidence            345677899998 77999999999999999999999999986321             345788887 666999999999


Q ss_pred             eeEEc---CCCeEEEEcccccc-cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CC
Q 035861           83 EVVMD---DHDSVYMVMEYMEH-DLKWLMESMK-QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QG  154 (332)
Q Consensus        83 ~~~~~---~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~  154 (332)
                      +++..   +....++||||++| ++.+.+.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.   ++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  157 (299)
T 3m2w_A           78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA  157 (299)
T ss_dssp             EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred             hhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC
Confidence            98854   34678999999986 6766666543 46999999999999999999999999999999999999998   78


Q ss_pred             cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          155 VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      .++|+|||++.....                       ..++.++|+||||+++|+|++|..||..............  
T Consensus       158 ~~kl~Dfg~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--  212 (299)
T 3m2w_A          158 ILKLTDFGFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--  212 (299)
T ss_dssp             CEEECCCTTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--
T ss_pred             cEEEecccccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--
Confidence            999999998865421                       3467899999999999999999999976543321100000  


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                           .    +..                  ............+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       213 -----~----~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 -----R----IRM------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             -----S----SCT------------------TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             -----H----Hhh------------------ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                 0    000                  000000001134789999999999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-43  Score=307.04  Aligned_cols=263  Identities=23%  Similarity=0.338  Sum_probs=196.4

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeE
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSV   92 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (332)
                      |...+.||+|+||+||+|.+.  ++.||||++..........    ....+.+|+.++++++||||+++++++. +....
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE----LKQQFDQEIKVMAKCQHENLVELLGFSS-DGDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTT----HHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSC
T ss_pred             cccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHH----HHHHHHHHHHHHHhcCCCCeEEEEEEEe-cCCce
Confidence            445589999999999999874  8899999987543221111    1125678999999999999999999984 44778


Q ss_pred             EEEcccccc-cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           93 YMVMEYMEH-DLKWLMESM--KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        93 ~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ++|||+++| ++.+.+...  ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            999999975 665655432  35699999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          170 PLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...  ......|++.|+|||.+.+  .++.++|+||||+++|+|++|..||...........+..........       
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  256 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT-------  256 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-------
T ss_pred             ccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-------
Confidence            221  1234568999999999875  47899999999999999999999998654332222222111000000       


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                     ...............++..+.+++.+||+.||.+||++.+++++
T Consensus       257 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          257 ---------------IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             ---------------HHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------hhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                           00011111111222356778899999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-43  Score=332.30  Aligned_cols=244  Identities=26%  Similarity=0.316  Sum_probs=195.4

Q ss_pred             ccccccCcEEEEEEEE--CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           17 NKISEGTYGIVYRARD--KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      +.||+|+||+||+|.+  ..+++.||||++.........      ...+.+|+.++++++||||+++++++ ++ ...++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~-~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL------KDELLAEANVMQQLDNPYIVRMIGIC-EA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGG------HHHHHHHHHHHHHCCCTTBCCEEEEE-ES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHH------HHHHHHHHHHHHhCCCCCEeeEEEEE-ec-CCEEE
Confidence            4799999999999955  456789999999754322211      12577999999999999999999988 44 45789


Q ss_pred             EcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC--
Q 035861           95 VMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--  172 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--  172 (332)
                      ||||++|+.+..+......+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........  
T Consensus       447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999998654444444577899999999999999999999999999999999999999999999999999987643221  


Q ss_pred             -CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          173 -PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||...+..+....+......              
T Consensus       527 ~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------------  591 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------------  591 (635)
T ss_dssp             --------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred             ccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence             2233456788999999976 678999999999999999998 99999988877766655443211              


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                            ..+..++.++.+||.+||+.||++||++++|++
T Consensus       592 ----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 ----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                  112337899999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=305.13  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=199.1

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|.+..   .+++|++.........      ...+.+|+..+++++|+||+++++++...
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQ------LKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCC------CCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHH------HHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            35689999999999999999999864   4999998765332211      22456899999999999999999999555


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ...++|||+++| ++.+.+......+++..++.++.||+.||+|||++|++|+||+|+||+++ ++.++|+|||++...
T Consensus       102 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          102 -PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             -SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             -CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence             779999999986 55555554445799999999999999999999999999999999999998 689999999987654


Q ss_pred             CC-----CCCCCccccccccccchhhhcC--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          168 GS-----PLKPYTSLVVTLWYRAPELLLG--------AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       168 ~~-----~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      ..     .........|+..|+|||.+..        ...++.++||||||+++|+|++|..||...........+....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  259 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM  259 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence            21     1122334568899999999874        2457899999999999999999999999887776655554321


Q ss_pred             CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ....                                   ....++.++.+||.+||+.||++||++.++++.
T Consensus       260 ~~~~-----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          260 KPNL-----------------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCC-----------------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCC-----------------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            1110                                   112378899999999999999999999999974

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.2e-44  Score=309.90  Aligned_cols=266  Identities=23%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             hhcc-cccccccccCcEEEEEEEE----CCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEF-EKLNKISEGTYGIVYRARD----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y-~~~~~lg~g~~g~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++| ++++.||+|+||+||++.+    ..+++.||||++........       ...+.+|+.++++++||||++++++
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~  101 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-------RSGWKQEIDILRTLYHEHIIKYKGC  101 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHH-------HHHHHHHHHHHHhCCCcchhhEEEE
Confidence            3456 9999999999999988764    34788999999975432111       1246789999999999999999999


Q ss_pred             EEcC-CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           85 VMDD-HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        85 ~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +... ....++||||++++.+..... ...+++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||.
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EecCCCceEEEEEecccCCcHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence            9654 467899999998744444443 34599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          164 SRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      +........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........  ...   ..... 
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~---~~~~~-  253 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELI---GIAQG-  253 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHH---CSCCH-
T ss_pred             cccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhh---ccccc-
Confidence            987644322   2234457888999999986 5688999999999999999999999975422110  000   00000 


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                     ...................+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       254 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          254 ---------------QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ---------------HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                           00000000000111222234458899999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.8e-45  Score=327.71  Aligned_cols=253  Identities=15%  Similarity=0.159  Sum_probs=193.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC-CCee----------
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PSIV----------   79 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~----------   79 (332)
                      .+|...+.||+|+||+||+|.+..+++.||||++.........     ....+.+|+..++.+.| .+..          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~  152 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-----AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  152 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHH-----HHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence            4688999999999999999999999999999998743332221     12356789999998876 2111          


Q ss_pred             e-----------eeeeEEcC----CCeEEEEcccccccHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 035861           80 N-----------VKEVVMDD----HDSVYMVMEYMEHDLKWLMES------MKQPFSTSEVKCLMLQLLEGVKYLHDNWV  138 (332)
Q Consensus        80 ~-----------~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~------~~~~l~~~~~~~i~~~l~~~L~~lh~~~i  138 (332)
                      .           +.......    ...++++|+.+.+++.+.+..      ....+++..+..++.||+.||+|||++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  232 (413)
T 3dzo_A          153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  232 (413)
T ss_dssp             CCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             chhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            1           11111111    234788999999988777742      24457888999999999999999999999


Q ss_pred             ccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhc---------CCCCCCchhHHHHHHHHHH
Q 035861          139 LHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL---------GAKKYSTAVDMWSVGCIMA  209 (332)
Q Consensus       139 ~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~sDi~slG~~l~  209 (332)
                      +||||||+|||++.++.+||+|||++...+..   .....| +.|+|||++.         ....++.++||||||+++|
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            99999999999999999999999998765432   344566 8999999983         3356888999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHh
Q 035861          210 ELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRL  289 (332)
Q Consensus       210 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (332)
                      +|++|..||...+.......                                         .....+.+++.+.+||.+|
T Consensus       309 elltg~~Pf~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~  347 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEW-----------------------------------------IFRSCKNIPQPVRALLEGF  347 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGG-----------------------------------------GGSSCCCCCHHHHHHHHHH
T ss_pred             HHHHCCCCCCCcchhhhHHH-----------------------------------------HHhhcccCCHHHHHHHHHH
Confidence            99999999976542211000                                         0111224789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          290 LTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       290 l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      |+.||++||++.++++||||+++.
T Consensus       348 l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          348 LRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             TCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccCChhhCcCHHHHHhCHHHHHHH
Confidence            999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=307.83  Aligned_cols=268  Identities=23%  Similarity=0.356  Sum_probs=201.1

Q ss_pred             chhcccccccccccCcEEEEEEE----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRAR----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      ...+|++++.||+|+||+||++.    ...+++.||||++.......        ...+.+|+.++++++||||++++++
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~  110 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--------LRDFEREIEILKSLQHDNIVKYKGV  110 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH--------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH--------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            44579999999999999999998    45689999999987532111        1246789999999999999999998


Q ss_pred             EEcCC-CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           85 VMDDH-DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +.... ...++|||+++| ++.+.+......+++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||
T Consensus       111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence            85442 468999999986 7777776656779999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          163 MSRQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       163 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      .+........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  ..+.   .+....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~~---~~~~~~  264 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRM---IGNDKQ  264 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHHH---HCTTCC
T ss_pred             chhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHHh---hccccc
Confidence            9987643322   1233456778999999876 56899999999999999999999998643211  1110   000000


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                      ..               ..................+..++.++.+||.+||+.||++||++.++++
T Consensus       265 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          265 GQ---------------MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TH---------------HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hh---------------hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00               0000000000111122234458899999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=327.39  Aligned_cols=254  Identities=22%  Similarity=0.371  Sum_probs=207.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||+|+||+||+|.+.. +..||||++.......         ..+.+|+.++++++|+||+++++++ .+ 
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~~~~-~~-  333 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP---------EAFLQEAQVMKKLRHEKLVQLYAVV-SE-  333 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCH---------HHHHHHHHHHHHCCCTTBCCEEEEE-CS-
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCH---------HHHHHHHHHHHhCCCCCEeeEEEEE-ee-
Confidence            4579999999999999999999975 4679999997543221         2467999999999999999999988 43 


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||+++ +|.+.+... ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            568899999986 666666542 356999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+.....          
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  482 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  482 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             CCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            3211 11223446778999999886 678999999999999999999 9999998877766665543311          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC--CCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH--YWFHEV  312 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--p~f~~~  312 (332)
                                                ...+..++..+.+||.+||+.||++||++++|++.  .+|...
T Consensus       483 --------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 --------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                                      11123478899999999999999999999999875  666553

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=329.00  Aligned_cols=248  Identities=25%  Similarity=0.330  Sum_probs=196.8

Q ss_pred             cccccc-cccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861           12 EFEKLN-KISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus        12 ~y~~~~-~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ++.+.+ .||+|+||+||+|.+.  .++..||||++.......       ....+.+|+.++++++||||+++++++.. 
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~E~~il~~l~hpniv~l~~~~~~-  407 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-------DTEEMMREAQIMHQLDNPYIVRLIGVCQA-  407 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST-------THHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH-------HHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence            344445 7999999999999875  356679999997542211       11256799999999999999999999844 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ...++||||++| ++.+.+......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             458999999986 565666555677999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          168 GSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .....   ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||...+..+....+.....        
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--------  557 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------  557 (613)
T ss_dssp             C--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            43221   1223345678999999976 678999999999999999998 9999998877776665543311        


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                  ...++.+++++.+||.+||+.||++||++.+|++
T Consensus       558 ----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                        1122347899999999999999999999999854

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=309.95  Aligned_cols=281  Identities=24%  Similarity=0.318  Sum_probs=189.3

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHH--HhhCCCCCeeeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI--LLSFDHPSIVNVKEV   84 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~   84 (332)
                      ...+++|++++.||+|+||+||+|+..  ++.||||++......           .+..|.++  +..++|+||+++++.
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-----------~~~~e~~~~~~~~~~h~~i~~~~~~   75 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQ-----------NFINEKNIYRVPLMEHDNIARFIVG   75 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGGHH-----------HHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             CcChHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccchh-----------hHHHHHHHHHHHhccCcchhhheec
Confidence            345789999999999999999999874  889999999754211           12234444  455899999999875


Q ss_pred             EE----cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCCCEEE
Q 035861           85 VM----DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN---------WVLHRDLKTSNLLL  150 (332)
Q Consensus        85 ~~----~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~---------~i~H~di~p~Nili  150 (332)
                      +.    .+...+++||||++| ++.+.+..  ...++..++.++.||+.||+|||+.         ||+|+||||+||++
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           76 DERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             EEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             ccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence            42    233467899999976 56555543  3458999999999999999999999         99999999999999


Q ss_pred             cCCCcEEEeecccccccCCCC--------CCCccccccccccchhhhcCC------CCCCchhHHHHHHHHHHHHHhCCC
Q 035861          151 NNQGVLKICDFGMSRQYGSPL--------KPYTSLVVTLWYRAPELLLGA------KKYSTAVDMWSVGCIMAELLAKKP  216 (332)
Q Consensus       151 ~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~------~~~~~~sDi~slG~~l~~lltg~~  216 (332)
                      +.++.+||+|||++.......        .......||+.|+|||++.+.      ..++.++||||||+++|+|++|..
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            999999999999997654221        122345689999999998752      245678999999999999999987


Q ss_pred             CCCCCChHHHH-HHHHHHcCCCCCCcccCCCCCccccccccCCchhhh-hhhCCC--CccCCCCCCCchHHHHHHHhcCC
Q 035861          217 LFSGTTEVDQI-DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLL-RKRFPA--ASFTGSPVLSESGFDLLNRLLTY  292 (332)
Q Consensus       217 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  292 (332)
                      ||......... ..........+.               ......... ....+.  ........+++.+.+||.+||+.
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  298 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPT---------------FEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ  298 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCC---------------HHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred             cCCCccchhHHHHhhhcccCCCch---------------HHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence            76442211000 000000000000               000000000 000000  00111122455799999999999


Q ss_pred             CCCCCCCHHHH------hcCCCCCCCCCCCC
Q 035861          293 DPEKRITVDDA------LNHYWFHEVPLPKS  317 (332)
Q Consensus       293 dp~~Rps~~el------l~hp~f~~~~~~~~  317 (332)
                      ||++|||+.|+      +.++|-++-..++.
T Consensus       299 dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~~  329 (336)
T 3g2f_A          299 DAEARLTAQXAEERMAELMMIWERNKSVSPT  329 (336)
T ss_dssp             SGGGSCCHHHHHHHHHHHHHCCCC-------
T ss_pred             ChhhCcchHHHHHHHHHHHHHHHhcccCCCc
Confidence            99999999999      55788888665554

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=305.73  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=188.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC--CCCCeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF--DHPSIVNVKE   83 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~   83 (332)
                      +....++|++++.||+|+||+||+|++.  ++.||||++......           ....|.+++..+  +||||+++++
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----------~~~~e~~~~~~~~~~h~~i~~~~~   98 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA-----------SWFRETEIYQTVLMRHENILGFIA   98 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHH-----------HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccc-----------hhhhHHHHHHHHhhcCCCeeeEEE
Confidence            4445679999999999999999999986  889999998643211           223455555444  8999999999


Q ss_pred             eEEcCC---CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCCEEEc
Q 035861           84 VVMDDH---DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN--------WVLHRDLKTSNLLLN  151 (332)
Q Consensus        84 ~~~~~~---~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~--------~i~H~di~p~Nili~  151 (332)
                      .+....   ...++||||++| ++.+.+..  ..+++..++.++.|++.||+|||+.        |++|+||||+||+++
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A           99 ADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             EEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             EEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence            986553   578999999987 66555543  4799999999999999999999998        999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCC----CccccccccccchhhhcCCCCCCc------hhHHHHHHHHHHHHHhC-------
Q 035861          152 NQGVLKICDFGMSRQYGSPLKP----YTSLVVTLWYRAPELLLGAKKYST------AVDMWSVGCIMAELLAK-------  214 (332)
Q Consensus       152 ~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~------~sDi~slG~~l~~lltg-------  214 (332)
                      .++.+||+|||++.........    .....|++.|+|||.+.+. ..+.      ++||||||+++|+|++|       
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            9999999999999765332221    2245789999999999763 3333      49999999999999999       


Q ss_pred             ---CCCCCCCC----hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHH
Q 035861          215 ---KPLFSGTT----EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLN  287 (332)
Q Consensus       215 ---~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  287 (332)
                         ..||....    ...............+..                           +  .......+++.+.+||.
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~--~~~~~~~~~~~l~~li~  306 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF---------------------------P--NRWSSDECLRQMGKLMT  306 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC---------------------------C--GGGGGSHHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCchhhhHHHHhhhccCccc---------------------------c--ccchhhHHHHHHHHHHH
Confidence               55554321    111111111110000000                           0  00001125677899999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q 035861          288 RLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       288 ~~l~~dp~~Rps~~ell~h  306 (332)
                      +||+.||++|||+.+++++
T Consensus       307 ~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          307 ECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHSCSSGGGSCCHHHHHHH
T ss_pred             HhhhhChhhCCCHHHHHHH
Confidence            9999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.2e-42  Score=325.33  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|++.+.||+|+||+||+|.+..+   +..||+|++.......  .     ...+.+|+.++++++||||+++++++ 
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~E~~~l~~l~HpnIv~l~~~~-  460 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--V-----REKFLQEALTMRQFDHPHIVKLIGVI-  460 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHH--H-----HHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHH--H-----HHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence            45799999999999999999998643   4578999876432111  1     12567899999999999999999988 


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+ ...++||||++| ++.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.
T Consensus       461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            43 457899999985 6666666555679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+......+      
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~------  612 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------  612 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC------
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            6543221 2223456788999999976 678999999999999999997 999999888777766665432111      


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                    .++.+++.+.+||.+||+.||++||++.++++.
T Consensus       613 ------------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          613 ------------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             ------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                          123378999999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.6e-42  Score=301.15  Aligned_cols=255  Identities=21%  Similarity=0.264  Sum_probs=193.7

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhh--CCCCCeeeeeeeE
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS--FDHPSIVNVKEVV   85 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~   85 (332)
                      ...++|++.+.||+|+||+||+|++.  ++.||||++.....           ..+..|++++..  ++||||+++++.+
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-----------~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-----------RSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGGH-----------HHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchhH-----------HHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            34578999999999999999999985  88999999864321           134578888877  7999999999999


Q ss_pred             EcCC---CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCCCEEEcCC
Q 035861           86 MDDH---DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH--------DNWVLHRDLKTSNLLLNNQ  153 (332)
Q Consensus        86 ~~~~---~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh--------~~~i~H~di~p~Nili~~~  153 (332)
                      ....   ...++||||+++ ++.+.+..  ..+++..++.++.|++.||+|||        +.|++|+||||+||+++.+
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence            6654   278999999997 66665543  46999999999999999999999        8999999999999999999


Q ss_pred             CcEEEeecccccccCCCCC----CCccccccccccchhhhcCCCC-----CCchhHHHHHHHHHHHHHhC----------
Q 035861          154 GVLKICDFGMSRQYGSPLK----PYTSLVVTLWYRAPELLLGAKK-----YSTAVDMWSVGCIMAELLAK----------  214 (332)
Q Consensus       154 ~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-----~~~~sDi~slG~~l~~lltg----------  214 (332)
                      +.++|+|||.+........    ......|++.|+|||.+.+...     ++.++||||||+++|+|++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            9999999999976644322    2344578999999999976322     23689999999999999999          


Q ss_pred             CCCCCCCCh----HHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhc
Q 035861          215 KPLFSGTTE----VDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLL  290 (332)
Q Consensus       215 ~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  290 (332)
                      ..||.....    ..............+     .+.                      .  ......++..+.+||.+||
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~----------------------~--~~~~~~~~~~l~~li~~cl  314 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLRP-----NIP----------------------N--RWQSCEALRVMAKIMRECW  314 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCC-----CCC----------------------G--GGGTSHHHHHHHHHHHHHC
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhCC-----CCc----------------------c--cccchhHHHHHHHHHHHHh
Confidence            677765321    112221111100000     000                      0  0001124467889999999


Q ss_pred             CCCCCCCCCHHHHhcC
Q 035861          291 TYDPEKRITVDDALNH  306 (332)
Q Consensus       291 ~~dp~~Rps~~ell~h  306 (332)
                      +.||++||++.++++|
T Consensus       315 ~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          315 YANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             ccChhhCCCHHHHHHH
Confidence            9999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=307.82  Aligned_cols=241  Identities=16%  Similarity=0.157  Sum_probs=187.7

Q ss_pred             hcccccccccccCcEEEEEEE-----ECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---CCCeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRAR-----DKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---HPSIVNVK   82 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~   82 (332)
                      ++|.+.+.||+|+||+||+|.     ...+++.||||++.....           ..+..|+..++.+.   |+||+.++
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-----------WEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH-----------HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh-----------hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            579999999999999999994     667899999999864321           13457778887776   89999999


Q ss_pred             eeEEcCCCeEEEEcccccc-cHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-----
Q 035861           83 EVVMDDHDSVYMVMEYMEH-DLKWLMES----MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-----  152 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-----  152 (332)
                      +.+..+ ...++||||++| ++.+.+..    ....+++..++.++.||+.||+|||++||+||||||+|||++.     
T Consensus       134 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          134 SAHLFQ-NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEECS-SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred             eeeecC-CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence            999555 778999999985 56665543    3567999999999999999999999999999999999999998     


Q ss_pred             ------CCcEEEeecccccccC--CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 035861          153 ------QGVLKICDFGMSRQYG--SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEV  224 (332)
Q Consensus       153 ------~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~  224 (332)
                            ++.+||+|||++....  ..........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                  8999999999996542  22233455679999999999987 56899999999999999999999999643211


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      ..              .                     ....+.      ....++.+.+++..||+.+|.+|++..+.|
T Consensus       292 ~~--------------~---------------------~~~~~~------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          292 EC--------------K---------------------PEGLFR------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             EE--------------E---------------------ECSCCT------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             ce--------------e---------------------echhcc------ccCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            00              0                     000000      001466788999999999999997654444


Q ss_pred             c
Q 035861          305 N  305 (332)
Q Consensus       305 ~  305 (332)
                      .
T Consensus       331 ~  331 (365)
T 3e7e_A          331 R  331 (365)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.9e-43  Score=308.33  Aligned_cols=256  Identities=18%  Similarity=0.202  Sum_probs=190.6

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---------CCCee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---------HPSIV   79 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---------h~~i~   79 (332)
                      ..++|++++.||+|+||+||+|++  +++.||||++..................+.+|+.+++.++         |+||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999998  5899999999876432111111111235678888888875         77777


Q ss_pred             eeeeeEEc-----------------------------CCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 035861           80 NVKEVVMD-----------------------------DHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEG  129 (332)
Q Consensus        80 ~~~~~~~~-----------------------------~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~  129 (332)
                      .+.+.++.                             +....|+||||++++ +++.+.  .+.+++..++.++.||+.|
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence            77666431                             257899999999764 555553  3678999999999999999


Q ss_pred             HHHHH-HCCcccccCCCCCEEEcCCC--------------------cEEEeecccccccCCCCCCCccccccccccchhh
Q 035861          130 VKYLH-DNWVLHRDLKTSNLLLNNQG--------------------VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL  188 (332)
Q Consensus       130 L~~lh-~~~i~H~di~p~Nili~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (332)
                      |+||| ++||+||||||+|||++.++                    .+||+|||+++....     ....||+.|+|||+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~  248 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhh
Confidence            99999 99999999999999999987                    999999999987643     24578999999999


Q ss_pred             hcCCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhh
Q 035861          189 LLGAKKYSTAVDMWSVGCI-MAELLAKKPLFSGTTEVD-QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKR  266 (332)
Q Consensus       189 ~~~~~~~~~~sDi~slG~~-l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (332)
                      +.+. . +.++|||||+.+ .+++++|..||....... ....+...........                         
T Consensus       249 ~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------  301 (336)
T 2vuw_A          249 FTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCN-------------------------  301 (336)
T ss_dssp             GCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCC-------------------------
T ss_pred             hcCC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccc-------------------------
Confidence            9863 3 899999998766 778889999985422111 1222221111110000                         


Q ss_pred             CCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh-cCCCCC
Q 035861          267 FPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL-NHYWFH  310 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell-~hp~f~  310 (332)
                           ....+.+++++++||++||+.|     |++|+| +||||+
T Consensus       302 -----~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          302 -----TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             -----SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             -----hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence                 0001126888999999999976     999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-41  Score=289.92  Aligned_cols=237  Identities=15%  Similarity=0.042  Sum_probs=180.8

Q ss_pred             ccccc-cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeee
Q 035861            3 MLQGC-RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNV   81 (332)
Q Consensus         3 ~~~~~-~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   81 (332)
                      +..|. ...++|++.+.||+|+||+||+|.+..+++.||||++..........     ...+.+|+..+++++||||+++
T Consensus        22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~hp~iv~~   96 (286)
T 3uqc_A           22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDV-----LQETLSRTLRLSRIDKPGVARV   96 (286)
T ss_dssp             CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHH-----HHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHH-----HHHHHHHHHHHhcCCCCCccee
Confidence            34455 34468999999999999999999999999999999997654332111     1246789999999999999999


Q ss_pred             eeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeec
Q 035861           82 KEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDF  161 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df  161 (332)
                      ++++..+ ...|+||||++|+.+..+.. .+ ..+.++..++.||+.||+|||++||+|+||||+||+++.+|.++|+++
T Consensus        97 ~~~~~~~-~~~~lv~e~~~g~~L~~~l~-~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A           97 LDVVHTR-AGGLVVAEWIRGGSLQEVAD-TS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             EEEEEET-TEEEEEEECCCEEEHHHHHT-TC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             eEEEEEC-CcEEEEEEecCCCCHHHHHh-cC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec
Confidence            9999554 78999999998654444443 23 466778999999999999999999999999999999999999999743


Q ss_pred             ccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          162 GMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      +                    |++        .++.++||||||+++|+|++|..||...+......           ..
T Consensus       174 ~--------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~  214 (286)
T 3uqc_A          174 A--------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PA  214 (286)
T ss_dssp             C--------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------EC
T ss_pred             c--------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HH
Confidence            3                    222        36899999999999999999999998754321000           00


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      ...+          ..         .+.......+.+++++.+||.+||+.||++| |+.|+++.
T Consensus       215 ~~~~----------~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          215 ERDT----------AG---------QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             CBCT----------TS---------CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHh----------cc---------CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            0000          00         0000111224488999999999999999999 99999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.3e-42  Score=326.33  Aligned_cols=247  Identities=27%  Similarity=0.340  Sum_probs=195.3

Q ss_pred             cccchhcccccccccccCcEEEEEEEECC-CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKK-SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      |....++|++++.||+|+||+||++.+.. +++.||||++.......  .     ...+.+|+.++++++||||++++++
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~--~-----~~~~~~E~~~l~~l~hp~iv~~~~~  147 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE--A-----QAMAMAERQFLAEVVHPSIVQIFNF  147 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHH--H-----HHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHH--H-----HHHHHHHHHHHHhcCCCCcCeEeee
Confidence            33445799999999999999999999976 78999999886432111  1     1145689999999999999999999


Q ss_pred             EEcCCC----eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEee
Q 035861           85 VMDDHD----SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICD  160 (332)
Q Consensus        85 ~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~d  160 (332)
                      +.....    ..|+||||++|+.+.....  ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ .+||+|
T Consensus       148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             EEEECTTSCEEEEEEEECCCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred             EeecCCCCCceeEEEEEeCCCCcHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence            865433    2799999999755444433  379999999999999999999999999999999999999985 999999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ||++......    ....||+.|+|||++.+.  ++.++||||||+++|+|++|..||......                
T Consensus       225 FG~a~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------  282 (681)
T 2pzi_A          225 LGAVSRINSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------  282 (681)
T ss_dssp             CTTCEETTCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------
T ss_pred             cccchhcccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------------
Confidence            9999876432    456789999999998762  489999999999999999998887642100                


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                         .+..           .             .....+++.+.+||.+||+.||.+||+..+.+.|+|+..
T Consensus       283 ---~~~~-----------~-------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 ---GLPE-----------D-------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ---SCCT-----------T-------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---cccc-----------c-------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence               0000           0             000014678889999999999999999999999988754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.1e-34  Score=266.88  Aligned_cols=193  Identities=17%  Similarity=0.043  Sum_probs=132.8

Q ss_pred             cccccCcEEEEEEEECCCCcEEEEEEeecccCCccccc--ccCCCcchhHHHHHHhhC-CCCCeeeeeeeEEcCCCeEEE
Q 035861           18 KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCL--EYGFPISSLREINILLSF-DHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        18 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      ..+.|+.|.+..++....|+.+++|++...........  .......+.+|+++|+++ .|+||+++++++ +++...||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-ed~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-ENAQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-ECSSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EECCEEEE
Confidence            35677777777777777899999999986543221111  111113577899999999 799999999999 55589999


Q ss_pred             EcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC
Q 035861           95 VMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY  174 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~  174 (332)
                      ||||++|+.+..+....+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++.........
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999986666666667888765   478999999999999999999999999999999999999999998776555556


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCC
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKP  216 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~  216 (332)
                      ...+||+.|+|||++.+  .+..++|+||+|++++++.++..
T Consensus       397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             cCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence            67789999999999875  46788999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=7.8e-28  Score=222.70  Aligned_cols=190  Identities=21%  Similarity=0.174  Sum_probs=137.1

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      ..+.||+|+||+||++...  +..+++|....................+.+|+.++++++||||+.+..+.... ...|+
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~l  416 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-DNKRI  416 (540)
T ss_dssp             --------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-TTTEE
T ss_pred             CCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-CccEE
Confidence            4568999999999999554  78899998765433222211111122467999999999999999555555433 44689


Q ss_pred             Ecccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCC
Q 035861           95 VMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKP  173 (332)
Q Consensus        95 v~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~  173 (332)
                      ||||++| ++.+.+..         +..++.|++.||+|||++||+|+||||+||+++.  .+||+|||+++........
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999985 55444332         6689999999999999999999999999999999  9999999999876432111


Q ss_pred             -------CccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 035861          174 -------YTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLF  218 (332)
Q Consensus       174 -------~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf  218 (332)
                             .....||+.|+|||++... ..|+..+|+||..+-..+-..++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   1356789999999998641 23677789999998888877776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4e-24  Score=182.06  Aligned_cols=150  Identities=19%  Similarity=0.146  Sum_probs=111.1

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccC----------CCcchhHHHHHHhhCCCCCeeeeee
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYG----------FPISSLREINILLSFDHPSIVNVKE   83 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~   83 (332)
                      .+.+.||+|++|.||+|.+ .+|+.||||++..............          ....+.+|+.+++++.  | +++.+
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3449999999999999999 7899999999975432211110000          0124679999999998  4 56666


Q ss_pred             eEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           84 VVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      .+ +. ...|+||||++|+.+..+       .......++.|++.||.+||++||+|+||||+||+++ ++.++|+|||+
T Consensus       169 ~~-~~-~~~~lvmE~~~g~~L~~l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          169 VY-AW-EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EE-EE-ETTEEEEECCCCEEGGGC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             EE-ec-cceEEEEEecCCCcHHHc-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            55 33 345899999987433322       2234567999999999999999999999999999999 99999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLL  190 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (332)
                      +....             .+.|||.+.
T Consensus       239 a~~~~-------------~~~a~e~l~  252 (282)
T 1zar_A          239 SVEVG-------------EEGWREILE  252 (282)
T ss_dssp             CEETT-------------STTHHHHHH
T ss_pred             CeECC-------------CCCHHHHHH
Confidence            97532             367888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.2e-21  Score=164.83  Aligned_cols=147  Identities=18%  Similarity=0.190  Sum_probs=105.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcE--EEEEEeecccCCccccc-----ccCC-----------CcchhHHHHHHhhC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEI--VALKKVKMNVGRKEDCL-----EYGF-----------PISSLREINILLSF   73 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~-----~~~~-----------~~~~~~e~~~l~~l   73 (332)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++...........     ...+           ...+.+|+..+.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999999777888  99999765421110000     0000           01456899999999


Q ss_pred             CCCCeeeeeeeEEcCCCeEEEEcccccc------cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCC
Q 035861           74 DHPSIVNVKEVVMDDHDSVYMVMEYMEH------DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTS  146 (332)
Q Consensus        74 ~h~~i~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~  146 (332)
                      .|+++....-+..   ...++||||+++      .+.+...    ..++..+..++.|++.+|.+|| +.||+|+||||.
T Consensus       128 ~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            8776422111111   235899999953      3433322    1346678899999999999999 999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccc
Q 035861          147 NLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus       147 Nili~~~~~~~l~df~~~~~~  167 (332)
                      |||++.  .++|+|||++...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.4e-19  Score=158.16  Aligned_cols=145  Identities=15%  Similarity=0.155  Sum_probs=97.9

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccccc---c--cCC-Ccc--------hhHHHHHHhhCCCCCe
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCL---E--YGF-PIS--------SLREINILLSFDHPSI   78 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~---~--~~~-~~~--------~~~e~~~l~~l~h~~i   78 (332)
                      |.+.+.||.|++|.||+|.+. +|+.||||+++..........   .  ... ...        ...|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999985 699999999865432111000   0  000 001        1235555555543333


Q ss_pred             eeeeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC----
Q 035861           79 VNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----  154 (332)
Q Consensus        79 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~----  154 (332)
                      . +...+...  ..+|||||++|..+..+      ...+....++.||+.+|.+||+.||+||||||.|||++.+|    
T Consensus       176 ~-vp~p~~~~--~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 P-VPEPIAQS--RHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             S-CCCEEEEE--TTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             C-CCeeeecc--CceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            2 11111111  13699999998643221      22334567899999999999999999999999999998876    


Q ss_pred             ------cEEEeeccccccc
Q 035861          155 ------VLKICDFGMSRQY  167 (332)
Q Consensus       155 ------~~~l~df~~~~~~  167 (332)
                            .+.|+||+-+...
T Consensus       247 ~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECCCTTCEET
T ss_pred             ccccccceEEEEeCCcccC
Confidence                  4899999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=7e-13  Score=111.52  Aligned_cols=142  Identities=15%  Similarity=0.135  Sum_probs=106.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      .+..|.+...++.|+.+.||++...  +..+++|+.........        ..+.+|+..++.+. +..+..+++... 
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~-   80 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFER-   80 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEEE-
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCH--------HHHHHHHHHHHHHhcCCCCCeEEEEEe-
Confidence            4567999999999999999999765  67899999875321111        14668999998884 556667777764 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD--------------------------------  135 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~--------------------------------  135 (332)
                      +.+..|+|||+++|..+....     .+......++.+++.+|+.||+                                
T Consensus        81 ~~~~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           81 HDGWSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             cCCceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            447889999999996554331     1223345788999999999998                                


Q ss_pred             ---------------------------CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 ---------------------------NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 ---------------------------~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                                                 ..++|||++|.||+++.++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                       3488999999999998755567999987753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1.5e-11  Score=103.07  Aligned_cols=136  Identities=13%  Similarity=0.124  Sum_probs=94.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe--eeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI--VNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~   87 (332)
                      +..|.+....+.|..+.||++.. .+|..+++|+.....           ...+..|+..++.+.+.++  ..++... .
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~-~   85 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVV-T   85 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEE-E
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----------chhhhHHHHHHHHHHhCCCCCCeEEEec-c
Confidence            34566554445667799999965 456789999975421           1145689998888854443  4466665 4


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW------------------------------  137 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~------------------------------  137 (332)
                      +.+..++|||+++|..+.  .  . ..+   ...++.+++.+|+.||+..                              
T Consensus        86 ~~~~~~~v~e~i~G~~l~--~--~-~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           86 EAGRDWLLLGEVPGQDLL--S--S-HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             CSSCEEEEEECCSSEETT--T--S-CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCCCCEEEEEecCCcccC--c--C-cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            446689999999986543  1  1 112   2356778888888888653                              


Q ss_pred             ----------------------------cccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          138 ----------------------------VLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       138 ----------------------------i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                                                  ++|||++|.||++++++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                        89999999999998766667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=9.1e-11  Score=103.19  Aligned_cols=142  Identities=13%  Similarity=0.243  Sum_probs=101.0

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEee--cccCCcccccccCCCcchhHHHHHHhhCCC--CCeeeeeeeEEcCC
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVK--MNVGRKEDCLEYGFPISSLREINILLSFDH--PSIVNVKEVVMDDH   89 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~   89 (332)
                      ..++.++.|.++.||++...  +..+++|+..  .......       ...+.+|+.+++.+..  ..+..++..+.+..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~-------~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~  111 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPS-------AHAIEREYRVMDALAGTDVPVAKMYALCEDES  111 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCc-------HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence            34677899999999999875  5678999876  3221110       1245689999988864  34566666653221


Q ss_pred             --CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 035861           90 --DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD--------------------------------  135 (332)
Q Consensus        90 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~--------------------------------  135 (332)
                        +..++|||+++|..+..  .....+++.....++.+++.+|+.||+                                
T Consensus       112 ~~g~~~~vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          112 VIGRAFYIMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             TTSSCEEEEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence              34789999999854311  112347888889999999999999997                                


Q ss_pred             --------------------------CCcccccCCCCCEEEcCCCc--EEEeecccccc
Q 035861          136 --------------------------NWVLHRDLKTSNLLLNNQGV--LKICDFGMSRQ  166 (332)
Q Consensus       136 --------------------------~~i~H~di~p~Nili~~~~~--~~l~df~~~~~  166 (332)
                                                .+++|||+++.||+++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                      35899999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.98  E-value=2e-10  Score=98.63  Aligned_cols=182  Identities=16%  Similarity=0.145  Sum_probs=114.7

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCe--eeeeeeEEcCC--C
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSI--VNVKEVVMDDH--D   90 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i--~~~~~~~~~~~--~   90 (332)
                      ++.++.|..+.||++.     ..+++|+.....    .      ...+..|+..++.+ .+..+  ...+.....+.  .
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~----~------~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~   89 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSR----G------STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ   89 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHH----H------HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcc----h------HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence            4568999999999873     468999865321    0      01356889888777 33332  22322221111  2


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-----------------------------------  135 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-----------------------------------  135 (332)
                      ..|+||++++|..+.....  ..++..+...++.+++..|+.||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            3578999999854332111  357788888899999999999886                                   


Q ss_pred             -----------------------CCcccccCCCCCEEEcC--CCcEEEeecccccccCCCCCCCccccccccc---cchh
Q 035861          136 -----------------------NWVLHRDLKTSNLLLNN--QGVLKICDFGMSRQYGSPLKPYTSLVVTLWY---RAPE  187 (332)
Q Consensus       136 -----------------------~~i~H~di~p~Nili~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y---~aPE  187 (332)
                                             ..++|||++|.||+++.  .+.+.|+||+.+...+...+    .......   .+|+
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D----l~~~~~~~~~~~~~  243 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND----FISLMEDDEEYGME  243 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH----HHTTCCTTTSCCHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH----HHHHHhhccccCHH
Confidence                                   13699999999999998  45688999998865422100    0000000   1222


Q ss_pred             hh----cCCC---------CCCchhHHHHHHHHHHHHHhCCCCC
Q 035861          188 LL----LGAK---------KYSTAVDMWSVGCIMAELLAKKPLF  218 (332)
Q Consensus       188 ~~----~~~~---------~~~~~sDi~slG~~l~~lltg~~pf  218 (332)
                      ..    ....         ......+.|+++.++|.+.+|..+|
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11    0000         1123468999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.68  E-value=8.9e-08  Score=82.04  Aligned_cols=136  Identities=17%  Similarity=0.089  Sum_probs=90.7

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCC---CeeeeeeeEEcCCCe
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHP---SIVNVKEVVMDDHDS   91 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~   91 (332)
                      -++.++.|....||+.     +..+++|+.....     .     ...+..|...++.+.+.   .+...+.+.....+.
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~-----~-----~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQQ-----G-----ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESSHH-----H-----HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCCch-----H-----HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            3456889999999998     5678999853210     0     01356899999888542   233444444334466


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN-----------------------------------  136 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~-----------------------------------  136 (332)
                      .++||++++|..+....  -..++......++.++...|+.||+.                                   
T Consensus        88 ~~~v~e~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~  165 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD  165 (306)
T ss_dssp             EEEEEECCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred             eEEEEeccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence            78999999996443321  12345666666666666666666643                                   


Q ss_pred             -------------------------CcccccCCCCCEEEcC---CCc-EEEeeccccccc
Q 035861          137 -------------------------WVLHRDLKTSNLLLNN---QGV-LKICDFGMSRQY  167 (332)
Q Consensus       137 -------------------------~i~H~di~p~Nili~~---~~~-~~l~df~~~~~~  167 (332)
                                               .++|||+++.||+++.   ++. +.|+||+.+...
T Consensus       166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                     2489999999999997   455 489999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.58  E-value=2.1e-07  Score=78.23  Aligned_cols=132  Identities=17%  Similarity=0.174  Sum_probs=88.1

Q ss_pred             ccccCc-EEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcCCCeEEEEc
Q 035861           19 ISEGTY-GIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDDHDSVYMVM   96 (332)
Q Consensus        19 lg~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~   96 (332)
                      +..|.. +.||+......+..+++|+......           ..+..|...++.+. +--+..++.++ ++.+..++||
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~-----------~~~~~E~~~l~~l~~~vPVP~v~~~~-~~~~~~~lvm   99 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVA-----------NDVTDEMVRLNWLTAFMPLPTIKHFI-RTPDDAWLLT   99 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHH-----------HHHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEEEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCH-----------hHHHHHHHHHHHhccCCCcCeEEEEE-EECCeEEEEE
Confidence            344444 4799988877778899998764321           13457888887773 22244555555 4447789999


Q ss_pred             ccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 035861           97 EYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDN----------------------------------------  136 (332)
Q Consensus        97 e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~----------------------------------------  136 (332)
                      |+++|.........    .......+..+++..|+.||+.                                        
T Consensus       100 e~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          100 TAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             ECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             EeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            99998544333221    1233345666666666666641                                        


Q ss_pred             ------------------CcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          137 ------------------WVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       137 ------------------~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                                        .++|||+++.||+++.++.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              168999999999999877777999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.51  E-value=1.8e-06  Score=68.51  Aligned_cols=101  Identities=13%  Similarity=0.067  Sum_probs=69.9

Q ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 035861          102 DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH-DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVT  180 (332)
Q Consensus       102 ~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh-~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  180 (332)
                      +|.+.+...+.+++++++|.++.|.+.+|.-+- ++.-...=+.|..|++..+|.|.+.+ ..+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            688888889999999999999999999988863 22222333567899999999999864 1110            112


Q ss_pred             ccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 035861          181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL  217 (332)
Q Consensus       181 ~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p  217 (332)
                      ..+.|||...  ...+.+.-|||||+++|..+--..|
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            2356787653  3457899999999999999854443

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.32  E-value=2e-06  Score=76.49  Aligned_cols=82  Identities=20%  Similarity=0.186  Sum_probs=46.9

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccC-CcccccccCCCcchhHHHHHHhhCCC--CCee-eeeeeEEcCCC
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVG-RKEDCLEYGFPISSLREINILLSFDH--PSIV-NVKEVVMDDHD   90 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~-~~~~~~~~~~~   90 (332)
                      ..+.+|.|..+.||++....+++.++||....... ....  ..........|.+.++.+..  +..+ .++. + +. .
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~--~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d~-~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES--WPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DT-E  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC---------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ET-T
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC--CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-cC-C
Confidence            35679999999999997765678899998753221 0000  00011234678888877632  3333 3443 3 22 3


Q ss_pred             eEEEEcccccc
Q 035861           91 SVYMVMEYMEH  101 (332)
Q Consensus        91 ~~~lv~e~~~~  101 (332)
                      ..++|||+++|
T Consensus       109 ~~~lvmE~l~g  119 (397)
T 2olc_A          109 MAVTVMEDLSH  119 (397)
T ss_dssp             TTEEEECCCTT
T ss_pred             ccEEEEEeCCC
Confidence            35799999976

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=7e-06  Score=71.76  Aligned_cols=84  Identities=7%  Similarity=0.035  Sum_probs=49.6

Q ss_pred             cccccc-cccCcEEEEEEEEC--C----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-C--CCeeeeee
Q 035861           14 EKLNKI-SEGTYGIVYRARDK--K----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-H--PSIVNVKE   83 (332)
Q Consensus        14 ~~~~~l-g~g~~g~v~~~~~~--~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~   83 (332)
                      ...+.| +.|..+.+|++...  .    ++..+++|+..........     ....+..|+..++.+. +  -.+.+++.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-----~~~~~~~E~~~l~~L~~~~~vpvP~v~~   97 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-----PTYRLDHQFEVIRLVGELTDVPVPRVRW   97 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-----SCCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-----chhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            345667 88889999998653  1    1567899976543200000     0124567888887773 2  23455555


Q ss_pred             eEEcCC--CeEEEEccccccc
Q 035861           84 VVMDDH--DSVYMVMEYMEHD  102 (332)
Q Consensus        84 ~~~~~~--~~~~lv~e~~~~~  102 (332)
                      ...+..  +..++|||+++|.
T Consensus        98 ~~~~~~~~g~~~~v~e~l~G~  118 (357)
T 3ats_A           98 IETTGDVLGTPFFLMDYVEGV  118 (357)
T ss_dssp             EECSSTTTSSCEEEEECCCCB
T ss_pred             EccCCCccCCceEEEEecCCC
Confidence            542221  3467999999873

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=5.3e-06  Score=71.95  Aligned_cols=31  Identities=23%  Similarity=0.257  Sum_probs=27.7

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .+++|||+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998888999999997753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.86  E-value=3.9e-05  Score=65.32  Aligned_cols=71  Identities=15%  Similarity=0.141  Sum_probs=42.1

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCee-eeeeeEEcCCCe
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIV-NVKEVVMDDHDS   91 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~   91 (332)
                      +.-++.|+.|..+.+|++      ..+++|+.......   ..      ....|...++.+...++. +++... .  ..
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~------~r~~E~~~l~~l~~~g~~P~~~~~~-~--~~   81 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YI------NRANEAVAAREAAKAGVSPEVLHVD-P--AT   81 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC-------CC------CHHHHHHHHHHHHHTTSSCCEEEEC-T--TT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc---ee------CHHHHHHHHHHHHHcCCCCceEEEE-C--CC
Confidence            333788999999999999      45899988653211   11      123677777666332332 333322 2  22


Q ss_pred             EEEEcccc-cc
Q 035861           92 VYMVMEYM-EH  101 (332)
Q Consensus        92 ~~lv~e~~-~~  101 (332)
                      -++++|++ +|
T Consensus        82 ~~~v~e~i~~g   92 (301)
T 3dxq_A           82 GVMVTRYIAGA   92 (301)
T ss_dssp             CCEEEECCTTC
T ss_pred             CEEEEeecCCC
Confidence            36889999 66

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00011  Score=65.70  Aligned_cols=78  Identities=13%  Similarity=0.042  Sum_probs=46.7

Q ss_pred             HCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCCccccc--cccccchhhhcCC--CCCCchhHHHHHHHHHHH
Q 035861          135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV--TLWYRAPELLLGA--KKYSTAVDMWSVGCIMAE  210 (332)
Q Consensus       135 ~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~~  210 (332)
                      ...++|||+++.||+++.++ +.|+||+.+...+...+ ......  ...|.+|+.....  ........+.++...+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            46799999999999999876 99999998865321000 000010  1235666544321  112234556677777777


Q ss_pred             HHhC
Q 035861          211 LLAK  214 (332)
Q Consensus       211 lltg  214 (332)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.63  E-value=0.00011  Score=62.80  Aligned_cols=75  Identities=12%  Similarity=0.151  Sum_probs=51.9

Q ss_pred             cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC---CCCeeeeeeeEEcCCC
Q 035861           14 EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD---HPSIVNVKEVVMDDHD   90 (332)
Q Consensus        14 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~   90 (332)
                      .-.+.|+.|..+.+|+....  +..+++|+.....   .        ..+..|+..++.+.   ...+...+... +..+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~~---~--------~~~~~E~~~L~~L~~~~~v~VP~vl~~~-~~~g  104 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERSY---R--------SMFRAEADQLALLAKTNSINVPLVYGIG-NSQG  104 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGGG---H--------HHHHHHHHHHHHHHHTTSSBCCCEEEEE-ECSS
T ss_pred             eeeEEeCCccceeeeEEEEC--CCeEEEEeCCccc---H--------HHHHHHHHHHHHHHhhCCCCcceEEEEe-ecCC
Confidence            34567899999999999763  6789999876431   0        13457877777763   23455566555 3346


Q ss_pred             eEEEEccccccc
Q 035861           91 SVYMVMEYMEHD  102 (332)
Q Consensus        91 ~~~lv~e~~~~~  102 (332)
                      ..++|||+++|.
T Consensus       105 ~~~lvme~l~G~  116 (312)
T 3jr1_A          105 HSFLLLEALNKS  116 (312)
T ss_dssp             EEEEEEECCCCC
T ss_pred             ceEEEEEeccCC
Confidence            789999999873

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00018  Score=61.67  Aligned_cols=139  Identities=16%  Similarity=0.167  Sum_probs=73.9

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-----CCCeeeee-e-eEEcC
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-----HPSIVNVK-E-VVMDD   88 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~-~-~~~~~   88 (332)
                      ++.|+.|..+.+|++...  +..+++|+.......          ..+..|..++..+.     .|.++... + .+...
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~----------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEK----------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC---C----------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCCCH----------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            456778888999999764  336899988652111          13446666666553     23332211 0 00111


Q ss_pred             CCeEEEEcccccccH---------------HHHHHhcCCCC--------CHHHHHH---------------HHHHHHHHH
Q 035861           89 HDSVYMVMEYMEHDL---------------KWLMESMKQPF--------STSEVKC---------------LMLQLLEGV  130 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l---------------~~~~~~~~~~l--------~~~~~~~---------------i~~~l~~~L  130 (332)
                      .+..++++++++|..               +..+......+        ....-..               +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            245789999998731               11111111111        1000000               011234455


Q ss_pred             HHHHH-------CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          131 KYLHD-------NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       131 ~~lh~-------~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      +.+.+       .+++|||+++.||++++++.+.|+||+.+..
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            55553       3689999999999999876668999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00015  Score=63.60  Aligned_cols=137  Identities=16%  Similarity=0.185  Sum_probs=76.2

Q ss_pred             cccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe-eeeeeeEEc
Q 035861           16 LNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI-VNVKEVVMD   87 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~   87 (332)
                      ++.|..|-...+|++....       +++.+++|+...... .  .      ....+|..+++.+...++ .++++.+ +
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-~--~------~~~~rE~~vl~~L~~~gv~P~ll~~~-~  124 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-G--V------DSLVLESVMFAILAERSLGPQLYGVF-P  124 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-C--H------HHHHHHHHHHHHHHHTTSSCCEEEEE-T
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-h--H------HHHHHHHHHHHHHHhcCCCCeEEEEc-C
Confidence            4567778888899998642       357899998633110 0  0      123478888877743233 3444443 3


Q ss_pred             CCCeEEEEcccccccHH-----------HHH-------HhcC----CCCC--HHHHHHHHHHHHH---------------
Q 035861           88 DHDSVYMVMEYMEHDLK-----------WLM-------ESMK----QPFS--TSEVKCLMLQLLE---------------  128 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~-----------~~~-------~~~~----~~l~--~~~~~~i~~~l~~---------------  128 (332)
                      +    .+|+|+++|..+           ..+       ....    +...  ...+.++..++..               
T Consensus       125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~  200 (379)
T 3feg_A          125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY  200 (379)
T ss_dssp             T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred             C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence            3    289999987211           111       1111    1112  3455555544422               


Q ss_pred             ----HHHHHH----HC----CcccccCCCCCEEEcCC----CcEEEeecccccc
Q 035861          129 ----GVKYLH----DN----WVLHRDLKTSNLLLNNQ----GVLKICDFGMSRQ  166 (332)
Q Consensus       129 ----~L~~lh----~~----~i~H~di~p~Nili~~~----~~~~l~df~~~~~  166 (332)
                          .+..|.    ..    .++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                223332    22    48999999999999886    7899999998763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.41  E-value=0.001  Score=55.99  Aligned_cols=76  Identities=14%  Similarity=0.076  Sum_probs=48.8

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC---eeeeeeeEEcC
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS---IVNVKEVVMDD   88 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~---i~~~~~~~~~~   88 (332)
                      +..-++.+|.|..+.||++... +|+.+++|+.........        ..+..|+..|+.+....   +..++..   +
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~--------~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~   83 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALD--------GLFRAEALGLDWLGRSFGSPVPQVAGW---D   83 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCT--------THHHHHHHHHHHHTCSTTCCSCCEEEE---E
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchh--------hHHHHHHHHHHHHHhhCCCCcceEEec---c
Confidence            4456788999999999999874 588999998754322111        12457888888774221   2233322   2


Q ss_pred             CCeEEEEcccccc
Q 035861           89 HDSVYMVMEYMEH  101 (332)
Q Consensus        89 ~~~~~lv~e~~~~  101 (332)
                      .  .++|||++.+
T Consensus        84 ~--~~lv~e~l~~   94 (288)
T 3f7w_A           84 D--RTLAMEWVDE   94 (288)
T ss_dssp             T--TEEEEECCCC
T ss_pred             C--ceEEEEeecc
Confidence            2  2688898864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.28  E-value=0.00084  Score=60.03  Aligned_cols=72  Identities=13%  Similarity=0.182  Sum_probs=45.4

Q ss_pred             ccccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe-eeeeeeEE
Q 035861           15 KLNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI-VNVKEVVM   86 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~   86 (332)
                      -++.|+.|....+|++....       ++..+++|+.... ....         .+..|..+++.+...++ .++++.+ 
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~---------~li~E~~~l~~L~~~g~~P~l~~~~-  145 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETES---------HLVAESVIFTLLSERHLGPKLYGIF-  145 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHH---------HHHHHHHHHHHHHHTTSSSCEEEEE-
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHH---------HHHHHHHHHHHHHhCCCCCcEEEEe-
Confidence            35668888899999998642       2578999988431 1101         23468887777743333 4455544 


Q ss_pred             cCCCeEEEEcccccc
Q 035861           87 DDHDSVYMVMEYMEH  101 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~  101 (332)
                      .+    .+|+||++|
T Consensus       146 ~~----g~v~e~l~G  156 (429)
T 1nw1_A          146 SG----GRLEEYIPS  156 (429)
T ss_dssp             TT----EEEECCCCE
T ss_pred             CC----CEEEEEeCC
Confidence            33    388999986

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.26  E-value=0.0009  Score=57.64  Aligned_cols=32  Identities=25%  Similarity=0.334  Sum_probs=27.5

Q ss_pred             CCcccccCCCCCEEEcCC----CcEEEeeccccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQ----GVLKICDFGMSRQY  167 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~----~~~~l~df~~~~~~  167 (332)
                      ..++|||+.+.||+++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            468999999999999875    68999999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.24  E-value=0.00045  Score=60.51  Aligned_cols=28  Identities=32%  Similarity=0.522  Sum_probs=23.7

Q ss_pred             CcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      +++|+|+.+.||++++++ +.|+||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            489999999999998654 8999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.23  E-value=0.0031  Score=56.78  Aligned_cols=73  Identities=14%  Similarity=0.204  Sum_probs=45.3

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe-eeeeeeEEcCCCeEE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI-VNVKEVVMDDHDSVY   93 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~   93 (332)
                      -++.|+.|....+|++....++..+++|+.....   ....      .-..|..+++.+...++ .++++.+ .+    .
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~-~~----G  177 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII------NREREKKISCILYNKNIAKKIYVFF-TN----G  177 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS------CHHHHHHHHHHHTTSSSBCCEEEEE-TT----E
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc------CHHHHHHHHHHHHhcCCCCCEEEEe-CC----e
Confidence            3567888989999999876445789999874321   1111      11378888888865555 3455544 32    2


Q ss_pred             EEcccccc
Q 035861           94 MVMEYMEH  101 (332)
Q Consensus        94 lv~e~~~~  101 (332)
                      +|+||++|
T Consensus       178 ~v~e~I~G  185 (458)
T 2qg7_A          178 RIEEFMDG  185 (458)
T ss_dssp             EEEECCCS
T ss_pred             EEEEeeCC
Confidence            59999986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.17  E-value=0.0023  Score=55.23  Aligned_cols=32  Identities=22%  Similarity=0.331  Sum_probs=27.8

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ..++|||+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35899999999999998889999999877643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.90  E-value=0.0026  Score=54.54  Aligned_cols=29  Identities=24%  Similarity=0.281  Sum_probs=25.1

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ..++|||+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3589999999999999 4 899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.45  E-value=0.0046  Score=54.97  Aligned_cols=29  Identities=31%  Similarity=0.494  Sum_probs=25.7

Q ss_pred             CcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          137 WVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       137 ~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            3799999999999 7788999999998763

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.29  E-value=0.019  Score=50.66  Aligned_cols=29  Identities=31%  Similarity=0.465  Sum_probs=24.8

Q ss_pred             cccccCCCCCEEE------cCCCcEEEeecccccc
Q 035861          138 VLHRDLKTSNLLL------NNQGVLKICDFGMSRQ  166 (332)
Q Consensus       138 i~H~di~p~Nili------~~~~~~~l~df~~~~~  166 (332)
                      ++|+|+.+.||++      +.++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3456899999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.42  E-value=1.3  Score=35.05  Aligned_cols=124  Identities=14%  Similarity=0.108  Sum_probs=80.6

Q ss_pred             hHHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 035861           64 LREINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRD  142 (332)
Q Consensus        64 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~d  142 (332)
                      ..|+.+|. ..+|++++. .+. +.++.+.+.++.-+.. ....    -..++....++++.+|+....++  ..-+|--
T Consensus        34 ~~el~LL~-~~~~~Fl~~-~I~-e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~  104 (215)
T 4ann_A           34 FHLMYLLE-QHSPYFIDA-ELT-ELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFV  104 (215)
T ss_dssp             GGGGGGGG-SCCTTBCCE-EEE-ECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGG--GSSEECC
T ss_pred             HHHHHHHh-ccCCcccce-EEE-EcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHh--cCceEEE
Confidence            35556554 378888877 344 3335666666665532 1111    23478899999999998877444  3346778


Q ss_pred             CCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 035861          143 LKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS  219 (332)
Q Consensus       143 i~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~  219 (332)
                      |+|+|++++.++.+++...|.-...                 +|      ...+...=.-.+=+++..+++++..|.
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~l-----------------~P------~~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNVV-----------------DP------LPVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTTB-----------------SC------CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EecceEEEcCCCCEEEEEccCccCC-----------------CC------CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999999877754332                 22      122333333346678888888887773

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.38  E-value=4.5  Score=32.02  Aligned_cols=121  Identities=16%  Similarity=0.070  Sum_probs=74.8

Q ss_pred             HHHHHHhhCCCCCeeeeeeeEEcCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHHCCccccc
Q 035861           65 REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVK-YLHDNWVLHRD  142 (332)
Q Consensus        65 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~-~lh~~~i~H~d  142 (332)
                      .+..++. ..||++ +..- . .+++.+.+.++.-++. ....+    ..++....++++.+|+.... ++  ..-+|--
T Consensus        40 ~e~~lL~-~~~~~f-~~~I-~-~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~  109 (219)
T 4ano_A           40 LELEVLK-EVDPCI-VRDI-D-VSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFI  109 (219)
T ss_dssp             GGGGGGG-GSCSSS-EEEE-E-ECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECC
T ss_pred             HHHHHHh-ccCCCC-CeEE-E-EeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEE
Confidence            3444443 267877 3322 2 3446666666665432 22233    35788999999998887555 33  4457778


Q ss_pred             CCCCCEEEcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 035861          143 LKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLF  218 (332)
Q Consensus       143 i~p~Nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf  218 (332)
                      ++|+|++++.++.+++...|.-...                 +|.      ..+...=.-++=+++..++.++..|
T Consensus       110 l~P~NL~f~~~~~p~i~hRGi~~~l-----------------pP~------e~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          110 VCPENLMFNRALEPFFLHVGVKESL-----------------PPD------EWDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CCGGGEEECTTCCEEESCCEETTTB-----------------SSC------SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EeCceEEEeCCCcEEEEEcCCcccC-----------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999999999887765432                 221      1222222334556777777777666

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.63  E-value=0.16  Score=45.60  Aligned_cols=63  Identities=11%  Similarity=0.051  Sum_probs=17.6

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEE------EEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVAL------KKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~i------K~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +.+.||   ||.||++.+.....+||+      |.........+      ....+.++..+++.++|+|++..+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e------~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEK------RLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccccccc------ccccccccccccccccccccCCCcceEE
Confidence            456676   999999999765567888      55543222111      1124567888888889999999888763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	332
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-90
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-88
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-85
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-81
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-79
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-78
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-77
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-76
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-76
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-75
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-74
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-74
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-73
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-73
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-71
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-71
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-71
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-71
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-71
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-69
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-69
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-68
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-68
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-68
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-67
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-64
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-63
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-62
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-61
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-61
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-60
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-56
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-54
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-42
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-29
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	0.002

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (686), Expect = 9e-90
 Identities = 125/309 (40%), Positives = 183/309 (59%), Gaps = 13/309 (4%)

Query: 14  EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF 73
           EKL+ + EG +  VY+ARDK + +IVA+KK+K+         + G   ++LREI +L   
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYL 133
            HP+I+ + +       ++ +V ++ME DL+ +++      + S +K  ML  L+G++YL
Sbjct: 58  SHPNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 134 HDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAK 193
           H +W+LHRDLK +NLLL+  GVLK+ DFG+++ +GSP + YT  VVT WYRAPELL GA+
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 194 KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKA 253
            Y   VDMW+VGCI+AELL + P   G +++DQ+ +IF+TLGTPTE  WP +  LP    
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP-DYV 235

Query: 254 NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP 313
            F   P   L   F AA         +   DL+  L  ++P  RIT   AL   +F   P
Sbjct: 236 TFKSFPGIPLHHIFSAA--------GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287

Query: 314 LPKSKDFMP 322
            P     +P
Sbjct: 288 GPTPGCQLP 296

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  264 bits (676), Expect = 5e-88
 Identities = 126/321 (39%), Positives = 185/321 (57%), Gaps = 24/321 (7%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           C  V ++EKL KI +GT+G V++AR +K+G+ VALKKV M   ++      GFPI++LRE
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALRE 59

Query: 67  INILLSFDHPSIVNVKEVVMD-------DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEV 119
           I IL    H ++VN+ E+             S+Y+V ++ EHDL  L+ ++   F+ SE+
Sbjct: 60  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 119

Query: 120 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG----SPLKPYT 175
           K +M  LL G+ Y+H N +LHRD+K +N+L+   GVLK+ DFG++R +     S    YT
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 176 SLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG 235
           + VVTLWYR PELLLG + Y   +D+W  GCIMAE+  + P+  G TE  Q+  I +  G
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 236 TPTETIWPGLSELPG-AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
           + T  +WP +       K    K     ++ R        + V      DL+++LL  DP
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDP 293

Query: 295 EKRITVDDALNHYWFHEVPLP 315
            +RI  DDALNH +F   P+P
Sbjct: 294 AQRIDSDDALNHDFFWSDPMP 314

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (658), Expect = 2e-85
 Identities = 135/304 (44%), Positives = 201/304 (66%), Gaps = 16/304 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F+K+ KI EGTYG+VY+AR+K +GE+VALKK++++   +      G P +++REI++L  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKE 57

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLME-SMKQPFSTSEVKCLMLQLLEGVK 131
            +HP+IV + +V +   + +Y+V E++  DLK  M+ S         +K  + QLL+G+ 
Sbjct: 58  LNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           + H + VLHRDLK  NLL+N +G +K+ DFG++R +G P++ YT  VVTLWYRAPE+LLG
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K YSTAVD+WS+GCI AE++ ++ LF G +E+DQ+ +IF+TLGTP E +WPG++ +P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K +F K       K  P         L E G  LL+++L YDP KRI+   AL H +F +
Sbjct: 237 KPSFPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

Query: 312 VPLP 315
           V  P
Sbjct: 289 VTKP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  246 bits (628), Expect = 4e-81
 Identities = 128/299 (42%), Positives = 183/299 (61%), Gaps = 16/299 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L KI EGTYG+VY+A++   GE  ALKK+++    +      G P +++REI+IL  
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE------GIPSTTIREISILKE 56

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IV + +V+      + +V E+++ DLK L++  +    +   K  +LQLL G+ Y
Sbjct: 57  LKHSNIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            HD  VLHRDLK  NLL+N +G LKI DFG++R +G P++ YT  +VTLWYRAP++L+G+
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 193 KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAK 252
           KKYST +D+WSVGCI AE++   PLF G +E DQ+ +IF+ LGTP    WP ++ELP   
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 253 ANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
            NF                      L ESG DLL+++L  DP +RIT   AL H +F E
Sbjct: 236 PNFTVYEPLPWESFLKG--------LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (617), Expect = 5e-79
 Identities = 71/309 (22%), Positives = 133/309 (43%), Gaps = 19/309 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FEK++++  G  G+V++   K SG ++A K + +        ++       +RE+ +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIRELQVLH 59

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             + P IV        D   + + ME+M+      +           +  + + +++G+ 
Sbjct: 60  ECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118

Query: 132 YLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLL 190
           YL + + ++HRD+K SN+L+N++G +K+CDFG+S Q    +    S V T  Y +PE L 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ 176

Query: 191 GAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET----IWPGL 245
           G   YS   D+WS+G  + E+   + P+     +  ++    +  G   ET      PG 
Sbjct: 177 G-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSP--VLSESGFDLLNRLLTYDPEKRITVDDA 303
                   +        L            P  V S    D +N+ L  +P +R  +   
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 304 LNHYWFHEV 312
           + H +    
Sbjct: 296 MVHAFIKRS 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (608), Expect = 4e-78
 Identities = 128/304 (42%), Positives = 185/304 (60%), Gaps = 16/304 (5%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +EKL KI EGTYG V++A+++++ EIVALK+V++      D  + G P S+LREI +L  
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLKE 57

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             H +IV + +V+  D   + +V E+ + DLK   +S         VK  + QLL+G+ +
Sbjct: 58  LKHKNIVRLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
            H   VLHRDLK  NLL+N  G LK+ +FG++R +G P++ Y++ VVTLWYR P++L GA
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 193 KKYSTAVDMWSVGCIMAELL-AKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
           K YST++DMWS GCI AEL  A +PLF G    DQ+ +IF+ LGTPTE  WP +++LP  
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           K          L    P         L+ +G DLL  LL  +P +RI+ ++AL H +F +
Sbjct: 237 KPYPMYPATTSLVNVVPK--------LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

Query: 312 VPLP 315
              P
Sbjct: 289 FCPP 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (608), Expect = 2e-77
 Identities = 100/328 (30%), Positives = 158/328 (48%), Gaps = 35/328 (10%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
             +     I  G++G+VY+A+   SGE+VA+KKV  +   K             RE+ I+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------------RELQIM 67

Query: 71  LSFDHPSIVNVKEVVMD-----DHDSVYMVMEYMEHDLKWLMESM---KQPFSTSEVKCL 122
              DH +IV ++          D   + +V++Y+   +  +       KQ      VK  
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 123 MLQLLEGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
           M QL   + Y+H   + HRD+K  NLLL+ +  VLK+CDFG ++Q     +P  S + + 
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSR 186

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +YRAPEL+ GA  Y++++D+WS GC++AELL  +P+F G + VDQ+ +I K LGTPT   
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
              ++           + +   +   P                L +RLL Y P  R+T  
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPR--------TPPEAIALCSRLLEYTPTARLTPL 298

Query: 302 DALNHYWFHEVP-----LPKSKDFMPTF 324
           +A  H +F E+      LP  +D    F
Sbjct: 299 EACAHSFFDELRDPNVKLPNGRDTPALF 326

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  235 bits (601), Expect = 3e-76
 Identities = 72/323 (22%), Positives = 130/323 (40%), Gaps = 47/323 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++   ++  G +G+V+R  ++ +G   A K V       ++ +         +EI  +  
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--------RKEIQTMSV 79

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP++VN+ +   DD + + M+ E+M   +L   +       S  E    M Q+ +G+ 
Sbjct: 80  LRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 132 YLHDNWVLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++H+N  +H DLK  N++   +    LK+ DFG++     P +       T  + APE+ 
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVA 197

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
            G K      DMWSVG +   LL+    F G  + + +  +        ++ + G     
Sbjct: 198 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG----- 251

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                                       +SE G D + +LL  DP  R+T+  AL H W 
Sbjct: 252 ----------------------------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283

Query: 310 HEVPLPKSKDFMPTFPPQHARNK 332
                P     +P+      R+ 
Sbjct: 284 TPGNAPGRDSQIPSSRYTKIRDS 306

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 3e-76
 Identities = 122/319 (38%), Positives = 189/319 (59%), Gaps = 27/319 (8%)

Query: 7   CRSVFEFEKLNKISEGTYGIVYRARDKKS-GEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           CR+  ++E + +I EG YG V++ARD K+ G  VALK+V++  G +      G P+S++R
Sbjct: 3   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------GMPLSTIR 56

Query: 66  EINI---LLSFDHPSIVNVKEVVM----DDHDSVYMVMEYMEHD-LKWLMESMKQPFSTS 117
           E+ +   L +F+HP++V + +V      D    + +V E+++ D   +L +  +    T 
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 118 EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSL 177
            +K +M QLL G+ +LH + V+HRDLK  N+L+ + G +K+ DFG++R Y S     TS+
Sbjct: 117 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSV 175

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           VVTLWYRAPE+LL    Y+T VD+WSVGCI AE+  +KPLF G+++VDQ+ KI   +G P
Sbjct: 176 VVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
            E  WP    LP  +  F  +    + K            + E G DLL + LT++P KR
Sbjct: 235 GEEDWPRDVALP--RQAFHSKSAQPIEKFVTD--------IDELGKDLLLKCLTFNPAKR 284

Query: 298 ITVDDALNHYWFHEVPLPK 316
           I+   AL+H +F ++   K
Sbjct: 285 ISAYSALSHPYFQDLERCK 303

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 7e-75
 Identities = 109/325 (33%), Positives = 165/325 (50%), Gaps = 26/325 (8%)

Query: 9   SVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL 64
            VF+    +  L+ I EG YG+V  A D  +   VA+KK+     +        +   +L
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-------TYCQRTL 54

Query: 65  REINILLSFDHPSIVNVKEVVMD----DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVK 120
           REI ILL F H +I+ + +++          VY+V   M  DL  L++   Q  S   + 
Sbjct: 55  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHIC 112

Query: 121 CLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP---LKPYTSL 177
             + Q+L G+KY+H   VLHRDLK SNLLLN    LKICDFG++R            T  
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 178 VVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP 237
           V T WYRAPE++L +K Y+ ++D+WSVGCI+AE+L+ +P+F G   +DQ++ I   LG+P
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR 297
           ++     +  L       +    N +            P       DLL+++LT++P KR
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWN------RLFPNADSKALDLLDKMLTFNPHKR 286

Query: 298 ITVDDALNHYWFHEVPLPKSKDFMP 322
           I V+ AL H +  +   P  +    
Sbjct: 287 IEVEQALAHPYLEQYYDPSDEPIAE 311

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 1e-74
 Identities = 103/321 (32%), Positives = 163/321 (50%), Gaps = 22/321 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +  L  +  G YG V  A D ++G  VA+KK+      +       F   + RE+ +L  
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLLKH 73

Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
             H +++ + +V      +DD    Y+VM +M  DL  LM+   +      ++ L+ Q+L
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQML 131

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
           +G++Y+H   ++HRDLK  NL +N    LKI DFG++RQ  S +   T  VVT WYRAPE
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPE 188

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++L   +Y+  VD+WSVGCIMAE++  K LF G+  +DQ+ +I K  GTP       L  
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                 N+ K    L +K F +         S    +LL ++L  D E+R+T  +AL H 
Sbjct: 249 DEA--KNYMKGLPELEKKDFASI----LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302

Query: 308 WFHEVPLPKSKDFMPTFPPQH 328
           +F  +   + +  +  +    
Sbjct: 303 YFESLHDTEDEPQVQKYDDSF 323

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 4e-74
 Identities = 68/302 (22%), Positives = 138/302 (45%), Gaps = 48/302 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E + ++ +G +G VY+A++K++  + A K +      + +          + EI+IL S
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--------MVEIDILAS 65

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            DHP+IV + +    + +++++++E+     +  +M  +++P + S+++ +  Q L+ + 
Sbjct: 66  CDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLHDN ++HRDLK  N+L    G +K+ DFG+S +    ++   S + T ++ APE+++ 
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 192 ----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
                + Y    D+WS+G  + E+   +P       +  + KI K+   PT         
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSR--- 240

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
                                          S +  D L + L  + + R T    L H 
Sbjct: 241 ------------------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270

Query: 308 WF 309
           + 
Sbjct: 271 FV 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 1e-73
 Identities = 77/307 (25%), Positives = 131/307 (42%), Gaps = 45/307 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +++ +  + EG YG V  A ++ + E VA+K V M   R  DC E     +  +EI I  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPE-----NIKKEICINK 58

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             +H ++V       +  +  Y+ +EY      +            + +    QL+ GV 
Sbjct: 59  MLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR--QYGSPLKPYTSLVVTLWYRAPELL 189
           YLH   + HRD+K  NLLL+ +  LKI DFG++   +Y +  +    +  TL Y APELL
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
              + ++  VD+WS G ++  +LA +  +   ++  Q    +K   T     W       
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKK----- 231

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                                       +  +   LL+++L  +P  RIT+ D     W+
Sbjct: 232 ----------------------------IDSAPLALLHKILVENPSARITIPDIKKDRWY 263

Query: 310 HEVPLPK 316
           ++ PL K
Sbjct: 264 NK-PLKK 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  225 bits (575), Expect = 8e-73
 Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 47/307 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           F  L +I  G++G VY ARD ++ E+VA+KK+  +  +  +  +       ++E+  L  
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQK 71

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+ +  +   + +H + ++VMEY       L+E  K+P    E+  +    L+G+ Y
Sbjct: 72  LRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGA 192
           LH + ++HRD+K  N+LL+  G++K+ DFG +      + P  S V T ++ APE++L  
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVILAM 186

Query: 193 --KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
              +Y   VD+WS+G    EL  +KP       +  +  I +      +           
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----------- 235

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH 310
                                   S   SE   + ++  L   P+ R T +  L H +  
Sbjct: 236 ------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

Query: 311 EVPLPKS 317
               P  
Sbjct: 272 RERPPTV 278

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 1e-71
 Identities = 75/312 (24%), Positives = 137/312 (43%), Gaps = 48/312 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           + +  KI +G  G VY A D  +G+ VA++++ +    K++ +        + EI ++  
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--------INEILVMRE 73

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             +P+IVN  +  +   D +++VMEY+    L  ++   +      ++  +  + L+ ++
Sbjct: 74  NKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           +LH N V+HRD+K+ N+LL   G +K+ DFG   Q        +++V T ++ APE++  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K Y   VD+WS+G +  E++  +P +     +  +  I    GTP       LS     
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLS--AIF 246

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE 311
           +                               D LNR L  D EKR +  + L H +   
Sbjct: 247 R-------------------------------DFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 312 V-PLPKSKDFMP 322
             PL      + 
Sbjct: 276 AKPLSSLTPLIA 287

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  224 bits (571), Expect = 1e-71
 Identities = 68/306 (22%), Positives = 136/306 (44%), Gaps = 48/306 (15%)

Query: 8   RSVFE-FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
            SV++ ++ L ++  G +G+V+R  +K +G +   K +       +  +          E
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV--------KNE 76

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
           I+I+    HP ++N+ +   D    + +++E++   +L   + +     S +EV   M Q
Sbjct: 77  ISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 135

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
             EG+K++H++ ++H D+K  N++   +    +KI DFG++ +  +P +       T  +
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEF 194

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE++   +      DMW++G +   LL+    F+G  +++ +  + +      E  + 
Sbjct: 195 AAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
            +S  P AK                               D +  LL  +P KR+TV DA
Sbjct: 254 SVS--PEAK-------------------------------DFIKNLLQKEPRKRLTVHDA 280

Query: 304 LNHYWF 309
           L H W 
Sbjct: 281 LEHPWL 286

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 2e-71
 Identities = 82/298 (27%), Positives = 127/298 (42%), Gaps = 46/298 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +FE    + +G +G VY AR+K+S  I+ALK +      K    + G      RE+ I  
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-----KAQLEKAGVEHQLRREVEIQS 61

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP+I+ +     D    VY+++EY      +        F        + +L   + 
Sbjct: 62  HLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           Y H   V+HRD+K  NLLL + G LKI DFG S    +P    T+L  TL Y  PE++ G
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG 178

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            + +   VD+WS+G +  E L  KP F   T  +   +I +                   
Sbjct: 179 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------------------- 218

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF 309
                      +   FP         ++E   DL++RLL ++P +R  + + L H W 
Sbjct: 219 -----------VEFTFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 2e-71
 Identities = 68/329 (20%), Positives = 129/329 (39%), Gaps = 49/329 (14%)

Query: 8   RSVFE-FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           + ++E +     +  G +GIV+R  +  S +    K VK+    +             +E
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---------KE 51

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQ 125
           I+IL    H +I+++ E      + + M+ E++   D+   + +     +  E+   + Q
Sbjct: 52  ISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQ--GVLKICDFGMSRQYGSPLKPYTSLVVTLWY 183
           + E +++LH + + H D++  N++   +    +KI +FG +RQ       +  L     Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEY 169

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE+       STA DMWS+G ++  LL+    F   T    I+ I     T  E  + 
Sbjct: 170 YAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
                                             +S    D ++RLL  + + R+T  +A
Sbjct: 229 E---------------------------------ISIEAMDFVDRLLVKERKSRMTASEA 255

Query: 304 LNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           L H W  +     S   + T   +   + 
Sbjct: 256 LQHPWLKQKIERVSTKVIRTLKHRRYYHT 284

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (565), Expect = 6e-71
 Identities = 102/332 (30%), Positives = 158/332 (47%), Gaps = 30/332 (9%)

Query: 8   RSVFE----FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISS 63
           ++++E    ++ L+ +  G YG V  A D K+G  VA+KK+                   
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT------ 64

Query: 64  LREINILLSFDHPSIVNVKEVVMD-----DHDSVYMVMEYMEHDLKWLMESMKQPFSTSE 118
            RE+ +L    H +++ + +V        + + VY+V   M  DL  +++   Q  +   
Sbjct: 65  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDH 122

Query: 119 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLV 178
           V+ L+ Q+L G+KY+H   ++HRDLK SNL +N    LKI DFG++R         T  V
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 179

Query: 179 VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPT 238
            T WYRAPE++L    Y+  VD+WSVGCIMAELL  + LF GT  +DQ+  I + +GTP 
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 239 ETIWPGLSELPGAKA--NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEK 296
             +   +S         +  + P       F  A        +    DLL ++L  D +K
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGA--------NPLAVDLLEKMLVLDSDK 291

Query: 297 RITVDDALNHYWFHEVPLPKSKDFMPTFPPQH 328
           RIT   AL H +F +   P  +     +    
Sbjct: 292 RITAAQALAHAYFAQYHDPDDEPVADPYDQSF 323

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  217 bits (553), Expect = 3e-69
 Identities = 74/306 (24%), Positives = 152/306 (49%), Gaps = 19/306 (6%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +++ + K+  G Y  V+ A +  + E V +K +K    +K             REI IL 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-----------KREIKILE 84

Query: 72  SF-DHPSIVNVKEVVMD-DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           +    P+I+ + ++V D    +  +V E++ +      + + Q  +  +++  M ++L+ 
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYDIRFYMYEILKA 141

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           + Y H   ++HRD+K  N++++++   L++ D+G++  Y  P + Y   V + +++ PEL
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPEL 200

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           L+  + Y  ++DMWS+GC++A ++ +K P F G    DQ+ +I K LGT     +     
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHY 307
           +            +  ++           ++S    D L++LL YD + R+T  +A+ H 
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320

Query: 308 WFHEVP 313
           +F+ V 
Sbjct: 321 YFYTVV 326

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  214 bits (546), Expect = 7e-69
 Identities = 78/307 (25%), Positives = 129/307 (42%), Gaps = 44/307 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEY-GFPISSLREINILL 71
           +E    +  G   +V R   K + +  A+K + +  G      E      ++L+E++IL 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 72  SF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
               HP+I+ +K+    +    ++V + M+  +L   +   K   S  E + +M  LLE 
Sbjct: 65  KVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEV 122

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           +  LH   ++HRDLK  N+LL++   +K+ DFG S Q   P +    +  T  Y APE++
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 181

Query: 190 LGA-----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
             +       Y   VDMWS G IM  LLA  P F    ++  +  I           W  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                                             S++  DL++R L   P+KR T ++AL
Sbjct: 242 ---------------------------------YSDTVKDLVSRFLVVQPQKRYTAEEAL 268

Query: 305 NHYWFHE 311
            H +F +
Sbjct: 269 AHPFFQQ 275

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 1e-68
 Identities = 103/330 (31%), Positives = 162/330 (49%), Gaps = 21/330 (6%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++ L  I  G  GIV  A D      VA+KK+      +             RE+ ++  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA------YRELVLMKC 72

Query: 73  FDHPSIVNVKEVV-----MDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +H +I+++  V      +++   VY+VME M+     L + ++       +  L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQML 129

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPE 187
            G+K+LH   ++HRDLK SN+++ +   LKI DFG++R  G+     T  VVT +YRAPE
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPE 188

Query: 188 LLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           ++LG   Y   VD+WSVGCIM E++  K LF G   +DQ +K+ + LGTP       L  
Sbjct: 189 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 248 -LPGAKANFAKQPYNLLRKRFPAASFTG----SPVLSESGFDLLNRLLTYDPEKRITVDD 302
            +     N  K       K FP + F      + + +    DLL+++L  DP KRI+VDD
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 303 ALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           AL H + +    P   +  P        ++
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDE 337

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-68
 Identities = 73/309 (23%), Positives = 123/309 (39%), Gaps = 52/309 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+    + EG++  V  AR+  +    A+K ++     KE+ + Y       RE +++ 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVMS 63

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             DHP  V +     DD + +Y  + Y ++            F  +  +    +++  ++
Sbjct: 64  RLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPELL 189
           YLH   ++HRDLK  N+LLN    ++I DFG ++     S      S V T  Y +PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
              K    + D+W++GCI+ +L+A  P F    E     KI K      E  +P      
Sbjct: 183 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR--- 238

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA------ 303
                                             DL+ +LL  D  KR+  ++       
Sbjct: 239 ----------------------------------DLVEKLLVLDATKRLGCEEMEGYGPL 264

Query: 304 LNHYWFHEV 312
             H +F  V
Sbjct: 265 KAHPFFESV 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 3e-68
 Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 53/307 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           ++E L  I  G+YG   + R K  G+I+  K++      + +          + E+N+L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML------VSEVNLLR 58

Query: 72  SFDHPSIVNVKEVVMD-DHDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQL 126
              HP+IV   + ++D  + ++Y+VMEY E  DL  ++      +Q      V  +M QL
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 127 LEGVKYLHD-----NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
              +K  H      + VLHRDLK +N+ L+ +  +K+ DFG++R          + V T 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +Y +PE +     Y+   D+WS+GC++ EL A  P F+  ++ +   KI           
Sbjct: 179 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------- 226

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
                     +  F + PY                  S+   +++ R+L      R +V+
Sbjct: 227 ---------REGKFRRIPYR----------------YSDELNEIITRMLNLKDYHRPSVE 261

Query: 302 DALNHYW 308
           + L +  
Sbjct: 262 EILENPL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  211 bits (539), Expect = 2e-67
 Identities = 82/327 (25%), Positives = 135/327 (41%), Gaps = 51/327 (15%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++  + +  G +  V  A DK++ ++VA+K +       ++        S   EI +L  
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG-------SMENEIAVLHK 63

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
             HP+IV + ++       +Y++M+ +   +L   +   K  ++  +   L+ Q+L+ VK
Sbjct: 64  IKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVK 121

Query: 132 YLHDNWVLHRDLKTSNLLL---NNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           YLHD  ++HRDLK  NLL    +    + I DFG+S+    P    ++   T  Y APE+
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEV 180

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L   K YS AVD WS+G I   LL   P F    +    ++I K         W      
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD---- 235

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                                        +S+S  D +  L+  DPEKR T + AL H W
Sbjct: 236 -----------------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266

Query: 309 FHE---VPLPKSKDFMPTFPPQHARNK 332
                 +     +          A++K
Sbjct: 267 IAGDTALDKNIHQSVSEQIKKNFAKSK 293

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-64
 Identities = 70/309 (22%), Positives = 129/309 (41%), Gaps = 42/309 (13%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++   ++  G + +V + R+K +G   A K +K    R +            RE++IL  
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKE 69

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
             HP+++ + EV  +    V +++E +     +   + K+  +  E    + Q+L GV Y
Sbjct: 70  IQHPNVITLHEVYENK-TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128

Query: 133 LHDNWVLHRDLKTSNLLLNNQGV----LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPEL 188
           LH   + H DLK  N++L ++ V    +KI DFG++ +       + ++  T  + APE+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEI 187

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           +   +      DMWS+G I   LL+    F G T+ + +  +        +  +   S L
Sbjct: 188 VNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYW 308
                                              D + RLL  DP+KR+T+ D+L H W
Sbjct: 247 ---------------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

Query: 309 FHEVPLPKS 317
                  ++
Sbjct: 274 IKPKDTQQA 282

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 9e-63
 Identities = 56/305 (18%), Positives = 114/305 (37%), Gaps = 52/305 (17%)

Query: 11  FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
            +F+   +I  G++  VY+  D ++   VA  +++     K +   +        E  +L
Sbjct: 11  LKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF------KEEAEML 62

Query: 71  LSFDHPSIVNVKEVVMD---DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
               HP+IV   +           + +V E M            +      ++    Q+L
Sbjct: 63  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122

Query: 128 EGVKYLHDN--WVLHRDLKTSNLLLNNQ-GVLKICDFGMSRQYGSPLKPYTSLVVTLWYR 184
           +G+++LH     ++HRDLK  N+ +    G +KI D G++    +      +++ T  + 
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFM 180

Query: 185 APELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           APE+     KY  +VD+++ G  M E+   +  +S      QI +   +   P       
Sbjct: 181 APEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF---- 234

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                                           V      +++   +  + ++R ++ D L
Sbjct: 235 ------------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

Query: 305 NHYWF 309
           NH +F
Sbjct: 265 NHAFF 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  198 bits (505), Expect = 3e-62
 Identities = 81/323 (25%), Positives = 139/323 (43%), Gaps = 54/323 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  +  G++G V+  R + +G   A+K +K  +  +   +E+     +  E  +L 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLMLS 59

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
              HP I+ +     D    ++M+M+Y+E    + +    Q F     K    ++   ++
Sbjct: 60  IVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   +++RDLK  N+LL+  G +KI DFG ++          +L  T  Y APE++  
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST 175

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K Y+ ++D WS G ++ E+LA    F  +  +   +KI                     
Sbjct: 176 -KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------------ 216

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNH 306
                         RFP       P  +E   DLL+RL+T D  +R+       +D  NH
Sbjct: 217 ------------ELRFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257

Query: 307 YWFHEVPLPK--SKDFMPTFPPQ 327
            WF EV   K  S++    + P 
Sbjct: 258 PWFKEVVWEKLLSRNIETPYEPP 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 62/323 (19%), Positives = 127/323 (39%), Gaps = 46/323 (14%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F     I  G +G VY  R   +G++ A+K +     + +        ++    ++++ 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIMLSLVS 62

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           + D P IV +        D +  +++ M         S    FS ++++    +++ G++
Sbjct: 63  TGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           ++H+ +V++RDLK +N+LL+  G ++I D G++  +       +  V T  Y APE+L  
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQK 179

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
              Y ++ D +S+GC++ +LL     F      D+  +I +   T    +    S  P  
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFS--PEL 236

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-----DDALNH 306
           +                                LL  LL  D  +R+        +    
Sbjct: 237 R-------------------------------SLLEGLLQRDVNRRLGCLGRGAQEVKES 265

Query: 307 YWFHEVPLPK--SKDFMPTFPPQ 327
            +F  +       + + P   P 
Sbjct: 266 PFFRSLDWQMVFLQKYPPPLIPP 288

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-61
 Identities = 84/321 (26%), Positives = 147/321 (45%), Gaps = 50/321 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL- 70
           +F     + +G++G V+ A  KK+ +  A+K +K +V   +D +E      ++ E  +L 
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLS 57

Query: 71  LSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
           L+++HP + ++        ++++ VMEY+   DL + ++S    F  S       +++ G
Sbjct: 58  LAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILG 115

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           +++LH   +++RDLK  N+LL+  G +KI DFGM ++         +   T  Y APE+L
Sbjct: 116 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP 249
           LG +KY+ +VD WS G ++ E+L  +  F G  E +    I                   
Sbjct: 176 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------------- 218

Query: 250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITV-DDALNHYW 308
                            +P         L +   DLL +L   +PEKR+ V  D   H  
Sbjct: 219 --------------NPFYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257

Query: 309 FHEVPLPK--SKDFMPTFPPQ 327
           F E+   +   K+  P F P+
Sbjct: 258 FREINWEELERKEIDPPFRPK 278

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-61
 Identities = 63/310 (20%), Positives = 115/310 (37%), Gaps = 54/310 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL- 70
           +++    +  G +G VY          VA+K V+ +       L  G  +    E+ +L 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV--PMEVVLLK 62

Query: 71  -LSFDHPSIVNVKEVVMDDHDSVYMVMEYME--HDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +S     ++ + +      DS  +++E  E   DL   +   +        +    Q+L
Sbjct: 63  KVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVL 120

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLN-NQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAP 186
           E V++ H+  VLHRD+K  N+L++ N+G LK+ DFG           YT    T  Y  P
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPP 178

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           E +   + +  +  +WS+G ++ +++     F    E+ +    F+              
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------------- 224

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                                          +S     L+   L   P  R T ++  NH
Sbjct: 225 -----------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255

Query: 307 YWFHEVPLPK 316
            W  +V LP+
Sbjct: 256 PWMQDVLLPQ 265

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 8e-61
 Identities = 59/310 (19%), Positives = 118/310 (38%), Gaps = 47/310 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +     +I  G++G VY+ +       VA+K + +     +    +        E+ +L 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAF------KNEVGVLR 59

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              H +I+            + +V ++ E   L   +  ++  F   ++  +  Q  +G+
Sbjct: 60  KTRHVNILLFMGY--STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY--GSPLKPYTSLVVTLWYRAPEL 188
            YLH   ++HRDLK++N+ L+    +KI DFG++      S    +  L  ++ + APE+
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 189 LLGAKK--YSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           +    K  YS   D+++ G ++ EL+  +  +S     DQI  +          + P LS
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSPDLS 232

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
           ++                               ++   L+   L    ++R      L  
Sbjct: 233 KVR--------------------------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

Query: 307 YWFHEVPLPK 316
                  LPK
Sbjct: 267 IELLARSLPK 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-60
 Identities = 70/331 (21%), Positives = 131/331 (39%), Gaps = 54/331 (16%)

Query: 12  EFEKLNK-ISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINIL 70
           +++  ++ +  G  G V +  +K++ E  ALK ++                 + RE+ + 
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELH 58

Query: 71  L-SFDHPSIVNVKEVVMD---DHDSVYMVMEYMEH-DL-KWLMESMKQPFSTSEVKCLML 124
             +   P IV + +V  +       + +VME ++  +L   + +   Q F+  E   +M 
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 125 QLLEGVKYLHDNWVLHRDLKTSNLLLN---NQGVLKICDFGMSRQYGSPLKPYTSLVVTL 181
            + E ++YLH   + HRD+K  NLL        +LK+ DFG +++  +     T+   T 
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTP 177

Query: 182 WYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           +Y APE+L   +KY  + DMWS+G IM  LL   P F     +     +           
Sbjct: 178 YYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------- 227

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD 301
                             Y      +          +SE    L+  LL  +P +R+T+ 
Sbjct: 228 ------------RIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTIT 267

Query: 302 DALNHYWFHEVPLPKSKDFMPTFPPQHARNK 332
           + +NH W  +           +   +  + +
Sbjct: 268 EFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 5e-60
 Identities = 78/323 (24%), Positives = 133/323 (41%), Gaps = 51/323 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+ L  + +GT+G V   R+K +G   A+K ++  V   +D + +     ++ E  +L 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 60

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           +  HP +  +K      HD +  VMEY      +   S ++ F+    +    +++  ++
Sbjct: 61  NTRHPFLTALKYA-FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   V++RD+K  NL+L+  G +KI DFG+ ++  S      +   T  Y APE+L  
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
              Y  AVD W +G +M E++  +  F         + I                     
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------ 220

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNH 306
                         RFP         LS     LL  LL  DP++R+        + + H
Sbjct: 221 ------------EIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 307 YWFHEVPLPK--SKDFMPTFPPQ 327
            +F  +       K  +P F PQ
Sbjct: 262 RFFLSINWQDVVQKKLLPPFKPQ 284

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  189 bits (481), Expect = 4e-59
 Identities = 59/302 (19%), Positives = 119/302 (39%), Gaps = 45/302 (14%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +E    +  G    V+ ARD +    VA+K ++ ++ R              RE     +
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL-----RFRREAQNAAA 63

Query: 73  FDHPSIVNVKEVVMDDHDS---VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEG 129
            +HP+IV V +    +  +    Y+VMEY++      +   + P +      ++    + 
Sbjct: 64  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY---GSPLKPYTSLVVTLWYRAP 186
           + + H N ++HRD+K +N++++    +K+ DFG++R     G+ +    +++ T  Y +P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 187 ELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS 246
           E   G        D++S+GC++ E+L  +P F+G + V    +  +    P      GLS
Sbjct: 184 EQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                                                 ++ + L  +PE R      +  
Sbjct: 243 --ADLD-------------------------------AVVLKALAKNPENRYQTAAEMRA 269

Query: 307 YW 308
             
Sbjct: 270 DL 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-56
 Identities = 57/298 (19%), Positives = 115/298 (38%), Gaps = 55/298 (18%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E + L  I +G +G V     +  G  VA+K +K +   +            L E +++ 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA----------FLAEASVMT 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H ++V +  V++++   +Y+V EYM     + +L    +       +    L + E 
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELL 189
           ++YL  N  +HRDL   N+L++   V K+ DFG++++  S      +  + + + APE L
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEAL 172

Query: 190 LGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
              KK+ST  D+WS G ++ E+ +  +  +      D + ++ K                
Sbjct: 173 RE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------- 216

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                          +   P            + ++++      D   R +       
Sbjct: 217 --------------YKMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (456), Expect = 1e-54
 Identities = 72/323 (22%), Positives = 127/323 (39%), Gaps = 54/323 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +F+++  +  G++G V   + K+SG   A+K +      K   +E+     +L E  IL 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TLNEKRILQ 96

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
           + + P +V ++    D+ +   ++      ++   +      FS    +    Q++   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFE 155

Query: 132 YLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLG 191
           YLH   +++RDLK  NLL++ QG +++ DFG +++         +L  T    APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILS 212

Query: 192 AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGA 251
            K Y+ AVD W++G ++ E+ A  P F     +   +KI              L      
Sbjct: 213 -KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL------ 265

Query: 252 KANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNH 306
                                           DLL  LL  D  KR       V+D  NH
Sbjct: 266 -------------------------------KDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294

Query: 307 YWFHEVPLPK--SKDFMPTFPPQ 327
            WF          +     F P+
Sbjct: 295 KWFATTDWIAIYQRKVEAPFIPK 317

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 72/338 (21%), Positives = 128/338 (37%), Gaps = 31/338 (9%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINI--L 70
           +  + K+  G +  V+ A+D  +   VA+K V+ +    E   +    +  + + +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 71  LSFDHPSIVNVKEVVMDDHDS----VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
            S     I+ + +       +    V +     E+ L  + +   +      VK +  QL
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 127 LEGVKYLHDNW-VLHRDLKTSNLLLNNQGV------LKICDFGMSRQYGSPLKPYTSLVV 179
           L G+ Y+H    ++H D+K  N+L+           +KI D G +  Y            
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ--- 191

Query: 180 TLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSG------TTEVDQIDKIFKT 233
           T  YR+PE+LLG   +    D+WS  C++ EL+    LF        T + D I +I + 
Sbjct: 192 TREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 234 LGTPTETIWPGLSELP------GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLN 287
           LG     +              G   N +K  +  L        +  S   ++   D L+
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDFLS 309

Query: 288 RLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMPTFP 325
            +L  DP KR      +NH W  +  L   +  +P   
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDT-LGMEEIRVPDRE 346

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 3e-52
 Identities = 66/329 (20%), Positives = 131/329 (39%), Gaps = 51/329 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARD---KKSGEIVALKKV-KMNVGRKEDCLEYGFPISSLREI 67
            FE L  +  G YG V+  R      +G++ A+K + K  + +K    E+     +  E 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-----TRTER 79

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            +L        +            ++++++Y+     +   S ++ F+  EV+  + +++
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYT--SLVVTLWYRA 185
             +++LH   +++RD+K  N+LL++ G + + DFG+S+++ +              +   
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL 245
             +  G   +  AVD WS+G +M ELL     F+   E +   +I + +          +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259

Query: 246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TV 300
           S    AK                               DL+ RLL  DP+KR+       
Sbjct: 260 S--ALAK-------------------------------DLIQRLLMKDPKKRLGCGPRDA 286

Query: 301 DDALNHYWFHEVPLPK--SKDFMPTFPPQ 327
           D+   H +F ++      +K     F P 
Sbjct: 287 DEIKEHLFFQKINWDDLAAKKVPAPFKPV 315

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (431), Expect = 2e-51
 Identities = 55/316 (17%), Positives = 102/316 (32%), Gaps = 61/316 (19%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           +    KI  G++G +Y   D  +GE VA+K   +     +             E  I   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----------HIESKIYKM 58

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
                 +        + D   MVME +   L+ L     + FS   V  L  Q++  ++Y
Sbjct: 59  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118

Query: 133 LHDNWVLHRDLKTSNLLLNNQG---VLKICDFGMSRQYGSP-------LKPYTSLVVTLW 182
           +H    +HRD+K  N L+       ++ I DFG++++Y           +   +L  T  
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKT----LGTPT 238
           Y +    LG  + S   D+ S+G ++         + G     +  K  +     + TP 
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI 298
           E +  G                                         LN   +   + + 
Sbjct: 238 EVLCKG---------------------------------YPSEFATYLNFCRSLRFDDKP 264

Query: 299 T---VDDALNHYWFHE 311
               +     + +  +
Sbjct: 265 DYSYLRQLFRNLFHRQ 280

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-51
 Identities = 57/298 (19%), Positives = 117/298 (39%), Gaps = 51/298 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +   L ++  G +G+V   + +     VA+K +K     +++ +          E  +++
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---------EEAKVMM 54

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
           +  H  +V +  V       ++++ EYM +  L   +  M+  F T ++  +   + E +
Sbjct: 55  NLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTLWYRAPELL 189
           +YL     LHRDL   N L+N+QGV+K+ DFG+SR                + +  PE+L
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 190 LGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           +   K+S+  D+W+ G +M E+ +  K  +   T  +  + I + L      +       
Sbjct: 174 MY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS----- 227

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                                          E  + ++        ++R T    L++
Sbjct: 228 -------------------------------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-51
 Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 55/311 (17%)

Query: 8   RSVFEFEKLNKISEGTYGIVYRA--RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLR 65
           R +   E   ++  G +G V +   + KK  + VA+K +K          E       L 
Sbjct: 5   RKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL------LA 57

Query: 66  EINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQ 125
           E N++   D+P IV +  +   + +S  +VME  E           +      +  L+ Q
Sbjct: 58  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115

Query: 126 LLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY---TSLVVTLW 182
           +  G+KYL ++  +HRDL   N+LL  Q   KI DFG+S+   +    Y   T     + 
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETI 241
           + APE +    K+S+  D+WS G +M E  +  +  + G    +    + K         
Sbjct: 176 WYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------- 226

Query: 242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-- 299
                                 R   P              +DL+N   TYD E R    
Sbjct: 227 ---------------------ERMGCP-------AGCPREMYDLMNLCWTYDVENRPGFA 258

Query: 300 -VDDALNHYWF 309
            V+  L +Y++
Sbjct: 259 AVELRLRNYYY 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 4e-51
 Identities = 55/298 (18%), Positives = 112/298 (37%), Gaps = 53/298 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             + + ++  G +G V+          VA+K +K      +  L          E N++ 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---------AEANLMK 63

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDL--KWLMESMKQPFSTSEVKCLMLQLLEG 129
              H  +V +  VV  +   +Y++ EYME+     +L        + +++  +  Q+ EG
Sbjct: 64  QLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTLWYRAPEL 188
           + ++ +   +HRDL+ +N+L+++    KI DFG++R    +           + + APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           +     ++   D+WS G ++ E++   +  + G T  + I  + +               
Sbjct: 182 INY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------------- 226

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN 305
                           R   P           E  + L+       PE R T D   +
Sbjct: 227 ---------------YRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (427), Expect = 6e-51
 Identities = 62/296 (20%), Positives = 113/296 (38%), Gaps = 49/296 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           +    +K+  G YG VY    KK    VA+K +K +    E+ L         +E  ++ 
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---------KEAAVMK 68

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH--DLKWLMESMKQPFSTSEVKCLMLQLLEG 129
              HP++V +  V   +    Y++ E+M +   L +L E  +Q  S   +  +  Q+   
Sbjct: 69  EIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY-GSPLKPYTSLVVTLWYRAPEL 188
           ++YL     +HRDL   N L+    ++K+ DFG+SR   G     +      + + APE 
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
           L    K+S   D+W+ G ++ E+           ++ Q+                     
Sbjct: 188 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------------- 225

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                      Y LL K +            E  ++L+     ++P  R +  +  
Sbjct: 226 -----------YELLEKDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 8e-51
 Identities = 60/311 (19%), Positives = 113/311 (36%), Gaps = 55/311 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
                 K+ +G +G V+      +   VA+K +K      E  L         +E  ++ 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---------QEAQVMK 67

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEHD--LKWLMESMKQPFSTSEVKCLMLQLLEG 129
              H  +V +  VV    + +Y+V EYM     L +L     +     ++  +  Q+  G
Sbjct: 68  KLRHEKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 130 VKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTLWYRAPEL 188
           + Y+     +HRDL+ +N+L+    V K+ DFG++R    +           + + APE 
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
            L   +++   D+WS G ++ EL    +  + G    + +D++ +    P          
Sbjct: 186 ALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--------- 235

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN-- 305
                                       P   ES  DL+ +    +PE+R T +      
Sbjct: 236 ---------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

Query: 306 HYWFHEVPLPK 316
             +F       
Sbjct: 269 EDYFTSTEPQY 279

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 9e-51
 Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 49/302 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREIN 68
           +   L K+ +G++G+V R            VA+K +K +V  + + ++       +RE+N
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DFIREVN 63

Query: 69  ILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLL 127
            + S DH +++ +  VV+     + MV E      L   +   +  F    +    +Q+ 
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY--TSLVVTLWYRA 185
           EG+ YL     +HRDL   NLLL  + ++KI DFG+ R        Y         +   
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
               L  + +S A D W  G  + E+    +  + G      + KI K            
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE----------- 230

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                               +R P           +  ++++ +   + PE R T     
Sbjct: 231 -------------------GERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

Query: 305 NH 306
           + 
Sbjct: 267 DF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 5e-50
 Identities = 62/298 (20%), Positives = 117/298 (39%), Gaps = 51/298 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           E   + +I  G +G+V+      + + VA+K ++     +ED +          E  +++
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---------EEAEVMM 55

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
              HP +V +  V ++    + +V E+MEH  L   + + +  F+   +  + L + EG+
Sbjct: 56  KLSHPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP-LKPYTSLVVTLWYRAPELL 189
            YL +  V+HRDL   N L+    V+K+ DFGM+R          T     + + +PE+ 
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 190 LGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
               +YS+  D+WS G +M E+ +  K  +   +  + ++ I                  
Sbjct: 175 SF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------------------ 215

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                          R   P        + S   + ++N      PE R      L  
Sbjct: 216 -----------STGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-49
 Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 56/302 (18%)

Query: 18  KISEGTYGIVYRA--RDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
           ++  G +G V +   R +K    VA+K +K    + +           +RE  I+   D+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------TEEMMREAQIMHQLDN 68

Query: 76  PSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
           P IV +  V   +   + +VME      L   +   ++    S V  L+ Q+  G+KYL 
Sbjct: 69  PYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126

Query: 135 DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV---TLWYRAPELLLG 191
           +   +HRDL   N+LL N+   KI DFG+S+  G+    YT+       L + APE +  
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

Query: 192 AKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG 250
            +K+S+  D+WS G  M E L+  +  +      + +  I +                  
Sbjct: 187 -RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----------------- 228

Query: 251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT---VDDALNHY 307
                        R   P       P      + L++    Y  E R     V+  +   
Sbjct: 229 ------------KRMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

Query: 308 WF 309
           ++
Sbjct: 270 YY 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 4e-49
 Identities = 56/322 (17%), Positives = 116/322 (36%), Gaps = 66/322 (20%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             E    +  G +G V  A      +     +V + + +++   +     + + E+ ++ 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95

Query: 72  SF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTS------------ 117
               H +IVN+          +Y++ EY  + DL   + S ++ FS              
Sbjct: 96  QLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 118 ----------EVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY 167
                     ++ C   Q+ +G+++L     +HRDL   N+L+ +  V+KICDFG++R  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 168 --GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV 224
              S      +  + + + APE L     Y+   D+WS G ++ E+ +     + G    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD 284
               K+ +                            N  +   P          +E  + 
Sbjct: 274 ANFYKLIQ----------------------------NGFKMDQP-------FYATEEIYI 298

Query: 285 LLNRLLTYDPEKRITVDDALNH 306
           ++     +D  KR +  +  + 
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSF 320

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  163 bits (414), Expect = 5e-49
 Identities = 44/251 (17%), Positives = 94/251 (37%), Gaps = 27/251 (10%)

Query: 13  FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS 72
           ++   +I EG++G+++   +  + + VA+K         +             E      
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----------LRDEYRTYKL 56

Query: 73  FDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
               + +        +     +V++ +   L+ L++   + FS   V     Q+L  V+ 
Sbjct: 57  LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 133 LHDNWVLHRDLKTSNLLLNNQ-----GVLKICDFGMSRQYGSPL-------KPYTSLVVT 180
           +H+  +++RD+K  N L+         ++ + DFGM + Y  P+       +   +L  T
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 181 LWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG----T 236
             Y +    LG ++ S   D+ ++G +    L     + G        K  +       T
Sbjct: 177 ARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235

Query: 237 PTETIWPGLSE 247
           P   +  G  E
Sbjct: 236 PLRELCAGFPE 246

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 63/302 (20%), Positives = 114/302 (37%), Gaps = 49/302 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             +    I  G +G V     K  G+      +K       +     F    L E +I+ 
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEASIMG 82

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            FDHP++++++ VV      V ++ E+ME+  L   +      F+  ++  ++  +  G+
Sbjct: 83  QFDHPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS-----LVVTLWYRA 185
           KYL D   +HRDL   N+L+N+  V K+ DFG+SR         T        + + + A
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
           PE +   +K+++A D+WS G +M E+++  +  +   T  D I+ I +    P       
Sbjct: 202 PEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                                               +   L+      D   R      +
Sbjct: 254 -----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 305 NH 306
           N 
Sbjct: 285 NT 286

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 5e-47
 Identities = 57/322 (17%), Positives = 115/322 (35%), Gaps = 52/322 (16%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREI 67
           EF+K+  +  G +G VY+      GE     VA+K+++     K +          L E 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-------EILDEA 62

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLL 127
            ++ S D+P +  +  + +       +        L   +   K    +  +    +Q+ 
Sbjct: 63  YVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 128 EGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTS--LVVTLWYRA 185
           +G+ YL D  ++HRDL   N+L+     +KI DFG+++  G+  K Y +    V + + A
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 186 PELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPG 244
            E +L  + Y+   D+WS G  + EL+      + G    +    + K            
Sbjct: 182 LESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------ 228

Query: 245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL 304
                               +R P       P+ +   + ++ +    D + R    + +
Sbjct: 229 -------------------GERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELI 264

Query: 305 NHYWFHEVPLPKSKDFMPTFPP 326
             +        +          
Sbjct: 265 IEFSKMARDPQRYLVIQGDERM 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 5e-47
 Identities = 61/298 (20%), Positives = 111/298 (37%), Gaps = 46/298 (15%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
             E    I EG +G V++              +K      ++C         L+E   + 
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK----TCKNCTSDSVREKFLQEALTMR 63

Query: 72  SFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGV 130
            FDHP IV +  V+ ++   V+++ME     +L+  ++  K     + +     QL   +
Sbjct: 64  QFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 131 KYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ-YGSPLKPYTSLVVTLWYRAPELL 189
            YL     +HRD+   N+L+++   +K+ DFG+SR    S     +   + + + APE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 190 LGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL 248
              +++++A D+W  G  M E+L      F G    D I +I                  
Sbjct: 182 NF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------------- 225

Query: 249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                          R   P       P    + + L+ +   YDP +R    +    
Sbjct: 226 --------------ERLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 3e-45
 Identities = 65/325 (20%), Positives = 114/325 (35%), Gaps = 77/325 (23%)

Query: 12  EFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
             E +  I EG +G V++AR       +   +VA+K +K                   RE
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-------DFQRE 66

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESM--------------- 110
             ++  FD+P+IV +  V       + ++ EYM + DL   + SM               
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 111 --------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG 162
                     P S +E  C+  Q+  G+ YL +   +HRDL T N L+    V+KI DFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185

Query: 163 MSRQY--GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFS 219
           +SR        K   +  + + +  PE +    +Y+T  D+W+ G ++ E+ +     + 
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 220 GTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLS 279
           G    + I  +              +   P                              
Sbjct: 245 GMAHEEVIYYVRD----------GNILACP--------------------------ENCP 268

Query: 280 ESGFDLLNRLLTYDPEKRITVDDAL 304
              ++L+    +  P  R +     
Sbjct: 269 LELYNLMRLCWSKLPADRPSFCSIH 293

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 9e-45
 Identities = 56/310 (18%), Positives = 105/310 (33%), Gaps = 49/310 (15%)

Query: 16  LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH 75
              I +G +G V+R + +  GE VA+K       R               EI   +   H
Sbjct: 8   QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWF---------REAEIYQTVMLRH 56

Query: 76  PSIVNVKEVVMDDHDS---VYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVK 131
            +I+        D+ +   +++V +Y EH  L   +   +   +   +  L L    G+ 
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLA 114

Query: 132 YLH--------DNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----TSLVV 179
           +LH           + HRDLK+ N+L+   G   I D G++ ++ S            V 
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 180 TLWYRAPELLLGA-----KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL 234
           T  Y APE+L  +      +     D++++G +  E+  +  +  G  E  Q+       
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 235 GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP 294
             P+      +      + N   +                S         ++      + 
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQ--------------SCEALRVMAKIMRECWYANG 279

Query: 295 EKRITVDDAL 304
             R+T     
Sbjct: 280 AARLTALRIK 289

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 8e-44
 Identities = 54/299 (18%), Positives = 113/299 (37%), Gaps = 53/299 (17%)

Query: 17  NKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF 73
             I  G +G VY      +       A+K +       E           L E  I+  F
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-------VSQFLTEGIIMKDF 85

Query: 74  DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKY 132
            HP+++++  + +    S  +V+ YM+H DL+  + +     +  ++    LQ+ +G+K+
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 133 LHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP----LKPYTSLVVTLWYRAPEL 188
           L     +HRDL   N +L+ +  +K+ DFG++R         +   T   + + + A E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 189 LLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE 247
           L   +K++T  D+WS G ++ EL+    P +      D    + +               
Sbjct: 206 LQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------------- 250

Query: 248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH 306
                            +R     +       +  ++++ +      E R +  + ++ 
Sbjct: 251 -----------------RRLLQPEY-----CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-42
 Identities = 60/302 (19%), Positives = 115/302 (38%), Gaps = 52/302 (17%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREI 67
              +   I  G +G VY+   K S       VA+K +K     K+        +  L E 
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-------VDFLGEA 60

Query: 68  NILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKW-LMESMKQPFSTSEVKCLMLQL 126
            I+  F H +I+ ++ V+      + ++ EYME+      +      FS  ++  ++  +
Sbjct: 61  GIMGQFSHHNIIRLEGVISKY-KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPYTSLVV---TLWY 183
             G+KYL +   +HRDL   N+L+N+  V K+ DFG+SR      +   +       + +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 184 RAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP 243
            APE +   +K+++A D+WS G +M E++             ++ K              
Sbjct: 180 TAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----------- 227

Query: 244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA 303
                            +  R   P            + + L+ +    +  +R    D 
Sbjct: 228 -----------------DGFRLPTP-------MDCPSAIYQLMMQCWQQERARRPKFADI 263

Query: 304 LN 305
           ++
Sbjct: 264 VS 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-42
 Identities = 64/313 (20%), Positives = 113/313 (36%), Gaps = 62/313 (19%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL 71
           + +  + I EG +G V +AR KK G  +     +M     +D            E+ +L 
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLC 65

Query: 72  SF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLM---------------ESMKQPF 114
               HP+I+N+          +Y+ +EY  H +L   +                S     
Sbjct: 66  KLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 115 STSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY 174
           S+ ++      +  G+ YL     +HRDL   N+L+    V KI DFG+SR     +K  
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-K 183

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKT 233
           T   + + + A E L     Y+T  D+WS G ++ E+++     + G T  +  +K+ + 
Sbjct: 184 TMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242

Query: 234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
                                         R   P           +  +DL+ +     
Sbjct: 243 -----------------------------YRLEKP-------LNCDDEVYDLMRQCWREK 266

Query: 294 PEKRITVDDALNH 306
           P +R +    L  
Sbjct: 267 PYERPSFAQILVS 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 6e-42
 Identities = 57/320 (17%), Positives = 112/320 (35%), Gaps = 68/320 (21%)

Query: 12  EFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
             +    +  G +G V  A         +   VA+K +K      E         + + E
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-------RALMSE 66

Query: 67  INILLSFDHPS-IVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESM-------------- 110
           + IL+   H   +VN+          + +++E+ +  +L   + S               
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 111 -KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS 169
            K   +   + C   Q+ +G+++L     +HRDL   N+LL+ + V+KICDFG++R    
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 170 P--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQ 226
                      + L + APE +   + Y+   D+WS G ++ E+ +     + G    ++
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 227 IDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLL 286
             +  K                               R R P          +   +  +
Sbjct: 246 FCRRLK----------------------------EGTRMRAP-------DYTTPEMYQTM 270

Query: 287 NRLLTYDPEKRITVDDALNH 306
                 +P +R T  + + H
Sbjct: 271 LDCWHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-40
 Identities = 65/332 (19%), Positives = 129/332 (38%), Gaps = 69/332 (20%)

Query: 12  EFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
           +     ++ +G++G+VY    K     +    VA+K V      +E        I  L E
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-------IEFLNE 73

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------QPFST 116
            +++  F+   +V +  VV        ++ME M   DLK  + S++          P S 
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 117 SEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPY 174
           S++  +  ++ +G+ YL+ N  +HRDL   N ++     +KI DFGM+R        +  
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKT 233
              ++ + + +PE L     ++T  D+WS G ++ E+    +  + G +    +  + + 
Sbjct: 193 GKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME- 250

Query: 234 LGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYD 293
                     GL + P                              +  F+L+     Y+
Sbjct: 251 ---------GGLLDKP--------------------------DNCPDMLFELMRMCWQYN 275

Query: 294 PEKRITVDDALN------HYWFHEVPLPKSKD 319
           P+ R +  + ++         F EV    S++
Sbjct: 276 PKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 7e-40
 Identities = 58/320 (18%), Positives = 104/320 (32%), Gaps = 71/320 (22%)

Query: 12  EFEKLNKISEGTYGIVYRARD-----KKSGEIVALKKVKMNVGRKEDCLEYGFPISSLRE 66
                  +  G +G V  A         +   VA+K +K +    E         + + E
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-------EALMSE 76

Query: 67  INILLSF-DHPSIVNVKEVVMDDHDSVYMVMEYMEH------------------DLKWLM 107
           + +L    +H +IVN+            ++ EY  +                      +M
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 108 ESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY 167
           E  +      ++     Q+ +G+ +L     +HRDL   N+LL +  + KICDFG++R  
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 168 --GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEV 224
              S      +  + + + APE +     Y+   D+WS G  + EL +     + G    
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFD 284
            +  K+ K                               R   P              +D
Sbjct: 255 SKFYKMIK----------------------------EGFRMLSP-------EHAPAEMYD 279

Query: 285 LLNRLLTYDPEKRITVDDAL 304
           ++      DP KR T    +
Sbjct: 280 IMKTCWDADPLKRPTFKQIV 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-37
 Identities = 50/321 (15%), Positives = 104/321 (32%), Gaps = 70/321 (21%)

Query: 12  EFEKLNKISEGTYGIVYRARDKKSGE-------IVALKKVKMNVGRKEDCLEYGFPISSL 64
                  + EG +G V  A      +        VA+K +K +   K+           +
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-------DLI 66

Query: 65  REINILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEH-DLKWLMESMKQP---------- 113
            E+ ++        +            +Y+++EY    +L+  +++ + P          
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 114 -----FSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG 168
                 S+ ++     Q+  G++YL     +HRDL   N+L+    V+KI DFG++R   
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 169 SPLKPYTSLV--VTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVD 225
                  +    + + + APE L   + Y+   D+WS G ++ E+       + G    +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245

Query: 226 QIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDL 285
               + +                               R   P          +   + +
Sbjct: 246 LFKLLKEG-----------------------------HRMDKP-------SNCTNELYMM 269

Query: 286 LNRLLTYDPEKRITVDDALNH 306
           +       P +R T    +  
Sbjct: 270 MRDCWHAVPSQRPTFKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  109 bits (274), Expect = 1e-29
 Identities = 31/208 (14%), Positives = 66/208 (31%), Gaps = 36/208 (17%)

Query: 17  NKISEGTYGIVYRARDKKSGEIVALK----------KVKMNVGRKEDCLEYGFPISSLRE 66
             + EG    V+    +K      +K          KVK      +         S+  E
Sbjct: 6   KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 67  INILLSFDHPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQL 126
              L      ++       +   +   ++ME ++    + +              ++  +
Sbjct: 65  FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENP-------DEVLDMI 112

Query: 127 LEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY----TSLVVTLW 182
           LE V   +   ++H DL   N+L++ +G+  I DF  S + G              +  +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITY 171

Query: 183 YRAPELLLGAKKYSTAVDMWSVGCIMAE 210
           +         + Y T  D+ S    + +
Sbjct: 172 FS--------RTYRTEKDINSAIDRILQ 191

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 19/130 (14%), Positives = 44/130 (33%), Gaps = 7/130 (5%)

Query: 18  KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPIS---SLREINILLSFD 74
           +I +G    V+   D++    + +K+         +     +P++   +  E + L+   
Sbjct: 33  EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE----SWPLTIDRARIESSALIRQG 88

Query: 75  HPSIVNVKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLH 134
                 V  V   D +    VME + H        ++        + +   L + + Y  
Sbjct: 89  EHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSS 148

Query: 135 DNWVLHRDLK 144
           D  +  +  K
Sbjct: 149 DYALEPKVKK 158

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	332
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.67
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.12
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.4
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.05

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-62  Score=409.92  Aligned_cols=258  Identities=31%  Similarity=0.477  Sum_probs=219.9

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|+||+||+|++..+++.||+|++........     .....+.+|+.++++++||||+++++++. 
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~-   76 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-----GVEHQLRREVEIQSHLRHPNILRLYGYFH-   76 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccCh-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEE-
Confidence            357899999999999999999999999999999999975432221     11225678999999999999999999995 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ++...|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence            44889999999997544444444678999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...  ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+.+.....          
T Consensus       157 ~~~--~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----------  223 (263)
T d2j4za1         157 PSS--RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----------  223 (263)
T ss_dssp             CCC--CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----------
T ss_pred             CCC--cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence            432  3355689999999999987 678999999999999999999999999888877777665432111          


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                 ++.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       224 ---------------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         224 ---------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ---------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                                       1237899999999999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-61  Score=419.48  Aligned_cols=277  Identities=27%  Similarity=0.440  Sum_probs=234.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||+||+|++..+|+.||||++.+.......     ....+.+|+.++++++||||+++++.+. +
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~-----~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~   76 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHTVTESRVLQNTRHPFLTALKYAFQ-T   76 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHSCCCTTBCCEEEEEE-C
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHH-----HHHHHHHHHHHHHhCCCCCEEEEEeeec-c
Confidence            578999999999999999999999999999999999865322211     1124678999999999999999999995 4


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...+|+||||++|+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            48899999999976555555557889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.......           
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~-----------  224 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-----------  224 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred             cCCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-----------
Confidence            55555667789999999999987 678999999999999999999999999998887777766542221           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC--CCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~--~~~~  321 (332)
                                                ++.+|+++++||.+||++||.+|++     ++|+++||||++++|...  +...
T Consensus       225 --------------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~  278 (337)
T d1o6la_         225 --------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL  278 (337)
T ss_dssp             --------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             --------------------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCC
Confidence                                      2237999999999999999999994     999999999999887655  3345


Q ss_pred             CCCCCccc
Q 035861          322 PTFPPQHA  329 (332)
Q Consensus       322 ~~~~~~~~  329 (332)
                      +++.|+..
T Consensus       279 ~p~~P~~~  286 (337)
T d1o6la_         279 PPFKPQVT  286 (337)
T ss_dssp             CSCCCCCS
T ss_pred             CCCCCCCC
Confidence            66666543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-62  Score=412.81  Aligned_cols=270  Identities=25%  Similarity=0.371  Sum_probs=225.0

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ...++|++++.||+|+||+||+|++..+++.||||++.........     ....+.+|+.++++++||||+++++++. 
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~-   78 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSRLDHPFFVKLYFTFQ-   78 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHHCCSTTBCCEEEEEE-
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHH-----HHHHHHHHHHHHHHcCCCCeeEEEEEEE-
Confidence            3457899999999999999999999999999999999754322211     1125679999999999999999999994 


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ++...|+||||++|+.+.......+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence            44889999999997544444444678999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ...  ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+...++.+.....        
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------  229 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--------  229 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------
T ss_pred             ccCCcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--------
Confidence            432  222345679999999999987 678999999999999999999999999988888777775432111        


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH------HhcCCCCCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD------ALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------ll~hp~f~~~~~~~~~~  319 (332)
                                                   +..+++++++||.+||+.||++|||++|      +++||||++++|....+
T Consensus       230 -----------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         230 -----------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             -----------------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             -----------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence                                         1237899999999999999999999988      58999999999988876


Q ss_pred             CC
Q 035861          320 FM  321 (332)
Q Consensus       320 ~~  321 (332)
                      ..
T Consensus       281 ~~  282 (288)
T d1uu3a_         281 QT  282 (288)
T ss_dssp             SC
T ss_pred             CC
Confidence            53

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-61  Score=409.13  Aligned_cols=256  Identities=27%  Similarity=0.449  Sum_probs=220.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      .+|++++.||+|+||+||+|++..+|+.||||++........        ..+.+|+.++++++||||+++++++.++ .
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~-~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--------ELIINEILVMRENKNPNIVNYLDSYLVG-D   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCH--------HHHHHHHHHHHHCCCTTBCCEEEEEEET-T
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHH--------HHHHHHHHHHHhCCCCCEeeEeEEEEEC-C
Confidence            479999999999999999999999999999999976543221        2467999999999999999999999555 7


Q ss_pred             eEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCC
Q 035861           91 SVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSP  170 (332)
Q Consensus        91 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~  170 (332)
                      .+|+||||++|+.+..+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        91 ~~~ivmEy~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            8999999999755555544 357999999999999999999999999999999999999999999999999999887655


Q ss_pred             CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          171 LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                      ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+........            
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~------------  236 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL------------  236 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC------------
T ss_pred             cccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence            555667789999999999987 6789999999999999999999999998888777766655432111            


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                            ..++.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       237 ----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         237 ----------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ----------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ----------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                                  112237899999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-61  Score=407.45  Aligned_cols=261  Identities=27%  Similarity=0.399  Sum_probs=212.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||+||+|++..+++.||||++........       ...+.+|+.++++++||||+++++++.++
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-------PENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-------HHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            46799999999999999999999999999999999976432211       12577999999999999999999999554


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                       ...|+||||++|+.+......++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        76 -~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          76 -NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             -TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             -ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence             8899999999974444344446789999999999999999999999999999999999999999999999999998653


Q ss_pred             CC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..  ........||+.|+|||++.+...++.++||||||+++|+|++|..||...................         
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------  225 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------  225 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Confidence            22  2234556899999999999875556788999999999999999999997765433322222211111         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                               ....+.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       226 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 -------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                                     1112337899999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-60  Score=407.46  Aligned_cols=294  Identities=40%  Similarity=0.767  Sum_probs=239.7

Q ss_pred             ccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           15 KLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        15 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      .++.||+|+||+||+|++..+|+.||||++........   .......+.+|+.++++++||||+++++++ .++...|+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-~~~~~~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA---KDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSNISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTCCEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh---hHHHHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCceee
Confidence            56889999999999999999999999999976543221   112234678999999999999999999999 44578999


Q ss_pred             EcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCCCC
Q 035861           95 VMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLKPY  174 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~~~  174 (332)
                      ||||+.|+++..+...+..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus        78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            99999999888888778889999999999999999999999999999999999999999999999999998776655556


Q ss_pred             ccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcccccc
Q 035861          175 TSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKAN  254 (332)
Q Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (332)
                      ....||+.|+|||++.....++.++||||||+++|+|++|..||.+.+..+...++.+..+.+....++...........
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            66789999999999987677899999999999999999999999999999999999998888877766655443322211


Q ss_pred             ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 035861          255 FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFM  321 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~  321 (332)
                      ... ........        .+.+++++++||.+||+.||++|||++|+|+||||++.+.+.....+
T Consensus       238 ~~~-~~~~~~~~--------~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~  295 (299)
T d1ua2a_         238 KSF-PGIPLHHI--------FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL  295 (299)
T ss_dssp             CCC-CCCCHHHH--------CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred             ccC-CCCChHHh--------cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCC
Confidence            111 10111111        23478999999999999999999999999999999988766554433

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-60  Score=412.12  Aligned_cols=273  Identities=28%  Similarity=0.451  Sum_probs=233.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.........     ....+.+|+.++++++||||+++++++.+ 
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~-   75 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-----QVEHTNDERLMLSIVTHPFIIRMWGTFQD-   75 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH-----HHHHHHHHHHHHHhccCcChhheeeeEee-
Confidence            578999999999999999999999999999999999754322111     12256789999999999999999999954 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        76 ~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          76 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             CCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            48899999999987777677778889999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..   .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+...++.......           
T Consensus       156 ~~---~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  220 (316)
T d1fota_         156 DV---TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-----------  220 (316)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-----------
T ss_pred             cc---cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence            32   345689999999999987 678999999999999999999999999998888887776543221           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC--CCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS--KDFM  321 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~--~~~~  321 (332)
                                                ++.++++++++|.+||..||.+|+     |++++++||||+++.|...  ++..
T Consensus       221 --------------------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~  274 (316)
T d1fota_         221 --------------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE  274 (316)
T ss_dssp             --------------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSC
T ss_pred             --------------------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCC
Confidence                                      123789999999999999999996     9999999999999987754  3445


Q ss_pred             CCCCCcc
Q 035861          322 PTFPPQH  328 (332)
Q Consensus       322 ~~~~~~~  328 (332)
                      +++.|+.
T Consensus       275 ~p~~p~~  281 (316)
T d1fota_         275 TPYEPPI  281 (316)
T ss_dssp             CSCCCCC
T ss_pred             cCCCCCc
Confidence            5566543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-60  Score=404.42  Aligned_cols=291  Identities=46%  Similarity=0.900  Sum_probs=241.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||+||+|++..+++.||||++.......      .....+.+|+.++++++||||+++++.+.++ 
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-   73 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHTE-   73 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh------HHHHHHHHHHHHHHhCCCCcEEEeccccccc-
Confidence            468999999999999999999999999999999996543221      1123577999999999999999999999554 


Q ss_pred             CeEEEEcccccccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...|+||||++|++...+... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+....
T Consensus        74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence            889999999999877766543 5679999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..........|++.|+|||.+.....++.++|+||||+++|+|++|+.||...+..+...++.+..+.+.+..++.....
T Consensus       154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence            65566667789999999999887677899999999999999999999999999988888888888887777766654443


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                      +.................        .+.+|.++++||++||+.||++|||++|+|+||||++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~--------~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKV--------VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHH--------STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccccchhhh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            333222222111111111        23478999999999999999999999999999999998665

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-60  Score=403.04  Aligned_cols=258  Identities=26%  Similarity=0.466  Sum_probs=217.1

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHD   90 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (332)
                      +.|++++.||+|+||+||+|++..+++.||||++.......        ...+.+|+.++++++||||+++++++.++ .
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--------LEDYMVEIDILASCDHPNIVKLLDAFYYE-N   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG--------GGGTHHHHHHHHHCCCTTBCCEEEEEEET-T
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH--------HHHHHHHHHHHHhCCCCCCCeEEEEEeeC-C
Confidence            36899999999999999999999999999999997543221        12567999999999999999999999554 7


Q ss_pred             eEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           91 SVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        91 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ..++||||++|+ +.+.+....+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            899999999865 4455555567899999999999999999999999999999999999999999999999999876533


Q ss_pred             CCCCCccccccccccchhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLG----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .........||+.|+|||++..    ...++.++||||||+++|+|++|..||...+..+...++........       
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-------  235 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-------  235 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-------
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            2223345679999999999852    35678999999999999999999999998888777777665422111       


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                 ..++.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       236 ---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         236 ---------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ---------------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ---------------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                       112237899999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.6e-60  Score=411.70  Aligned_cols=272  Identities=25%  Similarity=0.399  Sum_probs=229.6

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ....+++|++++.||+|+||+||+|++..+|+.||||++.......        ...+.+|+.++++++||||+++++++
T Consensus        21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~   92 (350)
T d1koaa2          21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--------KETVRKEIQTMSVLRHPTLVNLHDAF   92 (350)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH--------HHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh--------HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3456789999999999999999999999999999999996543211        12467899999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC--CCcEEEeecc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN--QGVLKICDFG  162 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~--~~~~~l~df~  162 (332)
                      .+ +...|+||||++| ++.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||
T Consensus        93 ~~-~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2          93 ED-DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             EE-TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             EE-CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence            54 4889999999986 566666565678999999999999999999999999999999999999964  5789999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.......+... 
T Consensus       172 ~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-  248 (350)
T d1koaa2         172 LTAHLDPK-QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-  248 (350)
T ss_dssp             TCEECCTT-SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG-
T ss_pred             hheecccc-cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-
Confidence            99876433 33455688999999999987 6789999999999999999999999999888888887776543322221 


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFM  321 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~  321 (332)
                                                      .+.+|+++++||.+||+.||++|||++|+|+||||+..+++......
T Consensus       249 --------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~  295 (350)
T d1koaa2         249 --------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI  295 (350)
T ss_dssp             --------------------------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred             --------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhC
Confidence                                            12278999999999999999999999999999999998876654433

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-60  Score=398.22  Aligned_cols=257  Identities=28%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC-
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD-   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   88 (332)
                      .++|++++.||+|+||+||+|++..+|+.||||++.........      ...+.+|+.++++++||||+++++++.+. 
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE------KQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH------HHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH------HHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            57999999999999999999999999999999999765433221      12467899999999999999999998643 


Q ss_pred             CCeEEEEcccccc-cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCCCEEEcCCCcEEEe
Q 035861           89 HDSVYMVMEYMEH-DLKWLMES---MKQPFSTSEVKCLMLQLLEGVKYLHDNW-----VLHRDLKTSNLLLNNQGVLKIC  159 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~i~~~l~~~L~~lh~~~-----i~H~di~p~Nili~~~~~~~l~  159 (332)
                      ....|+|||||+| ++.+.+..   .+..+++..++.++.||+.||+|||+.|     |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            4568999999986 55554432   3567999999999999999999999876     9999999999999999999999


Q ss_pred             ecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCC
Q 035861          160 DFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTE  239 (332)
Q Consensus       160 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  239 (332)
                      |||++..............||+.|+|||++.+ ..++.++||||||+++|+|+||..||...+..+....+.......  
T Consensus       157 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~--  233 (269)
T d2java1         157 DFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--  233 (269)
T ss_dssp             CHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--
T ss_pred             eccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            99999887554444556789999999999977 678999999999999999999999999888877777665532111  


Q ss_pred             CcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 035861          240 TIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWF  309 (332)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f  309 (332)
                                                        .+..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       234 ----------------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 ----------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                              122378999999999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-59  Score=403.27  Aligned_cols=257  Identities=28%  Similarity=0.477  Sum_probs=220.6

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCe
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDS   91 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (332)
                      .|+.++.||+|+||+||+|++..+++.||||++...........     ..+.+|+.++++++||||+++++++.++ ..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~   89 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEVRFLQKLRHPNTIQYRGCYLRE-HT   89 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHH-----HHHHHHHHHHTTCCCTTBCCEEEEEEET-TE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHH-----HHHHHHHHHHHHCCCCCEeeEEEEEEEC-CE
Confidence            59999999999999999999999999999999976543332211     2467899999999999999999998555 88


Q ss_pred             EEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCC
Q 035861           92 VYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPL  171 (332)
Q Consensus        92 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~  171 (332)
                      .|+|||||.|++++.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            999999999988887777788999999999999999999999999999999999999999999999999999986533  


Q ss_pred             CCCccccccccccchhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          172 KPYTSLVVTLWYRAPELLLG--AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       172 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                        .....||+.|+|||++.+  ...++.++||||||+++|+|++|..||.+.+..+....+........           
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------  234 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-----------  234 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence              245679999999999864  24588999999999999999999999998888777766655322111           


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                              .+..+|+++++||.+||+.||++|||++|+|+||||.+-.
T Consensus       235 ------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         235 ------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             ------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             ------------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence                                    1223789999999999999999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-59  Score=401.47  Aligned_cols=259  Identities=30%  Similarity=0.443  Sum_probs=204.4

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -+.|++++.||+|+||+||+|++..+++.||||++........       ...+.+|+.++++++||||+++++++. ++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~   79 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-------EGSMENEIAVLHKIKHPNIVALDDIYE-SG   79 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEE-CS
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-------HHHHHHHHHHHHhCCCCCCCcEEEEEE-EC
Confidence            3469999999999999999999999999999999976543221       124568999999999999999999994 45


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc---CCCcEEEeeccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN---NQGVLKICDFGMSR  165 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~---~~~~~~l~df~~~~  165 (332)
                      ...|+|||||+| +|.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+||++.   .++.+||+|||++.
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             CEEEEEEeccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            889999999996 5555554 477899999999999999999999999999999999999995   47899999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..+.. .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.+.....+..     
T Consensus       159 ~~~~~-~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  231 (307)
T d1a06a_         159 MEDPG-SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-----  231 (307)
T ss_dssp             ---------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT-----
T ss_pred             EccCC-CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc-----
Confidence            66432 33345679999999999987 678999999999999999999999999988888777776543222211     


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                  ..+.+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus       232 ----------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         232 ----------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ----------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ----------------------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                                        223479999999999999999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-59  Score=398.69  Aligned_cols=271  Identities=25%  Similarity=0.386  Sum_probs=220.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .-++|++++.||+|+||+||+|++..+|+.||||++.+.........  .....+.+|+.++++++||||+++++++ .+
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~   84 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG--VSREDIEREVSILKEIQHPNVITLHEVY-EN   84 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhh--HHHHHHHHHHHHHHhCCCCCCCcEEEEE-EE
Confidence            34569999999999999999999999999999999986544322111  1123567899999999999999999999 45


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC----cEEEeecccc
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG----VLKICDFGMS  164 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~----~~~l~df~~~  164 (332)
                      ....|+|||||+|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+||+++.++    .+|++|||++
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            588999999999754444444467899999999999999999999999999999999999998876    5999999999


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.......+..    
T Consensus       165 ~~~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----  238 (293)
T d1jksa_         165 HKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----  238 (293)
T ss_dssp             EECTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH----
T ss_pred             hhcCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch----
Confidence            876432 33455678999999999987 678999999999999999999999999988888777765543222111    


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~  317 (332)
                                                   ..+.+|+.+++||.+||+.||++|||++|+|+||||+..++...
T Consensus       239 -----------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         239 -----------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             -----------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             -----------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence                                         11237899999999999999999999999999999998776554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-58  Score=395.81  Aligned_cols=286  Identities=45%  Similarity=0.838  Sum_probs=235.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||+||+|+++ +++.||||++.......      .....+.+|+.++++++||||+++++.+..+ 
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-   72 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHTK-   72 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh------HHHHHHHHHHHHHHhCCCCcEEeeeeecccC-
Confidence            468999999999999999999986 78999999996643221      1223678999999999999999999999554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...+++++++.++++..+....+.+++..+..++.||+.||+|||+.||+||||||+||+++.++.+|++|||.+.....
T Consensus        73 ~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          73 KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            78999999999999999988889999999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCc
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELP  249 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (332)
                      .........+++.|+|||.+.....++.++|+||||+++|+|++|+.||.+.+..+...++....+.+....++......
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence            54555566789999999999876778999999999999999999999999999999999998888888777666554433


Q ss_pred             cccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          250 GAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      ..........        +.......+.+++.+++||++||+.||++|||++|+|+||||++
T Consensus       233 ~~~~~~~~~~--------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         233 KYDPNFTVYE--------PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCTTCCCCC--------CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hccccccccc--------CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            3222111111        11112223447899999999999999999999999999999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-59  Score=408.96  Aligned_cols=273  Identities=28%  Similarity=0.412  Sum_probs=229.0

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++..........     ...+.+|+.+++.++||||+++++.+..
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-----IEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC-----HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHH-----HHHHHHHHHHHHHcCCCcEeeccccccc
Confidence            34689999999999999999999999999999999997543222111     1246799999999999999999999954


Q ss_pred             CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           88 DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        88 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                       ....++|||++.|+.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       113 -~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         113 -NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence             4889999999997655445455678999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCC
Q 035861          168 GSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSE  247 (332)
Q Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
                      ...   .....||+.|+|||++.+ ..++.++|||||||++|+|+||..||.+.+......++.......+         
T Consensus       192 ~~~---~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---------  258 (350)
T d1rdqe_         192 KGR---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---------  258 (350)
T ss_dssp             SSC---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             ccc---cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC---------
Confidence            532   345689999999999987 6789999999999999999999999999888887777765432221         


Q ss_pred             CccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCC--CC
Q 035861          248 LPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKSK--DF  320 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~~--~~  320 (332)
                                                  +.+++++.+||++||+.||.+|+     +++++++||||++++|....  ..
T Consensus       259 ----------------------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~  310 (350)
T d1rdqe_         259 ----------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV  310 (350)
T ss_dssp             ----------------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             ----------------------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCC
Confidence                                        23799999999999999999995     99999999999998865442  23


Q ss_pred             CCCCCCc
Q 035861          321 MPTFPPQ  327 (332)
Q Consensus       321 ~~~~~~~  327 (332)
                      .+++.|.
T Consensus       311 ~~p~~p~  317 (350)
T d1rdqe_         311 EAPFIPK  317 (350)
T ss_dssp             CCSCCCC
T ss_pred             CcCccCC
Confidence            4445444

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.6e-59  Score=406.06  Aligned_cols=263  Identities=24%  Similarity=0.409  Sum_probs=223.9

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      +..+++|++++.||+|+||+||+|++..+|+.||||++........        ..+.+|+.++++++||||+++++++.
T Consensus        25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--------~~~~~Ei~il~~l~HpnIv~~~~~~~   96 (352)
T d1koba_          25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--------YTVKNEISIMNQLHHPKLINLHDAFE   96 (352)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH--------HHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHH--------HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3456789999999999999999999999999999999875432111        14668999999999999999999995


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEc--CCCcEEEeeccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLN--NQGVLKICDFGM  163 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~--~~~~~~l~df~~  163 (332)
                       ++..+|+|||||+| +|.+.+.....++++.+++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+
T Consensus        97 -~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_          97 -DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             -CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             -ECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence             45889999999996 45555555556799999999999999999999999999999999999998  568999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...... .......|++.|+|||++.+ ..++.++|||||||++|+|+||..||.+.+..+....+.......+...  
T Consensus       176 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--  251 (352)
T d1koba_         176 ATKLNPD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA--  251 (352)
T ss_dssp             CEECCTT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST--
T ss_pred             ceecCCC-CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--
Confidence            9876432 33455688999999999987 6789999999999999999999999999988888888776543333221  


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                                                     .+.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus       252 -------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         252 -------------------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             -------------------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                                           233799999999999999999999999999999998743

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=404.97  Aligned_cols=274  Identities=28%  Similarity=0.459  Sum_probs=224.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHh-hCCCCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILL-SFDHPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~   88 (332)
                      +++|++++.||+|+||+||+|++..+++.||||++.+.........     ..+..|...+. .++||||+++++++.+ 
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~-----~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-   74 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV-----ECTMVEKRVLSLAWEHPFLTHMFCTFQT-   74 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCH-----HHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHH-----HHHHHHHHHHHHhCCCCcEEEEEEEEcc-
Confidence            4689999999999999999999999999999999976432111111     13446666654 6899999999999954 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      +...|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus        75 ~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          75 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            48899999999975544455557789999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......           
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-----------  222 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-----------  222 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred             cccccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence            55556667789999999999987 678999999999999999999999999988888777765432211           


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCCCCCC--CCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD-DALNHYWFHEVPLPKS--KDFMPTFP  325 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~hp~f~~~~~~~~--~~~~~~~~  325 (332)
                                                ++.+|+++++||.+||+.||++||+++ ++++||||+++++...  ....+++.
T Consensus       223 --------------------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~~pp~~  276 (320)
T d1xjda_         223 --------------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFR  276 (320)
T ss_dssp             --------------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC---
T ss_pred             --------------------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCCCCCCC
Confidence                                      123799999999999999999999996 8999999999876533  33344454


Q ss_pred             Cc
Q 035861          326 PQ  327 (332)
Q Consensus       326 ~~  327 (332)
                      |+
T Consensus       277 p~  278 (320)
T d1xjda_         277 PK  278 (320)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=389.69  Aligned_cols=256  Identities=21%  Similarity=0.309  Sum_probs=207.6

Q ss_pred             hcc-cccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc--
Q 035861           11 FEF-EKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD--   87 (332)
Q Consensus        11 ~~y-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   87 (332)
                      .+| ++.++||+|+||+||+|++..++..||+|++..........      ..+.+|++++++++||||+++++++..  
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER------QRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHH------HHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHH------HHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            345 67778999999999999999999999999997654433221      246789999999999999999999853  


Q ss_pred             -CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCEEEc-CCCcEEEeeccc
Q 035861           88 -DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNW--VLHRDLKTSNLLLN-NQGVLKICDFGM  163 (332)
Q Consensus        88 -~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~--i~H~di~p~Nili~-~~~~~~l~df~~  163 (332)
                       +...+|+||||++|+.+.........+++..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence             34568999999997555444444678999999999999999999999999  99999999999997 478999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +.....  .......||+.|+|||++.+  .++.++||||||+++|+|++|..||..........+.+.... .+.    
T Consensus       162 a~~~~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~-~~~----  232 (270)
T d1t4ha_         162 ATLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPA----  232 (270)
T ss_dssp             GGGCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCG----
T ss_pred             ceeccC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC-CCc----
Confidence            986433  23346689999999999875  589999999999999999999999987654443333222110 000    


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFH  310 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~  310 (332)
                                                   ..+..+++++++||.+||+.||++|||++|+|+||||+
T Consensus       233 -----------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 -----------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                         01123688999999999999999999999999999996

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-58  Score=406.34  Aligned_cols=270  Identities=21%  Similarity=0.346  Sum_probs=215.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ++++|++++.||+|+||+||+|++..+|+.||||++.............  ......++.+++.++||||+.+++++.+ 
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~--~~~e~~~~~~l~~~~hpnIv~l~~~~~~-   78 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDCPFIVCMSYAFHT-   78 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHH--HHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHH--HHHHHHHHHHHhcCCCCcEEEEEEEEEE-
Confidence            4689999999999999999999999999999999997543211111000  0012244677788899999999999954 


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ....|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            48899999999965444444457789999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      ..  ......||+.|+|||++..+..++.++|||||||++|+|+||..||...+..+... +.....             
T Consensus       159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~-------------  222 (364)
T d1omwa3         159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL-------------  222 (364)
T ss_dssp             SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSS-------------
T ss_pred             CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcc-------------
Confidence            43  23456799999999999865678999999999999999999999998754332222 111111             


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRIT-----VDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~hp~f~~~~~~~~  317 (332)
                                          ......+..+|+++++||.+||+.||.+|||     ++|+++||||++++|...
T Consensus       223 --------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~  276 (364)
T d1omwa3         223 --------------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  276 (364)
T ss_dssp             --------------------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred             --------------------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence                                1111223348999999999999999999999     799999999999886544

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-58  Score=389.68  Aligned_cols=267  Identities=28%  Similarity=0.401  Sum_probs=223.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCccccc-ccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCL-EYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      .++|++++.||+|+||+||+|++..+++.||||++........... .......+.+|+.++++++ ||||+++++++. 
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-   80 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence            4689999999999999999999999999999999987654332111 1112235678999999996 999999999995 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ++...|+||||++| +|.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            55889999999986 56555544 67899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccccchhhhcC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLG-----AKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      .+.. .......||+.|+|||.+.+     ...++.++||||+|+++|+|++|..||.+.+.......+.......+.. 
T Consensus       160 ~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-  237 (277)
T d1phka_         160 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP-  237 (277)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred             ccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-
Confidence            6543 33455679999999999863     3457889999999999999999999999998888777776653322211 


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEV  312 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~  312 (332)
                                                      ..+.+|+++++||.+||+.||++|||++|||+||||++.
T Consensus       238 --------------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 --------------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             --------------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             --------------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                            122379999999999999999999999999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=405.13  Aligned_cols=296  Identities=24%  Similarity=0.355  Sum_probs=214.2

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      -++|++++.||+|+||+||+|++..+|+.||+|++........       ...+.+|+.++++++||||+++++++.++ 
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-   76 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-------RNQIIRELQVLHECNSPYIVGFYGAFYSD-   76 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-------HHHHHHHGGGGGGCCCTTBCCEEEEEECS-
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-------HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-
Confidence            4689999999999999999999999999999999976432211       12567899999999999999999999544 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...|+||||++|+.+..+....+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|....
T Consensus        77 ~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            8899999999975444444446789999999999999999999997 599999999999999999999999999998653


Q ss_pred             CCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HcCCCCCC----ccc
Q 035861          169 SPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFK-TLGTPTET----IWP  243 (332)
Q Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~-~~~~~~~~----~~~  243 (332)
                      ..  ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......... ..+.....    ...
T Consensus       157 ~~--~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         157 DS--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HH--TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CC--ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            22  2245689999999999988 6799999999999999999999999987654432211111 11100000    000


Q ss_pred             CCCCCc-cccccccCCchhhhhhhCCC-CccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          244 GLSELP-GAKANFAKQPYNLLRKRFPA-ASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       244 ~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      ...... .................... ........+|.++++||.+||+.||.+|||++|+|+||||++..+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence            000000 00000000000111111111 11112234788999999999999999999999999999998755443

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=387.30  Aligned_cols=290  Identities=40%  Similarity=0.726  Sum_probs=232.7

Q ss_pred             ccchhcccccccccccCcEEEEEEEECCC-CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC---CCCCeeeee
Q 035861            7 CRSVFEFEKLNKISEGTYGIVYRARDKKS-GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF---DHPSIVNVK   82 (332)
Q Consensus         7 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~   82 (332)
                      |+..++|++++.||+|+||+||+|++..+ ++.||||++.........      ...+.+|+.+++.+   +||||++++
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~   76 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLF   76 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------HHHHHHHHHHHHHHhhcCCCCcceee
Confidence            66778999999999999999999999765 667999999765433221      12455777776655   799999999


Q ss_pred             eeEEc----CCCeEEEEcccccccHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEE
Q 035861           83 EVVMD----DHDSVYMVMEYMEHDLKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLK  157 (332)
Q Consensus        83 ~~~~~----~~~~~~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~  157 (332)
                      +++..    .....++++|+++|+++..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCee
Confidence            98843    3357899999999987665443 456799999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 035861          158 ICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTP  237 (332)
Q Consensus       158 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  237 (332)
                      |+|||.+..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+....+.+
T Consensus       157 l~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         157 LADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             ECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecchhhhhhhcc-cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999999876532 234456789999999999987 678999999999999999999999999999999999998888777


Q ss_pred             CCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          238 TETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ....++............          ..........+.+++.+++||.+||+.||++|||++|+|+||||+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHS----------KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCC----------CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             chhcccccccchhhhhcc----------ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            766555433322211111          0111112223457899999999999999999999999999999998764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=382.43  Aligned_cols=289  Identities=42%  Similarity=0.752  Sum_probs=237.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++|++++.||+|+||+||+|++..+++.||||++........      ....+.+|+.+++.++||||+++++.+... 
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~niv~~~~~~~~~-   73 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLHDVLHSD-   73 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT------HHHHHHHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH------HHHHHHHHHHHHHhcCcCCEEeeccccccc-
Confidence            4689999999999999999999999999999999976543221      122567999999999999999999999554 


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCC
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGS  169 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~  169 (332)
                      ...+++++++.|+.+..+....+.+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+.....
T Consensus        74 ~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          74 KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            78899999999998888888888999999999999999999999999999999999999999999999999999988766


Q ss_pred             CCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHcCCCCCCcccCCCCC
Q 035861          170 PLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFS-GTTEVDQIDKIFKTLGTPTETIWPGLSEL  248 (332)
Q Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (332)
                      .........++..|+|||.+.....++.++||||||+++|+|++|..||. ..+..+....+....+.+....++.....
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            55555666788999999999876778999999999999999999999854 55666677777777777766655554433


Q ss_pred             ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          249 PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      ..........        .........+.+++.+++||++||+.||.+|||++|+|+||||+++.
T Consensus       234 ~~~~~~~~~~--------~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         234 PDYKPYPMYP--------ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TTCCCCCCCC--------TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccc--------ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            2221111110        01122223345789999999999999999999999999999999854

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=393.10  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=220.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||+||+|++..+++.||||++.......         ..+.+|+.++++++||||+++++++.+ 
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~---------~~~~~Ei~il~~l~HpnIv~~~~~~~~-   72 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---------VLVKKEISILNIARHRNILHLHESFES-   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH---------HHHHHHHHHHHHSCCTTBCCEEEEEEE-
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH---------HHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence            4678999999999999999999999999999999997543211         135689999999999999999999954 


Q ss_pred             CCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC--CcEEEeeccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ--GVLKICDFGMSR  165 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~--~~~~l~df~~~~  165 (332)
                      +..+|+|||||+| ++.+.+......+++.+++.++.||+.||+|||++||+||||||+||+++.+  +.++|+|||.+.
T Consensus        73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhh
Confidence            4889999999996 5666665555579999999999999999999999999999999999999854  489999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ..... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.+.....+...    
T Consensus       153 ~~~~~-~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----  226 (321)
T d1tkia_         153 QLKPG-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----  226 (321)
T ss_dssp             ECCTT-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH----
T ss_pred             ccccC-CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh----
Confidence            76432 33455678999999999887 6789999999999999999999999999998888888876543333221    


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                                                   .+.+|+++++||.+||..||.+|||++|+|+||||++
T Consensus       227 -----------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 -----------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -----------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -----------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                                         1237899999999999999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=386.03  Aligned_cols=299  Identities=41%  Similarity=0.765  Sum_probs=234.5

Q ss_pred             cccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            6 GCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         6 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .|..+++|++++.||+|+||+||+|++..+|+.||||++.......      ....++.+|+.++++++|||++++++++
T Consensus         5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~h~nii~~~~~~   78 (318)
T d3blha1           5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEIC   78 (318)
T ss_dssp             TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT------SSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch------HHHHHHHHHHHHHHHhcCCCccceEeee
Confidence            4677899999999999999999999999999999999987654322      1223567999999999999999999998


Q ss_pred             EcC-------CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEE
Q 035861           86 MDD-------HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKI  158 (332)
Q Consensus        86 ~~~-------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l  158 (332)
                      ...       ....|+|||++++++..........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        79 ~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          79 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             EC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred             ecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEe
Confidence            543       2468999999999988877777788999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCC----CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 035861          159 CDFGMSRQYGSP----LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTL  234 (332)
Q Consensus       159 ~df~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  234 (332)
                      +|||++......    ........||+.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+....
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~  238 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  238 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999765321    2233445789999999999876778999999999999999999999999999988888888887


Q ss_pred             CCCCCCcccCCCCCcccccc-ccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 035861          235 GTPTETIWPGLSELPGAKAN-FAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~  313 (332)
                      +.+................. ............+.      ....++.+++||.+||+.||++|||++|+|+||||+.-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHH------HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhc------cccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence            77766655444332211100 00000000000000      001467888999999999999999999999999999765


Q ss_pred             CCC
Q 035861          314 LPK  316 (332)
Q Consensus       314 ~~~  316 (332)
                      .|+
T Consensus       313 ~p~  315 (318)
T d3blha1         313 MPS  315 (318)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-57  Score=381.50  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=210.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC--CCCeeeeeeeEEc
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD--HPSIVNVKEVVMD   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~   87 (332)
                      -++|++.+.||+|+||+||+|++..+++.||||++...........  .....+.+|+.++++++  ||||+++++++. 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh--hHHHHHHHHHHHHHHhccCCCCccEEEEEEe-
Confidence            4689999999999999999999999999999999987654332211  11234678999999986  899999999994 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCC-CcEEEeeccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQ-GVLKICDFGMSR  165 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~-~~~~l~df~~~~  165 (332)
                      +....++|||++.+ +.+.........+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence            44889999999975 3333333446789999999999999999999999999999999999999855 799999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....  .......||+.|+|||++.+...++.++||||||+++|+|++|..||...+      .+.+...          
T Consensus       160 ~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~----------  221 (273)
T d1xwsa_         160 LLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV----------  221 (273)
T ss_dssp             ECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC----------
T ss_pred             eccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc----------
Confidence            6543  234566899999999999875556788999999999999999999997532      2222110          


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                                                 ..++.+|+++++||.+||+.||++|||++|+|+||||+++..|
T Consensus       222 ---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         222 ---------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             ---------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence                                       1123379999999999999999999999999999999987644

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=388.55  Aligned_cols=286  Identities=34%  Similarity=0.580  Sum_probs=227.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc--
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD--   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   87 (332)
                      ..+|+.++.||+|+||+||+|++..+|+.||||++.....            ...+|+.++++++|+||+++++++..  
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~   86 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSG   86 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence            3489999999999999999999999999999999965421            22379999999999999999999843  


Q ss_pred             ---CCCeEEEEcccccccHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEee
Q 035861           88 ---DHDSVYMVMEYMEHDLKWLME---SMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICD  160 (332)
Q Consensus        88 ---~~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~d  160 (332)
                         +..+.|+||||+++++...+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus        87 ~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             -CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred             ccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEec
Confidence               334689999999998755543   3466799999999999999999999999999999999999999875 899999


Q ss_pred             cccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          161 FGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       161 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ||++...... .......|+..|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+.+..+.+...
T Consensus       167 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         167 FGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             CTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            9999876432 334556889999999998876789999999999999999999999999999999888888877766654


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPK  316 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~  316 (332)
                      .+.......... .....       ..........+.+++++++||.+||..||++|||+.|+|+||||+++..+.
T Consensus       246 ~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         246 QIREMNPNYTEF-KFPQI-------KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             HHHHHCC---CC-CCCCC-------CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hhhhhccchhhc-ccccc-------ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence            332211100000 00000       000001112344789999999999999999999999999999999876544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-56  Score=387.69  Aligned_cols=294  Identities=33%  Similarity=0.553  Sum_probs=224.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.........      ...+.+|+.++++++||||+++++++...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF------AKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHH------HHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHH------HHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            456999999999999999999999999999999999754332211      12467899999999999999999998544


Q ss_pred             C-----CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           89 H-----DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        89 ~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                      +     ..+|+||||+++++.....  +..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++++|||.
T Consensus        90 ~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccccceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence            2     3579999999777665543  46799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +...+..   .....|++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.++...+.
T Consensus       168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            9876543   3456789999999999876778999999999999999999999999999988888888877766654433


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      .+.......      .................+.+++.+++||.+||..||.+|||+.|+|+||||++++.+....
T Consensus       245 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~  314 (346)
T d1cm8a_         245 RLQSDEAKN------YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP  314 (346)
T ss_dssp             TCSCHHHHH------HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred             hhcchhhhh------hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence            222110000      0000000001111122345789999999999999999999999999999999987554433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=362.93  Aligned_cols=249  Identities=23%  Similarity=0.393  Sum_probs=211.6

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|+||+||+|+++ ++..||||++.......         ..+.+|+..+++++||||+++++++.+ +
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---------~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~   71 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---------DEFIEEAKVMMNLSHEKLVQLYGVCTK-Q   71 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---------HHHHHHHHHHHTCCCTTBCCEEEEECC-S
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---------HHHHHHHHHHHhcCCCceeeEEEEEee-C
Confidence            468999999999999999999985 67789999998654322         156799999999999999999999844 4


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||+++ ++...+......+++..++.++.|+++||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            789999999985 5666666667789999999999999999999999999999999999999999999999999997654


Q ss_pred             CC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      .. ........+|+.|+|||.+.+ ..++.++||||||+++|||+| |+.||...+..+....+......+         
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---------  221 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---------  221 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred             CCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            32 223345678999999999987 678999999999999999998 899999988887777665432211         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                 .+..+++++.+||.+||+.||++|||+++|++|
T Consensus       222 ---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         222 ---------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                       122378899999999999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=366.38  Aligned_cols=255  Identities=20%  Similarity=0.276  Sum_probs=202.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|+||+||+|+.+   ..||||++.........      ...+.+|+.++++++||||+++++++ .+ 
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~~~~-~~-   75 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQ------LQAFKNEVGVLRKTRHVNILLFMGYS-TA-   75 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTH------HHHHHHHHHHHTTCCCTTBCCEEEEE-CS-
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeeeeEEE-ec-
Confidence            468999999999999999999865   35999999765433321      12567899999999999999999987 33 


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++| ++.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            457899999985 6666666666789999999999999999999999999999999999999999999999999997653


Q ss_pred             CC--CCCCccccccccccchhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          169 SP--LKPYTSLVVTLWYRAPELLLGA--KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       169 ~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..  ........||+.|+|||++.+.  ..++.++||||||+++|||+||..||.+.+..............++.     
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-----  230 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-----  230 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----
Confidence            22  2233456789999999998642  35799999999999999999999999887666555544433211111     


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                ....+..+++++.+||.+||+.||++|||+.||+++
T Consensus       231 --------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 --------------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                      111233478999999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=383.37  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=206.7

Q ss_pred             cccchhcccccc-cccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhh-CCCCCeeeeee
Q 035861            6 GCRSVFEFEKLN-KISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLS-FDHPSIVNVKE   83 (332)
Q Consensus         6 ~~~~~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~   83 (332)
                      ....+++|++++ .||+|+||+||+|++..+++.||||++....             .+.+|+.++.+ ++||||+++++
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------------~~~~E~~~~~~~~~hpnIv~l~~   72 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------------KARREVELHWRASQCPHIVRIVD   72 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH-------------HHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH-------------HHHHHHHHHHHhcCCCCCCeEEE
Confidence            344678999986 5999999999999999999999999986321             34589988654 58999999999


Q ss_pred             eEEc---CCCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CCc
Q 035861           84 VVMD---DHDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QGV  155 (332)
Q Consensus        84 ~~~~---~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~~  155 (332)
                      ++.+   .+..+|+|||||+| +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++.   .+.
T Consensus        73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~  152 (335)
T d2ozaa1          73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI  152 (335)
T ss_dssp             EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCC
T ss_pred             EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccc
Confidence            8843   34678999999985 666666553 356999999999999999999999999999999999999985   467


Q ss_pred             EEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 035861          156 LKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLG  235 (332)
Q Consensus       156 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  235 (332)
                      +||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|+||..||.+.+.......+.....
T Consensus       153 ~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~  230 (335)
T d2ozaa1         153 LKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  230 (335)
T ss_dssp             EEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC
T ss_pred             ccccccceeeeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh
Confidence            999999999876433 33456689999999999876 6789999999999999999999999987655444333322110


Q ss_pred             CCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 035861          236 TPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHE  311 (332)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~  311 (332)
                      ....                             ..+....+.+|+++++||.+||+.||++|||+.|+|+||||.+
T Consensus       231 ~~~~-----------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         231 MGQY-----------------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             SCSS-----------------------------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             cCCC-----------------------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            0000                             0000111237899999999999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=364.27  Aligned_cols=249  Identities=23%  Similarity=0.416  Sum_probs=197.7

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|+||+||+|.+. +++.||||++.......         ..+.+|+..+++++||||+++++++..+ 
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---------~~~~~E~~~l~~l~HpnIv~~~g~~~~~-   72 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---------EDFIEEAEVMMKLSHPKLVQLYGVCLEQ-   72 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---------HHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---------HHHHHHHHHHHhcCCCCcccccceeccC-
Confidence            468999999999999999999986 46789999987543222         2467999999999999999999999554 


Q ss_pred             CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||+++ ++.+.+......+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++...
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheecc
Confidence            778999999986 5566666666779999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          169 SPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ... .......||+.|+|||++.+ ..++.++||||||+++|||+| |.+||...+..+....+.......         
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---------  222 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------  222 (263)
T ss_dssp             ------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---------
T ss_pred             CCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---------
Confidence            332 22334578899999999987 678999999999999999999 566676666666666655432111         


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                 .+..+++++.+|+.+||+.||++|||++||++|
T Consensus       223 ---------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         223 ---------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                       122368899999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-54  Score=369.12  Aligned_cols=262  Identities=22%  Similarity=0.346  Sum_probs=207.9

Q ss_pred             cchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861            8 RSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus         8 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ..-++|++++.||+|+||+||+|.+..+++.||||++...........     ..+.+|+.+++.++||||+++++++..
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~-----~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY-----LRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHH-----HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHH-----HHHHHHHHHHHhcCCCCCCcccceeee
Confidence            445689999999999999999999999999999999976543322211     246799999999999999999999865


Q ss_pred             CC---CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           88 DH---DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        88 ~~---~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      ..   ...|+||||++|+.+.......+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhh
Confidence            43   358999999997655555555788999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCC---CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCc
Q 035861          165 RQYGSP---LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETI  241 (332)
Q Consensus       165 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (332)
                      ......   ........||+.|+|||++.+ ..++.++||||||+++|+|+||..||...+..+...++......++.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-  236 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-  236 (277)
T ss_dssp             EECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG-
T ss_pred             hhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch-
Confidence            654322   123445679999999999987 678999999999999999999999999988887777766543322211 


Q ss_pred             ccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-CHHHHhcCCCC
Q 035861          242 WPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-TVDDALNHYWF  309 (332)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~hp~f  309 (332)
                                                      ..+.+|+++.+||.+||++||++|| |++++ .|+|.
T Consensus       237 --------------------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         237 --------------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             --------------------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             --------------------------------hccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence                                            2234799999999999999999999 55555 45554

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-54  Score=367.82  Aligned_cols=250  Identities=22%  Similarity=0.342  Sum_probs=203.9

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.......         ..+.+|+.++++++||||+++++++.+ .
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~-~   85 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---------EEFLKEAAVMKEIKHPNLVQLLGVCTR-E   85 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH---------HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH---------HHHHHHHHHHHhCCCCCEecCCccEee-C
Confidence            458899999999999999999999999999999986543221         246799999999999999999999954 4


Q ss_pred             CeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||+++ ++.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            778999999995 566655543 467899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC-CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccCCC
Q 035861          168 GSPLK-PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLS  246 (332)
Q Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (332)
                      ..... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||..........+.....            
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------------  232 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------  232 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT------------
T ss_pred             CCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC------------
Confidence            43322 2334457889999999987 678999999999999999999777665544443333333221            


Q ss_pred             CCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          247 ELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                             .....++.+++++.+||.+||+.||++|||++||++
T Consensus       233 -----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 -----------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             -----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                   111122347899999999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=381.26  Aligned_cols=295  Identities=34%  Similarity=0.533  Sum_probs=220.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc-
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD-   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   87 (332)
                      .+++|++++.||+|+||+||+|++..+|+.||||++..........      ..+.+|+.++++++||||+++++++.. 
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~------~~~~~Ei~il~~l~hpnIv~~~~~f~~~   88 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA------KRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHH------HHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHH------HHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence            3478999999999999999999999999999999997654332211      146799999999999999999999853 


Q ss_pred             ----CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccc
Q 035861           88 ----DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGM  163 (332)
Q Consensus        88 ----~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~  163 (332)
                          .....|+||||+.|+++..+   ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++++|||.
T Consensus        89 ~~~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          89 KTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             cccccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence                33679999999999987765   35689999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          164 SRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      +..... ........+|+.|+|||++.+ ..++.++||||+|+++|+|++|..||.+.+.......+......+....+.
T Consensus       166 ~~~~~~-~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         166 ARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             ----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccc-ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            876543 233455678999999999987 678999999999999999999999999999888888888877666555444


Q ss_pred             CCCCCcccccccc-CCchhhhhhhCCCCc----cCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 035861          244 GLSELPGAKANFA-KQPYNLLRKRFPAAS----FTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPL  314 (332)
Q Consensus       244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~  314 (332)
                      ............. ...........+...    .......++++++||++||..||++|||++|+|+||||+.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence            3322111000000 000000000011100    0011124678899999999999999999999999999998654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=377.41  Aligned_cols=300  Identities=33%  Similarity=0.561  Sum_probs=229.8

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc--
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD--   87 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   87 (332)
                      .++|++++.||+|+||+||+|++..+|+.||||++..........      ..+.+|+.++++++|||++++++++..  
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA------KRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHH------HHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHH------HHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            368999999999999999999999999999999997544322211      146789999999999999999999843  


Q ss_pred             ---CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           88 ---DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        88 ---~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                         +...+++++++.+|+|.+.+.  .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence               223456666666567666553  457999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          165 RQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ....   .......|++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+.......
T Consensus       169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            7653   2334567899999999988767789999999999999999999999999999988888888776665543332


Q ss_pred             CCCCccccc--cccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 035861          245 LSELPGAKA--NFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKDFMP  322 (332)
Q Consensus       245 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~~~~  322 (332)
                      .........  ..........        ......+++++++||.+||..||.+|||++|+|+||||+++..++......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~  317 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNF--------ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD  317 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCH--------HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC
T ss_pred             ccchhhhhhhhhcccCCCcch--------hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC
Confidence            221110000  0000000000        001234789999999999999999999999999999999988777666555


Q ss_pred             CCCCcc
Q 035861          323 TFPPQH  328 (332)
Q Consensus       323 ~~~~~~  328 (332)
                      ++...+
T Consensus       318 ~~~~~~  323 (348)
T d2gfsa1         318 PYDQSF  323 (348)
T ss_dssp             CCCCGG
T ss_pred             CCCCcc
Confidence            554443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-54  Score=377.32  Aligned_cols=289  Identities=25%  Similarity=0.448  Sum_probs=215.4

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEc
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMD   87 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   87 (332)
                      ..++|++++.||+|+||+||+|++..+++.||||++....           ...+.+|+.+++.+. ||||+.+++++..
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~  101 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD  101 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence            5578999999999999999999999999999999986422           114568999999995 9999999999853


Q ss_pred             -CCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC-cEEEeeccccc
Q 035861           88 -DHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG-VLKICDFGMSR  165 (332)
Q Consensus        88 -~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~-~~~l~df~~~~  165 (332)
                       .....++||||++++.+..   ..+.+++..++.++.||+.||+|||++||+|+||||+|||++.++ .++|+|||.+.
T Consensus       102 ~~~~~~~~v~e~~~~~~L~~---~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         102 PVSRTPALVFEHVNNTDFKQ---LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             TTTCSEEEEEECCCSCBGGG---TTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             cCCCceeEEEeecCCCcHHH---HhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence             3467999999999765432   246799999999999999999999999999999999999999765 69999999998


Q ss_pred             ccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCCCcccC
Q 035861          166 QYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE-VDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      ..... .......+|+.|+|||.+.+...++.++|+||+|+++|++++|..||..... .+....+....+.+....+..
T Consensus       179 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         179 FYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             ECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            76433 3345667899999999998867789999999999999999999999976543 333333333322111000000


Q ss_pred             ---CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 035861          245 ---LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLP  315 (332)
Q Consensus       245 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~  315 (332)
                         ......................   ........+++++++||++||..||++|||++|+|+||||+++.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERF---VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGG---CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             hcccccCcccchhcccccccchhhc---ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence               0000000000000000000000   1111223378899999999999999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=367.34  Aligned_cols=253  Identities=21%  Similarity=0.354  Sum_probs=204.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      .++|++++.||+|+||+||+|.++ ++..||||++.......         ..+.+|+.++++++||||+++++++ .+ 
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---------~~~~~E~~~l~~l~HpnIv~~~g~~-~~-   79 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---------DAFLAEANLMKQLQHQRLVRLYAVV-TQ-   79 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---------HHHHHHHHHHHHCCCTTBCCEEEEE-CS-
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH---------HHHHHHHHHHHhCCCCCEeEEEeee-cc-
Confidence            368999999999999999999986 56789999986543222         2578999999999999999999987 44 


Q ss_pred             CeEEEEcccccccHHHH-HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccccc
Q 035861           90 DSVYMVMEYMEHDLKWL-MESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQY  167 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~-~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~  167 (332)
                      ...++||||++++.+.. +... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence            44689999999654443 3222 236999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          168 GSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      .... .......|++.|+|||++.+ ..++.++||||||+++|||+||. +||...+..+....+......         
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~---------  229 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---------  229 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             cCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence            4332 23344578899999999986 56899999999999999999965 455555655555554432111         


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN--HYWFHE  311 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~f~~  311 (332)
                                                 ..+..+++++.+|+.+||+.||++|||+++|++  |+||+.
T Consensus       230 ---------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         230 ---------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                       112337899999999999999999999999998  788864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-55  Score=375.98  Aligned_cols=281  Identities=24%  Similarity=0.405  Sum_probs=220.8

Q ss_pred             chhcccccccccccCcEEEEEEEEC---CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC-CCeeeeeee
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDK---KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PSIVNVKEV   84 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~   84 (332)
                      .+++|++++.||+|+||+||+|++.   .+|+.||||++.........    .....+.+|+.++++++| |||+.+++.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch----HHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            4689999999999999999999873   46899999999764332211    112256789999999977 799999999


Q ss_pred             EEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           85 VMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      +.+ ....+++|||+.|+.+.......+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus        98 ~~~-~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_          98 FQT-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEE-TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ecc-CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence            844 4789999999997555444555778899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCCCccccccccccchhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          165 RQYGSP-LKPYTSLVVTLWYRAPELLLGA-KKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ...... ........|++.|+|||.+... ..++.++||||||+++|+|++|..||...+..+....+.+.....     
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-----  251 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----  251 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----
Confidence            765322 2234456789999999999753 357889999999999999999999998765554444444321100     


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI-----TVDDALNHYWFHEVPLPKS  317 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~hp~f~~~~~~~~  317 (332)
                                                  ....++.+|+++++||.+||++||++||     +++|+++||||+++++.+.
T Consensus       252 ----------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l  303 (322)
T d1vzoa_         252 ----------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL  303 (322)
T ss_dssp             ----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ----------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHH
Confidence                                        0111234899999999999999999999     4899999999999886554


Q ss_pred             --CCCCCCCCCc
Q 035861          318 --KDFMPTFPPQ  327 (332)
Q Consensus       318 --~~~~~~~~~~  327 (332)
                        +...+++.|.
T Consensus       304 ~~~~~~~p~~p~  315 (322)
T d1vzoa_         304 AAKKVPAPFKPV  315 (322)
T ss_dssp             HTTCSCCSCCCC
T ss_pred             HhCCCCcCCCCC
Confidence              3455666553

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=365.26  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=208.7

Q ss_pred             hccccccc-ccccCcEEEEEEEECC--CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEc
Q 035861           11 FEFEKLNK-ISEGTYGIVYRARDKK--SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMD   87 (332)
Q Consensus        11 ~~y~~~~~-lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (332)
                      ++|.+.+. ||+|+||+||+|.+..  ++..||||++.......  .     ...+.+|+.++++++||||+++++++. 
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~--~-----~~~~~~E~~il~~l~HpnIv~l~g~~~-   79 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--D-----TEEMMREAQIMHQLDNPYIVRLIGVCQ-   79 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH--H-----HHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH--H-----HHHHHHHHHHHHhCCCCCEeeEeeeec-
Confidence            46778874 9999999999998754  45579999986543211  1     125679999999999999999999884 


Q ss_pred             CCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           88 DHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        88 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      + ...|+||||++| ++.+.+...+..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence            3 457899999996 55555566567899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          167 YGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ......   ......||+.|+|||++.+ ..++.++||||||+++|||+| |..||...+..+....+.+...       
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-------  230 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------  230 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-------
T ss_pred             ccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            643222   2234568899999999987 578999999999999999998 8999998887766665543321       


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHH---hcCCCCCCCCC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA---LNHYWFHEVPL  314 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~hp~f~~~~~  314 (332)
                                                   ...++.+++++.+||.+||+.||++|||+.+|   |+|+|+.....
T Consensus       231 -----------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         231 -----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             -----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             -----------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence                                         11234489999999999999999999999888   67888754333

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=373.15  Aligned_cols=290  Identities=37%  Similarity=0.632  Sum_probs=223.8

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC-
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH-   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   89 (332)
                      .+|++++.||+|+||+||+|.++.+|+.||||++.......  .     ...+++|+.++++++||||+++++++..+. 
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~-----~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--Y-----CQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHH--H-----HHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChH--H-----HHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            47999999999999999999999999999999997533211  1     124678999999999999999999985432 


Q ss_pred             ---CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           90 ---DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        90 ---~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                         ..+|++++.++|+|.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence               34778888777888777654  4799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC---CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          167 YGSPL---KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      .....   .......|++.|+|||++.....++.++||||+|+++|+|++|..||...+..+...........+......
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            53221   223456789999999999776778999999999999999999999999988888777777665555433222


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCC----ccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAA----SFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNHYWFHEVPLPKSKD  319 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~f~~~~~~~~~~  319 (332)
                      ........          ......+..    .....+.+++++++||.+||+.||.+|||++|+|+||||++...+....
T Consensus       239 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~  308 (345)
T d1pmea_         239 CIINLKAR----------NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP  308 (345)
T ss_dssp             TCCCHHHH----------HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC
T ss_pred             hhhhhhhh----------cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc
Confidence            11111000          000000000    0011234788999999999999999999999999999999877655443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=364.61  Aligned_cols=249  Identities=26%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             ccccccCcEEEEEEEEC--CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCCCeEEE
Q 035861           17 NKISEGTYGIVYRARDK--KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        17 ~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l   94 (332)
                      ++||+|+||+||+|.+.  .+++.||||++.........      ...+.+|+.++++++||||+++++++ ++ ...++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~g~~-~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL------KDELLAEANVMQQLDNPYIVRMIGIC-EA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHH------HHHHHHHHHHHHTCCCTTBCCEEEEE-ES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHH------HHHHHHHHHHHHhCCCCCCceEEEEe-cc-CCEEE
Confidence            46999999999999864  45678999999654322211      12578999999999999999999988 44 45789


Q ss_pred             EcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccCCCCC--
Q 035861           95 VMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--  172 (332)
Q Consensus        95 v~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~~~~~--  172 (332)
                      ||||++|+.+..+......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......  
T Consensus        85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999755555555578899999999999999999999999999999999999999999999999999986543322  


Q ss_pred             -CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCCCCCcc
Q 035861          173 -PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGLSELPG  250 (332)
Q Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (332)
                       ......||+.|+|||.+.+ ..++.++||||||+++|||+| |..||.+.+..+....+.+...               
T Consensus       165 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---------------  228 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------------  228 (277)
T ss_dssp             EC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred             ccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence             1233568899999999987 678999999999999999998 8999998887766665543211               


Q ss_pred             ccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHH---hcCCCCC
Q 035861          251 AKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDA---LNHYWFH  310 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~hp~f~  310 (332)
                                           ...++.+++++.+||.+||+.||++|||+++|   |+|+|+.
T Consensus       229 ---------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 ---------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                                 11223478999999999999999999999998   4566553

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-53  Score=363.09  Aligned_cols=253  Identities=25%  Similarity=0.377  Sum_probs=196.2

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCc---EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGE---IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ..++|++.+.||+|+||+||+|.+..+++   .||||.+........       ...+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-------RRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHH-------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHH-------HHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            35689999999999999999999976664   578887754322111       12467999999999999999999999


Q ss_pred             EcCCCeEEEEcccccccH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEHDL-KWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .. ....++||||++|+. .+.+....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_          97 TK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             CS-SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             ee-CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence            44 477899999999754 4445555667999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC-----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 035861          165 RQYGSPLK-----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPT  238 (332)
Q Consensus       165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  238 (332)
                      +.......     ......+|+.|+|||.+.+ ..++.++||||||+++|||+| |..||...+..+....+......  
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--  252 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL--  252 (299)
T ss_dssp             --------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            86533211     1223457889999999987 678999999999999999998 89999988887776666543211  


Q ss_pred             CCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          239 ETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                        ..+..++.++.+||.+||+.||++|||+.||+++
T Consensus       253 ----------------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 ----------------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                              1223478999999999999999999999998765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=359.88  Aligned_cols=255  Identities=23%  Similarity=0.383  Sum_probs=201.9

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      ..++|++.+.||+|+||+||+|+++.+ ..||||++.......         ..+.+|+.++++++||||+++++++ .+
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---------~~~~~E~~~l~~l~h~nIv~~~g~~-~~   83 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---------EAFLQEAQVMKKLRHEKLVQLYAVV-SE   83 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---------HHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---------HHHHHHHHHHHhcccCCEeEEEEEE-ec
Confidence            357999999999999999999999754 569999997543322         2577999999999999999999988 44


Q ss_pred             CCeEEEEccccccc-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEHD-LKWLMES-MKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~~-l~~~~~~-~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                       ...++||||++++ +...+.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus        84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence             4468999999975 4444433 245799999999999999999999999999999999999999999999999999976


Q ss_pred             cCCC-CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCCCcccC
Q 035861          167 YGSP-LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL-FSGTTEVDQIDKIFKTLGTPTETIWPG  244 (332)
Q Consensus       167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
                      .... ........|++.|+|||++.. ..++.++||||||+++|||++|..| +......+....+......        
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--------  233 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------  233 (285)
T ss_dssp             -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred             ccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence            5332 223344678999999999987 6789999999999999999996555 4555555555555433211        


Q ss_pred             CCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCCC
Q 035861          245 LSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN--HYWFHEV  312 (332)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~f~~~  312 (332)
                                                  +.++.+++++++||.+||+.||++||++++|++  ++||...
T Consensus       234 ----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 ----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                                        122347899999999999999999999999998  8999764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=368.52  Aligned_cols=252  Identities=22%  Similarity=0.363  Sum_probs=202.4

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc-----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeee
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE-----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEV   84 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (332)
                      ++|++++.||+|+||+||+|++..+++     .||+|++........       ...+.+|+.+++++ +||||++++++
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-------REALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH-------HHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            589999999999999999999875543     689998865432211       22567899999888 89999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESMK----------------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHR  141 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~  141 (332)
                      +. +....++|||||+| ++.+.+....                      ..+++..++.++.||+.||+|||++||+||
T Consensus       110 ~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         110 CT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EC-SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             Ee-eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            94 44778999999986 5655554432                      348999999999999999999999999999


Q ss_pred             cCCCCCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 035861          142 DLKTSNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLF  218 (332)
Q Consensus       142 di~p~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf  218 (332)
                      ||||+||+++.++.+||+|||+++.......  ......||+.|+|||++.+ ..++.++||||||+++|||+| |..||
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCC
Confidence            9999999999999999999999976543222  2235567999999999987 678999999999999999998 89999


Q ss_pred             CCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCC
Q 035861          219 SGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRI  298 (332)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  298 (332)
                      .+.+......++.....                                   ..+.+..+++++++||.+||+.||++||
T Consensus       268 ~~~~~~~~~~~~~~~~~-----------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RP  312 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGF-----------------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRP  312 (325)
T ss_dssp             TTCCCSHHHHHHHHTTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCHHHHHHHHHhcCC-----------------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCc
Confidence            88766655555544311                                   1122334789999999999999999999


Q ss_pred             CHHHHhcC
Q 035861          299 TVDDALNH  306 (332)
Q Consensus       299 s~~ell~h  306 (332)
                      |++||++|
T Consensus       313 t~~ei~~~  320 (325)
T d1rjba_         313 SFPNLTSF  320 (325)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=360.64  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=199.7

Q ss_pred             hcccccccccccCcEEEEEEEECCCCc----EEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGE----IVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .+|++++.||+|+||+||+|.+..+|+    +||+|.+.......       ....+.+|+.++++++||||+++++++.
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~g~~~   81 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-------ANKEILDEAYVMASVDNPHVCRLLGICL   81 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-------THHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            589999999999999999999987776    57777775332111       1225789999999999999999999996


Q ss_pred             cCCCeEEEEcccc-cccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYM-EHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      ++ .. +++++++ .|++.+.+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        82 ~~-~~-~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          82 TS-TV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             SS-SE-EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             cC-Ce-eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence            54 44 4555555 567888888878889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCC--CccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcc
Q 035861          166 QYGSPLKP--YTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIW  242 (332)
Q Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (332)
                      ........  .....||+.|+|||++.+ ..++.++||||||+++|||+| |..||...+..+....+.+....      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~------  232 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------  232 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC------
T ss_pred             ecccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            76433222  233467999999999987 678999999999999999998 78999887766665555443211      


Q ss_pred             cCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          243 PGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                    ..++.+++++.+|+.+||+.||.+|||+.||++|
T Consensus       233 ------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                          1223478999999999999999999999999988

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=352.24  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=195.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC----cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG----EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      .+.|++.+.||+|+||+||+|.+..++    ..||||++........       ...+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-------RVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH-------HHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence            457999999999999999999987554    4699999865432211       12467999999999999999999999


Q ss_pred             EcCCCeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      .+. ...++|||++.++ +.+.+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus        79 ~~~-~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          79 SKY-KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             CSS-SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ecC-CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence            544 7789999999875 45555565678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCCC
Q 035861          165 RQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPL-FSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      +.......   ......||+.|+|||++.+ ..++.++||||||+++|||+++..| +...+..+....+.....     
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-----  231 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-----  231 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-----
Confidence            87543222   2234467899999999987 6799999999999999999996555 555555555444433211     


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                     ...+..++.++.+||.+||+.||++|||+.||++
T Consensus       232 -------------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 -------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                           1122337889999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-53  Score=352.87  Aligned_cols=246  Identities=23%  Similarity=0.397  Sum_probs=198.0

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcC
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+++|++++.||+|+||.||+|.++  |..||||++.....          ...+.+|++.+++++||||+++++++.++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH----------HHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            5679999999999999999999986  78999999964321          12567999999999999999999998776


Q ss_pred             CCeEEEEcccccc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861           89 HDSVYMVMEYMEH-DLKWLMESM-KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus        89 ~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      ...+|+||||+++ ++.+.+... ...+++..++.++.||+.||+|||+.+++||||||+||+++.++.++++|||.+..
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence            6778999999986 555555443 24589999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCcccCC
Q 035861          167 YGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWPGL  245 (332)
Q Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (332)
                      ....   .....++..|+|||++.+ ..++.++||||||+++|||+| |..||...+..+....+.+..           
T Consensus       153 ~~~~---~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-----------  217 (262)
T d1byga_         153 ASST---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------  217 (262)
T ss_dssp             ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------
T ss_pred             cCCC---CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            5432   234567889999999987 678999999999999999998 788888777766666553321           


Q ss_pred             CCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          246 SELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                               ..+.++.+++++.+||.+||+.||.+|||+.+|+++
T Consensus       218 -------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 -------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                                     111233478999999999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=354.32  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=196.5

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC---cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEE
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG---EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVM   86 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (332)
                      .++|++++.||+|+||+||+|++..++   ..||||.+.......  .     ...+.+|+.++++++||||+++++++ 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~--~-----~~~~~~E~~~l~~l~HpnIv~l~~~~-   77 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--V-----REKFLQEALTMRQFDHPHIVKLIGVI-   77 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH--H-----HHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHH--H-----HHHHHHHHHHHHhCCCCCEeeEEEEE-
Confidence            468999999999999999999986543   467888775432211  1     12567999999999999999999988 


Q ss_pred             cCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeeccccc
Q 035861           87 DDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSR  165 (332)
Q Consensus        87 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~  165 (332)
                      .+ ...++||||+++ ++.+.+......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus        78 ~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          78 TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             ec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence            43 567899999986 5555566667789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCCccc
Q 035861          166 QYGSPL-KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ...... .......||+.|+|||++.+ ..++.++||||||+++|||++ |..||...+..+....+......       
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-------  228 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------  228 (273)
T ss_dssp             --------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred             eccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            754322 22344567899999999987 678999999999999999998 89999988887777666543211       


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                   ..++.+|+++.+||.+||+.||++|||++||++|
T Consensus       229 -----------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                         1233489999999999999999999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=352.45  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=198.7

Q ss_pred             chhcccccccccccCcEEEEEEEECCC---CcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKS---GEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (332)
                      ...+|++++.||+|+||+||+|+...+   ...||||++...........     ..+.+|+.++++++||||+++++++
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~-----~~~~~Ei~~l~~l~H~nIv~~~g~~   80 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-----DDFIREVNAMHSLDHRNLIRLYGVV   80 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHH-----HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHH-----HHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            356899999999999999999987533   23689999876543332222     2578999999999999999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccc
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMS  164 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~  164 (332)
                      . + ...++||||+++ ++.+.+....+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~-~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          81 L-T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             C-S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             e-e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence            4 4 356899999984 667677776778999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC---CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCCC
Q 035861          165 RQYGSPLK---PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTTEVDQIDKIFKTLGTPTET  240 (332)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (332)
                      ........   ......++..|+|||++.+ ..++.++||||||+++|||+| |..||.+.+..+....+.+....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~----  233 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER----  233 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC----
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC----
Confidence            87644322   1223457889999999987 678999999999999999998 89999998888877766543211    


Q ss_pred             cccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          241 IWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                                                     .+.++.+++++.+||.+||+.||++|||+.||++
T Consensus       234 -------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 -------------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                           1123347899999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=351.42  Aligned_cols=254  Identities=21%  Similarity=0.376  Sum_probs=193.6

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++++.||+|+||+||+|.+..     +++.||||++.........       ..+..|...+.++ .|+||+.+++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~-------~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-------RALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHH-------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHH-------HHHHHHHHHHHhhcCCCeEEEeee
Confidence            3689999999999999999999754     4468999998654322211       1355777777666 6889999999


Q ss_pred             eEEcCCCeEEEEcccccc-cHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 035861           84 VVMDDHDSVYMVMEYMEH-DLKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSN  147 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~N  147 (332)
                      .+.+++...++|||||+| ++.+.+...               ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence            987777789999999995 555555432               2358999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChH
Q 035861          148 LLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEV  224 (332)
Q Consensus       148 ili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg-~~pf~~~~~~  224 (332)
                      ||++.++.+||+|||+++......  .......||+.|+|||++.+ ..++.++||||||+++|||+|| ..||......
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999997653322  22345678999999999987 6789999999999999999986 5678776555


Q ss_pred             HHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHh
Q 035861          225 DQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDAL  304 (332)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  304 (332)
                      +...........+                                   ..+..+++++++||.+||+.||++|||++||+
T Consensus       244 ~~~~~~~~~~~~~-----------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil  288 (299)
T d1ywna1         244 EEFCRRLKEGTRM-----------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  288 (299)
T ss_dssp             HHHHHHHHHTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhcCCCC-----------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            5444444331111                                   11233789999999999999999999999999


Q ss_pred             cC
Q 035861          305 NH  306 (332)
Q Consensus       305 ~h  306 (332)
                      +|
T Consensus       289 ~~  290 (299)
T d1ywna1         289 EH  290 (299)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=352.58  Aligned_cols=252  Identities=24%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             chhcccccccccccCcEEEEEEEECCCCcE--EEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeeeeE
Q 035861            9 SVFEFEKLNKISEGTYGIVYRARDKKSGEI--VALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKEVV   85 (332)
Q Consensus         9 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (332)
                      .+++|++.+.||+|+||+||+|+++.++..  ||||.+........       ...+.+|+.+++++ +||||+++++++
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-------HHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            567999999999999999999999888775  56666643222111       22578999999998 799999999999


Q ss_pred             EcCCCeEEEEcccccc-cHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEE
Q 035861           86 MDDHDSVYMVMEYMEH-DLKWLMESM---------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLL  149 (332)
Q Consensus        86 ~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nil  149 (332)
                      .++ ...++||||++| ++.+.+...               ...+++..+..++.||+.||.|||+.|++||||||+|||
T Consensus        81 ~~~-~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL  159 (309)
T d1fvra_          81 EHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  159 (309)
T ss_dssp             EET-TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ecC-CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence            654 889999999996 555554322               357999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHH
Q 035861          150 LNNQGVLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK-PLFSGTTEVDQID  228 (332)
Q Consensus       150 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~-~pf~~~~~~~~~~  228 (332)
                      ++.++.+||+|||++...... .......||..|+|||.+.. ..++.++||||||+++|||++|. .||...+..+...
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EcCCCceEEcccccccccccc-ccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999999765332 22234568899999999987 67899999999999999999975 5677777766655


Q ss_pred             HHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          229 KIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                      .+.+...                                    ...+..+++++.+||.+||+.||++|||++||+++
T Consensus       238 ~i~~~~~------------------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 KLPQGYR------------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HGGGTCC------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCC------------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5533211                                    11223478999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-50  Score=343.67  Aligned_cols=267  Identities=20%  Similarity=0.237  Sum_probs=209.9

Q ss_pred             CcccccccchhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeee
Q 035861            1 MNMLQGCRSVFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVN   80 (332)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   80 (332)
                      |++-.|.    +|++++.||+|+||+||+|++..+++.||||++......          ..+..|+++++.+.|++++.
T Consensus         1 ~~~~vg~----rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~   66 (299)
T d1ckia_           1 MELRVGN----RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIP   66 (299)
T ss_dssp             CCCEETT----TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCC
T ss_pred             CCCeECC----EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----------HHHHHHHHHHHHccCCCccc
Confidence            5555554    799999999999999999999999999999998754322          14678999999999888777


Q ss_pred             eeeeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC---CCcEE
Q 035861           81 VKEVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN---QGVLK  157 (332)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~---~~~~~  157 (332)
                      .+..+..+....++|||++++++...+......+++..+..++.|++.||+|||++||+||||||+||+++.   +..++
T Consensus        67 ~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vk  146 (299)
T d1ckia_          67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY  146 (299)
T ss_dssp             CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred             EEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceee
Confidence            766666777889999999999998888887889999999999999999999999999999999999999864   45799


Q ss_pred             EeecccccccCCCC-------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 035861          158 ICDFGMSRQYGSPL-------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQIDKI  230 (332)
Q Consensus       158 l~df~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~~~~  230 (332)
                      |+|||++.......       .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             eeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence            99999998764322       12345579999999999987 67899999999999999999999999876554433332


Q ss_pred             HHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHH---HHhcCC
Q 035861          231 FKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVD---DALNHY  307 (332)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---ell~hp  307 (332)
                      ......                             ..........+.+|+++.+||.+||+.+|++||++.   ++|+|+
T Consensus       226 ~~~~~~-----------------------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         226 ERISEK-----------------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHHH-----------------------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HHhhcc-----------------------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            211000                             000000001223789999999999999999999976   557887


Q ss_pred             CCCC
Q 035861          308 WFHE  311 (332)
Q Consensus       308 ~f~~  311 (332)
                      |.++
T Consensus       277 ~~~~  280 (299)
T d1ckia_         277 FHRQ  280 (299)
T ss_dssp             HHHH
T ss_pred             HHHc
Confidence            7654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-50  Score=346.54  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=202.5

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|++++.||+|+||+||+|++..     +++.||||++........       ...+.+|+.++++++||||+.+++.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-------QADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHH-------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHH-------HHHHHHHHHHHHhcCCCCcccceee
Confidence            3589999999999999999999753     557899999865432111       1256799999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESM-----------------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLH  140 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H  140 (332)
                      +.. ....+++||++++ ++.+.+...                       ...+++..+..++.||+.||+|||+.|++|
T Consensus        85 ~~~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH  163 (301)
T d1lufa_          85 CAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  163 (301)
T ss_dssp             ECS-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ecc-CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence            954 4778999999985 555555432                       124899999999999999999999999999


Q ss_pred             ccCCCCCEEEcCCCcEEEeecccccccCCC--CCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCC-CC
Q 035861          141 RDLKTSNLLLNNQGVLKICDFGMSRQYGSP--LKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKK-PL  217 (332)
Q Consensus       141 ~di~p~Nili~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~-~p  217 (332)
                      |||||+|||++.++.+||+|||++......  ........+++.|+|||.+.+ ..++.++||||||+++|||++|. .|
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999765322  222335578899999999987 67999999999999999999985 67


Q ss_pred             CCCCChHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCC
Q 035861          218 FSGTTEVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKR  297 (332)
Q Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  297 (332)
                      |...+..+....+......                                    ..+..+++++.+||.+||+.||++|
T Consensus       243 ~~~~~~~e~~~~v~~~~~~------------------------------------~~p~~~~~~~~~li~~cl~~~P~~R  286 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGNIL------------------------------------ACPENCPLELYNLMRLCWSKLPADR  286 (301)
T ss_dssp             TTTSCHHHHHHHHHTTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCCHHHHHHHHHcCCCC------------------------------------CCCccchHHHHHHHHHHcCCChhHC
Confidence            8888877777666543211                                    1123478999999999999999999


Q ss_pred             CCHHHHhc
Q 035861          298 ITVDDALN  305 (332)
Q Consensus       298 ps~~ell~  305 (332)
                      ||+.||++
T Consensus       287 Pt~~ev~~  294 (301)
T d1lufa_         287 PSFCSIHR  294 (301)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=343.77  Aligned_cols=251  Identities=21%  Similarity=0.367  Sum_probs=198.1

Q ss_pred             hhcccccccccccCcEEEEEEEECCCC-------cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSG-------EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNV   81 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   81 (332)
                      .++|++++.||+|+||.||+|+...++       ..||||++........       ...+.+|...+.++ +||||+++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-------LSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-------HHHHHHHHHHHHHhcCCCeEEec
Confidence            479999999999999999999976544       3799999975432221       12456788888777 89999999


Q ss_pred             eeeEEcCCCeEEEEcccccc-cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861           82 KEVVMDDHDSVYMVMEYMEH-DLKWLMESMK---------------QPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                      ++++.++ ...++||||+++ ++.+.+....               ..+++..++.++.||+.||+|||++||+||||||
T Consensus        85 ~~~~~~~-~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp  163 (299)
T d1fgka_          85 LGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  163 (299)
T ss_dssp             EEEECSS-SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             ccccccC-CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence            9999554 778999999986 4555554332               3589999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCC--CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPL--KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +|||++.++.+||+|||.+.......  .......+++.|+|||.+.+ +.++.++||||||+++|+|++ |..||...+
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999999999999999988664322  22344578899999999987 679999999999999999998 788888877


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ..+....+.....                                    ...++.+++++.+||.+||+.||++|||+.|
T Consensus       243 ~~~~~~~i~~~~~------------------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~e  286 (299)
T d1fgka_         243 VEELFKLLKEGHR------------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  286 (299)
T ss_dssp             HHHHHHHHHTTCC------------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHcCCC------------------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHH
Confidence            7666555433211                                    1122347899999999999999999999999


Q ss_pred             Hhc
Q 035861          303 ALN  305 (332)
Q Consensus       303 ll~  305 (332)
                      |++
T Consensus       287 il~  289 (299)
T d1fgka_         287 LVE  289 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=342.52  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=196.3

Q ss_pred             ccccccccccCcEEEEEEEECCCC---cEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeeeEEcCC
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSG---EIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEVVMDDH   89 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (332)
                      +++.+.||+|+||+||+|++..++   ..||||++.......  .     ...+.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~--~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~  101 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--E-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSE  101 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHH--H-----HHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHH--H-----HHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence            344678999999999999986543   368999986432211  1     125789999999999999999999987776


Q ss_pred             CeEEEEccccccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecccccccC
Q 035861           90 DSVYMVMEYMEHD-LKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFGMSRQYG  168 (332)
Q Consensus        90 ~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~~~~~~~  168 (332)
                      ...++||||++++ +.+.+......+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            7899999999965 445555556678899999999999999999999999999999999999999999999999998653


Q ss_pred             CCCC----CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCCCccc
Q 035861          169 SPLK----PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT-EVDQIDKIFKTLGTPTETIWP  243 (332)
Q Consensus       169 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  243 (332)
                      ....    ......||..|+|||.+.+ ..++.++||||||+++|||+||..||.... ..+....+....         
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~---------  251 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------  251 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC---------
T ss_pred             ccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            3211    2233568899999999887 678999999999999999999888776543 222333332221         


Q ss_pred             CCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhcC
Q 035861          244 GLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALNH  306 (332)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  306 (332)
                                                 ....++.+++++.+||.+||+.||++||++.||++|
T Consensus       252 ---------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ---------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                       111223478899999999999999999999999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=344.65  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=210.5

Q ss_pred             hhcccccccccccCcEEEEEEEECC-----CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCeeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKK-----SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIVNVKEV   84 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (332)
                      .++|++.+.||+|+||+||+|.++.     ++..||||++........       ...+.+|+.++++++||||++++++
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~-------~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-------RIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-------HHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHH-------HHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            4799999999999999999998853     356899999864332211       1246799999999999999999999


Q ss_pred             EEcCCCeEEEEcccccc-cHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCC
Q 035861           85 VMDDHDSVYMVMEYMEH-DLKWLMESM---------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQG  154 (332)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~  154 (332)
                      +.. ....++||||+++ ++.+.+...         ...+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus        92 ~~~-~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          92 VSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             ECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             Eec-CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            944 4778999999985 454544332         13478999999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 035861          155 VLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAK-KPLFSGTTEVDQIDKIF  231 (332)
Q Consensus       155 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg-~~pf~~~~~~~~~~~~~  231 (332)
                      ++||+|||++........  ......+++.|+|||.+.+ ..++.++|+||||+++|||+|| ..||...+..+....+.
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999976533222  2233468899999999987 6789999999999999999998 57888888877777665


Q ss_pred             HHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc------
Q 035861          232 KTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN------  305 (332)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~------  305 (332)
                      +....                                    ..++.+++.+.+||.+||+.||++|||+++|++      
T Consensus       250 ~~~~~------------------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         250 EGGLL------------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             TTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             hCCCC------------------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43211                                    112337889999999999999999999999998      


Q ss_pred             CCCCCCCCC
Q 035861          306 HYWFHEVPL  314 (332)
Q Consensus       306 hp~f~~~~~  314 (332)
                      +|+|++++.
T Consensus       294 ~~~~~~~~~  302 (308)
T d1p4oa_         294 EPGFREVSF  302 (308)
T ss_dssp             CTTHHHHCS
T ss_pred             CCCCcCCCC
Confidence            788876553

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=338.59  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=202.5

Q ss_pred             hhcccccccccccCcEEEEEEEEC-----CCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-CCCCeeeeee
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDK-----KSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-DHPSIVNVKE   83 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   83 (332)
                      .++|++.+.||+|+||.||+|++.     .+++.||||++........       ...+.+|+.+++.+ +||||+++++
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------REALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-------HHHHHHHHHHHHhccCCCCEEEEEE
Confidence            368999999999999999999863     4667899999975432211       12467899999998 6999999999


Q ss_pred             eEEcCCCeEEEEccccccc-HHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 035861           84 VVMDDHDSVYMVMEYMEHD-LKWLMESM-----------------KQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKT  145 (332)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~-----------------~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p  145 (332)
                      ++. +....++||||++|+ +.+.+...                 ...+++..+..++.||+.||+|||++|++||||||
T Consensus        95 ~~~-~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp  173 (311)
T d1t46a_          95 ACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (311)
T ss_dssp             EEC-SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEe-eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence            994 447789999999864 44444432                 22589999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeecccccccCCCCC--CCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 035861          146 SNLLLNNQGVLKICDFGMSRQYGSPLK--PYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLA-KKPLFSGTT  222 (332)
Q Consensus       146 ~Nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~llt-g~~pf~~~~  222 (332)
                      +||+++.++.++++|||.+........  ......||+.|+|||.+.+ ..++.++||||||+++|+|+| |.+||...+
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987643322  2344678999999999987 678999999999999999998 566666666


Q ss_pred             hHHHHHHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHH
Q 035861          223 EVDQIDKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDD  302 (332)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  302 (332)
                      ..+...++......+.                                   .+..++.++.+||.+||+.||.+|||+++
T Consensus       253 ~~~~~~~~i~~~~~~~-----------------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         253 VDSKFYKMIKEGFRML-----------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             SSHHHHHHHHHTCCCC-----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhcCCCCC-----------------------------------CcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            6555555554321111                                   12237899999999999999999999999


Q ss_pred             Hhc
Q 035861          303 ALN  305 (332)
Q Consensus       303 ll~  305 (332)
                      |++
T Consensus       298 il~  300 (311)
T d1t46a_         298 IVQ  300 (311)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-47  Score=327.37  Aligned_cols=250  Identities=19%  Similarity=0.261  Sum_probs=202.0

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCC-CCeeeeeeeEEcCC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDH-PSIVNVKEVVMDDH   89 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~   89 (332)
                      ++|++++.||+|+||+||+|++..+|+.||||++......          ..+.+|++.++.+.| +|++.+++++. ..
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~   73 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQ-EG   73 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEE-ET
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEee-cC
Confidence            4899999999999999999999999999999988654321          145689999999965 88888888884 45


Q ss_pred             CeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcC-----CCcEEEeecccc
Q 035861           90 DSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNN-----QGVLKICDFGMS  164 (332)
Q Consensus        90 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~-----~~~~~l~df~~~  164 (332)
                      ...++|||++++++.+.+......+++..+..++.|++.||+|||++||+||||||+||+++.     ++.++|+|||++
T Consensus        74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            889999999999998888877778999999999999999999999999999999999999974     578999999999


Q ss_pred             cccCCCC-------CCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHc
Q 035861          165 RQYGSPL-------KPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTTE---VDQIDKIFKTL  234 (332)
Q Consensus       165 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~~---~~~~~~~~~~~  234 (332)
                      .......       .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.....   ......+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            8653221       12345679999999999987 6799999999999999999999999975433   22233332211


Q ss_pred             -CCCCCCcccCCCCCccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCCCCCCCHHHHhc
Q 035861          235 -GTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDPEKRITVDDALN  305 (332)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  305 (332)
                       ..+..                                 ...+.+++++.+++..|++.+|++||+.+.+.+
T Consensus       233 ~~~~~~---------------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 QSTPLR---------------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHSCHH---------------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCCChH---------------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             00000                                 012337889999999999999999998666543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=325.97  Aligned_cols=259  Identities=21%  Similarity=0.232  Sum_probs=184.6

Q ss_pred             hcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchh--HHHHHHhhCCCCCeeeeeeeEEcC
Q 035861           11 FEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSL--REINILLSFDHPSIVNVKEVVMDD   88 (332)
Q Consensus        11 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~   88 (332)
                      .+|.+.+.||+|+||+||+|+..  |+.||||++......           ...  .|+..+..++||||+++++++..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~-----------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~   69 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-----------SWFREAEIYQTVMLRHENILGFIAADNKD   69 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHH-----------HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-----------HHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence            47889999999999999999975  889999998643211           122  345555678999999999999654


Q ss_pred             C---CeEEEEcccccc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccccCCCCCEEEcCCCcE
Q 035861           89 H---DSVYMVMEYMEH-DLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD--------NWVLHRDLKTSNLLLNNQGVL  156 (332)
Q Consensus        89 ~---~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~--------~~i~H~di~p~Nili~~~~~~  156 (332)
                      .   ...|+||||+++ ++.+.+..  .++++..+..++.|++.||+|||+        +||+||||||+||||+.++.+
T Consensus        70 ~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          70 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence            3   258999999986 55555543  469999999999999999999996        599999999999999999999


Q ss_pred             EEeecccccccCCCCC----CCccccccccccchhhhcCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 035861          157 KICDFGMSRQYGSPLK----PYTSLVVTLWYRAPELLLGAK-----KYSTAVDMWSVGCIMAELLAKKPLFSGTTEVDQI  227 (332)
Q Consensus       157 ~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-----~~~~~sDi~slG~~l~~lltg~~pf~~~~~~~~~  227 (332)
                      ||+|||++........    ......||+.|+|||++.+..     .++.++||||||+++|||+||..||.........
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            9999999887643222    233567899999999987532     2577899999999999999999887543211000


Q ss_pred             HHHHHHcCCCCCCcccCCCCCccccccccCCchhhhhhhCCC--CccCC-----CCCCCchHHHHHHHhcCCCCCCCCCH
Q 035861          228 DKIFKTLGTPTETIWPGLSELPGAKANFAKQPYNLLRKRFPA--ASFTG-----SPVLSESGFDLLNRLLTYDPEKRITV  300 (332)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~  300 (332)
                                    .....        ...............  .....     .......+.+|+.+||+.||++|||+
T Consensus       228 --------------~~~~~--------~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  285 (303)
T d1vjya_         228 --------------YYDLV--------PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             --------------TTTTS--------CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             --------------hhhcc--------cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH
Confidence                          00000        000000000000000  00000     01123458899999999999999999


Q ss_pred             HHHhcC
Q 035861          301 DDALNH  306 (332)
Q Consensus       301 ~ell~h  306 (332)
                      .||+++
T Consensus       286 ~ei~~~  291 (303)
T d1vjya_         286 LRIKKT  291 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-46  Score=332.27  Aligned_cols=285  Identities=25%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             cccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-----------CCCeee
Q 035861           12 EFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-----------HPSIVN   80 (332)
Q Consensus        12 ~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~   80 (332)
                      +|++++.||+|+||+||+|++..+|+.||||++.......         ....+|+.+++.+.           |+||++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~---------~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---------EAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH---------HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccch---------HHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            6999999999999999999999999999999997542211         13457888777764           578998


Q ss_pred             eeeeEEc-CCCeEEEEcccc--cccHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCEEEcCCC-
Q 035861           81 VKEVVMD-DHDSVYMVMEYM--EHDLKW-LMESMKQPFSTSEVKCLMLQLLEGVKYLHD-NWVLHRDLKTSNLLLNNQG-  154 (332)
Q Consensus        81 ~~~~~~~-~~~~~~lv~e~~--~~~l~~-~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~-~~i~H~di~p~Nili~~~~-  154 (332)
                      +++++.. +....++++.++  .++... ........+++..++.++.||+.||+|||+ .||+|+||||+|||++.++ 
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence            9888743 234444555444  344333 334445779999999999999999999997 8999999999999998765 


Q ss_pred             -----cEEEeecccccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------h
Q 035861          155 -----VLKICDFGMSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIMAELLAKKPLFSGTT------E  223 (332)
Q Consensus       155 -----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~~lltg~~pf~~~~------~  223 (332)
                           .++++|||.+.....   ......|++.|+|||++.. ..++.++|+||+|+++++|++|+.||....      .
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             ccccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence                 499999999876532   2345679999999999987 678999999999999999999999997542      3


Q ss_pred             HHHHHHHHHHcCCCCCCcccCCCCC---------ccccccccCCchhhhhhhCCCCccCCCCCCCchHHHHHHHhcCCCC
Q 035861          224 VDQIDKIFKTLGTPTETIWPGLSEL---------PGAKANFAKQPYNLLRKRFPAASFTGSPVLSESGFDLLNRLLTYDP  294 (332)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  294 (332)
                      .+.....+...+.++..........         .................    .........++++++||.+||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT----EKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH----HTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc----cccccCcccCHHHHHHHHHHCCCCh
Confidence            3444445555554433322111000         00000000000000000    0111223357789999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCC
Q 035861          295 EKRITVDDALNHYWFHEVP  313 (332)
Q Consensus       295 ~~Rps~~ell~hp~f~~~~  313 (332)
                      .+|||++|+|+||||++..
T Consensus       317 ~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         317 RKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             TTCBCHHHHHTCGGGTTCT
T ss_pred             hHCcCHHHHhcCcccCCCC
Confidence            9999999999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=8.8e-26  Score=179.53  Aligned_cols=178  Identities=16%  Similarity=0.080  Sum_probs=120.9

Q ss_pred             ccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccc----------cCCCcchhHHHHHHhhCCCCCeeeee
Q 035861           13 FEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLE----------YGFPISSLREINILLSFDHPSIVNVK   82 (332)
Q Consensus        13 y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~   82 (332)
                      +.+.+.||+|+||+||+|.+. +|+.||||+++...........          .........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999984 6899999988643221111000          00011234578888899999988776


Q ss_pred             eeEEcCCCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCEEEcCCCcEEEeecc
Q 035861           83 EVVMDDHDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNQGVLKICDFG  162 (332)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~~~i~H~di~p~Nili~~~~~~~l~df~  162 (332)
                      +..  .   .+++||++++..       ...++...+..++.|++.+|++||++||+|+||||+|||++++ .++|+|||
T Consensus        81 ~~~--~---~~lvme~~~~~~-------~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          81 AWE--G---NAVLMELIDAKE-------LYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEE--T---TEEEEECCCCEE-------GGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             Eec--C---CEEEEEeecccc-------ccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            553  2   269999999853       2235667778899999999999999999999999999999965 58999999


Q ss_pred             cccccCCCCCCCccccccccccchhhhcCCCCCCchhHHHHHHHHH
Q 035861          163 MSRQYGSPLKPYTSLVVTLWYRAPELLLGAKKYSTAVDMWSVGCIM  208 (332)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l  208 (332)
                      .+...+.+..  ......-...-.+.+.  +.++.++|+||+.--+
T Consensus       148 ~a~~~~~~~~--~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGW--REILERDVRNIITYFS--RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTH--HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCc--HHHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence            9876542211  0000000000012222  4578889999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.67  E-value=4.9e-08  Score=79.61  Aligned_cols=141  Identities=16%  Similarity=0.152  Sum_probs=89.0

Q ss_pred             hhcccccccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCC-CCCeeeeeeeEEcC
Q 035861           10 VFEFEKLNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFD-HPSIVNVKEVVMDD   88 (332)
Q Consensus        10 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   88 (332)
                      +..|+..+..+.++.+.||++..  ++..+++|+.........        ..+..|...+..+. +--+..++... ++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~--------~~~~~E~~~l~~l~~~vpvP~vl~~~-~~   81 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFE-RH   81 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEE-EE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccch--------hhHHHHHHHHHHHhccCCCCcEEEEE-ec
Confidence            45777777766677789999864  366788888765433221        13457887776663 22234444444 44


Q ss_pred             CCeEEEEcccccccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 035861           89 HDSVYMVMEYMEHDLKWLMESMKQPFSTSEVKCLMLQLLEGVKYLHD---------------------------------  135 (332)
Q Consensus        89 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~i~~~l~~~L~~lh~---------------------------------  135 (332)
                      ++..++||++++|........     +......++.+++..++.||+                                 
T Consensus        82 ~~~~~lv~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             CCceEEEEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            477899999999854332211     111222334444455555553                                 


Q ss_pred             --------------------------CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 --------------------------NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 --------------------------~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                                                ..++|||+.|.||++++++.+-|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                      1278999999999999876667999997753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.22  E-value=1e-06  Score=75.95  Aligned_cols=82  Identities=17%  Similarity=0.181  Sum_probs=45.1

Q ss_pred             cccccccCcEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhC-C-CCC-eeeeeeeEEcCCCeE
Q 035861           16 LNKISEGTYGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSF-D-HPS-IVNVKEVVMDDHDSV   92 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~-h~~-i~~~~~~~~~~~~~~   92 (332)
                      .+.||.|....||++....+++.++||.-............ ....+...|.+.++.+ . .|. +..++. + +. ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-~-d~-~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFY-S-DT-EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ET-TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEE-E-cC-CCC
Confidence            45689999999999998777888999976432211100000 0011234678777766 2 233 333433 3 22 334


Q ss_pred             EEEcccccc
Q 035861           93 YMVMEYMEH  101 (332)
Q Consensus        93 ~lv~e~~~~  101 (332)
                      ++|||++++
T Consensus       107 ~lvmE~L~~  115 (392)
T d2pula1         107 VTVMEDLSH  115 (392)
T ss_dssp             EEEECCCTT
T ss_pred             EEEEeccCC
Confidence            689999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.12  E-value=4.2e-06  Score=67.40  Aligned_cols=72  Identities=13%  Similarity=0.103  Sum_probs=44.9

Q ss_pred             cccccC-cEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCC--eeeeeeeEEcCCCeEEE
Q 035861           18 KISEGT-YGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPS--IVNVKEVVMDDHDSVYM   94 (332)
Q Consensus        18 ~lg~g~-~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~l   94 (332)
                      .+..|. .+.||+.... .+..+++|.......           ..+..|...++.+....  +..++... .+.+..++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~-~~~~~~~~   83 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVV-TEAGRDWL   83 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEE-ECSSCEEE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH-----------hHHHHHHHHHHHHHhcCCCCCceeeec-ccccceEE
Confidence            334444 4689998764 466688887654321           13457888877663322  34445554 44577899


Q ss_pred             Eccccccc
Q 035861           95 VMEYMEHD  102 (332)
Q Consensus        95 v~e~~~~~  102 (332)
                      ||++++|.
T Consensus        84 v~~~i~G~   91 (255)
T d1nd4a_          84 LLGEVPGQ   91 (255)
T ss_dssp             EEECCSSE
T ss_pred             EEEeeecc
Confidence            99999873

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.40  E-value=0.00024  Score=60.74  Aligned_cols=71  Identities=14%  Similarity=0.173  Sum_probs=45.0

Q ss_pred             cccccccCcEEEEEEEECC-------CCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCee-eeeeeEEc
Q 035861           16 LNKISEGTYGIVYRARDKK-------SGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSIV-NVKEVVMD   87 (332)
Q Consensus        16 ~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~   87 (332)
                      ++.|+.|-...+|++....       .++.|++++.-...  ...        ...+|..+++.+.-.++. ++++.+ +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~i--------dr~~E~~i~~~ls~~gl~Pkll~~~-~  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TES--------HLVAESVIFTLLSERHLGPKLYGIF-S  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHH--------HHHHHHHHHHHHHHTTSSSCEEEEE-T
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhh--------HHHHHHHHHHHHHhCCCCCeEEEEc-C
Confidence            4678899999999998653       34567777765221  111        123688888777433443 455554 4


Q ss_pred             CCCeEEEEcccccc
Q 035861           88 DHDSVYMVMEYMEH  101 (332)
Q Consensus        88 ~~~~~~lv~e~~~~  101 (332)
                      +    .+|+||++|
T Consensus       116 ~----g~I~efi~g  125 (395)
T d1nw1a_         116 G----GRLEEYIPS  125 (395)
T ss_dssp             T----EEEECCCCE
T ss_pred             C----ceEEEEecc
Confidence            3    588999987

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00023  Score=59.22  Aligned_cols=68  Identities=13%  Similarity=0.184  Sum_probs=40.1

Q ss_pred             cEEEEEEEECCCCcEEEEEEeecccCCcccccccCCCcchhHHHHHHhhCCCCCe-----eeee-eeEEcCCCeEEEEcc
Q 035861           24 YGIVYRARDKKSGEIVALKKVKMNVGRKEDCLEYGFPISSLREINILLSFDHPSI-----VNVK-EVVMDDHDSVYMVME   97 (332)
Q Consensus        24 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~-~~~~~~~~~~~lv~e   97 (332)
                      ...||++... +|..+++|+.+.......         .+..|...+..|...++     +..- +.........+.+++
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~---------~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~  104 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERWTAD---------QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  104 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTSCHH---------HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCCCHH---------HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence            4689999773 588899999875433222         35567777766632222     1111 111123456788888


Q ss_pred             cccc
Q 035861           98 YMEH  101 (332)
Q Consensus        98 ~~~~  101 (332)
                      +++|
T Consensus       105 ~~~G  108 (325)
T d1zyla1         105 SVGG  108 (325)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            8876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.05  E-value=0.00012  Score=60.51  Aligned_cols=31  Identities=23%  Similarity=0.319  Sum_probs=27.4

Q ss_pred             CCcccccCCCCCEEEcCCCcEEEeecccccc
Q 035861          136 NWVLHRDLKTSNLLLNNQGVLKICDFGMSRQ  166 (332)
Q Consensus       136 ~~i~H~di~p~Nili~~~~~~~l~df~~~~~  166 (332)
                      .|++|||+.++||+++++...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4699999999999999987778999998753